PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Petrone, AB; Gionis, V; Giersch, R; Barr, TL				Petrone, Ashley B.; Gionis, Valerie; Giersch, Richard; Barr, Taura L.			Immune biomarkers for the diagnosis of mild traumatic brain injury	NEUROREHABILITATION			English	Article						Traumatic brain injury; inflammation; neutrophil-lymphocyte ratio	GENE-EXPRESSION; ISCHEMIC-STROKE	BACKGROUND: In 2010, there were approximately 2.2 million emergency room visits associated with traumatic brain injury (TBI), with 80 percent diagnosed as mild TBI or concussion. In addition, there are a large number of TBIs, especially mild TBIs, which go either unreported by patients or initially undiagnosed by clinicians. Our team has previously identified a panel of immune-related genes that can diagnose ischemic stroke at triage, and due to shared pathophysiological mechanisms of TBI and stroke, we hypothesized that this panel of genes may also be utilized for the diagnosis of TBI. OBJECTIVES: The primary aims of this pilot study were to: (1) characterize changes in a panel of immune-related genes in TBI; (2) identify immune-related biomarkers that may be used to diagnose TBI and (3) describe the peripheral immune response following TBI. METHODS: Blood was drawn from TBI patients no later than 24 h of injury onset and matched control subjects. Real-time PCR was used to measure gene expression, and a white blood cell differential was performed to obtain neutrophil and lymphocyte percentages. RESULTS: Relative mRNA expression of ARG1, LY96, MMP9, s100a12 was significantly increased and CCR7 was significantly decreased in peripheral blood of TBI patients within 24 hours of injury compared to control subjects. We also observed a different pattern of leukocyte dynamics following TBI between mild and severe TBI. CONCLUSIONS: We have described a panel of immune-related genes that can accurately predict/diagnose TBI with higher sensitivity and specificity of other biomarkers to date.	[Petrone, Ashley B.] West Virginia Univ, Dept Family Med, Morgantown, WV 26506 USA; [Petrone, Ashley B.] West Virginia Clin & Translat Sci Inst, Morgantown, WV USA; [Gionis, Valerie; Giersch, Richard; Barr, Taura L.] Valtari BioTM Inc, Morgantown, WV USA		Petrone, AB (corresponding author), One Med Ctr Dr,1387 Hlth Sci Ctr, Morgantown, WV 26506 USA.	abpetrone@wvumedicine.org			Robert Wood Johnson FoundationRobert Wood Johnson Foundation (RWJF) [70319]; Intramural NINR/NIH [HHSN263201100872P]; WVU Stroke COBRE Award Sub-Project [2P20 GM109098]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54GM104942] Funding Source: NIH RePORTER	The data in this manuscript was partially funded by a Robert Wood Johnson Foundation Nurse Faculty Scholar award to T. Barr ID: 70319, an Intramural NINR/NIH Contract ID: HHSN263201100872P to T. Barr and a WVU Stroke COBRE Award Sub-Project 2P20 GM109098 to T. Barr.	Al Nimer F, 2011, BRAIN BEHAV IMMUN, V25, P981, DOI 10.1016/j.bbi.2010.10.017; Barr TL, 2010, NEUROLOGY, V75, P1009, DOI 10.1212/WNL.0b013e3181f2b37f; Centers for Disease Control and Prevention (CDC), 2010, TRAUMATIC BRAIN INJU; Croall ID, 2014, NEUROLOGY, V83, P494, DOI 10.1212/WNL.0000000000000666; Dilektasli E, 2016, J TRAUMA ACUTE CARE, V81, P882, DOI 10.1097/TA.0000000000000980; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Guardado P, 2016, J ANXIETY DISORD, V38, P9, DOI 10.1016/j.janxdis.2015.12.004; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Kelso ML, 2014, CURR PHARM DESIGN, V20, P4284; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Lattanzi S, 2016, STROKE, V47, P1654, DOI 10.1161/STROKEAHA.116.013627; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Petrone AB, 2016, TRANSL STROKE RES, V7, P103, DOI 10.1007/s12975-015-0431-9; Souter MJ, 2015, NEUROCRIT CARE, V23, P4, DOI 10.1007/s12028-015-0137-6; Tang Y, 2006, J CEREBR BLOOD F MET, V26, P1089, DOI 10.1038/sj.jcbfm.9600264; Tobin RP, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0143-5	17	17	17	0	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2017	40	4					501	508		10.3233/NRE-171437			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EX7SC	WOS:000403447500005	28222567	Green Accepted			2022-02-06	
J	Pu, HJ; Jiang, XY; Wei, ZS; Hong, DD; Hassan, S; Zhang, WT; Liu, JL; Meng, HX; Shi, YJ; Chen, L; Chen, J				Pu, Hongjian; Jiang, Xiaoyan; Wei, Zhishuo; Hong, Dandan; Hassan, Sulaiman; Zhang, Wenting; Liu, Jialin; Meng, Hengxing; Shi, Yejie; Chen, Ling; Chen, Jun			Repetitive and Prolonged Omega-3 Fatty Acid Treatment After Traumatic Brain Injury Enhances Long-Term Tissue Restoration and Cognitive Recovery	CELL TRANSPLANTATION			English	Article; Proceedings Paper	23rd Annual Meeting of the American-Society-for-Neural-Therapy-and-Repair (ASNTR)	APR 29-30, 2016	Clearwater, FL	Amer Soc Neural Therapy & Repair		Omega-3 polyunsaturated fatty acid (n-3 PUFA); Water maze; Hippocampus; Angiogenesis; Oligodendrogenesis	POLYUNSATURATED FATTY-ACIDS; FOCAL CEREBRAL-ISCHEMIA; WHITE-MATTER INJURY; DOCOSAHEXAENOIC ACID; DIETARY SUPPLEMENTATION; NEUROGENESIS; THERAPIES; MECHANISMS; STROKE; PERFORMANCE	Traumatic brain injury (TBI) is one of the most disabling clinical conditions that could lead to neurocognitive disorders in survivors. Our group and others previously reported that prophylactic enrichment of dietary omega-3 polyunsaturated fatty acids (n-3 PUFAs) markedly ameliorate cognitive deficits after TBI. However, it remains unclear whether a clinically relevant therapeutic regimen with n-3 PUFAs administered after TBI would still offer significant improvement of long-term cognitive recovery. In the present study, we employed the decline of spatial cognitive function as a main outcome after TBI to investigate the therapeutic efficacy of post-TBI n-3 PUFA treatment and the underlying mechanisms. Mice were subjected to sham operation or controlled cortical impact, followed by random assignment to receive the following four treatments: (1) vehicle control; (2) daily intraperitoneal injections of n-3 PUFAs for 2 weeks, beginning 2 h after TBI; (3) fish oil dietary supplementation throughout the study, beginning 1 day after TBI; or (4) combination of treatments (2) and (3). Spatial cognitive deficits and chronic brain tissue loss, as well as endogenous brain repair processes such as neurogenesis, angiogenesis, and oligodendrogenesis, were evaluated up to 35 days after TBI. The results revealed prominent spatial cognitive deficits and massive tissue loss caused by TBI. Among all mice receiving post-TBI n-3 PUFA treatments, the combined treatment of fish oil dietary supplement and n-3 PUFA injections demonstrated a reproducible beneficial effect in attenuating cognitive deficits although without reducing gross tissue loss. Mechanistically, the combined treatment promoted post-TBI restorative processes in the brain, including generation of immature neurons, microvessels, and oligodendrocytes, each of which was significantly correlated with the improved cognitive recovery. These results indicated that repetitive and prolonged n-3 PUFA treatments after TBI are capable of enhancing brain remodeling and could be developed as a potential therapy to treat TBI victims in the clinic.	[Pu, Hongjian; Liu, Jialin; Meng, Hengxing; Chen, Ling] PLA, Gen Hosp, Dept Neurosurg, 28 Fuxing Rd, Beijing 100853, Peoples R China; [Pu, Hongjian; Jiang, Xiaoyan; Wei, Zhishuo; Hong, Dandan; Hassan, Sulaiman; Shi, Yejie; Chen, Jun] Univ Pittsburgh, Pittsburgh Inst Brain Disorders & Recovery, S507 Biomed Sci Tower,3500 Terrace St, Pittsburgh, PA 15213 USA; [Pu, Hongjian; Jiang, Xiaoyan; Wei, Zhishuo; Hong, Dandan; Hassan, Sulaiman; Shi, Yejie; Chen, Jun] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA; [Jiang, Xiaoyan; Zhang, Wenting; Chen, Jun] Fudan Univ, State Key Lab Med Neurobiol, Shanghai, Peoples R China; [Jiang, Xiaoyan; Zhang, Wenting; Chen, Jun] Fudan Univ, Inst Brain Sci, Shanghai, Peoples R China		Chen, L (corresponding author), PLA, Gen Hosp, Dept Neurosurg, 28 Fuxing Rd, Beijing 100853, Peoples R China.; Chen, J (corresponding author), Univ Pittsburgh, Pittsburgh Inst Brain Disorders & Recovery, S507 Biomed Sci Tower,3500 Terrace St, Pittsburgh, PA 15213 USA.	chen_ling301@163.com; chenj2@upmc.edu	Pu, Hongjian/AAW-3322-2020; Shi, Yejie/C-2355-2018	Shi, Yejie/0000-0001-7502-9201	US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS045048, NS095671, NS095029]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30970939, 81272804, 81529002, 81100978]; US Department of Veterans Affairs Senior Research Career Scientist AwardUS Department of Veterans Affairs; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS095671, R01NS095029, R01NS045048] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX003377] Funding Source: NIH RePORTER	This project was supported by the US National Institutes of Health grants NS045048, NS095671, and NS095029 (to J.C.), and the National Natural Science Foundation of China grants 30970939 and 81272804 (to L.C.), 81529002 (to J.C.), and 81100978 (to W.Z.). J.C. is also supported by the US Department of Veterans Affairs Senior Research Career Scientist Award. The authors are indebted to Pat Strickler for the excellent administrative support. J.C., L.C., and H.P. designed the research. H.P., X.J., Z.W., S.H., W.Z., J.L., and H.M. performed the research. X.J. and Y.S. analyzed the data. H.P., X.J., YS., D.H., and J.C. wrote the manuscript. All authors reviewed and approved the manuscript. The authors declare no conflicts of interest.	Bazan NG, 2006, TRENDS NEUROSCI, V29, P263, DOI 10.1016/j.tins.2006.03.005; Begum G, 2014, J NEUROSCI, V34, P3743, DOI 10.1523/JNEUROSCI.2872-13.2014; BLOCK F, 1993, NEUROSCI LETT, V149, P126, DOI 10.1016/0304-3940(93)90752-7; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chen JL, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00382; Chen SH, 2014, CELL TRANSPLANT, V23, P959, DOI 10.3727/096368913X667006; Dallerac G, 2016, PROG NEUROBIOL, V144, P48, DOI 10.1016/j.pneurobio.2016.01.003; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Dietrich WD, 2016, BRAIN RES, V1640, P94, DOI 10.1016/j.brainres.2015.12.034; El Waly B, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00145; Fancy SPJ, 2014, NAT NEUROSCI, V17, P506, DOI 10.1038/nn.3676; Franco R, 2015, PROG NEUROBIOL, V131, P65, DOI 10.1016/j.pneurobio.2015.05.003; Gao X, 2013, EXP NEUROL, V239, P38, DOI 10.1016/j.expneurol.2012.09.012; Gao X, 2009, EXP NEUROL, V219, P516, DOI 10.1016/j.expneurol.2009.07.007; Gibson CL, 2005, J CEREBR BLOOD F MET, V25, P431, DOI 10.1038/sj.jcbfm.9600033; Harvey LD, 2015, ASN NEURO, V7, DOI 10.1177/1759091415618969; Hasadsri L, 2013, J NEUROTRAUM, V30, P897, DOI 10.1089/neu.2012.2672; Hellewell S, 2016, BRAIN RES, V1640, P36, DOI 10.1016/j.brainres.2015.12.024; Hering H, 2003, J NEUROSCI, V23, P3262; Jiang XY, 2016, TRANSL STROKE RES, V7, P548, DOI 10.1007/s12975-016-0502-6; Kline AE, 2016, PROG NEUROBIOL, V142, P45, DOI 10.1016/j.pneurobio.2016.05.002; Kris-Etherton PM, 2000, AM J CLIN NUTR, V71, p179S, DOI 10.1093/ajcn/71.1.179S; Lazarov O, 2016, PROG NEUROBIOL, V138, P1, DOI 10.1016/j.pneurobio.2015.12.006; Lewis M, 2013, AM J EMERG MED, V31, DOI 10.1016/j.ajem.2012.05.014; Liu XF, 2014, PROG NEUROBIOL, V115, P92, DOI 10.1016/j.pneurobio.2013.11.007; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Mills JD, 2011, J NEUROSURG, V114, P77, DOI 10.3171/2010.5.JNS08914; OKADA M, 1995, J CEREBR BLOOD F MET, V15, P1012, DOI 10.1038/jcbfm.1995.127; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Patel K, 2016, BRAIN RES, V1640, P104, DOI 10.1016/j.brainres.2016.01.055; Prakash R, 2015, CURR OPIN NEUROL, V28, P556, DOI 10.1097/WCO.0000000000000248; Pu HJ, 2016, TRANSL STROKE RES, V7, P521, DOI 10.1007/s12975-016-0498-y; Pu HJ, 2013, J CEREBR BLOOD F MET, V33, P1474, DOI 10.1038/jcbfm.2013.108; Ren H, 2016, MOL NEUROBIOL; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Roberts L, 2008, J AM COLL SURGEONS, V207, P276, DOI 10.1016/j.jamcollsurg.2008.02.015; Rossi D, 2015, PROG NEUROBIOL, V130, P86, DOI 10.1016/j.pneurobio.2015.04.003; Shi H, 2015, EXP NEUROL, V272, P17, DOI 10.1016/j.expneurol.2015.03.017; Shin SS, 2011, NEUROSCI LETT, V496, P168, DOI 10.1016/j.neulet.2011.04.009; Silverberg ND, 2017, J NEUROTRAUM, V34, P363, DOI 10.1089/neu.2016.4443; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Verkhratsky A, 2016, PROG NEUROBIOL, V144, P188, DOI 10.1016/j.pneurobio.2015.09.003; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wang GH, 2015, P NATL ACAD SCI USA, V112, P2853, DOI 10.1073/pnas.1501441112; Wang GH, 2013, NEUROTHERAPEUTICS, V10, P124, DOI 10.1007/s13311-012-0157-2; Wang X, 2003, NEUROREPORT, V14, P2457, DOI 10.1097/00001756-200312190-00033; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Xiong Y, 2010, DISCOV MED, V10, P434; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Yonemori F, 1999, J CEREBR BLOOD F MET, V19, P483, DOI 10.1097/00004647-199905000-00002; Zhang WT, 2015, EXP NEUROL, V272, P170, DOI 10.1016/j.expneurol.2015.03.005; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4; Zuloaga KL, 2015, TRANSL STROKE RES, V6, P390, DOI 10.1007/s12975-015-0412-z	56	17	17	2	13	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0963-6897	1555-3892		CELL TRANSPLANT	Cell Transplant.		2017	26	4			SI		555	569		10.3727/096368916X693842			15	Cell & Tissue Engineering; Medicine, Research & Experimental; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Cell Biology; Research & Experimental Medicine; Transplantation	ET2SP	WOS:000400124700004	27938482	gold, Green Published, Green Accepted			2022-02-06	
J	Rigon, A; Voss, MW; Turkstra, LS; Mutlu, B; Duff, MC				Rigon, A.; Voss, M. W.; Turkstra, L. S.; Mutlu, B.; Duff, M. C.			Relationship between individual differences in functional connectivity and facial-emotion recognition abilities in adults with traumatic brain injury	NEUROIMAGE-CLINICAL			English	Article						Traumatic brain injury; Emotion recognition; Facial affect; Emotion labeling; Resting state; Network-based statistics	SOCIAL COMMUNICATION; WHITE-MATTER; STRUCTURAL CONNECTIVITY; INTRINSIC CONNECTIVITY; NEURAL SYSTEMS; AXONAL INJURY; HEAD-INJURY; NETWORKS; DEFICITS; PERCEPTION	Although several studies have demonstrated that facial-affect recognition impairment is common following moderate-severe traumatic brain injury (TBI), and that there are diffuse alterations in large-scale functional brain networks in TBI populations, little is known about the relationship between the two. Here, in a sample of 26 participants with TBI and 20 healthy comparison participants (HC) we measured facial-affect recognition abilities and resting-state functional connectivity (rs-FC) using fMRI. We then used network-based statistics to examine (A) the presence of rs-FC differences between individuals with TBI and HC within the facial-affect processing network, and (B) the association between inter-individual differences in emotion recognition skills and rs-FC within the facial-affect processing network. We found that participants with TBI showed significantly lower rs-FC in a component comprising homotopic and within-hemisphere, anterior-posterior connections with in the facial-affect processing network. In addition, within the TBI group, participants with higher emotion-labeling skills showed stronger rs-FC within a network comprised of intra-and inter-hemispheric bilateral connections. Findings indicate that the ability to successfully recognize facial-affect after TBI is related to rs-FC within components of facial-affective networks, and provide new evidence that further our understanding of the mechanisms underlying emotion recognition impairment in TBI. (C) 2016 The Authors. Published by Elsevier Inc.	[Rigon, A.; Voss, M. W.; Duff, M. C.] Univ Iowa, Interdisciplinary Neurosci Program, Iowa City, IA 52242 USA; [Voss, M. W.] Univ Iowa, Dept Psychol & Brain Sci, Iowa City, IA 52242 USA; [Turkstra, L. S.] Univ Wisconsin, Dept Commun Sci & Disorders, Madison, WI 53706 USA; [Turkstra, L. S.] Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA; [Mutlu, B.] Univ Wisconsin, Dept Comp Sci, Madison, WI 53706 USA; [Duff, M. C.] Univ Iowa, Dept Commun Sci & Disorders, Iowa City, IA 52242 USA; [Duff, M. C.] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA		Rigon, A (corresponding author), W506 Seashore Hall,328 Iowa Ave, Iowa City, IA 52242 USA.	Arianna-rigon@uiowa.edu	Turkstra, Lyn/ABC-5831-2021	Turkstra, Lyn/0000-0002-6948-6921	NICHD/NCMRRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD071089]; University of Iowa Magnetic Resonance Research Facilities; University of Iowa Graduate and Professional Student Government; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD071089] Funding Source: NIH RePORTER	This work was supported by NICHD/NCMRR grant R01 HD071089, the University of Iowa Magnetic Resonance Research Facilities and a research grant from the University of Iowa Graduate and Professional Student Government. The authors wish to thank Ruth Hanson, Katherine Jones and Kristina Warndahl for their help in scheduling participants.	ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Arenivas A, 2014, BRAIN IMAGING BEHAV, V8, P407, DOI 10.1007/s11682-012-9191-2; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Barbey AK, 2015, CURR OPIN BEHAV SCI, V4, P92, DOI 10.1016/j.cobeha.2015.04.002; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Bourke C, 2010, AUST NZ J PSYCHIAT, V44, P681, DOI 10.3109/00048674.2010.496359; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cox CL, 2012, SOC COGN AFFECT NEUR, V7, P727, DOI 10.1093/scan/nsr051; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; Demenescu LR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015058; FLEISS JL, 1983, J PERIODONTAL RES, V18, P601, DOI 10.1111/j.1600-0765.1983.tb00397.x; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Genova HM, 2015, SOC NEUROSCI-UK, V10, P27, DOI 10.1080/17470919.2014.959618; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Germine LT, 2011, PSYCHOL MED, V41, P937, DOI 10.1017/S0033291710001571; Graham D I, 1988, Prog Clin Biol Res, V264, P159; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Ham TE, 2014, BRAIN, V137, P586, DOI 10.1093/brain/awt350; Ham TE, 2012, CURR OPIN NEUROL, V25, P662, DOI 10.1097/WCO.0b013e328359488f; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Han K, 2016, J INT NEUROPSYCH SOC, V22, P263, DOI 10.1017/S1355617715001393; Hariri AR, 2002, NEUROIMAGE, V17, P317, DOI 10.1006/nimg.2002.1179; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Haxby JV, 2002, BIOL PSYCHIAT, V51, P59, DOI 10.1016/S0006-3223(01)01330-0; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Kennedy MRT, 2009, J INT NEUROPSYCH SOC, V15, P130, DOI 10.1017/S1355617708090024; Kessels RPC, 2014, J NEUROPSYCHOL, V8, P75, DOI 10.1111/jnp.12009; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Martins AT, 2012, NEURAL REGEN RES, V7, P101, DOI 10.3969/j.issn.1673-5374.2012.02.004; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Montagne B, 2007, PERCEPT MOTOR SKILL, V104, P589, DOI 10.2466/PMS.104.2.589-598; Montagne Barbara, 2005, Cogn Process, V6, P136, DOI 10.1007/s10339-005-0050-6; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Neumann D., 2015, BRAIN IMAGING BEHAV; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Palermo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068126; PETTERSEN L, 1991, PERCEPT MOTOR SKILL, V73, P1139, DOI 10.2466/PMS.73.8.1139-1150; Philippi CL, 2009, J NEUROSCI, V29, P15089, DOI 10.1523/JNEUROSCI.0796-09.2009; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Rigon A., 2016, COGN AFFECT BEHAV NE; Rigon A, 2016, J INT NEUROPSYCH SOC, V22, P705, DOI 10.1017/S1355617716000539; Rigon A, 2016, J NEUROTRAUM, V33, P977, DOI 10.1089/neu.2014.3847; Rosenberg H, 2014, J INT NEUROPSYCH SOC, V20, P994, DOI 10.1017/S1355617714000940; Sabatinelli D, 2007, J NEUROPHYSIOL, V98, P1374, DOI 10.1152/jn.00230.2007; Sabatinelli D, 2011, NEUROIMAGE, V54, P2524, DOI 10.1016/j.neuroimage.2010.10.011; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sours C, 2014, BRAIN IMAGING BEHAV; Spikman JM, 2013, NEUROPSYCHOL REHABIL, V23, P824, DOI 10.1080/09602011.2013.826138; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Tamamiya Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057325; Watts AJ, 2006, APHASIOLOGY, V20, P707, DOI 10.1080/02687030500489953; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104; Zalesky A, 2012, NEUROIMAGE, V60, P1055, DOI 10.1016/j.neuroimage.2012.01.068; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zar, 1996, BIOSTAT ANAL	71	17	17	1	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2017	13						370	377		10.1016/j.nicl.2016.12.010			8	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EV0FK	WOS:000401413700043	28123948	Green Published, gold			2022-02-06	
J	Schiehser, DM; Delano-Wood, L; Jak, AJ; Hanson, KL; Sorg, SF; Orff, H; Clark, AL				Schiehser, Dawn M.; Delano-Wood, Lisa; Jak, Amy J.; Hanson, Karen L.; Sorg, Scott F.; Orff, Henry; Clark, Alexandra L.			Predictors of cognitive and physical fatigue in post-acute mild-moderate traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Post-traumatic fatigue; traumatic brain injury; psychiatric symptoms; sleep quality; cognition	1ST 2 YEARS; QUALITY-OF-LIFE; MENTAL FATIGUE; IMPACT SCALE; INVENTORY; SLEEP; IDENTIFICATION; VALIDATION; DEPRESSION; SYMPTOMS	Post-traumatic fatigue (PTF) is a common, disabling, and often chronic symptom following traumatic brain injury (TBI). Yet, the impact of chronic cognitive and physical fatigue and their associations with psychiatric, sleep, cognitive, and psychosocial sequelae in mild-moderate TBI remain poorly understood. Sixty Veterans with a history of mild-moderate TBI and 40 Veteran controls (VC) were administered the Modified Fatigue Impact Scale, a validated measure of TBI-related cognitive and physical fatigue as well as measures of neuropsychiatric, psychosocial, sleep, and objective cognitive functioning. Compared to VC, TBI Veterans endorsed significantly greater levels of cognitive and physical fatigue. In TBI, psychiatric symptoms, sleep disturbance, and post-traumatic amnesia (PTA) were associated with both cognitive and physical fatigue, while loss of consciousness (LOC) and poor attention/processing speed were related to elevations in cognitive fatigue only. In regression analyses, anxiety, sleep disturbance, and LOC significantly predicted cognitive fatigue, while only post-traumatic stress symptoms and PTA contributed to physical fatigue. Cognitive and physical fatigue are problematic symptoms following mild-moderate TBI that are differentially associated with specific injury and psychiatric sequelae. Findings provide potential symptom targets for interventions aimed at ameliorating fatigue, and further underscore the importance of assessing and treating fatigue as a multi-dimensional symptom following TBI.	[Schiehser, Dawn M.; Delano-Wood, Lisa; Jak, Amy J.; Hanson, Karen L.; Sorg, Scott F.; Orff, Henry] VA San Diego Healthcare Syst VASDHS, Res & Psychol Serv, 3350 La Jolla Village Dr, San Diego, CA 92161 USA; [Schiehser, Dawn M.; Delano-Wood, Lisa; Jak, Amy J.; Hanson, Karen L.; Orff, Henry] Univ Calif San Diego, Sch Med, Dept Psychiat, 3350 La Jolla Village Dr, San Diego, CA 92161 USA; [Schiehser, Dawn M.; Delano-Wood, Lisa; Jak, Amy J.; Hanson, Karen L.; Orff, Henry] VASDHS, Ctr Excellence Stress & Mental Hlth, 3350 La Jolla Village Dr,151B, San Diego, CA 92161 USA; [Clark, Alexandra L.] Univ Calif San Diego, San Diego State Univ Joint Doctoral Program Clin, San Diego, CA 92103 USA		Schiehser, DM (corresponding author), Univ Calif San Diego, Sch Med, Dept Psychiat, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.; Schiehser, DM (corresponding author), VASDHS, Ctr Excellence Stress & Mental Hlth, 3350 La Jolla Village Dr,151B, San Diego, CA 92161 USA.	dschiehser@ucsd.edu			Department of Veterans Affairs, Veterans Health Administration, Office of Research and DevelopmentUS Department of Veterans Affairs [VA CSRD CDA-2-065-S, CX000842-01A2, 829-CDMH-13858]; Department of DefenseUnited States Department of Defense [W81XWH-10-2-0169]; Veterans AffairsUS Department of Veterans Affairs [IK2RX001512] Funding Source: NIH RePORTER	This work was supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development [VA CSR&D CDA-2-065-S (DMS)], [CX000842-01A2 & 829-CDMH-13858 (LDW)]; and the Department of Defense [LDW: W81XWH-10-2-0169].	Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Babor T.F., 2001, AUDIT THE ALCOHOL US; Bay E, 2011, J HEAD TRAUMA REHAB, V26, P355, DOI 10.1097/HTR.0b013e3181f20146; Beaulieu-Bonneau S, 2012, SLEEP MED, V13, P598, DOI 10.1016/j.sleep.2012.02.010; Beck A., 1996, MANUAL BDI 2; BECK AT, 1991, J ANXIETY DISORD, V5, P213, DOI 10.1016/0887-6185(91)90002-B; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Belmont A, 2009, NEUROREHAB NEURAL RE, V23, P939, DOI 10.1177/1545968309340327; Brouwer W., 1984, RIDDLES SELECTIVITY; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bryce S., 2015, SCREENING SUBSTANCE; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Cantor JB, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e318270f91e; Chaudhuri A, 2000, J NEUROL SCI, V179, P34, DOI 10.1016/S0022-510X(00)00411-1; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Clark A. L., 2016, BRAIN IMAGING BEHAV; Defense and Veterans Brain Injury Center, 2015, DOD WORLDW NUMB TBI; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; DeLuca J, 2005, ISS CLIN COGN NEUROP, P1; Englander J, 2010, BRAIN INJURY, V24, P1379, DOI 10.3109/02699052.2010.523041; Feinstein A, 2000, BRAIN COGNITION, V44, P78; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; Johansson B, 2015, NEUROREHABILITATION, V36, P195, DOI 10.3233/NRE-151207; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Keller-Ross ML, 2014, MED SCI SPORT EXER, V46, P1302, DOI 10.1249/MSS.0000000000000244; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; Management of Concussion/mTBI Working Group, 2009, VA DOD CLIN PRACT GU; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Preston J, 2014, CONSUMERS GUIDE PSYC; Riese H, 1999, NEUROPSYCHOL REHABIL, V9, P189, DOI 10.1080/713755600; Schiehser DM, 2015, J HEAD TRAUMA REHAB, V30, pE21, DOI 10.1097/HTR.0000000000000065; Schiehser DM, 2015, J HEAD TRAUMA REHAB, V30, P116, DOI 10.1097/HTR.0000000000000019; Schnieders J, 2012, J HEAD TRAUMA REHAB, V27, P404, DOI 10.1097/HTR.0b013e3182306341; Siegert RJ, 2009, J INT NEUROPSYCH SOC, V15, P142, DOI 10.1017/S1355617708090048; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; Steer, 1990, MANUAL BECK ANXIETY; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Vanderploeg RD, 2012, J REHABIL RES DEV, V49, P545, DOI 10.1682/JRRD.2011.04.0069; Weathers F. W., 1991, PCLBULLETM DSMBULLET; Wechsler D., 2008, WECHSLER ADULT INTEL; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Ziino C, 2006, J INT NEUROPSYCH SOC, V12, P100, DOI 10.1017/S1355617706060139; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383	50	17	17	1	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2017	27	7					1031	1046		10.1080/09602011.2016.1215999			16	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	FB4WK	WOS:000406142500004	27535726				2022-02-06	
J	Simon, M; Maerlender, A; Metzger, K; Decoster, L; Hollingworth, A; McLeod, TV				Simon, Madeline; Maerlender, Arthur; Metzger, Katelyn; Decoster, Laura; Hollingworth, Amy; McLeod, Tamara Valovich			Reliability and Concurrent Validity of Select C3 Logix Test Components	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							CONCUSSION; SPORTS; ASSOCIATION; STATEMENT; STABILITY	We sought to investigate the one-week and within-session reliability of the instrumented balance error scoring system test and the concurrent validity/one-week reliability of two neurocognitive assessments available through C3 Logix. (n = 37) Participants completed two balance error scoring system tests separated by the Trails A, Trails B, and Symbol Digit Modality test available through C3 Logix, and with paper and pencil. We found that the instrumented balance error scoring system test demonstrated strong one-week reliability and that neuropsychological tests available through C3 Logix show acceptable concurrent validity with standard (comparable) paper and pencil measures.	[Simon, Madeline; Metzger, Katelyn; Decoster, Laura; Hollingworth, Amy] New Hampshire Musculoskeletal Inst, 35 Kosciuszko St, Manchester, NH 03101 USA; [Maerlender, Arthur] Univ Nebraska Lincoln, Ctr Brain Biol & Behav, Lincoln, NE USA; [McLeod, Tamara Valovich] AT Still Univ, Athlet Training Programs, Mesa, AZ USA; [McLeod, Tamara Valovich] AT Still Univ, Sch Osteopath Med, Mesa, AZ USA		Simon, M (corresponding author), New Hampshire Musculoskeletal Inst, 35 Kosciuszko St, Manchester, NH 03101 USA.	mtsimon45@hotmail.com	Valovich McLeod, Tamara/AAU-9435-2020	Valovich McLeod, Tamara/0000-0001-9082-8722			Alberts JL, 2015, J ATHL TRAINING, V50, P578, DOI 10.4085/1062-6050-50.2.01; Amin DJ, 2014, J SPORTS SCI, V2, P200, DOI DOI 10.17265/2332-7839/2014.04.005; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; BARTH JT, 1989, MILD HEAD INJURY SPO, V1, P257; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brown HJ, 2014, MED SCI SPORT EXER, V46, P1610, DOI 10.1249/MSS.0000000000000263; Cantu Robert C, 2006, Neurosurg Focus, V21, pE3; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; Coppel DB, 2011, PHYS MED REH CLIN N, V22, P653, DOI 10.1016/j.pmr.2011.08.006; COPPEL DB, 2011, PHYS MED REHABILITAT, V22, pR8; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Hansen C, 2016, CLIN J SPORT MED, V26, P497, DOI 10.1097/JSM.0000000000000285; Kushner DS, 2001, AM FAM PHYSICIAN, V64, P1007; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; MCCRORY P, 2009, J SCI MED SPORT, V16, P83; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Mihalik JP, 2013, CLIN J SPORT MED, V23, P343, DOI 10.1097/JSM.0b013e318295a834; Nanda Anil, 2012, J La State Med Soc, V164, P246; Reitan RM, 1992, TRAIL MAKING TEST; Schatz P, 2003, APPL NEUROPSYCHOL, V10, P42, DOI 10.1207/S15324826AN1001_6; Silverberg ND, 2016, CLIN J SPORT MED, V26, P226, DOI 10.1097/JSM.0000000000000241; Siu KC, 2015, J AGROMEDICINE, V20, P327, DOI 10.1080/1059924X.2015.1042615; Smith A., 1982, SYMBOL DIGIT MODALIT; STEFANSKY W, 1972, J TECHNOMETRICS, V14, P469; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677	30	17	17	0	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.		2017	42	7-8					446	459		10.1080/87565641.2017.1383994			14	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	FY5WP	WOS:000426908800002	29068702	Green Published			2022-02-06	
S	Snow, P; Douglas, J		Cummings, L		Snow, Pamela; Douglas, Jacinta			Psychosocial Aspects of Pragmatic Disorders	RESEARCH IN CLINICAL PRAGMATICS	Perspectives in Pragmatics Philosophy and Psychology		English	Article; Book Chapter						Community integration; Employment; Friendship; Pragmatics; Psychosocial functioning; Restorative justice; School exclusion; Social relationship; Youth justice	TRAUMATIC BRAIN-INJURY; ORAL LANGUAGE COMPETENCE; SOCIAL COMMUNICATION; POSTSTROKE DEPRESSION; JUVENILE-OFFENDERS; COCHLEAR IMPLANTS; DEMENTIA PATIENTS; MARITAL QUALITY; MENTAL-HEALTH; CHILDREN	This chapter considers the everyday psychological and social costs attached to having pragmatic language difficulties. We briefly review key terminology concerning pragmatic language functions, before summarizing features of pragmatic language difficulties that occur in both the developmental period (e.g. associated with language impairment, autism spectrum disorder, hearing impairment, traumatic brain injury, intellectual disability) and in adulthood (e.g. in fronto-temporal dementia, aphasia, and Alzheimer's disease). We present a schematic model as a means of conceptualizing the elements of pragmatic language competence and its inverse, pragmatic language difficulties, within the broader psycho-social context. We argue that psychological factors such as coping style and self-efficacy for communication need to be considered alongside social factors (such as cultural mores and everyday communication contexts) if the true impact of pragmatic language difficulties is to be both documented and adequately addressed when interventions for affected individuals are designed, implemented, and evaluated.	[Snow, Pamela] La Trobe Univ, La Trobe Rural Hlth Sch, Bendigo, Vic, Australia; [Douglas, Jacinta] La Trobe Univ, Sch Allied Hlth, Melbourne, Vic, Australia		Snow, P (corresponding author), La Trobe Univ, La Trobe Rural Hlth Sch, Bendigo, Vic, Australia.	p.snow@latrobe.edu.au; j.douglas@latrobe.edu.au		Snow, Pamela/0000-0002-2426-8349			American Pshychiatric Association, 2013, DIAGN STAT MAN MENT; Anti-Bullying Network, 2016, INF CIRCL TIM; Australian Institute of Health and Welfare, 2008, DISABILITY AUSTR INT, V67; Ayerbe L, 2011, STROKE, V42, P1907, DOI 10.1161/STROKEAHA.110.605808; Bakas T, 2006, REHABIL NURS, V31, P33, DOI 10.1002/j.2048-7940.2006.tb00008.x; Barry S. S., 2000, ADV SPEECH LANGUAGE, V2, P77, DOI DOI 10.3109/14417040008996793; Baseman S, 2010, J NEUROSCI NURS, V42, P237, DOI 10.1097/JNN.0b013e3181ecafea; Beitchman J., 2014, 0ANGUAGE DISORDERS C; Bishop DVM, 2014, INT J LANG COMM DIS, V49, P381, DOI 10.1111/1460-6984.12101; Bittner R., 2006, BRAIN INJURY, V21, P971; Blieszner R, 2010, GERONTOLOGIST, V50, P11, DOI 10.1093/geront/gnp068; Blonder LX, 2012, J CLIN EXP NEUROPSYC, V34, P634, DOI 10.1080/13803395.2012.667069; Bogart E, 2012, BRAIN INJURY, V26, P221, DOI 10.3109/02699052.2011.648711; Boylstein C, 2012, J FAM ISSUES, V33, P584, DOI 10.1177/0192513X11416449; Bracy C., 2005, BRAIN IMPAIR, V6, P1, DOI DOI 10.1375/brim.6.1.1.65476; Braun M, 2009, AGING MENT HEALTH, V13, P426, DOI 10.1080/13607860902879441; Brinton B, 2015, LANG SPEECH HEAR SER, V46, P325, DOI 10.1044/2015_LSHSS-14-0096; Broderick A, 2005, THEOR PRACT, V44, P194, DOI 10.1207/s15430421tip4403_3; Bryan K, 2004, INT J LANG COMM DIS, V39, P391, DOI 10.1080/13682820410001666376; Bryan K, 2007, INT J LANG COMM DIS, V42, P505, DOI 10.1080/13682820601053977; Burleson BR., 1992, S J COMMUN, V57, P260, DOI DOI 10.1080/10417949209372873; Burnett N., 2015, RESTORATIVE PRACTICE; Camarata SM, 1999, MENT RETARD DEV D R, V5, P207, DOI 10.1002/(SICI)1098-2779(1999)5:3<207::AID-MRDD7>3.0.CO;2-O; Channon Shelley, 2003, Cogn Neuropsychiatry, V8, P243, DOI 10.1080/135468000344000002; Christle C, 2005, EXCEPTIONALITY, V13, P69, DOI DOI 10.1207/S15327035EX1302_2; Clare L, 2012, ALZ DIS ASSOC DIS, V26, P148, DOI 10.1097/WAD.0b013e318221ba23; Cohen N, 2001, LANGUAGE IMPAIRMENT; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037//0033-2909.98.2.310; Cohen S, 1997, JAMA-J AM MED ASSOC, V277, P1940; Cohen S, 2009, PERSPECT PSYCHOL SCI, V4, P375, DOI 10.1111/j.1745-6924.2009.01141.x; Cornelius-White J. H., 2010, LEARNER CENTERED INS; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Davidson JRT, 2008, J ALTERN COMPLEM MED, V14, P795, DOI 10.1089/acm.2008.0213; de Vugt ME, 2013, PROG NEUROBIOL, V110, P54, DOI 10.1016/j.pneurobio.2013.04.005; de Vugt ME, 2003, INT J GERIATR PSYCH, V18, P149, DOI 10.1002/gps.807; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Donnellan C, 2010, INT J GERIATR PSYCH, V25, P1288, DOI 10.1002/gps.2482; Douglas J., 2016, J SPEECH LA IN PRESS; Douglas J, 2015, INT J SPEECH-LANG PA, V17, P199, DOI 10.3109/17549507.2015.1016113; Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Douglas JM, 2013, BRAIN INJURY, V27, P60, DOI 10.3109/02699052.2012.722254; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; Duck S., 1988, RELATING TO OTHERS; Dunn M., 1995, J SPEECH LANG HEAR R, V39, P643; Ebbels S, 2014, INT J LANG COMM DIS, V49, P377, DOI 10.1111/1460-6984.12119; Eloniemi-Sulkava U, 2002, INT PSYCHOGERIATR, V14, P47, DOI 10.1017/S104161020200827X; Finestack LH, 2012, AM J SPEECH-LANG PAT, V21, P29, DOI 10.1044/1058-0360(2011/10-0095); Frank L, 2006, INT PSYCHOGERIATR, V18, P151, DOI 10.1017/S1041610205002450; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Garand L, 2007, WESTERN J NURS RES, V29, P976, DOI 10.1177/0193945907303086; Gill CJ, 2011, J HEAD TRAUMA REHAB, V26, P56, DOI 10.1097/HTR.0b013e3182048ee9; Gillies B, 2012, DEMENTIA-LONDON, V11, P657, DOI 10.1177/1471301211421262; Godwin E, 2014, BRAIN INJURY, V28, P398, DOI 10.3109/02699052.2014.880514; Goodwin RD, 2008, J GERIATR PSYCH NEUR, V21, P41, DOI 10.1177/0891988707311041; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Grawburg M, 2013, DISABIL REHABIL, V35, P1324, DOI 10.3109/09638288.2012.735341; Green BC, 2014, INT J LANG COMM DIS, V49, P15, DOI 10.1111/1460-6984.12056; Grice H. P., 1975, SYNTAX SEMANTICS, P41; Hackett ML, 2005, STROKE, V36, P2296, DOI 10.1161/01.STR.0000183622.75135.a4; Hale CM, 2005, AUTISM, V9, P157, DOI 10.1177/1362361305051395; Harciarek M, 2014, APHASIOLOGY, V28, P964, DOI 10.1080/02687038.2014.904498; Hay E, 2005, AM J SPEECH-LANG PAT, V14, P324, DOI 10.1044/1058-0360(2005/031); Hemphill SA, 2014, CHILD YOUTH SERV REV, V36, P187, DOI 10.1016/j.childyouth.2013.11.022; Hilari K, 2010, CLIN REHABIL, V24, P181, DOI 10.1177/0269215509346090; Hofgren C, 2010, WORK, V36, P431, DOI 10.3233/WOR-2010-1039; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Hurley AD, 2006, CURR OPIN PSYCHIATR, V19, P465, DOI 10.1097/01.yco.0000238471.84206.0a; Huttenen K., 2010, CLIN LINGUIST PHONET, V26, P833; Jetten J., 2012, SOCIAL CURE IDENTITY; Karlovits T, 1999, BRAIN INJURY, V13, P845; KINSELLA GJ, 1979, SCAND J REHABIL MED, V11, P129; Klusek J, 2014, J SPEECH LANG HEAR R, V57, P1692, DOI 10.1044/2014_JSLHR-L-13-0064; Knopman DS, 2011, J MOL NEUROSCI, V45, P330, DOI 10.1007/s12031-011-9538-y; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Lemieux L, 2001, SEX DISABIL, V19, P253, DOI 10.1023/A:1017953308761; Lindsay G, 2012, LANG SPEECH HEAR SER, V43, P445, DOI 10.1044/0161-1461(2012/11-0069); Lum JAG, 2015, J SPEECH LANG HEAR R, V58, P961, DOI 10.1044/2015_JSLHR-L-14-0056; Mackay J., 2004, ATLAS HEART DIS STRO; Martin GE, 2009, TOP LANG DISORD, V29, P112, DOI 10.1097/TLD.0b013e3181a71fe1; Massimo L, 2013, GERIATR NURS, V34, P302, DOI 10.1016/j.gerinurse.2013.05.001; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; Most T, 2010, J DEAF STUD DEAF EDU, V15, P422, DOI 10.1093/deafed/enq032; Mounce L., 2012, NOBODY MADE CONNECTI; National Institute of Neurological Disorders and Stroke, 2011, TRAUM BRAIN INJ; Nickels L, 2014, APHASIOLOGY, V28, P885, DOI 10.1080/02687038.2014.933521; Nussbaum JF., 1994, INTERPERSONAL COMMUN, P209; OFlaherty CA, 1997, APHASIOLOGY, V11, P889, DOI 10.1080/02687039708250463; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ouimet MA, 2001, CAN J PSYCHIAT, V46, P819, DOI 10.1177/070674370104600905; Ownsworth T, 2006, REHABIL PSYCHOL, V51, P50, DOI 10.1037/0090-5550.51.1.50; Paterson J., 2002, REHABIL NURS, V27, P13, DOI DOI 10.1002/J.2048-7940.2002.TB01973.X; PAUL R, 2011, LANGUAGE DISORDERS I; Perlman D., 2008, INTIMATE RELATIONSHI; Peterson CC, 2004, J CHILD PSYCHOL PSYC, V45, P1096, DOI 10.1111/j.1469-7610.2004.t01-1-00302.x; Ponsford J., 2013, TRAUMATIC BRAIN INJU, P291; Pound P, 1998, CLIN REHABIL, V12, P338, DOI 10.1191/026921598677661555; Pozzebon M, 2016, INT PSYCHOGERIATR, V28, P537, DOI 10.1017/S1041610215002239; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P567, DOI 10.1080/13803390500434466; Reilly S, 2014, INT J LANG COMM DIS, V49, P416, DOI 10.1111/1460-6984.12102; Rice ML, 2008, J SPEECH LANG HEAR R, V51, P394, DOI 10.1044/1092-4388(2008/029); Rogge RD, 1999, J CONSULT CLIN PSYCH, V67, P340, DOI 10.1037/0022-006X.67.3.340; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rutledge T, 2008, PSYCHOSOM MED, V70, P282, DOI 10.1097/PSY.0b013e3181656e09; Sanger D., 2001, COMMUN DISORD Q, V23, P17, DOI [10.1177/152574010102300104., DOI 10.1177/152574010102300104, 10.1177/152574010102300104]; Schorr E. A., 2008, COMMUN DISORDERS Q, V29, P195, DOI 10.1177/1525740108321217; Schrauf R. W., 2014, DIALOGUE DEMENTIA CO, P27; Sherer M, 2008, ARCH PHYS MED REHAB, V89, P42, DOI 10.1016/j.apmr.2007.08.128; Sherron P., 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [DOI 10.1097/00001199-199109000-00004, https://doi.org/10.1097/00001199-199109000-00004]; Shorland J, 2010, BRAIN INJURY, V24, P569, DOI 10.3109/02699051003610441; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Snow P, 1997, BRAIN INJURY, V11, P409; Snow PC, 2008, CHILD SOC, V22, P16, DOI 10.1111/j.1099-0860.2006.00076.x; Snow PC, 2016, INT J SPEECH-LANG PA, V18, P20, DOI 10.3109/17549507.2015.1081291; Snow PC, 2011, INT J SPEECH-LANG PA, V13, P480, DOI 10.3109/17549507.2011.578661; Snow PC, 2011, INT J LANG COMM DIS, V46, P324, DOI 10.3109/13682822.2010.496763; Snow PC, 2009, INT J SPEECH-LANG PA, V11, P95, DOI 10.1080/17549500802415712; St Clair MC, 2011, J COMMUN DISORD, V44, P186, DOI 10.1016/j.jcomdis.2010.09.004; Stewart A, 2002, PATHWAYS CHILD MALTR; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P4, DOI 10.1097/HTR.0b013e3182048e98; Sullivan JR, 2010, APPL NEUROPSYCHOL, V17, P93, DOI 10.1080/09084281003708852; Tarolla SM, 2002, AGGRESS VIOLENT BEH, V7, P125, DOI 10.1016/S1359-1789(00)00041-0; Turkstra L., 1995, BRAIN INJURY, V10, P319; Turkstra Lyn S., 2005, Seminars in Speech and Language, V26, P215, DOI 10.1055/s-2005-922101; Umberson D, 2006, J HEALTH SOC BEHAV, V47, P1, DOI 10.1177/002214650604700101; Wang YT, 2005, FOLIA PHONIATR LOGO, V57, P59, DOI 10.1159/000083569; Weissman M.M., 2000, COMPREHENSIVE GUIDE; WHELDALL K, 1988, EDUC REV, V40, P13, DOI 10.1080/0013191880400102; White CL, 2003, RES NURS HEALTH, V26, P177, DOI 10.1002/nur.10084; White P, 2005, AUST NZ J PSYCHIAT, V39, P395, DOI 10.1111/j.1440-1614.2005.01587.x; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Willmott P., 1987, FRIENDSHIP NETWORKS	138	17	17	4	8	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	2214-3807		978-3-319-47489-2; 978-3-319-47487-8	PERSP PRAGMAT PHILO			2017	11						617	649		10.1007/978-3-319-47489-2_23	10.1007/978-3-319-47489-2		33	Audiology & Speech-Language Pathology; Communication; Linguistics; Rehabilitation	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Audiology & Speech-Language Pathology; Communication; Linguistics; Rehabilitation	BI8BR	WOS:000414965000024					2022-02-06	
J	Sullivan, GM; Armstrong, RC				Sullivan, Genevieve M.; Armstrong, Regina C.			Transplanted Adult Neural Stem Cells Express Sonic Hedgehog In Vivo and Suppress White Matter Neuroinflammation after Experimental Traumatic Brain Injury	STEM CELLS INTERNATIONAL			English	Article							OLIGODENDROCYTE LINEAGE; ASTROCYTES; DIFFERENTIATION	Neural stem cells (NSCs) delivered intraventricularly may be therapeutic for diffuse white matter pathology after traumatic brain injury (TBI). To test this concept, NSCs isolated from adult mouse subventricular zone (SVZ) were transplanted into the lateral ventricle of adult mice at two weeks post-TBI followed by analysis at four weeks post-TBI. We examined sonic hedgehog (Shh) signaling as a candidate mechanism by which transplanted NSCs may regulate neuroregeneration and/or neuroinflammation responses of endogenous cells. Mouse fluorescent reporter lines were generated to enable in vivo genetic labeling of cells actively transcribing Shh or Gli1 after transplantation and/or TBI. Gli1 transcription is an effective readout for canonical Shh signaling. In Shh(CreERT2); R26tdTomato mice, Shh was primarily expressed in neurons and was not upregulated in reactive astrocytes or microglia after TBI. Corroborating results in Gli1(CreERT2); R26tdTomato mice demonstrated that Shh signaling was not upregulated in the corpus callosum, even after TBI or NSC transplantation. Transplanted NSCs expressed Shh in vivo but did not increase Gli1 labeling of host SVZ cells. Importantly, NSC transplantation significantly reduced reactive astrogliosis and microglial/macrophage activation in the corpus callosum after TBI. Therefore, intraventricular NSC transplantation after TBI significantly attenuated neuroinflammation, but did not activate host Shh signaling via Gli1 transcription.	[Sullivan, Genevieve M.; Armstrong, Regina C.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Sullivan, Genevieve M.; Armstrong, Regina C.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA		Armstrong, RC (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.; Armstrong, RC (corresponding author), Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	regina.armstrong@usuhs.edu	Sullivan, Genevieve/AAK-7415-2021	Sullivan, Genevieve/0000-0002-3561-223X; Armstrong, Regina/0000-0001-7296-6750	Department of Defense in the Center for Neuroscience and Regenerative Medicine (CNRM)	This work was funded by the Department of Defense in the Center for Neuroscience and Regenerative Medicine (CNRM). The authors appreciate the technical assistance of Tuan Le and Laurel Beer. The authors thank Dr. Sohyun Ahn ( National Institute for Child Health, Bethesda, MD) for providing the Gli1<SUP>CreERT2</SUP>; R26YFP and Gli1<SUP>CreERT2</SUP>; R26td-Tomato mice and Dr. Sharon Juliano for providing the C57BL/6-Tg(UBC-GFP) 30Scha/J mice.	Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Alvarez-Buylla A, 2014, SEMIN CELL DEV BIOL, V33, P105, DOI 10.1016/j.semcdb.2014.05.008; Armstrong RC, 2002, J NEUROSCI, V22, P8574; Brennan D, 2012, VITAM HORM, V88, P55, DOI 10.1016/B978-0-12-394622-5.00003-1; Martinez MC, 2006, BLOOD, V108, P3012, DOI 10.1182/blood-2006-04-019109; Dobson NR, 2012, GLIA, V60, P1378, DOI 10.1002/glia.22356; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Donega M., 2014, J VISUALIZED EXPT, V86; Drago D, 2013, BIOCHIMIE, V95, P2271, DOI 10.1016/j.biochi.2013.06.020; Einstein O, 2009, J NEUROSCI, V29, P15694, DOI 10.1523/JNEUROSCI.3364-09.2009; Farmer WT, 2016, SCIENCE, V351, P849, DOI 10.1126/science.aab3103; Ferent J, 2013, J NEUROSCI, V33, P1759, DOI 10.1523/JNEUROSCI.3334-12.2013; Garcia ADR, 2010, J NEUROSCI, V30, P13597, DOI 10.1523/JNEUROSCI.0830-10.2010; Giusto E, 2014, EXP NEUROL, V260, P19, DOI 10.1016/j.expneurol.2013.03.009; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Harwell CC, 2012, NEURON, V73, P1116, DOI 10.1016/j.neuron.2012.02.009; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Ihrie RA, 2011, NEURON, V71, P250, DOI 10.1016/j.neuron.2011.05.018; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Margulies S, 2016, J NEUROTRAUM, V33, P101, DOI 10.1089/neu.2014.3855; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Mierzwa AJ, 2014, ASN NEURO, V6, DOI 10.1177/1759091414551782; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Palma V, 2005, DEVELOPMENT, V132, P335, DOI 10.1242/dev.01567; Petrova R, 2013, J NEUROSCI, V33, P17490, DOI 10.1523/JNEUROSCI.2042-13.2013; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Rafuse VF, 2005, NEUROSCIENCE, V131, P899, DOI 10.1016/j.neuroscience.2004.11.048; Robbins DJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002906; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Samanta J, 2015, NATURE, V526, P448, DOI 10.1038/nature14957; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sirko S, 2013, CELL STEM CELL, V12, P426, DOI 10.1016/j.stem.2013.01.019; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sullivan GM, 2013, J NEUROPATH EXP NEUR, V72, P1106, DOI 10.1097/NEN.0000000000000009; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Zhang XL, 2013, J IMMUNOL, V191, P4551, DOI 10.4049/jimmunol.1300931; Zhou Q, 2011, NEUROSCI LETT, V500, P202, DOI 10.1016/j.neulet.2011.06.037; Zhou Q, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-50	42	17	17	1	2	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1687-966X	1687-9678		STEM CELLS INT	Stem Cells Int.		2017	2017								9342534	10.1155/2017/9342534			16	Cell & Tissue Engineering	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	FF8XV	WOS:000409302000001	29081811	gold, Green Submitted, Green Published			2022-02-06	
J	Tierney, GJ; Simms, CK				Tierney, Gregory J.; Simms, Ciaran K.			The effects of tackle height on inertial loading of the head and neck in Rugby Union: A multibody model analysis	BRAIN INJURY			English	Article						Sport; biomechanics; rugby	WORLD-CUP; CERVICAL RANGE; PLAYERS; INJURIES; IMPACT; CONTACT; CONCUSSION; MATCH; ACCELERATION; FORCES	Objective: There is evidence of chronic injury to the head-and-neck region of Rugby Union players. The aim of this study was to use multibody simulations to examine the effects of tackle height on both Tackier and Ball Carrier head kinematics and neck dynamics.& para;& para;Research Design: Quantitative Exploratory Study & para;& para; Methods and procedures: 45 front-on shoulder tackles with no direct contact to the head/neck were simulated with the MADYMO pedestrian model and used to assess differences between upper body tackles and lower body tackles. The average resultant head linear and angular accelerations as well as neck forces and moments were assessed.& para;& para;Main outcomes and results: Much higher Ball Carrier head kinematic values and neck loading were predicted for upper body tackles compared to lower body tackles, and principal findings were unaffected by a sensitivity analysis. Tackier results were less straightforward and trends were influenced by the sensitivity analysis for muscle activation.& para;& para;Conclusion: Although further model validation is required, the results of this study indicate the need for further research on tackle heights and inertial head-and-neck loading in the tackle phase of play in Rugby Union.	[Tierney, Gregory J.; Simms, Ciaran K.] Trinity Coll Dublin, Trinity Ctr Bioengn, Dublin, Ireland		Tierney, GJ (corresponding author), Trinity Coll Dublin, Trinity Ctr Bioengn, Dept Mech & Mfg Engn, Dublin 2, Ireland.	gtierne@tcd.ie	Simms, Ciaran/K-3100-2019	Simms, Ciaran/0000-0001-5564-1620; Tierney, Gregory/0000-0002-4666-4473	Irish Research CouncilIrish Research Council for Science, Engineering and Technology	Acknowledgment should be given to the Irish Research Council for funding this study.	Alexander DG, 2015, BRAIN INJURY, V29, P1113, DOI 10.3109/02699052.2015.1031699; Bathgate A, 2002, BRIT J SPORT MED, V36, P265, DOI 10.1136/bjsm.36.4.265; Best JP, 2005, BRIT J SPORT MED, V39, P812, DOI 10.1136/bjsm.2004.016402; Bonnoit J., 1995, SAE TECHNICAL PAPER; BOUQUET R, 1994, FOURTEENTH INTERNATIONAL TECHNICAL CONFERENCE ON ENHANCED SAFETY OF VEHICLES, PROCEEDINGS, VOLS 1 AND 2, P100; Burger N, 2016, BRIT J SPORT MED, V50, P932, DOI 10.1136/bjsports-2015-095295; Deutsch MU, 2007, J SPORT SCI, V25, P461, DOI 10.1080/02640410600631298; Elliott JR, 2012, P I MECH ENG K-J MUL, V226, P266, DOI 10.1177/1464419311430176; Fraas MR, 2014, PHYS THER SPORT, V15, P136, DOI 10.1016/j.ptsp.2013.08.002; Frechede B, 2009, MED SCI SPORT EXER, V41, P390, DOI 10.1249/MSS.0b013e318186b1c5; Fuller CW, 2008, BRIT J SPORT MED, V42, P452, DOI 10.1136/bjsm.2008.047035; Fuller CW, 2015, BRIT J SPORT MED, V49, P478, DOI 10.1136/bjsports-2013-093381; Fuller CW, 2013, BRIT J SPORT MED, V47, P1184, DOI 10.1136/bjsports-2012-091155; Fuller CW, 2010, BRIT J SPORT MED, V44, P159, DOI 10.1136/bjsm.2008.050864; Ghanouchi S., 1993, P 1993 INT C BIOM IM; Hendricks S, 2015, EUR J SPORT SCI, V15, P557, DOI 10.1080/17461391.2015.1046192; Hendricks S, 2014, EUR J SPORT SCI, V14, P753, DOI 10.1080/17461391.2014.905982; Hendricks S, 2012, J SPORT SCI, V30, P1215, DOI 10.1080/02640414.2012.707328; Hume PA, 2017, SPORTS MED, V47, P1209, DOI 10.1007/s40279-016-0608-8; KIM W, 1994, HUM MOVEMENT SCI, V13, P221, DOI 10.1016/0167-9457(94)90038-8; King D, 2016, SPORTS MED, V46, P151, DOI 10.1007/s40279-015-0423-7; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; Lark SD, 2007, J SPORT SCI, V25, P887, DOI 10.1080/02640410600944543; Lark SD, 2009, J SPORT SCI, V27, P491, DOI 10.1080/02640410802632136; McIntosh A., 2007, P ENH SAF VEH C; McIntosh AS, 2005, BRIT J SPORT MED, V39, P2, DOI 10.1136/bjsm.2004.016188; McIntosh AS, 2014, BMJ OPEN, V4, P5, DOI [10.1136/bmjopen-2014-005078., DOI 10.1136/BMJOPEN-2014-005078.]; Meyer E, 1994, CHOC LATERAL LEPAULE; Munoz D, 2005, P ENH SAF VEH C, P6; Pain MTG, 2008, J SPORT SCI, V26, P855, DOI 10.1080/02640410801910319; Pinsault N, 2010, PHYS THER SPORT, V11, P66, DOI 10.1016/j.ptsp.2010.02.004; Portero P, 2003, ISOKINET EXERC SCI, V11, P1; Sankarasubramanian H, 2011, P ENH SAF VEH C, P1; Scher A., 1978, DRUG RES, V5, P197; Shuttleworth-Rdwards AB, 2008, ARCH CLIN NEUROPSYCH, V23, P511, DOI 10.1016/j.acn.2008.05.002; Simms C.K., 2015, P INT RES COUNC BIOM, P180, DOI DOI 10.1002/NET.21589; Simms CK., 2016, ISBS C P ARCH, DOI DOI 10.1016/J.PUHE.2015.10.038; Smart DJ, 2008, BRIT J SPORT MED, V42, P198, DOI 10.1136/bjsm.2007.040162; Takarada Y, 2003, BRIT J SPORT MED, V37, P416, DOI 10.1136/bjsm.37.5.416; Talantikite Y, 1998, P ENH SAF VEH C, P1542; Tierney Gregory J, 2018, J Sci Med Sport, V21, P221, DOI 10.1016/j.jsams.2017.06.023; Tierney GJ, 2018, INT J SPORTS SCI COA, V13, P415, DOI 10.1177/1747954117751345; Tierney Gregory J, 2018, Sports Biomech, V17, P33, DOI 10.1080/14763141.2016.1271905; Tierney GJ, 2016, BRAIN INJURY, V30, P1350, DOI 10.1080/02699052.2016.1193630; TNO, 2015, MAD HUM BOD MOD MAN, P103; Usman J, 2011, J SCI MED SPORT, V14, P547, DOI 10.1016/j.jsams.2011.05.006; van Rooij L., 2003, P ENH SAF VEH C, P468; Viano D. C, 1989, SAE TECHNICAL PAPER; World Rugby, 2016, DESCR TACKL TACKL TY; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Yin S, 2017, ACCIDENT ANAL PREV, V106, P285, DOI 10.1016/j.aap.2017.06.005	51	17	17	0	15	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	13-14					1925	1931		10.1080/02699052.2017.1385853			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FO2MD	WOS:000416612500027	29064724				2022-02-06	
J	Gao, ZL; Chen, L; Fan, RC; Lu, W; Wang, DG; Cui, S; Huang, L; Zhao, SD; Guan, SD; Zhu, Y; Wang, JH				Gao, Zilong; Chen, Lei; Fan, Ruicheng; Lu, Wei; Wang, Dangui; Cui, Shan; Huang, Li; Zhao, Shidi; Guan, Sudong; Zhu, Yan; Wang, Jin-Hui			Associations of Unilateral Whisker and Olfactory Signals Induce Synapse Formation and Memory Cell Recruitment in Bilateral Barrel Cortices: Cellular Mechanism for Unilateral Training Toward Bilateral Memory	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						memory; glutamate; GABA; neuron; synapse; barrel cortex; whisker; olfaction	CORPUS-CALLOSUM EVIDENCE; TRAUMATIC BRAIN-INJURY; CORTEX; PLASTICITY; COORDINATION; NEURONS; LOCALIZATION; ORGANIZATION; INFORMATION; RETRIEVAL	Somatosensory signals and operative skills learned by unilateral limbs can be retrieved bilaterally. In terms of cellular mechanism underlying this unilateral learning toward bilateral memory, we hypothesized that associative memory cells in bilateral cortices and synapse innervations between them were produced. In the examination of this hypothesis, we have observed that paired unilateral whisker and odor stimulations led to odorant-induced whisker motions in bilateral sides, which were attenuated by inhibiting the activity of barrel cortices. In the mice that showed bilateral cross-modal responses, the neurons in both sides of barrel cortices became to encode this new odor signal alongside the innate whisker signal. Axon projections and synapse formations from the barrel cortex, which was co-activated with the piriform cortex, toward its contralateral barrel cortex (CBC) were upregulated. Glutamatergic synaptic transmission in bilateral barrel cortices was upregulated and GABAergic synaptic transmission was downregulated. The associative activations of the sensory cortices facilitate new axon projection, glutamatergic synapse formation and GABAergic synapse downregulation, which drive the neurons to be recruited as associative memory cells in the bilateral cortices. Our data reveal the productions of associative memory cells and synapse innervations in bilateral sensory cortices for unilateral training toward bilateral memory.	[Gao, Zilong; Wang, Dangui; Cui, Shan; Wang, Jin-Hui] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing, Peoples R China; [Gao, Zilong; Wang, Jin-Hui] Univ Chinese Acad Sci, Coll Life Sci, Beijing, Peoples R China; [Chen, Lei; Fan, Ruicheng; Huang, Li; Zhao, Shidi; Guan, Sudong; Zhu, Yan; Wang, Jin-Hui] Bengbu Med Coll, Dept Pathophysiol, Bengbu, Peoples R China; [Lu, Wei; Wang, Jin-Hui] Qingdao Univ, Sch Pharm, Qingdao, Shandong, Peoples R China		Wang, JH (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing, Peoples R China.; Wang, JH (corresponding author), Univ Chinese Acad Sci, Coll Life Sci, Beijing, Peoples R China.; Wang, JH (corresponding author), Bengbu Med Coll, Dept Pathophysiol, Bengbu, Peoples R China.; Wang, JH (corresponding author), Qingdao Univ, Sch Pharm, Qingdao, Shandong, Peoples R China.	jhw@sun5.ibp.ac.cn			National Basic Research ProgramNational Basic Research Program of China [2013CB531304, 2016YFC1307101]; Natural Science Foundation ChinaNational Natural Science Foundation of China (NSFC) [81671071, 81471123]	We thank Dr. Tom Sudhof for pAAV-SynaptoTag-mCherry-GFP, and Kim Davis for proof reading. This study is supported by National Basic Research Program (2013CB531304 and 2016YFC1307101) and Natural Science Foundation China (81671071 and 81471123) to J-HW.	Alloway KD, 2004, J COMP NEUROL, V480, P299, DOI 10.1002/cne.20339; Alloway KD, 2009, J COMP NEUROL, V515, P548, DOI 10.1002/cne.22073; ARMSTRONGJAMES M, 1988, EXP BRAIN RES, V70, P155; Aronoff R, 2010, EUR J NEUROSCI, V31, P2221, DOI 10.1111/j.1460-9568.2010.07264.x; Bracha V, 2009, NEUROSCIENCE, V162, P787, DOI 10.1016/j.neuroscience.2008.12.042; Burhans LB, 2008, BEHAV NEUROSCI, V122, P1191, DOI 10.1037/a0013599; Caeyenberghs K, 2011, J NEUROTRAUM, V28, P897, DOI 10.1089/neu.2010.1721; Chen N, 2008, J CELL SCI, V121, P2961, DOI 10.1242/jcs.022368; Chen N, 2006, BIOCHEM BIOPH RES CO, V346, P281, DOI 10.1016/j.bbrc.2006.05.120; CLARK CR, 1989, BRAIN, V112, P165, DOI 10.1093/brain/112.1.165; DAVIS M, 1993, BEHAV BRAIN RES, V58, P175, DOI 10.1016/0166-4328(93)90102-V; DeFelipe J, 2013, NAT REV NEUROSCI, V14, P202, DOI 10.1038/nrn3444; Diamond ME, 2013, PROG NEUROBIOL, V103, P28, DOI 10.1016/j.pneurobio.2012.05.013; Diamond ME, 2003, J PHYSIOL-PARIS, V97, P529, DOI 10.1016/j.jphysparis.2004.01.010; Dubb A, 2003, NEUROIMAGE, V20, P512, DOI 10.1016/S1053-8119(03)00313-6; Erickson RL, 2014, NEUROPSYCHOLOGIA, V60, P121, DOI 10.1016/j.neuropsychologia.2014.06.003; Ge RJ, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-26; Ge RJ, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-19; Glazewski S, 2007, J NEUROSCI, V27, P3910, DOI 10.1523/JNEUROSCI.0181-07.2007; Gooijers J, 2014, NEUROSCI BIOBEHAV R, V43, P1, DOI 10.1016/j.neubiorev.2014.03.008; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Harris JA, 2001, NEURON, V30, P315, DOI 10.1016/S0896-6273(01)00300-2; Hasegawa I, 1998, SCIENCE, V281, P814, DOI 10.1126/science.281.5378.814; Hasegawa I, 1999, ANN MED, V31, P380, DOI 10.3109/07853899908998795; Hasegawa I, 2000, REV NEUROSCIENCE, V11, P113; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; KAWAGUCHI Y, 1992, EXP BRAIN RES, V88, P33, DOI 10.1007/BF02259126; Kozlovskiy SA, 2012, INT J PSYCHOPHYSIOL, V85, P396, DOI 10.1016/j.ijpsycho.2012.07.092; Lansner A, 2009, TRENDS NEUROSCI, V32, P178, DOI 10.1016/j.tins.2008.12.002; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Lu W, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-38; Lum C, 2011, J NEUROIMAGING, V21, P65, DOI 10.1111/j.1552-6569.2009.00430.x; Ma K, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.181; Maren S, 2008, EUR J NEUROSCI, V28, P1661, DOI 10.1111/j.1460-9568.2008.06485.x; Matyas F, 2010, SCIENCE, V330, P1240, DOI 10.1126/science.1195797; Ni H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013736; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; OLAVARRIA J, 1984, BRAIN RES, V291, P364, DOI 10.1016/0006-8993(84)91270-8; Pashaie R, 2013, BIOMED OPT EXPRESS, V4, P122, DOI 10.1364/BOE.4.000122; Paxinos G., 2005, MOUSE BRAIN STEREOTA; Peltier J, 2012, J NEUROL, V259, P1860, DOI 10.1007/s00415-012-6421-x; Perkowski JJ, 2011, J NEUROSCI, V31, P46, DOI 10.1523/JNEUROSCI.2634-10.2011; Piercy M, 1967, Mod Trends Neurol, V4, P106; Pietrasanta M, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/838672; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Shuler MG, 2001, J NEUROSCI, V21, P5251, DOI 10.1523/JNEUROSCI.21-14-05251.2001; Steele CJ, 2013, J NEUROSCI, V33, P1282, DOI 10.1523/JNEUROSCI.3578-12.2013; Stevens CF, 2004, CURR OPIN NEUROBIOL, V14, P341, DOI 10.1016/j.conb.2004.04.004; Suzuki WA, 2008, PROG BRAIN RES, V169, P305, DOI 10.1016/S0079-6123(07)00019-2; Takatoh J, 2013, NEURON, V77, P346, DOI 10.1016/j.neuron.2012.11.010; Treble A, 2013, J NEUROTRAUM, V30, P1609, DOI 10.1089/neu.2013.2934; Wang DG, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00320; Wang J.-H., 2013, SOC NEUROSCI, V653; Wang JH, 2003, BRAIN RES BULL, V60, P53, DOI 10.1016/S0361-9230(03)00026-1; Wang JH, 2001, J PHYSIOL-LONDON, V533, P407, DOI 10.1111/j.1469-7793.2001.0407a.x; Wang JH, 2016, BIOPHYS J, V110, p481A, DOI 10.1016/j.bpj.2015.11.2571; Wang JH, 2008, J CELL SCI, V121, P2951, DOI 10.1242/jcs.025684; Wang JH, 2014, BIOPHYS J, V106, p191A, DOI 10.1016/j.bpj.2013.11.1114; Wasserman EA, 1997, ANNU REV PSYCHOL, V48, P573, DOI 10.1146/annurev.psych.48.1.573; Weinberger NM, 2004, NAT REV NEUROSCI, V5, P279, DOI 10.1038/nrn1366; Weinberger NM, 2007, LEARN MEMORY, V14, P1, DOI 10.1101/lm.421807; Wen B, 2015, CNS NEUROSCI THER, V21, P204, DOI 10.1111/cns.12336; WITELSON SF, 1985, SCIENCE, V229, P665, DOI 10.1126/science.4023705; Wong CW, 2000, MED HYPOTHESES, V55, P177, DOI 10.1054/mehy.1999.0934; Woodruff-Pak DS, 2008, TRENDS NEUROSCI, V31, P105, DOI 10.1016/j.tins.2007.11.006; Xu AP, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyv122; Xu W, 2013, SCIENCE, V339, P1290, DOI 10.1126/science.1229534; Ye B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041986; Zhang FY, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-20; Zhang GJ, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-2; Zhao J, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-12; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	72	17	17	0	19	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5102		FRONT CELL NEUROSCI	Front. Cell. Neurosci.	DEC 16	2016	10								285	10.3389/fncel.2016.00285			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EE7IS	WOS:000389789700001	28018178	gold, Green Published			2022-02-06	
J	Frohlich, M; Driessen, A; Bhmer, A; Nienaber, U; Igressa, A; Probst, C; Bouillon, B; Maegele, M; Mutschler, M				Froehlich, Matthias; Driessen, Arne; Bhmer, Andreas; Nienaber, Ulrike; Igressa, Alhadi; Probst, Christian; Bouillon, Bertil; Maegele, Marc; Mutschler, Manuel		TraumaRegister DGU	Is the shock index based classification of hypovolemic shock applicable in multiple injured patients with severe traumatic brain injury?-an analysis of the TraumaRegister DGU (R)	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Haemorrhagic shock; Shock index; Traumatic brain injury; Multiple trauma	EUROPEAN GUIDELINE; MASSIVE TRANSFUSION; MAJOR TRAUMA; COAGULOPATHY; MANAGEMENT; MORTALITY; RESPONSES; REGISTRY; UTILITY	Background: A new classification of hypovolemic shock based on the shock index (SI) was proposed in 2013. This classification contains four classes of shock and shows good correlation with acidosis, blood product need and mortality. Since their applicability was questioned, the aim of this study was to verify the validity of the new classification in multiple injured patients with traumatic brain injury. Methods: Between 2002 and 2013, data from 40 888 patients from the TraumaRegister DGU (R) were analysed. Patients were classified according to their initial SI at hospital admission (Class I: SI < 0.6, class II: SI >= 0.6 to <1.0, class III SI >= 1.0 to <1.4, class IV: SI >= 1.4). Patients with an additional severe TBI (AIS >= 3) were compared to patients without severe TBI. Results: 16,760 multiple injured patients with TBI (AIS(head) >= 3) were compared to 24,128 patients without severe TBI. With worsening of SI class, mortality rate increased from 20 to 53% in TBI patients. Worsening SI classes were associated with decreased haemoglobin, platelet counts and Quick's values. The number of blood units transfused correlated with worsening of SI. Massive transfusion rates increased from 3% in class I to 46% in class IV. The accuracy for predicting transfusion requirements did not differ between TBI and Non TBI patients. Discussion: The use of the SI based classification enables a quick assessment of patients in hypovolemic shock based on universally available parameters. Although the pathophysiology in TBI and Non TBI patients and early treatment methods such as the use of vasopressors differ, both groups showed an identical probability of recieving blood products within the respective SI class. Conclusion: Regardless of the presence of TBI, the classification of hypovolemic shock based on the SI enables a fast and reliable assessment of hypovolemic shock in the emergency department. Therefore, the presented study supports the SI as a feasible tool to assess patients at risk for blood product transfusions, even in the presence of severe TBI.	[Froehlich, Matthias; Driessen, Arne; Probst, Christian; Bouillon, Bertil; Maegele, Marc; Mutschler, Manuel] Univ Witten Herdecke, Dept Orthopaed Surg Traumatol & Sports Traumatol, Cologne Merheim Med Ctr, Ostmerheimer Str 200, D-51109 Cologne, Germany; [Froehlich, Matthias] Univ Witten Herdecke, Cologne Merheim Med Ctr, Inst Res Operat Med IFOM, Ostmerheimerstr 200, D-51109 Cologne, Germany; [Bhmer, Andreas] Univ Witten Herdecke, Cologne Merheim Med Ctr, Dept Anaesthesiol & Intens Care Med, Ostmerheimer Str 200, D-51109 Cologne, Germany; [Nienaber, Ulrike] AUC Acad Trauma Surg, Str 17 Juni 106-108, D-10623 Berlin, Germany; [Igressa, Alhadi] Cologne Merheim Med Ctr, Dept Neurosurg, Ostmerheimer Str 200, D-51109 Cologne, Germany; [Froehlich, Matthias; Driessen, Arne; Bhmer, Andreas; Nienaber, Ulrike; Igressa, Alhadi; Probst, Christian; Bouillon, Bertil; Maegele, Marc; Mutschler, Manuel; TraumaRegister DGU] German Trauma Soc, Comm Emergency Med Intens Care & Trauma Managemen, Sekt NIS, Berlin, Germany		Frohlich, M (corresponding author), Univ Witten Herdecke, Dept Orthopaed Surg Traumatol & Sports Traumatol, Cologne Merheim Med Ctr, Ostmerheimer Str 200, D-51109 Cologne, Germany.; Frohlich, M (corresponding author), Univ Witten Herdecke, Cologne Merheim Med Ctr, Inst Res Operat Med IFOM, Ostmerheimerstr 200, D-51109 Cologne, Germany.; Frohlich, M (corresponding author), German Trauma Soc, Comm Emergency Med Intens Care & Trauma Managemen, Sekt NIS, Berlin, Germany.	froehlichm@kliniken-koeln.de					20 years TraumaRegister DGU((R)), 2014, INJURY S3, V45, pS6; Bruijns SR, 2013, J TRAUMA ACUTE CARE, V74, P1432, DOI 10.1097/TA.0b013e31829246c7; Cannon CM, 2009, J TRAUMA, V67, P1426, DOI 10.1097/TA.0b013e3181bbf728; Chen B, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-77; Driessen A, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0233-4; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; Grote S, 2011, J NEUROTRAUM, V28, P527, DOI 10.1089/neu.2010.1433; Guly HR, 2011, RESUSCITATION, V82, P556, DOI 10.1016/j.resuscitation.2011.01.013; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Lefering R, 2014, INJURY, V45, pS83, DOI 10.1016/j.injury.2014.08.023; Maegele M, 2007, INJURY, V38, P298, DOI 10.1016/j.injury.2006.10.003; McMahon CG, 2008, CRIT CARE MED, V36, P216, DOI 10.1097/01.CCM.0000295425.41831.85; McMahon CG, 2011, SHOCK, V35, P53, DOI 10.1097/SHK.0b013e3181e687c6; McMahon CG, 2010, J TRAUMA, V69, P1169, DOI 10.1097/TA.0b013e3181cc8889; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Mutschler M, 2013, RESUSCITATION, V84, P309, DOI 10.1016/j.resuscitation.2012.07.012; Mutschler M, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-28; Mutschler M, 2013, CRIT CARE, V17, DOI 10.1186/cc12851; Olaussen A, 2015, INJURY, V46, P822, DOI 10.1016/j.injury.2014.12.009; Pacagnella RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057594; Rossaint R, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1265-x; Spahn DR, 2007, CRIT CARE, V11, DOI 10.1186/cc5686; Spahn DR, 2013, CRIT CARE, V17, DOI 10.1186/cc12685; Subcommittee A, 2013, J TRAUMA ACUTE CARE, V74, P1363; Vandromme MJ, 2011, J TRAUMA, V70, P384, DOI 10.1097/TA.0b013e3182095a0a; Wafaisade A, 2010, EMERG MED J, V27, P934, DOI 10.1136/emj.2009.088484; YUAN XQ, 1991, CIRC SHOCK, V35, P231; Zarzaur BL, 2008, J SURG RES, V147, P229, DOI 10.1016/j.jss.2008.03.025	29	17	17	0	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	DEC 12	2016	24								148	10.1186/s13049-016-0340-2			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	EG6GD	WOS:000391141700001	27955692	Green Published, gold			2022-02-06	
J	Halaweish, I; Bambakidis, T; Nikolian, VC; Georgoff, P; Bruhn, P; Piascik, P; Buckley, L; Srinivasan, A; Liu, BL; Li, YQ; Alam, HB				Halaweish, Ihab; Bambakidis, Ted; Nikolian, Vahagn C.; Georgoff, Patrick; Bruhn, Peter; Piascik, Patryk; Buckley, Lisa; Srinivasan, Ashok; Liu, Baoling; Li, Yongqing; Alam, Hasan B.			Early resuscitation with lyophilized plasma provides equal neuroprotection compared with fresh frozen plasma in a large animal survival model of traumatic brain injury and hemorrhagic shock	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	46th Annual Meeting of the Western-Trauma-Association	FEB 28-MAR 04, 2016	CA	Western Trauma Assoc		Hemorrhagic shock; lyophilized plasma; neuroprotection; traumatic brain injury; Yorkshire swine	SEVERE HEAD-INJURY; VALPROIC ACID; MAJOR TRAUMA; DRIED PLASMA; SWINE MODEL; COAGULOPATHY; COAGULATION; PERSPECTIVE; INSULTS; PROMMTT	BACKGROUND: Combined traumatic brain injury (TBI) and hemorrhagic shock (HS) is highly lethal. In previous models of combined TBI + HS, we showed that early resuscitation with fresh frozen plasma (FFP) improves neurologic outcomes. Delivering FFP, however, in austere environments is difficult. Lyophilized plasma (LP) is a logistically superior alternative to FFP, but data are limited regarding its efficacy for treatment of TBI. We conducted this study to determine the safety and long-term outcomes of early treatment with LP in a large animal model of TBI + HS. METHODS: Adult anesthetized swine underwent TBI and volume-controlled hemorrhage (40% blood volume) concurrently. After 2 hours of shock, animals were randomized (n = 5 per /group) to FFP or LP (1x shed blood) treatment. Serial blood gases were drawn, and thromboelastography was performed on citrated, kaolin-activated whole-blood samples. Five hours after treatment, packed red blood cells were administered, and animals recovered. A 32-point Neurologic Severity Score was assessed daily for 30 days (0 = normal, 32 = most severe injury). Cognitive functions were tested by training animals to retrieve food from color-coded boxes. Brain lesion size was measured on serial magnetic resonance imaging, and an autopsy was performed at 30 days. RESULTS: The severity of shock and the degree of resuscitation were similar in both groups. Administration of FFP and LP was well tolerated with no differences in reversal of shock or thromboelastography parameters. Animals in both groups displayed the worst Neurologic Severity Score on postoperative Day 1 with rapid recovery and return to baseline within 7 days of injury. Lesion size on Day 3 in FFP-treated animals was 645 +/- 85 versus 219 +/- 20 mm(3) in LP-treated animals (p < 0.05). There were no differences in cognitive functions or delayed treatment-related complications. CONCLUSIONS: Early treatment with LP in TBI + HS is safe and provides neuroprotection that is comparable to FFP. Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.	[Halaweish, Ihab; Bambakidis, Ted; Nikolian, Vahagn C.; Georgoff, Patrick; Piascik, Patryk; Liu, Baoling; Li, Yongqing; Alam, Hasan B.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Bruhn, Peter] Univ Copenhagen Hosp, Dept Surg Gastroenterol, Rigshosp, Copenhagen, Denmark; [Buckley, Lisa] Oregon Hlth & Sci Univ, Ctr Regenerat Med, Portland, OR 97201 USA; [Srinivasan, Ashok] Univ Michigan, Dept Radiol, Neuroradiol Sect, Ann Arbor, MI 48109 USA		Alam, HB (corresponding author), Univ Michigan Hosp, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	alamh@med.umich.edu	Buckley, Lisa/U-7467-2018	Buckley, Lisa/0000-0003-1542-938X			Alam HB, 2002, SURGERY, V132, P278, DOI 10.1067/msy.2002.125787; Chapman MP, 2015, SHOCK, V44, P63, DOI 10.1097/SHK.0000000000000376; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; del Junco DJ, 2013, J TRAUMA ACUTE CARE, V75, pS24, DOI 10.1097/TA.0b013e31828fa3b9; Difede J, 2010, ANN NY ACAD SCI, V1208, P1, DOI 10.1111/j.1749-6632.2010.05795.x; Faul M, 2010, TRAUMATIC BRAIN INJU; Halaweish I, 2015, J TRAUMA ACUTE CARE, V79, P911, DOI 10.1097/TA.0000000000000789; Halaweish I, 2015, J AM COLL SURGEONS, V220, P809, DOI 10.1016/j.jamcollsurg.2015.01.057; Holcomb JB, 2013, HEMATOL-AM SOC HEMAT, P656, DOI 10.1182/asheducation-2013.1.656; Holcomb JB, 2013, JAMA SURG, V148, P127, DOI 10.1001/2013.jamasurg.387; Hwabejire JO, 2013, J TRAUMA ACUTE CARE, V75, P968, DOI 10.1097/TA.0b013e31829a021a; Imam AM, 2013, J TRAUMA ACUTE CARE, V75, P976, DOI 10.1097/TA.0b013e31829e2186; Imam AM, 2013, SURGERY, V154, P388, DOI 10.1016/j.surg.2013.05.008; Jin G, 2012, J TRAUMA ACUTE CARE, V73, P1461, DOI 10.1097/TA.0b013e3182782641; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; McMahon CG, 1999, J TRAUMA, V47, P891, DOI 10.1097/00005373-199911000-00013; McSwain NE, 2011, J TRAUMA, V70, pS2, DOI 10.1097/TA.0b013e31821b201d; Pati S, 2010, J TRAUMA, V69, pS55, DOI 10.1097/TA.0b013e3181e453d4; Prevost TP, 2011, ACTA BIOMATER, V7, P4090, DOI 10.1016/j.actbio.2011.06.032; Rhee P, 2014, ANN SURG, V260, P13, DOI 10.1097/SLA.0000000000000600; Shuja F, 2008, J TRAUMA, V65, P975, DOI 10.1097/TA.0b013e3181801cd9; Shuja F, 2011, J TRAUMA, V70, P664, DOI 10.1097/TA.0b013e31820e83be; Spoerke N, 2009, ARCH SURG-CHICAGO, V144, P829, DOI 10.1001/archsurg.2009.154; Velik-Salchner C, 2006, THROMB RES, V117, P597, DOI 10.1016/j.thromres.2005.05.015; WALD SL, 1993, J TRAUMA, V34, P377, DOI 10.1097/00005373-199303000-00012	25	17	17	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	DEC	2016	81	6					1080	1087		10.1097/TA.0000000000001204			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	EE0BH	WOS:000389237900012	27893618				2022-02-06	
J	LaRovere, KL; O'Brien, NF; Tasker, RC				LaRovere, Kerri L.; O'Brien, Nicole F.; Tasker, Robert C.			Current Opinion and Use of Transcranial Doppler Ultrasonography in Traumatic Brain Injury in the Pediatric Intensive Care Unit	JOURNAL OF NEUROTRAUMA			English	Article						autoregulation; Doppler ultrasonography; transcranial; intracranial hypertension; severe TBI; vasospasm	CEREBRAL-BLOOD-FLOW; INTRACRANIAL-PRESSURE; CHILDREN; AUTOREGULATION; VELOCITY; VASOSPASM; MODERATE; VALUES	The purpose of this study was to identify and review clinical studies using transcranial Doppler (TCD) ultrasonography in children with severe traumatic brain injury (TBI) in the pediatric intensive care unit (PICU). We identified 16 articles from January 2005 to July 2015 that met inclusion (TBI, five or more cases in case series, subjects < 18 years old, TCD performed in PICU) and exclusion criteria (age not stated, data from subjects < 18 years not separated from adult data, < 85% study population < 18 years in mixed population with adults). TCD parameters were used to assess autoregulation, intracranial pressure, and vasospasm, and to predict neurological outcome. Incidence of impaired autoregulation varied in severe TBI from 25% to 80%. Altered TCD flows and pulsatility index variably predicted intracranial hypertension across studies. Sonographic vasospasm in the middle cerebral artery occurred in 34% of 69 children with severe TBI. Outcomes seem to be related to altered TCD-derived flow velocities while in the ICU. TCD may be a useful tool to assess autoregulation, intracranial pressure, and vasospasm following TBI in the PICU. Further research is needed to establish gold standards and validate the findings in children. TCD may then impact day-to-day management in the PICU, and potentially improve outcomes in children with severe TBI.	[LaRovere, Kerri L.; Tasker, Robert C.] Boston Childrens Hosp, Dept Neurol, 300 Longwood Ave,BCH 3224, Boston, MA 02115 USA; [Tasker, Robert C.] Boston Childrens Hosp, Dept Anesthesia Perioperat & Pain Med, Boston, MA USA; Harvard Med Sch, Boston, MA USA; [O'Brien, Nicole F.] Nationwide Childrens Hosp, Dept Pediat, Div Pediat Crit Care Med, Columbus, OH USA; [O'Brien, Nicole F.] Ohio State Univ, Columbus, OH 43210 USA		LaRovere, KL (corresponding author), Boston Childrens Hosp, Dept Neurol, 300 Longwood Ave,BCH 3224, Boston, MA 02115 USA.	kerri.larovere@childrens.harvard.edu	Tasker, Robert C/R-5837-2019	Tasker, Robert/0000-0003-3647-8113			AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Chaiwat O, 2009, J NEUROTRAUM, V26, P657, DOI 10.1089/neu.2008.0770; Chin RFM, 2004, EUR J NEUROL, V11, P800, DOI 10.1111/j.1468-1331.2004.00943.x; Figaji AA, 2010, NEUROCRIT CARE, V12, P430, DOI 10.1007/s12028-010-9344-3; Figaji AA, 2009, J NEUROSURG-PEDIATR, V4, P420, DOI 10.3171/2009.6.PEDS096; Figaji AA, 2009, SURG NEUROL, V72, P389, DOI 10.1016/j.surneu.2009.02.012; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; JENNETT B, 1975, LANCET, V1, P480; KETY SS, 1948, J CLIN INVEST, V27, P476, DOI 10.1172/JCI101994; MAEDA H, 1990, ULTRASOUND MED BIOL, V16, P9, DOI 10.1016/0301-5629(90)90080-V; Matta B., 2010, COTTRELL YOUNGS NEUR, P131; Moftakhar P, 2015, J NEUROSURG-PEDIATR, V15, P282, DOI 10.3171/2014.9.PEDS14313; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; NEWELL DW, 1994, STROKE, V25, P793, DOI 10.1161/01.STR.25.4.793; O'Brien NF, 2015, J NEUROSURG-PEDIATR, V16, P420, DOI 10.3171/2015.3.PEDS14521; O'Brien NF, 2015, CRIT CARE MED, V43, P674, DOI 10.1097/CCM.0000000000000745; O'Brien NF, 2015, CHILD NERV SYST, V31, P2269, DOI 10.1007/s00381-015-2873-5; O'Brien NF, 2010, INTENS CARE MED, V36, P680, DOI 10.1007/s00134-009-1747-2; OBRIST WD, 1975, STROKE, V6, P245, DOI 10.1161/01.STR.6.3.245; Philip S, 2009, CRIT CARE MED, V37, P2973, DOI 10.1097/CCM.0b013e3181a963f6; Scavarda D, 2010, CHILD NERV SYST, V26, P1555, DOI 10.1007/s00381-010-1150-x; STREBEL S, 1995, ANESTHESIOLOGY, V83, P66, DOI 10.1097/00000542-199507000-00008; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; Tontisirin N, 2007, CHILD NERV SYST, V23, P1163, DOI 10.1007/s00381-007-0339-0; Vavilala MS, 2006, DEV NEUROSCI-BASEL, V28, P348, DOI 10.1159/000094161; Vavilala MS, 2008, NEUROCRIT CARE, V9, P45, DOI 10.1007/s12028-007-9036-9; Vavilala MS, 2007, J NEUROTRAUM, V24, P87, DOI 10.1089/neu.2006.0058; Visocchi M, 2007, ACTA NEUROCHIR, V149, P347, DOI 10.1007/s00701-006-1102-0	28	17	17	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2016	33	23					2105	2114		10.1089/neu.2015.4344			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	ED2JG	WOS:000388669800006	26983462				2022-02-06	
J	Moretti, R; Chhor, V; Bettati, D; Banino, E; De Lucia, S; Le Charpentier, T; Lebon, S; Schwendimann, L; Pansiot, J; Rasika, S; Degos, V; Titomanlio, L; Gressens, P; Fleiss, B				Moretti, Raffaella; Chhor, Vibol; Bettati, Donatella; Banino, Elena; De Lucia, Silvana; Le Charpentier, Tifenn; Lebon, Sophie; Schwendimann, Leslie; Pansiot, Julien; Rasika, Sowmyalakshmi; Degos, Vincent; Titomanlio, Luigi; Gressens, Pierre; Fleiss, Bobbi			Contribution of Mast Cells to Injury Mechanisms in a Mouse Model of Pediatric Traumatic Brain Injury	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						neuroinflammation; histamine; apoptosis; myelin; neuron; microglia	WHITE-MATTER; SYSTEMIC INFLAMMATION; IMMATURE RAT; HISTAMINE; MICROGLIA; NEUROPROTECTION; RECEPTORS; ACCUMULATION; ACTIVATION; PLASTICITY	The cognitive and behavioral deficits caused by traumatic brain injury (TBI) to the immature brain are more severe and persistent than injuries to the adult brain. Understanding this developmental sensitivity is critical because children under 4 years of age of sustain TBI more frequently than any other age group. One of the first events after TBI is the infiltration and degranulation of mast cells (MCs) in the brain, releasing a range of immunomodulatory substances; inhibition of these cells is neuroprotective in other types of neonatal brain injury. This study investigates for the first time the role of MCs in mediating injury in a P7 mouse model of pediatric contusion-induced TBI. We show that various neural cell types express histamine receptors and that histamine exacerbates excitotoxic cell death in primary cultured neurons. Cromoglycate, an inhibitor of MC degranulation, altered the inflammatory phenotype of microglia activated by TBI, reversing several changes but accentuating others, when administered before TBI. However, without regard to the time of cromoglycate administration, inhibiting MC degranulation did not affect cell loss, as evaluated by ventricular dilatation or cleaved caspase-3 labeling, or the density of activated microglia, neurons, or myelin. In double-heterozygous cKit mutant mice lacking MCs, this overall lack of effect was confirmed. These results suggest that the role of MCs in this model of pediatric TBI is restricted to subtle effects and that they are unlikely to be viable neurotherapeutic targets. (C) 2016 Wiley Periodicals, Inc.	[Moretti, Raffaella; Chhor, Vibol; Bettati, Donatella; Banino, Elena; De Lucia, Silvana; Le Charpentier, Tifenn; Lebon, Sophie; Schwendimann, Leslie; Pansiot, Julien; Rasika, Sowmyalakshmi; Degos, Vincent; Titomanlio, Luigi; Gressens, Pierre; Fleiss, Bobbi] Unversit Paris Diderot, INSERM, PROTECT, Sorbonne Paris Cite, Paris, France; [Moretti, Raffaella; Chhor, Vibol; Bettati, Donatella; Banino, Elena; De Lucia, Silvana; Le Charpentier, Tifenn; Lebon, Sophie; Schwendimann, Leslie; Pansiot, Julien; Rasika, Sowmyalakshmi; Degos, Vincent; Titomanlio, Luigi; Gressens, Pierre; Fleiss, Bobbi] PremUP, Paris, France; [Moretti, Raffaella; Bettati, Donatella; Banino, Elena; De Lucia, Silvana] Univ Udine, Udine, Italy; [Chhor, Vibol] Georges Pompidou European Hosp, Dept Anesthesia & Intens Care, Paris, France; [Degos, Vincent] Hop La Pitie Salpetriere, Dept Anesthesia & Intens Care, Paris, France; [Gressens, Pierre; Fleiss, Bobbi] St Thomas Hosp, Kings Hlth Partners, Kings Coll London, Dept Perinatal Imaging & Hlth,Div Imaging Sci & B, London, England		Fleiss, B (corresponding author), Hop Robert Debre, INSERM, U1141, 48 Blvd Serurier, F-75019 Paris, France.	bobbi.fleiss@inserm.fr	Fleiss, Bobbi/F-9899-2011; gressens, pierre/M-7557-2017	Fleiss, Bobbi/0000-0001-7828-673X; gressens, pierre/0000-0002-0909-4221; Lebon, Sophie/0000-0003-0039-5519	INSERMInstitut National de la Sante et de la Recherche Medicale (Inserm)European Commission; Universite Paris Diderot; Universite Sorbonne-Paris-Cite, Investissement d'AvenirFrench National Research Agency (ANR) [ANR-11-INBS-0011 NeurATRIS]; ERA-NET Neuron (Micromet); DHU PROTECT; PremUP; Fondation de FranceFondation de France; Fondation pour la Recherche sur le Cerveau; Fondation des Gueules Cassees; Roger de Spoelberch Foundation; Grace de Monaco Foundation; Leducq FoundationLeducq Foundation; Cerebral Palsy Alliance Research Foundation Australia; Wellcome TrustWellcome TrustEuropean Commission [WSCR P32674]; National Institute for Health Research (NIHR)National Institute for Health Research (NIHR)	Contract grant sponsor: INSERM, Universite Paris Diderot, Universite Sorbonne-Paris-Cite, Investissement d'Avenir; Contract grant number: ANR-11-INBS-0011 NeurATRIS; Contract grant sponsor: ERA-NET Neuron (Micromet); Contract grant sponsor: DHU PROTECT; Contract grant sponsor: PremUP; Contract grant sponsor: Fondation de France; Contract grant sponsor: Fondation pour la Recherche sur le Cerveau; Contract grant sponsor: Fondation des Gueules Cassees; Contract grant sponsor: Roger de Spoelberch Foundation; Contract grant sponsor: Grace de Monaco Foundation; Contract grant sponsor: Leducq Foundation; Contract grant sponsor: Cerebral Palsy Alliance Research Foundation Australia; Contract grant sponsor: Wellcome Trust; Contract grant number: WSCR P32674; Contract grant sponsor: National Institute for Health Research (NIHR) (to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust).	Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Bennet L, 2013, CLIN EXP PHARMACOL P, V40, P774, DOI 10.1111/1440-1681.12135; Biran V, 2008, BRAIN PATHOL, V18, P1, DOI 10.1111/j.1750-3639.2007.00092.x; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; Chen RY, 2001, J CLIN INVEST, V108, P1151, DOI 10.1172/jci11494; Chhor V, 2013, BRAIN BEHAV IMMUN, V32, P70, DOI 10.1016/j.bbi.2013.02.005; Colton CA, 2010, CNS NEUROL DISORD-DR, V9, P174, DOI 10.2174/187152710791012053; Dean JM, 2010, BRAIN BEHAV IMMUN, V24, P776, DOI 10.1016/j.bbi.2009.10.018; Dimitriadou V, 1996, DEV BRAIN RES, V97, P29, DOI 10.1016/S0165-3806(96)00127-7; Dong H, 2016, MOL NEUROBIOL; DROPP JJ, 1979, ACTA ANAT, V105, P505; Favrais G, 2011, ANN NEUROL, V70, P550, DOI 10.1002/ana.22489; Ferreira R, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-90; Fleiss B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-70; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Hagberg H, 2012, ANN NEUROL, V71, P444, DOI 10.1002/ana.22620; Hendrix S, 2013, FASEB J, V27, P920, DOI 10.1096/fj.12-204800; Husson I, 2005, CEREB CORTEX, V15, P250, DOI 10.1093/cercor/bhh127; Jin YX, 2007, DEV NEUROSCI-BASEL, V29, P373, DOI 10.1159/000105478; Jin YX, 2009, STROKE, V40, P3107, DOI 10.1161/STROKEAHA.109.549691; Kaindl AM, 2007, PROTEOM CLIN APPL, V1, P640, DOI 10.1002/prca.200600696; Kaindl AM, 2012, ANN NEUROL, V72, P536, DOI 10.1002/ana.23626; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Khalil M, 2007, BRAIN RES, V1171, P18, DOI 10.1016/j.brainres.2007.07.034; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Levy D, 2016, CEPHALALGIA, V36, P915, DOI 10.1177/0333102415617412; Lozada A, 2005, NEUROPATH APPL NEURO, V31, P150, DOI 10.1111/j.1365-2990.2004.00622.x; MEININGER CJ, 1992, BLOOD, V79, P958; Mesples B, 2005, NEUROBIOL DIS, V18, P193, DOI 10.1016/j.nbd.2004.09.018; Monk KR, 2007, NEURON GLIA BIOL, V3, P233, DOI 10.1017/S1740925X08000021; Panula P, 2014, TRENDS NEUROSCI, V37, P159, DOI 10.1016/j.tins.2014.01.001; Patkai J, 2001, PEDIATR RES, V50, P222, DOI 10.1203/00006450-200108000-00010; Piliponsky AM, 2012, AM J PATHOL, V181, P875, DOI 10.1016/j.ajpath.2012.05.013; Pinto PS, 2012, J NEUROIMAGING, V22, pe1, DOI 10.1111/j.1552-6569.2011.00688.x; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Ribatti D, 2015, EXP CELL RES, V338, P119, DOI 10.1016/j.yexcr.2015.05.013; Rivara FP, 2012, J NEUROTRAUM, V29, P2499, DOI 10.1089/neu.2012.2434; Schang AL, 2014, BRAIN BEHAV IMMUN, V37, P95, DOI 10.1016/j.bbi.2013.11.005; Shimada R, 2012, J CLIN NEUROSCI, V19, P447, DOI 10.1016/j.jocn.2011.06.033; Silver R, 1996, TRENDS NEUROSCI, V19, P25, DOI 10.1016/0166-2236(96)81863-7; Smith PLP, 2014, DEV NEUROSCI-BASEL, V36, P119, DOI 10.1159/000359950; Stokely ME, 2008, J NEUROTRAUM, V25, P52, DOI 10.1089/neu.2007.0397; Stolp HB, 2005, CELL TISSUE RES, V320, P369, DOI 10.1007/s00441-005-1088-6; Strbian D, 2007, J CEREBR BLOOD F MET, V27, P795, DOI 10.1038/sj.jcbfm.9600387; Strbian D, 2006, J CEREBR BLOOD F MET, V26, P605, DOI 10.1038/sj.jcbfm.9600228; Turner CP, 2003, P NATL ACAD SCI USA, V100, P11718, DOI 10.1073/pnas.1931975100; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	47	17	17	0	8	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	DEC	2016	94	12			SI		1546	1560		10.1002/jnr.23911			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EC9DG	WOS:000388443700020	27614029	Green Submitted			2022-02-06	
J	Nagata, K; Kumasaka, K; Browne, KD; Li, SJ; St-Pierre, J; Cognetti, J; Marks, J; Johnson, VE; Smith, DH; Pascual, JL				Nagata, Katsuhiro; Kumasaka, Kenichiro; Browne, Kevin D.; Li, Shengjie; St-Pierre, Jesse; Cognetti, John; Marks, Joshua; Johnson, Victoria E.; Smith, Douglas H.; Pascual, Jose L.			Unfractionated heparin after TBI reduces in vivo cerebrovascular inflammation, brain edema and accelerates cognitive recovery	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	46th Annual Meeting of the Western-Trauma-Association	FEB 28-MAR 04, 2016	CA	Western Trauma Assoc		Heparin; traumatic brain injury; leukocyte	INHIBIT LEUKOCYTE ACCUMULATION; NEUROGENIC PULMONARY-EDEMA; MOLECULAR-WEIGHT HEPARIN; FOCAL CEREBRAL-ISCHEMIA; ACUTE LUNG INJURY; RAT MODEL; ENDOTHELIAL ACTIVATION; NEUROLOGIC RECOVERY; ENOXAPARIN; HEMORRHAGE	BACKGROUND: Severe traumatic brain injury (TBI) may increase the risk of venous thromboembolic complications; however, early prevention with heparinoids is often withheld for its anticoagulant effect. New evidence suggests low molecular weight heparin reduces cerebral edema and improves neurological recovery after stroke and TBI, through blunting of cerebral leukocyte (LEU) recruitment. It remains unknown if unfractionated heparin (UFH) similarly affects brain inflammation and neurological recovery post-TBI. We hypothesized that UFH after TBI reduces cerebral edema by reducing LEU-mediated inflammation and improves neurological recovery. METHODS: CD1 male mice underwent either TBI by controlled cortical impact (CCI) or sham craniotomy. UFH (75 U/kg or 225 U/kg) or vehicle (VEH, 0.9% saline) was administered 2, 11, 20, 27, and 34 hours after TBI. At 48 hours, pial intravital microscopy through a craniotomy was used to visualize live brain LEUs interacting with endothelium and microvascular fluorescein isothiocyanate-albumin leakage. Neurologic function (Garcia Neurological Test, GNT) and body weight loss ratios were evaluated 24 and 48 hours after TBI. Cerebral and lung wet-to-dry ratios were evaluated post mortem. ANOVA with Bonferroni correction was used to determine significance (p < 0.05). RESULTS: Compared to positive controls (CCI), both UFH doses reduced post-TBI in vivo LEU rolling on endothelium, concurrent cerebrovascular albumin leakage, and ipsilateral cerebral water content after TBI. Additionally, only low dose UFH(75 U/kg) improved GNT at both 24 and 48 hours after TBI. High dose UFH (225 U/kg) significantly increased body weight loss above sham at 48 hours. Differences in lung water content and blood pressure between groups were not significant. CONCLUSIONS: UFH after TBI reduces LEU recruitment, microvascular permeability, and brain edema to injured brain. Lower UFH doses concurrently improve neurological recovery whereas higher UFH may worsen functional recovery. Further study is needed to determine if this is caused by increased bleeding from injured brain with higher UFH doses. Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.	[Nagata, Katsuhiro; St-Pierre, Jesse; Pascual, Jose L.] Univ Penn, Perelman Sch Med, Div Traumatol Surg Crit Care & Emergency Surg, Philadelphia, PA 19104 USA; [Browne, Kevin D.; Cognetti, John; Johnson, Victoria E.; Smith, Douglas H.; Pascual, Jose L.] Univ Penn, Perelman Sch Med, Dept Neurosurg, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA; [Marks, Joshua] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Li, Shengjie] Shandong Univ, Dept Neurosurg, Qianfoshan Hosp, Jinan, Peoples R China; [Kumasaka, Kenichiro] Tokyo Med Univ, Hachioji Med Ctr, Dept Emergency & Crit Care Med, Tokyo, Japan		Pascual, JL (corresponding author), Univ Penn, Sch Med, Div Traumatol Surg Crit Care & Emergency Surg, 51 N 39th St,Med Off Bldg,1st Fl Suite 120, Philadelphia, PA 19104 USA.	jose.pascual@uphs.upenn.edu	Pascual, Jose/ABI-2291-2020	Pascual, Jose/0000-0002-1613-7912	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS094003, R01 NS092398] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094003, R01NS092398] Funding Source: NIH RePORTER		Antonenko D, 2013, AM J SURG, V206, P845; Baumann A, 2007, ACTA ANAESTH SCAND, V51, P447, DOI 10.1111/j.1399-6576.2007.01276.x; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; DIAMOND MS, 1995, J CELL BIOL, V130, P1473, DOI 10.1083/jcb.130.6.1473; DiStasi MR, 2009, TRENDS IMMUNOL, V30, P539, DOI 10.1016/j.it.2009.07.012; Dzieciuchowicz Lukasz, 2002, Med Sci Monit, V8, pCR657; Enzmann G, 2013, ACTA NEUROPATHOL, V125, P395, DOI 10.1007/s00401-012-1076-3; Farooqui A, 2013, J NEUROSURG, V119, P1576, DOI 10.3171/2013.8.JNS13424; Gajic O, 2007, CRIT CARE MED, V35, P1979, DOI 10.1097/01.CCM.0000277254.12230.7D; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Glassner S, 2013, RAMBAM MAIMONIDES ME, V4, DOI 10.5041/RMMJ.10101; Hao LN, 2011, BRAIN RES BULL, V86, P355, DOI 10.1016/j.brainresbull.2011.08.018; Hazeldine J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00235; Kim Luke, 2014, J Emerg Trauma Shock, V7, P141, DOI 10.4103/0974-2700.136846; Kubes P, 2000, BRAIN PATHOL, V10, P127; Lee JH, 2008, KOREAN J PHYSIOL PHA, V12, P231, DOI 10.4196/kjpp.2008.12.5.231; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li LF, 2009, CRIT CARE, V13, DOI 10.1186/cc7949; Li SJ, 2016, J TRAUMA ACUTE CARE, V80, P381, DOI 10.1097/TA.0000000000000935; Li SJ, 2015, J TRAUMA ACUTE CARE, V79, P78, DOI 10.1097/TA.0000000000000697; Li X, 2013, INFLAMMATION, V36, P1201, DOI 10.1007/s10753-013-9656-5; Logsdon AF, 2015, COMPR PHYSIOL, V5, P1147, DOI 10.1002/cphy.c140057; Lukaszewicz AC, 2011, CURR OPIN ANESTHESIO, V24, P138, DOI 10.1097/ACO.0b013e32834458af; Manaenko A, 2011, ACTA NEUROCHIR SUPPL, V111, P179, DOI 10.1007/978-3-7091-0693-8_30; Miller SJ, 1998, THROMB HAEMOSTASIS, V80, P481; Moxon-Emre I, 2011, J NEUROPATH EXP NEUR, V70, P218, DOI 10.1097/NEN.0b013e31820d94a5; Paschoa AF, 2016, J THROMB THROMBOLYS, V41, P636, DOI 10.1007/s11239-015-1261-z; Pascual JL, 2013, AM J SURG, V206, P840, DOI 10.1016/j.amjsurg.2013.07.016; Pop V, 2011, TRANSL STROKE RES, V2, P533, DOI 10.1007/s12975-011-0126-9; Reglero-Real N, 2012, CELL MOL LIFE SCI, V69, P3079, DOI 10.1007/s00018-012-0987-4; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Rhind SG, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-5; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Sen O, 2011, TURK NEUROSURG, V21, P203, DOI 10.5137/1019-5149.JTN.3646-10.1; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Stutzmann JM, 2002, CNS DRUG REV, V8, P1; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Vestweber D, 2012, CURR OPIN HEMATOL, V19, P212, DOI 10.1097/MOH.0b013e3283523e78; Wahl F, 2000, J NEUROTRAUM, V17, P1055, DOI 10.1089/neu.2000.17.1055; Wang LC, 2002, J CLIN INVEST, V110, P127, DOI 10.1172/JCI200214996; WANG P, 1990, AM J PHYSIOL, V259, pR645, DOI 10.1152/ajpregu.1990.259.3.R645; WANG P, 1993, J SURG RES, V54, P499, DOI 10.1006/jsre.1993.1077; Weber JR, 1997, J CEREBR BLOOD F MET, V17, P1221, DOI 10.1097/00004647-199711000-00011; Xie X, 1997, BRIT J PHARMACOL, V122, P906, DOI 10.1038/sj.bjp.0701454; Yanaka K, 1996, J NEUROSURG, V85, P1108, DOI 10.3171/jns.1996.85.6.1108; Yanaka K, 1996, J NEUROSURG, V85, P1102, DOI 10.3171/jns.1996.85.6.1102; Zupan Z, 2011, PROG NEURO-PSYCHOPH, V35, P1846, DOI 10.1016/j.pnpbp.2011.08.005	48	17	19	0	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	DEC	2016	81	6					1088	1094		10.1097/TA.0000000000001215			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	EE0BH	WOS:000389237900013	27533909	Green Accepted			2022-02-06	
J	Radabaugh, HL; Carlson, LJ; O'Neil, DA; LaPorte, MJ; Monaco, CM; Cheng, JP; de la Tremblaye, PB; Lajud, N; Bondi, CO; Kline, AE				Radabaugh, Hannah L.; Carlson, Lauren J.; O'Neil, Darik A.; LaPorte, Megan J.; Monaco, Christina M.; Cheng, Jeffrey P.; de la Tremblaye, Patricia B.; Lajud, Naima; Bondi, Corina O.; Kline, Anthony E.			Abbreviated environmental enrichment confers neurobehavioral, cognitive, and histological benefits in brain-injured female rats	EXPERIMENTAL NEUROLOGY			English	Article						Behavioral outcome; Controlled cortical impact; Environmental enrichment; Functional recovery; Learning and memory; Morris water maze; Traumatic brain injury	MEDIATED FUNCTIONAL IMPROVEMENT; RANDOMIZED CONTROLLED-TRIAL; RECEPTOR AGONIST 8-OH-DPAT; CONTROLLED CORTICAL IMPACT; TREATMENT REGIMEN; CLINICAL-TRIALS; RECOVERY; 5-HT1A; REHABILITATION; MODERATE	Environmental enrichment (EE) promotes behavioral recovery after experimental traumatic brain injury (TBI). However, the chronic rehabilitation provided in the laboratory is not analogous to the clinic where physiotherapy is typically limited. Moreover, females make up approximately 40% of the clinical TBI population, yet they are seldom studied in brain trauma. Hence, the goal of this study was to test the hypothesis that abbreviated EE would confer neurobehavioral, cognitive, and histological benefits in brain injured female rats. Anesthetized rats received a cortical impact of moderate-to-severe injury (2.8 mm tissue deformation at 4 m/s) or sham surgery and then were randomly assigned to groups receiving standard (STD) housing or 4 h, 6 h, or 24 h of EE daily. Motor function (beam-balance/walk and rotarod) was assessed on post-operative days 1-5 and every other day from 1 to 19, respectively. Spatial learning/memory (Morris water maze) was evaluated on days 14-19, and cortical lesion volume was quantified on day 21. No statistical differences were appreciated among the sham controls in any assessment and thus the data were pooled. All EE conditions improved motor function and memory retention, but only 6 h and 24 h enhanced spatial learning relative to STD (p < 0.05). Moreover, EE, regardless of duration reduced cortical lesion volume (p < 0.05). These data confirm that abbreviated EE confers robust neurobehavioral, cognitive, and histological benefits in TBI female rats, which supports the hypothesis and strengthens the utility of EE as a pre-clinical model of neurorehabilitation. (C) 2016 Elsevier Inc. All rights reserved.	[Radabaugh, Hannah L.; Carlson, Lauren J.; O'Neil, Darik A.; LaPorte, Megan J.; Monaco, Christina M.; Cheng, Jeffrey P.; de la Tremblaye, Patricia B.; Lajud, Naima; Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Radabaugh, Hannah L.; Carlson, Lauren J.; O'Neil, Darik A.; LaPorte, Megan J.; Monaco, Christina M.; Cheng, Jeffrey P.; de la Tremblaye, Patricia B.; Lajud, Naima; Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Safar Ctr Resuscitat Res, 3471 Fifth Ave,Suite 201, Pittsburgh, PA 15213 USA; [Lajud, Naima] Inst Mexicana Segura Social Morelia, Ctr Invest Biomed Michoacan, Div Neurociencias, Morelia, Michoacan, Mexico; [Bondi, Corina O.] Univ Pittsburgh, Neurobiol, Pittsburgh, PA 15213 USA; [Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15213 USA; [Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; [Kline, Anthony E.] Univ Pittsburgh, Crit Care Med, Pittsburgh, PA 15213 USA; [Kline, Anthony E.] Univ Pittsburgh, Psychol, Pittsburgh, PA 15213 USA; [Monaco, Christina M.] Philadelphia Coll Osteopath Med, Philadelphia, PA 19131 USA		Kline, AE (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, 3471 Fifth Ave,Suite 201, Pittsburgh, PA 15213 USA.; Kline, AE (corresponding author), Univ Pittsburgh, Phys Med & Rehabil, Crit Care Med, Psychol, 3471 Fifth Ave,Suite 201, Pittsburgh, PA 15213 USA.	klineae@upmc.edu	Lajud, Naima/B-4605-2018	Lajud, Naima/0000-0003-3905-798X; O'Neil, Darik/0000-0002-8222-7617; Bondi, Corina/0000-0002-5733-4912; O'Neil, Darik/0000-0002-2475-438X	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS060005, HD069620, HD069620-S1, NS084967, NS094950]; University of Pittsburgh Physicians/UPMC Academic Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD069620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS084967, R03NS094950, R01NS060005] Funding Source: NIH RePORTER	This work was supported, in part, by the National Institutes of Health grants NS060005, HD069620, HD069620-S1, NS084967 (AEK), NS094950 (COB), and the University of Pittsburgh Physicians/UPMC Academic Foundation (COB).	Barry NC, 2015, J CLIN EXP NEUROPSYC, V37, P994, DOI 10.1080/13803395.2015.1038981; Beery AK, 2011, NEUROSCI BIOBEHAV R, V35, P565, DOI 10.1016/j.neubiorev.2010.07.002; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; BLACKERBY W F, 1990, Brain Injury, V4, P167, DOI 10.3109/02699059009026162; Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Bondi CO, 2014, J NEUROTRAUM, V31, P873, DOI 10.1089/neu.2014.3328; Chen X, 2005, NEUROSCIENCE, V135, P11, DOI 10.1016/j.neuroscience.2005.05.041; Cheng JP, 2008, BEHAV BRAIN RES, V194, P79, DOI 10.1016/j.bbr.2008.06.025; Cheng JP, 2016, BRAIN RES, V1640, P5, DOI 10.1016/j.brainres.2015.11.026; Cheng JP, 2012, J NEUROTRAUM, V29, P2684, DOI 10.1089/neu.2012.2560; de Witt BW, 2011, NEUROREHAB NEURAL RE, V25, P343, DOI 10.1177/1545968310390520; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; Faul M, 2010, TRAUMATIC BRAIN INJU; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Garcia AN, 2011, PM&R, V3, pS18, DOI 10.1016/j.pmrj.2011.03.017; Gaulke LJ, 2005, MOL BRAIN RES, V141, P138, DOI 10.1016/j.molbrainres.2005.08.011; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hamm RJ, 1996, J NEUROTRAUM, V13, P41, DOI 10.1089/neu.1996.13.41; Hicks RR, 2002, NEUROSCIENCE, V112, P631, DOI 10.1016/S0306-4522(02)00104-5; Hoffman AN, 2008, NEUROSCI LETT, V431, P226, DOI 10.1016/j.neulet.2007.11.042; Horneman G, 2009, BRAIN INJURY, V23, P907, DOI 10.1080/02699050903283239; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Khaksari M, 2011, CAN J PHYSIOL PHARM, V89, P31, DOI [10.1139/Y10-103, 10.1139/y10-103]; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kline AE, 2002, BRAIN RES, V937, P22, DOI 10.1016/S0006-8993(02)02458-7; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Kline AE, 2016, PROG NEUROBIOL, V142, P45, DOI 10.1016/j.pneurobio.2016.05.002; Kline AE, 2012, J NEUROTRAUM, V29, P1960, DOI 10.1089/neu.2012.2385; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Maghool F, 2013, BRAIN RES, V1497, P61, DOI 10.1016/j.brainres.2012.12.014; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; Menon DK, 2009, CRIT CARE MED, V37, pS129, DOI 10.1097/CCM.0b013e3181921225; Monaco CM, 2014, J NEUROTRAUM, V31, P1934, DOI 10.1089/neu.2014.3541; Monaco CM, 2013, EXP NEUROL, V247, P410, DOI 10.1016/j.expneurol.2013.01.007; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Naderi V, 2015, IRAN J BASIC MED SCI, V18, P138; Olsen AS, 2012, J NEUROTRAUM, V29, P1898, DOI 10.1089/neu.2012.2358; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Richter KM, 2015, J CLIN EXP NEUROPSYC, V37, P571, DOI 10.1080/13803395.2015.1030358; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shiel A, 2001, CLIN REHABIL, V15, P501, DOI 10.1191/026921501680425225; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Yelleswarapu NK, 2012, NEUROSCI LETT, V515, P153, DOI 10.1016/j.neulet.2012.03.033; Zhu XL, 2007, BRAIN INJURY, V21, P681, DOI 10.1080/02699050701468941	53	17	17	0	10	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	DEC	2016	286						61	68		10.1016/j.expneurol.2016.09.015			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EC3ZB	WOS:000388064500007	27693618	Green Accepted			2022-02-06	
J	van der Horn, HJ; Liemburg, EJ; Scheenen, ME; de Koning, ME; Spikman, JM; van der Naalt, J				van der Horn, Harm J.; Liemburg, Edith J.; Scheenen, Myrthe E.; de Koning, Myrthe E.; Spikman, Jacoba M.; van der Naalt, Joukje			Post-concussive complaints after mild traumatic brain injury associated with altered brain networks during working memory performance	BRAIN IMAGING AND BEHAVIOR			English	Article						Mild traumatic brain injury; Post-concussive complaints; Brain networks; Working memory	RESTING-STATE FMRI; HEAD-INJURY; DEPRESSION SCALE; HOSPITAL ANXIETY; DEFAULT NETWORK; FUNCTIONAL MRI; CONNECTIVITY; SYMPTOMS; METAANALYSIS; VALIDATION	The aim was to investigate brain network function during working memory (WM) task performance in patients with uncomplicated mild traumatic brain injury (mTBI) in the sub-acute phase post-injury. We were particularly interested in differences between patients with (PCC-present) and without post-concussive complaints (PCC-absent). Fifty-two patients and twenty healthy controls (HCs) (matched for age, sex, education and handedness) were included. Two patient groups were created based on reported post-concussive complaints at two weeks post-injury: PCC-present (n = 32) and PCC-absent (n = 20). Functional MRI scans were made at approximately four weeks post-injury. Participants performed an n-back task consisting of three conditions (0-, 1- and 2-back) with increasing difficulty. General linear model analysis was performed to investigate activation patterns. Independent component analysis was used to identify brain networks. The frontal executive network (FEN), frontoparietal network (FPN) and default mode network (DMN) were selected for further analyses based on their highest task-relatedness. Task accuracy and reaction times were similar for patients with mTBI and HCs. During high WM load (2-vs.0-back contrast), mTBI patients exhibited lower activation within the medial prefrontal cortex compared to HCs. No differences were found between PCC-present and PCC-absent patients. Regarding network function, PCC-absent patients showed stronger deactivation of the DMN compared to PCC-present patients and HCs, especially during difficult task conditions. Furthermore, functional connectivity between the DMN and FEN was lower in PCC-absent patients compared to PCC-present patients. Interestingly, network function did not differ between PCC-present patients and HCs, suggesting that non-injury related factors may underlie post-concussive complaints after mTBI.	[van der Horn, Harm J.; de Koning, Myrthe E.; van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Hanzepl 1, NL-9700 RB Groningen, Netherlands; [Liemburg, Edith J.] Univ Groningen, Univ Med Ctr Groningen, BCN NeuroImaging Ctr, Groningen, Netherlands; [Liemburg, Edith J.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Groningen, Netherlands; [Scheenen, Myrthe E.; Spikman, Jacoba M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neuropsychol, Groningen, Netherlands		van der Horn, HJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Hanzepl 1, NL-9700 RB Groningen, Netherlands.	h.j.van.der.horn@umcg.nl		Spikman, Jacoba/0000-0002-6477-0763; van der Naalt, Joukje/0000-0001-9873-2418	de Hersenstichting Nederland [Ps2012-06]	This study was supported by de Hersenstichting Nederland (grant no. Ps2012-06). The authors thank R.J. Renken, PhD, for his assistance in the development of Matlab scrips for statistical analyses and the lively discussions about fMRI analyses, and J.C. de Groot, MD, PhD, for the assessment of structural imaging.	Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett CM, 2009, SOC COGN AFFECT NEUR, V4, P417, DOI 10.1093/scan/nsp053; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bocran C, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0354-0; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Borich M, 2015, J NEUROTRAUM, V32, P265, DOI 10.1089/neu.2013.3269; Bryer EJ, 2013, J INT NEUROPSYCH SOC, V19, P751, DOI 10.1017/S1355617713000490; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Chen CJ, 2012, RADIOLOGY, V264, P844, DOI 10.1148/radiol.12112154; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Cole MW, 2014, NEUROSCIENTIST, V20, P652, DOI 10.1177/1073858414525995; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Euston DR, 2012, NEURON, V76, P1057, DOI 10.1016/j.neuron.2012.12.002; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Iverson GL, 2000, BRAIN INJURY, V14, P1057; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Koshino H, 2014, SCI REP-UK, V4, DOI 10.1038/srep05954; Kullmann S, 2013, CEREB CORTEX, V23, P1247, DOI 10.1093/cercor/bhs124; Lange RT, 2015, ARCH CLIN NEUROPSYCH, V30, P7, DOI 10.1093/arclin/acu060; Li Y, 2006, SAMPLE DEPENDENCE CO; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Mayer AR, 2015, J NEUROTRAUM, V32, P1046, DOI 10.1089/neu.2014.3542; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Messina I, 2015, FRONT PSYCHOL, V6, DOI [10.3389/fpsyg.2015.00956, 10.3389/fpsyg.2015.01909]; Michopoulos Ioannis, 2008, Ann Gen Psychiatry, V7, P4, DOI 10.1186/1744-859X-7-4; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Palacios EM, 2012, NEUROLOGY, V78, P852, DOI 10.1212/WNL.0b013e31824c465a; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Servaas MN, 2014, HUM BRAIN MAPP, V35, P4303, DOI 10.1002/hbm.22476; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Sonuga-Barke EJS, 2007, NEUROSCI BIOBEHAV R, V31, P977, DOI 10.1016/j.neubiorev.2007.02.005; Sours C, 2015, BRAIN IMAGING BEHAV, V9, P190, DOI 10.1007/s11682-014-9295-y; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; van der Horn HJ, 2016, J NEUROTRAUM, V33, P1, DOI 10.1089/neu.2015.3905; Veer IM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00041; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Wylie GR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126110; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	59	17	17	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	DEC	2016	10	4					1243	1253		10.1007/s11682-015-9489-y			11	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EF0LC	WOS:000390015900029	26667033	hybrid, Green Published			2022-02-06	
J	Hansen, C; Cushman, D; Anderson, N; Chen, W; Cheng, C; Hon, SD; Hung, M				Hansen, Colby; Cushman, Dan; Anderson, Nicholas; Chen, Wei; Cheng, Christine; Hon, Shirley D.; Hung, Man			A Normative Dataset of the Balance Error Scoring System in Children Aged Between 5 and 14	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						brain concussion; sports; pediatrics; child; reference values	SPORTS-RELATED CONCUSSION; 2ND IMPACT SYNDROME; HIGH-SCHOOL; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; POSTURAL STABILITY; FOOTBALL PLAYERS; UNITED-STATES; INJURY; MANAGEMENT	Objective: Pediatric head injuries occur commonly and are being reported in increasing numbers. Balance testing is a key component in the evaluation of suspected concussion, and the balance error scoring system (BESS) is likely the most well-known and widely used measure. To date, normative BESS scores for adults have been reported but not for children. Design: Normative data for BESS scores and modified BESS scores were created in a cohort of healthy children. Potential variables were analyzed as predictors of BESS performance. Setting: Local elementary and junior high schools. Participants: A total of 373 healthy children between the ages of 5 and 14. Interventions: The BESS was performed on all children. Assessment of Risk Factors: Gender, body mass index percentile, previous concussions, athletic participation, age, and the parental opinion of child's balance ability were examined as factors associated with the BESS score. Main Outcome Measures: BESS scores. Results: Normative data are reported, stratified by age groups of 5 to 7 years, 8 to 10 years, and 11 to 14 years of age, for both BESS and modified BESS. Median BESS scores are 23 for children aged 5 to 7, 18 for children aged 8 to 10, and 16 for children aged 11 to 14. Median modified BESS scores are 8 for children age 5 to 7, 5 for children age 8 to 10, and 4 for children age 11 to 14. Increasing age and positive parental opinion regarding their child's balance ability were independently correlated with decreasing BESS scores (P < 0.01). Conclusions: The normative data on BESS scores for healthy children reported here provide age-stratified reference values for suspected balance alterations.	[Hansen, Colby; Cushman, Dan; Anderson, Nicholas] Univ Utah, Div Phys Med & Rehabil, 590 Wakara Way, Salt Lake City, UT 84108 USA; [Chen, Wei] Univ Utah, Div Epidemiol, Salt Lake City, UT USA; [Cheng, Christine] Roseman Univ, Coll Pharm, South Jordan, UT USA; [Hon, Shirley D.] Univ Utah, Dept Elect & Comp Engn, Salt Lake City, UT USA; [Hung, Man] Univ Utah, Dept Orthopaed, Salt Lake City, UT USA		Cushman, D (corresponding author), Univ Utah, Div Phys Med & Rehabil, 590 Wakara Way, Salt Lake City, UT 84108 USA.	dan.cushman.work@gmail.com	Hansen, Colby/AAP-7680-2021	Hansen, Colby/0000-0002-8012-2483; Cushman, Daniel/0000-0002-4580-1173	University of Utah, Division of PM&R pilot research grant fund; University of Utah Department of Orthopaedics; Center for Outcomes Research and Assessment; Study Design and Biostatistics Center; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR); National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [8UL1TR000105]	Supported by the University of Utah, Division of PM&R pilot research grant fund, the University of Utah Department of Orthopaedics, the Center for Outcomes Research and Assessment and the Study Design and Biostatistics Center, with funding in part from the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant 8UL1TR000105.	[Anonymous], 2013, Br J Sports Med, V47, P259; [Anonymous], 2013, Br J Sports Med, V47, P263; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Burk JM, 2013, CLIN J SPORT MED, V23, P312, DOI 10.1097/JSM.0b013e318285633f; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Davis GA, 2014, BRIT J SPORT MED, V48, P98, DOI 10.1136/bjsports-2012-092132; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Franjoine Mary Rose, 2003, Pediatr Phys Ther, V15, P114, DOI 10.1097/01.PEP.0000068117.48023.18; Furman GR, 2013, AM J SPORT MED, V41, P1404, DOI 10.1177/0363546513484446; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Iverson GL, 2008, BRAIN INJURY, V22, P147, DOI 10.1080/02699050701867407; Iverson GL, 2013, BRAIN INJURY, V27, P596, DOI 10.3109/02699052.2013.772237; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; May KH, 2014, INT J SPORTS PHYS TH, V9, P242; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McCrory P, 2009, PM&R, V1, P406, DOI 10.1016/j.pmrj.2009.03.010; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Parker TM, 2008, MED ENG PHYS, V30, P959, DOI 10.1016/j.medengphy.2007.12.006; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Stuart E, 2015, CURR RES, V2, P22; Zuckerman Scott L, 2012, Surg Neurol Int, V3, P130, DOI 10.4103/2152-7806.102945	33	17	17	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	NOV	2016	26	6					497	501		10.1097/JSM.0000000000000285			5	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	EB6DO	WOS:000387471600010	27783573				2022-02-06	
J	McKay, A; Liew, C; Schonberger, M; Ross, P; Ponsford, J				McKay, Adam; Liew, Carine; Schonberger, Michael; Ross, Pamela; Ponsford, Jennie			Predictors of the On-Road Driving Assessment After Traumatic Brain Injury: Comparing Cognitive Tests, Injury Factors, and Demographics	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cognitive; demographics; driving; neuropsychology; posttraumatic amnesia; severity; time postinjury; traumatic brain injury	DRIVERS; FITNESS; RETURN; PERFORMANCE; ABILITY; STROKE; RISK; SIMULATOR; SAFETY; DAMAGE	Objectives: (1) To examine the relations between performance on cognitive tests and on-road driving assessment in a sample of persons with traumatic brain injury (TBI). (2) To compare cognitive predictors of the on-road assessment with demographic and injury-related predictors. Participants: Ninety-nine people with mild-severe TBI who completed an on-road driving assessment in an Australian rehabilitation setting. Design: Retrospective case series. Main Measures: Wechsler Test of Adult Reading or National Adult Reading Test-Revised; 4 subtests from theWechsler Adult Intelligence Scale-III; Rey Auditory Verbal Leaning Test; Rey Complex Figure Test; TrailMaking Test; demographic factors (age, sex, years licensed); and injury-related factors (duration of posttraumatic amnesia; time postinjury). Results: Participants who failed the driving assessment did worse on measures of attention, visual memory, and executive processing; however, cognitive tests were weak correlates (r values < 0.3) and poor predictors of the driving assessment. Posttraumatic amnesia duration mediated by time postinjury was the strongest predictor of the driving assessment-that is, participants with more severe TBIs had later driving assessments and were more likely to fail. Conclusion: Cognitive tests are not reliable predictors of the on-road driving assessment outcome. Traumatic brain injury severity may be a better predictor of on-road driving; however, further research is needed to identify the best predictors of driving behavior after TBI.	[McKay, Adam; Liew, Carine; Schonberger, Michael; Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Melbourne, Vic, Australia; [McKay, Adam; Schonberger, Michael; Ross, Pamela; Ponsford, Jennie] Epworth HealthCare, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Schonberger, Michael] Univ Freiburg, Inst Psychol, Dept Rehabil Psychol & Psychotherapy, Freiburg, Germany; [Ponsford, Jennie] Natl Trauma Res Inst, Melbourne, Vic, Australia		McKay, A (corresponding author), Monash Univ, Sch Psychol Sci, Clayton, Vic 3800, Australia.	adam.mckay@monash.edu	McKay, Adam/M-6003-2017	McKay, Adam/0000-0002-0479-7681			[Anonymous], 1998, ROADS CORP VIC COMP; Anstey KJ, 2005, CLIN PSYCHOL REV, V25, P45, DOI 10.1016/j.cpr.2004.07.008; Austroads, 2012, ASS FITN DRIV COMM P; BROOKE MM, 1992, AM J PHYS MED REHAB, V71, P177, DOI 10.1097/00002060-199206000-00009; Christie N, 2001, NEUROPSYCHOL REHABIL, V11, P45, DOI 10.1080/09602010042000169; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Collins LM, 2001, PSYCHOL METHODS, V6, P330, DOI 10.1037//1082-989X.6.4.330; Crizzle AM, 2012, NEUROLOGY, V79, P2067, DOI 10.1212/WNL.0b013e3182749e95; Cullen N, 2014, BRAIN INJURY, V28, P38, DOI 10.3109/02699052.2013.849005; Cyr AA, 2009, J CLIN EXP NEUROPSYC, V31, P472, DOI 10.1080/13803390802255627; Devany Serio C, 1994, NeuroRehabilitation, V4, P53, DOI 10.3233/NRE-1994-4108; Devos H, 2011, NEUROLOGY, V76, P747, DOI 10.1212/WNL.0b013e31820d6300; Di Stefano M., 2006, DRIVER REHABILITATIO, P255, DOI DOI 10.1016/B978-032302937-7.50018-6; Fisk GD, 1998, BRAIN INJURY, V12, P683; Formisano R, 2005, BRAIN INJURY, V19, P159, DOI 10.1080/02699050400017163; Fox GK, 1998, ARCH PHYS MED REHAB, V79, P1288, DOI 10.1016/S0003-9993(98)90277-5; GALSKI T, 1993, AM J OCCUP THER, V47, P391, DOI 10.5014/ajot.47.5.391; Galski T, 1997, AM J OCCUP THER, V51, P352, DOI 10.5014/ajot.51.5.352; Graham J. W., 1999, STAT STRATEGIES SMAL, V1, P1, DOI DOI 10.1177/0013164496056006006; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Gregersen NP, 2000, ACCIDENT ANAL PREV, V32, P25, DOI 10.1016/S0001-4575(99)00045-7; Griffen JA, 2011, CLIN NEUROPSYCHOL, V25, P1158, DOI 10.1080/13854046.2011.609841; Hawley CA, 2001, J NEUROL NEUROSUR PS, V70, P761, DOI 10.1136/jnnp.70.6.761; Hinton-Bayre A, 2005, PSYCHOL ASSESSMENT, V17, P237, DOI 10.1037/1040-3590.17.2.237; Innes CRH, 2007, J NEUROL SCI, V260, P188, DOI 10.1016/j.jns.2007.04.052; Iverson DJ, 2010, NEUROLOGY, V74, P1316, DOI 10.1212/WNL.0b013e3181da3b0f; Korteling JE, 1996, ARCH PHYS MED REHAB, V77, P138, DOI 10.1016/S0003-9993(96)90158-6; La Guardia JG, 2007, J PERS, V75, P1205, DOI 10.1111/j.1467-6494.2007.00473.x; Lundqvist A, 2008, BRAIN INJURY, V22, P295, DOI 10.1080/02699050801966133; Lundqvist A, 1997, APPL NEUROPSYCHOL, V4, P220, DOI 10.1207/s15324826an0404_3; Meyers JE., 1995, REY COMPLEX FIGURE T; Morgan S.F., 1992, NEUROPSYCHOLOGY, V6, P327, DOI 10.1037/0894-4105.6.4.327; Nelson HE, 1991, REVISED NATL ADULT R; Neyens DM, 2012, ACCIDENT ANAL PREV, V49, P266, DOI 10.1016/j.aap.2012.01.008; Novack TA, 2006, BRAIN INJURY, V20, P455, DOI 10.1080/02699050600664541; Novack TA, 2010, BRAIN INJURY, V24, P464, DOI 10.3109/02699051003601713; Ortoleva C, 2012, J HEAD TRAUMA REHAB, V27, P302, DOI 10.1097/HTR.0b013e3182236299; PIDIKITI RD, 1991, ARCH PHYS MED REHAB, V72, P109; Pietrapiana P, 2005, BRAIN INJURY, V19, P197, DOI 10.1080/02699050400017197; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Radford KA, 2004, BRAIN INJURY, V18, P775, DOI 10.1080/02699050310001657394; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; Reitan R, 1985, HALSTEAD REITAN NEUR; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Roads Vic, 1999, PROGRAMMED OBSERVATI; Ross PE, 2015, ARCH PHYS MED REHAB, V96, P440, DOI 10.1016/j.apmr.2014.09.027; Schafer JL, 1997, ANAL INCOMPLETE MULT; Schanke AK, 2000, SCAND J PSYCHOL, V41, P113, DOI 10.1111/1467-9450.00179; Smith A., 1982, SYMBOL DIGIT MODALIT; Soderstrom ST, 2006, SCAND J PSYCHOL, V47, P419, DOI 10.1111/j.1467-9450.2006.00550.x; Sommer M, 2010, ARCH CLIN NEUROPSYCH, V25, P99, DOI 10.1093/arclin/acp109; Steyerberg, 2019, CLIN PREDICTION MODE; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Strypstein E., 2001, EUR J PHYS REHAB MED, V37, P227; VANZOMEREN AH, 1988, ARCH PHYS MED REHAB, V69, P90; VANZOMEREN AH, 1987, ARCH PHYS MED REHAB, V68, P697; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WechslerD, 2001, WECHSLER TEST ADULT	58	17	17	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2016	31	6					E44	E52		10.1097/HTR.0000000000000209			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EC0IW	WOS:000387784800005	26709586				2022-02-06	
J	Pasto, L; Portaccio, E; Goretti, B; Ghezzi, A; Lori, S; Hakiki, B; Giannini, M; Righini, I; Razzolini, L; Niccolai, C; Moiola, L; Falautano, M; Simone, M; Viterbo, RG; Patti, F; Cilia, S; Pozzilli, C; Bianchi, V; Roscio, M; Martinelli, V; Comi, G; Trojano, M; Amato, MP				Pasto, Luisa; Portaccio, Emilio; Goretti, Benedetta; Ghezzi, Angelo; Lori, Silvia; Hakiki, Bahia; Giannini, Marta; Righini, Isabella; Razzolini, Lorenzo; Niccolai, Claudia; Moiola, Lucia; Falautano, Monica; Simone, Marta; Viterbo, Rosa Gemma; Patti, Francesco; Cilia, Sabina; Pozzilli, Carlo; Bianchi, Valentina; Roscio, Marco; Martinelli, Vittorio; Comi, Giancarlo; Trojano, Maria; Amato, Maria Pia		Italian Neurological Soc	The cognitive reserve theory in the setting of pediatric-onset multiple sclerosis	MULTIPLE SCLEROSIS JOURNAL			English	Article						Pediatric-onset multiple sclerosis; cognitive reserve; cognitive impairment; intelligence quotient	TRAUMATIC BRAIN-INJURY; FOLLOW-UP; PSYCHOSOCIAL FEATURES; JUVENILE MS; IMPAIRMENT; CHILDHOOD; CHILDREN; EDUCATION; PREDICTORS; MODERATOR	Background: The study of cognitive reserve (CR) in relationship with cognitive impairment (CI) in pediatric-onset multiple sclerosis (POMS) may provide cues to identifying subjects at higher risk of impairment and scope for therapeutic strategies. Objectives: To assess the potential impact of CR on cognition in a cohort of POMS patients. Methods: In all, 48 POMS patients were followed up for 4.7 +/- 0.4 years. CI was defined as the failure of >= 3 tests on an extensive neuropsychological battery. Change of neuropsychological performance was assessed through the Reliable Change Index (RCI) method. At baseline, CR was estimated by measuring the intelligence quotient (IQ). The relationships were assessed through multivariable regression analyses. Results: At baseline, CI was detected in 14/48 (29.2%) patients. Two out of 57 healthy control (HC; 3.5%) met the same criteria of CI (p < 0.001). A deteriorating cognitive performance using the RCI method was observed in 18/48 patients (37.6%). Among the 34 cases who were cognitively preserved at baseline, a higher reserve predicted stable/improving performance (odds ratio (OR) = 1.11; 95% confidence interval (CI): 1.03-1.20; p = 0.006). Conclusion: Our results suggest that higher CR in POMS patients may protect from CI, particularly in subjects with initial cognitive preservation, providing relevant implications for counseling and rehabilitation strategies.	[Pasto, Luisa; Portaccio, Emilio; Goretti, Benedetta; Lori, Silvia; Hakiki, Bahia; Giannini, Marta; Righini, Isabella; Razzolini, Lorenzo; Niccolai, Claudia; Amato, Maria Pia] Univ Florence, Dept NEUROFARBA, Viale Pieraccini 6, I-50134 Florence, Italy; [Portaccio, Emilio; Hakiki, Bahia] Don Carlo Gnocchi Fdn, Florence, Italy; [Ghezzi, Angelo; Roscio, Marco] Hosp Gallarate, MS Ctr, Gallarate, Italy; [Moiola, Lucia; Falautano, Monica; Martinelli, Vittorio; Comi, Giancarlo] Ist Sci San Raffaele, Dept Neurol, Milan, Italy; [Simone, Marta; Viterbo, Rosa Gemma; Trojano, Maria] Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy; [Patti, Francesco] Univ Catania, Dept Med & Surg Sci & Adv Technol, Div Neurosci, Catania, Italy; [Patti, Francesco] Univ Catania, Dept GF Ingrassia Multiple Sclerosis Ctr, Catania, Italy; [Cilia, Sabina] ASP Trapani, Dept Psychol, Trapani, Italy; [Pozzilli, Carlo; Bianchi, Valentina] Sapienza Univ Rome, Dept Neurol & Psychiat, Rome, Italy		Amato, MP (corresponding author), Univ Florence, Dept NEUROFARBA, Viale Pieraccini 6, I-50134 Florence, Italy.	mariapia.amato@unifi.it	amato, Maria Pia/AAL-5998-2020; Moiola, Lucia/AAN-5568-2020; Martinelli, Vittorio/AAN-7240-2020; ghezzi, angelo/AAJ-9606-2020; Simone, Marta/AAE-9877-2020; Amato, Maria Pia/AAC-5940-2022; Hakiki, Bahia/AAB-8461-2022; Pozzilli, Carlo/AAC-3270-2022	amato, Maria Pia/0000-0003-3325-3760; Simone, Marta/0000-0003-4381-4613; Hakiki, Bahia/0000-0001-8540-7405; Pozzilli, Carlo/0000-0002-6360-4798; moiola, lucia/0000-0001-6313-4952; Portaccio, Emilio/0000-0002-9662-1762; patti, francesco/0000-0002-6923-0846; Simone, Marta/0000-0001-6556-3355; Niccolai, Claudia/0000-0003-2746-7500; Trojano, Maria/0000-0002-6329-8946	Fondazione Italiana Sclerosi MultiplaFondazione Italiana Sclerosi Multipla (FISM) [2014/R/2]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The study was funded by Fondazione Italiana Sclerosi Multipla (Grant No. 2014/R/2).	Amato MP, 2008, NEUROLOGY, V70, P1891, DOI 10.1212/01.wnl.0000312276.23177.fa; Amato MP, 2010, NEUROLOGY, V75, P1134, DOI 10.1212/WNL.0b013e3181f4d821; Amato MP, 2014, NEUROLOGY, V83, P1432, DOI 10.1212/WNL.0000000000000885; Amato MP, 2013, NEUROLOGY, V80, P1728, DOI 10.1212/WNL.0b013e3182918c6f; Amato MP, 2012, NEUROPEDIATRICS, V43, P174, DOI 10.1055/s-0032-1324400; AMATO MP, 1995, ARCH NEUROL-CHICAGO, V52, P168, DOI 10.1001/archneur.1995.00540260072019; Amato MP, 2001, ARCH NEUROL-CHICAGO, V58, P1602, DOI 10.1001/archneur.58.10.1602; Banwell B, 2007, LANCET NEUROL, V6, P887, DOI 10.1016/S1474-4422(07)70242-9; Brant AM, 2009, BEHAV GENET, V39, P393, DOI 10.1007/s10519-009-9268-x; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Desai S, 1998, DEMOGRAPHY, V35, P71, DOI 10.2307/3004028; Farmer JE, 2002, DEV NEUROPSYCHOL, V22, P455, DOI 10.1207/S15326942DN2202_2; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Filippi M, 2010, NEUROLOGY, V75, P2121, DOI 10.1212/WNL.0b013e318200d768; Gorman MP, 2009, ARCH NEUROL-CHICAGO, V66, P54, DOI 10.1001/archneurol.2008.505; Hinton-Bayre AD, 2010, ARCH CLIN NEUROPSYCH, V25, P244, DOI 10.1093/arclin/acq008; Hosseini B, 2014, J INT NEUROPSYCH SOC, V20, P796, DOI 10.1017/S1355617714000642; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Johnston MV, 2009, BRAIN DEV-JPN, V31, P1, DOI 10.1016/j.braindev.2008.03.014; KATZMAN R, 1993, NEUROLOGY, V43, P13, DOI 10.1212/WNL.43.1_Part_1.13; Kesler SR, 2010, BRAIN IMAGING BEHAV, V4, P256, DOI 10.1007/s11682-010-9104-1; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Kovacs M. C. D. I., 1988, CDI CHILDREN DEPRESS; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Masten AS, 2001, AM PSYCHOL, V56, P227, DOI 10.1037/0003-066X.56.3.227; Pietschnig J, 2015, PERSPECT PSYCHOL SCI, V10, P282, DOI 10.1177/1745691615577701; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Rocca MA, 2014, HUM BRAIN MAPP, V35, P4180, DOI 10.1002/hbm.22469; Rocca MA, 2014, NEUROLOGY, V82, P1314, DOI 10.1212/WNL.0000000000000309; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Sumowski JF, 2013, MULT SCLER J, V19, P1122, DOI 10.1177/1352458513498834; Sumowski JF, 2013, NEUROLOGY, V80, P2186, DOI 10.1212/WNL.0b013e318296e98b; Sumowski JF, 2010, BRAIN, V133, P362, DOI 10.1093/brain/awp307; Till C, 2011, NEUROPSYCHOLOGY, V25, P319, DOI 10.1037/a0022051; Till C, 2013, NEUROPSYCHOLOGY, V27, P210, DOI 10.1037/a0031665; Vernon-Feagans L, 2008, J APPL DEV PSYCHOL, V29, P213, DOI 10.1016/j.appdev.2008.02.007; Wechsler D, 1974, WISC R MANUAL WECHSL	38	17	18	0	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1352-4585	1477-0970		MULT SCLER J	Mult. Scler. J.	NOV	2016	22	13					1741	1749		10.1177/1352458516629559			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EF8JT	WOS:000390575800014	26869527				2022-02-06	
J	Ravi, S; Pena, KA; Chu, CT; Kiselyov, K				Ravi, Sreeram; Pena, Karina A.; Chu, Charleen T.; Kiselyov, Kirill			Biphasic regulation of lysosomal exocytosis by oxidative stress	CELL CALCIUM			English	Article						Lysosomes; Exocytosis; Calcium; TRPML1; Oxidative stress	MANGANESE SUPEROXIDE-DISMUTASE; MUCOLIPIDOSIS TYPE-IV; TRANSCRIPTION FACTOR EB; TRAUMATIC BRAIN-INJURY; DOUBLE-EDGED-SWORD; PARKINSONS-DISEASE; REACTIVE OXYGEN; POMPE DISEASE; CELL-DEATH; NEURODEGENERATIVE DISEASES	Oxidative stress drives cell death in a number of diseases including ischemic stroke and neurodegenerative diseases. A better understanding of how cells recover from oxidative stress is likely to lead to better treatments for stroke and other diseases. The recent evidence obtained in several models ties the process of lysosomal exocytosis to the clearance of protein aggregates and toxic metals. The mechanisms that regulate lysosomal exocytosis, under normal or pathological conditions, are only beginning to emerge. Here we provide evidence for the biphasic effect of oxidative stress on lysosomal exocytosis. Lysosomal exocytosis was measured using the extracellular levels of the lysosomal enzyme beta-hexosaminidase (beta-hex). Low levels or oxidative stress stimulated lysosomal exocytosis, but inhibited it at high levels. Deletion of the lysosomal ion channel TRPML1 eliminated the stimulatory effect of low levels of oxidative stress. The inhibitory effects of oxidative stress appear to target the component of lysosomal exocytosis that is driven by extracellular Ca2+. We propose that while moderate oxidative stress promotes cellular repair by stimulating lysosomal exocytosis, at high levels oxidative stress has a dual pathological effect: it directly causes cell damage and impairs damage repair by inhibiting lysosomal exocytosis. Harnessing these adaptive mechanisms may point to pharmacological interventions for diseases involving oxidative proteotoxicity or metal toxicity. (C) 2016 Elsevier Ltd. All rights reserved.	[Ravi, Sreeram; Pena, Karina A.; Kiselyov, Kirill] Dept Biol Sci, Pittsburgh, PA 15260 USA; [Chu, Charleen T.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA; [Pena, Karina A.] Univ Pittsburgh, Ctr Biol Imaging, Pittsburgh, PA USA		Kiselyov, K (corresponding author), Dept Biol Sci, Pittsburgh, PA 15260 USA.	kiselyov@pitt.edu	Chu, Charleen T/B-1601-2008	Chu, Charleen T/0000-0002-5052-8271	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD058577, ES01678, NS096755, NS094860, AG026389, NS065789]; Mucolipidosis type IV foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD058577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R21ES016782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R56NS065789, R01NS096755, R21NS094860, R01NS065789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG026389] Funding Source: NIH RePORTER	These studies were supported by NIH grants HD058577, ES01678, NS096755 and NS094860, and Mucolipidosis type IV foundation grant to KK, and NIH grants AG026389 and NS065789 to CTC.	Arantes RME, 2006, J NEUROSCI, V26, P4630, DOI 10.1523/JNEUROSCI.0009-06.2006; Barnett A, 2011, J ALZHEIMERS DIS, V25, P385, DOI 10.3233/JAD-2011-101989; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Bogeski I, 2012, J PHYSIOL-LONDON, V590, P4193, DOI 10.1113/jphysiol.2012.230565; Bogeski I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000672; Callio J, 2005, J BIOL CHEM, V280, P18536, DOI 10.1074/jbc.M413224200; Caruano-Yzermans AL, 2006, J BIOL CHEM, V281, P13581, DOI 10.1074/jbc.M601580200; Cheng XP, 2014, NAT MED, V20, P1187, DOI 10.1038/nm.3611; Cherra SJ, 2008, FUTUR NEUROL, V3, P309, DOI 10.2217/14796708.3.3.309; Chu CT, 2013, NAT CELL BIOL, V15, P1197, DOI 10.1038/ncb2837; Coblentz J, 2014, BIOCHEM J, V457, P361, DOI 10.1042/BJ20130647; Colletti GA, 2012, J BIOL CHEM, V287, P8082, DOI 10.1074/jbc.M111.285536; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Dagda RK, 2011, CELL DEATH DIFFER, V18, P1914, DOI 10.1038/cdd.2011.74; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; De Filippis B., 2015, BIOL MED, V83, P167; Decressac M, 2013, P NATL ACAD SCI USA, V110, pE1817, DOI 10.1073/pnas.1305623110; Drose S, 2012, ADV EXP MED BIOL, V748, P145, DOI 10.1007/978-1-4614-3573-0_6; Feeney EJ, 2013, AUTOPHAGY, V9, P1117, DOI 10.4161/auto.24920; Fiskum G, 2003, ANN NY ACAD SCI, V991, P111; Gaetke LM, 2003, TOXICOLOGY, V189, P147, DOI 10.1016/S0300-483X(03)00159-8; Gasier HG, 2013, UNDERSEA HYPERBAR M, V40, P125; Giordano S, 2014, REDOX BIOL, V2, P82, DOI 10.1016/j.redox.2013.12.013; Granzotto A, 2015, NEUROBIOL DIS, V81, P25, DOI 10.1016/j.nbd.2015.04.010; Gu F, 2015, CURR OPIN CLIN NUTR, V18, P89, DOI 10.1097/MCO.0000000000000134; Hegde ML, 2011, J ALZHEIMERS DIS, V24, P183, DOI 10.3233/JAD-2011-110281; HRUBAN Z, 1963, AM J PATHOL, V42, P657; Hwang JJ, 2008, J NEUROSCI, V28, P3114, DOI 10.1523/JNEUROSCI.0199-08.2008; Hwang JJ, 2010, BIOMETALS, V23, P997, DOI 10.1007/s10534-010-9346-9; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kalogeris T, 2014, REDOX BIOL, V2, P702, DOI 10.1016/j.redox.2014.05.006; Kim GW, 2002, STROKE, V33, P809, DOI 10.1161/hs0302.103745; Korolchuk VI, 2011, AUTOPHAGY, V7, P927, DOI 10.4161/auto.7.8.15862; Kukic I, 2014, J CELL SCI, V127, P3094, DOI 10.1242/jcs.145318; Kukic I, 2013, BIOCHEM J, V451, P155, DOI 10.1042/BJ20121506; La Spada AR, 2012, AUTOPHAGY, V8, P1845, DOI 10.4161/auto.21862; LaPlante JM, 2006, MOL GENET METAB, V89, P339, DOI 10.1016/j.ymgme.2006.05.016; Lee SJ, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-30; Lee SJ, 2010, GLIA, V58, P1186, DOI 10.1002/glia.20998; Li XR, 2016, NAT CELL BIOL, V18, P404, DOI 10.1038/ncb3324; MacMillan-Crow LA, 2001, FREE RADICAL RES, V34, P325, DOI 10.1080/10715760100300281; Martina JA, 2014, CELL MOL LIFE SCI, V71, P2483, DOI 10.1007/s00018-014-1565-8; Mazzio EA, 2004, BRAIN RES, V1004, P29, DOI 10.1016/j.brainres.2003.12.034; Medina DL, 2011, DEV CELL, V21, P421, DOI 10.1016/j.devcel.2011.07.016; Miedel MT, 2008, J EXP MED, V205, P1477, DOI 10.1084/jem.20072194; Milton NGN, 2001, NEUROTOXICOLOGY, V22, P767, DOI 10.1016/S0161-813X(01)00064-X; Mortiboys H, 2008, ANN NEUROL, V64, P555, DOI 10.1002/ana.21492; Nowak G, 2006, AM J PHYSIOL-RENAL, V291, pF840, DOI 10.1152/ajprenal.00219.2005; Nunes P, 2014, ANTIOXID REDOX SIGN, V21, P915, DOI 10.1089/ars.2013.5615; Osellame LD, 2014, BRIT J PHARMACOL, V171, P1958, DOI 10.1111/bph.12453; Parellada M, 2012, J PSYCHIATR RES, V46, P394, DOI 10.1016/j.jpsychires.2011.10.004; Pastore N, 2013, AUTOPHAGY, V9, P1094, DOI 10.4161/auto.24469; Pastore N, 2013, EMBO MOL MED, V5, P397, DOI 10.1002/emmm.201202046; Pena K, 2015, CELL CALCIUM, V57, P257, DOI 10.1016/j.ceca.2015.01.005; Pena KA, 2015, BIOCHEM J, V470, P65, DOI 10.1042/BJ20140645; Polishchuk EV, 2014, DEV CELL, V29, P686, DOI 10.1016/j.devcel.2014.04.033; Polito VA, 2014, EMBO MOL MED, V6, P1142, DOI 10.15252/emmm.201303671; Przedborski S, 2005, ANTIOXID REDOX SIGN, V7, P685, DOI 10.1089/ars.2005.7.685; Raben N, 2012, AM J MED GENET C, V160C, P13, DOI 10.1002/ajmg.c.31317; Rabin DM, 2013, AGING-US, V5, P51; Rao SK, 2004, J BIOL CHEM, V279, P20471, DOI 10.1074/jbc.M400798200; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Rossignol DA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00150; Salazar J, 2008, P NATL ACAD SCI USA, V105, P18578, DOI 10.1073/pnas.0804373105; Samie M, 2013, DEV CELL, V26, P511, DOI 10.1016/j.devcel.2013.08.003; Samie MA, 2014, J LIPID RES, V55, P995, DOI 10.1194/jlr.R046896; Schafer M, 2014, CELL TISSUE RES, V357, P395, DOI 10.1007/s00441-014-1807-y; Schrag M, 2011, PROG NEUROBIOL, V94, P296, DOI 10.1016/j.pneurobio.2011.05.001; Settembre C, 2015, METHOD CELL BIOL, V126, P45, DOI 10.1016/bs.mcb.2014.11.011; Sherer TB, 2005, ANTIOXID REDOX SIGN, V7, P627, DOI 10.1089/ars.2005.7.627; Spampanato C, 2013, EMBO MOL MED, V5, P691, DOI 10.1002/emmm.201202176; Testa CM, 2005, MOL BRAIN RES, V134, P109, DOI 10.1016/j.molbrainres.2004.11.007; Xie YX, 2015, NEURON, V87, P355, DOI 10.1016/j.neuron.2015.06.026; Zhang X, 2012, P NATL ACAD SCI US; Zhang XL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12109	76	17	17	0	13	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0143-4160	1532-1991		CELL CALCIUM	Cell Calcium	NOV	2016	60	5					356	362		10.1016/j.ceca.2016.08.002			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	EA8CA	WOS:000386861700007	27593159	Green Accepted			2022-02-06	
J	Silverberg, ND; Iverson, GL; Brubacher, JR; Holland, E; Hoshino, LC; Aquino, A; Lange, RT				Silverberg, Noah D.; Iverson, Grant L.; Brubacher, Jeffrey R.; Holland, Elizabeth; Hoshino, Lisa Casagrande; Aquino, Angela; Lange, Rael T.			The Nature and Clinical Significance of Preinjury Recall Bias Following Mild Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain concussion; good-old-days bias; postconcussion syndrome; psychological models; recall bias	GOOD-OLD-DAYS; POST-CONCUSSION SYMPTOMS; COGNITIVE-BEHAVIORAL PREVENTION; HEAD-INJURY; POSTCONCUSSION-SYNDROME; ETIOLOGY; EXPECTATION; PERCEPTION; SAMPLE	Objective: Patients with mild traumatic brain injury (MTBI) often underestimate their preinjury symptoms. This study aimed to clarify the mechanism underlying this recall bias and its contribution to MTBI outcome. Setting: Level I trauma center. Participants: Patients with uncomplicated MTBI (N = 88) and orthopedic injury (N = 67). Design: Prospective longitudinal. Main Measures: Current and retrospective ratings on the British Columbia Postconcussion Symptom Inventory, completed at 6 weeks and 1 year postinjury. Results: Preinjury symptom reporting was comparable across groups, static across time, and associated with compensation-seeking. High preinjury symptom reporting was related to high postinjury symptom reporting in the orthopedic injury group but less so in the MTBI group, indicating a stronger positive recall bias in highly symptomatic MTBI patients. Low preinjury symptom reporting was not a risk factor for poor MTBI outcome. Conclusion: The recall bias was stronger and more likely clinically significant in MTBI patients with high postinjury symptoms. Multiple mechanisms appear to contribute to recall bias after MTBI, including the reattribution of preexisting symptoms to MTBI as well as processes that are not specific to MTBI (eg, related to compensation-seeking).	[Silverberg, Noah D.] Univ British Columbia, Div Phys Med & Rehabil, Vancouver, BC, Canada; [Iverson, Grant L.; Lange, Rael T.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Brubacher, Jeffrey R.] Univ British Columbia, Dept Emergency Med, Vancouver, BC, Canada; [Aquino, Angela] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Silverberg, Noah D.] GF Strong Rehab Ctr, Rehabil Res Program, 4255 Laurel St, Vancouver, BC V5Z 2G9, Canada; [Iverson, Grant L.] Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Iverson, Grant L.] Red Sox Fdn, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp, Home Base Program, Boston, MA 02114 USA; [Hoshino, Lisa Casagrande] Simon Fraser Univ, Dept Psychol, Burnaby, BC, Canada; [Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA		Silverberg, ND (corresponding author), GF Strong Rehab Ctr, Rehabil Res Program, 4255 Laurel St, Vancouver, BC V5Z 2G9, Canada.	noah.silverberg@vch.ca		Brubacher, Jeffrey/0000-0002-4866-4231; Iverson, Grant/0000-0001-7348-9570	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [200903 MOP-200377-BSB-CAAA-161276]; Vancouver Coastal Health Research Institute; INTRuST Posttraumatic Stress Disorder and Traumatic Brain Injury Clinical Consortium - Department of Defense Psychological Health/Traumatic Brain Injury Research Program [X81XWH-07-CC-CSDoD]; MTBI	Primary funding for this study was provided by the Canadian Institutes of Health Research (200903 MOP-200377-BSB-CAAA-161276); provided to R.T.L. as principal investigator). N.D.S. received salary support from the Vancouver Coastal Health Research Institute. G.L.I. was supported in part by the INTRuST Posttraumatic Stress Disorder and Traumatic Brain Injury Clinical Consortium funded by the Department of Defense Psychological Health/Traumatic Brain Injury Research Program (X81XWH-07-CC-CSDoD). The authors thank Jan Buchanan for assistance with patient recruitment.; G.L.I. has been reimbursed by the government, professional scientific bodies, and commercial organizations for discussing or presenting research relating to mild traumatic brain injury (MTBI) and sport-related concussion at meetings, scientific conferences, and symposiums. He has a clinical practice in forensic neuropsychology involving individuals who have sustained MTBIs. He has received honorariums for serving on research panels that provide scientific peer review of programs. He is a coinvestigator, collaborator, or consultant on grants relating to MTBI funded by several organizations.	Alla S, 2012, BRIT J SPORT MED, V46, P562, DOI 10.1136/bjsm.2010.081299; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Barsky AJ, 2002, JAMA-J AM MED ASSOC, V287, P622, DOI 10.1001/jama.287.5.622; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P186, DOI 10.1093/arclin/act083; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Davis CH, 2002, AM J PHYS MED REHAB, V81, P609, DOI 10.1097/00002060-200208000-00009; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Ferguson RJ, 1999, NEUROPSYCHOLOGY, V13, P582, DOI 10.1037/0894-4105.13.4.582; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; GREENWALD AG, 1980, AM PSYCHOL, V35, P603, DOI 10.1037//0003-066X.35.7.603; Greiffenstein MF, 2002, PSYCHOL ASSESSMENT, V14, P202, DOI 10.1037//1040-3590.14.2.202; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Hilsabeck RC, 1998, J CLIN EXP NEUROPSYC, V20, P328, DOI 10.1076/jcen.20.3.328.813; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; King NS, 2014, BRAIN INJURY, V28, P1639, DOI 10.3109/02699052.2014.954271; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P478, DOI 10.1093/arclin/acu027; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; Langley J, 2010, BRAIN INJURY, V24, P939, DOI 10.3109/02699052.2010.491494; LeesHaley PR, 1997, BRAIN INJURY, V11, P791; Mitchell TR, 1997, J EXP SOC PSYCHOL, V33, P421, DOI 10.1006/jesp.1997.1333; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Panayiotou A, 2011, AUST PSYCHOL, V46, P210, DOI 10.1111/j.1742-9544.2010.00018.x; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P313, DOI 10.1097/HTR.0b013e3182915cb5; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Sullivan K, 2011, J HEAD TRAUMA REHAB, V26, P170, DOI 10.1097/HTR.0b013e3181e47f95; Sullivan KA, 2012, BRAIN INJURY, V26, P1098, DOI 10.3109/02699052.2012.666367; Vanderploeg RD, 2014, PSYCHOL INJ LAW, V7, P245, DOI 10.1007/s12207-014-9201-3; Vikane E, 2014, BRAIN INJURY, V28, P1374, DOI 10.3109/02699052.2014.919532; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Yang CC, 2014, J CLIN EXP NEUROPSYC, V36, P399, DOI 10.1080/13803395.2014.903899	39	17	17	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2016	31	6					388	396		10.1097/HTR.0000000000000198			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EC0IW	WOS:000387784800010	26580693				2022-02-06	
J	Strauss, SB; Kim, N; Branch, CA; Kahn, ME; Kim, M; Lipton, RB; Provataris, JM; Scholl, HF; Zimmerman, ME; Lipton, ML				Strauss, S. B.; Kim, N.; Branch, C. A.; Kahn, M. E.; Kim, M.; Lipton, R. B.; Provataris, J. M.; Scholl, H. F.; Zimmerman, M. E.; Lipton, M. L.			Bidirectional Changes in Anisotropy Are Associated with Outcomes in Mild Traumatic Brain Injury	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							POST-CONCUSSION SYMPTOMS; SICKNESS IMPACT PROFILE; TENSOR IMAGING DETECTS; WHITE-MATTER INJURY; AXONAL INJURY; IMPAIRMENT; ATTENTION; TIME; QUESTIONNAIRE; REGISTRATION	BACKGROUND AND PURPOSE: Mild traumatic brain injury results in a heterogeneous constellation of deficits and symptoms that persist in a subset of patients. This prospective longitudinal study identifies early diffusion tensor imaging biomarkers of mild traumatic brain injury that significantly relate to outcomes at 1 year following injury. MATERIALS AND METHODS: DTI was performed on 39 subjects with mild traumatic brain injury within 16 days of injury and 40 controls; 26 subjects with mild traumatic brain injury returned for follow-up at 1 year. We identified subject-specific regions of abnormally high and low fractional anisotropy and calculated mean fractional anisotropy, axial diffusivity, radial diffusivity, and mean diffusivity across all white matter voxels brain-wide and each of several white matter regions. Assessment of cognitive performance and symptom burden was performed at 1 year. RESULTS: Significant associations of brain-wide DTI measures and outcomes included the following: mean radial diffusivity and mean diffusivity with memory; and mean fractional anisotropy, radial diffusivity, and mean diffusivity with health-related quality of life. Significant differences in outcomes were found between subjects with and without abnormally high fractional anisotropy for the following white matter regions and outcome measures: left frontal lobe and left temporal lobe with attention at 1 year, left and right cerebelli with somatic postconcussion symptoms at 1 year, and right thalamus with emotional postconcussion symptoms at 1 year. CONCLUSIONS: Individualized assessment of DTI abnormalities significantly relates to long-term outcomes in mild traumatic brain injury. Abnormally high fractional anisotropy is significantly associated with better outcomes and might represent an imaging correlate of postinjury compensatory processes.	[Strauss, S. B.; Lipton, M. L.] Montefiore Med Ctr, Dept Radiol, 111 E 210th St, Bronx, NY 10467 USA; [Kim, N.; Lipton, M. L.] Albert Einstein Coll Med, Dept Radiol, Bronx, NY 10461 USA; [Branch, C. A.] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; [Kim, M.; Lipton, R. B.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA; [Lipton, M. L.] Albert Einstein Coll Med, Dept Psychiat & Behav Sci, Bronx, NY 10461 USA; [Kim, N.; Branch, C. A.; Kahn, M. E.; Scholl, H. F.; Lipton, M. L.] Albert Einstein Coll Med, Gruss Magnet Resonance Res Ctr, Bronx, NY 10461 USA; [Lipton, R. B.; Zimmerman, M. E.] Albert Einstein Coll Med, Saul R Korey Dept Neurol, Bronx, NY 10461 USA; [Lipton, M. L.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA; [Provataris, J. M.] Jacobi Med Ctr, Dept Emergency Med, Bronx, NY USA		Lipton, ML (corresponding author), Albert Einstein Coll Med, Jack & Pearl Resnick Campus, Bronx, NY 10461 USA.	michael.lipton@einstein.yu.edu	Lipton, Richard B/B-5060-2011; Lipton, Richard Bruce/AAY-2818-2021	Lipton, Richard/0000-0003-2652-2897; Kim, Namhee/0000-0003-1618-1363; Lipton, Michael/0000-0001-5421-8441	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS047256, R01NS082432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG003949, R01AG022374, R01AG012101, R01AG025119, R01AG034119, P01AG027734] Funding Source: NIH RePORTER	Mimi Kim-RELATED: Grant: National Institutes of Health*; UNRELATED: Consultancy: Lupus Foundation of America; Grants/Grants Pending: National Institutes of Health.* Richard B. Lipton-RELATED: Grant: National Institutes of Health R01*; UNRELATED: Consultancy: serves as consultant and advisory board member or has received honoraria from Alder, Allergan, American Headache Society, Autonomic Technologies, Avanir Pharmaceuticals, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, Colucid Pharmaceuticals, Dr Reddy's Laboratories, ElectroCore, Eli Lilly, eNeura Therapeutics, Informa, Merck & Co, Novartis, Pfizer, Teva, and Vedanta; Grants/Grants Pending: receives research support from the National Institutes of Health*: PO1AG003949 (Program Director), PO1AG027734 (Project Leader), RO1AG025119 (Investigator), RO1AG022374-06A2 (Investigator), RO1AG034119 (Investigator), RO1AG12101 (Investigator), 23NS05140901A1 (Mentor), and K23NS47256 (Mentor), and the National Headache Foundation*; Payment for Lectures (including service on Speakers Bureaus): lecture honoraria for Continuing Medical Education-accredited lectures from the American Headache Society, the American Academy of Neurology, and the Headache Cooperative of New England; Payment for Development of Educational Presentations: American Headache Society, Comments: Chronic Migraine Education Program; Stock/Stock Options: eNeura Therapeutics. Michael L. Lipton-UNRELATED: Expert Testimony: Various (on behalf of defendants and plaintiffs); Grants/Grants Pending: Resurrecting Lives Foundation,* Comments: grant for research on imaging in blast TBI; Patents (planned, pending or issued): image-processing methodology (patent pending)*; Royalties: Springer (MRI physics book); Other: the Dana Foundation,* Comments: grant for study of imaging in sports TBI. * Money paid to the institution.	Alhilali LM, 2014, RADIOLOGY, V272, P224, DOI 10.1148/radiol.14132670; Ardekani BA, 2005, J NEUROSCI METH, V142, P67, DOI 10.1016/j.jneumeth.2004.07.014; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; BERGNER M, 1976, MED CARE, V14, P57, DOI 10.1097/00005650-197601000-00006; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; Bocquillon P, 2009, HUM BRAIN MAPP, V30, P2267, DOI 10.1002/hbm.20666; Bonhoeffer T, 2002, NEURON, V35, P1019, DOI 10.1016/S0896-6273(02)00906-6; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Filley CM, 2011, NEUROL CLIN, V29, P81, DOI 10.1016/j.ncl.2010.10.003; Filley CM, 2010, NEUROPSYCHOL REV, V20, P158, DOI 10.1007/s11065-010-9127-9; FOSTER JK, 1994, COGNITIVE NEUROPSYCH, V11, P133, DOI 10.1080/02643299408251971; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Grossman EJ, 2016, J NEUROTRAUM, V33, P163, DOI 10.1089/neu.2015.3965; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kim N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059382; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Klawiter EC, 2011, NEUROIMAGE, V55, P1454, DOI 10.1016/j.neuroimage.2011.01.007; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2014, HUM BRAIN MAPP, V35, P5457, DOI 10.1002/hbm.22563; Nagahama Y, 2001, CEREB CORTEX, V11, P85, DOI 10.1093/cercor/11.1.85; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; OLTON DS, 1988, NEUROPSYCHOLOGIA, V26, P307, DOI 10.1016/0028-3932(88)90083-8; Oouchi H, 2007, AM J NEURORADIOL, V28, P1102, DOI 10.3174/ajnr.A0488; Paniak C, 2000, BRAIN INJURY, V14, P219; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Sbordone RJ, 2014, APPL NEUROPSYCH-ADUL, V21, P98, DOI 10.1080/09084282.2012.762630; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Williams LM, 2005, INT J NEUROSCI, V115, P1605, DOI 10.1080/00207450590958475; Yuspeh RL, 2000, ARCH CLIN NEUROPSYCH, V15, P319, DOI 10.1016/S0887-6177(99)00020-7	53	17	17	0	7	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	NOV	2016	37	11					1983	1991		10.3174/ajnr.A4851			9	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	EC2PI	WOS:000387965400011	27282864	hybrid, Green Published, Green Accepted			2022-02-06	
J	Pascarella, A; Trojano, L; Loreto, V; Bilo, L; Moretta, P; Estraneo, A				Pascarella, Angelo; Trojano, Luigi; Loreto, Vincenzo; Bilo, Leonilda; Moretta, Pasquale; Estraneo, Anna			Long-term outcome of patients with disorders of consciousness with and without epileptiform activity and seizures: a prospective single centre cohort study	JOURNAL OF NEUROLOGY			English	Article						Disorders of consciousness; Epileptiform activity; Epileptic seizures; Neurorehabilitation; Outcome	LATE RECOVERY; EEG PATTERNS; EPILEPSY; MECHANISMS; MORTALITY; REHABILITATION; RESPONSIVENESS; MULTICENTER; DEFINITION; PREDICTORS	Brain-injured patients can experience epileptic seizures beyond 1 week from injury (unprovoked remote symptomatic epileptic seizures). In our longitudinal observational study, we analysed occurrence of unprovoked remote epileptic seizures and interictal epileptiform activity in 130 traumatic, vascular or anoxic inpatients with disorders of consciousness (DOC), with a clinical diagnosis of vegetative state (n = 97) or minimally conscious state (n = 33). We also investigated impact of epileptic seizures and epileptiform activity on clinical outcome (30 months post-onset). Epileptic seizures occurred in 35/130 patients (26.9 %), epileptiform activity in 61/130 (46.9 %) patients, without significant differences related to clinical diagnosis or aetiology. Among patients with epileptiform activity, only 26/61 (42.6 %) developed clinically evident seizures. Mortality at 30 months was not significantly influenced by the presence of seizures or epileptiform activity. The proportion of patients who recovered at long-term follow-up was higher in patients without than in patients with epileptic seizures, but was similar in patients with or without epileptiform activity. The presence of epileptic seizures but not of epileptiform activity, significantly affected the level of responsiveness at final outcome. In conclusion, seizures were detected in about one third of the whole sample, and in about a half of patients with epileptiform activity, regardless of clinical diagnosis or aetiology. Although epileptic seizures or epileptiform activity did not significantly affect mortality rate, we demonstrated that epileptic seizures could hamper recovery of consciousness. Epileptic seizures thus qualify as one of the factors largely undetermined at the moment which can influence prognosis in DOC patients.	[Pascarella, Angelo; Loreto, Vincenzo; Moretta, Pasquale; Estraneo, Anna] IRCCS, Salvatore Maugeri Fdn, Inst Sci, Res Lab, Via Bagni Vecchi 1, I-82037 Telese Terme, BN, Italy; [Pascarella, Angelo; Loreto, Vincenzo; Moretta, Pasquale; Estraneo, Anna] IRCCS, Salvatore Maugeri Fdn, Inst Sci, Neurorehabilitat Unit Disorder Consciousness, Via Bagni Vecchi 1, I-82037 Telese Terme, BN, Italy; [Trojano, Luigi] Univ Naples 2, Dept Psychol, Caserta, Italy; [Bilo, Leonilda] Univ Naples Federico II, Dept Neurosci Reprod & Odontostomatol Sci, Naples, Italy		Estraneo, A (corresponding author), IRCCS, Salvatore Maugeri Fdn, Inst Sci, Res Lab, Via Bagni Vecchi 1, I-82037 Telese Terme, BN, Italy.; Estraneo, A (corresponding author), IRCCS, Salvatore Maugeri Fdn, Inst Sci, Neurorehabilitat Unit Disorder Consciousness, Via Bagni Vecchi 1, I-82037 Telese Terme, BN, Italy.	anna.estraneo@fsm.it	Pascarella, Angelo/A-9813-2016; Trojano, Luigi/F-2396-2016; Moretta, Pasquale/AAE-5162-2021	Pascarella, Angelo/0000-0002-0085-9494; Trojano, Luigi/0000-0002-0328-9642; Moretta, Pasquale/0000-0003-2244-254X; Bilo, Leonilda/0000-0002-9817-4193			Amantini A, 2009, NEUROPHYSIOL CLIN, V39, P85, DOI 10.1016/j.neucli.2009.01.006; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Askalan R, 2015, BRAIN RES, V1629, P94, DOI 10.1016/j.brainres.2015.10.020; Bagnato S, 2016, EPILEPSY BEHAV, V56, P83, DOI 10.1016/j.yebeh.2015.12.012; Bagnato S, 2013, EPILEPSY RES, V103, P106, DOI 10.1016/j.eplepsyres.2012.09.008; Beghi E, 2010, EPILEPSIA, V51, P671, DOI 10.1111/j.1528-1167.2009.02285.x; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Bodien YG, 2016, ARCH PHYS MED REHAB, V97, P490, DOI 10.1016/j.apmr.2015.08.422; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Claassen J, 2013, INTENS CARE MED, V39, P1337, DOI 10.1007/s00134-013-2938-4; Andraus MEC, 2012, ARQ NEURO-PSIQUIAT, V70, P145, DOI 10.1590/S0004-282X2012000200014; Demertzi A, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2010.00245; Estraneo A, 2015, EUR J PHYS REHAB MED, V51, P627; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Estraneo A, 2016, CLIN NEUROPHYSIOL, V127, P2379, DOI 10.1016/j.clinph.2016.03.021; Estraneo A, 2015, CLIN REHABIL, V29, P803, DOI 10.1177/0269215514556002; Estraneo A, 2014, ARCH PHYS MED REHAB, V95, P711, DOI 10.1016/j.apmr.2013.11.004; Estraneo A, 2013, NEUROLOGY, V80, P464, DOI 10.1212/WNL.0b013e31827f0f31; Fitzpatrick W, 2007, CAN J NEUROL SCI, V34, P443, DOI 10.1017/S0317167100007332; Ganesh S, 2013, ARCH PHYS MED REHAB, V94, P1899, DOI 10.1016/j.apmr.2012.12.026; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Guerit JM, 2009, NEUROPHYSIOL CLIN, V39, P71, DOI 10.1016/j.neucli.2009.03.002; Hauser WA, 2008, EPILEPSIA, V49, P8, DOI 10.1111/j.1528-1167.2008.01443.x; Hesdorffer DC, 2009, EPILEPSIA, V50, P1102, DOI 10.1111/j.1528-1167.2008.01945.x; Hirsch LJ, 2013, J CLIN NEUROPHYSIOL, V30, P1, DOI 10.1097/WNP.0b013e3182784729; Hirsch LJ, 2011, EPILEPSIA, V52, P21, DOI 10.1111/j.1528-1167.2011.03228.x; Holtkamp Martin, 2011, Ther Adv Neurol Disord, V4, P169, DOI 10.1177/1756285611403826; Keezer MR, 2016, NEUROLOGY, V86, P704, DOI 10.1212/WNL.0000000000002390; Librizzi L, 2012, ANN NEUROL, V72, P82, DOI 10.1002/ana.23567; Lucke-Wold BP, 2015, SEIZURE-EUR J EPILEP, V33, P13, DOI 10.1016/j.seizure.2015.10.002; Majerus S, 2005, PROG BRAIN RES, V150, P397, DOI 10.1016/S0079-6123(05)50028-1; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Mula M, 2009, CNS DRUGS, V23, P121, DOI 10.2165/00023210-200923020-00003; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Neligan A, 2010, EPILEPSIA, V51, P2241, DOI 10.1111/j.1528-1167.2010.02711.x; Noachtar S, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P21; SALINSKY M, 1987, EPILEPSIA, V28, P331, DOI 10.1111/j.1528-1157.1987.tb03652.x; Steppacher I, 2014, ANN CLIN TRANSL NEUR, V1, P401, DOI 10.1002/acn3.63; Striano S, 1992, Acta Neurol (Napoli), V14, P275; Thurman DJ, 2011, EPILEPSIA, V52, P2, DOI 10.1111/j.1528-1167.2011.03121.x; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1877, DOI 10.1016/j.apmr.2012.12.027; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd	43	17	18	1	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	OCT	2016	263	10					2048	2056		10.1007/s00415-016-8232-y			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DY5WA	WOS:000385173900017	27416857				2022-02-06	
J	Skop, NB; Calderon, F; Cho, CH; Gandhi, CD; Levison, SW				Skop, Nolan B.; Calderon, Frances; Cho, Cheul H.; Gandhi, Chirag D.; Levison, Steven W.			Optimizing a multifunctional microsphere scaffold to improve neural precursor cell transplantation for traumatic brain injury repair	JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE			English	Article						chitosan; fibroblast growth factors; fibronectin; immobilized growth factors; multifunctional scaffold; neurotrauma; radial glia; regenerative medicine	FIBROBLAST-GROWTH-FACTOR; SPINAL-CORD-INJURY; TISSUE ENGINEERING APPLICATIONS; STEM-CELLS; FUNCTIONAL RECOVERY; COGNITIVE FUNCTION; EXTRACELLULAR-MATRIX; ADULT BRAIN; RAT-BRAIN; CHITOSAN	Tissue engineering using stem cells is widely used to repair damaged tissues in diverse biological systems; however, this approach has met with less success in regenerating the central nervous system (CNS). In this study we optimized and characterized the surface chemistry of chitosan-based scaffolds for CNS repair. To maintain radial glial cell (RGC) character of primitive neural precursors, fibronectin was adsorbed to chitosan. The chitosan was further modified by covalently linking heparin using genipin, which then served as a linker to immobilize fibroblast growth factor-2 (FGF-2), creating a multifunctional film. Fetal rat neural precursors plated onto this multifunctional film proliferated and remained multipotent for at least 3 days without providing soluble FGF-2. Moreover, they remained less mature and more highly proliferative than cells maintained on fibronectin-coated substrates in culture medium supplemented with soluble FGF-2. To create a vehicle for cell transplantation, a 3% chitosan solution was electrosprayed into a coagulation bath to generate microspheres (range 30-100 mu m, mean 64 mu m) that were subsequently modified. Radial glial cells seeded onto these multifunctional microspheres proliferated for at least 7 days in culture and the microspheres containing cells were small enough to be injected, using 23 Gauge Hamilton syringes, into the brains of adult rats that had previously sustained cortical contusion injuries. When analysed 3 days later, the transplanted RGCs were positive for the stem cell/progenitor marker Nestin. These results demonstrate that this multifunctional scaffold can be used as a cellular and growth factor delivery vehicle for the use in developing cell transplantation therapies for traumatic brain injuries. Copyright (C) 2013 John Wiley & Sons, Ltd.	[Skop, Nolan B.; Calderon, Frances; Levison, Steven W.] Rutgers New Jersey Med Sch, Dept Neurol & Neurosci, Newark, NJ USA; [Skop, Nolan B.; Gandhi, Chirag D.] Rutgers New Jersey Med Sch, Dept Neurol Surg, Newark, NJ USA; [Cho, Cheul H.] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA		Levison, SW (corresponding author), NJMS UH Canc Ctr, Dept Neurol & Neurosci, Off H-1226,205 South Orange Ave, Newark, NJ 07103 USA.	steve.levison@umdnj.edu	Levison, Steven W./Q-6903-2019	Levison, Steven W./0000-0002-1264-7309	New Jersey Commission on Brain Injury Research grant [08.001.BIR2, CBIR12FEL025]	This study was partly supported by the New Jersey Commission on Brain Injury Research grant number 08.001.BIR2 awarded to CDG and SWL and grant number CBIR12FEL025 awarded to NBS.	Aplin AE, 1999, CURR OPIN CELL BIOL, V11, P737, DOI 10.1016/S0955-0674(99)00045-9; Aplin AE, 1999, J CELL SCI, V112, P695; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Ashikari-Hada S, 2004, J BIOL CHEM, V279, P12346, DOI 10.1074/jbc.M313523200; Bakshi A, 2006, EUR J NEUROSCI, V23, P2119, DOI 10.1111/j.1460-9568.2006.04743.x; Bjorklund A, 2003, LANCET NEUROL, V2, P437, DOI 10.1016/S1474-4422(03)00442-3; Bonner JF, 2011, J NEUROSCI, V31, P4675, DOI 10.1523/JNEUROSCI.4130-10.2011; Boockvar JA, 2005, NEUROSURGERY, V56, P163, DOI 10.1227/01.NEU.0000145866.25433.FF; Bozkurt G, 2010, NEUROSURGERY, V67, P1733, DOI 10.1227/NEU.0b013e3181f9af35; Caldwell MA, 2004, EXP NEUROL, V188, P408, DOI 10.1016/j.expneurol.2004.05.007; Campos LS, 2004, DEVELOPMENT, V131, P3433, DOI 10.1242/dev.01199; Comisar WA, 2007, BIOMATERIALS, V28, P4409, DOI 10.1016/j.biomaterials.2007.06.018; Crompton KE, 2007, BIOMATERIALS, V28, P441, DOI 10.1016/j.biomaterials.2006.08.044; Cui FZ, 2006, J MATER SCI-MATER M, V17, P1393, DOI 10.1007/s10856-006-0615-7; Dellatore SM, 2008, CURR OPIN BIOTECH, V19, P534, DOI 10.1016/j.copbio.2008.07.010; Dunnett S B, 2000, Prog Brain Res, V127, P345; Evans GRD, 2000, SEMIN SURG ONCOL, V19, P312, DOI 10.1002/1098-2388(200010/11)19:3<312::AID-SSU13>3.0.CO;2-M; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; Gong HP, 2000, J BIOMED MATER RES, V52, P285; Gupta KC, 2000, BIOMATERIALS, V21, P1115, DOI 10.1016/S0142-9612(99)00263-X; Harting MT, 2009, J SURG RES, V153, P188, DOI 10.1016/j.jss.2008.03.037; Hasegawa K, 2005, EXP NEUROL, V193, P394, DOI 10.1016/j.expneurol.2004.12.024; Hoane MR, 2004, J NEUROTRAUM, V21, P163, DOI 10.1089/089771504322778622; Hocking DC, 1998, J CELL BIOL, V141, P241, DOI 10.1083/jcb.141.1.241; Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016; Ingber D E, 1992, Semin Cancer Biol, V3, P57; Jurga M, 2011, BIOMATERIALS, V32, P3423, DOI 10.1016/j.biomaterials.2011.01.049; Kang JM, 2012, ACTA BIOMATER, V8, P1759, DOI 10.1016/j.actbio.2012.01.005; Kendall A L, 2000, Prog Brain Res, V127, P381; Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7; Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009; Kimura H, 2003, KIDNEY INT, V64, P1829, DOI 10.1046/j.1523-1755.2003.00285.x; Kou JH, 1997, J CONTROL RELEASE, V43, P123, DOI 10.1016/S0168-3659(96)01477-0; Kulbatski I, 2005, CURR DRUG TARGETS, V6, P111, DOI 10.2174/1389450053345037; Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Leone DP, 2005, J CELL SCI, V118, P2589, DOI 10.1242/jcs.02396; Lewis J, 1996, CURR OPIN NEUROBIOL, V6, P3, DOI 10.1016/S0959-4388(96)80002-X; Li XG, 2009, BIOMATERIALS, V30, P1121, DOI 10.1016/j.biomaterials.2008.10.063; Lindvall Olle, 2004, NeuroRx, V1, P382; Longhi L, 2005, TRANSPL IMMUNOL, V15, P143, DOI 10.1016/j.trim.2005.09.003; Ma HY, 2011, MOL MED REP, V4, P849, DOI 10.3892/mmr.2011.510; Martinez-Ramos C, 2012, J BIOMED MATER RES A, V100A, P3276, DOI 10.1002/jbm.a.34273; Martino MM, 2009, BIOMATERIALS, V30, P1089, DOI 10.1016/j.biomaterials.2008.10.047; Maysinger D, 1996, EXP NEUROL, V138, P177, DOI 10.1006/exnr.1996.0056; MEREDITH JE, 1993, MOL BIOL CELL, V4, P953, DOI 10.1091/mbc.4.9.953; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Mo LH, 2010, BIOMATERIALS, V31, P2184, DOI 10.1016/j.biomaterials.2009.11.078; MOONEY D, 1992, J CELL PHYSIOL, V151, P497, DOI 10.1002/jcp.1041510308; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muzzarelli R.A., 2013, CHITIN; Nicholas AP, 2002, NEUROSCI LETT, V323, P85, DOI 10.1016/S0304-3940(01)02534-4; Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332; Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751; Reid CB, 2002, J NEUROSCI, V22, P4002, DOI 10.1523/JNEUROSCI.22-10-04002.2002; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; RIFKIN DB, 1989, J CELL BIOL, V109, P1, DOI 10.1083/jcb.109.1.1; RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Salman H, 2004, J NEUROTRAUM, V21, P283, DOI 10.1089/089771504322972077; Sanberg PR, 2012, BRIT MED BULL, V101, P163, DOI 10.1093/bmb/lds001; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Shiba T, 2003, J BIOL CHEM, V278, P26788, DOI 10.1074/jbc.M303468200; Shindo T, 2006, J MED INVESTIG, V53, P42, DOI 10.2152/jmi.53.42; Skardelly M, 2011, J NEUROTRAUM, V28, P401, DOI 10.1089/neu.2010.1526; Skop NB, 2013, ACTA BIOMATER, V9, P6834, DOI 10.1016/j.actbio.2013.02.043; Snyder Evan Y., 1994, Current Opinion in Neurobiology, V4, P742, DOI 10.1016/0959-4388(94)90018-3; SOMMER A, 1989, J CELL PHYSIOL, V138, P215, DOI 10.1002/jcp.1041380129; Sun D, 2011, J NEUROTRAUM, V28, P961, DOI 10.1089/neu.2010.1697; Sun D, 2009, EXP NEUROL, V216, P56, DOI 10.1016/j.expneurol.2008.11.011; Tate CC, 2009, J TISSUE ENG REGEN M, V3, P208, DOI 10.1002/term.154; Tate MC, 2002, CELL TRANSPLANT, V11, P283; Wallenquist U, 2009, RESTOR NEUROL NEUROS, V27, P323, DOI 10.3233/RNN-2009-0481; Yoon KJ, 2004, J NEUROSCI, V24, P9497, DOI 10.1523/JNEUROSCI.0993-04.2004; Yoshida N, 2003, EXP CELL RES, V287, P262, DOI 10.1016/S0014-4827(03)00158-7; Yoshimura S, 2003, J CLIN INVEST, V112, P1202, DOI 10.1172/JCI200316618; ZIELINSKI BA, 1994, BIOMATERIALS, V15, P1049	77	17	17	2	34	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-6254	1932-7005		J TISSUE ENG REGEN M	J. Tissue Eng. Regen. Med.	OCT	2016	10	10					E419	E432		10.1002/term.1832			14	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Biotechnology & Applied Microbiology; Engineering	EC0JI	WOS:000387786200019	27730762				2022-02-06	
J	Goriely, A; Weickenmeier, J; Kuhl, E				Goriely, Alain; Weickenmeier, Johannes; Kuhl, Ellen			Stress Singularities in Swelling Soft Solids	PHYSICAL REVIEW LETTERS			English	Article							TRAUMATIC BRAIN-INJURY	When a swelling soft solid is rigidly constrained on all sides except for a circular opening, it will bulge out to expand as observed during decompressive craniectomy, a surgical procedure used to reduce stresses in swollen brains. While the elastic energy of the solid decreases throughout this process, large stresses develop close to the opening. At the point of contact, the stresses exhibit a singularity similar to the ones found in the classic punch indentation problem. Here, we study the stresses generated by swelling and the evolution of the bulging shape associated with this process. We also consider the possibility of damage triggered by zones of either high shear stresses or high fiber stretches.	[Goriely, Alain] Univ Oxford, Math Inst, Oxford OX2 6GG, England; [Weickenmeier, Johannes; Kuhl, Ellen] Stanford Univ, Living Matter Lab, Stanford, CA 94305 USA		Goriely, A (corresponding author), Univ Oxford, Math Inst, Oxford OX2 6GG, England.		Kuhl, Ellen/G-4444-2011	Kuhl, Ellen/0000-0002-6283-935X; Weickenmeier, Johannes/0000-0003-1889-5976	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U54GM072970]	This work was supported by the NIH Grant No. U54GM072970 to E. K. The authors are grateful to Michael Sutcliffe for sharing data and an earlier version of a manuscript and to Michel Destrade for discussions on Rivlin's work.	Ambrosi D, 2011, J MECH PHYS SOLIDS, V59, P863, DOI 10.1016/j.jmps.2010.12.011; [Anonymous], 2014, AB 6 14 AN US MAN; Barber JR, 1992, ELASTICITY; Ben Amar M., 2011, NEW TRENDS PHYS MECH; Cerruti, 1882, REND ACCAD LINCEI, V3, P81; Collins W.D., 1963, P EDINBURGH MATH SOC, V13, P235, DOI [10.1017/S0013091500010889,03, DOI 10.1017/S0013091500010889,03]; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Destrade M, 2015, INT J NONLIN MECH, V75, P54, DOI 10.1016/j.ijnonlinmec.2015.02.014; Fletcher T. L., 2016, ANN BIOMED ENG, V1; Fletcher TL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102131; GLADWELL GML, 1980, CONTACT PROBLEMS CLA; Goriely A, 2015, ADV APPL MECH, V48, P79, DOI 10.1016/bs.aams.2015.10.002; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; Johnson KL., 1987, CONTACT MECH; Lang GE, 2015, BIOMECH MODEL MECHAN, V14, P1197, DOI 10.1007/s10237-015-0665-1; Lang GE, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0123; Mihai LA, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0486; Muskhelishvili NI., 1977, SOME BASIC PROBLEMS; RIVLIN RS, 1947, J APPL PHYS, V18, P444, DOI 10.1063/1.1697674; Roitman A.B., 1973, INT APPL MECH+, V9, P725; Timofeev I, 2006, INJURY, V37, P1125, DOI 10.1016/j.injury.2006.07.031; Walberer M, 2008, J NEUROSURG, V109, P287, DOI 10.3171/JNS/2008/109/8/0287; Weickenmeier J, 2016, ACTA BIOMATER, V42, P265, DOI 10.1016/j.actbio.2016.07.040; Weickenmeier J., 2016, COMP METH APPL MECH; Weickenmeier J., J MECH PHYS SOLIDS; Weickenmeier J., ARXIV160903129	26	17	17	0	16	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0031-9007	1079-7114		PHYS REV LETT	Phys. Rev. Lett.	SEP 21	2016	117	13							138001	10.1103/PhysRevLett.117.138001			5	Physics, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Physics	DW7SF	WOS:000383851000021	27715096	Green Submitted, hybrid			2022-02-06	
J	Albrecht, JS; McCunn, M; Stein, DM; Simoni-Wastila, L; Smith, GS				Albrecht, Jennifer S.; McCunn, Maureen; Stein, Deborah M.; Simoni-Wastila, Linda; Smith, Gordon S.			Sex differences in mortality following isolated traumatic brain injury among older adults	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; mortality; sex differences	GLASGOW COMA SCALE; SEVERITY SCORE; CLINICAL-TRIAL; OUTCOMES; PROGESTERONE; GENDER; AGE; PREDICTION; STEROIDS; CRITERIA	BACKGROUND Older adults have the highest rates of hospitalization and mortality from traumatic brain injury (TBI), yet outcomes in this population are not well studied. In particular, contradictory reports on the protective effect of female sex on mortality following TBI may have been related to age differences in TBI and other injury severity and mechanism. The objective of this study was to determine if there are sex differences in mortality following isolated TBI among older adults and compare with findings using all TBI. A secondary objective was to characterize TBI severity and mechanism by sex in this population. METHODS This was a retrospective cohort study conducted among adults aged 65 and older treated for TBI at a single large Level I trauma center from 1996 to 2012 (n = 4,854). Individuals treated for TBI were identified using International Classification of Disease, Ninth Revision, Clinical Modification (ICD-9-CM) codes. Isolated TBI was defined as an Abbreviated Injury Scale score of 0 for other body regions. Our primary outcome was mortality at discharge. RESULTS Among those with isolated TBI (n = 1,320), women (45% of sample) were older (mean [SD], 78.9 [7.7] years) than men (76.8 [7.5] years) (p < 0.001). Women were more likely to have been injured in a fall (91% vs. 84%; p < 0.001). Adjusting for multiple injury severity measures, female sex was not significantly associated with decreased odds of mortality following isolated TBI (odds ratio, 1.01; 95% confidence interval, 0.66-1.54). Using all TBI cases, adjusted analysis found that female sex was significantly associated with decreased odd of mortality (odds ratio, 0.73; 95% confidence interval, 0.59-0.89). CONCLUSION We found no sex differences in mortality following isolated TBI among older adults, in contrast with other studies and our own analyses using all TBI cases. Researchers should consider isolated TBI in outcome studies to prevent residual confounding by severity of other injuries. LEVEL OF EVIDENCE Prognostic/epidemiologic study, level IV.	[Albrecht, Jennifer S.; Smith, Gordon S.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [McCunn, Maureen] Univ Maryland, Sch Med, R Adams Cowley Shock Trauma Ctr, Dept Anesthesiol,Div Trauma Anesthesiol, Baltimore, MD 21201 USA; [McCunn, Maureen] Univ Maryland, Sch Med, R Adams Cowley Shock Trauma Ctr, Dept Anesthesiol,Div Surg Crit Care, Baltimore, MD 21201 USA; [Stein, Deborah M.] Univ Maryland, Med Ctr, R Adams Cowley Shock Trauma Ctr, Div Surg Crit Care,Dept Surg, Baltimore, MD 21201 USA; [Simoni-Wastila, Linda] Univ Maryland, Sch Pharm, Dept Pharmaceut Hlth Serv Res, Baltimore, MD 21201 USA; [Smith, Gordon S.] Univ Maryland, Natl Study Ctr Trauma & Emergency Med Serv, Shock Trauma & Anesthesiol Res STAR Organized Res, Baltimore, MD 21201 USA		Albrecht, JS (corresponding author), Univ Maryland, Sch Med, 10 S Pine St,MSTF 334C, Baltimore, MD 21201 USA.	jalbrecht@epi.umaryland.edu		Albrecht, Jennifer/0000-0003-4838-2274; Smith, Gordon/0000-0002-2911-3071; Stein, Deborah/0000-0003-3683-3963	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K12HD43489-14]; US National Institute on Alcohol Abuse and AlcoholismUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA18707]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K01HS024560] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD043489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA018707, R01AA018313] Funding Source: NIH RePORTER	JSA was supported by NIH grant K12HD43489-14 (Tracey, PI). GSS was supported by a grant from the US National Institute on Alcohol Abuse and Alcoholism (R01AA18707). The remaining authors declare no conflicts of interest.	American Heart Association, UND BLOOD PRESS READ; [Anonymous], 1971, JAMA, V215, P277; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Brazinova A, 2010, J NEUROTRAUM, V27, P1549, DOI 10.1089/neu.2010.1315; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; Caterino JM, 2011, ACAD EMERG MED, V18, P1014, DOI 10.1111/j.1553-2712.2011.01164.x; Cauley JA, 2015, STEROIDS, V99, P11, DOI 10.1016/j.steroids.2014.12.010; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; Faul M, 2010, TRAUMATIC BRAIN INJU; Greendale GA, 1997, J BONE MINER RES, V12, P1833, DOI 10.1359/jbmr.1997.12.11.1833; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Mena JH, 2011, J TRAUMA, V71, P1185, DOI 10.1097/TA.0b013e31823321f8; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kehoe A, 2015, EMERG MED J, V32, P613, DOI 10.1136/emermed-2013-203488; Leitgeb J, 2011, J TRAUMA, V71, P1620, DOI 10.1097/TA.0b013e318226ea0e; Ma JP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008409.pub3; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Marr A., 2004, CENTRAL NERVOUS SYST; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Ottochian M, 2009, AM J SURG, V197, P155, DOI 10.1016/j.amjsurg.2008.09.008; Rogers E, 2006, J HEAD TRAUMA REHAB, V21, P279, DOI 10.1097/00001199-200605000-00008; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Salottolo K, 2014, JAMA SURG, V149, P727, DOI 10.1001/jamasurg.2014.13; Sasser SM, 2011, MMWR-MORBID MORTAL W, V61, P1; Scheetz LJ, 2015, INT EMERG NURS, V23, P162, DOI 10.1016/j.ienj.2014.09.003; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Slewa-Younan S, 2004, ARCH PHYS MED REHAB, V85, P376, DOI 10.1016/j.apmr.2003.05.007; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; TEASDALE G, 1974, LANCET, V2, P81; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thurman DJ., 1995, GUIDELINES SURVEILLA; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xiao Guo-min, 2007, Zhonghua Wai Ke Za Zhi, V45, P106; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887	39	17	18	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	SEP	2016	81	3					486	492		10.1097/TA.0000000000001118			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	DW8MX	WOS:000383911200012	27280939	Green Accepted			2022-02-06	
J	Delle Rose, D; Pezzotti, P; Fortunato, E; Sordillo, P; Gini, S; Boros, S; Meledandri, M; Gallo, MT; Prignano, G; Caccese, R; D'Ambrosio, M; Citterio, G; Rocco, M; Leonardis, F; Natoli, S; Fontana, C; Favaro, M; Celeste, MG; Franci, T; Testore, GP; Andreoni, M; Sarmati, L				Delle Rose, D.; Pezzotti, P.; Fortunato, E.; Sordillo, P.; Gini, S.; Boros, S.; Meledandri, M.; Gallo, M. T.; Prignano, G.; Caccese, R.; D'Ambrosio, M.; Citterio, G.; Rocco, M.; Leonardis, F.; Natoli, S.; Fontana, C.; Favaro, M.; Celeste, M. G.; Franci, T.; Testore, G. P.; Andreoni, M.; Sarmati, L.			Clinical predictors and microbiology of ventilator-associated pneumonia in the intensive care unit: a retrospective analysis in six Italian hospitals	EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES			English	Article							TRAUMATIC BRAIN-INJURY; MULTIDRUG-RESISTANT ORGANISMS; RISK-FACTORS; KLEBSIELLA-PNEUMONIAE; OUTCOMES; CARBAPENEMASES; INFECTIONS; PREVALENCE; PREVENTION; PATTERNS	The purpose of this study was to assess the main clinical predictors and microbiological features of ventilator-associated pneumonia (VAP) in the Intensive Care Unit (ICU) environment. This work is a retrospective analysis over one year from September 2010 to September 2011. Patients' risk factors, causes of admission, comorbidities and respiratory specimens collected in six Italian ICUs were reviewed. Incidence and case fatality rate of VAP were evaluated. After stratification for VAP development, univariate and multivariate analyses were performed to assess the impact of patients' conditions on the onset of this infection. A total of 1, 647 ICU patients (pts) were considered. Overall, 115 patients (6.9 %) experienced at least one episode of VAP. The incidence rate for VAP was 5.82/1,000 pts-days, with a case fatality rate of 44.3 %. Multivariate analysis showed that admission for neurological disorders (aIRR 4.12, CI 1.24-13.68, p = 0.02) and emergency referral to ICU from other hospitals (aIRR 2.11, CI 1.03-4.31, p = 0.04) were associated with higher risk of VAP, whereas a tendency to a higher risk of infection was detected for admission due to respiratory disease, cardiac disease, trauma and for having obesity or renal failure. A total of 372 microbiological isolates from respiratory specimens were collected in VAP patients. The most common species were Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa, showing high resistance rates to carbapenems. Neurological disorders and emergency referral at the admission into the ICU are significantly associated with the onset of VAP. A high incidence of multi-drug resistant Gram-species was detected in the respiratory specimens.	[Delle Rose, D.; Fortunato, E.; Sordillo, P.; Gini, S.; Testore, G. P.; Andreoni, M.; Sarmati, L.] Tor Vergata Univ Hosp, Clin Infect Dis, Vle Oxford 81, I-00133 Rome, Italy; [Pezzotti, P.; Boros, S.] Ist Super Sanita, Rome, Italy; [Meledandri, M.] S Filippo Neri Hosp, Rome, Italy; [Gallo, M. T.; Prignano, G.] IRCCS, IFO, San Gallicano Dermatol Inst, Rome, Italy; [Caccese, R.; D'Ambrosio, M.] S Giovanni Hosp, Intens Care Unit, Rome, Italy; [Citterio, G.; Rocco, M.] Univ Roma La Sapienza, Intens Care Unit, Rome, Italy; [Leonardis, F.; Natoli, S.] Tor Vergata Univ Hosp, Intens Care Unit, Rome, Italy; [Fontana, C.; Favaro, M.] Tor Vergata Univ Hosp, Clin Microbiol Labs, Rome, Italy; [Celeste, M. G.] Tor Vergata Univ Hosp, Clin Pharm, Rome, Italy; [Franci, T.] S Andrea Hosp, Rome, Italy		Delle Rose, D (corresponding author), Tor Vergata Univ Hosp, Clin Infect Dis, Vle Oxford 81, I-00133 Rome, Italy.	diego.dellerose82@gmail.com	Fontana, Carla/AAE-3757-2020; Fontana, Carla/AAH-6112-2019; Rocco, Monica/B-8407-2013; Prignano, Grazia/J-9509-2018	Fontana, Carla/0000-0003-2198-1947; Rocco, Monica/0000-0001-8380-3607; Prignano, Grazia/0000-0003-2474-3354; Boros, Stefano/0000-0003-2521-0883; Natoli, Silvia/0000-0003-3758-5375; sarmati, loredana/0000-0003-1452-0333	Italian Drug Agency (AIFA), Pharmacovigilance Projects in the Lazio Region, Analysis of Nosocomial Infections in Roman Intensive Care Units [D 3012]	This work was financially supported by a grant from the Italian Drug Agency (AIFA), Pharmacovigilance Projects in the Lazio Region, Analysis of Nosocomial Infections in Roman Intensive Care Units, 2009. Grant No D 3012 28/09/2009.	[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Bouadma L, 2010, CLIN INFECT DIS, V51, P1115, DOI 10.1086/656737; Boyer AF, 2015, CHEST, V147, P68, DOI 10.1378/chest.14-0544; Canton R, 2012, CLIN MICROBIOL INFEC, V18, P413, DOI 10.1111/j.1469-0691.2012.03821.x; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Chittawatanarat K, 2014, INFECT DRUG RESIST, V7, P203, DOI 10.2147/IDR.S67267; Corbellini S, 2014, NEW MICROBIOL, V37, P177; Corcione S, 2015, CLIN MICROBIOL INFEC, V21, pE11, DOI 10.1016/j.cmi.2014.09.012; Decelle L, 2013, EUR J EMERG MED, V20, P61, DOI 10.1097/MEJ.0b013e3283501677; Denys GA, 2014, CLIN LAB MED, V34, P257, DOI 10.1016/j.cll.2014.02.004; Djahmi N, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/305784; ECDC, 2012, ANT RES SURV EUR 201; Edwards JR, 2008, AM J INFECT CONTROL, V36, P609, DOI 10.1016/j.ajic.2008.08.001; Efrati S, 2010, J CLIN MONIT COMPUT, V24, P161, DOI 10.1007/s10877-010-9228-2; European Centre for Disease Prevention and Control, 2012, SURV HLTH CAR ASS IN; Gadani H, 2010, INDIAN J ANAESTH, V54, P535, DOI 10.4103/0019-5049.72643; Gastmeier P, 2006, J HOSP INFECT, V64, P16, DOI 10.1016/j.jhin.2006.04.017; Gianakis A, 2015, J TRAUMA NURS, V22, P125, DOI 10.1097/JTN.0000000000000121; Hui X, 2013, J SURG RES, V184, P438, DOI 10.1016/j.jss.2013.05.072; Hussein K, 2009, INFECT CONT HOSP EP, V30, P666, DOI 10.1086/598244; INVS, 2007, RES AL INV SURV INF; Jovanovic B, 2015, INT J INFECT DIS, V38, P46, DOI 10.1016/j.ijid.2015.07.005; Kalbfleisch JD., 2002, STAT ANAL FAILURE TI, V2; Khorvash F, 2014, J RES MED SCI, V19, pS46; Klompas M, 2008, CLIN INFECT DIS, V46, P1443, DOI 10.1086/587103; Kollef MH, 1997, CHEST, V112, P765, DOI 10.1378/chest.112.3.765; Martin-Loeches I, 2015, J INFECTION, V70, P213, DOI 10.1016/j.jinf.2014.10.004; Gago MM, 2013, MEDICC REV, V15, P26, DOI 10.37757/MR2013V15.N2.6; Parisi SG, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0996-7; Parker CM, 2008, J CRIT CARE, V23, P18, DOI 10.1016/j.jcrc.2008.02.001; Piskin N, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-268; Plurad DS, 2013, J SURG RES, V183, P371, DOI 10.1016/j.jss.2013.01.036; Quartin AA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-561; Ranjan N, 2014, INDIAN J CRIT CARE M, V18, P200, DOI 10.4103/0972-5229.130570; Rea-Neto A, 2008, CRIT CARE, V12, DOI 10.1186/cc6877; Safdar N, 2005, CRIT CARE MED, V33, P2184, DOI 10.1097/01.CCM.0000181731.53912.D9; Sandiumenge A, 2012, CURR OPIN PULM MED, V18, P187, DOI 10.1097/MCP.0b013e328351f974; Tan X, 2016, MED MYCOL; Terraneo S, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.09.002; Uckay I, 2008, CLIN INFECT DIS, V46, P557, DOI 10.1086/526534; Wayne P.A., 2010, M100S20 CLSI; Wilke M, 2014, INFECT DRUG RESIST, V7, P1, DOI 10.2147/IDR.S25985; Wroblewska MM, 2006, INT J ANTIMICROB AG, V27, P285, DOI 10.1016/j.ijantimicag.2005.11.015; Zhu S, 2015, INFECT CONT HOSP EP, V27, P1, DOI DOI 10.1088/0953-8984/27/36/362201	44	17	18	1	13	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0934-9723	1435-4373		EUR J CLIN MICROBIOL	Eur. J. Clin. Microbiol. Infect. Dis.	SEP	2016	35	9					1531	1539		10.1007/s10096-016-2694-9			9	Infectious Diseases; Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases; Microbiology	DZ4VC	WOS:000385857700022	27272120				2022-02-06	
J	Lombardi, NJ; Tucker, B; Freedman, KB; Austin, LS; Eck, B; Pepe, M; Tjoumakaris, FP				Lombardi, Nicholas J.; Tucker, Bradford; Freedman, Kevin B.; Austin, Luke S.; Eck, Brandon; Pepe, Matthew; Tjoumakaris, Fotios P.			Accuracy of Athletic Trainer and Physician Diagnoses in Sports Medicine	ORTHOPEDICS			English	Article								It is standard practice in high school athletic programs for certified athletic trainers to evaluate and treat injured student athletes. In some cases, a trainer refers an athlete to a physician for definitive medical management. This study was conducted to determine the rate of agreement between athletic trainers and physicians regarding assessment of injuries in student athletes. All high school athletes who were injured between 2010 and 2012 at 5 regional high schools were included in a research database. All patients who were referred for physician evaluation and treatment were identified and included in this analysis. A total of 286 incidents met the inclusion criteria. A total of 263 (92%) of the athletic trainer assessments and physician diagnoses were in agreement. In the 23 cases of disagreement, fractures and sprains were the most common injuries. Kappa analysis showed the highest interrater agreement in injuries classified as dislocations and concussions and the lowest interrater agreement in meniscal/labral injuries and fractures. In the absence of a confirmed diagnosis, agreement among health care providers can be used to infer accuracy. According to this principle, as agreement between athletic trainers and physicians improves, there is a greater likelihood of arriving at the correct assessment and treatment plan. Athletic trainers are highly skilled professionals who are well trained in the evaluation of athletic injuries. The current study showed that additional training in identifying fractures may be beneficial to athletic trainers and the athletes they treat.	[Lombardi, Nicholas J.; Tucker, Bradford; Freedman, Kevin B.; Austin, Luke S.; Pepe, Matthew; Tjoumakaris, Fotios P.] Thomas Jefferson Univ, Rothman Inst Orthopaed, 2500 English Creek Rd,Bldg 1300, Egg Harbor Township, NJ 08234 USA; [Eck, Brandon] Mercy Suburban Hosp, East Norriton, PA USA		Tjoumakaris, FP (corresponding author), Thomas Jefferson Univ, Rothman Inst Orthopaed, 2500 English Creek Rd,Bldg 1300, Egg Harbor Township, NJ 08234 USA.	Fotios.Tjoumakaris@rothmaninstitute.com	Tjoumakaris, Fotios/N-7039-2019	Tjoumakaris, Fotios/0000-0002-1013-7735			American Medical Association, 2015, ICD 9 CM 2015 PROF E, V2; American Medical Association, POL H 470 995 ATHL S; American Medical Association, 2015, ICD 9 CM 2015 PROF E, V1; Bernstein J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027620; Comstock RD, NATL HIGH SCH SPORTS; Glover Lori, 2010, Minn Med, V93, P43; SMITH AM, 1990, SPORTS MED, V9, P352, DOI 10.2165/00007256-199009060-00004; SMITH AM, 1994, J ATHL TRAINING, V29, P337; Swenson DM, 2010, CLIN J SPORT MED, V20, P293, DOI 10.1097/JSM.0b013e3181e8fae8	9	17	18	0	4	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0147-7447	1938-2367		ORTHOPEDICS	Orthopedics	SEP-OCT	2016	39	5					E944	E949		10.3928/01477447-20160623-10			6	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	EJ3JD	WOS:000393107500021	27398784				2022-02-06	
J	Stein, CJ; MacDougall, R; Quatman-Yates, CC; Myer, GD; Sugimoto, D; Dennison, RJ; Meehan, WP				Stein, Cynthia J.; MacDougall, Robert; Quatman-Yates, Catherine C.; Myer, Gregory D.; Sugimoto, Dai; Dennison, Roberta J.; Meehan, William P., III			Young Athletes' Concerns About Sport-Related Concussion: The Patient's Perspective	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; attitude; sports; athlete; pediatric; adolescent; concern; perspective	HIGH-SCHOOL; REPORTED OUTCOMES; RECOVERY; DURATION; SYMPTOMS	Objective:Few studies have examined the experience and concerns of the concussed athlete. The purpose of this study was to identify the most pressing concerns of athletes with concussion.Design:Cross-sectional survey of athletes who presented for evaluation of a new sport-related concussion during an 8-month period.Setting:Tertiary-level sports medicine division of a large academic pediatric medical center.Participants:One hundred twenty one patients (67 male, 54 female) aged 8 to 18 years who had sustained a sport-related concussion participated in the study by responding to What is the worst thing for you about having a concussion? on the study questionnaire. Questionnaires were completed in the clinic waiting room before the visit with a provider.Intervention:Inductive content analysis was used to identify themes in the responses to the study question.Main Outcome Measures:Age, sex, sport played at the time of the current injury, history of previous concussion, known contacts with concussion, and subjective report of worst aspect of concussion.Results:Seventy respondents (57.9%) cited symptoms, and 68 (56.2%) reported loss of activity as the worst part of concussion, including 17 (14.0%) who listed both symptoms and loss of activity.Conclusions:Over half of concussed athletes indicate that the most distressing part of the injury is loss of activities, which may result from symptoms of the injury itself and/or the prescribed treatment.Clinical Relevance:Health care providers should not underestimate the degree to which symptoms and loss of activities affect young athletes' general well-being. In addition to the negative impact of concussion symptoms, there is an obvious cost of physical, cognitive, and social activity restrictions for patients recovering from sport-related concussions that should be explicitly addressed.	[Stein, Cynthia J.; MacDougall, Robert; Sugimoto, Dai; Meehan, William P., III] Boston Childrens Hosp, Div Sports Med, Dept Orthopaed, Boston, MA USA; [Quatman-Yates, Catherine C.] Cincinnati Childrens Hosp Med Ctr, Div Occupat & Phys Therapy, Cincinnati, OH 45229 USA; [Quatman-Yates, Catherine C.; Myer, Gregory D.] Cincinnati Childrens Hosp Med Ctr, Div Sports Med, Cincinnati, OH 45229 USA; [Myer, Gregory D.] Cincinnati Childrens Hosp Med Ctr, Sports Med Biodynam Ctr, Cincinnati, OH 45229 USA; [Myer, Gregory D.] Cincinnati Childrens Hosp Med Ctr, Human Performance Lab, Cincinnati, OH 45229 USA; [Myer, Gregory D.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Myer, Gregory D.] Univ Cincinnati, Coll Med, Dept Orthopaed Surg, Cincinnati, OH USA; [Sugimoto, Dai; Meehan, William P., III] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Dennison, Roberta J.] Tufts Univ Family Med Residency, Cambridge Hlth Alliance, Malden, MA USA		Stein, CJ (corresponding author), Boston Childrens Hosp, Div Sports Med, 319 Longwood Ave, Boston, MA 02115 USA.	cynthia.stein@childrens.harvard.edu	Quatman-Yates, Catherine/AAK-4507-2021; Quatman-Yates, Catherine/U-9580-2019; Myer, Gregory/H-6572-2016	Myer, Gregory/0000-0002-9983-8422	National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament	W. P. Meehan receives research funding from the National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament. W. P. Meehan also receives royalties from ABC-Clio Publishing and Wolters-Kluwer Publishing. The other authors report no conflicts of interest.	Ahmed S, 2012, MED CARE, V50, P1060, DOI 10.1097/MLR.0b013e318268aaff; Baker JG, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/705309; Bergman K, 2013, J NEUROSCI NURS, V45, P124, DOI 10.1097/JNN.0b013e31828a418b; Bitton A, 2014, AM J MANAG CARE, V20, P281; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Fleurence R, 2013, HEALTH AFFAIR, V32, P393, DOI 10.1377/hlthaff.2012.1176; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Joyce AS, 2015, MED SCI SPORT EXER, V47, P1119, DOI 10.1249/MSS.0000000000000534; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Price RA, 2014, MED CARE RES REV, V71, P522, DOI 10.1177/1077558714541480; Selby JV, 2014, NEW ENGL J MED, V370, P592, DOI 10.1056/NEJMp1313061; Snell DL, 2015, BRAIN INJURY, V29, P291, DOI 10.3109/02699052.2014.976594; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966	24	17	17	0	18	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2016	26	5					386	390		10.1097/JSM.0000000000000268			5	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	DW8LH	WOS:000383906800009	26540601				2022-02-06	
J	Uccella, L; Zoia, C; Perlasca, F; Bongetta, D; Codeca, R; Gaetani, P				Uccella, Laura; Zoia, Cesare; Perlasca, Francesco; Bongetta, Daniele; Codeca, Roberta; Gaetani, Paolo			Mild Traumatic Brain Injury in Patients on Long-Term Anticoagulation Therapy: Do They Really Need Repeated Head CT Scan?	WORLD NEUROSURGERY			English	Article						Anticoagulants; GCS 15; Head CT scan; Mild traumatic brain injury; Minor head trauma	NEW-ORLEANS CRITERIA; COMPUTED-TOMOGRAPHY; INTRACRANIAL HEMORRHAGE; RULE; RISK	BACKGROUND: Mild traumatic brain injury (mTBI), defined as blunt trauma to the head resulting in witnessed loss of consciousness, definite amnesia, or witnessed disorientation with a Glasgow Coma Scale (GCS) score of 14 or 15 is a common occurrence in the emergency department. In mTBI, oral anticoagulation is known to be an important risk factor for hemorrhage. Clinical guidelines recommend baseline computed tomographic (CT) scan and observation for 24 hours plus a CT scan before discharge. METHODS: We compared the non-anticoagulated and anticoagulated patients presenting at our emergency department with mTBI and no neurologic signs (GCS[ 15). Every non-anticoagulated patient underwent only a baseline CT scan, whereas the anticoagulated group underwent a second CT scan after a 24-hour observation period. RESULTS: Between April 2012 and April 2013, we observed 908 adult patients with mTBI and a GCS score of 15; 74 patients (8.1%) were taking oral anticoagulant drugs as long-term therapy, whereas the remaining 834 patients (91.9%) were not. In the non-anticoagulation group, 38 patients (4.6%) were positive for hemorrhage. Two patients underwent neurosurgical intervention. In the anticoagulation group, 5 patients (6.8%) were positive for hemorrhage. No patient underwent neurosurgical intervention. None of them died. The differences between the two groups were not statistically significant. CONCLUSIONS: Patients with a GCS score of 15 who are taking long-term anticoagulation therapy and who present with mTBI have a risk of cranial hemorrhage that is likely to be similar to that of non-anticoagulated patients. It may be reasonable to envision a protocol including only one CT scan and an appropriate observation period.	[Uccella, Laura; Perlasca, Francesco; Codeca, Roberta] Osped Circolo & Fdn Macchi, Emergency Dept, Varese, Italy; [Zoia, Cesare; Bongetta, Daniele; Gaetani, Paolo] IRCCS Fdn Policlin San Matteo, Neurosurg Unit, Pavia, Italy; [Bongetta, Daniele] Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, Pavia, Italy		Zoia, C (corresponding author), IRCCS Fdn Policlin San Matteo, Neurosurg Unit, Pavia, Italy.	gioiaoffice@gmail.com	Zoia, Cesare/ABE-5286-2020; uccella, laura/ABD-2621-2021; Zoia, Cesare/B-8463-2015	Zoia, Cesare/0000-0001-7304-6120; uccella, laura/0000-0002-5401-8703; Zoia, Cesare/0000-0001-7304-6120; Gaetani, Paolo/0000-0003-0662-5872			AbdelFattah KR, 2012, J TRAUMA ACUTE CARE, V73, P685, DOI 10.1097/TA.0b013e318265ccd9; Agenzia per i Servizi Sanitari Regionali, 2007, TREATM MIN SEV HEAD; Beynon C, 2015, CLIN NEUROL NEUROSUR, V136, P73, DOI 10.1016/j.clineuro.2015.05.035; Board of Radiation Effects Research Division on Earth and Life Sciences National Research Council of the National Academies, 2006, HLTH RISKS EXP LOW L; Bouida W, 2013, ANN EMERG MED, V61, P521, DOI 10.1016/j.annemergmed.2012.07.016; Docimo S, 2014, AM SURGEON, V80, P610; Gaetani P, 2012, J NEUROSURG SCI, V56, P231; Garcia DA, 2011, J FAM PRACTICE, V60, P70; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Joseph B, 2014, AM SURGEON, V80, P43; Li J, 2001, LANCET, V357, P771, DOI 10.1016/S0140-6736(00)04163-5; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; McCammack KC, 2015, WEST J EMERG MED, V16, P43, DOI 10.5811/westjem.2014.10.19488; National Clinical Guideline Centre. National Institute for Health and Clinical Excellence: Guidance, 2014, HEAD INJ TRIAG ASS I; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Study Group on Head Injury of the Italian Society for Neurosurgery, 1996, J NEUROSURG SCI, V40, P11	17	17	17	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	SEP	2016	93						100	103		10.1016/j.wneu.2016.05.061			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EF5DX	WOS:000390352000016	27245564				2022-02-06	
J	Shishido, H; Kishimoto, Y; Kawai, N; Toyota, Y; Ueno, M; Kubota, T; Kirino, Y; Tamiya, T				Shishido, Hajime; Kishimoto, Yasushi; Kawai, Nobuyuki; Toyota, Yasunori; Ueno, Masaki; Kubota, Takashi; Kirino, Yutaka; Tamiya, Takashi			Traumatic brain injury accelerates amyloid-beta deposition and impairs spatial learning in the triple-transgenic mouse model of Alzheimer's disease	NEUROSCIENCE LETTERS			English	Article						Alzheimer's disease; Amyloid-beta protein; Cognitive impairment; Traumatic brain injury; Triple-transgenic AD-model mouse	CLOSED-HEAD INJURY; MICE; PROTEIN; RISK; ENCEPHALOPATHY; ACCUMULATION; DEMENTIA; RATS	Several pathological and epidemiological studies have demonstrated a possible relationship between traumatic brain injury (TBI) and Alzheimer's disease (AD). However, the exact contribution of TBI to AD onset and progression is unclear. Hence, we examined AD-related histopathological changes and cognitive impairment after TBI in triple transgenic (3 xTg)-AD model mice. Five- to seven-month-old 3 xTg-AD model mice were subjected to either TBI by the weight-drop method or a sham treatment. In the 3 xTg-AD mice subjected to TBI, the spatial learning was not significantly different 7 days after TBI compared to that of the sham-treated 3xTg-AD mice. However, 28 days after TBI, the 3 xTg-AD mice exhibited significantly lower spatial learning than the sham-treated 3xTg-AD mice. Correspondingly, while a few amyloid-beta (A beta) plaques were observed in both sham-treated and TBI-treated 3 xTg-AD mouse hippocampus 7 days after TBI, the A beta deposition was significantly greater in 3 xTg-AD mice 28 days after TBI. Thus, we demonstrated that TBI induced a significant increase in hippocampal A beta deposition 28 days after TBI compared to that of the control animals, which was associated with worse spatial learning ability in 3 xTg-AD mice. The present study suggests that TBI could be a risk factor for accelerated AD progression, particularly when genetic and hereditary predispositions are involved. (C) 2016 Elsevier Ireland Ltd. All rights reserved.	[Shishido, Hajime; Toyota, Yasunori; Tamiya, Takashi] Kagawa Univ, Fac Med, Dept Neurol Surg, Takamatsu, Kagawa, Japan; [Kishimoto, Yasushi; Kubota, Takashi; Kirino, Yutaka] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Biophys Lab, Tokushima, Japan; [Kawai, Nobuyuki] Kagawa Gen Rehabil Hosp, Dept Neurol Surg, 1114 Tamura Cho, Takamatsu, Kagawa 7618057, Japan; [Ueno, Masaki] Kagawa Univ, Fac Med, Dept Inflammat Pathol, Takamatsu, Kagawa, Japan		Kawai, N (corresponding author), Kagawa Gen Rehabil Hosp, Dept Neurol Surg, 1114 Tamura Cho, Takamatsu, Kagawa 7618057, Japan.; Kishimoto, Y (corresponding author), Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Dept Biophys, 1314-1 Shido, Sanuki, Kagawa 7612193, Japan.	kishimot@kph.bunri-u.ac.jp; nobu@kagawa-reha.net	Kishimoto, Yasushi/AAH-4923-2021	Kishimoto, Yasushi/0000-0002-4828-1249	Tokushima Bunri University for Educational Reform and Collaborative Research [TBU2012-2-2];  [24590133];  [15K07910];  [26462161]	This work was supported by Grants-in-Aid for Scientific Research (C) (grant No. 24590133, 15K07910 to Y Kishimoto and grant No. 26462161 to N Kawai), and a grant from Tokushima Bunri University for Educational Reform and Collaborative Research (No. TBU2012-2-2 to Y Kishimoto).	Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; Gimenez-Llort L, 2007, NEUROSCI BIOBEHAV R, V31, P125, DOI 10.1016/j.neubiorev.2006.07.007; Iwata A, 2002, J NEUROPATH EXP NEUR, V61, P1056, DOI 10.1093/jnen/61.12.1056; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kishimoto Y., 2016, DATA BRIEF; Kishimoto Y, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00134; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Launer LJ, 1999, NEUROLOGY, V52, P78, DOI 10.1212/WNL.52.1.78; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Mastrangelo MA, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-81; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mehta KM, 1999, NEUROLOGY, V53, P1959, DOI 10.1212/WNL.53.9.1959; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Su DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050172; Tajiri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078851; Tang YP, 1997, J NEUROTRAUM, V14, P851, DOI 10.1089/neu.1997.14.851; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Washington PM, 2014, J NEUROTRAUM, V31, P125, DOI 10.1089/neu.2013.3017; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	29	17	18	0	17	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	AUG 26	2016	629						62	67		10.1016/j.neulet.2016.06.066			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DU7QF	WOS:000382409000012	27373531				2022-02-06	
J	Song, Y; Pimentel, C; Walters, K; Boller, L; Ghiasvand, S; Liu, J; Staley, KJ; Berdichevsky, Y				Song, Yu; Pimentel, Corrin; Walters, Katherine; Boller, Lauren; Ghiasvand, Shabnam; Liu, Jing; Staley, Kevin J.; Berdichevsky, Yevgeny			Neuroprotective levels of IGF-1 exacerbate epileptogenesis after brain injury	SCIENTIFIC REPORTS			English	Article							GROWTH-FACTOR-I; TEMPORAL-LOBE EPILEPSY; TUBEROUS SCLEROSIS COMPLEX; HIPPOCAMPAL SLICE CULTURES; MAMMALIAN TARGET; RAT-BRAIN; SIGNALING PATHWAY; CELL-DEATH; POSTTRAUMATIC EPILEPSY; SYNAPTIC CONNECTIONS	Exogenous Insulin-Like Growth Factor-1 (IGF-1) is neuroprotective in animal models of brain injury, and has been considered as a potential therapeutic. Akt-mTOR and MAPK are downstream targets of IGF-1 signaling that are activated after brain injury. However, both brain injury and mTOR are linked to epilepsy, raising the possibility that IGF-1 may be epileptogenic. Here, we considered the role of IGF-1 in development of epilepsy after brain injury, using the organotypic hippocampal culture model of post-traumatic epileptogenesis. We found that IGF-1 was neuroprotective within a few days of injury but that long-term IGF-1 treatment was pro-epileptic. Pro-epileptic effects of IGF-1 were mediated by Akt-mTOR signaling. We also found that IGF-1-mediated increase in epileptic activity led to neurotoxicity. The dualistic nature of effects of IGF-1 treatment demonstrates that anabolic enhancement through IGF-1 activation of mTOR cascade can be beneficial or harmful depending on the stage of the disease. Our findings suggest that epilepsy risk may need to be considered in the design of neuroprotective treatments for brain injury.	[Song, Yu; Pimentel, Corrin; Boller, Lauren; Ghiasvand, Shabnam; Berdichevsky, Yevgeny] Lehigh Univ, Bioengn Program, Bethlehem, PA 18015 USA; [Walters, Katherine] Lehigh Univ, IDEAS Program, Bethlehem, PA 18015 USA; [Liu, Jing; Berdichevsky, Yevgeny] Lehigh Univ, Dept Elect & Comp Engn, Bethlehem, PA 18015 USA; [Staley, Kevin J.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02129 USA; [Staley, Kevin J.] Harvard Med Sch, Boston, MA 02129 USA		Berdichevsky, Y (corresponding author), Lehigh Univ, Bioengn Program, Bethlehem, PA 18015 USA.; Berdichevsky, Y (corresponding author), Lehigh Univ, Dept Elect & Comp Engn, Bethlehem, PA 18015 USA.	berdichevsky@lehigh.edu		Berdichevsky, Yevgeny/0000-0001-7539-601X	Taking Flight Award from Citizens United for Research in Epilepsy (CURE); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R37NS077908, R01NS034700] Funding Source: NIH RePORTER	This work was supported by Taking Flight Award from Citizens United for Research in Epilepsy (CURE).	BACH MA, 1991, MOL BRAIN RES, V10, P43; Bassil F, 2014, PROG NEUROBIOL, V118, P1, DOI 10.1016/j.pneurobio.2014.02.005; Bausch SB, 2000, J NEUROPHYSIOL, V84, P2918, DOI 10.1152/jn.2000.84.6.2918; BECK KD, 1995, NEURON, V14, P717, DOI 10.1016/0896-6273(95)90216-3; Beilharz EJ, 1998, MOL BRAIN RES, V59, P119, DOI 10.1016/S0169-328X(98)00122-3; Benarroch EE, 2012, NEUROLOGY, V79, P2148, DOI 10.1212/WNL.0b013e3182752eef; Berdichevsky Y, 2013, J NEUROSCI, V33, P9056, DOI 10.1523/JNEUROSCI.3870-12.2013; Berdichevsky Y, 2012, NEUROBIOL DIS, V45, P774, DOI 10.1016/j.nbd.2011.11.001; BONDY CA, 1993, ANN NY ACAD SCI, V692, P33; Brewster AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057808; Buckmaster PS, 2011, J NEUROSCI, V31, P2337, DOI 10.1523/JNEUROSCI.4852-10.2011; Buckmaster PS, 2009, J NEUROSCI, V29, P8259, DOI 10.1523/JNEUROSCI.4179-08.2009; Carrera E, 2006, NEUROLOGY, V67, P99, DOI 10.1212/01.wnl.0000223361.90278.ca; Chen SY, 2007, J CEREBR BLOOD F MET, V27, P939, DOI 10.1038/sj.jcbfm.9600393; Cohen E, 2008, NAT REV NEUROSCI, V9, P759, DOI 10.1038/nrn2474; Crino P. B., 2015, COLD SPRING HARB PER, V5; Crino PB, 2011, TRENDS MOL MED, V17, P734, DOI 10.1016/j.molmed.2011.07.008; Crino PB, 2009, EPILEPSIA, V50, P3, DOI 10.1111/j.1528-1167.2009.02289.x; De Simoni A, 2003, J PHYSIOL-LONDON, V550, P135, DOI 10.1113/jphysiol.2003.039099; DEBANNE D, 1995, J NEUROPHYSIOL, V73, P1282, DOI 10.1152/jn.1995.73.3.1282; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Dupraz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054462; Dyhrfjeld-Johnsen J, 2010, J CLIN NEUROPHYSIOL, V27, P418, DOI 10.1097/WNP.0b013e3181fe0709; Engel J., 2008, EPILEPSY COMPREHENSI, P45; Fernandez AM, 2012, NAT REV NEUROSCI, V13, P225, DOI 10.1038/nrn3209; Galanopoulou AS, 2012, EPILEPSIA, V53, P1119, DOI 10.1111/j.1528-1167.2012.03506.x; Goldberg EM, 2013, NAT REV NEUROSCI, V14, P337, DOI 10.1038/nrn3482; Goto J, 2011, P NATL ACAD SCI USA, V108, pE1070, DOI 10.1073/pnas.1106454108; Guan J, 2003, PROG NEUROBIOL, V70, P443, DOI 10.1016/j.pneurobio.2003.08.002; GUAN J, 1993, J CEREBR BLOOD F MET, V13, P609, DOI 10.1038/jcbfm.1993.79; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; GUTHRIE KM, 1995, J COMP NEUROL, V352, P147, DOI 10.1002/cne.903520111; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Huang XX, 2010, NEUROBIOL DIS, V40, P193, DOI 10.1016/j.nbd.2010.05.024; Jastrzebski K, 2007, GROWTH FACTORS, V25, P209, DOI 10.1080/08977190701779101; Jiang GH, 2015, CLIN SCI, V129, P1047, DOI 10.1042/CS20150312; Kooijman R, 2009, STROKE, V40, pE83, DOI 10.1161/STROKEAHA.108.528356; Lee WH, 1996, J CEREBR BLOOD F MET, V16, P227, DOI 10.1097/00004647-199603000-00007; LEE WH, 1992, MOL CELL NEUROSCI, V3, P36, DOI 10.1016/1044-7431(92)90006-N; Madathil S. K., 2015, BRAIN NEUROTRAUMA MO; Madathil SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067204; Madathil SK, 2010, J NEUROTRAUM, V27, P95, DOI 10.1089/neu.2009.1002; MCBAIN CJ, 1989, J NEUROSCI METH, V27, P35, DOI 10.1016/0165-0270(89)90051-4; MILLER LDP, 1994, NEUROSCIENCE, V63, P471, DOI 10.1016/0306-4522(94)90544-4; National Research Council, 2003, GUIDELINES CARE USE, DOI [10.17226/10732, DOI 10.17226/10732]; O'Kusky JR, 2000, J NEUROSCI, V20, P8435, DOI 10.1523/JNEUROSCI.20-22-08435.2000; Ostendorf AP, 2015, CNS DRUGS, V29, P91, DOI 10.1007/s40263-014-0223-x; Ozdinler PH, 2006, NAT NEUROSCI, V9, P1371, DOI 10.1038/nn1789; Park J, 2012, J CEREBR BLOOD F MET, V32, P330, DOI 10.1038/jcbfm.2011.131; Pitkanen A, 2009, EPILEPSY BEHAV, V14, P16, DOI 10.1016/j.yebeh.2008.09.023; Pitkanen A, 2011, NEUROSCI LETT, V497, P163, DOI 10.1016/j.neulet.2011.02.033; Pitkanen A, 2011, LANCET NEUROL, V10, P173, DOI 10.1016/S1474-4422(10)70310-0; Rubovitch V, 2010, NEUROBIOL DIS, V38, P299, DOI 10.1016/j.nbd.2010.01.021; Russo VC, 2005, ENDOCR REV, V26, P916, DOI 10.1210/er.2004-0024; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; Shcheglovitov A, 2013, NATURE, V503, P267, DOI 10.1038/nature12618; Sliwa A, 2012, NEUROSCI LETT, V509, P105, DOI 10.1016/j.neulet.2011.12.051; Sosa L, 2006, NAT NEUROSCI, V9, P993, DOI 10.1038/nn1742; van Vliet EA, 2012, EPILEPSIA, V53, P1254, DOI 10.1111/j.1528-1167.2012.03513.x; Walter HJ, 1997, ENDOCRINOLOGY, V138, P3024, DOI 10.1210/en.138.7.3024; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; Wine RN, 2009, NEUROTOX RES, V16, P280, DOI 10.1007/s12640-009-9060-y; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zeng LH, 2008, ANN NEUROL, V63, P444, DOI 10.1002/ana.21331; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009; Zhu W, 2008, STROKE, V39, P1254, DOI 10.1161/STROKEAHA.107.500801	68	17	17	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 26	2016	6								32095	10.1038/srep32095			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU1KN	WOS:000381966700003	27561791	gold, Green Published			2022-02-06	
J	Na, JY; Song, K; Lee, JW; Kim, S; Kwon, J				Na, Ji-Young; Song, Kibbeum; Lee, Ju-Woon; Kim, Sokho; Kwon, Jungkee			6-Shogaol has anti-amyloidogenic activity and ameliorates Alzheimer's disease via CysLT1R-mediated inhibition of cathepsin B	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						6-Shogaol; Alzheimer's disease; Cysteinyl leukotriene 1 receptor; Cathepsin B; Ginger	TRAUMATIC BRAIN-INJURY; LEUKOTRIENE RECEPTOR 1; BETA-SECRETASE; PRECURSOR PROTEIN; CELL-DEATH; IN-VITRO; MICE; MODEL; EXPRESSION; DEFICITS	Although 6-shogaol, a constituent of ginger, has been reported to have anti-inflammatory and antioxidant effects on neuronal cells, the effects of 6-shogaol on Alzheimer's disease (AD) have not yet been investigated. Here we aimed to determine whether 6-shogaol exerts neuroprotective effects against AD. Specifically, we investigated the effects of 6-shogaol on the cysteinyl leukotriene 1 receptor (CysLT1R), a major factor in AD pathogenesis. Moreover, we clarified the relationship between CysLT1R and cathepsin B, a cysteine protease. We used in vitro and in vivo models to determine whether 6-shogaol inhibits CysLT1R/cathepsin B in an amyloid-beta (A beta; 1-42)-induced model of neurotoxicity. We first confirmed that CysLT1R and cathepsin B are upregulated by A beta (1-42) and that CysLT1R activation induces cathepsin B. In contrast, we found that 6-shogaol-mediated inhibition of CysLT1R downregulates cathepsin B in both in vitro and in vivo models. Furthermore, we found that 6-shogaol-mediated inhibition of CysLT1R/cathepsin B reduces A beta deposition in the brain and ameliorates behavioral deficits in APPSw/PS1-dE9 Tg mice. Our results indicate that 6-shogaol is a CysLT1R/cathepsin B inhibitor and is a novel potential therapeutic agent for the treatment of various neurodegenerative diseases, including AD. (C) 2016 Elsevier Inc. All rights reserved.	[Na, Ji-Young; Song, Kibbeum; Kim, Sokho; Kwon, Jungkee] Chonbuk Natl Univ, Dept Lab Anim Med, Coll Vet Med, 79 Gobongro, Iksan 54596, South Korea; [Lee, Ju-Woon; Kwon, Jungkee] Between Co LTD, Cent Res & Dev, Iksan 54596, South Korea		Kim, S; Kwon, J (corresponding author), Chonbuk Natl Univ, Dept Lab Anim Med, Coll Vet Med, 79 Gobongro, Iksan 54596, South Korea.	raios@hanmail.net; jkwon@jbnu.ac.kr			Jeonbuk Research & Development Program [2013HA-A12]; National Research Foundation of Korea - Korean governmentNational Research Foundation of KoreaKorean Government [NRF-2015R1D1A1A01057696]	This research was supported by a grant (2013HA-A12) from the Jeonbuk Research & Development Program. This work was also supported by a grant from the National Research Foundation of Korea, funded by the Korean government (NRF-2015R1D1A1A01057696).	Azizi G, 2012, IMMUNOPHARM IMMUNOT, V34, P881, DOI 10.3109/08923973.2012.705292; Brink C, 2003, PHARMACOL REV, V55, P195, DOI 10.1124/pr.55.1.8; Ciceri P, 2001, BRIT J PHARMACOL, V133, P1323, DOI 10.1038/sj.bjp.0704189; Deacon RMJ, 2008, BEHAV BRAIN RES, V189, P126, DOI 10.1016/j.bbr.2007.12.024; Filali M, 2009, BRAIN RES, V1292, P93, DOI 10.1016/j.brainres.2009.07.066; Finch CE, 2007, CURR ALZHEIMER RES, V4, P185, DOI 10.2174/156720507780362254; Hook G, 2011, J ALZHEIMERS DIS, V26, P387, DOI 10.3233/JAD-2011-110101; Hook V, 2005, BIOL CHEM, V386, P931, DOI 10.1515/BC.2005.108; Hook VYH, 2008, J BIOL CHEM, V283, P7745, DOI 10.1074/jbc.M708362200; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Kim DSHL, 2004, BIOORG MED CHEM LETT, V14, P1287, DOI 10.1016/j.bmcl.2003.12.041; Kim S, 2013, PHYTOTHER RES, V27, P1795, DOI 10.1002/ptr.4946; Kyung KS, 2006, EUR J NEUROSCI, V24, P1042, DOI 10.1111/j.1460-9568.2006.04908.x; Luo CL, 2010, J NEUROSCI RES, V88, P2847, DOI 10.1002/jnr.22453; Martinez E, 2012, J ALZHEIMERS DIS, V30, P233, DOI 10.3233/JAD-2012-112102; Moechars D, 1999, J BIOL CHEM, V274, P6483, DOI 10.1074/jbc.274.10.6483; Pan MH, 2008, MOL NUTR FOOD RES, V52, P1467, DOI 10.1002/mnfr.200700515; Rosano C, 2012, AGING DIS, V3, P16; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Seo JS, 2010, J ETHNOPHARMACOL, V128, P206, DOI 10.1016/j.jep.2010.01.014; Singh RK, 2010, PHARMACOLOGY, V85, P336, DOI 10.1159/000312669; Tang SS, 2014, NEUROBIOL AGING, V35, P590, DOI 10.1016/j.neurobiolaging.2013.09.036; Tang SS, 2013, NEUROPHARMACOLOGY, V65, P182, DOI 10.1016/j.neuropharm.2012.08.026; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Yu SY, 2014, ACTA PHARMACOL SIN, V35, P33, DOI 10.1038/aps.2013.130; Zhang WP, 2004, NEUROSCI LETT, V363, P247, DOI 10.1016/j.neulet.2004.03.088	26	17	20	0	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	AUG 12	2016	477	1					96	102		10.1016/j.bbrc.2016.06.026			7	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	DS0OQ	WOS:000380297000015	27286707				2022-02-06	
J	Xu, Z; Lv, XA; Dai, Q; Ge, YQ; Xu, J				Xu, Zhen; Lv, Xiao-Ai; Dai, Qun; Ge, Yu-Qing; Xu, Jie			Acute upregulation of neuronal mitochondrial type-1 cannabinoid receptor and it's role in metabolic defects and neuronal apoptosis after TBI	MOLECULAR BRAIN			English	Article						Apoptosis; Mitochondrial type-1 cannabinoid receptor; Metabolic defects; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; CELL-DEATH; AKT; CB1; PROTEIN; PHOSPHORYLATION; DYSFUNCTION; ACTIVATION; ISCHEMIA; ENDOCANNABINOIDS	Metabolic defects and neuronal apoptosis initiated by traumatic brain injury (TBI) contribute to subsequent neurodegeneration. They are all regulated by mechanisms centered around mitochondrion. Type-1 cannabinoid receptor (CB1) is a G-protein coupled receptor (GPCR) enriched on neuronal plasma membrane. Recent evidences point to the substantial presence of CB1 receptors on neuronal mitochondrial outer membranes (mtCB1) and the activation of mtCB1 influences aerobic respiration via inhibiting mitochondrial cyclic adenosine monophosphate (cAMP)/protein kinase A (PKA)/complex I pathway. The expression and role of neuronal mtCB1 under TBI are unknown. Using TBI models of cultured neurons, wild type and CB1 knockout mice, we found mtCB1 quickly upregulated after TBI. Activation of mtCB1 promoted metabolic defects accompanied with ATP shortage but protected neurons from apoptosis. Selective activation of plasma membrane CB1 showed no effects on neuronal metabolism and apoptosis. Activation of mtCB1 receptors inhibited mitochondrial cAMP/PKA/complex I and resulted in exacerbated metabolic defects accompanied with a higher ratio of ATP reduction to oxygen consumption decrease as well as neuronal apoptosis. Further research found the remarkable accumulation of protein kinase B (AKT) on neuronal mitochondria following TBI and the activation of mtCB1 upregulated mitochondrial AKT/complex V activity. Upregulation of mitochondrial AKT/complex V activity showed anti-apoptosis effects and alleviated ATP shortage in metabolic defects. Taken together, we have identified mtCB1 quickly upregulate after TBI and a dual role the mtCB1 might play in metabolic defects and neuronal apoptosis initiated by TBI: the inhibition of mitochondrial cAMP/PKA/complex I aggravates metabolic defects, energy insufficiency as well as neuronal apoptosis, but the coactivation of mitochondrial AKT/complex V mitigates energy insufficiency and neuronal apoptosis.	[Xu, Zhen] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Dept Neurosurg, 54 Youdian Lane, Hangzhou 310006, Zhejiang, Peoples R China; [Lv, Xiao-Ai] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Dept Surg, 54 Youdian Lane, Hangzhou 310006, Zhejiang, Peoples R China; [Dai, Qun; Ge, Yu-Qing] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Cent Lab, 54 Youdian Lane, Hangzhou 310006, Zhejiang, Peoples R China; [Xu, Jie] Huzhou Cent Hosp, Dept Neurosurg, 198 Hongqi Lane, Huzhou 313003, Peoples R China		Xu, Z (corresponding author), Zhejiang Chinese Med Univ, Affiliated Hosp 1, Dept Neurosurg, 54 Youdian Lane, Hangzhou 310006, Zhejiang, Peoples R China.	xuzhenhangzhou@yeah.net			Zhejiang provincial natural science foundationNatural Science Foundation of Zhejiang Province [LY16H090014]; Zhejiang provincial medical health and science and technology project foundation [2016KYB213]	This work was supported by Zhejiang provincial natural science foundation (LY16H090014) and Zhejiang provincial medical health and science and technology project foundation (2016KYB213).	Benard G, 2012, NAT NEUROSCI, V15, P558, DOI 10.1038/nn.3053; Bijur GN, 2003, J NEUROCHEM, V87, P1427, DOI 10.1046/j.1471-4159.2003.02113.x; Caballero-Caballero A, 2013, J NEUROCHEM, V124, P749, DOI 10.1111/jnc.12133; Cabral GA, 2005, J LEUKOCYTE BIOL, V78, P1192, DOI 10.1189/jlb.0405216; Cammarota M, 1999, J NEUROCHEM, V72, P2272, DOI 10.1046/j.1471-4159.1999.0722272.x; Carre E, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00146; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Console-Bram L, 2012, PROG NEURO-PSYCHOPH, V38, P4, DOI 10.1016/j.pnpbp.2012.02.009; De Sarno P, 2002, NEUROPHARMACOLOGY, V43, P1158, DOI 10.1016/S0028-3908(02)00215-0; del Pulgar T, 2000, BIOCHEM J, V347, P369, DOI 10.1042/bj3470369; Dutcher SA, 1998, J NEUROTRAUM, V15, P411, DOI 10.1089/neu.1998.15.411; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Farook JM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.280; Golech SA, 2004, MOL BRAIN RES, V132, P87, DOI 10.1016/j.molbrainres.2004.08.025; Heimann AS, 2007, P NATL ACAD SCI USA, V104, P20588, DOI 10.1073/pnas.0706980105; Hoshi M, 1996, P NATL ACAD SCI USA, V93, P2719, DOI 10.1073/pnas.93.7.2719; Keightley ML, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00139; Madathil SK, 2010, J NEUROTRAUM, V27, P95, DOI 10.1089/neu.2009.1002; Maresz K, 2005, J NEUROCHEM, V95, P437, DOI 10.1111/j.1471-4159.2005.03380.x; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Nagayama T, 1999, J NEUROSCI, V19, P2987; Nguyen VH, 2012, PHARMACOLOGY, V89, P64, DOI 10.1159/000335368; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Pacher P, 2008, BRIT J PHARMACOL, V153, P252, DOI 10.1038/sj.bjp.0707582; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Pedersen PL, 2007, J BIOENERG BIOMEMBR, V39, P1, DOI 10.1007/s10863-007-9070-5; Robertson CL, 2004, J BIOENERG BIOMEMBR, V36, P363, DOI 10.1023/B:JOBB.0000041769.06954.e4; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Rozenfeld R, 2008, FASEB J, V22, P2311, DOI 10.1096/fj.07-102731; Sheng WS, 2005, GLIA, V49, P211, DOI 10.1002/glia.20108; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Slemmer JE, 2002, BRAIN, V125, P2699, DOI 10.1093/brain/awf271; Slemmer JE, 2008, AM J PATHOL, V173, P1795, DOI 10.2353/ajpath.2008.080168; Su CC, 2012, AM J PHYSIOL-HEART C, V302, pH716, DOI 10.1152/ajpheart.00455.2011; Tieu K, 2003, J CLIN INVEST, V112, P892, DOI 10.1172/JCI200318797; Wender R, 2000, J NEUROSCI, V20, P6804, DOI 10.1523/JNEUROSCI.20-18-06804.2000; Wright MJ, 2013, BRAIN IMAGING BEHAV, V7, P307, DOI 10.1007/s11682-013-9231-6; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Yang JY, 2013, J MOL CELL CARDIOL, V59, P167, DOI 10.1016/j.yjmcc.2013.02.016	39	17	18	0	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-6606			MOL BRAIN	Mol. Brain	AUG 2	2016	9								75	10.1186/s13041-016-0257-8			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DS7RJ	WOS:000380980300002	27485212	gold, Green Published			2022-02-06	
J	Delgado, T; Wolfe, B; Davis, G; Ansari, S				Delgado, Tim; Wolfe, Brianne; Davis, Gary; Ansari, Safdar			Safety of peripheral administration of phenylephrine in a neurologic intensive care unit: A pilot study	JOURNAL OF CRITICAL CARE			English	Article						Vasopressor; Traumatic brain injury; Ischemic stroke; Blood pressure augmentation; Hypotension; Cerebral perfusion pressure	NOREPINEPHRINE; MANAGEMENT; COMPLICATIONS; HYPERTENSION; GUIDELINES; DOPAMINE; PRESSURE; INJURY	Integral to the management of the neurocritically injured patient are the prevention and treatment of hypotension, maintenance of cerebral perfusion pressure, and occasionally blood pressure augmentation. When adequate volume resuscitation fails to meet perfusion needs, vasopressors are often used to restore end-organ perfusion. This has historically necessitated central venous access given well-documented incidence of extravasation injuries associated with peripheral administration of vasopressors. In this pilot study, we report our 6-month experience with peripheral administration of low-concentration phenylephrine (40 mu g/mL) in our neurocritical care unit. We were able to administer peripheral phenylephrine, up to a dose of 2 mu g/(kg min), for an average of 14.29 hours (1-54.3) in 20 patients with only 1 possible minor complication and no major complications. This was achieved by adding additional safety measures in our computerized physician order entry system and additional nurse-driven safety protocols. Thus, with careful monitoring and safety precautions, peripheral administration of phenylephrine at an optimized concentration appears to have an acceptable safety profile for use in the neurocritical care unit up to a mean infusion time of 14 hours. (C) 2016 Elsevier Inc. All rights reserved.	[Delgado, Tim; Wolfe, Brianne; Davis, Gary; Ansari, Safdar] Univ Utah, Salt Lake City, UT 84112 USA		Delgado, T (corresponding author), Univ Utah, Salt Lake City, UT 84112 USA.	tim.delgado@hsc.utah.edu; Brianne.wolfe@hsc.utah.edu; Gary.Davis@hsc.utah.edu; Safdar.Ansari@hsc.utah.edu					Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bunker N, 2006, CRIT CARE MED, V34, P935, DOI 10.1097/01.CCM.0000202202.85087.37; Chen JL, 1998, ANN PHARMACOTHER, V32, P545, DOI 10.1345/aph.17184; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Cooper BE, 2008, AACN ADV CRIT CARE, V19, P5, DOI 10.1097/01.AACN.0000310743.32298.1d; De Backer D, 2010, NEW ENGL J MED, V362, P779, DOI 10.1056/NEJMoa0907118; Dugger B, 1997, J Intraven Nurs, V20, P95; GREGORY JS, 1991, CRIT CARE MED, V19, P1395, DOI 10.1097/00003246-199111000-00016; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Havel C, 2011, COCHRANE DB SYST REV, P11; HENGSTMANN JH, 1982, EUR J CLIN PHARMACOL, V21, P335, DOI 10.1007/BF00637623; Hollenberg SM, 2004, CRIT CARE MED, V32, P1928, DOI 10.1097/01.CCM.0000139761.05492.D6; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Jia XF, 2013, J INTENSIVE CARE MED, V28, P12, DOI 10.1177/0885066611403270; Kahn JM, 2002, CRIT CARE MED, V30, P1899, DOI 10.1097/00003246-200208000-00038; Leone M, 2004, INTENS CARE MED, V30, P984, DOI 10.1007/s00134-004-2172-1; Lim TS, 2011, J NEUROL SCI, V308, P72, DOI 10.1016/j.jns.2011.06.009; Marzan AS, 2004, NEUROLOGY, V62, P1193, DOI 10.1212/01.WNL.0000118303.45735.04; McGee DC, 2003, NEW ENGL J MED, V348, P1123, DOI 10.1056/NEJMra011883; MCGINN JT, 1956, AM J SURG, V92, P594, DOI 10.1016/S0002-9610(56)80091-3; Merrer J, 2001, JAMA-J AM MED ASSOC, V286, P700, DOI 10.1001/jama.286.6.700; Mistri AK, 2006, STROKE, V37, P1565, DOI 10.1161/01.STR.0000222002.57530.05; Myburgh J A, 2005, Crit Care Resusc, V7, P200; Patel GP, 2010, SHOCK, V33, P375, DOI 10.1097/SHK.0b013e3181c6ba6f; PELNER L, 1958, AM J MED SCI, V236, P755, DOI 10.1097/00000441-195812000-00008; Raad I, 1998, LANCET, V351, P893, DOI 10.1016/S0140-6736(97)10006-X; Rordorf G, 2001, NEUROLOGY, V56, P1210, DOI 10.1212/WNL.56.9.1210; TAGER IB, 1983, AM J EPIDEMIOL, V118, P839; Taylor RW, 2007, CRIT CARE MED, V35, P1390, DOI 10.1097/01.CCM.0000260241.80346.1B; Walters BC, 2013, NEUROSURGERY, V60, P82, DOI 10.1227/01.neu.0000430319.32247.7f; White H, 2008, ANESTH ANALG, V107, P979, DOI 10.1213/ane.0b013e31817e7b1a; Wityk RJ, 2007, J NEUROL SCI, V261, P63, DOI 10.1016/j.jns.2007.04.033; YAMAZAKI T, 1982, CRIT CARE MED, V10, P432, DOI 10.1097/00003246-198207000-00003	34	17	19	1	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	AUG	2016	34						107	110		10.1016/j.jcrc.2016.04.004			4	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO3TK	WOS:000377704200022	27288620				2022-02-06	
J	Fahoum, F; Omer, N; Kipervasser, S; Bar-Adon, T; Neufeld, M				Fahoum, Firas; Omer, Nurit; Kipervasser, Svetlana; Bar-Adon, Tal; Neufeld, Miri			Safety in the epilepsy monitoring unit: A retrospective study of 524 consecutive admissions	EPILEPSY & BEHAVIOR			English	Article						Epilepsy monitoring unit; Safety adverse events; Antiepileptic drugs; Seizure clusters; Psychogenic nonepileptic seizure; Status epilepticus	ADVERSE EVENTS; VIDEO; TELEMETRY; TIME	The yield of monitoring patients at an epilepsy monitoring unit (EMU) depends on the recording of paroxysmal events in a timely fashion, however, increasing the risk of safety adverse events (AEs). We aimed to retrospectively study the frequency and risk factors for AE occurrences in all consecutive admissions to an adult EMU in a tertiary medical center. We also compared our findings with published data from other centers. Between January 2011 and June 2014, there were 524 consecutive admissions to the adult EMU at the Tel Aviv Sourasky Medical Center. Adverse events were recorded in 47 (9.0%) admissions. The most common AE was 4-hour seizure cluster (58.7% of AEs) and, in decreasing frequency, AEs related to antiepileptic drugs (AEDs, 11.1%), falls and traumatic injuries (9.5%), intravenous line complications (9.5%), electrode-related (4.8%), status epilepticus (SE, 3.2%), and cardiac (1.6%) and psychiatric (1.6%) complications. There were significantly more AEs among patients with a younger age at disease onset (p = 0.005), a history of temporal lobe epilepsy (p = 0.046), a history of focal seizures with altered consciousness (p = 0.008), a history of SE (p = 0.022), use of a vagal nerve stimulator (p = 0.039), and intellectual disability (p = 0.016) and when the indication for EMU monitoring was noninvasive or invasive presurgical evaluation (p = 0.001). Adverse events occurred more frequently when patients had more events in the EMU (p = 0.001) and among those administered carbamazepine (p = 0.037), levetiracetam (p = 0.004), clobazam (p = 0.008), and sulthiame (p = 0.016). Patients with a history of psychogenic nonepileptic seizures (PNESs) had significantly fewer AEs (p = 0.013). Adverse events were not associated with the age, gender, duration of hospitalization or monitoring, AED withdrawal and renewal, seizure frequency by history, presence of major psychiatric comorbidities, abnormal neurological exam, or the presence of a lesion as on brain magnetic resonance imaging. In conclusion, this study reveals that AEs are not unusual in the EMU and that seizure clustering is the most common among them. Adverse events occur more frequently in patients with more severe epilepsy and intellectual disability and in patients undergoing presurgical evaluations and less frequently in patients with PNESs. (C) 2016 Elsevier Inc. All rights reserved.	[Fahoum, Firas; Omer, Nurit; Kipervasser, Svetlana; Bar-Adon, Tal; Neufeld, Miri] Tel Aviv Sourasky Med Ctr, Epilepsy & EEG Unit, Dept Neurol, 6 Weizmann St, IL-6423906 Tel Aviv, Israel; [Kipervasser, Svetlana; Neufeld, Miri] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel		Fahoum, F (corresponding author), Tel Aviv Sourasky Med Ctr, Epilepsy & EEG Unit, Dept Neurol, 6 Weizmann St, IL-6423906 Tel Aviv, Israel.	firasf@tlvmc.gov.il		Fahoum, Firas/0000-0003-2262-5530			[Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Atkinson M, 2012, SEIZURE-EUR J EPILEP, V21, P124, DOI 10.1016/j.seizure.2011.10.004; Blum DE, 1996, NEUROLOGY, V47, P260, DOI 10.1212/WNL.47.1.260; Dericioglu N, 2000, SEIZURE-EUR J EPILEP, V9, P124, DOI 10.1053/seiz.1999.0341; Di Gennaro G, 2012, CLIN NEUROPHYSIOL, V123, P486, DOI 10.1016/j.clinph.2011.08.011; Dobesberger J, 2011, EPILEPSIA, V52, P443, DOI 10.1111/j.1528-1167.2010.02782.x; Hoppe C, 2007, ARCH NEUROL-CHICAGO, V64, P1595, DOI 10.1001/archneur.64.11.1595; Kandler R, 2013, SEIZURE-EUR J EPILEP, V22, P872, DOI 10.1016/j.seizure.2013.08.001; Lowenstein DH, 1999, EPILEPSIA, V40, P120, DOI 10.1111/j.1528-1157.1999.tb02000.x; Martz GU, 2014, EPILEPSIA, V55, P1800, DOI 10.1111/epi.12796; McCabe PH, 2003, NEUROLOGY, V60, P975, DOI 10.1212/01.WNL.0000053748.83309.28; Mohan KK, 1996, ACTA NEUROL SCAND, V94, P320, DOI 10.1111/j.1600-0404.1996.tb07073.x; Moien-Afshari F, 2009, CAN J NEUROL SCI, V36, P587, DOI 10.1017/S0317167100008088; Noe KH, 2009, MAYO CLIN PROC, V84, P495, DOI 10.1016/S0025-6196(11)60580-6; Pati S, 2013, EPILEPSY BEHAV, V29, P1, DOI 10.1016/j.yebeh.2013.06.013; Rheims S, 2014, CURR OPIN NEUROL, V27, P213, DOI 10.1097/WCO.0000000000000076; Sauro KM, 2014, EPILEPSY BEHAV, V33, P7, DOI 10.1016/j.yebeh.2014.01.021; Spanaki MV, 2012, EPILEPSY BEHAV, V25, P185, DOI 10.1016/j.yebeh.2012.06.028; Spritzer SD, 2015, EPILEPSY BEHAV, V48, P75, DOI 10.1016/j.yebeh.2015.05.026; Yen DJ, 2001, EPILEPSIA, V42, P251, DOI 10.1046/j.1528-1157.2001.15100.x	20	17	17	1	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	AUG	2016	61						162	167		10.1016/j.yebeh.2016.06.002			6	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	DT1MY	WOS:000381248000029	27351727				2022-02-06	
J	Kesinger, MR; Juengst, SB; Bertisch, H; Niemeier, JP; Krellman, JW; Pugh, M; Kumar, RG; Sperry, JL; Arenth, PM; Fann, JR; Wagner, AK				Kesinger, Matthew R.; Juengst, Shannon B.; Bertisch, Hillary; Niemeier, Janet P.; Krellman, Jason W.; Pugh, MaryJo; Kumar, Raj G.; Sperry, Jason L.; Arenth, Patricia M.; Fann, Jesse R.; Wagner, Amy K.			Acute Trauma Factor Associations With Suicidality Across the First 5 Years After Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Injury Severity Score; Multiple trauma; Rehabilitation; Suicidal ideation; Suicide; attempted	DEPLOYED MILITARY PERSONNEL; SUBSTANCE-ABUSE; RISK-FACTORS; CHRONIC PAIN; FOLLOW-UP; DEPRESSION; IDEATION; REHABILITATION; POPULATION; PREVALENCE	Objective: To determine whether severity of head and extracranial injuries (ECI) is associated with suicidal ideation (SI) or suicide attempt (SA) after traumatic brain injury (TBI). Design: Factors associated with SI and SA were assessed in this inception cohort study using data collected 1, 2, and 5 years post-TBI from the National Trauma Data Bank and Traumatic Brain Injury Model Systems (TRIMS) databases. Setting: Level I trauma centers, inpatient rehabilitation centers, and the community. Participants: Participants with TBI from 15 TBIMS Centers with linked National Trauma Data Bank trauma data (N=3575). Interventions: Not applicable. Main Outcome Measures: SI was measured via the Patient Health Questionnaire 9 (question 9). SA in the last year was assessed via interview. ECI was measured by the Injury Severity Scale (nonhead) and categorized as none, mild, moderate, or severe. Results: There were 293 (8.2%) participants who had SI without SA and 109 (3.0%) who had SA at least once in the first 5 years postinjury. Random effects logit modeling showed a higher likelihood of SI when ECI was severe (odds ratio = 2.73; 95% confidence interval, 1.55-4.82; P=.001). Drug use at time of injury was also associated with SI (odds ratio =1.69; 95% confidence interval, 1.11-2.86; P=.015). Severity of ECI was not associated with SA. Conclusions: Severe ECI carried a nearly 3-fold increase in the odds of SI after TBI, but it was not related to SA. Head injury severity and less severe ECI were not associated with SI or SA. These findings warrant additional work to identify factors associated with severe ECI that make individuals more susceptible to SI after TBI. (C) 2016 by the American Congress of Rehabilitation Medicine	[Kesinger, Matthew R.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Juengst, Shannon B.; Kumar, Raj G.; Arenth, Patricia M.; Wagner, Amy K.] Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, 3471 Fifth Ave, Pittsburgh, PA 15213 USA; [Bertisch, Hillary] NYU, Dept Rehabil Med, Sch Med, New York, NY USA; [Niemeier, Janet P.] Carolinas Med Ctr, Dept Phys Med & Rehabil, Charlotte, NC 28203 USA; [Niemeier, Janet P.] Univ N Carolina, Chapel Hill, NC USA; [Krellman, Jason W.] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Pugh, MaryJo] South Texas Vet Hlth Care Syst, San Antonio, TX USA; [Pugh, MaryJo] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Sperry, Jason L.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA USA; [Fann, Jesse R.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Wagner, Amy K.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA		Juengst, SB (corresponding author), Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, 3471 Fifth Ave, Pittsburgh, PA 15213 USA.	sbj7@pitt.edu	Juengst, Shannon B/AAC-5891-2019; Pugh, Mary Jo/K-5336-2019	Juengst, Shannon B/0000-0003-4709-545X; Pugh, Mary Jo/0000-0003-4196-7763	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DP0041]; NIDILRRUnited States Department of Health & Human Services [90DP0038, 90DP0047]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIH K23GM093032]; National Institute of Mental Health Medical Student Research Fellowship [TL1TR000005, R25 MH054318]; Rusk Advanced Rehabilitation Research Training Postdoctoral Fellowship [NIDILRR 90AR5014-01-00]; Polytrauma Rehabilitation Center Traumatic Brain Injury Model System; Department of Veterans Affairs (VA)US Department of Veterans Affairs; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1TR000054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K23GM093032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R25MH054318] Funding Source: NIH RePORTER	Support for the collection of the original data was by the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) (grant no. 90DP0041); and the National Trauma Data Bank. Support for the content of this article was by the NIDILRR (grant nos. 90DP0038 and 90DP0047); the National Institutes of Health (grant no. NIH K23GM093032); the National Institute of Mental Health Medical Student Research Fellowship (fellowship no. TL1TR000005) administered by the University of Pittsburgh (grant no. R25 MH054318); a Rusk Advanced Rehabilitation Research Training Postdoctoral Fellowship (grant no. NIDILRR 90AR5014-01-00); and the Polytrauma Rehabilitation Center Traumatic Brain Injury Model System.; The Polytrauma Rehabilitation Center Traumatic Brain Injury Model System is a funded collaboration between the Department of Veterans Affairs (VA) and the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR). The NIDILRR is a center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this article do not necessarily represent the policy of the VA, NIDILRR, ACL, NIH, or HHS, and endorsement of this content by the Federal Government should not be assumed.	Andruszkow H, 2013, CLIN ORTHOP RELAT R, V471, P2899, DOI 10.1007/s11999-013-3031-6; Artenie AA, 2015, ADDICTION, V110, P1636, DOI 10.1111/add.13030; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Beninato M, 2006, ARCH PHYS MED REHAB, V87, P32, DOI 10.1016/j.apmr.2005.08.130; Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brown AW, 2011, J NEUROTRAUM, V28, P167, DOI 10.1089/neu.2010.1400; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Bryan CJ, 2013, J HEAD TRAUMA REHAB, V28, P13, DOI 10.1097/HTR.0b013e31826c73cc; Campbell G, 2016, CLIN J PAIN, V32, P292, DOI 10.1097/AJP.0000000000000283; Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112; Cook AJ, 2015, BEHAV RES THER, V73, P25, DOI 10.1016/j.brat.2015.07.003; COPES WS, 1990, J TRAUMA, V30, P1200, DOI 10.1097/00005373-199010000-00003; Corrigan JD, 2008, BRAIN INJURY, V22, P223, DOI 10.1080/02699050801938967; Darke S, 2015, PSYCHIAT RES, V227, P166, DOI 10.1016/j.psychres.2015.04.010; Desseilles M, 2012, J AFFECT DISORDERS, V136, P398, DOI 10.1016/j.jad.2011.11.013; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Finley EP, 2015, AM J PUBLIC HEALTH, V105, P380, DOI 10.2105/AJPH.2014.301957; Fountoulakis KN, 2004, NEUROPSYCHOBIOLOGY, V49, P42, DOI 10.1159/000075338; Giegling I, 2009, J PSYCHIATR RES, V43, P1262, DOI 10.1016/j.jpsychires.2009.04.013; Gross T, 2012, ACTA ANAESTH SCAND, V56, P1163, DOI 10.1111/j.1399-6576.2012.02724.x; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Homaifar BY, 2012, REHABIL PSYCHOL, V57, P337, DOI 10.1037/a0030480; Juengst SB, 2014, BRAIN BEHAV IMMUN, V41, P134, DOI 10.1016/j.bbi.2014.05.020; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kesinger MR, 2016, AM J PHYS MED REHABI; Kishi Y, 2001, PSYCHOSOMATICS, V42, P382, DOI 10.1176/appi.psy.42.5.382; Lopez-Larson Melissa, 2013, Front Psychiatry, V4, P83, DOI 10.3389/fpsyt.2013.00083; March J, 2014, J TRAUMA ACUTE CARE, V76, P180, DOI 10.1097/TA.0b013e3182a900bc; McConnell D, 2015, COMMUNITY MENT HLTH; McCullumsmith CB, 2015, ARCH PHYS MED REHAB, V96, P799, DOI 10.1016/j.apmr.2014.12.017; Nowrangi MA, 2014, PSYCHOSOMATICS, V55, P430, DOI 10.1016/j.psym.2013.11.006; Ortiz-Gomez LD, 2014, J AFFECT DISORDERS, V169, P10, DOI 10.1016/j.jad.2014.07.033; Randall JR, 2014, CAN J PSYCHIAT, V59, P531, DOI 10.1177/070674371405901006; Reeves RR, 2012, J PSYCHOSOC NURS MEN, V50, P32, DOI 10.3928/02793695-20120207-02; Rockett IRH, 2015, JAMA PSYCHIAT, V72, P1069, DOI 10.1001/jamapsychiatry.2015.1418; Ryb GE, 2006, J TRAUMA, V61, P799, DOI 10.1097/01.ta.0000196763.14289.4e; Serafini G, 2013, EUR NEUROPSYCHOPHARM, V23, P1672, DOI 10.1016/j.euroneuro.2013.06.002; Simon GE, 2013, PSYCHIAT SERV, V64, P1195, DOI 10.1176/appi.ps.201200587; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; TEASDALE G, 1974, LANCET, V2, P81; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Tsaousides T, 2011, J HEAD TRAUMA REHAB, V26, P265, DOI 10.1097/HTR.0b013e3182225271; Tupler LA, 2015, J NERV MENT DIS, V203, P269, DOI 10.1097/NMD.0000000000000277; Wagner AK, 2000, AM J PHYS MED REHAB, V79, P235, DOI 10.1097/00002060-200005000-00004; Wagner AK, 2000, J TRAUMA, V49, P411, DOI 10.1097/00005373-200009000-00005; Wagner AK, 2000, ARCH PHYS MED REHAB, V81, P1267; Zhang XY, 2014, DRUG ALCOHOL DEPEN, V142, P63, DOI 10.1016/j.drugalcdep.2014.05.025	52	17	17	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2016	97	8					1301	1308		10.1016/j.apmr.2016.02.017			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	DT1LM	WOS:000381244200012	26987622	Green Published, Bronze			2022-02-06	
J	Tremoleda, JL; Thau-Zuchman, O; Davies, M; Foster, J; Khan, I; Vadivelu, KC; Yip, PK; Sosabowski, J; Trigg, W; Michael-Titus, AT				Tremoleda, J. L.; Thau-Zuchman, O.; Davies, M.; Foster, J.; Khan, I.; Vadivelu, K. C.; Yip, P. K.; Sosabowski, J.; Trigg, W.; Michael-Titus, A. T.			In vivo PET imaging of the neuroinflammatory response in rat spinal cord injury using the TSPO tracer [F-18]GE-180 and effect of docosahexaenoic acid	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Article						Spinal cord injury; Neuroinflammatory respone; [F-18]GE-180; Ratmodel; Docosahexaenoic acid	POSITRON-EMISSION-TOMOGRAPHY; PROTEIN 18 KDA; TRANSLOCATOR PROTEIN; MICROGLIAL ACTIVATION; INFLAMMATORY RESPONSE; BRAIN; MODEL; MACROPHAGES; NEUROPROTECTION; RADIOTRACER	Purpose Traumatic spinal cord injury (SCI) is a devastating condition which affects millions of people worldwide causing major disability and substantial socioeconomic burden. There are currently no effective treatments. Modulating the neuroinflammatory (NI) response after SCI has evolved as a major therapeutic strategy. PET can be used to detect the upregulation of the 18-kDa translocator protein (TSPO), a hallmark of activated microglia in the CNS. We investigated whether PET imaging using the novel TSPO tracer [F-18]GE-180 can be used as a clinically relevant biomarker for NI in a contusion SCI rat model, and we present data on the modulation of NI by the lipid docosahexaenoic acid (DHA). Methods A total of 22 adult male Wistar ratswere subjected to controlled spinal cord contusion at the T10 spinal cord level. Six non-injured and ten T10 laminectomy only (LAM) animals were used as controls. A subset of six SCI animals were treated with a single intravenous dose of 250 nmol/ kg DHA (SCI-DHA group) 30 min after injury; a saline-injected group of six animals was used as an injection control. PET and CT imaging was carried out 7 days after injury using the [F-18]GE-180 radiotracer. After imaging, the animals were killed and the spinal cord dissected out for biodistribution and autoradiography studies. In vivo data were correlated with ex vivo immunohistochemistry for TSPO. Results In vivo dynamic PET imaging revealed an increase in tracer uptake in the spinal cord of the SCI animals compared with the non-injured and LAM animals from 35 min after injection (P < 0.0001; SCI vs. LAM vs. non-injured). Biodistribution and autoradiography studies confirmed the high affinity and specific [F-18] GE-180 binding in the injured spinal cord compared with the binding in the control groups. Furthermore, they also showed decreased tracer uptake in the T10 SCI area in relation to the non-injured remainder of the spinal cord in the SCI-DHA group compared with the SCIsaline group (P< 0.05), supporting a NI modulatory effect of DHA. Immunohistochemistry showed a high level of TSPO expression (38 %) at the T10 injury site in SCI animals compared with that in the non-injured animals (6 %). Conclusion [F-18] GE-180 PET imaging can reveal areas of increased TSPO expression that can be visualized and quantified in vivo after SCI, offering a minimally invasive approach to the monitoring of NI in SCI models and providing a translatable clinical readout for the testing of new therapies.	[Tremoleda, J. L.; Thau-Zuchman, O.; Davies, M.; Vadivelu, K. C.; Yip, P. K.; Michael-Titus, A. T.] Blizard Inst, Ctr Trauma Sci, London, England; [Foster, J.; Sosabowski, J.] Queen Mary Univ London, Barts Canc Inst, London, England; [Khan, I.; Trigg, W.] GE Healthcare Ltd, Amersham, England		Tremoleda, JL (corresponding author), Blizard Inst, Ctr Trauma Sci, London, England.	j.lopez-tremoleda@qmul.ac.uk		Trigg, William/0000-0003-4046-0813; Thau-Zuchman, Orli/0000-0003-0403-7962	Centre for Trauma Sciences - Barts & The London Charity; GE Healthcare LtdGeneral Electric; Blizard Institute; Imaging Centre at the Barts Cancer Institute	This work was supported by the Centre for Trauma Sciences, funded by the Barts & The London Charity, GE Healthcare Ltd, the Experimental Medicine Awards from the Blizard Institute and the Imaging Centre at the Barts Cancer Institute.	Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Airas L, 2015, J NUCL MED, V56, P305, DOI 10.2967/jnumed.114.149955; Alexander JK, 2009, PROG BRAIN RES, V175, P125, DOI 10.1016/S0079-6123(09)17508-8; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Belayev L, 2011, TRANSL STROKE RES, V2, P33, DOI 10.1007/s12975-010-0046-0; Belayev L, 2009, STROKE, V40, P3121, DOI 10.1161/STROKEAHA.109.555979; Boutin H, 2015, EUR J NUCL MED MOL I, V42, P503, DOI 10.1007/s00259-014-2939-8; Boutin H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056441; Bowes AL, 2014, J NEUROTRAUM, V31, P1753, DOI 10.1089/neu.2014.3429; Casha S, 2012, BRAIN, V135, P1224, DOI 10.1093/brain/aws072; Chang PKY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0244-5; Chauveau F, 2008, EUR J NUCL MED MOL I, V35, P2304, DOI 10.1007/s00259-008-0908-9; Cosenza-Nashat M, 2009, NEUROPATH APPL NEURO, V35, P306, DOI 10.1111/j.1365-2990.2008.01006.x; Cruz CD, 2015, ADV DRUG DELIVER REV, V82-83, P153, DOI 10.1016/j.addr.2014.11.007; Dickens AM, 2014, J NUCL MED, V55, P466, DOI 10.2967/jnumed.113.125625; Faria DD, 2014, J NUCL MED, V55, P1330, DOI 10.2967/jnumed.114.137216; Fehlings MG, 2011, J NEUROTRAUM, V28, P1329, DOI 10.1089/neu.2011.1955; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Gallagher CN, 2007, CURR OPIN NEUROL, V20, P403, DOI 10.1097/WCO.0b013e32821b987b; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Greenhalgh AD, 2014, J NEUROSCI, V34, P6316, DOI 10.1523/JNEUROSCI.4912-13.2014; Hall JCE, 2012, J NEUROCHEM, V121, P738, DOI 10.1111/j.1471-4159.2012.07726.x; Huang WL, 2007, BRAIN, V130, P3004, DOI 10.1093/brain/awm223; Imaizumi M, 2008, NEUROIMAGE, V39, P1289, DOI 10.1016/j.neuroimage.2007.09.063; Jucaite A, 2015, BRAIN, V138, P2687, DOI 10.1093/brain/awv184; Krause JS, 2011, ARCH PHYS MED REHAB, V92, P1770, DOI 10.1016/j.apmr.2011.05.024; Krishna V, 2013, JOVE-J VIS EXP, DOI 10.3791/50111; Kuhle J, 2015, J NEUROL NEUROSUR PS, V86, P273, DOI 10.1136/jnnp-2013-307454; Larochelle A, 2016, BBA-MOL BASIS DIS, V1862, P310, DOI 10.1016/j.bbadis.2015.09.017; Lim SN, 2013, EXP NEUROL, V239, P13, DOI 10.1016/j.expneurol.2012.09.015; Liu B, 2015, J NEUROSCI, V35, P15716, DOI 10.1523/JNEUROSCI.0996-15.2015; Liu GJ, 2014, BRAIN PATHOL, V24, P631, DOI 10.1111/bpa.12196; Liu HL, 2010, J CEREBR BLOOD F MET, V30, P177, DOI 10.1038/jcbfm.2009.179; Liu ZH, 2015, J NEUROSCI, V35, P12733, DOI 10.1523/JNEUROSCI.0605-15.2015; Marquardt G, 2009, NEUROL RES, V31, P265, DOI 10.1179/174313209X382287; Nariai Tadashi, 2013, Acta Neurochir Suppl, V118, P251, DOI 10.1007/978-3-7091-1434-6_47; O'Brien ER, 2014, J NUCL MED, V55, P275, DOI 10.2967/jnumed.113.127449; Ostuni MA, 2009, BIOL CELL, V101, P573, DOI 10.1042/BC20080231; Owen DRJ, 2011, INT REV NEUROBIOL, V101, P19, DOI 10.1016/B978-0-12-387718-5.00002-X; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Paterniti I, 2014, J NEUROINFLAMM, V11, DOI [10.1186/1742-2094-11-6, 10.1186/s12974-014-0136-0]; Pottier G, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4508; Pouw MH, 2009, SPINAL CORD, V47, P519, DOI 10.1038/sc.2008.176; Sandiego CM, 2015, P NATL ACAD SCI USA, V112, P12468, DOI 10.1073/pnas.1511003112; Su ZJ, 2015, J NUCL MED, V56, P512, DOI 10.2967/jnumed.114.151621; Takano A, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-30; Tewarie RDSN, 2010, MOL IMAGING, V9, P108, DOI 10.2310/7290.2010.00011; Varley J, 2015, ALZHEIMERS DEMENT, V11, P1110, DOI 10.1016/j.jalz.2014.08.105; Venneti S, 2013, GLIA, V61, P10, DOI 10.1002/glia.22357; Wadsworth H, 2012, BIOORG MED CHEM LETT, V22, P1308, DOI 10.1016/j.bmcl.2011.12.084; Ward RE, 2010, J NEUROTRAUM, V27, P1769, DOI 10.1089/neu.2010.1348; Wickstrom T, 2014, J LABELLED COMPD RAD, V57, P42, DOI 10.1002/jlcr.3112; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457	54	17	17	0	10	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	AUG	2016	43	9					1710	1722		10.1007/s00259-016-3391-8			13	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	DQ2FK	WOS:000379017500017	27154521	hybrid, Green Published			2022-02-06	
J	Narayanan, V; Veeramuthu, V; Ahmad-Annuar, A; Ramli, N; Waran, V; Chinna, K; Bondi, MW; Delano-Wood, L; Ganesan, D				Narayanan, Vairavan; Veeramuthu, Vigneswaran; Ahmad-Annuar, Azlina; Ramli, Norlisah; Waran, Vicknes; Chinna, Karuthan; Bondi, Mark William; Delano-Wood, Lisa; Ganesan, Dharmendra			Missense Mutation of Brain Derived Neurotrophic Factor (BDNF) Alters Neurocognitive Performance in Patients with Mild Traumatic Brain Injury: A Longitudinal Study	PLOS ONE			English	Article							FACTOR VAL66MET POLYMORPHISM; APOLIPOPROTEIN-E POLYMORPHISM; FACTOR GENE; VAL(66)MET POLYMORPHISM; HIPPOCAMPAL ACTIVITY; ALZHEIMERS-DISEASE; COGNITIVE FUNCTION; MEMORY FORMATION; RAT HIPPOCAMPUS; ASSOCIATION	The predictability of neurocognitive outcomes in patients with traumatic brain injury is not straightforward. The extent and nature of recovery in patients with mild traumatic brain injury (mTBI) are usually heterogeneous and not substantially explained by the commonly known demographic and injury-related prognostic factors despite having sustained similar injuries or injury severity. Hence, this study evaluated the effects and association of the Brain Derived Neurotrophic Factor (BDNF) missense mutations in relation to neurocognitive performance among patients with mTBI. 48 patients with mTBI were prospectively recruited and MRI scans of the brain were performed within an average 10.1 (SD 4.2) hours post trauma with assessment of their neuropsychological performance post full Glasgow Coma Scale (GCS) recovery. Neurocognitive assessments were repeated again at 6 months follow-up. The paired t-test, Cohen's d effect size and repeated measure ANOVA were performed to delineate statistically significant differences between the groups [wildtype G allele (Val homozygotes) vs. minor A allele (Met carriers)] and their neuropsychological performance across the time point (T-1 = baseline/admission vs. T-2 = 6th month follow-up). Minor A allele carriers in this study generally performed more poorly on neuropsychological testing in comparison wildtype G allele group at both time points. Significant mean differences were observed among the wildtype group in the domains of memory (M = -11.44, SD = 10.0, p = .01, d = 1.22), executive function (M = -11.56, SD = 11.7, p = .02, d = 1.05) and overall performance (M = -6.89 SD = 5.3, p = .00, d = 1.39), while the minor A allele carriers showed significant mean differences in the domains of attention (M = -11.0, SD = 13.1, p = .00, d = .86) and overall cognitive performance ( M = -5.25, SD = 8.1, p = .01, d = .66). The minor A allele carriers in comparison to the wildtype G allele group, showed considerably lower scores at admission and remained impaired in most domains across the timepoints, although delayed signs of recovery were noted to be significant in the domains attention and overall cognition. In conclusion, the current study has demonstrated the role of the BDNF rs6265 Val66Met polymorphism in influencing specific neurocognitive outcomes in patients with mTBI. Findings were more detrimentally profound among Met allele carriers.	[Narayanan, Vairavan; Veeramuthu, Vigneswaran; Waran, Vicknes; Ganesan, Dharmendra] Univ Malaya, Fac Med, Dept Surg, Div Neurosurg, Kuala Lumpur, Wilayah Perseku, Malaysia; [Ahmad-Annuar, Azlina] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur 50603, Wilayah Perseku, Malaysia; [Ramli, Norlisah] Univ Malaya, Res Imaging Ctr, Kuala Lumpur, Wilayah Perseku, Malaysia; [Chinna, Karuthan] Univ Malaya, Julius Ctr, Dept Social & Prevent Med, Kuala Lumpur, Wilayah Perseku, Malaysia; [Bondi, Mark William; Delano-Wood, Lisa] VA San Diego Healthcare Syst, San Diego, CA USA; [Bondi, Mark William; Delano-Wood, Lisa] Univ Calif San Diego, Dept Psychiat, San Diego, CA USA		Narayanan, V; Veeramuthu, V (corresponding author), Univ Malaya, Fac Med, Dept Surg, Div Neurosurg, Kuala Lumpur, Wilayah Perseku, Malaysia.	nvairavan@um.edu.my; vicveera@gmail.com	RAMLI, NORLISAH MOHD/G-5209-2010; AHMAD ANNUAR, AZLINA/B-8305-2010; Mathaneswaran, Vickneswaran/E-5180-2010; GANESAN, DHARMENDRA/B-8437-2010; NARAYANAN, VAIRAVAN/B-9191-2010; Veeramuthu, Vigneswaran/F-2220-2015	RAMLI, NORLISAH MOHD/0000-0001-7497-8093; NARAYANAN, VAIRAVAN/0000-0002-1118-5042; Veeramuthu, Vigneswaran/0000-0003-2052-0858	University Malaya Research Grant (UMRG) [RG447-12HTM]; High Impact Research Grant of University of Malaya [HIR-UM.C/625/1/HIRMOHE/12]	This study was partially funded by University Malaya Research Grant (UMRG; RG447-12HTM) (to VN)-Link: http://umresearch.um.edu.my/; High Impact Research Grant of University of Malaya (HIR-UM.C/625/1/HIRMOHE/12) (VW)-Link: http://hir.um.edu.my/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anderson GD, 2009, EPILEPSY BEHAV, V16, P501, DOI 10.1016/j.yebeh.2009.08.025; Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; Ashman TA, 2006, MT SINAI J MED, V73, P999; Bales James W, 2010, Open Drug Discov J, V2, P119; Barbey AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088733; Bekinschtein P, 2008, NEUROSCIENTIST, V14, P147, DOI 10.1177/1073858407305850; Bennett ER, 2016, TRANSLATIONAL RES TR; Beste C, 2010, J NEUROSCI, V30, P10727, DOI 10.1523/JNEUROSCI.2493-10.2010; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Blyth BJ, 2010, EMERG MED CLIN N AM, V28, P571, DOI 10.1016/j.emc.2010.03.003; Cabelli RJ, 1997, NEURON, V19, P63, DOI 10.1016/S0896-6273(00)80348-7; Chao HM, 2008, AM J MED GENET B, V147B, P505, DOI 10.1002/ajmg.b.30619; Chiang MF, 2003, ACTA NEUROCHIR, V145, P649, DOI 10.1007/s00701-003-0069-3; Cohen-Cory S, 2010, DEV NEUROBIOL, V70, P271, DOI 10.1002/dneu.20774; Comings DE, 1996, PHARMACOGENETICS, V6, P223, DOI 10.1097/00008571-199606000-00004; Coronado VG, 2011, SURVEILLANCE TRAUMAT; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; DEKOSKY ST, 1998, SEMIN CLIN NEUROPSYC, V3, P176; Dennis NA, 2011, HIPPOCAMPUS, V21, P980, DOI 10.1002/hipo.20809; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dutcher SA, 2001, NEUROL RES, V23, P203, DOI 10.1179/016164101101198343; Ebstein RP, 2000, EUR J PHARMACOL, V410, P205, DOI 10.1016/S0014-2999(00)00852-9; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Failla M.D., 2015, NEUROREHABIL NEURAL; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P83, DOI 10.1177/1545968315586465; Gajewski PD, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.06.010; Getzmann S, 2013, NEUROIMAGE, V64, P290, DOI 10.1016/j.neuroimage.2012.08.079; Gogos JA, 1998, P NATL ACAD SCI USA, V95, P9991, DOI 10.1073/pnas.95.17.9991; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Harris SE, 2006, MOL PSYCHIATR, V11, P505, DOI 10.1038/sj.mp.4001799; Hartman RE, 2002, J NEUROSCI, V22, P10083; Hashimoto R, 2008, NEUROSCI RES, V61, P360, DOI 10.1016/j.neures.2008.04.003; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Hicks RR, 1998, MOL BRAIN RES, V59, P264, DOI 10.1016/S0169-328X(98)00158-2; Hong CJ, 2011, BRAIN RES BULL, V86, P287, DOI 10.1016/j.brainresbull.2011.08.019; Horch HW, 1999, NEURON, V23, P353; Huang CC, 2014, PSYCHONEUROENDOCRINO, V39, P94, DOI 10.1016/j.psyneuen.2013.09.027; Huang R, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.044883; Jonsson EG, 2006, PROG NEURO-PSYCHOPH, V30, P924, DOI 10.1016/j.pnpbp.2006.02.008; Kang JI, 2010, NEUROPHARMACOLOGY, V58, P1109, DOI 10.1016/j.neuropharm.2010.02.001; Karpova NN, 2014, NEUROPHARMACOLOGY, V76, P709, DOI 10.1016/j.neuropharm.2013.04.002; Kauppi K, 2013, NEUROPSYCHOLOGIA, V51, P2462, DOI 10.1016/j.neuropsychologia.2012.11.028; Korley FK, 2016, J NEUROTRAUM, V33, P215, DOI 10.1089/neu.2015.3949; Kors EE, 2001, ANN NEUROL, V49, P753, DOI 10.1002/ana.1031; Kraus MF, 2005, BRAIN INJURY, V19, P471, DOI 10.1080/02699050400025059; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; Kulbatski I, 2005, CURR DRUG TARGETS, V6, P111, DOI 10.2174/1389450053345037; Kurowski BG, 2015, J HEAD TRAUMA REHAB, DOI [10.1097/HTR.0000000000000162, DOI 10.1097/HTR.00000000000001621545968315586465]; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Laurer HL, 2001, CURR PHARM DESIGN, V7, P1505, DOI 10.2174/1381612013397285; Lin WJ, 2013, FRONT ENDOCRINOL, P4; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; Martinez-Lucas P, 2005, INTENS CARE MED, V31, P1168, DOI 10.1007/s00134-005-2715-0; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; McAllister TW, 2012, J NEUROTRAUM, V29, P1111, DOI 10.1089/neu.2011.1930; McAllister TW, 2010, PM&R, V2, pS241, DOI 10.1016/j.pmrj.2010.10.005; McAllister TW, 2014, HDB CLIN NEUROL, V128, P723; Michael DB, 2005, J CLIN NEUROSCI, V12, P284, DOI 10.1016/j.jocn.2004.11.003; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Miyajima F, 2008, GENES BRAIN BEHAV, V7, P411, DOI 10.1111/j.1601-183X.2007.00363.x; Mohajeri MH, 2012, BRAIN RES BULL, V88, P429, DOI 10.1016/j.brainresbull.2011.12.003; Morley KI, 2001, BEHAV GENET, V31, P511, DOI 10.1023/A:1013337209957; Nathoo N, 2003, J NEUROSURG, V98, P302, DOI 10.3171/jns.2003.98.2.0302; Ninan I, 2014, NEUROPHARMACOLOGY, V76, P684, DOI 10.1016/j.neuropharm.2013.04.011; Okada T, 2006, MOL PSYCHIATR, V11, P695, DOI 10.1038/sj.mp.4001822; Organization W. H., 2013, WHO GLOB STAT REP RO; Parasuraman R, 2002, NEUROPSYCHOLOGY, V16, P254, DOI 10.1037//0894-4105.16.2.254; Perkovic MN, 2014, PSYCHOPHARMACOLOGY, V231, P3757, DOI 10.1007/s00213-014-3515-4; Petryshen TL, 2010, MOL PSYCHIATR, V15, P810, DOI 10.1038/mp.2009.24; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Pivac N, 2009, CROAT MED J, V50, P43, DOI 10.3325/cmj.2009.50.43; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Pruthi N, 2010, NEUROL INDIA, V58, P264, DOI 10.4103/0028-3886.63810; Quan N, 2002, HISTOL HISTOPATHOL, V17, P273, DOI 10.14670/HH-17.273; Rostami E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027389; Rybakowski JK, 2003, BIPOLAR DISORD, V5, P468, DOI 10.1046/j.1399-5618.2003.00071.x; Rybakowski JK, 2006, MOL PSYCHIATR, V11, P122, DOI 10.1038/sj.mp.4001765; Savitz J, 2006, GENES BRAIN BEHAV, V5, P311, DOI 10.1111/j.1601-183X.2005.00163.x; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shimizu E, 2004, AM J MED GENET B, V126B, P122, DOI 10.1002/ajmg.b.20118; Stam AH, 2009, J NEUROL NEUROSUR PS, V80, P1125, DOI 10.1136/jnnp.2009.177279; Stern RA, 2003, NEUROPSYCHOLOGICAL A; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Tost H, 2013, NEUROPSYCHOPHARMACOL, V38, P525, DOI 10.1038/npp.2012.214; UniProt Consortium, UNIPROTKB P23560 BDN; Uzan M, 2005, ACTA NEUROCHIR, V147, P715, DOI 10.1007/s00701-005-0529-z; van Wingen G, 2010, NEUROIMAGE, V50, P1212, DOI 10.1016/j.neuroimage.2010.01.058; Veeramuthu V, 2015, J NEUROTRAUM, V32, P1497, DOI 10.1089/neu.2014.3750; Voineskos AN, 2011, ARCH GEN PSYCHIAT, V68, P198, DOI 10.1001/archgenpsychiatry.2010.194; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Wang HY, 2013, NEURAL REGEN RES, V8, P843, DOI 10.3969/j.issn.1673-5374.2013.09.009; Wang JC, 2004, HUM MOL GENET, V13, P1903, DOI 10.1093/hmg/ddh194; Weese-Mayer DE, 2002, AM J MED GENET, V107, P306, DOI 10.1002/ajmg.10133; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039; World Health Organization, 2009, GLOB STAT REP ROAD S; Yudofsky S.C., 2005, TXB TRAUMATIC BRAIN, P27; Yue JK, 2015, NEUROSURGERY, V62, P225	102	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0158838	10.1371/journal.pone.0158838			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	WOS:000380170100024	27438599	Green Published, gold, Green Submitted, Green Accepted			2022-02-06	
J	Zhou, Z; Jiang, BH; Cao, LB; Zhu, F; Mao, HJ; Yang, KH				Zhou, Zhou; Jiang, Binhui; Cao, Libo; Zhu, Feng; Mao, Haojie; Yang, King H.			Numerical simulations of the 10-year-old head response in drop impacts and compression tests	COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE			English	Article						Pediatric head finite element model; Child cadaver test; Fall accident reconstruction; Skull fracture; Brain injury	FINITE-ELEMENT MODEL; DIFFUSE AXONAL INJURY; REAL-WORLD TRAUMA; CRANIAL BONE; DYNAMIC-RESPONSE; BRAIN-INJURIES; CHILD; AGE; VALIDATION; CRITERIA	Background and objective: Studies on traumatic injuries of children indicate that impact to the head is a major cause of severe injury and high mortality. However, regulatory and ethical concerns very much limit development and validation of computer models representing the pediatric head. The purpose of this study was to develop a child head finite element model with high-biofidelity to be used for studying pediatric head injury mechanisms. Methods: A newly developed 10-year-old (YO) pediatric finite element head model was limitedly validated for kinematic and kinetic responses against data from quasi-static compressions and drop tests obtained from an experimental study involving a child-cadaver specimen. The validated model was subsequently used for a fall accident reconstruction and associated injury analysis. Results: The model predicted the same shape of acceleration-time histories as was found in drop tests with the largest discrepancy of -8.2% in the peak acceleration at a drop height of 15 cm. Force-deflection responses predicted by the model for compression loading had a maximum discrepancy of 7.5% at a strain rate of 0.3 s(-1). The model-predicted maximum von Mises stress (sigma(v)) and principal strain (epsilon(p)) in the skull, intracranial pressure (ICP), maximum sigma(v) and maximum epsilon(p) in the brain, head injury criterion (HIC), brain injury criterion (BrIC), and head impact power (HIP) were used for analyzing risks of injury in the accident reconstruction. Conclusions: Based on the results of the injury analyses, the following conclusions can be drawn: (1) ICP cannot be used to accurately predict the locations of brain injury, but it may reflect the overall energy level of the impact event. (2) The brain regions predicted by the model to have high sigma(v) coincide with the locations of subdural hematoma with transtentorial herniation and the impact position of an actual injury. (3) The brain regions with high epsilon(p) predicted by the model coincide with locations commonly found where diffuse axonal injuries (DAI) due to blunt-impact and rapid acceleration have taken place. (C) 2016 Elsevier Ireland Ltd. All rights reserved.	[Zhou, Zhou; Jiang, Binhui; Cao, Libo; Zhu, Feng] Hunan Univ, State Key Lab Adv Design & Mfg Vehicle Body, Changsha 410082, Hunan, Peoples R China; [Jiang, Binhui; Mao, Haojie; Yang, King H.] Wayne State Univ, Bioengn Ctr, Detroit, MI 48201 USA; [Zhu, Feng] Embry Riddle Aeronaut Univ, Dept Mech Engn, Daytona Beach, FL 32114 USA		Jiang, BH (corresponding author), Hunan Univ, State Key Lab Adv Design & Mfg Vehicle Body, Changsha 410082, Hunan, Peoples R China.	jjhhzz123@163.com	Mao, Haojie/Q-7514-2018; Jiang, Binhui/V-9272-2019	Mao, Haojie/0000-0002-7563-9234; Jiang, Binhui/0000-0001-9255-5780; zhou, zhou/0000-0002-3910-0418	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [11172099]; National Science Foundational for Young Scientists of China [51405148]; Fund of State Key Laboratory of Advanced Design and Manufacturing for Vehicle Body [51475001, 3135001]	The authors would like to thank the National Natural Science Foundation of China (No. 11172099) and The National Science Foundational for Young Scientists of China (No. 51405148) for the financial support. The project was also supported by the Fund of State Key Laboratory of Advanced Design and Manufacturing for Vehicle Body No. 51475001 and 3135001. The authors would also like to thank Ms. Barbara R. Presley from Wayne State University for her careful proofreading of this paper.	ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Altair Engineering Inc, 2009, HYPERVIEW US GUID; Beusenberg MC., 2000, P INT RES C BIOM IMP; Cai Y., 2013, ASME 2013 SUMM BIOEN; Chatelin S, 2012, J MECH BEHAV BIOMED, V6, P166, DOI 10.1016/j.jmbbm.2011.09.013; CLAESSENS M, 1997, P 41 STAPP CAR CRASH, P315, DOI DOI 10.4271/973338; Curry JD, 1975, J BONE JOINT SURG AM, V57, P810; Davis MT, 2012, J BIOMECH, V45, P2493, DOI 10.1016/j.jbiomech.2012.07.001; DEKABAN AS, 1977, ANN NEUROL, V2, P485, DOI 10.1002/ana.410020607; Desantis Klinich Kathleen, 2002, Stapp Car Crash J, V46, P165; Domont A., 1992, P 36 STAPP CAR CRASH, DOI [10.4271/922527, DOI 10.4271/922527]; Dong LQ, 2013, ANN BIOMED ENG, V41, P2538, DOI 10.1007/s10439-013-0858-7; Eppinger R. H., 1984, SAE GOV IND M EXP WA; Finan JD, 2012, ANN BIOMED ENG, V40, P70, DOI 10.1007/s10439-011-0394-2; GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; HUBBARD RP, 1971, J BIOMECH, V4, P251, DOI 10.1016/0021-9290(71)90031-5; Irwin Annette L, 2002, Stapp Car Crash J, V46, P297; James HE, 1999, ACT NEUR S, V73, P85; Jiang BH, 2014, COMPUT METHOD BIOMEC, V17, P1185, DOI 10.1080/10255842.2012.739164; Kennard MA, 1940, ARCH NEURO PSYCHIATR, V44, P377, DOI 10.1001/archneurpsyc.1940.02280080137008; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Li Yan, 2011, Stapp Car Crash J, V55, P25; Li ZG, 2013, COMPUT METH PROG BIO, V112, P309, DOI 10.1016/j.cmpb.2013.05.008; Li ZG, 2011, ANN BIOMED ENG, V39, P2984, DOI 10.1007/s10439-011-0409-z; Loyd A. M., 2011, THESIS DUKE U; Mao HJ, 2014, ANN BIOMED ENG, V42, P2143, DOI 10.1007/s10439-014-1078-5; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Mao HJ, 2013, COMPUT METHOD BIOMEC, V16, P271, DOI 10.1080/10255842.2011.617005; Margulies SS, 2000, J BIOMECH ENG-T ASME, V122, P364, DOI 10.1115/1.1287160; MCPHERSON GK, 1980, J BIOMECH, V13, P9, DOI 10.1016/0021-9290(80)90003-2; Mertz H., 1989, SP782 AUTOMOTIVE FRO, P133; Mertz H. J., 1997, STAPP CAR CRASH J, V41, P261; MILLER RT, 1998, P 42 STAPP CAR CRASH, P155; Mizuno Koji, 2005, Traffic Inj Prev, V6, P361, DOI 10.1080/15389580500255922; Nahum A. M., 1977, P 21 STAPP CAR CRASH, P339; O'Riordain K, 2003, CLIN BIOMECH, V18, P590, DOI 10.1016/S0268-0033(03)00111-6; Plunkett J, 2001, AM J FOREN MED PATH, V22, P1, DOI 10.1097/00000433-200103000-00001; Prange Michael T, 2004, Stapp Car Crash J, V48, P279; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Ren LH, 2015, INT J CRASHWORTHINES, V20, P602, DOI 10.1080/13588265.2015.1073132; Roth S, 2008, COMPUT METH PROG BIO, V90, P262, DOI 10.1016/j.cmpb.2008.01.007; Roth S, 2010, COMPUT METH PROG BIO, V99, P25, DOI 10.1016/j.cmpb.2009.10.004; Roth S, 2009, COMPUT METH PROG BIO, V93, P32, DOI 10.1016/j.cmpb.2008.08.001; Ruan J., 2013, P FISITA 2012 WORLD, P207; RUAN JS, 1991, J BIOMECH ENG-T ASME, V113, P276, DOI 10.1115/1.2894885; Sevagan G, 2013, P I MECH ENG H, V227, P778, DOI 10.1177/0954411913483430; Shen M., 2015, INT RES COUNC BIOM I, P672; Takhounts E. G., 2011, 22 INT TECHN C ENH S, P1; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; TSAI FY, 1980, AM J NEURORADIOL, V1, P23; Ward C., 1980, P 24 STAPP CAR CRASH, P163; WEBER W, 1984, Z RECHTSMED, V92, P87, DOI 10.1007/BF02116216; Weber W, 1985, 7 RECHTSMED, V94, P93; WOOD JL, 1971, J BIOMECH, V4, P1, DOI 10.1016/0021-9290(71)90010-8; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhu F, 2016, ANN BIOMED ENG, V44, P258, DOI 10.1007/s10439-015-1372-x	65	17	18	5	19	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-2607	1872-7565		COMPUT METH PROG BIO	Comput. Meth. Programs Biomed.	JUL	2016	131						13	25		10.1016/j.cmpb.2016.04.013			13	Computer Science, Interdisciplinary Applications; Computer Science, Theory & Methods; Engineering, Biomedical; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Medical Informatics	DN8AA	WOS:000377300100003	27265045				2022-02-06	
J	Hu, JZ; Yang, ZM; Li, XN; Lu, HB				Hu, Jianzhong; Yang, Zhiming; Li, Xiaoning; Lu, Hongbin			C-C motif chemokine ligand 20 regulates neuroinflammation following spinal cord injury via Th17 cell recruitment	JOURNAL OF NEUROINFLAMMATION			English	Article						Spinal cord injury; Neuroinflammation; CCL20; Th17; Chemokine; Flow cytometry	INFLAMMATORY RESPONSE; CONSEQUENCES; REGENERATION; EXPRESSION; BRAIN	Background: Spinal cord injury (SCI) is a severe traumatic injury that often leads to paralysis. The neuroinflammation following SCI plays an important role during the secondary injury phase. C-C motif chemokine ligand 20 (CCL20) works like a magnet to attract inflammatory cells and subsequently regulate inflammation. However, the role and mechanisms of CCL20 in neuroinflammation following traumatic injury are poorly understood. Methods: A modified Allen's weight drop method was applied to induce a rat moderate contusion injury model. HE staining was used to assess spinal cord histopathology, and the water content test was used to estimate spinal cord edema. Motor function scores were quantified to evaluate locomotor ability, and leukocyte infiltration was observed by CD45 immunofluorescence and flow cytometry. Additionally, qRT-PCR and ELISA were used to determine inflammatory mediator gene expression. Th17 cell recruitment was identified by flow cytometry. Results: Compared with the injury control groups, histological analysis of the lesion area and tissue edema revealed reduced spinal cord edema and decreased lesion volume in the group administrated with CCL20 neutralizing antibody. Locomotor activity, as assessed by Basso, Beattie, and Bresnahan (BBB) score, showed that CCL20 blockade was beneficial for motor function recovery. Results also showed that leukocyte infiltration was reduced by neutralizing CCL20 at 7 days post-injury. More importantly, expression levels of IL-1 beta, IL-6, and TNF-alpha at 24 h after SCI demonstrated that a reduced inflammatory reaction in the CCL20 antibody group compared with the injury controls. Although CCL20 altered the expression of IL-1 beta, IL-6, and TNF-alpha, it had no effect on anti-inflammatory IL-10 expression at 24 h after damage. Notably, tissue flow cytometry confirmed that Th17 cell recruitment in the CCL20 antibody group was decreased compared with the control groups at 14 days post-injury. Additionally, IL-17A expression, which is mainly secreted by Th17 cell, suggested that CCL20 blockade also reduced IL-17A levels at 14 days after SCI. Conclusions: These results suggested that CCL20 aggravates neuroinflammation following SCI via regulation of Th17 cell recruitment and IL-17A level. Thus, CCL20-target therapy could be a promising clinical application for the treatment of SCI.	[Li, Xiaoning; Lu, Hongbin] Cent S Univ, Xiangya Hosp, Res Ctr Sports Med, Dept Sports Med, 87 Xiangya Rd, Changsha 410000, Hunan, Peoples R China; [Hu, Jianzhong; Yang, Zhiming] Cent S Univ, Xiangya Hosp, Dept Spine Surg, 87 Xiangya Rd, Changsha 410000, Hunan, Peoples R China		Lu, HB (corresponding author), Cent S Univ, Xiangya Hosp, Res Ctr Sports Med, Dept Sports Med, 87 Xiangya Rd, Changsha 410000, Hunan, Peoples R China.	hongbinlu@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171698, 81371956]; Specialized Research Fund for the Doctoral Program of Higher EducationSpecialized Research Fund for the Doctoral Program of Higher Education (SRFDP) [20130162110078]	This work was supported by grants from the National Natural Science Foundation of China (No. 81171698 and No. 81371956) and from the Specialized Research Fund for the Doctoral Program of Higher Education (No. 20130162110078).	Alcaide P, 2012, J IMMUNOL, V188, P1421, DOI 10.4049/jimmunol.1101647; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bethea JR, 2000, PROG BRAIN RES, V128, P33; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Blight AR, 2002, NAT NEUROSCI, V5, P1051, DOI 10.1038/nn939; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Das M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-148; David Samuel, 2012, Handb Clin Neurol, V109, P485, DOI 10.1016/B978-0-444-52137-8.00030-9; Dohlman TH, 2013, INVEST OPHTH VIS SCI, V54, P4081, DOI 10.1167/iovs.12-11216; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Fee D, 2003, J NEUROIMMUNOL, V136, P54, DOI 10.1016/S0165-5728(03)00008-0; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Ge R, 2013, BRAIN RES, V1527, P40, DOI 10.1016/j.brainres.2013.06.009; Gonzalez R, 2003, EXP NEUROL, V184, P456, DOI 10.1016/S0014-4886(03)00257-7; Gris D, 2004, J NEUROSCI, V24, P4043, DOI 10.1523/JNEUROSCI.5343-03.2004; Harper EG, 2009, J INVEST DERMATOL, V129, P2175, DOI 10.1038/jid.2009.65; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Hu JZ, 2013, J NEUROTRAUM, V30, P1349, DOI 10.1089/neu.2012.2748; Kuypers NJ, 2013, EXP NEUROL, V247, P615, DOI 10.1016/j.expneurol.2013.02.014; Leonardo CC, 2012, TRANSL STROKE RES, V3, P357, DOI 10.1007/s12975-012-0203-8; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Meng T, 2014, PLOS ONE, V9; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Morishima Y, 2013, CLIN DEV IMMUNOL, V2013, P162; National Spinal Cord Injury Statistical Center, 2013, J Spinal Cord Med, V36, P1, DOI 10.1179/1079026813Z.000000000136; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Pino PA, 2011, JOVE-J VIS EXP, DOI 10.3791/2348; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Popovich PG, 2002, J NEUROPATH EXP NEUR, V61, P623, DOI 10.1093/jnen/61.7.623; Saadoun S, 2008, BRAIN, V131, P1087, DOI 10.1093/brain/awn014; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889; Singh SP, 2008, J IMMUNOL, V180, P214, DOI 10.4049/jimmunol.180.1.214; Sroga JM, 2003, J COMP NEUROL, V462, P223, DOI 10.1002/cne.10736; Terao Y, 2009, NEUROSCI RES, V64, P75, DOI 10.1016/j.neures.2009.01.017; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; Yin YQ, 2006, NAT NEUROSCI, V9, P843, DOI 10.1038/nn1701; Yu M, 2013, CELL PHYSIOL BIOCHEM, V32, P1437, DOI 10.1159/000356581	41	17	19	1	8	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	JUN 23	2016	13								162	10.1186/s12974-016-0630-7			14	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	DQ0BW	WOS:000378863800001	27334337	Green Published, gold			2022-02-06	
J	Abdelmalik, PA; Boorman, DW; Tracy, J; Jallo, J; Rincon, F				Abdelmalik, Peter A.; Boorman, David W.; Tracy, Joseph; Jallo, Jack; Rincon, Fred			Acute Traumatic Coagulopathy Accompanying Isolated Traumatic Brain Injury is Associated with Worse Long-Term Functional and Cognitive Outcomes	NEUROCRITICAL CARE			English	Article						Coagulation; Trauma; Neuropsychology; Head injury	VERBAL-LEARNING TEST; DISSEMINATED INTRAVASCULAR COAGULATION; DISABILITY RATING-SCALE; FRESH-FROZEN PLASMA; EDITION CVLT-II; EXTRACRANIAL COMPLICATIONS; 2ND EDITION; HEAD-INJURY; DYSFUNCTION; DISORDERS	Approximately one-third of patients with isolated traumatic brain injury (iTBI) present with acute traumatic coagulopathy (ATC). ATC is associated with increased morbidity and mortality. Its effects on long-term functional and cognitive outcomes are not as well characterized. Data from the Citicoline Brain Injury Treatment Trial (COBRIT) were analyzed retrospectively. Exclusion criteria were renal failure or malignancy, and any extracranial injury severity score > 3. ATC was defined as INR > 1.3, PTT > 38 s, or platelets < 100 K, determined at baseline, and during the first 7 days of hospitalization. Six hundred forty-seven patients were included; 21 % were found to have ATC. Highest incidence occurred at baseline, and Day Two. Forty-two percent of ATC patients had a GCS < 8, compared with 11.3 % of non-ATC patients (p < 0.001). A significantly higher proportion of ATC patients was transfused blood products, required greater than 4L of fluids, demonstrated hyperthermia and hypothermia, were hypotensive and demonstrated elevated lactate when compared to non-ATC patients. In-hospital mortality, mean hospital length of stay, incidence of DVT and seizures were also significantly higher in ATC patients. A significantly lower portion of ATC patients had good outcomes on the GOS-E (i.e., score > 6), and the DRS (i.e., score < 2) at 180 days, for which ATC was found to be an independent predictor with binary logistic regression. ATC patients also performed significantly worse on several components of the CVLT-II at 180 days. ATC accompanying iTBI is associated with worse functional and cognitive outcomes at 180 days.	[Abdelmalik, Peter A.; Tracy, Joseph; Rincon, Fred] Thomas Jefferson Univ Hosp, Dept Neurol, 909 Walnut St,4th Floor COB Bldg, Philadelphia, PA 19107 USA; [Boorman, David W.; Jallo, Jack; Rincon, Fred] Thomas Jefferson Univ Hosp, Dept Neurosurg, Philadelphia, PA 19107 USA		Abdelmalik, PA; Rincon, F (corresponding author), Thomas Jefferson Univ Hosp, Dept Neurol, 909 Walnut St,4th Floor COB Bldg, Philadelphia, PA 19107 USA.; Rincon, F (corresponding author), Thomas Jefferson Univ Hosp, Dept Neurosurg, Philadelphia, PA 19107 USA.	peterabdelmalik@yahoo.com; fred.rincon@jefferson.edu		Jallo, Jack/0000-0002-5512-1729; Boorman, David/0000-0002-5974-8692; Rincon, Fred/0000-0002-8510-118X	American Heart Association (AHA)American Heart Association [12CRP12050342]; GenentechRoche HoldingGenentech [G-29902]; National Institute of Child Health and Human Development of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institute Award [NICHD U01HD042823, U01HD042738, U01HD 042687, U01HD042736, U01HD042678, U01HD042686, U01H D042653, U01HD042689, U01HD042652]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U01HD042652] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U01HD042678, U01HD042823, U01HD042736, U01HD042687, U01HD042738, U01HD042653, U01HD042689, U01HD042686] Funding Source: NIH RePORTER	Drs. Abdelmalik, Tracy and Jallo, as well as Mr. Boorman, have no sources of funding to disclose. Dr. Rincon has received salary and research grant support from the American Heart Association (AHA 12CRP12050342) and Genentech (G-29902). Data used in this study was generated by the investigators in the Clinical Sites and Data Coordinating Center composing the NIH Collaborative Multicenter TBI Clinical Trials Network. This project was funded by the National Institute of Child Health and Human Development of the National Institutes of Health. COBRIT was supported in part by National Institute Award numbers NICHD U01HD042823, U01HD042738, U01HD 042687, U01HD042736, U01HD042678, U01HD042686, U01H D042653, U01HD042689, and U01HD042652, to eight clinical sites and a data coordinating center.	AUER L, 1978, ACTA NEUROCHIR, V43, P51, DOI 10.1007/BF01809225; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; BREDBACKA S, 1994, J NEUROSURG ANESTH, V6, P75; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Cristofori Irene, 2015, Handb Clin Neurol, V128, P579, DOI 10.1016/B978-0-444-63521-1.00037-6; Dams-O'Connor K, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000073; Manoel ALD, 2015, NEUROCRIT CARE, V22, P34, DOI 10.1007/s12028-014-0026-4; DeJong J, 2010, J CLIN EXP NEUROPSYC, V32, P953, DOI 10.1080/13803391003645640; Donders J, 2007, J INT NEUROPSYCH SOC, V13, P354, DOI 10.1017/S1355617707070439; DRAKE TA, 1989, AM J PATHOL, V134, P1087; Elwood RW, 1995, NEUROPSYCHOL REV, V5, P173, DOI 10.1007/BF02214761; Epstein DS, 2015, BRIT J NEUROSURG, V29, P118, DOI 10.3109/02688697.2014.950632; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Etemadrezaie H, 2007, CLIN NEUROL NEUROSUR, V109, P166, DOI 10.1016/j.clineuro.2006.09.001; Franschman G, 2012, BRAIN INJURY, V26, P1464, DOI 10.3109/02699052.2012.694566; Gardner RC, 2014, JAMA NEUROL, V94121, P1; Geerts W, 1994, MED NEW ENGL J; Genet GF, 2013, J NEUROTRAUM, V30, P301, DOI 10.1089/neu.2012.2612; GOODNIGHT SH, 1974, NEW ENGL J MED, V290, P1043, DOI 10.1056/NEJM197405092901903; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; HUBER A, 1993, INT J LEGAL MED, V106, P152, DOI 10.1007/BF01225238; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; Jacobs ML, 2008, ARCH CLIN NEUROPSYCH, V23, P113, DOI 10.1016/j.acn.2007.09.003; KEIMOWITZ RM, 1973, J NEUROSURG, V39, P178, DOI 10.3171/jns.1973.39.2.0178; Kemp CD, 2008, AM SURGEON, V74, P866; Kushimoto S, 2001, NEUROSURGERY, V49, P1084, DOI 10.1097/00006123-200111000-00011; Lustenberger T, 2010, J TRAUMA, V69, P1410, DOI 10.1097/TA.0b013e3181cdae81; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; Maegele M, 2014, SHOCK, V41, P21, DOI 10.1097/SHK.0000000000000088; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; Mascia L, 2008, INTENS CARE MED, V34, P720, DOI 10.1007/s00134-007-0974-7; Massaro AM, 2015, NEUROCRIT CARE, V22, P45, DOI 10.1007/s12028-014-0051-3; MCNAMARA JJ, 1972, ANN SURG, V176, P243, DOI 10.1097/00000658-197208000-00021; Nekludov M, 2007, J NEUROTRAUM, V24, P1699, DOI 10.1089/neu.2007.0322; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Pringsheim T, 2014, NEUROLOGY, V83, P1661, DOI 10.1212/WNL.0000000000000929; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Schochl H, 2011, J NEUROTRAUM, V28, P2033, DOI 10.1089/neu.2010.1744; Schrieber M, 2007, J TRAUMA, V63, P1261; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Sun YR, 2011, BRIT J NEUROSURG, V25, P363, DOI 10.3109/02688697.2011.552650; Talving P, 2013, J TRAUMA ACUTE CARE, V75, P699, DOI 10.1097/TA.0b013e31829a2c19; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; VANDERSANDE JJ, 1978, J NEUROSURG, V49, P357, DOI 10.3171/jns.1978.49.3.0357; VECHT CJ, 1975, J NEUROL NEUROSUR PS, V38, P567, DOI 10.1136/jnnp.38.6.567; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; WINTER JP, 1989, ANN EMERG MED, V18, P553, DOI 10.1016/S0196-0644(89)80842-X; Zafonte RD, 2012, JAMA-J AM MED ASSOC, V308, P1993, DOI 10.1001/jama.2012.13256	51	17	19	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2016	24	3					361	370		10.1007/s12028-015-0191-0			10	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DN2ZP	WOS:000376932100006	26293923				2022-02-06	
J	Bang, SA; Song, YS; Moon, BS; Lee, BC; Lee, HY; Kim, JM; Kim, SE				Bang, Seong Ae; Song, Yoo Sung; Moon, Byung Seok; Lee, Byung Chul; Lee, Ho-young; Kim, Jong-Min; Kim, Sang Eun			Neuropsychological, Metabolic, and GABA(A) Receptor Studies in Subjects with Repetitive Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain metabolism; GABA(A) receptor; neuropsychological evaluation; repetitive traumatic brain injury	POSITRON-EMISSION-TOMOGRAPHY; MOTOR COORDINATION; CORTICAL DAMAGE; BASAL GANGLIA; ENCEPHALOPATHY; SPORT; RISK; HYPOMETABOLISM; NEUROGENESIS; RELIABILITY	Repetitive traumatic brain injury (rTBI) occurs as a result of mild and accumulative brain damage. A prototype of rTBI is chronic traumatic encephalopathy (CTE), which is a degenerative disease that occurs in patients with histories of multiple concussions or head injuries. Boxers have been the most commonly studied patient group because they may experience thousands of subconcussive hits over the course of a career. This study examined the consequences of rTBI with structural brain imaging and biomolecular imaging and investigated whether the neuropsychological features of rTBI were related to the findings of the imaging studies. Five retired professional boxers (mean age, 46.8 +/- 3.19 years) and four age-matched controls (mean age, 48.5 +/- 3.32 years) were studied. Cognitive-motor related functional impairment was assessed, and all subjects underwent neuropsychological evaluation and behavioral tasks, as well as structural brain imaging and functional-molecular imaging. In neuropsychological tests, boxers showed deficits in delayed retrieval of visuospatial memory and motor coordination, which had a meaningful relationship with biomolecular imaging results indicative of neuronal injury. Morphometric abnormalities were not found in professional boxers by structural magnetic resonance imaging (MRI). Glucose metabolism was impaired in frontal areas associated with cognitive dysfunction, similar to findings in Alzheimer's disease. Low binding potential (BP) of F-18-flumazenil (FMZ) was found in the angular gyrus and temporal cortical regions, revealing neuronal deficits. These results suggested that cognitive impairment and motor dysfunction reflect chronic damage to neurons in professional boxers with rTBI.	[Bang, Seong Ae; Kim, Sang Eun] Seoul Natl Univ, Coll Med, Dept Neurosci, Seoul, South Korea; [Bang, Seong Ae; Song, Yoo Sung; Moon, Byung Seok; Lee, Byung Chul; Lee, Ho-young; Kim, Sang Eun] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Nucl Med, 300 Gumi Dong, Songnam 463707, South Korea; [Kim, Jong-Min] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Neurol, Songnam, South Korea; [Kim, Sang Eun] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Transdisciplinary Studies, Seoul, South Korea; [Lee, Byung Chul; Kim, Sang Eun] Adv Inst Convergence Technol, Ctr Nanomol Imaging & Innovat Drug Dev, Suwon, South Korea		Kim, SE (corresponding author), Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Nucl Med, 300 Gumi Dong, Songnam 463707, South Korea.	kse@snu.ac.kr			Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI); Ministry of Health & Welfare, Republic of KoreaMinistry of Health & Welfare, Republic of Korea [HI14C1072]; National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning, Republic of Korea [NRF-2014M3C7A1046042]	This research was supported by grants from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI14C1072) and the National Research Foundation of Korea (NRF) grant funded by the Ministry of Science, ICT and Future Planning, Republic of Korea (NRF-2014M3C7A1046042).	Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; BEAUVOIS MF, 1978, BRAIN, V101, P381, DOI 10.1093/brain/101.3.381; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Brett M., 2002, NEUROIMAGE, V16, pS497; BUSS AH, 1957, J CONSULT PSYCHOL, V21, P343, DOI 10.1037/h0046900; BUTLER RJ, 1994, BRIT J SPORT MED, V28, P187, DOI 10.1136/bjsm.28.3.187; Claassen DO, 2013, NEUROPSYCHOLOGIA, V51, P267, DOI 10.1016/j.neuropsychologia.2012.09.018; Clausen H, 2005, BRIT J SPORT MED, V39, P661, DOI 10.1136/bjsm.2004.017046; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Costanza A, 2011, NEUROPATH APPL NEURO, V37, P570, DOI 10.1111/j.1365-2990.2011.01186.x; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; DAVIE CA, 1995, J NEUROL NEUROSUR PS, V58, P688, DOI 10.1136/jnnp.58.6.688; DELFORGE J, 1995, J CEREBR BLOOD F MET, V15, P284, DOI 10.1038/jcbfm.1995.34; Elliott R, 2003, BRIT MED BULL, V65, P49, DOI 10.1093/bmb/65.1.49; Gardner A, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00141; Gavett BE, 2011, CURR OPIN NEUROL, V24, P525, DOI 10.1097/WCO.0b013e32834cd477; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; GUTERMAN A, 1987, SPORTS MED, V4, P194, DOI 10.2165/00007256-198704030-00004; HAGLUND Y, 1993, AM J SPORT MED, V21, P97, DOI 10.1177/036354659302100117; Heiss WD, 2000, STROKE, V31, P366, DOI 10.1161/01.STR.31.2.366; Heiss WD, 1998, STROKE, V29, P454, DOI 10.1161/01.STR.29.2.454; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Hylin MJ, 2013, J NEUROTRAUM, V30, P716, DOI 10.1089/neu.2012.2717; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; JORDAN BD, 1990, JAMA-J AM MED ASSOC, V263, P1670, DOI 10.1001/jama.263.12.1670; JORDAN BD, 1992, RADIOLOGY, V185, P509, DOI 10.1148/radiology.185.2.1410364; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Karchemskiy A, 2011, PSYCHIAT RES-NEUROIM, V194, P319, DOI 10.1016/j.pscychresns.2011.03.006; Kuroda S, 2004, J NUCL MED, V45, P943; Lalonde R, 2003, BEHAV GENET, V33, P59, DOI 10.1023/A:1021003600900; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MENDEZ MF, 1995, INT J PSYCHIAT MED, V25, P249, DOI 10.2190/CUMK-THT1-X98M-WB4C; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Moon BS, 2014, MOL IMAGING BIOL, V16, P619, DOI 10.1007/s11307-014-0738-z; Moon BS, 2011, ORG BIOMOL CHEM, V9, P8346, DOI 10.1039/c1ob06277h; Odano I, 2009, NEUROIMAGE, V45, P891, DOI 10.1016/j.neuroimage.2008.12.005; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pugh KR, 2000, PSYCHOL SCI, V11, P51, DOI 10.1111/1467-9280.00214; Quadrato G, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00017; Ramaker C, 2002, MOVEMENT DISORD, V17, P867, DOI 10.1002/mds.10248; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; ROSS RJ, 1987, CLIN SPORT MED, V6, P41; Rudolf J, 2000, LANCET, V355, P115, DOI 10.1016/S0140-6736(99)04280-4; Saing T, 2012, J NEUROTRAUM, V29, P1054, DOI 10.1089/neu.2011.1957; Schiffmann SN, 1999, P NATL ACAD SCI USA, V96, P5257, DOI 10.1073/pnas.96.9.5257; Shiga T, 2006, EUR J NUCL MED MOL I, V33, P817, DOI 10.1007/s00259-005-0033-y; Siderowf A, 2002, MOVEMENT DISORD, V17, P758, DOI 10.1002/mds.10011; Sosa I, 2011, MED HYPOTHESES, V77, P633, DOI 10.1016/j.mehy.2011.07.002; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Tiffin J, 1948, J APPL PSYCHOL, V32, P234, DOI 10.1037/h0061266; Zhang LJ, 2003, AM J NEURORADIOL, V24, P52	56	17	17	0	24	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2016	33	11					1005	1014		10.1089/neu.2015.4051			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	DN3SU	WOS:000376984600004	26414498				2022-02-06	
J	Ettenhofer, ML; Barry, DM				Ettenhofer, Mark L.; Barry, David M.			Saccadic Impairment Associated With Remote History of Mild Traumatic Brain Injury	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							MINOR HEAD-INJURY; EYE-MOVEMENTS; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; SPORTS CONCUSSION; PREMOTOR THEORY; ATTENTION; PERFORMANCE; METAANALYSIS; PREDICTORS	Evidence suggests that mild traumatic brain injury (TBI) is associated with long-term changes in brain function, but conventional neurocognitive tools are often insensitive to deficits after 90 days. Eye movements have been proposed as a means to identify more chronic forms of impairment. In this study, saccadic, manual, and conventional neuropsychological measures were compared between participants with remote mild TBI and well-matched control participants. Saccadic impairment was more frequent within the mild TBI group, and a history of multiple injuries or high symptom burden appeared to compound this risk. However, other neurocognitive measures did not differ by group, number of injuries, or symptom severity. These results suggest that saccadic impairment may reflect chronic effects of mild TBI that conventional measures are unable to detect.	[Ettenhofer, Mark L.; Barry, David M.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Med & Clin Psychol, Bethesda, MD 20814 USA		Ettenhofer, ML (corresponding author), Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Med & Clin Psychol, Bethesda, MD 20814 USA.	mark.ettenhofer@usuhs.edu	Ettenhofer, Mark L./J-7171-2019	Ettenhofer, Mark L./0000-0001-9381-7578	USUHS Research Award [R072LP]; Uniformed Services University of the Health Sciences	This study was supported by USUHS Research Award #R072LP to Dr. Ettenhofer and institutional support from the Uniformed Services University of the Health Sciences. The technology described in this manuscript is included in U.S. Patent Application No. 61/779,801, U.S. Patent Application No. 14/773,987, European Patent Application No. 14780396.9, and International Patent Application No. PCT/US2014/022468 (rights assigned to the Uniformed Services University of the Health Sciences [USUHS]). The views and opinions presented in this manuscript are those of the authors and do not necessarily represent the position of USUHS, the Department of Defense, or the United States government.	Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bryan C, 2012, J HEAD TRAUMA REHAB, V27, P45, DOI 10.1097/HTR.0b013e318238f146; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cifu DX, 2015, J HEAD TRAUMA REHAB, V30, P21, DOI 10.1097/HTR.0000000000000036; Coldren RL, 2012, MIL MED, V177, P179, DOI 10.7205/MILMED-D-11-00278; Conners C. K., 2000, CONNERS CONTINUOUS P; Crawford TJ, 2005, BIOL PSYCHIAT, V57, P1052, DOI 10.1016/j.biopsych.2005.01.017; Culotta VP, 1996, NEUROSURGERY, V38, P245, DOI 10.1097/00006123-199602000-00002; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; de Haan B, 2008, BRAIN RES, V1204, P102, DOI 10.1016/j.brainres.2008.01.105; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Diwakar M, 2015, NEUROIMAGE-CLIN, V8, P210, DOI 10.1016/j.nicl.2015.04.011; Ettenhofer ML, 2016, J CLIN EXP NEUROPSYC, V38, P96, DOI 10.1080/13803395.2015.1089978; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Gualtieri C Thomas, 2008, Medscape J Med, V10, P90; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Holdnack JA., 2001, WECHSLER TEST ADULT; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Johnson B, 2015, NEUROLOGY, V85, P1163, DOI 10.1212/WNL.0000000000001968; Johnson B, 2015, BRAIN IMAGING BEHAV, V9, P564, DOI 10.1007/s11682-014-9316-x; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kraus MF, 2007, COGN BEHAV NEUROL, V20, P170, DOI 10.1097/WNN.0b013e318142badb; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; RIZZOLATTI G, 1994, ATTENTION PERFORM, V15, P231; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Schutte C., 2013, MILD TRAUMATIC BRAIN, P159; SHELIGA BM, 1994, EXP BRAIN RES, V98, P507; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith DT, 2012, NEUROPSYCHOLOGIA, V50, P1104, DOI 10.1016/j.neuropsychologia.2012.01.025; Trites RL, 1989, LAFAYETTE GROOVED PE; Tschanz JT, 2000, NEUROLOGY, V54, P1290, DOI 10.1212/WNL.54.6.1290; van Stockum S, 2008, NEUROPSYCHOLOGIA, V46, P3108, DOI 10.1016/j.neuropsychologia.2008.07.002; Ventura RE, 2015, J NEURO-OPHTHALMOL, V35, P73, DOI 10.1097/WNO.0000000000000223; Wechsler D., 2008, WAIS 4 TECHNICAL INT; Wechsler D., 2008, WECHSLER ADULT INTEL; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3	46	17	17	1	8	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SUM	2016	28	3					223	231		10.1176/appi.neuropsych.15100243			9	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	DV9MI	WOS:000383264200012	27019067	Bronze			2022-02-06	
J	Alm, KH; Rolheiser, T; Olson, IR				Alm, Kylie H.; Rolheiser, Tyler; Olson, Ingrid R.			Inter-individual variation in fronto-temporal connectivity predicts the ability to learn different types of associations	NEUROIMAGE			English	Article						Orbitofrontal cortex; White matter; Limbic; Diffusion imaging; Faces; Proper names; Associative memory; Temporal pole; Uncinate fasciculus	SUPERIOR LONGITUDINAL FASCICULUS; INFERIOR TEMPORAL CORTEX; TRAUMATIC BRAIN-INJURY; WHITE-MATTER; UNCINATE FASCICULUS; PREFRONTAL CORTEX; EPISODIC MEMORY; DIFFUSION MRI; LOBE EPILEPSY; TRACTOGRAPHY	The uncinate fasciculus connects portions of the anterior and medial temporal lobes to the lateral orbitofrontal cortex, so it has long been thought that this limbic fiber pathway plays an important role in episodic memory. Some types of episodic memory are impaired after damage to the uncinate, while others remain intact. Because of this, the specific role played by the uncinate fasciculus in episodic memory remains undetermined. In the present study, we tested the hypothesis that the uncinate fasciculus is involved in episodic memory tasks that have high competition between representations at retrieval. To test this hypothesis, healthy young adults performed three tasks: Experiment 1 in which they learned to associate names with faces through feedback provided at the end of each trial; Experiment 2 in which they learned to associate fractals with cued locations through feedback provided at the end of each trial; and Experiment 3 in which unique faces were remembered in a paradigm with low retrieval competition. Diffusion tensor imaging and deterministic tractography methods were used to extract measures of uncinate fasciculus microstructure. Results revealed that microstructural properties of the uncinate, but not a control tract, the inferior longitudinal fasciculus, significantly predicted individual differences in performance on the face-name and fractal-location tasks. However, no relationship was observed for simple face memory (Experiment 3). These findings suggest that the uncinate fasciculus may be important for adjudicating between competing memory representations at the time of episodic retrieval. (C) 2016 Elsevier Inc. All rights reserved.	[Alm, Kylie H.; Rolheiser, Tyler; Olson, Ingrid R.] Temple Univ, Dept Psychol, Philadelphia, PA 19122 USA		Olson, IR (corresponding author), Temple Univ, Weiss Hall,1701 N 13th St, Philadelphia, PA 19122 USA.	iolson@temple.edu			National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 MH091113]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH091113] Funding Source: NIH RePORTER	We would like to thank Ashley Unger, Tehila Nugiel, Hyden Zhang, and Vanessa Troiani for assistance with participant testing and tract tracing. This work was supported by a National Institute of Health grant to I. Olson [RO1 MH091113]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Mental Health or the National Institutes of Health. The authors declare no competing financial interests.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Alexander AL, 2011, BRAIN CONNECT, V1, P423, DOI 10.1089/brain.2011.0071; Alm KH, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00343; Barredo J, 2015, CEREB CORTEX, V25, P1004, DOI 10.1093/cercor/bht291; Bennett IJ, 2010, HUM BRAIN MAPP, V31, P378, DOI 10.1002/hbm.20872; Browning PGF, 2005, EUR J NEUROSCI, V22, P3281, DOI 10.1111/j.1460-9568.2005.04477.x; Browning PGF, 2008, BEHAV NEUROSCI, V122, P477, DOI 10.1037/0735-7044.122.2.477; Bussey TJ, 2002, BEHAV NEUROSCI, V116, P703, DOI 10.1037//0735-7044.116.4.703; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Catani M, 2013, NEUROSCI BIOBEHAV R, V37, P1724, DOI 10.1016/j.neubiorev.2013.07.001; Chance SA, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00820; Damasio H, 1996, NATURE, V380, P499, DOI 10.1038/380499a0; Delis D.C., 2000, CALIFORNIA VERBAL LE; Drane DL, 2008, NEUROPSYCHOLOGIA, V46, P1242, DOI 10.1016/j.neuropsychologia.2007.11.034; Duchaine B, 2006, NEUROPSYCHOLOGIA, V44, P576, DOI 10.1016/j.neuropsychologia.2005.07.001; Duffau H, 2009, J NEUROL, V256, P382, DOI 10.1007/s00415-009-0053-9; Easton A, 2000, BEHAV NEUROSCI, V114, P1041, DOI 10.1037/0735-7044.114.6.1041; Elmer S, 2011, HUM BRAIN MAPP, V32, P2064, DOI 10.1002/hbm.21169; GAFFAN D, 1995, EXP BRAIN RES, V105, P175; Gaffan D, 2002, J NEUROSCI, V22, P7288; GAFFAN EA, 1988, J NEUROSCI, V8, P3144; Gong GL, 2011, NEUROSCIENTIST, V17, P575, DOI 10.1177/1073858410386492; Grabowski TJ, 2001, HUM BRAIN MAPP, V13, P199, DOI 10.1002/hbm.1033.abs; Gutnikov SA, 1997, EUR J NEUROSCI, V9, P1524, DOI 10.1111/j.1460-9568.1997.tb01507.x; Hirni DI, 2013, NEUROPSYCHOLOGIA, V51, P930, DOI 10.1016/j.neuropsychologia.2013.01.013; Hiyoshi-Taniguchi K, 2015, J NEUROIMAGING, V25, P748, DOI 10.1111/jon.12196; Hoeft F, 2007, J NEUROSCI, V27, P11960, DOI 10.1523/JNEUROSCI.3591-07.2007; Huang H, 2004, MAGN RESON MED, V52, P559, DOI 10.1002/mrm.20147; Imfeld A, 2009, NEUROIMAGE, V46, P600, DOI 10.1016/j.neuroimage.2009.02.025; Jones DK, 2008, CORTEX, V44, P936, DOI 10.1016/j.cortex.2008.05.002; Kanaan RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038272; LEIRER VO, 1990, EXP AGING RES, V16, P155, DOI 10.1080/07340669008251544; Mabbott DJ, 2009, BRAIN RES, V1294, P80, DOI 10.1016/j.brainres.2009.07.046; MacKay D.G, 1987, THE ORGANIZATION OF; MARKOWITSCH HJ, 1982, NEUROSCI BIOBEHAV R, V6, P351, DOI 10.1016/0149-7634(82)90046-X; McDonald CR, 2008, NEUROLOGY, V71, P1869, DOI 10.1212/01.wnl.0000327824.05348.3b; Metzler-Baddeley C, 2011, J NEUROSCI, V31, P13236, DOI 10.1523/JNEUROSCI.2317-11.2011; Mori S, 2002, MAGN RESON MED, V47, P215, DOI 10.1002/mrm.10074; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Nomura K, 2013, BEHAV NEUROL, V27, P229, DOI [10.3233/BEN-110249, 10.1155/2013/267408]; Oechslin MS, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/neuro.09.076.2009; Old SR, 2008, PSYCHOL AGING, V23, P104, DOI 10.1037/0882-7974.23.1.104; Olson IR, 2015, DEV COGN NEUROS-NETH, V14, P50, DOI 10.1016/j.dcn.2015.06.003; Olson IR, 2015, NEUROCASE, V21, P554, DOI 10.1080/13554794.2014.959025; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Papagno C, 2016, BRAIN STRUCT FUNCT, V221, P687, DOI 10.1007/s00429-014-0920-8; Papagno C, 2011, BRAIN, V134, P405, DOI 10.1093/brain/awq283; Parker A, 1998, NEUROPSYCHOLOGIA, V36, P259, DOI 10.1016/S0028-3932(97)00112-7; Passamonti L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048789; Paternoster R, 1998, CRIMINOLOGY, V36, P859, DOI 10.1111/j.1745-9125.1998.tb01268.x; Pyles JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061611; Roozeboom, 2006, MULTIPLE LINEAR REGR, V32, P1; Ross LA, 2011, FRONT AGING NEUROSCI, V3, DOI 10.3389/fnagi.2011.00016; Sarkar S, 2013, PSYCHOL MED, V43, P401, DOI 10.1017/S003329171200116X; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; Scholz J, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P237, DOI 10.1016/B978-0-12-374709-9.00011-0; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Social Security Administration, 2014, TOP NAM 2000S; Tavor I, 2014, NEUROIMAGE, V86, P123, DOI 10.1016/j.neuroimage.2013.07.085; Thomas C, 2015, CORTEX, V72, P65, DOI 10.1016/j.cortex.2015.01.023; Thomas C, 2011, CORTEX, V47, P863, DOI 10.1016/j.cortex.2010.07.006; Thomas C, 2009, NAT NEUROSCI, V12, P29, DOI 10.1038/nn.2224; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Tranel D, 1997, NEUROPSYCHOLOGIA, V35, P1319, DOI 10.1016/S0028-3932(97)00085-7; Unger A, 2016, J INT NEUROPSYCH SOC, V22, P180, DOI 10.1017/S1355617715001009; Von Der Heide RJ, 2013, BRAIN, V136, P1692, DOI 10.1093/brain/awt094; Von Der Heide R, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00017; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wang R., 2007, P INT SOC MAG RESON, V15, P3720; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wendelken C, 2015, CEREB CORTEX, V25, P2574, DOI 10.1093/cercor/bhu059; Zhang J, 2014, BOUND VALUE PROBL, DOI [10.1155/2014/673165, 10.1186/s13661-014-0257-5]	77	17	17	0	12	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	MAY 15	2016	132						213	224		10.1016/j.neuroimage.2016.02.038			12	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	DK3QK	WOS:000374832200023	26908315	Green Accepted			2022-02-06	
J	Huang, H; Li, RH; Yuan, JX; Zhou, X; Liu, X; Ott, S; Xu, T; Chen, YM				Huang, Hao; Li, Ruohan; Yuan, Jinxian; Zhou, Xin; Liu, Xi; Ott, Shu; Xu, Tao; Chen, Yangmei			Up-regulated ephrinB3/EphB3 expression in intractable temporal lobe epilepsy patients and pilocarpine induced experimental epilepsy rat model	BRAIN RESEARCH			English	Article						EphrinB3; EphB3; Temporal lobe epilepsy; Pilocarpine; Synaptogenesis; Synaptic plasticity	TRAUMATIC BRAIN-INJURY; SYNAPTIC FUNCTIONS; EPH RECEPTORS; CNS INJURY; FAMILY; EPHRIN-B3; SYNAPSES; SEIZURE; DEATH; CELLS	EphB family receptor tyrosine kinases, in cooperation with cell surface-bound ephrinB ligands, play a critical role in maintenance of dendritic spine morphogenesis, axons guidance, synaptogenesis, synaptic reorganization and plasticity in the central nervous system (CNS). However, the expression pattern of ephrinB/EphB in intractable temporal lobe epilepsy (TLE) and the underlying molecular mechanisms during epileptogenesis remain poorly understood. Here we investigated the expression pattern and cellular distribution of ephrinB/EphB in intractable TLE patients and lithium chloride-pilocarpine induced TLE rats using real-time quantitative polymerase chain reaction (RT-qPCR), immunohistochemistry, double-labeled immunofluorescence and Western blot analysis. Compared to control groups, ephrinB3 and EphB3 mRNA expression were significantly up regulated in intractable TLE patients and TLE rats, while the mRNA expression trend of ephrinB1/2 and EphB1/2/4/6 in intractable TLE patients and TLE rats were inconsistent. Western blot analysis and semi-quantitative immunohistochemistry confirmed that ephrinB3 and EphB3 protein level were up-regulated in intractable TLE patients and TLE rats. At the same time, double-labeled immunofluorescence indicate that ephrinB3 was expressed mainly in the cytoplasm and protrusions of glia and neurons, while EphB3 was expressed mainly in the cytoplasm of neurons. Taken together, up-regulated expression of ephrinB3/EphB3 in intractable TLE patients and experimental TLE rats suggested that ephrinB3/EphB3 might be involved in the pathogenesis of TLE. (C) 2016 Elsevier B.V. All rights reserved.	[Huang, Hao; Li, Ruohan; Yuan, Jinxian; Zhou, Xin; Liu, Xi; Ott, Shu; Xu, Tao; Chen, Yangmei] Chongqing Med Univ, Affiliated Hosp 2, Dept Neurol, 74 Lin Jiang Rd, Chongqing 400010, Peoples R China		Chen, YM (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Dept Neurol, 74 Lin Jiang Rd, Chongqing 400010, Peoples R China.	chenym1997@sina.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171225, 81571259]	This work was supported by a grant from the National Natural Science Foundation of China (Nos. 81171225 and 81571259). The authors sincerely thank the Xinqiao Hospital of The Third Military Medical University for supplying the brain tissues used in this study, the patients and their families for their participation in this study, and the National Board of the Medical Affairs and the local ethics committee.	Aoto J, 2007, BRAIN RES, V1184, P72, DOI 10.1016/j.brainres.2006.11.033; Aoto J, 2007, J NEUROSCI, V27, P7508, DOI 10.1523/JNEUROSCI.0705-07.2007; Arisi GM, 2007, BRAIN RES, V1165, P126, DOI 10.1016/j.brainres.2007.06.037; Bellot A, 2014, BRAIN RES, V1573, P1, DOI 10.1016/j.brainres.2014.05.024; Bharucha NE, 1997, EPILEPSIA, V38, P614; Boyd AW, 2014, NAT REV DRUG DISCOV, V13, P39, DOI 10.1038/nrd4175; Duffy P, 2012, P NATL ACAD SCI USA, V109, P5063, DOI 10.1073/pnas.1113953109; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; ENGEL J, 1995, EPILEPSIA, V36, pS23; Flanagan JG, 1997, CELL, V90, P403; Gardiner J, 2010, NEUROSCIENTIST, V16, P28, DOI 10.1177/1073858409334422; Gauthier LR, 2003, LIFE SCI, V74, P207, DOI 10.1016/j.lfs.2003.09.029; Himanen JP, 2007, CURR OPIN CELL BIOL, V19, P534, DOI 10.1016/j.ceb.2007.08.004; Hruska M, 2015, NAT NEUROSCI, V18, P1594, DOI 10.1038/nn.4140; Huang H, 2015, INT J CLIN EXP PATHO, V8, P12708; Huang H, 2015, INT J CLIN EXP MED, V8, P625; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Kullander K, 2003, SCIENCE, V299, P1889, DOI 10.1126/science.1079641; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Lackmann M, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.115re2; Lai KO, 2009, CURR OPIN NEUROBIOL, V19, P275, DOI 10.1016/j.conb.2009.04.009; Liu X, 2006, J NEUROSCI, V26, P3087, DOI 10.1523/JNEUROSCI.4797-05.2006; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 1997, CURR OPIN CELL BIOL, V9, P608, DOI 10.1016/S0955-0674(97)80113-5; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Scharfman HE, 2007, EPILEPSIA, V48, P33, DOI 10.1111/j.1528-1167.2007.01065.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sloniowski S, 2012, SEMIN CELL DEV BIOL, V23, P75, DOI 10.1016/j.semcdb.2011.10.020; Theus MH, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.165; Theus MH, 2010, STEM CELLS, V28, P1231, DOI 10.1002/stem.449; Thurman DJ, 2011, EPILEPSIA, V52, P2, DOI 10.1111/j.1528-1167.2011.03121.x; Wang L, 2008, BRAIN RES, V1241, P157, DOI 10.1016/j.brainres.2008.07.097; Xu NJ, 2011, NAT NEUROSCI, V14, P1421, DOI 10.1038/nn.2931; Yamaguchi Y, 2004, CURR OPIN NEUROBIOL, V14, P288, DOI 10.1016/j.conb.2004.04.003	36	17	17	0	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAY 15	2016	1639						1	12		10.1016/j.brainres.2016.02.035			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DP4DW	WOS:000378447400001	26930615				2022-02-06	
J	Lian, D; He, DK; Wu, J; Liu, Y; Zhu, MJ; Sun, JM; Chen, F; Li, L				Lian, Di; He, Dake; Wu, Jing; Liu, Ying; Zhu, Mingjie; Sun, Jiaming; Chen, Feng; Li, Ling			Exogenous BDNF increases neurogenesis in the hippocampus in experimental Streptococcus pneumoniae meningitis	JOURNAL OF NEUROIMMUNOLOGY			English	Article						Streptococcus pneumoniae meningitis; Brain-derived neurotrophic factor; Neural stem cells; Endogenous neurogenesis	NEURAL STEM-CELLS; TRAUMATIC BRAIN-INJURY; EXPERIMENTAL PNEUMOCOCCAL MENINGITIS; NEUROTROPHIC FACTOR BDNF; BACTERIAL-MENINGITIS; DENTATE GYRUS; RESTRICTED PROGENITORS; FOREBRAIN NEUROGENESIS; COGNITIVE IMPAIRMENT; ANTIBIOTIC-TREATMENT	Background: Despite the effective use of antibiotics, occurrences of mortality and neurological sequelae following Streptococcus pneumoniae meningitis remain high. Methods: We investigated the neurogenesis of endogenous neural stem cells (NSCs) after inoculation with exogenous brain-derived neurotrophic factor (BDNF) in the hippocampus dentate gyrus following experimental S. pneumoniae meningitis using a double-labeling immunofluorescence analysis with 5-bromo-2'-deoxyuridine (BrdU), Nestin, DCX and NeuN. Results: Our results showed that 7 days after inoculation, the number of BrdU & Nestin co-labeled cells increased in the hippocampus in meningitis rats compared with control rats (p < 0.05). But the number of DCX-positive cells decreased in the dentate gyrus of infected rats treated with saline (p < 0.05). However, these cell numbers returned to close to normal-control levels in infected rats treated with BDNF (p > 0.05). After treatment with exogenous BDNF, the number of BrdU & Nestin co-labeled cells increased in the hippocampus in both the meningitis rats and normal control rats (p < 0.05), but this increase was more significant in the former (p < 0.05). We found that the percentage of BrdU & DCX/BrdU co-labeled cells increased in infected rats treated with BDNF both 7 days and 14 days after inoculation in a greater proportion compared to other groups (p < 0.05). No significant differences were found in the percentage of BrdU & NeuN/BrdU 28 days after inoculation among all of the groups (p > 0.05). Conclusion: Our findings suggest that S. pneumoniae meningitis activates the proliferation of endogenous NSCs, but impairs their early differentiation. Administration of exogenous BDNF might improve the neurogenesis of endogenous NSCs in the hippocampus and may provide a promising therapy after bacterial meningitis. (C) 2016 Elsevier B.V. All rights reserved.	[Lian, Di; He, Dake; Wu, Jing; Li, Ling] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Dept Pediat Neurol, Shanghai, Peoples R China; [Liu, Ying; Chen, Feng] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Dept Clin Lab, Shanghai, Peoples R China; [Zhu, Mingjie; Sun, Jiaming] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Dept Pathol, Shanghai, Peoples R China		Li, L (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Dept Pediat Neurol, Shanghai, Peoples R China.	linglidoctor@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171630, 81271337]	The work of the authors is supported by grants from the National Natural Science Foundation of China (no.81171630; and no.81271337).	Anderson V, 1997, J Int Neuropsychol Soc, V3, P147; Barichello T., 2014, MOL NEUROBIOL, P1; Barichello T, 2015, J NEURAL TRANSM, V122, P643, DOI 10.1007/s00702-014-1302-3; Barichello T, 2015, J NEUROIMMUNOL, V278, P262, DOI 10.1016/j.jneuroim.2014.11.015; Barichello T, 2014, EXP BIOL MED, V239, P1360, DOI 10.1177/1535370214535896; Barichello T, 2010, J NEUROIMMUNOL, V223, P73, DOI 10.1016/j.jneuroim.2010.04.004; Bifrare YD, 2005, J INFECT DIS, V191, P40, DOI 10.1086/426399; Bingham B, 2005, BRAIN RES, V1058, P167, DOI 10.1016/j.brainres.2005.07.075; Brouwer MC, 2010, CLIN MICROBIOL REV, V23, P467, DOI 10.1128/CMR.00070-09; Chandran A, 2011, PEDIATR INFECT DIS J, V30, P3, DOI 10.1097/INF.0b013e3181ef25f7; Chen JL, 2005, J NEUROSCI, V25, P2366, DOI 10.1523/JNEUROSCI.5071-04.2005; Chen L, 2015, J NEUROPATH EXP NEUR, V74, P557, DOI 10.1097/NEN.0000000000000199; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Duan X, 2008, CURR OPIN NEUROBIOL, V18, P108, DOI 10.1016/j.conb.2008.04.001; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gerber J, 2003, J NEUROSCI RES, V73, P441, DOI 10.1002/jnr.10682; Gerber J, 2010, CURR OPIN NEUROL, V23, P312, DOI 10.1097/WCO.0b013e32833950dd; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gounder P. P., 2015, J INFECT; Grimwood K, 2000, ARCH DIS CHILD, V83, P111, DOI 10.1136/adc.83.2.111; Hattiangady B, 2007, STEM CELLS, V25, P2104, DOI 10.1634/stemcells.2006-0726; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Hofer S, 2011, J NEUROPATH EXP NEUR, V70, P890, DOI 10.1097/NEN.0b013e3182303f31; Islam O, 2009, CURR NEUROVASC RES, V6, P42, DOI 10.2174/156720209787466028; Jit M, 2010, J INFECTION, V61, P114, DOI 10.1016/j.jinf.2010.04.008; Kalyani AJ, 1999, J NEUROBIOL, V38, P207, DOI 10.1002/(SICI)1097-4695(19990205)38:2<207::AID-NEU4>3.3.CO;2-7; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kiprianova I, 1999, EXP NEUROL, V159, P511, DOI 10.1006/exnr.1999.7109; Kuhn HG, 2007, CURR PHARM BIOTECHNO, V8, P127; Leib SL, 2001, BRAIN, V124, P1734, DOI 10.1093/brain/124.9.1734; Li L, 2003, J CHILD NEUROL, V18, P828, DOI 10.1177/088307380301801202; Li L, 2007, PEDIATR NEUROL, V36, P324, DOI 10.1016/j.pediatrneurol.2007.01.007; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Liechti FD, 2015, FUTURE MICROBIOL, V10, P1195, DOI 10.2217/fmb.15.43; Liu JL, 1998, J NEUROSCI, V18, P7768; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Ma HY, 2012, NEUROCHEM RES, V37, P69, DOI 10.1007/s11064-011-0584-1; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Muralidharan R, 2014, EUR J NEUROL, V21, P447, DOI 10.1111/ene.12328; Nau R, 1999, J NEUROPATH EXP NEUR, V58, P265, DOI 10.1097/00005072-199903000-00006; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Scharfman H, 2005, EXP NEUROL, V192, P348, DOI 10.1016/j.expneurol.2004.11.016; Seaberg RM, 2002, J NEUROSCI, V22, P1784, DOI 10.1523/JNEUROSCI.22-05-01784.2002; Song XQ, 2014, NEUROL SCI, V35, P1915, DOI 10.1007/s10072-014-1862-x; Sun D, 2009, EXP NEUROL, V216, P56, DOI 10.1016/j.expneurol.2008.11.011; Tauber SC, 2005, J NEUROPATH EXP NEUR, V64, P806, DOI 10.1097/01.jnen.0000178853.21799.88; Taupin P, 2007, BRAIN RES REV, V53, P198, DOI 10.1016/j.brainresrev.2006.08.002; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Vukovic J, 2013, J NEUROSCI, V33, P6603, DOI 10.1523/JNEUROSCI.3064-12.2013; Wellmer A, 2000, NEUROSCI LETT, V296, P137, DOI 10.1016/S0304-3940(00)01645-1; Woehrl B, 2011, EXPERT REV ANTI-INFE, V9, P1053, DOI [10.1586/ERI.11.129, 10.1586/eri.11.129]; Zhu JM, 2011, J INT MED RES, V39, P488, DOI 10.1177/147323001103900216	52	17	17	2	14	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-5728	1872-8421		J NEUROIMMUNOL	J. Neuroimmunol.	MAY 15	2016	294						46	55		10.1016/j.jneuroim.2016.03.014			10	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	DM7MQ	WOS:000376545100008	27138098				2022-02-06	
J	Concannon, LG				Concannon, Leah G.			Effects of Legislation on Sports-Related Concussion	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Concussion; Legislation; Athletics; Sports	HIGH-SCHOOL; YOUTH SPORTS; LYSTEDT LAW; KNOWLEDGE; EDUCATION; COACHES; GUIDELINES; MANAGEMENT; INJURIES; HEADS	Following the lead of Washington state and passage of the Lystedt Law in 2009, all states now have sports concussion laws designed to help protect youth athletes. This article examines the 3 basic tenets of youth sports concussion laws, challenges in implementation of state laws, and the first measures of success. Some of the major differences among state laws are also discussed.	[Concannon, Leah G.] Univ Washington, Dept Rehabil Med, Div Sports & Spine, 325 9th Ave,Box 359721, Seattle, WA 98104 USA		Concannon, LG (corresponding author), Univ Washington, Dept Rehabil Med, Div Sports & Spine, 325 9th Ave,Box 359721, Seattle, WA 98104 USA.	lgconcan@uw.edu					Adler RH, 2011, PM&R, V3, pS468, DOI 10.1016/j.pmrj.2011.08.006; Adler RH, 2011, PHYS MED REH CLIN N, V22, P721, DOI 10.1016/j.pmr.2011.08.010; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Bompadre V, 2014, J ATHL TRAINING, V49, P486, DOI 10.4085/1062-6050-49.3.30; Carl RL, 2014, CLIN PEDIATR, V53, P689, DOI 10.1177/0009922814526979; Centers for disease control and prevention, HEADS UP ONL TRAIN C; Centers for Disease Control and Prevention, HEADS UP; Centers for disease control and prevention, HEADS UP CONC YOUTH; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Institute of Medicine (IOM) & National Research Council (NRC), 2013, SPORTS REL CONC YOUT; Kirschen MP, 2014, NEUROLOGY, V83, P352, DOI 10.1212/WNL.0000000000000613; Kurowski B, 2014, J TRAUMA ACUTE CARE, V77, pS12, DOI 10.1097/TA.0000000000000316; Lowrey KM, 2014, J LAW MED ETHICS, V42, P290, DOI 10.1111/jlme.12146; Lowrey KM, 2014, J BUSINESS TECH L, V10, P61; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; Morrissey D, 2014, J TRAUMA ACUTE CARE, V77, pS8, DOI 10.1097/TA.0000000000000331; O'Kane JW, 2014, PHYSICIAN SPORTSMED, V42, P39, DOI 10.3810/psm.2014.09.2074; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Sarris CE, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.7.FOCUS12224; Shenouda C, 2012, PM&R, V4, P427, DOI 10.1016/j.pmrj.2012.02.016; Williamson Richard W, 2014, Neurosurgery, V75 Suppl 4, pS131, DOI 10.1227/NEU.0000000000000482; Yard EE, 2009, BRAIN INJURY, V23, P888, DOI 10.1080/02699050903283171	29	17	17	2	19	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	MAY	2016	27	2					513	+		10.1016/j.pmr.2015.12.006			16	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	DN4RU	WOS:000377055700012	27154860				2022-02-06	
J	Griffin, JH; Fernandez, JA; Lyden, PD; Zlokovic, BV				Griffin, John H.; Fernandez, Jose A.; Lyden, Patrick D.; Zlokovic, Berislav V.			Activated protein C promotes neuroprotection: mechanisms and translation to the clinic	THROMBOSIS RESEARCH			English	Article						activated protein C (APC); stroke; neuroprotection; neurogenesis; traumatic brain injury	REDUCED ANTICOAGULANT ACTIVITY; TISSUE-PLASMINOGEN ACTIVATOR; FOCAL ISCHEMIC-STROKE; GLUTAMATE EXCITOTOXICITY; RECEPTOR 1; HIPPOCAMPAL-NEURONS; THERAPEUTIC WINDOW; ENDOTHELIAL-CELLS; MICE; DEFICIENCY	Activated protein C (APC) is a plasma serine protease that is capable of antithrombotic, anti-inflammatory, anti-apoptotic, and cell-signaling activities. Animal injury studies show that recombinant APC and some of its mutants are remarkably therapeutic for a wide range of injuries. In particular, for neurologic injuries, APC reduces damage caused by ischemia/reperfusion in the brain, by acute brain trauma, and by chronic neurodegenerative conditions. For these neuroprotective effects, APC requires endothelial cell protein C receptor. APC activates cell signaling networks with alterations in gene expression profiles by activating protease activated receptors 1 and 3. To minimize APC-induced bleeding risk, APC variants were engineered to lack > 90% anticoagulant activity but retain normal cell signaling. The neuroprotective APC mutant, 3K3A-APC which has Lys191-193 mutated to Ala191-193, is very neuroprotective and it is currently in clinical trials for ischemic stroke. (C) 2016 Elsevier Ltd. All rights reserved.	[Griffin, John H.; Fernandez, Jose A.] Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Griffin, John H.] Univ Calif San Diego, Dept Med, Div Hematol Oncol, San Diego, CA 92103 USA; [Lyden, Patrick D.] Cedars Sinai Med Ctr, Dept Neurol, Los Angeles, CA 90048 USA; [Zlokovic, Berislav V.] Univ So Calif, Keck Sch Med, Dept Neurosurg, Los Angeles, CA 90033 USA; [Zlokovic, Berislav V.] Univ So Calif, Keck Sch Med, Dept Neurosurg, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA		Griffin, JH (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.; Griffin, JH (corresponding author), Univ Calif San Diego, Dept Med, Div Hematol Oncol, San Diego, CA 92103 USA.	jgriffin@scripps.edu	Fernandez, Jose A/A-3211-2008	Fernandez, Jose A/0000-0002-0804-1865; Griffin, John/0000-0002-4302-2547	NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R37 HL052246, P01 HL031950, R01 HL021544, R01 HL052246] Funding Source: Medline; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50 AG005142] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01 NS088312, R01 NS090904] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL052246, P01HL031950, R01HL021544, R37HL052246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS088312, R01NS090904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50AG005142] Funding Source: NIH RePORTER		Amar AP, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00344; Bock F, 2014, THROMB HAEMOSTASIS, V111, P610, DOI 10.1160/TH13-11-0967; BRANSON HE, 1983, LANCET, V2, P1165; Burnier L, 2013, BLOOD, V122, P807, DOI 10.1182/blood-2013-03-488957; Chalmers E, 2011, ARCH DIS CHILD, V96, P1066, DOI 10.1136/adc.2010.199919; Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826; Cheng T, 2006, NAT MED, V12, P1278, DOI 10.1038/nm1498; DREYFUS M, 1995, SEMIN THROMB HEMOST, V21, P371, DOI 10.1055/s-2007-1000658; Esmon CT, 2012, SEMIN IMMUNOPATHOL, V34, P127, DOI 10.1007/s00281-011-0284-6; Fernandez JA, 2003, BLOOD CELL MOL DIS, V30, P271, DOI 10.1016/S1079-9796(03)00034-2; Folsom AR, 1999, CIRCULATION, V100, P736, DOI 10.1161/01.CIR.100.7.736; Gorbacheva L, 2010, NEUROSCIENCE, V165, P1138, DOI 10.1016/j.neuroscience.2009.11.027; Gorbacheva LR, 2008, BIOCHEMISTRY-MOSCOW+, V73, P717, DOI 10.1134/S0006297908060138; Gorbacheva L, 2013, NEUROCHEM INT, V63, P101, DOI 10.1016/j.neuint.2013.05.008; Gorbacheva LR, 2007, THROMB HAEMOSTASIS, V98, P1150, DOI 10.1160/TH07-03-0228; Gorbacheva L, 2009, J NEUROCHEM, V111, P967, DOI 10.1111/j.1471-4159.2009.06380.x; Griffin JH, 2002, SEMIN HEMATOL, V39, P197, DOI 10.1053/shem.2002.34093; Griffin JH, 2015, BLOOD, V125, P2898, DOI 10.1182/blood-2015-02-355974; Griffin JH, 2012, INT J HEMATOL, V95, P333, DOI 10.1007/s12185-012-1059-0; Guo H, 2004, NEURON, V41, P563, DOI 10.1016/S0896-6273(04)00019-4; Guo H, 2013, J NEUROSCI, V33, P6181, DOI 10.1523/JNEUROSCI.4491-12.2013; Guo H, 2009, EUR J NEUROSCI, V29, P1119, DOI 10.1111/j.1460-9568.2009.06664.x; Han MH, 2008, NATURE, V451, P1076, DOI 10.1038/nature06559; Jalbert LR, 1998, J CLIN INVEST, V102, P1481, DOI 10.1172/JCI3011; Joyce DE, 2001, J BIOL CHEM, V276, P11199, DOI 10.1074/jbc.C100017200; Lay AJ, 2005, J CLIN INVEST, V115, P1552, DOI 10.1172/JCI24030; Liu D, 2004, NAT MED, V10, P1379, DOI 10.1038/nm1122; Lyden P, 2013, CURR PHARM DESIGN, V19, P7479; Macko RF, 1996, STROKE, V27, P2005, DOI 10.1161/01.STR.27.11.2005; Macko RF, 1999, STROKE, V30, P542, DOI 10.1161/01.STR.30.3.542; McKelvey Kelly, 2014, World J Biol Chem, V5, P169, DOI 10.4331/wjbc.v5.i2.169; Mosnier LO, 2007, J BIOL CHEM, V282, P33022, DOI 10.1074/jbc.M705824200; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; Mosnier LO, 2014, THROMB HAEMOSTASIS, V112, P883, DOI 10.1160/TH14-05-0448; Mosnier LO, 2012, BLOOD, V120, P5237, DOI 10.1182/blood-2012-08-452169; Mosnier LO, 2004, BLOOD, V104, P1740, DOI 10.1182/blood-2004-01-0110; Mosnier LO, 2003, BIOCHEM J, V373, P65, DOI 10.1042/BJ20030341; Ohga S, 2013, HAEMOPHILIA, V19, P378, DOI 10.1111/hae.12097; PETRAGLIA AL, 2010, NEUROSURGERY, V66, P71; Petraglia AL, 2010, NEUROSURGERY, V66, P165, DOI 10.1227/01.NEU.0000363148.49779.68; Quinn LM, 2015, BIOCHEM SOC T, V43, P691, DOI 10.1042/BST20140312; Rezaie AR, 2014, THROMB HAEMOSTASIS, V112, P876, DOI 10.1160/TH14-02-0167; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Shibata M, 2001, CIRCULATION, V103, P1799, DOI 10.1161/01.CIR.103.13.1799; Thiyagarajan M, 2008, J NEUROSCI, V28, P12788, DOI 10.1523/JNEUROSCI.3485-08.2008; Walker CT, 2010, BRAIN RES, V1347, P125, DOI 10.1016/j.brainres.2010.05.075; Wang YM, 2013, STROKE, V44, P3529, DOI 10.1161/STROKEAHA.113.003350; Wang YM, 2013, BLOOD CELL MOL DIS, V51, P104, DOI 10.1016/j.bcmd.2013.02.009; Wang YM, 2013, BRAIN RES, V1507, P97, DOI 10.1016/j.brainres.2013.02.023; Wang YM, 2012, STROKE, V43, P2444, DOI 10.1161/STROKEAHA.112.658997; Wang YM, 2009, STROKE, V40, P1864, DOI 10.1161/STROKEAHA.108.536680; Wildhagen KCAA, 2011, THROMB HAEMOSTASIS, V106, P1034, DOI 10.1160/TH11-08-0522; Williams PD, 2012, CURR PHARM DESIGN, V18, P4215; Zhong ZH, 2009, J CLIN INVEST, V119, P3437, DOI 10.1172/JCI38476; Zlokovic BV, 2011, TRENDS NEUROSCI, V34, P198, DOI 10.1016/j.tins.2011.01.005	55	17	17	0	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0049-3848			THROMB RES	Thromb. Res.	MAY	2016	141			2			S62	S64					3	Hematology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Hematology; Cardiovascular System & Cardiology	DM2TR	WOS:000376201100017	27207428	Green Accepted			2022-02-06	
J	Jourdan, C; Bayen, E; Bahrami, S; Ghout, I; Darnoux, E; Azerad, S; Ruet, A; Vallat-Azouvi, C; Weiss, JJ; Aegerter, P; Mateo, J; Vigue, B; Tazarourte, K; Pradat-Diehl, P; Azouvi, P				Jourdan, Claire; Bayen, Eleonore; Bahrami, Stephane; Ghout, Idir; Darnoux, Emmanuelle; Azerad, Sylvie; Ruet, Alexis; Vallat-Azouvi, Claire; Weiss, Jean-Jacques; Aegerter, Philippe; Mateo, Joaquim; Vigue, Bernard; Tazarourte, Karim; Pradat-Diehl, Pascale; Azouvi, Philippe			Loss to Follow-Up and Social Background in an Inception Cohort of Patients With Severe Traumatic Brain Injury: Results From the PariS-TBI Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						alcohol-related disorders; bias (epidemiology); brain injuries; cohort studies; craniocerebral trauma; lost to follow-up; patient outcome assessment; socioeconomic factors	NATIONAL INSTITUTE; SYSTEMATIC BIAS; REHABILITATION; MODEL; EPIDEMIOLOGY; OUTCOMES; PRODUCTIVITY; PREDICTION; DISABILITY; MODERATE	Objectives: To assess determinants of loss to follow-up (FU) at 2 time points of an inception traumatic brain injury (TBI) cohort. Design and Participants: The PariS-TBI study consecutively included 504 adults with severe TBI on the accident scene (76% male, mean age 42 years, mean Glasgow Coma Scale 5). No exclusion criteria were used. Main Measure: Loss to FU at 1 and 4 years was defined among survivors as having no outcome data other than survival status. Results: Among 257 1-year survivors, 118 (47%) were lost to FU at 1 year and 98 (40%) at 4 years. Main reasons for loss to FU were impossibility to achieve contact (109 at 1 year, 52 at 4 years) and refusal to participate (respectively 5 and 24). At 1 year, individuals not working preinjury or with nonaccidental traumas were more often lost to FU in univariate and multivariable analyses. At 4 years, loss to FU was significantly associated with preinjury alcohol abuse and unemployment. Relationship with injury severity was not significant. Conclusions: Socially disadvantaged persons are underrepresented in TBI outcome research. It could result in overestimation of outcome and biased estimates of sociodemographic characteristics' effects. These persons, particularly unemployed individuals, require special attention in clinical practice.	[Jourdan, Claire; Ruet, Alexis; Vallat-Azouvi, Claire; Azouvi, Philippe] Hop Raymond Poincare, APHP, Serv Med Phys & Readaptat, 104 Bd Raymond Poincare, F-92380 Garches, France; [Jourdan, Claire; Bahrami, Stephane; Ruet, Alexis; Azouvi, Philippe] Univ Versailles St Quentin, EA ECIPSY 4047, St Quentin en Yvelines, France; [Bayen, Eleonore] Univ Paris 09, Lab Econ & Gest Org Sante LEDa LEGOS, Paris, France; [Bayen, Eleonore; Pradat-Diehl, Pascale] Univ Paris 06, Paris, France; [Bayen, Eleonore; Pradat-Diehl, Pascale] Hop Univ Pitie Salpetriere Charles Foix, APHP, Serv Med Phys & Readaptat, Paris, France; [Bahrami, Stephane] Hop Raymond Poincare, APHP, Unite Sante Publ, F-92380 Garches, France; [Bahrami, Stephane] INSERM, CIC IT 805, F-92380 Garches, France; [Ghout, Idir; Darnoux, Emmanuelle; Azerad, Sylvie; Aegerter, Philippe] Hop Ambroise Pare, APHP, URC, Boulogne, France; [Darnoux, Emmanuelle; Azerad, Sylvie; Weiss, Jean-Jacques] CRFTC, Paris, France; [Vallat-Azouvi, Claire] Hop Raymond Poincare, UGECAM IDF, Antenne UEROS SAMSAH92, F-92380 Garches, France; [Mateo, Joaquim] Hop Lariboisiere, APHP, Dept Anesthesiol, Soins Intensifs & SAMU, Paris, France; [Vigue, Bernard] Hop Bicetre, APHP, Dept Anesthesiol & Soins Intensifs, Le Kremlin Bicetre, France; [Tazarourte, Karim] Hop Marc Jacquet, Mobile Care Unit, SAMU 77, Melun, France		Jourdan, C (corresponding author), Hop Raymond Poincare, APHP, Serv Med Phys & Readaptat, 104 Bd Raymond Poincare, F-92380 Garches, France.	claire.jourdan@rpc.aphp.fr	RUET, Alexis/L-8726-2015; AEGERTER, Philippe/AAY-6003-2021	RUET, Alexis/0000-0002-5080-5734; AEGERTER, Philippe/0000-0002-9156-5028; tazarourte, karim/0000-0002-3376-1258			Arango-Lasprilla JC, 2012, BRAIN INJURY, V26, P814, DOI 10.3109/02699052.2012.655360; Bayen E, 2016, J HEAD TRAUMA REHAB, V31, pE59, DOI 10.1097/HTR.0000000000000079; Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; Braveman P, 2014, PUBLIC HEALTH REP, V129, P19, DOI 10.1177/00333549141291S206; Burnett DM, 2003, ARCH PHYS MED REHAB, V84, P263, DOI 10.1053/apmr.2003.50091; Collie A, 2013, INJURY, V44, P1514, DOI 10.1016/j.injury.2013.03.006; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; CRIQUI MH, 1979, AM J EPIDEMIOL, V109, P394, DOI 10.1093/oxfordjournals.aje.a112695; Foster M, 2003, SOC SCI MED, V56, P2201, DOI 10.1016/S0277-9536(02)00236-8; Gerhart KA, 2003, J TRAUMA, V55, P1045, DOI 10.1097/01.TA.0000044353.69681.96; HIGH WM, 1995, J HEAD TRAUMA REHAB, V10, P64, DOI 10.1097/00001199-199508000-00007; Husson EC, 2010, J REHABIL MED, V42, P425, DOI 10.2340/16501977-0566; INSEE, POP POP AG 2007 2040; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Jourdan C, 2013, NEUROREHAB NEURAL RE, V27, P35, DOI 10.1177/1545968312440744; KRAUS JF, 1986, AM J PUBLIC HEALTH, V76, P1345, DOI 10.2105/AJPH.76.11.1345; Krellman JW, 2014, ARCH PHYS MED REHAB, V95, P633, DOI 10.1016/j.apmr.2013.10.016; Langley J, 2010, BRAIN INJURY, V24, P939, DOI 10.3109/02699052.2010.491494; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Luoto TM, 2013, J NEUROTRAUM, V30, P11, DOI 10.1089/neu.2012.2611; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P2478, DOI 10.1016/j.apmr.2013.06.019; R Development Core Team, 2012, R LANG ENV STAT COMP; Shafi S, 2007, J TRAUMA, V63, P1263, DOI 10.1097/TA.0b013e31815b8f00; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; TEASDALE G, 1974, LANCET, V2, P81; Traumatic Brain Injury Model Systems National Data and Statistical Center, GUID STRAT MAX FOLL; Veerbeek JM, 2011, STROKE, V42, P1482, DOI 10.1161/STROKEAHA.110.604090; von Elm E, 2007, B WORLD HEALTH ORGAN, V85, P867, DOI [10.2471/BLT.07.045120, 10.1371/journal.pmed.0040296]; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107	34	17	17	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2016	31	3					E42	E48		10.1097/HTR.0000000000000147			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DR3FK	WOS:000379787800005	26098257				2022-02-06	
J	Rodgman, C; Verrico, CD; Holst, M; Thompson-Lake, D; Haile, CN; De La Garza, R; Raskind, MA; Newton, TF				Rodgman, Christopher; Verrico, Christopher D.; Holst, Manuela; Thompson-Lake, Daisy; Haile, Colin N.; De La Garza, Richard, II; Raskind, Murray A.; Newton, Thomas F.			Doxazosin XL Reduces Symptoms of Posttraumatic Stress Disorder in Veterans With PTSD: A Pilot Clinical Trial	JOURNAL OF CLINICAL PSYCHIATRY			English	Article						Posttraumatic Stress Disorder; Veterans and Military Issues	TRAUMATIC BRAIN-INJURY; SEXUAL DYSFUNCTION; COMBAT VETERANS; DOUBLE-BLIND; ANTAGONIST DOXAZOSIN; MEDICATION ADHERENCE; PLACEBO; NIGHTMARES; SERTRALINE; PRAZOSIN	Background: Serotonin and norepinephrine reuptake inhibitors are effective first-line agents for the treatment of posttraumatic stress disorder (PTSD), but treatment is associated with a range of side effects that limit treatment adherence. Prazosin, an alpha(1)-noradrenergic antagonist with a half-life of roughly 2-3 hours, has shown promise in the treatment of sleep disturbance and nightmares. Doxazosin extended release (XL) is also an alpha(1)-noradrenergic antagonist but with a half-life of approximately 15-19 hours. Methods: We conducted a double-blind, placebo-controlled, within-subjects trial to characterize the impact of doxazosin XL on PTSD symptoms. Participants (N = 8) were diagnosed using DSM-IV criteria. They completed the study twice, once during treatment with doxazosin XL and once during treatment with matched placebo, with a 2-week washout separating the 2 episodes. Doxazosin XL was titrated from 4 mg/d to 16 mg/d over 12 days. After 4 days of treatment at 16 mg/d or the equivalent number of placebo capsules, PTSD symptoms were assessed using the Clinician-Administered PTSD Scale (CAPS(17)) and the PTSD Checklist-Military version (PCL-M). Repeated measures analysis of variance were used to evaluate effects of treatment, time, and treatment x time. This study was run from November 20, 2013, to June 31, 2014. Results: Doxazosin XL treatment was associated with a nonsignificant treatment x time reduction in ratings on the CAPS hyperarousal subscale (P < .10) (but not on the CAPS Total score) and with significant treatment x time reductions in PCL-M ratings (P = .002). Conclusions: Doxazosin XL may be an effective alternative to prazosin for the treatment of some PTSD symptoms. (C) Copyright 2016 Physicians Postgraduate Press, Inc.	[Rodgman, Christopher; Verrico, Christopher D.; Holst, Manuela; Thompson-Lake, Daisy; Haile, Colin N.; De La Garza, Richard, II; Newton, Thomas F.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Rodgman, Christopher; Verrico, Christopher D.; Holst, Manuela; Thompson-Lake, Daisy; Haile, Colin N.; De La Garza, Richard, II; Newton, Thomas F.] Baylor Coll Med, Menninger Dept Psychiat, Houston, TX 77030 USA; [De La Garza, Richard, II] Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX USA; [Raskind, Murray A.] VISN 20 Northwest Network Mental Illness Res Educ, Seattle, WA USA; [Raskind, Murray A.] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA		Newton, TF (corresponding author), Baylor Coll Med, Dept Psychiat, Michael E DeBakey VA Med Ctr, 2002 Holcombe, Houston, TX 77030 USA.	tnewton@bcm.edu	Verrico, Christopher D./I-4552-2013; De La Garza, Richard/B-2489-2014	Verrico, Christopher D./0000-0002-8272-0778; De La Garza, Richard/0000-0003-1943-4469; Thompson-Lake, Daisy/0000-0003-3096-0910	Michael E. DeBakey VA Medical CenterUS Department of Veterans Affairs; NIH grantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R25DA028976]	This study was conducted at and funded by a grant from the Michael E. DeBakey VA Medical Center. NIH grant R25DA028976 also provided financial support.	Arnsten AFT, 1999, BIOL PSYCHIAT, V45, P26, DOI 10.1016/S0006-3223(98)00296-0; Arnsten AFT, 2011, BIOL PSYCHIAT, V69, pE89, DOI 10.1016/j.biopsych.2011.01.027; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Birnbaum S, 1999, BIOL PSYCHIAT, V46, P1266, DOI 10.1016/S0006-3223(99)00138-9; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Brady K, 2000, JAMA-J AM MED ASSOC, V283, P1837, DOI 10.1001/jama.283.14.1837; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cassano Paolo, 2004, Ann Clin Psychiatry, V16, P15, DOI 10.1080/10401230490281618; Clayton AH, 2002, J CLIN PSYCHIAT, V63, P357, DOI 10.4088/JCP.v63n0414; CUBEDDU LX, 1988, AM HEART J, V116, P133, DOI 10.1016/0002-8703(88)90261-X; Davidson J, 2001, AM J PSYCHIAT, V158, P1974, DOI 10.1176/appi.ajp.158.12.1974; De Jong J, 2010, J CLIN PSYCHOPHARM, V30, P84, DOI 10.1097/JCP.0b013e3181c827ae; Department of Defense, 2007, ACH VIS REP DEP DEF; ELLIOTT HL, 1982, BRIT J CLIN PHARMACO, V13, P699, DOI 10.1111/j.1365-2125.1982.tb01439.x; Friedman MJ, 2007, J CLIN PSYCHIAT, V68, P711, DOI 10.4088/JCP.v68n0508; Goodson JT, 2013, J TRAUMA STRESS, V26, P419, DOI 10.1002/jts.21830; GUO TZ, 1991, ANESTHESIOLOGY, V75, P252, DOI 10.1097/00000542-199108000-00013; Haile CN, 2012, BRAIN SCI, V2, P619, DOI 10.3390/brainsci2040619; Higgins A, 2010, DRUG HEALTHC PATIENT, V2, P141, DOI 10.2147/DHPS.S7634; KAYE B, 1986, BRIT J CLIN PHARMACO, V21, pS19, DOI 10.1111/j.1365-2125.1986.tb02849.x; Kronish IM, 2012, J PSYCHIATR RES, V46, P1595, DOI 10.1016/j.jpsychires.2012.06.011; Liu XC, 2011, CLINICOECONOMIC OUTC, V3, P63, DOI 10.2147/CEOR.S17846; Lockwood A, 2009, ANN PHARMACOTHER, V43, P1227, DOI 10.1345/aph.1M017; McNally RJ, 2012, SCIENCE, V336, P872, DOI 10.1126/science.1222069; Monson CM, 2008, PSYCHOL ASSESSMENT, V20, P131, DOI 10.1037/1040-3590.20.2.131; Monson CM, 2006, J CONSULT CLIN PSYCH, V74, P898, DOI 10.1037/0022-006X.74.5.898; Newton TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030854; Nurnberg HG, 2003, JAMA-J AM MED ASSOC, V289, P56, DOI 10.1001/jama.289.1.56; Raskind MA, 2003, AM J PSYCHIAT, V160, P371, DOI 10.1176/appi.ajp.160.2.371; Raskind MA, 2002, J CLIN PSYCHIAT, V63, P565, DOI 10.4088/JCP.v63n0705; Raskind MA, 2007, BIOL PSYCHIAT, V61, P928, DOI 10.1016/j.biopsych.2006.06.032; Raskind MA, 2013, AM J PSYCHIAT, V170, P1003, DOI 10.1176/appi.ajp.2013.12081133; Ruff RL, 2012, J REHABIL RES DEV, V49, P1305, DOI 10.1682/JRRD.2011.12.0251; Sanchez S., 2014, OCCUP ENVIRON MED, V71, pA68, DOI [10.1136/oemed-2014-102362.213, DOI 10.1136/OEMED-2014-102362.213]; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Shorter D, 2013, DRUG ALCOHOL DEPEN, V131, P66, DOI 10.1016/j.drugalcdep.2012.11.021; Stein DJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002795.pub2; VANDERKOLK BA, 1994, J CLIN PSYCHIAT, V55, P517; Vasterling JJ, 2002, NEUROPSYCHOLOGY, V16, P5, DOI 10.1037//0894-4105.16.1.5; Weathers FW, PTSD CHECKLIST DSM 4; Zohar J, 2002, J CLIN PSYCHOPHARM, V22, P190, DOI 10.1097/00004714-200204000-00013	43	17	17	0	11	PHYSICIANS POSTGRADUATE PRESS	MEMPHIS	P O BOX 752870, MEMPHIS, TN 38175-2870 USA	0160-6689	1555-2101		J CLIN PSYCHIAT	J. Clin. Psychiatry	MAY	2016	77	5					E561	E565		10.4088/JCP.14m09681			5	Psychology, Clinical; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	DQ6GH	WOS:000379302000003	27249080				2022-02-06	
J	Schmidt, JD; Pierce, AF; Guskiewicz, KM; Register-Mihalik, JK; Pamukoff, DN; Mihalik, JP				Schmidt, Julianne D.; Pierce, Alice F.; Guskiewicz, Kevin M.; Register-Mihalik, Johna K.; Pamukoff, Derek N.; Mihalik, Jason P.			Safe-Play Knowledge, Aggression, and Head-Impact Biomechanics in Adolescent Ice Hockey Players	JOURNAL OF ATHLETIC TRAINING			English	Article						concussions; mild traumatic brain injuries; head trauma; adolescent sports	BODY-CHECKING; YOUTH; CONCUSSION; INJURY; EPIDEMIOLOGY; FOOTBALL; POSITION; RULES; SPORT; RISK	Context: Addressing safe-play knowledge and player aggression could potentially improve ice hockey sport safety. Objectives: To compare (1) safe-play knowledge and aggression between male and female adolescent ice hockey players and (2) head-impact frequency and severity between players with high and low levels of safe-play knowledge and aggression during practices and games. Design: Cohort study. Setting: On field. Patients or Other Participants: Forty-one male (n = 29) and female (n = 12) adolescent ice hockey players. Intervention(s): Players completed the Safe Play Questionnaire (0 = less knowledge, 7 = most knowledge) and Competitive Aggressiveness and Anger Scale (12 = less aggressive, 60 = most aggressive) at midseason. Aggressive penalty minutes were recorded throughout the season. The Head Impact Telemetry System was used to capture headimpact frequency and severity (linear acceleration [g], rotational acceleration [rad/s(2)], Head Impact Technology severity profile) at practices and games. Main Outcome Measure(s): One-way analyses of variance were used to compare safe play knowledge and aggression between sexes. Players were categorized as having high or low safe-play knowledge and aggression using a median split. A 23 2 mixed-model analysis of variance was used to compare headimpact frequency, and random-intercept general linear models were used to compare head-impact severity between groups (high, low) and event types (practice, game). Results: Boys (5.8 of 7 total; 95% confidence interval [CI] = 5.3, 6.3) had a trend toward better safe-play knowledge compared with girls (4.9 of 7 total; 95% CI = 3.9, 5.9; F-1,F-36 = 3.40, P =.073). Less aggressive male players sustained significantly lower head rotational accelerations during practices (1512.8 rad/s(2), 95% CI = 1397.3, 1637.6 rad/s(2)) versus games (1754.8 rad/s(2), 95% CI = 1623.9, 1896.2 rad/s(2)) and versus high-aggression players during practices (1773.5 rad/s(2), 95% CI = 1607.9, 1956.3 rad/s(2); F-1,F-26 = 6.04, P = .021). Conclusions: Coaches and sports medicine professionals should ensure that athletes of all levels, ages, and sexes have full knowledge of safe play and should consider aggression interventions for reducing head-impact severity among aggressive players during practice.	[Schmidt, Julianne D.] Univ Georgia, Dept Kinesiol & Concuss Res Lab, 330 River Rd, Athens, GA 30602 USA; [Pierce, Alice F.] Carolina Family Practice & Sports Med, Cary, NC USA; [Guskiewicz, Kevin M.; Register-Mihalik, Johna K.; Mihalik, Jason P.] Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, Matthew A Gfeller Sport Related Traumat Brain Inj, Chapel Hill, NC USA; [Guskiewicz, Kevin M.; Register-Mihalik, Johna K.; Mihalik, Jason P.] Univ North Carolina Chapel Hill, Injury Prevent Res Ctr, Chapel Hill, NC USA; [Pamukoff, Derek N.] Calif State Univ Fullerton, Dept Kinesiol, Fullerton, CA 92634 USA		Schmidt, JD (corresponding author), Univ Georgia, Dept Kinesiol & Concuss Res Lab, 330 River Rd, Athens, GA 30602 USA.	schmidtj@uga.edu	Pamukoff, Derek/AAL-9296-2021				Allison MA, 2014, MED SCI SPORT EXER, V46, P115, DOI 10.1249/MSS.0b013e3182a32d0d; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Cusimano MD, 2013, CAN MED ASSOC J, V185, pE57, DOI 10.1503/cmaj.112017; Cusimano Michael D, 2011, Open Med, V5, pe57; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Emery CA, 2011, BRIT J SPORT MED, V45, P1289, DOI 10.1136/bjsports-2011-090538; Emery CA, 2009, CLIN J SPORT MED, V19, P207, DOI 10.1097/JSM.0b013e31819d658e; Forward KE, 2014, PAED CHILD HEALT-CAN, V19, P418, DOI 10.1093/pch/19.8.418; Gee CJ, 2007, PSYCHOL SPORT EXERC, V8, P567, DOI 10.1016/j.psychsport.2006.06.006; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Kukaswadia A, 2010, PEDIATRICS, V125, P735, DOI 10.1542/peds.2009-2083; Macpherson A, 2006, PEDIATRICS, V117, pE143, DOI 10.1542/peds.2005-1163; Malenfant S, 2012, J SCI MED SPORT, V15, P463, DOI 10.1016/j.jsams.2012.03.003; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marchie A, 2003, CAN MED ASSOC J, V169, P124; Maxwell JP, 2007, PSYCHOL SPORT EXERC, V8, P179, DOI 10.1016/j.psychsport.2006.03.002; Mihalik JP, 2008, P I MECH ENG P-J SPO, V222, P45, DOI 10.1243/17543371JSET4; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mihalik JP, 2012, ANN BIOMED ENG, V40, P141, DOI 10.1007/s10439-011-0405-3; Mihalik JP, 2010, MED SCI SPORT EXER, V42, P1431, DOI 10.1249/MSS.0b013e3181d2521a; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; NIXON HL, 1994, SOCIOL SPORT J, V11, P79, DOI 10.1123/ssj.11.1.79; Paul RJ, 2013, INT J SPORT FINANC, V8, P21; Roberts WO, 1996, ARCH PEDIAT ADOL MED, V150, P140, DOI 10.1001/archpedi.1996.02170270022003; Smith AM, 2013, CURR SPORT MED REP, V12, P356, DOI 10.1249/JSR.0000000000000004; Smith AM, 2011, CLIN J SPORT MED, V21, P281, DOI 10.1097/JSM.0b013e318225bc15; Swartz EE, 2009, J ATHL TRAINING, V44, P306, DOI 10.4085/1062-6050-44.3.306; Wilcox BJ, 2014, J ATHL TRAINING, V49, P514, DOI 10.4085/1062-6050-49.3.19	30	17	17	0	12	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	MAY	2016	51	5					366	372		10.4085/1062-6050-51.5.04			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	EI9VD	WOS:000392856500001	27111585	Green Published, Green Submitted, Bronze			2022-02-06	
J	Sun, F; Nguyen, T; Jin, X; Huang, RQ; Chen, ZL; Cunningham, RL; Singh, M; Su, C				Sun, Fen; Trinh Nguyen; Jin, Xin; Huang, Renqi; Chen, Zhenglan; Cunningham, Rebecca L.; Singh, Meharvan; Su, Chang			Pgrmc1/BDNF Signaling Plays a Critical Role in Mediating Glia-Neuron Cross Talk	ENDOCRINOLOGY			English	Article							MEMBRANE COMPONENT 1; TRAUMATIC BRAIN-INJURY; NEUROTROPHIC FACTOR; PROGESTERONE; PROTEIN; BDNF; HIPPOCAMPUS; EXPRESSION; LTP; ESTROGEN	Progesterone (P4) exerts robust cytoprotection in brain slice cultures (containing both neurons and glia), yet such protection is not as evident in neuron-enriched cultures, suggesting that glia may play an indispensable role in P4's neuroprotection. We previously reported that a membrane-associated P4 receptor, P4 receptor membrane component 1, mediates P4-induced brain-derived neurotrophic factor (BDNF) release from glia. Here, we sought to determine whether glia are required for P4's neuroprotection and whether glia's roles are mediated, at least partially, via releasing soluble factors to act on neighboring neurons. Our data demonstrate that P4 increased the level of mature BDNF (neuroprotective) while decreasing pro-BDNF (potentially neurotoxic) in the conditioned media (CMs) of cultured C6 astrocytes. We examined the effects of CMs derived from P4-treated astrocytes (P4-CMs) on 2 neuronal models: 1) all-trans retinoid acid-differentiated SH-SY5Y cells and 2) mouse primary hippocampal neurons. P4-CM increased synaptic marker expression and promoted neuronal survival against H2O2. These effects were attenuated by Y1036 (an inhibitor of neurotrophin receptor [tropomysin-related kinase] signaling), as well as tropomysin-related kinase B-IgG (a more specific inhibitor to block BDNF signaling), which pointed to BDNF as the key protective component within P4-CM. These findings suggest that P4 may exert its maximal protection by triggering a glia-neuron cross talk, in which P4 promotes mature BDNF release from glia to enhance synaptogenesis as well as survival of neurons. This recognition of the importance of glia in mediating P4's neuroprotection may also inform the design of effective therapeutic methods for treating diseases wherein neuronal death and/or synaptic deficits are noted.	[Sun, Fen; Trinh Nguyen; Jin, Xin; Huang, Renqi; Chen, Zhenglan; Cunningham, Rebecca L.; Singh, Meharvan; Su, Chang] Univ N Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA		Su, C (corresponding author), Univ N Texas, Hlth Sci Ctr, Inst Hlth Aging, Ctr Neurosci Discovery, Ft Worth, TX 76107 USA.	chang.su@unthsc.edu	Sun, Fen/I-8516-2016	Cunningham, Rebecca/0000-0001-5984-5516; Singh, Meharvan/0000-0002-8072-1769	American Federation of Aging Research; American Heart AssociationAmerican Heart Association; National Institutes of Health National Institute of AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG022550, AG027956]; Alzheimer's AssociationAlzheimer's Association; Texas Garvey Foundation; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG022550, P01AG027956, T32AG020494] Funding Source: NIH RePORTER	This work was supported by funds from the American Federation of Aging Research and the American Heart Association (C.S.), National Institutes of Health National Institute of Aging Grants AG022550 and AG027956, the Alzheimer's Association, and the Texas Garvey Foundation (M.S.).	Ahmed IS, 2010, J PHARMACOL EXP THER, V333, P564, DOI 10.1124/jpet.109.164210; Atif F, 2013, NEUROPHARMACOLOGY, V67, P78, DOI 10.1016/j.neuropharm.2012.10.004; Bali N, 2012, ENDOCRINOLOGY, V153, P759, DOI 10.1210/en.2011-1699; Barha CK, 2011, EXP NEUROL, V231, P72, DOI 10.1016/j.expneurol.2011.05.016; Bashour NM, 2012, ENDOCRINOLOGY, V153, P4457, DOI 10.1210/en.2012-1122; Causing CG, 1997, NEURON, V18, P257, DOI 10.1016/S0896-6273(00)80266-4; Chamniansawat S, 2009, NEUROSCI LETT, V452, P130, DOI 10.1016/j.neulet.2009.01.010; Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235; Connor B, 1997, MOL BRAIN RES, V49, P71, DOI 10.1016/S0169-328X(97)00125-3; Diamond DM, 2005, HIPPOCAMPUS, V15, P1006, DOI 10.1002/hipo.20107; Encinas M, 1999, J NEUROCHEM, V73, P1409, DOI 10.1046/j.1471-4159.1999.0731409.x; Frye CA, 2008, NEUROSCI LETT, V437, P116, DOI 10.1016/j.neulet.2008.04.004; Fumagalli F, 2006, PHARMACOGENOMICS J, V6, P8, DOI 10.1038/sj.tpj.6500337; Guennoun R, 2008, BRAIN RES REV, V57, P493, DOI 10.1016/j.brainresrev.2007.05.009; Heldt SA, 2007, MOL PSYCHIATR, V12, P656, DOI 10.1038/sj.mp.4001957; Hock C, 1998, NEUROSCI LETT, V241, P151, DOI 10.1016/S0304-3940(98)00019-6; Intlekofer KA, 2011, NEUROSCIENCE, V172, P55, DOI 10.1016/j.neuroscience.2010.10.051; Lewis MC, 2008, HORM BEHAV, V54, P455, DOI 10.1016/j.yhbeh.2008.05.010; Liu AL, 2012, ENDOCRINOLOGY, V153, P3747, DOI 10.1210/en.2012-1138; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Lu Y, 2008, NEUROBIOL LEARN MEM, V89, P312, DOI 10.1016/j.nlm.2007.08.018; Ma JP, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008409.pub2; Matsumoto T, 2008, NAT NEUROSCI, V11, P131, DOI 10.1038/nn2038; Minichiello L, 2009, NAT REV NEUROSCI, V10, P850, DOI 10.1038/nrn2738; Morita S, 2013, CELL BIOCHEM FUNCT, V31, P400, DOI 10.1002/cbf.2914; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Murer MG, 2001, PROG NEUROBIOL, V63, P71, DOI 10.1016/S0301-0082(00)00014-9; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Peluso JJ, 2010, MOL CELL ENDOCRINOL, V320, P153, DOI 10.1016/j.mce.2010.02.005; PHILLIPS HS, 1991, NEURON, V7, P695, DOI 10.1016/0896-6273(91)90273-3; PrugininBluger M, 1997, MECH DEVELOP, V61, P99, DOI 10.1016/S0925-4773(96)00623-5; Rohe HJ, 2009, PHARMACOL THERAPEUT, V121, P14, DOI 10.1016/j.pharmthera.2008.09.006; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Sarkar SN, 2008, P NATL ACAD SCI USA, V105, P15148, DOI 10.1073/pnas.0802379105; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Singh M, 1999, J NEUROSCI, V19, P1179; STROEMER RP, 1992, NEUROSCI LETT, V147, P21, DOI 10.1016/0304-3940(92)90765-Y; Su C, 2012, ENDOCRINOLOGY, V153, P4389, DOI 10.1210/en.2011-2177; Vandromme M, 2008, CRIT CARE, V12, DOI 10.1186/cc6899; Wali B, 2011, RESTOR NEUROL NEUROS, V29, P61, DOI 10.3233/RNN-2011-0579; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Yoshii A, 2010, DEV NEUROBIOL, V70, P304, DOI 10.1002/dneu.20765; Zhao YZ, 2011, SYNAPSE, V65, P880, DOI 10.1002/syn.20915	45	17	19	1	6	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	MAY	2016	157	5					2067	2079		10.1210/en.2015-1610			13	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	DL3XT	WOS:000375567600034	26990062	Green Published, Bronze			2022-02-06	
J	Wan, XY; Liu, SW; Wang, S; Zhang, SJ; Yang, HK; Ou, YB; Zhao, M; James, L; Shu, K; Chen, JC; Lei, T				Wan, Xueyan; Liu, Shengwen; Wang, Sheng; Zhang, Suojun; Yang, Hongkuan; Ou, Yibo; Zhao, Min; James, Lubuulwa; Shu, Kai; Chen, Jincao; Lei, Ting			Elderly Patients with Severe Traumatic Brain Injury Could Benefit from Surgical Treatment	WORLD NEUROSURGERY			English	Article						Elderly; Prognosis; Surgery; Therapeutic approach; Traumatic brain injury	SEVERE HEAD-INJURY; OLDER-ADULTS; DECOMPRESSIVE CRANIECTOMY; MORTALITY; AGE; MANAGEMENT; DIAGNOSIS; INCREASES; OUTCOMES; RISK	OBJECTIVE: In elderly patients with severe traumatic brain injury, the use of aggressive versus conservative management remains controversial. The aim of this study was to assess the outcome of surgical alternatives for treatment of severe traumatic intracranial hematoma in patients >= 65 years old and identify factors that may contribute to the outcome. METHODS: This retrospective study included 112 patients with traumatic intracranial hematoma. Logistic regression analysis was used to identify independent predictors of unfavorable outcome. The Glasgow Outcome Scale was used to evaluate the outcome. RESULTS: Surgery was performed in 70 (62.5%) patients >= 65 years old. A favorable outcome occurred in 33 (47.1%) surgical patients, and 23 (32.9%) surgical patients died. Patients who underwent surgery were less likely to have an unfavorable outcome (52.9% vs. 95.2%) and less likely to die (32.9% vs. 88.1%) at 6 months postinjury compared with patients treated conservatively. Multivariate logistic regression analysis revealed that lower Glasgow Coma Scale score (<= 5) was a significant factor associated with unfavorable outcome (odds ratio [OR] = 18.7, 95% confidence interval [CI] = 5.2-95.5, P < 0.001) and mortality (OR = 10.7, 95% CI = 4.4-28.5, P < 0.001). However, neurosurgical intervention was a significant factor to negatively predict unfavorable outcome (OR = 0.03, 95% CI = 0.01-0.1, P < 0.001) and mortality (OR = 0.04, 95% CI = 0.01-0.1, P < 0.001). CONCLUSIONS: This study showed that Glasgow Coma Scale score (<= 5) was a major determinant of outcome in elderly patients with severe traumatic brain injury. However, surgical treatment reduced mortality and improved outcome in the elderly patients in this study.	[Wan, Xueyan; Liu, Shengwen; Wang, Sheng; Zhang, Suojun; Yang, Hongkuan; Ou, Yibo; Zhao, Min; James, Lubuulwa; Shu, Kai; Chen, Jincao; Lei, Ting] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Neurosurg, Wuhan 430074, Peoples R China		Wang, S (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Neurosurg, Wuhan 430074, Peoples R China.	wangsheng@tjh.tjmu.edu.cn	Lubuulwa, James/M-2924-2016	Lubuulwa, James/0000-0002-4671-2607; Wan, Xueyan/0000-0002-7148-9857	"Dawn" Program of Science and Technology for Young Scientists of Wuhan, China [201150431121]; National Clinical Key Specialty Construction Project	This work was supported by the "Dawn" Program of Science and Technology for Young Scientists of Wuhan, China (Grant No. 201150431121), and National Clinical Key Specialty Construction Project. The authors thank Wenhua Liu (Clinical and Translational Medical Center) for statistical assistance.	Brazinova A, 2010, J NEUROTRAUM, V27, P1549, DOI 10.1089/neu.2010.1315; Bullock MR, 2006, NEUROSURGERY, V58, pS1; Chibbaro S, 2011, WORLD NEUROSURG, V75, P558, DOI 10.1016/j.wneu.2010.10.020; Colantonio A, 2008, J TRAUMA, V64, P876, DOI 10.1097/TA.0b013e31804d493e; De Bonis P, 2011, J NEUROTRAUM, V28, P2043, DOI 10.1089/neu.2011.1889; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Gan BK, 2004, ANN ACAD MED SINGAP, V33, P63; Grossman MD, 2002, J TRAUMA, V52, P242, DOI 10.1097/00005373-200202000-00007; Huang YH, 2013, J NEUROSURG, V118, P1329, DOI 10.3171/2013.1.JNS121775; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Labib N, 2011, J TRAUMA, V71, P1908, DOI 10.1097/TA.0b013e31820989ed; Lecours A, 2012, J HEAD TRAUMA REHAB, V27, P379, DOI 10.1097/HTR.0b013e31823b2385; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McIntyre A, 2013, NEUROREHABILITATION, V32, P409, DOI 10.3233/NRE-130862; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Munro PT, 2002, BRIT MED J, V325, P1001, DOI 10.1136/bmj.325.7371.1001; Patel HC, 2010, ACTA NEUROCHIR, V152, P1353, DOI 10.1007/s00701-010-0666-x; Perdue PW, 1998, J TRAUMA, V45, P805, DOI 10.1097/00005373-199810000-00034; PETERSEN OF, 1984, NEURORADIOLOGY, V26, P363, DOI 10.1007/BF00327488; R Core Team, R A LANG ENV STAT CO; Richmond R, 2011, J TRAUMA, V71, pE8, DOI 10.1097/TA.0b013e3181fbaa46; Shimoda K, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.08.014; Stieg PE, 1998, NEUROL CLIN, V16, P373, DOI 10.1016/S0733-8619(05)70069-4; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Taussky P, 2012, WORLD NEUROSURG, V78, P306, DOI 10.1016/j.wneu.2011.10.030; Thompson HJ, 2008, CRIT CARE MED, V36, P282, DOI 10.1097/01.CCM.0000297884.86058.8A; Tokutomi T, 2008, J NEUROTRAUM, V25, P1407, DOI 10.1089/neu.2008.0577; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Wang ZC., 1974, NEUROSURGERY	31	17	18	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2016	89						147	152		10.1016/j.wneu.2016.01.084			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DM6GM	WOS:000376448700023	26855305				2022-02-06	
J	Warren, AM; Rainey, EE; Weddle, RJ; Bennett, M; Roden-Foreman, K; Foreman, ML				Warren, Ann Marie; Rainey, Evan Elizabeth; Weddle, Rebecca Joanne; Bennett, Monica; Roden-Foreman, Kenleigh; Foreman, Michael L.			The Intensive Care Unit Experience: Psychological Impact on Family Members of Patients With and Without Traumatic Brain Injury	REHABILITATION PSYCHOLOGY			English	Article						intensive care unit; traumatic brain injury; family caregiver	POSTTRAUMATIC-STRESS; CRITICAL ILLNESS; DEPRESSION; CAREGIVERS; SYMPTOMS; PREDICTORS; ANXIETY; SCREEN	Purpose/Objective: The intensive care unit (ICU) has been identified as a possible contributor to emotional distress. This study seeks to identify whether families of traumatic brain injury (TBI) patients in the ICU experience psychological differences as compared with non-TBI patients' family members. Method: Eighty-two family members in a trauma/critical care ICU were assessed at baseline and again at 3 months. The Patient Health Questionnaire 8-Item measured depression, the Primary Care PTSD Screen measured symptoms of posttraumatic stress (PTS). Results: Forty of these individuals were the family members of ICU patients who had sustained a TBI; 42 of the individuals were the family members of non-TBI patients in the ICU. At baseline, 39% (33% non-TBI, 45% TBI, p = .28) of the total sample screened positive for depressive symptoms and 24.3% (26% non-TBI, 23% TBI, p = .69) screened positive for PTS symptoms. However, differences emerged between the groups at 3 months, with family members in the non-TBI group showing a significant decrease in both baseline depression and PTS symptoms. Conclusions/Implications: This study, to our knowledge, is the first of its kind to examine psychological differences in the ICU in those whose family members either have or do not have a TBI. Results suggest the TBI group endorsed more symptoms of depression and PTS symptoms at 3 months. Although it is unclear whether symptoms were directly related to the ICU experience or the injury itself, future research should explore the possible additive effect of postintensive care syndrome-family symptoms.	[Warren, Ann Marie; Foreman, Michael L.] Baylor Univ, Med Ctr, Div Trauma Crit Care & Acute Care Surg, 3409 Worth St,Suite C2-500, Dallas, TX 75246 USA; [Rainey, Evan Elizabeth; Weddle, Rebecca Joanne] Baylor Res Inst, Dallas, TX USA; [Bennett, Monica] Baylor Scott & White Hlth, Dallas, TX USA; [Roden-Foreman, Kenleigh] Univ Texas Southwestern Med Ctr, Dept Psychiat, Dallas, TX USA		Warren, AM (corresponding author), Baylor Univ, Med Ctr, Div Trauma Crit Care & Acute Care Surg, 3409 Worth St,Suite C2-500, Dallas, TX 75246 USA.; Warren, AM (corresponding author), Baylor Univ, Med Ctr, Div Trauma Crit Care & Acute Care Surg, Trauma Res, 3409 Worth St,Suite C2-500, Dallas, TX 75246 USA.	annmarie.warren@BSWHealth.org		McShan, Evan Elizabeth/0000-0002-9250-3240; McMinn, PhD, Kenleigh/0000-0002-4623-8634; Warren, Ann Marie/0000-0002-3753-5573			Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Baumhover NC, 2013, AACN ADV CRIT CARE, V24, P130, DOI 10.1097/NCI.0b013e318286489e; Davidson JE, 2007, CRIT CARE MED, V35, P605, DOI 10.1097/01.CCM.0000254067.14607.EB; Davidson JE, 2012, CRIT CARE MED, V40, P618, DOI 10.1097/CCM.0b013e318236ebf9; Ennis N, 2013, NEUROPSYCHOL REHABIL, V23, P1, DOI 10.1080/09602011.2012.712871; Gonzalez O., 2010, Morbidity and Mortality Weekly Report, V59, P1229; Hanley J, 2013, J TRAUMA ACUTE CARE, V75, P722, DOI 10.1097/TA.0b013e3182a53a5f; Institute for Patient-and Family-Centered Care, 2015, FREQ ASK QUEST WHAT; Jones C, 2004, INTENS CARE MED, V30, P456, DOI 10.1007/s00134-003-2149-5; Jutte JE, 2015, SEMIN RESP CRIT CARE, V36, P943, DOI 10.1055/s-0035-1566002; Kreutzer JS, 2010, NEUROREHABILITATION, V27, P19, DOI 10.3233/NRE-2010-0578; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lefkowitz DS, 2010, J CLIN PSYCHOL MED S, V17, P230, DOI 10.1007/s10880-010-9202-7; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; National Center for PTSD, 2015, HOW COMM IS PTSD; National Quality Forum, 2012, END SUMM PULM CRIT C; Ouimette P, 2008, J ANXIETY DISORD, V22, P337, DOI 10.1016/j.janxdis.2007.02.010; Pochard F, 2005, J CRIT CARE, V20, P90, DOI 10.1016/j.jcrc.2004.11.004; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; Rainey EE, 2014, AM J SURG, V208, P517, DOI 10.1016/j.amjsurg.2014.05.016; Rivera P, 2007, NEUROREHABILITATION, V22, P3; Saban KL, 2015, REHABIL NURS, V40, P277, DOI 10.1002/rnj.182; Sander AM, 2013, BRAIN IMPAIR, V14, P113, DOI 10.1017/BrImp.2013.12; Schmidt M, 2012, CURR OPIN CRIT CARE, V18, P540, DOI 10.1097/MCC.0b013e328357f141; Schonberger M, 2010, NEUROPSYCHOL REHABIL, V20, P813, DOI 10.1080/09602011003620077; Society of Critical Care Medicine, 2011, POSTINT CAR SYNDR PI; Stead LG, 2013, INT J EMERG MED, V6, DOI 10.1186/1865-1380-6-5; Ulman A. J., 2014, COCHRANE DB SYST REV, P12; Warren AM, 2014, J TRAUMA NURS, V21, P139, DOI 10.1097/TA.0b013e3182858ab9	31	17	17	0	9	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	MAY	2016	61	2					179	185		10.1037/rep0000080			7	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	DN2XS	WOS:000376926900008	27196860				2022-02-06	
J	Schmid, AA; Miller, KK; van Puymbroeck, M; Schalk, N				Schmid, Arlene A.; Miller, Kristine K.; van Puymbroeck, Marieke; Schalk, Nancy			Feasibility and results of a case study of yoga to improve physical functioning in people with chronic traumatic brain injury	DISABILITY AND REHABILITATION			English	Article						Balance; yoga; traumatic brain injury	MOTOR REHABILITATION; UNITED-STATES; CHRONIC PAIN; PILOT; BALANCE; PREVALENCE; STROKE; SWAY; RELIABILITY	Purpose: The purpose of this mixed-methods case study was to investigate whether an 8-week 1:1 yoga program was feasible and beneficial to people with traumatic brain injury (TBI). Method: This was a mixed-methods case study of one-to-one yoga for people with TBI included three people. We completed assessments before and after the 8-week yoga intervention and included measures of balance, balance confidence, pain, range of motion, strength and mobility. Qualitative interviews were included at the post-assessment. We include a percent change calculation and salient quotes that represent the perceived impact of the yoga intervention. Results: All participants completed the yoga intervention and all demonstrated improvements in physical outcome measures. For the group, balance increased by 36%, balance confidence by 39%, lower extremity strength by 100% and endurance by 105%. Qualitative data support the use of yoga to improve multiple aspects of physical functioning, one participant stated: "I mean it's rocked my world. It's changed my life. I mean all the different aspects. I mean physically, emotionally, mentally, it's given me you know my life back horizontal ellipsis ". Conclusions: Yoga, delivered in a one-to-one setting, appears to be feasible and beneficial to people with chronic TBI. Implications for Rehabilitation Chronic traumatic brain injury (TBI) leads to many aspects of physical functioning impairment. Yoga delivered in a one-to-one setting may be feasible and beneficial for people with chronic TBI.	[Schmid, Arlene A.] Colorado State Univ, Coll Hlth & Human Sci, Dept Occupat Therapy, Ft Collins, CO 80523 USA; [Miller, Kristine K.] Indiana Univ, Sch Hlth & Rehabil Sci, Dept Phys Therapy, Indianapolis, IN 46204 USA; [Miller, Kristine K.] Roudebush Vet Adm VA Med Ctr, Ctr Implementing Evidence Based Practice, HSR&D, Indianapolis, IN USA; [van Puymbroeck, Marieke] Clemson Univ, Coll Hlth & Human Dev, Dept Pk Recreat & Tourism Management, Clemson, SC USA; [Schalk, Nancy] Heartland Yoga Therapy, Indianapolis, IN USA		Schmid, AA (corresponding author), Colorado State Univ, Dept Occupat Therapy, Ft Collins, CO 80523 USA.	arlene.schmid@colostate.edu		Schmid, Arlene/0000-0002-7755-199X; Van Puymbroeck, Marieke/0000-0002-5881-8409	VA Career Development Award [VA RRD CDA D6174W]	Dr. Schmid and this study were supported by a VA Career Development Award (VA RR&D CDA D6174W).	Arain M, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-67; Bosco MA, 2013, HEADACHE, V53, P1518, DOI 10.1111/head.12172; Breceda EY, 2013, CURR OPIN NEUROL, V26, P595, DOI 10.1097/WCO.0000000000000024; BROWN DR, 1995, MED SCI SPORT EXER, V27, P765; Callahan CM, 2002, MED CARE, V40, P771, DOI 10.1097/00005650-200209000-00007; Cantor JB, 2013, CURR PHYS MED REHABI, V1, P159; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Feld JA, 2001, NEUROREHAB NEURAL RE, V15, P239, DOI 10.1177/154596830101500312; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Hager, 2008, BEN SUN SAL TRAUM BR; Krebs EE, 2009, J GEN INTERN MED, V24, P733, DOI 10.1007/s11606-009-0981-1; LEHMANN JF, 1990, ARCH PHYS MED REHAB, V71, P955; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; McFadyen BJ, 2003, J HEAD TRAUMA REHAB, V18, P512, DOI 10.1097/00001199-200311000-00005; Mossberg KA, 2003, AM J PHYS MED REHAB, V82, P385, DOI 10.1097/01.PHM.0000052589.96202.BE; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; Page SJ, 2012, ARCH PHYS MED REHAB, V93, P1395, DOI 10.1016/j.apmr.2012.03.005; Paveza GJ, 1990, BEHAV HLTH AGING, V1, P133; Rikil R, 2001, SENIOR FITNESS TEST; Schmid AA, 2014, COMPLEMENT THER MED, V22, P994, DOI 10.1016/j.ctim.2014.09.005; Schmid AA, 2012, STROKE, V43, P2402, DOI 10.1161/STROKEAHA.112.658211; Schmid AA, 2012, ARCH PHYS MED REHAB, V93, P1101, DOI 10.1016/j.apmr.2012.01.020; Schmid AA, 2010, ARCH PHYS MED REHAB, V91, P576, DOI 10.1016/j.apmr.2009.12.018; Silverthorne Colin, 2012, Int J Yoga Therap, P47; Van Loo MA, 2004, BRAIN INJURY, V18, P1041, DOI 10.1080/02699050410001672314; Van Puymbroeck M, 2014, J RECREAT THER, V13, P23; Wade LD, 1997, ARCH PHYS MED REHAB, V78, P1107, DOI 10.1016/S0003-9993(97)90136-2; WOBER C, 1993, ARCH PHYS MED REHAB, V74, P1151; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	31	17	17	0	22	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	APR 23	2016	38	9					914	920		10.3109/09638288.2015.1062927			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	DE5CB	WOS:000370647400014	26208245				2022-02-06	
J	Davies, DR; Olson, D; Meyer, DL; Scholl, JL; Watt, MJ; Manzerra, P; Renner, KJ; Forster, GL				Davies, Daniel R.; Olson, Dawne; Meyer, Danielle L.; Scholl, Jamie L.; Watt, Michael J.; Manzerra, Pasquale; Renner, Kenneth J.; Forster, Gina L.			Mild Traumatic Brain Injury with Social Defeat Stress Alters Anxiety, Contextual Fear Extinction, and Limbic Monoamines in Adult Rats	FRONTIERS IN BEHAVIORAL NEUROSCIENCE			English	Article						mild traumatic brain injury; social stress; posttraumatic stress disorder; anxiety; fear conditioning; monoamine	CORTICOTROPIN-RELEASING-FACTOR; PREFRONTAL CORTEX; CONDITIONED FEAR; VENTRAL HIPPOCAMPUS; AMYGDALA RESPONSE; WORKING-MEMORY; CUED FEAR; DISORDER; PTSD; BEHAVIOR	Mild traumatic brain injury (mTBI) produces symptoms similar to those typifying posttraumatic stress disorder (PTSD) in humans. We sought to determine whether a rodent model of stress concurrent with mTBI produces characteristics of PTSD such as impaired contextual fear extinction, while also examining concurrent alterations to limbic monoamine activity in brain regions relevant to fear and anxiety states. Male rats were exposed to social stress or control conditions immediately prior to mTBI induction, and 6 days later were tested either for anxiety-like behavior using the elevated plus maze (EPM), or for contextual fear conditioning and extinction. Brains were collected 24 h after EPM testing, and tissue from various limbic regions analyzed for content of monoamines, their precursors and metabolites using HPLC with electrochemical detection. Either social defeat or mTBI alone decreased time spent in open arms of the EPM, indicating greater anxiety-like behavior. However, this effect was enhanced by the combination of treatments. Further, rats exposed to both social defeat and mTBI exhibited greater freezing within extinction sessions compared to all other groups, suggesting impaired contextual fear extinction. Social defeat combined with mTBI also had greater effects on limbic monoamines than either insult alone, particularly with respect to serotonergic effects associated with anxiety and fear learning. The results suggest social stress concurrent with mTBI produces provides a relevant animal model for studying the prevention and treatment of post-concussive psychobiological outcomes.	[Davies, Daniel R.; Olson, Dawne; Meyer, Danielle L.; Scholl, Jamie L.; Watt, Michael J.; Manzerra, Pasquale; Forster, Gina L.] Univ S Dakota, Sanford Sch Med, Div Basic Biomed Sci, Ctr Brain & Behav Res, Vermillion, SD 57069 USA; [Renner, Kenneth J.] Univ S Dakota, Dept Biol, Ctr Brain & Behav Res, Vermillion, SD 57069 USA		Forster, GL (corresponding author), Univ S Dakota, Sanford Sch Med, Div Basic Biomed Sci, Ctr Brain & Behav Res, Vermillion, SD 57069 USA.	gforster@usd.edu		Watt, Michael/0000-0003-1164-1367	Department of DefenseUnited States Department of Defense [W81XWH-10-1-0578]; USD U. Discover fellowship	This work was funded by Department of Defense Grant W81XWH-10-1-0578, and DD was funded by an USD U. Discover fellowship.	Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Armony JL, 2005, AM J PSYCHIAT, V162, P1961, DOI 10.1176/appi.ajp.162.10.1961; Attar CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042397; Baratz R, 2010, J NEUROTRAUM, V27, P555, DOI 10.1089/neu.2009.0891; Barr JL, 2013, EUR J NEUROSCI, V37, P479, DOI 10.1111/ejn.12050; Bauer EP, 2015, BEHAV BRAIN RES, V277, P68, DOI 10.1016/j.bbr.2014.07.028; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Berton O, 1999, NEUROSCIENCE, V92, P327, DOI 10.1016/S0306-4522(98)00742-8; Bjorkqvist K, 2001, PHYSIOL BEHAV, V73, P435, DOI 10.1016/S0031-9384(01)00490-5; Blechert J, 2007, BEHAV RES THER, V45, P2019, DOI 10.1016/j.brat.2007.02.012; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAND T, 1993, J MOL CELL CARDIOL, V25, P1325, DOI 10.1006/jmcc.1993.1145; Bryant RA, 1999, BRAIN INJURY, V13, P15, DOI 10.1080/026990599121836; Calfa G, 2006, BEHAV BRAIN RES, V172, P324, DOI 10.1016/j.bbr.2006.05.022; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; CLEMENT HW, 1992, EUR J PHARMACOL, V217, P43, DOI 10.1016/0014-2999(92)90509-3; Darwish H, 2012, BRAIN INJURY, V26, P1763, DOI [10.3109/02699052.2012.741452, 10.3109/02699052.2011.635362]; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Forster GL, 2006, NEUROSCIENCE, V141, P1047, DOI 10.1016/j.neuroscience.2006.04.006; Forster GL, 2012, AMYGDALA - A DISCRETE MULTITASKING MANAGER, P61, DOI 10.5772/50323; Genovese RF, 2013, NEUROSCIENCE, V254, P120, DOI 10.1016/j.neuroscience.2013.09.021; Grillon C, 1999, J ABNORM PSYCHOL, V108, P134, DOI 10.1037/0021-843X.108.1.134; GUBITS RM, 1991, J NEUROSCI RES, V30, P625, DOI 10.1002/jnr.490300405; Hammels C, 2015, NEUROSCI BIOBEHAV R, V59, P111, DOI 10.1016/j.neubiorev.2015.10.006; Hendler T, 2003, NEUROIMAGE, V19, P587, DOI 10.1016/S1053-8119(03)00141-1; Henninger N, 2005, EXP NEUROL, V195, P447, DOI 10.1016/j.expneurol.2005.06.013; Henninger N, 2007, CRIT CARE MED, V35, P2607, DOI 10.1097/01.CCM.0000286395.79654.8D; Hitora-Imamura N, 2015, ELIFE, V4, DOI 10.7554/eLife.08274; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huhman KL, 2006, HORM BEHAV, V50, P640, DOI 10.1016/j.yhbeh.2006.06.022; Hunsaker MR, 2008, NEUROBIOL LEARN MEM, V89, P61, DOI 10.1016/j.nlm.2007.08.016; Jovanovic Tanja, 2011, Front Behav Neurosci, V5, P44, DOI 10.3389/fnbeh.2011.00044; Jovanovic T, 2009, PSYCHIAT RES, V167, P151, DOI 10.1016/j.psychres.2007.12.014; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kim MJ, 2008, J PSYCHIATR RES, V42, P268, DOI 10.1016/j.jpsychires.2007.02.003; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Lehner M, 2008, BEHAV BRAIN RES, V192, P203, DOI 10.1016/j.bbr.2008.04.003; Liberzon I, 1999, BIOL PSYCHIAT, V45, P817, DOI 10.1016/S0006-3223(98)00246-7; MacBeth AH, 2008, BRAIN RES, V1241, P136, DOI 10.1016/j.brainres.2008.09.006; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McCullers D, 2002, NEUROSCIENCE, V109, P219, DOI 10.1016/S0306-4522(01)00477-8; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; Milad MR, 2008, J PSYCHIATR RES, V42, P515, DOI 10.1016/j.jpsychires.2008.01.017; Milad MR, 2007, BIOL PSYCHIAT, V62, P446, DOI 10.1016/j.biopsych.2006.10.011; Milad MR, 2014, BEHAV RES THER, V62, P17, DOI 10.1016/j.brat.2014.08.006; Milad MR, 2006, BIOL PSYCHOL, V73, P61, DOI 10.1016/j.biopsycho.2006.01.008; Millan MJ, 2003, PROG NEUROBIOL, V70, P83, DOI 10.1016/s0301-0082(03)00087-X; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Morey RA, 2012, ARCH GEN PSYCHIAT, V69, P1169, DOI 10.1001/archgenpsychiatry.2012.50; Morey RA, 2009, J PSYCHIATR RES, V43, P809, DOI 10.1016/j.jpsychires.2008.10.014; Novick AM, 2011, BRAIN RES BULL, V86, P123, DOI 10.1016/j.brainresbull.2011.06.009; Ohmura Y, 2010, NEUROPSYCHOPHARMACOL, V35, P1271, DOI 10.1038/npp.2009.229; Ojo JO, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00213; Orr SP, 2000, J ABNORM PSYCHOL, V109, P290, DOI 10.1037//0021-843X.109.2.290; Pissiota A, 2002, EUR ARCH PSY CLIN N, V252, P68, DOI 10.1007/s004060200014; Quirk GJ, 2006, BIOL PSYCHIAT, V60, P337, DOI 10.1016/j.biopsych.2006.03.010; Radwanska K, 2015, NEUROBIOL LEARN MEM, V125, P106, DOI 10.1016/j.nlm.2015.08.007; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Rauch SL, 2000, BIOL PSYCHIAT, V47, P769, DOI 10.1016/S0006-3223(00)00828-3; Rod AMK, 2012, STRESS, V15, P658, DOI 10.3109/10253890.2012.663836; Scholl JL, 2009, PHYSIOL BEHAV, V96, P493, DOI 10.1016/j.physbeh.2008.12.001; Shin LM, 2005, ARCH GEN PSYCHIAT, V62, P273, DOI 10.1001/archpsyc.62.3.273; Shin LM, 1999, AM J PSYCHIAT, V156, P575; Shin LM, 2004, HIPPOCAMPUS, V14, P292, DOI 10.1002/hipo.10183; Shin LM, 2001, BIOL PSYCHIAT, V50, P932, DOI 10.1016/S0006-3223(01)01215-X; Shin LM, 1997, ARCH GEN PSYCHIAT, V54, P233; Sierra-Mercado D, 2015, BRAIN RES, V1606, P133, DOI 10.1016/j.brainres.2015.02.031; Soeda A, 2005, NEURORADIOLOGY, V47, P501, DOI 10.1007/s00234-005-1372-x; Steiger F, 2015, INT J PSYCHOPHYSIOL, V98, P584, DOI 10.1016/j.ijpsycho.2015.06.009; Stockhorst U, 2016, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00359; Toth I, 2013, CELL TISSUE RES, V354, P107, DOI 10.1007/s00441-013-1636-4; TRULSON ME, 1984, LIFE SCI, V35, P511, DOI 10.1016/0024-3205(84)90244-3; Watt MJ, 2009, BEHAV NEUROSCI, V123, P564, DOI 10.1037/a0015752; Williams LM, 2006, NEUROIMAGE, V29, P347, DOI 10.1016/j.neuroimage.2005.03.047; Woon FL, 2010, PROG NEURO-PSYCHOPH, V34, P1181, DOI 10.1016/j.pnpbp.2010.06.016; Xie K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064907	78	17	17	1	14	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5153			FRONT BEHAV NEUROSCI	Front. Behav. Neurosci.	APR 19	2016	10								71	10.3339/fnbeh.2015.00071			13	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	DJ8EM	WOS:000374445300001	27147992				2022-02-06	
J	Brooks, BL; Iverson, GL; Atkins, JE; Zafonte, R; Berkner, PD				Brooks, Brian L.; Iverson, Grant L.; Atkins, Joseph E.; Zafonte, Ross; Berkner, Paul D.			Sex Differences and Self-Reported Attention Problems During Baseline Concussion Testing	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						adolescents; baseline; children; gender; return to play; TBI	SPORTS-RELATED CONCUSSION; DEFICIT HYPERACTIVITY DISORDER; HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; SYMPTOMS; RECOVERY; AGE; PLAYERS	Amateur athletic programs often use computerized cognitive testing as part of their concussion management programs. There is evidence that athletes with preexisting attention problems will have worse cognitive performance and more symptoms at baseline testing. The purpose of this study was to examine whether attention problems affect assessments differently for male and female athletes. Participants were drawn from a database that included 6,840 adolescents from Maine who completed Immediate Postconcussion Assessment and Cognitive Testing (ImPACT) at baseline (primary outcome measure). The final sample included 249 boys and 100 girls with self-reported attention problems. Each participant was individually matched for sex, age, number of past concussions, and sport to a control participant (249 boys, 100 girls). Boys with attention problems had worse reaction time than boys without attention problems. Girls with attention problems had worse visual-motor speed than girls without attention problems. Boys with attention problems reported more total symptoms, including more cognitive-sensory and sleep-arousal symptoms, compared with boys without attention problems. Girls with attention problems reported more cognitive-sensory, sleep-arousal, and affective symptoms than girls without attention problems. When considering the assessment, management, and outcome from concussions in adolescent athletes, it is important to consider both sex and preinjury attention problems regarding cognitive test results and symptom reporting.	[Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Neurosci Program Brain Injury & Rehabil, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada; [Brooks, Brian L.] Univ Calgary, Dept Pediat, Cumming Sch Med, Calgary, AB T2N 1N4, Canada; [Brooks, Brian L.] Univ Calgary, Cumming Sch Med, Dept Clin Neurosci, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Iverson, Grant L.] Harvard Univ, Spaulding Rehabil Hosp, Sch Med, Dept Phys Med & Rehabil,MassGen Hosp Children Spo, Boston, MA USA; [Iverson, Grant L.; Zafonte, Ross] Red Sox Fdn, Boston, MA USA; [Iverson, Grant L.; Zafonte, Ross] Massachusetts Gen Hosp Home Base Program, Boston, MA USA; [Atkins, Joseph E.] Colby Coll, Dept Psychol, Waterville, ME 04901 USA; [Zafonte, Ross] Harvard Univ, Brigham & Womens Hosp, Massachusetts Gen Hosp, Spaulding Rehabil Hosp,Sch Med,Dept Phys Med & Re, Boston, MA 02115 USA; [Berkner, Paul D.] Colby Coll, Hlth Serv, Waterville, ME 04901 USA; [Berkner, Paul D.] Colby Coll, Dept Biol, Waterville, ME 04901 USA		Brooks, BL (corresponding author), Alberta Childrens Prov Gen Hosp, Neurosci Program, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada.	brian.brooks@albertahealthservices.ca		Iverson, Grant/0000-0001-7348-9570	Goldfarb Center for Public Policy and Civic Engagement/Colby College; Bill and Joan Alfond Foundation; Harvard Integrated Program to Protect and Improve the Health of National Football League Players Association Members; Mooney-Reed Charitable Foundation	This work was funded in part by the Goldfarb Center for Public Policy and Civic Engagement/Colby College and the Bill and Joan Alfond Foundation. RZ was supported in part by the Harvard Integrated Program to Protect and Improve the Health of National Football League Players Association Members. GLI and RZ acknowledge support from the Mooney-Reed Charitable Foundation.	[Anonymous], 2010, IBM SPSS STAT WIND V; Brooks BL, 2014, J HEAD TRAUMA REHAB, V29, P257, DOI 10.1097/HTR.0000000000000016; Brooks BL, 2013, J NEUROTRAUM, V30, P1469, DOI 10.1089/neu.2012.2720; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Collins MW, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P498; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/316575; Kirkwood MW, 2012, CLIN J SPORT MED, V22, P383, DOI 10.1097/JSM.0b013e31826396fc; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kontos AP, 2011, BRAIN INJURY, V25, P1234, DOI 10.3109/02699052.2011.608209; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Mckay CD, 2014, J ORTHOP SPORT PHYS, V44, P329, DOI 10.2519/jospt.2014.5053; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Piland SG, 2010, J ATHL TRAINING, V45, P273, DOI 10.4085/1062-6050-45.3.273; Purcell L, 2009, BRIT J SPORT MED, V43, pI51, DOI 10.1136/bjsm.2009.058214; Putukian M, 2011, CLIN J SPORT MED, V21, P392, DOI 10.1097/JSM.0b013e3182262eb1; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Thomas DG, 2011, ACAD EMERG MED, V18, P246, DOI 10.1111/j.1553-2712.2011.01015.x; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Wasserman T, 2012, APPL NEUROPSYCH-CHIL, V1, P90, DOI 10.1080/21622965.2012.702025; White RD, 2014, SPORTS HEALTH, V6, P149, DOI 10.1177/1941738113484679; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524; Zuckerman SL, 2012, J NEUROSURG-PEDIATR, V10, P504, DOI 10.3171/2012.8.PEDS12139	44	17	17	0	12	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child	APR 2	2016	5	2					119	126		10.1080/21622965.2014.1003066			8	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	DJ1BG	WOS:000373937500005	25923339				2022-02-06	
J	Ban, VS; Madden, CJ; Bailes, JE; Batjer, HH; Lonser, RR				Ban, Vin Shen; Madden, Christopher J.; Bailes, Julian E.; Batjer, H. Hunt; Lonser, Russell R.			The science and questions surrounding chronic traumatic encephalopathy	NEUROSURGICAL FOCUS			English	Article						chronic traumatic encephalopathy; concussion; subconcussion; diagnosis; treatment; research directions; controversies	LIFE COGNITIVE IMPAIRMENT; COLLEGIATE FOOTBALL PLAYERS; HIGH-SCHOOL FOOTBALL; PROFESSIONAL FOOTBALL; HEAD IMPACTS; RECURRENT CONCUSSION; 1ST EXPOSURE; BRAIN-INJURY; IN-VIVO; AGE	Recently, the pathobiology, causes, associated factors, incidence and prevalence, and natural history of chronic traumatic encephalopathy (CTE) have been debated. Data from retrospective case series and high-profile media reports have fueled public fear and affected the medical community's understanding of the role of sports-related traumatic brain injury (TBI) in the development of CTE. There are a number of limitations posed by the current evidence that can lead to confusion within the public and scientific community. In this paper, the authors address common questions surrounding the science of CTE and propose future research directions.	[Ban, Vin Shen; Madden, Christopher J.; Batjer, H. Hunt] Univ Texas SW Med Ctr Dallas, Dept Neurol Surg, 5323 Harry Hines Blvd, Dallas, TX 75235 USA; [Bailes, Julian E.] Univ Chicago, Pritzker Sch Med, Dept Neurol Surg, NorthShore Univ HealthSyst, Evanston, IL USA; [Lonser, Russell R.] Ohio State Univ, Wexner Med Ctr, Dept Neurol Surg, Columbus, OH 43210 USA		Ban, VS (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurol Surg, 5323 Harry Hines Blvd, Dallas, TX 75235 USA.	vinshen.ban@cantab.net		Ban, Vin Shen/0000-0002-4532-8101			Anthony IC, 2010, BRAIN, V133, P3685, DOI 10.1093/brain/awq263; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Belson K, 2015, NY TIMES; Belson K., 2014, NY TIMES; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Breslow J., 2015, NEW 87 DECEASED NFL; Breslow JM, 76 79 DEC NFL PLAYER; Broglio SP, 2013, AM J SPORT MED, V41, P2877, DOI 10.1177/0363546513502458; Cairns NJ, 1 NIH CONS C DEF NEU; Carroll L, 2015, NBC NEWS        0318; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; CTE Awareness Foundation, WHAT CAUS CTE; Davis GA, 2015, NEUROSURGERY, V76, P643, DOI 10.1227/NEU.0000000000000722; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hanna J, 2015, CNN             1011; Iverson GL, 2015, NEUROSCI BIOBEHAV R, V56, P276, DOI 10.1016/j.neubiorev.2015.05.008; Kovacs GG, 2015, NEUROPATH APPL NEURO, V41, P3, DOI 10.1111/nan.12208; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Maroon JC, 2015, NEUROLOGY, V85, P1007, DOI 10.1212/WNL.0000000000001942; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117338; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCaffrey MA, 2007, NEUROSURGERY, V61, P1236, DOI 10.1227/01.neu.0000306102.91506.8b; McCrory P, 2013, J AM COLL SURGEONS, V216, pE55, DOI 10.1016/j.jamcollsurg.2013.02.020; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mitsis EM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.91; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Neporent L., 2013, ABC NEWS; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Ramage SN, 2005, NEUROPATH APPL NEURO, V31, P439, DOI 10.1111/j.1365-2990.2005.00670.x; Reynolds BB, 2016, J NEUROSURG, V124, P501, DOI 10.3171/2015.5.JNS15573; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Savica R, 2012, MAYO CLIN PROC, V87, P335, DOI 10.1016/j.mayocp.2011.12.016; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Shen H, 2015, NATURE, V518, P466, DOI 10.1038/518466a; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Solomon G, 2015, PHYSICIAN SPORTSMED, V43, P247, DOI 10.1080/00913847.2015.1024582; Solomon GS, 2014, PHYSICIAN SPORTSMED, V42, P26, DOI 10.3810/psm.2014.09.2072; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Sundman M, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00334; Tator CH, 2014, BRIT J SPORT MED, V48, P81, DOI 10.1136/bjsports-2013-093040	51	17	17	0	57	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	APR	2016	40	4							E15	10.3171/2016.2.FOCUS15609			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DI4NL	WOS:000373476500015	27032918	gold			2022-02-06	
J	Khalin, I; Jamari, NLA; Razak, NBA; Hasain, ZB; Nor, MAB; Zainudin, MHB; Omar, AB; Alyautdin, R				Khalin, Igor; Jamari, Nor Laili Azua; Razak, Nadiawati Bt Abdul; Hasain, Zubaidah Bt; Nor, Mohd Asri bin Mohd; Zainudin, Mohd Hakimi bin Ahmad; Omar, Ainsah Bt; Alyautdin, Renad			A mouse model of weight-drop closed head injury: emphasis on cognitive and neurological deficiency	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; traumatic brain injury; neurological severity score; passive avoidance; weight-drop injury model; C57BL/6 mice; neural regeneration	TRAUMATIC BRAIN-INJURY; NEURONAL CELL LOSS; ANIMAL-MODELS; MICE; RECOVERY; MOTOR	Traumatic brain injury (TBI) is a leading cause of death and disability in individuals worldwide. Producing a clinically relevant TBI model in small-sized animals remains fairly challenging. For good screening of potential therapeutics, which are effective in the treatment of TBI, animal models of TBI should be established and standardized. In this study, we established mouse models of closed head injury using the Shohami weight-drop method with some modifications concerning cognitive deficiency assessment and provided a detailed description of the severe TBI animal model. We found that 250 g falling weight from 2 cm height produced severe closed head injury in C57BL/6 male mice. Cognitive disorders in mice with severe closed head injury could be detected using passive avoidance test on day 7 after injury. Findings from this study indicate that weight-drop injury animal models are suitable for further screening of brain neuroprotectants and potentially are similar to those seen in human TBI.	[Khalin, Igor; Razak, Nadiawati Bt Abdul; Hasain, Zubaidah Bt; Omar, Ainsah Bt] Natl Def Univ Malaysia, Fac Med & Def Hlth, Kuala Lumpur, Malaysia; [Jamari, Nor Laili Azua] Natl Def Univ Malaysia, Dept Chem, Ctr Def Fdn Studies, Kuala Lumpur, Malaysia; [Nor, Mohd Asri bin Mohd] Natl Def Univ Malaysia, Fac Engn, Dept Civil Engn, Kuala Lumpur, Malaysia; [Zainudin, Mohd Hakimi bin Ahmad] Natl Def Univ Malaysia, Ctr Res & Innovat Management, Kuala Lumpur, Malaysia; [Alyautdin, Renad] Sci Ctr Expertise Med Applicat Prod, Petrovsky Blvd, Moscow, Russia		Khalin, I (corresponding author), Natl Def Univ Malaysia, Fac Med & Def Hlth, Kuala Lumpur, Malaysia.	igor@upnm.edu.my	Alyautdin, Renad N/L-9261-2014	Alyautdin, Renad N/0000-0002-4647-977X; Khalin, Igor/0000-0003-1041-5747; AHMAD ZAINUDIN, MOHD HAKIMI/0000-0002-1211-2937	Ministry of Higher Education of MalaysiaMinistry of Education, Malaysia [RAGS/2013/UPNM/SKK/01/2]	The study was supported by a grant from the Ministry of Higher Education of Malaysia, No. RAGS/2013/UPNM/SKK/01/2.	Albert-WeiSSenberger Christiane, 2012, Exp Transl Stroke Med, V4, P1, DOI 10.1186/2040-7378-4-1; Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; Bachstetter AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0289-5; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Budinich CS, 2013, PHARMACOL BIOCHEM BE, V108, P66, DOI 10.1016/j.pbb.2013.04.001; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; King JT, 2005, J NEUROTRAUM, V22, P947, DOI 10.1089/neu.2005.22.947; Meybodi KT, 2005, BEHAV PHARMACOL, V16, P139, DOI 10.1097/00008877-200505000-00002; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Tucker LB, 2016, J NEUROTRAUM, V33, P880, DOI 10.1089/neu.2015.3977; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Walker EA, 2010, ADV EXP MED BIOL, V678, P138; Wu CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113397; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Yu FS, 2012, J NEUROTRAUM, V29, P2342, DOI 10.1089/neu.2012.2449	25	17	17	1	16	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	APR	2016	11	4					630	635		10.4103/1673-5374.180749			6	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	DO1XF	WOS:000377572700028	27212925	Green Published, gold			2022-02-06	
J	Murphy, PB; Sothilingam, N; Stewart, TC; Batey, B; Moffat, B; Gray, DK; Parry, NG; Vogt, KN				Murphy, Patrick B.; Sothilingam, Niroshan; Stewart, Tanya Charyk; Batey, Brandon; Moffat, Brad; Gray, Daryl K.; Parry, Neil G.; Vogt, Kelly N.			Very early initiation of chemical venous thromboembolism prophylaxis after blunt solid organ injury is safe	CANADIAN JOURNAL OF SURGERY			English	Article							PRACTICE MANAGEMENT GUIDELINE; MOLECULAR-WEIGHT HEPARIN; TRAUMATIC BRAIN-INJURY; NONOPERATIVE MANAGEMENT; EASTERN ASSOCIATION; MAJOR TRAUMA; THROMBOSIS; ANTICOAGULATION; PREVENTION; SURGERY	Background The optimal timing of initiating low-molecular weight heparin (LMWH) in patients who have undergone nonoperative management (NOM) of blunt solid organ injuries (SOIs) remains controversial. We describe the safety of early initiation of chemical venous thromboembolism (VTE) prophylaxis among patients undergoing NOM of blunt SOIs. Methods We retrospectively studied severely injured adults who sustained blunt SOI without significant intracranial hemorrhage and underwent an initial NOM at a Canadian lead trauma hospital between 2010 and 2014. Safety was assessed based on failure of NOM, defined as the need for operative intervention, in patients who received early (< 48 h) or late LMWH (>= 48 h, or early discharge [< 72 h] without LMWH). Results We included 162 patients in our analysis. Most were men (69%), and the average age was 42 +/- 18 years. The median injury severity score was 17, and splenic injuries were most common (97 [60%], median grade 2), followed by liver (57 [35%], median grade 2) and kidney injuries (31 [19%], median grade 1). Combined injuries were present in 14% of patients. A total of 78 (48%) patients received early LMWH, while 84 (52%) received late LMWH. The groups differed only in percent of high-grade splenic injury (14% v. 32%). Overall 2% of patients failed NOM, none after receiving LMWH. Semielective angiography was performed in 23 (14%) patients. The overall rate of confirmed VTE on imaging was 1.9%. Conclusion Early initiation of medical thromboembolic prophylaxis appears safe in select patients with isolated SOI following blunt trauma. A prospective multicentre study is warranted.	[Murphy, Patrick B.; Sothilingam, Niroshan; Moffat, Brad; Gray, Daryl K.; Parry, Neil G.; Vogt, Kelly N.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Surg, London, ON, Canada; [Sothilingam, Niroshan; Stewart, Tanya Charyk; Batey, Brandon; Gray, Daryl K.; Parry, Neil G.; Vogt, Kelly N.] London Hlth Sci Ctr, Trauma Program, London, ON, Canada; [Parry, Neil G.] Ctr Crit Illness Res, London, ON, Canada		Vogt, KN (corresponding author), Victoria Hosp, London Hlth Sci Ctr, Div Gen Surg, Rm E2-214,800 Commissioners Rd East, London, ON N6A 5W9, Canada.	kelly.vogt@lhsc.on.ca	Murphy, Patrick/T-5337-2019				Alejandro KV, 2003, AM SURGEON, V69, P1006; Bertens KA, 2015, EUR J TRAUMA EMERG S, V41, P81, DOI 10.1007/s00068-014-0431-6; Chapman BC, 2013, AM J SURG, V206, P917, DOI 10.1016/j.amjsurg.2013.07.024; Datta Indraneel, 2009, J Trauma Manag Outcomes, V3, P7, DOI 10.1186/1752-2897-3-7; DeMuro JP, 2013, J BLOOD DISORD TRANS, P04; Eberle BM, 2011, J TRAUMA, V70, P141, DOI 10.1097/TA.0b013e3182032f45; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; HILL SL, 1994, AM SURGEON, V60, P405; Joseph B, 2015, AM J SURG, V209, P194, DOI 10.1016/j.amjsurg.2014.03.007; Joseph B, 2013, AM J SURG, V206, P922; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; Phelan HA, 2013, SEMIN THROMB HEMOST, V39, P541, DOI 10.1055/s-0033-1343356; Piotrowski JJ, 1996, AM J SURG, V172, P210, DOI 10.1016/S0002-9610(96)00154-7; Rogers FB, 2002, J TRAUMA, V53, P142, DOI 10.1097/00005373-200207000-00032; Saadeh Y, 2012, J TRAUMA ACUTE CARE, V73, P426, DOI 10.1097/TA.0b013e31825a758b; Stassen NA, 2012, J TRAUMA ACUTE CARE, V73, pS294, DOI 10.1097/TA.0b013e3182702afc; Stassen NA, 2012, J TRAUMA ACUTE CARE, V73, pS288, DOI 10.1097/TA.0b013e318270160d	18	17	17	0	2	CMA-CANADIAN MEDICAL ASSOC	OTTAWA	1867 ALTA VISTA DR, OTTAWA, ONTARIO K1G 5W8, CANADA	0008-428X	1488-2310		CAN J SURG	Can. J. Surg.	APR	2016	59	2					118	122		10.1503/cjs.010815			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	DI8TI	WOS:000373774400004	26820318	Green Published			2022-02-06	
J	Wang, ZQ; Wu, WZ; Liu, YK; Wang, TY; Chen, X; Zhang, JH; Zhou, GX; Chen, R				Wang, Zhongqiu; Wu, Wenzhong; Liu, Yongkang; Wang, Tianyao; Chen, Xiao; Zhang, Jianhua; Zhou, Guoxing; Chen, Rong			Altered Cerebellar White Matter Integrity in Patients with Mild Traumatic Brain Injury in the Acute Stage	PLOS ONE			English	Article							AXONAL INJURY; DEFICITS	Background and Purpose Imaging studies of traumatic brain injury demonstrate that the cerebellum is often affected. We aim to examine fractional anisotropy alteration in acute-phase mild traumatic brain injury patients in cerebellum-related white matter tracts. Materials and Methods This prospective study included 47 mild traumatic brain injury patients in the acute stage and 37 controls. MR imaging and neurocognitive tests were performed in patients within 7 days of injury. White matter integrity was examined by using diffusion tensor imaging. We used three approaches, tract-based spatial statistics, graphical-model-based multivariate analysis, and region-of-interest analysis, to detect altered cerebellar white matter integrity in mild traumatic brain injury patients. Results Results from three analysis methods were in accordance with each other, and suggested fractional anisotropy in the middle cerebellar peduncle and the pontine crossing tract was changed in the acute-phase mild traumatic brain injury patients, relative to controls (adjusted p-value < 0.05). Higher fractional anisotropy in the middle cerebellar peduncle was associated with worse performance in the fluid cognition composite (r = -0.289, p-value = 0.037). Conclusion Altered cerebellar fractional anisotropy in acute-phase mild traumatic brain injury patients is localized in specific regions and statistically associated with cognitive deficits detectable on neurocognitive testing.	[Wang, Zhongqiu; Liu, Yongkang; Chen, Xiao] Nanjing Univ Chinese Med, Affiliated Hosp, Dept Radiol, 155 Hanzhong Rd, Nanjing 210029, Jiangsu, Peoples R China; [Wu, Wenzhong] Nanjing Univ Chinese Med, Affiliated Hosp, Dept Acupuncture & Rehabil, 155 Hanzhong Rd, Nanjing 210029, Jiangsu, Peoples R China; [Wang, Tianyao] Fudan Univ, Peoples Hosp Shanghai 5, Dept Radiol, Shanghai 200240, Peoples R China; [Zhang, Jianhua; Zhou, Guoxing] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Radiol, Shanghai 200120, Peoples R China; [Chen, Rong] Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, Baltimore, MD 21201 USA		Wang, ZQ (corresponding author), Nanjing Univ Chinese Med, Affiliated Hosp, Dept Radiol, 155 Hanzhong Rd, Nanjing 210029, Jiangsu, Peoples R China.; Chen, R (corresponding author), Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, Baltimore, MD 21201 USA.	Zhq2001us@163.com; rchen@umm.edu					Alhilali LM, 2014, RADIOLOGY, V272, P224, DOI 10.1148/radiol.14132670; Chen R, 2005, IEEE T MED IMAGING, V24, P1237, DOI 10.1109/TMI.2005.854305; Chen R, 2007, NEUROIMAGE, V35, P635, DOI 10.1016/j.neuroimage.2006.11.040; Chen R, 2012, NEUROINFORMATICS, V10, P119, DOI 10.1007/s12021-011-9129-7; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Ellison-Wright I, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-99; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Gershon RC, 2010, LANCET NEUROL, V9, P138, DOI 10.1016/S1474-4422(09)70335-7; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; IWADATE Y, 1989, Neurosurgical Review, V12, P500, DOI 10.1007/BF01790695; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Liu W, 2013, NMR BIOMED, V26, P651, DOI 10.1002/nbm.2910; Louis ED, 1996, ARCH NEUROL-CHICAGO, V53, P450, DOI 10.1001/archneur.1996.00550050080027; Lupi A, 2007, CLIN NUCL MED, V32, P445, DOI 10.1097/RLU.0b013e3180537621; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mendoza J., 2007, CLIN NEUROANATOMY NE; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Park E, 2007, PROG BRAIN RES, V161, P327, DOI 10.1016/S0079-6123(06)61023-6; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; Ravizza SM, 2006, BRAIN, V129, P306, DOI 10.1093/brain/awh685; Schmahmann JD, 2006, BRAIN, V129, P290, DOI 10.1093/brain/awh729; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Spanos GK, 2007, AM J NEURORADIOL, V28, P537; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7	34	17	17	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151489	10.1371/journal.pone.0151489			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG3SC	WOS:000371989200059	26967320	Green Submitted, Green Published, gold			2022-02-06	
J	Boychuk, JA; Butler, CR; Halmos, KC; Smith, BN				Boychuk, Jeffery A.; Butler, Corwin R.; Halmos, Katalin Cs; Smith, Bret N.			Enduring changes in tonic GABA(A) receptor signaling in dentate granule cells after controlled cortical impact brain injury in mice	EXPERIMENTAL NEUROLOGY			English	Article						GABA(A) receptors; Tonic GABA current; Controlled cortical impact; Traumatic brain injury; Post-traumatic epilepsy	DELTA-SUBUNIT; RAT MODEL; PHARMACOLOGICAL CHARACTERIZATION; POSTTRAUMATIC EPILEPSY; PHASIC INHIBITION; OVARIAN CYCLE; MOUSE MODEL; EXPRESSION; ACTIVATION; GYRUS	Changes in functional GABA(A)R signaling in hippocampus have previously been evaluated using pre-clinical animal models of either diffuse brain injury or extreme focal brain injury that precludes measurement of cells located ipsilateral to injury. As a result, there is little information about the status of functional GABA(A)R signaling in dentate granule cells (DGCs) located ipsilateral to focal brain injury, where significant cellular changes have been documented. We used whole-cell patch-clamp recordings from hippocampal slices to measure changes in GABA(A)Rs in dentate granule cells (DGCs) at 1-2,3-5, and 8-13 weeks after controlled cortical impact (CCI) brain injury. Synaptic and tonic GABA(A)R currents (I-TronicGABA) were measured in DGCs at baseline conditions and during application of the GABA(A)R agonist 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridine-3-ol hydrochloride (THIP) to assess in the function of 8 subunit-containing GABA(A)Rs. DGCs ipsilateral to CCI exhibited no changes in the amplitude of resting I-TonicGABA relative to DGCs after sham-injury or contralateral to CCI. In contrast, there was a significant reduction in the THIP-evoked I-TronicGABA in DGCs ipsilateral to CCI at both time-points. Tonic GABAergic inhibition of DGCs ipsilateral to injury also exhibited reduced responsiveness to the neurosteroid THDOC. I-TonicGABA in DGCs ipsilateral to CCI did not exhibit a change in sensitivity to L655,708, an inverse agonist with selectivity for alpha(5) subunit-containing GABA(A)Rs, suggesting a lack of functional change in GABA(A)Rs containing this subunit. At the 8-13 week time-point, gene expression of GABA(A)R subunits expected to contribute to I-TronicGABA (i.e., alpha(4), alpha(5) and delta) was not significantly altered by CCI injury in isolated dentate gyrus. Collectively, these results demonstrate enduring functional changes in I-TonicGABA in DGCs ipsilateral to focal brain injury that occur independent of altered gene expression. (C) 2016 Elsevier Inc All rights reserved.	[Boychuk, Jeffery A.; Butler, Corwin R.; Halmos, Katalin Cs; Smith, Bret N.] Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA; [Boychuk, Jeffery A.; Smith, Bret N.] Univ Kentucky, Epilepsy Ctr, Lexington, KY 40536 USA; [Boychuk, Jeffery A.] Univ Kentucky, Ctr Adv Translat Stroke Sci, Lexington, KY 40536 USA; [Smith, Bret N.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr SCoBIRC, Lexington, KY 40536 USA		Smith, BN (corresponding author), Univ Kentucky, Coll Med, Dept Physiol, MS508 Chandler Med Ctr,800 Rose St, Lexington, KY 40536 USA.	bret.smith@uky.edu		Boychuk, Jeffery A/0000-0002-7003-1553; Butler, Corwin/0000-0001-5134-4151	Department of Defense (USAMRMC) Grant [W81XWH-11-1-0502]; American Epilepsy Society; Lennox and Lombroso Trust for Epilepsy Research and Training	Supported by Department of Defense (USAMRMC) Grant W81XWH-11-1-0502 (BNS) and a Fellowship from the American Epilepsy Society and Lennox and Lombroso Trust for Epilepsy Research and Training (JAB).	Adkins CE, 2001, J BIOL CHEM, V276, P38934, DOI 10.1074/jbc.M104318200; AKAIKE N, 1986, J PHYSIOL-LONDON, V379, P171, DOI 10.1113/jphysiol.1986.sp016246; Barnard EA, 1998, PHARMACOL REV, V50, P291; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Bianchi MT, 2003, J NEUROSCI, V23, P10934; Bonin RP, 2007, J NEUROPHYSIOL, V98, P2244, DOI 10.1152/jn.00482.2007; Boychuk CR, 2015, J NEUROPHYSIOL, V114, P698, DOI 10.1152/jn.00209.2015; Bright DP, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00193; Brooks-Kayal AR, 1998, NAT MED, V4, P1166, DOI 10.1038/2661; Brown N, 2002, BRIT J PHARMACOL, V136, P965, DOI 10.1038/sj.bjp.0704795; Butler CR, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00163; Caraiscos VB, 2004, P NATL ACAD SCI USA, V101, P3662, DOI 10.1073/pnas.0307231101; Chang YC, 1996, J NEUROSCI, V16, P5415; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; COLLINGRIDGE GL, 1984, J PHYSIOL-LONDON, V356, P551, DOI 10.1113/jphysiol.1984.sp015482; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; Coulter DA, 2007, PROG BRAIN RES, V163, P235, DOI 10.1016/S0079-6123(07)63014-3; Davies PA, 1997, NATURE, V385, P820, DOI 10.1038/385820a0; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DRAGUHN A, 1990, NEURON, V5, P781, DOI 10.1016/0896-6273(90)90337-F; Drexel M, 2015, NEUROPHARMACOLOGY, V88, P122, DOI 10.1016/j.neuropharm.2014.08.023; EBERT B, 1994, MOL PHARMACOL, V46, P957; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Gibbs JW, 1997, J NEUROPHYSIOL, V77, P1924, DOI 10.1152/jn.1997.77.4.1924; Glykys J, 2008, J NEUROSCI, V28, P1421, DOI 10.1523/JNEUROSCI.4751-07.2008; Glykys J, 2007, NEURON, V56, P763, DOI 10.1016/j.neuron.2007.11.002; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; Gupta A, 2012, J NEUROSCI, V32, P2523, DOI 10.1523/JNEUROSCI.4141-11.2012; Hagihara Hideo, 2009, J Vis Exp, DOI 10.3791/1543; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hoestgaard-Jensen K, 2014, J NEUROSCI, V34, P16256, DOI 10.1523/JNEUROSCI.1495-14.2014; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Hunt RF, 2012, EPILEPSY RES, V99, P167, DOI 10.1016/j.eplepsyres.2011.10.011; Hunt RF, 2011, J NEUROSCI, V31, P6880, DOI 10.1523/JNEUROSCI.0032-11.2011; Hunt RF, 2010, J NEUROPHYSIOL, V103, P1490, DOI 10.1152/jn.00957.2009; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Kapur J, 1997, J NEUROSCI, V17, P7532, DOI 10.1523/jneurosci.17-19-07532.1997; Kapur J, 1999, MOL PHARMACOL, V55, P444; Kharlamov EA, 2008, BRAIN RES, V1210, P29, DOI 10.1016/j.brainres.2008.02.070; Kharlamov EA, 2011, EPILEPSY RES, V95, P20, DOI 10.1016/j.eplepsyres.2011.02.008; KUSAMA T, 1993, BRIT J PHARMACOL, V109, P200, DOI 10.1111/j.1476-5381.1993.tb13554.x; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; Leroy C, 2004, J PHYSIOL-LONDON, V557, P473, DOI 10.1113/jphysiol.2003.059246; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; LUDDENS H, 1991, TRENDS PHARMACOL SCI, V12, P49, DOI 10.1016/0165-6147(91)90495-E; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.ne.17.030194.003033; Maguire J, 2007, J NEUROSCI, V27, P2155, DOI 10.1523/JNEUROSCI.4945-06.2007; Maguire JL, 2005, NAT NEUROSCI, V8, P797, DOI 10.1038/nn1469; MAJEWSKA MD, 1986, SCIENCE, V232, P1004, DOI 10.1126/science.2422758; Mihalek RM, 1999, P NATL ACAD SCI USA, V96, P12905, DOI 10.1073/pnas.96.22.12905; Mody I, 2004, TRENDS NEUROSCI, V27, P569, DOI 10.1016/j.tins.2004.07.002; Mody I, 2001, NEUROCHEM RES, V26, P907, DOI 10.1023/A:1012376215967; Mtchedlishvili Z, 2006, MOL PHARMACOL, V69, P564, DOI 10.1124/mol.105.016683; Mtchedlishvili Z, 2001, J PHYSIOL-LONDON, V537, P453, DOI 10.1111/j.1469-7793.2001.00453.x; Mtchedlishvili Z, 2010, NEUROBIOL DIS, V38, P464, DOI 10.1016/j.nbd.2010.03.012; Nakamura Y, 2015, ADV PHARMACOL, V72, P97, DOI 10.1016/bs.apha.2014.11.008; Nusser Z, 1998, J NEUROSCI, V18, P1693; Pavlov I, 2011, NEUROSCIENCE, V194, P208, DOI 10.1016/j.neuroscience.2011.07.074; Pavlov I, 2009, J NEUROSCI, V29, P15341, DOI 10.1523/JNEUROSCI.2747-09.2009; Peng ZC, 2004, J NEUROSCI, V24, P8629, DOI 10.1523/JNEUROSCI.2877-04.2004; Quirk K, 1996, NEUROPHARMACOLOGY, V35, P1331, DOI 10.1016/S0028-3908(96)00061-5; Raible DJ, 2015, EXP NEUROL, V271, P445, DOI 10.1016/j.expneurol.2015.07.001; Raible DJ, 2012, J NEUROTRAUM, V29, P2548, DOI 10.1089/neu.2012.2483; Redecker C, 2002, J CEREBR BLOOD F MET, V22, P1463, DOI 10.1097/01.WCB.0000034149.72481.BD; Rivera C, 2004, J NEUROSCI, V24, P4683, DOI 10.1523/JNEUROSCI.5265-03.2004; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SEGAL M, 1984, J NEUROPHYSIOL, V52, P469, DOI 10.1152/jn.1984.52.3.469; Semyanov A, 2004, TRENDS NEUROSCI, V27, P262, DOI 10.1016/j.tins.2004.03.005; Spigelman I, 2002, EPILEPSIA, V43, P3, DOI 10.1046/j.1528-1157.43.s.5.8.x; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Storustovu SI, 2006, J PHARMACOL EXP THER, V316, P1351, DOI 10.1124/jpet.105.092403; Sun CS, 2007, J NEUROSCI, V27, P12641, DOI 10.1523/JNEUROSCI.4141-07.2007; Swartz BE, 2006, EPILEPSIA, V47, P1373, DOI 10.1111/j.1528-1167.2006.00602.x; Tao WC, 2013, J NEUROSCI, V33, P3738, DOI 10.1523/JNEUROSCI.4829-12.2013; vandenPol AN, 1996, J NEUROSCI, V16, P4283; VERDOORN TA, 1990, NEURON, V4, P919, DOI 10.1016/0896-6273(90)90145-6; Wei WZ, 2003, J NEUROSCI, V23, P10650; WEISS DS, 1988, J NEUROPHYSIOL, V59, P495, DOI 10.1152/jn.1988.59.2.495; WEISS DS, 1988, J NEUROPHYSIOL, V59, P514, DOI 10.1152/jn.1988.59.2.514; Whiting PJ, 1999, ANN NY ACAD SCI, V868, P645, DOI 10.1111/j.1749-6632.1999.tb11341.x; Wohlfarth KM, 2002, J NEUROSCI, V22, P1541, DOI 10.1523/JNEUROSCI.22-05-01541.2002; Wood CE, 2003, J PHYSIOL-LONDON, V549, P573, DOI 10.1113/jphysiol.2002.038398; YOON KW, 1994, J NEUROPHYSIOL, V71, P2151, DOI 10.1152/jn.1994.71.6.2151; Zhan RZ, 2009, J NEUROPHYSIOL, V102, P670, DOI 10.1152/jn.00147.2009; Zhang NH, 2007, J NEUROSCI, V27, P7520, DOI 10.1523/JNEUROSCI.1555-07.2007; Zhang W, 2012, J NEUROSCI, V32, P1183, DOI 10.1523/JNEUROSCI.5342-11.2012	92	17	18	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAR	2016	277						178	189		10.1016/j.expneurol.2016.01.005			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DF2ST	WOS:000371194800019	26772635	Bronze			2022-02-06	
J	Goble, DJ; Manyak, KA; Abdenour, TE; Rauh, MJ; Baweja, HS				Goble, Daniel J.; Manyak, Kristin A.; Abdenour, Thomas E.; Rauh, Mitchell J.; Baweja, Harsimran S.			AN INITIAL EVALUATION OF THE BTRACKS BALANCE PLATE AND SPORTS BALANCE SOFTWARE FOR CONCUSSION DIAGNOSIS	INTERNATIONAL JOURNAL OF SPORTS PHYSICAL THERAPY			English	Article						balance; BTrackS; concussion; diagnostic accuracy; sensitivity	MILD HEAD-INJURY; POSTURAL STABILITY; FOOTBALL PLAYERS; RECOVERY; RELIABILITY; COLLEGIATE; STATEMENT; VALIDITY	Background: As recently dictated by the American Medical Society, balance testing is an important component in the clinical evaluation of concussion. Despite this, previous research on the efficacy of balance testing for concussion diagnosis suggests low sensitivity (similar to 30%), based primarily on the popular Balance Error Scoring System (BESS). The Balance Tracking System (BTrackS, Balance Tracking Systems Inc., San Diego, CA, USA) consists of a force plate (BTrackS Balance Plate) and software (BTrackS Sport Balance) which can quickly (<2 min) perform concussion balance testing with gold standard accuracy. Purpose: The present study aimed to determine the sensitivity of the BTrackS Balance Plate and Sports Balance Software for concussion diagnosis. Study Design: Cross-Sectional Study Methods: Preseason baseline balance testing of 519 healthy Division I college athletes playing sports with a relatively high risk for concussions was performed with the BTrackS Balance Test. Testing was administered by certified athletic training staff using the BTrackS Balance Plate and Sport Balance software. Of the baselined athletes, 25 later experienced a concussion during the ensuing sport season. Post-injury balance testing was performed on these concussed athletes within 48 of injury and the sensitivity of the BTrackS Balance Plate and Sport Balance software was estimated based on the number of athletes showing a balance decline according to the criteria specified in the Sport Balance software. This criteria is based on the minimal detectable change statistic with a 90% confidence level (i.e. 90% specificity). Results: Of 25 athletes who experienced concussions, 16 had balance declines relative to baseline testing results according to the BTrackS Sport Balance software criteria. This corresponds to an estimated concussion sensitivity of 64%, which is twice as great as that reported previously for the BESS. Conclusions: The BTrackS Balance Plate and Sport Balance software has the greatest concussion sensitivity of any balance testing instrument reported to date.	[Goble, Daniel J.; Rauh, Mitchell J.; Baweja, Harsimran S.] San Diego State Univ, Sch Exercise & Nutr Sci, Coll Hlth & Human Sci, San Diego, CA 92182 USA; [Manyak, Kristin A.; Abdenour, Thomas E.] San Diego State Univ, Dept Athlet, San Diego, CA 92182 USA		Goble, DJ (corresponding author), San Diego State Univ, Dept Exercise & Nutr Sci, 5500 Campanile Dr, San Diego, CA 92182 USA.	dgoble@mail.sdsu.edu	Goble, Daniel/A-1317-2007	Goble, Daniel/0000-0002-8027-6722			Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Chang JO, 2014, CLIN J SPORT MED, V24, P256, DOI 10.1097/JSM.0000000000000016; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Goble D. J., 2015, BALANCE TRACKING SYS; Golriz S, 2012, CHIROPR MAN THER, V20, DOI 10.1186/2045-709X-20-15; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Kerr ZY, J ATHL TRAI IN PRESS; Lin DD, 2008, GAIT POSTURE, V28, P337, DOI 10.1016/j.gaitpost.2008.01.005; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, J AM COLL SURGEONS, V216, pE55, DOI 10.1016/j.jamcollsurg.2013.02.020; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Reed-Jones RJ, 2014, SEMIN SPEECH LANG, V35, P186, DOI 10.1055/s-0034-1384680; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Wasserman EB, AM J SPORTS IN PRESS	23	17	17	0	6	AMER PHYSICAL THERAPY ASSOC	ALEXANDRIA	1111 N FAIRFAX ST, ALEXANDRIA, VA 22314 USA	2159-2896			INT J SPORTS PHYS TH	Int. J. Sports Phys. Ther.	MAR	2016	11	2					149	155					7	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	FG1PP	WOS:000409600700001	27104048				2022-02-06	
J	Lawrence, DW; Comper, P; Hutchison, MG				Lawrence, David W.; Comper, Paul; Hutchison, Michael G.			Influence of Extrinsic Risk Factors on National Football League Injury Rates	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						National Football League; NFL; concussion; injury prevention; temperature; epidemiology	SYNTHETIC PLAYING SURFACES; UPPER EXTREMITY INJURIES; HAMSTRING INJURIES; SPORTS INJURIES; PREVENTION; TEMPERATURE; CONCUSSION; PLAYERS; ANKLE; KNEE	Background: The risk of injury associated with American football is significant, with recent reports indicating that football has one of the highest rates of all-cause injury, including concussion, of all major sports. There are limited studies examining risk factors for injuries in the National Football League (NFL). Purpose: To identify risk factors for NFL concussions and musculoskeletal injuries. Study Design: Case-control study; Level of evidence, 3. Methods: Injury report data were collected prospectively for each week over the 2012-2013 and 2013-2014 regular seasons for all 32 teams. Poisson regression models were used to identify the relationship between predetermined variables and the risk of the 5 most frequent injuries (knee, ankle, hamstring, shoulder, and concussion). Results: A total of 480 games or 960 team games (TGs) from the 2012-2013 and 2013-2014 regular seasons were included in this study. A trend to an increasing risk of concussion and TG ankle injury with decreasing mean game-day temperature was observed. The risk of TG concussion (incidence rate ratio [IRR], 2.16; 95% CI, 1.35-3.45; P = .001) and TG ankle injury (IRR, 1.48; 95% CI, 1.10-1.98; P = .01) was significantly greater for TGs played at a mean game-day temperature of 9.7 degrees C (49.5 degrees F) compared with a mean game-day temperature of 21.0 degrees C (69.8 degrees F). The risk of TG shoulder injury was significantly increased for TGs played on grass surfaces (IRR, 1.36; 95% CI, 1.02-1.81; P = .038) compared with synthetic surfaces. The risk of TG injury was not associated with time in season, altitude, time zone change prior to game, or distance traveled to a game. Conclusion: This study evaluated extrinsic risk factors for injury in the NFL. A hazardous association was identified for risk of concussion and ankle injury with colder game-day temperature. Further research should be conducted to substantiate this relationship and its potential implication for injury prevention initiatives.	[Lawrence, David W.; Comper, Paul; Hutchison, Michael G.] Univ Toronto, Toronto, ON M5B 1W8, Canada		Lawrence, DW (corresponding author), Univ Toronto, St Michaels Hosp, Dept Family & Community Med, 30 Bond St, Toronto, ON M5B 1W8, Canada.	dw.lawrence@mail.utoronto.ca					[Anonymous], STAR TRIBUNE; [Anonymous], ASS PRESS; [Anonymous], NFL INJ; Archer T, ROMO TORE RIB CARTIL; Balazs GC, 2015, AM J SPORT MED, V43, P1798, DOI 10.1177/0363546514545864; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bowen M., 2016, ESPN; Carlisle JC, 2008, AM J SPORT MED, V36, P1945, DOI 10.1177/0363546508318198; Dewhurst S, 2005, EUR J APPL PHYSIOL, V94, P491, DOI 10.1007/s00421-005-1384-6; Ekstrand J, 2004, BRIT J SPORT MED, V38, P493, DOI 10.1136/bjsm.2003.009134; Emery CA, 2011, BRIT J SPORT MED, V45, P1289, DOI 10.1136/bjsports-2011-090538; Florio M., NFL RESUMES QUIET PU; Florio M. M, MORE COUNTRIES COULD; Fuller CW, 2015, BRIT J SPORT MED, V49, P458, DOI 10.1136/bjsports-2014-094369; Gever J., NFL STEPS WARNINGS P; Hershman EB, 2012, AM J SPORT MED, V40, P2200, DOI 10.1177/0363546512458888; HESS GP, 1989, SPORTS MED, V8, P371, DOI 10.2165/00007256-198908060-00005; Krause BA, 2000, J SPORT REHABIL, V9, P253, DOI 10.1123/jsr.9.3.253; Kujala UM, 1997, SPORTS MED, V23, P397, DOI 10.2165/00007256-199723060-00005; Lawrence DW, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115583653; Lee AJ, 1996, BRIT J SPORT MED, V30, P213, DOI 10.1136/bjsm.30.3.213; Lynch TS, 2013, AM J SPORT MED, V41, P2904, DOI 10.1177/0363546513504284; Mair SD, 1996, AM J SPORT MED, V24, P137, DOI 10.1177/036354659602400203; Mall NA, 2008, AM J SPORT MED, V36, P1938, DOI 10.1177/0363546508318197; Mazer B, 2010, CLIN J SPORT MED, V20, P249, DOI 10.1097/JSM.0b013e3181e0b913; Myer GD, 2014, J ORTHOP SPORT PHYS, V44, P164, DOI 10.2519/jospt.2014.5298; Newton D., 2016, ESPN; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Orchard J, 2002, SPORTS MED, V32, P419, DOI 10.2165/00007256-200232070-00002; Orchard JW, 2013, OPEN ACCESS J SPORTS, V4, P251, DOI 10.2147/OAJSM.S52417; Orchard JW, 2003, MED SCI SPORT EXER, V35, P1118, DOI 10.1249/01.MSS.0000074563.61975.9B; Petersen J, 2005, BRIT J SPORT MED, V39, P319, DOI 10.1136/bjsm.2005.018549; Radil K, INFLUENCE TEMPERATUR; Ruedl G, 2012, SCAND J MED SCI SPOR, V22, P185, DOI 10.1111/j.1600-0838.2011.01286.x; Schwellnus MP, 2012, BRIT J SPORT MED, V46, P816, DOI 10.1136/bjsports-2012-091395; Sessler M., R GOODELL SAYS INJUR; Smith DW, 2013, ORTHOP J SPORTS MED, V1, DOI 10.1177/2325967113511588; Stevenson MR, 2000, BRIT J SPORT MED, V34, P188, DOI 10.1136/bjsm.34.3.188; Taylor SA, 2012, PHYSICIAN SPORTSMED, V40, P66, DOI 10.3810/psm.2012.11.1989; Teramoto M, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115620365; Triplett M, PAYTON CRITICAL EXTR; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Zarvosky GS., 2014, ORTHOP J SPORTS MED, V2; Zavorsky GS, 2014, J ORTHOP SPORT PHYS, V44, P458, DOI 10.2519/jospt.2014.0201	44	17	17	1	17	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	MAR	2016	4	3							2325967116639222	10.1177/2325967116639222			9	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	DJ8VV	WOS:000374492200010	27088102	gold, Green Published			2022-02-06	
J	Li, SJ; Eisenstadt, R; Kumasaka, K; Johnson, VE; Marks, J; Nagata, K; Browne, KD; Smith, DH; Pascual, JL				Li, Shengjie; Eisenstadt, Rachel; Kumasaka, Kenichiro; Johnson, Victoria E.; Marks, Joshua; Nagata, Katsuhiro; Browne, Kevin D.; Smith, Douglas H.; Pascual, Jose L.			Does enoxaparin interfere with HMGB1 signaling after TBI? A potential mechanism for reduced cerebral edema and neurologic recovery	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	74th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma (AAST) / Clinical Congress of Acute Care Surgery	SEP 09-12, 2015	Las Vegas, NV	Amer Assoc Surg Trauma		Enoxaparin; HMGB1; TBI; Leukocyte; mice	TRAUMATIC BRAIN-INJURY; MOLECULAR-WEIGHT HEPARIN; MOBILITY GROUP BOX-1; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IN-VIVO; LUNG INJURY; LEUKOCYTE EXTRAVASATION; STERILE INFLAMMATION; RATS; HEMORRHAGE	BACKGROUND Enoxaparin (ENX) has been shown to reduce cerebral edema and improve neurologic recovery after traumatic brain injury (TBI), through blunting of cerebral leukocyte (LEU) recruitment. High mobility group box 1 (HMGB1) protein may induce inflammation through LEU activation. We hypothesized that ENX after TBI reduces LEU-mediated edema through blockade of HMGB1 signaling. METHODS Twenty-three CD1 mice underwent severe TBI by controlled cortical impact and were randomized to one of four groups receiving either monoclonal antibody against HMGB1 (MAb) or isotype (Iso) and either ENX (1 mg/kg) or normal saline (NS): NS + Iso (n = 5), NS + MAb (n = 6), ENX + Iso (n = 6), ENX + MAb (n = 6). ENX or NS was administered 2, 8, 14, 23 and 32 hours after TBI. MAb or Iso (25 g) was administered 2 hours after TBI. At 48 hours, cerebral intravital microscopy served to visualize live LEU interacting with endothelium and microvascular fluorescein isothiocyanate-albumin leakage. The Neurological Severity Score (NSS) graded neurologic recovery; wet-to-dry ratios determined cerebral/lung edema. Analysis of variance with Bonferroni correction was used for statistical analyses. RESULTS ENX and MAb similarly reduced in vivo pial LEU rolling without demonstrating additive effect. In vivo albumin leakage was greatest in vehicle-treated animals but decreased by 25% with either MAb or ENX but by 50% when both were combined. Controlled cortical impact-induced cerebral wet-to-dry ratios were reduced by MAb or ENX without additive effect. Postinjury lung water was reduced by ENX but not by MAb. Neurologic recovery at 24 hours and 48 hours was similarly improved with ENX, MAb, or both treatments combined. CONCLUSION Mirroring ENX, HMGB1 signaling blockade reduces LEU recruitment, cerebrovascular permeability, and cerebral edema following TBI. ENX further reduced lung edema indicating a multifaceted effect beyond HMGB1 blockade. Further study is needed to determine how ENX may play a role in blunting HMGB1 signaling in brain injury patients.	[Li, Shengjie; Eisenstadt, Rachel; Kumasaka, Kenichiro; Marks, Joshua; Nagata, Katsuhiro; Pascual, Jose L.] Univ Penn, Perelman Sch Med, Div Traumatol Surg Crit Care & Emergency Surg, Philadelphia, PA 19104 USA; [Johnson, Victoria E.; Browne, Kevin D.; Smith, Douglas H.; Pascual, Jose L.] Univ Penn, Perelman Sch Med, Ctr Brain Injury & Repair, Dept Neurosurg, Philadelphia, PA 19104 USA; [Li, Shengjie] Shandong Univ, Qianfoshan Hosp, Dept Neurosurg, Jinan 250100, Peoples R China		Pascual, JL (corresponding author), Univ Penn, Div Traumatol Surg Crit Care & Emergency Surg, Dept Surg, Perelman Sch Med, 3400 Spruce St, Philadelphia, PA 19104 USA.	jose.pascual@uphs.upenn.edu	Pascual, Jose/ABI-2291-2020	Pascual, Jose/0000-0002-1613-7912	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS094003, R01 NS092398] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094003, R01NS092398] Funding Source: NIH RePORTER		Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Daley MJ, 2015, AM SURGEON, V81, P207; Dong C, 2000, J BIOMECH, V33, P35, DOI 10.1016/S0021-9290(99)00174-8; Dudley RR, 2010, J NEUROTRAUM, V27, P2165, DOI 10.1089/neu.2010.1366; Fang P, 2012, MOL NEUROBIOL, V45, P499, DOI 10.1007/s12035-012-8264-y; Gao HM, 2011, J NEUROSCI, V31, P1081, DOI 10.1523/JNEUROSCI.3732-10.2011; Gao TL, 2012, J TRAUMA ACUTE CARE, V72, P643, DOI 10.1097/TA.0b013e31823c54a6; Kawabata H, 2010, SPINE, V35, P1109, DOI 10.1097/BRS.0b013e3181bd14b6; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kumasaka K, 2014, AM J SURG, V208, P961, DOI 10.1016/j.amjsurg.2014.08.004; Li L, 2015, CYTOKINE, V72, P36, DOI 10.1016/j.cyto.2014.12.010; Li LF, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-90; Li LF, 2009, CRIT CARE, V13, DOI 10.1186/cc7949; Li SJ, 2015, J TRAUMA ACUTE CARE, V79, P78, DOI 10.1097/TA.0000000000000697; Li S, 2011, CRIT CARE MED, V39, P1493, DOI 10.1097/CCM.0b013e31821201d3; Liu K, 2007, FASEB J, V21, P3904, DOI 10.1096/fj.07-8770com; Liu Y, 2014, INT J CARDIOL, V176, P543, DOI 10.1016/j.ijcard.2014.07.027; Magna M, 2014, MOL MED, V20, P138, DOI 10.2119/molmed.2013.00164; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; Maugeri N, 2007, THROMB HAEMOSTASIS, V97, P965, DOI 10.1160/TH06-12-0680; Miller SJ, 1998, THROMB HAEMOSTASIS, V80, P481; Ning FY, 2015, GENE, V557, P88, DOI 10.1016/j.gene.2014.12.018; Norwood SH, 2008, J TRAUMA, V65, P1021, DOI 10.1097/TA.0b013e31818a0e74; Okuma Y, 2012, ANN NEUROL, V72, P373, DOI 10.1002/ana.23602; Pascual JL, 2013, AM J SURG, V206, P840, DOI 10.1016/j.amjsurg.2013.07.016; Peter K, 1999, CIRCULATION, V100, P1533, DOI 10.1161/01.CIR.100.14.1533; RANA MW, 1992, J TRAUMA, V32, P420, DOI 10.1097/00005373-199204000-00003; Reglero-Real N, 2012, CELL MOL LIFE SCI, V69, P3079, DOI 10.1007/s00018-012-0987-4; Robinson AP, 2013, J AUTOIMMUN, V43, P32, DOI 10.1016/j.jaut.2013.02.005; Schaar Krystal L, 2010, Exp Transl Stroke Med, V2, P13, DOI 10.1186/2040-7378-2-13; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; Schwarzmaier SM, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00358; Schwarzmaier SM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-32; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Sun Q, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-106; Sundd P, 2011, BIORHEOLOGY, V48, P1, DOI 10.3233/BIR-2011-0579; Uzawa A, 2013, CLIN EXP IMMUNOL, V172, P37, DOI 10.1111/cei.12036; Valle EJ, 2014, J TRAUMA ACUTE CARE, V77, P243, DOI 10.1097/TA.0000000000000307; Venereau E, 2013, MOL IMMUNOL, V55, P76, DOI 10.1016/j.molimm.2012.10.037; Venereau E, 2012, J EXP MED, V209, P1519, DOI 10.1084/jem.20120189; Vestweber D, 2012, ANN NY ACAD SCI, V1257, P184, DOI 10.1111/j.1749-6632.2012.06558.x; Vestweber D, 2012, CURR OPIN HEMATOL, V19, P212, DOI 10.1097/MOH.0b013e3283523e78; Wahl F, 2000, J NEUROTRAUM, V17, P1055, DOI 10.1089/neu.2000.17.1055; WANG P, 1990, AM J PHYSIOL, V259, pR645, DOI 10.1152/ajpregu.1990.259.3.R645; WANG P, 1993, J SURG RES, V54, P499, DOI 10.1006/jsre.1993.1077; Yanai H, 2012, TRENDS IMMUNOL, V33, P633, DOI 10.1016/j.it.2012.10.005; Yang H, 2013, J LEUKOCYTE BIOL, V93, P865, DOI 10.1189/jlb.1212662; Zhang JY, 2011, STROKE, V42, P1420, DOI 10.1161/STROKEAHA.110.598334; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Zupan Z, 2011, PROG NEURO-PSYCHOPH, V35, P1846, DOI 10.1016/j.pnpbp.2011.08.005	50	17	17	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAR	2016	80	3					381	387		10.1097/TA.0000000000000935			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	DF7XT	WOS:000371571900007	26670109	Green Accepted			2022-02-06	
J	Mullah, SH; Saha, BK; Abutarboush, R; Walker, PB; Haque, A; Arnaud, FG; Hazzard, B; Auker, CR; McCarron, RM; Scultetus, AH; Moon-Massat, P				Mullah, Saad H.; Saha, Biswajit K.; Abutarboush, Rania; Walker, Peter B.; Haque, Ashraful; Arnaud, Francoise G.; Hazzard, Brittany; Auker, Charles R.; McCarron, Richard M.; Scultetus, Anke H.; Moon-Massat, Paula			Perfluorocarbon NVX-108 increased cerebral oxygen tension after traumatic brain injury in rats	BRAIN RESEARCH			English	Article						Brain interstitial oxygen pressure; Oxygen therapeutics; Perfluorocarbon; Early resuscitation; Traumatic brain injury; Phosphorescence quenching method	SEVERE HEAD-INJURY; DODECAFLUOROPENTANE EMULSION; INTRACRANIAL-PRESSURE; NORMOBARIC HYPEROXIA; TISSUE OXYGENATION; INTERSTITIAL SPACE; SKELETAL-MUSCLE; CORTICAL IMPACT; STROKE MODEL; IN-VIVO	Background: Hypoxia is a critical secondary injury mechanism in traumatic brain injury (TBI), and early intervention to alleviate post-TBI hypoxia may be beneficial. NVX-108, a dodecafluoropentane perfluorocarbon, was screened for its ability to increase brain tissue oxygen tension (PbtO(2)) when administered soon after TBI. Methods: Ketamine-acepromazine anesthetized rats ventilated with 40% oxygen underwent moderate controlled cortical impact (CCI)-TBI at time O (TO). Rats received either no treatment (NON, n=8) or 0.5 ml/kg intravenous (IV) NVX-108 (NVX, n=9) at T15 (15 min after TBI) and T75. Results: Baseline cortical PbtO(2) was 28+3 mm Hg and CCI-TBI resulted in a 46+6% reduction in PbtO(2) at T15 (P <0.001). Significant differences in time-group interactions (P=0.013) were found when comparing either absolute or percentage change of PbtO(2) to post-injury (mixed-model ANOVA) suggesting that administration of NVX-108 increased PbtO(2) above injury levels while it remained depressed in the NON group. Specifically in the NVX group, PbtO(2) increased to a peak 143% of T15 (P=0.02) 60 min after completion of NVX-108 injection (T135). Systemic blood pressure was not different between the groups. Conclusion: NVX-108 caused an increase in PbtO(2) following CCI-TBI in rats and should be evaluated further as a possible immediate treatment for TBI. Published by Elsevier B.V.	[Mullah, Saad H.; Saha, Biswajit K.; Abutarboush, Rania; Walker, Peter B.; Haque, Ashraful; Arnaud, Francoise G.; Hazzard, Brittany; Auker, Charles R.; McCarron, Richard M.; Scultetus, Anke H.; Moon-Massat, Paula] Naval Med Res Ctr, NeuroTrauma Dept, 503 Robert Grant Ave, Silver Spring, MD 20910 USA; [Arnaud, Francoise G.; Auker, Charles R.; McCarron, Richard M.; Scultetus, Anke H.] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA		Mullah, SH (corresponding author), Naval Med Res Ctr, NeuroTrauma Dept, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.				Defense Health Program (DHP) work unit [603115HP.3730.001.A1247]	The work was supported by Defense Health Program (DHP) work unit number 603115HP.3730.001.A1247.	Brenner M, 2012, ARCH SURG-CHICAGO, V147, P1042, DOI 10.1001/archsurg.2012.1560; Briceno JC, 1999, ASAIO J, V45, P322, DOI 10.1097/00002480-199907000-00013; Cabrales P, 2011, ANESTHESIOLOGY, V114, P901, DOI 10.1097/ALN.0b013e31820efb36; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Chowdhury T, 2014, SAUDI J ANAESTH, V8, P114, DOI 10.4103/1658-354X.125971; Correas JM, 1996, CLIN RADIOL, V51, P11; Culp WC, 2012, J VASC INTERV RADIOL, V23, P116, DOI 10.1016/j.jvir.2011.10.001; Daugherty WP, 2004, NEUROSURGERY, V54, P1223, DOI 10.1227/01.NEU.0000119238.68938.5D; Esipova TV, 2011, ANAL CHEM, V83, P8756, DOI 10.1021/ac2022234; Fraker CA, 2013, CELL TRANSPLANT, V22, P1723, DOI 10.3727/096368912X657873; GEYER RP, 1988, BIOMATER ARTIF CELL, V16, P31; Johnson JLH, 2015, J BIOMED NANOTECHNOL, V11, P274, DOI 10.1166/jbn.2015.1903; Johnson JLH, 2009, ARTIF CELL BLOOD SUB, V37, P156, DOI 10.1080/10731190903043192; Kim HW, 2004, ARTIF ORGANS, V28, P813, DOI 10.1111/j.1525-1594.2004.07345.x; Lundgren CEG, 2006, ARTIF CELL BLOOD SUB, V34, P473, DOI 10.1080/10731190600769271; Melani A, 2003, BRAIN RES, V959, P243, DOI 10.1016/S0006-8993(02)03753-8; Mendez DR, 2004, J TRAUMA, V57, P244, DOI 10.1097/01.TA.0000103983.22362.67; Menzel M, 1999, J NEUROSURG ANESTH, V11, P240, DOI 10.1097/00008506-199910000-00003; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; Moon-Massat P., 2015, J NEUROTRAUMA; Moon-Massat P.F., 2014, CURR DRUG DISCOV TEC; Mullah S.H., 2013, ACTA NEUROCHIR SUP S, V118, pS89; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Ohata H, 2001, ANESTH ANALG, V93, P697, DOI 10.1097/00000539-200109000-00032; Paxian M, 2003, SHOCK, V20, P449, DOI 10.1097/01.shk.0000090601.26659.87; Riess JG, 2005, ARTIF CELL BLOOD SUB, V33, P47, DOI 10.1081/BIO-200046659; Schroeder JL, 2008, J NEUROSURG-SPINE, V9, P213, DOI 10.3171/SPI/2008/9/8/213; Swyer T, 2014, PERFUSION; Tisdall MM, 2008, J NEUROSURG, V109, P424, DOI 10.3171/JNS/2008/109/9/0424; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Torres IP, 1996, MICROVASC RES, V51, P202; Tsai AG, 2007, ANTIOXID REDOX SIGN, V9, P979, DOI 10.1089/ars.2007.1633; Varma MR, 2002, BRAIN RES, V951, P191, DOI 10.1016/S0006-8993(02)03161-X; WEINER M, 1994, ARTIF CELL BLOOD SUB, V22, P763, DOI 10.3109/10731199409117909; Wilson DF, 2008, ADV EXP MED BIOL, V614, P53, DOI 10.1007/978-0-387-74911-2_7; Wilson DF, 2006, J APPL PHYSIOL, V101, P1648, DOI 10.1152/japplphysiol.00394.2006; Woods SD, 2013, MOL NEUROBIOL, V48, P363, DOI 10.1007/s12035-013-8495-6; Yu J, 2013, ANAESTHESIA, V68, P723, DOI 10.1111/anae.12227	38	17	17	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAR 1	2016	1634						132	139		10.1016/j.brainres.2016.01.012			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DH3LK	WOS:000372688300013	26794250	Bronze			2022-02-06	
J	Schaufelberger, SA; Rosselli, M; Barchiesi, F; Gillespie, DG; Jackson, EK; Dubey, RK				Schaufelberger, Sara A.; Rosselli, Marinella; Barchiesi, Federica; Gillespie, Delbert G.; Jackson, Edwin K.; Dubey, Raghvendra K.			2-Methoxyestradiol, an endogenous 17 beta-estradiol metabolite, inhibits microglial proliferation and activation via an estrogen receptor-independent mechanism	AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM			English	Article						stroke; microglia; 17 beta-estradiol; 2-hydroxyestradiol; 2-methoxyestradiol	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CEREBRAL-ARTERY OCCLUSION; TRAUMATIC BRAIN-INJURY; ISCHEMIC-STROKE; CATECHOLAMINES BLOCK; ESTRADIOL; RISK; BETA; THERAPY; ALPHA	17 beta-Estradiol (estradiol) inhibits microglia proliferation. 2-Methoxyestradiol (2-ME) is an endogenous metabolite of estradiol with little affinity for estrogen receptors (ERs). We hypothesize that 2-ME inhibits microglial proliferation and activation and contributes to estradiol's inhibitory effects on microglia. We compared the effects of estradiol, 2-hydroxyestradiol [2-OE; estradiol metabolite produced by cytochrome P450 (CYP450)], and 2-ME [formed by catechol-O-methyltransferase (COMT) acting upon 2-OE] on microglial (BV2 cells) DNA synthesis, cell proliferation, activation, and phagocytosis. 2-ME and 2-OE were approximately three-and 10-fold, respectively, more potent than estradiol in inhibiting microglia DNA synthesis. The antimitogenic effects of estradiol were reduced by pharmacological inhibitors of CYP450 and COMT. Inhibition of COMT blocked the conversion of 2-OE to 2-ME and the antimitogenic effects of 2-OE but not 2-ME. Microglia expressed ER beta and GPR30 but not ER alpha. 2,3-Bis(4-hydroxyphenyl)-propionitrile (ER beta agonist), but not 4,4', 4 ''-(4-propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol (ER alpha agonist) or G1 (GPR30 agonist), inhibited microglial proliferation. The antiproliferative effects of estradiol, but not 2-OE or 2-ME, were partially reversed by ICI-182,780 (ER alpha/beta antagonist) but not by 1,3-bis(4-hydroxyphenyl)-4-methyl-5-[4-(2-piperidinylethoxy)phenol]-1H-pyrazole (ER alpha antagonist) or G15 (GPR30 antagonist). Lipopolysaccharide increased microglia iNOS and COX-2 expression and phagocytosing activity of microglia; these effects were inhibited by 2-ME. We conclude that in microglia, 2-ME inhibits proliferation, proinflammatory responses, and phagocytosis. 2-ME partially mediates the effects of estradiol via ER-independent mechanisms involving sequential metabolism of estradiol to 2-OE and 2-ME. 2-ME could be of potential therapeutic use in postischemic stroke injuries. Interindividual differences in estradiol metabolism might affect the individual's ability to recover from stroke.	[Schaufelberger, Sara A.; Rosselli, Marinella; Barchiesi, Federica; Dubey, Raghvendra K.] Univ Zurich Hosp, Dept Reprod Endocrinol, CH-8091 Zurich, Switzerland; [Dubey, Raghvendra K.] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Gillespie, Delbert G.; Jackson, Edwin K.; Dubey, Raghvendra K.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA		Dubey, RK (corresponding author), Areal Wagi Schlieren, Univ Zurich Hosp, Dept Reprod Endocrinol, Wagistr 14, CH-8952 Schlieren, Switzerland.	raghvendra.dubey@usz.ch		Jackson, Edwin/0000-0002-8101-6009; Dubey, Raghvendra/0000-0003-1000-7137	Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [IZERO-142213/1, 31003A-138067]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS-087978, HL-109002, DK-091190, HL-069846, DK-068575, DK-079307]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL069846, R01HL109002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P30DK079307, R01DK068575, R01DK091190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS087978] Funding Source: NIH RePORTER	This work was supported by Swiss National Science Foundation Grants IZERO-142213/1 and 31003A-138067 (to R. K. Dubey) and by National Institutes of Health Grants NS-087978, HL-109002, DK-091190, HL-069846, DK-068575, and DK-079307 (to E. K. Jackson).	Azcoitia I, 2011, NEUROSCIENCE, V191, P139, DOI 10.1016/j.neuroscience.2011.02.012; Baker AE, 2004, ENDOCRINOLOGY, V145, P5021, DOI 10.1210/en.2004-0619; BERG D, 1983, ACTA ENDOCRINOL-COP, V103, P282, DOI 10.1530/acta.0.1030282; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bruce-Keller AJ, 2000, ENDOCRINOLOGY, V141, P3646, DOI 10.1210/en.141.10.3646; BRUEGGEMEIER RW, 1981, J BIOL CHEM, V256, P239; Carswell HVO, 2004, AM J PHYSIOL-HEART C, V287, pH1501, DOI 10.1152/ajpheart.00227.2004; Chen CH, 2007, J NEUROCHEM, V102, P1831, DOI 10.1111/j.1471-4159.2007.04652.x; Chen Y, 2014, CURR MED CHEM, V21, P2146, DOI 10.2174/0929867321666131228203906; Dawling S, 2003, CANCER RES, V63, P3127; Dubal DB, 2001, P NATL ACAD SCI USA, V98, P1952, DOI 10.1073/pnas.98.4.1952; Dubey RK, 2007, ENDOCRINOLOGY, V148, P4125, DOI 10.1210/en.2007-0514; Dubey RK, 2001, J APPL PHYSIOL, V91, P1868, DOI 10.1152/jappl.2001.91.4.1868; Dubey RK, 2005, J CLIN ENDOCR METAB, V90, P247, DOI 10.1210/jc.2003-032154; Dubey RK, 2004, J CLIN ENDOCR METAB, V89, P3922, DOI 10.1210/jc.2004-0115; Duncan GS, 2012, P NATL ACAD SCI USA, V109, P21034, DOI 10.1073/pnas.1215558110; Dutheil F, 2009, DRUG METAB DISPOS, V37, P1528, DOI 10.1124/dmd.109.027011; Gaikwad NW, 2011, BIOMARKERS, V16, P434, DOI 10.3109/1354750X.2011.588725; Henn A, 2009, ALTEX-ALTERN TIEREXP, V26, P83; Koellhoffer EC, 2013, TRANSL STROKE RES, V4, P390, DOI 10.1007/s12975-012-0230-5; Koenigsknecht J, 2004, J NEUROSCI, V24, P9838, DOI 10.1523/JNEUROSCI.2557-04.2004; Kognati S, 2014, EUR J PHARMACOL, V723, P131; Lemaitre RN, 2002, ARCH INTERN MED, V162, P1954, DOI 10.1001/archinte.162.17.1954; Li R, 2005, FRONT BIOSCI-LANDMRK, V10, P257, DOI 10.2741/1525; Mikkola TS, 2015, MENOPAUSE, V22, P976, DOI 10.1097/GME.0000000000000450; Neher JJ, 2011, J IMMUNOL, V186, P4973, DOI 10.4049/jimmunol.1003600; Offner H, 2006, ANN NY ACAD SCI, V1089, P343, DOI 10.1196/annals.1386.021; Ostensen M, 2007, SEMIN IMMUNOPATHOL, V29, P185, DOI 10.1007/s00281-007-0072-5; Patel Anita R, 2013, Int J Physiol Pathophysiol Pharmacol, V5, P73; Redell JB, 2007, NEUROSCI LETT, V413, P36, DOI 10.1016/j.neulet.2006.11.060; Rocca WA, 2012, MENOPAUSE, V19, P272, DOI 10.1097/gme.0b013e31822a9937; Sampei K, 2000, STROKE, V31, P738, DOI 10.1161/01.STR.31.3.738; Schaible EV, 2014, J NEUROCHEM, V129, P940, DOI 10.1111/jnc.12708; Schulze J, 2014, AGING DIS, V5, P327, DOI 10.14336/AD.2014.0500327; Thiel A, 2011, STROKE, V42, P507, DOI 10.1161/STROKEAHA.110.598821; Vegeto E, 2003, P NATL ACAD SCI USA, V100, P9614, DOI 10.1073/pnas.1531957100; Wise PM, 2005, ENDOCR REV, V26, P308, DOI 10.1210/er.2004-0014; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769; Zacharia LC, 2002, HYPERTENSION, V39, P854, DOI 10.1161/01.HYP.0000014502.44988.39; Zhang ZG, 1997, BRAIN RES, V744, P189, DOI 10.1016/S0006-8993(96)01085-2	40	17	17	0	13	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0193-1849	1522-1555		AM J PHYSIOL-ENDOC M	Am. J. Physiol.-Endocrinol. Metab.	MAR 1	2016	310	5					E313	E322		10.1152/ajpendo.00418.2015			10	Endocrinology & Metabolism; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Physiology	DF4EN	WOS:000371300700002	26732685	Green Published			2022-02-06	
J	Simpson, GK; Daher, M; Hodgkinson, A; Strettles, B				Simpson, Grahame K.; Daher, Maysaa; Hodgkinson, Adeline; Strettles, Barbara			Comparing the Injury Profile, Service Use, Outcomes, and Comorbidities of People With Severe TBI Across Urban, Regional, and Remote Populations in New South Wales: A Multicentre Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						rehabilitation; traumatic brain injury; rural; service utilization	TRAUMATIC BRAIN-INJURY; COMMUNITY-DWELLING ADULTS; CHALLENGING BEHAVIORS; CARE; REHABILITATION; SCALE; PARTICIPATION; PREVALENCE; CAREGIVERS; CLIENTS	Objective: To compare the demographic/injury profile, outcomes, service utilization, and unmet service needs of individuals with severe traumatic brain injury across urban, regional, and remote areas of New South Wales. Setting: The 11 community-based rehabilitation teams of the New South Wales Brain Injury Rehabilitation Program. Participants: Active clients (N = 503) with severe traumatic brain injury. Design: A prospective cross-sectional multicenter study. Main Measures: Overt Behaviour Scale, Health of the Nation Outcome Scale-Acquired Brain Injury, Disability Rating Scale, Sydney Psychosocial Reintegration Scale-2, Care and Needs Scale, data protocol on service utilization, and unmet needs. Results: There were no differences in injury severity or functional outcomes across the 3 locations. However, clients in regional and remote areas had significantly higher levels of premorbid and postinjury comorbidities and lower levels of participation in comparison to urban clients. Although accessing the same number of services as their urban counterparts, clients in regional and remote areas had significantly higher levels of unmet needs suggesting problems with under-servicing. Conclusions: Geographical location had a significant impact on service access and outcomes.	[Simpson, Grahame K.; Hodgkinson, Adeline] Liverpool Hosp, Liverpool Brain Injury Rehabil Unit, Sydney, NSW, Australia; [Simpson, Grahame K.] Univ Sydney, Sydney Sch Med, John Walsh Ctr Rehabil Res, Sydney, NSW 2006, Australia; [Simpson, Grahame K.; Daher, Maysaa] Ingham Inst Appl Med Res, Brain Injury Rehabil Res Grp, Sydney, NSW, Australia; [Strettles, Barbara] Agcy Clin Innovat, Sydney, NSW, Australia		Simpson, GK (corresponding author), Ingham Inst Appl Med Res, Brain Injury Rehabil Res Grp, Liverpool Brain Injury Rehabil Unit, POB 7279, Liverpool Bc, NSW 1871, Australia.	grahame.simpson@sswahs.nsw.gov.au	Simpson, Grahame K/W-1074-2019	Simpson, Grahame K/0000-0001-8156-9060	New South Wales Agency for Clinical Innovation (ACI)	The New South Wales Agency for Clinical Innovation (ACI) funded the project. Thanks to Dr Mark Sabaz, Dr Jeff Rogers, Inika Gillis, the project steering committee, and the participating BIRP clinicians.	Access Economics Pty Ltd, 2009, EC COST SPIN CORD IN; Anderson S., 2004, J COGNITIVE REHABILI, V22, P6; Australian Bureau of Statistics, 2010, YB AUSTR 2009 10; Australian Bureau of Statistics, 2011, AUSTR SOC TRENDS MAR; Australian Bureau of Statistics, 2014, REG POP GROWTH AUSTR; Australian Bureau of Statistics, 2006, STAT GEOGR; Australian Bureau of Statistics, 2004, YB AUSTR 2004; Australian Bureau of Statistics, 2008, AUSTR SOC TRENDS ART; Brain Injury Rehabilitation Directorate, 2014, 2011 2012 ANN REP; Brain Injury Rehabilitation Directorate, 2014, NSW BRAIN INJ REH PR; Chiang MF, 2006, SURG NEUROL, V66, pS14, DOI 10.1016/j.surneu.2006.08.029; Coetzer B R, 2002, Aust J Rural Health, V10, P229, DOI 10.1046/j.1440-1584.2002.00425.x; Coetzer R., 2001, PSYCHIATR BULL, V25, P421, DOI [https://doi.org/10.1192/pb.25.11.421, DOI 10.1192/PB.25.11.421]; Curtin M, 2011, BRAIN INJURY, V25, P266, DOI 10.3109/02699052.2010.542793; Department of Economic and Social Affairs, 2013, 2012 DEM YB; Ducharme JM, 2001, BRAIN INJURY, V15, P333, DOI 10.1080/02699050010005869; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; Farmer JE, 2003, J HEAD TRAUMA REHAB, V18, P116, DOI 10.1097/00001199-200303000-00003; Fleminger S, 2005, PSYCHIATR BULL, V29, P53, DOI 10.1192/pb.29.2.53; Foster M, 2000, BRAIN INJURY, V14, P1035; Fyffe C, 1996, Aust J Rural Health, V4, P232, DOI 10.1111/j.1440-1584.1996.tb00216.x; Gontkovsky ST, 2006, BRAIN INJURY, V20, P701, DOI 10.1080/02699050600744103; Harradine PG, 2004, MED J AUSTRALIA, V181, P130, DOI 10.5694/j.1326-5377.2004.tb06202.x; Jackson H, 2001, NEUROREHABILITATION, V16, P27; Johnstone B, 2003, NEUROREHABILITATION, V18, P197; Johnstone B, 2002, J RURAL HEALTH, V18, P109, DOI 10.1111/j.1748-0361.2002.tb00882.x; Jones J, 2010, QUAL HEALTH RES, V20, P942, DOI 10.1177/1049732310365501; Kelly G, 2006, BRAIN INJURY, V20, P307, DOI 10.1080/02699050500488074; Miller S., 2011, RURAL REMOT IN PRESS; Mitsch V, 2014, BRAIN INJURY, V28, P1504, DOI 10.3109/02699052.2014.938120; Murphy J., 2004, TOPICS EMERG MED, V26, P231; O'Callaghan AM, 2009, AUST J RURAL HEALTH, V17, P119, DOI 10.1111/j.1440-1584.2009.01054.x; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Ponsford J, 2010, BRAIN IMPAIR, V11, P253, DOI 10.1375/brim.11.3.253; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Sabaz M., 2010, NSW BRAIN INJURY REH; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Sample PL, 2007, SUBST USE MISUSE, V42, P705, DOI 10.1080/10826080701202536; Sample PL, 1998, BRAIN INJURY, V12, P855, DOI 10.1080/026990598122089; Sander AM, 2013, BRAIN IMPAIR, V14, P113, DOI 10.1017/BrImp.2013.12; Sander AM, 2009, J HEAD TRAUMA REHAB, V24, P248, DOI 10.1097/HTR.0b013e3181ad593a; Schootman M, 1999, BRAIN INJURY, V13, P995; Schopp LH, 2006, J HEAD TRAUMA REHAB, V21, P213, DOI 10.1097/00001199-200605000-00002; Schopp LH, 2000, J TELEMED TELECARE, V6, P146, DOI 10.1258/1357633001934474; Simpson GK, 2014, BRAIN IMPAIR, V15, P28, DOI 10.1017/BrImp.2014.7; Tate R. L., 2015, HDB VOCATIONAL REHAB, P263, DOI [10.1007/978-3-319-08825-9_12, DOI 10.1007/978-3-319-08825-9_12]; Tate R.L., 2006, BRAIN IMPAIR, V7, P1, DOI DOI 10.1375/brim.7.1.1; Tate RL, 2004, BRAIN INJURY, V18, P445, DOI 10.1080/02699050310001641183; Tate RL, 2004, BRAIN IMPAIR, V5, P81, DOI [DOI 10.1375/BRIM.5.1.81.35408, 10.1375/brim.5.1.81.35408, DOI 10.1375/brim.5.1.81.35408]; Tate RL, 2011, J REHABIL MED, V43, P609, DOI 10.2340/16501977-0829; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; US Department of Commerce, 2009, STAT ABSTR US 2010	52	17	18	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2016	31	2			SI		E26	E38		10.1097/HTR.0000000000000160			13	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DH7NQ	WOS:000372981300003	26098264				2022-02-06	
J	Gagnon, A; Lin, J; Stergiou-Kita, M				Gagnon, Alicia; Lin, Jenny; Stergiou-Kita, Mary			Family members facilitating community re-integration and return to productivity following traumatic brain injury - motivations, roles and challenges	DISABILITY AND REHABILITATION			English	Article							REHABILITATION; WORK; INTERVENTION; MODERATE; OUTCOMES		[Gagnon, Alicia; Lin, Jenny; Stergiou-Kita, Mary] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Stergiou-Kita, Mary] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada		Gagnon, A (corresponding author), Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada.	alicia.gagnon@mail.utoronto.ca					Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Chan J, 2009, ADV MENT HEALTH, V8, P155, DOI 10.5172/jamh.8.2.155; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; Evans CC, 2008, J HEAD TRAUMA REHAB, V23, P329, DOI 10.1097/01.HTR.0000336845.06704.bc; Foster AM, 2012, DISABIL REHABIL, V34, P1855, DOI 10.3109/09638288.2012.670028; Gilworth G, 2008, J REHABIL MED, V40, P334, DOI 10.2340/16501977-0169; Inzaghi M G, 2005, Eura Medicophys, V41, P265; Jumisko E, 2007, J FAM NURS, V13, P353, DOI 10.1177/1074840707303842; Kendall E, 2003, J VOCAT REHABIL, V19, P31; Kolakowsky-Hayner SA, 2001, NEUROREHABILITATION, V16, P41; Laroi F, 2003, BRAIN INJURY, V17, P175, DOI 10.1080/0269905021000010140; Macaden AS, 2010, DISABIL REHABIL, V32, P1140, DOI 10.3109/09638280903311594; Portney L.G., 2009, FDN CLIN RES APPL PR, V3rd ed.; Rubenson Camilla, 2007, Scand J Occup Ther, V14, P205, DOI 10.1080/11038120601110934; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P842, DOI 10.1016/j.apmr.2011.11.031; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Smith Michele S, 2002, Rehabil Nurs, V27, P209; Stejskal TM, 2012, NEUROREHABILITATION, V31, P75, DOI 10.3233/NRE-2012-0776; Stergiou-Kita M, 2011, J OCCUP REHABIL, V21, P374, DOI 10.1007/s10926-010-9282-0; Stergiou-Kita M, 2009, CAN J OCCUP THER, V76, P276, DOI 10.1177/000841740907600406; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x	22	17	17	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	FEB 27	2016	38	5					433	441		10.3109/09638288.2015.1044035			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	DA5HS	WOS:000367834600004	25974226				2022-02-06	
J	Liu, CX; Ye, YJ; Zhou, Q; Zhang, RJ; Zhang, H; Liu, W; Xu, C; Liu, L; Huang, SL; Chen, L				Liu, Chunxiao; Ye, Yangjing; Zhou, Qian; Zhang, Ruijie; Zhang, Hai; Liu, Wen; Xu, Chong; Liu, Lei; Huang, Shile; Chen, Long			Crosstalk between Ca2+ signaling and mitochondrial H2O2 is required for rotenone inhibition of mTOR signaling pathway leading to neuronal apoptosis	ONCOTARGET			English	Article						rotenone; apoptosis; calcium ion; CaMKII; H2O2; mTOR; Pathology	PROTEIN-KINASE-II; TRAUMATIC BRAIN-INJURY; MEDIATED S6K1; OXIDATIVE STRESS; CELL-DEATH; CALCIUM; ACTIVATION; INVOLVEMENT; SUPPRESSION; DAMAGE	Rotenone, a neurotoxic pesticide, induces loss of dopaminergic neurons related to Parkinson's disease. Previous studies have shown that rotenone induces neuronal apoptosis partly by triggering hydrogen peroxide (H2O2)-dependent suppression of mTOR pathway. However, the underlying mechanism is not fully understood. Here, we show that rotenone elevates intracellular free calcium ion ([Ca2+](i)) level, and activates CaMKII, resulting in inhibition of mTOR signaling and induction of neuronal apoptosis. Chelating [Ca2+](i) with BAPTA/AM, preventing extracellular Ca2+ influx using EGTA, inhibiting CaMKII with KN93, or silencing CaMKII significantly attenuated rotenone-induced H2O2 production, mTOR inhibition, and cell death. Interestingly, using TTFA, antimycin A, catalase or Mito-TEMPO, we found that rotenone-induced mitochondrial H2O2 also in turn elevated [Ca2+](i) level, thereby stimulating CaMKII, leading to inhibition of mTOR pathway and induction of neuronal apoptosis. Expression of wild type mTOR or constitutively active S6K1, or silencing 4E-BP1 strengthened the inhibitory effects of catalase, Mito-TEMPO, BAPTA/AM or EGTA on rotenone-induced [Ca2+](i) elevation, CaMKII phosphorylation and neuronal apoptosis. Together, the results indicate that the crosstalk between Ca2+ signaling and mitochondrial H2O2 is required for rotenone inhibition of mTOR-mediated S6K1 and 4E-BP1 pathways. Our findings suggest that how to control over-elevation of intracellular Ca2+ and overproduction of mitochondrial H2O2 may be a new approach to deal with the neurotoxicity of rotenone.	[Liu, Chunxiao; Ye, Yangjing; Zhou, Qian; Zhang, Ruijie; Zhang, Hai; Liu, Wen; Xu, Chong; Chen, Long] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Microbes & Funct Genom, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing, Jiangsu, Peoples R China; [Liu, Lei; Huang, Shile] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71105 USA; [Huang, Shile] Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Shreveport, LA 71105 USA		Chen, L (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Microbes & Funct Genom, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing, Jiangsu, Peoples R China.; Huang, SL (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71105 USA.; Huang, SL (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Shreveport, LA 71105 USA.	shuan1@lsuhsc.edu; lchen@njnu.edu.cn	Huang, Shile/I-1632-2019	Huang, Shile/0000-0002-3239-1072	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271416]; Project for the Priority Academic Program Development; Natural Science Foundation of Jiangsu Higher Education Institutions of China [10KJA180027]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [CA115414]; American Cancer SocietyAmerican Cancer Society [RSG-08-135-01-CNE]; Louisiana Board of Regents [NSF-2009-PFUND-144]; Innovative Research Program of Jiangsu College Graduate of China [KYLX15_0733]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA115414] Funding Source: NIH RePORTER	This work was supported in part by the grants from National Natural Science Foundation of China (81271416; L.C.), Project for the Priority Academic Program Development and Natural Science Foundation of Jiangsu Higher Education Institutions of China (10KJA180027; L.C.), NIH (CA115414; S.H.), American Cancer Society (RSG-08-135-01-CNE; S.H.). Louisiana Board of Regents (NSF-2009-PFUND-144; S.H.), and Innovative Research Program of Jiangsu College Graduate of China (KYLX15_0733; C.L.).	Adam-Vizi V, 2005, ANTIOXID REDOX SIGN, V7, P1140, DOI 10.1089/ars.2005.7.1140; Bao L, 2005, J NEUROSCI, V25, P10029, DOI 10.1523/JNEUROSCI.2652-05.2005; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Bian XP, 1997, AM J PHYSIOL-CELL PH, V272, pC1241, DOI 10.1152/ajpcell.1997.272.4.C1241; Blesa J, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/845618; Cannon JR, 2009, NEUROBIOL DIS, V34, P279, DOI 10.1016/j.nbd.2009.01.016; Chen L, 2008, J NEUROCHEM, V105, P251, DOI 10.1111/j.1471-4159.2007.05133.x; Chen L, 2011, FREE RADICAL BIO MED, V50, P624, DOI 10.1016/j.freeradbiomed.2010.12.032; Chen L, 2010, LAB INVEST, V90, P762, DOI 10.1038/labinvest.2010.36; Chen S, 2014, NEUROPATH APPL NEURO, V40, P759, DOI 10.1111/nan.12103; Chen SJ, 2011, J NEUROCHEM, V119, P1108, DOI 10.1111/j.1471-4159.2011.07493.x; Cheng AW, 2003, J BIOL CHEM, V278, P7591, DOI 10.1074/jbc.M207232200; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Choi SS, 2006, BRAIN RES, V1108, P28, DOI 10.1016/j.brainres.2006.06.048; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Colbran RJ, 2004, CURR OPIN NEUROBIOL, V14, P318, DOI 10.1016/j.conb.2004.05.008; Drechsel DA, 2008, FREE RADICAL BIO MED, V44, P1873, DOI 10.1016/j.freeradbiomed.2008.02.008; Fernandez M, 2011, INT J PHARMACEUT, V419, P271, DOI 10.1016/j.ijpharm.2011.07.029; Franklin JL, 2011, ANTIOXID REDOX SIGN, V14, P1437, DOI 10.1089/ars.2010.3596; Freestone PS, 2009, EUR J NEUROSCI, V30, P1849, DOI 10.1111/j.1460-9568.2009.06990.x; Gao HM, 2003, J NEUROSCI, V23, P1228, DOI 10.1523/JNEUROSCI.23-04-01228.2003; GIBBONS SJ, 1993, ANN NY ACAD SCI, V679, P22, DOI 10.1111/j.1749-6632.1993.tb18286.x; Gunter TE, 2009, BBA-BIOENERGETICS, V1787, P1291, DOI 10.1016/j.bbabio.2008.12.011; Hajnoczky G, 2003, BIOCHEM BIOPH RES CO, V304, P445, DOI 10.1016/S0006-291X(03)00616-8; Hao BH, 2013, ANTIMICROB AGENTS CH, V57, P326, DOI 10.1128/AAC.01366-12; Jaworski J, 2006, MOL NEUROBIOL, V34, P205, DOI 10.1385/MN:34:3:205; Kim BW, 2008, CELL SIGNAL, V20, P714, DOI 10.1016/j.cellsig.2007.12.009; Kim JS, 2006, AM J PHYSIOL-HEART C, V290, pH2024, DOI 10.1152/ajpheart.00683.2005; Koopman WJH, 2010, ANTIOXID REDOX SIGN, V12, P1431, DOI 10.1089/ars.2009.2743; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Liu L, 2008, ONCOGENE, V27, P4998, DOI 10.1038/onc.2008.137; Liu L, 2006, ONCOGENE, V25, P7029, DOI 10.1038/sj.onc.1209691; Marambaud P, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-20; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; Miller RL, 2009, NEUROCHEM RES, V34, P55, DOI 10.1007/s11064-008-9656-2; Moreno-Sanchez R, 2013, FEBS J, V280, P927, DOI 10.1111/febs.12086; Mustafa AG, 2010, J NEUROCHEM, V114, P271, DOI 10.1111/j.1471-4159.2010.06749.x; Nicotera P, 1998, CELL CALCIUM, V23, P173, DOI 10.1016/S0143-4160(98)90116-6; Niizuma K, 2010, BBA-MOL BASIS DIS, V1802, P92, DOI 10.1016/j.bbadis.2009.09.002; Pizzo P, 2007, TRENDS CELL BIOL, V17, P511, DOI 10.1016/j.tcb.2007.07.011; Rodriguez-Rocha H, 2013, FREE RADICAL BIO MED, V61, P370, DOI 10.1016/j.freeradbiomed.2013.04.021; SCHWORER CM, 1986, J BIOL CHEM, V261, P8581; Song B, 2010, J BIOL CHEM, V285, P41122, DOI 10.1074/jbc.M110.130351; Swarnkar S, 2010, TOXICOLOGY, V272, P17, DOI 10.1016/j.tox.2010.03.019; Swarnkar S, 2012, ARCH TOXICOL, V86, P1387, DOI 10.1007/s00204-012-0853-z; Swiech L, 2008, BBA-PROTEINS PROTEOM, V1784, P116, DOI 10.1016/j.bbapap.2007.08.015; Taetzsch T, 2013, J BIOCHEM MOL TOXIC, V27, P137, DOI 10.1002/jbt.21464; Tamilselvam K, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/102741; Toescu EC, 2007, AGING CELL, V6, P265, DOI 10.1111/j.1474-9726.2007.00299.x; Tretter L, 2004, NEUROCHEM RES, V29, P569, DOI 10.1023/B:NERE.0000014827.94562.4b; Wang XH, 2005, NEUROSCI LETT, V376, P127, DOI 10.1016/j.neulet.2004.11.041; Xiong N, 2012, CRIT REV TOXICOL, V42, P613, DOI 10.3109/10408444.2012.680431; Xu BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019052; Xu LJ, 2014, J APPL TOXICOL, V34, P651, DOI 10.1002/jat.2890; Xu YJ, 2014, CELL SIGNAL, V26, P1680, DOI 10.1016/j.cellsig.2014.04.009; Yamanaka A, 2007, ARCH BIOCHEM BIOPHYS, V466, P234, DOI 10.1016/j.abb.2007.06.009; Yeh YT, 2014, FREE RADICAL BIO MED, V74, P1, DOI 10.1016/j.freeradbiomed.2014.06.008; Zhou Q, 2015, TOXICOL SCI, V143, P81, DOI 10.1093/toxsci/kfu211	60	17	18	2	9	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA		1949-2553		ONCOTARGET	Oncotarget	FEB 16	2016	7	7					7534	7549		10.18632/oncotarget.7183			16	Oncology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Cell Biology	DE0PD	WOS:000370325900015	26859572	Green Published, gold, Green Submitted			2022-02-06	
J	Seedat, J; Penn, C				Seedat, Jaishika; Penn, Claire			Implementing oral care to reduce aspiration pneumonia amongst patients with dysphagia in a South African setting	SOUTH AFRICAN JOURNAL OF COMMUNICATION DISORDERS			English	Article							HEALTH; INTERVENTIONS; NURSES; WATER	Oral care is a crucial routine for patients with dysphagia that, when completed routinely, can prevent the development of aspiration pneumonia. There is no standardised protocol for oral care within government hospitals in South Africa. This study aimed to investigate the outcome of an oral care protocol. Participants were patients with oropharyngeal dysphagia, with either stroke or traumatic brain injury as the underlying medical pathology, and nurses. All participants were recruited from one tertiary level government hospital in Gauteng, South Africa. 139 nurses participated in the study and received training on the oral care protocol. There were two groups of participants with oropharyngeal dysphagia. Group one (study group, n = 23) was recruited by consecutive sampling, received regular oral care and were not restricted from drinking water; however, all other liquids were restricted. Group two (comparison group, n = 23) was recruited via a retrospective record review, received inconsistent oral care and were placed on thickened liquids or liquid restricted diets. Results showed that a regimen of regular oral care and free water provision when combined with dysphagia intervention did prevent aspiration pneumonia in patients with oropharyngeal dysphagia. The article highlights two key findings: that regular and routine oral care is manageable within an acute government hospital context and a strict routine of oral care can reduce aspiration pneumonia in patients with oropharyngeal dysphagia. An implication from these findings is confirmation that teamwork in acute care settings in developing contexts must be prioritised to improve dysphagia management and patient prognosis.	[Seedat, Jaishika; Penn, Claire] Univ Witwatersrand, Dept Speech Pathol & Audiol, Johannesburg, South Africa		Seedat, J (corresponding author), Univ Witwatersrand, Dept Speech Pathol & Audiol, Johannesburg, South Africa.	jaishika.seedat@wits.ac.za		Seedat, Jaishika/0000-0003-2402-3947			Adams R, 1996, J ADV NURS, V24, P552, DOI 10.1046/j.1365-2648.1996.22416.x; Becker D. L., 2008, AM SPEECH LANG HEAR; Begley CM, 2009, NURS EDUC TODAY, V29, P276, DOI 10.1016/j.nedt.2008.09.006; Berry Angela M, 2006, Intensive Crit Care Nurs, V22, P318, DOI 10.1016/j.iccn.2006.04.003; Bronson-Lowe C, 2008, DYSPHAGIA, V23, P430; Byers J F, 2000, Am J Crit Care, V9, P344; Carlaw C, 2012, DYSPHAGIA, V27, P297, DOI 10.1007/s00455-011-9366-9; Cichero JA, 2006, DYSPHAGIA FDN THEORY; Colodny N, 2005, AM J SPEECH-LANG PAT, V14, P61, DOI 10.1044/1058-0360(2005/008); Cook IJ, 1999, GASTROENTEROLOGY, V116, P455, DOI 10.1016/S0016-5085(99)70144-7; DONOGHUE H, 1987, NEW SCI, V113, P61; Effros R. M., 2000, AM J MED, V108, P15; El-Solh AA, 2003, AM J RESP CRIT CARE, V167, P1650, DOI 10.1164/rccm.200212-1543OC; Evans G, 2001, Nurs Stand, V15, P33; Fields LB, 2008, J NEUROSCI NURS, V40, P291, DOI 10.1097/01376517-200810000-00007; Frey KL, 2011, J NEUROSCI NURS, V43, P165, DOI 10.1097/JNN.0b013e3182135adf; Garon BR, 1997, J NEUROL REHABIL, V11, P139; Grap MJ, 2003, AM J CRIT CARE, V12, P113, DOI 10.4037/ajcc2003.12.2.113; Jones C V, 1998, Br J Nurs, V7, P74; Karagiannis MJP, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-9; Kite K, 1995, Intensive Crit Care Nurs, V11, P71, DOI 10.1016/S0964-3397(95)82017-5; LANGMORE S E, 1991, Seminars in Speech and Language, V12, P199, DOI 10.1055/s-2008-1064221; Langmore SE, 2002, DYSPHAGIA, V17, P298, DOI 10.1007/s00455-002-0072-5; LANGMORE SE, 1994, ARCH PHYS MED REHAB, V75, P1154, DOI 10.1016/0003-9993(94)90094-9; Logemanin JA, 2008, J SPEECH LANG HEAR R, V51, P173, DOI 10.1044/1092-4388(2008/013); Logemann J. A., 1994, Acta Oto-Rhino-Laryngologica Belgica, V48, P235; Logemann JA, 1983, EVALUATION TREATMENT; Marik PE, 2003, CHEST, V124, P328, DOI 10.1378/chest.124.1.328; MARSH PD, 1992, ORAL MICROBIOL IMMUN, P98; Martin Bonnie J. W., 1994, Dysphagia, V9, P1; Mathivha LR, 2002, CRIT CARE, V6, P22; McCullough G. H., 2013, CLIN EVALUATION PATI, P11, DOI [10.1007/978-1-4614-3779-6_2, DOI 10.1007/978-1-4614-3779-6_2]; Milins B, 2003, GERONTOLOGY, V49, P173, DOI 10.1159/000069171; Miller R, 1987, J Nurs Educ, V26, P362; Mojoyinolla JK, 2008, STUD ETHNO-MED, V2, P143, DOI 10.1080/09735070.2008.11886326; Nevitt J., 2010, FRAZIER FREE WATER P; Panther K., 2005, PERSPECTIVES SWALLOW, V14, P4, DOI DOI 10.1161/STR.0000000000000098; Rello J, 2007, INTENS CARE MED, V33, P1066, DOI 10.1007/s00134-007-0605-3; Robbins J, 2002, J REHABIL RES DEV, V39, P543; Robbins J, 2008, ANN INTERN MED, V148, P509, DOI 10.7326/0003-4819-148-7-200804010-00007; Rofes L, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/818979; Rosenvinge SK, 2005, AGE AGEING, V34, P587, DOI 10.1093/ageing/afi187; Sarin J, 2008, J AM MED DIR ASSOC, V9, P128, DOI 10.1016/j.jamda.2007.10.003; Scott A., 2010, EMBEDDING EVIDENCE B, P184; Scribante J., 2008, S AFR MED J, V97, P1315; Seedat J., 2013, THESIS; Singh S, 2006, POSTGRAD MED J, V82, P383, DOI 10.1136/pgmj.2005.043281; South African Nursing Council (SANC), 2004, CHART NURS PRACT 200; Steele C., 2006, AM SPEECH LANG HEAR; THEILADE E, 1986, J CLIN PERIODONTOL, V13, P905, DOI 10.1111/j.1600-051X.1986.tb01425.x; Wardh I, 1997, Gerodontology, V14, P28, DOI 10.1111/j.1741-2358.1997.00028.x; Yoneyama T, 2002, J AM GERIATR SOC, V50, P430, DOI 10.1046/j.1532-5415.2002.50106.x; Yoon MN, 2007, TOP GERIATR REHABIL, V23, P280; [No title captured]	54	17	17	1	9	AOSIS	CAPE TOWN	POSTNET SUITE 55, PRIVATE BAG X22, TYGERVALLEY, CAPE TOWN, 00000, SOUTH AFRICA	0379-8046	2225-4765		S AFR J COMMUN DISOR	S. Afr. J. Commun. Disord.	FEB 16	2016	63	1							102	10.4102/sajcd.v63i1.102			11	Audiology & Speech-Language Pathology	Emerging Sources Citation Index (ESCI)	Audiology & Speech-Language Pathology	EA6QD	WOS:000386752900001	26974243	Green Published, gold			2022-02-06	
J	Wilson, NM; Titus, DJ; Oliva, AA; Furones, C; Atkins, CM				Wilson, Nicole M.; Titus, David J.; Oliva, Anthony A., Jr.; Furones, Concepcion; Atkins, Coleen M.			Traumatic Brain Injury Upregulates Phosphodiesterase Expression in the Hippocampus	FRONTIERS IN SYSTEMS NEUROSCIENCE			English	Article						cAMP; CREB; fluid-percussion; hippocampus; inflammation; phosphodiesterase; traumatic brain injury	LONG-TERM POTENTIATION; CONTROLLED CORTICAL IMPACT; ADENYLYL-CYCLASE; COGNITIVE DEFICITS; SPATIAL MEMORY; IN-VITRO; ROLIPRAM; INHIBITORS; AGE; MOUSE	Traumatic brain injury (TBI) results in significant impairments in hippocampal synaptic plasticity. A molecule critically involved in hippocampal synaptic plasticity, 3',5'-cyclic adenosine monophosphate, is downregulated in the hippocampus after TBI, but the mechanism that underlies this decrease is unknown. To address this question, we determined whether phosphodiesterase (PDE) expression in the hippocampus is altered by TBI. Young adult male Sprague Dawley rats received sham surgery or moderate parasagittal fluid-percussion brain injury. Animals were analyzed by western blotting for changes in PDE expression levels in the hippocampus. We found that PDE1A levels were significantly increased at 30 min, 1 h and 6 h after TBI. PDE4B2 and 4D2 were also significantly increased at 1, 6, and 24 h after TBI. Additionally, phosphorylation of PDE4A was significantly increased at 6 and 24 h after TBI. No significant changes were observed in levels of PDE1B, 1C, 3A, 8A, or 8B between 30 min to 7 days after TBI. To determine the spatial profile of these increases, we used immunohistochemistry and flow cytometry at 24 h after TBI. PDE1A and phospho-PDE4A localized to neuronal cell bodies. PDE4B2 was expressed in neuronal dendrites, microglia and infiltrating CD11b(+) immune cells. PDE4D was predominantly found in microglia and infiltrating GD11 b(+) immune cells. To determine if inhibition of PDE4 would improve hippocampal synaptic plasticity deficits after TBI, we treated hippocampal slices with rolipram, a pan-PDE4 inhibitor. Rolipram partially rescued the depression in basal synaptic transmission and converted a decaying form of long-term potentiation (UP) into long-lasting LIP. Overall, these results identify several possible PDE targets for reducing hippocampal synaptic plasticity deficits and improving cognitive function acutely after TBI.	[Wilson, Nicole M.; Titus, David J.; Oliva, Anthony A., Jr.; Furones, Concepcion; Atkins, Coleen M.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, Miami, FL 33136 USA		Atkins, CM (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, Miami, FL 33136 USA.	catkins@med.miami.edu		Atkins, Coleen/0000-0003-4718-7493	National Institutes of Health/NINDS Grants [R01 NS069721, P31 NS089351]; Miami Project to Cure Paralysis; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS069721, F31NS089351] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health/NINDS Grants R01 NS069721 and P31 NS089351, and The Miami Project to Cure Paralysis.	Amen DG, 2011, J PSYCHOACTIVE DRUGS, V43, P1, DOI 10.1080/02791072.2011.566489; Araki T, 1995, BRAIN RES, V704, P227, DOI 10.1016/0006-8993(95)01117-X; Ariga M, 2004, J IMMUNOL, V173, P7531, DOI 10.4049/jimmunol.173.12.7531; Atkins CM, 2012, J NEUROSCI RES, V90, P1861, DOI 10.1002/jnr.23069; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Atkins CM, 2013, NEUROSCI LETT, V532, P1, DOI 10.1016/j.neulet.2012.10.019; Atkins CM, 2011, TRANSL STROKE RES, V2, P546, DOI 10.1007/s12975-011-0123-z; Bach ME, 1999, P NATL ACAD SCI USA, V96, P5280, DOI 10.1073/pnas.96.9.5280; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Blackman BE, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.203604; Boswell-Smith V, 2006, BRIT J PHARMACOL, V147, pS252, DOI 10.1038/sj.bjp.0706495; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Carito V, 2012, BBA-GEN SUBJECTS, V1820, P96, DOI 10.1016/j.bbagen.2011.10.015; Chen CC, 2010, NEUROPSYCHOPHARMACOL, V35, P1605, DOI 10.1038/npp.2010.33; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; Dong HL, 2010, BIOCHEM PHARMACOL, V79, P321, DOI 10.1016/j.bcp.2009.09.001; Faul M, 2010, TRAUMATIC BRAIN INJU; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Ghosh M, 2012, GLIA, V60, P1839, DOI 10.1002/glia.22401; Giachini FR, 2011, HYPERTENSION, V57, P655, DOI 10.1161/HYPERTENSIONAHA.110.164327; Giralt A, 2013, HIPPOCAMPUS, V23, P684, DOI 10.1002/hipo.22128; Gong B, 2004, J CLIN INVEST, V114, P1624, DOI 10.1172/JCI200422831; Haering C, 2015, J BIOL CHEM, V290, P9767, DOI 10.1074/jbc.M115.640656; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hansen RT, 2015, CURR PHARM DESIGN, V21, P291; Heckman PRA, 2015, CURR PHARM DESIGN, V21, P317; Henkel-Tigges J., 1990, MOL PHARM, V37, P7; Houslay MD, 2010, TRENDS BIOCHEM SCI, V35, P91, DOI 10.1016/j.tibs.2009.09.007; Imanishi T, 1997, EUR J PHARMACOL, V321, P273, DOI 10.1016/S0014-2999(96)00969-7; Jin SLC, 2002, P NATL ACAD SCI USA, V99, P7628, DOI 10.1073/pnas.122041599; Johansson EM, 2012, NEUROSCI LETT, V525, P1, DOI 10.1016/j.neulet.2012.07.050; KATO H, 1995, EUR J PHARMACOL, V272, P107, DOI 10.1016/0014-2999(94)00694-3; Kelly MP, 2009, PROG BRAIN RES, V179, P67, DOI 10.1016/S0079-6123(09)17908-6; Kharlamov EA, 2011, EPILEPSY RES, V95, P20, DOI 10.1016/j.eplepsyres.2011.02.008; Klann E, 1998, J BIOL CHEM, V273, P4516, DOI 10.1074/jbc.273.8.4516; Kunal SB, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-25; Kuroiwa M, 2012, PSYCHOPHARMACOLOGY, V219, P1065, DOI 10.1007/s00213-011-2436-8; Lakics V, 2010, NEUROPHARMACOLOGY, V59, P367, DOI 10.1016/j.neuropharm.2010.05.004; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lew HL, 2006, J REHABIL RES DEV, V43, pVII, DOI 10.1682/JRRD.2006.05.0054; Li W, 2008, NEUROSCIENCE, V151, P1198, DOI 10.1016/j.neuroscience.2007.11.020; Li YF, 2011, J NEUROSCI, V31, P172, DOI 10.1523/JNEUROSCI.5236-10.2011; MacKenzie KF, 2011, BIOCHEM J, V435, P755, DOI 10.1042/BJ20101184; MacKenzie SJ, 2002, BRIT J PHARMACOL, V136, P421, DOI 10.1038/sj.bjp.0704743; Man HY, 2007, P NATL ACAD SCI USA, V104, P3579, DOI 10.1073/pnas.0611698104; Martinez A, 2014, EXPERT OPIN THER PAT, V24, P1311, DOI 10.1517/13543776.2014.968127; Maurice DH, 2014, NAT REV DRUG DISCOV, V13, P290, DOI 10.1038/nrd4228; Maxwell WL, 2003, J NEUROPATH EXP NEUR, V62, P272, DOI 10.1093/jnen/62.3.272; Menniti FS, 2006, NAT REV DRUG DISCOV, V5, P660, DOI 10.1038/nrd2058; Middei S, 2013, HIPPOCAMPUS, V23, P488, DOI 10.1002/hipo.22108; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; Mons N, 2004, NEUROBIOL AGING, V25, P1095, DOI 10.1016/j.neurobiolaging.2003.10.014; Nagakura A, 2002, NEUROSCI LETT, V317, P69, DOI 10.1016/S0304-3940(01)02421-1; Navakkode S, 2004, J NEUROSCI, V24, P7740, DOI 10.1523/JNEUROSCI.1796-04.2004; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Oliva AA, 2012, J NEUROCHEM, V123, P1019, DOI 10.1111/jnc.12049; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Perez-Torres S, 2000, J CHEM NEUROANAT, V20, P349, DOI 10.1016/S0891-0618(00)00097-1; Ramos BP, 2003, NEURON, V40, P835, DOI 10.1016/S0896-6273(03)00694-9; Reneerkens OAH, 2009, PSYCHOPHARMACOLOGY, V202, P419, DOI 10.1007/s00213-008-1273-x; Rutten K, 2008, PSYCHOPHARMACOLOGY, V196, P643, DOI 10.1007/s00213-007-0999-1; Rutten K, 2008, EUR J NEUROSCI, V28, P625, DOI 10.1111/j.1460-9568.2008.06349.x; Schaal SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043634; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Schumann J, 2008, J NEUROTRAUM, V25, P945, DOI 10.1089/neu.2008.0521; Shepherd MC, 2004, BRIT J PHARMACOL, V142, P339, DOI 10.1038/sj.bjp.0705770; Shimizu-Albergine M, 2012, MOL PHARMACOL, V81, P556, DOI 10.1124/mol.111.076125; Sierksma ASR, 2014, NEUROPHARMACOLOGY, V77, P120, DOI 10.1016/j.neuropharm.2013.09.015; Soler F, 2015, EUR J PHARMACOL, V765, P429, DOI 10.1016/j.ejphar.2015.09.001; Spina D, 2008, BRIT J PHARMACOL, V155, P308, DOI 10.1038/bjp.2008.307; Suhasini A. N., 2015, LEUKEMIA; Temple MD, 2001, J NEUROTRAUM, V18, P47, DOI 10.1089/089771501750055767; Titus DJ, 2013, NEUROSCIENCE, V231, P182, DOI 10.1016/j.neuroscience.2012.12.002; Titus DJ, 2015, CURR PHARM DESIGN, V21, P332; Titus DJ, 2015, EXP NEUROL, V263, P254, DOI 10.1016/j.expneurol.2014.10.020; Titus DJ, 2013, J NEUROSCI, V33, P5216, DOI 10.1523/JNEUROSCI.5133-12.2013; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; Wiescholleck V, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.17; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Yamamoto M, 2000, BBA-MOL BASIS DIS, V1535, P60, DOI 10.1016/S0925-4439(00)00083-1; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	82	17	17	0	9	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5137		FRONT SYST NEUROSCI	Front. Syst. Neurosci.	FEB 5	2016	10								5	10.3389/fnsys.2016.00005			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DD0HW	WOS:000369602000001	26903822	Green Published, gold			2022-02-06	
J	Chi, YC; Wu, HL; Chu, CP; Huang, MC; Lee, PC; Chen, YY				Chi, Ying-Chen; Wu, Hyun-Ling; Chu, Chih-Pang; Huang, Ming-Chyi; Lee, Pei-Chen; Chen, Ying-Yeh			Traumatic brain injury and affective disorder: A nationwide cohort study in Taiwan, 2000-2010	JOURNAL OF AFFECTIVE DISORDERS			English	Article						Traumatic brain injury; Affective disorders; Bipolar disorder; Major depression; Taiwan	MAJOR DEPRESSIVE DISORDER; PSYCHIATRIC-DISORDERS; MOOD DISORDERS; HEAD-INJURY; RISK-FACTOR; EPIDEMIOLOGY; ASSOCIATION; ADOLESCENTS; PREVALENCE; ADULTS	Background: Studies investigating the relationship between head injury and the subsequent onset of affective disorders often show conflicting results. Aims: To investigate the risk of affective disorders following traumatic brain injury in a large Taiwanese cohort. Method: This retrospective cohort study makes use of the National Health Insurance Research Database. A cohort containing 68,376 individuals who experienced traumatic brain injury (TBI) during 2000-2010 and had no prior history of mental disorders before the injury was identified. Using Cox Proportional Hazards regression, the subsequent risk of affective disorders was determined. Results: TBI was associated with a higher risk of both bipolar disorder (Hazard Ratio [HR] =1.42, 95% Confidence Interval [CI] = [1.26, 1.59]) and major depression (HR=1.41, 95% Cl= [1.28, 1.54]). More severe injury was associated with greater risk. The first year following the injury was the highest risk period for major depression, while the highest risk period for bipolar disorder was delayed until two to four years following the injury. Limitations: Using a claims database, we were unable to assess confounding variables that were not contained in the data set. Conclusions: The elevated risks of affective disorders after TBI speak to the psychiatric need of individuals who suffer from brain injury. Early detection and timely intervention may help prevent secondary and tertiary disability associated with head trauma. (c) 2015 Published by Elsevier By.	[Chi, Ying-Chen] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan; [Chi, Ying-Chen] Univ Kang Ning, Dept Informat Management, Taipei, Taiwan; [Wu, Hyun-Ling; Lee, Pei-Chen] Natl Taipei Univ Nursing & Hlth Sci, Taipei, Taiwan; [Chu, Chih-Pang; Huang, Ming-Chyi; Chen, Ying-Yeh] Taipei City Hosp, Taipei City Psychiat Ctr, Taipei, Taiwan; [Huang, Ming-Chyi] Taipei Med Univ, Sch Med, Dept Psychiat, Taipei, Taiwan; [Chen, Ying-Yeh] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Chen, Ying-Yeh] Natl Yang Ming Univ, Dept Publ Hlth, Taipei 112, Taiwan		Lee, PC (corresponding author), Taipei City Psychiat Ctr, Dept Gen Psychiat, 309 Songde Rd, Taipei 110, Taiwan.	pcl0807@gmail.com; ychen@tpech.gov.tw	Huang, Ming-Chyi/W-9515-2019; Chen, Ying-Yeh/AAY-1478-2021	, Pei-Chen/0000-0001-7813-0823; Chen, Ying-Yeh/0000-0001-5543-5704	Ministry of Science and TechnologyMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [MOST 103-2314-B-532-003-MY2, MOST 103-2314-B-227-002-MY2]; Department of Health Taipei City Government [10401-62-011]	Y.-Y.C. was supported by the Ministry of Science and Technology (Grant number: MOST 103-2314-B-532-003-MY2) and the Department of Health Taipei City Government (Grant number: 10401-62-011). P.-C.L. was supported by the Ministry of Science and Technology (Grant number: MOST 103-2314-B-227-002-MY2).	Blumberg HP, 2004, ANN NY ACAD SCI, V1021, P376, DOI 10.1196/annals.1308.048; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brown TA, 2001, J ABNORM PSYCHOL, V110, P585, DOI 10.1037//0021-843X.110.4.585; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Diamond B, 2009, NAT REV IMMUNOL, V9, P449, DOI 10.1038/nri2529; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Jorge RE, 2014, PSYCHIAT CLIN N AM, V37, P13, DOI 10.1016/j.psc.2013.11.005; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Lam C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/487985; Liao SC, 2012, PSYCHOL MED, V42, P1227, DOI 10.1017/S0033291711002364; Lin JW, 2008, ACT NEUR S, V101, P113; Liu CY, 2006, J HEALTHC MANAG, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Ma J, 2000, AM J HEALTH PROMOT, V15, P107, DOI 10.4278/0890-1171-15.2.107; Malec JF, 2010, ARCH PHYS MED REHAB, V91, P1087, DOI 10.1016/j.apmr.2010.04.002; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; Mortensen PB, 2003, J AFFECT DISORDERS, V76, P79, DOI 10.1016/S0165-0327(02)00073-3; Oquendo M, 2005, AM J PSYCHIAT, V162, P560, DOI 10.1176/appi.ajp.162.3.560; Orlovska S, 2014, AM J PSYCHIAT, V171, P463, DOI 10.1176/appi.ajp.2013.13020190; Patino-Alonso MC, 2015, BR J NUTR, P1; Patton GC, 2007, LANCET, V369, P1130, DOI 10.1016/S0140-6736(07)60366-3; Ritz B, 2010, ANN NEUROL, V67, P600, DOI 10.1002/ana.21937; Shen HN, 2012, PANCREAS, V41, P696, DOI 10.1097/MPA.0b013e31823db941; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Tsai MC, 2014, J PEDIATR-US, V164, P136, DOI 10.1016/j.jpeds.2013.08.042; *US SURG GEN, 1984, HLTH CONS SMOK CHRON; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; WILCOX JA, 1987, PSYCHIAT RES, V21, P303, DOI 10.1016/0165-1781(87)90013-8; Zhang Y, 2011, DISCOV MED, V11, P395	35	17	17	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0327	1573-2517		J AFFECT DISORDERS	J. Affect. Disord.	FEB	2016	191						56	61		10.1016/j.jad.2015.11.035			6	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	DB1FL	WOS:000368253400009	26650968				2022-02-06	
J	Cirulis, MM; Hamele, MT; Stockmann, CR; Bennett, TD; Bratton, SL				Cirulis, Meghan M.; Hamele, Mitchell T.; Stockmann, Chris R.; Bennett, Tellen D.; Bratton, Susan L.			Comparison of the New Adult Ventilator-Associated Event Criteria to the Centers for Disease Control and Prevention Pediatric Ventilator-Associated Pneumonia Definition (PNU2) in a Population of Pediatric Traumatic Brain Injury Patients	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						traumatic brain injury; ventilator-associated condition; ventilator-associated event; ventilator-associated pneumonia	CARE-ASSOCIATED INFECTIONS; SAFETY NETWORK; BRONCHOALVEOLAR LAVAGE; SURVEILLANCE PARADIGM; CHILDREN; DIAGNOSIS; HYPOTHERMIA; COMPLICATIONS; PREVALENCE; VALIDATION	Objectives: The new Centers for Disease Control and Prevention paradigm for ventilator-associated events is intended to simplify surveillance of infectious and noninfectious complications of mechanical ventilation in adults. We assessed the ventilator-associated events algorithm in pediatric patients. Design: A retrospective observational cohort study. Setting: This single-center study took place in a PICU at an urban academic medical facility. Patients: Pediatric (ages 0-18 yr old) trauma patients with moderate-to-severe traumatic brain injury ventilated for greater than or equal to 2 days. Measurements and Main Results: We assessed for pediatric ventilator-associated pneumonia (as defined by current Centers for Disease Control and Prevention PNU2 guidelines), adult ventilator-associated events, and an experimental ventilator-associated events definition modified for pediatric patients. We compared ventilator-associated events to ventilator-associated pneumonia to calculate the test characteristics. Thirty-nine of 119 patients (33%) developed ventilator-associated pneumonia. Sensitivity of the adult ventilator-associated condition definition was 23% (95% CI, 11-39%), which increased to 56% (95% CI, 40-72%) using the modified pediatric ventilator-associated pneumonia criterion. Specificity reached 100% for both original and modified pediatric probable ventilator-associated pneumonia using ventilator-associated events criteria. Children who developed ventilator-associated pneumonia or ventilator-associated condition had similar baseline characteristics: age, mechanism of injury, injury severity scores, and use of an intracranial pressure monitor. Diagnosis of ventilator-associated pneumonia and ventilator-associated condition portended similarly unfavorable outcomes: longer median duration of ventilation, ICU and hospital length of stay, and more discharges to rehabilitation, home health, or nursing care compared with patients with no pulmonary complication. Conclusions: Both current and modified ventilator-associated events criteria have poor sensitivity but good specificity in identifying pediatric ventilator-associated pneumonia. Despite poor sensitivity, the high specificity of the ventilator-associated events diagnoses does provide a useful and objective metric for interinstitution ICU comparison. Ventilator-associated pneumonia and ventilator-associated condition were both associated with excess morbidity in pediatric traumatic brain injury patients.	[Cirulis, Meghan M.; Stockmann, Chris R.] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT USA; [Cirulis, Meghan M.] Univ Utah, Internal Med Pediat Residency Program, Salt Lake City, UT USA; [Hamele, Mitchell T.; Bratton, Susan L.] Univ Utah, Sch Med, Dept Pediat, Div Crit Care, Salt Lake City, UT USA; [Bennett, Tellen D.] Univ Colorado, Dept Pediat, Sch Med, Pediat Crit Care, Aurora, CO USA		Cirulis, MM (corresponding author), Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT USA.; Cirulis, MM (corresponding author), Univ Utah, Internal Med Pediat Residency Program, Salt Lake City, UT USA.	meghan.cirulis@hsc.utah.edu	Sherwin, Catherine Mary Turner/B-2888-2012; Bratton, Susan L./O-2353-2013	Sherwin, Catherine Mary Turner/0000-0002-0844-3207; Bratton, Susan L./0000-0002-4605-8078; Bennett, Tellen/0000-0003-1483-4236	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NICHD K23 HD074620]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074620] Funding Source: NIH RePORTER	Dr. Cirulis received support for article research from the National Institutes of Health (NIH) (Dr. Bennett was supported by NICHD K23 HD074620). Dr. Hamele disclosed government work (This work was not part of his official duties for the U.S. government as an Army medical officer). He is an active duty United States Army officer. The views in the article do not reflect those of the Army, the Department of Defense, or the U.S. government and are those of the authors alone. Dr. Bennett received support for article research from the NIH. His institution received financial support from NICHD. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Alharfi IM, 2014, J NEUROTRAUM, V31, P452, DOI [10.1089/neu.2013.2904, 10.1089/NEU.2013.2904]; Bigham MT, 2009, J PEDIAT, V154; Boyer AF, 2015, CHEST, V147, P68, DOI 10.1378/chest.14-0544; Conway P, ASL US EFFORTS REDUC; Curley MAQ, 2006, PEDIATR CLIN N AM, V53, P1231, DOI 10.1016/j.pcl.2006.09.001; Fabregas N, 1999, THORAX, V54, P867, DOI 10.1136/thx.54.10.867; Foglia E, 2007, CLIN MICROBIOL REV, V20, P409, DOI 10.1128/CMR.00041-06; Gauvin France, 2003, Pediatr Crit Care Med, V4, P437, DOI 10.1097/01.PCC.0000090290.53959.F4; Gupta S, 2015, PEDIATR CRIT CARE ME, V16, pE65, DOI 10.1097/PCC.0000000000000338; Hamele M, 2015, J NEUROTRAUMA; Hayashi Y, 2013, CLIN INFECT DIS, V56, P471, DOI 10.1093/cid/cis926; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Kallel H, 2005, J TRAUMA, V59, P705, DOI 10.1097/01.ta.0000177749.09844.c6; Klompas M, 2007, ANN INTERN MED, V147, P803, DOI 10.7326/0003-4819-147-11-200712040-00013; Klompas M, 2014, CURR INFECT DIS REP, V16, DOI 10.1007/s11908-014-0430-0; Klompas M, 2012, CRIT CARE, V16, DOI 10.1186/cc11656; Klompas M, 2013, NEW ENGL J MED, V368, P1472, DOI 10.1056/NEJMp1300633; Klompas M, 2012, CRIT CARE MED, V40, P3154, DOI 10.1097/CCM.0b013e318260c6d9; Klompas M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018062; Klouwenberg PMCK, 2014, AM J RESP CRIT CARE, V189, P947, DOI 10.1164/rccm.201307-1376OC; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Labenne M, 1999, CRIT CARE MED, V27, P2537, DOI 10.1097/00003246-199911000-00035; Lilly CM, 2014, CRIT CARE MED, V42, P2019, DOI 10.1097/CCM.0000000000000396; Magill SS, 2014, CURR OPIN INFECT DIS, V27, P394, DOI 10.1097/QCO.0000000000000083; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Magill Shelley S, 2013, Ann Am Thorac Soc, V10, pS220, DOI 10.1513/AnnalsATS.201309-314OT; Muscedere J, 2013, CHEST, V144, P1453, DOI 10.1378/chest.13-0853; Patrick SW, 2014, PEDIATRICS, V134, P705, DOI 10.1542/peds.2014-0613; PUGIN J, 1991, AM REV RESPIR DIS, V143, P1121, DOI 10.1164/ajrccm/143.5_Pt_1.1121; Reid SR, 2001, ARCH PEDIAT ADOL MED, V155, P784, DOI 10.1001/archpedi.155.7.784; Safdar N, 2005, CRIT CARE MED, V33, P2184, DOI 10.1097/01.CCM.0000181731.53912.D9; Septimus Edward, 2015, Crit Care Med, V43, pe59, DOI 10.1097/CCM.0000000000000638; Skrupky LP, 2012, CRIT CARE MED, V40, P281, DOI 10.1097/CCM.0b013e31822d7913; Stevens JP, 2014, CRIT CARE MED, V42, P497, DOI 10.1097/CCM.0b013e3182a66903; Stoeppel CM, 2014, J TRAUMA ACUTE CARE, V77, P934, DOI 10.1097/TA.0000000000000425; Taira BR, 2009, PEDIATR CRIT CARE ME, V10, P491, DOI 10.1097/PCC.0b013e3181a3108d; Wheeler Derek S, 2011, Open Inflamm J, V4, P4; Willson DF, 2014, PEDIATR CRIT CARE ME, V15, P299, DOI 10.1097/PCC.0000000000000106	40	17	18	5	17	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	FEB	2016	17	2					157	164		10.1097/PCC.0000000000000590			8	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	DD1HW	WOS:000369672900008	26673842	Green Accepted			2022-02-06	
J	Donders, J; Strong, CAH				Donders, Jacobus; Strong, Carrie-Ann H.			Latent Structure of the Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A) After Mild Traumatic Brain Injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Executive functioning; Mild traumatic brain injury; Factor analysis	ECOLOGICAL VALIDITY; WORKING-MEMORY; OLDER-ADULTS; SELF-REPORT; SYMPTOMS; TESTS; SCHIZOPHRENIA; MULTITASKING; IMPACT	One hundred persons with mild traumatic brain injury (TBI) and their informants completed the Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A) within 1-12 months after injury. Exploratory maximum-likelihood factor analysis with oblique rotation revealed that although a traditional 2-factor model fit the informant-report data well, a 3-factor solution fit the self-report data relatively best. These factors were labeled Metacognition, Behavioral Regulation, and Emotional Regulation. The presence of a premorbid history of outpatient psychiatric treatment was strongly predictive of higher scores (reflecting more perceived problems) on each of these 3 factors. Lower educational attainment was associated with higher scores on the Behavioral Regulation factor, whereas absence of intracranial findings on neuroimaging was associated with higher scores on the Emotional Regulation factor. It is concluded that, after mild TBI, self-report data on the BRIEF-A can be interpreted along a 3-factorial model and that high elevations on this instrument are strongly affected by premorbid complications.	[Donders, Jacobus; Strong, Carrie-Ann H.] Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy St SE, Grand Rapids, MI 49503 USA		Donders, J (corresponding author), Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy St SE, Grand Rapids, MI 49503 USA.	jacobus.donders@maryfreebed.com					American Educational Research Association American Psychological Association & National Council on Measurement in Education, 2014, STAND ED PSYCH TEST; Anderson PJ, 2010, STUD NEUROPSYCHOL NE, P3; Bonelli Raphael M, 2007, Dialogues Clin Neurosci, V9, P141; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Culbertson W C, 2005, TOWER LONDON DREXEL; Donders J, 2007, BRAIN INJURY, V21, P319, DOI 10.1080/02699050701253129; Donders J, 2015, J HEAD TRAUMA REHAB, V30, pE30, DOI 10.1097/HTR.0000000000000120; Fox J., 1991, REGRESSION DIAGNOSTI; Garcia-Molina A, 2012, BRAIN INJURY, V26, P864, DOI 10.3109/02699052.2012.655362; Gioia GA, 2005, PSYCHOL ASSESS RESOU; Hatcher L, 1994, STEP BY STEP APPROAC, P325; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Jha AP, 2010, EMOTION, V10, P54, DOI 10.1037/a0018438; Kompus K, 2009, NEUROSCI LETT, V467, P76, DOI 10.1016/j.neulet.2009.10.005; Laloyaux J, 2014, PSYCHIAT RES, V217, P163, DOI 10.1016/j.psychres.2014.03.026; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levens SM, 2010, J EXP PSYCHOL GEN, V139, P654, DOI 10.1037/a0020283; Llewellyn CD, 2013, PSYCHO-ONCOLOGY, V22, P97, DOI 10.1002/pon.2065; Lovstad M, 2012, BRAIN INJURY, V26, P1586, DOI 10.3109/02699052.2012.698787; Millis SR, 2003, CHILD NEUROPSYCHOL, V9, P221, DOI 10.1076/chin.9.3.221.16455; Mitchell M, 2008, J CLIN EXP NEUROPSYC, V30, P683, DOI 10.1080/13803390701679893; Mohanty A, 2007, PSYCHOPHYSIOLOGY, V44, P343, DOI 10.1111/j.1469-8986.2007.00515.x; Murphy KR, 2004, STAT POWER ANAL; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; Pietrzak RH, 2013, DEPRESS ANXIETY, V30, P432, DOI 10.1002/da.22083; Power BD, 2012, J NEUROPSYCH CLIN N, V24, P215, DOI 10.1176/appi.neuropsych.11060145; Rabin LA, 2006, ARCH CLIN NEUROPSYCH, V21, P721, DOI 10.1016/j.acn.2006.08.004; Rike PO, 2014, BRAIN INJURY, V28, P1687, DOI 10.3109/02699052.2014.947632; Roberts ME, 2010, J PSYCHIATR RES, V44, P964, DOI 10.1016/j.jpsychires.2010.03.001; Rohling ML, 2002, ARCH CLIN NEUROPSYCH, V17, P205, DOI 10.1016/S0887-6177(01)00109-3; Roth RM, 2013, ARCH CLIN NEUROPSYCH, V28, P425, DOI 10.1093/arclin/act031; Scott JC, 2011, NEUROPSYCHOLOGY, V25, P511, DOI 10.1037/a0022491; Trontel HG, 2013, J CLIN EXP NEUROPSYC, V35, P960, DOI 10.1080/13803395.2013.844770; Tsanadis J, 2008, CLIN NEUROPSYCHOL, V22, P1080, DOI 10.1080/13854040701796928; Van der Elst W, 2008, ARCH CLIN NEUROPSYCH, V23, P787, DOI 10.1016/j.acn.2008.09.002; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339	41	17	17	0	17	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	FEB	2016	31	1					29	36		10.1093/arclin/acv048			8	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	DD8QQ	WOS:000370192400006	26209247	Bronze			2022-02-06	
J	Jang, SH; Kwon, HG				Jang, Sung Ho; Kwon, Hyeok Gyu			Injury of the Ascending Reticular Activating System in Patients With Fatigue and Hypersomnia Following Mild Traumatic Brain Injury Two Case Reports	MEDICINE			English	Article							AROUSAL SYSTEM; CONNECTIVITY; SLEEPINESS	We report on patients with post-traumatic fatigue and hypersomnia who showed injury of the lower portion of the ascending reticular activating system (ARAS) between the pontine reticular formation (RF) and the intralaminar thalamic nucleus (ILN) following mild traumatic brain injury (TBI), using diffusion tensor tractography (DTT). Two patients with mild TBI resulting from a car accident were enrolled in this study. Patient 1 was a 51-year-old woman showed abnormalities as 6.9 (cut off: 3.7 points) and 18 (cut off: 10) on the Fatigue Severity Scale and the Epworth Sleepiness Scale at 11 months after onset. Patient 2 was a 64-year-old woman who revealed abnormalities on the Fatigue Severity Scale and the Epworth Sleepiness Scale with 6.8 and 19 at 3 months after onset. In both patients, the upper ARAS in which the neural connectivity of the ILN to the cerebral cortex did not show significant abnormalities. However, we observed the narrowing of the left dorsal lower ARAS between the pontine RF and the ILN in both patients and the tearing (patient 1) and narrowing (patient 2) of the left ventral lower ARAS between the pontine RF and the hypothalamus. Injuries of the dorsal and ventral lower ARAS were demonstrated in patients with fatigue and hypersomnia following mild TBI. We believe that these injuries of the ARAS might be a pathogenetic mechanism of fatigue and hypersomnia in patients with TBI.	[Jang, Sung Ho; Kwon, Hyeok Gyu] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyung Dong, Taegu, South Korea		Kwon, HG (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyung Dong, Taegu, South Korea.	khg0715@hanmail.net			National Research Foundation of Korea (NRF) - Korea government (MSIP) [NRF-2015R1A2A2A01004073]	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (NRF-2015R1A2A2A01004073).	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS, V2nd; Beaulieu-Bonneau S, 2012, SLEEP MED, V13, P598, DOI 10.1016/j.sleep.2012.02.010; Bloch KE, 1999, RESPIRATION, V66, P440, DOI 10.1159/000029408; Edlow BL, 2013, J NEUROPATH EXP NEUR, V72, P505, DOI 10.1097/NEN.0b013e3182945bf6; Edlow BL, 2012, J NEUROPATH EXP NEUR, V71, P531, DOI 10.1097/NEN.0b013e3182588293; Jang SH, 2015, NEUROSCI LETT, V590, P58, DOI 10.1016/j.neulet.2015.01.071; Jang SH, 2015, AM J PHYS MED REHAB, V94, P250, DOI 10.1097/PHM.0000000000000274; Jang SH, 2014, NEUROSCI LETT, V579, P140, DOI 10.1016/j.neulet.2014.07.024; Menzler K, 2012, SLEEP MED, V13, P736, DOI 10.1016/j.sleep.2012.02.013; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; SCHWARTZ JE, 1993, J PSYCHOSOM RES, V37, P753, DOI 10.1016/0022-3999(93)90104-N; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Tapia JA, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.129; Yamada K, 2009, MAGN RESON MED SCI, V8, P165, DOI 10.2463/mrms.8.165; Yassin W, 2015, J CLIN SLEEP MED, V11, P581, DOI 10.5664/jcsm.4710; Yeo SS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00416; Zasler ND, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P1	19	17	17	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	FEB	2016	95	6							e2628	10.1097/MD.0000000000002628			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE5CL	WOS:000370648500001	26871783	Green Published, gold			2022-02-06	
J	Moeini-Naghani, I; Hashemi-Zonouz, T; Jabbari, B				Moeini-Naghani, Iman; Hashemi-Zonouz, Taraneh; Jabbari, Bahman			Botulinum Toxin Treatment of Spasticity in Adults and Children	SEMINARS IN NEUROLOGY			English	Article						Spasticity; Botulinum toxin; Botulinum neurotoxin; Stroke; Multiple sclerosis; Cerebral palsy; Trauma	UPPER-LIMB SPASTICITY; PLACEBO-CONTROLLED TRIAL; RANDOMIZED CONTROLLED-TRIAL; SPINAL-CORD-INJURY; QUALITY-OF-LIFE; MULTIPLE-SCLEROSIS PATIENTS; UPPER EXTREMITY SPASTICITY; TRAUMATIC BRAIN-INJURY; DOUBLE-BLIND; CEREBRAL-PALSY	Spasticity is a frequent symptom in stroke, multiple sclerosis, cerebral or spinal trauma, and cerebral palsy that affects and disables a large number of adults and children. In this review, we discuss the pathophysiology and nonpharmacologic and pharmacologic treatments of spasticity with emphasis on the role of botulinum neurotoxins (BoNTs). The world literature is reviewed on double-blind and placebo -controlled clinical trials reporting safety and efficacy of BoNT treatment in adult spasticity and spasticity of children with cerebral palsy. The evidence for efficacy is presented from recommendations of the Assessment and Therapeutics subcommittee of the American Academy of Neurology. A technical section describes the techniques and recommended doses of BoNTs in spasticity.	[Moeini-Naghani, Iman; Jabbari, Bahman] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Hashemi-Zonouz, Taraneh] Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06510 USA		Jabbari, B (corresponding author), Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA.; Jabbari, B (corresponding author), 31 Silver Pine Dr, Newport Coast, CA USA.	Bahman.jabbari@yale.edu					Alter KE, 2010, PHYS MED REH CLIN N, V21, P607, DOI 10.1016/j.pmr.2010.05.001; Arroyo R, 2013, INT J NEUROSCI, V123, P850, DOI 10.3109/00207454.2013.812084; Baker R, 2002, DEV MED CHILD NEUROL, V44, P666, DOI 10.1111/j.1469-8749.2002.tb00268.x; Bakheit AMO, 2000, STROKE, V31, P2402, DOI 10.1161/01.STR.31.10.2402; Bakheit AMO, 2001, EUR J NEUROL, V8, P559, DOI 10.1046/j.1468-1331.2001.00277.x; Barnes MP, 2003, NEUROREHAB NEURAL RE, V17, P66, DOI 10.1177/0888439002250449; Bethoux F, 2015, PHYS MED REH CLIN N, V26, P625, DOI 10.1016/j.pmr.2015.07.003; Bhakta BB, 2000, J NEUROL NEUROSUR PS, V69, P217, DOI 10.1136/jnnp.69.2.217; Bose P., 2015, TRAUMATIC BRAIN INJU; Brashear A, 2004, ARCH PHYS MED REHAB, V85, P705, DOI 10.1016/j.apmr.2003.08.077; Brashear A, 2002, NEW ENGL J MED, V347, P395, DOI 10.1056/NEJMoa011892; CENDROWSKI W, 1977, EUR NEUROL, V16, P257, DOI 10.1159/000114906; Childers MK, 2004, ARCH PHYS MED REHAB, V85, P1063, DOI 10.1016/j.apmr.2003.10.015; Copeland L, 2014, J PEDIATR-US, V165, P140, DOI 10.1016/j.jpeds.2014.01.050; Corry IS, 1997, DEV MED CHILD NEUROL, V39, P185; Crone C, 2003, BRAIN, V126, P495, DOI 10.1093/brain/awg036; Dunne JW, 2012, CLIN REHABIL, V26, P787, DOI 10.1177/0269215511432016; Elovic EP, 2015, MUSCLE NERVE; Ferrari A, 2014, RES DEV DISABIL, V35, P2505, DOI 10.1016/j.ridd.2014.06.001; FIETZEK UM, 2014, LIVER TRANSPLANT, V21, P1089, DOI DOI 10.1111/ENE.12381; French J, 2008, NEUROLOGY, V71, P1634, DOI 10.1212/01.wnl.0000336533.19610.1b; Gillen G, 2010, STROKE REHABILITATIO; GIOUX M, 1993, J APPL PHYSIOL, V75, P2629, DOI 10.1152/jappl.1993.75.6.2629; Goodin DS, 1999, MULT SCLER J, V5, P78; Gracies JM, 2015, LANCET NEUROL, V14, P992, DOI 10.1016/S1474-4422(15)00216-1; Gracies JM, 2014, ARCH PHYS MED REHAB, V95, P1303, DOI 10.1016/j.apmr.2014.03.016; Gracies JM, 2005, MUSCLE NERVE, V31, P535, DOI 10.1002/mus.20284; Gracies JM, 2005, MUSCLE NERVE, V31, P552, DOI 10.1002/mus.20285; Gronseth G, 2008, NEUROLOGY, V71, P1639, DOI 10.1212/01.wnl.0000336535.27773.c0; Hesse S, 1998, CLIN REHABIL, V12, P381, DOI 10.1191/026921598668275996; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Hyman N, 2000, J NEUROL NEUROSUR PS, V68, P707, DOI 10.1136/jnnp.68.6.707; Jain NB, 2015, JAMA-J AM MED ASSOC, V313, P2236, DOI 10.1001/jama.2015.6250; Kaji R, 2010, J NEUROL, V257, P1330, DOI 10.1007/s00415-010-5526-3; Kaji R, 2010, CURR MED RES OPIN, V26, P1983, DOI 10.1185/03007995.2010.497103; Kanovsky P, 2009, CLIN NEUROPHARMACOL, V32, P259, DOI 10.1097/WNF.0b013e3181b13308; KATZ R, 1982, BRAIN, V105, P103, DOI 10.1093/brain/105.1.103; Koman LA, 2013, J HAND SURG-AM, V38A, P435, DOI 10.1016/j.jhsa.2012.12.019; Koman LA, 2000, J PEDIATR ORTHOPED, V20, P108, DOI 10.1097/00004694-200001000-00022; Krause T, 2004, ANAESTHESIA, V59, P364, DOI 10.1111/j.1365-2044.2004.03658.x; Krigger KW, 2006, AM FAM PHYSICIAN, V73, P91; Lam K, 2012, J AM MED DIR ASSOC, V13, P477, DOI 10.1016/j.jamda.2012.03.005; Lance J.W., 1980, SPASTICITY DISORDERE, P485; Maanum G, 2011, J REHABIL MED, V43, P338, DOI 10.2340/16501977-0672; Mall V, 2006, DEV MED CHILD NEUROL, V48, P10, DOI 10.1017/S0012162206000041; Marco E, 2007, J REHABIL MED, V39, P440, DOI 10.2340/16501977-0066; Marque P, 2001, J NEUROL NEUROSUR PS, V70, P36, DOI 10.1136/jnnp.70.1.36; Martin A, 2014, NEUROPSYCH DIS TREAT, V10, P111, DOI 10.2147/NDT.S53913; Mathew A, 2005, J TROP PEDIATRICS, V51, P109, DOI 10.1093/tropej/fmh095; McCrory P, 2009, J REHABIL MED, V41, P536, DOI 10.2340/16501977-0366; Mills PB, 2015, CLIN REHABIL; Moore AP, 2008, NEUROLOGY, V71, P122, DOI 10.1212/01.wnl.0000316801.74683.c0; Nam HS, 2015, J NEUROL SCI, V357, P192, DOI 10.1016/j.jns.2015.07.028; Noreau L, 2000, AM J PHYS MED REHAB, V79, P526, DOI 10.1097/00002060-200011000-00009; Ota Tetsuo, 2014, Brain Nerve, V66, P1031; Pieper C, 2001, Pediatr Phys Ther, V13, P92, DOI 10.1097/00001577-200107000-00007; Pittock SJ, 2003, CEREBROVASC DIS, V15, P289, DOI 10.1159/000069495; Richardson D, 2000, J NEUROL NEUROSUR PS, V69, P499, DOI 10.1136/jnnp.69.4.499; Rizzo MA, 2004, MULT SCLER, V10, P589, DOI 10.1191/1352458504ms1085oa; Rosales RL, 2012, NEUROREHAB NEURAL RE, V26, P812, DOI 10.1177/1545968311430824; Santamato A, 2015, J NEUROL SCI, V350, P1, DOI 10.1016/j.jns.2015.01.033; Shaw LC, 2011, STROKE, V42, P1371, DOI 10.1161/STROKEAHA.110.582197; Simpson DM, 1996, NEUROLOGY, V46, P1306, DOI 10.1212/WNL.46.5.1306; Smith SJ, 2000, CLIN REHABIL, V14, P5, DOI 10.1191/026921500666642221; Sunnerhagen KS, 2013, NEUROLOGY, V80, pS35, DOI 10.1212/WNL.0b013e3182764aa2; Suputtitada A, 2005, DISABIL REHABIL, V27, P176, DOI 10.1080/09638280400009360; Svensson J, 2014, ACTA NEUROL SCAND, V129, P13, DOI 10.1111/ane.12139; Tao W, 2015, J PHYS THER SCI, V27, P759, DOI 10.1589/jpts.27.759; Ubhi T, 2000, ARCH DIS CHILD, V83, P481, DOI 10.1136/adc.83.6.481; Watkins CL, 2002, CLIN REHABIL, V16, P515, DOI 10.1191/0269215502cr512oa; Wedekind C, 2005, BRAIN INJURY, V19, P681, DOI 10.1080/02699050400025182; Wichers MJ, 2005, DISABIL REHABIL, V27, P583, DOI 10.1080/09638280400018445; WILLIAMS RG, 1980, J PHYSIOL-LONDON, V306, pP26; Wissel J, 1999, NEUROPEDIATRICS, V30, P120, DOI 10.1055/s-2007-973475; Yeargin-Allsopp M, 2008, PEDIATRICS, V121, P547, DOI 10.1542/peds.2007-1270; YOUNG RR, 1981, NEW ENGL J MED, V304, P96; Zwibel HL, 2009, ADV THER, V26, P1043, DOI 10.1007/s12325-009-0082-x	77	17	17	0	9	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	FEB	2016	36	1					64	72		10.1055/s-0036-1571847			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DE1NX	WOS:000370394800011	26866498				2022-02-06	
J	Zangbar, B; Khalil, M; Rhee, P; Joseph, B; Kulvatunyou, N; Tang, A; Friese, RS; O'Keeffe, T				Zangbar, Bardiya; Khalil, Mazhar; Rhee, Peter; Joseph, Bellal; Kulvatunyou, Narong; Tang, Andrew; Friese, Randall S.; O'Keeffe, Terence			Metoprolol improves survival in severe traumatic brain injury independent of heart rate control	JOURNAL OF SURGICAL RESEARCH			English	Article						Beta-blockers; Traumatic brain injury; Metoprolol; Heart rate control; Propensity score matching	BETA-BLOCKERS; CEREBRAL PERFUSION; PROPRANOLOL	Background: Multiple prior studies have suggested an association between survival and beta-blocker administration in patients with severe traumatic brain injury (TBI). However, it is unknown whether this benefit of beta-blockers is dependent on heart rate control. The aim of this study was to assess whether rate control affects survival in patients receiving metoprolol with severe TBI. Our hypothesis was that improved survival from beta-blockade would be associated with a reduction in heart rate. Methods: We performed a 7-y retrospective analysis of all blunt TBI patients at a level-1 trauma center. Patients aged >16 y with head abbreviated injury scale 4 or 5, admitted to the intensive care unit (ICU) from the operating room or emergency room (ER), were included. Patients were stratified into two groups: metoprolol and no beta-blockers. Using propensity score matching, we matched the patients in two groups in a 1: 1 ratio controlling for age, gender, race, admission vital signs, Glasgow coma scale, injury severity score, mean heart rate monitored during ICU admission, and standard deviation of heart rate during the ICU admission. Our primary outcome measure was mortality. Results: A total of 914 patients met our inclusion criteria, of whom 189 received beta-blockers. A propensity-matched cohort of 356 patients (178: metoprolol and 178: no beta-blockers) was created. Patients receiving metoprolol had higher survival than those patients who did not receive beta-blockers (78% versus 68%; P = 0.04); however, there was no difference in the mean heart rate (89.9 +/- 13.9 versus 89.9 +/- 15; P = 0.99). Nor was there a difference in the mean of standard deviation of the heart rates (14.7 +/- 6.3 versus 14.4 +/- 6.5; P = 0.65) between the two groups. In Kaplane-Meier survival analysis, patients who received metoprolol had a survival advantage (P = 0.011) compared with patients who did not receive any beta-blockers. Conclusions: Our study shows an association with improved survival in patients with severe TBI receiving metoprolol, and this effect appears to be independent of any reduction in heart rate. We suggest that beta-blockers should be administered to all severe TBI patients irregardless of any perceived beta-blockade effect on heart rate. Published by Elsevier Inc.	[Zangbar, Bardiya; Khalil, Mazhar; Rhee, Peter; Joseph, Bellal; Kulvatunyou, Narong; Tang, Andrew; Friese, Randall S.; O'Keeffe, Terence] Univ Arizona, Dept Surg, Div Trauma Crit Care Burn & Emergency Surg, Tucson, AZ 85727 USA		O'Keeffe, T (corresponding author), Univ Arizona, Dept Surg, Div Trauma Crit Care Burn & Emergency Surg, 1501 N Campbell Ave,Room 5411,POB 245063, Tucson, AZ 85727 USA.	tokeeffe@surgery.arizona.edu					Abu Khaber H, 2010, CRIT CARE MED, V38, pU21; Alali AS, 2014, NEUROCRIT CARE, V20, P514, DOI 10.1007/s12028-013-9903-5; [Anonymous], TRAUM BRAIN INJ US F; [Anonymous], TBI STAT; Arbabi S, 2007, J TRAUMA, V62, P-2; Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; ASGEIRSSON B, 1995, ACTA ANAESTH SCAND, V39, P347, DOI 10.1111/j.1399-6576.1995.tb04075.x; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; BRAUNWALD E, 1982, NEW ENGL J MED, V307, P1618; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chou EK, 2010, J TRAUMA, V69, P239, DOI 10.1097/TA.0b013e3181647c81; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; HORTNAGL H, 1980, INTENS CARE MED, V6, P169, DOI 10.1007/BF01757299; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; Kendall MJ, 1997, AM J CARDIOL, V80, pJ15, DOI 10.1016/S0002-9149(97)00833-3; Ley EJ, 2012, J TRAUMA ACUTE CARE, V73, P33, DOI 10.1097/TA.0b013e31825a769b; Ley EJ, 2010, J TRAUMA, V68, P353, DOI 10.1097/TA.0b013e3181c8269a; Ley EJ, 2009, J TRAUMA, V66, P154, DOI 10.1097/TA.0b013e31819388be; LINDEMANN JP, 1982, AM HEART J, V103, P746, DOI 10.1016/0002-8703(82)90482-3; MACKENZIE ET, 1976, AM J PHYSIOL, V231, P489, DOI 10.1152/ajplegacy.1976.231.2.489; MCAINSH J, 1990, PHARMACOL THERAPEUT, V46, P163, DOI 10.1016/0163-7258(90)90092-G; MCLEOD AA, 1982, BRIT HEART J, V47, P221; Naredi S, 2000, STROKE, V31, P901, DOI 10.1161/01.STR.31.4.901; Neil-Dwyer G, 1990, Acta Neurochir Suppl (Wien), V47, P102; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Schroeppel TJ, 2014, J TRAUMA ACUTE CARE, V76, P504, DOI 10.1097/TA.0000000000000104; Schroeppel TJ, 2010, J TRAUMA, V69, P776, DOI 10.1097/TA.0b013e3181e981b8; Sharma D, 2011, J NEUROSURG ANESTH, V23, P363, DOI 10.1097/01.ana.0000405613.27980.ea; Singh Jaspal, 2011, J Emerg Trauma Shock, V4, P446, DOI 10.4103/0974-2700.86626; WEKSLER BB, 1977, BLOOD, V49, P185	32	17	17	0	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	FEB	2016	200	2					586	592		10.1016/j.jss.2015.08.020			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	CZ1BU	WOS:000366841500022	26365164				2022-02-06	
J	Zhan, J; Gao, L; Zhou, FQ; Bai, LJ; Kuang, HM; He, LC; Zeng, XJ; Gong, HH				Zhan, Jie; Gao, Lei; Zhou, Fuqing; Bai, Lijun; Kuang, Hongmei; He, Laichang; Zeng, Xianjun; Gong, Honghan			Amplitude of Low-Frequency Fluctuations in Multiple-Frequency Bands in Acute Mild Traumatic Brain Injury	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						resting-state fMRI; mild traumatic brain injury; acute; amplitude of low-frequency fluctuations; frequency band	POSTTRAUMATIC-STRESS-DISORDER; STATE FUNCTIONAL CONNECTIVITY; DEFAULT MODE NETWORK; VOXEL-BASED ANALYSIS; VISUAL-CORTEX; MOTION; MRI; REGISTRATION; OSCILLATIONS; DYSFUNCTION	Functional disconnectivity during the resting state has been observed in mild traumatic brain injury (mTBI) patients during the acute stage. However, it remains largely unknown whether the abnormalities are related to specific frequency bands of the low-frequency oscillations (LFO). Here, we used the amplitude of low-frequency fluctuations (ALFF) to examine the amplitudes of LFO in different frequency bands (slow-5: 0.01-0.027 Hz; slow-4: 0.027-0.073 Hz; and typical: 0.01-0.08 Hz) in patients with acute mTBI. A total of 24 acute mTBI patients and 24 age-, sex-, and education-matched healthy controls participated in this study. In the typical band, acute mTBI patients showed lower standardized ALFF in the right middle frontal gyrus and higher standardized ALFF in the right lingual/fusiform gyrus and left middle occipital gyrus. Further analyses showed that the difference between groups was concentrated in a narrower (slow-4) frequency band. In the slow-5 band, mTBI patients only exhibited higher standardized ALFF in the occipital areas. No significant correlation between the mini-mental state examination score and the standardized ALFF value was found in any brain region in the three frequency bands. Finally, no significant interaction between frequency bands and groups was found in any brain region. We concluded that the abnormality of spontaneous brain activity in acute mTBI patients existed in the frontal lobe as well as in distributed brain regions associated with integrative, sensory, and emotional roles, and the abnormal spontaneous neuronal activity in different brain regions could be better detected by the slow-4 band. These findings might contribute to a better understanding of local neural psychopathology of acute mTBI. Future studies should take the frequency bands into account when measuring intrinsic brain activity of mTBI patients.	[Zhan, Jie; Gao, Lei; Zhou, Fuqing; Kuang, Hongmei; He, Laichang; Zeng, Xianjun; Gong, Honghan] Nanchang Univ, Dept Radiol, Affiliated Hosp 1, Nanchang, Peoples R China; [Bai, Lijun] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Minist Educ, Key Lab Biomed Informat Engn,Dept Biomed Engn, Xian 710049, Peoples R China		Gong, HH (corresponding author), Nanchang Univ, Dept Radiol, Affiliated Hosp 1, Nanchang, Peoples R China.	honghan_gong@sina.com		Gao, Lei/0000-0002-0081-0172	National Natural Science Foundations of ChinaNational Natural Science Foundation of China (NSFC) [81260217, 81460263, 81371630]; Shaanxi Nova Program; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities	This work was supported by the National Natural Science Foundations of China (grants 81260217,81460263,and 81371630), the Shaanxi Nova Program, and the Fundamental Research Funds for the Central Universities.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bai F, 2011, J ALZHEIMERS DIS, V23, P87, DOI 10.3233/JAD-2010-101533; Baillieux H, 2010, CORTEX, V46, P869, DOI 10.1016/j.cortex.2009.09.002; Baliki MN, 2011, J NEUROSCI, V31, P13981, DOI 10.1523/JNEUROSCI.1984-11.2011; Baria AT, 2011, J NEUROSCI, V31, P7910, DOI 10.1523/JNEUROSCI.1296-11.2011; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; Capehart B, 2012, J REHABIL RES DEV, V49, P789, DOI 10.1682/JRRD.2011.10.0185; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Gao L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120323; Garcia-Panach J, 2011, J NEUROTRAUM, V28, P1707, DOI 10.1089/neu.2011.1851; Graner J, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00016; Gross H, 1996, J NEUROPSYCH CLIN N, V8, P324; Han Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028664; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoptman MJ, 2010, SCHIZOPHR RES, V117, P13, DOI 10.1016/j.schres.2009.09.030; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mahon BZ, 2007, NEURON, V55, P507, DOI 10.1016/j.neuron.2007.07.011; Mayer AR, 2015, J NEUROTRAUM, V32, P1046, DOI 10.1089/neu.2014.3542; Mayer AR, 2014, J NEUROTRAUM, V31, P189, DOI 10.1089/neu.2013.3069; Mazard A, 2005, COGNITIVE BRAIN RES, V24, P423, DOI 10.1016/j.cogbrainres.2005.02.018; Metting Z, 2009, ANN NEUROL, V66, P809, DOI 10.1002/ana.21785; Nathan DE, 2015, BRAIN CONNECT, V5, P102, DOI 10.1089/brain.2014.0273; Nir Y, 2006, NEUROIMAGE, V30, P1313, DOI 10.1016/j.neuroimage.2005.11.018; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Rosenfeld JV, 2010, INJURY, V41, P437, DOI 10.1016/j.injury.2009.11.018; Salvador R, 2008, NEUROIMAGE, V39, P279, DOI 10.1016/j.neuroimage.2007.08.018; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Schmahmann JD, 2006, BRAIN, V129, P290, DOI 10.1093/brain/awh729; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Sui SG, 2010, ASIA-PAC PSYCHIAT, V2, P129, DOI 10.1111/j.1758-5872.2010.00076.x; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wang K, 2008, CEREB CORTEX, V18, P697, DOI 10.1093/cercor/bhm105; Wang L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051769, 10.1371/journal.pone.0039845, 10.1371/journal.pone.0045491, 10.1371/journal.pone.0044596]; Wang ZQ, 2011, HUM BRAIN MAPP, V32, P1720, DOI 10.1002/hbm.21140; Wee CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037828; Yan CG, 2013, NEUROIMAGE, V80, P246, DOI 10.1016/j.neuroimage.2013.04.081; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Yin Y, 2011, BRAIN RES, V1411, P98, DOI 10.1016/j.brainres.2011.07.016; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhou YX, 2014, J MAGN RESON IMAGING, V39, P1558, DOI 10.1002/jmri.24310; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	59	17	20	1	14	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	FEB 1	2016	10								27	10.3389/fnhum.2016.00027			9	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	DC1NX	WOS:000368984100001	26869907	gold, Green Published			2022-02-06	
J	Isokuortti, H; Iverson, GL; Kataja, A; Brander, A; Ohman, J; Luoto, TM				Isokuortti, Harri; Iverson, Grant L.; Kataja, Anneli; Brander, Antti; Ohman, Juha; Luoto, Teemu M.			Who Gets Head Trauma or Recruited in Mild Traumatic Brain Injury Research?	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; comorbidity; concussion; head injury; patient recruitment	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; WHITE-MATTER INTEGRITY; MAJOR DEPRESSIVE DISORDER; TENSOR IMAGING FINDINGS; PSYCHIATRIC-DISORDERS; COGNITIVE IMPAIRMENT; EMERGENCY-DEPARTMENT; EXECUTIVE FUNCTION; SUBSTANCE-ABUSE; WORKING-MEMORY	Mild traumatic brain injury (mTBI) is a public health problem. Outcome from mTBI is heterogeneous in part due to pre-injury individual differences that typically are not well described or understood. Pre-injury health characteristics of all consecutive patients (n=3023) who underwent head computed tomography due to acute head trauma in the emergency department of Tampere University Hospital, Finland, between August 2010 and July 2012 were examined. Patients were screened to obtain a sample of working age adults with no pre-injury medical or mental health problems who had sustained a pure mTBI. Of all patients screened, 1990 (65.8%) fulfilled the mTBI criteria, 257 (8.5%) had a more severe TBI, and 776 (25.7%) had a head trauma without obvious signs of brain injury. Injury-related data and participant-related data (e.g., age, sex, diagnosed diseases, and medications) were collected from hospital records. The most common pre-injury diseases were circulatory (39.4%-43.2%), neurological (23.7%-25.2%), and psychiatric (25.8%-27.5%) disorders. Alcohol abuse was present in 18.4%-26.8%. The most common medications were for cardiovascular (33.1%-36.6%), central nervous system (21.4%-30.8%), and blood clotting and anemia indications (21.5%-22.6%). Of the screened patients, only 2.5% met all the enrollment criteria. Age, neurological conditions, and psychiatric problems were the most common reasons for exclusion. Most of the patients sustaining an mTBI have some pre-injury diseases or conditions that could affect clinical outcome. By excluding patients with pre-existing conditions, the patients with known risk factors for poor outcome remain poorly studied.	[Isokuortti, Harri] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Iverson, Grant L.] Harvard Univ, Dept Phys Med & Rehabil, Sch Med, Boston, MA USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Boston, MA USA; [Iverson, Grant L.] MassGen Hosp Children, Sports Concuss Program, Boston, MA USA; [Iverson, Grant L.] Red Sox Fdn, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp, Home Base Program, Boston, MA 02114 USA; [Kataja, Anneli; Brander, Antti] Tampere Univ Hosp, Dept Radiol, Tampere, Finland; [Ohman, Juha] Tampere Univ Hosp, Dept Neurosci & Rehabil, Tampere, Finland; [Luoto, Teemu M.] Tampere Univ Hosp, Dept Neurosurg, Tampere, Finland		Isokuortti, H (corresponding author), Univ Tampere, Sch Med, Tampereen Yliopisto 33014, Finland.	harri.isokuortti@gmail.com	Luoto, Teemu/W-6468-2018	Luoto, Teemu/0000-0002-7329-3284; Iverson, Grant/0000-0001-7348-9570; Ohman, Juha/0000-0002-6592-1367	INTRuST Posttraumatic Stress Disorder and Traumatic Brain Injury Clinical Consortium - Department of Defense Psychological Health/Traumatic Brain Injury Research Program [X81XWH-07-CC-CSDoD]	The authors thank research assistants Anne Simi and Marika Suopanki-Ervasti for their contribution in data collection. GLI notes that he was supported in part by the INTRuST Posttraumatic Stress Disorder and Traumatic Brain Injury Clinical Consortium funded by the Department of Defense Psychological Health/Traumatic Brain Injury Research Program (X81XWH-07-CC-CSDoD). This study was conducted as part of the first author's PhD thesis research program.	Alderson RM, 2013, NEUROPSYCHOLOGY, V27, P287, DOI 10.1037/a0032371; Ashley J, 1990, Health Trends, V22, P135; Backman L, 2005, NEUROPSYCHOLOGY, V19, P520, DOI 10.1037/0894-4105.19.4.520; Baker STE, 2013, NEUROSCI BIOBEHAV R, V37, P1713, DOI 10.1016/j.neubiorev.2013.06.015; Baldacchino A, 2012, NEUROSCI BIOBEHAV R, V36, P2056, DOI 10.1016/j.neubiorev.2012.06.006; Barker MJ, 2004, ARCH CLIN NEUROPSYCH, V19, P437, DOI 10.1016/S0887-6177(03)00096-9; Bell RP, 2011, DRUG ALCOHOL DEPEN, V114, P159, DOI 10.1016/j.drugalcdep.2010.10.001; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cheng G, 2012, INTERN MED J, V42, P484, DOI 10.1111/j.1445-5994.2012.02758.x; Colby JB, 2012, PSYCHIAT RES-NEUROIM, V204, P140, DOI 10.1016/j.pscychresns.2012.04.017; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Fortier-Brochu E, 2012, SLEEP MED REV, V16, P83, DOI 10.1016/j.smrv.2011.03.008; Frazier TW, 2004, NEUROPSYCHOLOGY, V18, P543, DOI 10.1037/0894-4105.18.3.543; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gifford KA, 2013, ARCH CLIN NEUROPSYCH, V28, P649, DOI 10.1093/arclin/act046; Gons RAR, 2010, STROKE, V41, P2801, DOI 10.1161/STROKEAHA.110.597237; Gordon KE, 2006, PEDIATR NEUROL, V34, P376, DOI 10.1016/j.pediatrneurol.2005.09.007; Hartholt KA, 2011, J NEUROTRAUM, V28, P739, DOI 10.1089/neu.2010.1488; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hoogenboom WS, 2014, DIABETES, V63, P728, DOI 10.2337/db13-1219; Horner MD, 2005, J INT NEUROPSYCH SOC, V11, P322, DOI 10.1017/S135561770505037X; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Iverson GL., 2012, PTSD MILD TRAUMATIC; Kloppenborg RP, 2014, NEUROLOGY, V82, P2127, DOI 10.1212/WNL.0000000000000505; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P478, DOI 10.1093/arclin/acu027; Lange RT, 2014, J NEUROTRAUM, V31, P198, DOI 10.1089/neu.2013.2866; Laws KR, 2007, HUM PSYCHOPHARM CLIN, V22, P381, DOI 10.1002/hup.857; Lebel C, 2013, PSYCHIAT RES-NEUROIM, V213, P161, DOI 10.1016/j.pscychresns.2013.04.002; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Luoto TM, 2014, J NEUROTRAUM, V31, P728, DOI 10.1089/neu.2013.3174; Luoto TM, 2013, J NEUROTRAUM, V30, P11, DOI 10.1089/neu.2012.2611; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Mack LR, 2003, J EMERG MED, V24, P157, DOI 10.1016/S0736-4679(02)00714-X; Madden DJ, 2012, BBA-MOL BASIS DIS, V1822, P386, DOI 10.1016/j.bbadis.2011.08.003; Maller JJ, 2010, BRAIN RES REV, V64, P213, DOI 10.1016/j.brainresrev.2010.04.003; Monnig MA, 2013, PSYCHOL ADDICT BEHAV, V27, P455, DOI 10.1037/a0027168; Olaithe M, 2013, SLEEP, V36, P1297, DOI 10.5665/sleep.2950; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Poyry T, 2013, J HEAD TRAUMA REHAB, V28, P89, DOI 10.1097/HTR.0b013e318250eadd; Puljula J, 2007, ALCOHOL ALCOHOLISM, V42, P474, DOI 10.1093/alcalc/agm003; Sareen J, 2013, DEPRESS ANXIETY, V30, P321, DOI 10.1002/da.22077; Savola O, 2005, ALCOHOL ALCOHOLISM, V40, P269, DOI 10.1093/alcalc/agh159; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Silverberg ND, 2014, BRAIN INJURY, V28, P1590, DOI 10.3109/02699052.2014.943287; Smith E, 2011, OBES REV, V12, P740, DOI 10.1111/j.1467-789X.2011.00920.x; Snyder HR, 2013, PSYCHOL BULL, V139, P81, DOI 10.1037/a0028727; Stanek KM, 2011, OBESITY, V19, P500, DOI 10.1038/oby.2010.312; Stavro K, 2013, ADDICT BIOL, V18, P203, DOI 10.1111/j.1369-1600.2011.00418.x; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Swanson HL, 2009, J LEARN DISABIL-US, V42, P260, DOI 10.1177/0022219409331958; Symonds C. P., 1937, GUYS HOSP GAZETTE; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Tosetti P, 2013, J NEUROTRAUM, V30, P1211, DOI 10.1089/neu.2013.2896; Umene-Nakano W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087890; van Ewijk H, 2012, NEUROSCI BIOBEHAV R, V36, P1093, DOI 10.1016/j.neubiorev.2012.01.003; Vandermosten M, 2012, NEUROSCI BIOBEHAV R, V36, P1532, DOI 10.1016/j.neubiorev.2012.04.002; Walhovd KB, 2010, AM J NEURORADIOL, V31, P894, DOI 10.3174/ajnr.A1957; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Whelan-Goodinson R, 2008, J REHABIL MED, V40, P850, DOI 10.2340/16501977-0271; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970	76	17	17	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2016	33	2					232	241		10.1089/neu.2015.3888			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	DA7PH	WOS:000367995800009	26054639				2022-02-06	
J	Francis, HM; Fisher, A; Rushby, JA; McDonald, S				Francis, Heather M.; Fisher, Alana; Rushby, Jacqueline A.; McDonald, Skye			Reduced heart rate variability in chronic severe traumatic brain injury: Association with impaired emotional and social functioning, and potential for treatment using biofeedback	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; Heart rate variability; Social cognition; Emotion	NEUROVISCERAL INTEGRATION; INDIVIDUAL-DIFFERENCES; COGNITIVE PERFORMANCE; NERVOUS-SYSTEM; EMPATHY; ALEXITHYMIA; RECOGNITION; DEPRESSION; BEHAVIOR; DAMAGE	Heart rate variability (HRV) may provide an index of capacity for social functioning and may be remediated by HRV biofeedback. Given reductions in HRV are found following traumatic brain injury (TBI), the present study aimed to determine whether lower HRV in TBI is associated with social function, and whether HRV biofeedback might be a useful remediation technique in this population. Resting state HRV and measures of social and emotional processing were collected in 30 individuals with severe TBI (3-34years post-injury) and 30 controls. This was followed by a single session of HRV biofeedback. HRV was positively associated with social cognition and empathy, and negatively associated with alexithymia for the TBI group. Both TBI and control groups showed significantly increased HRV on both time-domain (i.e., SDNN, rMSSD) and frequency-domain measures (LF, HF, LF:HF ratio) during biofeedback compared to baseline. These results suggest that decreased HRV is linked to social and emotional function following severe TBI, and may be a novel target for therapy using HRV biofeedback techniques.	[Francis, Heather M.; Fisher, Alana; Rushby, Jacqueline A.; McDonald, Skye] Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia		Francis, HM (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia.	h.francis@unsw.edu.au	Fisher, Alana/T-1869-2019; Rushby, Jacqueline/D-1820-2010	Rushby, Jacqueline/0000-0002-5018-638X; Fisher, Alana/0000-0002-6027-659X; Francis, Heather/0000-0002-7223-7782	Australian National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia [APP1013796]; Centre of Research Excellence in traumatic brain injury - NHMRCNational Health and Medical Research Council of Australia	JAR is supported by an Australian National Health and Medical Research Council (NHMRC) Postdoctoral Fellowship [Clinical Training; APP1013796]. The project was supported by other initiatives including a Centre of Research Excellence in traumatic brain injury funded by NHMRC. The researchers received no direct personal benefit of a financial or other kind.	Alcala V., 2013, REV PSICOPATOLOGIA P, V18, P73, DOI [10.5944/rppc.vol.18.num.1.2013.12764, DOI 10.5944/RPPC.VOL.18.NUM.1.2013.12764]; Alvares GA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070468; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Baguley IJ, 2006, BRAIN INJURY, V20, P437, DOI 10.1080/02699050600664715; Bal E, 2010, J AUTISM DEV DISORD, V40, P358, DOI 10.1007/s10803-009-0884-3; Berger S, 2010, PROG NEURO-PSYCHOPH, V34, P406, DOI 10.1016/j.pnpbp.2010.01.009; Camm AJ, 1996, CIRCULATION, V93, P1043; Cicerone KD, 1997, ARCH CLIN NEUROPSYCH, V12, P173, DOI 10.1016/S0887-6177(96)00022-4; Daluwatte C, 2013, J AUTISM DEV DISORD, V43, P1910, DOI 10.1007/s10803-012-1741-3; Davis M.H., 1980, JSAS CATALOG SELECTE, V10, P85; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; de Sousa A, 2012, J CLIN EXP NEUROPSYC, V34, P606, DOI 10.1080/13803395.2012.667067; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; de Sousa A, 2010, NEUROPSYCHOLOGIA, V48, P3585, DOI 10.1016/j.neuropsychologia.2010.08.008; Diamond LM, 2013, INT J PSYCHOPHYSIOL, V88, P339, DOI 10.1016/j.ijpsycho.2012.08.008; Diamond LM, 2011, PERS SOC PSYCHOL B, V37, P731, DOI 10.1177/0146167211400620; Diamond LM, 2005, J SOC PERS RELAT, V22, P499, DOI 10.1177/0265407505054520; Forbes CE, 2010, ANNU REV NEUROSCI, V33, P299, DOI 10.1146/annurev-neuro-060909-153230; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; Holt-Lunstad J, 2007, ANN BEHAV MED, V33, P278, DOI 10.1007/BF02879910; Karavidas MK, 2007, APPL PSYCHOPHYS BIOF, V32, P19, DOI 10.1007/s10484-006-9029-z; Kemp AH, 2010, BIOL PSYCHIAT, V67, P1067, DOI [10.1016/j.biopsych.2009.12.012, 10.1016/j.biopsych.2009.11.019]; Keren O, 2005, BRAIN INJURY, V19, P605, DOI 10.1080/02699050400024946; Kim S, 2013, BRAIN INJURY, V27, P209, DOI 10.3109/02699052.2012.729292; King ML, 1997, BRAIN INJURY, V11, P445; Kraus M. F., 1999, TRAUMATIC BRAIN INJU, V14; LACQUANITI LG, 1993, INT J CLIN MONIT COM, V10, P181, DOI 10.1007/BF01246453; Lane RD, 2009, NEUROIMAGE, V44, P213, DOI 10.1016/j.neuroimage.2008.07.056; Lehrer PM, 2003, PSYCHOSOM MED, V65, P796, DOI 10.1097/01.PSY.0000089200.81962.19; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; McDonald S, 2011, J CLIN EXP NEUROPSYC, V33, P17, DOI 10.1080/13803391003761967; MEHRABIAN A, 1972, J PERS, V40, P525, DOI 10.1111/j.1467-6494.1972.tb00078.x; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Neumann D, 2012, ARCH PHYS MED REHAB, V93, P1414, DOI 10.1016/j.apmr.2012.03.009; Nunan D, 2010, PACE, V33, P1407, DOI 10.1111/j.1540-8159.2010.02841.x; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Porges SW, 2003, PHYSIOL BEHAV, V79, P503, DOI 10.1016/S0031-9384(03)00156-2; Prinsloo GE, 2011, APPL COGNITIVE PSYCH, V25, P792, DOI 10.1002/acp.1750; Quintana DS, 2012, INT J PSYCHOPHYSIOL, V86, P168, DOI 10.1016/j.ijpsycho.2012.08.012; Rapenne T, 2001, J NEUROSURG ANESTH, V13, P260, DOI 10.1097/00008506-200107000-00016; Riganello F, 2010, CLIN NEUROPHYSIOL, V121, P2024, DOI 10.1016/j.clinph.2010.05.010; Sanchez-Navarro JP, 2005, BEHAV NEUROSCI, V119, P87, DOI 10.1037/0735-7044.119.1.87; Siepmann M, 2008, APPL PSYCHOPHYS BIOF, V33, P195, DOI 10.1007/s10484-008-9064-z; Soo CA., 2005, BRAIN IMPAIR, V6, P75, DOI [DOI 10.1375/BRIM.2005.6.2.75, 10.1375/brim.2005.6.2.75]; Thayer JF, 2000, J AFFECT DISORDERS, V61, P201, DOI 10.1016/S0165-0327(00)00338-4; Thayer JF, 2009, ANN BEHAV MED, V37, P141, DOI 10.1007/s12160-009-9101-z; Tranel D, 2002, CORTEX, V38, P589, DOI 10.1016/S0010-9452(08)70024-8; Vaschillo E, 2002, APPL PSYCHOPHYS BIOF, V27, P1, DOI 10.1023/A:1014587304314; von Borries AKL, 2012, PSYCHIAT RES, V200, P761, DOI 10.1016/j.psychres.2012.06.026; Vorst HCM, 2001, PERS INDIV DIFFER, V30, P413, DOI 10.1016/S0191-8869(00)00033-7; Wells R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046597; Williams C, 2009, ARCH CLIN NEUROPSYCH, V24, P478; Wood RL, 2008, J INT NEUROPSYCH SOC, V14, P289, DOI 10.1017/S1355617708080326; Zucker TL, 2009, APPL PSYCHOPHYS BIOF, V34, P135, DOI 10.1007/s10484-009-9085-2	58	17	18	2	48	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JAN 2	2016	26	1					103	125		10.1080/09602011.2014.1003246			23	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	CU7EM	WOS:000363699300005	25627984				2022-02-06	
J	Scott, KL; Strong, CAH; Gorter, B; Donders, J				Scott, Katie L.; Strong, Carrie-Ann H.; Gorter, Bethany; Donders, Jacobus			Predictors of Post-concussion Rehabilitation Outcomes at Three-month Follow-up	CLINICAL NEUROPSYCHOLOGIST			English	Article						Mild traumatic brain injury; Rehabilitation.; Outcome measurement	TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; NEUROPSYCHOLOGICAL OUTCOMES; POSTCONCUSSIVE SYMPTOMS; METAANALYSIS; PERFORMANCE	Objective: To determine factors related to three-month follow-up outcomes for individuals participating in an outpatient rehabilitative treatment program for mild traumatic brain injury (TBI). Method: Fifty participants underwent neuropsychological screening prior to treatment initiation and completed the Mayo-Portland Adaptability Inventory-4 (MPAI-4) at treatment initiation, discharge from treatment, and three months following discharge. Results: Regression models indicated that information garnered from the neuropsychological screening prior to treatment initiation (e.g., mood symptoms and prior psychiatric history) accounted for unique variance in three-month post-discharge outcomes on several MPAI-4 subscales. Specifically, after controlling for baseline MPAI-4 ratings, higher Beck Depression Inventory-second edition (BDI-II) scores were associated with worse MPAI-4 Ability scores at three-month follow-up, and the presence of a psychiatric history was associated with worse MPAI-4 Adjustment scores at three-month follow-up. Conclusions: Neuropsychological screening prior to the initiation of treatment for mild TBI can help to identify patients who may be at greater risk for poorer rehabilitation outcomes, thus allowing for the implementation of specific interventions to address these risk factors.	[Scott, Katie L.; Strong, Carrie-Ann H.; Donders, Jacobus] Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy SE, Grand Rapids, MI 49503 USA; [Gorter, Bethany] Calvin Coll, Dept Psychol, Grand Rapids, MI 49506 USA		Strong, CAH (corresponding author), Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy SE, Grand Rapids, MI 49503 USA.	carrie.strong@maryfreebed.com					Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Azulay J, 2013, J HEAD TRAUMA REHAB, V28, P323, DOI 10.1097/HTR.0b013e318250ebda; Beck A, 1996, BECK DEPRESSION INVE, P12, DOI DOI 10.1037/T00742-000; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P1016, DOI 10.1080/13854040802441135; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS278, DOI 10.1016/j.apmr.2013.08.295; Centers for Disease Control and Prevention, 2003, C MILD TRAUM BRAIN I; Dikmen SS, 1999, J INT NEUROPSYCH SOC, V5, P346, DOI 10.1017/S1355617799544056; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Donders J, 2007, BRAIN INJURY, V21, P319, DOI 10.1080/02699050701253129; Eicher V, 2012, ARCH PHYS MED REHAB, V93, P100, DOI 10.1016/j.apmr.2011.06.038; Fox J, 1991, QUANTITATIVE APPL SO; Harrell Jr F. E., 2001, REGRESSION MODELING, DOI [10.1007/978-1-4757-3462-1, DOI 10.1007/978-1-4757-3462-1]; Heaton R. K., 2004, REVISED COMPREHENSIV; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kumar RG, 2014, AM J PHYS MED REHAB, V93, P687, DOI 10.1097/PHM.0000000000000077; Larson EB, 2013, J INT NEUROPSYCH SOC, V19, P88, DOI 10.1017/S1355617712000999; Leininger S, 2014, J HEAD TRAUMA REHAB, V29, P109, DOI 10.1097/HTR.0b013e3182860506; Lezak, 2008, MANUAL MAYO PORTLAND; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Malec J., 2005, MAYO PORTLAND ADAPTA; McCrea M., 2008, MILD TRAUMATIC BRAIN; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Millis SR, 2003, CHILD NEUROPSYCHOL, V9, P221, DOI 10.1076/chin.9.3.221.16455; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Murphy KR, 2004, STAT POWER ANAL; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Reitan R. M., 1985, HALSTEED REITAN NEUR; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P313, DOI 10.1097/HTR.0b013e3182915cb5; Snell DL, 2013, NEUROPSYCHOL REHABIL, V23, P333, DOI 10.1080/09658211.2012.758419; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105	41	17	17	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	JAN 2	2016	30	1					66	81		10.1080/13854046.2015.1127427			16	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	DH4CM	WOS:000372733100005	26732525				2022-02-06	
J	Afshar, M; Netzer, G; Salisbury-Afshar, E; Murthi, S; Smith, GS				Afshar, Majid; Netzer, Giora; Salisbury-Afshar, Elizabeth; Murthi, Sarah; Smith, Gordon S.			Injured patients with very high blood alcohol concentrations	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Injury; Injury prevention; Blood alcohol level; Ethanol; Trauma recidivism; Alcohol consumption; Alcohol use disorder; Blunt trauma; Forensic toxicology; Alcohol poisoning	TRAUMA CENTER PATIENTS; GLASGOW COMA SCALE; INTOXICATION; SEVERITY; ETHANOL; DEATHS; SCORE; VALIDATION; DRIVER; ABUSE	Objective: Most data regarding high blood alcohol concentrations (BAC) >= 400 mg/dL have been from alcohol poisoning deaths. Few studies have described this group and reported their alcohol consumption patterns or outcomes compared to other trauma patients. We hypothesised trauma patients with very high BACs arrived to the trauma centre with less severe injuries than their sober counterparts. Method: Historical cohort of 46,222 patients admitted to a major trauma centre between January 1, 2002 and October 31, 2011. BAC was categorised into ordinal groups by 100 mg/dL intervals. Alcohol questionnaire data on frequency and quantity was captured in the BAC >= 400 mg/dL group. The primary analysis was for BAC >= 400 mg/dL. Results: BAC was recorded in 44,502 (96.3%) patients. Those with a BAC >= 400 mg/dL accounted for 1.1% (147) of BAC positive cases. These patients had the lowest proportion of severe trauma and in-hospital death in comparison with the other alcohol groups (p < 0.001). In adjusted analysis, the risk for severe injury increased with the BAC groups between 1 and 199 mg/dL and was not different or decreased for groups above 200 mg/dL in reference to the BAC negative group (test for trend p = 0.001). BAC >= 400 group encountered more injuries caused by blunt trauma in comparison with the other alcohol groups (p < 0.001), and the group comprised mainly of falls. Admission Glasgow Coma Scale was a poor predictor for traumatic brain injury in the high BAC group. Readmission occurred in 22.4% (33) of patients the BAC >= 400 group. The majority of these patients reported drinking alcohol 4 or more days per week (81, 67.5%) and five or more drinks per day (79, 65.8%), evident of risky alcohol use. Conclusions: Most traumas admitted with BAC >= 400 mg/dL survived and their injuries were less severe than their less intoxicated and sober counterparts. They also had evidence for risky alcohol use and nearly one-quarter returned to the trauma centre with another injury over the study period. Recognition of this highest BAC group presents an opportunity to provide focused care for their risky alcohol use. (C) 2015 Elsevier Ltd. All rights reserved.	[Afshar, Majid] Loyola Univ Hlth Sci, Div Pulm & Crit Care Med, Maywood, IL USA; [Afshar, Majid] Loyola Univ, Sch Med, Dept Publ Hlth Sci, Maywood, IL 60153 USA; [Netzer, Giora] Univ Maryland, Div Pulm & Crit Care Med, Baltimore, MD 21201 USA; [Netzer, Giora; Smith, Gordon S.] Univ Maryland, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Salisbury-Afshar, Elizabeth] Heartland Hlth Outreach, Chicago, IL USA; [Murthi, Sarah] Univ Maryland, R Adams Cowley Shock Trauma Ctr, Program Trauma, Baltimore, MD 21201 USA; [Smith, Gordon S.] Univ Maryland, Shock Trauma & Anesthesiol Res STAR Organized Res, Baltimore, MD 21201 USA		Afshar, M (corresponding author), 2160 South First Ave,Bldg 54, Maywood, IL 60153 USA.	majid_afshar@luhs.org	Salisbury-Afshar, Elizabeth M/AAK-4180-2020; Afshar, Majid/AAD-8365-2019	Afshar, Majid/0000-0002-6368-4652; Smith, Gordon/0000-0002-2911-3071; Salisbury-Afshar, Elizabeth/0000-0003-4096-6822	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1RO1AA018313];  [F32AA022553-01]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA018313, F32AA022553] Funding Source: NIH RePORTER	This research was supported in part by National Institute of Health grants 1RO1AA018313 (Gordon Smith) and F32AA022553-01 (Majid Afshar).	ADACHI J, 1991, J STUD ALCOHOL, V52, P448, DOI 10.15288/jsa.1991.52.448; Afshar M, 2014, J TRAUMA ACUTE CARE, V76, P1447, DOI 10.1097/TA.0000000000000238; BRICKLEY MR, 1995, INJURY, V26, P311, DOI 10.1016/0020-1383(95)00034-7; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; CIVIL ID, 1988, J TRAUMA, V28, P87, DOI 10.1097/00005373-198801000-00012; Fleming M, 2009, ALCOHOL CLIN EXP RES, V33, P1777, DOI 10.1111/j.1530-0277.2009.01016.x; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Friedman LS, 2012, ALCOHOL, V46, P769, DOI 10.1016/j.alcohol.2012.08.006; Friedmann PD, 2001, J STUD ALCOHOL, V62, P234, DOI 10.15288/jsa.2001.62.234; Friedmann PD, 2013, NEW ENGL J MED, V368, P365, DOI [10.1056/NEJMcp1204714, 10.1056/NEJMc1302445]; Garriott J, 2008, GARRIOTS MEDICOLEGAL; Gentilello LM, 1999, ANN SURG, V230, P473, DOI 10.1097/00000658-199910000-00003; Graham JDP, 1962, DIAGNOSIS TREATMENT; HEATLEY MK, 1990, MED SCI LAW, V30, P101, DOI 10.1177/002580249003000203; Jones AW, 2003, J FORENSIC SCI, V48, P874; Jones AW, 1999, J STUD ALCOHOL, V60, P400, DOI 10.15288/jsa.1999.60.400; JURKOVICH GJ, 1992, ANN EMERG MED, V21, P704, DOI 10.1016/S0196-0644(05)82783-0; JURKOVICH GJ, 1993, JAMA-J AM MED ASSOC, V270, P51, DOI 10.1001/jama.270.1.51; Kanny D, 2015, MMWR-MORBID MORTAL W, V63, P1238; Knight B, 1991, FORENSIC PATHOLOGY; MacLeod JBA, 2011, INJURY, V42, P922, DOI 10.1016/j.injury.2010.01.098; PERPER JA, 1986, J FORENSIC SCI, V31, P212; Purssell RA, 2001, ANN EMERG MED, V38, P653, DOI 10.1067/mem.2001.119455; RIVARA FP, 1993, JAMA-J AM MED ASSOC, V270, P1962, DOI 10.1001/jama.270.16.1962; Simpson K, 1952, FORENSIC MED; Smith GS, 1999, ANN EMERG MED, V33, P659, DOI 10.1016/S0196-0644(99)70195-2; Soderstrom CA, 1997, ACCIDENT ANAL PREV, V29, P715, DOI 10.1016/S0001-4575(97)00040-7; Soderstrom CA, 1997, JAMA-J AM MED ASSOC, V277, P1769, DOI 10.1001/jama.277.22.1769; Soderstrom CA, 2007, J TRAUMA, V62, P1102, DOI 10.1097/TA.0b013e31804bdb26; Sperry JL, 2006, J TRAUMA, V61, P1305, DOI 10.1097/01.ta.0000240113.13552.96; Stahre M, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130293; Stuke L, 2007, ANN SURG, V245, P651, DOI 10.1097/01.sla.0000250413.41265.d3; TAYLOR HL, 1977, J FORENSIC SCI, V22, P639; TEASDALE G, 1974, LANCET, V2, P81; WALLER PF, 1986, JAMA-J AM MED ASSOC, V256, P1461, DOI 10.1001/jama.256.11.1461; WINEK CL, 1976, CLIN CHEM, V22, P832	36	17	17	1	13	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JAN	2016	47	1					83	88		10.1016/j.injury.2015.10.063			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	CZ8HD	WOS:000367339900016	26556488	Green Accepted			2022-02-06	
J	Belanger, HG; Lange, RT; Bailie, J; Iverson, GL; Arrieux, JP; Ivins, BJ; Cole, WR				Belanger, Heather G.; Lange, Rael T.; Bailie, Jason; Iverson, Grant L.; Arrieux, Jacques P.; Ivins, Brian J.; Cole, Wesley R.			Interpreting change on the neurobehavioral symptom inventory and the PTSD checklist in military personnel	CLINICAL NEUROPSYCHOLOGIST			English	Article						Traumatic brain injury; mild TBI; PTSD; military; concussion; reliable change	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; POSTCONCUSSION SYMPTOMS; CLINICAL-SIGNIFICANCE; CIVILIAN VERSION; SERVICE MEMBERS; NATIONAL-GUARD; NORMATIVE DATA; IRAQ; ASSOCIATIONS	Objective: The purpose of this study was to examine the prevalence and stability of symptom reporting in a healthy military sample and to develop reliable change indices for two commonly used self-report measures in the military health care system. Participants and method: Participants were 215 U.S. active duty service members recruited from Fort Bragg, NC as normal controls as part of a larger study. Participants completed the Neurobehavioral Symptom Inventory (NSI) and Posttraumatic Checklist (PCL) twice, separated by approximately 30days. Results: Depending on the endorsement level used (i.e. ratings of mild' or greater vs. ratings of moderate' or greater), approximately 2-15% of this sample met DSM-IV symptom criteria for Postconcussional Disorder across time points, while 1-6% met DSM-IV symptom criteria for Posttraumatic Stress Disorder. Effect sizes for change from Time 1 to Time 2 on individual symptoms were small (Cohen's d=.01 to .13). The test-retest reliability for the NSI total score was r=.78 and the PCL score was r=.70. An eight-point change in symptom reporting represented reliable change on the NSI total score, with a seven-point change needed on the PCL. Conclusions: Postconcussion-like symptoms are not unique to mild TBI and are commonly reported in a healthy soldier sample. It is important for clinicians to use normative data when evaluating a service member or veteran and when evaluating the likelihood that a change in symptom reporting is reliable and clinically meaningful.	[Belanger, Heather G.] James A Haley VAMC, Dept Mental Hlth & Behav Sci, Tampa, FL 33612 USA; [Belanger, Heather G.] Univ S Florida, Dept Psychiat & Behav Neurosci, Tampa, FL 33620 USA; [Belanger, Heather G.; Lange, Rael T.; Bailie, Jason; Iverson, Grant L.; Arrieux, Jacques P.; Ivins, Brian J.; Cole, Wesley R.] Def & Vet Brain Injury Ctr, Silver Spring, MD 20910 USA; [Lange, Rael T.] Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Lange, Rael T.] Univ British Columbia, Vancouver, BC, Canada; [Bailie, Jason] Naval Hosp, Camp Pendleton, CA USA; [Iverson, Grant L.] Harvard Med Sch, Boston, MA USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Charlestown, MA USA; [Iverson, Grant L.] Red Sox Fdn, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp, Home Base Program, Boston, MA 02114 USA; [Arrieux, Jacques P.; Cole, Wesley R.] Womack Army Med Ctr, Ft Bragg, NC USA		Belanger, HG (corresponding author), James A Haley VAMC, Dept Mental Hlth & Behav Sci, Tampa, FL 33612 USA.; Belanger, HG (corresponding author), Univ S Florida, Dept Psychiat & Behav Neurosci, Tampa, FL 33620 USA.; Belanger, HG (corresponding author), Def & Vet Brain Injury Ctr, Silver Spring, MD 20910 USA.	Heather.Belanger@va.gov		Iverson, Grant/0000-0001-7348-9570			American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Belanger HG, 2017, J HEAD TRAUMA REHAB, V32, P46, DOI 10.1097/HTR.0000000000000208; Belanger HG, 2015, MIL MED, V180, P192, DOI 10.7205/MILMED-D-14-00388; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Bryant RA, 2009, J INT NEUROPSYCH SOC, V15, P862, DOI 10.1017/S1355617709990671; Chemtob CM, 1998, J NERV MENT DIS, V186, P701, DOI 10.1097/00005053-199811000-00007; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cohen J., 2013, STAT POWER ANAL BEHA; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Conybeare D, 2012, J CLIN PSYCHOL, V68, P699, DOI 10.1002/jclp.21845; Department of Veterans Affairs, 2010, SCREEN EV POSS TRAUM; Department of Veterans Affairs and Department of Defense, 2009, VA DOD CLIN PRACT GU; Dretsch M, 2016, J HEAD TRAUMA REHAB, V31, P23, DOI 10.1097/HTR.0000000000000109; Duff K, 2012, ARCH CLIN NEUROPSYCH, V27, P248, DOI 10.1093/arclin/acr120; Gewirtz AH, 2010, J CONSULT CLIN PSYCH, V78, P599, DOI 10.1037/a0020571; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Guyatt GH, 2002, MAYO CLIN PROC, V77, P371, DOI 10.4065/77.4.371; Heaton RK, 2001, ARCH CLIN NEUROPSYCH, V16, P75, DOI 10.1016/S0887-6177(99)00062-1; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Karatzias A, 2007, EUR ARCH PSY CLIN N, V257, P40, DOI 10.1007/s00406-006-0682-2; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Lang AJ, 2012, GEN HOSP PSYCHIAT, V34, P332, DOI 10.1016/j.genhosppsych.2012.02.003; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P329, DOI 10.1093/arclin/acu013; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Meyers JE, 2015, APPL NEUROPSYCH-ADUL, V22, P427, DOI 10.1080/23279095.2014.968919; Regasa LE, 2016, J HEAD TRAUMA REHAB, V31, pE28, DOI 10.1097/HTR.0000000000000155; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Sullivan KW, 2012, STUD HEALTH TECHNOL, V181, P71, DOI 10.3233/978-1-61499-121-2-71; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Weathers FW, 1991, PCL C FOR DSM 4	40	17	17	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2016	30	7					1063	1073		10.1080/13854046.2016.1193632			11	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	DY9FU	WOS:000385440100009	27266484				2022-02-06	
J	Dagher, JH; Costa, C; Lamoureux, J; de Guise, E; Feyz, M				Dagher, Jehane H.; Costa, Camille; Lamoureux, Julie; de Guise, Elaine; Feyz, Mitra			Comparative Outcomes of Traumatic Brain Injury from Biking Accidents With or Without Helmet Use	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article						Acute Care; Bicycle; Helmets; Outcome; Traumatic Brain Injury	PREVENTING HEAD-INJURY; BICYCLE SAFETY HELMETS; SEVERITY SCORE; EMERGENCY; CHILDREN; IMPACT; SCALE	Objective: To determine if health outcomes and demographics differ according to helmet status between persons with cycling-related traumatic brain injuries (TBI). Methods: This is a retrospective study of 128 patients admitted to the Montreal General Hospital following a TBI that occurred while cycling from 2007-2011. Information was collected from the Quebec trauma registry and the coroner's office in cases of death from cycling accidents. The independent variables collected were socio-demographic, helmet status, clinical and neurological patient information. The dependent variables evaluated were length of stay (LOS), extended Glasgow outcome scale (GOS-E), injury severity scale (ISS), discharge destination and death. Results: 25% of cyclists wore a helmet. The helmet group was older, more likely to be university educated, married and retired. Unemployment, longer intensive care unit (ICU) stay, severe intracranial bleeding and neurosurgical interventions were more common in the no helmet group. There was no significant association between the severity of the TBI, ISS scores, GOS-E or death and helmet wearing. The median age of the subjects who died was higher than those who survived. Conclusion: Cyclists without helmets were younger, less educated, single and unemployed. They had more severe TBIs on imaging, longer LOS in ICU and more neurosurgical interventions. Elderly cyclists admitted to the hospital appear to be at higher risk of dying in the event of a TBI.	[Dagher, Jehane H.] McGill Univ, Hlth Centre, Montreal Gen Hosp, Phys Med & Rehabil Dept, Montreal, PQ H3G 1A4, Canada; [de Guise, Elaine; Feyz, Mitra] McGill Univ, Hlth Centre, Montreal Gen Hosp, Traumat Brain Injury Programme, Montreal, PQ H3G 1A4, Canada; [de Guise, Elaine] McGill Univ, Hlth Centre, Montreal Gen Hosp, Neurol & Neurosurg Dept, Montreal, PQ H3G 1A4, Canada; [Dagher, Jehane H.; Costa, Camille] Univ Montreal, Phys Med & Rehabil Dept, Montreal, PQ, Canada; Univ Montreal, Inst Readaptat Lindsay Gingras Montreal, Montreal, PQ, Canada; [Lamoureux, Julie] Univ Montreal, Social & Prevent Med Dept, Montreal, PQ, Canada; [Dagher, Jehane H.] McGill Univ, Ctr Hlth, Montreal Gen Hosp Site, Phys Med & Rehabil, Room D13-124,1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada		Dagher, JH (corresponding author), McGill Univ, Ctr Hlth, Montreal Gen Hosp Site, Phys Med & Rehabil, Room D13-124,1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	DrDagher@hotmail.com					Adams J, 2001, Inj Prev, V7, P343, DOI 10.1136/ip.7.4.343; American Association of Neurological Surgeons Web site, 2011, SPORTS REL HEAD INJ; [Anonymous], 1971, JAMA, V215, P277; Attewell RG, 2001, ACCIDENT ANAL PREV, V33, P345, DOI 10.1016/S0001-4575(00)00048-8; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Burigusa G, 2011, SECURITE ELEVES PRIM; Canadian Institute for Health Information, 2006, HEAD INJ CAN DEC CHA; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; Cripton PA, 2014, ACCIDENT ANAL PREV, V70, P1, DOI 10.1016/j.aap.2014.02.016; Depreitere B, 2004, ACCIDENT ANAL PREV, V36, P561, DOI 10.1016/S0001-4575(03)00062-9; DORSCH MM, 1987, ACCIDENT ANAL PREV, V19, P183, DOI 10.1016/0001-4575(87)90002-9; Ekman R, 2001, PUBLIC HEALTH, V115, P38, DOI 10.1016/S0033-3506(01)00411-5; Finkelstein E., 2006, INCIDENCE EC BURDEN; Fyhri A, 2012, TRANSPORT RES F-TRAF, V15, P612, DOI 10.1016/j.trf.2012.06.003; Goldacre B, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3817; Gouvernement du Quebec, 2005, OR MIN TRAUM CRAN LE; Grenier T, 2013, CAN J PUBLIC HEALTH, V104, pE400, DOI 10.17269/cjph.104.3936; Irvine A, 2002, CAN J PUBLIC HEALTH, V93, P368, DOI 10.1007/BF03404572; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jennett B., 2005, NEPAL J NEUROSCI, V2, P24; Jolicoeur MC, 2010, ETAT VELO QUEBEC 201; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Linn S, 1998, Inj Prev, V4, P122; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MAIMARIS C, 1994, BRIT MED J, V308, P1537, DOI 10.1136/bmj.308.6943.1537; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MCDERMOTT FT, 1993, J TRAUMA, V34, P834, DOI 10.1097/00005373-199306000-00015; PAL J, 1989, J TRAUMA, V29, P746, DOI 10.1097/00005373-198906000-00008; Salottolo K, 2009, INJURY, V40, P999, DOI 10.1016/j.injury.2009.05.013; Shafi S, 1998, J PEDIATR SURG, V33, P317, DOI 10.1016/S0022-3468(98)90454-7; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; THOMAS S, 1994, BRIT MED J, V308, P173, DOI 10.1136/bmj.308.6922.173; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1968, DOI 10.1001/jama.276.24.1968; Thompson DC, 2000, COCHRANE DB SYST REV, V2; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101; WASSERMAN RC, 1988, AM J PUBLIC HEALTH, V78, P1220, DOI 10.2105/AJPH.78.9.1220; WASSERMAN RC, 1990, AM J SPORT MED, V18, P96, DOI 10.1177/036354659001800116; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	40	17	20	0	25	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	JAN	2016	43	1					56	64		10.1017/cjn.2015.281			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	DB5FW	WOS:000368541000008	26786638	Bronze			2022-02-06	
J	De Marco, AP; Broshek, DK				De Marco, Anthony P.; Broshek, Donna K.			Computerized Cognitive Testing in the Management of Youth Sports-Related Concussion	JOURNAL OF CHILD NEUROLOGY			English	Article						sports-related concussion; computerized testing; cognition	TEST-RETEST RELIABILITY; TRAUMATIC BRAIN-INJURIES; NEUROPSYCHOLOGICAL ASSESSMENT; HIGH-SCHOOL; FOOTBALL PLAYERS; ONLINE VERSION; UNITED-STATES; IMPACT; SPECIFICITY; SENSITIVITY	Computerized neurocognitive testing has become a growing practice across medical populations, but particularly within sports medicine and the management of sports-related concussion. Although traditional neuropsychological measures are solely administered and interpreted by neuropsychologists, computerized cognitive tests are marketed to and utilized by a wide range of professionals involved in the management of sports-related concussions, many of whom lack specialized psychometric training. Although the benefits of computerized testing allow for many youth athletes to be evaluated quickly, professionals implementing their use should be aware of the potential pitfalls and the high potential for misuse. After briefly reviewing the recommended guidelines set forth by the American Academy of Clinical Neuropsychology and the National Academy of Neuropsychology, we review the benefits/limitations of computerized testing in the management of sports-related concussion and the basic psychometric properties of some of the more widely used computerized measures. Lastly, we discuss the practical application of these devices.	[De Marco, Anthony P.; Broshek, Donna K.] Univ Virginia, Sch Med, Dept Psychiat & Neurobehav Sci, Charlottesville, VA 22908 USA		De Marco, AP (corresponding author), Univ Virginia, Sch Med, Dept Psychiat & Neurobehav Sci, Charlottesville, VA 22908 USA.	Apd3e@virginia.edu	Meijer, Anna/K-5118-2016; Broshek, Donna/ABA-4208-2021	Broshek, Donna/0000-0002-7175-7815			*AM ED RES ASS AM, 1999, STAND ED PSYCH TEST; American Educational Research Association, 1985, STAND ED PSYCH TEST; American Educational Research Association American Psychological Association and National Council on Measurement in Education, 1974, STAND ED PSYCH TEST; Barr W. B, 2008, TXB CLIN NEUROPSYCHO; Barth JT, 1989, MILD HEAD INJURY, P257; Bauer RM, 2012, ARCH CLIN NEUROPSYCH, V27, P362, DOI 10.1093/arclin/acs027; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bleiberg J, 1998, J HEAD TRAUMA REHAB, V13, P36, DOI 10.1097/00001199-199804000-00006; Bleiberg J, 1997, NEUROPSY NEUROPSY BE, V10, P247; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bleiberg J, 2000, CLIN NEUROPSYCHOL, V14, P287, DOI 10.1076/1385-4046(200008)14:3;1-P;FT287; Bleiberg J, 2002, AM AC NEUR DENV CO; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Cernich AN, 2007, ARCH CLIN NEUROPSYCH, V22, pS39, DOI 10.1016/j.acn.2006.10.004; CogState, 2011, COGST RES MAN VERS 6; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Comper P, 2010, BRAIN INJURY, V24, P1257, DOI 10.3109/02699052.2010.506854; Echemendia RJ, 2009, BRIT J SPORT MED, V43, pI32, DOI 10.1136/bjsm.2009.058164; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Echemendia RJ, 2012, ARCH CLIN NEUROPSYCH, V27, P119, DOI 10.1093/arclin/acr077; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Gioia GA, 2013, BRIT J SPORT MED, V47, P44; Gioia GA, PROFESSIONAL M UNPUB; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Lichtenstein JD, 2014, AM J SPORT MED, V42, P479, DOI 10.1177/0363546513509225; Louey AG, 2013, BRIT J SPORT MED, V47, P15; Lovell M, 2000, IMPACT IMMEDIATE POS; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Mayers LB, 2012, J CLIN EXP NEUROPSYC, V34, P235, DOI 10.1080/13803395.2011.630655; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2012, PEDIATRICS, V129, P38, DOI 10.1542/peds.2011-1972; Moser RS, 2015, APPL NEUROPSYCH-CHIL, V4, P41, DOI 10.1080/21622965.2013.791825; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Newman E., 1966, AM PSYCHOL, V21, P1151; Randolph C, 2005, J ATHL TRAINING, V40, P139; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; Resch JE, 2013, CLIN NEUROPSYCHOL, V27, P1265, DOI 10.1080/13854046.2013.845247; ROME HP, 1962, MAYO CLIN PROC, V37, P61; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2006, APPL NEUROPSYCHOL, V13, P151, DOI 10.1207/s15324826an1303_2; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Segalowitz SJ, 2007, NEUROREHABILITATION, V22, P243; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; United States Food and Drug Administration, FDA WORKSH SEIZ DET; Vaughan CG, 2014, AM J SPORT MED, V42, P1716, DOI 10.1177/0363546514531732; Woodard J., 2002, J INT NEUROPSYCHOLOG, V8, P175	58	17	17	1	17	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	JAN	2016	31	1			SI		68	75		10.1177/0883073814559645			8	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	CY8HW	WOS:000366650400007	25477270				2022-02-06	
J	Faber, J; Wilde, EA; Hanten, G; Ewing-Cobbs, L; Aitken, ME; Yallampalli, R; MacLeod, MC; Mullins, SH; Chu, ZD; Li, X; Hunter, JV; Noble-Haeusslein, L; Levin, HS				Faber, J.; Wilde, E. A.; Hanten, G.; Ewing-Cobbs, L.; Aitken, M. E.; Yallampalli, R.; MacLeod, M. C.; Mullins, S. H.; Chu, Z. D.; Li, X.; Hunter, J. V.; Noble-Haeusslein, L.; Levin, H. S.			Ten-year outcome of early childhood traumatic brain injury: Diffusion tensor imaging of the ventral striatum in relation to executive functioning	BRAIN INJURY			English	Article						Neuroimaging; MRI; paediatric	CLOSED-HEAD INJURY; RECOVERY 10 YEARS; YOUNG-ADULTS; ATTENTION PROBLEMS; AXONAL INJURY; UNITED-STATES; CHILDREN; MODERATE; ADOLESCENTS; PREDICTORS	Primary objective: The long-term effects of TBI on verbal fluency and related structures, as well as the relation between cognition and structural integrity, were evaluated. It was hypothesized that the group with TBI would evidence poorer performance on cognitive measures and a decrease in structural integrity. Research design: Between a paediatric group with TBI and a group of typically-developing children, the long-term effects of traumatic brain injury were investigated in relation to both structural integrity and cognition. Common metrics for diffusion tensor imaging (DTI) were used as indicators of white matter integrity. Methods and procedures: Using DTI, this study examined ventral striatum (VS) integrity in 21 patients aged 10-18 years sustaining moderate-to-severe traumatic brain injury (TBI) 5-15 years earlier and 16 demographically comparable subjects. All participants completed Delis-Kaplan Executive Functioning System (D-KEFS) sub-tests. Main outcomes and results: The group with TBI exhibited lower fractional anisotropy (FA) and executive functioning performance and higher apparent diffusion coefficient (ADC). DTI metrics correlated with D-KEFS performance (right VS FA with Inhibition errors, right VS ADC with Letter Fluency, left VS FA and ADC with Category Switching). Conclusions: TBI affects VS integrity, even in a chronic phase, and may contribute to executive functioning deficits.	[Faber, J.] Rice Univ, Houston, TX USA; [Faber, J.; Wilde, E. A.; Hanten, G.; Yallampalli, R.; MacLeod, M. C.; Li, X.; Hunter, J. V.; Levin, H. S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Wilde, E. A.; Levin, H. S.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Wilde, E. A.; Chu, Z. D.; Hunter, J. V.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Wilde, E. A.; Yallampalli, R.; Levin, H. S.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Ewing-Cobbs, L.] Univ Texas Hlth Sci Ctr Houston, Childrens Learning Inst, Houston, TX 77030 USA; [Ewing-Cobbs, L.] Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Houston, TX 77030 USA; [Aitken, M. E.; Mullins, S. H.] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; [Chu, Z. D.; Hunter, J. V.] Texas Childrens Hosp, Dept Pediat Radiol, Houston, TX 77030 USA; [Noble-Haeusslein, L.] Univ Calif San Francisco, Dept Neurosurg Surg, San Francisco, CA 94143 USA; [Noble-Haeusslein, L.] Univ Calif San Francisco, Dept Phys Therapy & Rehabil Sci, San Francisco, CA 94143 USA		Faber, J (corresponding author), Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA.	jesfaber@gmail.com	Aitken, Mary/ABG-6119-2021	Aitken, Mary/0000-0002-8318-9755	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21 NS065937]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS065937] Funding Source: NIH RePORTER	This study was supported by the National Institute of Health grant R21 NS065937 ('Trauma to Developing Brain: Model Refinement and Therapeutic Intervention'; Levin, PI and Noble, PI). We thank the participants and their families for their participation in this research. The authors report no conflicts of interest. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Basar K, 2010, PROG NEUROBIOL, V92, P533, DOI 10.1016/j.pneurobio.2010.08.007; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bonekamp D, 2007, NEUROIMAGE, V34, P733, DOI 10.1016/j.neuroimage.2006.09.020; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Catroppa C, 2011, BRAIN INJURY, V25, P858, DOI 10.3109/02699052.2011.589794; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Crowe LM, 2012, J PEDIATR PSYCHOL, V37, P745, DOI 10.1093/jpepsy/jss070; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Faul M, 2010, TRAUMATIC BRAIN INJU; Gorman S, 2012, J INT NEUROPSYCH SOC, V18, P29, DOI 10.1017/S1355617711001251; Hanten G, 2008, NEUROPSYCHOLOGY, V22, P357, DOI 10.1037/0894-4105.22.3.357; Horneman G, 2009, BRAIN INJURY, V23, P907, DOI 10.1080/02699050903283239; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jonsson CA, 2004, BRAIN INJURY, V18, P921, DOI 10.1080/02699050410001671900; Jonsson CA, 2013, J NEUROTRAUM, V30, P76, DOI 10.1089/neu.2012.2592; Jonsson CA, 2009, BRAIN INJURY, V23, P1008, DOI 10.3109/02699050903379354; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Levin HS, 2003, BRAIN INJURY, V17, P665, DOI 10.1080/0269905031000107151; Levin HS, 2001, NEUROPSYCHOLOGIA, V39, P122, DOI 10.1016/S0028-3932(00)00111-1; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Newcombe VFJ, 2011, BRAIN, V134, P759, DOI 10.1093/brain/awq388; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Phillips OR, 2013, BRAIN CONNECT, V3, P146, DOI 10.1089/brain.2012.0111; Scott JG, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P219, DOI 10.1007/978-0-387-76978-3_10; Shah S, 2012, BRAIN INJURY, V26, P201, DOI 10.3109/02699052.2012.654591; Simard F, 2011, CEREB CORTEX, V21, P1084, DOI 10.1093/cercor/bhq182; Snook L, 2005, NEUROIMAGE, V26, P1164, DOI 10.1016/j.neuroimage.2005.03.016; Strangman GE, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00182; TEASDALE G, 1974, LANCET, V2, P81; Weisskoff RM, 1996, MAGNET RESON MED, V36, P643, DOI 10.1002/mrm.1910360422; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Wilde EA, 2009, J CLIN EXP NEUROPSYC, V31, P205, DOI 10.1080/13803390802098118; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64	47	17	17	0	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	13-14					1635	1641		10.1080/02699052.2016.1199910			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EG8YO	WOS:000391343800017	27680309				2022-02-06	
J	Guo, J; Yang, CX; Yang, JJ; Yao, Y				Guo, Jie; Yang, Chunxiao; Yang, Jiajia; Yao, Yang			Glycyrrhizic Acid Ameliorates Cognitive Impairment in a Rat Model of Vascular Dementia Associated with Oxidative Damage and Inhibition of Voltage-Gated Sodium Channels	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						Glycyrrhizic acid; neuroprotection; oxidative damage; vascular dementia; voltage-dependent sodium channels	18-BETA-GLYCYRRHETINIC ACID; ISCHEMIA-REPERFUSION; CEREBRAL-ISCHEMIA; HYDROGEN-PEROXIDE; SPINAL-CORD; BRAIN; INJURY; NEURONS; HMGB1; EXCITABILITY	Vascular dementia (VD) is the second most common cause of cognitive impairment in the elderly population. Our study aims to investigate the neuroprotective effects of glycyrrhizic acid (GA), a major active constituent of Glycyrrhiza glabra root, in a VD rat model induced by permanent occlusion of the bilateral common carotid arteries. Spatial cognitive function was examined by the Morris water maze test and synaptic plasticity was explored by assessing long-term potentiation. The results showed that GA (20 mg/kg for 5 days) significantly improved the performance of learning and memory of VD rats in the Morris water maze test and attenuated induction of long-term potentiation. Histopathological studies showed that GA significantly attenuated cell damage in VD rats. Malondialdehyde levels and superoxide dismutase activity were analyzed in the hippocampus and cortex to investigate anti-oxidant status. The results showed that GA decreased the level of lipid peroxidation and increased the activity of superoxide dismutase in VD rats. Lastly, whole-cell patch-clamp analysis was used to examine the effect of GA on voltage-gated sodium channels (VGSCs) in hippocampal CA1 pyramidal neurons. GA (10, 20 and 50 mu M) inhibited the current amplitude of the VGSCs. These results suggest that the neuroprotective effects of GA in VD rats relate to the reduction of oxidative stress and inhibition of VGSCs. Our study provides experimental evidence for the application of GA in the treatment of cognitive deficits induced by Alzheimer's disease, stroke, or traumatic brain injury.	[Guo, Jie; Yao, Yang] Tianjin First Ctr Hosp, Dept Neurol, Tianjin 300192, Peoples R China; [Yang, Chunxiao] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China; [Yang, Jiajia] Tianjin Univ, Sch Precis Instrument & Optoelect Engn, Tianjin 300072, Peoples R China		Yao, Y (corresponding author), Tianjin First Ctr Hosp, Dept Neurol, Tianjin 300192, Peoples R China.; Yang, JJ (corresponding author), Tianjin Univ, Sch Precis Instrument & Optoelect Engn, Tianjin 300072, Peoples R China.	jiajia.yang@tju.edu.cn; nkyaoyang@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31300923, 31500865]; Tianjin Municipal Health Bureau Foundation [2014KY14, 14KG22]	The study was supported by grants from the National Natural Science Foundation of China (31300923, 31500865) and Tianjin Municipal Health Bureau Foundation (2014KY14, 14KG22). We thank Xiaoyuan SUO for assistance with preparation of the manuscript.	Akman T, 2015, INFLAMMATION, V38, P1581, DOI 10.1007/s10753-015-0133-1; Alagona G, 2004, NEUROSCI LETT, V362, P95, DOI 10.1016/j.neulet.2004.03.006; An L, 2013, NEUROBIOL LEARN MEM, V100, P18, DOI 10.1016/j.nlm.2012.12.003; Ates O, 2007, NEUROL RES, V29, P317, DOI 10.1179/016164107X159225; Barakat W, 2014, EUR J PHARMACOL, V724, P43, DOI 10.1016/j.ejphar.2013.12.032; BECKMAN JS, 1994, PROG BRAIN RES, V103, P371; Brahma MK, 2009, J NEUROSCI RES, V87, P1400, DOI 10.1002/jnr.21960; Cherng JM, 2006, EUR J PHARMACOL, V547, P10, DOI 10.1016/j.ejphar.2006.06.080; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; Gong G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089450; Gong G, 2012, ACTA PHARMACOL SIN, V33, P11, DOI 10.1038/aps.2011.151; Kao TC, 2009, J AGR FOOD CHEM, V57, P754, DOI 10.1021/jf802864k; Kim KW, 2008, J GERIATR PSYCH NEUR, V21, P12, DOI [10.1177/0891988707311028, 10.1177/08988707311028]; Kim SW, 2012, NEUROBIOL DIS, V46, P147, DOI 10.1016/j.nbd.2011.12.056; Kim SW, 2011, ANAT CELL BIOL, V44, P304, DOI 10.5115/acb.2011.44.4.304; Lee Ae Young, 2011, Chonnam Med J, V47, P66, DOI 10.4068/cmj.2011.47.2.66; Li XL, 2011, INT J MOL SCI, V12, P905, DOI 10.3390/ijms12020905; Lin CSY, 2002, J PHYSIOL-LONDON, V538, P435, DOI 10.1113/jphysiol.2001.012478; Liu C, 2007, PHARMACOL BIOCHEM BE, V86, P423, DOI 10.1016/j.pbb.2006.11.005; Ma JH, 2005, ACTA PHARMACOL SIN, V26, P828, DOI 10.1111/j.1745-7254.2005.00154.x; Martinez-Sanchez M, 2004, NEUROSCIENCE, V128, P729, DOI 10.1016/j.neuroscience.2004.06.074; Mongin Alexander A, 2007, Pathophysiology, V14, P183, DOI 10.1016/j.pathophys.2007.09.009; Ni B, 2013, INT J NEUROSCI, V123, P745, DOI 10.3109/00207454.2013.796551; Ogiku M, 2011, J PHARMACOL EXP THER, V339, P93, DOI 10.1124/jpet.111.182592; Ohnishi M, 2011, NEUROPHARMACOLOGY, V61, P975, DOI 10.1016/j.neuropharm.2011.06.026; Okuma Y, 2014, NEUROPHARMACOLOGY, V85, P18, DOI 10.1016/j.neuropharm.2014.05.007; Orazizadeh M, 2014, CHEM-BIOL INTERACT, V220, P214, DOI 10.1016/j.cbi.2014.07.001; Park HY, 2004, ARCH PHARM RES, V27, P57, DOI 10.1007/BF02980047; Rackova L, 2007, NAT PROD RES, V21, P1234, DOI 10.1080/14786410701371280; Raley-Susman KM, 2001, J NEUROPHYSIOL, V86, P2715, DOI 10.1152/jn.2001.86.6.2715; Roger S, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00152; Roman GC, 2002, J NEUROL SCI, V203, P7, DOI 10.1016/S0022-510X(02)00252-6; Smolarczyk R, 2012, ARCH IMMUNOL THER EX, V60, P391, DOI 10.1007/s00005-012-0183-0; Song JH, 2013, MOLECULES, V18, P15788, DOI 10.3390/molecules181215788; Song Y, 2006, J PHARMACOL EXP THER, V318, P214, DOI 10.1124/jpet.106.101832; Tabuchi M, 2012, CELL MOL NEUROBIOL, V32, P1139, DOI 10.1007/s10571-012-9839-x; Xiao AY, 2002, J NEUROSCI, V22, P1350, DOI 10.1523/JNEUROSCI.22-04-01350.2002; XiYang YB, 2016, MOL NEUROBIOL, V53, P955, DOI 10.1007/s12035-014-9048-3; Yang JJ, 2014, NEUROMOL MED, V16, P376, DOI 10.1007/s12017-013-8284-4; Yanpallewar S, 2005, LIFE SCI, V76, P1325, DOI 10.1016/j.lfs.2004.06.029; Yao Y, 2010, PHYTOTHER RES, V24, P136, DOI 10.1002/ptr.2902; Yao Y, 2012, AM J PHYSIOL-REG I, V302, pR815, DOI 10.1152/ajpregu.00452.2011; Zaghloul N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108168; Zhu XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046286	45	17	19	2	19	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets		2016	15	8					1001	1008		10.2174/1871527315666160527163526			8	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	EB1OG	WOS:000387121800016	27238153				2022-02-06	
J	Huang, CH; Huang, CC; Sun, CK; Lin, GH; Hou, WH				Huang, Chi-Hsien; Huang, Chia-Chen; Sun, Cheuk-Kwan; Lin, Gong-Hong; Hou, Wen-Hsuan			Methylphenidate on Cognitive Improvement in Patients with Traumatic Brain Injury: A Meta-Analysis	CURRENT NEUROPHARMACOLOGY			English	Article						Attention; cognitive function; methylphenidate; traumatic brain injury	A-META-ANALYSIS; DOUBLE-BLIND; NEUROPSYCHIATRIC SEQUELAE; ATTENTION DEFICITS; CONTROLLED-TRIAL; PLACEBO; REHABILITATION; CROSSOVER; EFFICACY; IMPACT	Although methylphenidate has been used as a neurostimulant to treat patients with attention deficit hyperactivity disorder, its therapeutic role in the psychomotor or cognitive recovery of patients with traumatic brain injuries (TBIs) in both intensive care and rehabilitation settings has not been adequately explored. To address this issue, this meta-analysis searched the available electronic databases using the key words "methylphenidate", "brain injuries", "head injuries", and "traumatic brain injury". Analysis of the ten double-blind RCTs demonstrated significant benefit in using methylphenidate for enhancing vigilance-associated attention (i.e., selective, sustained, and divided attention) in patients with TBIs (standardized mean difference: 0.45, 95% CI: 0.10 to 0.79), especially in sustained attention (standardized mean difference: 0.66, 95% CI: 0.22 to 1.10). However, no significant positive impact was noted on the facilitation of memory or processing speed. More studies on the efficacy and safety of methylphenidate for the cognitive improvement of patients with TBIs are warranted.	[Huang, Chi-Hsien] E DA Hosp, Dept Family Med, Kaohsiung, Taiwan; [Huang, Chi-Hsien] E DA Hosp, Ctr Evidence Based Med, Kaohsiung, Taiwan; [Huang, Chia-Chen] E DA Hosp, Dept Pharm, Kaohsiung, Taiwan; [Sun, Cheuk-Kwan] E DA Hosp, Dept Med Res, Kaohsiung, Taiwan; [Sun, Cheuk-Kwan] E DA Hosp, Dept Emergency Med, Kaohsiung, Taiwan; [Lin, Gong-Hong] Natl Taiwan Univ, Coll Med, Sch Occupat Therapy, Taipei 10764, Taiwan; [Hou, Wen-Hsuan] Taipei Med Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Hou, Wen-Hsuan] Taipei Med Univ, Coll Nursing, Sch Gerontol Healthcare Management, Taipei, Taiwan; [Hou, Wen-Hsuan] Taipei Med Univ, Coll Nursing, Master Program Long Term Care, 250 Wuxing St, Taipei 11031, Taiwan		Hou, WH (corresponding author), Taipei Med Univ, Coll Nursing, Master Program Long Term Care, 250 Wuxing St, Taipei 11031, Taiwan.	houwh@tmu.edu.tw	Sun, Cheuk-Kwan/K-5723-2012; Hou, Wen-Hsuan/ABB-2903-2021	Hou, Wen-Hsuan/0000-0002-4376-6298			Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Baker B.K., 1990, DISS ABSTR INT; Ben Azouz Olfa, 2009, Tunis Med, V87, P680; BIRMAHER B, 1989, J AM ACAD CHILD PSY, V28, P768, DOI 10.1097/00004583-198909000-00020; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P917; Bush G, 2010, NEUROPSYCHOPHARMACOL, V35, P278, DOI 10.1038/npp.2009.120; Frenette A.J., 2011, CRIT CARE, V15, pS111; Frenette AJ, 2012, J NEUROTRAUM, V29, P1, DOI 10.1089/neu.2011.1812; GREENDYKE RM, 1986, J NERV MENT DIS, V174, P290, DOI 10.1097/00005053-198605000-00005; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; JOHNSON ML, 1992, AM J PHYS MED REHAB, V71, P239, DOI 10.1097/00002060-199208000-00008; Kim J, 2012, PSYCHOPHARMACOLOGY, V222, P47, DOI 10.1007/s00213-011-2622-8; Kim YH, 2006, CLIN REHABIL, V20, P24, DOI 10.1191/0269215506cr927oa; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; Leonard BE, 2004, HUM PSYCHOPHARM CLIN, V19, P151, DOI 10.1002/hup.579; Levin H., 2007, AM J PHY MED REHAB, V86, P329; Mahalick DM, 1998, PEDIATR NEUROSURG, V29, P121, DOI 10.1159/000028705; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; Nuechterlein KH, 2004, SCHIZOPHR RES, V72, P29, DOI 10.1016/j.schres.2004.09.007; Oradell N., 1956, NM M RITALIN METHYLP; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Phillips JP, 2003, J HEAD TRAUMA REHAB, V18, P342, DOI 10.1097/00001199-200307000-00005; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P321, DOI 10.1097/HTR.0000000000000072; Shire US Inc, 2009, PROD INF DAYTR TM TR; Sivan M, 2010, CLIN REHABIL, V24, P110, DOI 10.1177/0269215509343234; Speech Thomas J., 1993, Brain Injury, V7, P333, DOI 10.3109/02699059309034959; Vance DE, 2012, J PSYCHOSOC NURS MEN, V50, P30, DOI 10.3928/02793695-20120508-03; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Weber P, 2002, PEDIATR NEUROL, V26, P261, DOI 10.1016/S0887-8994(01)00408-8; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; Wheaton P, 2011, J CLIN PSYCHOPHARM, V31, P745, DOI 10.1097/JCP.0b013e318235f4ac; Wheaton P, 2009, J CLIN PSYCHOPHARM, V29, P468, DOI 10.1097/JCP.0b013e3181b66f04; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; Whyte J, 2002, J HEAD TRAUMA REHAB, V17, P284, DOI 10.1097/00001199-200208000-00003; Williams SE, 1998, J HEAD TRAUMA REHAB, V13, P73, DOI 10.1097/00001199-199806000-00007; Willmott C, 2009, J NEUROL NEUROSUR PS, V80, P552, DOI 10.1136/jnnp.2008.159632; ZAMETKIN AJ, 1987, J AM ACAD CHILD PSY, V26, P676, DOI 10.1097/00004583-198709000-00011	40	17	17	0	3	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1570-159X	1875-6190		CURR NEUROPHARMACOL	Curr. Neuropharmacol.		2016	14	3					272	281		10.2174/1570159X13666150514233033			10	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	DI4EM	WOS:000373453200007	26951094	Green Submitted, Green Published			2022-02-06	
J	Krivitzky, LS; Walsh, KS; Fisher, EL; Berl, MM				Krivitzky, Lauren S.; Walsh, Karin S.; Fisher, Evelyn L.; Berl, Madison M.			Executive functioning profiles from the BRIEF across pediatric medical disorders: Age and diagnosis factors	CHILD NEUROPSYCHOLOGY			English	Article						Executive functions; Pediatric; Working memory; Age at diagnosis; Medical disorders	ACUTE LYMPHOBLASTIC-LEUKEMIA; SLUGGISH COGNITIVE TEMPO; TRAUMATIC BRAIN-INJURY; WORKING-MEMORY; PARENT-REPORT; CHILDHOOD EPILEPSY; ATTENTION-DEFICIT; TUMOR SURVIVORS; CHILDREN; ADOLESCENTS	The objective of the study was to compare executive functioning (EF) profiles across several pediatric medical conditions and explore the influence of age of diagnosis and evaluation. A retrospective, cross-sectional study of 734 children aged 5 to 18 years was conducted across five medical groups (brain tumor, leukemia [ALL], epilepsy [EPI], neurofibromatosis type 1 [NF1], and ornithine transcarbamylase deficiency [OTC-D]), attention deficit hyperactivity disorder (ADHD) controls, and matched healthy controls. We compared groups across the scales of a parent-completed Behavior Rating Inventory of Executive Functioning (BRIEF) using a repeated measures analysis of variance (ANOVA). Separate ANOVAs were conducted to look at age factors. The results showed that the ADHD group differed from all other groups and had the highest level of reported EF problems. The NF1 and OTC-D groups differed significantly from the healthy comparison group for overall EF problems, while the EPI and cancer groups did not. Working memory was the most elevated scale across medical groups, followed by plan/organize. Children with medical disorders were two to four times more likely than healthy controls to have clinically significant problems in several EF domains. There was a main effect for age at diagnosis and age at evaluation. A subset of children with medical disorders were found to have parent-reported EF difficulties, with particular vulnerability noted in working memory and organizational/planning skills. This has relevance for the development of interventions that may be helpful across disorders. Children with particular diagnoses and earlier age of diagnosis and evaluation had greater reported EF problems.	[Krivitzky, Lauren S.] Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Krivitzky, Lauren S.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Walsh, Karin S.; Fisher, Evelyn L.; Berl, Madison M.] Childrens Natl Hlth Syst, 111 Michigan Ave NW, Washington, DC 20010 USA; [Walsh, Karin S.] George Washington Univ, Med Ctr, Washington, DC 20037 USA; [Fisher, Evelyn L.] Georgia State Univ, Atlanta, GA 30303 USA		Berl, MM (corresponding author), Childrens Natl Hlth Syst, 111 Michigan Ave NW, Washington, DC 20010 USA.	mberl@childrensnational.org			NIH Office of Rare Diseases Research (ORDR) at the National Center for Advancing Translational Science (NCATS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [U54HD061221]; National Institute of Child Health and Human Development (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54HD061221]; O'Malley Foundation; Rotenberg Family Fund; Dietmar-Hopp Foundation; Kettering Fund; Gilbert Family Neurofibromatosis Institute; National Institutes of Neurological Disorders and Stroke, NIHs [R01NS44280, K23NS065121-01A2]; NICHD Intellectual and Developmental Disabilities Research Center; NICHD Children's National Medical Center [P30HD040677]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD040677, U54HD061221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS044280, K23NS065121] Funding Source: NIH RePORTER	Some data used in this manuscript was provided by the Urea Cycle Disorders Consortium (U54HD061221), part of the National Institute of Health (NIH) Rare Diseases Clinical Research Network (RDCRN), supported through collaboration between the NIH Office of Rare Diseases Research (ORDR) at the National Center for Advancing Translational Science (NCATS) and the National Institute of Child Health and Human Development (NICHD). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIHs. The Urea Cycle Disorders Consortium is also supported by the O'Malley Foundation, the Rotenberg Family Fund, the Dietmar-Hopp Foundation, and the Kettering Fund.; This work was supported by the Gilbert Family Neurofibromatosis Institute; the National Institutes of Neurological Disorders and Stroke, NIHs [grant numbers R01NS44280, K23NS065121-01A2]; NICHD Intellectual and Developmental Disabilities Research Center and Children's National Medical Center Grant [grant number P30HD040677].	Alloway TP, 2006, WORKING MEMORY AND NEURODEVELOPMENTAL DISORDERS, P1; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Briere ME, 2008, PEDIATR BLOOD CANCER, V50, P337, DOI 10.1002/pbc.21223; Buizer AI, 2009, PEDIATR BLOOD CANCER, V52, P447, DOI 10.1002/pbc.21869; Catroppa C, 2006, Pediatr Rehabil, V9, P89, DOI 10.1080/13638490500155458; Chelune GJ, 2010, CLIN NEUROPSYCHOL, V24, P454, DOI 10.1080/13854040802360574; Dahlin K.I., 2013, J ED LEARNING, V2, P118, DOI [DOI 10.5539/JEL.V2N1P118, https://doi.org/10.5539/jel.v2n1p118, 10.5539/jel.v2n1p118]; Dennis M, 2000, J COMMUN DISORD, V33, P321, DOI 10.1016/S0021-9924(00)00028-9; Diaz GA, 2013, HEPATOLOGY, V57, P2171, DOI 10.1002/hep.26058; Duffner PK, 2004, NEUROLOGIST, V10, P293, DOI 10.1097/01.nrl.0000144287.35993.96; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Faridi N, 2015, NEUROPSYCHOLOGY, V29, P82, DOI 10.1037/neu0000079; Gathercole S.E., 2003, EDUC CHILD PSYCHOL, V20, P109, DOI DOI 10.1037/A0036633; Gathercole S. E., 2008, APPL COGNITIVE RES K, P17; Giedd JN, 2010, NEURON, V67, P728, DOI 10.1016/j.neuron.2010.08.040; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P121, DOI 10.1076/chin.8.2.121.8727; Holmes J. D., 2010, PARKINSONS DIS, P1, DOI DOI 10.4061/2010/696492; Holmes J, 2014, EDUC PSYCHOL-UK, V34, P440, DOI 10.1080/01443410.2013.797338; Howarth RA, 2013, J INT NEUROPSYCH SOC, V19, P380, DOI 10.1017/S1355617712001567; Huijbregts S, 2010, DEV NEUROPSYCHOL, V35, P737, DOI 10.1080/87565641.2010.508670; Hyman SL, 2005, NEUROLOGY, V65, P1037, DOI 10.1212/01.wnl.0000179303.72345.ce; Kahalley LS, 2013, PSYCHO-ONCOLOGY, V22, P1979, DOI 10.1002/pon.3255; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Krivitzky L, 2009, PEDIATR RES, V66, P96, DOI 10.1203/PDR.0b013e3181a27a16; MacAllister WS, 2012, CHILD NEUROPSYCHOL, V18, P404, DOI 10.1080/09297049.2011.613812; Maddrey AM, 2005, J NEURO-ONCOL, V72, P245, DOI 10.1007/s11060-004-3009-z; Mahone EM, 2009, J INT NEUROPSYCH SOC, V15, P31, DOI 10.1017/S1355617708090164; Makris N, 2007, CEREB CORTEX, V17, P1364, DOI 10.1093/cercor/bhl047; Mares D, 2007, CAN J PSYCHIAT, V52, P527, DOI 10.1177/070674370705200811; McCann JP, 2014, CHILD NEUROPSYCHOL, V20, P737, DOI 10.1080/09297049.2013.859663; Miller B.L., 2007, HUMAN FRONTAL LOBES, V2nd; Mulhern RK, 2004, LANCET ONCOL, V5, P399, DOI 10.1016/S1470-2045(04)01507-4; Olsson IT, 2014, PEDIATR NEUROL, V51, P515, DOI 10.1016/j.pediatrneurol.2014.06.011; Parrish J, 2007, DEV MED CHILD NEUROL, V49, P412, DOI 10.1111/j.1469-8749.2007.00412.x; Payne JM, 2011, CHILD NEUROPSYCHOL, V17, P313, DOI 10.1080/09297049.2010.542746; Pride N, 2010, J CHILD NEUROL, V25, P834, DOI 10.1177/0883073809350723; Reeves CB, 2007, J PEDIATR PSYCHOL, V32, P1050, DOI 10.1093/jpepsy/jsm063; Robinson KE, 2014, NEUROPSYCHOLOGY, V28, P791, DOI 10.1037/neu0000077; Rowbotham I, 2009, NEUROPSYCHOLOGY, V23, P50, DOI 10.1037/a0013927; Scott MN, 2012, J DEV BEHAV PEDIATR, V33, P202, DOI 10.1097/DBP.0b013e3182475287; Scott RB, 2001, DEV MED CHILD NEUROL, V43, P685, DOI 10.1017/S0012162201001232; Slick DJ, 2006, CHILD NEUROPSYCHOL, V12, P181, DOI 10.1080/09297040600611320; Spiegler BJ, 2004, J CLIN ONCOL, V22, P706, DOI 10.1200/JCO.2004.05.186; Swanson JM, 2002, ATTENTION DEFICIT HY, V7, P7; Taylor HG, 2000, NEUROPSYCHOLOGY, V14, P509, DOI 10.1037/0894-4105.14.4.509; Toplak ME, 2013, J CHILD PSYCHOL PSYC, V54, P131, DOI 10.1111/jcpp.12001; Visser SN, 2014, J AM ACAD CHILD PSY, V53, P34, DOI 10.1016/j.jaac.2013.09.001; von der Weid N, 2003, EUR J CANCER, V39, P359, DOI 10.1016/S0959-8049(02)00260-5; Waber DP, 2006, PEDIATR NEUROL, V34, P13, DOI 10.1016/j.pediatrneurol.2005.06.002; Walsh KS, 2015, CHILD NEUROPSYCHOL, V21, P78, DOI 10.1080/09297049.2013.876491; Wang Y, 2012, PSYCHIAT RES-NEUROIM, V202, P245, DOI 10.1016/j.pscychresns.2012.01.005; Warren SL, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00271; Willard VW, 2013, J NEURO-ONCOL, V114, P71, DOI 10.1007/s11060-013-1149-8; Winter AL, 2014, J CLIN EXP NEUROPSYC, V36, P818, DOI 10.1080/13803395.2014.943695; Wochos GC, 2014, CLIN NEUROPSYCHOL, V28, P1243, DOI 10.1080/13854046.2014.971875; Wolfe KR, 2013, CHILD NEUROPSYCHOL, V19, P370, DOI 10.1080/09297049.2012.669470; Wolfe KR, 2012, DEV NEUROPSYCHOL, V37, P153, DOI 10.1080/87565641.2011.632462; Ziegler G, 2013, NEUROIMAGE, V82, P284, DOI 10.1016/j.neuroimage.2013.05.088	58	17	17	0	10	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.		2016	22	7					870	888		10.1080/09297049.2015.1054272			19	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	DV0BR	WOS:000382583200006	26143938	Green Accepted			2022-02-06	
J	Lu, W; Krellman, JW; Dijkers, MP				Lu, William; Krellman, Jason W.; Dijkers, Marcel P.			Can Cognitive Behavioral Therapy for Insomnia also treat fatigue, pain, and mood symptoms in individuals with traumatic brain injury? - A multiple case report	NEUROREHABILITATION			English	Article						Insomnia; traumatic brain injury; cognitive behavioral therapy; case study	SLEEP QUALITY INDEX; HOSPITAL ANXIETY; MULTIDIMENSIONAL ASSESSMENT; IMPORTANT DIFFERENCE; DEPRESSION SCALE; SEVERITY INDEX; OF-LIFE; DISTURBANCES; VALIDITY; POPULATION	BACKGROUND: Individuals with traumatic brain injury (TBI) often develop sleep disorders post-injury. The most common one is insomnia, which can exacerbate other post-injury symptoms, including fatigue, impaired cognition, depression, anxiety, and pain. Cognitive Behavioral Therapy for Insomnia (CBT-I) is a manualized treatment that effectively treats insomnia with secondary effects on cognition, mood, and pain in various populations. OBJECTIVE: This paper reviews the use of CBT-I for three participants with TBI of different severities. METHODS: Pre- and post-treatment assessments of insomnia, fatigue, depression, anxiety, and pain were conducted. Mood was further assessed at follow-up. Minimal clinically important difference (MCID) scores derived from the research literature were used to establish clinically meaningful symptom improvement on self-report questionnaires. RESULTS: The reduction in insomnia severity scores for all three participants were not large enough to be considered a clinically significant improvement following CBT-I, although trends toward improvement were observed. However, all participants showed clinically significant reductions in anxiety at post-treatment; the effects persisted for 2 participants at follow-up. Reductions in depression symptoms were observed for 2 participants at post-treatment, and treatment effects persisted for 1 participant at follow-up. One participant endorsed clinically significant improvements in fatigue and pain severity. CONCLUSIONS: We conclude that CBT-I may provide secondary benefits for symptoms commonly experienced by individuals with TBI, especially mood disturbances.	[Lu, William] NYU, Langone Med Ctr, Rusk Rehabil, New York, NY 10003 USA; [Krellman, Jason W.; Dijkers, Marcel P.] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA		Lu, W (corresponding author), NYU, Langone Med Ctr, Rusk Rehabil, New York, NY 10003 USA.	william.lu@nyumc.org			Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [5U49CE002092-02]; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE002092] Funding Source: NIH RePORTER	Supported by the Centers for Disease Control and Prevention (grant no. 5U49CE002092-02). No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit on the authors or on any organization with which the authors are associated.	American Psychiatric Association & American Psychiatric Association. Task Force on DSM-V, 2013, DIAGNOSTIC AND STATI; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; BELZA BL, 1995, J RHEUMATOL, V22, P639; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; Daley M, 2009, SLEEP, V32, P55; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; Fairbrother N, 2008, PSYCHOL ASSESSMENT, V20, P150, DOI 10.1037/1040-3590.20.2.150; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Ferguson JM, 2001, J CLIN PSYCHIAT, V62, P22; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Frieboes RM, 1999, J NEUROPSYCH CLIN N, V11, P354, DOI 10.1176/jnp.11.3.354; Gagnon C, 2013, J AM BOARD FAM MED, V26, P701, DOI 10.3122/jabfm.2013.06.130064; Given B, 2008, J PAIN SYMPTOM MANAG, V35, P126, DOI 10.1016/j.jpainsymman.2007.03.012; Goligher EC, 2008, J RHEUMATOL, V35, P635; Harvey AG, 2002, BEHAV RES THER, V40, P869, DOI 10.1016/S0005-7967(01)00061-4; Hughes CM, 2009, ACUPUNCT MED, V27, P163, DOI 10.1136/aim.2009.000760; Keller S, 2004, CLIN J PAIN, V20, P309, DOI 10.1097/00002508-200409000-00005; Lequerica A, 2012, J HEAD TRAUMA REHAB, V27, pE28, DOI 10.1097/HTR.0b013e31826fe574; Lu W, 2015, BRAIN INJURY, V29, P1342, DOI 10.3109/02699052.2015.1043947; Manber R, 2008, SLEEP, V31, P489, DOI 10.1093/sleep/31.4.489; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Mathias Susan D, 2011, J Support Oncol, V9, P72; Mollayeya T, 2013, SLEEP MED REV, V17, P411, DOI 10.1016/j.smrv.2013.02.001; Morin CM, 2007, SLEEP, V30, P1547, DOI 10.1093/sleep/30.11.1547; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Mykletun A, 2001, BRIT J PSYCHIAT, V179, P540, DOI 10.1192/bjp.179.6.540; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Martinez MP, 2014, J BEHAV MED, V37, P683, DOI 10.1007/s10865-013-9520-y; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; PORTA M, 1975, EUR NEUROL, V13, P545, DOI 10.1159/000114710; Puhan MA, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-46; Rao V, 2014, BRAIN INJURY, V28, P20, DOI 10.3109/02699052.2013.847210; Rosekind MR, 2010, AM J MANAG CARE, V16, P617; Roth Thomas, 2007, J Clin Sleep Med, V3, pS7; Savard J, 2005, J CLIN ONCOL, V23, P6083, DOI 10.1200/JCO.2005.09.548; Schonberger M, 2010, PSYCHIAT RES, V179, P342, DOI 10.1016/j.psychres.2009.07.003; SPIELMAN AJ, 1987, PSYCHIAT CLIN N AM, V10, P541; SPIELMAN AJ, 1987, SLEEP, V10, P45; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Viola-Saltzman M, 2012, NEUROL CLIN, V30, P1299, DOI 10.1016/j.ncl.2012.08.008; Walker MP, 2009, PSYCHOL BULL, V135, P731, DOI 10.1037/a0016570; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Yang M, 2009, CURR MED RES OPIN, V25, P2487, DOI 10.1185/03007990903167415; Zeitzer JM, 2009, J REHABIL RES DEV, V46, P827, DOI 10.1682/JRRD.2008.08.0099; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	50	17	18	0	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2016	38	1					59	69		10.3233/NRE-151296			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DE6CC	WOS:000370719800008	26889799				2022-02-06	
J	Madura, SA; McDevitt, JK; Tierney, RT; Mansell, JL; Hayes, DJ; Gaughan, JP; Krynetskiy, E				Madura, Stephanie A.; McDevitt, Jane K.; Tierney, Ryan T.; Mansell, Jamie L.; Hayes, David J.; Gaughan, John P.; Krynetskiy, Evgeny			Genetic variation in SLC17A7 promoter associated with response to sport-related concussions	BRAIN INJURY			English	Article						Polymorphism; VGLUT1; vesicular transporters; rs74174284; prolonged recovery; head impact; mild traumatic brain injury; athletes	VESICULAR GLUTAMATE TRANSPORTER-1; STATES HIGH-SCHOOL; RISK-FACTORS; RECOVERY; PATHOPHYSIOLOGY; EPIDEMIOLOGY; SENSITIVITY; COLLEGIATE; VGLUT1	Objective: To determine the association of the single nucleotide polymorphism (SNP) rs74174284 within SLC17A7 promoter with concussion severity or duration. Design: A between-subjects design was utilized. Methods: Saliva samples and concussion severity and duration data were collected from 40 athletes diagnosed with a sport-related concussion by a physician, utilizing a standardized concussion assessment protocol. DNA was extracted, estimated and genotyped. Results: An association was found between the dominant genetic model (CC vs GG + GC; p = 0.0179) and recovery, where those carrying the minor allele were 6.33-times more likely to experience prolonged recovery rates. Within the ImPACT assessment, those carrying the CC genotype (33.38 +/- 10.15, p = 0.01) had worse motor speed scores upon initial assessment compared to both heterozygous (CG) and homozygous (GG) genotypes (41.59 +/- 7.39). Conclusions: This study was the first to demonstrate an association between genetic polymorphism at rs7417284 SNP in the promoter region of the SLC17A7 gene and concussion severity and duration. Based upon these findings, rs74174284 is a potential predictive genetic marker for identifying athletes who are more susceptible for altered recovery times and worse motor speed ImPACT scores after sport-related concussion.	[Madura, Stephanie A.; McDevitt, Jane K.; Tierney, Ryan T.; Mansell, Jamie L.; Hayes, David J.] Temple Univ, Dept Kinesiol, Philadelphia, PA 19122 USA; [Gaughan, John P.] Biostat Consulting Ctr, Philadelphia, PA USA; [Krynetskiy, Evgeny] Temple Univ, Sch Pharm, Philadelphia, PA 19122 USA		Madura, SA (corresponding author), 18 Fox Run, Glen Gardner, NJ 08826 USA.	steph.madura@gmail.com					Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Beneyto M, 2006, CURRENT PSYCHOSIS TH, V4, P27; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Finnoff JT, 2011, PM&R, V3, pS452, DOI 10.1016/j.pmrj.2011.07.014; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Liguz-Lecznar M, 2007, INT J DEV NEUROSCI, V25, P107, DOI 10.1016/j.ijdevneu.2006.12.005; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea HJ, 2013, SPORTS HEALTH, V5, P160, DOI 10.1177/1941738112462203; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McDevitt JK, 2011, BRAIN INJURY, V25, P1108, DOI 10.3109/02699052.2011.607790; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Schaal K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019007; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Silverthorn D, 2007, HUMAN PHYSL INTEGRAT, pA34; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Terrell TR, 2008, CLIN J SPORT MED, V18, P10, DOI 10.1097/JSM.0b013e31815c1d4c; Tierney RT, 2010, CLIN J SPORT MED, V20, P464, DOI 10.1097/JSM.0b013e3181fc0a81; Upshaw JE, 2012, PEDIATR EMERG CARE, V28, P926, DOI 10.1097/PEC.0b013e318267f674; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101	32	17	17	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	7					908	913		10.3109/02699052.2016.1146958			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DP2MI	WOS:000378322400010	27029226				2022-02-06	
J	Marsh, NV; Ludbrook, MR; Gaffaney, LC				Marsh, Nigel V.; Ludbrook, Maria R.; Gaffaney, Lauren C.			Cognitive functioning following traumatic brain injury: A five-year follow-up	NEUROREHABILITATION			English	Article						Traumatic brain injury; cognitive functioning; neuropsychological assessment; long-term outcome	COMPLEX FIGURE TEST; HEAD-INJURY; NEUROPSYCHOLOGICAL IMPAIRMENT; PRACTICAL SCALE; WORKING-MEMORY; VERBAL FLUENCY; TBI; PERFORMANCE; MODERATE; AGE	OBJECTIVE: To describe the long-term prevalence and severity of cognitive deficits following significant (i.e., ventilation required for >24 hours) traumatic brain injury. To assess a comprehensive range of cognitive functions using psychometric measures with established normative, reliability, and validity data. METHODS: A group of 71 adults was assessed at approximately five years (mean = 66 months) following injury. Assessment of cognitive functioning covered the domains of intelligence, attention, verbal and visual memory, visual-spatial construction, and executive functions. RESULTS: Impairment was evident across all domains but prevalence varied both within and between domains. Across aspects of intelligence clinical impairment ranged from 8-25%, attention 39-62%, verbal memory 16-46%, visual memory 23-51%, visual-spatial construction 38%, and executive functions (verbal fluency) 13%. In addition, 3-23% of performances across the measures were in the borderline range, suggesting a high prevalence of subclinical deficit. CONCLUSIONS: Although the prevalence of impairment may vary across cognitive domains, long-term follow-up documented deficits in all six domains. These findings provide further evidence that while improvement of cognitive functioning following significant traumatic brain injury may be possible, recovery of function is unlikely.	[Marsh, Nigel V.] Sunway Univ, Dept Psychol, Bandar Sunway, Selangor, Malaysia; [Ludbrook, Maria R.; Gaffaney, Lauren C.] Univ Waikato, Dept Psychol, Hamilton, New Zealand		Marsh, NV (corresponding author), Sunway Univ, Dept Psychol, 5 Jalan Univ, Bandar Sunway 47500, Selangor Darul, Malaysia.	nigelm@sunway.edu.my	Marsh, Nigel/ABA-3609-2021; Marsh, Nigel V./F-5433-2019	Marsh, Nigel/0000-0002-4060-6432; Marsh, Nigel V./0000-0002-4060-6432	Neurological Foundation of New Zealand [NF 98/17PG]	This study was supported by grant number NF 98/17PG from the Neurological Foundation of New Zealand.	Ashton VL, 2005, J CLIN EXP NEUROPSYC, V27, P55, DOI 10.1080/138033990513636; Clune-Ryberg M, 2011, BRAIN INJURY, V25, P819, DOI 10.3109/02699052.2011.589790; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Havill JH, 1998, NEW ZEAL MED J, V111, P161; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; JENNETT B, 1975, LANCET, V1, P480; JOHNSTONE B, 1995, BRAIN INJURY, V9, P377, DOI 10.3109/02699059509005777; Kennedy JE, 2003, CLIN NEUROPSYCHOL, V17, P303, DOI 10.1076/clin.17.3.303.18091; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Marsh NV, 2005, J CLIN EXP NEUROPSYC, V27, P352, DOI 10.1080/13803390490515685; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McKenna K, 2006, BRAIN INJURY, V20, P507, DOI 10.1080/02699050600664368; Meyers JE., 1995, REY COMPLEX FIGURE T; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P567, DOI 10.1080/13803390500434466; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Schmidt M., 1996, REY AUDITORY VERBAL; Schwarz L, 2009, CLIN NEUROPSYCHOL, V23, P255, DOI 10.1080/13854040802220034; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; Silverberg ND, 2009, J INT NEUROPSYCH SOC, V15, P94, DOI 10.1017/S1355617708090139; Slovarp L, 2012, BRAIN INJURY, V26, P48, DOI 10.3109/02699052.2011.635355; Smith A., 1982, SYMBOL DIGIT MODALIT; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; TATE RL, 1991, J NERV MENT DIS, V179, P117, DOI 10.1097/00005053-199103000-00001; TEASDALE G, 1974, LANCET, V2, P81; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246	36	17	18	0	23	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2016	38	1					71	78		10.3233/NRE-151297			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DE6CC	WOS:000370719800009	26889800	Green Accepted			2022-02-06	
J	Missios, S; Bekelis, K				Missios, Symeon; Bekelis, Kimon			The association of insurance status and race with the procedural volume of traumatic brain injury patients	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Traumatic brain injury; Insurance coverage; Race; Procedural volume; Resource utilization; NTDB	DIAGNOSTIC-TESTS; OUTCOMES; DISPARITIES; CHILDREN; CARE	Introduction: The influence of non-medical factors on the volume of procedures undergone by TBI patients remains an issue of debate. We investigated the association of lack of insurance and African-American race with the procedural volume of TBI patients. Methods: We performed a retrospective cohort study involving TBI patients, who were registered in the National Trauma Data Bank (NTDB) between 2009 and 2011. Multivariable logistic regression with mixed effects to control for clustering at the hospital level was used to investigate the association of insurance status and race with high volume of procedures for TBI patients. Results: Of the 392,292 TBI patients, who were registered in NTDB and met the inclusion criteria, 9850 (3.8%) underwent high procedural volume, defined as 2 or more procedures during hospitalization (2 standard deviations over the mean). Multivariable logistic regression analysis demonstrated an association of uninsured patients with decreased possibility of high procedural volume (OR, 0.68; 95% CI, 0.63-0.73). This persisted after using a mixed effects model to control for clustering at the hospital level (OR, 0.66; 95% CI, 0.61-0.71). In stratified samples, uninsured patients demonstrated similar associations even for GCS below 8 (OR, 0.69; 95% CI, 0.64-0.75), or ISS above 15 (OR, 0.74; 95% CI, 0.69-0.79). Multivariable logistic regression analysis did not demonstrate an association of African Americans with procedural volume (OR, 0.93; 95% CI, 0.86-1.02). Conclusions: During the hospitalization of TBI patients, lack of insurance was associated with lower procedural volume. When controlling for insurance status, we did not observe any race associated disparities in procedural volume. (C) 2015 Elsevier Ltd. All rights reserved.	[Missios, Symeon] Louisiana State Univ, Hlth Sci Ctr, Dept Neurosurg, Shreveport, LA 71105 USA; [Bekelis, Kimon] Dartmouth Hitchcock Med Ctr, Dept Surg, Lebanon, NH 03756 USA		Bekelis, K (corresponding author), Dartmouth Hitchcock Med Ctr, One Med Ctr Dr, Lebanon, NH 03756 USA.	kbekelis@gmail.com	Bekelis, Kimon/Y-3402-2019				American College of Surgeons, 2011, ANN REPORT; Bolorunduro OB, 2013, AM J SURG, V205, P365, DOI 10.1016/j.amjsurg.2012.10.026; Fisher ES, 2011, NEW ENGL J MED, V365, P2445, DOI 10.1056/NEJMp1112442; Fowler RA, 2010, AM J RESP CRIT CARE, V181, P1003, DOI 10.1164/rccm.200902-0281ST; Greene WR, 2010, AM J SURG, V199, P554, DOI 10.1016/j.amjsurg.2009.11.005; Haider AH, 2012, J AM COLL SURGEONS, V214, P756, DOI 10.1016/j.jamcollsurg.2011.12.013; Halpern MT, 2009, ANN SURG ONCOL, V16, P562, DOI 10.1245/s10434-008-0205-7; Institute of Medicine (IOM), CAR COV TOO LITTL TO; Kelly DF, 2001, WORLD J SURG, V25, P1179; Quintana JM, 1997, INT J QUAL HEALTH C, V9, P419, DOI 10.1093/intqhc/9.6.419; Rosen H, 2009, J PEDIATR SURG, V44, P1952, DOI 10.1016/j.jpedsurg.2008.12.026; Tepas JJ, 2011, J AM COLL SURGEONS, V212, P722, DOI 10.1016/j.jamcollsurg.2010.12.016; Tilford JM, 2005, CRIT CARE MED, V33, P2074, DOI 10.1097/01.CCM.0000171839.65687.F5; Traumatic Brain Injury in the United States, 2010, TRAUMATIC BRAIN INJU; WENNEKER MB, 1990, JAMA-J AM MED ASSOC, V264, P1255, DOI 10.1001/jama.264.10.1255	15	17	17	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JAN	2016	47	1					154	159		10.1016/j.injury.2015.06.037			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	CZ8HD	WOS:000367339900028	26187434				2022-02-06	
J	Pappu, S; Lerma, J; Khraishi, T				Pappu, Suguna; Lerma, Jesus; Khraishi, Tariq			Brain CT to Assess Intracranial Pressure in Patients with Traumatic Brain Injury	JOURNAL OF NEUROIMAGING			English	Article						Cerebrospinal fluid; computed tomography; image analysis; intracranial monitor; intracranial pressure	HEAD-INJURY; IMPACT	INTRODUCTIONMorphologic features of computed tomography (CT) scans of the brain can be used to estimate intracranial pressure (ICP) via an image-processing algorithm. Clinically, such estimations can be used to prognosticate outcomes and avoid placement of invasive intracranial monitors in certain patients with severe traumatic brain injury. Features on a CT scan that may correlate with measurements of low ICP are sought. METHODSA measure is proposed that is a function of the distribution of cerebrospinal fluid (CSF) in and around the brain. In our method, we present an algorithm that semiautomatically segments brain parenchyma from CSF, and apply standard image processing calculations. The ratio of CSF volume to the size of the intracranial vault (ICV) or volume inside the skull, csf(v)/icv(v) is calculated and then plotted against the actual recorded ICP, yielding a relationship between the image features and ICP. RESULTSWe analyzed a total of 45 scans from 20 patients with severe traumatic brain injury (TBI). We showed that a ratio csf(v)/icv(v) > .034 correlates with an ICP < 20 mmHg (P = .0046). For csf(v)/icv(v) .034, a distinction between low and high ICP cannot be effectively estimated by this univariate measure. CONCLUSIONThis method permits a noninvasive means of identifying patients who are low risk for having elevated ICP; by following Brain Trauma Foundation guidelines strictly such a patient may be subjected to an unnecessary, invasive procedure. This work is a promising pilot study that will need to be analyzed for a larger population.	Univ New Mexico, Dept Neurosurg, Albuquerque, NM 87131 USA; [Lerma, Jesus; Khraishi, Tariq] Univ New Mexico, Dept Mech Engn, Albuquerque, NM 87131 USA; [Pappu, Suguna] Univ New Mexico, Dept Neurosurg, Albuquerque, NM 87131 USA		Pappu, S (corresponding author), Univ New Mexico, Dept Neurosurg, MSC10 5615, Albuquerque, NM 87131 USA.	spappu@salud.unm.edu					Binz DD, 2009, NEUROCRIT CARE, V10, P253, DOI 10.1007/s12028-009-9193-0; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chen WA, 2010, IEEE INT C BIOINFORM, P510, DOI 10.1109/BIBM.2010.5706619; Faul M, 2002, TRAUMATIC BRAIN INJU; Glowacki M, 2010, ACTA NEUROCHIR SUPPL, V106, P199, DOI 10.1007/978-3-211-98811-4_37; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; KISHORE PRS, 1981, AM J ROENTGENOL, V137, P829, DOI 10.2214/ajr.137.4.829; Lauric A, SOFT SEGMENTATION CT; Lozier AP, 2002, NEUROSURGERY, V51, P170, DOI 10.1097/00006123-200207000-00024; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MIZUTANI T, 1990, SURG NEUROL, V33, P178, DOI 10.1016/0090-3019(90)90181-N; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Ngo QN, 2009, PEDIATR CRIT CARE ME, V10, P346, DOI 10.1097/PCC.0b013e3181a320cd; Rosenberg JB, 2011, NEUROCRIT CARE, V15, P599, DOI 10.1007/s12028-011-9545-4; Ross IB, 2003, AM J NEURORADIOL, V24, P1528; Zeng T, 2010, CHIN J TRAUMATOL, V13, P146, DOI 10.3760/cma.j.issn.1008-1275.2010.03.003	17	17	17	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1051-2284	1552-6569		J NEUROIMAGING	J. Neuroimaging	JAN-FEB	2016	26	1					37	40		10.1111/jon.12289			4	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	DA7VI	WOS:000368012400004	26752449				2022-02-06	
J	de Sousa, MVP; Ferraresi, C; Kawakubo, M; Kaippert, B; Yoshimura, EM; Hamblin, MR				Pires de Sousa, Marcelo Victor; Ferraresi, Cleber; Kawakubo, Masayoshi; Kaippert, Beatriz; Yoshimura, Elisabeth Mateus; Hamblin, Michael R.			Transcranial low-level laser therapy (810 nm) temporarily inhibits peripheral nociception: photoneuromodulation of glutamate receptors, prostatic acid phophatase, and adenosine triphosphate	NEUROPHOTONICS			English	Article						transcranial low-level laser therapy; photobiomodulation; pain threshold; nociception; Von Frey filaments; tail flick test; cold plate test; formalin injection; adenosine triphosphate; prostatic acid phosphatase; metabotropic glutamate receptor	TRAUMATIC BRAIN-INJURY; ISCHEMIC-STROKE; LIGHT THERAPY; CHRONIC PAIN; IRRADIATION; MECHANISMS; MODELS; PHOSPHATASE; RELIEF	Photobiomodulation or low-level light therapy has been shown to attenuate both acute and chronic pain, but the mechanism of action is not well understood. In most cases, the light is applied to the painful area, but in the present study we applied light to the head. We found that transcranial laser therapy (TLT) applied to mouse head with specific parameters (810 nm laser, 300 mW/cm(2), 7.2 or 36 J/cm(2)) decreased the reaction to pain in the foot evoked either by pressure (von Frey filaments), cold, or inflammation (formalin injection) or in the tail (evoked by heat). The pain threshold increasing is maximum around 2 h after TLT, remains up to 6 h, and is finished 24 h after TLT. The mechanisms were investigated by quantification of adenosine triphosphate (ATP), immunofluorescence, and hematoxylin and eosin (H&E) staining of brain tissues. TLT increased ATP and prostatic acid phosphatase (an endogenous analgesic) and reduced the amount of glutamate receptor (mediating a neurotransmitter responsible for conducting nociceptive information). There was no change in the concentration of tubulin, a constituent of the cytoskeleton, and the H&E staining revealed no tissue damage. (C) 2016 Society of Photo-Optical Instrumentation Engineers (SPIE)	[Pires de Sousa, Marcelo Victor; Ferraresi, Cleber; Kawakubo, Masayoshi; Kaippert, Beatriz; Hamblin, Michael R.] Massachusetts Gen Hosp, Wellman Ctr Photomed, BAR414,40 Blossom St, Boston, MA 02114 USA; [Pires de Sousa, Marcelo Victor; Yoshimura, Elisabeth Mateus] Univ Sao Paulo, Inst Phys, Lab Radiat Dosimetry & Med Phys, Rua Matao,Travessa R,187,Cidade Univ, Sao Paulo, Brazil; [Pires de Sousa, Marcelo Victor] Bright Photomed Ltd, CIETEC Bldg,2242 Lineu Prestes, BR-05508000 Sao Paulo, Brazil; [Ferraresi, Cleber] Univ Fed Sao Carlos, Dept Phys Therapy, Lab Electrothermophototherapy, St Washington Luis,Km 235, BR-13565905 Sao Paulo, Brazil; [Ferraresi, Cleber] Univ Fed Sao Carlos, Postgrad Program Biotechnol, St Washington Luis,Km 235, BR-13560000 Sao Paulo, Brazil; [Ferraresi, Cleber] Univ Sao Paulo, Opt Grp, Phys Inst Sao Carlos, St Miguel Petroni,146 Jardim Bandeirantes, BR-13560970 Sao Paulo, Brazil; [Kaippert, Beatriz] Univ Fed Rio de Janeiro, 373 Cidade Univ, BR-21941170 Rio De Janeiro, RJ, Brazil; [Hamblin, Michael R.] Harvard Univ, Sch Med, Dept Dermatol, 50 Staniford St 807, Boston, MA 02114 USA; [Hamblin, Michael R.] Harvard MIT, Div Hlth Sci & Technol, 77 Massachusetts Ave,E25-518, Cambridge, MA 02139 USA		de Sousa, MVP; Hamblin, MR (corresponding author), Massachusetts Gen Hosp, Wellman Ctr Photomed, BAR414,40 Blossom St, Boston, MA 02114 USA.; de Sousa, MVP (corresponding author), Univ Sao Paulo, Inst Phys, Lab Radiat Dosimetry & Med Phys, Rua Matao,Travessa R,187,Cidade Univ, Sao Paulo, Brazil.; de Sousa, MVP (corresponding author), Bright Photomed Ltd, CIETEC Bldg,2242 Lineu Prestes, BR-05508000 Sao Paulo, Brazil.; Hamblin, MR (corresponding author), Harvard Univ, Sch Med, Dept Dermatol, 50 Staniford St 807, Boston, MA 02114 USA.; Hamblin, MR (corresponding author), Harvard MIT, Div Hlth Sci & Technol, 77 Massachusetts Ave,E25-518, Cambridge, MA 02139 USA.	marcelo230786@gmail.com; hamblin@helix.mgh.harvard.edu	Ferraresi, Cleber/B-2458-2014; Hamblin, Michael R/H-2758-2019; Yoshimura, Elisabeth M/E-8848-2012	Ferraresi, Cleber/0000-0002-1361-8390; Hamblin, Michael R/0000-0001-6431-4605; Yoshimura, Elisabeth/0000-0003-4778-1230	NIAID NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01 AI050875] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01AI050875] Funding Source: NIH RePORTER		Abramoff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI [DOI 10.1117/1.3589100, DOI 10.1201/9781420005615.AX4]; Alayat MSM, 2014, LASER MED SCI, V29, P1065, DOI 10.1007/s10103-013-1472-5; Alves ACA, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4296; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bjordal JM, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-75; Bjordal JM, 2003, AUST J PHYSIOTHER, V49, P107, DOI 10.1016/S0004-9514(14)60127-6; Cambier D, 2000, LASER MED SCI, V15, P195, DOI 10.1007/PL00011317; Chow R, 2015, LASERS IN DENTISTRY: GUIDE FOR CLINICAL PRACTICE, P34; Chow RT, 2007, J PERIPHER NERV SYST, V12, P28, DOI 10.1111/j.1529-8027.2007.00114.x; Chow RT, 2009, LANCET, V374, P1897, DOI 10.1016/S0140-6736(09)61522-1; Gonzalez-Lima F, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00036; Goodman L. S, 1996, GOODMAN GILMANS PHAR, V1549; Hamblin M., 2011, LOW LEVEL LIGHT THER; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; Hurt JK, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-28; Jimbo K, 1998, NEUROSCI LETT, V240, P93, DOI 10.1016/S0304-3940(97)00935-X; Karu TI, 2005, J PHOTOCH PHOTOBIO B, V81, P98, DOI 10.1016/j.jphotobiol.2005.07.002; Karu TI, 2014, IEEE J SEL TOP QUANT, V20, DOI 10.1109/JSTQE.2013.2273411; Kington JA, 2014, SPRINGERBR ENV SECUR, V19, P5, DOI 10.1007/978-3-319-07704-8_2; Kuner R, 2010, NAT MED, V16, P1258, DOI 10.1038/nm.2231; Lampl Y., 2007, EXPERT REV NEUROTHER, V8; Lampl Y, 2007, STROKE, V38, P1843, DOI 10.1161/STROKEAHA.106.478230; Lapchak PA, 2012, EXPERT REV MED DEVIC, V9, P71, DOI 10.1586/ERD.11.64; Lapchak PA, 2010, ANN MED, V42, P576, DOI 10.3109/07853890.2010.532811; Le Bars D, 2001, PHARMACOL REV, V53, P597; Masoumipoor M, 2014, ARCH NEUROSCI, V1, P76, DOI 10.5812/archneurosci.13740; Moges H, 2009, LASER SURG MED, V41, P52, DOI 10.1002/lsm.20732; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P443, DOI 10.1089/pho.2011.9908; Navratil L., 1997, Laser Therapy, V9, P33; Oron A, 2007, J NEUROTRAUM, V24, P651, DOI 10.1089/neu.2006.0198; Pallotta RC, 2012, LASER MED SCI, V27, P71, DOI 10.1007/s10103-011-0906-1; de Sousa MVP, 2014, J NEUROSCI METH, V232, P1, DOI 10.1016/j.jneumeth.2014.04.017; Pitcher GM, 1999, J NEUROSCI METH, V87, P185, DOI 10.1016/S0165-0270(99)00004-7; Rickards LD, 2006, INT J OSTEOPATH MED, V9, P120, DOI DOI 10.1016/J.IJ0SM.2006.07.007; Rojas JC, 2011, EYE BRAIN, V3, P49, DOI 10.2147/EB.S21391; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Sousa MVP, 2012, PROC SPIE, V8427, DOI 10.1117/12.912616; Sowa NA, 2010, J NEUROSCI, V30, P10282, DOI 10.1523/JNEUROSCI.2162-10.2010; Tao YX, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-30; Trimmer PA, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-26; WALKER J, 1983, NEUROSCI LETT, V43, P339, DOI 10.1016/0304-3940(83)90211-2; Yousefi-Nooraie R., 2008, LOW LEVEL LASER THER; Zhang H, 2012, CELL SIGNAL, V24, P224, DOI 10.1016/j.cellsig.2011.09.004; Zylka MJ, 2008, NEURON, V60, P111, DOI 10.1016/j.neuron.2008.08.024	44	17	17	0	4	SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS	BELLINGHAM	1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA	2329-423X	2329-4248		NEUROPHOTONICS	Neurophotonics	JAN-MAR	2016	3	1							015003	10.1117/1.NPh.3.1.015003			9	Neurosciences; Optics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Optics	DI8SJ	WOS:000373771200007	26835486	Green Published, Bronze			2022-02-06	
J	Sigurdardottir, S; Andelic, N; Skandsen, T; Anke, A; Roe, C; Holthe, OO; Wehling, E				Sigurdardottir, Solrun; Andelic, Nada; Skandsen, Toril; Anke, Audny; Roe, Cecilie; Holthe, Oyvor Oistensen; Wehling, Eike			Olfactory Identification and Its Relationship to Executive Functions, Memory, and Disability One Year After Severe Traumatic Brain Injury	NEUROPSYCHOLOGY			English	Article						anosmia; olfaction; executive functions; memory; disability	MILD COGNITIVE IMPAIRMENT; ODOR IDENTIFICATION; ALZHEIMERS-DISEASE; HEAD-INJURY; APOLIPOPROTEIN-E; SMELL; DYSFUNCTION; PERFORMANCE; DEFICITS; ANOSMIA	Objective: To explore the frequency of posttraumatic olfactory (dys) function 1 year after severe traumatic brain injury (TBI) and determine whether there is a relationship between olfactory identification and neuropsychological test performance, injury severity and TBI-related disability. Method: A population-based multicenter study including 129 individuals with severe TBI (99 males; 16 to 85 years of age) that could accomplish neuropsychological examinations. Olfactory (dys) function (anosmia, hyposmia, normosmia) was assessed by the University of Pennsylvania Smell Identification Test (UPSIT) or the Brief Smell Identification Test (B-SIT). Three tests of the Delis-Kaplan Executive Function System (D-KEFS) were used to assess processing speed, verbal fluency, inhibition and set-shifting, and the California Verbal Learning Test-II was used to examine verbal memory. The Glasgow Outcome Scale-Extended (GOSE) was used to measure disability level. Results: Employing 2 different smell tests in 2 equal-sized subsamples, the UPSIT sample (n = 65) classified 34% with anosmia and 52% with hyposmia, while the B-SIT sample (n = 64) classified 20% with anosmia and 9% with hyposmia. Individuals classified with anosmia by the B-SIT showed significantly lower scores for set-shifting, category switching fluency and delayed verbal memory compared to hyposmia and normosmia groups. Only the B-SIT scores were significantly correlated with neuropsychological performance and GOSE scores. Brain injury severity (Rotterdam CT score) and subarachnoid hemorrhage were related to anosmia. Individuals classified with anosmia demonstrated similar disability as those with hyposmia/normosmia. Conclusions: Different measures of olfaction may yield different estimates of anosmia. Nevertheless, around 1 third of individuals with severe TBI suffered from anosmia, which may also indicate poorer cognitive outcome.	[Sigurdardottir, Solrun] Sunnaas Rehabil Hosp, Dept Res, N-1450 Nesoddtangen, Norway; [Sigurdardottir, Solrun; Andelic, Nada] Univ Oslo, Inst Hlth & Soc, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Fac Med, N-0316 Oslo, Norway; [Andelic, Nada; Roe, Cecilie; Holthe, Oyvor Oistensen] Oslo Univ Hosp, Div Surg & Clin Neurosci, Dept Phys Med & Rehabil, Oslo, Norway; [Skandsen, Toril] Univ Trondheim Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Skandsen, Toril] Norwegian Univ Sci & Technol, Dept Neurosci, Fac Med, Trondheim, Norway; [Anke, Audny] Univ Hosp North Norway, Dept Rehabil, Tromso, Norway; [Anke, Audny] Univ Tromso, Dept Clin Med, N-9001 Tromso, Norway; [Anke, Audny] Arctic Univ Norway, Tromso, Norway; [Roe, Cecilie] Univ Oslo, Fac Med, Inst Clin Med, N-0316 Oslo, Norway; [Wehling, Eike] Haukeland Hosp, Dept Phys Med & Rehabil, N-5021 Bergen, Norway; [Wehling, Eike] Univ Bergen, Dept Biol & Med Psychol, N-5020 Bergen, Norway		Sigurdardottir, S (corresponding author), Sunnaas Rehabil Hosp, N-1450 Nesoddtangen, Norway.	solrun.sigurdardottir@medisin.uio.no		Anke, Audny/0000-0002-2491-2560; Andelic, Nada/0000-0002-3719-4406	Research Council of NorwayResearch Council of Norway; Institute of Health and Society, CHARM (Research Centre for Habilitation and Rehabilitation Models and Services), Faculty of Medicine, University of Oslo	We thank all the individuals for their participation. Our special thanks to all the neuropsychologists who were involved in collecting neuropsychological data. Our warm thanks to Tone Jerstad, neuroradiologist, and other neuroradiologists at the trauma hospitals for the classification of the CT scans. We thank the reviewers for their valuable comments that substantially improved the manuscript. This study was funded by grants from the Research Council of Norway and the Institute of Health and Society, CHARM (Research Centre for Habilitation and Rehabilitation Models and Services), Faculty of Medicine, University of Oslo.	Alexander MP, 2007, NEUROLOGY, V68, P1515, DOI 10.1212/01.wnl.0000261482.99569.fb; Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Anke A, 2014, J HEAD TRAUMA REHABI; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL; Backman L, 1999, NEUROLOGY, V52, P1861, DOI 10.1212/WNL.52.9.1861; Bacon AW, 1998, ANN NY ACAD SCI, V855, P723, DOI 10.1111/j.1749-6632.1998.tb10651.x; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barresi M, 2012, J NEUROL SCI, V323, P16, DOI 10.1016/j.jns.2012.08.028; Bitter T, 2010, CHEM SENSES, V35, P407, DOI 10.1093/chemse/bjq028; Bramerson A, 2004, LARYNGOSCOPE, V114, P733; Callahan CD, 2002, J HEAD TRAUMA REHAB, V17, P251, DOI 10.1097/00001199-200206000-00006; Callahan CD, 1999, J HEAD TRAUMA REHAB, V14, P581, DOI 10.1097/00001199-199912000-00006; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Costanzo R. M., 1992, J HEAD TRAUMA REHAB, V7, P15, DOI DOI 10.1097/00001199-199203000-00005; Crowe SF, 2013, J CLIN EXP NEUROPSYC, V35, P298, DOI 10.1080/13803395.2013.771616; Croy I, 2014, CHEM SENSES, V39, P185, DOI 10.1093/chemse/bjt072; Dade LA, 2002, BRAIN, V125, P86, DOI 10.1093/brain/awf003; de Kruijk JR, 2003, BRAIN INJURY, V17, P73, DOI 10.1080/0269905021000010221; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Djordjevic J, 2008, NEUROBIOL AGING, V29, P693, DOI 10.1016/j.neurobiolaging.2006.11.014; Doty R.L., 2001, BRIEF SMELL IDENTIFI; Doty RL, 2007, AM J RHINOL, V21, P460, DOI 10.2500/ajr.2007.21.3043; Doty RL, 1997, ARCH NEUROL-CHICAGO, V54, P1131, DOI 10.1001/archneur.1997.00550210061014; Doty RL, 1995, SMELL IDENTIFICATION, Vthird; Driscoll I, 2009, NEUROLOGY, V72, P1906, DOI 10.1212/WNL.0b013e3181a82634; Drummond M, 2013, BRAIN INJURY, V27, P332, DOI 10.3109/02699052.2012.750743; Duraski SA, 2014, REHABIL NURS, V39, P140, DOI 10.1002/rnj.138; Fornazieri MA, 2015, CHEM SENSES, V40, P141, DOI 10.1093/chemse/bju068; Fortin A, 2010, BRAIN INJURY, V24, P27, DOI 10.3109/02699050903446815; Green P, 2003, BRAIN INJURY, V17, P479, DOI 10.1080/0269905031000070242; Green P, 2001, NEUROREHABILITATION, V16, P237; Greiffenstein MF, 2002, J CLIN EXP NEUROPSYC, V24, P705, DOI 10.1076/jcen.24.5.705.1011; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Hedner M, 2010, J CLIN EXP NEUROPSYC, V32, P1062, DOI 10.1080/13803391003683070; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; JONESGOTMAN M, 1988, NEUROPSYCHOLOGIA, V26, P387, DOI 10.1016/0028-3932(88)90093-0; Larsson M, 2000, J GERONTOL B-PSYCHOL, V55, pP304, DOI 10.1093/geronb/55.5.P304; Larsson M, 1997, CHEM SENSES, V22, P623, DOI 10.1093/chemse/22.6.623; Larsson M, 2004, CHEM SENSES, V29, P547, DOI 10.1093/chemse/bjh059; LEVIN HS, 1985, BRAIN, V108, P579, DOI 10.1093/brain/108.3.579; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lovstad M, 2012, BRAIN INJURY, V26, P1586, DOI 10.3109/02699052.2012.698787; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Merkley TL, 2013, J INT NEUROPSYCH SOC, V19, P899, DOI 10.1017/S135561771300074X; Murphy C, 1998, ANN NY ACAD SCI, V855, P744, DOI 10.1111/j.1749-6632.1998.tb10654.x; Myers CS, 1915, LANCET, V1, P316; Neumann D, 2012, ARCH PHYS MED REHAB, V93, P1414, DOI 10.1016/j.apmr.2012.03.009; Ogle W, 1870, Med Chir Trans, V53, P263; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Reiter ER, 2004, OTOLARYNG CLIN N AM, V37, P1167, DOI 10.1016/j.otc.2004.06.005; Robinson G, 2012, BRAIN, V135, P2202, DOI 10.1093/brain/aws142; Roe C, 2013, J REHABIL MED, V45, P734, DOI 10.2340/16501977-1198; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Rombaux P, 2006, LARYNGOSCOPE, V116, P901, DOI 10.1097/01.mlg.0000217533.60311.e7; Schiffman SS, 2000, EUR J CLIN NUTR, V54, pS54, DOI 10.1038/sj.ejcn.1601026; Schiffman SS, 2002, NEUROBIOL AGING, V23, P397, DOI 10.1016/S0197-4580(01)00337-2; Schofield PW, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00005; Serby M, 1996, BIOL PSYCHIAT, V39, P375, DOI 10.1016/0006-3223(95)00472-6; Sigurdardottir S, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000039; Sigurdardottir S, 2010, NEUROPSYCHOLOGY, V24, P504, DOI 10.1037/a0018934; Streiner DL, 2011, CHEST, V140, P16, DOI 10.1378/chest.11-0523; Stuss D. T., 2009, REHABILITATION EXECU, P3; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Varney NR, 1999, EVALUATION AND TREATMENT OF MILD TRAUMATIC BRAIN INJURY, P115; Weddell RA, 2010, ARCH PHYS MED REHAB, V91, P897, DOI 10.1016/j.apmr.2010.01.020; Wehling EI, 2010, AGING NEUROPSYCHOL C, V17, P205, DOI 10.1080/13825580903042684; Westervelt HJ, 2008, J CLIN EXP NEUROPSYC, V30, P151, DOI 10.1080/13803390701287408; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson RS, 2007, J NEUROL NEUROSUR PS, V78, P30, DOI 10.1136/jnnp.2006.099721; Wilson RS, 2006, NEUROEPIDEMIOLOGY, V26, P61, DOI 10.1159/000090250; Yochim B, 2007, J INT NEUROPSYCH SOC, V13, P704, DOI 10.1017/S1355617707070907; Yousem DM, 1999, ACAD RADIOL, V6, P264, DOI 10.1016/S1076-6332(99)80449-8; Yousem DM, 1996, AM J NEURORADIOL, V17, P1171; Zald DH, 2010, NEUROPSYCHOLOGIA, V48, P3377, DOI 10.1016/j.neuropsychologia.2010.08.012	76	17	17	1	13	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	JAN	2016	30	1					98	108		10.1037/neu0000206			11	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	CZ8CC	WOS:000367326600010	26076319				2022-02-06	
J	Sullivan, KA; Lange, RT; Edmed, SL				Sullivan, Karen A.; Lange, Rael T.; Edmed, Shannon L.			Utility of the Neurobehavioral Symptom Inventory Validity-10 index to detect symptom exaggeration: An analogue simulation study	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Diagnostic efficiency; Neurobehavioral Symptom Inventory; sensitivity; specificity; symptom exaggeration	TRAUMATIC BRAIN-INJURY; POSTCONCUSSIVE SYMPTOMS; TEST-PERFORMANCE; SCALE; VETERANS	The Neurobehavioral Symptom Inventory (NSI) has been recommended by the interagency Traumatic Brain Injury (TBI) Outcome Workgroup as an outcome measure for TBI research. A new symptom exaggeration indexthe NSI Validity-10can be calculated from its items, but its utility has not been evaluated in a malingering simulation study. Data from a prior analogue study were reanalyzed to examine the NSI Validity-10 test properties. The data were from a sample of 85 Australian undergraduate students. A battery of measures was completed under 1 of 3 experimental conditions: control (i.e., honest responding, n=24), feign postconcussional disorder (PCD; n=29), and feign posttraumatic stress disorder (PTSD; n=32). Participants who feigned PTSD or PCD had significantly higher scores on the NSI Validity-10 compared with controls. There were minimal differences between the 2 feigning groups. Using the combined data from the feigning groups and assuming a 35% symptom exaggeration base rate, the optimal NSI Validity-10 cutoff score was 10. This cutoff score identified probable exaggeration (sensitivity=.75, specificity=1.0, positive predictive power=1.0, negative predictive power=.88). Diagnostic efficiency statistics for 25% and 45% base rates were also generated. The cutoff score identified in this study is lower than previously reported. Its properties are promising, but its usage requires careful consideration.	[Sullivan, Karen A.; Edmed, Shannon L.] Queensland Univ Technol, Sch Psychol & Counselling, Clin Neuropsychol Res Grp, Brisbane, Qld, Australia; [Sullivan, Karen A.; Edmed, Shannon L.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [Lange, Rael T.] Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Lange, Rael T.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada		Sullivan, KA (corresponding author), Queensland Univ Technol, Sch Psychol & Counselling, O Block B Wing,Kelvin Grove Campus,Victoria Pk Rd, Kelvin Grove, Qld 4059, Australia.	karen.sullivan@qut.edu.au			School of Psychology and Counselling, Queensland University of Technology	Funding for this project was provided by the School of Psychology and Counselling, Queensland University of Technology.	Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cohen J., 2013, STAT POWER ANAL BEHA; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; Finn S. E., 2009, OXFORD HDB PERSONALI, P140; Gervais RO, 2010, ARCH CLIN NEUROPSYCH, V25, P274, DOI 10.1093/arclin/acq018; Gizzi M, 2003, J HEAD TRAUMA REHAB, V18, P398, DOI 10.1097/00001199-200309000-00002; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2003, HANDBOOK OF FORENSIC NEUROPSYCHOLOGY, P137; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P853, DOI 10.1080/13803395.2015.1064864; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P325, DOI 10.1080/13803395.2015.1013021; Lange RT, 2013, J CLIN EXP NEUROPSYC, V35, P192, DOI 10.1080/13803395.2012.761677; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2009, CLIN NEUROPSYCHOL, V23, P746, DOI 10.1080/13854040802696829; Logan B. W., 2014, BEHAV SCI LAW, V31, P803, DOI [10.1002/bsl/2092, DOI 10.1002/BSL/2092]; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Morey, 1991, PERSONALITY ASSESSME; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; Rogers R., 2008, CLIN ASSESSMENT MALI, P411; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Streiner DL, 2003, J PERS ASSESS, V81, P209, DOI 10.1207/S15327752JPA8103_03; Tellegen, 2008, MINNESOTA MULTIPHASI; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Whitney KA, 2010, APPL NEUROPSYCHOL, V17, P196, DOI 10.1080/09084282.2010.499787; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P145, DOI 10.1093/arclin/acp020; Widows M. R., 2005, STRUCTURED INVENTORY; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033	32	17	17	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2016	23	5					353	362		10.1080/23279095.2015.1079714			10	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	DR8DX	WOS:000380129700006	26943718				2022-02-06	
J	Tamano, H; Koike, Y; Nakada, H; Shakushi, Y; Takeda, A				Tamano, Hanuna; Koike, Yuta; Nakada, Hiroyuki; Shakushi, Yukina; Takeda, Atsushi			Significance of synaptic Zn2+ signaling in zincergic and non-zincergic synapses in the hippocampus in cognition	JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY			English	Article						Zinc; Hippocampus; Memory; Schaffer collateral; Mossy fiber; Perforant pathway	LONG-TERM POTENTIATION; CENTRAL-NERVOUS-SYSTEM; MAMMALIAN ZINC TRANSPORTERS; TRAUMATIC BRAIN-INJURY; MOSSY FIBER TERMINALS; DENTATE GYRUS; MICROMOLAR CONCENTRATIONS; RECOGNITION MEMORY; RAT HIPPOCAMPUS; CA2+ CHANNELS	A portion of zinc concentrates in the synaptic vesicles in the brain and is released from glutamatergic (zincergic) neuron terminals. It serves as a signaling factor (in a form of free Zn2+). Both extracellular Zn2+ signaling, which predominantly originates in Zn2+ release from zincergic neuron terminals, and intracellular Zn2+ signaling, which is often linked to extracellular Zn2+ signaling, are involved in hippocampus-dependent memory. At mossy fiber-CA3 pyramidal cell synapses and Schaffer collateral-CA1 pyramidal cell synapses, which are zincergic, extracellular Zn2+ signaling leads to intracellular Zn2+ signaling and is involved in learning and memory. At medial perforant pathway-dentate granule cell synapses, which are non-zincergic, intracellular Zn2+ signaling, which originates in the internal stores containing Zn2+, is involved in learning and memory. The blockade of Zn2+ signaling with Zn2+ chelators induces memory deficit, while the optimal amount range of Zn2+ signaling is unknown. It is possible that the degree and frequency of Zn2+ signaling, which determine the increased Zn2+ levels, modulates learning and memory as well as intracellular Ca2+ signaling. To understand the precise role of synaptic Zn2+ signaling in the hippocampus, the present paper summarizes the current knowledge on Zn2+ signaling at zincergic and non-zincergic synapses in the hippocampus in cognition and involvement of zinc transporters and zinc-binding proteins in synaptic Zn2+ signaling. (C) 2016 Elsevier GmbH. All rights reserved.	[Tamano, Hanuna; Koike, Yuta; Nakada, Hiroyuki; Shakushi, Yukina; Takeda, Atsushi] Univ Shizuoka, Sch Pharmaceut Sci, Dept Neurophysiol, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan		Takeda, A (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Neurophysiol, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	takedaa@u-shizuoka-ken.ac.jp					Adlard PA, 2015, NEUROBIOL DIS, V81, P196, DOI 10.1016/j.nbd.2014.12.012; Adlard PA, 2014, AGING CELL, V13, P351, DOI 10.1111/acel.12178; Adlard PA, 2010, J NEUROSCI, V30, P1631, DOI 10.1523/JNEUROSCI.5255-09.2010; Ando M, 2010, NEUROCHEM INT, V57, P608, DOI 10.1016/j.neuint.2010.07.010; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Breustedt J, 2003, P NATL ACAD SCI USA, V100, P12450, DOI 10.1073/pnas.2035117100; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; Ceccom J, 2014, LEARN MEMORY, V21, P287, DOI 10.1101/lm.033472.113; Ceccom J, 2013, LEARN MEMORY, V20, P348, DOI 10.1101/lm.029017.112; Chen NS, 1997, MOL PHARMACOL, V51, P1015, DOI 10.1124/mol.51.6.1015; Choi YB, 1999, NEURON, V23, P171, DOI 10.1016/S0896-6273(00)80763-1; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; Colvin RA, 2008, AM J PHYSIOL-CELL PH, V294, pC726, DOI 10.1152/ajpcell.00541.2007; Colvin RA, 2006, BRAIN RES, V1085, P1, DOI 10.1016/j.brainres.2006.02.043; Cope EC, 2016, EXP NEUROL, V279, P96, DOI 10.1016/j.expneurol.2016.02.017; Cope EC, 2011, PHYSIOL BEHAV, V104, P942, DOI 10.1016/j.physbeh.2011.06.007; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Danscher G, 2005, J HISTOCHEM CYTOCHEM, V53, P141, DOI 10.1369/jhc.4R6460.2005; DiGirolamo AM, 2009, AM J CLIN NUTR, V89, p940S, DOI 10.3945/ajcn.2008.26692C; Erickson JC, 1997, J NEUROSCI, V17, P1271; Frazzini V, 2006, BIOGERONTOLOGY, V7, P307, DOI 10.1007/s10522-006-9045-7; Frederickson CJ, 2006, EXP NEUROL, V198, P285, DOI 10.1016/j.expneurol.2005.08.030; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Gonzalez J, 2014, J NEUROPHYSIOL, V111, P1259, DOI 10.1152/jn.00941.2012; Heiliger E, 2015, METALLOMICS, V7, P355, DOI 10.1039/c4mt00300d; Huang LP, 2013, MOL ASPECTS MED, V34, P548, DOI 10.1016/j.mam.2012.05.008; Huang YZ, 2008, NEURON, V57, P546, DOI 10.1016/j.neuron.2007.11.026; Izumi Y, 2006, J NEUROSCI, V26, P7181, DOI 10.1523/JNEUROSCI.1258-06.2006; Kawahara M, 2014, METALLOMICS, V6, P209, DOI 10.1039/c3mt00257h; Kheirbek MA, 2012, J NEUROSCI, V32, P8696, DOI 10.1523/JNEUROSCI.1692-12.2012; Koumura A, 2009, NEUROSCI LETT, V467, P11, DOI 10.1016/j.neulet.2009.09.051; Lavoie N, 2011, J NEUROSCI, V31, P18251, DOI 10.1523/JNEUROSCI.4164-11.2011; Lee JY, 2011, BRAIN RES, V1418, P12, DOI 10.1016/j.brainres.2011.08.055; Li Y, 2001, J NEUROSCI, V21, P8015, DOI 10.1523/JNEUROSCI.21-20-08015.2001; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Liuzzi JP, 2004, ANNU REV NUTR, V24, P151, DOI 10.1146/annurev.nutr.24.012003.132402; Lorca RA, 2011, EUR J NEUROSCI, V33, P1175, DOI 10.1111/j.1460-9568.2010.07589.x; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MARKESBERY WR, 1984, NEUROBIOL AGING, V5, P19, DOI 10.1016/0197-4580(84)90081-2; Martel G, 2010, LEARN MEMORY, V17, P582, DOI 10.1101/lm.1962010; Minami A, 2006, J NEUROSCI RES, V83, P167, DOI 10.1002/jnr.20714; Mocchegiani E, 2005, PROG NEUROBIOL, V75, P367, DOI 10.1016/j.pneurobio.2005.04.005; Nakashima AS, 2009, BRAIN RES REV, V59, P347, DOI 10.1016/j.brainresrev.2008.10.003; Nakashima AS, 2008, J NEUROSCI, V28, P13995, DOI 10.1523/JNEUROSCI.4645-08.2008; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Pan EH, 2011, NEURON, V71, P1116, DOI 10.1016/j.neuron.2011.07.019; Paoletti P, 1997, J NEUROSCI, V17, P5711; Qian J, 2005, J PHYSIOL-LONDON, V566, P747, DOI 10.1113/jphysiol.2005.089276; Qian J, 2011, J NEUROSCI, V31, P97, DOI 10.1523/JNEUROSCI.5162-10.2011; Sandstead HH, 2014, J TRACE ELEM MED BIO, V28, P414, DOI 10.1016/j.jtemb.2014.08.011; Sandstead HH, 2012, J TRACE ELEM MED BIO, V26, P70, DOI 10.1016/j.jtemb.2012.04.018; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Sensi SL, 2003, P NATL ACAD SCI USA, V100, P6157, DOI 10.1073/pnas.1031598100; Sensi SL, 1997, J NEUROSCI, V17, P9554; Sensi SL, 2011, J NEUROSCI, V31, P16076, DOI 10.1523/JNEUROSCI.3454-11.2011; Seth R, 2015, J TRACE ELEM MED BIO, V30, P59, DOI 10.1016/j.jtemb.2014.10.010; Sindreu C, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-16; Sindreu C, 2011, P NATL ACAD SCI USA, V108, P3366, DOI 10.1073/pnas.1019166108; Sindreu CB, 2003, CEREB CORTEX, V13, P823, DOI 10.1093/cercor/13.8.823; Stork Christian J, 2010, J Mol Signal, V5, P5, DOI 10.1186/1750-2187-5-5; Suh SW, 2009, J CEREBR BLOOD F MET, V29, P1579, DOI 10.1038/jcbfm.2009.80; Szewczyk B, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00033; Takeda A, 2015, NEUROSCIENCE, V304, P209, DOI 10.1016/j.neuroscience.2015.07.042; TAKEDA A, 1994, BRAIN RES, V658, P252, DOI 10.1016/S0006-8993(09)90032-4; TAKEDA A, 1995, BRAIN RES, V695, P53, DOI 10.1016/0006-8993(95)00916-E; Takeda A, 2003, J NEUROSCI RES, V72, P537, DOI 10.1002/jnr.10600; Takeda A, 2009, NEUROSCIENCE, V158, P585, DOI 10.1016/j.neuroscience.2008.10.009; Takeda A, 2001, J NEUROSCI RES, V63, P447, DOI 10.1002/1097-4547(20010301)63:5&lt;447::AID-JNR1040&gt;3.0.CO;2-C; Takeda A, 2008, J NEUROSCI RES, V86, P2906, DOI 10.1002/jnr.21732; Takeda A, 2016, BIOMETALS, V29, P177, DOI 10.1007/s10534-015-9907-z; Takeda A, 2014, HIPPOCAMPUS, V24, P1404, DOI 10.1002/hipo.22322; Takeda A, 2014, J NEUROSCI RES, V92, P819, DOI 10.1002/jnr.23385; Takeda A, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00026; Takeda A, 2013, METALLOMICS, V5, P417, DOI 10.1039/c3mt20269k; Takeda A, 2012, BEHAV BRAIN RES, V226, P259, DOI 10.1016/j.bbr.2011.09.026; Takeda A, 2011, MOL NEUROBIOL, V44, P166, DOI 10.1007/s12035-010-8158-9; Takeda A, 2009, BRAIN RES REV, V62, P33, DOI 10.1016/j.brainresrev.2009.09.003; Takeda A, 2009, NEUROTOXICOLOGY, V30, P712, DOI 10.1016/j.neuro.2009.05.009; Tamano H, 2015, HIPPOCAMPUS, V25, P952, DOI 10.1002/hipo.22418; Tyszka-Czochara M, 2014, ACTA POL PHARM, V71, P369; Valente T, 2002, EXP NEUROL, V174, P215, DOI 10.1006/exnr.2002.7876; Valente T, 2002, MOL CELL NEUROSCI, V21, P189, DOI 10.1006/mcne.2002.1159; Wang HB, 2003, MOL PHARMACOL, V63, P463, DOI 10.1124/mol.63.3.463; Weiss JH, 2000, TRENDS PHARMACOL SCI, V21, P395, DOI 10.1016/S0165-6147(00)01541-8; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; Xia ZG, 2005, NAT REV NEUROSCI, V6, P267, DOI 10.1038/nrn1647; Yu XD, 2013, BRIT J NUTR, V110, P2194, DOI 10.1017/S0007114513001657	91	17	17	0	11	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0946-672X			J TRACE ELEM MED BIO	J. Trace Elem. Med. Biol.		2016	38				SI		93	98		10.1016/j.jtemb.2016.03.003			6	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	DY9RU	WOS:000385473600011	26995290				2022-02-06	
J	Turner-Stokes, L; Ashford, S; Jacinto, J; Maisonobe, P; Balcaitiene, J; Fheodoroff, K				Turner-Stokes, Lynne; Ashford, Stephen; Jacinto, Jorge; Maisonobe, Pascal; Balcaitiene, Jovita; Fheodoroff, Klemens			Impact of integrated upper limb spasticity management including botulinum toxin A on patient-centred goal attainment: rationale and protocol for an international prospective, longitudinal cohort study (ULIS-III)	BMJ OPEN			English	Article						botulinum toxin A; goal attainment scaling (GAS); spasticity; rehabilitation; REHABILITATION MEDICINE	TRAUMATIC BRAIN-INJURY; POSTSTROKE SPASTICITY; MUSCLE SPASTICITY; ASHWORTH SCALE; RELIABILITY; STROKE; REHABILITATION; TRIAL; PATHOPHYSIOLOGY; INTERRATER	Objectives Describe the rationale and protocol for the Upper Limb International Spasticity (ULIS)-III study, which aims to evaluate the impact of integrated spasticity management, involving multiple botulinum toxin A (BoNT-A) injection cycles and concomitant therapies, on patient-centred goal attainment. Outline novel outcome assessment methods for ULIS-III and report initial evaluation data from goal setting in early stages of the study. Design Large international longitudinal cohort study of integrated upper limb spasticity management, including BoNT-A. Participants and setting ULIS-III is a 2-year study expected to enrol >1000 participants at 58 study centres across 14 countries. Interventions The study design is non-interventional and intended to reflect real-life clinical practice. It will describe injection practices and additional treatment strategies, and record clinical decision-making in a serial approach to long-term spasticity management. Outcome measures ULIS-III will use a goal-directed approach to selection of targeted standardised measures to capture the diversity of presentation, goals and outcomes. ULIS-III will implement the Upper Limb Spasticity Index, a battery of assessments including a structured approach to goal attainment scaling (Goal Attainment ScalingEvaluation of Outcomes for Upper Limb Spasticity tool), alongside a limited set of standardised measures, chosen according to patients' selected goal areas. Concomitant therapy inputs, patient satisfaction with engagement in goal setting, health economic end points and health-related quality of life data will also be captured. Results of initial evaluation of goal quality Recruitment started in January 2015. By June 2015, 58 sites had been identified and initial data collected for 79 patients across 13 sites in 3 countries. Goal setting data were quality-checked and centres rated on the basis of function-related and Specific, Measurable, Achievable, Realistic, Timed (SMART) characteristics of goal statements. Overall, 11/13 centres achieved the highest rating (A++). Conclusions ULIS-III will provide valuable information regarding treatment of and outcomes from real-life upper limb spasticity management worldwide. Trial registration number NCT02454803; Pre-results.	[Turner-Stokes, Lynne; Ashford, Stephen] Kings Coll London, Dept Palliat Care Policy & Rehabil, Sch Med, Northwick Pk Hosp, London, England; [Turner-Stokes, Lynne; Ashford, Stephen] Kings Coll London, Reg Rehabil Unit, Sch Med, Northwick Pk Hosp, London, England; [Jacinto, Jorge] Ctr Med Reabilitacaode Alcoitao, Serv Reabilitacao Adultos, Estoril, Portugal; [Maisonobe, Pascal; Balcaitiene, Jovita] Ipsen Pharma, Med Affairs, Boulogne, France; [Fheodoroff, Klemens] Gailtal Klin, Dept Neurorehabil, Hermagor, Austria		Turner-Stokes, L (corresponding author), Kings Coll London, Dept Palliat Care Policy & Rehabil, Sch Med, Northwick Pk Hosp, London, England.; Turner-Stokes, L (corresponding author), Kings Coll London, Reg Rehabil Unit, Sch Med, Northwick Pk Hosp, London, England.	lynne.turner-stokes@doctors.org.uk	Turner-Stokes, Lynne/F-4418-2012; Fheodoroff, Klemens/H-6406-2013; Ashford, Stephen/D-6653-2013	Turner-Stokes, Lynne/0000-0002-3302-9462; Fheodoroff, Klemens/0000-0002-6508-5055; Jacinto, Jorge/0000-0002-3428-2312; Ashford, Stephen/0000-0001-5541-7063	Ipsen PharmaIpsen; National Institute for Health ResearchNational Institute for Health Research (NIHR) [CAT-CL-03-2012-010] Funding Source: researchfish	Ipsen Pharma.	[Anonymous], 2010, MAN PAT STROK REH PR; Ashford S, 2006, PHYSIOTHER RES INT, V11, P24, DOI 10.1002/pri.36; Ashford S, 2016, CLIN REHABIL, V30, P617, DOI 10.1177/0269215515593391; Ashford S, 2013, CLIN REHABIL, V27, P728, DOI 10.1177/0269215512474942; Ashford S, 2009, DISABIL REHABIL, V31, P220, DOI 10.1080/09638280801906388; Bakheit AM, 2010, INT J REHABIL RES, V33, P199, DOI 10.1097/MRR.0b013e328332f5e0; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Brashear A, 2002, ARCH PHYS MED REHAB, V83, P1349, DOI 10.1053/apmr.2002.35474; Brown M, 2014, DISABIL REHABIL, V36, P1020, DOI 10.3109/09638288.2013.825653; BROWN P, 1994, J NEUROL NEUROSUR PS, V57, P773, DOI 10.1136/jnnp.57.7.773; Childers MK, 2004, ARCH PHYS MED REHAB, V85, P1063, DOI 10.1016/j.apmr.2003.10.015; Council for International Organizations of Medical Sciences (CIOMS), 2009, INT EITH GUID EP STU; Gracies JM, 2015, LANCET NEUROL, V14, P992, DOI 10.1016/S1474-4422(15)00216-1; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; HOLDEN MK, 1984, PHYS THER, V64, P35, DOI 10.1093/ptj/64.1.35; Holliday RC, 2007, J NEUROL NEUROSUR PS, V78, P576, DOI 10.1136/jnnp.2006.102509; International Society for Pharmacoepidemiology, 2007, GUID GOOD PHARM PRAC; Ipsen, ATT PERS CTR GOALS B; Jackson D, 2006, CLIN MED, V6, P580, DOI 10.7861/clinmedicine.6-6-580; KIRESUK TJ, 1968, COMMUNITY MENT HLT J, V4, P443, DOI 10.1007/BF01530764; Levack WMM, 2011, PATIENT EDUC COUNS, V85, P206, DOI 10.1016/j.pec.2011.01.011; Macfarlane A, 2002, CLIN REHABIL, V16, P726, DOI 10.1191/0269215502cr546oa; McCrory P, 2009, J REHABIL MED, V41, P536, DOI 10.2340/16501977-0366; McPherson KM, 2009, CLIN REHABIL, V23, P296, DOI 10.1177/0269215509102980; Oemar M, 2013, EQ 5D 5L US GUID BAS; Royal College of Physicians British Society of Rehabilitation Medicine Chartered Society of Physiotherapy Association of Chartered Physiotherapists Interested in Neurology, 2009, SPAST AD MAN US BOT; Sheean G, 2002, EUR J NEUROL, V9, P3, DOI 10.1046/j.1468-1331.2002.0090s1003.x; Tennant A, 2007, DISABIL REHABIL, V29, P1583, DOI 10.1080/09638280701618828; Turner-Stokes L, 2012, PHYS MED REHABILITAT, V2, pS190; Turner-Stokes L, 2012, NEUROREHAB NEURAL RE, V26, P695; Turner-Stokes L, 2015, INT J THER REHABIL, V22, P210, DOI 10.12968/ijtr.2015.22.5.210; Turner-Stokes L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002771; Turner-Stokes L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002230; Turner-Stokes L, 2014, DISABIL REHABIL, V36, P23, DOI 10.3109/09638288.2013.775360; Turner-Stokes L, 2010, J REHABIL MED, V42, P81, DOI 10.2340/16501977-0474; Turner-Stokes L, 2009, CLIN REHABIL, V23, P362, DOI 10.1177/0269215508101742; Ward AB, 2014, J REHABIL MED, V46, P504, DOI 10.2340/16501977-1817; WHO, 2002, INT CLASS FUNCT DIS	38	17	18	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2016	6	6							e011157	10.1136/bmjopen-2016-011157			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DR9ST	WOS:000380237100106	27315835	Green Published, gold			2022-02-06	
J	Weaver, LK; Chhoeu, A; Lindblad, AS; Churchill, S; Wilson, SH				Weaver, Lindell K.; Chhoeu, Austin; Lindblad, Anne S.; Churchill, Susan; Wilson, Stefanie H.			Hyperbaric oxygen for mild traumatic brain injury: Design and baseline summary	UNDERSEA AND HYPERBARIC MEDICINE			English	Article						hyperbaric oxygenation; brain concussion; post-concussive syndrome; methodology	PERSISTENT POSTCONCUSSION SYMPTOMS; POSTTRAUMATIC-STRESS-DISORDER; OBSTRUCTIVE SLEEP-APNEA; QUESTIONNAIRE; HBO2	The Brain Injury and Mechanisms of Action of Hyperbaric Oxygen for Persistent Post-Concussive Symptoms after Mild Traumatic Brain Injury (mTBI) (BIMA) study, sponsored by the Department of Defense, is a randomized double-blind, sham-controlled clinical trial that has a longer duration of follow-up and more comprehensive assessment battery compared to recent HBO2 studies. BIMA randomized 71 participants from September 2012 to May 2014. Primary results are expected in 2017. Randomized military personnel received hyperbaric oxygen (HBO2) at 1.5 atmospheres absolute (ATA) or sham chamber sessions at 1.2 ATA, air, for 60 minutes daily for 40 sessions. Outcomes include neuropsychological, neuroimaging, neurological, vestibular, autonomic function, electroencephalography, and visual systems evaluated at baseline, immediately following intervention at 13 weeks and six months with self-report symptom and quality of life questionnaires at 12 months, 24 months and 36 months. Characteristics include: median age 33 years (range 21-53), 99% male, 82% Caucasian, 49% diagnosed post-traumatic stress disorder, 28% with most recent injury three months to one year prior to enrollment, 32% blast injuries, and 73% multiple injuries. This manuscript describes the study design, outcome assessment battery, and baseline characteristics. Independent of a therapeutic role of HBO2, results of BIMA will aid understanding of mTBI.	[Weaver, Lindell K.; Churchill, Susan] Intermt Med Ctr, Div Hyperbar Med, Murray, UT 84107 USA; [Weaver, Lindell K.; Churchill, Susan] Intermt LDS Hosp, Salt Lake City, UT 84143 USA; [Weaver, Lindell K.] Univ Utah, Sch Med, Salt Lake City, UT 84132 USA; [Chhoeu, Austin] US Army Med Mat Dev Act USAMMDA, Hyperbar Oxygen Res Program Management Off HBO2 P, Ft Detrick, MD USA; [Lindblad, Anne S.; Wilson, Stefanie H.] Emmes Corp, Rockville, MD USA		Weaver, LK (corresponding author), Intermt Med Ctr, Div Hyperbar Med, Murray, UT 84107 USA.; Weaver, LK (corresponding author), Intermt LDS Hosp, Salt Lake City, UT 84143 USA.; Weaver, LK (corresponding author), Univ Utah, Sch Med, Salt Lake City, UT 84132 USA.	lindell.weaver@imail.org			U.S. Army Medical Materiel Development Activity	This work was supported by the U.S. Army Medical Materiel Development Activity. Any opinions, findings and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the US Army or its subordinate activities. Because the BIMA study is still ongoing, clinical trial data summarized in this publication has not yet been locked and is therefore subject to change.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Boussi-Gross R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079995; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chung F, 2012, BRIT J ANAESTH, V108, P768, DOI 10.1093/bja/aes022; Chung F, 2014, J CLIN SLEEP MED, V10, P951, DOI 10.5664/jcsm.4022; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cifu DX, 2014, J HEAD TRAUMA REHAB, V29, P11, DOI 10.1097/HTR.0b013e3182a6aaf0; Department of Veterans Affairs and Department of Defense, 2009, VA DOD CLIN PRACT GU; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Falck-Ytter Y, 2009, RATING EVIDENCE USIN; First M., 1997, STRUCTURED CLIN INTE; Harch PG, 2012, J NEUROTRAUM, V29, P168, DOI 10.1089/neu.2011.1895; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; McCrary BF, 2013, UNDERSEA HYPERBAR M, V40, P443; Miller RS, 2015, JAMA INTERN MED, V175, P43, DOI 10.1001/jamainternmed.2014.5479; National Research Council, 2009, SYST ENG IMPR TRAUM; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Weaver LK, 2013, UNDERSEA HYPERBAR M, V40, P439; Weaver LK, 2014, HYPERBARIC OXYGEN TH; Wolf G, 2012, J NEUROTRAUM, V29, P2606, DOI 10.1089/neu.2012.2549	25	17	18	0	8	UNDERSEA & HYPERBARIC MEDICAL SOC INC	DURHAM	21 WEST COLONY PLACE, STE 280, DURHAM, NC 27705 USA	1066-2936			UNDERSEA HYPERBAR M	Undersea Hyperb. Med.		2016	43	5			SI		491	509					19	Marine & Freshwater Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Marine & Freshwater Biology; Research & Experimental Medicine	EA8EE	WOS:000386867300002	28768069				2022-02-06	
J	Willemse, RB; Hillebrand, A; Ronner, HE; Vandertop, WP; Stam, CJ				Willemse, Ronald B.; Hillebrand, Arjan; Ronner, Hanneke E.; Vandertop, W. Peter; Stam, Cornelis J.			Magnetoencephalographic study of hand and foot sensorimotor organization in 325 consecutive patients evaluated for tumor or epilepsy surgery	NEUROIMAGE-CLINICAL			English	Article						Brain mapping; Brain neoplasms; Cortical reorganization; Epilepsy; Magnetoencephalography	PRIMARY SOMATOSENSORY CORTEX; TIBIAL NERVE-STIMULATION; SPATIALLY FILTERED MAGNETOENCEPHALOGRAPHY; TRANSCRANIAL MAGNETIC STIMULATION; PRIMARY MOTOR CORTEX; VOLUNTARY MOVEMENTS; INTERHEMISPHERIC INTERACTIONS; CEREBRAL ACTIVATION; TACTILE INFORMATION; EXPERIMENTAL-DESIGN	Objectives: The presence of intracranial lesions or epilepsy may lead to functional reorganization and hemispheric lateralization. We applied a clinical magnetoencephalography (MEG) protocol for the localization of the contralateral and ipsilateral S1 and M1 of the foot and hand in patients with non-lesional epilepsy, stroke, developmental brain injury, traumatic brain injury and brain tumors. We investigated whether differences in activation patterns could be related to underlying pathology. Methods: Using dipole fitting, we localized the sources underlying sensory and motor evoked magnetic fields (SEFs and MEFs) of both hands and feet following unilateral stimulation of the median nerve (MN) and posterior tibial nerve (PTN) in 325 consecutive patients. The primary motor cortex was localized using beamforming following a self-paced repetitive motor task for each hand and foot. Results: The success rate for motor and sensory localization for the feet was significantly lower than for the hands (motor_hand 94.6% versus motor_feet 81.8%, p < 0.001; sensory_hand 95.3% versus sensory_feet 76.0%, p < 0.001). MN and PTN stimulation activated 86.6% in the contralateral S1, with ipsilateral activation < 0.5%. Motor cortex activation localized contralaterally in 76.1% (5.2% ipsilateral, 7.6% bilateral and 11.1% failures) of all motor MEG recordings. The ipsilateral motor responses were found in 43 (14%) out of 308 patients with motor recordings (range: 8.3-50%, depending on the underlying pathology), and had a higher occurrence in the foot than in the hand (motor_foot 44.8% versus motor_hand 29.6%, p = 0.031). Ipsilateral motor responses tended to be more frequent in patients with a history of stroke, traumatic brain injury (TBI) or developmental brain lesions (p = 0.063). Conclusions: MEG localization of sensorimotor cortex activation was more successful for the hand compared to the foot. In patients with neural lesions, there were signs of brain reorganization as measured by more frequent ipsilateral motor cortical activation of the foot in addition to the traditional sensory and motor activation patterns in the contralateral hemisphere. The presence of ipsilateral neural reorganization, especially around the foot motor area, suggests that careful mapping of the hand and foot in both contralateral and ipsilateral hemispheres prior to surgery might minimize postoperative deficits. (C) 2015 The Authors. Published by Elsevier Inc.	[Willemse, Ronald B.; Vandertop, W. Peter] Vrije Univ Amsterdam Med Ctr, Neurosurg Ctr Amsterdam, Amsterdam, Netherlands; [Hillebrand, Arjan; Ronner, Hanneke E.; Stam, Cornelis J.] Vrije Univ Amsterdam Med Ctr, Dept Clin Neurophysiol, Amsterdam, Netherlands; [Hillebrand, Arjan; Ronner, Hanneke E.; Stam, Cornelis J.] Vrije Univ Amsterdam Med Ctr, MEG Ctr, Amsterdam, Netherlands		Willemse, RB (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Neurosurg, 2F 01,de Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.	r.willemse@vumc.nl; a.hillebrand@vumc.nl; he.ronner@vumc.nl; wp.vandertop@vumc.nl; cj.stam@vumc.nl	Vandertop, William P./K-9288-2018	Vandertop, William/0000-0001-5417-0265; Hillebrand, Arjan/0000-0002-8508-3532			Allison JD, 2000, NEUROLOGY, V54, P135, DOI 10.1212/WNL.54.1.135; Anderson CT, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0446-8; Bradnam LV, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00184; Brookes MJ, 2008, NEUROIMAGE, V39, P1788, DOI 10.1016/j.neuroimage.2007.09.050; Caciagli L, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00411; Cao Y, 1998, STROKE, V29, P112, DOI 10.1161/01.STR.29.1.112; Carpentier AC, 2001, J NEUROSURG, V94, P946, DOI 10.3171/jns.2001.94.6.0946; Castillo EM, 2004, NEUROIMAGE, V21, P973, DOI 10.1016/j.neuroimage.2003.10.020; Chen ACN, 2012, BRAIN TOPOGR, V25, P228, DOI 10.1007/s10548-011-0209-7; Cheyne D, 2006, HUM BRAIN MAPP, V27, P213, DOI 10.1002/hbm.20178; Chlebus P, 2004, NEUROCASE, V10, P326, DOI 10.1080/13554790490507669; Ciccarelli O, 2005, EXP BRAIN RES, V166, P31, DOI 10.1007/s00221-005-2335-5; FERBERT A, 1992, J PHYSIOL-LONDON, V453, P525, DOI 10.1113/jphysiol.1992.sp019243; Ganslandt O, 1999, Neurosurg Focus, V6, pe3; Guzzetta A, 2007, CLIN NEUROPHYSIOL, V118, P1110, DOI 10.1016/j.clinph.2007.02.014; Hari R, 1999, PHILOS T R SOC B, V354, P1145, DOI 10.1098/rstb.1999.0470; Hari R, 1996, NEUROIMAGE, V4, P111, DOI 10.1006/nimg.1996.0035; Hillebrand A, 2005, INT REV NEUROBIOL, V68, P149, DOI 10.1016/S0074-7742(05)68006-3; Hillebrand A, 2005, HUM BRAIN MAPP, V25, P199, DOI 10.1002/hbm.20102; Hillebrand A, 2003, NEUROIMAGE, V20, P2302, DOI 10.1016/j.neuroimage.2003.07.031; Hillebrand A, 2013, CLIN NEUROPHYSIOL, V124, P107, DOI 10.1016/j.clinph.2012.06.013; Hillebrand A, 2002, NEUROIMAGE, V16, P638, DOI 10.1006/nimg.2002.1102; Hlushchuk Y, 2006, J NEUROSCI, V26, P5819, DOI 10.1523/JNEUROSCI.5536-05.2006; Huang MX, 2004, HUM BRAIN MAPP, V23, P26, DOI 10.1002/hbm.20038; Jurkiewicz MT, 2006, NEUROIMAGE, V32, P1281, DOI 10.1016/j.neuroimage.2006.06.005; KAKIGI R, 1995, ELECTROEN CLIN NEURO, V95, P127, DOI 10.1016/0013-4694(95)00053-2; Kakigi R, 2000, PROG NEUROBIOL, V61, P495, DOI 10.1016/S0301-0082(99)00063-5; Kanno A, 2003, NEUROIMAGE, V18, P169, DOI 10.1006/nimg.2002.1283; Knowlton Robert C, 2008, Epilepsy Curr, V8, P1, DOI 10.1111/j.1535-7511.2007.00215.x; Kobayashi M, 2003, NEUROIMAGE, V20, P2259, DOI 10.1016/S1053-8119(03)00220-9; Korvenoja A, 1995, NEUROREPORT, V6, P2589, DOI 10.1097/00001756-199512150-00033; Korvenoja A, 1999, HUM BRAIN MAPP, V8, P13, DOI 10.1002/(SICI)1097-0193(1999)8:1<13::AID-HBM2>3.0.CO;2-B; Korvenoja A, 2006, RADIOLOGY, V241, P213, DOI 10.1148/radiol.2411050796; KRISTEVA R, 1991, ELECTROEN CLIN NEURO, V81, P284, DOI 10.1016/0168-5597(91)90015-P; Lee HW, 2009, J NEUROL NEUROSUR PS, V80, P285, DOI 10.1136/jnnp.2008.156067; Liuzzi G, 2010, CEREB CORTEX, V20, P1323, DOI 10.1093/cercor/bhp196; MacIntosh BJ, 2004, NEUROIMAGE, V22, P1619, DOI 10.1016/j.neuroimage.2004.03.035; Maegaki Y, 1995, NEUROLOGY, V45, P2255, DOI 10.1212/WNL.45.12.2255; Makela JP, 2001, HUM BRAIN MAPP, V12, P180, DOI 10.1002/1097-0193(200103)12:3<180::AID-HBM1014>3.0.CO;2-N; Makela JP, 2013, BRAIN STIMUL, V6, P286, DOI 10.1016/j.brs.2012.04.012; Muller-Putz GR, 2007, BRAIN RES, V1137, P84, DOI 10.1016/j.brainres.2006.12.052; Nagarajan S, 2008, J NEUROSURG, V109, P228, DOI 10.3171/JNS/2008/109/8/0228; Nakamura A, 1998, NEUROIMAGE, V7, P377, DOI 10.1006/nimg.1998.0332; Neuper C, 2006, PROG BRAIN RES, V159, P211, DOI 10.1016/S0079-6123(06)59014-4; Pfurtscheller G, 1997, INT J PSYCHOPHYSIOL, V26, P121, DOI 10.1016/S0167-8760(97)00760-5; Pittaccio S, 2013, IEEE ENG MED BIO, P6353, DOI 10.1109/EMBC.2013.6611007; Pittaccio S, 2011, HUM BRAIN MAPP, V32, P60, DOI 10.1002/hbm.20998; Sahyoun C, 2004, NEUROIMAGE, V21, P568, DOI 10.1016/j.neuroimage.2003.09.065; Schiffbauer H, 2002, J NEUROSURG, V97, P1333, DOI 10.3171/jns.2002.97.6.1333; SCHNITZLER A, 1995, NEUROSCI LETT, V200, P25, DOI 10.1016/0304-3940(95)12065-C; Sekihara K, 2004, IEEE T BIO-MED ENG, V51, P1726, DOI 10.1109/TBME.2004.827926; Solodkin A, 2001, EUR J NEUROL, V8, P425, DOI 10.1046/j.1468-1331.2001.00242.x; Staudt M, 2010, J ANAT, V217, P469, DOI 10.1111/j.1469-7580.2010.01262.x; Stippich C, 2007, NEUROIMAGE, V34, P1227, DOI 10.1016/j.neuroimage.2006.08.046; Stoeckel MC, 2010, EXP NEUROL, V221, P13, DOI 10.1016/j.expneurol.2009.10.021; Sutherland MT, 2006, NEUROIMAGE, V33, P1042, DOI 10.1016/j.neuroimage.2006.08.015; Takeuchi N, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/823285; Taniguchi M, 2000, NEUROIMAGE, V12, P298, DOI 10.1006/nimg.2000.0611; Taniguchi M, 2004, J NEUROL NEUROSUR PS, V75, P466, DOI 10.1136/jnnp.2002.001834; Tarapore PE, 2012, J NEUROSURG, V117, P354, DOI 10.3171/2012.5.JNS112124; Tozakidou M, 2013, NEUROIMAGE-CLIN, V2, P221, DOI 10.1016/j.nicl.2013.01.002; van Wijk BCM, 2012, EUR J NEUROSCI, V36, P2088, DOI 10.1111/j.1460-9568.2012.08122.x; Verstynen T, 2005, J NEUROPHYSIOL, V93, P1209, DOI 10.1152/jn.00720.2004; Vrba J, 2001, METHODS, V25, P249, DOI 10.1006/meth.2001.1238; Whalen C, 2008, HUM BRAIN MAPP, V29, P1288, DOI 10.1002/hbm.20465; Wilke M, 2009, HUM BRAIN MAPP, V30, P776, DOI 10.1002/hbm.20545; Willemse R.B., 2007, NEUROSURGERY, V61, P1209; Willemse Ronald B, 2010, Open Neuroimag J, V4, P93, DOI 10.2174/1874440001004010093; Willernse RB, 2007, NEUROSURGERY, V61, P1209, DOI 10.1227/01.NEU.0000280159.49731.B5; Zhu Z, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-21; Ziemann U, 1999, J PHYSIOL-LONDON, V518, P895, DOI 10.1111/j.1469-7793.1999.0895p.x	71	17	17	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2016	10						46	53		10.1016/j.nicl.2015.11.002			8	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DI0LX	WOS:000373189000005	26693401	Green Published, gold			2022-02-06	
J	Zacks, JM; Kurby, CA; Landazabal, CS; Krueger, F; Grafman, J				Zacks, Jeffrey M.; Kurby, Christopher A.; Landazabal, Claudia S.; Krueger, Frank; Grafman, Jordan			Effects of penetrating traumatic brain injury on event segmentation and memory	CORTEX			English	Article						Traumatic brain injury; Event perception; Memory	MEDIAL PREFRONTAL CORTEX; PARSE CONTINUOUS ACTIONS; INFANTS ABILITY; WORKING-MEMORY; DYNAMIC ACTION; PERCEPTION; KNOWLEDGE; LOBE; REPRESENTATION; ORGANIZATION	Penetrating traumatic brain injury (pTBI) is associated with deficits in cognitive tasks including comprehension and memory, and also with impairments in tasks of daily living. In naturalistic settings, one important component of cognitive task performance is event segmentation, the ability to parse the ongoing stream of behavior into meaningful units. Event segmentation ability is associated with memory performance and with action control, but is not well assessed by standard neuropsychological assessments or laboratory tasks. Here, we measured event segmentation and memory in a sample of 123 male military veterans aged 59-81 who had suffered a traumatic brain injury as young men, and 34 demographically similar controls. Participants watched movies of everyday activities and segmented them to identify fine-grained or coarse-grained events, and then completed tests of recognition memory for pictures from the movies and of memory for the temporal order of actions in the movies. Lesion location and volume were assessed with computed tomography (CT) imaging. Patients with traumatic brain injury were impaired on event segmentation. Those with larger lesions had larger impairments for fine segmentation and also impairments for both memory measures. Further, the degree of memory impairment was statistically mediated by the degree of event segmentation impairment. There was some evidence that lesions to the ventromedial prefrontal cortex (vmPFC) selectively impaired coarse segmentation; however, lesions outside of a priori regions of interest also were associated with impaired segmentation. One possibility is that the effect of vmPFC damage reflects the role of prefrontal event knowledge representations in ongoing comprehension. These results suggest that assessment of naturalistic event comprehension can be a valuable component of cognitive assessment in cases of traumatic brain injury, and that interventions aimed at event segmentation could be clinically helpful. (C) 2015 Elsevier Ltd. All rights reserved.	[Zacks, Jeffrey M.; Kurby, Christopher A.; Landazabal, Claudia S.] Washington Univ, St Louis, MO 63130 USA; [Kurby, Christopher A.] Grand Valley State Univ, Allendale, MI 49401 USA; [Krueger, Frank] George Mason Univ, Fairfax, VA 22030 USA; [Grafman, Jordan] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Grafman, Jordan] Northwestern Univ, Chicago, IL 60611 USA		Zacks, JM (corresponding author), Washington Univ, Dept Psychol, St Louis, MO 63130 USA.	jzacks@wustl.edu	Zacks, Jeffrey M/E-9099-2011	Zacks, Jeffrey M/0000-0003-1171-3690	 [T32AG000030];  [R01MH070674];  [R01AG031150]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH070674] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG031150, T32AG000030] Funding Source: NIH RePORTER	This study was conducted by the U.S. National Institute of Neurological Disorders and Stroke Intramural Research Program and took place at the National Institutes of Health Clinical Research Center. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the U.S. Government. For further information about the Vietnam Head Injury Study, contact J.G. at jgrafman@northwestern.edu. We thank the National Institutes of Health Clinical Center for the provision of their facilities and for their supportive services. We thank Sandra Bonifant, Michael Tierney, Leila Glass, Lyanne Yozawitz, Carolee Noury, Vivien YJ Tsen, and Anne Leopold who worked tirelessly to test subjects and organize the study. We thank Yinyuan Zheng for assistance with data coding. As always, the authors are grateful to all of the Vietnam veterans and care-givers who participated in this study. Their unending commitment to improving the health care of veterans is the reason this study could be completed. CAK's contribution was supported in part by training grant T32AG000030. JMZ's contribution was supported in part by grants R01MH070674 and R01AG031150.	Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Bailey HR, 2013, NEUROPSYCHOLOGIA, V51, P2294, DOI 10.1016/j.neuropsychologia.2013.06.022; Bailey HR, 2013, PSYCHOL SCI, V24, P1113, DOI 10.1177/0956797612466676; Baldwin DA, 2001, CHILD DEV, V72, P708, DOI 10.1111/1467-8624.00310; Barker R.G., 1963, STREAM BEHAV, P23, DOI [DOI 10.1037/11177-002, 10.1037/11177-002]; Beck AT, 1996, BDI 2 BECK DEPRESSIO; BOLTZ M, 1992, J EXP PSYCHOL HUMAN, V18, P90, DOI 10.1037/0096-1523.18.1.90; Cohen NJ, 1995, MEMORY AMNESIA HIPPO; Cooper RP, 2006, PSYCHOL REV, V113, P887, DOI 10.1037/0033-295X.113.4.887; Cowan N., 1999, MODELS WORKING MEMOR, P62, DOI [10.1017/CBO9781139174909.006, DOI 10.1017/CBO9781139174909.006]; Crozier S, 1999, NEUROPSYCHOLOGIA, V37, P1469, DOI 10.1016/S0028-3932(99)00054-8; D'Esposito M., 2002, PRINCIPLES FRONTAL L, P168, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0011; Delis DC., 2001, DELIS KAPLAN EXECUTI; ERICSSON KA, 1995, PSYCHOL REV, V102, P211, DOI 10.1037/0033-295X.102.2.211; Flores S., 2014, EFFECTIVE EVENT SEGM, V17, P204; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Glass L, 2013, CEREB CORTEX, V23, P1663, DOI 10.1093/cercor/bhs153; Gold D. A., 2014, P 26 ANN CONV ASS PS; Grafman J, 1995, ANN NY ACAD SCI, V769, P337, DOI 10.1111/j.1749-6632.1995.tb38149.x; Grafman J., 1993, J HEAD TRAUMA REHAB, V8, P73, DOI DOI 10.1097/00001199-199303000-00008; HANSON C, 1989, J EXP PSYCHOL GEN, V118, P136, DOI 10.1037/0096-3445.118.2.136; HANSON C, 1991, J EXP PSYCHOL GEN, V120, P211, DOI 10.1037/0096-3445.120.2.211; Hard BM, 2006, MEM COGNITION, V34, P1221, DOI 10.3758/BF03193267; Hard BM, 2011, J EXP PSYCHOL GEN, V140, P586, DOI 10.1037/a0024310; Hespos SJ, 2010, NEURAL NETWORKS, V23, P1026, DOI 10.1016/j.neunet.2010.07.010; Hespos SJ, 2009, DEV PSYCHOL, V45, P575, DOI 10.1037/a0014145; Humphreys GW, 1998, COGN NEUROPSYCHOL, V15, P771; Kaplan E, 1983, BOSTON NAMING TEST; Koechlin E, 2000, P NATL ACAD SCI USA, V97, P7651, DOI 10.1073/pnas.130177397; Krueger F, 2007, CEREB CORTEX, V17, P2346, DOI 10.1093/cercor/bhl143; Krueger F, 2009, TRENDS COGN SCI, V13, P103, DOI 10.1016/j.tics.2008.12.005; Kurby CA, 2011, MEM COGNITION, V39, P75, DOI 10.3758/s13421-010-0027-2; LASSITER GD, 1991, J EXP PSYCHOL GEN, V120, P80, DOI 10.1037/0096-3445.120.1.80; NEWTSON D, 1973, J PERS SOC PSYCHOL, V28, P28, DOI 10.1037/h0035584; Newtson D, 1976, NEW DIRECTIONS ATTRI, P223; Partiot A, 1996, NEUROREPORT, V7, P761, DOI 10.1097/00001756-199602290-00020; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; Radvansky G. A, 2014, EVENT COGNITION; Radvansky GA, 2010, PSYCHON B REV, V17, P900, DOI 10.3758/PBR.17.6.900; Raymont V., 2011, FRONTIERS NEUROLOGY, V2; Raymont V, 2008, BRAIN, V131, P543, DOI 10.1093/brain/awm300; Rosen VM, 2003, BEHAV RES METH INS C, V35, P32, DOI 10.3758/BF03195495; Rubin DC, 2015, PSYCHOL REV, V122, P1, DOI 10.1037/a0037907; Sargent JQ, 2013, COGNITION, V129, P241, DOI 10.1016/j.cognition.2013.07.002; Schacter D. L., 1994, MEMORY SYSTEMS 1994; Schwan S, 2000, MEM COGNITION, V28, P214, DOI 10.3758/BF03213801; Schwartz MF, 1995, ANN NY ACAD SCI, V769, P321, DOI 10.1111/j.1749-6632.1995.tb38148.x; Sharon T, 1998, PSYCHOL SCI, V9, P357, DOI 10.1111/1467-9280.00068; SIRIGU A, 1995, CORTEX, V31, P301, DOI 10.1016/S0010-9452(13)80364-4; Sirigu A., 1995, ANN NY ACAD SCI, V769, P411; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Speer NK, 2007, PSYCHOL SCI, V18, P449, DOI 10.1111/j.1467-9280.2007.01920.x; Speer NK, 2003, COGN AFFECT BEHAV NE, V3, P335, DOI 10.3758/CABN.3.4.335; Tingley D., 2014, MEDIATION R PACKAGE; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Warrington E. K., 1991, VISUAL OBJECT SPACE; Wechsler D., 1997, WECHSLER MEMORY SCAL; Whitney C, 2009, NEUROIMAGE, V47, P360, DOI 10.1016/j.neuroimage.2009.04.037; Zacks JM, 2007, PSYCHOL BULL, V133, P273, DOI 10.1037/0033-2909.133.2.273; Zacks JM, 2006, PSYCHOL AGING, V21, P466, DOI 10.1037/0882-7974.21.3.466; Zacks JM, 2011, J COGNITIVE NEUROSCI, V23, P4057, DOI 10.1162/jocn_a_00078; Zacks JM, 2009, J EXP PSYCHOL GEN, V138, P307, DOI 10.1037/a0015305; Zacks JM, 2004, COGNITIVE SCI, V28, P979, DOI 10.1016/j.cogsci.2004.06.003; Zacks JM, 2003, J EXP PSYCHOL-APPL, V9, P88, DOI 10.1037/1076-898X.9.2.88; Zacks JM, 2001, J EXP PSYCHOL GEN, V130, P29, DOI 10.1037//0096-3445.130.1.29; Zacks JM, 2001, NAT NEUROSCI, V4, P651, DOI 10.1038/88486; Zalla T, 2004, PSYCHIAT RES, V128, P39, DOI 10.1016/j.psychres.2003.12.026; Zalla T, 2000, J COGNITIVE NEUROSCI, P115; Zalla T, 2013, J AUTISM DEV DISORD, V43, P2353, DOI 10.1007/s10803-013-1784-0	69	17	17	1	14	ELSEVIER MASSON	MILANO	VIA PALEOCAPA 7, 20121 MILANO, ITALY	0010-9452	1973-8102		CORTEX	Cortex	JAN	2016	74						233	246		10.1016/j.cortex.2015.11.002			14	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychology	DC8GS	WOS:000369458500018	26704077	Green Accepted			2022-02-06	
J	Saxena, MK; Taylor, C; Billot, L; Bompoint, S; Gowardman, J; Roberts, JA; Lipman, J; Myburgh, J				Saxena, Manoj K.; Taylor, Colman; Billot, Laurent; Bompoint, Severine; Gowardman, John; Roberts, Jason A.; Lipman, Jeffery; Myburgh, John			The Effect of Paracetamol on Core Body Temperature in Acute Traumatic Brain Injury: A Randomised, Controlled Clinical Trial	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; ACUTE ISCHEMIC-STROKE; DOUBLE-BLIND; INTENSIVE-CARE; ACETAMINOPHEN; HYPERTHERMIA; HYPOTHERMIA; MANAGEMENT; MORTALITY; MULTICENTER	Background Strategies to prevent pyrexia in patients with acute neurological injury may reduce secondary neuronal damage. The aim of this study was to determine the safety and efficacy of the routine administration of 6 grams/day of intravenous paracetamol in reducing body temperature following severe traumatic brain injury, compared to placebo. Methods A multicentre, randomised, blind, placebo-controlled clinical trial in adult patients with traumatic brain injury (TBI). Patients were randomised to receive an intravenous infusion of either 1g of paracetamol or 0.9% sodium chloride (saline) every 4 hours for 72 hours. The primary outcome was the mean difference in core temperature during the study intervention period. Results Forty-one patients were included in this study: 21 were allocated to paracetamol and 20 to saline. The median (interquartile range) number of doses of study drug was 18 (17-18) in the paracetamol group and 18 (16-18) in the saline group (P = 0.85). From randomisation until 4 hours after the last dose of study treatment, there were 2798 temperature measurements (median 73 [67-76] per patient). The mean +/- standard deviation temperature was 37.4 +/- 0.5 degrees C in the paracetamol group and 37.7 +/- 0.4 degrees C in the saline group (absolute difference -0.3 degrees C; 95% confidence interval -0.6 to 0.0; P = 0.09). There were no significant differences in the use of physical cooling, or episodes of hypotension or hepatic abnormalities, between the two groups. Conclusion The routine administration of 6g/day of intravenous paracetamol did not significantly reduce core body temperature in patients with TBI.	[Saxena, Manoj K.; Taylor, Colman; Myburgh, John] George Inst Global Hlth, Div Crit Care, Sydney, NSW, Australia; [Saxena, Manoj K.; Taylor, Colman; Myburgh, John] George Inst Global Hlth, Trauma Div, Sydney, NSW, Australia; [Saxena, Manoj K.; Myburgh, John] Univ New S Wales, St George Hosp, Sch Clin, Dept Intens Care Med, Sydney, NSW 2052, Australia; [Taylor, Colman; Billot, Laurent] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Billot, Laurent; Bompoint, Severine] George Inst Global Hlth, Div Stat, Sydney, NSW, Australia; [Gowardman, John; Roberts, Jason A.; Lipman, Jeffery] Royal Brisbane & Womens Hosp, Dept Intens Care Med, Brisbane, Qld, Australia; [Gowardman, John; Roberts, Jason A.; Lipman, Jeffery] Univ Queensland, Burns Trauma & Crit Care Res Ctr, Brisbane, Qld, Australia; [Lipman, Jeffery] Queensland Univ Technol, Fac Hlth, Brisbane, Qld 4001, Australia		Saxena, MK (corresponding author), George Inst Global Hlth, Div Crit Care, Sydney, NSW, Australia.	m.saxena@georgeinstitute.org.au	Billot, Laurent/Y-1241-2019; Lipman, Jeffrey/G-2211-2010; Roberts, Jason A/F-6272-2010	Billot, Laurent/0000-0002-4975-9793; Lipman, Jeffrey/0000-0002-5965-9876; Roberts, Jason A/0000-0001-6218-435X; Saxena, Manoj/0000-0002-0385-6731	Australia and New Zealand College of Anaesthetists; St. George Medical research Foundation	This work was supported by: Project grant from the Australia and New Zealand College of Anaesthetists (MS JM JG JL); Unrestricted grant from the St. George Medical research Foundation (The Honda-St. George Critical Care and Trauma Fellowship) (MS JM). The funders had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, and approval of the manuscript.	Adelson PD, 2013, THE LANCET NEUROLOGY; Andrews P. J., 2015, N ENGL J MED; Badjatia N, 2009, CRIT CARE MED, V37, pS250, DOI 10.1097/CCM.0b013e3181aa5e8d; Beltramo M, 1997, SCIENCE, V277, P1094, DOI 10.1126/science.277.5329.1094; Brain Trauma F, 2008, J NEUROTRAUM, V25, P276; Brain Trauma F, 2007, J NEUROTRAUM, V24, pS21; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Brown JM, 2008, CHILD NERV SYST, V24, P477, DOI 10.1007/s00381-007-0517-0; Daly FFS, 2004, ANN EMERG MED, V44, P393, DOI 10.1016/j.annemergmed.2004.05.005; den Hertog HM, 2009, LANCET NEUROL, V8, P434, DOI 10.1016/S1474-4422(09)70051-1; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; Dippel DWJ, 2003, BMC CARDIOVASC DISOR, V3, DOI 10.1186/1471-2261-3-2; Dippel DWJ, 2001, STROKE, V32, P1607, DOI 10.1161/01.STR.32.7.1607; Geffroy A, 2004, INTENS CARE MED, V30, P785, DOI 10.1007/s00134-004-2280-y; Heyland DK, 1996, INTENS CARE MED, V22, P1339, DOI 10.1007/s001340050261; Hogestatt ED, 2005, J BIOL CHEM, V280, P31405, DOI 10.1074/jbc.M501489200; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jefferies S, 2012, CRIT CARE RESUSC, V14, P74; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Li J, 2012, J NEUROTRAUM, V29, P96, DOI 10.1089/neu.2011.1753; Maekawa T, 2014, J NEUROTRAUMA; Marion DW, 2004, CRIT CARE MED, V32, pS43, DOI 10.1097/01.CCM.0000110731.69637.16; Mullins ME, 2011, NEUROCRIT CARE, V15, P375, DOI 10.1007/s12028-011-9533-8; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; PERUCCA E, 1979, BRIT J CLIN PHARMACO, V7, P201, DOI 10.1111/j.1365-2125.1979.tb00922.x; Reith J, 1996, LANCET, V347, P422, DOI 10.1016/S0140-6736(96)90008-2; Ridder IR, 2013, INT J; Sacho RH, 2008, BRIT J NEUROSURG, V22, P497, DOI 10.1080/02688690802245558; Saxena M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006811.pub3; Saxena M, 2015, INTENS CARE MED, V41, P823, DOI 10.1007/s00134-015-3676-6; Saxena MK, 2015, CRIT CARE RESUSC, V17, P129; Saxena MK, 2013, CRIT CARE RESUSC, V15, P110; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; van der Jagt M, 2015, INTENS CARE MED, V41, P1129, DOI 10.1007/s00134-015-3844-8; Wang Y, 2000, STROKE, V31, P404, DOI 10.1161/01.STR.31.2.404; World Health Organization, 2006, NEUROLOGICAL DISORDE; Young P, 2015, N ENGL J MED	39	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144740	10.1371/journal.pone.0144740			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	WOS:000366723400023	26678710	Green Published, gold, Green Submitted			2022-02-06	
J	Eslami, M; Sayyah, M; Soleimani, M; Alizadeh, L; Hadjighassem, M				Eslami, Mansoureh; Sayyah, Mohammad; Soleimani, Mansoureh; Alizadeh, Leila; Hadjighassem, Mahmoudreza			Lipopolysaccharide preconditioning prevents acceleration of kindling epileptogenesis induced by traumatic brain injury	JOURNAL OF NEUROIMMUNOLOGY			English	Article						Controlled cortical impact; Epileptogenesis; LPS preconditioning; PTZ kindling	TEMPORAL-LOBE EPILEPSY; SELECTIVE VULNERABILITY; POSTTRAUMATIC EPILEPSY; ISCHEMIC TOLERANCE; NERVOUS-SYSTEM; MOUSE-BRAIN; SPINAL-CORD; RAT-BRAIN; NEUROPROTECTION; SEIZURES	10-20% of symptomatic epilepsies are post-traumatic. We examined effect of LPS preconditioning on epileptogenesis after controlled cortical impact (CCI). LPS (0.01, 0.1 and 0.5 mg/kg) was injected i.p. to rats 5 days before induction of CCI to parieto-temporal cortex. Kindling started 24 h after CCI by i.p. injection of 30 mg/kg of pentylenetetrazole every other day until manifestation of 3 consecutive generalized seizures. CCI injury accelerated the rate of kindled seizures acquisition. LPS (0.1 and 0.5 mg/kg) prevented the acceleration of kindling. LPS preconditioning significantly decreased IL-1 beta and TNF-alpha over-expression and the number of damaged neurons in the hippocampus of traumatic rats. (C) 2015 Elsevier B.V. All rights reserved.	[Eslami, Mansoureh; Soleimani, Mansoureh] Iran Univ Med Sci, Cellular & Mol Res Ctr, Tehran, Iran; [Eslami, Mansoureh] Iran Univ Med Sci, Fac Adv Technol Med, Dept Neurosci, Tehran, Iran; [Eslami, Mansoureh; Sayyah, Mohammad] Pasteur Inst Iran, Dept Physiol & Pharmacol, Tehran 1316943551, Iran; [Eslami, Mansoureh] Shahid Beheshti Univ Med Sci, Sch Allied Med Sci, Dept Basic Sci, Tehran, Iran; [Alizadeh, Leila] Shefa Neurosci Res Ctr, Tehran, Iran; [Hadjighassem, Mahmoudreza] Univ Tehran Med Sci, Neurosci Inst, Imam Khomeini Hosp, Brain & Spinal Cord Injury Res Ctr, Tehran, Iran; [Hadjighassem, Mahmoudreza] Univ Tehran Med Sci, Sch Adv Technol Med, Dept Neurosci, Tehran, Iran		Sayyah, M (corresponding author), Pasteur Inst Iran, Dept Physiol & Pharmacol, Tehran 1316943551, Iran.	sayyahm2@pasteur.ac.ir; mhadjighassem@tums.ac.ir	Sayyah, Mohammad/K-4871-2017; Hadjighassem, Mahmoudreza/AAD-8498-2019; Hadjighassem, Mahmoudreza/R-7811-2019	Sayyah, Mohammad/0000-0003-0603-2444; Hadjighassem, Mahmoudreza/0000-0001-9046-2767	Pasteur Institute of Iran [634]; Iran University of Medical Sciences. [15734]	This work is supported by grant no. 634 from the Pasteur Institute of Iran and grant no. 15734 from the Iran University of Medical Sciences.	Abdallah DM, 2010, BRAIN RES, V1351, P246, DOI 10.1016/j.brainres.2010.06.034; Ahmadi A, 2013, EXP BRAIN RES, V226, P107, DOI 10.1007/s00221-013-3415-6; Ajmone-Cat MA, 2013, GLIA, V61, P1698, DOI 10.1002/glia.22550; Annegers J.F., 2000, SEIZURE, V1, P453; Bachstetter AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0289-5; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Bingham D, 2013, J NEUROIMMUNOL, V256, P28, DOI 10.1016/j.jneuroim.2012.12.009; Bingham D, 2011, BRAIN RES BULL, V85, P403, DOI 10.1016/j.brainresbull.2011.04.007; Bordet R, 2000, J CEREBR BLOOD F MET, V20, P1190, DOI 10.1097/00004647-200008000-00004; Briggs R, 2015, DEV MED CHILD NEUROL, V57, P618, DOI 10.1111/dmcn.12674; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Cristofori Irene, 2015, Handb Clin Neurol, V128, P579, DOI 10.1016/B978-0-444-63521-1.00037-6; D'Ambrosio R, 2013, EXPERT REV NEUROTHER, V13, P615, DOI [10.1586/ern.13.54, 10.1586/ERN.13.54]; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; Davis AEM, 2005, EUR J NEUROSCI, V22, P2441, DOI 10.1111/j.1460-9568.2005.04447.x; Dmowska M, 2010, NEUROCHEM RES, V35, P262, DOI 10.1007/s11064-009-0050-5; Eslami M., 2015, NEUROL RES; Fukuda M, 2015, METAB BRAIN DIS, V30, P813, DOI 10.1007/s11011-014-9648-7; Furuya K, 2005, J NEUROSURG, V103, P715, DOI 10.3171/jns.2005.103.4.0715; Goodrich GS, 2013, J NEUROTRAUM, V30, P1434, DOI 10.1089/neu.2012.2712; Greiffenstein M F, 1996, J Int Neuropsychol Soc, V2, P477; Hayakawa K, 2014, J NEUROSCI RES, V92, P1647, DOI 10.1002/jnr.23448; Hoogland ICM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0332-6; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Jayaram B, 2013, J MOL NEUROSCI, V49, P523, DOI 10.1007/s12031-012-9924-0; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Larochelle A, 2015, BRAIN BEHAV IMMUN, V46, P221, DOI 10.1016/j.bbi.2015.02.019; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Li G, 2011, SEIZURE-EUR J EPILEP, V20, P249, DOI 10.1016/j.seizure.2010.12.005; Lin HY, 2009, PEDIATR RES, V66, P254, DOI 10.1203/PDR.0b013e3181b0d336; Loscher W, 2010, PHARMACOL REV, V62, P668, DOI 10.1124/pr.110.003046; Longhi L, 2011, J CEREBR BLOOD F MET, V31, P1919, DOI 10.1038/jcbfm.2011.42; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Marsh BJ, 2009, NEUROSCIENCE, V158, P1007, DOI 10.1016/j.neuroscience.2008.07.067; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; MELDRUM BS, 1993, BRAIN PATHOL, V3, P405, DOI 10.1111/j.1750-3639.1993.tb00768.x; Mirrione MM, 2010, NEUROBIOL DIS, V39, P85, DOI 10.1016/j.nbd.2010.04.001; NAWASHIRO H, 1995, NEUROL RES, V17, P455, DOI 10.1080/01616412.1995.11740363; Noe FM, 2013, NEUROBIOL DIS, V59, P183, DOI 10.1016/j.nbd.2013.07.015; Noh H, 2014, NEUROCHEM INT, V69, P35, DOI 10.1016/j.neuint.2014.02.008; Ooigawa H, 2006, ACTA NEUROPATHOL, V112, P471, DOI 10.1007/s00401-006-0108-2; Parsons MP, 2014, NEURON, V82, P279, DOI 10.1016/j.neuron.2014.03.030; Pitkanen A., 2012, JASPERS BASIC MECH E, V4th; Pitkanen A, 2014, EPILEPSY BEHAV, V38, P19, DOI 10.1016/j.yebeh.2014.01.013; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Ravizza T, 2011, NEUROSCI LETT, V497, P223, DOI 10.1016/j.neulet.2011.02.040; Rosenzweig HL, 2004, STROKE, V35, P2576, DOI 10.1161/01.STR.0000143450.04438.ae; Rosenzweig HL, 2007, J CEREBR BLOOD F MET, V27, P1663, DOI 10.1038/sj.jcbfm.9600464; ROTHWELL NJ, 1995, TRENDS NEUROSCI, V18, P130, DOI 10.1016/0166-2236(95)93890-A; Savin C, 2009, J R SOC INTERFACE, V6, P655, DOI 10.1098/rsif.2008.0387; Sayyah M, 2003, EPILEPSY RES, V57, P175, DOI 10.1016/j.eplepsyres.2003.11.002; Schaafsma W, 2015, BRAIN BEHAV IMMUN, V48, P205, DOI 10.1016/j.bbi.2015.03.013; Song MY, 2014, CLIN LAB, V60, P233, DOI 10.7754/Clin.Lab.2013.130207; Tasaki K, 1997, BRAIN RES, V748, P267, DOI 10.1016/S0006-8993(96)01383-2; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Tompkins P, 2013, J NEUROTRAUM, V30, P1888, DOI 10.1089/neu.2012.2674; Turrigiano GG, 2006, TRENDS MOL MED, V12, P458, DOI 10.1016/j.molmed.2006.08.002; Vandresen S, 2013, NEUROTOX RES, V24, P55, DOI 10.1007/s12640-012-9359-y; Vezzani A, 2015, NEUROPHARMACOLOGY, V96, P70, DOI 10.1016/j.neuropharm.2014.10.027; Vezzani A, 2013, NEUROPHARMACOLOGY, V69, P16, DOI 10.1016/j.neuropharm.2012.04.004; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; Xiao ZH, 2015, J NEUROIMMUNOL, V282, P110, DOI 10.1016/j.jneuroim.2015.04.003; Zhang F., 2012, ANIMAL MODELS ACUTE, P93, DOI DOI 10.1007/978-1-61779-782-8_9	66	17	17	0	17	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-5728	1872-8421		J NEUROIMMUNOL	J. Neuroimmunol.	DEC 15	2015	289						143	151		10.1016/j.jneuroim.2015.11.003			9	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	CZ0HA	WOS:000366784500020	26616884				2022-02-06	
J	Jang, SH; Kwon, HG				Jang, Sung Ho; Kwon, Hyeok Gyu			Injury of the dentato- rubro- thalamic tract in a patient with mild traumatic brain injury	BRAIN INJURY			English	Article							INDUCED AXONAL INJURY; MOVEMENT-DISORDERS; STIMULATION; TRACKING; TREMOR; SCALE		[Jang, Sung Ho; Kwon, Hyeok Gyu] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Daegu 705717, South Korea		Kwon, HG (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyung Dong, Daegu 705717, South Korea.	khg0715@hanmail.net			DGIST R&D Program of the Ministry of Science, ICT and Future Planning [15-BD-0401]	The authors report no conflicts of interest. This work was supported by the DGIST R&D Program of the Ministry of Science, ICT and Future Planning (15-BD-0401).	Afifi AK, 2005, FUNCTIONAL NEUROANAT; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Anderson T, 2006, PRACTICAL NEUROLOGY, V6, P342, DOI DOI 10.1136/JNNP.2006.106583; Blum L, 2008, PHYS THER, V88, P559, DOI 10.2522/ptj.20070205; Coenen VA, 2014, NEUROSURGERY, V75, P657, DOI 10.1227/NEU.0000000000000540; Coenen VA, 2011, ACTA NEUROCHIR, V153, P1579, DOI 10.1007/s00701-011-1036-z; Coenen VA, 2011, NEUROSURGERY, V68, P1069, DOI 10.1227/NEU.0b013e31820a1a20; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; Kasahara K, 2012, MAGN RESON IMAGING, V30, P496, DOI 10.1016/j.mri.2011.12.018; Krauss JK, 1997, MOVEMENT DISORD, V12, P428, DOI 10.1002/mds.870120326; Kwon HG, 2014, BRAIN INJURY, V28, P511, DOI 10.3109/02699052.2014.887228; Kwon HG, 2011, NEURORADIOLOGY, V53, P787, DOI 10.1007/s00234-011-0878-7; Lee HD, 2014, BRAIN INJURY, V28, P1485, DOI 10.3109/02699052.2014.930178; Lehericy S, 2001, NEUROLOGY, V57, P1055, DOI 10.1212/WNL.57.6.1055; Marek M, 2015, J NEUROL, V262, P54, DOI 10.1007/s00415-014-7503-8; Marx JJ, 2008, NEUROIMAGE, V39, P1625, DOI 10.1016/j.neuroimage.2007.10.006; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Schlaier J, 2015, NEUROMODULATION, V18, P105, DOI 10.1111/ner.12238; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Weyer A, 2007, MOVEMENT DISORD, V22, P1633, DOI 10.1002/mds.21544; Yamada K, 2009, P NATL ACAD SCI USA, V106, pE14, DOI 10.1073/pnas.0812352106; Zasler ND, 2013, BRAIN INJURY MED PRI, p[1480, xxxii]	26	17	17	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2015	29	13-14					1725	1728		10.3109/02699052.2015.1075170			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CY8LL	WOS:000366659800026	26479208				2022-02-06	
J	Chen, FQ; Zhou, J; Li, Y; Wang, YB; Li, LH; Yue, HZ				Chen, Fuqian; Zhou, Jun; Li, Yan; Wang, Yongbo; Li, Lihong; Yue, Hongzhi			Mechanical Properties of Porcine Brain Tissue in the Coronal Plane: Interregional Variations of the Corona Radiata	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Traumatic brain injury; Indentation; Hereditary integral; Viscoelasticity; Biomechanics; Heterogeneity	ELEMENT HEAD MODEL; IN-VIVO; INJURY; INDENTATION; DEFORMATION; MATTER; WHITE; TESTS	Most biomechanical models that aim to investigate traumatic brain injury consider the corona radiata as a homogeneous structure. To verify this, indentation-relaxation tests using a custom-designed indentation device were performed on the anterior, superior, and posterior region of the corona radiata in the coronal plane of the porcine brain. Using Boltzmann hereditary integral, a linear viscoelastic model with a Prony series approximation was fitted to the time-dependent shear modulus for different regions of the corona radiata, and the fit parameters were generated. The posterior region was the stiffest and the anterior region was the least stiff. A statistical analysis revealed a significant difference in biomedical properties between the anterior and superior regions, as well as between the anterior and posterior regions in the short time scale. However, the results showed that these differences faded away as the tissue approached equilibrium. No significant difference was observed between the superior and posterior regions along the total time history of relaxation. This is the first demonstration of the regional biomechanical heterogeneity of the corona radiata, and these results will improve future biomedical models of the porcine brain.	[Chen, Fuqian; Zhou, Jun; Li, Yan; Wang, Yongbo; Li, Lihong; Yue, Hongzhi] Shandong Univ, Sch Mech Engn, Jinan 250061, Peoples R China; [Chen, Fuqian; Zhou, Jun; Li, Yan; Wang, Yongbo; Li, Lihong; Yue, Hongzhi] Shandong Univ, Minist Educ, Key Lab High Efficiency & Clean Mech Mfg, Jinan 250061, Peoples R China		Zhou, J (corresponding author), Shandong Univ, Sch Mech Engn, Jinan 250061, Peoples R China.	zhoujun@sdu.edu.cn		Yue, Hongzhi/0000-0003-4101-9368	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [51375268]; Independent Innovation Foundation of Shandong University [2012ZD009]	The authors thank Dr. Fei Gao and Dr. Xiaochen Wang for assistance with the slicing of porcine brain tissue and Dr. Qinhe Zhang and Dr. Renzhi Zhan for use of laboratory equipment. This research was supported financially by the National Natural Science Foundation of China (Grant No. 51375268) and the Independent Innovation Foundation of Shandong University (Grant No. 2012ZD009).	Allen M.P., 1997, UNDERSTANDING REGRES; Belingardi G, 2005, P 19 INT TECHN C ENH; Bonferroni, 1935, STUDI ONORE PROFESSO, P13; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Cheng L, 2000, J POLYM SCI POL PHYS, V38, P10, DOI 10.1002/(SICI)1099-0488(20000101)38:1<10::AID-POLB2>3.0.CO;2-6; Cheng S, 2008, MED ENG PHYS, V30, P1318, DOI 10.1016/j.medengphy.2008.06.003; Christ AF, 2010, J BIOMECH, V43, P2986, DOI 10.1016/j.jbiomech.2010.07.002; Darvish KK, 2001, MED ENG PHYS, V23, P633, DOI 10.1016/S1350-4533(01)00101-1; Elkin BS, 2007, J NEUROTRAUM, V24, P812, DOI 10.1089/neu.2006.0169; Elkin BS, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004494; Elkin BS, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000164; Feng Y, 2013, J MECH BEHAV BIOMED, V23, P117, DOI 10.1016/j.jmbbm.2013.04.007; Finan JD, 2014, BIOMECH MODEL MECHAN, V13, P573, DOI 10.1007/s10237-013-0519-7; GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; Garo A, 2007, BIORHEOLOGY, V44, P51; Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; GURDJIAN ES, 1962, JAMA-J AM MED ASSOC, V182, P502; HARDING JW, 1945, P CAMB PHILOS SOC, V41, P16, DOI 10.1017/S0305004100022325; HAYES WC, 1972, J BIOMECH, V5, P541, DOI 10.1016/0021-9290(72)90010-3; Hrapko M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907746; Iwamoto M., 2000, SAE T J PASSENGER CA, V109, P846; Kang HS, 1997, P 41 STAPP CAR CRASH; Kaster T, 2011, J BIOMECH, V44, P1158, DOI 10.1016/j.jbiomech.2011.01.019; King A. I., 2003, P IRCBOI INT RES COU; Levchakov A, 2006, J NEUROTRAUM, V23, P1570, DOI 10.1089/neu.2006.23.1570; Lippert SA, 2004, BIORHEOLOGY, V41, P681; Mao Haojie, 2006, Stapp Car Crash J, V50, P583; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Nicolle Stephane, 2004, Stapp Car Crash J, V48, P239; Prange M T, 2000, Stapp Car Crash J, V44, P205; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Sahoo D, 2013, COMPUT METHOD BIOMEC, V16, P198, DOI 10.1080/10255842.2013.815908; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts EG, 2008, STAPP CAR C, V52, P1; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; van Dommelen JAW, 2010, J MECH BEHAV BIOMED, V3, P158, DOI 10.1016/j.jmbbm.2009.09.001; Versace, 1971, P 15 STAPP CAR CRASH, DOI DOI 10.4271/710881; Zamir EA, 2004, J BIOMECH ENG-T ASME, V126, P276, DOI 10.1115/1.1695573	40	17	17	5	22	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	DEC	2015	43	12					2903	2910		10.1007/s10439-015-1350-3			8	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	CV0LD	WOS:000363941300007	26048198				2022-02-06	
J	Greenwald, BD; Hammond, FM; Harrison-Felix, C; Nakase-Richardson, R; Howe, LLS; Kreider, S				Greenwald, Brian D.; Hammond, Flora M.; Harrison-Felix, Cynthia; Nakase-Richardson, Risa; Howe, Laura L. S.; Kreider, Scott			Mortality following Traumatic Brain Injury among Individuals Unable to Follow Commands at the Time of Rehabilitation Admission: A National Institute on Disability and Rehabilitation Research Traumatic Brain Injury Model Systems Study	JOURNAL OF NEUROTRAUMA			English	Article						brain injuries; brain injury; chronic; disorder of consciousness; epidemiology; life expectancy; mortality; rehabilitation	LONG-TERM SURVIVAL; REPRESENTATIVENESS; CONSCIOUSNESS; DATABASE; OUTCOMES; COMA; CARE; TBI	Severe traumatic brain injury (TBI) has been associated with increased mortality. This study characterizes long-term mortality, life expectancy, causes of death, and risk factors for death among patients admitted within the National Institute on Disability and Rehabilitation Research (NIDRR) TBI Model Systems Programs (TBIMS) who lack command following at the time of admission for inpatient TBI rehabilitation. Of the 8084 persons enrolled from 1988 and 2009, 387 from 20 centers met study criteria. Individuals with moderate to severe TBI who received inpatient rehabilitation were 2.2 times more likely to die than individuals in the U.S. general population of similar age, gender, and race, with an average life expectancy (LE) reduction of 6.6 years. The subset of individuals who were unable to follow commands on admission to rehabilitation was 6.9 times more likely to die, with an average LE reduction of 12.2 years. Relative to the U.S. general population matched for age, gender, and race/ethnicity, these non-command following individuals were more than four times more likely to die of circulatory conditions, 44 times more likely to die of pneumonia, and 38 times more likely to die of aspiration pneumonia. The subset of individuals with TBI who are unable to follow commands upon admission to inpatient rehabilitation are at a significantly increased risk of death when compared with the U.S. general population and compared with all individuals with moderate to severe TBI receiving inpatient rehabilitation. Respiratory causes of death predominate, compared with the general population.	[Greenwald, Brian D.] Rutgers Robert Wood Johnson Med Sch, JFK Johnson Rehabil Ctr Head Injuries, Edison, NJ USA; [Hammond, Flora M.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Harrison-Felix, Cynthia] Craig Hosp, Englewood, CO USA; [Harrison-Felix, Cynthia] Univ Colorado Denver, Dept Phys Med & Rehabil, Aurora, CO USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, Dept Mental Hlth & Behav Sci, Tampa, FL 33612 USA; [Howe, Laura L. S.] VA Palo Alto Hlth Care Syst, Psychol Serv, Palo Alto, CA USA; [Kreider, Scott] Univ No Colorado, Dept Educ & Behav Sci, Greeley, CO 80639 USA		Greenwald, BD (corresponding author), JFK Johnson Rehabil Inst, 65 James St, Edison, NJ 08818 USA.	bgreenwald@jfkhealth.org			National Institute on Disability and Rehabilitation Research, Office of Special Education Services, Department of Education [H133A110006]; Indiana University School of Medicine [H133A120085]; Mount Sinai School of Medicine [H133A100284]; Department of Veterans AffairsUS Department of Veterans Affairs; Department of Education, National Institute on Disability and Rehabilitation Research; VA HSRD; Department of EducationUS Department of Education;  [1 I50 HX001233-01];  [SDR 13-228]	This work was supported, in part, by grants from the National Institute on Disability and Rehabilitation Research, Office of Special Education Services, Department of Education to the Traumatic Brain Injury Model Systems National Data and Statistical Center at Craig Hospital (H133A110006); Indiana University School of Medicine (H133A120085) and Mount Sinai School of Medicine (H133A100284). The Polytrauma Rehabilitation Center Traumatic Brain Injury Model System Collaboration was funded through an interagency agreement between the Department of Veterans Affairs and the Department of Education, National Institute on Disability and Rehabilitation Research, and VA HSRD; 1 I50 HX001233-01 & SDR 13-228. Although the contents of this manuscript were developed under a grant from the Department of Education, the manuscript contents do not necessarily represent the policy of the Department of Education and should not assume endorsement by the federal government.	[Anonymous], 1997, GUIDE UNIFORM DATA S; Baguley I, 2000, BRAIN INJURY, V14, P505; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Centers for Disease Control and Prevention, 2017, INJ PREV CONTR TRAUM; Coronado V. G., 2012, EPIDEMIOLOG IN PRESS; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Cuthbert JP, 2012, J HEAD TRAUMA REHAB, V27, pE15, DOI 10.1097/HTR.0b013e31826da983; DeVivo M. J, 2002, TOP SPINAL CORD INJ, V7, P49; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Englander J, 2009, J NEUROTRAUM, V26, P1471, DOI 10.1089/neu.2008.0729; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Griffin GD, 2011, MIL MED, V176, P364, DOI 10.7205/MILMED-D-10-00021; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE45, DOI 10.1097/HTR.0b013e31827340ba; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; KOTWICA Z, 1995, ACTA NEUROCHIR, V133, P56, DOI 10.1007/BF01404948; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mazzeo AT, 2006, J NEUROTRAUM, V23, P962, DOI 10.1089/neu.2006.23.962; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P1884, DOI 10.1016/j.apmr.2012.11.054; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; QUATTROCCHI K B, 1990, Journal of Neurotrauma, V7, P77, DOI 10.1089/neu.1990.7.77; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Shavelle R, 2000, J Insur Med, V32, P163; Strauss DJ, 1998, ARCH PHYS MED REHAB, V79, P1095, DOI 10.1016/S0003-9993(98)90177-0; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Traumatic Brain Injury Model Systems National Data and Statistical Center, 2014, TRAUM BRAIN INJ MOD; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1855, DOI 10.1016/j.apmr.2012.10.041	32	17	17	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2015	32	23			SI		1883	1892		10.1089/neu.2014.3454			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	CX4TW	WOS:000365694200005	25518731	Green Submitted			2022-02-06	
J	Masel, BE; Urban, R				Masel, Brent E.; Urban, Randy			Chronic Endocrinopathies in Traumatic Brain Injury Disease	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; hypopituitarism; medical; rehabilitation	GROWTH-HORMONE GH; ANTERIOR-PITUITARY FUNCTION; ANEURYSMAL SUBARACHNOID HEMORRHAGE; PROFESSIONAL FOOTBALL PLAYERS; QUALITY-OF-LIFE; REPLACEMENT THERAPY; COGNITIVE IMPAIRMENT; PREMATURE MORTALITY; DEFICIENT PATIENTS; ADULT PATIENTS	The aim of this review was to explain the role played by pituitary hormonal deficiencies in the traumatic brain injury (TBI) disease process. Chronic dysfunction of the pituitary axis is observed in approximately 35% of individuals who sustain a moderate-to-severe TBI. The most common deficiency is that of growth hormone, followed by gonadotropin, cortisol, and thyroid. The medical, psychological, and psychiatric consequences of untreated hypopituitarism are extensive and can be devastating. Many of the consequences of a chronic symptomatic TBI have, in the past, been solely attributed to the brain injury per se. Analysis of the signs and symptoms of pituitary axis dysfunction suggests that many of these consequences can be attributed to post-traumatic hypopituitarism (PTH). PTH may well play a significant role in the progressive signs and symptoms that follow a chronic TBI.	[Masel, Brent E.] Transit Learning Ctr Galveston, Galveston, TX 77550 USA; [Urban, Randy] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA		Masel, BE (corresponding author), Transit Learning Ctr Galveston, 1528 PO St, Galveston, TX 77550 USA.	bmasel@tlc-galveston.org					Acerini CL, 2006, EUR J ENDOCRINOL, V155, P663, DOI 10.1530/eje.1.02284; Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Aimaretti G, 2005, THESCIENTIFICWORLDJO, V5, P777, DOI 10.1100/tsw.2005.100; BENGTSSON BA, 1993, J CLIN ENDOCR METAB, V76, P309, DOI 10.1210/jc.76.2.309; Bengtsson BA, 1999, J CLIN ENDOCR METAB, V84, P3929, DOI 10.1210/jc.84.11.3929; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bhagia V, 2010, BRAIN INJURY, V24, P560, DOI 10.3109/02699051003601705; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Briscoe VJ, 2007, APPL PHYSIOL NUTR ME, V32, P576, DOI 10.1139/H07-025; Bushnik T, 2007, BRAIN INJURY, V21, P559, DOI 10.1080/02699050701426915; Centers for Disease Control and Prevention, 2007, TBI US CHILDR 0 14 Y; Cherrier MM, 2005, NEUROLOGY, V64, P290, DOI 10.1212/01.WNL.0000149639.25136.CA; Cherrier MM, 2003, J ANDROL, V24, P568; Cleare AJ, 2001, AM J PSYCHIAT, V158, P641, DOI 10.1176/appi.ajp.158.4.641; Colao A, 2004, J CLIN ENDOCR METAB, V89, P5998, DOI 10.1210/jc.2004-1042; Colao A, 1999, J CLIN ENDOCR METAB, V84, P1277, DOI 10.1210/jc.84.4.1277; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; DANIEL PM, 1959, LANCET, V2, P927; Davis J D, 2007, Minerva Endocrinol, V32, P49; Davis Jennifer Duncan, 2003, Curr Psychiatry Rep, V5, P384, DOI 10.1007/s11920-003-0073-6; DENICOFF KD, 1990, AM J PSYCHIAT, V147, P94; Einaudi S, 2006, J PEDIATR ENDOCR MET, V19, P691; Garber JR, 2012, ENDOCR PRACT, V18, P989, DOI 10.4158/EP12280.GL; Genazzani AR, 2007, HUM REPROD UPDATE, V13, P175, DOI 10.1093/humupd/dml042; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Gibney J, 1999, J CLIN ENDOCR METAB, V84, P2596, DOI 10.1210/jc.84.8.2596; Grais IM, 2014, AM J MED, V127, P691, DOI 10.1016/j.amjmed.2014.03.009; Guerrero AF, 2010, MIL MED, V175, P574, DOI 10.7205/MILMED-D-09-00189; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; HAGGERTY JJ, 1993, AM J PSYCHIAT, V150, P508; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Hatton J, 2006, J NEUROSURG, V105, P843, DOI 10.3171/jns.2006.105.6.843; Heather NL, 2012, J CLIN ENDOCR METAB, V97, P599, DOI 10.1210/jc.2011-2284; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Hohl A., 2014, OPEN J ENDOCR METAB, V4, P13; Ives JC, 2007, J ATHL TRAINING, V42, P431; KAMPEN DL, 1994, OBSTET GYNECOL, V83, P979, DOI 10.1097/00006250-199406000-00017; Kaulfers AMD, 2010, J PEDIATR-US, V157, P894, DOI 10.1016/j.jpeds.2010.07.004; Kelestimur F, 2004, J ENDOCRINOL INVEST, V27, pRC28, DOI 10.1007/BF03345299; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kelly DF, 2014, J NEUROTRAUM, V31, P1161, DOI 10.1089/neu.2013.3212; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Kokshoorn NE, 2011, EUR J ENDOCRINOL, V165, P225, DOI 10.1530/EJE-11-0365; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; KORNBLUM RN, 1969, ARCH PATHOL, V88, P242; Krahulik D, 2010, J NEUROSURG, V113, P581, DOI 10.3171/2009.10.JNS09930; Kreitschmann-Andermahr I, 2008, GROWTH HORM IGF RES, V18, P472, DOI 10.1016/j.ghir.2008.08.007; Lauzier F, 2014, CRIT CARE MED, V42, P712, DOI 10.1097/CCM.0000000000000046; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Leon-Carrion J, 2007, BRAIN INJURY, V21, P871, DOI 10.1080/02699050701484849; Leon-Carrion J, 2001, BRAIN INJURY, V15, P175, DOI 10.1080/026990501458407; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mitchell JL, 2003, ARCH INTERN MED, V163, P2485, DOI 10.1001/archinte.163.20.2485; Moreau OK, 2013, J NEUROTRAUM, V30, P998, DOI 10.1089/neu.2012.2705; Moreau OK, 2012, J NEUROTRAUM, V29, P81, DOI 10.1089/neu.2011.2048; Muller M, 2005, NEUROLOGY, V64, P866, DOI 10.1212/01.WNL.0000153072.54068.E3; National Research Council, 2008, GULF WAR AND HLTH, V7; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P514, DOI 10.1097/00001199-200611000-00006; Cenci MCP, 2009, PITUITARY, V12, P322, DOI 10.1007/s11102-009-0182-2; Pfeifer M, 1999, J CLIN ENDOCR METAB, V84, P453, DOI 10.1210/jc.84.2.453; Poomthavorn P, 2008, ARCH DIS CHILD, V93, P133, DOI 10.1136/adc.2007.121137; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Reimunde P, 2011, BRAIN INJURY, V25, P65, DOI 10.3109/02699052.2010.536196; Rose SR, 2012, PITUITARY, V15, P267, DOI 10.1007/s11102-011-0360-x; ROSEN T, 1990, LANCET, V336, P285, DOI 10.1016/0140-6736(90)91812-O; Samuels MH, 2007, THYROID, V17, P249, DOI 10.1089/thy.2006.0252; Schneider HJ, 2011, J NEUROTRAUM, V28, P1693, DOI 10.1089/neu.2011.1887; Sherwin BB, 2003, ENDOCR REV, V24, P133, DOI 10.1210/er.2001-0016; SOCKALOSKY JJ, 1987, J PEDIATR-US, V110, P373, DOI 10.1016/S0022-3476(87)80497-3; Tanriverdi F, 2010, PITUITARY, V13, P111, DOI 10.1007/s11102-009-0204-0; Tanriverdi F, 2008, ANN INTERN MED, V148, P827, DOI 10.7326/0003-4819-148-11-200806030-00005; Tanriverdi F, 2007, CLIN ENDOCRINOL, V66, P360, DOI 10.1111/j.1365-2265.2006.02737.x; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Tanriverdi F, 2013, J NEUROTRAUM, V30, P1426, DOI 10.1089/neu.2012.2752; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Tomlinson JW, 2001, LANCET, V357, P425, DOI 10.1016/S0140-6736(00)04006-X; Ulutabanca H, 2014, CHILD NERV SYST, V30, P1021, DOI 10.1007/s00381-013-2334-y; Wekking EM, 2005, EUR J ENDOCRINOL, V153, P747, DOI 10.1530/eje.1.02025; WHITEHEAD HM, 1992, CLIN ENDOCRINOL, V36, P45, DOI 10.1111/j.1365-2265.1992.tb02901.x; Wilkinson C. W., 2012, FRONT NEUROL, V3, P11, DOI DOI 10.3389/FNEUR.2012.00011	86	17	17	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2015	32	23			SI		1902	1910		10.1089/neu.2014.3526			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CX4TW	WOS:000365694200007	25325517				2022-02-06	
J	Parks, AC; Moore, RD; Wu, CT; Broglio, SP; Covassin, T; Hillman, CH; Pontifex, MB				Parks, Andrew C.; Moore, Robert D.; Wu, Chien-Ting; Broglio, Steven P.; Covassin, Tracey; Hillman, Charles H.; Pontifex, Matthew B.			The association between a history of concussion and variability in behavioral and neuroelectric indices of cognition	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						mTBI; Intra-individual variability; ERPs; P3	TRAUMATIC BRAIN-INJURY; INTRAINDIVIDUAL VARIABILITY; REACTION-TIME; PERFORMANCE; RECOVERY; ATTENTION; SPORTS; ABNORMALITIES; TRACKING; DECLINE	Associations between a history of concussion and variability in behavioral and neuroelectric indices of cognition were assessed in college-aged adults with a history of concussion and a healthy control group, in response to a stimulus discrimination task and a more attentionally demanding flanker task. Greater intra-individual variability was observed only for behavioral indices of reaction time in response to the flanker task for those with a history of concussion. An association was also observed between the number of concussions resulting in a loss of consciousness and greater variability of reaction time regardless of the type of task. Relative to neuroelectric measures, a concussive history was associated with smaller P3 amplitude only in response to the flanker task; with no differences between groups observed in response to the oddball task or for intra-individual variability measures. Thus, increased variability associated with a history of concussion appears to be behavior and process specific. The behavioral metrics and functions assessed are important considerations for identifying subtle, yet persistent influences of concussion on cognitive performance. Further, factors such as loss of consciousness associated with a concussive injury may moderate the extent to which these increases in behavioral variability manifest. Thus, the identification of persistent cognitive impairment following concussive injuries necessitates the utilization of appropriate tasks and may be facilitated by going beyond behavioral measures of central tendency. (C) 2015 Elsevier B.V. All rights reserved.	[Parks, Andrew C.; Covassin, Tracey; Pontifex, Matthew B.] Michigan State Univ, E Lansing, MI 48824 USA; [Moore, Robert D.; Wu, Chien-Ting; Hillman, Charles H.] Univ Illinois, Champaign, IL USA; [Broglio, Steven P.] Univ Michigan, Ann Arbor, MI 48109 USA		Pontifex, MB (corresponding author), Michigan State Univ, Dept Kinesiol, 27P IM Sports Circle, E Lansing, MI 48824 USA.	pontifex@msu.edu	Hillman, Charles/AAD-4828-2019; Parks, Andrew/O-9038-2017; Parks, Andrew/T-3480-2019; Pontifex, Matthew B/A-4474-2009	Parks, Andrew/0000-0001-5864-7921; Pontifex, Matthew B/0000-0001-9819-9625; Hillman, Charles/0000-0002-3722-5612	Summer Research Development Fellowship through College of Education; Summer Research Development Fellowship through Graduate School at Michigan State University	Support for our research and the preparation of this manuscript was provided by the National Athletic Trainer's Association Research and Education Fund, the Mary Jane Neer Fund for Disability Research, the Research Board at the University of Illinois, and a Summer Research Development Fellowship awarded to A. Parks through the College of Education and the Graduate School at Michigan State University.	Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Bigler ED, 2013, CLIN NEUROPSYCHOL, V27, P176, DOI 10.1080/13854046.2012.693950; BRITTON TC, 1991, J NEUROL NEUROSUR PS, V54, P505, DOI 10.1136/jnnp.54.6.505; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Bunce D, 2007, NEUROPSYCHOLOGIA, V45, P2009, DOI 10.1016/j.neuropsychologia.2007.02.006; BUNCE DJ, 1993, PSYCHOL AGING, V8, P26, DOI 10.1037/0882-7974.8.1.26; Chatrian G. E., 1985, American Journal of EEG Technology, V25, P83; Chen JK, 2008, CLIN J SPORT MED, V18, P241, DOI 10.1097/JSM.0b013e318170b59d; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Compumedics Neuroscan, 2003, SCAN 4 3, VII; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Ellemberg D, 2007, CLIN J SPORT MED, V17, P369, DOI 10.1097/JSM.0b013e31814c3e3e; ERIKSEN CW, 1979, PERCEPT PSYCHOPHYS, V25, P249, DOI 10.3758/BF03198804; Fjell AM, 2011, J NEUROSCI, V31, P18060, DOI 10.1523/JNEUROSCI.4735-11.2011; Fjell AM, 2009, NEUROBIOL AGING, V30, P2065, DOI 10.1016/j.neurobiolaging.2008.01.015; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Gamaldo AA, 2012, NEUROPSYCHOLOGY, V26, P534, DOI 10.1037/a0028686; Gamer M, 2010, PSYCHOPHYSIOLOGY, V47, P355, DOI 10.1111/j.1469-8986.2009.00933.x; Garrett DD, 2013, NEUROSCI BIOBEHAV R, V37, P610, DOI 10.1016/j.neubiorev.2013.02.015; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gosselin N, 2012, J NEUROTRAUM, V29, P2625, DOI 10.1089/neu.2012.2312; Guskiewicz KM, 2002, AM J SPORT MED, V30, P157, DOI 10.1177/03635465020300020201; Hagen GF, 2006, INT J PSYCHOPHYSIOL, V59, P8, DOI 10.1016/j.ijpsycho.2005.08.003; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Karr JE, 2014, J CLIN EXP NEUROPSYC, V36, P15, DOI 10.1080/13803395.2013.863833; Kaufman A.S., 1990, KAUFMAN BRIEF INTELL; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Livingston SC, 2010, BRAIN INJURY, V24, P904, DOI 10.3109/02699051003789245; Lovden M, 2007, NEUROPSYCHOLOGIA, V45, P2827, DOI 10.1016/j.neuropsychologia.2007.05.005; Lovden M, 2013, NEUROIMAGE, V64, P209, DOI 10.1016/j.neuroimage.2012.09.039; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Mayr U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091379; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2008, S AFR J SPORTS MED, V21, P36; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P3, DOI 10.1111/j.1365-2214.2009.01006.x; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Moore RD, 2015, BIOL PSYCHOL, V109, P93, DOI 10.1016/j.biopsycho.2015.04.008; Moore RD, 2014, J ATHL TRAINING, V49, P24, DOI 10.4085/1062-6050-49.1.01; Moore RD, 2014, J ATHL TRAINING, V49, P36, DOI 10.4085/1062-6050-49.1.02; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Pontifex MB, 2011, J COGNITIVE NEUROSCI, V23, P1332, DOI 10.1162/jocn.2010.21528; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Sass SM, 2010, PSYCHOPHYSIOLOGY, V47, P247, DOI 10.1111/j.1469-8986.2009.00926.x; Sosnoff JJ, 2007, NEUROPSYCHOLOGY, V21, P796, DOI 10.1037/0894-4105.21.6.796; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Sozda CN, 2011, INT J PSYCHOPHYSIOL, V82, P97, DOI 10.1016/j.ijpsycho.2011.06.019; Stuss DT, 2003, BRAIN, V126, P2363, DOI 10.1093/brain/awg237; Tamnes CK, 2012, J NEUROSCI, V32, P972, DOI 10.1523/JNEUROSCI.4779-11.2012; Theriault M, 2009, BRAIN INJURY, V23, P899, DOI 10.1080/02699050903283189; Tremblay S, 2011, J NEUROTRAUM, V28, P493, DOI 10.1089/neu.2010.1615; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Verleger R, 1997, PSYCHOPHYSIOLOGY, V34, P131, DOI 10.1111/j.1469-8986.1997.tb02125.x; Walhovd KB, 2007, NEUROPSYCHOLOGIA, V45, P2277, DOI 10.1016/j.neuropsychologia.2007.02.022; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54	64	17	17	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	DEC	2015	98	3	1				426	434		10.1016/j.ijpsycho.2015.08.006			9	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology; Physiology	DA0NH	WOS:000367493600005	26327621				2022-02-06	
J	Song, Z; Zhao, X; Liu, M; Jin, HX; Wang, L; Hou, MX; Gao, Y				Song, Zhi; Zhao, Xiu; Liu, Martin; Jin, Hongxu; Wang, Ling; Hou, Mingxiao; Gao, Yan			Recombinant human brain natriuretic peptide attenuates trauma-/haemorrhagic shock-induced acute lung injury through inhibiting oxidative stress and the NF-B-dependent inflammatory/MMP-9 pathway	INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY			English	Article						acute lung injury; antioxidative enzymes; brain natriuretic peptide; NF-B; trauma; haemorrhagic shock	KAPPA-B; HEMORRHAGIC-SHOCK; SEPSIS; MODEL; RATS; ISCHEMIA/REPERFUSION; SUPPRESSION; DYSFUNCTION; ENDOTOXIN; PROBNP	Acute lung injury (ALI) is one of the most serious complications in traumatic patients and is an important part of multiple organ dysfunction syndrome (MODS). Recombinant human brain natriuretic peptide (rhBNP) is a peptide with a wide range of biological activity. In this study, we investigated local changes in oxidative stress and the NF-B-dependent matrix metalloproteinase-9 (MMP-9) pathway in rats with trauma/haemorrhagic shock (TH/S)-induced ALI and evaluated the effects of pretreatment with rhBNP. Forty-eight rats were randomly divided into four groups: sham operation group, model group, low-dosage rhBNP group and high-dosage rhBNP group (n=12 for each group). Oxidative stress and MPO activity were measured by ELISA kits. MMP-9 activity was detected by zymography analysis. NF-B activity was determined using Western blot assay. With rhBNP pretreatment, TH/S-induced protein leakage, increased MPO activity, lipid peroxidation and metalloproteinase (MMP)-9 activity were inhibited. Activation of antioxidative enzymes was reversed. The phosphorylation of NF-B and the degradation of its inhibitor IB were suppressed. The results suggested that the protection mechanism of rhBNP is possibly mediated through upregulation of anti-oxidative enzymes and inhibition of NF-B activation. More studies are needed to further evaluate whether rhBNP is a suitable candidate as an effective inhaling drug to reduce the incidence of TH/S-induced ALI.	[Song, Zhi; Jin, Hongxu; Wang, Ling; Hou, Mingxiao; Gao, Yan] Gen Hosp Shenyang Mil Dist, Dept Emergency & Crit Care Med, 83 Wenhua Rd, Shenyang 110016, Peoples R China; [Zhao, Xiu] Shenyang Med Coll, Sch Stomatol, Centralab, Shenyang, Peoples R China; [Liu, Martin] Univ Nebraska Med Ctr, Dept Internal Med, Pulm Crit Care Sleep & Allergy Med, Omaha, NE USA		Gao, Y (corresponding author), Gen Hosp Shenyang Mil Dist, Dept Emergency & Crit Care Med, 83 Wenhua Rd, Shenyang 110016, Peoples R China.	gaoyan7879@163.com			Chinese Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2014M552693]; Science and Technology Project of Liaoning, China [2013225089]	This work was supported by Chinese Postdoctoral Science Foundation (2014M552693, to Z.S.) and Science and Technology Project of Liaoning, China (2013225089, to Z.S.).	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; Azoulay E, 2002, CRIT CARE MED, V30, P781, DOI 10.1097/00003246-200204000-00010; Borregaard N, 2007, TRENDS IMMUNOL, V28, P340, DOI 10.1016/j.it.2007.06.002; Burger M R, 2001, Curr Opin Investig Drugs, V2, P929; Chiang CH, 2011, TRANSL RES, V158, P17, DOI 10.1016/j.trsl.2011.02.002; Ci XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034634; Corbel M, 2000, BRAZ J MED BIOL RES, V33, P749, DOI 10.1590/S0100-879X2000000700004; Deitch EA, 2004, SHOCK, V22, P221, DOI 10.1097/01.shk.0000133592.55400.83; Deree J, 2007, J SURG RES, V143, P99, DOI 10.1016/j.jss.2007.03.083; El-Benna J, 2005, ARCH IMMUNOL THER EX, V53, P199; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Hellermann G, 2004, J ALLERGY CLIN IMMUN, V113, P79, DOI 10.1016/j.jaci.2003.10.009; Irwin DC, 2005, AM J PHYSIOL-LUNG C, V288, pL849, DOI 10.1152/ajplung.00294.2004; Jarrar D, 1999, INT J MOL MED, V4, P575; Jin XN, 2014, LIFE SCI, V117, P40, DOI 10.1016/j.lfs.2014.09.023; Kang JL, 2001, AM J RESP CRIT CARE, V164, P2206, DOI 10.1164/ajrccm.164.12.2104017; Kher A, 2005, SHOCK, V23, P1, DOI 10.1097/01.shk.0000148055.12387.15; Kuo MY, 2011, FOOD CHEM TOXICOL, V49, P2660, DOI 10.1016/j.fct.2011.07.012; LEHR HA, 1991, J CLIN INVEST, V87, P2036, DOI 10.1172/JCI115233; Li N, 2014, CELL BIOCHEM BIOPHYS, V70, P1317, DOI 10.1007/s12013-014-0057-7; Li N, 2013, FRONT BIOSCI-LANDMRK, V18, P1237, DOI 10.2741/4175; Li XL, 2007, AM J PHYSIOL-LUNG C, V292, pL1193, DOI 10.1152/ajplung.00408.2006; Lv X, 2011, INT J MED SCI, V8, P353, DOI 10.7150/ijms.8.353; MAEKAWA K, 1988, BIOCHEM BIOPH RES CO, V157, P410, DOI 10.1016/S0006-291X(88)80062-7; MANCA D, 1991, TOXICOLOGY, V67, P303, DOI 10.1016/0300-483X(91)90030-5; Mueller C, 2004, NEW ENGL J MED, V350, P647, DOI 10.1056/NEJMoa031681; Murphy TJ, 2004, J LEUKOCYTE BIOL, V75, P400, DOI 10.1189/jlb.0503233; Pandit Kaushik, 2011, Indian J Endocrinol Metab, V15 Suppl 4, pS345, DOI 10.4103/2230-8210.86978; Parthasarathy A, 2013, MOL CELL BIOCHEM, V378, P217, DOI 10.1007/s11010-013-1612-z; Romero M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071992; Roy SK, 2013, SHOCK, V40, P210, DOI 10.1097/SHK.0b013e31829efb06; Santry HP, 2010, SHOCK, V33, P229, DOI 10.1097/SHK.0b013e3181c30f0c; Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200; Song Z, 2013, INT IMMUNOPHARMACOL, V17, P508, DOI 10.1016/j.intimp.2013.05.028; Subramanian V, 2014, EUR J PHARMACOL, V740, P388, DOI 10.1016/j.ejphar.2014.07.024; Teng L, 2012, MOL CELL BIOCHEM, V360, P271, DOI 10.1007/s11010-011-1066-0; Trocha M, 2014, ARCH MED SCI, V10, P817, DOI 10.5114/aoms.2013.38087; Wang F, 2012, CRIT CARE, V16, DOI 10.1186/cc11331; Ward PA, 2010, ANN NY ACAD SCI, V1203, P53, DOI 10.1111/j.1749-6632.2010.05552.x; Xia XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077823; Xing JJ, 2010, MICROVASC RES, V79, P56, DOI 10.1016/j.mvr.2009.11.006; Yamanouchi S, 2010, TOHOKU J EXP MED, V221, P175, DOI 10.1620/tjem.221.175; Yang HS, 2014, INT IMMUNOPHARMACOL, V19, P262, DOI 10.1016/j.intimp.2014.01.023; Yang SF, 2008, ARCH ORAL BIOL, V53, P287, DOI 10.1016/j.archoralbio.2007.09.001	44	17	20	0	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0959-9673	1365-2613		INT J EXP PATHOL	Int. J. Exp. Pathol.	DEC	2015	96	6					406	413		10.1111/iep.12160			8	Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Pathology	DD6UH	WOS:000370059500007	26852688	Green Published			2022-02-06	
J	Arun, P; Oguntayo, S; Van Albert, S; Gist, I; Wang, Y; Nambiar, MP; Long, JB				Arun, Peethambaran; Oguntayo, Samuel; Van Albert, Stephen; Gist, Irene; Wang, Ying; Nambiar, Madhusoodana P.; Long, Joseph B.			Acute decrease in alkaline phosphatase after brain injury: A potential mechanism for tauopathy	NEUROSCIENCE LETTERS			English	Article						Blast exposure; Head impact/acceleration; Tauopathy; Chronic traumatic encephalopathy; Traumatic brain injury; Tissue non-specific alkaline phosphatase	AMYLOID PRECURSOR PROTEIN; TAU-PHOSPHORYLATION; BIOLOGICAL-ACTIVITY; BLAST OVERPRESSURE; ALZHEIMERS-DISEASE; BETA-APP; EXPRESSION; MODEL; EXPOSURE; ACCUMULATION	Dephosphorylation of phosphorylated Tau (pTau) protein, which is essential for the preservation of neuronal microtubule assemblies and for protection against trauma-induced tauopathy and chronic traumatic encephalopathy (CTE), is primarily achieved in brain by tissue non-specific alkaline phosphatase (TNAP). Paired helical filaments (PHFs) and Tau isolated from Alzheimer's disease (AD) patients' brains have been shown to form microtubule assemblies with tubulin only after treatment with TNAP or protein phosphatase-2A, 2B and -1, suggesting that Tau protein in the PHFs of neurons in AD brain is hyperphosphorylated, which prevents microtubule assembly. Using blast or weight drop models of traumatic brain injury (TBI) in rats, we observed pTau accumulation in the brain as early as 6 h post-injury and further accumulation which varied regionally by 24 h post-injury. The pTau accumulation was accompanied by reduced TNAP expression and activity in these brain regions and a significantly decreased plasma total alkaline phosphatase activity after the weight drop. These results reveal that both blast- and impact acceleration-induced head injuries cause an acute decrease in the level/activity of TNAP in the brain, which potentially contributes to trauma-induced accumulation of pTau and the resultant tauopathy. The regional changes in the level/activity of TNAP or accumulation of pTau after these injuries did not correlate with the accumulation of amyloid precursor protein, suggesting that the basic mechanism underlying tauopathy in TBI might be distinct from that associated with AD. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Arun, Peethambaran; Oguntayo, Samuel; Van Albert, Stephen; Gist, Irene; Wang, Ying; Nambiar, Madhusoodana P.; Long, Joseph B.] Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA		Arun, P (corresponding author), Walter Reed Army Inst Res, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	peethambaran.arun.ctr@mail.mil; joseph.b.long.civ@mail.mil			Congressionally Directed Medical Research ProgramUnited States Department of Defense [W81XWH-08-2-0018, W81XWH-11-2-0127]	Technical help received from Rania Abu-Taleb, Andrea Edwards and Cory Riccio is greatly acknowledged. This work was supported by Congressionally Directed Medical Research Program awards W81XWH-08-2-0018 and W81XWH-11-2-0127 to JBL.	Arun P, 2013, NEUROSCI LETT, V552, P87, DOI 10.1016/j.neulet.2013.07.047; Arun P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033798; Bertrand J, 2010, NEUROSCIENCE, V168, P323, DOI 10.1016/j.neuroscience.2010.04.009; BOSSI M, 1993, J BIOL CHEM, V268, P25409; BUSCIGLIO J, 1995, NEURON, V14, P879, DOI 10.1016/0896-6273(95)90232-5; Calabrese E, 2014, J NEUROTRAUM, V31, P938, DOI 10.1089/neu.2013.3144; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; De Gasperi Rita, 2012, Front Neurol, V3, P177, DOI 10.3389/fneur.2012.00177; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; GREENBERG SM, 1994, P NATL ACAD SCI USA, V91, P7104, DOI 10.1073/pnas.91.15.7104; HANGER DP, 1991, BIOCHEM J, V275, P99, DOI 10.1042/bj2750099; HANGER DP, 1992, NEUROSCI LETT, V147, P58, DOI 10.1016/0304-3940(92)90774-2; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; IQBAL K, 1994, FEBS LETT, V349, P104, DOI 10.1016/0014-5793(94)00650-4; Kocsis JD, 2009, J REHABIL RES DEV, V46, P667, DOI 10.1682/JRRD.2008.08.0100; Langer D, 2007, NEUROSCIENCE, V150, P863, DOI 10.1016/j.neuroscience.2007.07.064; Le WD, 1997, J NEUROCHEM, V69, P978; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; NARISAWA S, 1994, DEV DYNAM, V201, P227, DOI 10.1002/aja.1002010306; Negyessy L, 2011, NEUROSCIENCE, V172, P406, DOI 10.1016/j.neuroscience.2010.10.049; NISHIHARA Y, 1994, BBA-PROTEIN STRUCT M, V1209, P274, DOI 10.1016/0167-4838(94)90196-1; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Saljo A, 2002, J NEUROTRAUM, V19, P379, DOI 10.1089/089771502753594945; Samura E, 2006, BRAIN RES, V1094, P192, DOI 10.1016/j.brainres.2005.12.134; Seino Y, 2010, J NEUROSCI RES, V88, P3547, DOI 10.1002/jnr.22516; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Tomidokoro Y, 2001, NEUROSCI LETT, V299, P169, DOI 10.1016/S0304-3940(00)01767-5; Wang JZ, 1996, MOL BRAIN RES, V38, P200, DOI 10.1016/0169-328X(95)00316-K; Wang Y, 2014, J NEUROTRAUM, V31, P498, DOI [10.1089/NEU.2013.3074, 10.1089/neu.2013.3074]; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Wang ZF, 2006, J NEUROCHEM, V98, P1167, DOI 10.1111/j.1471-4159.2006.03956.x; Xia D, 2015, BBA-MOL BASIS DIS, V1852, P913, DOI 10.1016/j.bbadis.2014.12.017; Yamashita M, 1989, Neurol Med Chir (Tokyo), V29, P995, DOI 10.2176/nmc.29.995	36	17	19	0	8	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	NOV 16	2015	609						152	158		10.1016/j.neulet.2015.10.036			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CZ0CK	WOS:000366772500027	26483321	Bronze			2022-02-06	
J	Buonora, JE; Mousseau, M; Jacobowitz, DM; Lazarus, RC; Yarnell, AM; Olsen, CH; Pollard, HB; Diaz-Arrastia, R; Latour, L; Mueller, GP				Buonora, John E.; Mousseau, Michael; Jacobowitz, David M.; Lazarus, Rachel C.; Yarnell, Angela M.; Olsen, Cara H.; Pollard, Harvey B.; Diaz-Arrastia, Ramon; Latour, Lawrence; Mueller, Gregory P.			Autoimmune Profiling Reveals Peroxiredoxin 6 as a Candidate Traumatic Brain Injury Biomarker	JOURNAL OF NEUROTRAUMA			English	Article						autoantibodies; autoimmune profiling; biomarker; peroxiredoxin 6; traumatic brain injury	C-TERMINAL HYDROLASE; CENTRAL-NERVOUS-SYSTEM; HUMAN PLATELETS; 2-DIMENSIONAL ELECTROPHORESIS; RHEUMATOID-ARTHRITIS; GEL-ELECTROPHORESIS; NEUROTROPHIC FACTOR; OXIDATIVE STRESS; SERUM-LEVELS; PROTEIN	Autoimmune profiling in rats revealed the antioxidant enzyme, peroxiredoxin 6 (PRDX6), as a target for autoantibodies evoked in response to traumatic brain injury (TBI). Consistent with this proposal, immunohistochemical analysis of rat cerebral cortex demonstrated that PRDX6 is highly expressed in the perivascular space, presumably contained within astrocytic foot processes. Accordingly, an immunosorbent electrochemiluminescence assay was developed for investigating PRDX6 in human samples. PRDX6 was found to be measurable in human blood and highly expressed in human cerebral cortex and platelets. Circulating levels of PRDX6 were elevated fourfold over control values 4 to 24h following mild-to-moderate TBI. These findings suggest that PRDX6 may serve as a biomarker for TBI and that autoimmune profiling is a viable strategy for the discovery of novel TBI biomarkers.	[Buonora, John E.; Mousseau, Michael; Pollard, Harvey B.; Diaz-Arrastia, Ramon; Mueller, Gregory P.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Buonora, John E.; Jacobowitz, David M.; Lazarus, Rachel C.; Yarnell, Angela M.; Pollard, Harvey B.; Diaz-Arrastia, Ramon; Mueller, Gregory P.] Uniformed Serv Univ Hlth Sci, Program Neurosci, Bethesda, MD 20814 USA; [Mousseau, Michael; Jacobowitz, David M.; Pollard, Harvey B.; Mueller, Gregory P.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Olsen, Cara H.] Uniformed Serv Univ Hlth Sci, Biostat Consulting Ctr, Bethesda, MD 20814 USA; [Diaz-Arrastia, Ramon] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Latour, Lawrence] NINDS, Sect Stroke Diagnost & Therapeut, Bethesda, MD 20892 USA		Mueller, GP (corresponding author), USUHS, C2117,4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	gregory.mueller@usuhs.edu	Latour, Larry/AAH-5663-2021	Latour, Larry/0000-0001-6160-5263; Diaz-Arrastia, Ramon/0000-0001-6051-3594	Department of Defense in the Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [G1703D]; Defense Medical Research and Development Command [D61_I_10_J6_152]; TriService Nursing Research Program [N12-P12]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [ZIANS003120] Funding Source: NIH RePORTER	The authors would like to acknowledge the expert technical assistance of Ms. Tinghua Chen and Mr. James Freedy. Support for this work included funding from: Department of Defense in the Center for Neuroscience and Regenerative Medicine (G1703D), Defense Medical Research and Development Command (D61_I_10_J6_152) and TriService Nursing Research Program (N12-P12).	Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI 10.1089/neu.2008-0738; Chen AS, 2010, J NEUROTRAUM, V27, P263, DOI 10.1089/neu.2009.1051; Chowdhury I, 2009, FREE RADICAL BIO MED, V46, P146, DOI 10.1016/j.freeradbiomed.2008.09.027; Cirillo C, 2011, WORLD J GASTROENTERO, V17, P1261, DOI 10.3748/wjg.v17.i10.1261; Czeiter E, 2012, J NEUROTRAUM, V29, P1770, DOI 10.1089/neu.2011.2127; DAY INM, 1984, CLIN CHIM ACTA, V136, P219, DOI 10.1016/0009-8981(84)90295-X; Driscoll WJ, 1999, MOL PHARMACOL, V55, P1067, DOI 10.1124/mol.55.6.1067; Escartin C, 2008, MOL NEUROBIOL, V38, P231, DOI 10.1007/s12035-008-8043-y; Fujii T, 2001, HISTOCHEM J, V33, P267, DOI 10.1023/A:1017972906570; Fujimura H, 2002, THROMB HAEMOSTASIS, V87, P728; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; Hattori Fumiyuki, 2007, V44, P357; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Heydorn W.E., 1988, NEURONAL GLIAL PROTE, P25; HEYDORN WE, 1983, J NEUROSCI, V3, P2597; Jacobowitz DM, 2012, BRAIN RES, V1465, P80, DOI 10.1016/j.brainres.2012.05.008; Jin MH, 2005, NEUROSCI LETT, V381, P252, DOI 10.1016/j.neulet.2005.02.048; KENT C, 1992, DEV BRAIN RES, V68, P241, DOI 10.1016/0165-3806(92)90066-6; Khan F, 2006, J BIOCHEM MOL BIOL, V39, P189; Klareskog L, 2008, CURR OPIN RHEUMATOL, V20, P300, DOI 10.1097/BOR.0b013e3282fbd22a; Kumin A, 2006, AM J PATHOL, V169, P1194, DOI 10.2353/ajpath.2006.060119; Liu G, 2010, FREE RADICAL BIO MED, V49, P1172, DOI 10.1016/j.freeradbiomed.2010.07.002; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lommatzsch M, 2005, NEUROBIOL AGING, V26, P115, DOI 10.1016/j.neurobiolaging.2004.03.002; Manevich Y, 2005, FREE RADICAL BIO MED, V38, P1422, DOI 10.1016/j.freeradbiomed.2005.02.011; Manevich Y, 2014, FREE RADICAL BIO MED, V72, P210, DOI 10.1016/j.freeradbiomed.2014.04.002; MARANGOS PJ, 1980, J NEUROCHEM, V34, P1254, DOI 10.1111/j.1471-4159.1980.tb09967.x; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Massabki PS, 2003, J RHEUMATOL, V30, P2606; MERRIL CR, 1983, METHOD ENZYMOL, V96, P230; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Muth E, 2004, BBA-PROTEINS PROTEOM, V1699, P263, DOI 10.1016/j.bbapap.2004.03.007; Newman TA, 2013, HUM REPROD, V28, P2502, DOI 10.1093/humrep/det274; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Ousman SS, 2012, NAT NEUROSCI, V15, P1096, DOI 10.1038/nn.3161; Pan J, 2014, CURR MOL MED, V14, P1186, DOI 10.2174/1566524014666141021143333; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Power JHT, 2008, ACTA NEUROPATHOL, V115, P611, DOI 10.1007/s00401-008-0373-3; Routsias JG, 2011, RHEUMATOLOGY, V50, P1189, DOI 10.1093/rheumatology/ker090; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Scofield RH, 2005, FREE RADICAL BIO MED, V38, P719, DOI 10.1016/j.freeradbiomed.2004.11.001; Sedaghat F, 2008, HIPPOKRATIA, V12, P198; Seo MS, 2000, J BIOL CHEM, V275, P20346, DOI 10.1074/jbc.M001943200; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stein TD, 2002, J NEUROPATH EXP NEUR, V61, P1100, DOI 10.1093/jnen/61.12.1100; Strey CW, 2004, AM J PATHOL, V165, P1701, DOI 10.1016/S0002-9440(10)63426-8; Sung JH, 2009, J PINEAL RES, V46, P300, DOI 10.1111/j.1600-079X.2008.00661.x; Szodoray P, 2010, AUTOIMMUN REV, V9, P140, DOI 10.1016/j.autrev.2009.04.006; Tamura S, 2011, THROMB RES, V128, pE55, DOI 10.1016/j.thromres.2011.06.002; Tulsawani R, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-125; Wang Y, 2008, J CELL BIOCHEM, V104, P1274, DOI 10.1002/jcb.21703; Xu Y, 2014, EXP ANIM TOKYO, V63, P247, DOI 10.1538/expanim.63.247; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092698	57	17	17	1	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2015	32	22					1805	1814		10.1089/neu.2014.3736			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CV6ST	WOS:000364401500011	25938937	Green Published, Bronze, Green Submitted			2022-02-06	
J	de Kloet, AJ; Berger, MAM; Bedell, GM; Catsman-Berrevoets, CE; van Markus-Doornbosch, F; Vlieland, TPMV				de Kloet, Arend J.; Berger, Monique A. M.; Bedell, Gary M.; Catsman-Berrevoets, Coriene E.; van Markus-Doornbosch, Frederike; Vlieland, Thea P. M. Vliet			Psychometric evaluation of the Dutch language version of the Child and Family Follow-up Survey	DEVELOPMENTAL NEUROREHABILITATION			English	Article						Acquired brain injury; adolescents; children; participation; traumatic brain injury; young adults	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; GENERIC CORE SCALES; CROSS-CULTURAL ADAPTATION; INPATIENT REHABILITATION; PARTICIPATION OUTCOMES; PHYSICAL-DISABILITIES; PARENT PERSPECTIVES; RELIABILITY; VALIDITY	Aim: The Child and Family Follow-up Survey (CFFS) is developed to monitor long-term outcomes of children and youth with acquired brain injury (ABI). The aim of this study was to translate and adapt it into the Dutch language and to evaluate its reliability and validity.Methods: The CFFS includes the Child and Adolescent Scale of Participation (CASP), the Child and Adolescent Factors Inventory (CAFI) and the Child and Adolescent Scale of Environment (CASE). The CFFS was translated into Dutch following international guidelines and adapted. The internal consistency, validity and test-retest reliability were examined among two groups of patients (n=140 and n=27) in the age of 5-22 years with ABI and their parents.Results: The translation and adaptation resulted in the CFFS-DLV, Dutch language version. The CASP-DLV, CAFI-DLV and CASE-DLV had a good internal consistency, with Cronbach's alpha being 0.95, 0.89 and 0.83, respectively. There were statistically significant correlations among the three CFFS subscale scores. These scores were also significantly correlated with the total scores of the Pediatric Quality of Life Inventory (PedsQL, parent) and the Pediatric Stroke Outcome Measure, but not with the domain scores of the Children's Assessment of Participation and Enjoyment (CAPE). The test-retest reliability was good to moderate, with the intra-class correlation coefficients being 0.90 for the CASP-DLV, 0.95 for the CAFI-DLV and 0.81 for the CASE-DLV.Conclusions: The CFFS-DLV, as translation and adaptation of the CFFS into Dutch, proved to be a promising instrument to measure long-term outcomes of children and youth with ABI. Further research is needed to examine its responsiveness to change and potential in other patient groups.	[de Kloet, Arend J.; van Markus-Doornbosch, Frederike; Vlieland, Thea P. M. Vliet] Sophia Rehabil, NL-2543 SW The Hague, Netherlands; [de Kloet, Arend J.; Berger, Monique A. M.] Hague Univ Appl Sci, Dept Res & Dev, The Hague, Netherlands; [Bedell, Gary M.] Tufts Univ, Dept Occupat Therapy, Medford, MA 02155 USA; [Catsman-Berrevoets, Coriene E.] Erasmus Univ Hosp, Sophia Childrens Hosp, Dept Paediat Neurol, Rotterdam, Netherlands; [Vlieland, Thea P. M. Vliet] Leiden Univ, Med Ctr, Dept Orthopaed, Leiden, Netherlands		de Kloet, AJ (corresponding author), Sophia Rehabil, Vrederustlaan 180, NL-2543 SW The Hague, Netherlands.	a.dekloet@sophiarevalidatie.nl	Vlieland, Thea Vliet/AAJ-8119-2020	Vlieland, Thea Vliet/0000-0001-6322-3859; Bedell, Gary/0000-0002-9555-8861	Revalidatiefonds [2010/0029]; Johanna Kinder Fonds; Kinderrevalidatie Fonds Adriaanstichting [2009/0075-1403]	The Revalidatiefonds (Grant 2010/0029), Johanna Kinder Fonds and Kinderrevalidatie Fonds Adriaanstichting (Grant 2009/0075-1403) supported this project financially. The authors report no conflict of interest.	Anaby D, 2012, DEV MED CHILD NEUROL, V54, P339, DOI 10.1111/j.1469-8749.2011.04204.x; BARTKO JJ, 1966, PSYCHOL REP, V19, P3, DOI 10.2466/pr0.1966.19.1.3; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bedell G., 2012, MEASURES OUTCOMES TH; Bedell G, 2009, DEV NEUROREHABIL, V12, P342, DOI 10.3109/17518420903087277; Bedell GM, 2011, ARCH PHYS MED REHAB, V92, P765, DOI 10.1016/j.apmr.2010.12.029; Bedell GM, 2004, NEUROREHABILITATION, V19, P191; Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; BONITA R, 1988, STROKE, V19, P1497, DOI 10.1161/01.STR.19.12.1497; BROWN M, 1987, ARCH PHYS MED REHAB, V68, P828; Bult MK, 2010, CLIN REHABIL, V24, P843, DOI 10.1177/0269215510367545; Chevignard M, 2010, CHILD CARE HLTH DEV, V36, P31, DOI 10.1111/j.1365-2214.2009.00949.x; Cronin AF, 2001, AM J OCCUP THER, V55, P377, DOI 10.5014/ajot.55.4.377; de Kloet AJ, 2013, BRAIN INJURY, V27, P843, DOI 10.3109/02699052.2013.775496; deVeber GA, 2000, J CHILD NEUROL, V15, P316, DOI 10.1177/088307380001500508; Dunning J, 2004, ARCH DIS CHILD, V89, P763, DOI 10.1136/adc.2003.042523; Engelmann KA, 2012, ARCH NEUROL-CHICAGO, V69, P23, DOI 10.1001/archneurol.2011.1015; Fitzsimmons D, 2009, EUR J CANCER, V45, P19, DOI 10.1016/j.ejca.2008.07.036; Galvin J, 2010, AUST OCCUP THER J, V57, P118, DOI 10.1111/j.1440-1630.2009.00822.x; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Haley S, 1992, PEDIAT EVALUATION DI; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; Holmes JF, 2005, ACAD EMERG MED, V12, P814, DOI 10.1197/j.aem.2005.04.019; Horneman G, 2005, INT J REHABIL RES, V28, P245, DOI 10.1097/00004356-200509000-00007; IBM Corp, 2011, REL IBM SPSS STAT WI; King G., 2004, CAPE PAC CHILDRENS A; King G, 2006, CHILD HEALTH CARE, V35, P209, DOI 10.1207/s15326888chc3503_2; Kitchen L, 2012, STROKE, V43, P1602, DOI 10.1161/STROKEAHA.111.639583; Law M, 2011, BRAIN INJURY, V25, P587, DOI 10.3109/02699052.2011.572945; Limond J, 2009, BRAIN INJURY, V23, P617, DOI 10.1080/02699050902997870; MacDougall J, 2012, YOUTH REPORT VERSION; Marx RG, 2003, J CLIN EPIDEMIOL, V56, P730, DOI 10.1016/S0895-4356(03)00084-2; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; McCauley SR, 2011, J NEUROTRAUM, V28, P1; Morrow AM, 2012, CHILD CARE HLTH DEV, V38, P186, DOI 10.1111/j.1365-2214.2011.01240.x; Norman, 2003, HLTH MEASUREMENT SCA; Prigatano GP, 2008, J HEAD TRAUMA REHAB, V23, P378, DOI 10.1097/01.HTR.0000341433.67251.01; Rivara FP, 2012, J NEUROTRAUM, V29, P2499, DOI 10.1089/neu.2012.2434; Russell KMW, 2006, CANCER-AM CANCER SOC, V106, P2267, DOI 10.1002/cncr.21871; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; TEASDALE G, 1974, LANCET, V2, P81; van Tol E, 2011, BRAIN INJURY, V25, P1279, DOI 10.3109/02699052.2011.613089; Varni JW, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-2; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Varni JW, 2006, DEV MED CHILD NEUROL, V48, P442, DOI 10.1017/S001216220600096X; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428; World Health Organization, 2007, INT CLASS FUNCT DIS; World Health Organization, 2004, INT CLASS FUNCT DIS; Ziviani J, 2010, BRAIN IMPAIR, V11, P93, DOI 10.1375/brim.11.2.93	50	17	17	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1751-8423	1751-8431		DEV NEUROREHABIL	Dev. Neurorehabil.	NOV 2	2015	18	6					357	364		10.3109/17518423.2013.850749			8	Clinical Neurology; Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Rehabilitation	CX5CK	WOS:000365718800002	24304040				2022-02-06	
J	Geva, S; Correia, MM; Warburton, EA				Geva, Sharon; Correia, Marta M.; Warburton, Elizabeth A.			Contributions of bilateral white matter to chronic aphasia symptoms as assessed by diffusion tensor MRI	BRAIN AND LANGUAGE			English	Article						Arcuate fasciculus; Diffusion Tensor Imaging; Language; Stroke	POSITRON-EMISSION-TOMOGRAPHY; PERISYLVIAN LANGUAGE NETWORKS; TRAUMATIC BRAIN-INJURY; ARCUATE FASCICULUS; POSTSTROKE APHASIA; STROKE PATIENTS; FUNCTIONAL MRI; NEUROLOGICAL RECOVERY; CONDUCTION APHASIA; HEALTHY-SUBJECTS	Language reorganisation following stroke has been studied widely. However, while studies of brain activation and grey matter examined both hemispheres, studies of white matter changes have mostly focused on the left hemisphere. Here we examined the relationship between bilateral hemispheric white matter and aphasia symptoms. 15 chronic stroke patients with aphasia and 18 healthy adults were studied using Diffusion Weighted Imaging data. By applying histogram analysis, Tract-Based Spatial Statistics, tractography and lesion-tract overlap methods, it was found that damage to the left hemisphere in general, and to the arcuate fasciculus in particular, correlated with impairments on word repetition, object naming, sentence comprehension and homophone and rhyme judgement. However, no such relationship was found in the right hemisphere. It is suggested that while some language function in aphasia can be explained by damage to the left arcuate fasciculus, it cannot be explained by looking at the contra-lesional tract. (C) 2015 The Authors. Published by Elsevier Inc.	[Geva, Sharon; Warburton, Elizabeth A.] Univ Cambridge, Dept Clin Neurosci, Cambridge CB2 1TN, England; [Geva, Sharon] UCL Inst Child Hlth, Cognit Neurosci & Neuropsychiat Sect, London WC1N 1EH, England; [Correia, Marta M.] MRC Cognit & Brain Sci Unit, Cambridge, England		Geva, S (corresponding author), UCL Inst Child Hlth, Cognit Neurosci & Neuropsychiat Sect, 30 Guilford St, London WC1N 1EH, England.	sharon.geva@cantab.net		Morgado Correia, Marta/0000-0002-3231-7040	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0500874]; Pinsent-Darwin Fellowship; Wingate scholarship; Cambridge Overseas Trust; B'nai Brith Scholarship; Biomedical Centre Grant (BMC) from the UK National Institute of Health Research (NIHR); MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0500874] Funding Source: UKRI	This work was supported by the Medical Research Council (grant number G0500874). SG was supported by the Pinsent-Darwin Fellowship, Wingate scholarship, The Cambridge Overseas Trust and B'nai Brith Scholarship. EAW received support from the Biomedical Centre Grant (BMC) to Cambridge from the UK National Institute of Health Research (NIHR).	Abel S, 2015, BRAIN, V138, P1097, DOI 10.1093/brain/awv022; Allendorfer JB, 2012, RESTOR NEUROL NEUROS, V30, P103, DOI 10.3233/RNN-2011-0627; Anglade C, 2014, BRAIN INJURY, V28, P138, DOI 10.3109/02699052.2013.859734; Benson D. F., 1996, APHASIA CLIN PERSPEC; Berthier ML, 2012, CORTEX, V48, P133, DOI 10.1016/j.cortex.2011.06.014; Brandstack N, 2013, RADIOLOGY, V267, P231, DOI 10.1148/radiol.12112570; Brauer J, 2011, CEREB CORTEX, V21, P459, DOI 10.1093/cercor/bhq108; Breier JI, 2008, AM J NEURORADIOL, V29, P483, DOI 10.3174/ajnr.A0846; Brett M, 2001, NEUROIMAGE, V14, P486, DOI 10.1006/nimg.2001.0845; Burgess P.W., 1997, HAYLING BRIXTON TEST; Calvert GA, 2000, BRAIN LANG, V71, P391, DOI 10.1006/brln.1999.2272; Campbell J. S. W., 2013, BRAIN LANGUAGE; Cappa SF, 1997, BRAIN LANG, V56, P55, DOI 10.1006/brln.1997.1737; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Catani M, 2008, CORTEX, V44, P953, DOI 10.1016/j.cortex.2008.04.002; Catani M, 2007, P NATL ACAD SCI USA, V104, P17163, DOI 10.1073/pnas.0702116104; Ciccarelli O, 2008, LANCET NEUROL, V7, P715, DOI 10.1016/S1474-4422(08)70163-7; Crosson B, 2007, NEUROPSYCHOL REV, V17, P157, DOI 10.1007/s11065-007-9024-z; Dabul B.L., 1979, APRAXIA BATTERY ADUL; De Vega M., 2014, J COGNITIVE NEUROSCI; Diaz MT, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00167; Dick AS, 2012, BRAIN, V135, P3529, DOI 10.1093/brain/aws222; Fernandez B, 2004, STROKE, V35, P2171, DOI 10.1161/01.STR.0000139323.76769.b0; Floel A, 2009, NEUROIMAGE, V47, P1974, DOI 10.1016/j.neuroimage.2009.05.046; Forkel SJ, 2014, BRAIN, V137, P2027, DOI 10.1093/brain/awu113; Fridriksson J, 2010, J NEUROSCI, V30, P11057, DOI 10.1523/JNEUROSCI.1120-10.2010; Friederici A. D., 2009, TRENDS COGNITIVE SCI; Friederici A. D., 2011, PHYSL REV; Furlan M, 1996, ANN NEUROL, V40, P216, DOI 10.1002/ana.410400213; Galantucci S, 2011, BRAIN, V134, P3011, DOI 10.1093/brain/awr099; Geva S, 2012, NEUROIMAGE-CLIN, V1, P37, DOI 10.1016/j.nicl.2012.08.003; Geva S, 2011, BRAIN, V134, P3071, DOI 10.1093/brain/awr232; Geva S, 2011, APHASIOLOGY, V25, P323, DOI 10.1080/02687038.2010.511236; Hamilton RH, 2011, BRAIN LANG, V118, P40, DOI 10.1016/j.bandl.2011.02.005; Heller SL, 2005, CLIN IMAG, V29, P283, DOI 10.1016/j.clinimag.2004.09.003; Henriques RN, 2015, NEUROIMAGE, V111, P85, DOI 10.1016/j.neuroimage.2015.02.004; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hosomi A, 2009, NEURORADIOLOGY, V51, P549, DOI 10.1007/s00234-009-0534-7; Iglesias S, 1996, STROKE, V27, P1192, DOI 10.1161/01.STR.27.7.1192; Jang SH, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00749; Jones OP, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00024; Kay J., 1992, PSYCHOLINGUISTIC ASS; Kim SH, 2011, NEUROREHABILITATION, V29, P305, DOI 10.3233/NRE-2011-0706; Kummerer D, 2013, BRAIN, V136, P619, DOI 10.1093/brain/aws354; Kunimatsu A, 2003, NEURORADIOLOGY, V45, P532, DOI 10.1007/s00234-003-0974-4; Kurland J, 2004, BEHAV NEUROL, V15, P87, DOI 10.1155/2004/974094; Kwon HG, 2011, NEUROREHABILITATION, V29, P401, DOI 10.3233/NRE-2011-0718; Lazar RM, 2008, CURR NEUROL NEUROSCI, V8, P497, DOI 10.1007/s11910-008-0079-x; Lebel C, 2009, HUM BRAIN MAPP, V30, P3563, DOI 10.1002/hbm.20779; Liegeois FJ, 2013, BRAIN LANG, V127, P388, DOI 10.1016/j.bandl.2013.05.003; Mao H, 2007, J NEUROIMAGING, V17, P292, DOI 10.1111/j.1552-6569.2007.00146.x; Marchina S, 2011, STROKE, V42, P2251, DOI 10.1161/STROKEAHA.110.606103; Mathuranath PS, 2000, NEUROLOGY, V55, P1613, DOI 10.1212/01.wnl.0000434309.85312.19; Meinzer M, 2010, NEUROIMAGE, V53, P283, DOI 10.1016/j.neuroimage.2010.06.004; Meyers JE., 1995, REY COMPLEX FIGURE T; Mori N, 2008, MAGN RESON IMAGING, V26, P835, DOI 10.1016/j.mri.2008.01.036; Naeser MA, 2004, NEUROIMAGE, V22, P29, DOI 10.1016/j.neuroimage.2003.11.016; Nelles M, 2008, AM J NEURORADIOL, V29, P488, DOI 10.3174/ajnr.A0855; Newman SD, 2012, PSYCHOL RES-PSYCH FO, V76, P280, DOI 10.1007/s00426-011-0347-2; Pagani E, 2005, NEUROIMAGE, V26, P258, DOI 10.1016/j.neuroimage.2005.01.008; Poeppel D, 2004, COGNITION, V92, P1, DOI 10.1016/j.cognition.2003.11.001; Powell HWR, 2007, NEUROIMAGE, V36, P209, DOI 10.1016/j.neuroimage.2007.02.028; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Price CJ, 1999, J COGNITIVE NEUROSCI, V11, P371, DOI 10.1162/089892999563481; Price CJ, 2005, CURR OPIN NEUROL, V18, P429, DOI 10.1097/01.wco.0000168081.76859.c1; Raven, 1938, RAVENS PROGR MATRICE; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Rosso C, 2014, BRAIN STIMUL, V7, P627, DOI 10.1016/j.brs.2014.06.004; Saur D, 2006, BRAIN, V129, P1371, DOI 10.1093/brain/awl090; Schlaug G., 2009, NEUROSCIENCES MUSIC, V1; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Schoot L, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00208; Selnes OA, 2002, APHASIOLOGY, V16, P897, DOI 10.1080/02687030244000374; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song XJ, 2011, NEUROL RES, V33, P529, DOI 10.1179/016164111X13007856084322; Swinburn K., 2004, COMPREHENSIVE APHASI; Szaflarski JP, 2013, RESTOR NEUROL NEUROS, V31, P347, DOI 10.3233/RNN-120267; Thiebaut de Schotten M, 2011, NEUROIMAGE, V54, P49, DOI 10.1016/j.neuroimage.2010.07.055; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Vernooij MW, 2007, NEUROIMAGE, V35, P1064, DOI 10.1016/j.neuroimage.2006.12.041; Wan CY, 2014, BRAIN LANG, V136, P1, DOI 10.1016/j.bandl.2014.03.011; Warburton E, 1999, J NEUROL NEUROSUR PS, V66, P155, DOI 10.1136/jnnp.66.2.155; WEILLER C, 1995, ANN NEUROL, V37, P723, DOI 10.1002/ana.410370605; Winhuisen L, 2005, STROKE, V36, P1759, DOI 10.1161/01.STR.0000174487.81126.ef; Xu XJ, 2004, CHINESE MED J-PEKING, V117, P1011; Yamada K, 2007, NEUROLOGY, V69, P321; Yamada K, 2004, J MAGN RESON IMAGING, V20, P923, DOI 10.1002/jmri.20215; Zhang YM, 2010, NEUROL RES, V32, P775, DOI 10.1179/016164109X12478302362653; Zipse L, 2012, ANN NY ACAD SCI, V1252, P237, DOI 10.1111/j.1749-6632.2012.06454.x	93	17	17	0	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0093-934X	1090-2155		BRAIN LANG	Brain Lang.	NOV	2015	150						117	128		10.1016/j.bandl.2015.09.001			12	Audiology & Speech-Language Pathology; Linguistics; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Psychology	CY1EG	WOS:000366148900012	26401977	Green Published, hybrid			2022-02-06	
J	Jawa, RS; Shapiro, MJ; McCormack, JE; Huang, EC; Rutigliano, DN; Vosswinkel, JA				Jawa, Randeep S.; Shapiro, Marc J.; McCormack, Jane E.; Huang, Emily C.; Rutigliano, Daniel N.; Vosswinkel, James A.			Preadmission Do Not Resuscitate advanced directive is associated with adverse outcomes following acute traumatic injury	AMERICAN JOURNAL OF SURGERY			English	Article						Do Not Resuscitate; DNR; Trauma; Injury; Outcome	INTENSIVE-CARE-UNIT; SURGICAL-PATIENTS; BRAIN-INJURY; ORDERS; MORTALITY; AGE; WITHDRAWAL; FRAILTY; IMPACT	BACKGROUND: Do Not Resuscitate (DNR) orders have been associated with poor outcomes in surgical patients. There is limited literature on admitted trauma patients with advanced directives indicating DNR status before admission (preadmission DNR [PADNR]). METHODS: A retrospective review of the trauma registry of a suburban county was carried out for admitted trauma patients with age >= 41 years, who were admitted between 2008 and 2013. RESULTS: Of 7,937 admitted patients, 327 had a preadmission advanced directive indicating DNR. PADNR patients were significantly older (87 vs 69 years), with more frequent comorbidities, and were more often admitted after a fall (94.2% vs 65.8%). PADNR patients had a higher Injury Severity Score (14 vs 11). They also had significantly increased rates of pneumonia, sepsis, myocardial infarction, and death (33.6% vs 5.9%). On multivariate logistic regression, the presence of a preadmission advanced directive indicating DNR status was independently associated with a 5.2-fold increased odds of mortality. CONCLUSION: An advanced directive indicating DNR is associated with adverse outcomes following trauma. Published by Elsevier Inc.	[Jawa, Randeep S.; Shapiro, Marc J.; McCormack, Jane E.; Huang, Emily C.; Rutigliano, Daniel N.; Vosswinkel, James A.] SUNY Stony Brook, Dept Surg, Div Trauma, Stony Brook, NY 11794 USA		Jawa, RS (corresponding author), SUNY Stony Brook, Dept Surg, Div Trauma, Stony Brook, NY 11794 USA.	Randeep.jawa@stonybrookmedicine.edu					Adams SD, 2013, J TRAUMA ACUTE CARE, V74, P1327, DOI 10.1097/TA.0b013e31828c4698; Adams SD, 2012, J TRAUMA ACUTE CARE, V72, P112, DOI 10.1097/TA.0b013e318241f073; American College of Surgeons, ANN REPORT; Centers for Disease Control and Prevention, FALLOLD AD OV; Cooper Z, 2009, J TRAUMA, V66, P1327, DOI 10.1097/TA.0b013e31819ea047; [Federal Highway Administration U. S. Department of Transportation], LIC DRIV; Franklin GA, 2011, SURGERY, V150, P854, DOI 10.1016/j.surg.2011.07.065; Gordy Stephanie, 2011, Int J Crit Illn Inj Sci, V1, P132, DOI 10.4103/2229-5151.84800; Hemphill JC, 2007, CRIT CARE, V11, DOI 10.1186/cc5687; Hemphill JC, 2004, STROKE, V35, P1130, DOI 10.1161/01.STR.0000125858.71051.ca; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Joseph B, 2014, JAMA SURG, V149, P766, DOI 10.1001/jamasurg.2014.296; Joseph B, 2014, J AM COLL SURGEONS, V219, P10, DOI 10.1016/j.jamcollsurg.2014.03.020; Kazaure H, 2011, ARCH SURG-CHICAGO, V146, P922, DOI 10.1001/archsurg.2011.69; Mahon MM, 2011, J PAIN SYMPTOM MANAG, V41, P801, DOI 10.1016/j.jpainsymman.2011.01.002; Mirarchi FL, 2012, J EMERG MED, V42, P511, DOI 10.1016/j.jemermed.2011.07.015; Morrell ED, 2008, J MED ETHICS, V34, P642, DOI 10.1136/jme.2007.022517; Mosenthal AC, 2008, J TRAUMA, V64, P1587, DOI 10.1097/TA.0b013e318174f112; Nathens AB, 2008, J TRAUMA, V64, P81, DOI 10.1097/TA.0b013e31815dd4d7; *PRES COMM STUD, 1983, DEC FOR LIF SUST TRE; Puchalski C M, 2001, Proc (Bayl Univ Med Cent), V14, P352; Rothenberg D., 2011, CLIN ETHICS ANESTHES; Saager L, 2011, CRIT CARE MED, V39, P1036, DOI 10.1097/CCM.0b013e31820eb4fc; Salottolo K, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0094-2; Scarborough JE, 2012, ANN SURG, V256, P453, DOI 10.1097/SLA.0b013e31826578fb; Searle Samuel D, 2008, BMC Geriatr, V8, P24, DOI 10.1186/1471-2318-8-24; Shepardson LB, 1999, MED CARE, V37, P727, DOI 10.1097/00005650-199908000-00003; SLATER A L, 1991, Focus on Critical Care, V18, P476; Thompson HJ, 2008, CRIT CARE MED, V36, P282, DOI 10.1097/01.CCM.0000297884.86058.8A; Tornetta P, 1999, J TRAUMA, V46, P702, DOI 10.1097/00005373-199904000-00024; U. S. Department of Transportation, HIGHW STAT 2001; Volandes A, PALLIATIVE MED, P98; Wade CE, 2013, J TRAUMA ACUTE CARE, V75, pS89, DOI 10.1097/TA.0b013e31828fa422; WENGER NS, 1995, ARCH INTERN MED, V155, P2063, DOI 10.1001/archinte.155.19.2063; Zehtabchi S, 2011, ACAD EMERG MED, V18, P637, DOI 10.1111/j.1553-2712.2011.01083.x; ZIMMERMAN JE, 1986, JAMA-J AM MED ASSOC, V255, P351, DOI 10.1001/jama.255.3.351	36	17	17	0	1	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	NOV	2015	210	5					814	821		10.1016/j.amjsurg.2015.04.007			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	CW6DC	WOS:000365086700004	26116324				2022-02-06	
J	Lin, Y; Wan, JQ; Gao, GY; Pan, YH; Ding, SH; Fan, YL; Wang, Y; Jiang, JY				Lin, Yong; Wan, Jie-qing; Gao, Guo-yi; Pan, Yao-hua; Ding, Sheng-hao; Fan, Yi-ling; Wang, Yong; Jiang, Ji-yao			Direct hippocampal injection of pseudo lentivirus-delivered nerve growth factor gene rescues the damaged cognitive function after traumatic brain injury in the rat	BIOMATERIALS			English	Article						Traumatic brain injury; Nerve growth factor; Gene; Pseudo lentivirus; Hippocampus	PC12 CELL-DIFFERENTIATION; CORTICAL IMPACT MODEL; NEUROTROPHIC FACTOR; OXIDATIVE STRESS; IN-VIVO; EXPRESSION; ACTIVATION; VECTORS; NEURONS; REPAIR	Traumatic brain injury (TBI) treatment is a long-term process and requires repeated medicine administration, which, however, can cause high expense, infection, and hemorrhage to patients. To investigate how a long-term expression of nerve growth factor (Ngf) gene affects the injured hippocampus function post-TBI, in this study, a pseudo lentivirus carrying the beta-Ngf fusion gene, with green fluorescence protein (GFP) gene, was constructed to show the gene expression and its ability of protecting cells from oxidative damage in vitro. Then, the pseudo lentivirus-carried beta-Ngf fusion gene was directly injected into the injured brain to evaluate its influence on the injured hippocampus function post-TBI in vivo. We found that the expression of the pseudo lentivirus-delivered beta-Ngf fusion gene lasted more than four-week after the cell transduction and the encoded beta-NGF fusion protein could induce the neuron-like PC12 cell differentiation. Moreover, the hippocampal injection of the pseudo lentivirus-carried beta-Ngf fusion gene sped the injured cognitive function recovery of the rat subjected to TBI. Together, our findings indicate that the long-term expression of the beta-Ngf fusion gene, delivered by the pseudo lentivirus, can promote the neurite outgrowth of the neuron-like cells and protect the cells from the oxidative damage in vitro, and that the direct and single dose hippocampal injection of the pseudo lentivirus-carried beta-Ngf fusion gene is able to rescue the hippocampus function after the TBI in the rat. (C) 2015 Elsevier Ltd. All rights reserved.	[Lin, Yong; Wan, Jie-qing; Gao, Guo-yi; Pan, Yao-hua; Ding, Sheng-hao; Fan, Yi-ling; Wang, Yong; Jiang, Ji-yao] Shanghai Jiao Tong Univ, Dept Neurol Surg, Sch Med, Ren Ji Hosp, Shanghai 200127, Peoples R China		Jiang, JY (corresponding author), Shanghai Jiao Tong Univ, Dept Neurol Surg, Sch Med, Ren Ji Hosp, 160 Pujian Rd, Shanghai 200127, Peoples R China.	jiyaojiang@126.com			National Science and Nature Committee of China [81271381, 81471856, 81471244]; National Key project [2012CB518100]; Shanghai Science and Technology CommitteeShanghai Science & Technology Committee [11JC1408602]; Natural Science Foundation of Shanghai Jiao Tong University School of Medicine [14XJ10021]	This work was supported by the Grants from the National Science and Nature Committee of China (No. 81271381, 81471856, 81471244), National Key project (No. 2012CB518100), Shanghai Science and Technology Committee (No. 11JC1408602), and Natural Science Foundation of Shanghai Jiao Tong University School of Medicine (No. 14XJ10021).	Ahmed BY, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-4; Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; Aurelie D, 2013, CURR DRUG TARGETS, V14, P1336; Begley DJ, 2004, PHARMACOL THERAPEUT, V104, P29, DOI 10.1016/j.pharmthera.2004.08.001; Benraiss A, 2001, J NEUROSCI, V21, P6718, DOI 10.1523/JNEUROSCI.21-17-06718.2001; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; Boyce VS, 2012, EUR J NEUROSCI, V35, P221, DOI 10.1111/j.1460-9568.2011.07950.x; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Das KP, 2004, NEUROTOXICOL TERATOL, V26, P397, DOI 10.1016/j.ntt.2004.02.006; DIXON CE, 1994, J NEUROTRAUM, V11, P275, DOI 10.1089/neu.1994.11.275; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DRUBIN DG, 1985, J CELL BIOL, V101, P1799, DOI 10.1083/jcb.101.5.1799; Flowers BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114535; Hohsfield LA, 2013, J IMMUNOL METHODS, V391, P112, DOI 10.1016/j.jim.2013.02.016; Jakobsson J, 2006, MOL THER, V13, P484, DOI 10.1016/j.ymthe.2005.11.012; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; Kirkland RA, 2007, J NEUROSCI, V27, P11315, DOI 10.1523/JNEUROSCI.3590-07.2007; Kline AE, 2001, NEUROSCIENCE, V106, P547, DOI 10.1016/S0306-4522(01)00300-1; KROMER LF, 1987, SCIENCE, V235, P214, DOI 10.1126/science.3798108; Lewen A, 2001, NEUROBIOL DIS, V8, P380, DOI 10.1006/nbdi.2001.0396; Longhi L, 2004, J NEUROTRAUM, V21, P1723, DOI 10.1089/neu.2004.21.1723; Migdal C, 2011, M S-MED SCI, V27, P405, DOI 10.1051/medsci/2011274017; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mullenbrock S, 2011, J BIOL CHEM, V286, P45131, DOI 10.1074/jbc.M111.274076; Onyango IG, 2010, J NEUROCHEM, V114, P1605, DOI 10.1111/j.1471-4159.2010.06871.x; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Parr-Brownlie LC, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00014; Pathan Shadab A, 2009, Recent Pat Drug Deliv Formul, V3, P71; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Salinas M, 2003, J BIOL CHEM, V278, P13898, DOI 10.1074/jbc.M209164200; Schabitz WR, 1997, J CEREBR BLOOD F MET, V17, P500, DOI 10.1097/00004647-199705000-00003; Singleton RH, 2010, J NEUROTRAUM, V27, P1091, DOI 10.1089/neu.2010.1291; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Terada K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093223; Tuszynski MH, 1996, EXP NEUROL, V137, P157, DOI 10.1006/exnr.1996.0016; Utley DS, 1996, ARCH OTOLARYNGOL, V122, P407; Valdovinos-Flores C, 2013, FREE RADICAL RES, V47, P404, DOI 10.3109/10715762.2013.783210; Vavrek R, 2006, BRAIN, V129, P1534, DOI 10.1093/brain/awl087; Virk MS, 2008, BONE, V42, P921, DOI 10.1016/j.bone.2007.12.216; Watson DJ, 2003, J NEUROPATH EXP NEUR, V62, P368, DOI 10.1093/jnen/62.4.368; Zhao RR, 2011, J NEUROSCI METH, V201, P228, DOI 10.1016/j.jneumeth.2011.08.003; Zou LL, 1999, GENE THER, V6, P994, DOI 10.1038/sj.gt.3300936	43	17	18	4	34	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	NOV	2015	69						148	157		10.1016/j.biomaterials.2015.08.010			10	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	CR5UI	WOS:000361409500015	26285082				2022-02-06	
J	Logan, TT; Rusnak, M; Symes, AJ				Logan, T. T.; Rusnak, M.; Symes, A. J.			Runx1 promotes proliferation and neuronal differentiation in adult mouse neurosphere cultures	STEM CELL RESEARCH			English	Article						Runx1; AML1; Adult neural stem cells; Neurosphere; Proliferation; Neuronal differentiation	TRAUMATIC BRAIN-INJURY; NEURAL STEM-CELLS; TRANSCRIPTION FACTOR RUNX1; ACUTE MYELOID-LEUKEMIA; CENTRAL-NERVOUS-SYSTEM; CBF-BETA-SUBUNIT; SUBVENTRICULAR ZONE; PROGENITOR CELLS; GENE-EXPRESSION; GROWTH-FACTOR	Traumatic brain injury alters the signaling environment of the adult neurogenic niche and may activate unique proliferative cell populations that contribute to the post-injury neurogenic response. Runx1 is not normally expressed by adult neural stem or progenitor cells (NSPCs) but is induced in a subpopulation of putative NSPCs after brain injury in adult mice. In order to investigate the role of Runx1 in NSPCs, we established neurosphere cultures of adult mouse subventricular zone NSPCs. We show that Runx1 is basally expressed in neurosphere culture. Removal of the mitogen bFGF or addition of 1% FBS decreased Runxl expression. Inhibition of endogenous Runxl activity with either Ro5-3335 or shRNA-mediated Runx1 knockdown inhibited NSPC proliferation without affecting differentiation. Lentiviral mediated over-expression of Runx1 in neurospheres caused a significant change in cell morphology without reducing proliferation. Runx1-overexpressing neurospheres changed from floating spheres to adherent colonies or individual unipolar or bipolar cells. Flow cytometry analysis indicated that Runx1 over-expression produced a significant increase in expression of the neuronal marker TuJ1 and a minor increase in the astrocytic marker S100 beta. Thus, Runx1 expression drove adult NSPC differentiation, predominantly toward a neuronal lineage. These data suggest that Runx1 could be manipulated after injury to promote neuronal differentiation to facilitate repair of the CNS. Published by Elsevier B.V.	Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA		Symes, AJ (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pharmacol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	aviva.symes@usuhs.edu	Symes, Aviva J/S-7471-2016	Symes, Aviva J/0000-0003-2557-9939	Centre for Neuroscience and Regenerative Medicine; Henry M. Jackson Foundation	This work was supported by a grant from the Centre for Neuroscience and Regenerative Medicine to AJS and by a fellowship from the Henry M. Jackson Foundation to TTL. We thank all members of the Symes lab for helpful discussions, Jill Shah and Sapna Gopolasubramanian for technical assistance with experiments and figures. We also thank Dr. Andrew Snow and his lab members, and Dr. Kateryna Lund and the USUHS Biomedical Instrumentation Facility for technical assistance with flow cytometry experiments. The opinions and assertions contained herein are the private opinions of the authors and are not to be construed as reflecting the views of the Uniformed Services University of the Health Sciences or the US Department of Defense. The authors report no conflicts of interest.	Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bernal GM, 2011, AGING CELL, V10, P466, DOI 10.1111/j.1474-9726.2011.00694.x; Bernardin-Fried F, 2004, J BIOL CHEM, V279, P15678, DOI 10.1074/jbc.M310023200; Biggs JR, 2006, MOL CELL BIOL, V26, P7420, DOI 10.1128/MCB.00597-06; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; Bonnert TP, 2006, EUR J NEUROSCI, V24, P661, DOI 10.1111/j.1460-9568.2006.04912.x; Bravo J, 2001, NAT STRUCT BIOL, V8, P371, DOI 10.1038/86264; Cazzalini O, 2010, MUTAT RES-REV MUTAT, V704, P12, DOI 10.1016/j.mrrev.2010.01.009; Challen GA, 2010, EXP HEMATOL, V38, P403, DOI 10.1016/j.exphem.2010.02.011; Chen XH, 2003, J NEUROTRAUM, V20, P623, DOI 10.1089/089771503322144545; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Cunningham L, 2012, P NATL ACAD SCI USA, V109, P14592, DOI 10.1073/pnas.1200037109; Fischer JA, 2015, MOL CANCER, V14, DOI 10.1186/s12943-014-0283-z; Friedman AD, 2009, J CELL PHYSIOL, V219, P520, DOI 10.1002/jcp.21738; Gao X, 2009, EXP NEUROL, V219, P516, DOI 10.1016/j.expneurol.2009.07.007; Gil-Perotin S, 2013, ANAT REC, V296, P1435, DOI 10.1002/ar.22746; Hoi CSL, 2010, MOL CELL BIOL, V30, P2518, DOI 10.1128/MCB.01308-09; Huang G, 2001, EMBO J, V20, P723, DOI 10.1093/emboj/20.4.723; Imai Y, 2004, MOL CELL BIOL, V24, P1033, DOI 10.1128/MCB.24.3.1033-1043.2004; Ito Y, 2008, ADV CANCER RES, V99, P33, DOI 10.1016/S0065-230X(07)99002-8; Katsetos CD, 2003, J CHILD NEUROL, V18, P851, DOI 10.1177/088307380301801205; Konig N, 2011, STEM CELLS DEV, V20, P1847, DOI 10.1089/scd.2010.0555; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Logan TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059250; Lopez-Juarez A, 2013, GENE DEV, V27, P1272, DOI 10.1101/gad.217539.113; Miao YS, 2015, CELL SIGNAL, V27, P156, DOI 10.1016/j.cellsig.2014.10.008; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; MIYOSHI H, 1991, P NATL ACAD SCI USA, V88, P10431, DOI 10.1073/pnas.88.23.10431; Muller-Tidow C, 2004, MOL CELL BIOL, V24, P8917, DOI 10.1128/MCB.24.20.8917-8928.2004; Murthy M, 2014, GENE, V540, P191, DOI 10.1016/j.gene.2014.02.038; Pineda JR, 2013, EMBO MOL MED, V5, P548, DOI 10.1002/emmm.201202197; Ramasamy S, 2013, ARCH BIOCHEM BIOPHYS, V534, P71, DOI 10.1016/j.abb.2013.02.004; Raponi E, 2007, GLIA, V55, P165, DOI 10.1002/glia.20445; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Robertson AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003770; Rossetti S, 2013, INT J MOL SCI, V14, P1566, DOI 10.3390/ijms14011566; Scheitz CJF, 2013, J CELL BIOCHEM, V114, P985, DOI 10.1002/jcb.24453; Sohur US, 2006, PHILOS T R SOC B, V361, P1477, DOI 10.1098/rstb.2006.1887; Stifani S, 2009, BLOOD CELL MOL DIS, V43, P20, DOI 10.1016/j.bcmd.2009.03.001; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Susarla BTS, 2011, J NEUROCHEM, V119, P868, DOI 10.1111/j.1471-4159.2011.07470.x; Tang YY, 2000, J BIOL CHEM, V275, P39579, DOI 10.1074/jbc.M007350200; Tang YY, 2000, FEBS LETT, V470, P167, DOI 10.1016/S0014-5793(00)01312-0; Theriault FM, 2005, J NEUROSCI, V25, P2050, DOI 10.1523/JNEUROSCI.5108-04.2005; Tsuzuki S, 2007, PLOS MED, V4, P880, DOI 10.1371/journal.pmed.0040172; VESCOVI AL, 1993, NEURON, V11, P951, DOI 10.1016/0896-6273(93)90124-A; Voronov D, 2013, INVEST OPHTH VIS SCI, V54, P3115, DOI 10.1167/iovs.13-11791; Wagner JP, 1999, J NEUROSCI, V19, P6006, DOI 10.1523/JNEUROSCI.19-14-06006.1999; Wang Q, 1996, CELL, V87, P697, DOI 10.1016/S0092-8674(00)81389-6; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579; Zusso M, 2012, J NEUROSCI, V32, P11285, DOI 10.1523/JNEUROSCI.6182-11.2012	54	17	17	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1873-5061	1876-7753		STEM CELL RES	Stem Cell Res.	NOV	2015	15	3					554	564		10.1016/j.scr.2015.09.014			11	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Biotechnology & Applied Microbiology	DC2GY	WOS:000369036400013	26473321	gold			2022-02-06	
J	Papa, L; Zonfrillo, MR; Ramirez, J; Silvestri, S; Giordano, P; Braga, CF; Tan, CN; Ameli, NJ; Lopez, M; Mittal, MK				Papa, Linda; Zonfrillo, Mark R.; Ramirez, Jose; Silvestri, Salvatore; Giordano, Philip; Braga, Carolina F.; Tan, Ciara N.; Ameli, Neema J.; Lopez, Marco; Mittal, Manoj K.			Performance of Glial Fibrillary Acidic Protein in Detecting Traumatic Intracranial Lesions on Computed Tomography in Children and Youth With Mild Head Trauma	ACADEMIC EMERGENCY MEDICINE			English	Article							BRAIN-INJURY; CANCER-RISKS; BIOMARKERS; RADIATION; RECOMMENDATIONS; GFAP; CT	Objectives: This study examined the performance of serum glial fibrillary acidic protein (GFAP) in detecting traumatic intracranial lesions on computed tomography (CT) scan in children and youth with mild and moderate traumatic brain injury (TBI) and assessed its performance in trauma control patients without head trauma. Methods: This prospective cohort study enrolled children and youth presenting to three Level I trauma centers following blunt head trauma with Glasgow Coma Scale (GCS) scores of 9 to 15, as well as trauma control patients with GCS scores of 15 who did not have blunt head trauma. The primary outcome measure was the presence of intracranial lesions on initial CT scan. Blood samples were obtained in all patients within 6 hours of injury and measured by enzyme-linked immunosorbent assay for GFAP (ng/mL). Results: A total of 257 children and youth were enrolled in the study and had serum samples drawn within 6 hours of injury for analysis: 197 had blunt head trauma and 60 were trauma controls. CT scan of the head was performed in 52 patients and traumatic intracranial lesions on CT scan were evident in 18 (11%), all of whom had GCS scores of 13 to 15. When serum levels of GFAP were compared in children and youth with traumatic intracranial lesions on CT scan to those without CT lesions, median GFAP levels were significantly higher in those with intracranial lesions (1.01, interquartile range [IQR] = 0.59 to 1.48) than those without lesions (0.18, IQR = 0.06 to 0.47). The area under the receiver operating characteristic curve (AUC) for GFAP in detecting children and youth with traumatic intracranial lesions on CT was 0.82 (95% confidence interval [CI] = 0.71 to 0.93). In those presenting with GCS scores of 15, the AUC for detecting lesions was 0.80 (95% CI = 0.68 to 0.92). Similarly, in children under 5 years old the AUC was 0.83 (95% CI = 0.56 to 1.00). Performance for detecting intracranial lesions at a GFAP cutoff level of 0.15 ng/mL yielded a sensitivity of 94%, a specificity of 47%, and a negative predictive value of 98%. Conclusions: In children and youth of all ages, GFAP measured within 6 hours of injury was associated with traumatic intracranial lesions on CT and with severity of TBI. Further study is required to validate these findings before clinical application. (C) 2015 by the Society for Academic Emergency Medicine	[Papa, Linda; Silvestri, Salvatore; Giordano, Philip; Braga, Carolina F.; Tan, Ciara N.; Ameli, Neema J.; Lopez, Marco] Orlando Reg Med Ctr Inc, Dept Emergency Med, Orlando, FL 32806 USA; [Papa, Linda; Ramirez, Jose; Silvestri, Salvatore; Giordano, Philip] Arnold Palmer Hosp Children, Dept Pediat Emergency Med, Orlando, FL USA; [Zonfrillo, Mark R.; Mittal, Manoj K.] Childrens Hosp Philadelphia, Div Emergency Med, Philadelphia, PA 19104 USA; [Zonfrillo, Mark R.; Mittal, Manoj K.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA		Papa, L (corresponding author), Orlando Reg Med Ctr Inc, Dept Emergency Med, Orlando, FL 32806 USA.	lpstat@aol.com	Zonfrillo, Mark R./H-9403-2017	Zonfrillo, Mark R./0000-0002-0610-9563	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS057676]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS057676] Funding Source: NIH RePORTER	This study was supported in part by award R01NS057676 from the National Institute of Neurological Disorders and Stroke. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke or the National Institutes of Health.	Berger RP, 2012, J NEUROTRAUM, V29, P672, DOI 10.1089/neu.2011.1861; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Brenner DJ, 2010, RADIAT RES, V174, P809, DOI 10.1667/RR1859.1; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2002, PEDIATR RADIOL, V32, P228, DOI 10.1007/s00247-002-0671-1; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; ENG LF, 1971, BRAIN RES, V28, P351, DOI 10.1016/0006-8993(71)90668-8; Faul M, TRAUMATIC BRAIN INJU; Gallagher CN, 2007, CURR OPIN NEUROL, V20, P403, DOI 10.1097/WCO.0b013e32821b987b; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI [10.1067/mem.2002.125782, 10.1016/j.jen.2008.12.010]; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Linet MS, 2012, CA-CANCER J CLIN, V62, P75, DOI 10.3322/caac.21132; Long A E, 1985, Emerg Med Clin North Am, V3, P437; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Nigrovic LE, 2011, PEDIATRICS, V127, P1067, DOI 10.1542/peds.2010-3373; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Papa L., 2014, CONCUSSIONS ATHLETIC, P235; Papa L, 2012, PROTEOMICS HUMAN DID, P89; Papa L, 2014, ACAD EMERG MED, V21, pS315; Papa L, 2016, J NEUROTRAUM, V33, P58, DOI 10.1089/neu.2015.3869; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Papa L, 2013, J NEUROTRAUM, V30, P324, DOI 10.1089/neu.2012.2545; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Stein SC, 2009, ANN EMERG MED, V53, P180, DOI 10.1016/j.annemergmed.2008.01.002	30	17	19	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	NOV	2015	22	11					1274	1282		10.1111/acem.12795			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	CW1VG	WOS:000364779300005	26469937	Bronze, Green Accepted			2022-02-06	
J	Sviri, GE				Sviri, Gill E.			Massive cerebral swelling immediately after cranioplasty, a fatal and unpredictable complication: report of 4 cases	JOURNAL OF NEUROSURGERY			English	Article						cranioplasty; traumatic brain injury; decompressive craniectomy; complication; cerebral edema; death	DEATH FOLLOWING CRANIOPLASTY; DECOMPRESSIVE CRANIECTOMY; HEAD-INJURY	Cranioplasty after decompressive craniectomy (DC) is associated with increased morbidity, but the reported mortality rate is low. Recently, some authors have reported a rare unexplained complication of sudden death in association with massive cerebral edema immediately after cranioplasty. The author reports on 4 patients who underwent cranioplasty after DC between January 2005 and August 2010 at his department and died because of massive cerebral edema immediately after uneventful surgery and anesthesia. All 4 of the new cases reported involved young male patients who underwent decompressive hemicraniectomy after traumatic brain injury. They developed massive cerebral swelling immediately after uneventful cranioplasty (3 patients) or after removal of an epidural hematoma several hours after surgery (1 patient). All 4 patients had a large skull defect and significantly sunken craniotomy site, and all were treated with a closed vacuum suction system that was placed under the scalp and kept open at the end of the cranioplasty procedure. After surgery, the patients' pupils became fixed and dilated, and brain CT scans showed massive brain edema. Despite emergency DC, the patients did not recover, and all 4 died. A MEDLINE search showed 8 similar cases that were reported previously. Fatal cerebral swelling after uneventful cranioplasty is a distinct clinical entity, although it is unpredictable. It is postulated that a negative pressure difference from the elimination of atmospheric pressure that had been chronically applied on the injured sinking brain in combination with the negative pressure applied by the closed subgaleal suction drain may lead to a massive brain shift toward the cranioplasty site and initiate a fatal vasomotor reaction.	[Sviri, Gill E.] Rambam Maimonides Med Ctr, Dept Neurosurg, Haifa, Israel		Sviri, GE (corresponding author), Dept Neurosurg, Rambam Maimonides Hlth Care Campus, Haifa, Israel.	g_sviri@rambam.health.gov.il					Chang V, 2010, J NEUROSURG, V112, P1120, DOI 10.3171/2009.6.JNS09133; Chitale R, 2013, NEUROLOGIST, V19, P17, DOI 10.1097/NRL.0b013e31827c6bb6; Eom KS, 2010, CLIN NEUROL NEUROSUR, V112, P336, DOI 10.1016/j.clineuro.2009.10.010; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Honeybul S, 2011, BRIT J NEUROSURG, V25, P343, DOI 10.3109/02688697.2011.568643; Mukherjee S, 2014, ACTA NEUROCHIR, V156, P989, DOI 10.1007/s00701-014-2024-x; Rocque BG, 2013, J NEUROSURG-PEDIATR, V12, P120, DOI 10.3171/2013.4.PEDS12605; Santana-Cabrera Luciano, 2012, Int J Crit Illn Inj Sci, V2, P107, DOI 10.4103/2229-5151.97277; Stephens FL, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1026; Thavarajah D, 2012, BRIT J NEUROSURG, V26, P78, DOI 10.3109/02688697.2011.603850; Van Roost D, 2003, NEUROSURGERY, V53, P1315, DOI 10.1227/01.NEU.0000093498.08913.9E; Zebian B, 2011, BRIT J NEUROSURG, V25, P785, DOI 10.3109/02688697.2011.623801	12	17	17	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	2015	123	5					1188	1193		10.3171/2014.11.JNS141152			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CU3QL	WOS:000363439800012	26090828	Bronze			2022-02-06	
J	Magou, GC; Pfister, BJ; Berlin, JR				Magou, George C.; Pfister, Bryan J.; Berlin, Joshua R.			Effect of acute stretch injury on action potential and network activity of rat neocortical neurons in culture	BRAIN RESEARCH			English	Article						Traumatic brain injury; Hyperexcitability; Hypoexcitability; Action potential; Bursting activity; Current clamp technique	TRAUMATIC BRAIN-INJURY; LONG-TERM POTENTIATION; IN-VITRO MODEL; MECHANICAL INJURY; CORTICAL-NEURONS; EARLY SEIZURES; CALCIUM; HYPEREXCITABILITY; TETRODOTOXIN; EXCITABILITY	The basis for acute seizures following traumatic brain injury (TBI) remains unclear. Animal models of TBI have revealed acute hyperexcitablility in cortical neurons that could underlie seizure activity, but studying initiating events causing hyperexcitability is difficult in these models. In vitro models of stretch injury with cultured cortical neurons, a surrogate for TBI, allow facile investigation of cellular changes after injury but they have only demonstrated post-injury hypoexcitability. The goal of this study was to determine if neuronal hyperexcitability could be triggered by in vitro stretch injury. Controlled uniaxial stretch injury was delivered to a spatially delimited region of a spontaneously active network of cultured rat cortical neurons, yielding a region of stretch-injured neurons and adjacent regions of non-stretched neurons that did not directly experience stretch injury. Spontaneous electrical activity was measured in non-stretched and stretch-injured neurons, and in control neuronal networks not subjected to stretch injury. Non-stretched neurons in stretch-injured cultures displayed a three-fold increase in action potential firing rate and bursting activity 30-60 min post-injury. Stretch-injured neurons, however, displayed dramatically lower rates of action potential firing and bursting. These results demonstrate that acute hyperexcitability can be observed in non-stretched neurons located in regions adjacent to the site of stretch injury, consistent with reports that seizure activity can arise from regions surrounding the site of localized brain injury. Thus, this in vitro procedure for localized neuronal stretch injury may provide a model to study the earliest cellular changes in neuronal function associated with acute post-traumatic seizures. (c) 2015 Published by Elsevier B.V.	[Magou, George C.; Pfister, Bryan J.] New Jersey Inst Technol, Dept Biomed Engn, Ctr Injury Biomech Mat & Med, Newark, NJ 07102 USA; [Magou, George C.; Berlin, Joshua R.] Rutgers State Univ, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07102 USA		Pfister, BJ (corresponding author), New Jersey Inst Technol, Dept Biomed Engn, Ctr Injury Biomech Mat & Med, Newark, NJ 07102 USA.	pfister@njit.edu			New Jersey Commission on Brain Injury Research [CBIR11PJT003]	The authors wish to thank Dr. Farzan Nadim for advice on analysis of spontaneous network activity, and Dr. Vijayalakshmi Santhakumar for technical advice and comments on the manuscript. Funding was provided by the New Jersey Commission on Brain Injury Research (CBIR11PJT003).	Ahmed SM, 2002, J NEUROTRAUM, V19, P1619, DOI 10.1089/089771502762300274; Ai JL, 2002, NEUROSCI LETT, V332, P155, DOI 10.1016/S0304-3940(02)00945-X; Arndt DH, 2013, EPILEPSIA, V54, P1780, DOI 10.1111/epi.12369; Aungst S, 2013, J NEUROPHYSIOL, V109, P813, DOI 10.1152/jn.00869.2012; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Cargill RS, 1996, J NEUROTRAUM, V13, P395, DOI 10.1089/neu.1996.13.395; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; DeLima AD, 1997, J COMP NEUROL, V388, P526; Faul F., 2010, TRAUMATIC BRAIN INJU; Ferrario CR, 2013, J NEUROPHYSIOL, V110, P131, DOI 10.1152/jn.01011.2012; Goforth PB, 2011, J NEUROPHYSIOL, V105, P2350, DOI 10.1152/jn.00467.2010; Goforth PB, 2004, J NEUROTRAUM, V21, P719, DOI 10.1089/0897715041269704; Griesemer D, 2007, J NEUROTRAUM, V24, P1823, DOI 10.1089/neu.2006.0237; Gurkoff GG, 2012, EPILEPSIA, V53, P53, DOI 10.1111/j.1528-1167.2012.03475.x; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Johnstone VPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063454; Kao CQ, 2004, J NEUROTRAUM, V21, P259, DOI 10.1089/089771504322972059; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; LaPlaca MC, 1997, J NEUROTRAUM, V14, P355, DOI 10.1089/neu.1997.14.355; Lea PM, 2003, J NEUROTRAUM, V20, P1233, DOI 10.1089/089771503770802907; LEE ST, 1992, J NEUROSURG, V76, P435, DOI 10.3171/jns.1992.76.3.0435; Lee ST, 1995, ACTA NEUROCHIR, V137, P151, DOI 10.1007/BF02187187; Lusardi TA, 2004, ANN BIOMED ENG, V32, P1546, DOI 10.1114/B:ABME.0000049038.75368.75; Magou GC, 2011, J NEUROTRAUM, V28, P2203, DOI 10.1089/neu.2010.1596; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; Morrison B, 1998, ANN BIOMED ENG, V26, P381, DOI 10.1114/1.61; Patel TP, 2014, J NEUROSCI, V34, P4200, DOI 10.1523/JNEUROSCI.4172-13.2014; Pfister BJ, 2003, ANN BIOMED ENG, V31, P589, DOI 10.1114/1.1566445; Prince DA, 2012, JASPERS BASIC MECH E; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Reeves TM, 2000, J NEUROSCI RES, V60, P370, DOI 10.1002/(SICI)1097-4547(20000501)60:3<370::AID-JNR12>3.0.CO;2-B; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; Shahlaie K, 2010, J NEUROTRAUM, V27, P175, DOI 10.1089/neu.2009.1003; Sick TJ, 1998, BRAIN RES, V785, P287, DOI 10.1016/S0006-8993(97)01418-2; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 1999, J NEUROSCI, V19, P4263; STICHEL CC, 1991, DEV BRAIN RES, V64, P145, DOI 10.1016/0165-3806(91)90218-8; Tavalin SJ, 1995, J NEUROPHYSIOL, V74, P2767, DOI 10.1152/jn.1995.74.6.2767; Topolnik L, 2003, EUR J NEUROSCI, V18, P486, DOI 10.1046/j.1460-9568.2003.02742.x; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; von Reyn CR, 2012, J NEUROCHEM, V121, P793, DOI 10.1111/j.1471-4159.2012.07735.x; von Reyn CR, 2009, J NEUROSCI, V29, P10350, DOI 10.1523/JNEUROSCI.2339-09.2009; Wang WW, 2008, GLIA, V56, P241, DOI 10.1002/glia.20609; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Yu Z, 2009, J NEUROTRAUM, V26, P1135, DOI 10.1089/neu.2008.0810; ZAUNER A, 1995, J NEUROTRAUM, V12, P547, DOI 10.1089/neu.1995.12.547; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921	48	17	17	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	OCT 22	2015	1624						525	535		10.1016/j.brainres.2015.07.056			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CW5PY	WOS:000365050100053	26296661				2022-02-06	
J	Lax, ID; Paniccia, M; Agnihotri, S; Reed, N; Garmaise, E; Azadbakhsh, M; Ng, J; Monette, G; Wiseman-Hakes, C; Taha, T; Keightley, M				Lax, Ilyse D.; Paniccia, Melissa; Agnihotri, Sabrina; Reed, Nick; Garmaise, Evan; Azadbakhsh, Mahdis; Ng, Justin; Monette, Georges; Wiseman-Hakes, Catherine; Taha, Tim; Keightley, Michelle			Developmental and gender influences on executive function following concussion in youth hockey players	BRAIN INJURY			English	Article						Athletes; concussion; executive functioning; gender; youth	SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; SEX-DIFFERENCES; PHYSICAL-ACTIVITY; HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; ICE HOCKEY; INTERNATIONAL-CONFERENCE; ATTENTIONAL DEFICITS; CONSENSUS STATEMENT	Background: Concussion is the most common athletic injury in youth who are simultaneously undergoing rapid developmental changes in the brain, specifically the development of executive functions (EF). The developing brain is more vulnerable to concussive injury with a protracted and different trajectory of recovery than that of adults. Thus, there is a critical need to enhance understanding of how concussion affects EF in youth.Objective: To investigate the effects of age, gender and concussion history (i.e. concussion incidence, recency, severity) on EF in youth hockey players.Methods: This 3-year cross-sectional and longitudinal multiple cohort study examined data from 211 hockey players of 8-15 years of age. Mixed-effects modelling was used to examine the influence of age, gender and concussion on EF in youth athletes.Findings: Baseline analyses revealed significant age and gender effects on measures of EF. Multiple effects of concussion history on measures of cognitive flexibility (F=2.48, p=0.03) and psychomotor speed (F=2.59, p=0.04) were found.Implications: This study highlights the impact of age, gender and concussion on EF in youth. These findings provide foundational knowledge to better manage cognitive sequelae following sports-related concussion.	[Lax, Ilyse D.; Paniccia, Melissa; Reed, Nick; Keightley, Michelle] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Lax, Ilyse D.; Paniccia, Melissa; Agnihotri, Sabrina; Reed, Nick; Wiseman-Hakes, Catherine; Keightley, Michelle] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada; [Lax, Ilyse D.] Univ Hlth Network, Princess Margaret Canc Ctr, Pencer Brain Tumor Ctr, Toronto, ON, Canada; [Paniccia, Melissa; Agnihotri, Sabrina; Reed, Nick; Wiseman-Hakes, Catherine; Keightley, Michelle] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON, Canada; [Garmaise, Evan; Azadbakhsh, Mahdis; Ng, Justin; Monette, Georges; Keightley, Michelle] York Univ, Grad Dept Math & Stat, Toronto, ON M3J 2R7, Canada; [Keightley, Michelle] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Garmaise, Evan] Deloitte Inc, Toronto, ON, Canada; [Taha, Tim] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada		Keightley, M (corresponding author), Univ Toronto, Holland Bloorview Kids Rehabil Hosp, Acquired Brain Injury, Bloorview Res Inst, 150 Kilgour Rd,Room 2W355, Toronto, ON M4G 1R8, Canada.	mkeightley@hollandbloorview.ca	Meijer, Anna/K-5118-2016; Wiseman-Hakes, Catherine/AAC-8303-2021	Wiseman-Hakes, Catherine/0000-0001-8441-884X	Ontario Neurotrauma Foundation	The authors offer their sincere gratitude to all of the participating youth hockey players and their families for their involvement as well as the Ontario Neurotrauma Foundation who provided funding for this research. All of the members of the BrainFit lab are thanked for their support throughout all stages of this project.	Adirim TA, 2007, CLIN PEDIATR EMERG M, V8, P2, DOI 10.1016/j.cpem.2007.02.002; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; Bernstein DM, 2002, J INT NEUROPSYCHOLOG, V8; Best JR, 2010, DEV REV, V30, P331, DOI 10.1016/j.dr.2010.08.001; Blair C, 2007, CHILD DEV, V78, P647, DOI 10.1111/j.1467-8624.2007.01019.x; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Chan RCK, 2001, BRAIN INJURY, V15, P71, DOI 10.1080/02699050150209156; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chu BC, 2007, J CLIN EXP NEUROPSYC, V29, P617, DOI 10.1080/13803390600878893; Cohen JS, 2009, CURR OPIN PEDIATR, V21, P288, DOI 10.1097/MOP.0b013e32832b1195; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Daniel JC, 1999, NEUROPSY NEUROPSY BE, V12, P167; Dennis M, 2009, J INT NEUROPSYCH SOC, V15, P331, DOI 10.1017/S1355617709090481; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Donders J, 2002, NEUROPSYCHOLOGY, V16, P491, DOI 10.1037//0894-4105.16.4.491; DYCHE GM, 1991, PERCEPT MOTOR SKILL, V72, P563, DOI 10.2466/PMS.72.2.563-572; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10210; Ellemberg D, 2007, CLIN J SPORT MED, V17, P369, DOI 10.1097/JSM.0b013e31814c3e3e; Emery C, 2011, CAN MED ASSOC J, V183, P1249, DOI 10.1503/cmaj.101540; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gardner A, 2012, APPL NEUROPSYCH-ADUL, V19, P90, DOI 10.1080/09084282.2011.643945; Golden CJ., 2002, STROOP COLOR WORD TE; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Hicks B, 2009, HARD TIMES AHEAD NAT; Hillman CH, 2011, PREV MED, V52, pS21, DOI 10.1016/j.ypmed.2011.01.024; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Johnston K. M, 2005, THINKFIRST CONCUSSIO; Landry BW, 2012, PM&R, V4, P826, DOI 10.1016/j.pmrj.2012.09.585; Llorente AM., 2003, CHILDRENS COLOR TRAI; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; MacDonald S, 2013, FUNCTIONAL ASSESSMEN; MAJERES RL, 1988, INTELLIGENCE, V12, P149, DOI 10.1016/0160-2896(88)90013-X; MAJERES RL, 1990, INTELLIGENCE, V14, P357, DOI 10.1016/0160-2896(90)90023-M; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2001, CLIN J SPORT MED, V11, P160, DOI 10.1097/00042752-200107000-00006; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2011, CLIN SPORT MED, V30, P201, DOI 10.1016/j.csm.2010.08.002; Memmert D, 2011, J SPORT SCI, V29, P93, DOI 10.1080/02640414.2010.528014; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Ontario Minor Hockey Association, 2014, CHECK GUID PROGR APP; Ozen LJ, 2013, BRAIN INJURY, V27, P1244, DOI 10.3109/02699052.2013.804207; Patel DR, 2005, SPORTS MED, V35, P671, DOI 10.2165/00007256-200535080-00002; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Pratt H, 2003, CHILD ADOLESCENT NEU, P624; Purcell L, 2008, CLIN PEDIATR, V47, P106, DOI 10.1177/0009922807306053; RYAN SM, 1994, J AM COLL CARDIOL, V24, P1700, DOI 10.1016/0735-1097(94)90177-5; Schneider KJ, 2010, BRIT J SPORT MED, V44, P1112, DOI 10.1136/bjsm.2009.071266; Smith A., 2002, SYMBOL DIGIT MODALIT; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Stein DG, 2007, PROG BRAIN RES, V161, P339, DOI 10.1016/S0079-6123(06)61024-8; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Trost S., 2009, ACTIVE ED PHYS ED PH; Trudeau F, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-10; van Donkelaar P, 2005, BRAIN INJURY, V19, P1031, DOI 10.1080/02699050500110363; Vestberg T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034731; Voss MW, 2010, APPL COGNITIVE PSYCH, V24, P812, DOI 10.1002/acp.1588; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; Weiss EM, 2003, PERS INDIV DIFFER, V35, P863, DOI 10.1016/S0191-8869(02)00288-X	84	17	17	2	36	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT 15	2015	29	12					1409	1419		10.3109/02699052.2015.1043344			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CV7CO	WOS:000364430200003	26362811				2022-02-06	
J	Cook, AJ; Meyer, EC; Evans, LD; Vowles, KE; Klocek, JW; Kimbrel, NA; Gulliver, SB; Morissette, SB				Cook, Andrew J.; Meyer, Eric C.; Evans, Lianna D.; Vowles, Kevin E.; Klocek, John W.; Kimbrel, Nathan A.; Gulliver, Suzy Bird; Morissette, Sandra B.			Chronic pain acceptance incrementally predicts disability in polytrauma-exposed veterans at baseline and 1-year follow-up	BEHAVIOUR RESEARCH AND THERAPY			English	Article						Chronic pain; Acceptance; Functioning; Disability; Posttraumatic stress disorder; Veterans	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; COMORBID CHRONIC PAIN; VALUES-BASED ACTION; COMMITMENT THERAPY; OIF/OEF VETERANS; MENTAL-HEALTH; PRIMARY-CARE; PREVALENCE; PTSD	War veterans are at increased risk for chronic pain and co-occurring neurobehavioral problems, including posttraumatic stress disorder (PTSD), depression, alcohol-related problems, and mild traumatic brain injury (mTBI). Each condition is associated with disability, particularly when co-occurring. Pain acceptance is a strong predictor of lower levels of disability in chronic pain. This study examined whether acceptance of pain predicted current and future disability beyond the effects of these co-occurring conditions in war veterans. Eighty trauma-exposed veterans with chronic pain completed a PTSD diagnostic interview, clinician-administered mTBI screening, and self-report measures of disability, pain acceptance, depression, and alcohol use. Hierarchical regression-models showed pain acceptance to be incrementally associated with disability after accounting for symptoms of PTSD, depression, alcohol-related problems, and mTBI (total adjusted R-2 =.57, p <.001, Delta R-2 =.03, p =.02). At 1-year follow-up, the total variance in disability accounted for by the model decreased (total adjusted R-2 =.29, p <.001), whereas the unique contribution of pain acceptance increased (Delta R-2 =.07, p =.008). Pain acceptance remained significantly associated with 1-year disability when pain severity was included in the model. Future research should evaluate treatments that address chronic pain acceptance and co-occurring conditions to promote functional recovery in the context of polytrauma in war veterans. Published by Elsevier Ltd.	[Cook, Andrew J.; Meyer, Eric C.; Evans, Lianna D.; Morissette, Sandra B.] VISN 17 Ctr Excellence Res Returning War Vet, Dept Vet Affairs, Waco, TX USA; [Cook, Andrew J.; Meyer, Eric C.; Evans, Lianna D.; Morissette, Sandra B.] Cent Texas Vet Hlth Care Syst, Temple, TX USA; [Cook, Andrew J.; Meyer, Eric C.; Gulliver, Suzy Bird; Morissette, Sandra B.] Texas A&M Hlth Sci Ctr, Coll Med, Temple, TX USA; [Vowles, Kevin E.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Klocek, John W.] Baylor Univ, Dept Psychol & Neurosci, Waco, TX 76798 USA; [Kimbrel, Nathan A.] Durham VA Med Ctr, Durham, NC USA; [Kimbrel, Nathan A.] VA Midatlantic Mental Illness Res Educ & Clin Ctr, Durham, NC USA; [Kimbrel, Nathan A.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Gulliver, Suzy Bird] Baylor Scott & White Healthcare Syst, Warriors Res Inst, Waco, TX USA		Meyer, EC (corresponding author), Cent Texas Vet Healthcare Syst 151C, Ctr Excellence Res Returning War Vet, VA VISN 17, Waco, TX 76711 USA.	Eric.Meyer2@va.gov	Vowles, Kevin/AAD-4508-2019; Kimbrel, Nathan/P-3109-2016; Gulliver, Suzy/X-9776-2019	Kimbrel, Nathan/0000-0001-7218-1005; Vowles, Kevin/0000-0003-4255-9067; Gulliver, Suzy Bird/0000-0002-6476-9447; Cook, Andrew/0000-0001-7185-8328	Department of Veterans Affairs (VA) VISN 17 New Investigator AwardUS Department of Veterans Affairs; Rehabilitation Research & Development Service of the Department of Veterans Affairs Office of Research and Development (VA ORD) [I01 RX000304]; VISN 17 Center of Excellence for Research on Returning War Veterans; Central Texas Veterans Health Care System; Clinical Science Research and Development Service of VA ORD [IK2 CX000525]; Research & Development and Mental Health Services of the Durham VA Medical Center; VA Mid-Atlantic Mental Illness Research, Education, and Clinical Center; Veterans AffairsUS Department of Veterans Affairs [IK2CX000525, I01RX000304] Funding Source: NIH RePORTER	This research was supported by a Department of Veterans Affairs (VA) VISN 17 New Investigator Award to Dr. Meyer, a Merit Award (I01 RX000304) to Dr. Morissette from the Rehabilitation Research & Development Service of the Department of Veterans Affairs Office of Research and Development (VA ORD), the VISN 17 Center of Excellence for Research on Returning War Veterans, and Central Texas Veterans Health Care System. Dr. Kimbrel was supported by a Career Development Award (IK2 CX000525) from the Clinical Science Research and Development Service of VA ORD, the Research & Development and Mental Health Services of the Durham VA Medical Center, and the VA Mid-Atlantic Mental Illness Research, Education, and Clinical Center. Writing of this manuscript was further supported by the VA Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government. The authors also wish to thank our Veteran participants and research support staff.	Adler DA, 2011, PSYCHIAT SERV, V62, P39, DOI 10.1176/ps.62.1.pss6201_0039; Alschuler KN, 2014, PSYCHOL SERV, V11, P273, DOI 10.1037/a0036201; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Andersson HI, 2004, EUR J PAIN, V8, P47, DOI 10.1016/S1090-3801(03)00064-8; Barry LC, 2003, PAIN, V104, P131, DOI 10.1016/S0304-3959(02)00471-2; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bosco MA, 2013, PAIN RES TREAT, V2013, DOI 10.1155/2013/174728; Bosco MA, 2013, HEADACHE, V53, P1518, DOI 10.1111/head.12172; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Bricker J, 2013, NICOTINE TOB RES, V15, P1756, DOI 10.1093/ntr/ntt056; Butchart A, 2009, CLIN J PAIN, V25, P293, DOI 10.1097/AJP.0b013e31818bf574; Campbell W. I., 2008, CLIN PAIN MANAGEMENT, P12; Clancy C. M., 2014, COMMUNICATION; Dobie DJ, 2004, ARCH INTERN MED, V164, P394, DOI 10.1001/archinte.164.4.394; Dobscha SK, 2009, JAMA-J AM MED ASSOC, V301, P1242, DOI 10.1001/jama.2009.377; Elliott AM, 2002, PAIN, V99, P299, DOI 10.1016/S0304-3959(02)00138-0; Fish RA, 2010, PAIN, V149, P435, DOI 10.1016/j.pain.2009.12.016; Gifford EV, 2004, BEHAV THER, V35, P689, DOI 10.1016/S0005-7894(04)80015-7; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Goldberg J, 2014, QUAL LIFE RES, V23, P1579, DOI 10.1007/s11136-013-0585-4; Haskell SG, 2012, CLIN J PAIN, V28, P163, DOI 10.1097/AJP.0b013e318223d951; Hayes S.C., 6 CORE PROCESSES ACT; Hayes S.C., 2005, CLIN CASE STUD, V4, P246, DOI [10.1177/1534650103259689, DOI 10.1177/1534650103259689]; Hayes SC, 2004, BEHAV THER, V35, P667, DOI 10.1016/S0005-7894(04)80014-5; Helmer DA, 2009, PAIN MED, V10, P1174, DOI 10.1111/j.1526-4637.2009.00723.x; Hermann B.A., PILOT STUDY IN PRESS; Higgins DM, 2014, PAIN MED, V15, P782, DOI 10.1111/pme.12388; Hill KG, 2000, ALCOHOL CLIN EXP RES, V24, P892, DOI 10.1097/00000374-200006000-00021; Holowka DW, 2011, OXFORD HDB TRAUMATIC; Jensen M. P., 1992, HDB PAIN ASSESSMENT, P135; Kehle SM, 2012, PSYCHOL ADDICT BEHAV, V26, P42, DOI 10.1037/a0024663; Kerns RD, 2003, J REHABIL RES DEV, V40, P371, DOI 10.1682/JRRD.2003.09.0371; Konecky B, 2014, AM J PSYCHIAT, V171, P818, DOI 10.1176/appi.ajp.2014.14050587; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lewis JD, 2012, NEUROREHABILITATION, V31, P367, DOI 10.3233/NRE-2012-00805; Matthias MS, 2014, MIL MED, V179, P26, DOI 10.7205/MILMED-D-13-00196; McCracken LA, 2008, HEALTH PSYCHOL, V27, P215, DOI 10.1037/0278-6133.27.2.215; McCracken LM, 2014, AM PSYCHOL, V69, P178, DOI 10.1037/a0035623; McCracken LM, 2004, PAIN, V107, P159, DOI 10.1016/j.pain.2003.10.012; McCracken LM, 2005, CONTEXTUAL COGNITIVE; Meyer EC, 2013, PSYCHOL TRAUMA-US, V5, P521, DOI 10.1037/a0030178; Otis JD, 2010, PSYCHOL SERV, V7, P126, DOI 10.1037/a0020512; Otis JD, 2011, J CLIN PSYCHOL MED S, V18, P145, DOI 10.1007/s10880-011-9239-2; Otis JD, 2009, PAIN MED, V10, P1300, DOI 10.1111/j.1526-4637.2009.00715.x; Outcalt SD, 2014, PAIN MED, V15, P1872, DOI 10.1111/pme.12045; Plagge JM, 2013, PAIN MED, V14, P1164, DOI 10.1111/pme.12155; Reneman MF, 2010, EUR J PAIN, V14, P457, DOI 10.1016/j.ejpain.2009.08.003; Rodriguez P, 2012, J REHABIL RES DEV, V49, P649, DOI 10.1682/JRRD.2011.09.0162; Ruff RL, 2009, J REHABIL RES DEV, V46, P1071, DOI 10.1682/JRRD.2009.05.0062; Schwab KA, 2006, NEUROLOGY, V66, pA235; Smith BH, 2001, FAM PRACT, V18, P292, DOI 10.1093/fampra/18.3.292; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Thompson M, 2011, CURR PAIN HEADACHE R, V15, P144, DOI 10.1007/s11916-010-0170-2; U.S. Department of Veterans Affairs, 2014, TABL 1L VETPOP2014 L, P2013; Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231; Ustun T, 2010, MEASURING HLTH DISAB; Vasterling J. J., 2008, TBI SCREENING UNPUB; Veterans Health Administration, 2006, VHA HDB; Vowles KE, 2008, J CONSULT CLIN PSYCH, V76, P397, DOI 10.1037/0022-006X.76.3.397; Vowles KE, 2014, J CONTEXT BEHAV SCI, V3, P74, DOI 10.1016/j.jcbs.2014.04.003; Vowles KE, 2014, J PAIN, V15, P101, DOI 10.1016/j.jpain.2013.10.002; Vowles KE, 2008, PAIN, V140, P284, DOI 10.1016/j.pain.2008.08.012; Walker RL, 2010, PSYCHOL SERV, V7, P136, DOI 10.1037/a0019684; Walser RD, 2013, BEHAV RES THER, V51, P555, DOI 10.1016/j.brat.2013.05.009; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; WHITE HR, 1989, J STUD ALCOHOL, V50, P30, DOI 10.15288/jsa.1989.50.30; Wicksell RK, 2009, EUR J PAIN, V13, P760, DOI 10.1016/j.ejpain.2008.09.003; World Health Organization, 2007, INT CLASS FUNCT DIS; Yunus MB, 2008, SEMIN ARTHRITIS RHEU, V37, P339, DOI 10.1016/j.semarthrit.2007.09.003	71	17	17	0	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0005-7967	1873-622X		BEHAV RES THER	Behav. Res. Ther.	OCT	2015	73						25	32		10.1016/j.brat.2015.07.003			8	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	CS5QI	WOS:000362132600004	26233854	Green Accepted			2022-02-06	
J	Moore, M; Robinson, G; Mink, R; Hudson, K; Dotolo, D; Gooding, T; Ramirez, A; Zatzick, D; Giordano, J; Crawley, D; Vavilala, MS				Moore, Megan; Robinson, Gabrielle; Mink, Richard; Hudson, Kimberly; Dotolo, Danae; Gooding, Tracy; Ramirez, Alma; Zatzick, Douglas; Giordano, Jessica; Crawley, Deborah; Vavilala, Monica S.			Developing a Family-Centered Care Model for Critical Care After Pediatric Traumatic Brain Injury	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						family-centered care; pediatrics; qualitative research; traumatic brain injury	HEALTH-CARE; SATISFACTION; CHILDREN; PARENTS; OUTCOMES; SUPPORT; NEEDS; UNIT	Objectives: This study examined the family experience of critical care after pediatric traumatic brain injury in order to develop a model of specific factors associated with family-centered care. Design: Qualitative methods with semi-structured interviews were used. Setting: Two level 1 trauma centers. Participants: Fifteen mothers of children who had an acute hospital stay after traumatic brain injury within the last 5 years were interviewed about their experience of critical care and discharge planning. Participants who were primarily English, Spanish, or Cantonese speaking were included. Interventions: None. Measurements and Main Results: Content analysis was used to code the transcribed interviews and develop the family-centered care model. Three major themes emerged: 1) thorough, timely, compassionate communication, 2) capacity building for families, providers, and facilities, and 3) coordination of care transitions. Participants reported valuing detailed, frequent communication that set realistic expectations and prepared them for decision making and outcomes. Areas for capacity building included strategies to increase provider cultural humility, parent participation in care, and institutional flexibility. Coordinated care transitions, including continuity of information and maintenance of partnerships with families and care teams, were highlighted. Participants who were not primarily English speaking reported particular difficulty with communication, cultural understanding, and coordinated transitions. Conclusions: This study presents a family-centered traumatic brain injury care model based on family perspectives. In addition to communication and coordination strategies, the model offers methods to address cultural and structural barriers to meeting the needs of non-English-speaking families. Given the stress experienced by families of children with traumatic brain injury, careful consideration of the model themes identified here may assist in improving overall quality of care to families of hospitalized children with traumatic brain injury.	[Moore, Megan; Robinson, Gabrielle; Gooding, Tracy; Zatzick, Douglas; Vavilala, Monica S.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Moore, Megan; Hudson, Kimberly; Dotolo, Danae] Univ Washington, Sch Social Work, 4101 15th Ave NE,Box 354900, Seattle, WA 98195 USA; [Robinson, Gabrielle; Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Mink, Richard] Harbor UCLA Med Ctr, Torrance, CA 90509 USA; [Mink, Richard; Ramirez, Alma] Los Angeles BioMed Res Inst, Torrance, CA USA; [Zatzick, Douglas] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Giordano, Jessica; Crawley, Deborah] Brain Injury Alliance Washington, Seattle, WA USA		Moore, M (corresponding author), Univ Washington, Sch Social Work, 4101 15th Ave NE,Box 354900, Seattle, WA 98195 USA.	mm99@uw.edu	Hudson, Kimberly/AAO-4353-2021		National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000421]; National Institute for Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS072308]; National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS); University of WashingtonUniversity of Washington; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Center for Advancing Translational Sciences of the NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS); NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NIH through the University of WashingtonUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; PCORIPatient-Centered Outcomes Research Institute - PCORI; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS072308] Funding Source: NIH RePORTER	Dr. Moore is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health (KL2TR000421). Dr. Vavilala (PI) is supported by the National Institute for Neurological Disorders and Stroke (1R01NS072308). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Dr. Moore received support for travel from the National Center for Advancing Translational Sciences of the National Institutes of Health (travel to conference provided by grant), received support for the development of educational presentations from the University of Washington (Received payment for 1 lecture provided to ALTSA group), and received support for article research from the National Institutes of Health (NIH) Dr. Moore and her institution received grant support from the National Center for Advancing Translational Sciences of the NIH. Dr. Mink consulted for the American Board of Pediatrics (Honorarium to serve on Education and Training Committee) and received support for article research from the NIH. His institution received grant support from a NIH Subcontract through the University of Washington. Dr. Dotolo received support for article research from the NIH. Her institution received grant support from the NIH. Dr. Gooding's institution received grant support from PCORI. Dr. Ramirez's institution received grant support from a NIH Subcontract through the University of Washington. Dr. Giordano's institution received support for participation in review activities from the Brain Injury Alliance of Washington. Dr. Crawley's institution received support for participation in review activities from the Brain Injury Alliance of Washington. Dr. Vavilala received support for article research from the NIH. Her institution received grant support from the NIH. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Aitken ME, 2004, ARCH PHYS MED REHAB, V85, P567, DOI 10.1016/j.apmr.2003.06.018; Ammentorp J, 2005, ARCH PEDIAT ADOL MED, V159, P127, DOI 10.1001/archpedi.159.2.127; Bond A Elaine, 2003, Crit Care Nurse, V23, P63; Cavanagh S, 1997, Nurse Res, V4, P5, DOI 10.7748/nr.4.3.5.s2; Coker TR, 2010, PEDIATRICS, V125, P1159, DOI 10.1542/peds.2009-1994; Davidson JE, 2007, CRIT CARE MED, V35, P605, DOI 10.1097/01.CCM.0000254067.14607.EB; Dunn MS, 2006, PEDIATRICS, V118, pS95, DOI 10.1542/peds.2006-0913F; Eichner JM, 2012, PEDIATRICS, V129, P394, DOI 10.1542/peds.2011-3084; Fassier T, 2010, CURR OPIN CRIT CARE, V16, P654, DOI 10.1097/MCC.0b013e32834044f0; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Gubrium Jaber F., 2002, HDB INTERVIEW RES CO; Hemmelgarn AL, 2001, CHILD HEALTH CARE, V30, P93, DOI 10.1207/S15326888CHC3002_2; Heyland DK, 2002, CRIT CARE MED, V30, P1413, DOI 10.1097/00003246-200207000-00002; Lewin S. A., 2001, COCHRANE DB SYST REV, V4, P3267, DOI DOI 10.1002/14651858.CD003267; Long AC, 2014, CRIT CARE MED, V42, P461, DOI 10.1097/CCM.0b013e3182a525b8; Mayring P, QUALITATIVE CONTENT; Neff JM, 2003, PEDIATRICS, V112, P691; Ngui EM, 2006, PEDIATRICS, V117, P1184, DOI 10.1542/peds.2005-1088; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; Peigne V, 2011, CRIT CARE MED, V39, P1365, DOI 10.1097/CCM.0b013e3182120b68; Pollack MM, 2003, CRIT CARE MED, V31, P1620, DOI 10.1097/01.CCM.0000063302.76602.86; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Roscigno CI, 2011, QUAL HEALTH RES, V21, P1413, DOI 10.1177/1049732311410988; ROTER DL, 1995, ARCH INTERN MED, V155, P1877, DOI 10.1001/archinte.155.17.1877; Rusinova K, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-21; Stewart M, 2000, J FAM PRACTICE, V49, P796; Tervalon M, 1998, J HEALTH CARE POOR U, V9, P117	27	17	17	3	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	OCT	2015	16	8					758	765		10.1097/PCC.0000000000000494			8	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Pediatrics	DD1UP	WOS:000369708000017	26135064	Green Accepted			2022-02-06	
J	Bailey, ZS; Grinter, MB; Campos, DD; VandeVord, PJ				Bailey, Zachary S.; Grinter, Michael B.; Campos, Diego De La Torre; VandeVord, Pamela J.			Blast induced neurotrauma causes overpressure dependent changes to the DNA methylation equilibrium	NEUROSCIENCE LETTERS			English	Article						Blast neurotrauma; Brain injury; Epigenetics; DNA methylation	TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; CONSEQUENCES; SINGLE; MEMORY	Traumatic brain injury (TBI) has a high prevalence in our society and often leads to morbidity and mortality. TBI also occurs frequently in a military setting where exposure to blast waves is common. Abnormal gene expression involved with oxidative stress, inflammation and neuronal apoptosis has been well documented following blast induced neurotrauma (BINT). Altered epigenetic transcriptional regulation through DNA methylation has been implicated in the pathology of the injury. Imbalance between DNA methylation and DNA demethylation may lead to altered methylation patterns and subsequent changes in gene transcription. DNA methyltransferase enzymes (DNMT1, DNMT3a, and DNMT3b) are responsible for the addition of methyl groups to DNA, DNA methylation. Whereas the combined function of ten-eleven translocation enzymes (TET1, TET2, and TET3) and thymine-DNA glycosylase (TDG) result in the removal of methyl groups from DNA, DNA demethylation. We used an established rodent model of BINT to assess changes in DNA methylation and demethylation enzymes following injury. Three different blast overpressures were investigated (10, 17 and 23 psi). Gene expression was investigated in the prefrontal cortex and hippocampus two weeks following injury. We observed DNMT, TET and TDG expression changes between pressure groups and brain regions. The hippocampus was more vulnerable to enzyme expression changes than the prefrontal cortex, which correlated with aberrant DNA methylation. A significant negative correlation was found between global DNA methylation and the magnitude of blast overpressure exposure. Through transcriptional regulation, altered DNA methylation patterns may offer insight into the characteristic outcomes associated with the injury pathology including inflammation, oxidative stress and apoptosis. As such, these enzymes may be important targets to future therapeutic intervention strategies. Published by Elsevier Ireland Ltd.	[Bailey, Zachary S.; Grinter, Michael B.; Campos, Diego De La Torre; VandeVord, Pamela J.] Virginia Tech, Biomed Engn & Mech, Blacksburg, VA 24060 USA; [VandeVord, Pamela J.] Salem Vet Affairs Med Ctr, Salem, VA 24153 USA		VandeVord, PJ (corresponding author), 447 Kelly Hall,325 Stanger St, Blacksburg, VA 24061 USA.	pvord@vt.edu			Department of Veterans Affairs RED [RX001104-01]; Veterans AffairsUS Department of Veterans Affairs [I21RX001104] Funding Source: NIH RePORTER	This project was support by the Department of Veterans Affairs RED contract #RX001104-01. We would also like to thank Brad Hubbard, Dr. Michael Urban, C. Shaylen Hall, and Dr. Sujith Sajja for their technical assistance.	Ahmed FA, 2013, ELECTROPHORESIS, V34, P2229, DOI 10.1002/elps.201300077; Bandeira F, 2009, P NATL ACAD SCI USA, V106, P14108, DOI 10.1073/pnas.0804650106; Berdasco M, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt83; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Finkelstein EA., 2007, J EPIDEMIOL COMMUNIT, V61, P926, DOI DOI 10.1136/JECH.2007.059717; Franco R, 2008, CANCER LETT, V266, P6, DOI 10.1016/j.canlet.2008.02.026; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Haghighi F, 2015, J NEUROTRAUM, V32, P1200, DOI 10.1089/neu.2014.3640; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kamnaksh A, 2012, ELECTROPHORESIS, V33, P3680, DOI 10.1002/elps.201200319; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Lundberg J, 2009, NEUROSCI LETT, V457, P8, DOI 10.1016/j.neulet.2009.03.105; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Preston AR, 2013, CURR BIOL, V23, pR764, DOI 10.1016/j.cub.2013.05.041; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Sajja VSSS, 2014, NEUROSCI LETT, V570, P33, DOI 10.1016/j.neulet.2014.03.072; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Wachsman JT, 1997, MUTAT RES-FUND MOL M, V375, P1, DOI 10.1016/S0027-5107(97)00003-1; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Watanabe D, 2006, NEUROSCIENCE, V142, P727, DOI 10.1016/j.neuroscience.2006.07.053; Weiner MW, 2013, ALZHEIMERS DEMENT, V9, P445, DOI 10.1016/j.jalz.2013.03.005; Yoon T, 2008, LEARN MEMORY, V15, P97, DOI 10.1101/lm.850808; Zhang ZY, 2007, NEUROSCI LETT, V429, P1, DOI 10.1016/j.neulet.2007.09.061	33	17	18	0	11	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	SEP 14	2015	604						119	123		10.1016/j.neulet.2015.07.035			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CS1TG	WOS:000361850000022	26232681				2022-02-06	
J	Beauchamp, MH; Brooks, BL; Barrowman, N; Aglipay, M; Keightley, M; Anderson, P; Yeates, KO; Osmond, MH; Zemek, R				Beauchamp, Miriam H.; Brooks, Brian L.; Barrowman, Nick; Aglipay, Mary; Keightley, Michelle; Anderson, Peter; Yeates, Keith O.; Osmond, Martin H.; Zemek, Roger			Empirical Derivation and Validation of a Clinical Case Definition for Neuropsychological Impairment in Children and Adolescents	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Neuropsychology; Assessment; Pediatric; Cognition; Performance; Brain injury	TRAUMATIC BRAIN-INJURY; WECHSLER INTELLIGENCE SCALE; LOW SCORES; NEUROCOGNITIVE OUTCOMES; HEALTHY-CHILDREN; PREFRONTAL CORTEX; EARLY-CHILDHOOD; WORKING-MEMORY; FRONTAL-CORTEX; 4TH EDITION	Neuropsychological assessment aims to identify individual performance profiles in multiple domains of cognitive functioning; however, substantial variation exists in how deficits are defined and what cutoffs are used, and there is no universally accepted definition of neuropsychological impairment. The aim of this study was to derive and validate a clinical case definition rule to identify neuropsychological impairment in children and adolescents. An existing normative pediatric sample was used to calculate base rates of abnormal functioning on eight measures covering six domains of neuropsychological functioning. The dataset was analyzed by varying the range of cutoff levels [1, 1.5, and 2 standard deviations (SDs) below the mean] and number of indicators of impairment. The derived rule was evaluated by bootstrap, internal and external clinical validation (orthopedic and traumatic brain injury). Our neuropsychological impairment (NPI) rule was defined as two or more test scores that fall 1.5 SDs below the mean. The rule identifies 5.1% of the total sample as impaired in the assessment battery and consistently targets between 3 and 7% of the population as impaired even when age, domains, and number of tests are varied. The NPI rate increases in groups known to exhibit cognitive deficits. The NPI rule provides a psychometrically derived method for interpreting performance across multiple tests and may be used in children 6-18 years. The rule may be useful to clinicians and scientists who wish to establish whether specific individuals or clinical populations present within expected norms versus impaired function across a battery of neuropsychological tests.	[Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Beauchamp, Miriam H.] Ste Justine Hosp Res Ctr, Montreal, PQ, Canada; [Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Neurosci Program Brain Injury & Rehabil, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Dept Pediat, Calgary, AB T2N 1N4, Canada; [Brooks, Brian L.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Brooks, Brian L.; Yeates, Keith O.] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Brooks, Brian L.; Barrowman, Nick; Yeates, Keith O.] Univ Calgary, Dept Psychol, Calgary, AB T2N 1N4, Canada; [Aglipay, Mary] Childrens Hosp Eastern Ontario, Res Inst, Clin Res Unit, Ottawa, ON K1H 8L1, Canada; [Keightley, Michelle] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada; [Keightley, Michelle] Univ Toronto, Dept Occupat Sci, Toronto, ON, Canada; [Keightley, Michelle] Univ Toronto, Dept Occupat Therapy, Toronto, ON, Canada; [Keightley, Michelle] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Keightley, Michelle] Toronto Rehabil Inst, Toronto, ON, Canada; [Anderson, Peter] Childrens Hosp Eastern Ontario, Behav Neurosci & Consultat Liaison Program, Ottawa, ON K1H 8L1, Canada; [Anderson, Peter; Osmond, Martin H.; Zemek, Roger] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada; [Yeates, Keith O.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Osmond, Martin H.; Zemek, Roger] Univ Ottawa, Dept Pediat, Ottawa, ON K1N 6N5, Canada; [Osmond, Martin H.; Zemek, Roger] Univ Ottawa, Dept Emergency Med, Ottawa, ON K1N 6N5, Canada		Beauchamp, MH (corresponding author), Univ Montreal, Dept Psychol, CP Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	miriam.beauchamp@umontreal.ca	Barrowman, Nick/AAL-3166-2020; Zemek, Roger/H-1039-2018; Yeates, Keith/AAJ-4223-2020	Barrowman, Nick/0000-0002-4704-9595; Yeates, Keith/0000-0001-7680-2892; Osmond, Martin/0000-0001-8275-8381	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [293380, 231125]; National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institute on Drug AbuseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH); National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [N01-HD02-3343, N01-MH9-0002, N01-NS-9-2314, -2315, -2316, -2317, -2319, -2320]; CNS Vital Signs; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [N01HD023343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [N01MH090002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [N01NS092316, N01NS092315, N01NS092319, N01NS092317, N01NS092314] Funding Source: NIH RePORTER	This work was supported by the Canadian Institutes of Health Research (R.Z. 293380), (M.B. 231125). We would like to thank Dr. Gerry Taylor for his willingness to provide the external validation data and for facilitating access to it. B.L.B. reports that he receives royalties for a pediatric memory test (Sherman and Brooks, 2015, Child and Adolescent Memory Profile [ChAMP (TM)], PAR Inc.), past research support from a computerized test publisher (CNS Vital Signs) through in-kind test credits, and book royalties from Oxford University Press. None of the other authors report any conflicts of interest. Data used in the preparation of this article were obtained from the Pediatric MRI Data Repository created by the NIH MRI Study of Normal Brain Development. This is a multi-site, longitudinal study of typically developing children, from ages newborn through young adulthood, conducted by the Brain Development Cooperative Group and supported by the National Institute of Child Health and Human Development, the National Institute on Drug Abuse, the National Institute of Mental Health, and the National Institute of Neurological Disorders and Stroke (Contract #s N01-HD02-3343, N01-MH9-0002, and N01-NS-9-2314, -2315, -2316, -2317, -2319, and -2320). A listing of the participating sites and a complete listing of the study investigators can be found at http://www.bic.mni.mcgill.ca/nihpd/info/participating_centers.html.	Achenbach T., 1991, INTEGRATIVE GUIDE 19; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Beauchamp MH, 2013, HAND CLINIC, V112, P913, DOI 10.1016/B978-0-444-52910-7.00013-1; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Binder LM, 2009, ARCH CLIN NEUROPSYCH, V24, P31, DOI 10.1093/arclin/acn001; Brooks B. L., 2012, PEDIAT FORENSIC NEUR, P66; Brooks BL, 2013, APPL NEUROPSYCH-CHIL, V2, P70, DOI 10.1080/21622965.2012.742792; Brooks BL, 2010, PSYCHOL ASSESSMENT, V22, P650, DOI 10.1037/a0019781; Brooks BL, 2010, ARCH CLIN NEUROPSYCH, V25, P182, DOI 10.1093/arclin/acq005; Brooks BL, 2010, APPL NEUROPSYCHOL, V17, P37, DOI 10.1080/09084280903526083; Brooks BL, 2009, J INT NEUROPSYCH SOC, V15, P613, DOI 10.1017/S1355617709090651; Brooks BL, 2009, DEMENT GERIATR COGN, V27, P439, DOI 10.1159/000215390; Carey CL, 2004, J CLIN EXP NEUROPSYC, V26, P307, DOI 10.1080/13803390490510031; Casey BJ, 2008, ANN NY ACAD SCI, V1124, P111, DOI 10.1196/annals.1440.010; Conklin HM, 2008, BRAIN INJURY, V22, P847, DOI 10.1080/02699050802403565; Crawford JR, 2007, NEUROPSYCHOLOGY, V21, P419, DOI 10.1037/0894-4105.21.4.419; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; Delis D.C., 1994, CVLT C CALIFORNIA VE; Diamond A, 2000, CHILD DEV, V71, P44, DOI 10.1111/1467-8624.00117; Evans AC, 2006, NEUROIMAGE, V30, P184, DOI 10.1016/j.neuroimage.2005.09.068; Ewing-Cobbs L, 2003, DEV NEUROPSYCHOL, V24, P669, DOI 10.1207/S15326942DN242&3_08; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Gathercole SE, 1998, J CHILD PSYCHOL PSYC, V39, P3, DOI 10.1111/1469-7610.00301; Gazzaley A, 2012, TRENDS COGN SCI, V16, P129, DOI 10.1016/j.tics.2011.11.014; Hackman DA, 2010, NAT REV NEUROSCI, V11, P651, DOI 10.1038/nrn2897; Hung Ryan, 2014, Arch Phys Med Rehabil, V95, pS174, DOI 10.1016/j.apmr.2013.08.301; Hurks PPM, 2013, CLIN NEUROPSYCHOL, V27, P988, DOI 10.1080/13854046.2013.797502; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; HUTTENLOCHER PR, 1997, DEV PREFRONTAL CORTE, P69; Isquith PK, 2005, MENT RETARD DEV D R, V11, P209, DOI 10.1002/mrdd.20075; Kemp, 1998, NEPSY DEV NEUROPSYCH; Kolb B, 2004, BRAIN COGNITION, V55, P104, DOI 10.1016/s0278-2626(03)00278-1; Levin HS, 2013, J NEUROTRAUM, V30, P625, DOI 10.1089/neu.2012.2627; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Mather N., 2001, WOODCOCK JOHNSON 3 T; Rieger BP, 2013, BRAIN INJURY, V27, P169, DOI 10.3109/02699052.2012.729290; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; SAHAKIAN BJ, 1992, J ROY SOC MED, V85, P399; SAHAKIAN BJ, 1988, BRAIN, V111, P695, DOI 10.1093/brain/111.3.695; Schoenberg MR, 2007, J CHILD NEUROL, V22, P379, DOI 10.1177/0883073807301925; Tiffin, 1968, PURDUE PEGBOARD EXAM; Tiffin J, 1948, J APPL PSYCHOL, V32, P234, DOI 10.1037/h0061266; Tsujimoto S, 2008, NEUROSCIENTIST, V14, P345, DOI 10.1177/1073858408316002; van der Sluis S, 2008, BEHAV GENET, V38, P348, DOI 10.1007/s10519-008-9212-5; Waber DP, 2007, J INT NEUROPSYCH SOC, V13, P729, DOI 10.1017/S1355617707070841; Wechsler D., 2011, WECHSLER ABBREVIATED; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; Zemek R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003550; Zimmerman I. L., 2002, PRESCHOOL LANGUAGE S	52	17	17	0	7	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	SEP	2015	21	8					596	609		10.1017/S1355617715000636			14	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	CT6HB	WOS:000362913000003	26307381				2022-02-06	
J	Hendriksen, JGM; Peijnenborgh, JCAW; Aldenkamp, AP; Vles, JSH				Hendriksen, J. G. M.; Peijnenborgh, J. C. A. W.; Aldenkamp, A. P.; Vles, J. S. H.			Diagnostic overshadowing in a population of children with neurological disabilities: A cross sectional descriptive study on acquired ADHD	EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY			English	Article						ADHD; Neurology; Neuropsychology; Learning disabilities	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; DUCHENNE MUSCULAR-DYSTROPHY; TRAUMATIC BRAIN-INJURY; ADOLESCENTS; DISTURBANCE; TYPE-1	Aim: Diagnostic overshadowing refers to the underdiagnosis of comorbid conditions in children with known neurological diagnoses. To demonstrate diagnostic overshadowing we determined the prevalence of attention deficit-hyperactivity disorders (ADHD) in a cohort of children with a wide range of neurological disabilities. Method: The study cohort consisted of 685 children (mean age 10.3 years, SD: 3.1; 425 boys and 260 girls) who visited a tertiary outpatient multidisciplinary clinic for neurological learning disabilities. Patients with ADHD were identified by retrospective chart review using DSM-IV criteria. Results: The prevalence of ADHD in this cohort was 38.8% (266 children); of these children only 28.2% (75 children) were diagnosed with ADHD before referral. Interpretation: ADHD is a common problem in children with neurological disabilities and may be underdiagnosed due to overshadowing of somatic, physical or syndromal features of the disability. In our heterogeneous population ADHD was overshadowed in 71.8% of the cases. This finding may have important implications for diagnosis and treatment of mental health needs in children with neurological disabilities. (C) 2015 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.	[Hendriksen, J. G. M.; Peijnenborgh, J. C. A. W.; Vles, J. S. H.] Kempenhaeghe, Dept Neurol Learning Disabil, NL-5590 AB Heeze, Netherlands; [Hendriksen, J. G. M.; Peijnenborgh, J. C. A. W.; Aldenkamp, A. P.] Kernpenhaeghe Epilepsy Ctr, Dept Behav Sci, NL-5590 AB Heeze, Netherlands; [Hendriksen, J. G. M.; Aldenkamp, A. P.; Vles, J. S. H.] Maastricht Univ, Med Ctr, Dept Neurol, NL-6202 AZ Maastricht, Netherlands; [Peijnenborgh, J. C. A. W.; Aldenkamp, A. P.; Vles, J. S. H.] Maastricht Univ, Sch Mental Hlth & Neurosci, NL-6229 ER Maastricht, Netherlands; [Aldenkamp, A. P.] Univ Technol, Dept Elect Engn, NL-5600 MB Eindhoven, Netherlands		Hendriksen, JGM (corresponding author), Kempenhaeghe, Ctr Neurol Learning Disabil, POB 61, NL-5590 AB Heeze, Netherlands.	Hendriksenj@kempenhaeghe.nl; Peijnenborghj@kempenhaeghe.nl; Aldenkampb@kempenhaege.nl; Jsh.vles@mumc.nl					Bjorgaas HM, 2012, RES DEV DISABIL, V33, P1287, DOI 10.1016/j.ridd.2012.02.024; Ewen Joshua B, 2005, Semin Pediatr Neurol, V12, P229, DOI 10.1016/j.spen.2005.12.005; Garg S, 2013, DEV MED CHILD NEUROL, V55, P139, DOI 10.1111/dmcn.12043; Goldman LS, 1998, JAMA-J AM MED ASSOC, V279, P1100, DOI 10.1001/jama.279.14.1100; GRAHAM P, 1968, BRIT MED J, V3, P695, DOI 10.1136/bmj.3.5620.695; Johnson H, 2005, DEV MED CHILD NEUROL, V47, P237, DOI 10.1017/S0012162205000460; Lion-Francois L, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0142-4; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Pane M, 2012, J PEDIATR-US, V161, P705, DOI 10.1016/j.jpeds.2012.03.020; Polanczyk G., 2007, AM J PSYCHIAT; REISS S, 1982, AM J MENT DEF, V86, P567; Snow WM, 2013, NEUROSCI BIOBEHAV R, V37, P743, DOI 10.1016/j.neubiorev.2013.03.016; Spencer TJ, 2007, J PEDIATR PSYCHOL, V32, P631, DOI 10.1093/jpepsy/jsm005; Tramontana MG, 2014, BRAIN INJURY, V28, P1461, DOI 10.3109/02699052.2014.930179	14	17	17	0	16	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1090-3798	1532-2130		EUR J PAEDIATR NEURO	Eur. J. Paediatr. Neurol.	SEP	2015	19	5					521	524		10.1016/j.ejpn.2015.04.004			4	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	CQ7IU	WOS:000360777000004	25976065				2022-02-06	
J	Jones, D				Jones, Danielle			A family living with Alzheimer's disease: The communicative challenges	DEMENTIA-INTERNATIONAL JOURNAL OF SOCIAL RESEARCH AND PRACTICE			English	Article						Alzheimer's disease; conversation analysis; communication; interaction; collaborative	TRAUMATIC BRAIN-INJURY; FRONTOTEMPORAL DEMENTIA; SENILE-DEMENTIA; CONVERSATION; DISCOURSE; DISORDER; LANGUAGE; CARE; IMPAIRMENT; DECEPTION	Alzheimer's disease irrevocably challenges a person's capacity to communicate with others. Earlier research on these challenges focused on the language disorders associated with the condition and situated language deficit solely in the limitations of a person's cognitive and semantic impairments. This research falls short of gaining insight into the actual interactional experiences of a person with Alzheimer's and their family. Drawing on a UK data set of 70 telephone calls recorded over a two-and-a-half year period (2006-2008) between one elderly woman with Alzheimer's disease, and her daughter and son-in-law, this paper explores the role which communication (and its degeneration) plays in family relationships. Investigating these interactions, using a conversation analytic approach, reveals that there are clearly communicative difficulties, but closer inspection suggests that they arise due to the contingencies that are generated by the other's contributions in the interaction. That being so, this paper marks a departure from the traditional focus on language level analysis and the assumption that deficits are intrinsic to the individual with Alzheimer's, and instead focuses on the collaborative communicative challenges that arise in the interaction itself and which have a profound impact on people's lives and relationships.	Univ Bradford, Sch Hlth Studies, Bradford BD7 1DP, W Yorkshire, England		Jones, D (corresponding author), Univ Bradford, Sch Hlth Studies, Bradford BD7 1DP, W Yorkshire, England.	d.k.jones1@bradford.ac.uk		Jones, Danielle/0000-0002-2875-781X	Economic and Social Research Council 1 + 3 PhD Studentship	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The PhD research, from which this work originated, was supported by the Economic and Social Research Council 1 + 3 PhD Studentship.	Aggarwal N, 2003, J Psychiatr Ment Health Nurs, V10, P187; APPELL J, 1982, BRAIN LANG, V17, P73, DOI 10.1016/0093-934X(82)90006-2; Bayles K. A., 1985, AGING BRAIN COMMUNIC, P157; Bayles KA, 2003, J COMMUN DISORD, V36, P209, DOI 10.1016/S0021-9924(03)00020-0; BAYLES KA, 1983, BRAIN LANG, V19, P98, DOI 10.1016/0093-934X(83)90057-3; BINETTI G, 1995, J CLIN EXP NEUROPSYC, V17, P82, DOI 10.1080/13803399508406584; Blair M, 2007, J INT NEUROPSYCH SOC, V13, P237, DOI 10.1017/S1355617707070269; Body R, 2005, CLIN LINGUIST PHONET, V19, P379, DOI 10.1080/02699200400027189; Body R, 2007, APHASIOLOGY, V21, P394, DOI 10.1080/02687030600911450; BRAY JT, 1984, BIOL TRACE ELEM RES, V6, P1, DOI 10.1007/BF02918315; Campbell-Taylor I., 1984, THESIS U NEW YORK BU; Curl TS, 2008, RES LANG SOC INTERAC, V41, P129, DOI 10.1080/08351810802028613; Day AM, 2011, AGING MENT HEALTH, V15, P822, DOI 10.1080/13607863.2011.569489; Drew P, 2005, LEA COMMUN SER, P71; Drew P., 2013, HDB CONVERSATION ANA, P131, DOI DOI 10.1002/9781118325001.CH7; Elvish R, 2010, AGING MENT HEALTH, V14, P255, DOI 10.1080/13607861003587610; Freeman M, 2008, ROUT STUD HLTH SOC W, V2, P169; FROMM D, 1989, J SPEECH HEAR DISORD, V54, P535, DOI 10.1044/jshd.5404.535; Garcia LJ, 1997, BRAIN LANG, V58, P92, DOI 10.1006/brln.1997.1871; GARDNER H, 1974, SHATTERED MIND PERSO; GARWICK AW, 1994, FAM PROCESS, V33, P327, DOI 10.1111/j.1545-5300.1994.00327.x; Goodwin C., 2002, LANGUAGE TURN SEQUEN, P56; Goodwin C., 2003, CONVERSATION BRAIN D, P90; Guendouzi J. A., 2006, APPROACHES DISCOURSE; Hamilton H.E., 1994, CONVERSATIONS ALZHEI; Hamilton HE, 2008, ANNU REV APPL LINGUI, V28, P91, DOI 10.1017/S0267190508080069; Hasselkus BR, 1997, GERONTOLOGIST, V37, P640, DOI 10.1093/geront/37.5.640; Heritage J., 1984, STRUCTURES SOCIAL AC, P299, DOI DOI 10.1017/CB09780511665868; HERITAGE JC, 1995, RES LANG SOC INTERAC, V28, P1, DOI 10.1207/s15327973rlsi2801_1; HIER DB, 1985, BRAIN LANG, V25, P117, DOI 10.1016/0093-934X(85)90124-5; HUFF FJ, 1986, BRAIN LANG, V28, P235, DOI 10.1016/0093-934X(86)90103-3; Hutchinson J., 1980, LANGUAGE COMMUNICATI; James O., 2008, CONTENTED DEMENTIA 2; Jefferson G., 1983, TILBURG PAPERS LANGU, V34, P1; Jefferson G., 2004, CONVERSATION ANAL ST, P13, DOI [10.1075/pbns.125.02jef, DOI 10.1080/13613320902995475]; Jones D., 2006, THESIS U YORK UK; Jones D., 2012, THESIS U YORK YORK; Kennard C., 2009, CAREGIVER TIPS MANAG; LAWSON JS, 1968, BRIT J MED PSYCHOL, V41, P411, DOI 10.1111/j.2044-8341.1968.tb02050.x; LOCAL J, 1995, CLIN LINGUIST PHONET, V9, P155, DOI 10.3109/02699209508985330; MARTIN A, 1983, BRAIN LANG, V19, P124, DOI 10.1016/0093-934X(83)90059-7; Marzanski M, 2000, WESTERN J MED, V173, P318, DOI 10.1136/ewjm.173.5.318; Mates A., 2010, LANGUAGE INTERACTION; MENTIS M, 1995, J SPEECH HEAR RES, V38, P1054, DOI 10.1044/jshr.3805.1054; Mikesell L, 2010, DISCOURSE STUD, V12, P465, DOI 10.1177/1461445610370127; Mikesell L, 2009, RES LANG SOC INTERAC, V42, P135, DOI 10.1080/08351810902864552; Muller N, 2008, CLIN LINGUIST PHONET, V22, P767, DOI 10.1080/02699200801948488; Muller N, 2005, CLIN LINGUIST PHONET, V19, P393, DOI 10.1080/02699200400027213; Muller N, 2002, CLIN LINGUIST PHONET, V16, P345, DOI 10.1080/02699200210135875; Nebes R. D., 1985, THE AGING BRAIN, P109; Orange JB, 1996, J SPEECH HEAR RES, V39, P881, DOI 10.1044/jshr.3904.881; Perkins L, 1998, J NEUROLINGUIST, V11, P33, DOI 10.1016/S0911-6044(98)00004-9; POMERANTZ A, 1986, HUM STUD, V9, P219, DOI 10.1007/BF00148128; Psathas, 1979, EVERYDAY LANGUAGE ST, P97, DOI DOI 10.1111/J.1475-682X.1980.TB00024.X; RAMANATHANABBOTT V, 1994, LANG SOC, V23, P31, DOI 10.1017/S0047404500017668; RIPICH DN, 1991, BRAIN LANG, V40, P330, DOI 10.1016/0093-934X(91)90133-L; RIPICH DN, 1988, J SPEECH HEAR DISORD, V53, P8, DOI 10.1044/jshd.5301.08; RITCHIE K, 1992, J CLIN EPIDEMIOL, V45, P1391, DOI 10.1016/0895-4356(92)90201-W; Sabat S., 1991, EXPERIENCE ALZHEIMER; SABAT S, 1991, GEORGETOWN J LANGUAG, V2, P161; SCHELLENBERG GD, 1995, P NATL ACAD SCI USA, V92, P8552, DOI 10.1073/pnas.92.19.8552; Schermer M, 2007, BIOETHICS, V21, P13, DOI 10.1111/j.1467-8519.2007.00519.x; SHUTTLEWORTH EC, 1988, BRAIN LANG, V34, P222, DOI 10.1016/0093-934X(88)90134-4; Sidnell J., 2010, CONVERSATION ANAL IN; Small JA, 2005, J SPEECH LANG HEAR R, V48, P125, DOI 10.1044/1092-4388(2005/010); Spilkin M., 2003, ADV SPEECH LANGUAGE, V5, P105, DOI DOI 10.1080/14417040510001669131; Stivers T, 2011, MORALITY KNOWLEDGE C; Stribling P, 2009, CLIN LINGUIST PHONET, V23, P555, DOI 10.1080/02699200802491165; Tuckett AG, 2012, NURS ETHICS, V19, P7, DOI 10.1177/0969733011412104; Watson CM, 1999, APHASIOLOGY, V13, P195, DOI 10.1080/026870399402181; Wechsler D., 1981, WAIS R MANUAL; Wilensky A., 2000, PASSING FOR NORMAL; Wilkinson R, 1999, APHASIOLOGY, V13, P327, DOI 10.1080/026870399402127; Wilkinson R, 2010, RES LANG SOC INTERAC, V43, P57, DOI 10.1080/08351810903471506; Williams V., 2011, DISABILITY DISCOURSE; Wilson BT, 2007, CLIN LINGUIST PHONET, V21, P1001, DOI 10.1080/02699200701580175; Wood-Mitchell A., 2006, J DEMENTIA CARE, V14, P30; Wootton A. J, 1997, INTERACTION DEV MIND	78	17	17	1	19	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1471-3012	1741-2684		DEMENTIA-LONDON	Dement.-Int. J. soc. Res. Pract.	SEP	2015	14	5					555	573		10.1177/1471301213502213			19	Gerontology	Social Science Citation Index (SSCI)	Geriatrics & Gerontology	CS8LJ	WOS:000362338800001	24339113	Green Accepted			2022-02-06	
J	Yamal, JM; Rubin, ML; Benoit, JS; Tilley, BC; Gopinath, S; Hannay, HJ; Doshi, P; Aisiku, IP; Robertson, CS				Yamal, Jose-Miguel; Rubin, M. Laura; Benoit, Julia S.; Tilley, Barbara C.; Gopinath, Shankar; Hannay, H. Julia; Doshi, Pratik; Aisiku, Imoigele P.; Robertson, Claudia S.			Effect of Hemoglobin Transfusion Threshold on Cerebral Hemodynamics and Oxygenation	JOURNAL OF NEUROTRAUMA			English	Article						blood flow; clinical trial; intracranial pressure; prospective study; traumatic brain injury	TRAUMATIC BRAIN-INJURY; BLOOD-FLOW; CELL TRANSFUSION; HEMATOCRIT; INFORMATION; MODEL	Cerebral dysfunction caused by traumatic brain injury may adversely affect cerebral hemodynamics and oxygenation leading to worse outcomes if oxygen capacity is decreased due to anemia. In a randomized clinical trial of 200 patients comparing transfusion thresholds <7g/dl versus 10g/dl, where transfusion of leukoreduced packed red blood cells was used to maintain the assigned hemoglobin threshold, no long-term neurological difference was detected. The current study examines secondary outcome measures of intracranial pressure (ICP), cerebral perfusion pressure (CPP), and brain tissue oxygenation (PbtO(2)) in patients enrolled in this randomized clinical trial. We observed a lower hazard for death (hazard ratio [HR]=0.12, 95% confidence interval [CI]=0.02-0.99) during the first 3 days post-injury, and a higher hazard for death after three days (HR=2.55, 95% CI=1.00-6.53) in the 10g/dl threshold group as compared to the 7g/dL threshold group. No significant differences were observed for ICP and CPP but MAP was slightly lower in the 7g/dL group, although the decreased MAP did not result in increased hypotension. Overall brain tissue hypoxia events were not significantly different in the two transfusion threshold groups. When the PbtO(2) catheter was placed in normal brain, however, tissue hypoxia occurred in 25% of patients in the 7g/dL threshold group, compared to 10.2% of patients in the 10g/dL threshold group (p=0.04). Although we observed a few differences in hemodynamic outcomes between the transfusion threshold groups, none were of major clinical significance and did not affect long-term neurological outcome and mortality.	[Yamal, Jose-Miguel; Rubin, M. Laura; Tilley, Barbara C.] Univ Texas Houston, Sch Publ Hlth, Dept Biostat, Houston, TX 77005 USA; [Benoit, Julia S.] Univ Texas Houston, Coll Optometry, Dept Basic Vis Sci, Houston, TX 77005 USA; [Benoit, Julia S.] Univ Texas Houston, Texas Inst Measurement Evaluat & Stat, Houston, TX 77005 USA; [Gopinath, Shankar; Robertson, Claudia S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Hannay, H. Julia] Univ Texas Houston, Dept Psychol, Houston, TX 77005 USA; [Doshi, Pratik] Univ Texas Hlth Sci Ctr Houston, Dept Emergency Med & Internal Med, Houston, TX 77030 USA; [Aisiku, Imoigele P.] Brigham & Womens Hosp, Dept Emergency Med, Boston, MA 02115 USA		Yamal, JM (corresponding author), Univ Texas Houston, Sch Publ Hlth, Div Biostat, 1200 Pressler St,RAS W928, Houston, TX 77005 USA.	Jose-Miguel.Yamal@uth.tmc.edu		Hannay, H. Julia/0000-0001-7023-912X; Benoit, Julia/0000-0002-2734-5477	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01-NS38660]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM074902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS038660] Funding Source: NIH RePORTER	This study was supported by National Institute of Neurological Disorders and Stroke (grant #P01-NS38660).	BROWN MM, 1985, BRAIN, V108, P81, DOI 10.1093/brain/108.1.81; BROWN MM, 1985, LANCET, V1, P604; Cooper DJ, 2013, J NEUROTRAUM, V30, P512, DOI 10.1089/neu.2012.2573; Engelborghs K, 2000, J NEUROTRAUM, V17, P667, DOI 10.1089/089771500415418; Figaji AA, 2010, PEDIATR CRIT CARE ME, V11, P325, DOI 10.1097/PCC.0b013e3181b80a8e; HENRIKSEN L, 1981, ANN NEUROL, V9, P454, DOI 10.1002/ana.410090507; Johnston Andrew J, 2002, Curr Opin Crit Care, V8, P121, DOI 10.1097/00075198-200204000-00006; KUSUNOKI M, 1981, J CEREBR BLOOD F MET, V1, P413, DOI 10.1038/jcbfm.1981.45; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Pendem S, 2006, NEUROCRIT CARE, V4, P63, DOI 10.1385/NCC:4:1:063; Ponce LL, 2012, NEUROSURGERY, V70, P1492, DOI 10.1227/NEU.0b013e31824ce933; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Rubin D.B., 2004, MULTIPLE IMPUTATION; Smith MJ, 2005, CRIT CARE MED, V33, P1104, DOI 10.1097/01.CCM.0000162685.60609.49; Tango HK, 2009, J TRAUMA, V66, P720, DOI 10.1097/TA.0b013e3181719b35; THOMAS DJ, 1977, LANCET, V2, P161; Utter GH, 2011, J NEUROTRAUM, V28, P155, DOI 10.1089/neu.2010.1451; VORSTRUP S, 1992, J CEREBR BLOOD F MET, V12, P745, DOI 10.1038/jcbfm.1992.105; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	19	17	17	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2015	32	16					1239	1245		10.1089/neu.2014.3752			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CU9RU	WOS:000363883400008	25566694	Green Published			2022-02-06	
J	Beaulieu, CL; Dijkers, MP; Barrett, RS; Horn, SD; Giuffrida, CG; Timpson, ML; Carroll, DM; Smout, RJ; Hammond, FM				Beaulieu, Cynthia L.; Dijkers, Marcel. P.; Barrett, Ryan S.; Horn, Susan D.; Giuffrida, Clare G.; Timpson, Misti L.; Carroll, Deborah M.; Smout, Randy J.; Hammond, Flora M.			Occupational, Physical, and Speech Therapy Treatment Activities During Inpatient Rehabilitation for Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Occupational therapy; Physical therapy specialty; Rehabilitation; Speech therapy; Therapeutics	TREATMENT TIME; GALVESTON ORIENTATION; STROKE REHABILITATION; SCIREHAB; OUTCOMES; INTENSITY; DESIGN; KNEE	Objective: To describe the use of occupational therapy (OT), physical therapy (PT), and speech therapy (ST) treatment activities throughout the acute rehabilitation stay of patients with traumatic brain injury. Design: Multisite prospective observational cohort study. Setting: Inpatient rehabilitation settings. Participants: Patients (N=2130) admitted for initial acute rehabilitation after traumatic brain injury. Patients were categorized on the basis of admission FIM cognitive scores, resulting in 5 fairly homogeneous cognitive groups. Interventions: Not applicable. Main Outcome Measures: Percentage of patients engaged in specific activities and mean time patients engaged in these activities for each 10-hour block of time for OT, PT, and ST combined. Results: Therapy activities in OT, PT, and ST across all 5 cognitive groups had a primary focus on basic activities. Although advanced activities occurred in each discipline and within each cognitive group, these advanced activities occurred with fewer patients and usually only toward the end of the rehabilitation stay. Conclusions: The pattern of activities engaged in was both similar to and different from patterns seen in previous practice-based evidence studies with different rehabilitation diagnostic groups. (C) 2015 by the American Congress of Rehabilitation Medicine	[Beaulieu, Cynthia L.] Brooks Rehabil Hosp, Jacksonville, FL 32216 USA; [Dijkers, Marcel. P.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Barrett, Ryan S.; Horn, Susan D.; Smout, Randy J.] Inst Clin Outcomes Res, Salt Lake City, UT USA; [Giuffrida, Clare G.] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Timpson, Misti L.; Carroll, Deborah M.] Intermt Med Ctr, Salt Lake City, UT USA; [Timpson, Misti L.] Rocky Mt Univ Hlth Profess, Provo, UT USA; [Hammond, Flora M.] Carolinas Rehabil, Charlotte, NC USA; [Hammond, Flora M.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA		Beaulieu, CL (corresponding author), Brooks Rehabil Hosp, 3599 Univ Blvd South, Jacksonville, FL 32216 USA.	cynthia.beaulieu@brooksrehab.org			National Institutes of Health, National Center for Medical Rehabilitation ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01HD050439-01]; National Institute on Disability and Rehabilitation Research [H133A080023]; Ontario Neurotrauma Foundation [2007-ABI-ISIS-525]; American Congress of Rehabilitation Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD050439] Funding Source: NIH RePORTER	Supported by the National Institutes of Health, National Center for Medical Rehabilitation Research (grant no. 1R01HD050439-01), National Institute on Disability and Rehabilitation Research (grant no. H133A080023), and Ontario Neurotrauma Foundation (grant no. 2007-ABI-ISIS-525).; Publication of this article was supported by the American Congress of Rehabilitation Medicine	Bode RK, 2004, ARCH PHYS MED REHAB, V85, P1901, DOI 10.1016/j.apmr.2004.02.023; Brougham R, 2011, J SPINAL CORD MED, V34, P186, DOI 10.1179/107902611X12971826988174; Cifu DX, 2003, ARCH PHYS MED REHAB, V84, P1441, DOI 10.1016/S0003-9993(03)00272-7; DeJong G, 2011, PHYS THER, V91, P1826, DOI 10.2522/ptj.20100424; DeJong G, 2009, ARCH PHYS MED REHAB, V90, P1269, DOI 10.1016/j.apmr.2008.11.021; Dijkers MP, 2013, ARCH PHYS MED REHAB, V94, pS61, DOI 10.1016/j.apmr.2012.11.048; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Eng Janice J, 2007, Expert Rev Neurother, V7, P1417, DOI 10.1586/14737175.7.10.1417; Foy T, 2011, J SPINAL CORD MED, V34, P162, DOI 10.1179/107902611X12971826988093; Hatfield B, 2005, ARCH PHYS MED REHAB, V86, pS61, DOI 10.1016/j.apmr.2005.08.111; HEINEMANN AW, 1995, AM J PHYS MED REHAB, V74, P315, DOI 10.1097/00002060-199507000-00011; Horn SD, 2005, ARCH PHYS MED REHAB, V86, pS8, DOI 10.1016/j.apmr.2005.08.116; Horn SD, 2005, ARCH PHYS MED REHAB, V86, pS101, DOI 10.1016/j.apmr.2005.09.016; Horn SD, 2007, MED CARE, V45, pS50, DOI 10.1097/MLR.0b013e318070c07b; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS178, DOI 10.1016/j.apmr.2014.09.042; Horn SD, 2012, ARCH PHYS MED REHAB, V93, pS127, DOI 10.1016/j.apmr.2011.10.031; Horn SD, 2010, MED CARE, V48, pS17, DOI 10.1097/MLR.0b013e3181d57473; Karges J, 2009, J ALLIED HLTH, V38, P1; Latham NK, 2005, ARCH PHYS MED REHAB, V86, pS41, DOI 10.1016/j.apmr.2005.08.128; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Mallinson, 2011, RASCH MEAS T, V251, P1317; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; Richards LG, 2005, ARCH PHYS MED REHAB, V86, pS51, DOI 10.1016/j.apmr.2005.08.127; Taylor-Schroeder S, 2011, J SPINAL CORD MED, V34, P149, DOI 10.1179/107902611X12971826988057; The Moran Company, 2011, UT TRENDS INP REH UP; Whiteneck GG, 2013, ARCH PHYS MED REHAB, V94, pS67, DOI 10.1016/j.apmr.2012.12.022	26	17	18	0	34	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2015	96	8		3			S222	S234		10.1016/j.apmr.2014.10.028			13	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	CO3CV	WOS:000359035100005	26212399	Green Accepted, Bronze			2022-02-06	
J	Beier, M; Amtmann, D; Ehde, DM				Beier, Meghan; Amtmann, Dagmar; Ehde, Dawn M.			Beyond Depression: Predictors of Self-Reported Cognitive Function in Adults Living With MS	REHABILITATION PSYCHOLOGY			English	Article						multiple sclerosis; metacognition	TRAUMATIC BRAIN-INJURY; FATIGUE IMPACT SCALE; MULTIPLE-SCLEROSIS; NEUROPSYCHOLOGICAL PERFORMANCE; MEMORY COMPLAINTS; CANCER-PATIENTS; BREAST-CANCER; ITEM BANKS; DYSFUNCTION; IMPAIRMENT	Objective: To investigate the association between self-reported cognition and demographic/psychosocial variables in individuals with a self-reported diagnosis of multiple sclerosis (MS). Design: Secondary longitudinal analysis of mailed self-report surveys over a period of 2 years. Setting: Community. Participants: 407 community-dwelling individuals from the Pacific Northwest with a self-reported diagnosis of MS. Main Outcome Measures: Subjective general cognitive concerns and subjective executive difficulties as measured by the Neuro-QOL Applied Cognition-Executive Function-Short Form (SF) and the Applied Cognition-General Concerns-SF. Results: Univariate and multiple linear regression analyses were used to identify statistically significant longitudinal predictors of perceived cognitive difficulties 2 years later. Fatigue and anxiety were statistically significant predictors of general cognitive concerns. Fatigue and perceived stress were statistically significant predictors of perceived executive difficulties. Fatigue was the strongest predictor in both models. Conclusions: In MS, perceived cognitive impairment is frequently linked to depression without consideration of other possible contributors. This study suggests that in people with MS, fatigue is a stronger predictor of self-reported cognitive function 2 years later than depression.	[Beier, Meghan; Amtmann, Dagmar; Ehde, Dawn M.] Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98195 USA		Beier, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Phipps Room 178,600 North Wolfe St, Baltimore, MD 21287 USA.	mbeier1@jhu.edu	Ehde, Dawn/K-1883-2016	Ehde, Dawn/0000-0002-9555-2347	Department of Education, NIDRR [H133B031129, H133B080025]; National Institutes of Health through NIH Roadmap for Medical ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01AR52171]; National Multiple Sclerosis SocietyNational Multiple Sclerosis Society [MB 0008]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [U01AR052171] Funding Source: NIH RePORTER	This work was previously presented at the May 2013 Consortium of Multiple Sclerosis Centers (CMSC) and Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS), Orlando, FL. No party having a direct interest in the results of the research supporting this article has or will confer a benefit on the authors or on any organization with which they are associated. The contents of this article were developed under grants from the Department of Education, NIDRR grants H133B031129 and H133B080025. However, these contents do not necessarily represent the policy of the Department of Education, and you should not assume endorsement by the Federal Government. In addition, the work reported in this article was supported by a grant from the National Institutes of Health through the NIH Roadmap for Medical Research, Grant U01AR52171 to University of Washington, Amtmann (PI), and a grant from the National Multiple Sclerosis Society, Grant MB 0008, Ehde (PI). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akbar N, 2011, COGN BEHAV NEUROL, V24, P115, DOI 10.1097/WNN.0b013e31822a20ae; Amtmann D, 2010, PAIN, V150, P173, DOI 10.1016/j.pain.2010.04.025; Bamer AM, 2007, MULT SCLER J, V13, P1033, DOI 10.1177/1352458507077624; Becker Heather, 2012, Int J MS Care, V14, P71; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Benedict RHB, 2008, MULT SCLER J, V14, P940, DOI 10.1177/1352458508090923; Benedict RHB, 2006, J INT NEUROPSYCH SOC, V12, P549, DOI 10.1017/S1355617706060723; Benedict RHB, 2003, MULT SCLER J, V9, P95, DOI 10.1191/1352458503ms861oa; Benedict RHB, 2001, J NEUROPSYCH CLIN N, V13, P70, DOI 10.1176/appi.neuropsych.13.1.70; Bosma FK, 2002, NEUROPSY NEUROPSY BE, V15, P56; Bowen J, 2001, MULT SCLER, V7, P201, DOI 10.1191/135245801678438447; Bruce JM, 2010, ARCH CLIN NEUROPSYCH, V25, P39, DOI 10.1093/arclin/acp092; Buysse DJ, 2010, SLEEP, V33, P781, DOI 10.1093/sleep/33.6.781; Carone DA, 2005, J INT NEUROPSYCH SOC, V11, P574, DOI 10.1017/S135561770505068X; Cella D, 2011, ARCH PHYS MED REHAB, V92, pS28, DOI 10.1016/j.apmr.2011.01.025; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Christodoulou C, 2005, J INT NEUROPSYCH SOC, V11, P614, DOI 10.1017/S1355617705050733; COHEN S, 1988, CLAR SYMP, P31; DeLuca J, 1998, J CLIN EXP NEUROPSYC, V20, P376, DOI 10.1076/jcen.20.3.376.819; DELUCA J, 1994, J CLIN EXP NEUROPSYC, V16, P183, DOI 10.1080/01688639408402629; Dufouil C, 2005, J AM GERIATR SOC, V53, P616, DOI 10.1111/j.1532-5415.2005.53209.x; Ehde Dawn M, 2005, Phys Med Rehabil Clin N Am, V16, P437, DOI 10.1016/j.pmr.2005.01.010; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; Flachenecker P, 2002, MULT SCLER J, V8, P523, DOI 10.1191/1352458502ms839oa; Gass CS, 1997, J CLIN EXP NEUROPSYC, V19, P290, DOI 10.1080/01688639708403858; Gershon RC, 2012, QUAL LIFE RES, V21, P475, DOI 10.1007/s11136-011-9958-8; Hinkin CH, 1996, J CLIN EXP NEUROPSYC, V18, P431, DOI 10.1080/01688639608408999; Hutchinson AD, 2012, CANCER TREAT REV, V38, P926, DOI 10.1016/j.ctrv.2012.05.002; Jorm AF, 2001, PSYCHOL MED, V31, P441, DOI 10.1017/S0033291701003245; Julian L, 2007, MULT SCLER J, V13, P81, DOI 10.1177/1352458506070255; Kinsinger SW, 2010, NEUROPSYCHOLOGY, V24, P573, DOI 10.1037/a0019222; Knoop H, 2007, J NEUROL NEUROSUR PS, V78, P434, DOI 10.1136/jnnp.2006.100974; Kos D, 2005, MULT SCLER, V11, P76, DOI 10.1191/1352458505ms1117oa; Kraft GH, 2008, MULT SCLER J, V14, P1292, DOI 10.1177/1352458508093891; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Marrie RA, 2007, MULT SCLER, V13, P770, DOI 10.1177/1352458506075031; Metzger FA, 2002, ANN BEHAV MED, V24, P106, DOI 10.1207/S15324796ABM2402_07; Middleton LS, 2006, ARCH CLIN NEUROPSYCH, V21, P487, DOI 10.1016/j.acn.2006.06.008; Mills RJ, 2008, QJM-INT J MED, V101, P49, DOI 10.1093/qjmed/hcm122; Multiple Sclerosis Council for Clinical Practice Guidelines, 1998, FATIGUE AND MULTIPLE; National Institute of Neurological Disorders and Stroke (NINDS), 2010, USER MANUAL FOR THE, V1.0; Noonan VK, 2012, QUAL LIFE RES, V21, P1123, DOI 10.1007/s11136-011-0040-3; O'Brien A, 2007, ARCH CLIN NEUROPSYCH, V22, P933, DOI 10.1016/j.acn.2007.07.002; Olazaran J, 2009, EUR NEUROL, V61, P87, DOI 10.1159/000177940; Pilkonis PA, 2011, ASSESSMENT, V18, P263, DOI 10.1177/1073191111411667; Poppelreuter M, 2004, EUR J CANCER, V40, P43, DOI 10.1016/j.ejca.2003.08.001; PROMIS, DYNAMIC TOOLS TO MEA; Pullens MJJ, 2010, PSYCHO-ONCOLOGY, V19, P1127, DOI 10.1002/pon.1673; Randolph JJ, 2001, CLIN NEUROPSYCHOL, V15, P357, DOI 10.1076/clin.15.3.357.10278; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; Reisberg B, 2008, ALZHEIMERS DEMENT, V4, pS98, DOI 10.1016/j.jalz.2007.11.017; Roth RS, 2005, ARCH PHYS MED REHAB, V86, P1147, DOI 10.1016/j.apmr.2004.10.041; Russo AC, 2012, ARCH CLIN NEUROPSYCH, V27, P840, DOI 10.1093/arclin/acs090; Shin SY, 2013, ARTHRIT CARE RES, V65, P481, DOI 10.1002/acr.21814; Slavin MJ, 2010, AM J GERIAT PSYCHIAT, V18, P701, DOI 10.1097/JGP.0b013e3181df49fb; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Stewart A, 2008, PSYCHO-ONCOLOGY, V17, P122, DOI 10.1002/pon.1210; Stewart R, 2012, CURR OPIN PSYCHIATR, V25, P445, DOI 10.1097/YCO.0b013e3283586fd8; Suhr JA, 2003, J PSYCHOSOM RES, V55, P321, DOI 10.1016/S0022-3999(02)00628-1; Sullivan M, 1990, CAN J REHABIL, V4, P99; Tellez N, 2005, MULT SCLER J, V11, P198, DOI 10.1191/1352458505ms1148oa; Thornton AE, 2002, J INT NEUROPSYCH SOC, V8, P395, DOI 10.1017/S1355617702813200; van der Hiele K, 2012, EUR J NEUROL, V19, P562, DOI 10.1111/j.1468-1331.2011.03538.x; VICKREY BG, 1995, QUAL LIFE RES, V4, P187, DOI 10.1007/BF02260859; Warttig SL, 2013, J HEALTH PSYCHOL, V18, P1617, DOI 10.1177/1359105313508346; Weber MT, 2012, MENOPAUSE, V19, P735, DOI 10.1097/gme.0b013e318241fd22	66	17	17	0	7	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2015	60	3					254	262		10.1037/rep0000045			9	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	CR0UB	WOS:000361037600006	26192051	Green Accepted, Bronze			2022-02-06	
J	Hammond, FM; Barrett, R; Dijkers, MP; Zanca, JM; Horn, SD; Smout, RJ; Guerrier, T; Hauser, E; Dunning, MR				Hammond, Flora M.; Barrett, Ryan; Dijkers, Marcel. P.; Zanca, Jeanne M.; Horn, Susan D.; Smout, Randall J.; Guerrier, Tami; Hauser, Elizabeth; Dunning, Megan R.			Group Therapy Use and Its Impact on the Outcomes of Inpatient Rehabilitation After Traumatic Brain Injury: Data From Traumatic Brain Injury-Practice Based Evidence Project	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Health services; Health services research; Occupational therapy; Physical therapy specialty; Psychology; Recreation therapy; Rehabilitation; Speech therapy; Therapeutics	OCCUPATIONAL-THERAPY; PHYSIOTHERAPY	Objectives: To describe the amount and content of group therapies provided during inpatient rehabilitation for traumatic brain injury (TBI), and to assess the relations of group therapy with patient, injury, and treatment factors and outcomes. Design: Prospective observational cohort. Setting: Inpatient rehabilitation. Participants: Consecutive admissions (N=2130) for initial TBI rehabilitation at 10 inpatient rehabilitation facilities (9 in the United States, 1 in Canada) from October 2008 to September 2011. Interventions: Not applicable. Main Outcome Measures: Proportion of sessions that were group therapy (>= 2 patients were treated simultaneously by >= 1 clinician); proportion of patients receiving group therapy; type of activity performed and amount of time spent in group therapy, by discipline; rehabilitation length of stay; discharge location; and FIM cognitive and motor scores at discharge. Results: Of the patients, 79% received at least 1 session of group therapy, with group therapy accounting for 13.7% of all therapy sessions and 15.8% of therapy hours. On average, patients spent 2.9h/wk in group therapy. The greatest proportion of treatment time in group format was in therapeutic recreation (25.6%), followed by speech therapy (16.2%), occupational therapy (10.4%), psychology (8.1%), and physical therapy (7.9%). Group therapy time and type of treatment activities varied among admission FIM cognitive subgroups and treatment sites. Several factors appear to be predictive of receiving group therapy, with the treatment site being a major influence. However, group therapy as a whole offered little explanation of differences in the outcomes studied. Conclusions: Group therapy is commonly used in TBI rehabilitation, to varying degrees among disciplines, sites, and cognitive impairment subgroups. Various therapeutic activities take place in group therapy, indicating its perceived value in addressing many domains of functioning. Variation in outcomes is not explained well by overall percentage of therapy time delivered in groups. (C) 2015 by the American Congress of Rehabilitation Medicine	[Hammond, Flora M.; Guerrier, Tami; Hauser, Elizabeth] Carolinas Rehabil, Charlotte, NC USA; [Hammond, Flora M.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Barrett, Ryan; Horn, Susan D.; Smout, Randall J.] Inst Clin Outcomes Res, Salt Lake City, UT USA; [Dijkers, Marcel. P.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Zanca, Jeanne M.] Kessler Fdn, New York, NY USA; [Dunning, Megan R.] Rush Univ, Med Ctr, Chicago, IL 60612 USA		Hammond, FM (corresponding author), 4141 Shore Dr, Indianapolis, IN 46254 USA.	flora.hammond@rhin.com			National Institutes of Health, National Center for Medical Rehabilitation ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01HD050439-01]; National Institute on Disability and Rehabilitation Research [H133A080023]; Ontario Neurotrauma Foundation [2007-ABI-ISIS-525]; American Congress of Rehabilitation Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD050439] Funding Source: NIH RePORTER	Supported by the National Institutes of Health, National Center for Medical Rehabilitation Research (grant no. 1R01HD050439-01), National Institute on Disability and Rehabilitation Research (grant no. H133A080023), and Ontario Neurotrauma Foundation (grant no. 2007-ABI-ISIS-525).; Publication of this article was supported by the American Congress of Rehabilitation Medicine.	[Anonymous], 2012, INP REH THER SERV CO; Backhaus SL, 2010, ARCH PHYS MED REHAB, V91, P840, DOI 10.1016/j.apmr.2010.03.015; Corrigan JD, 2015, ARCH PHYS MED REHAB, V96, pS209, DOI 10.1016/j.apmr.2015.03.026; Coulter CL, 2009, ARCH PHYS MED REHAB, V90, P1727, DOI 10.1016/j.apmr.2009.04.019; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; De Weerdt W, 2001, AUST J PHYSIOTHER, V47, P53, DOI 10.1016/S0004-9514(14)60298-1; Dobrez DG, 2004, ARCH PHYS MED REHAB, V85, P1909, DOI 10.1016/j.apmr.2004.06.064; DUNCOMBE LW, 1995, AM J OCCUP THER, V49, P199, DOI 10.5014/ajot.49.3.199; Fuller PR, 2013, J PSYCHOSOC NURS MEN, V51, P22, DOI 10.3928/02793692-20130314-01; Gage B, 2007, LONG TERM CARE HOSP; GAUTHIER L, 1987, AM J OCCUP THER, V41, P360, DOI 10.5014/ajot.41.6.360; Heinemann Allen W, 1994, Top Stroke Rehabil, V1, P1; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS178, DOI 10.1016/j.apmr.2014.09.042; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS304, DOI 10.1016/j.apmr.2014.11.030; KURASIK S, 1967, J AM GERIATR SOC, V15, P852, DOI 10.1111/j.1532-5415.1967.tb02443.x; LUNDGREN CC, 1986, AM J OCCUP THER, V40, P397, DOI 10.5014/ajot.40.6.397; Oouchida Y, 2013, INT J PHYS MED REHAB, V1, P146, DOI [10.4172/2329-9096.1000146, DOI 10.4172/2329-9096.1000146]; TRAHEY PJ, 1991, AM J OCCUP THER, V45, P397, DOI 10.5014/ajot.45.5.397; van Langeveld SA, 2011, PHYS THER, V91, P210, DOI 10.2522/ptj.20090417; Vestri A, 2014, BRAIN INJURY, V28, P1102, DOI 10.3109/02699052.2014.910698; Zanca JM, 2013, ARCH PHYS MED REHAB, V94, pS145, DOI 10.1016/j.apmr.2012.11.049; Zanca JM, 2011, PHYS THER, V91, P1877, DOI 10.2522/ptj.20100392	22	17	17	1	20	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2015	96	8		3			S282	S292		10.1016/j.apmr.2014.11.029			11	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	CO3CV	WOS:000359035100010	26212404	Bronze, Green Accepted			2022-02-06	
J	Karagyaur, M; Dyikanov, D; Makarevich, P; Semina, E; Stambolsky, D; Plekhanova, O; Kalinina, N; Tkachuk, V				Karagyaur, M.; Dyikanov, D.; Makarevich, P.; Semina, E.; Stambolsky, D.; Plekhanova, O.; Kalinina, N.; Tkachuk, V.			Non-viral transfer of BDNF and uPA stimulates peripheral nerve regeneration	BIOMEDICINE & PHARMACOTHERAPY			English	Article						BDNF; Urokinase; Nerve regeneration	PLASMINOGEN-ACTIVATOR; SCIATIC-NERVE; NEUROTROPHIC FACTORS; INJURY; ANGIOGENESIS; SKELETAL; PROTECTS; MUSCLE	Peripheral nerves connect brain and spinal cord with the extremities and inner organs, and nerves injury can lead the disability and social exclusion. Growth factors and other natural stimulators of regeneration processes look very promising as future medicines. In our study, we tested the influence of genetic constructions that contain genes of brain-derived neurotrophic factor and urokinase plasminogen activator on nerve's structure and function after traumatic and ischemic injuries. Injection of pVax1-hBDNF and pVax1-muPA after traumatic injury led to better restoration of nerve's structure and function compared to similar parameters of control group mice. In ischemic injury model pVax1-hBDNF and pVax1-muPA slowed and reduced the damage progression and stimulated nerve regeneration as well. However, the treatment with pVax1-muPA was less effective after the traumatic injury. As we chose a non-viral method of gene delivery during our study the optimal conditions of plasmid intramuscular delivery were also determined. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Karagyaur, M.; Makarevich, P.; Semina, E.; Stambolsky, D.; Plekhanova, O.; Tkachuk, V.] Russian Cardiol Res & Prod Complex, Inst Expt Cardiol, Moscow 121552, Russia; [Dyikanov, D.; Kalinina, N.; Tkachuk, V.] Moscow MV Lomonosov State Univ, Fac Fundamental Med, Dept Biol & Med Chem, Moscow 119192, Russia		Kalinina, N (corresponding author), Moscow MV Lomonosov State Univ, Fac Fundamental Med, Dept Biol & Med Chem, Lomonosovsky Prospekt 31-5, Moscow 119192, Russia.	n_i_kalinina@mail.ru	Tkachuk, Vsevolod A/J-9357-2012; Stambolsky, Dmitry/A-8358-2014; Kalinina, Natalia I./L-6475-2013; Makarevich, Pavel/A-8157-2014; Semina, Ekaterina/AAB-4817-2020; Karagyaur, Maxim N/A-8385-2014; Semina, Ekaterina V/A-8184-2014; Plekhanova, Olga/B-9945-2014; Kalinina, Natalia/AAN-6763-2020	Stambolsky, Dmitry/0000-0001-6983-9697; Kalinina, Natalia I./0000-0003-3497-9619; Makarevich, Pavel/0000-0001-8869-5190; Semina, Ekaterina/0000-0002-3927-9286; Karagyaur, Maxim N/0000-0003-4289-3428; Plekhanova, Olga/0000-0002-4693-295X; Kalinina, Natalia/0000-0003-3497-9619; Tkachuk, Vsevolod/0000-0002-7492-747X	Russian Scientific Foundation (project RNF)Russian Science Foundation (RSF) [14-24-00086]; Russian Science FoundationRussian Science Foundation (RSF) [14-24-00086] Funding Source: Russian Science Foundation	This study was supported by Russian Scientific Foundation (project RNF No 14-24-00086).	Adams RA, 2004, MOL INTERV, V4, P163; Adams WE, 1943, J ANAT, V77, P243; Akassoglou K, 2000, J CELL BIOL, V149, P1157, DOI 10.1083/jcb.149.5.1157; Balezina O. P., 2004, Uspekhi Fiziologicheskikh Nauk, V35, P37; Balezina OP, 2005, B EXP BIOL MED+, V139, P4, DOI 10.1007/s10517-005-0196-3; Boyd JG, 2003, MOL NEUROBIOL, V27, P277, DOI 10.1385/MN:27:3:277; Burnett MG, 2004, NEUROSURG FOCUS, V16, pE1; CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0; Cho E, 2012, NEUROBIOL DIS, V46, P215, DOI 10.1016/j.nbd.2012.01.010; Jang HS, 2004, MOL THER, V9, P464, DOI 10.1016/j.ymthe.2003.12.002; Kadiyala RK, 2005, J BONE JOINT SURG BR, V87B, P337, DOI 10.1302/0301-620X.87B3.15694; Li ST, 2014, CNS NEUROSCI THER, V20, P154, DOI 10.1111/cns.12182; Lopatina T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017899; Makarevich P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038776; Seddon HJ, 1943, BRAIN, V66, P237, DOI 10.1093/brain/66.4.237; Siconolfi LB, 2001, J NEUROSCI, V21, P4336, DOI 10.1523/JNEUROSCI.21-12-04336.2001; Terenghi G, 1999, J ANAT, V194, P1, DOI 10.1046/j.1469-7580.1999.19410001.x; Tkachuk VA, 2009, CAN J PHYSIOL PHARM, V87, P231, DOI 10.1139/Y08-113; Traktuev DO, 2007, MOL THER, V15, P1939, DOI 10.1038/sj.mt.6300262; Vard'ya I V, 2000, Dokl Biol Sci, V371, P112; Wong KH, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1093/ecam/neq062; Zeder M, 2005, SOFTWARE FOR BIOL	22	17	24	0	9	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0753-3322	1950-6007		BIOMED PHARMACOTHER	Biomed. Pharmacother.	AUG	2015	74						63	70		10.1016/j.biopha.2015.07.002			8	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	CR2TD	WOS:000361182600009	26349964				2022-02-06	
J	Khajeh, L; Blijdorp, K; Heijenbrok-Kal, MH; Sneekes, EM; van den Berg-Emons, HJG; van der Lely, AJ; Dippel, DWJ; Neggers, SJCMM; Ribbers, GM; van Kooten, F				Khajeh, L.; Blijdorp, K.; Heijenbrok-Kal, M. H.; Sneekes, E. M.; van den Berg-Emons, H. J. G.; van der Lely, A. J.; Dippel, D. W. J.; Neggers, S. J. C. M. M.; Ribbers, G. M.; van Kooten, F.			Pituitary dysfunction after aneurysmal subarachnoid haemorrhage: course and clinical predictors the HIPS study	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; NEUROENDOCRINE DYSFUNCTION; HIGH-RISK; HYPOPITUITARISM; DIAGNOSIS; PREVALENCE; DEFICIENCY; SURVIVORS	Objective We describe the occurrence and course of anterior pituitary dysfunction (PD) after aneurysmal subarachnoid haemorrhage (SAH), and identify clinical determinants for PD in patients with recent SAH. Methods We prospectively collected demographic and clinical parameters of consecutive survivors of SAH and measured fasting state endocrine function at baseline, 6 and 14 months. We included dynamic tests for growth-hormone function. We used logistic regression analysis to compare demographic and clinical characteristics of patients with SAH with and without PD. Results 84 patients with a mean age of 55.8 (11.9) were included. Thirty-three patients (39%) had PD in one or more axes at baseline, 22(26%) after 6 months and 6 (7%) after 14 months. Gonadotropin deficiency in 29 (34%) patients and growth hormone deficiency (GHD) in 26 (31%) patients were the most common deficiencies. PD persisted until 14 months in 6 (8%) patients: GHD in 5(6%) patients and gonadotropin deficiency in 4 (5%). Occurrence of a SAH-related complication was associated with PD at baseline (OR 2.6, CI 2.2 to 3.0). Hydrocephalus was an independent predictor of PD 6 months after SAH (OR 3.3 CI 2.7 to 3.8). PD was associated with a lower score on health-related quality of life at baseline (p=0.06), but not at 6 and 14 months. Conclusions Almost 40% of SAH survivors have PD. In a small but substantial proportion of patients GHD or gonadotropin deficiency persists over time. Hydrocephalus is independently associated with PD 6 months after SAH.	[Khajeh, L.; Dippel, D. W. J.; van Kooten, F.] Erasmus MC, Univ Med Ctr Rotterdam, Dept Neurol, NL-3000 CA Rotterdam, Netherlands; [Blijdorp, K.; van der Lely, A. J.; Neggers, S. J. C. M. M.] Erasmus MC, Univ Med Ctr Rotterdam, Dept Med, Endocrinol Sect, NL-3000 CA Rotterdam, Netherlands; [Heijenbrok-Kal, M. H.; Sneekes, E. M.; van den Berg-Emons, H. J. G.; Ribbers, G. M.] Erasmus MC, Univ Med Ctr, Dept Rehabil, NL-3000 CA Rotterdam, Netherlands; [Heijenbrok-Kal, M. H.; Sneekes, E. M.; van den Berg-Emons, H. J. G.; Ribbers, G. M.] Rijndam Rehabil Ctr Rotterdam, Rotterdam, Netherlands		Khajeh, L (corresponding author), Erasmus MC, Univ Med Ctr, POB 2040, NL-3000 CA Rotterdam, Netherlands.	l.khajeh@erasmusmc.nl	Dippel, Diederik/AAJ-2192-2020; Ribbers, Gerard/N-3623-2019; Ribbers, Gerard M/C-1454-2014	Dippel, Diederik/0000-0002-9234-3515; Ribbers, Gerard M/0000-0002-6114-349X; Heijenbrok-Kal, Majanka H./0000-0002-2982-4404	PfizerPfizer; Dutch Brain Foundation	This study was financially supported by an unrestricted grant from Pfizer and by the Dutch Brain Foundation.	Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, HORM RES, V62, P26, DOI 10.1159/000080755; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; Berry E, 1998, BRIT J CLIN PSYCHOL, V37, P365, DOI 10.1111/j.2044-8260.1998.tb01392.x; Biller BMK, 2002, J CLIN ENDOCR METAB, V87, P2067, DOI 10.1210/jcem.87.5.8509; Blijdorp K, 2013, EUR J ENDOCRINOL, V169, P497, DOI 10.1530/EJE-13-0436; Brandt L, 2004, ACTA NEUROL SCAND, V109, P91, DOI 10.1046/j.0001-6314.2003.00189.x; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; Dutta P, 2012, NEUROL INDIA, V60, P390, DOI 10.4103/0028-3886.100729; Fu QL, 2012, ENDOCRINOLOGY, V153, P3224, DOI 10.1210/en.2012-1152; Gardner CJ, 2013, EUR J ENDOCRINOL, V168, P473, DOI 10.1530/EJE-12-0849; Gasco V, 2013, EUR J ENDOCRINOL, V168, P23, DOI 10.1530/EJE-12-0584; Ghigo E, 2008, GROWTH HORM IGF RES, V18, P1, DOI 10.1016/j.ghir.2007.07.004; Herschbach P, 2001, EUR J ENDOCRINOL, V145, P255, DOI 10.1530/eje.0.1450255; Hop JW, 1998, STROKE, V29, P798, DOI 10.1161/01.STR.29.4.798; Jovanovic V, 2010, HORM-INT J ENDOCRINO, V9, P235, DOI 10.14310/horm.2002.1273; Kioussi C, 1999, MECH DEVELOP, V81, P23, DOI 10.1016/S0925-4773(98)00229-9; Klose M, 2010, CLIN ENDOCRINOL, V73, P95, DOI 10.1111/j.1365-2265.2010.03791.x; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Kreitschmann-Andermahr I, 2003, J NEUROL NEUROSUR PS, V74, P1133, DOI 10.1136/jnnp.74.8.1133; Lammert A, 2011, EXP CLIN ENDOCR DIAB, V119, P111, DOI 10.1055/s-0030-1262815; Popovic V, 2013, J CLIN ENDOCR METAB, V98, P1789, DOI 10.1210/jc.2013-1099; Regal M, 2001, CLIN ENDOCRINOL, V55, P735, DOI 10.1046/j.1365-2265.2001.01406.x; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Srinivasan L, 2009, BRAIN INJURY, V23, P639, DOI 10.1080/02699050902970778; Tanriverdi F, 2007, CLIN ENDOCRINOL, V67, P931, DOI 10.1111/j.1365-2265.2007.02989.x; VANGIJN J, 1985, J NEUROSURG, V63, P355, DOI 10.3171/jns.1985.63.3.0355; Visser-Meily JMA, 2009, STROKE, V40, P1526, DOI 10.1161/STROKEAHA.108.531277	29	17	18	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	AUG	2015	86	8					905	910		10.1136/jnnp-2014-307897			6	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	CM7ON	WOS:000357884300014	25378238	Green Published, hybrid			2022-02-06	
J	Kostering, L; Schmidt, CSM; Egger, K; Amtage, F; Peter, J; Kloppel, S; Beume, LA; Hoeren, M; Weiller, C; Kaller, CP				Koestering, Lena; Schmidt, Charlotte S. M.; Egger, Karl; Amtage, Florian; Peter, Jessica; Kloeppel, Stefan; Beume, Lena-A.; Hoeren, Markus; Weiller, Cornelius; Kaller, Christoph P.			Assessment of planning performance in clinical samples: Reliability,and validity of the Tower of London task (TOL-F)	NEUROPSYCHOLOGIA			English	Article						Executive function; Neuropsychological tests; Psychometrics; Stroke; Parkinson disease; Mild cognitive impairment	MILD COGNITIVE IMPAIRMENT; QUALITY-OF-LIFE; EXECUTIVE FUNCTION DEFICITS; TRAUMATIC BRAIN-INJURY; PARKINSONS-DISEASE; FUNCTIONAL STATUS; OLDER-ADULTS; DYSEXECUTIVE SYNDROME; ALZHEIMERS-DISEASE; LOWER BOUNDS	Objective: Executive deficits are frequent sequelae of neurological and psychiatric disorders, but their adequate neuropsychological assessment is still a matter of contention, given that executive tasks draw on a multitude of cognitive processes that are often not sufficiently specified. In line with this, results on psychometric properties of the Tower of London, a task measuring planning ability as a prototypical executive function, are equivocal and furthermore lacking completely for adult clinical populations. Methods: We used a structurally balanced item set implemented in the Tower of London (Freiburg version, TOL-F) that accounts for major determinants of problem difficulty beyond the commonly used minimum number of moves to solution. Split-half reliability, internal consistency, and criterion-related concurrent validity of TOL-F accuracy were assessed in patients with stroke (N=60), Parkinson syndrome (N=51), and mild cognitive impairment (N=29), and healthy adults (N=155). Results: Across samples, mean split-half and lower-bound indices of reliability of accuracy scores were adequate (r >=.7) or higher. Compared to a subset of healthy controls matched for age, sex, and education levels, deficits in planning accuracy emerged for all three clinical samples. Conclusions: Based on consistently adequate reliability and a good criterion-related validity of accuracy scores, the TOL-F demonstrates its utility for testing planning ability in clinical samples and healthy adults. Using item sets systematically accounting for several determinants of task difficulty can thus significantly enhance the contended reliability of executive tasks and provide an opportunity to resolve the underspecification of cognitive processes contributing to executive functioning in health and disease. (C) 2015 Elsevier Ltd. All rights reserved.	[Koestering, Lena; Schmidt, Charlotte S. M.; Amtage, Florian; Kloeppel, Stefan; Beume, Lena-A.; Hoeren, Markus; Weiller, Cornelius; Kaller, Christoph P.] Univ Freiburg, Dept Neurol, Univ Med Ctr, D-79106 Freiburg, Germany; [Koestering, Lena; Schmidt, Charlotte S. M.; Egger, Karl; Amtage, Florian; Peter, Jessica; Kloeppel, Stefan; Beume, Lena-A.; Hoeren, Markus; Weiller, Cornelius; Kaller, Christoph P.] Univ Freiburg, Freiburg Brain Imaging, D-79106 Freiburg, Germany; [Koestering, Lena; Schmidt, Charlotte S. M.] Univ Freiburg, Dept Psychol, Biol & Personal Psychol, D-79106 Freiburg, Germany; [Koestering, Lena; Schmidt, Charlotte S. M.; Beume, Lena-A.; Hoeren, Markus; Weiller, Cornelius; Kaller, Christoph P.] Univ Freiburg, BrainLinks BrainTools Cluster Excellence, D-79106 Freiburg, Germany; [Egger, Karl] Univ Freiburg, Univ Med Ctr, Dept Neuroradiol, D-79106 Freiburg, Germany; [Peter, Jessica; Kloeppel, Stefan] Univ Freiburg, Univ Med Ctr, Dept Psychiat & Psychotherapy, D-79106 Freiburg, Germany		Kostering, L (corresponding author), Univ Freiburg, Dept Neurol, Univ Med Ctr, Breisacher Str 64, D-79106 Freiburg, Germany.	lena.koestering@uniklinik-freiburg.de		Peter, Jessica/0000-0002-0817-8431; Kloppel, Stefan/0000-0001-6452-9964; Kaller, Christoph/0000-0003-1206-889X; Schumacher, Lena/0000-0003-3785-9866	Brain-Links Brain-Tools Cluster of Excellence - German Research Foundation (DFG)German Research Foundation (DFG) [EXC 1086]; Wissenschaftliche Gesellschaft Freiburg im Breisgau; State Graduate Funding Program of Baden-Wurttemberg, Germany	This work was supported by the Brain-Links Brain-Tools Cluster of Excellence funded by the German Research Foundation (DFG; Grant no. EXC 1086) and the Wissenschaftliche Gesellschaft Freiburg im Breisgau. L.K. is supported by a PhD scholarship from the State Graduate Funding Program of Baden-Wurttemberg, Germany.	Andrews G, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01032; Bell-McGinty S, 2002, INT J GERIATR PSYCH, V17, P828, DOI 10.1002/gps.646; BENTLER PM, 1980, PSYCHOMETRIKA, V45, P249, DOI 10.1007/BF02294079; Berg WK, 2010, BRAIN COGNITION, V72, P472, DOI 10.1016/j.bandc.2010.01.002; Berg WK, 2002, J CLIN EXP NEUROPSYC, V24, P586, DOI 10.1076/jcen.24.5.586.1006; Biederman J, 2006, AM J PSYCHIAT, V163, P1730, DOI 10.1176/appi.ajp.163.10.1730; Bottari C, 2009, BRAIN INJURY, V23, P322, DOI 10.1080/02699050902788436; Brookes RL, 2014, NEUROPSYCHOLOGY, V28, P247, DOI 10.1037/neu0000015; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Burgess P., 1997, METHODOLOGY FRONTAL, P81; Carder HP, 2004, Q J EXP PSYCHOL-A, V57, P1459, DOI 10.1080/02724980343000864; Carlin D, 2000, NEUROPSYCHOLOGIA, V38, P655, DOI 10.1016/S0028-3932(99)00102-5; Cattie JE, 2012, J CLIN EXP NEUROPSYC, V34, P906, DOI 10.1080/13803395.2012.692772; CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037/0021-9010.78.1.98; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Culbertson WC, 2004, ASSESSMENT, V11, P27, DOI 10.1177/1073191103258590; Culbertson WC, 1998, ARCH CLIN NEUROPSYCH, V13, P285, DOI 10.1016/S0887-6177(97)00033-4; Culbertson WC, 1998, ASSESSMENT, V5, P215, DOI 10.1177/107319119800500302; Davis JC, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-16; de Paula JJ, 2012, PSYCHOL REP, V110, P477, DOI 10.2466/03.10.13.PR0.110.2.477-488; Debelak R., ASSESSMENT OF PLANNI; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dirnberger G, 2013, J NEUROPSYCHOL, V7, P193, DOI 10.1111/jnp.12028; Ettenhofer ML, 2012, MIL MED, V177, P1272, DOI 10.7205/MILMED-D-12-00095; European Federation of Psychologists' Association (EFPA), 2013, EFPA REV MOD DESCR E; Fay MP, 2010, R J, V2, P53; Fox J, 2011, AN R COMPANION TO AP; Franceschi M, 2007, DEMENT GERIATR COGN, V24, P424, DOI 10.1159/000109827; Godefroy O, 2010, ANN NEUROL, V68, P855, DOI 10.1002/ana.22117; GUTTMAN L, 1945, PSYCHOMETRIKA, V10, P255, DOI DOI 10.1007/BF02288892; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Humes GE, 1997, ASSESSMENT, V4, P249, DOI 10.1177/107319119700400305; JACKSON PH, 1977, PSYCHOMETRIKA, V42, P567, DOI 10.1007/BF02295979; Kafer K L, 1997, J Int Neuropsychol Soc, V3, P108; Kaller CP, 2014, BIOL PSYCHIAT, V76, P486, DOI 10.1016/j.biopsych.2014.03.012; Kaller CP, 2012, PSYCHOL ASSESSMENT, V24, P46, DOI 10.1037/a0025174; Kaller CP, 2011, BEHAV BRAIN RES, V216, P1, DOI 10.1016/j.bbr.2010.07.029; Kaller CP, 2004, COGNITIVE BRAIN RES, V20, P462, DOI 10.1016/j.cogbrainres.2004.04.002; Kostering L, 2014, DEV PSYCHOL, V50, P293, DOI 10.1037/a0032467; Kostering L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038855; Kostering L., 2014, J GERONTOL B; Marchegiani A, 2010, AGING MENT HEALTH, V14, P155, DOI 10.1080/13607860903228804; Masson JD, 2010, J INTELL DISABIL RES, V54, P457, DOI 10.1111/j.1365-2788.2010.01280.x; Mastering L., 2015, PSYCHOL ASSESS; McDonald M. P., 1999, TEST THEORY UNIFIED; McKinlay A, 2008, NEUROPSYCHOLOGIA, V46, P384, DOI 10.1016/j.neuropsychologia.2007.08.018; McKinlay A, 2009, APPL NEUROPSYCHOL, V16, P177, DOI 10.1080/09084280903098661; Miller M, 2012, J ABNORM CHILD PSYCH, V40, P657, DOI 10.1007/s10802-011-9599-y; Mitchell M, 2008, J CLIN EXP NEUROPSYC, V30, P683, DOI 10.1080/13803390701679893; Miyake Akira, 2000, Seminars in Speech and Language, V21, P169, DOI 10.1055/s-2000-7563; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Norman DA., 1986, CONSCIOUSNESS SELF R, P1, DOI [10.1007/978-1-4757-0629-1_1, DOI 10.1007/978-1-4757-0629-1_1]; Nys GMS, 2006, J NEUROL SCI, V247, P149, DOI 10.1016/j.jns.2006.04.005; Ownsworth T, 2008, DISABIL REHABIL, V30, P531, DOI 10.1080/09638280701355694; Perfetti B, 2010, PARKINSONISM RELAT D, V16, P46, DOI 10.1016/j.parkreldis.2009.07.011; Petersen RC, 2011, NEW ENGL J MED, V364, P2227, DOI 10.1056/NEJMcp0910237; Pfeiffer HCV, 2014, ACTA NEUROL SCAND, V129, P307, DOI 10.1111/ane.12189; R Core Team, 2014, LANG ENV STAT COMP; Rabbitt P., 1997, METHODOLOGY FRONTAL, P1; Rainville C, 2012, J CLIN EXP NEUROPSYC, V34, P306, DOI 10.1080/13803395.2011.639298; Revelle W., 2015, PSYCH PROCEDURES PSY, V1; Revelle W, 2009, PSYCHOMETRIKA, V74, P145, DOI 10.1007/s11336-008-9102-z; Rog LA, 2014, CLIN NEUROPSYCHOL, V28, P215, DOI 10.1080/13854046.2013.876101; Royall DR, 2004, J AM GERIATR SOC, V52, P346, DOI 10.1111/j.1532-5415.2004.52104.x; Sanchez-Benavides G, 2010, J INT NEUROPSYCH SOC, V16, P836, DOI 10.1017/S135561771000069X; Schnirman GM, 1998, ASSESSMENT, V5, P355, DOI 10.1177/107319119800500404; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Shum D, 2009, BRAIN IMPAIR, V10, P320, DOI 10.1375/brim.10.3.320; Sijtsma K, 2009, PSYCHOMETRIKA, V74, P107, DOI 10.1007/s11336-008-9101-0; Sireci S. G., 2013, APA HDB TESTING ASSE, V1, P61, DOI DOI 10.1037/14047-; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Sullivan JR, 2009, APPL NEUROPSYCHOL, V16, P62, DOI 10.1080/09084280802644243; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Tunstall J. R., 2014, J NEUROPSYCHOL; Unterrainer J. M., 2012, TOWER OF LONDON FREI; Ward G, 1997, Q J EXP PSYCHOL-A, V50, P49, DOI 10.1080/027249897392224; Zartman AL, 2013, ARCH CLIN NEUROPSYCH, V28, P307, DOI 10.1093/arclin/act014	78	17	18	0	29	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	AUG	2015	75						646	655		10.1016/j.neuropsychologia.2015.07.017			10	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	CQ4TE	WOS:000360596700061	26197091				2022-02-06	
J	Brazinova, A; Majdan, M; Leitgeb, J; Trimmel, H; Mauritz, W				Brazinova, Alexandra; Majdan, Marek; Leitgeb, Johannes; Trimmel, Helmut; Mauritz, Walter		Austrian Working Grp Improvement E	Factors that may improve outcomes of early traumatic brain injury care: prospective multicenter study in Austria	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Traumatic brain injury; Prehospital care; Early care; Emergency care; Comparative effectiveness research	HEAD-INJURY; CONTROLLED-TRIAL; MAJOR TRAUMA; MANAGEMENT; EPIDEMIOLOGY; IMPACT; RESUSCITATION; CAPNOGRAPHY; VENTILATION; POPULATION	Background: Existing evidence concerning the management of traumatic brain injury (TBI) patients underlines the importance of appropriate treatment strategies in both prehospital and early in-hospital care. The objectives of this study were to analyze the current state of early TBI care in Austria with its physician-based emergency medical service. Subsequently, identified areas for improvement were transformed into treatment recommendations. The proposed changes were implemented in participating emergency medical services and hospitals and evaluated for their effect. Methods: 14 Austrian centers treating TBI patients participated in the study. Between 2009 and 2012 all patients with Glasgow Coma Scale score < 13 and/or AIS head > 2 within 48 h after the accident, were enrolled. Data were collected in 2 phases: in the first phase data of 408 patients were analyzed. Based on this, a set of recommendations expected to improve outcomes was developed by the study group and implemented in participating centers. Recommendations included time factors (transport to appropriate trauma center, avoiding secondary transfer), adequate treatment strategies (prehospital fluid and airway management, anesthesia, ventilation), monitoring (pulse oximetry and blood pressure monitoring in all patients, capnography in ventilated patients) for prehospital treatment. In the emergency department focus was on first CT scan as soon as possible, short interval between CT scan and surgery and early use of thrombelastometry to optimize coagulation. Following implementation of these recommendations, data on 325 patients were collected and analyzed in phase 2. Final analysis investigated the impact of the recommendations on patient outcomes. Results: Patients in both data collection phases showed comparable demographic and injury severity characteristics. Treatment changes, especially in terms of fluid management, monitoring and normoventilation as well as thrombelastometry measurements were implemented successfully in phase 2, and led to significant improvement of patient outcomes. Hospital mortality was reduced from 31 % to 23 %. We found a lower rate of unfavorable outcomes, a significant increase in unexpected survivors and more patients with unexpected favorable outcomes as well. Conclusions: The results of this study clearly demonstrate that the outcomes of TBI patients can be improved with appropriate early care.	[Brazinova, Alexandra; Majdan, Marek; Mauritz, Walter] INRO, A-1080 Vienna, Austria; [Brazinova, Alexandra; Majdan, Marek] Trnava Univ, Fac Hlth Sci & Social Work, Dept Publ Hlth, Trnava, Slovakia; [Leitgeb, Johannes] Med Univ Vienna, Dept Traumatol, A-1090 Vienna, Austria; [Trimmel, Helmut] Wiener Neustadt Reg Hosp, Dept Anesthesiol Intens Care & Emergency Med, A-2700 Wiener Neustadt, Austria; [Mauritz, Walter] Trauma Hosp Lorenz Boehler, Dept Anesthesiol & Intens Care Med, A-1200 Vienna, Austria		Brazinova, A (corresponding author), INRO, Molker Gasse 4-3, A-1080 Vienna, Austria.	abrazinova@igeh.org	Brazinova, Alexandra/C-4265-2016; Majdan, Marek/K-5017-2012	Brazinova, Alexandra/0000-0003-0625-256X; Majdan, Marek/0000-0001-8037-742X	Austrian Ministry of Health; Austrian Worker's Compensation Board (AUVA) [FK 11/2008, FK 11/2010, FK 09/13]; Mrs. Ala Auersperg-Isham through Neurotrauma Foundation; Mr. Ralph Isham through Neurotrauma Foundation	The project was funded jointly by the Austrian Ministry of Health (Contract Oct. 15, 2008) and by the Austrian Worker's Compensation Board (AUVA; FK 11/2008 and FK 11/2010). Data analysis was supported by a grant from AUVA (FK 09/13). INRO is supported by an annual grant from Mrs. Ala Auersperg-Isham and Mr. Ralph Isham through Neurotrauma Foundation, and by small donations from various sources.	Ackery A, 2007, INJURY PREV, V13, P368, DOI 10.1136/ip.2007.017285; Auman KM, 2002, AM J PUBLIC HEALTH, V92, P1352, DOI 10.2105/AJPH.92.8.1352; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bowman SM, 2009, INJURY PREV, V15, P3, DOI 10.1136/ip.2008.019372; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; BULL JP, 1978, INJURY, V9, P184, DOI 10.1016/0020-1383(78)90004-9; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Edwards P, 2005, LANCET, V365, P1957; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Gabriel Edward J., 2002, Journal of Neurotrauma, V19, P111; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Helm M, 2003, BRIT J ANAESTH, V90, P327, DOI 10.1093/bja/aeg069; Jin PHPFK, 2008, J NEUROTRAUM, V25, P1003, DOI 10.1089/neu.2007.0463; Lier H, 2009, ANAESTHESIST, V58, P1010, DOI 10.1007/s00101-009-1595-z; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Majdan M, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0068-9; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P64, DOI 10.1007/s00508-006-0765-0; Schochl H, 2011, J NEUROTRAUM, V28, P2033, DOI 10.1089/neu.2010.1744; Schochl H, 2010, CRIT CARE, V14, DOI 10.1186/cc8948; Steudel WI, 2005, ACTA NEUROCHIR, V147, P231, DOI 10.1007/s00701-004-0441-y; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Tohme S, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-1; Warner KJ, 2009, J TRAUMA, V66, P26, DOI 10.1097/TA.0b013e3181957a25; Weninger P, 2007, J TRAUMA, V62, P584, DOI 10.1097/01.ta.0000221797.46249.ee; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; World Health Organization, 2004, WORLD REPORT ON ROAD	33	17	17	0	10	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	JUL 16	2015	23								53	10.1186/s13049-015-0133-z			11	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	CN4KV	WOS:000358399900001	26179747	gold, Green Published			2022-02-06	
J	Fitch, T; Villanueva, G; Quadir, MM; Sagiraju, HKR; Alamgir, H				Fitch, Taylor; Villanueva, Gabriela; Quadir, Mohammad M.; Sagiraju, Hari K. R.; Alamgir, Hasanat			The prevalence and risk factors of Post-Traumatic Stress Disorder among workers injured in Rana Plaza building collapse in Bangladesh	AMERICAN JOURNAL OF INDUSTRIAL MEDICINE			English	Article							PTSD; HEALTH; CHECKLIST; EPIDEMIOLOGY; BURDEN; TRAUMA	ObjectivesPrevalence and risk factors of PTSD among injured garment workers who survived a major factory collapse. MethodsSurvivors receiving treatment or rehabilitation care at one year post event were surveyed, which included Post Traumatic Stress Disorder Checklist Specific version. ResultsThe respondents consisted of 181 people with a mean age of 27.8 years and a majority had less than high school education (91.2%). Multivariable logistic regression found that the odds of having PTSD was higher among married (OR: 3.2 [95% CI: 1.3-8.0]), those who used to work more than 70hr/week (OR: 2.4 [1.1-5.3]), workers who used to hold higher job positions (OR: 2.6 [1.2-5.6]) or who had a concussion injury (OR: 3.7 [1.4-9.8]). Among the respondents, 83.4% remained unemployed, and only 57.3% (63 people) reported receiving a quarter or less of what they were promised as compensation. ConclusionsProbable PTSD was prevalent among surviving workers of the Rana Plaza building collapse in Bangladesh. Am. J. Ind. Med. 58:756-763, 2015. (c) 2015 Wiley Periodicals, Inc.	[Fitch, Taylor; Villanueva, Gabriela; Sagiraju, Hari K. R.; Alamgir, Hasanat] Univ Texas San Antonio, Sch Publ Hlth, San Antonio, TX 78229 USA; [Fitch, Taylor; Villanueva, Gabriela] Univ Texas Hlth Sci Ctr San Antonio, Sch Med, San Antonio, TX 78229 USA; [Quadir, Mohammad M.] CRP, Dhaka, Bangladesh		Alamgir, H (corresponding author), Univ Texas San Antonio, Sch Publ Hlth, San Antonio Campus,7411 John Smith Dr,Suite 1100, San Antonio, TX 78229 USA.	Abul.h.alamgir@uth.tmc.cedu	Alamgir, Hasanat/U-9354-2019	Quadir, Mohammad Morshedul/0000-0002-2627-4726; Sagiraju, Hari Krishna Raju/0000-0002-9719-9380; Fitch, Taylor/0000-0002-8396-8919	Deutsche Gesellschaft fuer Internationale Zusammenarbeit (GIZ)	Deutsche Gesellschaft fuer Internationale Zusammenarbeit (GIZ) for partially funding the research and also to Dr. Anisuzzaman from GIZ for reviewing the study survey questionnaires.	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081585; [Anonymous], 2013, SAF HLTH WORK HOP CH; [Anonymous], 2012, NY TIMES; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Brady KT, 2000, J CLIN PSYCHIAT, V61, P22; Cerda M, 2013, DEPRESS ANXIETY, V30, P413, DOI 10.1002/da.22007; Cloitre M, 2001, WOMEN HEALTH, V34, P1, DOI 10.1300/J013v34n03_01; DeAngelis T, 2008, APA MONITOR PSYCHOL, V39, P40; Devnath A, 2013, BLOOMBERG       1114; Forbes D, 2001, BEHAV RES THER, V39, P977, DOI 10.1016/S0005-7967(00)00084-X; Galea S, 2005, EPIDEMIOL REV, V27, P78, DOI 10.1093/epirev/mxi003; Hidalgo RB, 2000, J CLIN PSYCHIAT, V61, P5; Hoge CW, 2014, JAMA-J AM MED ASSOC, V312, P1685, DOI 10.1001/jama.2014.6670; Jason M., 2014, WASHINGTON POST; Jim Yardley, 2013, NY TIMES; Kessler RC, 2000, J CLIN PSYCHIAT, V61, P4; Lanius RA, 2006, J PSYCHIATR RES, V40, P709, DOI 10.1016/j.jpsychires.2005.07.007; Litz B, 2009, PTSD RES Q, V20; Maes M, 2001, J AFFECT DISORDERS, V63, P113, DOI 10.1016/S0165-0327(00)00173-7; Manguno-Mire G, 2007, J NERV MENT DIS, V195, P144, DOI 10.1097/01.nmd.0000254755.53549.69; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Pietrzak Robert H, 2009, J Spec Oper Med, V9, P67; Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231; Walker WC, 2014, J REHABIL RES DEV, V51, P1203, DOI 10.1682/JRRD.2013.12.0271; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	25	17	17	1	15	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0271-3586	1097-0274		AM J IND MED	Am. J. Ind. Med.	JUL	2015	58	7					756	763		10.1002/ajim.22471			8	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	CK1PM	WOS:000355979300006	25964138				2022-02-06	
J	Hwang, H; Jeong, HS; Oh, PS; Na, KS; Kwon, J; Kim, J; Lim, S; Sohn, MH; Jeong, HJ				Hwang, Hyosook; Jeong, Hwan-Seok; Oh, Phil-Sun; Na, Kyung-Suk; Kwon, JeongIl; Kim, Jeonghun; Lim, SeokTae; Sohn, Myung-Hee; Jeong, Hwan-Jeong			Improving Cerebral Blood Flow Through Liposomal Delivery of Angiogenic Peptides: Potential of F-18-FDG PET Imaging in Ischemic Stroke Treatment	JOURNAL OF NUCLEAR MEDICINE			English	Article						liposomes; angiogenic peptides; therapy; F-18-FDG PET imaging	TRAUMATIC BRAIN INJURY; GLUCOSE-UTILIZATION; NEUROPROTECTION; EXPRESSION	Strategies to promote angiogenesis can benefit cerebral ischemia. We determined whether liposomal delivery of angiogenic peptides with a known biologic activity of vascular endothelial growth factor benefitted cerebral ischemia. Also, the study examined the potential of F-18-FDG PET imaging in ischemic stroke treatment. Methods: Male Sprague Dawley rats (n = 40) underwent 40 min of middle cerebral artery occlusion. After 15 min of reperfusion, the rats (n = 10) received angiogenic peptides incorporated into liposomes. Animals receiving phosphate-buffered solution or liposomes without peptides served as controls. One week later, F-18-FDG PET imaging was performed to examine regional changes in glucose utilization in response to the angiogenic, therapy. The following day, Tc-99m-hexamethylpropyleneamine oxime autoradiography was performed to determine changes in cerebral perfusion after angiogenic therapy. Corresponding changes in angiogenic markers, including von Willebrand factor and angiopoietin-1 and -2, were determined by immunostaining and polymerase chain reaction analysis, respectively. Results: A 40-min period of middle cerebral artery occlusion decreased blood perfusion in the ipsilateral ischemic cortex of the brain, compared with that in the contralateral cortex, as measured by Tc-99m-hexamethylpropyleneamine oxime autoradiography. Liposomal delivery of angiogenic peptides to the ischemic hemisphere of the brain attenuated the cerebral perfusion defect compared with controls. Similarly, vascular density evidenced by von Willebrand factor positive staining was increased in response to angiogenic therapy, compared with that of controls. This increase was accompanied by an early increase in angiopoietin-2 expression, a gene participating in angiogenesis. F-18-FDG PET imaging measured at 7 d after treatment revealed that liposomal delivery of angiogenic peptides facilitated glucose utilization in the ipsilateral ischemic cortex of the brain, compared with that in the controls. Furthermore, the change in regional glucose utilization was correlated with the extent of improvement in cerebral perfusion (r = 0.742, P = 0.035). Conclusion: Liposomal delivery of angiogenic peptides benefits cerebral ischemia. F-18-FDG PET imaging holds promise as an indicator of the effectiveness of angiogenic therapy in cerebral ischemia.	[Hwang, Hyosook; Jeong, Hwan-Seok; Oh, Phil-Sun; Na, Kyung-Suk; Kwon, JeongIl; Kim, Jeonghun; Lim, SeokTae; Sohn, Myung-Hee; Jeong, Hwan-Jeong] Chonbuk Natl Univ, Mol Imaging & Therapeut Med Res Ctr, Med Sch & Hosp, Cyclotron Res Ctr,Inst Med Sci,Biomed Res Inst,De, Jeonju 561756, Jeonbuk, South Korea		Jeong, HJ (corresponding author), Chonbuk Natl Univ, Med Sch & Hosp, Mol Imaging & Therapeut Med Res Ctr, Jeonbuk Reg Cyclotron Res Ctr, 634-18 GeumAm Dong, Jeonju Si, Jeollabuk Do, South Korea.	jayjeong@jbnu.ac.kr			Radiation Technology RD program [2012M2A2A7035779]; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science ICT and Future Planning [2014R1A1A2008959]	The costs of publication of this article were defrayed in part by the payment of page charges. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 USC section 1734. This research was funded by Radiation Technology R&D program 2012M2A2A7035779 and Basic Science Research Program 2014R1A1A2008959 through the National Research Foundation of Korea grant funded by the Ministry of Science ICT and Future Planning. No other potential conflict of interest relevant to this article was reported.	ALLEN CMC, 1984, J NEUROL NEUROSUR PS, V47, P475, DOI 10.1136/jnnp.47.5.475; BARON JC, 1984, J CEREBR BLOOD F MET, V4, P140, DOI 10.1038/jcbfm.1984.22; Beck H, 2000, AM J PATHOL, V157, P1473, DOI 10.1016/S0002-9440(10)64786-4; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Boche D, 2003, J CEREBR BLOOD F MET, V23, P1174, DOI 10.1097/01.WCB.0000090080.64176.44; Bunevicius A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/634598; Finetti F, 2012, BIOCHEM PHARMACOL, V84, P303, DOI 10.1016/j.bcp.2012.04.011; GINSBERG MD, 1977, NEUROLOGY, V27, P1042, DOI 10.1212/WNL.27.11.1042; Giordano RJ, 2010, P NATL ACAD SCI USA, V107, P5112, DOI 10.1073/pnas.0915141107; Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P166, DOI 10.1097/00004647-200302000-00004; Hwang H, 2014, RADIOLOGY, V273, P160, DOI 10.1148/radiol.14132942; Garcia-Aranda MI, 2011, BIOORGAN MED CHEM, V19, P7526, DOI 10.1016/j.bmc.2011.10.032; Ishii T, 2013, FASEB J, V27, P1362, DOI 10.1096/fj.12-221325; KRUPINSKI J, 1994, STROKE, V25, P1794, DOI 10.1161/01.STR.25.9.1794; Lee TK, 2014, NUCL MED MOLEC IMAG, V48, P225, DOI 10.1007/s13139-014-0273-5; Liu Shimin, 2011, J Exp Stroke Transl Med, V4, P16; Marklund N, 2002, J NEUROTRAUM, V19, P1139, DOI 10.1089/08977150260337958; PASCHEN W, 1992, EXP NEUROL, V117, P325, DOI 10.1016/0014-4886(92)90142-D; Schmidt R, 2000, J NEUROL, V247, P81, DOI 10.1007/s004150050021; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Szpak GM, 1999, FOLIA NEUROPATHOL, V37, P264; Trendelenburg G, 2005, GLIA, V50, P307, DOI 10.1002/glia.20204; WISE RJS, 1983, ANN NEUROL, V14, P627, DOI 10.1002/ana.410140605	23	17	17	0	12	SOC NUCLEAR MEDICINE INC	RESTON	1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA	0161-5505	1535-5667		J NUCL MED	J. Nucl. Med.	JUL	2015	56	7					1106	1111		10.2967/jnumed.115.154443			6	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	CM5UN	WOS:000357754600045	25977466	Bronze			2022-02-06	
J	Li, YM; Gu, JW; Zhou, JH; Xia, X; Wang, KY; Zheng, XS; Kuang, YQ; Zhang, XY; Ou, S; He, C; Zhu, H; Qiu, J				Li, Yunming; Gu, Jianwen; Zhou, Jihong; Xia, Xun; Wang, Kuiying; Zheng, Xiushan; Kuang, Yongqin; Zhang, Xinyan; Ou, Shan; He, Ci; Zhu, Hui; Qiu, Jun			The epidemiology of traumatic brain injury in civilian inpatients of Chinese Military Hospitals, 2001-2007	BRAIN INJURY			English	Article						China; epidemiology; inpatient; military hospital; traumatic brain injury	UNITED-STATES; CARE	Primary objective: To investigate the epidemiology of TBI in Chinese inpatients. Research design: Civilian inpatients of Chinese military hospitals diagnosed with TBI between 2001-2007 were identified using ICD-9-CM codes. Methods and procedures: Demographic characteristics, admission time, injury cause, injury severity, length of stay and outcomes were compared between ICD-9-CM diagnosis groups. Main outcomes and results: In total, 203 553 civilian patients with TBI (74.86% male, 25.14% female) were identified from >200 Chinese military hospitals. TBI diagnoses increased by a mean of 4.67% each year. Admission peaked during the third quarter of the year and October annually. The leading causes of TBI were motor vehicle-traffic (51.41%), falls (21.49%) and assaults (15.77%). TBI was categorized by abbreviated injury scale score as mild in 36.64%, serious in 20.13%, severe in 26.81% and critical in 15.68% of inpatients. The mean length of stay was 17.8 +/- 24.1 days. Recovery rate was 93.06% and mortality was 4.14%. Conclusions: The epidemiological data may contribute to the development of effective, targeted strategies to prevent TBI.	[Li, Yunming; Gu, Jianwen; Xia, Xun; Wang, Kuiying; Zheng, Xiushan; Kuang, Yongqin; Zhang, Xinyan; Ou, Shan; He, Ci; Zhu, Hui] Chengdu Mil Gen Hosp Peoples Liberat Army, Dept Neurosurg, Chengdu 610000, Sichuan, Peoples R China; [Zhou, Jihong; Qiu, Jun] Third Mil Med Univ, Daping Hosp, State Key Lab Trauma Burns & Combined Injury, Inst Surg Res, Chongqing, Peoples R China		Gu, JW (corresponding author), Chengdu Mil Gen Hosp Peoples Liberat Army, Dept Neurosurg, Chengdu 610000, Sichuan, Peoples R China.	gu031702556@126.com		Li, Yunming/0000-0001-6363-4869	53 China postdoctoral science foundation projects [2013M532123]; Chengdu Military Command General Hospital [2013YG-B021]	The authors report no conflicts of interest. This work was supported by the 53 China postdoctoral science foundation projects (No. 2013M532123) and the Chengdu Military Command General Hospital first funded research talents (No. 2013YG-B021).	Aghakhani N, 2013, IRAN RED CRESCENT ME, V15, P173, DOI 10.5812/ircmj.2090; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Carroll Christopher P, 2010, Ann Adv Automot Med, V54, P233; Chen AY, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-16; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Faul M, 2010, TRAUMATIC BRAIN INJU; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Orlando Alessandro, 2013, J Clin Med Res, V5, P168, DOI 10.4021/jocmr1333w; Shao JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051634; Sun ZG, 1997, HOSP ADM J CHINESE P, V4, P373; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; WANG CC, 1986, ARCH NEUROL-CHICAGO, V43, P570, DOI 10.1001/archneur.1986.00520060034013; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Yang YC, 1987, CHINESE J NEUROSURGE, V3, P23; Yao Y, 2011, BURNS, V37, P1023, DOI 10.1016/j.burns.2011.03.021; Zhang YH, 2007, INT J MED INFORM, V76, P614, DOI 10.1016/j.ijmedinf.2006.05.003; Zhao YD, 2001, WORLD J SURG, V25, P1202	23	17	22	1	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2015	29	7-8					981	988		10.3109/02699052.2014.989405			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CO0BJ	WOS:000358814800026	25915805				2022-02-06	
J	Nemes, O; Kovacs, N; Czeiter, E; Kenyeres, P; Tarjanyi, Z; Bajnok, L; Buki, A; Doczi, T; Mezosi, E				Nemes, Orsolya; Kovacs, Noemi; Czeiter, Endre; Kenyeres, Peter; Tarjanyi, Zita; Bajnok, Laszlo; Buki, Andras; Doczi, Tamas; Mezosi, Emese			Predictors of post-traumatic pituitary failure during long-term follow-up	HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM			English	Article						Traumatic brain injury; Hypopituitarism; GCS; Growth hormone deficiency	TRAUMATIC BRAIN-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; GROWTH-HORMONE DEFICIENCY; ANTIPITUITARY ANTIBODIES; NATURAL-HISTORY; HIGH-RISK; HYPOPITUITARISM; DYSFUNCTION; PREVALENCE; ADULTS	OBJECTIVE: There is increasing awareness among physicians of the risks of traumatic brain injury (TBI)-induced hypopituitarism. We have assessed the prevalence and risk factors of post-traumatic hypopituitarism by analyzing the TBI database of the University of Pecs. DESIGN: This consecutive analysis of 126 TBI survivors (mean age: 42.4 years, average follow-up time: 48 months) revealed that 60.3% had severe and 39.7% moderately severe trauma based on GCS score. Subdural hemorrhage (29.3%) and diffuse injury (27%) were the most common types of injury; 17.5% of patients suffered basal skull fractures. RESULTS: The prevalence of major anterior pituitary failure was 57.1%. Occurrence of total and partial growth hormone deficiency (GHD/GHI) was 39.7%, while LH/FSH, TSH and ACTH deficiencies were less frequent, namely 23.0%, 16.7% and 10.3%, respectively. Of the 82 patients with multiple endocrine evaluations, 31.7% presented significant changes in hormonal deficiencies during the follow-up period: new hormone deficiencies developed in 16 patients, while hormonal disturbances resolved in 10 subjects. Looking for factors influencing the prevalence of pituitary dysfunction, endocrine results were analyzed in relation to age, gender, GCS scores, injury types, basal skull fracture, ventricular drain insertion and necessity of neurosurgical intervention. All hormonal disturbances were more prevalent after severe trauma (OR: 3.25, p=0.002), while the need for surgery proved to be an independent determinant of multiple and GH deficits (OR: 3.72 (p=0.004) and 9.33 (p=0.001)). CONCLUSION: Post-traumatic hypopituitarism is common and may evolve or resolve over time. Victims of severe TBI and/or patients who have undergone neurosurgical intervention for head injury are the most prone to post-traumatic hypopituitarism.	[Nemes, Orsolya; Kenyeres, Peter; Tarjanyi, Zita; Bajnok, Laszlo; Mezosi, Emese] Univ Pecs, Dept Internal Med 1, H-7624 Pecs, Hungary; [Kovacs, Noemi; Czeiter, Endre; Buki, Andras; Doczi, Tamas] Univ Pecs, Dept Neurosurg, H-7624 Pecs, Hungary		Mezosi, E (corresponding author), Univ Pecs, Dept Internal Med 1, 13 Ifjusag, H-7624 Pecs, Hungary.	emese.mezosi@aok.pte.hu	Schernhammer, Eva S/L-7898-2018; Czeiter, Endre/B-1404-2009	Schernhammer, Eva S/0000-0002-4337-9415; Czeiter, Endre/0000-0002-9578-6944			Agha A, 2005, AM J PHYS MED REHAB, V84, P381, DOI 10.1097/01.PHM.0000156898.47097.93; Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, GROWTH HORM IGF RES, V14, pS114, DOI 10.1016/j.ghir.2004.03.025; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Blair JC, 2010, BRIT J NEUROSURG, V24, P10, DOI 10.3109/02688690903536637; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; DANIEL PM, 1959, LANCET, V2, P927; Ghigo E, 2008, GROWTH HORM IGF RES, V18, P1, DOI 10.1016/j.ghir.2007.07.004; Glynn N, 2013, CLIN ENDOCRINOL, V78, P17, DOI 10.1111/cen.12010; Herrmann BL, 2006, EXP CLIN ENDOCR DIAB, V114, P316, DOI 10.1055/s-2006-924254; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; KORNBLUM RN, 1969, ARCH PATHOL, V88, P242; Krahulik D, 2010, J NEUROSURG, V113, P581, DOI 10.3171/2009.10.JNS09930; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Murray RD, 2004, J CLIN ENDOCR METAB, V89, P1586, DOI 10.1210/jc.2003-030761; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Schneider HJ, 2007, J ENDOCRINOL INVEST, V30, pRC9, DOI 10.1007/BF03346291; Schneider HJ, 2011, J NEUROTRAUM, V28, P1693, DOI 10.1089/neu.2011.1887; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Schneider M, 2008, CLIN ENDOCRINOL, V68, P206, DOI 10.1111/j.1365-2265.2007.03020.x; Secco A, 2009, J CLIN ENDOCR METAB, V94, P4195, DOI 10.1210/jc.2009-0602; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tanriverdi F, 2011, J ENDOCRINOL INVEST, V34, P541, DOI 10.3275/7805; Tanriverdi F, 2008, J NEUROTRAUM, V25, P1071; Tanriverdi F, 2008, EUR J ENDOCRINOL, V159, P7, DOI 10.1530/EJE-08-0050; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Tanriverdi F, 2010, EUR J ENDOCRINOL, V162, P861, DOI 10.1530/EJE-09-1024; Ulfarsson T, 2013, J NEUROTRAUM, V30, P271, DOI 10.1089/neu.2012.2494; Van Baalen B, 2003, DISABIL REHABIL, V25, P9, DOI 10.1080/713813430	38	17	18	0	6	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	1109-3099	2520-8721		HORM-INT J ENDOCRINO	Horm.-Int. J. Endocrinol. Metab.	JUL-SEP	2015	14	3					383	391		10.14310/horm.2002.1564			9	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	CW6FG	WOS:000365092400006	25553764	Green Accepted, Bronze			2022-02-06	
J	Watts, LT; Shen, Q; Deng, SW; Chemello, J; Duong, TQ				Watts, Lora Talley; Shen, Qiang; Deng, Shengwen; Chemello, Jonathan; Duong, Timothy Q.			Manganese-Enhanced Magnetic Resonance Imaging of Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						calcium activity; controlled cortical impact; cortical spreading depolarization; gliosis; MEMRI; TBI	REACTIVE GLIOSIS; MRI; CALCIUM; ACTIVATION; VISUALIZATION; CONNECTIVITY; PERFUSION; MICE	Calcium dysfunction is involved in secondary traumatic brain injury (TBI). Manganese-enhanced MRI (MEMRI), in which the manganese ion acts as a calcium analog and a MRI contrast agent, was used to study rats subjected to a controlled cortical impact. Comparisons were made with conventional T2 MRI, sensorimotor behavior, and immunohistology. The major findings were: (1) Low-dose manganese (29mg/kg) yielded excellent contrast with no negative effects on behavior scores relative to vehicle; (2) T1-weighted MEMRI was hyperintense in the impact area at 1-3h, hypointense on day 2, and markedly hypointense with a hyperintense area surrounding the core on days 7 and/or 14, in contrast to the vehicle group, which did not show a biphasic profile; (3) in the hyperacute phase, the area of hyperintense T1-weighted MEMRI was larger than that of T2 MRI; (4) glial fibrillary acidic protein staining revealed that the MEMRI signal void in the impact core and the hyperintense area surrounding the core on day 7 and/or 14 corresponded to tissue cavitation and reactive gliosis, respectively; (5) T2 MRI showed little contrast in the impact core at 2h, hyperintense on day 2 (indicative of vasogenic edema), hyperintense in some animals but pseudonormalized in others on day 7 and/or 14; (6) behavioral deficit peaked on day 2. We concluded that MEMRI detected early excitotoxic injury in the hyperacute phase, preceding vasogenic edema. In the subacute phase, MEMRI detected contrast consistent with tissue cavitation and reactive gliosis. MEMRI offers novel contrasts of biological processes that complement conventional MRI in TBI.	[Watts, Lora Talley; Shen, Qiang; Deng, Shengwen; Chemello, Jonathan; Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, San Antonio, TX 78229 USA; [Watts, Lora Talley] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Watts, Lora Talley] Univ Texas Hlth Sci Ctr San Antonio, Dept Neurol, San Antonio, TX 78229 USA; [Shen, Qiang; Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Ophthalmol, San Antonio, TX 78229 USA; [Duong, Timothy Q.] South Texas Vet Hlth Care Syst, San Antonio, TX USA		Duong, TQ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, 8403 Floyd Curl Dr, San Antonio, TX 78229 USA.	duongt@uthscsa.edu	Shen, Qiang/B-8784-2008; Duong, Tim/AAL-8357-2021	Shen, Qiang/0000-0002-4287-3403; Duong, Tim/0000-0001-6403-2827	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001120, KL2TR001118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045879] Funding Source: NIH RePORTER; NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR001120, KL2 TR001118] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS045879] Funding Source: Medline		Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bouilleret V, 2009, J NEUROTRAUM, V26, P1999, DOI 10.1089/neu.2009.0943; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; De La Garza BH, 2012, INVEST OPHTH VIS SCI, V53, P4352, DOI 10.1167/iovs.11-8826; Du S, 1999, EXP NEUROL, V157, P96, DOI 10.1006/exnr.1999.7041; Duong TQ, 2000, MAGN RESON MED, V43, P383, DOI 10.1002/(SICI)1522-2594(200003)43:3<383::AID-MRM10>3.0.CO;2-Q; Fitch MT, 1997, CELL TISSUE RES, V290, P379, DOI 10.1007/s004410050944; Henning EC, 2005, MAGN RESON MED, V53, P851, DOI 10.1002/mrm.20438; Kawai Y, 2010, NEUROIMAGE, V49, P3122, DOI 10.1016/j.neuroimage.2009.11.005; Kivity S, 2010, ANN NY ACAD SCI, V1193, P70, DOI 10.1111/j.1749-6632.2009.05302.x; Li W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114173; Lin YJ, 1997, MAGN RESON MED, V38, P378, DOI 10.1002/mrm.1910380305; Long J. A., 2014, J NEUROTRAUMA; McGraw J, 2001, J NEUROSCI RES, V63, P109, DOI 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J; Meng XJ, 2004, ANN NEUROL, V55, P207, DOI 10.1002/ana.10803; Obenaus A, 2007, J NEUROTRAUM, V24, P1147, DOI 10.1089/neu.2006.0211; Pautler RG, 2002, NEUROIMAGE, V16, P441, DOI 10.1006/nimg.2002.1075; Shen Q, 2005, J CEREBR BLOOD F MET, V25, P1265, DOI 10.1038/sj.jcbfm.9600132; Shen Q, 2003, J CEREBR BLOOD F MET, V23, P1479, DOI 10.1097/01.WCB.0000100064.36077.03; Silva AC, 2004, NMR BIOMED, V17, P532, DOI 10.1002/nbm.945; Smith KDB, 2007, NEUROIMAGE, V35, P1401, DOI 10.1016/j.neuroimage.2007.01.046; TRUMP BF, 1995, FASEB J, V9, P219, DOI 10.1096/fasebj.9.2.7781924; Tucciarone J, 2009, NEUROIMAGE, V44, P923, DOI 10.1016/j.neuroimage.2008.07.036; van der Zijden JP, 2007, NEUROIMAGE, V34, P1650, DOI 10.1016/j.neuroimage.2006.11.001; Watts LT, 2014, J NEUROTRAUM, V31, P1063, DOI 10.1089/neu.2013.3193; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; YOUNG W, 1992, J NEUROTRAUM, V9, pS9	28	17	18	0	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2015	32	13					1001	1010		10.1089/neu.2014.3737			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CV0SU	WOS:000363964200009	25531419	Green Published			2022-02-06	
J	Wolf, EG; Baugh, LM; Kabban, CMS; Richards, MF; Prye, J				Wolf, E. George; Baugh, Laura M.; Kabban, Christine M. Schubert; Richards, Michael F.; Prye, Jennifer			Cognitive function in a traumatic brain injury hyperbaric oxygen randomized trial	UNDERSEA AND HYPERBARIC MEDICINE			English	Article						traumatic brain injury; hyperbaric oxygen; cognitive function; TBI; HBO; HBO2; HBOT; hydrostatic pressure; PTSD; post-traumatic stress disorder; PCL; PCL-M; PCL-C	TEST-RETEST RELIABILITY; DELAYED NEUROPSYCHIATRIC SYNDROME; GENE-EXPRESSION; SYMPTOMS; CHECKLIST; VALIDITY; THERAPY; PTSD	Objective: Determine changes in cognition and post traumatic stress disorder (PTSD) symptoms in subjects with traumatic brain injury (TBI) exposed to 2.4 atmospheres absolute (atm abs) breathing 100% oxygen vs. sham (1.3 atm-abs air). Methods: Fifty randomized subjects completed a total of 30 exposures. A concussion history was taken, then baseline, post-series, and six-week follow-up immediate post-concussion assessment and cognitive testing, Brain checkers and PTSD Checklist for Military (PCL-M) tests were administered. Results: No statistically significant differences between groups were noted, but both groups improved. Subgroups analyses, based on concussion history and individual test components, showed improvement in the treatment group vs. the sham. These subgroups included the number of concussive events, time from event to consent, loss of consciousness, visual memory, processing, go no go, and simple reaction time. Conclusion: There was no statistically significant difference between a sham and 2.4 atm abs hyperbaric oxygen (HBO2) in cognitive scores from ImPACT and Brain checkers or composite scores in the PCL-M; however both groups showed improvement. Subgroups with favorable response to treatment are identified. Future studies evaluating HBO2 should consider concussion histories or focus on validating subgroup response to determine HBO2 as a potential adjunctive treatment for persistent symptoms following TBI.	[Wolf, E. George; Richards, Michael F.; Prye, Jennifer] US Air Force, Sch Aerosp Med, Hyperbar Med Dept, 59th Med Wing, Lackland AFB, TX USA; [Baugh, Laura M.] US Air Force Acad, Dept Neurol, Med Grp 10, Colorado Springs, CO 80840 USA; [Kabban, Christine M. Schubert] ENC Air Force Inst Technol, Dept Math & Stat, Wright Patterson AFB, OH USA		Wolf, EG (corresponding author), US Air Force, Sch Aerosp Med, Hyperbar Med Dept, 59th Med Wing, Lackland AFB, TX USA.	earl.wolf.ctr@us.af.mil			Air Force Medical Service; U.S. Navy Bureau of Medicine and Surgery; U.S. Army Medical Materiel Development Activity; Injured Marine Semper Fi Fund	The authors would like to recognize and thank the Air Force Medical Service for funding this research project; the U.S. Navy Bureau of Medicine and Surgery for funding temporary duty requirements; the U.S. Army Medical Materiel Development Activity for end of study funding; Ms. Sheila Galvin, Traumatic Brain Injury Program Coordinator for the Wounded Warrior Regiment USMC for her superb service in coordinating subject requirements; Ms. Karen Guenther and the Injured Marine Semper Fi Fund for transportation support for subjects; and Dr. Jason Cromar, while at USAFSAM, for coordinating the protocol.	[Anonymous], ANN REP, P29; [Anonymous], 2008, DOD HBOT TBI CONS C; Boussi-Gross R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079995; Bralic M, 2012, COLLEGIUM ANTROPOL, V36, P1319; Bryan C, 2012, J HEAD TRAUMA REHAB, V27, P45, DOI 10.1097/HTR.0b013e318238f146; Chang DC, 2010, UNDERSEA HYPERBAR M, V37, P23; Chen Y, 2009, NEUROCHEM RES, V34, P1047, DOI 10.1007/s11064-008-9873-8; Cifu DX, 2014, ANN NEUROL, V75, P277, DOI 10.1002/ana.24067; Cifu DX, 2014, J HEAD TRAUMA REHAB, V29, P11, DOI 10.1097/HTR.0b013e3182a6aaf0; de Vet HCW, 2006, J RHEUMATOL, V33, P434; Dean JB, 2003, J APPL PHYSIOL, V95, P883, DOI 10.1152/japplphysiol.00920.2002; Department of Veterans Affairs Department of Defense, 2009, VA DOD CLIN PRACT GU, p[6, 16, 57]; Department of Veterans Affairs Department of Defense, 2010, VA DOD CLIN PRACT GU, p[91, 177]; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Eggum TJ, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2979864; Elsmore TF, 2006, COGNITIVE STATUS REP; Elsmore TF, 2007, ARCH CLIN NEUROPSYCH, V22, pS135, DOI 10.1016/j.acn.2006.10.009; Forbes D, 2001, BEHAV RES THER, V39, P977, DOI 10.1016/S0005-7967(00)00084-X; Godman CA, 2010, CELL STRESS CHAPERON, V15, P431, DOI 10.1007/s12192-009-0159-0; Gore KL, 2013, PSYCHOL ASSESSMENT, V25, P1032, DOI 10.1037/a0033325; [郭紫芬 Guo Zifen], 2011, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V15, P9353; Harch PG, 2013, J NEUROTRAUM, V30, P1995, DOI 10.1089/neu.2012.2799; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; JACOBSON NS, 1984, BEHAV THER, V15, P336, DOI 10.1016/S0005-7894(84)80002-7; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; Jones WP, 2008, CLIN NEUROPSYCHOL, V22, P305, DOI 10.1080/13854040701281483; Kaminski TW, 2009, J CLIN EXP NEUROPSYC, V31, P689, DOI 10.1080/13803390802484771; Kendall AC, 2013, UNDERSEA HYPERBAR M, V40, P115; Khusid M, 2013, PSYCHIAT ANN, V43, P340, DOI 10.3928/00485713-20130703-11; King EG, 2013, REHABIL PSYCHOL, V58, P272, DOI 10.1037/a0033116; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Lo CP, 2007, EUR J NEUROL, V14, P777, DOI 10.1111/j.1468-1331.2007.01854.x; Lovell M, 2012, MANAGEMENT SPORTS CO; Ma M, 2013, NEUROBIOL DIS, V60, P61, DOI 10.1016/j.nbd.2013.08.010; Macdonald AG, 1999, COMP BIOCHEM PHYS A, V122, P13, DOI 10.1016/S1095-6433(98)10173-3; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; McDonagh MS, 2003, AHRQ PUBLICATION, V03-E050; MedCalc Software, 2013, MEDCALC US FRIENDL S; Monson CM, 2008, PSYCHOL ASSESSMENT, V20, P131, DOI 10.1037/1040-3590.20.2.131; Mulkey DK, 2003, J APPL PHYSIOL, V95, P922, DOI 10.1152/japplphysiol.00865.2002; Nakayama Y, 2014, AM J SPORT MED, V42, P2000, DOI 10.1177/0363546514535901; Proponency Office for Rehabilitation & Reintegration, 2009, AUT NEUR ASS METR AN; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Scorza KA, 2013, UNDERSEA HYPERBAR M, V40, P548; Tofighi R, 2006, BRAIN RES, V1098, P1, DOI 10.1016/j.brainres.2006.04.095; U. S. Department of Veterans Affairs, 2014, US PTSD CHECKL DSM 4; Walker WC, 2013, NEUROREHABILITATION; Weaver LK, 2012, UNDERSEA HYPERBAR M, V39, P807; Weaver LK, 2002, NEW ENGL J MED, V347, P1057, DOI 10.1056/NEJMoa013121; Wolf EG, 2012, UNDERSEA HYPERBAR M, V39, P1075; Wolf G, 2012, J NEUROTRAUM, V29, P2606, DOI 10.1089/neu.2012.2549; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092698	54	17	19	1	7	UNDERSEA & HYPERBARIC MEDICAL SOC INC	DURHAM	21 WEST COLONY PLACE, STE 280, DURHAM, NC 27705 USA	1066-2936			UNDERSEA HYPERBAR M	Undersea Hyperb. Med.	JUL-AUG	2015	42	4					313	332					20	Marine & Freshwater Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Marine & Freshwater Biology; Research & Experimental Medicine	DB5RM	WOS:000368571300004	26403017				2022-02-06	
J	Cheng, OM; Li, R; Zhao, L; Yu, LJ; Yang, B; Wang, J; Chen, BB; Yang, JQ				Cheng, Oumei; Li, Rong; Zhao, Lei; Yu, Lijuan; Yang, Bin; Wang, Jia; Chen, Beibei; Yang, Junqing			Short-Term Sleep Deprivation Stimulates Hippocampal Neurogenesis in Rats Following Global Cerebral Ischemia/Reperfusion	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; NEUROTROPHIC FACTOR; FOREBRAIN ISCHEMIA; ADULT HIPPOCAMPUS; DENTATE GYRUS; MEMORY; BDNF; RESTRICTION; MECHANISMS; EXPRESSION	Background Sleep deprivation (SD) plays a complex role in central nervous system (CNS) diseases. Recent studies indicate that short-term SD can affect the extent of ischemic damage. The aim of this study was to investigate whether short-term SD could stimulate hippocampal neurogenesis in a rat model of global cerebral ischemia/reperfusion (GCIR). Methods One hundred Sprague-Dawley rats were randomly divided into Sham, GCIR and short-term SD groups based on different durations of SD; the short-term SD group was randomly divided into three subgroups: the GCIR+6hSD*3d-treated, GCIR+12hSD-treated and GCIR +12hSD*3d-treated groups. The GCIR rat model was induced via the bilateral occlusion of the common carotid arteries and hemorrhagic hypotension. The rats were sleep-deprived starting at 48 h following GCIR. A Morris water maze test was used to assess learning and memory ability; cell proliferation and differentiation were analyzed via 5-bromodeoxyuridine (BrdU) and neuron-specific enolase (NSE), respectively, at 14 and 28 d; the expression of hippocampal BDNF was measured after 7 d. Results The different durations of short-term SD designed in our experiment exhibited improvement in cognitive function as well as increased hippocampal BDNF expression. Additionally, the short-term SD groups also showed an increased number of BrdU-and BrdU/NSE-positive cells compared with the GCIR group. Of the three short-term SD groups, the GCIR +12hSD*3d-treated group experienced the most substantial beneficial effects. Conclusions Short-term SD, especially the GCIR+ 12hSD*3d-treated method, stimulates neurogenesis in the hippocampal dentate gyrus (DG) of rats that undergo GCIR, and BDNF may be an underlying mechanism in this process.	[Cheng, Oumei; Li, Rong; Chen, Beibei] Chongqing Med Univ, Dept Neurol, Affiliated Hosp 1, Chongqing 400016, Peoples R China; [Zhao, Lei; Yu, Lijuan; Yang, Bin; Wang, Jia; Yang, Junqing] Chongqing Med Univ, Dept Pharmacol, Key Lab Biochem & Mol Pharmacol, Chongqing 400016, Peoples R China		Yang, JQ (corresponding author), Chongqing Med Univ, Dept Pharmacol, Key Lab Biochem & Mol Pharmacol, Chongqing 400016, Peoples R China.	1139627371@qq.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81100981, 81471334]; National Key Clinical Specialties Construction Program of China	This research was supported by the National Natural Science Foundation of China (No. 81100981, 81471334) and the National Key Clinical Specialties Construction Program of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANO M, 1993, JPN J PHARMACOL, V63, P469, DOI 10.1254/jjp.63.469; Bachmann V, 2012, SLEEP, V35, P335, DOI 10.5665/sleep.1690; Chen J, 1998, J NEUROSCI, V18, P4914; Cheng OM, 2012, BRAIN RES, V1470, P111, DOI 10.1016/j.brainres.2012.06.026; Doyle KP, 2008, NEUROPHARMACOLOGY, V55, P310, DOI 10.1016/j.neuropharm.2008.01.005; Faraguna U, 2008, J NEUROSCI, V28, P4088, DOI 10.1523/JNEUROSCI.5510-07.2008; Fujihara H, 2003, J MOL NEUROSCI, V21, P223, DOI 10.1385/JMN:21:3:223; Gao B, 2010, SLEEP, V33, P879, DOI 10.1093/sleep/33.7.879; Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263; Graves LA, 2003, LEARN MEMORY, V10, P168, DOI 10.1101/lm.48803; Hairston IS, 2005, J NEUROPHYSIOL, V94, P4224, DOI 10.1152/jn.00218.2005; Hairston IS, 2004, J NEUROPHYSIOL, V91, P1586, DOI 10.1152/jn.00894.2003; Harukuni I, 2006, NEUROL CLIN, V24, P1, DOI 10.1016/j.ncl.2005.10.004; Hsu JC, 2003, BRAIN RES, V984, P170, DOI 10.1016/S0006-8993(03)03128-7; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Junek A, 2010, NEUROSCIENCE, V170, P1140, DOI 10.1016/j.neuroscience.2010.08.018; Kawai T, 2004, J CEREBR BLOOD F MET, V24, P548, DOI 10.1097/00004647-200405000-00009; Kee NJ, 2001, EXP BRAIN RES, V136, P313, DOI 10.1007/s002210000591; Kuang G, 2012, PPAR RES, V2012, DOI [10.1155/2012/209794, DOI 10.1155/2012/209794]; Kushikata T, 1999, AM J PHYSIOL-REG I, V276, pR1334, DOI 10.1152/ajpregu.1999.276.5.R1334; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Liu JL, 1998, J NEUROSCI, V18, P7768; LONGSTRETH WT, 1993, ANN EMERG MED, V22, P64, DOI 10.1016/S0196-0644(05)80252-5; Martinez-Vargas M, 2012, NEUROSCI LETT, V529, P118, DOI 10.1016/j.neulet.2012.09.037; Medeiros R, 1998, BRAZ J MED BIOL RES, V31, P675, DOI 10.1590/S0100-879X1998000500012; Mirescu C, 2006, P NATL ACAD SCI USA, V103, P19170, DOI 10.1073/pnas.0608644103; Moldovan M, 2010, EXP NEUROL, V222, P135, DOI 10.1016/j.expneurol.2009.12.023; Murray Patrick S, 2011, Int J Pept, V2011, P654085, DOI 10.1155/2011/654085; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Peskine A, 2010, BRAIN INJURY, V24, P755, DOI 10.3109/02699051003709581; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Quintard H, 2014, NEUROSCIENCE, V277, P72, DOI 10.1016/j.neuroscience.2014.06.047; Scharfman H, 2005, EXP NEUROL, V192, P348, DOI 10.1016/j.expneurol.2004.11.016; SMITH ML, 1984, ACTA NEUROL SCAND, V69, P385, DOI 10.1111/j.1600-0404.1984.tb07822.x; Taliaz D, 2010, MOL PSYCHIATR, V15, P80, DOI 10.1038/mp.2009.67; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Weil ZM, 2009, EXP NEUROL, V218, P129, DOI 10.1016/j.expneurol.2009.04.018; Yagita Y, 2001, STROKE, V32, P1890, DOI 10.1161/01.STR.32.8.1890; Zhou YL, 2013, J MOL HISTOL, V44, P291, DOI 10.1007/s10735-012-9466-3; Zucconi GG, 2006, BRAIN RES BULL, V69, P375, DOI 10.1016/j.brainresbull.2006.01.009; Zunzunegui C, 2011, SLEEP, V34, P1261, DOI 10.5665/SLEEP.1252	42	17	19	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2015	10	6							e0125877	10.1371/journal.pone.0125877			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7ST	WOS:000355700700016	26039740	Green Published, gold, Green Submitted			2022-02-06	
J	Bannard-Smith, J; Alexander, P; Glassford, N; Chan, MJ; Lee, M; Wong, BT; Crawford, G; Bailey, M; Bellomo, R				Bannard-Smith, Jonathan; Alexander, Paschal; Glassford, Neil; Chan, Matthew J.; Lee, Matthew; Wong, Ben T.; Crawford, Grant; Bailey, Michael; Bellomo, Rinaldo			Haemodynamic and biochemical responses to fluid bolus therapy with human albumin solution, 4% versus 20%, in critically ill adults	CRITICAL CARE AND RESUSCITATION			English	Article							ACUTE LUNG INJURY; SEVERE SEPSIS; HYDROXYETHYL STARCH; 0.9-PERCENT SALINE; PATIENT OUTCOMES; INTENSIVE-CARE; SEPTIC SHOCK; RESUSCITATION; MORTALITY; BALANCE	Background: Fluid bolus therapy (FBT) is common in critically ill patients. With the exception of use in patients with traumatic brain injury, FBT with human albumin solution (HAS) appears safe and perhaps superior in severe sepsis. Objective: To determine the physiological effects of FBT with 4% v 20% HAS. Design, setting and participants: A retrospective observational study of 202 critically ill patients receiving FBT with HAS in a tertiary intensive care unit between April 2012 and March 2013. Methods: FBT was instituted with 4% or 20% HAS, according to clinician preference. Main outcome measures: We compared biochemical and haemodynamic data between groups at baseline and at 1, 2 and 4 hours after FBT. Results: Patients who had received 20% HAS had more liver disease, a greater need for renal replacement therapy and higher Acute Physiology and Chronic Health Evaluation III scores on admission. Patients who had received 4% HAS received a median volume of 500 mL (interquartile range [IQR], 350-500 mL), compared with 100 mL (IQR, 100 200 mL) in the 20% HAS group (P < 0.0001); a median of 70 mmol v 10 mmol of sodium (P < 0.0001); and a median of 64 mmol v 2 mmol of chloride (P < 0.0001). There was a trend toward higher mean arterial pressures in the 20% group after FBT (78.2 mmHg v 76.4 mmHg, P = 0.03). There were no significant differences in the absolute or percentage change for any haemodynamic parameters. Serum biochemical test results were comparable with a non-significant signal of higher serum chloride and more negative base excess in patients receiving 4% HAS. Conclusions: Haemodynamically, FBT with 100 mL of 20% HAS performs in an equivalent way to 500 mL of 4% HAS but delivers much less fluid, sodium and chloride.	[Bannard-Smith, Jonathan; Alexander, Paschal; Glassford, Neil; Chan, Matthew J.; Lee, Matthew; Wong, Ben T.; Crawford, Grant] Austin Hlth, Dept Intens Care, Melbourne, Vic, Australia; [Bellomo, Rinaldo] Austin Hlth, Dept Intens Care, Res, Melbourne, Vic, Australia; [Glassford, Neil; Bailey, Michael; Bellomo, Rinaldo] Monash Univ, Alfred Hosp, Sch Publ Hlth & Preventat Med, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic 3181, Australia		Bellomo, R (corresponding author), Austin Hlth, Dept Intens Care, Res, Melbourne, Vic, Australia.	rinaldo.bellomo@austin.org.au	Bailey, Michael J/A-4499-2012	Bailey, Michael J/0000-0002-5551-1401; Glassford, Neil/0000-0003-1647-3745; Bellomo, Rinaldo/0000-0002-1650-8939; Bannard-Smith, Jonathan/0000-0001-7120-480X			Bayer O, 2012, CRIT CARE MED, V40, P2543, DOI 10.1097/CCM.0b013e318258fee7; Bayer O, 2011, CRIT CARE MED, V39, P1335, DOI 10.1097/CCM.0b013e318212096a; Bellomo R, 2012, CRIT CARE MED, V40, P1753, DOI 10.1097/CCM.0b013e318246b9c6; Bihari S, 2013, CRIT CARE RESUSC, V15, P294; Bihari S, 2013, SHOCK, V40, P28, DOI 10.1097/SHK.0b013e31829727f1; Bihari S, 2013, CRIT CARE RESUSC, V15, P89; Boyd JH, 2011, CRIT CARE MED, V39, P259, DOI 10.1097/CCM.0b013e3181feeb15; BRANT R, INFERENCE MEANS COMP; Brunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716; Caironi P, 2014, NEW ENGL J MED, V370, P1412, DOI 10.1056/NEJMoa1305727; Chowdhury AH, 2012, ANN SURG, V256, P18, DOI 10.1097/SLA.0b013e318256be72; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Finfer S, 2011, INTENS CARE MED, V37, P86, DOI 10.1007/s00134-010-2039-6; Gattas DJ, 2013, CRIT CARE RESUSC, V15, P255; Handy JM, 2008, BRIT J ANAESTH, V101, P141, DOI 10.1093/bja/aen148; Martin GS, 2005, CRIT CARE MED, V33, P1681, DOI 10.1097/01.CCM.0000171539.47006.02; Myburgh JA, 2012, NEW ENGL J MED, V367, P1901, DOI 10.1056/NEJMoa1209759; Perel P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000567.pub6; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; Scheingraber S, 1999, ANESTHESIOLOGY, V90, P1265, DOI 10.1097/00000542-199905000-00007; Shaw AD, 2012, ANN SURG, V255, P821, DOI 10.1097/SLA.0b013e31825074f5; Sort P, 1999, NEW ENGL J MED, V341, P403, DOI 10.1056/NEJM199908053410603; STEWART PA, 1983, CAN J PHYSIOL PHARM, V61, P1444, DOI 10.1139/y83-207; WAGNER BKJ, 1993, CLIN PHARMACY, V12, P335; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; Yunos NM, 2012, JAMA-J AM MED ASSOC, V308, P1566, DOI 10.1001/jama.2012.13356	26	17	18	0	0	AUSTRALASIAN MED PUBL CO LTD	PYRMONT	LEVEL 2, 26-32 PYRMONT BRIDGE RD, PYRMONT, NSW 2009, AUSTRALIA	1441-2772			CRIT CARE RESUSC	Crit Care Resusc.	JUN	2015	17	2					122	128					7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ0ID	WOS:000355158100012	26017130				2022-02-06	
J	Friess, SH; Lapidus, JB; Brody, DL				Friess, Stuart H.; Lapidus, Jodi B.; Brody, David L.			Decompressive Craniectomy Reduces White Matter Injury after Controlled Cortical Impact in Mice	JOURNAL OF NEUROTRAUMA			English	Article						axonal injury; controlled cortical impact; intracranial pressure; traumatic brain injury; white matter	TRAUMATIC BRAIN-INJURY; CEREBRAL PERFUSION-PRESSURE; DIFFUSE AXONAL INJURY; SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; VEGETATIVE STATE; NEUROPATHOLOGY; ISOFLURANE; SEVOFLURANE; HIPPOCAMPUS	Reduction and avoidance of increases in intracranial pressure (ICP) after severe traumatic brain injury (TBI) continue to be the mainstays of treatment. Traumatic axonal injury is a major contributor to morbidity after TBI, but it remains unclear whether elevations in ICP influence axonal injury. Here we tested the hypothesis that reduction in elevations in ICP after experimental TBI would result in decreased axonal injury and white matter atrophy in mice. Six-week-old male mice (C57BL/6J) underwent either moderate controlled cortical impact (CCI) (n=48) or Sham surgery (Sham, n=12). Immediately after CCI, injured animals were randomized to a loose fitting plastic cap (Open) or replacement of the previously removed bone flap (Closed). Elevated ICP was observed in Closed animals compared with Open and Sham at 15min (21.4 +/- 4.2 vs. 12.3 +/- 2.9 and 8.8 +/- 1.8mm Hg, p<0.0001) and 1 day (17.8 +/- 3.7 vs. 10.6 +/- 2.0 and 8.9 +/- 1.9mm Hg, p<0.0001) after injury. Beta amyloid precursor protein staining in the corpus callosum and ipsilateral external capsule revealed reduced axonal swellings and bulbs in Open compared with Closed animals (32% decrease, p<0.01 and 40% decrease, p<0.001 at 1 and 7 days post-injury, respectively). Open animals were also found to have decreased neurofilament-200 stained axonal swellings at 7 days post-injury compared with Open animals (32% decrease, p<0.001). At 4 weeks post-injury, Open animals had an 18% reduction in white matter volume compared with 34% in Closed animals (p<0.01). Thus, our results indicate that CCI with decompressive craniectomy was associated with reductions in ICP and reduced pericontusional axonal injury and white matter atrophy. If similar in humans, therapeutic interventions that ameliorate intracranial hypertension may positively influence white matter injury severity.	[Friess, Stuart H.; Lapidus, Jodi B.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Brody, David L.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA		Friess, SH (corresponding author), Washington Univ, Sch Med, Dept Pediat, Div Crit Care Med, Campus Box 8028,5th Floor MPRB,660 S Euclid Ave, St Louis, MO 63110 USA.	Friess_S@kid.wustl.edu			NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR027552] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS064051, R01NS065069] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10 RR027552] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08 NS064051, R01 NS065069] Funding Source: Medline		Adams JH, 1999, J CLIN PATHOL, V52, P804, DOI 10.1136/jcp.52.11.804; Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Brockman EC, 2013, J CEREBR BLOOD F MET, V33, P1457, DOI 10.1038/jcbfm.2013.104; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chambers IR, 2001, J NEUROSURG, V94, P412, DOI 10.3171/jns.2001.94.3.0412; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Clausen F, 2005, ACTA NEUROCHIR, V147, P775, DOI 10.1007/s00701-005-0550-2; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; Figaji AA, 2009, CHILD NERV SYST, V25, P1325, DOI 10.1007/s00381-009-0822-x; Friess SH, 2011, NEUROSURGERY, V69, P1139, DOI 10.1227/NEU.0b013e3182284aa1; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Glover LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033646; Goren S, 2001, J NEUROSURG ANESTH, V13, P113, DOI 10.1097/00008506-200104000-00008; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Graham DI, 2005, NEUROPSYCHOL REHABIL, V15, P198, DOI 10.1080/09602010443000452; Graham DI, 2004, FORENSIC SCI INT, V146, P89, DOI 10.1016/S0379-0738(03)00274-3; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Jiang Y, 2012, J NEUROTRAUM, V29, P2332, DOI 10.1089/neu.2012.2362; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; KAIEDA R, 1989, ANESTHESIOLOGY, V71, P571, DOI 10.1097/00000542-198910000-00016; Kaur B, 1999, J CLIN PATHOL, V52, P203, DOI 10.1136/jcp.52.3.203; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Lafrenaye AD, 2012, J CEREBR BLOOD F MET, V32, P1919, DOI 10.1038/jcbfm.2012.95; Lee TT, 1998, ACTA NEUROCHIR, V140, P41, DOI 10.1007/s007010050055; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Ratanalert S, 2004, SURG NEUROL, V61, P429, DOI 10.1016/S0090-3019(03)00579-2; Rogatsky GG, 2005, BRAIN RES, V1047, P131, DOI 10.1016/j.brainres.2005.02.049; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Slawik H, 2009, J NEUROTRAUM, V26, P1891, DOI 10.1089/neu.2009.0942; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Sponheim S, 2003, ACTA ANAESTH SCAND, V47, P932, DOI 10.1034/j.1399-6576.2003.00199.x; Stein DM, 2013, NEUROCRIT CARE, V18, P332, DOI 10.1007/s12028-013-9832-3; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; Tasker RC, 2010, DEV NEUROSCI-BASEL, V32, P374, DOI 10.1159/000316806; Terpolilli NA, 2013, J CEREBR BLOOD F MET, V33, P311, DOI 10.1038/jcbfm.2012.176; Terpolilli NA, 2009, J NEUROTRAUM, V26, P1963, DOI 10.1089/neu.2008.0853; Yanagawa Y, 2009, J TRAUMA, V66, P162, DOI 10.1097/TA.0b013e3181469857; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	48	17	17	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2015	32	11					791	800		10.1089/neu.2014.3564			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CV0YU	WOS:000363980700004	25557588	Green Published, Green Submitted			2022-02-06	
J	Kim, MO; Adji, A; O'Rourke, MF; Avolio, AP; Smielewski, P; Pickard, JD; Czosnyka, M				Kim, Mi Ok; Adji, Audrey; O'Rourke, Michael F.; Avolio, Alberto P.; Smielewski, Peter; Pickard, John D.; Czosnyka, Marek			Principles of cerebral hemodynamics when intracranial pressure is raised: lessons from the peripheral circulation	JOURNAL OF HYPERTENSION			English	Article						aortic pressure; intracranial pressure; plateau waves	INTENSIVE-CARE MANAGEMENT; BLOOD-FLOW-VELOCITY; ARTERIAL; TONOMETRY; FAILURE; STROKE; BRAIN; TRIAL; INDEX	Background: The brain is highly vascular and richly perfused, and dependent on continuous flow for normal function. Although confined within the skull, pressure within the brain is usually less than 15 mmHg, and shows small pulsations related to arterial pulse under normal circumstances. Pulsatile arterial hemodynamics in the brain have been studied before, but are still inadequately understood, especially during changes of intracranial pressure (ICP) after head injury. Method: In seeking cohesive explanations, we measured ICP and radial artery pressure (RAP) invasively with high-fidelity manometer systems, together with middle cerebral artery flow velocity (MCAFV) (transcranial Doppler) and central aortic pressure (CAP) generated from RAP, using a generalized transfer function technique, in eight young unconscious, ventilated adults following closed head trauma. We focused on vascular effects of spontaneous rises of ICP ('plateau waves'). Results: A rise in mean ICP from 29 to 53 mmHg caused no consistent change in pressure outside the cranium, or in heart rate, but ICP pulsations increased in amplitude from 8 to 20 mmHg, and ICP waveform came to resemble that in the aorta. Cerebral perfusion pressure (=central aortic pressure - ICP), which equates with transmural pressure, fell from 61 to 36 mmHg. Mean MCAFV fell from 53 to 40 cm/s, whereas pulsatile MCAFV increased from 77 to 98 cm/s. These significant changes (all P < 0.01) may be explained using the Monro-Kellie doctrine, because of compression of the brain, as occurs in a limb when external pressure is applied. Conclusion: The findings emphasize importance of reducing ICP, when raised, and on the additional benefits of reducing wave reflection from the lower body.	[Kim, Mi Ok; Adji, Audrey; O'Rourke, Michael F.; Avolio, Alberto P.] Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia; [Adji, Audrey; O'Rourke, Michael F.] St Vincents Clin, Sydney, NSW 2010, Australia; [O'Rourke, Michael F.] Univ New S Wales, Sydney, NSW, Australia; [O'Rourke, Michael F.] Victor Chang Cardiac Res Inst, Sydney, NSW, Australia; [Smielewski, Peter; Pickard, John D.; Czosnyka, Marek] Univ Cambridge, Addenbrookes Hosp, Acad Neurosurg Unit, Cambridge CB2 2QQ, England		O'Rourke, MF (corresponding author), St Vincents Clin, Suite 810,438 Victoria St, Sydney, NSW 2010, Australia.	m.orourke@unsw.edu.au	Adji, Audrey/AAN-5624-2020	Adji, Audrey/0000-0002-5567-6206; czosnyka, marek/0000-0003-2446-8006; Avolio, Alberto/0000-0002-8311-2010; Smielewski, Peter/0000-0001-5096-3938	National Institute of Health ResearchNational Institute for Health Research (NIHR); Biomedical Research Centre (Neuroscience Theme); Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986, G9439390]; NIHRNational Institute for Health Research (NIHR); Australian Research CouncilAustralian Research Council [LP0884094]; AtCor Medical Australia; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0001237, G0600986, G9439390] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0001237] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327] Funding Source: researchfish	This study was supported by the National Institute of Health Research, the Biomedical Research Centre (Neuroscience Theme), and the Medical Research Council (Grants G0600986 and G9439390). J.D.P. has received the NIHR Investigator Awards. M.O.K. is sponsored by an Australian Postgraduate Awards Industrial Linkage Grant from the Australian Research Council (LP0884094), with AtCor Medical Australia as the collaborating organization.	Adji A, 2012, J HYPERTENS, V30, P1540, DOI 10.1097/HJH.0b013e328354e859; Avezaat C, 1984, CEREBROSPINAL FLUID; Byrom FB, 1969, HYPERTENSIVE VASCULA; Castellani G, 2009, NEUROCRIT CARE, V11, P143, DOI 10.1007/s12028-009-9235-7; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; DeBaun MR, 2014, NEW ENGL J MED, V371, P699, DOI 10.1056/NEJMoa1401731; DRZEWIECKI GM, 1983, J BIOMECH, V16, P141, DOI 10.1016/0021-9290(83)90037-4; Eide PK, 2011, NEUROSURGERY, V69, P1105, DOI 10.1227/NEU.0b013e318227e0e1; FOLKOW B, 1970, ACTA PHYSIOL SCAND, V80, P61, DOI 10.1111/j.1748-1716.1970.tb04770.x; FOLKOW B, 1993, PHYSIOL REV, V73, P725, DOI 10.1152/physrev.1993.73.4.725; FRY DL, 1969, CIRC RES, V24, P93, DOI 10.1161/01.RES.24.1.93; Fry DL, 1973, SYMPOSIUM, P93; Gupta S, 2014, HEART LUNG CIRC, V23, P963, DOI 10.1016/j.hlc.2014.04.259; Hirata K, 2007, J CLIN HYPERTENS SA, V9, pA29; Kellie George, 1824, Trans Med Chir Soc Edinb, V1, P84; Kety S., 1964, CIRCULATION BLOOD ME, P703; Kim DJ, 2009, PHYSIOL MEAS, V30, P647, DOI 10.1088/0967-3334/30/7/009; Kim MO, 2014, CIRCULATION, V130; Kim MO, 2013, ARTERY RES, V7, P119; Kirkman MA, 2014, INTENS CARE MED, V40, P640, DOI 10.1007/s00134-014-3266-z; Kwiatkowski JL, 2006, BRIT J HAEMATOL, V134, P333, DOI 10.1111/j.1365-2141.2006.06193.x; Marmarou A, 1973, THESIS DREXER U PHIL; Mokri B, 2001, NEUROLOGY, V56, P1746, DOI 10.1212/WNL.56.12.1746; Monro A., 1783, OBSERVATIONS STRUCTU; Moore W., 2005, KNIFE MAN; Nichols WW, 2011, MCDONALD'S BLOOD FLOW IN ARTERIES: THEORETICAL, EXPERIMENTAL AND CLINICAL PRINCIPLES, 6TH EDITION, P1; O'Rourke M. F., 1993, ARTERIAL VASODILATIO; Oliver G, 1895, PULSE GAUGING CLIN S; OROURKE MF, 1982, PHYSIOL REV, V62, P570, DOI 10.1152/physrev.1982.62.2.570; Pauca AL, 2005, HEART, V91, P1428, DOI 10.1136/hrt.2004.057356; Pauca AL, 2001, HYPERTENSION, V38, P932, DOI 10.1161/hy1001.096106; RUSSELL RWR, 1975, LANCET, V2, P1283; Schmidt M, 2014, AM J RESP CRIT CARE, V189, P1374, DOI 10.1164/rccm.201311-2023OC; Smielewski P, 2005, ACT NEUR S, V95, P43; Soiza RL, 2010, AM J HYPERTENS, V23, P737, DOI 10.1038/ajh.2010.66; Wagshul ME, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-5; Zweifel C, 2012, NEUROSURGERY, V71, P853, DOI 10.1227/NEU.0b013e3182675b42	37	17	17	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0263-6352	1473-5598		J HYPERTENS	J. Hypertens.	JUN	2015	33	6					1233	1241		10.1097/HJH.0000000000000539			9	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	CH1YN	WOS:000353819700018	25764046	Green Published			2022-02-06	
J	Maxwell, WL; Bartlett, E; Morgan, H				Maxwell, William L.; Bartlett, Emma; Morgan, Hanna			Wallerian Degeneration in the Optic Nerve Stretch-Injury Model of Traumatic Brain Injury: A Stereological Analysis	JOURNAL OF NEUROTRAUMA			English	Article						central myelinated nerve fibers; secondary axotomy; stretch-injury; Wallerian degeneration	NONDISRUPTIVE AXONAL INJURY; WHITE-MATTER; CYTOSKELETAL CHANGES; LONGITUDINAL CHANGES; DIFFUSION-TENSOR; SPINAL-CORD; RAT; REGENERATION; FIBERS; MYELIN	Patients with chronic traumatic encephalopathy (CTE) show loss of central white matter, central gray matter, and cortical gray matter with increasing post-traumatic survival. The majority of experimental studies using animals have, however, discussed only the ultrastructural pathophysiology of injured central white matter leading to secondary axotomy and the formation of axonal terminal bulbs. Using the stretch-injured optic nerve model in adult guinea pigs, the present study provides novel quantitative data concerning Wallerian degeneration of disconnected axonal fragments following secondary axotomy out to 12 weeks after injury to an optic nerve. The time course of Wallerian degeneration at the level of an individual nerve fiber is comparable to that reported in earlier studies over 48h to two weeks after secondary axotomy. But only a relatively small proportion of nerve fibers within the optic tract degenerate via Wallerian degeneration during the first two weeks. Rather, examples of each of the three stages of Wallerian degenerationacute axonal degeneration, latency of the distal axonal segment, and granular fragmentationoccur within the optic tract across the entire experimental survival of 12 weeks used in the present study. This data suggests that some nerve fibers initiate Wallerian degeneration days and weeks after the initial time of mechanical injury to an optic nerve. The number of intact nerve fibers continues to fall over at least three months after injury in the stretch-injury model of traumatic axonal injury. It is suggested that these novel findings relate to the mechanism(s) whereby central white matter volume decreases over months and years in CTE patients.	[Maxwell, William L.; Bartlett, Emma; Morgan, Hanna] Univ Glasgow, Dept Anat, Glasgow G12 8QQ, Lanark, Scotland		Maxwell, WL (corresponding author), Univ Glasgow, Dept Anat, Glasgow G12 8QQ, Lanark, Scotland.	maxwellwilliam90@gmail.com					Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; BAUR PS, 1977, J MICROSC-OXFORD, V109, P315, DOI 10.1111/j.1365-2818.1977.tb01145.x; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Biiki A., 1999, J NEUROPATHOL EXP NE, V58, P365; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Buss A, 2004, BRAIN, V127, P34, DOI 10.1093/brain/awh001; CHAUDHRY V, 1992, MUSCLE NERVE, V15, P687, DOI 10.1002/mus.880150610; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; Dinkel J, 2014, AM J NEURORADIOL, V35, P23, DOI 10.3174/ajnr.A3616; FRAHER JP, 1972, J ANAT, V112, P99; GENNARELLI TA, 1989, J NEUROSURG, V71, P244, DOI 10.3171/jns.1989.71.2.0244; GEORGE R, 1994, EXP NEUROL, V129, P225, DOI 10.1006/exnr.1994.1164; GILLIATT RW, 1972, J NEUROL NEUROSUR PS, V35, P335, DOI 10.1136/jnnp.35.3.335; GLASS JD, 1994, J NEUROCHEM, V62, P2472, DOI 10.1046/j.1471-4159.1994.62062472.x; Griffin J.W., 1993, PERIPHERAL NEUROPATH, VThird, P361; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; Jafari SS, 1998, J NEUROTRAUM, V15, P955, DOI 10.1089/neu.1998.15.955; Jafari SS, 1997, J NEUROCYTOL, V26, P207, DOI 10.1023/A:1018588114648; JEFFERY G, 1981, EXP BRAIN RES, V44, P34; Kampfl A, 1996, J NEUROCHEM, V67, P1575; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; KREUTZBERG GW, 1971, ACTA NEUROPATHOL, V17, P220, DOI 10.1007/BF00685055; Leuissen I., 2014, CORTEX, V51, P67; LUBINSKA L, 1977, BRAIN RES, V130, P47, DOI 10.1016/0006-8993(77)90841-1; Ma M, 2013, NEUROBIOL DIS, V56, P34, DOI 10.1016/j.nbd.2013.03.009; Maxwell W.L., 2015, BRAIN INJURY PRINCIP, P15; Maxwell WL, 2013, BRAIN SCI, V3, P1374, DOI 10.3390/brainsci3031374; Maxwell WL, 2010, BRAIN, V133, P139, DOI 10.1093/brain/awp264; Maxwell WL, 1997, J NEUROTRAUM, V14, P603, DOI 10.1089/neu.1997.14.603; Maxwell WL, 2003, J NEUROTRAUM, V20, P151, DOI 10.1089/08977150360547071; Moldovan M, 2009, BRAIN, V132, P511, DOI 10.1093/brain/awn332; MORGAN JE, 1987, NEUROSCIENCE, V20, P519, DOI 10.1016/0306-4522(87)90108-4; Narciso MS, 2001, AN ACAD BRAS CIENC, V73, P231, DOI 10.1590/S0001-37652001000200008; Neveu MM, 2007, EYE, V21, P1264, DOI 10.1038/sj.eye.6702839; Payne SC, 2012, INVEST OPHTH VIS SCI, V53, P6093, DOI 10.1167/iovs.12-10080; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; RICHARDSON PM, 1982, J NEUROCYTOL, V11, P949, DOI 10.1007/BF01148310; Rodriguez-Paez AC, 2005, ACTA NEUROPATHOL, V109, P603, DOI 10.1007/s00401-005-1010-z; Saatman K.E., HDB NEUROCHEMISTRY M; Saggu SK, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-97; Sulaiman AM, 2011, J NEUROTRAUM, V28, P383, DOI 10.1089/neu.2010.1707; Tomaiuolo F, 2005, J NEUROTRAUM, V22, P76, DOI 10.1089/neu.2005.22.76; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; TSAO JW, 1994, EUR J NEUROSCI, V6, P516, DOI 10.1111/j.1460-9568.1994.tb00295.x; Wang JT, 2012, J CELL BIOL, V196, P7, DOI 10.1083/jcb.201108111; Wang JQ, 2011, J NEUROTRAUM, V28, P1185, DOI 10.1089/neu.2011.1756; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; WAXMAN SG, 1992, BRAIN RES, V574, P105, DOI 10.1016/0006-8993(92)90806-K; WEGNER JE, 1976, BIOL GUINEA PIG	52	17	20	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2015	32	11					780	790		10.1089/neu.2014.3369			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CV0YU	WOS:000363980700003	25333317				2022-02-06	
J	Pang, KCH; Sinha, S; Avcu, P; Roland, JJ; Nadpara, N; Pfister, B; Long, M; Santhakumar, V; Servatius, RJ				Pang, Kevin C. H.; Sinha, Swamini; Avcu, Pelin; Roland, Jessica J.; Nadpara, Neil; Pfister, Bryan; Long, Mathew; Santhakumar, Vijayalakshmi; Servatius, Richard J.			Long-Lasting Suppression of Acoustic Startle Response after Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						concussion; lateral fluid percussion; memory; pons; spatial learning	WORKING-MEMORY DEFICITS; FLUORO-JADE; RETICULAR-FORMATION; NEURONS; RATS; SEVERITY; REFLEX; PATHOPHYSIOLOGY; HIPPOCAMPUS; INHIBITION	Acoustic startle response (ASR) is a defensive reflex that is largely ignored unless greatly exaggerated. ASR is suppressed after moderate and severe traumatic brain injury (TBI), but the effect of mild TBI (mTBI) on ASR has not been investigated. Because the neural circuitry for ASR resides in the pons in all mammals, ASR may be a good measure of brainstem function after mTBI. The present study assessed ASR in Sprague-Dawley rats after mTBI using lateral fluid percussion and compared these effects to those on spatial working memory. mTBI caused a profound, long-lasting suppression of ASR. Both probability of emitting a startle and startle amplitude were diminished. ASR suppression was observed as soon as 1 day after injury and remained suppressed for the duration of the study (21 days after injury). No indication of recovery was observed. mTBI also impaired spatial working memory. In contrast to the suppression of ASR, working memory impairment was transient; memory was impaired 1 and 7 days after injury, but recovered by 21 days. The long-lasting suppression of ASR suggests long-term dysfunction of brainstem neural circuits at a time when forebrain neural circuits responsible for spatial working memory have recovered. These results have important implications for return-to-activity decisions because recovery of cognitive impairments plays an important role in these decisions.	[Pang, Kevin C. H.; Servatius, Richard J.] New Jersey Hlth Care Syst, Dept Vet Affairs Med Ctr, Neurobehav Res Lab, E Orange, NJ 07018 USA; [Pang, Kevin C. H.; Sinha, Swamini; Avcu, Pelin; Roland, Jessica J.; Servatius, Richard J.] Univ Med & Dent New Jersey, New Jersey Med Sch, Rutgers Biomed & Hlth Sci, Stress & Motivated Behav Inst, Newark, NJ 07103 USA; [Pang, Kevin C. H.; Roland, Jessica J.; Santhakumar, Vijayalakshmi; Servatius, Richard J.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol & Neurosci, Rutgers Biomed & Hlth Sci, Newark, NJ 07103 USA; [Pang, Kevin C. H.; Sinha, Swamini; Avcu, Pelin; Long, Mathew; Santhakumar, Vijayalakshmi; Servatius, Richard J.] Univ Med & Dent New Jersey, New Jersey Med Sch, Grad Sch Biomed Sci, Rutgers Biomed & Hlth Sci, Newark, NJ 07103 USA; [Pfister, Bryan; Long, Mathew] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA; [Nadpara, Neil] Coll New Jersey, Ewing, NJ USA		Pang, KCH (corresponding author), New Jersey Hlth Care Syst, VA Med Ctr, 385 Tremont Ave,Mailstop 15, E Orange, NJ 07018 USA.	kevin.pang@va.gov	Santhakumar, Viji/K-4856-2019	Santhakumar, Viji/0000-0001-6278-4187; Servatius, Richard/0000-0002-7023-4895	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS044373] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX000132] Funding Source: NIH RePORTER; VAUS Department of Veterans Affairs [2I01BX000132-05A2, 5I01BX000132-04] Funding Source: Federal RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS044373, R01-NS44373] Funding Source: Medline; BLRD VA [I01 BX000132] Funding Source: Medline		Abdul-Wahab R., 2011, IEEE 37 ANN NE, V1, P22011; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; BROWN JS, 1951, J EXP PSYCHOL, V41, P317, DOI 10.1037/h0060166; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; Carlson S, 1998, J NEUROPHYSIOL, V79, P2603, DOI 10.1152/jn.1998.79.5.2603; Chaparro RE, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-23; DAVIS M, 1982, J NEUROSCI, V2, P791; DAVIS M, 1972, J COMP PHYSIOL PSYCH, V78, P260, DOI 10.1037/h0032811; Eakin K, 2012, J NEUROTRAUM, V29, P1180, DOI 10.1089/neu.2011.2192; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Gupta A, 2012, J NEUROSCI, V32, P2523, DOI 10.1523/JNEUROSCI.4141-11.2012; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; Hellmich HL, 2007, BRAIN RES, V1127, P119, DOI 10.1016/j.brainres.2006.09.094; HOY R, 1989, J EXP BIOL, V146, P287; Kalia M, 2005, METABOLISM, V54, P24, DOI 10.1016/j.metabol.2005.01.009; Kobori N, 2011, NEUROSCIENCE, V172, P293, DOI 10.1016/j.neuroscience.2010.10.048; Koch M, 1999, PROG NEUROBIOL, V59, P107, DOI 10.1016/S0301-0082(98)00098-7; LINGENHOHL K, 1994, J NEUROSCI, V14, P1176, DOI 10.1523/JNEUROSCI.14-03-01176.1994; Lu J, 2003, NEUROPHARMACOLOGY, V44, P253, DOI 10.1016/S0028-3908(02)00380-5; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; Neuberger EJ, 2014, J NEUROSCI RES, V92, P1350, DOI 10.1002/jnr.23401; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Pissiota A, 2002, EUR J NEUROSCI, V15, P395, DOI 10.1046/j.0953-816x.2001.01870.x; Reid WM, 2010, J NEUROTRAUM, V27, P1243, DOI 10.1089/neu.2010.1270; Sanders MJ, 1999, J NEUROTRAUM, V16, P915, DOI 10.1089/neu.1999.16.915; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Saunders JC, 2006, NEUROPSYCHOLOGY, V20, P224, DOI 10.1037/0894-4105.20.2.224; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Servatius RJ, 2005, BIOL PSYCHIAT, V57, P865, DOI 10.1016/j.biopsych.2005.01.015; Teng SX, 2014, J NEUROTRAUM, V31, P378, DOI 10.1089/neu.2013.3093; Trillo L, 2013, NEUROSCI BIOBEHAV R, V37, P1363, DOI 10.1016/j.neubiorev.2013.05.008; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; Wiley JL, 1996, BRAIN RES, V716, P47, DOI 10.1016/0006-8993(96)00045-5; Williams C, 2012, J CLIN EXP NEUROPSYC, V34, P948, DOI 10.1080/13803395.2012.703641; Xing GQ, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00196; Yeomans JS, 1995, BRAIN RES REV, V21, P301, DOI 10.1016/0165-0173(96)00004-5; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	42	17	17	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2015	32	11					801	810		10.1089/neu.2014.3451			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CV0YU	WOS:000363980700005	25412226	Green Published			2022-02-06	
J	Sun, B; Hu, C; Fang, H; Zhu, LN; Gao, N; Zhu, JC				Sun, Bo; Hu, Chen; Fang, Huan; Zhu, Lina; Gao, Ning; Zhu, Jingci			The Effects of Lactobacillus acidophilus on the Intestinal Smooth Muscle Contraction through PKC/MLCK/MLC Signaling Pathway in TBI Mouse Model	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; DEPENDENT PROTEIN-KINASE; LIGHT-CHAIN KINASE; INTERSTITIAL-CELLS; PHOSPHORYLATION; RELAXATION; CPI-17; GROWTH; SUPPLEMENTATION; SENSITIZATION	Clinical studies have shown that probiotics influence gastrointestinal motility. However, the molecular mechanisms by which probiotic Lactobacillus modulates intestinal motility in traumatic brain injury (TBI) mouse model have not been explored. In the present study, we provided evidence showing that treatment of TBI mice with Lactobacillus acidophilus significantly improved the terminal ileum villus morphology, restored the impaired interstitial cells of Cajal (ICC) and the disrupted ICC networks after TBI, and prevented TBI-mediated inhibition of contractile activity in intestinal smooth muscle. Mechanistically, the decreased concentration of MLCK, phospho-MLC20 and phospho-MYPT1 and increased concentration of MLCP and PKC were observed after TBI, and these events mediated by TBI were efficiently prevented by Lactobacillus acidophilus application. These findings may provide a novel mechanistic basis for the application of Lactobacillus acidophilus in the treatment of TBI.	[Sun, Bo; Hu, Chen; Fang, Huan; Zhu, Lina; Zhu, Jingci] Third Mil Med Univ, Sch Nursing, Chongqing 400038, Peoples R China; [Gao, Ning] Third Mil Med Univ, Coll Pharm, Chongqing 400038, Peoples R China		Gao, N (corresponding author), Third Mil Med Univ, Coll Pharm, Chongqing 400038, Peoples R China.	gaoning59@163.com; zhujingci2009@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81272079]	This study was funded by the National Natural Science Foundation of China, grant number 81272079, URL: http://www.nsfc.gov.cn/, received by JCZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayman S, 2003, BRIT J PHARMACOL, V139, P1532, DOI 10.1038/sj.bjp.0705394; Bar F, 2009, NEUROGASTROENT MOTIL, V21, P575, DOI 10.1111/j.1365-2982.2008.01258.x; BATEUP JM, 1995, APPL ENVIRON MICROB, V61, P1147, DOI 10.1128/AEM.61.3.1147-1149.1995; Biancani P, 1997, AM J MED, V103, p23S, DOI 10.1016/S0002-9343(97)00316-1; Borthakur A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075664; Botes M, 2008, ARCH MICROBIOL, V190, P573, DOI 10.1007/s00203-008-0408-0; Bowen Denise M, 2013, J Dent Hyg, V87, P5; Cao WB, 2003, AM J PHYSIOL-GASTR L, V285, pG86, DOI 10.1152/ajpgi.00156.2002; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Duan HB, 2013, J SURG RES, V184, P1006, DOI 10.1016/j.jss.2013.03.096; Dumonceaux TJ, 2006, APPL ENVIRON MICROB, V72, P2815, DOI 10.1128/AEM.72.4.2815-2823.2006; Ehrmann MA, 2002, J APPL MICROBIOL, V92, P966, DOI 10.1046/j.1365-2672.2002.01608.x; Farhad K, 2013, J NEUROTRAUM, V30, P84, DOI 10.1089/neu.2011.2283; Folkerts MM, 2007, J NEUROTRAUM, V24, P638, DOI 10.1089/neu.2006.0188; Garaulet M, 2013, INT J OBESITY, V37, P604, DOI 10.1038/ijo.2012.229; Gomes AMP, 1999, TRENDS FOOD SCI TECH, V10, P139, DOI 10.1016/S0924-2244(99)00033-3; Hersch E, 2004, AM J PHYSIOL-CELL PH, V287, pC1209, DOI 10.1152/ajpcell.00198.2004; Ihara E, 2007, CAN J PHYSIOL PHARM, V85, P79, DOI 10.1139/Y06-103; IKEBE M, 1985, J BIOL CHEM, V260, P4547; Kitazawa T, 2003, J PHYSIOL-LONDON, V546, P879, DOI 10.1113/jphysiol.2002.029306; Lipp P, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004556; Liu S, 2013, NEURAL REGEN RES, V8, P3334, DOI 10.3969/j.issn.1673-5374.2013.35.008; Liu ZH, 2014, MOL BIOL REP, V41, P8037, DOI 10.1007/s11033-014-3701-9; Lorincz A, 2008, GASTROENTEROLOGY, V134, P1083, DOI 10.1053/j.gastro.2008.01.036; Mahavadi S, 2014, CELL BIOCHEM BIOPHYS, V68, P1, DOI 10.1007/s12013-013-9677-6; Massi M, 2006, WORLD J GASTROENTERO, V12, P5987, DOI 10.3748/wjg.v12.i37.5987; Murthy KS, 2006, ANNU REV PHYSIOL, V68, P345, DOI 10.1146/annurev.physiol.68.040504.094707; Murthy KS, 2003, BIOCHEM J, V374, P145, DOI 10.1042/BJ20021274; Nalli AD, 2014, J PHARMACOL EXP THER, V350, P89, DOI 10.1124/jpet.113.212522; Nazzaro F, 2012, ANAEROBE, V18, P280, DOI 10.1016/j.anaerobe.2012.03.002; Ojetti V, 2014, J GASTROINTEST LIVER, V23, P387, DOI 10.15403/jgld.2014.1121.234.elr; Olsen AB, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12121; Pan Hong, 2014, Fa Yi Xue Za Zhi, V30, P169; Porcher C, 2002, AM J GASTROENTEROL, V97, P118; Rauch S, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.12.002; Savard P, 2011, INT J FOOD MICROBIOL, V149, P50, DOI 10.1016/j.ijfoodmicro.2010.12.026; Singhi SC, 2008, INDIAN J PEDIATR, V75, P621, DOI 10.1007/s12098-008-0119-1; Surks HK, 2007, CIRC RES, V101, P1078, DOI 10.1161/CIRCRESAHA.107.165779; Tan M, 2011, BRIT J NEUROSURG, V25, P2, DOI 10.3109/02688697.2010.522745; Webb RC, 2003, ADV PHYSIOL EDUC, V27, P201, DOI 10.1152/advan.00025.2003; Weber LP, 2000, BIOCHEM J, V352, P573, DOI 10.1042/0264-6021:3520573; Ye J, 2006, J CELL MOL MED, V10, P687, DOI 10.1111/j.1582-4934.2006.tb00428.x; Yu QH, 2013, HUM VACC IMMUNOTHER, V9, P805, DOI 10.4161/hv.23302	43	17	23	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128214	10.1371/journal.pone.0128214			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	WOS:000356630900127	26030918	Green Published, Green Submitted, gold			2022-02-06	
J	Saluja, RS; Chen, JK; Gagnon, IJ; Keightley, M; Ptito, A				Saluja, Rajeet Singh; Chen, Jen-Kai; Gagnon, Isabelle J.; Keightley, Michelle; Ptito, Alain			Navigational Memory Functional Magnetic Resonance Imaging: A Test for Concussion in Children	JOURNAL OF NEUROTRAUMA			English	Article						fMRI; children; navigational memory; concussion	TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; FMRI; MRI; SPORTS; PERFORMANCE; SYMPTOMS; RECOVERY	Concussions are high incidence injuries with potentially devastating consequences. Youths are at risk because of a higher threat of repeated injury, and cumulative effects of concussions exist, making accurate diagnosis and follow-up essential. This study examines a navigational memory functional magnetic resonance imaging (fMRI) task to determine whether activation differences exist between children with concussion and uninjured controls. Fifty adolescents were recruited-35 controls and 15 with concussion. All subjects underwent structural and fMRI testing using our navigational memory task, and a battery of neuropsychological testing. The activation patterns of the 15 subjects with concussion were compared with those of 15 age and sex-matched controls. Subtraction and regression analyses were performed using the matched controls along with scatter-plots using means and 95% quantiles of the 35 controls. While no differences were seen with neuropsychological testing or task performance, subjects with concussion had significantly diminished activation in the retrosplenial, thalamic, and parahippocampal areas bilaterally, along with the right dorsolateral prefrontal cortex and left precuneus. Interestingly, they had increased activation in the left hippocampus and right middle temporal gyrus. Regression analysis demonstrated negative correlations between activation and post-concussive symptoms in the left premotor cortex, superior and inferior parietal lobules, and parahippocampal gyrus. Subjects with concussion show both diminished and increased activation in specific cerebral regions, differentiating them from controls. This is one of the first studies to look at such a task using fMRI and its applicability in testing for concussion in children. These findings support navigational memory fMRI as a potential objective test for concussions.	[Saluja, Rajeet Singh; Chen, Jen-Kai; Ptito, Alain] McGill Univ, Dept Neurol & Neurosurg, Hlth Ctr Res Inst, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; [Gagnon, Isabelle J.] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ H3A 2B4, Canada; [Gagnon, Isabelle J.] McGill Univ, Ctr Hlth, Trauma Programs, Montreal Childrens Hosp, Montreal, PQ H3A 2B4, Canada; [Gagnon, Isabelle J.] McGill Univ, Ctr Hlth, Div Gen Pediat, Montreal Childrens Hosp, Montreal, PQ H3A 2B4, Canada; [Keightley, Michelle] Univ Toronto, Bloorview Res Inst, Holland Bloorview Kids Rehabil Hosp, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Keightley, Michelle] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON, Canada		Ptito, A (corresponding author), McGill Univ, Dept Neurol Neurosurg, 3801 Univ, Montreal, PQ H3A 2B4, Canada.	alain.ptito@mcgill.ca	Meijer, Anna/K-5118-2016	Gagnon, Isabelle/0000-0003-2043-1644	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Frank Litvack Fellowship for Clinician Scientists; Fonds de recherche du Quebec - SanteFonds de la Recherche en Sante du Quebec; CIHRCanadian Institutes of Health Research (CIHR) [231257]	This study was supported by grants from the Canadian Institutes of Health Research. R.S.S. was a recipient of the Frank Litvack Fellowship for Clinician Scientists and an award from the Fonds de recherche du Quebec - Sante for resident physician scientists. J- K.C. was a recipient of a postdoctoral award from Fonds de recherche du Quebec-Sante. IG is supported by a career award from the Fonds de recherche du Quebec-Sante. A.P. and I.G. are supported by CIHR grant #231257. The neuropsychological testing was performed by Dr. Gabriel Leonard at the Montreal Neurological Institute.	Alonso A, 2008, NEUROLOGY, V71, P129, DOI 10.1212/01.wnl.0000316802.35974.34; BOHNEN N, 1992, ACTA NEUROL SCAND, V85, P116, DOI 10.1111/j.1600-0404.1992.tb04009.x; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen JK, 2008, CLIN J SPORT MED, V18, P241, DOI 10.1097/JSM.0b013e318170b59d; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chuah YML, 2004, BRAIN COGNITION, V56, P304, DOI 10.1016/j.bandc.2004.08.002; Coronado VG, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P84; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Iaria G, 2007, EUR J NEUROSCI, V25, P890, DOI 10.1111/j.1460-9568.2007.05371.x; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Keightley ML, 2012, CURR OPIN PEDIATR, V24, P709, DOI 10.1097/MOP.0b013e3283599a55; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Mami Ahmed G, 2008, Adv Pediatr, V55, P385, DOI 10.1016/j.yapd.2008.07.011; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; NEWCOMBE F, 1994, J NEUROL NEUROSUR PS, V57, P709, DOI 10.1136/jnnp.57.6.709; Ptito A, 2007, NEUROREHABILITATION, V22, P217; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Sander JW, 2003, CURR OPIN NEUROL, V16, P165, DOI 10.1097/00019052-200304000-00008; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Spiers HJ, 2007, NEUROSCIENCE, V149, P7, DOI 10.1016/j.neuroscience.2007.06.056; Steer, 2005, BECK YOUTH INVENTORI; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Thesen S, 2000, MAGNET RESON MED, V44, P457, DOI 10.1002/1522-2594(200009)44:3<457::AID-MRM17>3.0.CO;2-R; Twelves D, 2003, MOVEMENT DISORD, V18, P19, DOI 10.1002/mds.10305; Waber DP, 2007, J INT NEUROPSYCH SOC, V13, P729, DOI 10.1017/S1355617707070841; Worsley KJ, 2002, NEUROIMAGE, V15, P1, DOI 10.1006/nimg.2001.0933; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Yang Z, 2012, J NEUROTRAUM, V29, P2124, DOI 10.1089/neu.2012.2395	33	17	17	1	15	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2015	32	10					712	722		10.1089/neu.2014.3470			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CH3ZP	WOS:000353970200006	25270364				2022-02-06	
J	Sierra-Mercado, D; McAllister, LM; Lee, CCH; Milad, MR; Eskandar, EN; Whalen, MJ				Sierra-Mercado, Demetrio; McAllister, Lauren M.; Lee, Christopher C. H.; Milad, Mohammed R.; Eskandar, Emad N.; Whalen, Michael J.			Controlled cortical impact before or after fear conditioning does not affect fear extinction in mice	BRAIN RESEARCH			English	Article						Traumatic brain injury; Fear learning; Extinction; Anxiety disorder; Dorsal hippocampus; Learning and memory; Rodent	TRAUMATIC BRAIN-INJURY; VENTROMEDIAL PREFRONTAL CORTEX; POSTTRAUMATIC-STRESS-DISORDER; VENTRAL HIPPOCAMPUS; DORSAL HIPPOCAMPUS; AMYGDALA; LESIONS; MILD; EXPRESSION; ANXIETY	Post-traumatic stress disorder (PTSD) is characterized in part by impaired extinction of conditioned fear. Traumatic brain injury (TBI) is thought to be a risk factor for development of PTSD. We tested the hypothesis that controlled cortical impact (CCI) would impair extinction of fear learned by Pavlovian conditioning, in mice. To mimic the scenarios in which TBI occurs prior to or after exposure to an aversive event, severe CCI was delivered to the left parietal cortex at one of two time points: (1) Prior to fear conditioning, or (2) after conditioning. Delay auditory conditioning was achieved by pairing a tone with a foot shock in "context A". Extinction training involved the presentation of tones in a different context (context B) in the absence of foot shock. Test for extinction memory was achieved by presentation of additional tones alone in context B over the following two days. In pre- or post-injury paradigms, CCI did not influence fear learning and extinction. Furthermore, CCI did not affect locomotor activity or elevated plus maze testing. Our results demonstrate that, within the time frame studied, CCI does not impair the acquisition and expression of conditioned fear or extinction memory. (C) 2015 Elsevier B.V. All rights reserved.	[Sierra-Mercado, Demetrio; McAllister, Lauren M.; Lee, Christopher C. H.; Whalen, Michael J.] Massachusetts Gen Hosp, Neurosci Ctr, Boston, MA 02114 USA; [Sierra-Mercado, Demetrio; McAllister, Lauren M.; Lee, Christopher C. H.; Whalen, Michael J.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Sierra-Mercado, Demetrio; McAllister, Lauren M.; Lee, Christopher C. H.; Milad, Mohammed R.; Eskandar, Emad N.; Whalen, Michael J.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Sierra-Mercado, Demetrio; Eskandar, Emad N.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Milad, Mohammed R.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Sierra-Mercado, Demetrio] Univ Puerto Rico, Sch Med, Dept Anat & Neurobiol, San Juan, PR 00936 USA		Sierra-Mercado, D (corresponding author), Univ Puerto Rico, Sch Med, Dept Anat & Neurobiol, San Juan, PR 00936 USA.	demetrio.sierra@upr.edu; LMCALLISTER1@mgh.harvard.edu; lee.chris.ch@gmail.com; milad@nmr.mgh.harvard.edu; eeskandar@mgh.harvard.edu; mwhalen@partners.org	Milad, Mohammed R/O-4553-2018		RCMI [8G12MD007600]; Brain & Behavior Research Foundation (NARSAD) [MH097964, MH097880, MH086400, NS086422]; DOD/CIMIT [W81XWH-07-2-0011]; Behavioral Core Facility [P01NS5510406];  [DA026297]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH097880, R01MH097964, P50MH086400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS055104, R01NS086422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA026297] Funding Source: NIH RePORTER; National Institute on Minority Health and Health DisparitiesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [G12MD007600] Funding Source: NIH RePORTER	We thank Jimmy Zhang for technical assistance. This study was supported in part by RCMI 8G12MD007600, a supplement from DA026297 and a Young Investigator Grant from the Brain & Behavior Research Foundation (NARSAD) to DS-M, MH097964 and MH097880 to MRM, MH086400 and NS086422 to ENE, DOD/CIMIT W81XWH-07-2-0011 to MJW, and Behavioral Core Facility (P01NS5510406).	Abrous DN, 1999, BRAIN RES, V826, P181, DOI 10.1016/S0006-8993(99)01259-7; Anglada-Figueroa D, 2005, J NEUROSCI, V25, P9680, DOI 10.1523/JNEUROSCI.2600-05.2005; Bahraini NH, 2014, PSYCHIAT CLIN N AM, V37, P55, DOI 10.1016/j.psc.2013.11.002; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Bouton ME, 2004, LEARN MEMORY, V11, P485, DOI 10.1101/lm.78804; Corcoran KA, 2005, J NEUROSCI, V25, P8978, DOI 10.1523/JNEUROSCI.2246-05.2005; Devan BD, 1999, J NEUROSCI, V19, P2789; Devan BD, 1996, NEUROBIOL LEARN MEM, V66, P305, DOI 10.1006/nlme.1996.0072; Farinelli M, 2006, LEARN MEMORY, V13, P329, DOI 10.1101/lm.204806; Gallistel CR, 2000, PSYCHOL REV, V107, P289, DOI 10.1037/0033-295X.107.2.289; Genovese RF, 2013, NEUROSCIENCE, V254, P120, DOI 10.1016/j.neuroscience.2013.09.021; Hefner K, 2008, J NEUROSCI, V28, P8074, DOI 10.1523/JNEUROSCI.4904-07.2008; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hogg S, 1998, BEHAV BRAIN RES, V93, P157, DOI 10.1016/S0166-4328(97)00145-9; Khuman J, 2011, J CEREBR BLOOD F MET, V31, P778, DOI 10.1038/jcbfm.2010.172; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lowing JL, 2014, J NEUROTRAUM, V31, P1700, DOI 10.1089/neu.2013.3286; Maren S, 1997, BEHAV BRAIN RES, V88, P261, DOI 10.1016/S0166-4328(97)00088-0; Maren S, 2004, BEHAV NEUROSCI, V118, P97, DOI 10.1037/0735-7044.118.1.97; Maren S, 2008, EUR J NEUROSCI, V28, P1661, DOI 10.1111/j.1460-9568.2008.06485.x; McHugh SB, 2004, BEHAV NEUROSCI, V118, P63, DOI 10.1037/0735-7044.118.1.63; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; Milad MR, 2006, BIOL PSYCHOL, V73, P61, DOI 10.1016/j.biopsycho.2006.01.008; Milad MR, 2012, ANNU REV PSYCHOL, V63, P129, DOI 10.1146/annurev.psych.121208.131631; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; Milad MR, 2005, PSYCHOPHYSIOLOGY, V42, P456, DOI 10.1111/j.1469-8986.2005.00302.x; MORRIS RGM, 1990, EUR J NEUROSCI, V2, P1016, DOI 10.1111/j.1460-9568.1990.tb00014.x; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Pavlov I.P., 1927, CONDITIONED REFLEXES; PELLOW S, 1985, NEUROSCI BIOBEHAV R, V9, P55, DOI 10.1016/0149-7634(85)90032-6; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pitman RK, 2012, NAT REV NEUROSCI, V13, P769, DOI 10.1038/nrn3339; Quinn JJ, 2008, HIPPOCAMPUS, V18, P640, DOI 10.1002/hipo.20424; Quirk GJ, 2000, J NEUROSCI, V20, P6225, DOI 10.1523/JNEUROSCI.20-16-06225.2000; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Richmond MA, 1999, BEHAV NEUROSCI, V113, P1189, DOI 10.1037/0735-7044.113.6.1189; Rothbaum BO, 2003, ANN NY ACAD SCI, V1008, P112, DOI 10.1196/annals.1301.012; Rougemont-Bucking A, 2011, CNS NEUROSCI THER, V17, P227, DOI 10.1111/j.1755-5949.2010.00152.x; Runyan JD, 2004, J NEUROSCI, V24, P1288, DOI 10.1523/JNEUROSCI.4880-03.2004; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sierra-Mercado D, 2011, NEUROPSYCHOPHARMACOL, V36, P529, DOI 10.1038/npp.2010.184; Sierra-Mercado D, 2006, EUR J NEUROSCI, V24, P1751, DOI 10.1111/j.1460-9568.2006.05014.x; Sotres-Bayon F, 2007, NEUROPSYCHOPHARMACOL, V32, P1929, DOI 10.1038/sj.npp.1301316; Sotres-Bayon F, 2012, NEURON, V76, P804, DOI 10.1016/j.neuron.2012.09.028; Sotres-Bayon F, 2010, CURR OPIN NEUROBIOL, V20, P231, DOI 10.1016/j.conb.2010.02.005; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Vidal-Gonzalez I, 2006, LEARN MEMORY, V13, P728, DOI 10.1101/lm.306106; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Yang JS, 2010, J NEUROTRAUM, V27, P1037, DOI 10.1089/neu.2009.1229	55	17	17	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAY 5	2015	1606						133	141		10.1016/j.brainres.2015.02.031			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CH0XR	WOS:000353746200014	25721797	Green Accepted			2022-02-06	
J	Coste, C; Navarro, B; Vallat-Azouvi, C; Brami, M; Azouvi, P; Piolino, P				Coste, Cecile; Navarro, Beatrice; Vallat-Azouvi, Claire; Brami, Marie; Azouvi, Philippe; Piolino, Pascale			Disruption of temporally extended self-memory system following traumatic brain injury	NEUROPSYCHOLOGIA			English	Article						Self-memory system; Autobiographical memory; Future; Mental time travel; Self-concept; Executive function; Working memory binding; Verbal fluency; Traumatic brain injury	EPISODIC FUTURE THINKING; MENTAL TIME-TRAVEL; AUTOBIOGRAPHICAL MEMORY; WORKING-MEMORY; EXECUTIVE FUNCTIONS; PROJECTING ONESELF; SEMANTIC MEMORY; VISUAL-IMAGERY; OLDER-ADULTS; SIMULATION	We investigated for the first time the episodic/semantic distinction in remembering the past and imagining the future in traumatic brain injury (TB!), and explored cognitive mechanisms that may underlie their deficits. Fifteen severe TBI patients and 15 control participants performed a battery of neuropsychological tests and a set of verbal fluency tasks designed to assess semantic (personality traits knowledge and general events), and episodic (specific events and details) facets of self-representations according to three time periods (remote/retrograde past, recent/anterograde past, future). Compared to controls, TBI patients showed deficits in both semantic and episodic self-representations, regardless of the time period, and controlling for basic cognitive functions. By contrast, a subjective evaluation of self-concept measuring the degree of certitude and the valence of self did not differ between patients and controls. The deficits were mainly predicted by altered executive function (i.e., updating) for past periods, as well as by general semantic and feature binding in working memory for the future period, independently of the injury characteristics. For controls, only episodic self-representation for each time period was mediated by executive or working memory functions, while semantic self-representation was mediated by the certitude of the self. This study highlights the dual role of semantic and episodic representations in temporally extended self, and shows the global disruption of self-representations across extended time in severe TBI. This encourages the extension of past and future thinking research to TBI populations to provide important insights into the nature and origin of these deficits and their role in recovery and to suggest future lines of research on rehabilitation procedures. (C) 2015 Elsevier Ltd. All rights reserved.	[Coste, Cecile; Navarro, Beatrice; Piolino, Pascale] Paris Descartes Univ, Sorbonne Paris Cite, Inst Psychol, Memory & Cognit Lab, Paris, France; [Coste, Cecile; Navarro, Beatrice; Piolino, Pascale] Paris Descartes Univ, Inserm UMR S 894, Ctr Psychiat & Neurosci, Paris, France; [Coste, Cecile] Hop St Maurice, Adults Neurol Unity, St Maurice, France; [Vallat-Azouvi, Claire] Hop Raymond Poincare, UEROS UGECAM, Garches, France; [Brami, Marie] ADEP CICL, Puteaux La Defense, France; [Azouvi, Philippe] Hop Raymond Poincare, Phys Med & Rehabil Serv, Garches, France		Piolino, P (corresponding author), Ctr Psychiat & Neurosci, Memory & Cognit Lab, Inserm UMR 894, 2 Ter Rue Alesia, F-75014 Paris, France.	pascale.piolino@parisdescartes.fr			French Ministry of ResearchMinistry of Research, FranceEuropean Commission	The study was funded by a PhD allocation to CC from the French Ministry of Research. The authors would like to thank the participants and the patients for volunteering for this study, and all members of the French UEROS - Unity of Evaluation, Re-training and Social and Professional Orientation - and French CICL Unit Insertion unit for brain-injured patients for their valuable help.	Abram M, 2014, CONSCIOUS COGN, V29, P76, DOI 10.1016/j.concog.2014.07.011; Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Addis DR, 2010, PSYCHOL AGING, V25, P369, DOI 10.1037/a0017280; Addis DR, 2009, NEUROPSYCHOLOGIA, V47, P2660, DOI 10.1016/j.neuropsychologia.2009.05.018; Addis DR, 2004, MEMORY, V12, P56, DOI 10.1080/09658210244000423; Anderson RJ, 2009, MEMORY, V17, P367, DOI 10.1080/09658210902751669; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Belleville S, 2006, BRAIN COGNITION, V62, P113, DOI 10.1016/j.bandc.2006.04.006; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Burgess P, 1996, BEHAV ASSESSMENT DYS; CARDEBAT D, 1990, ACTA NEUROL BELG, V90, P207; Carlesimo GA, 1998, CORTEX, V34, P1, DOI 10.1016/S0010-9452(08)70734-2; Chessell Z. J., 2013, SELF IDENTITY, P1; Cole SN, 2013, Q J EXP PSYCHOL, V66, P1687, DOI 10.1080/17470218.2012.758157; Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261; Conway MA, 2005, J MEM LANG, V53, P594, DOI 10.1016/j.jml.2005.08.005; Conway MA, 2004, SOC COGNITION, V22, P491, DOI 10.1521/soco.22.5.491.50768; Conway MA, 2009, NEUROPSYCHOLOGIA, V47, P2305, DOI 10.1016/j.neuropsychologia.2009.02.003; Coste C, 2011, CORTEX, V47, P771, DOI 10.1016/j.cortex.2010.07.004; D'Argembeau A, 2004, CONSCIOUS COGN, V13, P844, DOI 10.1016/j.concog.2004.07.007; D'Argembeau A, 2006, CONSCIOUS COGN, V15, P342, DOI 10.1016/j.concog.2005.09.001; D'Argembeau A, 2010, MEM COGNITION, V38, P809, DOI 10.3758/MC.38.6.809; de Vito S, 2012, NEUROPSYCHOLOGIA, V50, P1494, DOI 10.1016/j.neuropsychologia.2012.03.001; Delis DC, 1987, CALIFORNIA VERBAL LE; Deltour J. J., 1993, ECHELLE VOCABULAIRE; Dritschel BH, 1998, BRAIN INJURY, V12, P875; Duval C, 2007, PSYCHOL NEUROPSYCHIA, V5, P179, DOI 10.1684/pnv.2007.0100; Duval C, 2012, NEUROPSYCHOLOGIA, V50, P254, DOI 10.1016/j.neuropsychologia.2011.11.019; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Ergorul C, 2004, LEARN MEMORY, V11, P397, DOI 10.1101/lm.73304; Fedio A, 2014, ARCH CLIN NEUROPSYCH, V29; Fitts WH., 1996, TENNESSEE SELF CONCE; Gueguen N., 2009, EUROPEAN J SCI RES, V38, P20; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Haslam C, 2011, BRIT J PSYCHOL, V102, P184, DOI 10.1348/000712610X508091; Hassabis D, 2007, P NATL ACAD SCI USA, V104, P1726, DOI 10.1073/pnas.0610561104; Hewitt J, 2006, NEUROPSYCHOLOGIA, V44, P1468, DOI 10.1016/j.neuropsychologia.2005.11.016; Hill PF, 2013, CONSCIOUS COGN, V22, P677, DOI 10.1016/j.concog.2013.04.002; Hughes DL, 2002, J CLIN EXP NEUROPSYC, V24, P642, DOI 10.1076/jcen.24.5.642.1002; Irish M, 2013, CORTEX, V49, P2377, DOI 10.1016/j.cortex.2013.03.002; Irish M, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00027; Irish M, 2012, NEUROPSYCHOLOGIA, V50, P3488, DOI 10.1016/j.neuropsychologia.2012.09.012; Irish M, 2012, BRAIN, V135, P2178, DOI 10.1093/brain/aws119; Irish M, 2012, NAT REV NEUROL, V8, P152, DOI 10.1038/nrneurol.2012.11; Klein SB, 2002, SOC COGNITION, V20, P353, DOI 10.1521/soco.20.5.353.21125; Klein SB, 2013, WIRES COGN SCI, V4, P63, DOI 10.1002/wcs.1210; Klein SB, 2010, WIRES COGN SCI, V1, P172, DOI 10.1002/wcs.25; Knight RG, 2009, J CLIN EXP NEUROPSYC, V31, P575, DOI 10.1080/13803390802363710; Kopelman MD, 2002, BRAIN, V125, P2152, DOI 10.1093/brain/awf229; Kwan D, 2010, NEUROPSYCHOLOGIA, V48, P3179, DOI 10.1016/j.neuropsychologia.2010.06.011; Lalanne J, 2015, NEUROPSYCHOL REHABIL, V25, P254, DOI 10.1080/09602011.2014.949276; Lalanne J, 2013, CURR ALZHEIMER RES, V10, P1107, DOI 10.2174/15672050113106660175; Lalova M, 2013, COMPR PSYCHIAT, V54, P369, DOI 10.1016/j.comppsych.2012.10.005; Maguire EA, 2010, NEUROPSYCHOLOGIA, V48, P3187, DOI 10.1016/j.neuropsychologia.2010.06.037; MARKUS H, 1986, AM PSYCHOL, V41, P954, DOI 10.1037/0003-066X.41.9.954; Martinelli P, 2013, NEUROPSYCHOLOGY, V27, P69, DOI 10.1037/a0030453; McPartland T., 1954, AM SOCIOLOGICAL Q, V5, P61; Mcwilliams J, 2008, BRAIN INJURY, V22, P243, DOI 10.1080/02699050801935252; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; MORRIS N, 1990, PERCEPT PSYCHOPHYS, V47, P291, DOI 10.3758/BF03205003; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Okuda J, 2003, NEUROIMAGE, V19, P1369, DOI 10.1016/S1053-8119(03)00179-4; Picard L, 2013, CORTEX, V49, P1463, DOI 10.1016/j.cortex.2012.10.003; Piolino P, 2007, CORTEX, V43, P176, DOI 10.1016/S0010-9452(08)70474-X; Piolino P, 2010, NEUROPSYCHOLOGIA, V48, P429, DOI 10.1016/j.neuropsychologia.2009.09.035; Prabhakaran V, 2000, NAT NEUROSCI, V3, P85, DOI 10.1038/71156; Prebble SC, 2013, PSYCHOL BULL, V139, P815, DOI 10.1037/a0030146; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Quinette P, 2003, BRAIN, V126, P1917, DOI 10.1093/brain/awg201; Quinette P, 2006, NEUROPSYCHOLOGIA, V44, P2508, DOI 10.1016/j.neuropsychologia.2006.03.031; Rasmussen KW, 2014, J NEUROPSYCHOL, V8, P34, DOI 10.1111/jnp.12003; Raven J., MANUAL RAVENS PROGR; Rosenbaum RS, 2004, NEUROPSYCHOLOGIA, V42, P1619, DOI 10.1016/j.neuropsychologia.2004.04.010; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sanchez-Carrion R, 2008, NEUROIMAGE, V43, P421, DOI 10.1016/j.neuroimage.2008.08.003; Schacter DL, 2007, BEHAV BRAIN SCI, V30, P331, DOI 10.1017/S0140525X07002178; Schacter DL, 2007, PHILOS T R SOC B, V362, P773, DOI 10.1098/rstb.2007.2087; Schacter DL, 2008, ANN NY ACAD SCI, V1124, P39, DOI 10.1196/annals.1440.001; Serino A, 2006, BRAIN INJURY, V20, P23, DOI 10.1080/02699050500309627; SPECTOR A, 1976, AM J PSYCHOL, V89, P669, DOI 10.2307/1421465; Squire LR, 2010, P NATL ACAD SCI USA, V107, P19044, DOI 10.1073/pnas.1014391107; Suddendorf T, 2009, PHILOS T R SOC B, V364, P1317, DOI 10.1098/rstb.2008.0301; Szpunar KK, 2007, P NATL ACAD SCI USA, V104, P642, DOI 10.1073/pnas.0610082104; Szpunar KK, 2010, PERSPECT PSYCHOL SCI, V5, P142, DOI 10.1177/1745691610362350; TEASDALE G, 1974, LANCET, V2, P81; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; TULVING E, 1988, BRAIN COGNITION, V8, P3, DOI 10.1016/0278-2626(88)90035-8; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vallat-Azouvi C, 2007, J INT NEUROPSYCH SOC, V13, P770, DOI 10.1017/S1355617707070993; Viard A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111046; Viard A, 2012, BRAIN COGNITION, V80, P111, DOI 10.1016/j.bandc.2012.05.004; Viard A, 2011, BRAIN COGNITION, V75, P1, DOI 10.1016/j.bandc.2010.10.009; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	99	17	17	0	20	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	MAY	2015	71						133	145		10.1016/j.neuropsychologia.2015.03.014			13	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	CI8PR	WOS:000355034700015	25795040				2022-02-06	
J	Gajavelli, S; Kentaro, S; Diaz, J; Yokobori, S; Spurlock, M; Diaz, D; Jackson, C; Wick, A; Zhao, WZ; Leung, LY; Shear, D; Tortella, F; Bullock, MR				Gajavelli, Shyam; Kentaro, Shimoda; Diaz, Julio; Yokobori, Shoji; Spurlock, Markus; Diaz, Daniel; Jackson, Clayton; Wick, Alexandra; Zhao, Weizhao; Leung, Lai Y.; Shear, Deborah; Tortella, Frank; Bullock, M. Ross			Glucose and oxygen metabolism after penetrating ballistic-like brain injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						2-deoxy glucose; cerebral metabolism; Fluorojade B; glucose; neurodegeneration; oxygen	ISCHEMIC PENUMBRA; GUNSHOT WOUNDS; UNITED-STATES; RAT MODEL; ACTIVATION; HEMORRHAGE; EXPRESSION; BIOMARKERS; SEVERITY	Traumatic brain injury (TBI) is a major cause of death and disability in all age groups. Among TBI, penetrating traumatic brain injuries (PTBI) have the worst prognosis and represent the leading cause of TBI-related morbidity and death. However, there are no specific drugs/interventions due to unclear pathophysiology. To gain insights we looked at cerebral metabolism in a PTBI rat model: penetrating ballistic-like brain injury (PBBI). Early after injury, regional cerebral oxygen tension and consumption significantly decreased in the ipsilateral cortex in the PBBI group compared with the control group. At the same time point, glucose uptake was significantly reduced globally in the PBBI group compared with the control group. Examination of Fluorojade B-stained brain sections at 24 hours after PBBI revealed an incomplete overlap of metabolic impairment and neurodegeneration. As expected, the injury core had the most severe metabolic impairment and highest neurodegeneration. However, in the peri-lesional area, despite similar metabolic impairment, there was lesser neurodegeneration. Given our findings, the data suggest the presence of two distinct zones of primary injury, of which only one recovers. We anticipate the peri-lesional area encompassing the PBBI ischemic penumbra, could be salvaged by acute therapies.	[Gajavelli, Shyam; Kentaro, Shimoda; Diaz, Julio; Spurlock, Markus; Diaz, Daniel; Jackson, Clayton; Wick, Alexandra; Zhao, Weizhao; Bullock, M. Ross] Univ Miami, Miller Sch Med, Dept Neurosurg, Miami, FL 33136 USA; [Yokobori, Shoji] Nippon Med Sch, Dept Emergency & Crit Care Med, Tokyo 113, Japan; [Leung, Lai Y.; Shear, Deborah; Tortella, Frank] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect & Neurorestorat, Silver Spring, MD USA		Bullock, MR (corresponding author), Univ Miami, Miller Sch Med, Dept Neurosurg, Lois Pope LIFE Ctr, Room 3-20,1095 NW 14th Terrace, Miami, FL 33136 USA.	RBullock@med.miami.edu	Gajavelli, Shyam/AAI-1374-2019	Gajavelli, Shyam/0000-0002-5947-6973	Department of DefenseUnited States Department of Defense [PT074521W81XWH-08-1-0419]	This work was supported by Department of Defense Grant #PT074521W81XWH-08-1-0419 to RB.	ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; BACK T, 1995, J CEREBR BLOOD F MET, V15, P566, DOI 10.1038/jcbfm.1995.70; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Cartagena CM, 2014, MOL CELL NEUROSCI, V60, P81, DOI 10.1016/j.mcn.2014.04.005; CAVALIERE R, 1988, ACTA NEUROCHIR, V94, P133, DOI 10.1007/BF01435866; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Davis CHO, 2014, P NATL ACAD SCI USA, V111, P9633, DOI 10.1073/pnas.1404651111; De Fazio M, 2011, NEUROCRIT CARE, V14, P91, DOI 10.1007/s12028-010-9494-3; Fu ES, 2005, CURR OPIN ANESTHESIO, V18, P181, DOI 10.1097/01.aco.0000162838.56344.88; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Heiss WD, 2011, CEREBROVASC DIS, V32, P307, DOI 10.1159/000330462; Henry Boret, 2012, J Emerg Trauma Shock, V5, P103, DOI 10.4103/0974-2700.93101; Jahrling N, 2009, ORGANOGENESIS, V5, P227, DOI 10.4161/org.5.4.10403; Joseph B, 2014, J AM COLL SURGEONS, V218, P58, DOI 10.1016/j.jamcollsurg.2013.08.018; Kalesan B, 2014, AM J EPIDEMIOL, V179, P303, DOI 10.1093/aje/kwt255; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; Kazim Syed Faraz, 2011, J Emerg Trauma Shock, V4, P395, DOI 10.4103/0974-2700.83871; Levasseur JE, 2000, J NEUROTRAUM, V17, P101, DOI 10.1089/neu.2000.17.101; Maxwell WL, 2010, BRAIN, V133, P139, DOI 10.1093/brain/awp264; Murakami Y, 2012, J NEUROSCI METH, V203, P115, DOI 10.1016/j.jneumeth.2011.09.025; Pandya JD, 2009, EXP NEUROL, V218, P381, DOI 10.1016/j.expneurol.2009.05.023; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Semenza GL, 2011, BBA-MOL CELL RES, V1813, P1263, DOI 10.1016/j.bbamcr.2010.08.006; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; Tsukada H, 2014, J CEREBR BLOOD F MET, V34, P708, DOI 10.1038/jcbfm.2014.5; Vaccari JPD, 2014, J CEREBR BLOOD F MET, V34, P369, DOI 10.1038/jcbfm.2013.227; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Wei G, 2010, J NEUROTRAUM, V27, P1635, DOI 10.1089/neu.2010.1378; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Williams AJ, 2006, NEUROSCI LETT, V408, P183, DOI 10.1016/j.neulet.2006.08.086; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; Wu HM, 2013, J NEUROTRAUM, V30, P352, DOI 10.1089/neu.2012.2610; Yao CP, 2011, J NEUROTRAUM, V28, P1237, DOI 10.1089/neu.2010.1678; Yao CP, 2009, J NEUROTRAUM, V26, P1295, DOI [10.1089/neu.2008.0811, 10.1089/neu.2008-0811]; Yokobori S, 2013, J NEUROSURG, V118, P370, DOI 10.3171/2012.10.JNS12725; ZHAO WZ, 1995, J CEREBR BLOOD F MET, V15, P552, DOI 10.1038/jcbfm.1995.69; Zoltewicz JS, 2013, J NEUROTRAUM, V30, P1161, DOI 10.1089/neu.2012.2762	40	17	18	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAY	2015	35	5					773	780		10.1038/jcbfm.2014.243			8	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	CH1GK	WOS:000353769100012	25669903	Green Published			2022-02-06	
J	Neumann, D; Malec, JF; Hammond, FM				Neumann, Dawn; Malec, James F.; Hammond, Flora M.			The Association of Negative Attributions With Irritation and Anger After Brain Injury	REHABILITATION PSYCHOLOGY			English	Article						irritation; anger; aggression; attribution styles; social cognition; traumatic brain injury	EPISODIC DISORDERS; AGGRESSION; BEHAVIOR; MANAGEMENT; VALIDITY; PERSONALITY; SURVIVORS; MARRIAGE; EMOTION; SYSTEM	Objectives: Study objectives were to examine associations of irritation and anger with negative attributions, and associations of negative attributions with trait aggression in participants with traumatic brain injury (TBI). Participants: Forty-eight participants with moderate to severe TBI participated in this study. Participants were primarily male (68.8%), and on average, approximately 5 years postinjury. Design: Prospective study using a quasi-experimental design. Main measures: Participants were presented with 21 vignettes that hypothetically led to negative consequences for the participant. Stories portrayed characters' actions as benign, ambiguous, or hostile. After each vignette, participants rated how irritated and angry they would be, and how intentional, hostile, and blameworthy they perceived the characters' actions. Participants' trait aggression was evaluated with the aggression questionnaire. Results: Irritation and anger ratings were strongly correlated with intent, hostility, and blame ratings of the character (p<.001). Trait aggression was significantly associated with attributions of intent, hostility, and blame (p<.001). Conclusion: These preliminary findings suggest that irritation and anger after TBI may be linked to the negative attributions they make about others' behaviors. Findings further indicate a relationship between negative attributions and trait aggression. Thus, individuals with TBI who have higher trait aggression may have a tendency to make more negative attributions about others' behaviors, and in turn, have stronger feelings of irritation and anger as a response. Future studies with healthy controls and larger sample sizes are needed to build upon this clinically relevant topic.	[Neumann, Dawn; Malec, James F.; Hammond, Flora M.] Indiana Univ Sch Med, Rehabil Hosp Indiana, Dept Phys Med & Rehabil, Indianapolis, IN 46254 USA		Neumann, D (corresponding author), Indiana Univ Sch Med, Rehabil Hosp Indiana, Dept Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46254 USA.	dmneuman@iupui.edu			National Institute on Disability and Rehabilitation Research (NIDRR) Switzer Research Fellowships Program Priority (CFDA) [84.133F-1]; Indiana Spinal Cord and Brain Injury Research Fund	This research was funded by the National Institute on Disability and Rehabilitation Research (NIDRR) Switzer Research Fellowships Program Priority (CFDA No. 84.133F-1) and the Indiana Spinal Cord and Brain Injury Research Fund. No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit on the authors or on any organization with which the authors are associated. The authors thank James Epps, PhD for permission to use his hypothetical scenarios, and Lyn Turkstra, PhD for her assistance in modifying the hypothetical scenarios to improve readability for participants with brain injury.	Alderman N, 2003, NEUROPSYCHOL REHABIL, V13, P211, DOI 10.1080/09602010244000327; An SK, 2010, SCHIZOPHR RES, V118, P54, DOI 10.1016/j.schres.2010.01.025; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Bailey CA, 2008, J YOUTH ADOLESCENCE, V37, P713, DOI 10.1007/s10964-007-9211-5; Beck R, 1998, COGNITIVE THER RES, V22, P63, DOI 10.1023/A:1018763902991; Brookshire R. H., 1993, DISCOURSE COMPREHENS; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Combs Dennis R, 2007, Cogn Neuropsychiatry, V12, P128, DOI 10.1080/13546800600787854; Delis DC., 2001, DELIS KAPLAN EXECUTI; Demark J, 2002, BRAIN INJURY, V16, P91, DOI 10.1080/02699050110102059; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Dyer KFW, 2006, BRAIN INJURY, V20, P1163, DOI 10.1080/02699050601049312; Eames P, 2003, NEUROPSYCHOL REHABIL, V13, P241, DOI 10.1080/09602010244000435; Ellsworth PC, 2003, SER AFFECTIVE SCI, P572; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; EPPS J, 1995, COGNITIVE THER RES, V19, P159, DOI 10.1007/BF02229692; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; FINCHAM FD, 1992, J PERS SOC PSYCHOL, V62, P457, DOI 10.1037/0022-3514.62.3.457; Greve KW, 2001, BRAIN INJURY, V15, P255; Hart T, 2012, J HEAD TRAUMA REHAB, V27, P113, DOI 10.1097/HTR.0b013e31820e686c; Holtzworth-Munroe A, 2001, BEHAV THER, V31, P603; Holtzworth-Munroe A, 1996, Violence Vict, V11, P319; Hoptman MJ, 2010, SCHIZOPHRENIA BULL, V36, P1020, DOI 10.1093/schbul/sbp012; Inzaghi M G, 2005, Eura Medicophys, V41, P265; Julian LJ, 2011, ARTHRIT CARE RES, V63, pS467, DOI 10.1002/acr.20561; Kassinove H, 1995, Issues Compr Pediatr Nurs, V18, P173, DOI 10.3109/01460869509087270; KELLEY HH, 1980, ANNU REV PSYCHOL, V31, P457, DOI 10.1146/annurev.ps.31.020180.002325; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Palmer EJ, 2005, AGGRESSIVE BEHAV, V31, P56, DOI 10.1002/ab.20072; Parmenter BA, 2007, J CLIN EXP NEUROPSYC, V29, P215, DOI 10.1080/13803390600672163; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Sanford K, 2005, J FAM PSYCHOL, V19, P180, DOI 10.1037/0893-3200.19.2.180; Scherer K., 2001, APPRAISAL PROCESSES, V92, P120, DOI DOI 10.1016/S0166-4115(08)62387-0; Smith CA, 2004, EMOTION, V4, P133, DOI 10.1037/1528-3542.4.2.133; Spielberger CD., 1970, STATE TRAIT ANXIETY; Stout JC, 2003, ASSESSMENT, V10, P79, DOI 10.1177/1073191102250339; Vitale JE, 2005, AGGRESSIVE BEHAV, V31, P99, DOI 10.1002/ab.20050; Williams WH, 2003, NEUROPSYCHOL REHABIL, V13, P1, DOI [10.1016/S0960-9822(02)01374-X, 10.1080/09602010244000444]; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; Wood RLL, 2013, BRAIN INJURY, V27, P253, DOI 10.3109/02699052.2012.743181	44	17	17	1	7	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	MAY	2015	60	2					155	161		10.1037/rep0000036			7	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	CL5CG	WOS:000356976800007	26120741	Bronze			2022-02-06	
J	Parker, EM; Gilchrist, J; Schuster, D; Lee, R; Sarmiento, K				Parker, Erin M.; Gilchrist, Julie; Schuster, Dan; Lee, Robin; Sarmiento, Kelly			Reach and Knowledge Change Among Coaches and Other Participants of the Online Course: "Concussion in Sports: What You Need to Know"	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						adolescent; brain concussion; coach; Heads Up; sports; TBI (traumatic brain injury); training programs	TRAUMATIC BRAIN-INJURIES; HIGH-SCHOOL; RECREATION ACTIVITIES; UNITED-STATES; RECOVERY; CHILDREN; HEADS	Objectives: To describe the reach of the Heads Up "Concussion in Sports: What You Need to Know," online course and to assess knowledge change. Setting: Online. Participants: Individuals who have taken the free online course since its inception in May 2010 to July 2013. Design: Descriptive, uncontrolled, before and after study design. Main Measures: Reach is measured by the number of unique participants and the number of times the course was completed by state and sport coached and the rate of participation per 100 000 population by state. Knowledge change is measured by the distribution and mean of pre- and posttest scores by sex, primary role (eg, coach, student, and parent), and sport coached. Results: Between May 2010 and July 2013, the online concussion course was completed 819 223 times, reaching 666 026 unique participants, including residents from all US states and the District of Columbia. The distribution of overall scores improved from pre- to posttests, with 21% answering all questions correctly on the pretest and 60% answering all questions correctly on the posttest. Conclusion: Online training can be effective in reaching large audiences and improving knowledge about emerging health and safety issues such as concussion awareness.	[Parker, Erin M.; Gilchrist, Julie; Lee, Robin; Sarmiento, Kelly] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Unintent Injury Prevent, Atlanta, GA 30341 USA; [Schuster, Dan] Natl Federat State High Sch Associat, Indianapolis, IN USA		Parker, EM (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Unintent Injury Prevent, 4770 Buford Hwy NE,MS F-62, Atlanta, GA 30341 USA.	eparker@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline		Brosseau-Lachaine O, 2008, BRAIN INJURY, V22, P657, DOI 10.1080/02699050802203353; Centers for Disease Control and Prevention, 10 YEAR ANN VIEWB; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; Faure CE, 2011, SPORT J, V37, P112; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; HENNEKENS CH, 1987, EPIDEMIOLOGY MED, P243; Institute of Medicine (IOM) & National Research Council (NRC), 2013, SPORTS REL CONC YOUT; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Washington Interscholastic Activities Association, WIAA CONC MAN TRAIN	19	17	17	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2015	30	3					198	206		10.1097/HTR.0000000000000097			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CH8PJ	WOS:000354298100132	25955706	Green Accepted			2022-02-06	
J	Sabre, L; Remmer, S; Adams, A; Vali, M; Rekand, T; Asser, T; Korv, J				Sabre, L.; Remmer, S.; Adams, A.; Vaeli, M.; Rekand, T.; Asser, T.; Korv, J.			Impact of fatal cases on the epidemiology of traumatic spinal cord injury in Estonia	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						early mortality; incidence; traumatic spinal cord injury	BRAIN-INJURY	Background and purposeMost epidemiological studies on traumatic spinal cord injury (TSCI) have not included patients who die before hospitalization. The aim of the research was to study the incidence of TSCI by including the individuals who die at the scene of the accident in addition to data retrieved from all hospitals in Estonia. MethodsMedical records of patients with TSCI from all hospitals in Estonia from 2005 to 2007 were studied. With collaboration from the Estonian Forensic Science Institute the data of the victims of TSCI who died before hospitalization were included. ResultsFrom 2005 to 2007, 391 TSCI cases were identified: 183 patients were found retrospectively from medical records and 208 cases were detected from autopsy reports. Fifty-three per cent of patients died before hospitalization. The annual incidence rate was 97.0 per million population (95% confidence interval 87.4-106.6). The mean age at injury was 44.418.7years. Motor vehicle accidents were the leading cause of TSCI amongst the individuals who died before hospitalization (75%). Falls accounted for the highest number of TSCIs (43%) amongst the patients who reached hospital. ConclusionsOur study shows that, when the cases that die at the scene of the accident are included, the incidence of TSCI in Estonia rises from 39.7 to 97.0 per million population.	[Sabre, L.; Asser, T.; Korv, J.] Univ Tartu, Dept Neurol & Neurosurg, EE-51014 Tartu, Estonia; [Remmer, S.; Adams, A.; Vaeli, M.] Estonian Forens Sci Inst, Tallinn, Estonia; [Remmer, S.; Adams, A.; Vaeli, M.] Univ Tartu, Inst Pathol Anat & Forens Med, EE-51014 Tartu, Estonia; [Rekand, T.] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway		Sabre, L (corresponding author), Univ Tartu, Dept Neurol & Neurosurg, 8 L Puusepa St, EE-51014 Tartu, Estonia.	liis.sabre@ut.ee	Sabre, Liis/D-7931-2014; Rekand, Tiina/V-7189-2019; Korv, Janika/I-4395-2015; Asser, Toomas/G-8446-2015; Rekand, Tiina/A-6201-2008	Sabre, Liis/0000-0002-5727-8404; Korv, Janika/0000-0002-6074-0727; Rekand, Tiina/0000-0002-2506-9501	Estonian Science Foundation [7868]; Estonian IUT2-4 grant	The study was supported by the Estonian Science Foundation research grant No. 7868 and by an Estonian IUT2-4 grant. The authors would like to thank Anne Selart for valuable statistical assistance.	Bernhard M, 2005, RESUSCITATION, V66, P127, DOI 10.1016/j.resuscitation.2005.03.005; Dryden DM, 2003, CAN J NEUROL SCI, V30, P113, DOI 10.1017/S0317167100053373; GRIFFIN MR, 1985, AM J EPIDEMIOL, V121, P884, DOI 10.1093/oxfordjournals.aje.a114058; Hagen EM, 2010, ACTA NEUROL SCAND, V122, P51, DOI 10.1111/j.1600-0404.2010.01376.x; Hagen EM, 2005, ACTA NEUROL SCAND, V112, P42, DOI 10.1111/j.1600-0404.2005.00430.x; Martins F, 1998, SPINAL CORD, V36, P574, DOI 10.1038/sj.sc.3100657; National Spinal Cord Injury Statistical Centre (NSCISC), 2010, ANN STAT REP 2010 CO; Sabre L, 2013, EUR J NEUROL, V20, P293, DOI 10.1111/j.1468-1331.2012.03845.x; Sabre L, 2012, SPINAL CORD, V50, P755, DOI 10.1038/sc.2012.54; Sabre L, 2013, J SPINAL CORD MED, V36, P687, DOI 10.1179/2045772313Y.0000000120; Surkin J, 2000, SPINE, V25, P716, DOI 10.1097/00007632-200003150-00011; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; THURMAN DJ, 1994, PARAPLEGIA, V32, P665, DOI 10.1038/sc.1994.107; van Asbeck FWA, 2000, SPINAL CORD, V38, P420, DOI 10.1038/sj.sc.3101003; van den Berg MEL, 2010, J NEUROTRAUM, V27, P1517, DOI 10.1089/neu.2009.1138; Warren S, 1995, Alaska Med, V37, P11; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893	17	17	17	0	7	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-5101	1468-1331		EUR J NEUROL	Eur. J. Neurol.	MAY	2015	22	5					768	772		10.1111/ene.12478			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CF5BC	WOS:000352568600008	24948203				2022-02-06	
J	Li, M; Lin, YP; Chen, JL; Li, H; Jiang, RC; Zhang, JN				Li, Min; Lin, Yun-Peng; Chen, Jie-Li; Li, Hong; Jiang, Rong-Cai; Zhang, Jian-Ning			Role of Regulatory T cell in Clinical Outcome of Traumatic Brain Injury	CHINESE MEDICAL JOURNAL			English	Article						Clinical Outcome; Dynamic Change; Prognostic Marker; Regulatory T cell; Traumatic Brain Injury	CENTRAL-NERVOUS-SYSTEM; AUTOIMMUNE ENCEPHALOMYELITIS; TOLERANCE	Background: Traumatic brain injury (TBI) is a life-threatening disease worldwide. Regulatory T cells (Treg cells) were involved in the immunological system in central nervous system. It is defined as a subpopulation of CD4(+) cells that express CD25 and transcription factor forkhead box P3. The level of circulating Treg cells increases in a variety of pathologic conditions. The purpose of this study was to uncover the role of circulating Treg cells in TBI. Methods: A clinical study was conducted in two neurosurgical intensive care units of Tianjin Medical University General Hospital and Second Hospital of Tianjin Medical University (Tianjin, China). Forty patients and 30 healthy controls were recruited from August 2013 to November 2013. Circulating Treg cells was detected on the follow-up period of 1, 4, 7, 14, and 21 days after TBI. Blood sample (1 ml) was withdrawn in the morning and processed within 2 h. Results: There was no significant difference in the level of circulating Treg cells between TBI patients and normal controls during follow-up. TBI patients exhibited higher circulating Treg level than normal controls on the 1st day after TBI. Treg level was decreased on the 4th day, climbed up on the 7th day and peaked on 14th day after TBI. Treg cells declined to the normal level on 21th day after TBI. The level of circulating Treg cells was significantly higher in survival TBI patients when compared to nonsurvival TBI patients. TBI patients with improved conditions exhibited significantly higher circulating Treg level when compared to those with deteriorated conditions. The circulating Treg level was correlated with neurologic recovery after TBI. A better neural recovery and lower hospital mortality were found in TBI patients with circulating Treg cells more than 4.91% in total CD4(+) mononuclear cells as compared to those with circulating Treg cells less than 4.91% in total CD4(+) mononuclear cells in the first 14 days. Conclusions: The level of circulating Treg cells is positively correlated with clinical outcome of TBI. The level of Treg cells predicts the progress for TBI patients and may be a target in TBI treatment.	[Li, Min; Lin, Yun-Peng; Jiang, Rong-Cai; Zhang, Jian-Ning] Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurosurg, Tianjin 300052, Peoples R China; [Chen, Jie-Li] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Li, Hong] Tianjin Med Univ, Hosp 2, Dept Neurosurg, Tianjin 300211, Peoples R China		Zhang, JN (corresponding author), Tianjin Gen Hosp, Tianjin Neurol Inst, Dept Neurosurg, Tianjin 300052, Peoples R China.	jianningzhang@hotmail.com					Beissert S, 2006, J INVEST DERMATOL, V126, P15, DOI 10.1038/sj.jid.5700004; Cabbage SE, 2007, J IMMUNOL, V178, P887, DOI 10.4049/jimmunol.178.2.887; Hilton GD, 2008, J CEREBR BLOOD F MET, V28, P1845, DOI 10.1038/jcbfm.2008.75; Huang XY, 2009, J NEUROIMMUNOL, V211, P3, DOI 10.1016/j.jneuroim.2009.04.006; Jia WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064397; Kipnis J, 2004, P NATL ACAD SCI USA, V101, P14663, DOI 10.1073/pnas.0404842101; Kipnis J, 2002, P NATL ACAD SCI USA, V99, P15620, DOI 10.1073/pnas.232565399; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Liu L, 2011, CRIT CARE MED, V39, P1760, DOI 10.1097/CCM.0b013e3182186cee; Liu YW, 2006, NAT MED, V12, P518, DOI 10.1038/nm1402; McGeachy MJ, 2005, J IMMUNOL, V175, P3025, DOI 10.4049/jimmunol.175.5.3025; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; O'Connor RA, 2008, J NEUROIMMUNOL, V193, P1, DOI 10.1016/j.jneuroim.2007.11.016; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Yan YP, 2010, J IMMUNOL, V185, P5953, DOI 10.4049/jimmunol.1001628	17	17	20	0	5	CHINESE MEDICAL ASSOC	BEIJING	42 DONGSI XIDAJIE, BEIJING 100710, PEOPLES R CHINA	0366-6999			CHINESE MED J-PEKING	Chin. Med. J.	APR 20	2015	128	8					1072	1078		10.4103/0366-6999.155094			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8MX	WOS:000353563300014	25881602	gold, Green Published			2022-02-06	
J	Gu, Y; Zhao, Y; Qian, K; Sun, M				Gu, Y.; Zhao, Y.; Qian, K.; Sun, M.			TAURINE ATTENUATES HIPPOCAMPAL AND CORPUS CALLOSUM DAMAGE, AND ENHANCES NEUROLOGICAL RECOVERY AFTER CLOSED HEAD INJURY IN RATS	NEUROSCIENCE			English	Article						taurine; closed head injury; calpain; corpus callosum; hippocampus	TRAUMATIC BRAIN-INJURY; DOWN-REGULATING CALPAIN; MYELIN BASIC-PROTEIN; ALPHA-II-SPECTRIN; WHITE-MATTER; BEHAVIORAL DEFICITS; CALPASTATIN; PATHOPHYSIOLOGY; DEGRADATION; PROTEOLYSIS	The protective effects of taurine against closed head injury (CHI) have been reported. This study was designed to investigate whether taurine reduced white matter damage and hippocampal neuronal death through suppressing calpain activation after CHI in rats. Taurine (50 mg/kg) was administered intravenously 30 min and 4 h again after CHI. It was found that taurine lessened the corpus callosum damage, attenuated the neuronal cell death in hippocampal CA1 and CA3 subfields and improved the neurological functions 7 days after CHI. Moreover, it suppressed the over-activation of calpain, enhanced the levels of calpastatin, and reduced the degradation of neurofilament heavy protein, myelin basic protein and alpha II-spectrin in traumatic tissue 24 h after CHI. These data confirm the protective effects of taurine against gray and white matter damage due to CHI, and suggest that down-regulating calpain activation could be one of the protective mechanisms of taurine against CHI. (C) 2014 IBRO. Published by Elsevier Ltd. All rights reserved.	[Gu, Y.; Zhao, Y.; Sun, M.] Capital Med Univ, Beijing Key Lab Cent Nervous Syst Injury, China Natl Clin Res Ctr Neurol Dis, Beijing Neurosurg Inst,Dept Neuropharmacol, Beijing 100050, Peoples R China; [Qian, K.] Capital Med Univ, Beijing Key Lab Cent Nervous Syst Injury, China Natl Clin Res Ctr Neurol Dis, Beijing Tiantan Hosp,Dept Neurosurg, Beijing 100050, Peoples R China		Sun, M (corresponding author), Capital Med Univ, Beijing Key Lab Cent Nervous Syst Injury, China Natl Clin Res Ctr Neurol Dis, Beijing Neurosurg Inst,Dept Neuropharmacol, 6 Tiantan Xili, Beijing 100050, Peoples R China.	sunming999@yahoo.com			National Key Technology Research and Development Program of the Ministry of Science and Technology of ChinaNational Key Technology R&D Program [2013BAI091303]	We would like to express our gratitude to Ms Jingjing Yang for her help in biochemical assay. This study was supported by National Key Technology Research and Development Program of the Ministry of Science and Technology of China (No. 2013BAI091303).	Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; Bartosik-Psujek H, 2001, Ann Univ Mariae Curie Sklodowska Med, V56, P389; Blomgren K, 1999, J BIOL CHEM, V274, P14046, DOI 10.1074/jbc.274.20.14046; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cernak I, 2004, NEURORX, V2, P410; Chao PK, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-121; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Cheng CM, 1998, J NEUROSCI, V18, P5673; El Idrissi A, 2004, NEUROCHEM RES, V29, P189, DOI 10.1023/B:NERE.0000010448.17740.6e; El Idrissi A, 2003, ADV EXP MED BIOL, V526, P527; Foos TM, 2002, NEUROCHEM RES, V27, P21, DOI 10.1023/A:1014890219513; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; GOODMAN SR, 1986, AM J PHYSIOL, V250, pC347, DOI 10.1152/ajpcell.1986.250.3.C347; Griesemer D, 2007, J NEUROTRAUM, V24, P1823, DOI 10.1089/neu.2006.0237; HAMAKUBO T, 1986, J NEUROSCI, V6, P3103, DOI 10.1523/jneurosci.06-11-03103.1986; Harauz G, 2004, MICRON, V35, P503, DOI 10.1016/j.micron.2004.04.005; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; Kamisaki Y, 1996, ADV EXP MED BIOL, V403, P445; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; LEE MK, 1994, CURR OPIN CELL BIOL, V6, P34, DOI 10.1016/0955-0674(94)90113-9; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Louzada PR, 2004, FASEB J, V18, P511, DOI 10.1096/fj.03-0739com; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MASSARO AR, 1990, ITAL J NEUROL SCI, V11, P537, DOI 10.1007/BF02337436; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McCarthy MM, 2003, EXP NEUROL, V184, P40, DOI 10.1016/j.expneurol.2003.08.020; McCracken E, 1999, J NEUROTRAUM, V16, P749, DOI 10.1089/neu.1999.16.749; McGinn MJ, 2009, J NEUROPATH EXP NEUR, V68, P241, DOI 10.1097/NEN.0b013e3181996bfe; MOSS DE, 1991, PHARMACOL BIOCHEM BE, V39, P495, DOI 10.1016/0091-3057(91)90214-M; Palmi M, 1999, BIOCHEM PHARMACOL, V58, P1123, DOI 10.1016/S0006-2952(99)00183-5; Pantoni L, 1996, STROKE, V27, P1641, DOI 10.1161/01.STR.27.9.1641; Park SH, 2006, J MED FOOD, V9, P33, DOI 10.1089/jmf.2006.9.33; PERLMUTTER LS, 1990, J COMP NEUROL, V296, P269, DOI 10.1002/cne.902960207; Pinder JC, 2000, NATURE, V406, P253, DOI 10.1038/35018679; Posmantur RM, 2000, EXP NEUROL, V161, P15, DOI 10.1006/exnr.1999.7244; Rami A, 2003, NEUROSCI RES, V47, P373, DOI 10.1016/j.neures.2003.07.002; Reeves TM, 2010, BRAIN PATHOL, V20, P1055, DOI 10.1111/j.1750-3639.2010.00412.x; Richter-Landsberg C, 2000, J NEUROSCI RES, V59, P11, DOI 10.1002/(SICI)1097-4547(20000101)59:1<11::AID-JNR2>3.0.CO;2-O; Ringger NC, 2004, J NEUROTRAUM, V21, P829, DOI 10.1089/0897715041526177; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Salinska E, 2005, FOLIA NEUROPATHOL, V43, P322; Sande A, 2010, J VET EMERG CRIT CAR, V20, P177, DOI 10.1111/j.1476-4431.2010.00527.x; Saransaari P, 2000, AMINO ACIDS, V19, P509, DOI 10.1007/s007260070003; SCHLAEPFER WW, 1985, J NEUROCHEM, V44, P502, DOI 10.1111/j.1471-4159.1985.tb05442.x; Schoch KM, 2012, EXP NEUROL, V236, P371, DOI 10.1016/j.expneurol.2012.04.022; Schuller-Levis GB, 2004, NEUROCHEM RES, V29, P117, DOI 10.1023/B:NERE.0000010440.37629.17; Stys PK, 1998, J CEREBR BLOOD F MET, V18, P2, DOI 10.1097/00004647-199801000-00002; Sun M, 2014, J NEUROTRAU IN PRESS; Sun M, 2008, CELL MOL NEUROBIOL, V28, P593, DOI 10.1007/s10571-007-9183-8; Sun M, 2011, AMINO ACIDS, V40, P1419, DOI 10.1007/s00726-010-0751-8; Sun M, 2009, NEUROCHEM INT, V54, P339, DOI 10.1016/j.neuint.2008.12.017; Voas MG, 2007, CURR BIOL, V17, P562, DOI 10.1016/j.cub.2007.01.071; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wang KKW, 1998, ARCH BIOCHEM BIOPHYS, V356, P187, DOI 10.1006/abbi.1998.0748; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Wu HV, 2006, MOL NEUROBIOL, V33, P215, DOI 10.1385/MN:33:3:215; WU JY, 1994, ADV EXP MED BIOL, V359, P289; YOSHIDA K, 1993, BIOCHIM BIOPHYS ACTA, V1182, P215, DOI 10.1016/0925-4439(93)90143-O	59	17	18	0	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	APR 16	2015	291						331	340		10.1016/j.neuroscience.2014.09.073			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CD7VN	WOS:000351303100029	25290011				2022-02-06	
J	Shukla, DR; Pillai, G; McAnany, S; Hausman, M; Parsons, BO				Shukla, Dave R.; Pillai, Gita; McAnany, Steven; Hausman, Michael; Parsons, Bradford O.			Heterotopic ossification formation after fracture-dislocations of the elbow	JOURNAL OF SHOULDER AND ELBOW SURGERY			English	Article						Elbow; heterotopic ossification; fracture-dislocation; terrible triad; coronoid; radial head	RISK-FACTORS; RADIAL HEAD; BONE	Background: Heterotopic ossification (HO) is a serious complication of traumatic elbow injuries, particularly fracture-dislocations. Limited data exist in the literature regarding the risk factors associated with HO formation in these injuries. The purpose of this study was to review the incidence of HO after fracture-dislocation of the elbow and to identify potential risk factors associated with its formation. Methods: Twenty-seven patients (28 elbows) were surgically treated for elbow fracture-dislocations during 8 years, with an average follow-up of 14 months. Records were reviewed with attention paid to several factors: demographic data, comorbidities, time interval from injury to surgical intervention, number of closed reductions attempted before surgery, surgical approach, management of the radial head, treatment of the anterior capsular injury, and coronoid fixation. Results: Of the 28 elbows, 12 (43%) developed HO postoperatively; 9 of 28 elbows underwent multiple attempted closed reductions before definitive surgical stabilization, with HO formation in 7 of the 9 (77%). Time to surgery, age, gender, radial head fixation or replacement, coronoid open reduction and internal fixation, capsular repair, and medical comorbidities were not found to influence HO formation, although the performance of multiple reductions was identified as a risk factor. Discussion: HO developed in 77% of patients with multiple attempted closed reductions. We found a 43% incidence of HO in patients surgically treated for elbow fracture-dislocations. Neither time to surgery after the injury nor demographic or other factors relating to the manner in which associated osseous or soft tissue injuries were managed influenced the formation of HO. (C) 2015 Journal of Shoulder and Elbow Surgery Board of Trustees.	[Shukla, Dave R.; Pillai, Gita; McAnany, Steven; Hausman, Michael; Parsons, Bradford O.] Icahn Sch Med Mt Sinai, Leni & Peter May Dept Orthopaed Surg, New York, NY 10029 USA		Shukla, DR (corresponding author), Icahn Sch Med Mt Sinai, Leni & Peter May Dept Orthopaed Surg, 5 East 98th St, New York, NY 10029 USA.	dshukla@gmail.com		McAnany, Steven/0000-0002-1157-3790			Abrams GD, 2012, J SHOULDER ELB SURG, V21, P1550, DOI 10.1016/j.jse.2012.05.040; Bauer AS, 2012, J HAND SURG-AM, V37A, P1422, DOI 10.1016/j.jhsa.2012.03.013; BROBERG MA, 1987, CLIN ORTHOP RELAT R, P109; BROOKER AF, 1973, J BONE JOINT SURG AM, VA 55, P1629, DOI 10.2106/00004623-197355080-00006; Douglas K, 2012, ORTHOPEDICS, V35, pE815, DOI 10.3928/01477447-20120525-18; GARLAND DE, 1982, CLIN ORTHOP RELAT R, P38; GARLAND DE, 1991, CLIN ORTHOPAEDICS, V263, P13; GASTON SR, 1949, AM J SURG, V78, P631, DOI 10.1016/0002-9610(49)90300-1; Ilahi OA, 1998, ORTHOPEDICS, V21, P265; Lee EK, 2013, J SHOULDER ELB SURG, V22, P716, DOI 10.1016/j.jse.2012.11.020; McLaughlin HL, 1955, SURG CLIN N AM, P553; Pugh DMW, 2004, J BONE JOINT SURG AM, V86A, P1122, DOI 10.2106/00004623-200406000-00002; PUZAS JE, 1989, CLIN ORTHOP RELAT R, P269; Ring D, 2002, J BONE JOINT SURG AM, V84A, P547, DOI 10.2106/00004623-200204000-00006; Smith FM, 1949, AM J SURG, V78, P47; Thompson H C 3rd, 1967, Clin Orthop Relat Res, V50, P129	16	17	23	0	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1058-2746			J SHOULDER ELB SURG	J. Shoulder Elbow Surg.	MAR	2015	24	3					333	338		10.1016/j.jse.2014.11.037			6	Orthopedics; Sport Sciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences; Surgery	CB6SR	WOS:000349757500004	25601384				2022-02-06	
J	Eum, RS; Seel, RT; Goldstein, R; Brown, AW; Watanabe, TK; Zasler, ND; Roth, EJ; Zafonte, RD; Glenn, MB				Eum, Regina S.; Seel, Ronald T.; Goldstein, Richard; Brown, Allen W.; Watanabe, Thomas K.; Zasler, Nathan D.; Roth, Elliot J.; Zafonte, Ross D.; Glenn, Mel B.			Predicting Institutionalization after Traumatic Brain Injury Inpatient Rehabilitation	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; traumatic brain injury; outcome measures; rehabilitation; predictive modeling	NURSING-HOME PLACEMENT; LONG-TERM DISABILITY; GALVESTON ORIENTATION; UNITED-STATES; AMNESIA TEST; HOSPITALIZATION; MODEL; POPULATION; REPRESENTATIVENESS; DISPOSITION	Risk factors contributing to institutionalization after inpatient rehabilitation for people with traumatic brain injury (TBI) have not been well studied and need to be better understood to guide clinicians during rehabilitation. We aimed to develop a prognostic model that could be used at admission to inpatient rehabilitation facilities to predict discharge disposition. The model could be used to provide the interdisciplinary team with information regarding aspects of patients' functioning and/or their living situation that need particular attention during inpatient rehabilitation if institutionalization is to be avoided. The study population included 7219 patients with moderate-severe TBI in the Traumatic Brain Injury Model Systems (TBIMS) National Database enrolled from 2002-2012 who had not been institutionalized prior to injury. Based on institutionalization predictors in other populations, we hypothesized that among people who had lived at a private residence prior to injury, greater dependence in locomotion, bed-chair-wheelchair transfers, bladder and bowel continence, feeding, and comprehension at admission to inpatient rehabilitation programs would predict institutionalization at discharge. Logistic regression was used, with adjustment for demographic factors, proxy measures for TBI severity, and acute-care length-of-stay. C-statistic and predictiveness curves validated a five-variable model. Higher levels of independence in bladder management (adjusted odds ratio [OR], 0.88; 95% CI 0.83, 0.93), bed-chair-wheelchair transfers (OR, 0.81 [95% CI, 0.83-0.93]), and comprehension (OR, 0.78 [95% CI, 0.68, 0.89]) at admission were associated with lower risks of institutionalization on discharge. For every 10-year increment in age was associated with a 1.38 times higher risk for institutionalization (95% CI, 1.29, 1.48) and living alone was associated with a 2.34 times higher risk (95% CI, 1.86, 2.94). The c-statistic was 0.780. We conclude that this simple model can predict risk of institutionalization after inpatient rehabilitation for patients with TBI.	[Eum, Regina S.] Pioneer Spine & Sports Phys, West Springfield, MA USA; [Seel, Ronald T.] Shepherd Ctr, Crawford Res Inst, Atlanta, GA USA; [Goldstein, Richard; Zafonte, Ross D.; Glenn, Mel B.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA; [Brown, Allen W.] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN USA; [Watanabe, Thomas K.] Moss Rehab, Dept Phys Med & Rehabil, Philadelphia, PA USA; [Zasler, Nathan D.] Concuss Care Ctr Virginia Ltd, Richmond, VA USA; [Zasler, Nathan D.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Tree Life Serv, Richmond, VA USA; [Roth, Elliot J.] Northwestern Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL USA		Eum, RS (corresponding author), West Haven Med Grp, 689 Campbell Ave, West Haven, CT 06516 USA.	regina.eum@gmail.com		Brown, Allen W./0000-0001-7228-3351	National Institute on Disability and Rehabilitation Research; Office of Special Education Services; Department of Education to Spaulding Rehabilitation Hospital [H133A120085]; Shepherd Center-Georgia Model Brain Injury System [H133A110006]; Mayo Clinic [H133-A120026]; MossRehab [H133A120037]; Virginia Commonwealth University [H133A120031]; Rehabilitation Institute of Chicago [H133A080045]; Department of Physical Medicine and Rehabilitation, Spaulding Rehabilitation Hospital/Harvard Medical School	This work was supported by grants from the National Institute on Disability and Rehabilitation Research, Office of Special Education Services, Department of Education to Spaulding Rehabilitation Hospital (H133A120085), Shepherd Center-Georgia Model Brain Injury System (H133A110006), Mayo Clinic (H133-A120026), MossRehab (H133A120037), Virginia Commonwealth University (H133A120031), and Rehabilitation Institute of Chicago (H133A080045). However, the contents of this manuscript do not necessarily represent the policy of the Department of Education and endorsement by the federal government should not be assumed. This work also was supported in part by a grant from the Department of Physical Medicine and Rehabilitation, Spaulding Rehabilitation Hospital/Harvard Medical School.	Bharucha AJ, 2004, J AM GERIATR SOC, V52, P434, DOI 10.1111/j.1532-5415.2004.52118.x; Black T M, 1999, Rehabil Nurs, V24, P109; Bode RK, 2000, J HEAD TRAUMA REHAB, V15, P637, DOI 10.1097/00001199-200002000-00004; Buhr GT, 2006, GERONTOLOGIST, V46, P52, DOI 10.1093/geront/46.1.52; Cai Q, 2009, SOC WORK HEALTH CARE, V48, P154, DOI 10.1080/00981380802580588; Cameron AC, 2011, HDB EMPIRICAL EC; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Cuthbert JP, 2012, J HEAD TRAUMA REHAB, V27, pE15, DOI 10.1097/HTR.0b013e31826da983; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Gaugler Joseph E, 2007, BMC Geriatr, V7, P13, DOI 10.1186/1471-2318-7-13; Goodwin JS, 2011, J GERONTOL A-BIOL, V66, P1321, DOI 10.1093/gerona/glr171; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Grunkemeier GL, 2004, ANN THORAC SURG, V77, P1142, DOI 10.1016/j.athoracsur.2004.01.005; Harrell FE Jr, 2017, REGRESSION MODELING; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Luppa M, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-186; Medicare Payment Advisory Commission, 2013, REP C MED PAYM POL; Medicare Payment Advisory Commission, 2013, REH FAC INP PAYM SYS; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Penna S, 2010, J HEAD TRAUMA REHAB, V25, P52, DOI 10.1097/HTR.0b013e3181c29952; Pepe MS, 2008, AM J EPIDEMIOL, V167, P362, DOI 10.1093/aje/kwm305; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Rockhill CM, 2012, J NEUROTRAUM, V29, P1038, DOI 10.1089/neu.2010.1562; Rozzini L, 2006, J AM MED DIR ASSOC, V7, P345, DOI 10.1016/j.jamda.2005.11.008; Schlegel D, 2004, ARCH NEUROL-CHICAGO, V61, P1061, DOI 10.1001/archneur.61.7.1061; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Traumatic Brain Injury Model Systems National Data and Statistical Center, 2009, TRAUM BRAIN INJ MOD; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Witlox J, 2010, JAMA-J AM MED ASSOC, V304, P443, DOI 10.1001/jama.2010.1013; Yaffe K, 2002, JAMA-J AM MED ASSOC, V287, P2090, DOI 10.1001/jama.287.16.2090; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	41	17	17	0	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2015	32	4					280	286		10.1089/neu.2014.3351			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CB0KN	WOS:000349314900009	25203001	Green Published			2022-02-06	
J	Angstman, NB; Kiessling, MC; Frank, HG; Schmitz, C				Angstman, Nicholas B.; Kiessling, Maren C.; Frank, Hans-Georg; Schmitz, Christoph			High interindividual variability in dose-dependent reduction in speed of movement after exposing C. elegans to shock waves	FRONTIERS IN BEHAVIORAL NEUROSCIENCE			English	Article						C. elegans; mild traumatic brain injury; blast trauma; shock wave; locomotion; paralysis; tracking	TRAUMATIC BRAIN-INJURY; MILD; CAVITATION; MECHANISM; DAMAGE	In blast-related mild traumatic brain injury (br-mTBI) little is known about the connections between initial trauma and expression of individual clinical symptoms. Partly due to limitations of current in vitro and in vivo models of br-mTBI, reliable prediction of individual short-and long-term symptoms based on known blast input has not yet been possible. Here we demonstrate a dose-dependent effect of shock wave exposure on C. elegans using shock waves that share physical characteristics with those hypothesized to induce br-mTBI in humans. Increased exposure to shock waves resulted in decreased mean speed of movement while increasing the proportion of worms rendered paralyzed. Recovery of these two behavioral symptoms was observed during increasing post-traumatic waiting periods. Although effects were observed on a population-wide basis, large interindividual variability was present between organisms exposed to the same highly controlled conditions. Reduction of cavitation by exposing worms to shock waves in polyvinyl alcohol resulted in reduced effect, implicating primary blast effects as damaging components in shock wave induced trauma. Growing worms on NGM agar plates led to the same general results in initial shock wave effect in a standard medium, namely dose-dependence and high interindividual variability, as raising worms in liquid cultures. Taken together, these data indicate that reliable prediction of individual clinical symptoms based on known blast input as well as drawing conclusions on blast input from individual clinical symptoms is not feasible in br-mTBI.	[Angstman, Nicholas B.; Kiessling, Maren C.; Frank, Hans-Georg; Schmitz, Christoph] Univ Munich, Dept Neuroanat, D-80336 Munich, Germany		Schmitz, C (corresponding author), Univ Munich, Dept Neuroanat, Pettenkoferstr 11, D-80336 Munich, Germany.	christoph_schmitz@med.uni-muenchen.de	Frank, Hans-Georg/G-6038-2012; Cote, Rick H/G-3363-2013	Frank, Hans-Georg/0000-0002-3562-138X; Cote, Rick H/0000-0002-1573-6526	Friedrich-Baur Foundation at the Ludwig-Maximilians University of Munich	This work was supported by a grant from the Friedrich-Baur Foundation at the Ludwig-Maximilians University of Munich (to Maren C. Kiessling and Christoph Schmitz).	Associated Press, 2007, CARS STUD 1 6 SHOWS; Boyd WA, 2010, NEUROTOXICOL TERATOL, V32, P68, DOI 10.1016/j.ntt.2008.12.004; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Csaszar Nikolaus B M, 2013, J Orthop Surg Res, V8, P22, DOI 10.1186/1749-799X-8-22; de Bono M, 2005, ANNU REV NEUROSCI, V28, P451, DOI 10.1146/annurev.neuro.27.070203.144259; Delius M., 1992, LITHOTROPSY RELATED, P27; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Department of Defense and Department of Veterans Affairs, 2013, DOD VA COD FIN PROP; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Gerdesmeyer L, 2008, AM J SPORT MED, V36, P2100, DOI 10.1177/0363546508324176; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; GOLDING EM, 1994, BRAIN RES, V668, P46, DOI 10.1016/0006-8993(94)90509-6; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hayakawa K., 1991, N Y I ELECT ELECT EN, V1989, P969; Heltemes KJ, 2012, INJURY, V43, P1990, DOI 10.1016/j.injury.2011.07.021; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Jorgensen EM, 2002, NAT REV GENET, V3, P356, DOI 10.1038/nrg794; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Ohta M, 2013, BRAIN RES, V1490, P184, DOI 10.1016/j.brainres.2012.09.011; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; PORTMAN DS, 2006, PROFILING C ELEGANS; R Development Core Team, 2008, R LANG ENV STAT COMP; Rajini PS, 2008, J TOXICOL ENV HEAL A, V71, P1043, DOI 10.1080/15287390801989002; Rassweiler JJ, 2011, EUR UROL, V59, P784, DOI 10.1016/j.eururo.2011.02.033; Ritz C, 2005, J STAT SOFTW, V12, P1; Robinson D. E., 1978, ULTRASOUND ITS APPL, P593, DOI [10.1016/B978-0-444-41641-4.50008-X, DOI 10.1016/B978-0-444-41641-4.50008-X]; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; SCHELLING G, 1994, BIOPHYS J, V66, P133, DOI 10.1016/S0006-3495(94)80758-1; Schmitz C, 2013, J ORTHOP SURG RES, V8, DOI 10.1186/1749-799X-8-31; Scott SG, 2006, J AM OSTEOPATH ASSOC, V106, P265; Speed C, 2014, BRIT J SPORT MED, V48, P1538, DOI 10.1136/bjsports-2012-091961; SULSTON JE, 1974, GENETICS, V77, P95; Tukey JW, 1977, EXPLORATORY DATA ANA, V2, P131; Wang CJ, 2012, J ORTHOP SURG RES, V7, DOI 10.1186/1749-799X-7-11; Waters RJ, 2013, J NEUROTRAUM, V30, P1710, DOI 10.1089/neu.2012.2792; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	40	17	17	0	7	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5153			FRONT BEHAV NEUROSCI	Front. Behav. Neurosci.	FEB 6	2015	9								12	10.3389/fnbeh.2015.00012			11	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	CA5XS	WOS:000348982300003	25705183	Green Published, gold			2022-02-06	
J	Chan, V; Thurairajah, P; Colantonio, A				Chan, Vincy; Thurairajah, Pravheen; Colantonio, Angela			Defining pediatric traumatic brain injury using International Classification of Diseases Version 10 Codes: A systematic review	BMC NEUROLOGY			English	Article						Coding; International Classification of Diseases; Pediatric brain injury	SHAKEN BABY SYNDROME; ABUSIVE HEAD TRAUMA; FACIAL FRACTURES; CONCOMITANT INJURIES; RETINAL HEMORRHAGE; YOUNG-CHILDREN; POST-TBI; EPIDEMIOLOGY; CONCUSSION; PATTERNS	Background: Although healthcare administrative data are commonly used for traumatic brain injury (TBI) research, there is currently no consensus or consistency on the International Classification of Diseases Version 10 (ICD-10) codes used to define TBI among children and youth internationally. This study systematically reviewed the literature to explore the range of ICD-10 codes that are used to define TBI in this population. The identification of the range of ICD-10 codes to define this population in administrative data is crucial, as it has implications for policy, resource allocation, planning of healthcare services, and prevention strategies. Methods: The databases MEDLINE, MEDLINE In-Process, Embase, PsychINFO, CINAHL, SPORTDiscus, and Cochrane Database of Systematic Reviews were systematically searched. Grey literature was searched using Grey Matters and Google. Reference lists of included articles were also searched for relevant studies. Two reviewers independently screened all titles and abstracts using pre-defined inclusion and exclusion criteria. A full text screen was conducted on articles that met the first screen inclusion criteria. All full text articles that met the pre-defined inclusion criteria were included for analysis in this systematic review. Results: A total of 1,326 publications were identified through the predetermined search strategy and 32 articles/reports met all eligibility criteria for inclusion in this review. Five articles specifically examined children and youth aged 19 years or under with TBI. ICD-10 case definitions ranged from the broad injuries to the head codes (ICD-10 S00 to S09) to concussion only (S06.0). There was overwhelming consensus on the inclusion of ICD-10 code S06, intracranial injury, while codes S00 (superficial injury of the head), S03 (dislocation, sprain, and strain of joints and ligaments of head), and S05 (injury of eye and orbit) were only used by articles that examined head injury, none of which specifically examined children and youth. Conclusion: This review provides evidence for discussion on how best to use ICD codes for different goals. This is an important first step in reaching an appropriate definition and can inform future work on reaching consensus on the ICD-10 codes to define TBI for this vulnerable population.	[Chan, Vincy; Colantonio, Angela] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON M5G 2A2, Canada; [Chan, Vincy; Colantonio, Angela] Univ Toronto, Rehabil Sci Inst, Toronto, ON M5G 1V7, Canada; [Chan, Vincy; Thurairajah, Pravheen; Colantonio, Angela] Univ Toronto, Acquired Brain Injury Res Lab, Toronto, ON M5G 1V7, Canada		Colantonio, A (corresponding author), Univ Hlth Network, Toronto Rehabil Inst, 550 Univ Ave, Toronto, ON M5G 2A2, Canada.	angela.colantonio@utoronto.ca	Meijer, Anna/K-5118-2016; Chan, Vincy/AAA-7813-2020	Chan, Vincy/0000-0002-6884-044X; Colantonio, Angela/0000-0003-2094-4765	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Pediatric Oncology Group of Ontario for a Doctoral Research Award; Brain Canada; Ontario Neurotrauma Foundation for the Jane Gillett Pediatric ABI Studentship; CIHR Research Chair in Gender, Work and Health [CGW-126580]; Toronto Rehabilitation Institute-University Health Network (TRI-UHN); CIBC	This study had no external funding source. VC received support from the Canadian Institutes of Health Research (CIHR) and Pediatric Oncology Group of Ontario for a Doctoral Research Award, Brain Canada and CIBC for a Brain Cancer Training Award, and the Ontario Neurotrauma Foundation for the Jane Gillett Pediatric ABI Studentship. AC received support through a CIHR Research Chair in Gender, Work and Health (# CGW-126580). We recognize support from the Toronto Rehabilitation Institute-University Health Network (TRI-UHN). We would like to thank Ms. Jessica Babineau, information specialist from TRI-UHN, for her assistance with the search strategies and Ms. Sabrina Curatolo for assistance in formatting and editing this paper.	Afrooz PN, 2012, J CRANIOFAC SURG, V23, P1270, DOI 10.1097/SCS.0b013e31824e6447; Alvi A, 2003, LARYNGOSCOPE, V113, P102, DOI 10.1097/00005537-200301000-00019; Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; [Anonymous], BIG DAT KNOWL; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Barker-Collo SL, TRENDS HEAD INJURY I; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Bener Abdulbari, 2009, Int Emerg Nurs, V17, P52, DOI 10.1016/j.ienj.2008.07.007; Bhardwaj G, 2010, OPHTHALMOLOGY, V117, P983, DOI 10.1016/j.ophtha.2009.09.040; Bhatoe CHS, 2007, INDIAN J NEUROTRAUM, V4, P89, DOI 10.1016/S0973-0508(07)80022-0; Blume H, 2012, CURR OPIN PEDIATR, V24, P724, DOI 10.1097/MOP.0b013e328359e4cc; Blumenthal I, 2002, POSTGRAD MED J, V78, P732, DOI 10.1136/pmj.78.926.732; Canadian Agency for Drugs and Technologies in Health, GREY MATT PRACT SEAR; Canadian Institute for Health Information, CAN COD STAND VERS 2; Canadian Institute for Health Information, HEAD INJ CAN DEC CHA; Canadian Institute for Health Information, ICD 10 CA CCI IMPL S; Canadian Institute for Health Information Canadian Neurological Sciences Federation & Canadian Brain and Nerve Health Coalition, BURD NEUR DIS DIS IN; Cancelliere C, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-17; Case ME, 2008, BRAIN PATHOL, V18, P571, DOI 10.1111/j.1750-3639.2008.00204.x; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Centers for Disease Control and Prevention, HEADS PREV SHAK BAB; Centers for Disease Control and Prevention, MANY PEOPL HAV TBI; Chan V, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-102; Chen AY, 2011, EMERG THEMES EPIDEMI, V8, DOI 10.1186/1742-7622-8-4; Child Safety Link & Atlantic Collaborative on Injury Prevention, CHILD YOUTH UN INJ A; Colantonio A, ONTARIO ACQUIRED BRA; Colantonio A, 2010, CAN J NEUROL SCI, V37, P783, DOI 10.1017/S0317167100051441; Coronado VG, 1997, SURVEILLANCE TRAUMAT; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Deb S, 1999, BRAIN INJURY, V13, P369, DOI 10.1080/026990599121557; Deisch J, 2011, J FORENSIC SCI, V56, P1049, DOI 10.1111/j.1556-4029.2011.01765.x; Department of Health and Human Resources USA, ICD 10 CM PCS ENXT G; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; DUHAIME AC, 1995, NEUROSURGERY, V37, P401, DOI 10.1227/00006123-199509000-00005; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Faul M, 2002, TRAUMATIC BRAIN INJR; Fujiwara T, 2012, AM J PREV MED, V43, P215, DOI 10.1016/j.amepre.2012.04.028; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Greenwald BA, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50052; Gruskin KD, 1999, ARCH PEDIAT ADOL MED, V153, P15; Harrison JE, 2012, BRAIN INJURY, V26, P996, DOI 10.3109/02699052.2012.660515; Hoyt CS, 2007, EYE, V21, P1285, DOI 10.1038/sj.eye.6702849; Hubbard G, 2012, TRAUMATIC BRAIN INJR; Hyder AA, IMPOACT TRUAMATIC BR; Imahara SD, 2008, J AM COLL SURGEONS, V207, P710, DOI 10.1016/j.jamcollsurg.2008.06.333; Jin H, 2010, INJURY, V41, P918, DOI 10.1016/j.injury.2010.03.007; Kennan HT, 1999, ARCH SURG-CHICAGO, V134, P14, DOI 10.1001/archsurg.134.1.14; Kivlin J D, 1999, Trans Am Ophthalmol Soc, V97, P545; Kleiven Svein, 2003, Inj Control Saf Promot, V10, P173, DOI 10.1076/icsp.10.3.173.14552; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Kraus JF, 2003, ANN EMERG MED, V41, P18, DOI 10.1067/mem.2003.1; Laupacis A., CANADIAN I HLTH INFO; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Levin AV, 2010, PEDIATRICS, V126, P961, DOI 10.1542/peds.2010-1220; Martin RCG, 2002, AM SURGEON, V68, P477; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; Matschke J, 2009, INT J LEGAL MED, V123, P189, DOI 10.1007/s00414-008-0293-8; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Morad Y, 2004, J AAPOS, V8, P521, DOI 10.1016/j.jaapos.2004.07.009; Morad Y, 2004, J AAPOS, V8, P445, DOI 10.1016/j.jaapos.2004.06.007; Mungan NK, 2007, CURR OPIN OPHTHALMOL, V18, P392, DOI 10.1097/ICU.0b013e3282a167f0; Nestman P, CHILD YOUTH INJRIES; Nicholl J, 2009, SEMIN NEUROL, V29, P247, DOI 10.1055/s-0029-1223878; O'Rance L, DISABILITY AUSTR ACQ; Ontario Injury Prevention Resource Centre, ONT INJ DAT REP; Pappachan B, 2006, J ORAL MAXIL SURG, V64, P1023, DOI 10.1016/j.joms.2006.03.021; Parks SE, PEDIATRIC ABUSE HEAD; Parks SE, 2012, INJURY PREV, V18, P193, DOI 10.1136/injuryprev-2011-040128; Peloso PM, 2004, J REHABIL MED, V36, P22, DOI 10.1080/16501960410023714; Piteau SJ, 2012, PEDIATRICS, V130, P315, DOI 10.1542/peds.2011-1545; Prasad MR, 1999, J CHILD NEUROL, V14, P496, DOI 10.1177/088307389901400803; Puljula J, 2012, INJURY, V43, P2100, DOI 10.1016/j.injury.2012.04.010; Roberts RF, 1998, MED J AUSTRALIA, V169, pS32, DOI 10.5694/j.1326-5377.1998.tb123473.x; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Ropper AH, CONCUSSION OTHER HEA; Russell HV, 2013, PEDIATRICS, V131, pE273, DOI 10.1542/peds.2012-0912; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Shao JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051634; Sills MR, 2005, ARCH PEDIAT ADOL MED, V159, P665, DOI 10.1001/archpedi.159.7.665; Smith Hayden, 2012, J Trauma Nurs, V19, P57, DOI 10.1097/JTN.0b013e31823a4c0e; Socie E, SPORTS RECREATION RE; Squier W, 2011, ACTA NEUROPATHOL, V122, P519, DOI 10.1007/s00401-011-0875-2; St Germaine-Smith C, 2012, NEUROLOGY, V79, P1049, DOI 10.1212/WNL.0b013e3182684707; Steudel WI, 2005, ACTA NEUROCHIR, V147, P231, DOI 10.1007/s00701-004-0441-y; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Takeshi M, 2006, J TRAUMA, V60, P1245, DOI 10.1097/01.ta.0000196932.11384.ac; Tang Johnny, 2008, Int Ophthalmol Clin, V48, P237, DOI 10.1097/IIO.0b013e3181693236; Tennant A, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-21; The Victorian Neurotrauma Initiative, EC COST SPIN CORD IN; Thoren H, 2012, J ORAL MAXIL SURG, V70, P92, DOI 10.1016/j.joms.2011.06.227; Thurman DJ, STANDARDS SURVEILLAN; WellFlorida Council Inc, TRAUM BRAIN INJ FLOR; WILKINSON WS, 1989, ARCH OPHTHALMOL-CHIC, V107, P1472, DOI 10.1001/archopht.1989.01070020546037; World Health Organization, INT CLASS DIS; World Health Organization, NEUR DIS PUBL HLTH C; Wymann NME, 2008, J ORAL MAXIL SURG, V66, P58, DOI 10.1016/j.joms.2007.04.023; Xia X, 2012, INT J ENV RES PUB HE, V9, P4187, DOI 10.3390/ijerph9114187; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Zimmermann CE, 2006, INT J ORAL MAX SURG, V35, P1, DOI 10.1016/j.ijom.2005.06.015	105	17	17	1	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2377			BMC NEUROL	BMC Neurol.	FEB 4	2015	15								7	10.1186/s12883-015-0259-7			26	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CD0UR	WOS:000350789900001	25648197	Green Published, gold			2022-02-06	
J	Cartwright, C; Igbaseimokumo, U				Cartwright, Cathy; Igbaseimokumo, Usiakimi			Lumbar Puncture Opening Pressure Is Not a Reliable Measure of Intracranial Pressure in Children	JOURNAL OF CHILD NEUROLOGY			English	Article						lumbar puncture; Camino((R)) bolt; intracranial pressure	TRAUMATIC BRAIN-INJURY; HYPERTENSION; SIGNALS	There is very little data correlating lumbar puncture pressures to formal intracranial pressure monitoring despite the widespread use of both procedures. The hypothesis was that lumbar puncture is a single-point measurement and hence it may not be a reliable evaluation of intracranial pressure. The study was therefore carried out to compare lumbar puncture opening pressures with the Camino((R)) bolt intracranial pressure monitor in children. Twelve children with a mean age of 8.5 years who had both lumbar puncture and intracranial pressure monitoring were analyzed. The mean lumbar puncture opening pressure was 22.4 mm Hg versus a mean Camino bolt intracranial pressure of 7.8 mm Hg (P < .0001). Lumbar puncture therefore significantly overestimates the intracranial pressure in children. There were no complications from the intracranial pressure monitoring, and the procedure changed the treatment of all 12 children avoiding invasive operative procedures in most of the patients.	[Cartwright, Cathy; Igbaseimokumo, Usiakimi] Childrens Mercy Hosp, Div Neurosurg, Kansas City, MO 64108 USA		Igbaseimokumo, U (corresponding author), Childrens Mercy Hosp, Div Neurosurg, 2401 Gillham Rd, Kansas City, MO 64108 USA.	usiakimi@gmail.com					Baird LC, 2012, CHILD NERV SYST, V28, P411, DOI 10.1007/s00381-011-1615-6; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Eide PK, 2006, MED ENG PHYS, V28, P542, DOI 10.1016/j.medengphy.2005.09.003; Eide PK, 2005, PEDIATR NEUROSURG, V41, P122, DOI 10.1159/000085868; Eidlitz-Markus T, 2005, PEDIATR ANESTH, V15, P1078, DOI 10.1111/j.1460-9592.2005.01675.x; Ellis JA, 2012, J NEUROSURG-PEDIATR, V10, P14, DOI 10.3171/2012.3.PEDS11228; Horton JC, 2011, J NEURO-OPHTHALMOL, V31, P199, DOI 10.1097/WNO.0b013e31822b5aec; Hughes A, 2013, BMJ CASE REP, V2013; Inagaki T, 2007, CHILD NERV SYST, V23, P1455, DOI 10.1007/s00381-007-0436-0; Kapadia FN, 1996, BRIT J NEUROSURG, V10, P585; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Larsen G Y, 1999, Pediatr Rev, V20, P234, DOI 10.1542/pir.20-7-234; Lenfeldt N, 2007, NEUROLOGY, V68, P155, DOI 10.1212/01.wnl.0000250270.54587.71; Luerssen T G, 1997, Semin Pediatr Neurol, V4, P146, DOI 10.1016/S1071-9091(97)80033-2; Padayachy LC, 2010, CHILD NERV SYST, V26, P441, DOI 10.1007/s00381-009-1034-0; Seruya M, 2011, J NEUROSURG-PEDIATR, V8, P40, DOI 10.3171/2011.4.PEDS1160; Tataryn Z, 2013, CHILD NERV SYST, V29, P2127, DOI 10.1007/s00381-013-2167-8; Warden KF, 2011, J NEURO-OPHTHALMOL, V31, P202, DOI 10.1097/WNO.0b013e3182183c8d; Wiegand C, 2007, DEV MED CHILD NEUROL, V49, P935, DOI 10.1111/j.1469-8749.2007.00935.x	20	17	17	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	FEB	2015	30	2					170	173		10.1177/0883073814533006			4	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	CA9CY	WOS:000349219200004	24799366				2022-02-06	
J	Donnelly, J; Czosnyka, M; Sudhan, N; Varsos, GV; Nasr, N; Jalloh, I; Liu, XY; Dias, C; Sekhon, MS; Carpenter, KLH; Menon, DK; Hutchinson, PJ; Smielewski, P				Donnelly, Joseph; Czosnyka, Marek; Sudhan, Nazneen; Varsos, Georgios V.; Nasr, Nathalie; Jalloh, Ibrahim; Liu, Xiuyun; Dias, Celeste; Sekhon, Mypinder S.; Carpenter, Keri L. H.; Menon, David K.; Hutchinson, Peter J.; Smielewski, Peter			Increased Blood Glucose is Related to Disturbed Cerebrovascular Pressure Reactivity After Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Glucose; Cerebral haemodynamics; Pressure reactivity; Vascular function; ICP; Traumatic brain injury	HEAD-INJURY; CEREBRAL METABOLISM; HYPERGLYCEMIA; FLOW; ISCHEMIA; TRIAL	Increased blood glucose and impaired pressure reactivity (PRx) after traumatic brain injury (TBI) are both known to correlate with unfavorable patient outcome. However, the relationship between these two variables is unknown. To test the hypothesis that increased blood glucose leads to increased PRx, we retrospectively analyzed data from 86 traumatic brain injured patients admitted to the Neurocritical Care Unit. Data analyzed included arterial glucose concentration, intracranial pressure (ICP), cerebral perfusion pressure (CPP) and end-tidal CO2. PRx was calculated as the moving correlation coefficient between averaged (10 seconds) arterial blood pressure and ICP. One arterial glucose concentration and one time-aligned PRx value were obtained for each patient, during each day until the fifth day after ictus. Mean arterial glucose concentrations during the first 5 days since ictus were positively correlated with mean PRx (Pearson correlation coefficient = 0.25, p = 0.02). The correlation was strongest on the first day after injury (Pearson correlation coefficient = 0.47, p = 0.008). Our preliminary findings indicate that increased blood glucose may impair cerebrovascular reactivity, potentially contributing to a mechanistic link between increased blood glucose and poorer outcome after TBI.	[Donnelly, Joseph; Czosnyka, Marek; Varsos, Georgios V.; Nasr, Nathalie; Jalloh, Ibrahim; Liu, Xiuyun; Carpenter, Keri L. H.; Hutchinson, Peter J.; Smielewski, Peter] Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Cambridge CB2 0QQ, England; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland; [Sudhan, Nazneen; Sekhon, Mypinder S.; Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Dept Anaesthesia, Cambridge CB2 0QQ, England; [Nasr, Nathalie] Univ Toulouse 3, Hop Rangueil, Serv Neurol Vasc, INSERM,U1048,Team Toulouse 11 I2MC, F-31062 Toulouse, France; [Dias, Celeste] Hosp Sao Joao, Dept Intens Care, Neurocrit Care Unit, Oporto, Portugal; [Sekhon, Mypinder S.] Univ British Columbia, Vancouver Gen Hosp, Dept Med, Div Crit Care Med, Vancouver, BC V5Z 1M9, Canada		Donnelly, J (corresponding author), Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Cambridge Biomed Campus,Box 167, Cambridge CB2 0QQ, England.	jd634@cam.ac.uk	NASR, NATHALIE/K-3521-2019; Donnelly, Joseph/E-9235-2018; Dias, Celeste/AAV-3820-2020; Dias, Celeste/L-9901-2014; Donnelly, Joseph/N-6803-2019; Dias, Celeste/AAD-8711-2019; Liu, Xiuyun/V-4427-2017	Donnelly, Joseph/0000-0002-6502-8069; Dias, Celeste/0000-0003-0340-9808; Dias, Celeste/0000-0003-0340-9808; Donnelly, Joseph/0000-0002-6502-8069; Liu, Xiuyun/0000-0001-9540-4865; czosnyka, marek/0000-0003-2446-8006; Hutchinson, Peter/0000-0002-2796-1835; Carpenter, Keri/0000-0001-8236-7727; Smielewski, Peter/0000-0001-5096-3938	Woolf Fisher scholarship; A. G. Leventis Foundation Scholarship; St Edmund's College, Cambridge; NIHR Research Professorship; NIHR Cambridge Biomedical Research CentreNational Institute for Health Research (NIHR); NIHR Biomedical Research Centre, Cambridge (Brain Injury and Repair Theme); NIHR Biomedical Research Centre in Cambridge, UK; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0001237, G1002277, G0600986, G9439390] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0001237, G1000183B, G0600986, G1002277, G0001354, G0001354B, G9439390] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327, NF-SI-0512-10090, NIHR-RP-R3-12-013] Funding Source: researchfish	We express our thanks to the whole NCCU team, the patients, and their families. JD is supported by a Woolf Fisher scholarship. GVV is supported by an A. G. Leventis Foundation Scholarship and a Charter Studentship from St Edmund's College, Cambridge. PJH is supported by an NIHR Research Professorship, the NIHR Cambridge Biomedical Research Centre and has been appointed as the Surgical Specialty Lead for Neurosurgery, Royal College of Surgeons of England Clinical Research Initiative. KLHC is supported by the NIHR Biomedical Research Centre, Cambridge (Brain Injury and Repair Theme). MC is supported by NIHR Biomedical Research Centre in Cambridge, UK.	Baird TA, 2003, STROKE, V34, P2208, DOI 10.1161/01.STR.0000085087.41330.FF; Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 1997, NEUROSURGERY, V41, P17; Diaz-Parejo P, 2003, INTENS CARE MED, V29, P544, DOI 10.1007/s00134-003-1669-3; DUCKROW RB, 1985, ANN NEUROL, V17, P267, DOI 10.1002/ana.410170308; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; Holbein M, 2009, CRIT CARE, V13, DOI 10.1186/cc7711; Kawai N, 1997, STROKE, V28, P149, DOI 10.1161/01.STR.28.1.149; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; LASSEN NA, 1964, CIRC RES, V15, P201; Lott MEJ, 2007, AM J PHYSIOL-HEART C, V292, pH304, DOI 10.1152/ajpheart.00940.2005; Meierhans R, 2010, CRIT CARE, V14, DOI 10.1186/cc8869; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; Moro N, 2013, BRAIN RES, V1535, P124, DOI 10.1016/j.brainres.2013.08.044; Page KA, 2013, JAMA-J AM MED ASSOC, V309, P63, DOI 10.1001/jama.2012.116975; PENTELENYI T, 1977, INJURY, V8, P264, DOI 10.1016/0020-1383(77)90099-7; REHNCRONA S, 1981, J CEREBR BLOOD F MET, V1, P297, DOI 10.1038/jcbfm.1981.34; Title LM, 2000, J AM COLL CARDIOL, V36, P2185, DOI 10.1016/S0735-1097(00)00980-3; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; Vespa P, 2012, CRIT CARE MED, V40, P1923, DOI 10.1097/CCM.0b013e31824e0fcc; Ward ME, 2002, ANESTHESIOLOGY, V97, P471, DOI 10.1097/00000542-200208000-00026; Yang SY, 1995, SURG NEUROL, V44, P373, DOI 10.1016/0090-3019(96)80243-6; YIP PK, 1991, NEUROLOGY, V41, P899, DOI 10.1212/WNL.41.6.899; Zygun DA, 2004, NEUROSURGERY, V55, P877, DOI 10.1227/01.NEU.0000137658.14906.E4	25	17	18	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2015	22	1					20	25		10.1007/s12028-014-0042-4			6	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CA3FH	WOS:000348791300004	25124103	Green Accepted			2022-02-06	
J	Gibson, TJ; Whitehead, C; Taylor, R; Sykes, O; Chancellor, NM; Limon, G				Gibson, Troy J.; Whitehead, Claire; Taylor, Rebecca; Sykes, Olivia; Chancellor, Natalie M.; Limon, Georgina			Pathophysiology of penetrating captive bolt stunning in Alpacas (Vicugna pacos)	MEAT SCIENCE			English	Article						Alpaca; Behaviour; Captive bolt; Stunning; Slaughter	HALOTHANE-ANESTHETIZED CALVES; BRAIN-FUNCTION; ELECTROENCEPHALOGRAPHIC RESPONSES; CONCUSSIVE METHODS; CATTLE SHOT; SLAUGHTER; SHEEP; FEASIBILITY; LIVESTOCK; POSITION	The aim of this study was to examine the behavioural and cranial/spinal responses of alpacas culled by captive bolt shooting and the resulting pathophysiology of captive bolt injury. Ninety-six alpacas were shot (103 shots) in a range of locations with a penetrating captive bolt gun (CBG). Ten (9.8%) alpacas were incompletely concussed following the first shot. No animals required more than two shots. Incorrectly placed shots accounted for all of the animals that displayed signs of sensibility. Damage to the thalamus, hypothalamus, midbrain, medulla, cerebellum, parietal and occipital lobes were significantly associated with decreasing odds of incomplete concussion. In conclusion, the study confirmed that CBG stunning can induce insensibility in alpacas and suggests that the top of the head (crown) position maximises damage to structures of the thalamus and brainstem. (C) 2014 The Authors. Published by Elsevier Ltd.	[Gibson, Troy J.; Taylor, Rebecca; Sykes, Olivia; Chancellor, Natalie M.; Limon, Georgina] Royal Vet Coll, Hatfield AL9 7TA, Herts, England; [Whitehead, Claire] Camelid Vet Serv, Reading RG8 7NU, Berks, England		Gibson, TJ (corresponding author), Royal Vet Coll, Hawkshead Lane, Hatfield AL9 7TA, Herts, England.	tgibson@rvc.ac.uk	Gibson, Troy/AAA-8687-2019	Gibson, Troy/0000-0002-1242-2695	Humane Slaughter Association Dorothy Sidley Memorial Award	The authors would like to thank Dr. NG Gregory for helpful discussion and comments on the early draft of the manuscript. This study was partly supported by a Humane Slaughter Association Dorothy Sidley Memorial Award.	Atkinson S, 2013, ANIM WELFARE, V22, P473, DOI 10.7120/09627286.22.4.473; BLACKMORE DK, 1982, MEAT SCI, V7, P19, DOI 10.1016/0309-1740(82)90094-8; BLACKMORE DK, 1979, VET REC, V105, P372, DOI 10.1136/vr.105.16.372; BLACKMORE DK, 1984, RES VET SCI, V37, P223, DOI 10.1016/S0034-5288(18)31909-X; Bonaci CG, 2011, MANAGEMENT OF TECHNOLOGICAL CHANGES, BOOK 2, P477; Cardellino R. C., 2009, Matching genetics and environment: a new look at an old topic. Proceedings of the 18th Conference of the Association for the Advancement of Animal Breeding and Genetics, Barossa Valley, South Australia, Australia, 28 September-1 October, 2009, P366; DALY CC, 1986, RES VET SCI, V41, P349, DOI 10.1016/S0034-5288(18)30628-3; DALY CC, 1989, RES VET SCI, V46, P406, DOI 10.1016/S0034-5288(18)31189-5; DALY CC, 1986, RES VET SCI, V41, P353, DOI 10.1016/S0034-5288(18)30629-5; DALY CC, 1987, BRIT VET J, V143, P574, DOI 10.1016/0007-1935(87)90049-2; Dembo J.A, 1894, JEWISH METHOD SLAUGH; Finnie JW, 2002, AUST VET J, V80, P67, DOI 10.1111/j.1751-0813.2002.tb12840.x; FRICKER C, 1981, FLEISCHWIRTSCHAFT, V61, P124; Fries R, 2012, ANIMAL, V6, P1124, DOI 10.1017/S1751731111002667; Gibson TJ, 2012, ANIM WELFARE, V21, P35, DOI 10.7120/096272812X13353700593446; Gibson TJ, 2009, NEW ZEAL VET J, V57, P96, DOI 10.1080/00480169.2009.36885; Gibson TJ, 2009, NEW ZEAL VET J, V57, P90, DOI 10.1080/00480169.2009.36884; Gouveia KG, 2009, ANIM WELFARE, V18, P171; Grandin T, 1998, APPL ANIM BEHAV SCI, V56, P121, DOI 10.1016/S0168-1591(97)00102-0; Grandin T, 2002, J AM VET MED ASSOC, V221, P1258, DOI 10.2460/javma.2002.221.1258; GRANDIN T, 1980, INT J STUD ANIM PROB, V1, P242; GRANDIN T, 1994, J AM VET MED ASSOC, V204, P1354; Gregory N., 2000, Journal of Applied Animal Welfare Science, V3, P215, DOI 10.1207/S15327604JAWS0303_3; Gregory N. G., 1990, Veterinary History, V6, P73; Gregory N. G., 2007, Animal welfare and meat production, P191, DOI 10.1079/9781845932152.0191; Gregory NG, 2007, MEAT SCI, V77, P499, DOI 10.1016/j.meatsci.2007.04.026; Jabbar A., 2013, PARASITES VECTORS, V6; LAMBOOY E, 1981, VET REC, V109, P359, DOI 10.1136/vr.109.16.359; Limon G, 2012, ANIM WELFARE, V21, P3, DOI 10.7120/096272812X13353700593248; Limon G, 2010, MEAT SCI, V84, P352, DOI 10.1016/j.meatsci.2009.09.001; Limon G, 2009, MEAT SCI, V82, P405, DOI 10.1016/j.meatsci.2009.01.022; Svendsen O, 2008, VET REC, V162, P90, DOI 10.1136/vr.162.3.90; von Wenzlawowicz M, 2012, ANIM WELFARE, V21, P51, DOI 10.7120/096272812X13353700593527; Whitehead C, 2013, IN PRACTICE, V35, P317, DOI 10.1136/inp.f3641	34	17	18	1	10	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0309-1740	1873-4138		MEAT SCI	Meat Sci.	FEB	2015	100						227	231		10.1016/j.meatsci.2014.10.022			5	Food Science & Technology	Science Citation Index Expanded (SCI-EXPANDED)	Food Science & Technology	AY7WC	WOS:000347765700032	25460130	hybrid, Green Accepted			2022-02-06	
J	Chen, ST; Chang, CJ; Su, WC; Chang, LW; Chu, IH; Lin, MS				Chen, Shuo-Tsung; Chang, Cheng-Jen; Su, Wei-Chin; Chang, Lin-Wan; Chu, I-Hsuan; Lin, Muh-Shi			3-D titanium mesh reconstruction of defective skull after frontal craniectomy in traumatic brain injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Frontal intracranial haemorrhage; Head injury; Decompressive craniectomy; Three-dimensional titanium mesh; Reconstruction; Cosmesis; Quality of life	DECOMPRESSIVE CRANIECTOMY; CRANIOPLASTY; TECHNOLOGIES; FRACTURE; CHILDREN	Introduction: Decompressive craniectomy (DC) is a treatment strategy used to reduce intracranial pressure in patients with traumatic brain injuries. However, this procedure has a number of shortcomings, such as excessive sinking of the skin flap, which can lead to cerebral compromise and negatively affect the appearance of the patient. The reconstruction of skull defects has been proposed as a means to overcome these disadvantages. Few previous studies have reported the reconstruction of frontal skull defects using titanium mesh. The aim of this study was to provide a comprehensive review of aesthetic and surgical outcomes associated with this procedure and to list the complications encountered during the repair of frontal skull defects using three-dimensional (3-D) titanium mesh. Methods: A retrospective review was conducted using records from seven adult patients (32-60 years of age) who received titanium mesh implants at a university hospital in Taiwan between January 2011 and June 2012. Aesthetic outcomes, the function of cranial nerves V and VII, and complications (hardware extrusions, meningitis, osteomyelitis, brain abscess, and pneumocephalus) were evaluated. Results: An algorithm capable of accounting for bifrontal skull defects and median bone ridges was developed to improve computer-assisted design/manufacturing (CAD/CAM) of one-piece 3-D titanium mesh implants, thereby making it possible to repair bifrontal skull defects in a single operation. Following this procedure, aesthetic and functional outcomes were excellent and the implants in all patients appeared stable. However, extended healing times in two of the patients resulted in subclinical infections, which were resolved by administering antibiotics over a period of 2 weeks. No patients suffered trigeminal or facial dysfunction. Conclusions: Our findings support the use of 3-D titanium mesh in frontal skull reconstruction. Few complications were encountered, the contours of the forehead were faithfully rendered, and the cosmetic appearance of patients was excellent. For patients with bifrontal skull defects, the use of one-piece implants in a single operation provides numerous advantages over conventional staged surgeries. This application helps to reduce operating time, which is particularly beneficial for elderly patients and those requiring bifrontal cranioplasties. (C) 2014 Elsevier Ltd. All rights reserved.	[Chen, Shuo-Tsung] Tunghai Univ, Dept Math, Taichung 40704, Taiwan; [Chang, Cheng-Jen] Chang Gung Univ, Chang Gung Mem Hosp, Dept Plast Surg, Taoyuan, Taiwan; [Lin, Muh-Shi] Natl Yang Ming Univ, Sch Med, Fac Med, Dept Surg, Taipei 112, Taiwan; [Su, Wei-Chin; Chang, Lin-Wan; Chu, I-Hsuan; Lin, Muh-Shi] Taipei City Hosp, Zhong Xiao Branch, Dept Neurosurg, Taipei, Taiwan; [Lin, Muh-Shi] Natl Ilan Univ, Dept Biotechnol & Anim Sci, Ilan, Taiwan		Lin, MS (corresponding author), Dept Neurosurg, 87 Tongde Rd, Taipei 115, Taiwan.	neurosurgery2005@yahoo.com.tw	Lin, 林牧熹 醫學博士 法學碩士 Muh-Shi/U-7004-2019	Lin, 林牧熹 醫學博士 法學碩士 Muh-Shi/0000-0002-9798-8160			Bratzler Dale W, 2013, Am J Health Syst Pharm, V70, P195, DOI 10.2146/ajhp120568; Cabraja M, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS091; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Di SM, 2013, ADV ORTHOP, V2013; Galantucci L. M., 2006, Journal of Medical Engineering & Technology, V30, P102, DOI 10.1080/03091900500131714; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; HOUSE JW, 1985, OTOLARYNG HEAD NECK, V93, P146, DOI 10.1177/019459988509300202; Huang X, 2010, INT J MED SCI, V7, P385; Hung KS, 2004, J CLIN NEUROSCI, V11, P849, DOI 10.1016/j.jocn.2003.06.009; Janecka IP, 2000, ARCH OTOLARYNGOL, V126, P396, DOI 10.1001/archotol.126.3.396; Joseph V, 2009, J NEUROSURG, V111, P650, DOI 10.3171/2009.3.JNS0984; Ju DT, 2008, ACTA NEUROCHIR SUPPL, V101, P169; KAISER A, 1993, EUR J PEDIATR SURG, V3, P236, DOI 10.1055/s-2008-1063551; Kung WM, 2012, BRAIN INJURY, V26, P1737, DOI 10.3109/02699052.2012.698361; Kung WM, 2012, J NEUROTRAUM, V29, P2030, DOI 10.1089/neu.2011.2220; Lakhani RS, 2001, ARCH OTOLARYNGOL, V127, P665, DOI 10.1001/archotol.127.6.665; MALIS LI, 1989, NEUROSURGERY, V25, P351, DOI 10.1227/00006123-198909000-00005; Marbacher S, 2008, J CRANIOFAC SURG, V19, P490, DOI 10.1097/SCS.0b013e3181534ae8; Margules A, 2010, JHN J, V5, P9; Matic DB, 2004, J CRANIOFAC SURG, V15, P415, DOI 10.1097/00001665-200405000-00012; Schaller B, 2003, BRAIN RES, V982, P31, DOI 10.1016/S0006-8993(03)02900-7; Scholz M, 2007, J CRANIO MAXILL SURG, V35, P388, DOI 10.1016/j.jcms.2007.06.006; SEGAL DH, 1994, NEUROSURGERY, V34, P729, DOI 10.1227/00006123-199404000-00024; Staffa G, 2007, ACTA NEUROCHIR, V149, P161, DOI 10.1007/s00701-006-1078-9; STATHAM PF, 1989, J NEUROL NEUROSUR PS, V52, P351, DOI 10.1136/jnnp.52.3.351	25	17	18	0	12	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JAN	2015	46	1					80	85		10.1016/j.injury.2014.09.019			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	AX1YJ	WOS:000346739600016	25452005				2022-02-06	
J	Conder, R; Conder, AA				Conder, Robert; Conder, Alanna Adler			Neuropsychological and psychological rehabilitation interventions in refractory sport-related post-concussive syndrome	BRAIN INJURY			English	Article						Biofeedback; biopsychosocial; cognitive behavioural therapy; mild traumatic brain injury; neurofeedback; sport concussion	TRAUMATIC BRAIN-INJURY; HEART-RATE-VARIABILITY; OF-THE-LITERATURE; HIGH-SCHOOL; COGNITIVE REHABILITATION; NEUROCOGNITIVE PERFORMANCE; CLINICAL MANAGEMENT; EARLY-CHILDHOOD; SEX-DIFFERENCES; SYMPTOMS	Background: The neuropsychological, physical, vestibular and oculomotor sequelae of sports-related concussion are extremely well documented. However, there is a paucity of interventions for these symptoms in refractory sports-related concussions. Aim: The intent of this article is to review the known and emerging neuropsychological and psychological rehabilitation interventions for reducing morbidity in refractory sports-related concussions (SRCs). Methods: The authors openly acknowledge the limited amount of empirical data available for review, as did the Zurich consensus papers, but posit a mindful and ethical approach towards rehabilitation interventions in the absence of evidence-based guidelines. Further, rehabilitation interventions proven useful with similar injuries or illnesses, particularly non-sports-related mild TBI, will be reviewed for applicability. Such interventions include Cognitive-Behavioural psychotherapy, biofeedback, cranial electrical stimulation, neurofeedback and cognitive rehabilitation. Results and conclusions: Modified approaches for rehabilitation with young children within family and school systems are provided. Recommendations for further research are offered.	[Conder, Robert; Conder, Alanna Adler] Carolina Neuropsychol Serv, Raleigh, NC 27607 USA		Conder, R (corresponding author), Carolina Neuropsychol Serv, 1540 Sunday Dr, Raleigh, NC 27607 USA.	bconder10@gmail.com	Meijer, Anna/K-5118-2016				Ahn S, 2011, J PEDIATR PSYCHOL, V36, P385, DOI 10.1093/jpepsy/jsq107; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; ANDERSEN MB, 1988, J SPORT EXERCISE PSY, V10, P294, DOI 10.1123/jsep.10.3.294; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Anderson V, 2010, NEUROPSYCHOLOGIA, V48, P2041, DOI 10.1016/j.neuropsychologia.2010.03.025; Andraisik F, 2003, BIOFEEDBACK PRACTITI, P687; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; Barr WB, 2012, BRAIN INJURY, V26, P58, DOI 10.3109/02699052.2011.608216; Beauchamp MK, 2012, J CLIN SPORT PSYCHOL, V6, P67, DOI 10.1123/jcsp.6.1.67; Beauchamp MR, 2012, OXFORD HDB SPORT PER, P273, DOI DOI 10.1093/OXFORDHB/9780199731763.013.0014; Beck A. T., 2000, MANUAL BECK DEPRESSI; Beck J.S., 2011, COGNITIVE BEHAV THER, V2nd ed; Bender MC, 2003, WILL TRAUM BRAIN INJ; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bracken B. A., 2005, CLIN ASSESSMENT ATTE; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Brooks J, 2006, SPORTS MEUROPSYCHOLO, P131; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Brown RP, 2009, ANN NY ACAD SCI, V31, P11; Burns D, 2008, FEELING GOOD NEW MOO; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Conder AA, 2011, 61 C EXC CHILDR GREE; Conder R, 1988, Brain Inj, V2, P365, DOI 10.3109/02699058809150909; Conder R, 1992, NEUROREHABILITATIVE, P7; Conder RL, 2012, 1 ANN M NHL NEUR CON; Conder RL, 2015, APPL NEUROPSYCH-CHIL, V4, P141, DOI 10.1080/21622965.2013.816849; Couch CM, 2011, ARCH CLIN NEUROPSYCH, V26, P349, DOI 10.1093/arclin/acr028; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; COWINGS PS, 1982, AVIAT SPACE ENVIR MD, V53, P570; Defence Centres of Excellence for Psychological Health and Traumatic Brain Injury US, 2012, ASS MAN DIZZ ASS MIL; Duff J, 2004, CLIN EEG NEUROSCI, V35, P198, DOI 10.1177/155005940403500410; Dunkley C, 2011, EPILEPSY RES, V93, P96, DOI 10.1016/j.eplepsyres.2010.11.002; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Elliot AJ, 2011, PSYCHOPHYSIOLOGY, V48, P1340, DOI 10.1111/j.1469-8986.2011.01216.x; Engel G, 1997, SCIENCE, V196, P129; ENGEL GL, 1980, AM J PSYCHIAT, V137, P535; Ewing ME, 2002, CHILDREN YOUTH SPORT, P39; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Feltz DL, 1984, COGNITIVE SPORT PSYC, P114; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Gass JJ, 2013, APPL PSYCHOPHYS BIOF, V38, P67; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Gioia G, 2006, HEADS UP IN SPORTS; Gioia GA, 2012, PEDIAT ADOLESCENT CO, P687; Giza CC, 2001, J ATHL TRAINING, V36, P228; Goodman B, 2013, NEUROLOGY, V80, P265; Gronwall D, 1997, J Int Neuropsychol Soc, V3, P592; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Hanna-Pladdy B, 2001, CLIN NEUROPSYCHOL, V15, P289, DOI 10.1076/clin.15.3.289.10272; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Harvey DJ, 2011, TXB TRAUMATIC BRAIN, P453; Heil J., 2012, OXFORD HDB SPORT PER; Helmick K, 2010, NEUROREHABILITATION, V26, P239, DOI 10.3233/NRE-2010-0560; Hermann C, 2002, APPL PSYCHOPHYS BIOF, V27, P143, DOI 10.1023/A:1016295727345; Hinkle J L, 1986, J Neurosci Nurs, V18, P268; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Hunt CA, 2013, SPORT EXERC PERFORM, V2, P220, DOI 10.1037/a0031957; Ievleva L., 1991, SPORT PSYCHOL, V5, P25, DOI [DOI 10.1123/TSP.5.1.25, 10.1123/tsp.5.1.25]; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Jacobs GD, 2004, ARCH INTERN MED, V164, P1888, DOI 10.1001/archinte.164.17.1888; Jacobson E., 1938, PROGR RELAXATION; Kennard MA, 1940, ARCH NEURO PSYCHIATR, V44, P377, DOI 10.1001/archneurpsyc.1940.02280080137008; Kennerly R., 2004, J NEUROTHER, V8, P112; Kirk JW, 2012, MILD TRAUMATIC BRAIN, P321; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Kirsch DL, 2008, PAIN MANAGEMENT  JUL, P70; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Kreutzer JS, 1989, COGNITIVE REHABILITA, V7, P30; Lagos L., 2012, BIOFEEDBACK, V40, P150, DOI [10.5298/1081-5937-40.4.05, DOI 10.5298/1081-5937-40.4.05]; Lagos L., 2013, BIOFEEDBACK, V41, P136, DOI [DOI 10.5298/1081-5937-41.3.02, 10.5298/1081-5937-41.3.02]; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Lehrer PM, 2000, APPL PSYCHOPHYS BIOF, V25, P177, DOI 10.1023/A:1009554825745; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; LeUnes A, 2008, SPORTS PSYCHOL; Linden M, 2013, P 2013 INT SOC NEUR; Linden W., 2007, PRINCIPLES PRACTICE, P151; Lovell MR, 2004, STUD NEUROPSYCHOL DE, P221; Lovell MR, 2006, SPORTS NEUROPSYCHOLO, P176; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; McLeod TCV, 2010, ATHLET THER TODAY, V15, P1, DOI 10.1123/att.15.2.1; Meehan WP, 2011, CLIN SPORT MED, V30, P133, DOI 10.1016/j.csm.2010.08.004; Meyers MC, 2001, INT J SPORT PSYCHOL, V32, P29; Mihovich EG, 2009, P AM PSYCH ASS; National Collegiate Athletic Association [Internet], 2012, NCAA STUD PART HITS; Nestoriuc Y, 2008, APPL PSYCHOPHYS BIOF, V33, P125, DOI 10.1007/s10484-008-9060-3; Norris PA, 2003, BIOFEEDBACK PRACTITI, P175; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Register-Mihalik J, 2007, CLIN J SPORT MED, V17, P282, DOI 10.1097/JSM.0b013e31804ca68a; Rieck T, 2013, MED SCI SPORT EXER, V45, P1083, DOI 10.1249/MSS.0b013e3182831db1; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Russell-Chapin L, 2013, J NEUROTHERAPY, V17, P35, DOI DOI 10.1080/10874208.2013.759017; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Schwartz M.S., 2003, BIOFEEDBACK PRACTITI, V3rd; Schwartz MS, 2003, BIOFEEDBACK PRACTITI, P265; Shah AJ, 2011, PSYCHOSOM MED, V73, P475, DOI 10.1097/PSY.0b013e3182227d6a; Sherman R. A., 2012, PAIN ASSESSMENT INTE; Sime W., 2003, BIOFEEDBACK PRACTITI, P560; SMITH RB, 1994, BRAIN INJURY, V8, P357, DOI 10.3109/02699059409150986; SMITH RE, 1995, J SPORT EXERCISE PSY, V17, P379, DOI 10.1123/jsep.17.4.379; Strack BW, 2011, BIOFEEDBACK NEUROFEE, P145; Tan G, 2009, PAIN MED, V10, P1237, DOI 10.1111/j.1526-4637.2009.00712.x; Tatrow K, 2003, APPL PSYCHOPHYS BIOF, V28, P267, DOI 10.1023/A:1027326808356; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; TAYLOR J, 1992, PROF PSYCHOL-RES PR, V23, P318, DOI 10.1037/0735-7028.23.4.318; Thatcher RW, 2006, FOUNDATIONS OF SPORT-RELATED BRAIN INJURIES, P241, DOI 10.1007/0-387-32565-4_11; Thayer JF, 2009, ANN BEHAV MED, V37, P141, DOI 10.1007/s12160-009-9101-z; Tinius T. P., 2000, J NEUROTHER, V4, P27, DOI [DOI 10.1300/J184v04n02_05, 10.1300/J184v04n02_05]; Trzepacz P. T., 1993, PSYCHIAT MENTAL STAT; Weiss M.R., 2012, OXFORD HDB SPORT PER, P448, DOI DOI 10.1093/OXFORDHB/9780199731763.013.0024; Werthner P, 2013, NEUROCONNECTIONS, V2, P32; Wilson P. E., 2012, MILD TRAUMATIC BRAIN, P303; Wilson VE, 2011, BIOFEEDBACK NEUROFEE, P145; Wilson VE, 2011, BIOFEEDBACK NEUROFEE, P107; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Yi JY, 2013, CURR SPORT MED REP, V12, P28, DOI 10.1249/JSR.0b013e31827ec9e3; Yucha C., 2008, EVIDENCE BASED PRACT; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	134	17	17	1	38	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	2					249	262		10.3109/02699052.2014.965209			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AZ4OI	WOS:000348201500014	25291459				2022-02-06	
J	Giese, H; Sauvigny, T; Sakowitz, OW; Bierschneider, M; Guresir, E; Henker, C; Hohne, J; Lindner, D; Mielke, D; Pannewitz, R; Rohde, V; Scholz, M; Schuss, P; Regelsberger, J				Giese, Henrik; Sauvigny, Thomas; Sakowitz, Oliver W.; Bierschneider, Michael; Gueresir, Erdem; Henker, Christian; Hoehne, Julius; Lindner, Dirk; Mielke, Dorothee; Pannewitz, Robert; Rohde, Veit; Scholz, Martin; Schuss, Patrick; Regelsberger, Jan			German Cranial Reconstruction Registry (GCRR): protocol for a prospective, multicentre, open registry	BMJ OPEN			English	Article							MIDDLE-CEREBRAL-ARTERY; TRAUMATIC BRAIN-INJURY; EDEMA TRIAL HAMLET; DECOMPRESSIVE CRANIECTOMY; MALIGNANT INFARCTION; TERRITORY INFARCTION; HEMICRANIECTOMY; CRANIOPLASTY; SURGERY; EFFICACY	Introduction: Owing to increasing numbers of decompressive craniectomies in patients with malignant middle cerebral artery infarction, cranioplastic surgery becomes more relevant. However, the current literature mainly consists of retrospective single-centre (evidence class III) studies. This leads to a wide variability of technical approaches and clinical outcomes. To improve our knowledge about the key elements of cranioplasty, which may help optimising clinical treatment and long-term outcome, a prospective multicentre registry across Germany, Austria and Switzerland will be established. Methods: All patients undergoing cranioplastic surgery in participating centres will be invited to join the registry. Technical methods, materials, medical history, adverse events and clinical outcome measures, including modified Rankin scale and EQ-5D, will be assessed at several time points. Patients will be accessible to inclusion either at initial decompressive surgery or when cranioplasty is planned. Scheduled monitoring will be carried out at time of inclusion and subsequently at time of discharge, if any readmission is necessary, and at follow-up presentation. Cosmetic results and patient satisfaction will also be assessed. Collected data will be managed and statistically analysed by an independent biometric institute. The primary endpoint will be mortality, need for operative revision and neurological status at 3 months following cranioplasty. Ethics and dissemination: Ethics approval was obtained at all participating centres. The registry will provide reliable prospective evidence on surgical techniques, used materials, adverse events and functional outcome, to optimise patient treatment. We expect this study to give new insights in the treatment of skull defects and to provide a basis for future evidence-based therapy regarding cranioplastic surgery.	[Giese, Henrik] Heidelberg Univ, Dept Neurosurg, Heidelberg, Germany; [Sauvigny, Thomas; Regelsberger, Jan] Univ Med Ctr Hamburg Eppendorf, Dept Neurol Surg, Hamburg, Germany; [Sakowitz, Oliver W.] Heidelberg Univ, Klinikum Ludwigsburg, Dept Neurosurg, Ludwigsburg, Germany; [Bierschneider, Michael] Trauma Ctr Murnau, Dept Neurosurg, Murnau, Germany; [Gueresir, Erdem; Schuss, Patrick] Univ Hosp Bonn, Dept Neurosurg, Bonn, Germany; [Henker, Christian] Univ Hosp Rostock, Dept Neurosurg, Rostock, Germany; [Hoehne, Julius] Univ Hosp Regensburg, Dept Neurosurg, Regensburg, Germany; [Lindner, Dirk] Univ Hosp Leipzig, Dept Neurosurg, Leipzig, Germany; [Mielke, Dorothee; Rohde, Veit] Univ Med Ctr Gottingen, Dept Neurosurg, Gottingen, Germany; [Pannewitz, Robert] Univ Dusseldorf, Dept Neurosurg, Dusseldorf, Germany; [Scholz, Martin] Duisburg Med Ctr, Dept Neurosurg, Duisburg, Germany		Giese, H (corresponding author), Heidelberg Univ, Dept Neurosurg, Heidelberg, Germany.	henrik.giese@med.uni-heidelberg.de	Guresir, Erdem/AAV-7224-2021; Mielke, Dorothee/AAU-6776-2021; Hohne, Julius/J-6159-2015; Guresir, Erdem/AAL-4484-2020; Hoehne, Julius/M-4210-2019; Schuss, Patrick/ABC-6469-2020	Guresir, Erdem/0000-0001-8319-0847; Hohne, Julius/0000-0002-8238-2211; Hoehne, Julius/0000-0002-8238-2211; Schuss, Patrick/0000-0002-5806-2576; Henker, Christian/0000-0002-7591-3192; Sakowitz, Oliver/0000-0003-3248-6335	IMBI	The cost of maintaining the GCRR will be met by a consortium of cranioplasty suppliers/companies supporting the registry. Currently, funding is still in process. Contracts have been sent to the companies for verification. As soon as funding is available, the companies will be mentioned by name as well as the amount of payment, on the GCRR website (http://www.GCRR.zz.mu). Funding will be primarily used for data management and analysis, which are made by the IMBI and a study nurse. It is to be emphasised that the registry is initiated as an independent scientific effort investigating the surgical procedure of DC and CP.	Adeoye O, 2011, J STROKE CEREBROVASC, V20, P251, DOI 10.1016/j.jstrokecerebrovasdis.2010.01.006; Beauchamp KM, 2010, J TRAUMA, V69, P270, DOI 10.1097/TA.0b013e3181e491c2; BILLER J, 1991, ANGIOLOGY, V42, P224, DOI 10.1177/000331979104200307; Chang V, 2010, J NEUROSURG, V112, P1120, DOI 10.3171/2009.6.JNS09133; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; De Bonis P, 2012, J NEUROTRAUM, V29, P1071, DOI 10.1089/neu.2011.2116; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Gouello G, 2014, SCI WORLD J, DOI 10.1155/2014/207585; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; Hg LKY, 1970, STROKE, V1, P158, DOI 10.1161/01.STR.1.3.158; Hofmeijer J, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-29; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Honeybul S, 2013, J NEUROSURG, V119, P1566, DOI 10.3171/2013.8.JNS13857; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Iwama T, 2003, NEUROSURGERY, V52, P591, DOI 10.1227/01.NEU.0000047891.86938.46; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Juttler E, 2014, NEW ENGL J MED, V370, P1091, DOI 10.1056/NEJMoa1311367; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kolias AG, 2014, BRIT J NEUROSURG, V28, P310, DOI 10.3109/02688697.2013.859657; Kolias AG, 2012, ACTA NEUROCHIR, V154, P1563, DOI 10.1007/s00701-012-1349-6; Neugebauer H, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-115; O'Kane MC, 1997, EUR J PEDIATR SURG, V7, P56; Piitulainen JM, 2015, WORLD NEUROSURG, V83, P708, DOI 10.1016/j.wneu.2015.01.014; Rahme R, 2012, J NEUROSURG, V117, P749, DOI 10.3171/2012.6.JNS111140; Richards HK, 2009, J NEUROSURG-PEDIATR, V4, P389, DOI 10.3171/2009.4.PEDS09210; Sarov M, 2010, STROKE, V41, P560, DOI 10.1161/STROKEAHA.109.568543; Schuss P, 2013, J NEUROTRAUM, V30, P91, DOI 10.1089/neu.2012.2542; Sobani Zain A, 2011, Surg Neurol Int, V2, P123, DOI 10.4103/2152-7806.85055; Timofeev I, 2006, ACTA NEUROCHIR SUPPL, V96, P11; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Wachter D, 2013, CLIN NEUROL NEUROSUR, V115, P1293, DOI 10.1016/j.clineuro.2012.12.002; Zweckberger K, 2014, CEREBROVASC DIS, V38, P313, DOI 10.1159/000365864	33	17	17	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2015	5	9							e009273	10.1136/bmjopen-2015-009273			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU4FZ	WOS:000363484000093	26423857	Green Published, gold			2022-02-06	
J	Hauger, SL; Schnakers, C; Andersson, S; Becker, F; Moberget, T; Giacino, JT; Schanke, AK; Lovstad, M				Hauger, Solveig L.; Schnakers, Caroline; Andersson, Stein; Becker, Frank; Moberget, Torgeir; Giacino, Joseph T.; Schanke, Anne-Kristine; Lovstad, Marianne			Neurophysiological Indicators of Residual Cognitive Capacity in the Minimally Conscious State	BEHAVIOURAL NEUROLOGY			English	Article							EVENT-RELATED POTENTIALS; TRAUMATIC BRAIN-INJURY; LOCKED-IN SYNDROME; SUBJECTS OWN NAME; VEGETATIVE STATE; UNRESPONSIVE WAKEFULNESS; RESPONSIVE PATIENTS; COVERT COGNITION; NOVELTY P3; DISORDERS	Background. The diagnostic usefulness of electrophysiological methods in assessing disorders of consciousness (DoC) remains to be established on an individual patient level, and there is need to determine what constitutes robust experimental paradigm to elicit electrophysiological indices of covert cognitive capacity. Objectives. Two tasks encompassing active and passive conditions were explored in an event-related potentials (ERP) study. The task robustness was studied in healthy controls, and their utility to detect covert signs of command-following on an individual patient level was investigated in patients in a minimally conscious state (MCS). Methods. Twenty healthy controls and 20 MCS patients participated. The active tasks included (1) listening for a change of pitch in the subject's own name (SON) and (2) counting SON, both contrasted to passive conditions. Midline ERPs are reported. Results. A larger P3 response was detected in the counting task compared to active listening to pitch change in the healthy controls. On an individual level, the counting task revealed a higher rate of responders among both healthy subjects and MCS patients. Conclusion. ERP paradigms involving actively counting SON represent a robust paradigm in probing for volitional cognition in minimally conscious patients and add important diagnostic information in some patients.	[Hauger, Solveig L.; Becker, Frank; Schanke, Anne-Kristine; Lovstad, Marianne] Sunnaas Rehabil Hosp, Dept Res, N-1450 Nesoddtangen, Norway; [Schnakers, Caroline] Univ Calif Los Angeles, Dept Psychol & Neurosurg, Los Angeles, CA 90095 USA; [Andersson, Stein; Schanke, Anne-Kristine] Univ Oslo, Dept Psychol, N-0317 Oslo, Norway; [Becker, Frank] Univ Oslo, Inst Clin Med, N-0318 Oslo, Norway; [Moberget, Torgeir] Oslo Univ Hosp, Norwegian Ctr Mental Disorders Res NORMENT, KG Jebsen Ctr Psychosis Res, Div Mental Hlth & Addict, N-0424 Oslo, Norway; [Moberget, Torgeir] Sunnaas Rehabil Hosp, Reg Ctr Knowledge Translat Rehabil, N-1450 Nesoddtangen, Norway; [Giacino, Joseph T.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Charlestown, MA 02129 USA; [Giacino, Joseph T.] Spaulding Rehabil Hosp, Charlestown, MA 02129 USA		Hauger, SL (corresponding author), Sunnaas Rehabil Hosp, Dept Res, N-1450 Nesoddtangen, Norway.	solveig.hauger@gmail.com	Giacino, Joseph/AAF-1952-2021; Laureys, Steven/A-3349-2011; Laureys, Steven/AAN-2097-2021	Giacino, Joseph/0000-0002-7916-9698; Laureys, Steven/0000-0002-3096-3807; Becker, Frank/0000-0002-0857-0628	Norwegian Extra Foundation for Health and Rehabilitation through EXTRA funds [2012/2/0084]; Sunnaasstiftelsen	The authors wish to thank all the patients and their relatives in contributing to this study and Dr. T. Skandsen for help with patients' recruitment. This research is supported by the Norwegian Extra Foundation for Health and Rehabilitation through EXTRA funds (Grant 2012/2/0084), and Sunnaasstiftelsen funded NeuroScan equipment.	Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Bardin JC, 2011, BRAIN, V134, P769, DOI 10.1093/brain/awr005; Beaumont JG, 2005, NEUROPSYCHOL REHABIL, V15, P184, DOI 10.1080/09602010443000489; Boly M, 2007, NEUROIMAGE, V36, P979, DOI 10.1016/j.neuroimage.2007.02.047; Bruno MA, 2012, J NEUROL, V259, P1087, DOI 10.1007/s00415-011-6303-7; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Cavinato M, 2011, CLIN NEUROPHYSIOL, V122, P719, DOI 10.1016/j.clinph.2010.08.024; Chennu S, 2013, NEUROIMAGE-CLIN, V3, P450, DOI 10.1016/j.nicl.2013.10.008; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Cruse D, 2012, NEUROLOGY, V78, P816, DOI 10.1212/WNL.0b013e318249f764; Cruse D, 2014, BRAIN INJURY, V28, P1197, DOI 10.3109/02699052.2014.920517; Daltrozzo J, 2007, CLIN NEUROPHYSIOL, V118, P606, DOI 10.1016/j.clinph.2006.11.019; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Faugeras F, 2012, NEUROPSYCHOLOGIA, V50, P403, DOI 10.1016/j.neuropsychologia.2011.12.015; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Fischer C, 2008, CLIN NEUROPHYSIOL, V119, P2224, DOI 10.1016/j.clinph.2008.03.035; Fischer C, 2010, CLIN NEUROPHYSIOL, V121, P1032, DOI 10.1016/j.clinph.2010.02.005; Folmer RL, 1997, BRAIN LANG, V56, P306, DOI 10.1006/brln.1997.1828; Fowler B, 1997, BIOL PSYCHOL, V46, P113, DOI 10.1016/S0301-0511(97)05253-8; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2013, SEMIN NEUROL, V33, P142, DOI 10.1055/s-0033-1348960; Giacino JT, 2009, PROG BRAIN RES, V177, P33, DOI 10.1016/S0079-6123(09)17704-X; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gibson RM, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00950; Godbolt AK, 2013, J REHABIL MED, V45, P741, DOI 10.2340/16501977-1167; Herrmann CS, 2001, NEUROSCI BIOBEHAV R, V25, P465, DOI 10.1016/S0149-7634(01)00027-6; Kotchoubey B, 2013, RESTOR NEUROL NEUROS, V31, P473, DOI 10.3233/RNN-120307; Laureys S, 2007, CONSCIOUS COGN, V16, P722, DOI 10.1016/j.concog.2007.04.004; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Leonardi M, 2013, BRAIN INJURY, V27, P473, DOI 10.3109/02699052.2012.750758; Lovstad M, 2014, J HEAD TRAUMA REHAB, V29, pE31, DOI 10.1097/HTR.0000000000000017; Lovstad M, 2010, J HEAD TRAUMA REHAB, V25, P349, DOI 10.1097/HTR.0b013e3181cec841; Lule D, 2013, CLIN NEUROPHYSIOL, V124, P101, DOI 10.1016/j.clinph.2012.04.030; Majerus S, 2005, PROG BRAIN RES, V150, P397, DOI 10.1016/S0079-6123(05)50028-1; Majerus S, 2009, PROG BRAIN RES, V177, P49, DOI 10.1016/S0079-6123(09)17705-1; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Perrin F, 2005, NEUROPSYCHOLOGIA, V43, P12, DOI 10.1016/j.neuropsychologia.2004.07.002; Perrin F, 2006, ARCH NEUROL-CHICAGO, V63, P562, DOI 10.1001/archneur.63.4.562; Perrin F, 1999, CLIN NEUROPHYSIOL, V110, P2153, DOI 10.1016/S1388-2457(99)00177-7; Peterson A, 2015, NEUROIMAGE-CLIN, V7, P588, DOI 10.1016/j.nicl.2015.02.008; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Pratt H, 1999, CLIN NEUROPHYSIOL, V110, P53, DOI 10.1016/S0168-5597(98)00044-6; Reinvang I, 1999, NEUROPSYCHOL REV, V9, P231, DOI 10.1023/A:1021638723486; Risetti M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00775; Schnakers C, 2008, NEUROLOGY, V71, P1614, DOI 10.1212/01.wnl.0000334754.15330.69; Schnakers C, 2015, NEUROREHAB NEURAL RE, V29, P308, DOI 10.1177/1545968314547767; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Schnakers C, 2009, NEUROCASE, V15, P271, DOI 10.1080/13554790902724904; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Solbakk AK, 2002, CLIN ELECTROENCEPHAL, V33, P102, DOI 10.1177/155005940203300306; Soltani Maryam, 2000, Critical Reviews in Neurobiology, V14, P199; Tabachnick B.G., 2013, USING MULTIVARIATE S; Tome D, 2015, J NEURAL TRANSM, V122, P375, DOI 10.1007/s00702-014-1258-3; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1877, DOI 10.1016/j.apmr.2012.12.027	60	17	18	1	4	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0953-4180	1875-8584		BEHAV NEUROL	Behav. Neurol.		2015	2015								145913	10.1155/2015/145913			12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CT9KL	WOS:000363135800001	26504351	Green Published, gold, Green Submitted			2022-02-06	
J	Lei, J; Gao, GY; Mao, Q; Feng, JF; Wang, L; You, WD; Jiang, JY				Lei, Jin; Gao, Guoyi; Mao, Qing; Feng, Junfeng; Wang, Lei; You, Wendong; Jiang, Jiyao		LTH-Trial Collaborators	Rationale, methodology, and implementation of a nationwide multicenter randomized controlled trial of long-term mild hypothermia for severe traumatic brain injury (the LTH-1 trial)	CONTEMPORARY CLINICAL TRIALS			English	Article						Long-term mild hypothermia; Severe traumatic brain injury; Multicenter randomized trial; Efficacy; Safety	THERAPEUTIC HYPOTHERMIA; INTRACRANIAL HYPERTENSION; MODERATE HYPOTHERMIA; HEAD-INJURY; PREVENTION; GUIDELINES; ADULT	Background: Traumatic brain injury (TB!) is a major public health problem recently, however, no intervention showing convincing efficacy. Therapeutic hypothermia with a relatively long duration (more than 48 h), as a promising treatment measure, might improve the patient outcome following severe TBI. Methods/design: The LTH-1 trial is a prospective, nationwide multicenter, randomized, controlled clinical trial to examine the efficacy and safety of long-term mild hypothermia in adult patients after severe traumatic brain injury. A total of 300 consecutive patients will be recruited from 15 large neurosurgical centers in China. The eligible patient will be randomized to receive either long-term mild hypothermia (34-35 degrees C) for 5 days, or normothermia (36-37 degrees C). Additionally, a standardized management protocol will be used in all patients. The primary end point is the neurological outcome 6 months post-injury on the Glasgow Outcome Scale. The secondary outcomes include GOS score at one month post-injury, mortality during six months after injury, length of ICU and hospital stay, intracranial pressure control and Glasgow Coma Scale score during the hospital stay and frequency of complications during the six-month follow-up period. Discussion: Long-term hypothermia is recommended by most recent studies and its efficacy urgently needs to be established in randomized controlled settings. The LTH-1 trial, together with other ongoing studies, will present more evidence for optimal use of hypothermia in severe TB! patients. (C) 2014 Elsevier Inc. All rights reserved.	Shanghai Inst Head Trauma, Shanghai, Peoples R China; [Jiang, Jiyao] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Neurosurg, Shanghai 200127, Peoples R China		Jiang, JY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Neurosurg, 1630 Dongfang Rd, Shanghai 200127, Peoples R China.	doctorjinlei@l63.com; guoyigao@gmail.com; maoq@netease.com; fengifmail@l63.com; dIdtshwl@l26.com; smiles1949@l63.com; jiyaojiangrenji@126.com			National Key Basic Research ProjectNational Basic Research Program of China [2012CB518100]; National Natural Scientific grants [81271381]; Program for Shanghai Outstanding Medical Academic Leader [2014529]	This work was supported by grants from the National Key Basic Research Project (No. 2012CB518100), National Natural Scientific grants (No. 81271381) and Program for Shanghai Outstanding Medical Academic Leader (No. 2014529).	Abelson-Mitchell N, 2008, J CLIN NURS, V17, P46, DOI 10.1111/j.1365-2702.2007.01941.x; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Andrews PJD, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-8; Auer RN, 2001, ANN NY ACAD SCI, V939, P271; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Faul M, 2010, TRAUMATIC BRAIN INJU, P2; Fay T, 1943, RES PUBL ASSOC RES N, V24, P611; Jiang JY, 2009, J NEUROTRAUM, V26, P399, DOI 10.1089/neu.2008.0525; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; Kramer C, 2012, NEUROLOGIST, V18, P173, DOI 10.1097/NRL.0b013e318253f8ef; Lei J, 2013, J NEUROTRAUM, V30, P529, DOI 10.1089/neu.2012.2548; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Maas A, 2011, LANCET NEUROL, V10, P111, DOI 10.1016/S1474-4422(10)70312-4; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Marion D, 2009, J NEUROTRAUM, V26, P455, DOI 10.1089/neu.2008.0582; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Moore EM, 2011, INJURY, V42, P843, DOI 10.1016/j.injury.2011.03.027; Nolan JP, 2005, RESUSCITATION, V67, pS39, DOI 10.1016/j.resuscitation.2005.10.009; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Polderman KH, 2011, LANCET NEUROL, V10, P404, DOI 10.1016/S1474-4422(11)70084-9; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Shann F, 2003, LANCET, V362, P1950, DOI 10.1016/S0140-6736(03)15083-0; Shiozaki T, 2003, J NEUROSURG, V99, P47, DOI 10.3171/jns.2003.99.1.0047; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; TEASDALE G, 1974, LANCET, V2, P81; Ueda Y, 2003, J NEUROSURG, V99, P899, DOI 10.3171/jns.2003.99.5.0899; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; World Medical Association. World Medical Association Declaration of Helsinki, 2011, B WORLD HEALTH ORGAN, V79, P373; Zweifler Richard M, 2003, J Stroke Cerebrovasc Dis, V12, P237, DOI 10.1016/j.jstrokecerebrovasdis.2003.09.006	31	17	18	1	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1551-7144	1559-2030		CONTEMP CLIN TRIALS	Contemp. Clin. Trials	JAN	2015	40						9	14		10.1016/j.cct.2014.11.008			6	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	CB6IZ	WOS:000349732000002	25460339				2022-02-06	
J	Mbakile-Mahlanza, L; Manderson, L; Ponsford, J				Mbakile-Mahlanza, Lingani; Manderson, Lenore; Ponsford, Jennie			The experience of traumatic brain injury in Botswana	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; Botswana; Caregivers; Healthcare workers; Experiences; Coping; Qualitative	ETHNIC DISPARITIES; OUTCOMES; HEALTH; ASSOCIATION; FAMILIES; AFRICA; RACE	Whilst the consequences of traumatic brain injury (TBI) are understood in Western countries, it is not known how cultural background and beliefs affect response and outcome following TBI in low and middle income countries. This study aimed to explore the experiences of TBI in Botswana. Participants included 21 individuals with moderate to severe TBI (68% males, mean age 35.2 years), 18 caregivers and 25 healthcare workers. Qualitative semi-structured interviews were transcribed, translated and thematically coded. Thematic analysis indicated several themes: Injury-related changes, attributions and beliefs about the cause of the injury, family reactions, attitudes, and resources. Participants described the common injury-related effects of TBI. Many participants attributed their injury to supernatural causes. Immediate family members of participants with TBI expressed a sense of love and devotion towards the injured person. Communication was characterised by inadequate information given to those injured and their caregivers. Provision of care was impeded by insufficient staff, limited supplies and lack of training of nurses. The current healthcare system would therefore appear to be ill-equipped to meet the needs of TBI survivors in Botswana. This study will improve understanding of cultural responses and approaches to brain injuries in Botswana which may, in turn, inform improved practice.	[Mbakile-Mahlanza, Lingani; Manderson, Lenore; Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Melbourne, Vic 3004, Australia; [Manderson, Lenore] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Ponsford, Jennie] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia		Ponsford, J (corresponding author), Monash Univ, Sch Psychol Sci, Clayton, Vic 3800, Australia.	jennie.ponsford@monash.edu		Manderson, Lenore/0000-0002-7883-1790; Mbakile-Mahlanza, Lingani/0000-0002-1285-3276	Australian Psychological Society (APS); Epworth Healthcare	We are grateful to the participants for their time and willingness to share their experiences. This work was supported by Australian Psychological Society (APS) Grant for Intercultural/International Projects and a travel grant from Epworth Healthcare.	Arango-Lasprilla JC, 2010, J HEAD TRAUMA REHAB, V25, P128, DOI 10.1097/HTR.0b013e3181d36ca3; Brodin J, 2000, INT J REHABIL RES, V23, P163, DOI 10.1097/00004356-200023030-00004; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Central Statistics Office, 2013, BOTSW AIDS IMP SURV; CORBIN J, 1990, Z SOZIOL, V19, P418, DOI 10.1007/BF00988593; Creswell JW, 2017, DESIGNING CONDUCTING, V3rd; Dahodwala N, 2007, NEUROLOGY, V68, pE15, DOI 10.1212/01.wnl.0000257827.43171.23; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Denbow J.R., 2006, CULTURE CUSTOMS BOTS; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hanche-Olsen TP, 2012, WORLD J SURG, V36, P2371, DOI 10.1007/s00268-012-1659-0; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P158, DOI 10.1097/00001199-200503000-00004; Helps Y., 2008, HOSP SEPARATIONS DUE; Ingstad B., 1997, COMMUNITY BASED REHA, V7; Ingstad Benedicte, 2007, DISABILITY LOCAL GLO, P237; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kleinman Arthur., 1980, PATIENTS HEALERS CON; Lincoln Y., 2002, QUALITATIVE INQUIRY; Livingston J., 2012, IMPROVISING MED AFRI; Lopez-Jimenez H., 2011, BEHAV MODERATE UNPUB; Mkhize N., 2014, MEDITERRANEAN J SOCI, V5, P2413; Mokhosi MT, 2004, S AFR J PSYCHOL, V34, P301, DOI 10.1177/008124630403400208; Nolan S, 2005, CRIT CARE NURS Q, V28, P188, DOI 10.1097/00002727-200504000-00010; Nsamenang AB, 2010, CONTEMP ISS EARLY CH, V11, P20, DOI 10.2304/ciec.2010.11.1.20; ODEK AW, 2007, E AFRICA SOCIAL SCI, V23, P1; Plano Clark, 2018, DESIGNING CONDUCTING; Ponsford J., 2012, TRAUMATIC BRAIN INJU, V2nd Edition; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Raymont V, 2008, BRAIN, V131, P543, DOI 10.1093/brain/awm300; Republic of Botswana, 2002, HOUS INC EXP SURV; Saltapidas H, 2008, BRAIN IMPAIR, V9, P1, DOI 10.1375/brim.9.1.1; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; Smith-Morris, 2010, CHRONIC CONDITIONS F; Staudenmayer KL, 2007, J TRAUMA, V63, P1364, DOI 10.1097/TA.0b013e31815b897b; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tobin GA, 2004, J ADV NURS, V48, P388, DOI 10.1111/j.1365-2648.2004.03207.x; Unantenne N, 2013, J RELIG HEALTH, V52, P1147, DOI 10.1007/s10943-011-9554-9; Walsh K., 2005, NEUROPSYCHOLOGY CLIN; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; Whelan-Goodinson R, 2008, J REHABIL MED, V40, P850, DOI 10.2340/16501977-0271; [No title captured]	41	17	17	0	11	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2015	25	6					936	958		10.1080/09602011.2014.999000			23	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	DP1TC	WOS:000378271300008	25558888				2022-02-06	
S	McCarthy, MT; Kosofsky, BE		Fink, ME; Barchas, JD; Sheikh, JI		McCarthy, Matthew T.; Kosofsky, Barry E.			Clinical features and biomarkers of concussion and mild traumatic brain injury in pediatric patients	AFFECTIVE DISORDERS AND TRAUMATIC BRAIN INJURY	Annals of the New York Academy of Sciences		English	Article; Proceedings Paper	Qatar Clinical Neuroscience Conference	MAR 15-17, 2014	Doha, QATAR	Qatar Fdn Educ Sci & Community Dev			NEURON-SPECIFIC ENOLASE; HIGH-SCHOOL; INTRACRANIAL LESIONS; SERUM CONCENTRATIONS; BIOCHEMICAL MARKERS; COMPUTED-TOMOGRAPHY; OUTCOME PREDICTION; ELEVATED LEVELS; SOCCER PLAYERS; DAMAGE S-100B	There has been increasing awareness of the incidence and potential long-term consequences of mild traumatic brain injury (mTBI) in children and young adults. While parents, school systems, and athletic programs are clamoring for evidence-based guidelines, the field remains primitive in understanding the factors resulting in a spectrum of individual outcomes, most of which are complete, but some of which are not. In this article, we discuss the definition, epidemiology, clinical presentation, course, and outcomes of mTBI, with a focus on the pediatric population as the context for reviewing the mechanisms and pathophysiology mediating, and biomarkers reflective of, more significant concussion-induced brain injury. Our goal is to present a general overview of the features of mTBI in the pediatric population in order to provide a conceptual model for pediatricians and pediatric subspecialists. This model emphasizes the importance of establishing actionable, noninvasive biomarkers that are reflective of brain injury and that may identify those pediatric patients who can benefit from earlier and more aggressive interventions. We will focus on the specific features of mTBI in pediatric patients; although given the relative lack of research in the pediatric population, we will also extrapolate from research on adults.	[McCarthy, Matthew T.; Kosofsky, Barry E.] NewYork Presbyterian Weill Cornell Med Ctr, Dept Pediat, New York, NY 10021 USA		Kosofsky, BE (corresponding author), NewYork Presbyterian Weill Cornell Med Ctr, Dept Pediat, Div Child Neurol, 1300 York Ave,Box 91, New York, NY 10021 USA.	bar2009@med.cornell.edu		McCarthy, Matthew/0000-0001-8543-7225			Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Centers for disease control and prevention, 2014, INJ PREV CONTR TRAUM; Colbert CA, 2010, RADIOLOGY, V256, P898, DOI 10.1148/radiol.10091842; Dietrich MO, 2003, CAN J APPL PHYSIOL, V28, P710, DOI 10.1139/h03-054; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Faul M, 2010, TRAUMATIC BRAIN INJU; Galloway NR, 2008, J NEUROTRAUM, V25, P1153, DOI 10.1089/neu.2007.0494; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grubenhoff JA, 2014, PEDIATRICS, V134, P54, DOI 10.1542/peds.2013-2988; Haneef Z, 2013, J NEUROTRAUM, V30, P653, DOI 10.1089/neu.2012.2585; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hasselblatt M, 2004, NEUROLOGY, V62, P1634, DOI 10.1212/01.WNL.0000123092.97047.B1; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hung Ryan, 2014, Arch Phys Med Rehabil, V95, pS174, DOI 10.1016/j.apmr.2013.08.301; Institute of Medicine, 2014, SPORTS REL CONC YOUT; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Keightley ML, 2012, CURR OPIN PEDIATR, V24, P709, DOI 10.1097/MOP.0b013e3283599a55; Kerr ZY, 2011, CLIN PEDIATR, V50, P594, DOI 10.1177/0009922810390513; Kosofsky B. E., 2014, PREP AUDIO, V9; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Meehan WP, 2015, PEDIATRICS, V135, P362, DOI 10.1542/peds.2014-3665; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Mussack T, 2003, EUR J MED RES, V8, P457; Neselius S, 2013, BRAIN INJURY, V27, P425, DOI 10.3109/02699052.2012.750752; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Otto M, 2000, INT J SPORTS MED, V21, P551, DOI 10.1055/s-2000-8480; Papa L, 2015, J NEUROTRAUM, V32, P661, DOI 10.1089/neu.2014.3655; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Papa L, 2013, J NEUROTRAUM, V30, P324, DOI 10.1089/neu.2012.2545; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Petraglia Anthony L, 2014, Neurosurgery, V75 Suppl 4, pS34, DOI 10.1227/NEU.0000000000000472; Pickering A, 2011, ARCH DIS CHILD, V96, P414, DOI 10.1136/adc.2010.202820; Prichep LS, 2014, COMPUT BIOL MED, V53, P125, DOI 10.1016/j.compbiomed.2014.07.011; Rockhill CM, 2010, BRAIN INJURY, V24, P1051, DOI 10.3109/02699052.2010.494586; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Ryan NP, 2015, NEUROPSYCHOLOGIA, V66, P32, DOI 10.1016/j.neuropsychologia.2014.10.040; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Stalnacke BM, 2006, BRIT J SPORT MED, V40, P313, DOI 10.1136/bjsm.2005.021584; Stalnacke BM, 2004, BRAIN INJURY, V18, P899, DOI 10.1080/02699050410001671865; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; Teasdale TW, 2003, J NEUROL NEUROSUR PS, V74, P933, DOI 10.1136/jnnp.74.7.933; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Yuh Esther L, 2014, Neurosurgery, V75 Suppl 4, pS50, DOI 10.1227/NEU.0000000000000491; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zetterberg H, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.037143; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	68	17	17	2	15	BLACKWELL SCIENCE PUBL	OXFORD	OSNEY MEAD, OXFORD OX2 0EL, ENGLAND	0077-8923			ANN NY ACAD SCI	Ann.NY Acad.Sci.		2015	1345						89	98		10.1111/nyas.12736			10	Clinical Neurology; Psychiatry	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	BC7XP	WOS:000355312300011	25809391				2022-02-06	
J	Moreno, A; Gan, C; Zasler, N; McKerral, M				Moreno, Alexander; Gan, Caron; Zasler, Nathan; McKerral, Michelle			Experiences, attitudes, and needs related to sexuality and service delivery in individuals with traumatic brain injury	NEUROREHABILITATION			English	Article						Experiences; attitudes; needs; traumatic brain injury; sexuality; service delivery	DYSFUNCTION; PREDICTORS; EDUCATION; PATIENT; HEALTH; ADULTS; SEX	OBJECTIVE: To explore the experiences, attitudes, and needs related to service delivery regarding sexuality issues in individuals with traumatic brain injury (TBI). METHODS: Community-dwelling individuals with TBI having completed a post-acute TBI rehabilitation program. The TBI sample consisted of 16 men (42.1%) and 22 women (57.9%), with an average age of 38.9 years (SD = 9.9) and 12.8 years of education (SD = 2.8). They were on average 2.6 years post-injury (SD = 1.4). Glasgow coma scale at admission was on average 12.6 (SD = 3.5). Participants completed a questionnaire adapted to individuals with TBI addressing experiences, attitudes, and needs regarding sexuality and service delivery. RESULTS: Individuals with TBI reported a low frequency of specific discussions with their treating clinician(s) about sexual and reproductive health issues, as well as many unmet needs regarding sexuality. None of the participants considered discussion about these issues to be inappropriate. They reported more favourable attitudes towards discussing sexual health topics compared to actual service delivery with family physicians, general practitioners, psychologists, and other health care professionals (p's < 0.05). CONCLUSIONS: Individuals with TBI desired more openness about discussing sexual concerns. Findings are discussed in terms of the clinical implications to meet the individuals' needs regarding sexual concerns after TBI.	[Moreno, Alexander; McKerral, Michelle] CRLB, CRIR, Montreal, PQ H2H 2N8, Canada; [Moreno, Alexander; McKerral, Michelle] Univ Montreal, Dept Psychol, Ctr Rech Neuropsychol & Cognit CERNEC, Montreal, PQ H3C 3J7, Canada; [Gan, Caron] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada; [Zasler, Nathan] Concuss Care Ctr Virginia Ltd, Richmond, VA USA; [Zasler, Nathan] Tree Life Serv Inc, Richmond, VA USA; [Zasler, Nathan] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA		Moreno, A (corresponding author), CRLB, CRIR, 2275 Laurier Ave East, Montreal, PQ H2H 2N8, Canada.	jhon.alexander.moreno@umontreal.ca			CRIR; CERNEC; Faculte des etudes superieures et postdoctorales de l'Universite de Montreal; CRLB	The authors wish to thank the CRIR, CERNEC, and Faculte des etudes superieures et postdoctorales de l'Universite de Montreal (scholarships to J.A.M.), the CRLB for partial funding of this study (grant to M.M.), as well the individuals who took part in this study.	Aloni A, 1999, BRAIN INJURY, V13, P89, DOI 10.1080/026990599121755; Aloni R., 2003, SEXUAL DIFFICULTIES; Aloni Ronit, 2009, Harefuah, V148, P615; Anand P, 2010, AIDS BEHAV, V14, P1213, DOI 10.1007/s10461-010-9684-1; Bertazone E do C, 2000, Rev Lat Am Enfermagem, V8, P115; BLACKBURN M, 1991, EUR J PEDIATR SURG, V1, P37; Blackerby WF., 1990, J HEAD TRAUMA REHAB, V5, P73, DOI [10.1097/00001199-199005020-00012, DOI 10.1097/00001199-199005020-00012]; CATANIA JA, 1990, PSYCHOL BULL, V108, P339, DOI 10.1037/0033-2909.108.3.339; Comfort A., 1978, SEXUAL CONSEQUENCES; D'Eath M, 2013, J CARDIOVASC NURS, V28, pE1, DOI 10.1097/JCN.0b013e318281d0b3; De Wispelaere J, 2014, DISABIL SOC, V29, P402, DOI 10.1080/09687599.2013.823076; Dyer K, 2014, DISABIL REHABIL, V36, P1431, DOI 10.3109/09638288.2013.859747; Dyer K, 2013, J SEX MED, V10, P2658, DOI 10.1111/j.1743-6109.2012.02856.x; Franits LE, 2005, AM J OCCUP THER, V59, P577, DOI 10.5014/ajot.59.5.577; Fronek P, 2005, SEX DISABIL, V23, P51, DOI 10.1007/s11195-005-4669-0; Fronek P, 2011, SEX DISABIL, V29, P87, DOI 10.1007/s11195-010-9177-1; Garden F. H., 1990, J HEAD TRAUMA REHAB, V5, P52, DOI DOI 10.1097/00001199-199005020-00009; Gouvernement du Quebec/Ministere de la Sante et des Services Sociaux, 2005, OR MIN TCCL; Griffith ER, 1993, SEXUALITY PERSON TRA; Gumus H, 2014, J SEX MED, V11, P481, DOI 10.1111/jsm.12397; Hall Joy, 2013, Br J Nurs, V22, P556; Hanks RA, 2013, J HEAD TRAUMA REHAB, V28, P179, DOI 10.1097/HTR.0b013e31828b4fae; IBM, 2012, IBM SPSS ADV STAT 21; Iezzoni LI, 2012, DISABIL HEALTH J, V5, P136, DOI 10.1016/j.dhjo.2012.03.003; Jimenez-Garcia R, 2012, PRIM CARE DIABETES, V6, P269, DOI 10.1016/j.pcd.2012.02.005; Katz S, 1999, INT J REHABIL RES, V22, P45, DOI 10.1097/00004356-199903000-00006; Kelly G, 2011, SEX DISABIL, V29, P313, DOI 10.1007/s11195-011-9213-9; Kobelt G, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-170; Kreutzer J S, 1989, Brain Inj, V3, P177, DOI 10.3109/02699058909004550; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mapou R. L., 1990, J HEAD TRAUMA REHAB, V5, P67, DOI DOI 10.1097/00001199-199005020-00011; Medlar T. M., 1993, SEX DISABIL, V11, P57, DOI DOI 10.1007/BF01102309; Moreno A., 2012, SEXUALITY INT J PSYC, V47, P684; Moreno A., 2014, 91 AM C REH MED TRAN; Moreno JA, 2013, NEUROREHABILITATION, V32, P69, DOI 10.3233/NRE-130824; Murdoch BE, 2001, TRAUMATIC BRAIN INJU; Neese LE, 2003, PSYCHO-ONCOL, V12, P463, DOI 10.1002/pon.657; Niderost S, 2011, AIDS CARE, V23, P908, DOI 10.1080/09540121.2010.538661; OPSQ, 2014, ORDR PROF SEX QUEB; Pederson A, 2010, CAN J PUBLIC HEALTH, V101, P259, DOI 10.1007/BF03404386; Post MWM, 2008, SEX DISABIL, V26, P3, DOI 10.1007/s11195-007-9068-2; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sandel ME, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P915; SANDEL ME, 2007, BRAIN INJURY MED PRI, P673; Sander A.M., 2011, SEXUAL FUNCTIONING S; Sander AM, 2013, J HEAD TRAUMA REHAB, V28, P186, DOI 10.1097/HTR.0b013e31828b4f91; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P1331, DOI 10.1016/j.apmr.2012.03.037; Simpson G, 2004, J HEAD TRAUMA REHAB, V19, P413, DOI 10.1097/00001199-200409000-00006; Simpson G., 1999, YOU ME GUIDE SEX SEX; SIMPSON GK, 1999, YOU ME ED PROGRAM SE; Sipski M, 1997, SEXUAL FUNCTION PEOP; Taylor Bridget, 2006, Nurs Stand, V21, P35; Valvano A., 2014, SEXUALITY DISABILITY; Verschuren JEA, 2010, J SEX RES, V47, P153, DOI 10.1080/00224491003658227; WHO, 2014, SEX REP HLTH; World Health Organization, 2010, DEV SEX HLTH PROGR F; Zasler N. D., 1990, HEAD INJURY FAMILY M, P253; Zasler ND, 2011, TXB TRAUMATIC BRAIN, P397	58	17	17	0	9	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2015	37	1					99	116		10.3233/NRE-151243			18	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CQ2ET	WOS:000360412900009	26409696				2022-02-06	
J	Roe, C; Skandsen, T; Manskow, U; Ader, T; Anke, A				Roe, Cecilie; Skandsen, Toril; Manskow, Unn; Ader, Tiina; Anke, Audny			Mortality and One-Year Functional Outcome in Elderly and Very Old Patients with Severe Traumatic Brain Injuries: Observed and Predicted	BEHAVIOURAL NEUROLOGY			English	Article							EXTERNAL VALIDATION; HEAD-INJURY; MODELS; IMPACT; ADULTS; AGE; HEMATOMA; QUALITY; NORWAY; SCORES	The aim of the present study was to evaluate mortality and functional outcome in old and very old patients with severe traumatic brain injury (TBI) and compare to the predicted outcome according to the internet based CRASH (Corticosteroid Randomization After Significant Head injury) model based prediction, fromtheMedical Research Council (MRC). Methods. Prospective, national multicenter study including patients with severe TBI >65 years. Predicted mortality and outcome were calculated based on clinical information (CRASH basic) (age, GCS score, and pupil reactivity to light), as well as with additional CT findings (CRASH CT). Observed 14-day mortality and favorable/unfavorable outcome according to the Glasgow Outcome Scale at one year was compared to the predicted outcome according to the CRASHmodels. Results. 97 patients, mean age 75 (SD 7) years, 64% men, were included. Two patients were lost to follow-up; 48 died within 14 days. The predicted versus the observed odds ratio (OR) for mortality was 2.65. Unfavorable outcome (GOSE < 5) was observed at one year follow-up in 72% of patients. The CRASH models predicted unfavorable outcome in all patients. Conclusion. The CRASH model overestimated mortality and unfavorable outcome in old and very old Norwegian patients with severe TBI.	[Roe, Cecilie] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Roe, Cecilie] Univ Oslo, Fac Med, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Oslo, Norway; [Skandsen, Toril] Norwegian Univ Sci & Technol NTNU, Fac Med, Dept Neurosci, Trondheim, Norway; [Skandsen, Toril] Univ Trondheim Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Manskow, Unn; Anke, Audny] Univ Tromso, Inst Clin Med, Fac Hlth Sci, N-9001 Tromso, Norway; [Manskow, Unn] Univ Hosp North Norway, Dept Neurosurg, Tromso, Norway; [Ader, Tiina] Haukeland Hosp, Dept Phys Med & Rehabil, N-5021 Bergen, Norway; [Anke, Audny] Univ Hosp North Norway, Dept Rehabil, Tromso, Norway		Roe, C (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway.	eller@medisin.uio.no		Anke, Audny/0000-0002-2491-2560	Norwegian Research CouncilResearch Council of NorwayEuropean Commission	The authors thank all patients and relatives participating and the Norwegian Research Council for financial support. Special thanks are due to Nada Andelic responsible for assessment of patients and preparation of databases and paper.	Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Anke A., 2015, J HEAD TRAUMA REHABI, V30; Brazinova A, 2010, J NEUROTRAUM, V27, P1549, DOI 10.1089/neu.2010.1315; CARDOSO ER, 1989, ACTA NEUROCHIR, V97, P40, DOI 10.1007/BF01577738; Corral L, 2007, BRAIN INJURY, V21, P1225, DOI 10.1080/02699050701727460; de Guise E, 2015, BRAIN INJURY, V29, P558, DOI 10.3109/02699052.2014.976593; Eastvold AD, 2013, J HEAD TRAUMA REHAB, V28, P48, DOI 10.1097/HTR.0b013e31823c9317; Edwards P, 2005, LANCET, V365, P1957; Flanagan Steven R, 2005, Phys Med Rehabil Clin N Am, V16, P163, DOI 10.1016/j.pmr.2004.06.012; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Gaetani P, 2012, J NEUROSURG SCI, V56, P231; Haring RS, 2015, J SURG RES, V195, P1, DOI 10.1016/j.jss.2015.01.017; JENNETT B, 1975, LANCET, V1, P480; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kristiansen Thomas, 2011, J Trauma Manag Outcomes, V5, P9, DOI 10.1186/1752-2897-5-9; LEE KL, 1986, AM J MED, V80, P553, DOI 10.1016/0002-9343(86)90807-7; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Majdan M, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0068-9; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; McIntyre A, 2013, NEUROREHABILITATION, V32, P409, DOI 10.3233/NRE-130862; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Munro PT, 2002, BRIT MED J, V325, P1001, DOI 10.1136/bmj.325.7371.1001; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Patel HC, 2010, ACTA NEUROCHIR, V152, P1353, DOI 10.1007/s00701-010-0666-x; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Roe C, 2013, J REHABIL MED, V45, P734, DOI 10.2340/16501977-1198; Ronning PA, 2011, J TRAUMA, V70, pE56, DOI 10.1097/TA.0b013e3181e80f0a; Sovik S, 2014, INJURY, V45, P1722, DOI 10.1016/j.injury.2014.05.038; Sundstrom Terje, 2005, Tidsskr Nor Laegeforen, V125, P1310; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	37	17	17	0	2	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0953-4180	1875-8584		BEHAV NEUROL	Behav. Neurol.		2015	2015								845491	10.1155/2015/845491			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CX9AU	WOS:000365997900001	26688614	gold, Green Published			2022-02-06	
J	Roscigno, CI; Fleig, DK; Knafl, KA				Roscigno, Cecelia I.; Fleig, Denise K.; Knafl, Kathleen A.			Parent management of the school reintegration needs of children and youth following moderate or severe traumatic brain injury	DISABILITY AND REHABILITATION			English	Article						Children; parents; traumatic brain injury; young adults	SECONDARY ANALYSIS; STUDENTS; SUPPORT; CARE; TBI; REHABILITATION; PERCEPTIONS; ADOLESCENTS; RETURN	Purpose: School reintegration following children's traumatic brain injury (TBI) is still poorly understood from families' perspectives. We aimed to understand how both unique and common experiences during children's school reintegration were explained by parents to influence the family. Methods: Data came from an investigation using descriptive phenomenology (2005-2007) to understand parents' experiences in the first five years following children's moderate to severe TBI. Parents (N = 42 from 37 families in the United States) participated in two 90-min interviews (first M = 15 months; second M = 27 months). Two investigators independently coded parents' discussions of school reintegration using content analysis to understand the unique and common factors that parents perceived affected the family. Results: Parents' school negotiation themes included the following: (1) legal versus moral basis for helping the child; (2) inappropriate state and local services that did not consider needs specific to TBI; and (3) involvement in planning, implementing and evaluating the child's education plan. Parents perceived that coordinated and collaboration leadership with school personnel lessened families' workload. Families who home-schooled had unique challenges. Conclusions: School reintegration can add to family workload by changing roles and relationships and by adding to parents' perceived stress in managing of the child's condition.	[Roscigno, Cecelia I.; Knafl, Kathleen A.] Univ N Carolina, Sch Nursing, Chapel Hill, NC 27599 USA; [Fleig, Denise K.] Advocate Lutheran Gen Hosp, Park Ridge, IL USA		Roscigno, CI (corresponding author), Univ N Carolina, Sch Nursing, Family Hlth Div, Carrington Hall,CB 7460, Chapel Hill, NC 27599 USA.	croscign@email.unc.edu			Irving B. Harris Foundation Faculty Scholars Initiative at the University of Illinois at Chicago College of Nursing; National Institutes of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [5T32NR007091-17]; NINR Ruth L. Kirschstein Predoctoral Research Fellowship [1 F31 NR009599-02]; Psi Chapter of Sigma Theta Tau Grant; American Nurses Foundation Martha E. Brill Scholars Award; University of Washington School of Nursing Hester McLaws Scholarship Fund; University of Washington LEND Training Grant [6 T73 MC 00041-11-03]; University of Washington Gatzert Child Welfare Fellowship; Integra Lifesciences Grant; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [T32NR007091, F31NR009599] Funding Source: NIH RePORTER	The authors disclosed receipt of the following financial support for the research, training or authorship of this article: The first author was supported by a post-doctoral fellowship (Irving B. Harris Foundation Faculty Scholars Initiative at the University of Illinois at Chicago College of Nursing, Dr, White-Traut, PI) during the conceptualization and analysis phases of the study. The authorship of the manuscript was supported by a National Institutes of Nursing Research post-doctoral training fellowship, Interventions for Preventing and Managing Chronic Illness (5T32NR007091-17).; The original research study was funded by a NINR Ruth L. Kirschstein Predoctoral Research Fellowship (1 F31 NR009599-02); a Psi Chapter of Sigma Theta Tau Grant; a 2006 American Nurses Foundation Martha E. Brill Scholars Award; a University of Washington School of Nursing Hester McLaws Scholarship Fund; a University of Washington LEND Training Grant (TG # 6 T73 MC 00041-11-03); a University of Washington Gatzert Child Welfare Fellowship; and an Integra Lifesciences Grant. The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of any of the funders.	Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Arroyos-Jurado E, 2000, J SCHOOL PSYCHOL, V38, P571, DOI 10.1016/S0022-4405(00)00053-4; Ayres L, 2003, QUAL HEALTH RES, V13, P871, DOI 10.1177/1049732303013006008; Barnard-Brak L, 2010, QUAL REP, V15, P411; BRONFENBRENNER U, 1977, ECOLOGY HUMAN DEV; Bronfenbrenner U., 2005, MAKING HUMAN BEINGS; Bronfenbrenner U., 1989, ANN CHILD DEV, P185; Carney J, 2009, DEV DISABIL RES REV, V15, P152, DOI 10.1002/ddrr.57; Chevignard M, 2010, CHILD CARE HLTH DEV, V36, P31, DOI 10.1111/j.1365-2214.2009.00949.x; Copeland SR, 2004, REM SPEC EDUC, V25, P342, DOI 10.1177/07419325040250060201; Crothers IR, 2007, BRAIN INJURY, V21, P47, DOI 10.1080/02699050601149054; Farmer TW, 2011, J APPL DEV PSYCHOL, V32, P247, DOI 10.1016/j.appdev.2011.04.006; Gfroerer SD, 2008, BRAIN INJURY, V22, P649, DOI 10.1080/02699050802227162; Glang A, 2008, NEUROREHABILITATION, V23, P477; Gordon W. A., 2013, STATE STATES M ED NE; Government Accountability Office, 2009, GAO1033; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; Health Resources and Services Administration, FED TRAUM BRAIN INJ; Hinds PS, 1997, QUAL HEALTH RES, V7, P408, DOI 10.1177/104973239700700306; Hooper S., 2006, EXCEPTIONALITY, V14, P171, DOI [DOI 10.1207/S15327035EX1403_5, DOI 10.1207/s15327035ex1403_5]; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Husserl Edmund, 1965, PHENOMENOLOGY CRISIS; Juster F. H., 2004, CHANGING TIMES AM YO; Kennedy CH, 1997, EXCEPT CHILDREN, V64, P31, DOI 10.1177/001440299706400103; Knafl KA, 2012, J FAM NURS, V18, P11, DOI 10.1177/1074840711427294; Koro-Ljungberg M, 2008, QUAL HEALTH RES, V18, P983, DOI 10.1177/1049732308318039; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Morina A, 2010, DISABIL SOC, V25, P163, DOI 10.1080/09687590903534346; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; Perie M, 2005, 2006459 NCES USDA; Piatt JH, 2012, J NEUROSURG-PEDIATR, V10, P257, DOI 10.3171/2012.7.PEDS11532; Rivara FP, 2012, J NEUROTRAUM, V29, P2499, DOI 10.1089/neu.2012.2434; Roscigno CI, 2013, BRAIN INJURY, V27, P1536, DOI 10.3109/02699052.2013.831122; Roscigno CI, 2011, QUAL HEALTH RES, V21, P1413, DOI 10.1177/1049732311410988; Roscigno CI, 2011, BRAIN INJURY, V25, P882, DOI 10.3109/02699052.2011.581638; Ryan-Nicholls Kimberley D, 2009, Nurse Res, V16, P70; Savage RC, 2001, NEUROREHABILITATION, V16, P49; SEMIN GR, 1988, J PERS SOC PSYCHOL, V54, P558, DOI 10.1037/0022-3514.54.4.558; Sharp NL, 2006, DISABIL REHABIL, V28, P767, DOI 10.1080/09638280500386668; Simeonsson RJ, 2001, DISABIL REHABIL, V23, P49; Szabo V, 1997, ADV NURS SCI, V20, P66, DOI 10.1097/00012272-199712000-00008; U. S. Department of Education National Center for Education Statistics, 2010, HOM US 2003 PAR SURV; Ularntinon S, 2010, CURR PSYCHIATRY REV, V6, P261, DOI 10.2174/157340010793499422; Wigboldus D, 2007, FRONT SOC PSYCHOL, P79; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009	46	17	17	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2015	37	6					523	533		10.3109/09638288.2014.933896			11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	CD3UK	WOS:000351007500007	24969697	Green Submitted, Green Accepted			2022-02-06	
J	Shapi'i, A; Zin, NAM; Elaklouk, AM				Shapi'i, Azrulhizam; Zin, Nor Azan Mat; Elaklouk, Ahmed Mohammed			A Game System for Cognitive Rehabilitation	BIOMED RESEARCH INTERNATIONAL			English	Article							BENEFITS	Brain injury such as traumatic brain injury (TBI) and stroke is the major cause of long-term disabilities in many countries. The increasing rate of brain damaged victims and the heterogeneity of impairments decrease rehabilitation effectiveness and competence resulting in higher cost of rehabilitation treatment. On the other hand, traditional rehabilitation exercises are boring, thus leading patients to neglect the prescribed exercises required for recovery. Therefore, we propose game-based approach to address these problems. This paper presents a rehabilitation gaming system (RGS) for cognitive rehabilitation. The RGS is developed based on a proposed conceptual framework which has also been presented in this paper.	[Shapi'i, Azrulhizam; Zin, Nor Azan Mat; Elaklouk, Ahmed Mohammed] UKM, Fac Informat Sci & Technol, Bangi 43600, Selangor, Malaysia		Shapi'i, A (corresponding author), UKM, Fac Informat Sci & Technol, Bangi 43600, Selangor, Malaysia.	azrul@ftsm.ukm.my	Zin, Nor Azan Mat/AAE-3363-2019; SHAPII, AZRULHIZAM/ABD-8856-2020	SHAPII, AZRULHIZAM/0000-0003-4274-5011			Alankus G, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P2113; Belchior P. D. C., 2007, THESIS U FLORIDA; Burdea GC, 2003, METHOD INFORM MED, V42, P519; Burke W., 2010, P 8 INT C DIS VIRT R; Doidge Norman, 2007, BRAIN CHANGES ITSELF; Elaklouk A., 2012, P 5 ANN INT C COMP G; Elaklouk A.M., 2012, GSTF J COMPUTING JOC, V2, P25; Elaklouk AM, 2013, LECT NOTES COMPUT SC, V8237, P218, DOI 10.1007/978-3-319-02958-0_21; Garris R., 2002, Simulation & Gaming, V33, P441, DOI 10.1177/1046878102238607; Karlsson P., 2010, P ARATA 2010 NAT C H; Koenig S., 2012, THESIS U CANTERBURY; Lopresti EF, 2008, IEEE ENG MED BIOL, V27, P29, DOI 10.1109/EMB.2007.907396; Maclean N, 2002, STROKE, V33, P444, DOI 10.1161/hs0202.102367; Mattheiss E., 2009, LERNEN DIGITALEN ZEI, P77; Panic A. S., 2010, THESIS DELFT U TECHN; Perry J. C., 2010, HDB RES IMPROVING LE, P683; Rosenbaum Peter, 2004, Semin Pediatr Neurol, V11, P5, DOI 10.1016/j.spen.2004.01.002; Scherer MJ, 2005, REHABIL PSYCHOL, V50, P132, DOI 10.1037/0090-5550.50.2.132; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tam S., 2010, THESIS WASHINGTON U; Torrente J, 2012, LECT NOTES COMPUT SC, V7666, P603, DOI 10.1007/978-3-642-34478-7_73; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099	22	17	17	0	9	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2015	2015								493562	10.1155/2015/493562			7	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	CD8VB	WOS:000351373400001	25815320	Green Published, Green Submitted, gold			2022-02-06	
J	Bell, JD; Thomas, TC; Lass, E; Ai, JL; Wan, H; Lifshitz, J; Baker, AJ; Macdonald, RL				Bell, Joshua D.; Thomas, Theresa Currier; Lass, Elliot; Ai, Jinglu; Wan, Hoyee; Lifshitz, Jonathan; Baker, Andrew J.; Macdonald, R. Loch			Platelet-mediated changes to neuronal glutamate receptor expression at sites of microthrombosis following experimental subarachnoid hemorrhage	JOURNAL OF NEUROSURGERY			English	Article						subarachnoid hemorrhage; platelet; microthrombi; glutamate receptor expression; traumatic brain injury; vascular disorders	EXTRACELLULAR GLUTAMATE; GLUR2 ENDOCYTOSIS; AMPA-RECEPTOR; STRIATUM; RATS; PERMEABILITY; PLASTICITY; TRAUMA; INJURY; PICK1	Object. Glutamate is important in the pathogenesis of brain damage after cerebral ischemia and traumatic brain injury. Notably, brain extracellular and cerebrospinal fluid as well as blood glutamate concentrations increase after experimental and clinical trauma. While neurons are one potential source of glutamate, platelets also release glutamate as part of their recruitment and might mediate neuronal damage. This study investigates the hypothesis that platelet microthrombi release glutamate that mediates excitotoxic brain injury and neuron dysfunction after subarachnoid hemorrhage (SAH). Methods. The authors used two models, primary neuronal cultures exposed to activated platelets, as well as a whole-animal SAH preparation. Propidium iodide was used to evaluate neuronal viability, and surface glutamate receptor staining was used to evaluate the phenotype of platelet-exposed neurons. Results. The authors demonstrate that thrombin-activated platelet-rich plasma releases glutamate, at concentrations that can exceed 300 mu M. When applied to neuronal cultures, this activated plasma is neurotoxic, and the toxicity is attenuated in part by glutamate receptor antagonists. The authors also demonstrate that exposure to thrombin-activated platelets induces marked downregulation of the surface glutamate receptor glutamate receptor 2, a marker of excitotoxicity exposure and a possible mechanism of neuronal dysfunction. Linear regression demonstrated that 7 days after SAH in rats there was a strong correlation between proximity to microthrombi and reduction of surface glutamate receptors. Conclusions. The authors conclude that platelet-mediated microthrombosis contributes to neuronal glutamate receptor dysfunction and might mediate brain injury after SAH.	[Bell, Joshua D.; Baker, Andrew J.; Macdonald, R. Loch] Univ Toronto, Fac Med, Toronto, ON M5B 1W8, Canada; [Baker, Andrew J.] Univ Toronto, Dept Anesthesia, Toronto, ON M5B 1W8, Canada; [Baker, Andrew J.; Macdonald, R. Loch] Univ Toronto, Dept Surg, Toronto, ON M5B 1W8, Canada; [Baker, Andrew J.] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON M5B 1W8, Canada; [Bell, Joshua D.; Lass, Elliot; Ai, Jinglu; Wan, Hoyee; Baker, Andrew J.; Macdonald, R. Loch] St Michaels Hosp, Labatt Family Ctr Excellence Brain Injury & Traum, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Baker, Andrew J.] St Michaels Hosp, Dept Anesthesia, Toronto, ON M5B 1W8, Canada; [Baker, Andrew J.] St Michaels Hosp, Dept Crit Care, Toronto, ON M5B 1W8, Canada; [Macdonald, R. Loch] St Michaels Hosp, Div Neurosurg, Toronto, ON M5B 1W8, Canada; [Thomas, Theresa Currier; Lifshitz, Jonathan] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Thomas, Theresa Currier; Lifshitz, Jonathan] Univ Arizona, Dept Child Hlth, Coll Med Phoenix, Phoenix, AZ USA; [Thomas, Theresa Currier; Lifshitz, Jonathan] Phoenix VA Healthcare Syst, Phoenix, AZ USA; [Lifshitz, Jonathan] Arizona State Univ, Dept Psychol, Tempe, AZ 85287 USA		Macdonald, RL (corresponding author), Univ Toronto, St Michaels Hosp, Div Neurosurg, 30 Bond St, Toronto, ON M5B 1W8, Canada.	macdonaldlo@smh.ca	Thomas, Theresa Currier/K-1979-2019	Thomas, Theresa Currier/0000-0002-9619-7666; AI, JINGLU/0000-0001-7414-0207	Physicians Services Incorporated Foundation; Brain Aneurysm Foundation; Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of CanadaHeart & Stroke Foundation of Canada	Dr. Macdonald receives grant support from the Physicians Services Incorporated Foundation, Brain Aneurysm Foundation, Canadian Institutes for Health Research, and the Heart and Stroke Foundation of Canada; and is a consultant for Actelion Pharmaceuticals and the Chief Scientific Officer of Edge Therapeutics, Inc.	Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; Bell JD, 2009, CELL DEATH DIFFER, V16, P1665, DOI 10.1038/cdd.2009.106; Bell JD, 2007, BRAIN, V130, P2528, DOI 10.1093/brain/awm164; Burmeister JJ, 2002, J NEUROSCI METH, V119, P163, DOI 10.1016/S0165-0270(02)00172-3; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; Dalmau J, 2011, LANCET NEUROL, V10, P63, DOI 10.1016/S1474-4422(10)70253-2; Friedrich V, 2010, NEUROSCIENCE, V165, P968, DOI 10.1016/j.neuroscience.2009.10.038; Friedrich V, 2010, BRAIN RES, V1354, P179, DOI 10.1016/j.brainres.2010.07.040; GERMANO A, 1992, NEUROSURGERY, V30, P882, DOI 10.1227/00006123-199206000-00011; Hanley JG, 2005, EMBO J, V24, P3266, DOI 10.1038/sj.emboj.7600801; Hinzman JM, 2012, J NEUROTRAUM, V29, P1197, DOI 10.1089/neu.2011.2261; Hinzman JM, 2010, J NEUROTRAUM, V27, P889, DOI 10.1089/neu.2009.1238; Jeon H, 2010, NEUROSCIENCE, V169, P1805, DOI 10.1016/j.neuroscience.2010.06.039; Jeon H, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-103; LeRoux P D, 1994, Clin Neurosurg, V41, P325; Lovelock CE, 2010, NEUROLOGY, V74, P1494, DOI 10.1212/WNL.0b013e3181dd42b3; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; MCKENNA P, 1989, NEUROSURGERY, V24, P361, DOI 10.1227/00006123-198903000-00009; Morrell CN, 2008, J EXP MED, V205, P575, DOI 10.1084/jem.20071474; Nickell J, 2005, J NEURAL TRANSM, V112, P87, DOI 10.1007/s00702-004-0151-x; Prunell GF, 2002, NEUROREPORT, V13, P2553, DOI 10.1097/00001756-200212200-00034; Sattler R, 2000, J MOL MED, V78, P3, DOI 10.1007/s001090000077; Tariq A, 2010, NEUROSCIENCE, V165, P418, DOI 10.1016/j.neuroscience.2009.10.040; Terashima A, 2008, NEURON, V57, P872, DOI 10.1016/j.neuron.2008.01.028; Thomas TC, 2009, NEUROPSYCHOPHARMACOL, V34, P436, DOI 10.1038/npp.2008.74; Vergouwen MDI, 2008, J CEREBR BLOOD F MET, V28, P1761, DOI 10.1038/jcbfm.2008.74	26	17	20	0	6	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	DEC	2014	121	6					1424	1431		10.3171/2014.3.JNS132130			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AU3CP	WOS:000345490700020	24745710				2022-02-06	
J	Echlin, PS; Johnson, AM; Holmes, JD; Tichenoff, A; Gray, S; Gatavackas, H; Walsh, J; Middlebro, T; Blignaut, A; MacIntyre, M; Anderson, C; Fredman, E; Mayinger, M; Skopelja, EN; Sasaki, T; Bouix, S; Pasternak, O; Helmer, KG; Koerte, IK; Shenton, ME; Forwell, LA				Echlin, Paul S.; Johnson, Andrew M.; Holmes, Jeffrey D.; Tichenoff, Annalise; Gray, Sarah; Gatavackas, Heather; Walsh, Joanne; Middlebro, Tim; Blignaut, Angelique; MacIntyre, Martin; Anderson, Chris; Fredman, Eli; Mayinger, Michael; Skopelja, Elaine N.; Sasaki, Takeshi; Bouix, Sylvain; Pasternak, Ofer; Helmer, Karl G.; Koerte, Inga K.; Shenton, Martha E.; Forwell, Lorie A.			The Sport Concussion Education Project. A brief report on an educational initiative: from concept to curriculum	JOURNAL OF NEUROSURGERY			English	Article						concussion; mild traumatic brain injury; education; student; youth athlete	TRAUMATIC BRAIN-INJURY; FOR-DISEASE-CONTROL; RECURRENT CONCUSSION; KNOWLEDGE TRANSFER; PLAYERS; EPIDEMIOLOGY; TRENDS; HEADS	Current research on concussion is primarily focused on injury identification and treatment. Prevention initiatives are, however, important for reducing the incidence of brain injury. This report examines the development and implementation of an interactive electronic teaching program (an e-module) that is designed specifically for concussion education within an adolescent population. This learning tool and the accompanying consolidation rubric demonstrate that significant engagement occurs in addition to the knowledge gained among participants when it is used in a school curriculum setting.	[Echlin, Paul S.] Elliott Sports Med Clin, Burlington, ON L7N 2G3, Canada; [Gray, Sarah; Gatavackas, Heather; Walsh, Joanne; Middlebro, Tim; Blignaut, Angelique; MacIntyre, Martin; Anderson, Chris] Halton Dist Board Educ, Burlington, ON, Canada; [Johnson, Andrew M.; Tichenoff, Annalise] Univ Western Ontario, Sch Hlth Studies, London, ON, Canada; [Holmes, Jeffrey D.] Univ Western Ontario, Sch Occupat Therapy, London, ON, Canada; [Forwell, Lorie A.] Univ Western Ontario, Sch Phys Therapy, London, ON, Canada; [Forwell, Lorie A.] Univ Western Ontario, Fowler Kennedy Sports Med Clin, London, ON, Canada; [Fredman, Eli; Mayinger, Michael; Sasaki, Takeshi; Bouix, Sylvain; Pasternak, Ofer; Koerte, Inga K.; Shenton, Martha E.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Koerte, Inga K.; Shenton, Martha E.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Helmer, Karl G.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Shenton, Martha E.] VA Boston Healthcare Syst, Brockton, MA USA; [Skopelja, Elaine N.] Indiana Univ, Sch Med Lib, Indianapolis, IN 46204 USA; [Mayinger, Michael; Koerte, Inga K.] Univ Munich, Inst Clin Radiol, Munich, Germany		Echlin, PS (corresponding author), Elliott Sports Med Clin, 1100 Walkers Line,Ste 102, Burlington, ON L7N 2G3, Canada.	psechlin@gmail.com	Shenton, Martha/V-8780-2019; Johnson, Andrew M/B-2048-2012; Holmes, Jeffrey/M-6484-2015; Koerte, Inga Katharina/AAW-3031-2021	Holmes, Jeffrey/0000-0002-5744-8338; Skopelja, Elaine/0000-0002-2847-8909; Johnson, Andrew M./0000-0002-7269-3016	Ontario Trillium Foundation; Dave Irwin Foundation for Brain Injury Recovery; Ontario Neurotrauma Foundation, Air Canada; Ontario Ministry of Health and Long-Term CareMinistry of Health and Long-Term Care, Ontario; Ontario Ministry of Tourism, Culture and Sport; Ontario Ministry of Education; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P41RR013218, P41EB015902, R01MH074794]; Department of DefenseUnited States Department of Defense [X81XWH-07-CC-CSDoD]; VA merit grant; Brain & Behavior Research FoundationNARSAD; Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science; Petraeic Legate Foundation; NIEI grant; Henry Jackson Foundation; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P41RR013218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH074794] Funding Source: NIH RePORTER	This work is funded by the Ontario Trillium Foundation, the Dave Irwin Foundation for Brain Injury Recovery, the Ontario Neurotrauma Foundation, Air Canada, the Ontario Ministry of Health and Long-Term Care, the Ontario Ministry of Tourism, Culture and Sport, and the Ontario Ministry of Education. This work was partially funded by grants from the National Institutes of Health (NIH) (P41RR013218, P41EB015902, R01MH074794), the Department of Defense (X81XWH-07-CC-CSDoD), and a VA merit grant. Dr. Ofer Pasternak was partially supported by a NARSAD Young Investigator grant from the Brain & Behavior Research Foundation. Dr. Inga Koerte is supported by the Else Kroner-Fresenius Stiftung, Germany. Dr. Takeshi Sasaki is supported by the Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation from the Japan Society for the Promotion of Science. Mr. Michael Mayinger is supported by the Petraeic Legate Foundation. Dr. Shenton is a consultant on an NIEI grant to SUNY on velocardiofascial syndrome and on a grant supported by the Henry Jackson Foundation.	Bonk C. J., 2006, DISTANCE EDUC, V27, P249, DOI DOI 10.1080/01587910600789670; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Burke MJ, 2012, CAN J NEUROL SCI, V39, P763, DOI 10.1017/S0317167100015584; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Ciavarro C, 2008, COMPUT HUM BEHAV, V24, P2862, DOI 10.1016/j.chb.2008.04.011; Cusimano MD, 2014, BRIT J SPORT MED, V48, P141, DOI 10.1136/bjsports-2012-091660; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Echlin PS, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12286; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10187; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.10.FOCUS10222; Echlin PS, 2012, NEUROSURG FOCUS, V33, P1, DOI DOI 10.3171/2012.10.F0CUS12286; Faul M, 2010, TRAUMATIC BRAIN INJU; Faure C, 2010, AM SECONDARY ED, V39, P5; Faure CE, 2011, SPORT J; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Graham ID, 2006, J CONTIN EDUC HEALTH, V26, P13, DOI 10.1002/chp.47; Guerriero RM, 2012, CURR OPIN PEDIATR, V24, P696, DOI 10.1097/MOP.0b013e3283595175; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Saunders EA, 2013, ATHLETIC TRAINING SP, V5, P175; Sawyer RJ, 2010, HEALTH PROMOT PRACT, V11, P34, DOI 10.1177/1524839907309377; Schwarzer R, 2011, REHABIL PSYCHOL, V56, P161, DOI 10.1037/a0024509	38	17	17	0	49	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	DEC	2014	121	6					1331	1336		10.3171/2014.8.JNS132804			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	AU3CP	WOS:000345490700005	25280091	Green Published, Green Accepted			2022-02-06	
J	Salentijn, EG; Collin, JD; Boffano, P; Forouzanfar, T				Salentijn, Erik G.; Collin, John D.; Boffano, Paolo; Forouzanfar, Tymour			A ten year analysis of the traumatic maxillofacial and brain injury patient in Amsterdam: Complications and treatment	JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY			English	Article						Maxillofacial; Trauma; Brain; Injury; Complications; Treatment	FACIAL FRACTURES; MANAGEMENT; CHILDREN; REPAIR	Maxillofacial trauma is often associated with injuries to the cranium, especially in high-energy trauma. The management of such cases can be challenging and requires close cooperation between oral and maxillofacial surgery and neurosurgical teams. There are few reports in the current literature describing the complications that develop in patients with maxillofacial trauma and traumatic brain injury (TBI).Complications can be categorized as early or late and/or minor and major. The exact definition of complications and their categorization remains a matter of current debate. We present a 10 year retrospective study of complications and their subsequent management in patients receiving maxillofacial and neurosurgical treatment for maxillofacial trauma associated with TBI. The study population consisted of 47 people, excluded from a maxillofacial trauma population of 579 patients. The severity of the trauma was scored as mild, moderate or severe, using the Glasgow Coma Scale at presentation of the Emergency Department. In total 36 patients (76.6%) developed complications. Patients involved in road traffic collision were most likely to develop complications (92.3%). This was followed by falls (66.7%) as mechanism of the injury. Patients aged 60-69 years experienced the highest complication rate (5), followed by patients aged 20-29 years (4.1) and 30-39 years (3.5). The majority of complications were infection and inflammation (36.4%), followed by neurological deficit (24.0%), physiological dysregulation (11.6%) and facial bone deformity (8.3%). Patients who developed no complications, most often presented with mild TBI (72.7%). The most common treatment modality employed to manage complications was pharmacological, followed by antibiotic treatment, conservative treatment and decompression therapy. The mean hospital stay after the trauma for the patients with complications was 28 days. Thirteen patients (36.1%) were transferred to a rehabilitation centre, a nursing home, or a home for the elderly. Nine patients (25%) completely recovered from their complications and 4 patients (11.1%) died after the trauma. This report provides useful data concerning the rate and type of complications that occur, and the multidisciplinary treatment that is required in traumatic maxillofacial and brain injury patients. c 2014 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.	[Salentijn, Erik G.; Boffano, Paolo; Forouzanfar, Tymour] Vrije Univ Amsterdam Med Ctr, Acad Ctr Dent Amsterdam, Dept Oral & Maxillofacial Surg Oral Pathol, NL-1007 MB Amsterdam, Netherlands; [Collin, John D.] Bristol Dent Hosp, Dept Oral & Maxillofacial Surg, Bristol BS2 1LY, Avon, England		Salentijn, EG (corresponding author), Vrije Univ Amsterdam Med Ctr, Acad Ctr Dent Amsterdam, Dept Oral & Maxillofacial Surg Oral Pathol, POB 7057, NL-1007 MB Amsterdam, Netherlands.	e.salentijn@vumc.nl	Boffano, Paolo/J-1094-2016	Boffano, Paolo/0000-0002-0782-9933			Bogusiak K, 2010, J CRANIOFAC SURG, V21, P1018, DOI 10.1097/SCS.0b013e3181e62e47; BRANDT KE, 1991, J TRAUMA, V31, P15, DOI 10.1097/00005373-199101000-00003; Calderoni DR, 2010, J CRANIOMAXILLOFAC S, V39, P593; Cannon DE, 2012, AM J OTOLARYNG, V33, P615, DOI 10.1016/j.amjoto.2011.12.003; Clauser L, 2004, CHILD NERV SYST, V20, P168, DOI 10.1007/s00381-003-0868-0; DAVIDOFF G, 1988, ANN EMERG MED, V17, P6, DOI 10.1016/S0196-0644(88)80492-X; Fishman G, 2009, CHILD NERV SYST, V25, P915, DOI 10.1007/s00381-009-0887-6; Giuliani G., 1997, Revue de Stomatologie et de Chirurgie Maxillo-Faciale, V98, P100; HAUG RH, 1994, J ORAL MAXIL SURG, V52, P729, DOI 10.1016/0278-2391(94)90488-X; HAUG RH, 1990, J ORAL MAXIL SURG, V48, P926, DOI 10.1016/0278-2391(90)90004-L; Mena JH, 2011, J TRAUMA, V71, P1185, DOI 10.1097/TA.0b013e31823321f8; Kanowitz SJ, 2006, INT J PEDIATR OTORHI, V70, P2087, DOI 10.1016/j.ijporl.2006.08.007; Katzen JT, 2003, J TRAUMA, V54, P1026, DOI 10.1097/01.TA.0000066180.14666.8B; KAUFMAN MS, 1984, J ORAL MAXIL SURG, V42, P250, DOI 10.1016/0278-2391(84)90457-9; Lee TT, 1998, J TRAUMA, V44, P665, DOI 10.1097/00005373-199804000-00018; Pappachan B, 2006, J ORAL MAXIL SURG, V64, P1023, DOI 10.1016/j.joms.2006.03.021; Salentijn EG, 2012, J CRANIOMAXILLOFAC S, V41, P630; Salentijn EG, 2014, J CRANIO MAXILL SURG, V42, P705, DOI 10.1016/j.jcms.2013.12.008; Shibuya TY, 2007, J ORAL MAXIL SURG, V65, P1693, DOI 10.1016/j.joms.2006.06.309; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; van den Bergh B, 2012, J CRANIO MAXILL SURG, V40, pE165, DOI 10.1016/j.jcms.2011.08.006	21	17	17	0	6	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1010-5182	1878-4119		J CRANIO MAXILL SURG	J. Cranio-MaxilloFac. Surg.	DEC	2014	42	8					1717	1722		10.1016/j.jcms.2014.06.005			6	Dentistry, Oral Surgery & Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Surgery	AX3IM	WOS:000346833200031	25176495				2022-02-06	
J	Tu, TW; Turtzo, LC; Williams, RA; Lescher, JD; Dean, DD; Frank, JA				Tu, Tsang-Wei; Turtzo, L. Christine; Williams, Rashida A.; Lescher, Jacob D.; Dean, Dana D.; Frank, Joseph A.			Imaging of Spontaneous Ventriculomegaly and Vascular Malformations in Wistar Rats: Implications for Preclinical Research	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						Arteriovenous malformation; Diffusion tensor MRI; Hydrocephalus; MR angiography; Ventriculomegaly; Wistar rats	WHITE-MATTER INTEGRITY; BLOOD-FLOW; CONGENITAL HYDROCEPHALUS; SPINAL-CORD; INTRACRANIAL-PRESSURE; REACTIVE ASTROCYTOSIS; OPTIC-NERVE; DIFFUSION; INJURY; AXON	Wistar rats are widely used in biomedical research and commonly serve as a model organism in neuroscience studies. In most cases when noninvasive imaging is not used, studies assume a consistent baseline condition in rats that lack visible differences. While performing a series of traumatic brain injury studies, we discovered mild spontaneous ventriculomegaly in 70 (43.2%) of 162 Wistar rats that had been obtained from 2 different vendors. Advanced magnetic resonance (MR) imaging techniques, including MR angiography and diffusion tensor imaging, were used to evaluate the rats. Multiple neuropathologic abnormalities, including presumed arteriovenous malformations, aneurysms, cysts, white matter lesions, and astrogliosis were found in association with ventriculomegaly. Postmortem microcomputed tomography and immunohistochemical staining confirmed the presence of aneurysms and arteriovenous malformations. Diffusion tensor imaging showed significant decreases in fractional anisotropy and increases in mean diffusivity, axial diffusivity, and radial diffusivity in multiple white matter tracts (p < 0.05). These results could impact the interpretation, for example, of a pseudo-increase of axon integrity and a pseudo-decrease of myelin integrity, based on characteristics intrinsic to rats with ventriculomegaly. We suggest the use of baseline imaging to prevent the inadvertent introduction of a high degree of variability in preclinical studies of neurologic disease or injury in Wistar rats.	[Tu, Tsang-Wei; Turtzo, L. Christine; Williams, Rashida A.; Lescher, Jacob D.; Frank, Joseph A.] NIH, Frank Lab, Ctr Clin, Bethesda, MD 20892 USA; [Dean, Dana D.] Baylor Univ, Dept Environm Sci, Waco, TX 76798 USA; [Frank, Joseph A.] Natl Inst Biomed Imaging & Bioengn, NIH, Bethesda, MD USA		Tu, TW (corresponding author), NIH, Ctr Clin, Bldg 10,Room B1N256,10 Ctr Dr MSC 1074, Bethesda, MD 20892 USA.	tut@cc.nih.gov	Frank, Joseph/W-2021-2019		Department of Defense through the Center for Neuroscience and Regenerative Medicine (Henry M. Jackson Foundation Award) [300604-8.01-60855, 305500-8.01-60855]; Intramural Research Programs of the Clinical Center; National Institute of Biomedical Imaging and Bioengineering at the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); CLINICAL CENTER [ZIACL090020] Funding Source: NIH RePORTER	This work was supported by funding from the Department of Defense through the Center for Neuroscience and Regenerative Medicine (Henry M. Jackson Foundation Award 300604-8.01-60855 and 305500-8.01-60855) and from the Intramural Research Programs of the Clinical Center and of the National Institute of Biomedical Imaging and Bioengineering at the National Institutes of Health.	Alperin N, 2005, ACT NEUR S, V95, P177; Bragin DE, 2011, J NEUROTRAUM, V28, P775, DOI 10.1089/neu.2010.1692; Brodbelt A, 2007, BRIT J NEUROSURG, V21, P510, DOI 10.1080/02688690701447420; Budde MD, 2009, J NEUROSCI, V29, P2805, DOI 10.1523/JNEUROSCI.4605-08.2009; Couzin-Frankel J, 2013, SCIENCE, V342, P922, DOI 10.1126/science.342.6161.922; Del Bigio MR, 2001, NEUROSURG CLIN N AM, V12, P639, DOI 10.1016/S1042-3680(18)30022-6; Deren KE, 2010, EXP NEUROL, V226, P110, DOI 10.1016/j.expneurol.2010.08.010; Ding GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061241; Diringer MN, 1998, STROKE, V29, P1352, DOI 10.1161/01.STR.29.7.1352; Eskandari R, 2011, CHILD NERV SYST, V27, P2067, DOI 10.1007/s00381-011-1552-4; FRANKLIN JB, 1964, J MORPHOL, V115, P273, DOI 10.1002/jmor.1051150210; Fukumitsu H, 2000, CHILD NERV SYST, V16, P516, DOI 10.1007/s003810000305; GRUBB RL, 1975, J NEUROSURG, V43, P385, DOI 10.3171/jns.1975.43.4.0385; ITAKURA T, 1989, ACTA NEUROCHIR, V96, P154, DOI 10.1007/BF01456176; Jain-Ghai S, 2014, PEDIATRICS, V133, pE1092, DOI 10.1542/peds.2013-1230; Johnson GA, 2012, NEUROIMAGE, V62, P1848, DOI 10.1016/j.neuroimage.2012.05.041; Jones Hazel C, 2005, Cerebrospinal Fluid Res, V2, P2, DOI 10.1186/1743-8454-2-2; JONES HC, 1988, NEUROPATH APPL NEURO, V14, P263, DOI 10.1111/j.1365-2990.1988.tb00887.x; Khan OH, 2006, EXP NEUROL, V200, P311, DOI 10.1016/j.expneurol.2006.02.113; KOHN DF, 1977, INFECT IMMUN, V16, P680, DOI 10.1128/IAI.16.2.680-689.1977; KOHN DF, 1981, ACTA NEUROPATHOL, V54, P211, DOI 10.1007/BF00687744; KOTO M, 1987, EXP ANIM TOKYO, V36, P157, DOI 10.1538/expanim1978.36.2_157; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Levy ML, 2004, J NEUROSURG, V101, P25, DOI 10.3171/ped.2004.101.2.0025; McAllister James P 2nd, 2010, Cerebrospinal Fluid Res, V7, P7, DOI 10.1186/1743-8454-7-7; McAllister JP, 2012, SEMIN FETAL NEONAT M, V17, P285, DOI 10.1016/j.siny.2012.06.004; Miller Janet M, 2007, Cerebrospinal Fluid Res, V4, P5, DOI 10.1186/1743-8454-4-5; Miyan JA, 2001, EXPTL BIOL REV, P91; Mulla MSA, 2012, SCAND J LAB ANIM SCI, V39, P65; MYERS RR, 1982, J NEUROPATH EXP NEUR, V41, P391, DOI 10.1097/00005072-198207000-00002; Ohmiya M, 2001, J NEUROSCI RES, V65, P228, DOI 10.1002/jnr.1146; Otsubo Yutaka, 1997, Neurologia Medico-Chirurgica, V37, P669, DOI 10.2176/nmc.37.669; Pierpaoli C., 2010, P INT SOC MAGNETIC R, P1597; Sabharwal Paramveer, 2013, J Pediatr Neurosci, V8, P126, DOI 10.4103/1817-1745.117843; SASAKI S, 1983, NEUROSURGERY, V13, P548, DOI 10.1227/00006123-198311000-00011; Selinummi J, 2005, BIOTECHNIQUES, V39, P859, DOI 10.2144/000112018; SHIMIZU A, 1992, CHILD NERV SYST, V8, P25, DOI 10.1007/BF00316558; Sival DA, 2011, BRAIN PATHOL, V21, P163, DOI 10.1111/j.1750-3639.2010.00432.x; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Tu T., 2013, J NEUROSCI NEUROENG, V2, P415; Tu TW, 2014, MAGN RESON IMAGING, V32, P1335, DOI 10.1016/j.mri.2014.07.004; Tu TW, 2013, NMR BIOMED, V26, P1484, DOI 10.1002/nbm.2981; Tu TW, 2010, J NEUROTRAUM, V27, P253, DOI 10.1089/neu.2009.1026; Turtzo LC, 2013, NMR BIOMED, V26, P468, DOI 10.1002/nbm.2886; VANEDEN CG, 1986, LAB ANIM, V20, P257, DOI 10.1258/002367786780865548; Walker EJ, 2011, JOVE-J VIS EXP, DOI 10.3791/2958; Wang R., 2007, P INT SOC MAG RESON, V15, P3720; Wang Y, 2011, BRAIN, V134, P3587, DOI 10.1093/brain/awr307; Xie MQ, 2010, J NEUROPATH EXP NEUR, V69, P704, DOI 10.1097/NEN.0b013e3181e3de90; YANG GY, 1994, J NEUROSURG, V81, P93, DOI 10.3171/jns.1994.81.1.0093; YOSHIDA Y, 1990, Neurologia Medico-Chirurgica, V30, P445, DOI 10.2176/nmc.30.445; Zhang J, 2006, J NEUROL, V253, P1255, DOI 10.1007/s00415-006-0245-5	53	17	17	0	5	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-3069	1554-6578		J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	DEC	2014	73	12					1152	1165		10.1097/NEN.0000000000000140			14	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	AU0DQ	WOS:000345294200007	25383642	Green Accepted, Bronze			2022-02-06	
J	Volman, V; Ng, LJ				Volman, Vladislav; Ng, Laurel J.			Primary paranode demyelination modulates slowly developing axonal depolarization in a model of axonal injury	JOURNAL OF COMPUTATIONAL NEUROSCIENCE			English	Article						Traumatic axonal injury; Demyelination; Trauma; Potassium regulation; Computational neuroscience	TRAUMATIC BRAIN-INJURY; COLLEGIATE FOOTBALL PLAYERS; CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD AXONS; MYELINATED AXONS; ACTION-POTENTIALS; WHITE-MATTER; EXCITABILITY PROPERTIES; POTASSIUM CHANNELS; HUMAN MOTOR	Neurological sequelae of mild traumatic brain injury are associated with the damage to white matter myelinated axons. In vitro models of axonal injury suggest that the progression to pathological ruin is initiated by the mechanical damage to tetrodotoxin-sensitive voltage-gated sodium channels that breaches the ion balance through alteration in kinetic properties of these channels. In myelinated axons, sodium channels are concentrated at nodes of Ranvier, making these sites vulnerable to mechanical injury. Nodal damage can also be inflicted by injury-induced partial demyelination of paranode/juxtaparanode compartments that flank the nodes and contain high density of voltage-gated potassium channels. Demyelination-induced potassium deregulation can further aggravate axonal damage; however, the role of paranode/juxtaparanode demyelination in immediate impairment of axonal function, and its contribution to the development of axonal depolarization remain elusive. A biophysically realistic computational model of myelinated axon that incorporates ion exchange mechanisms and nodal/paranodal/juxtaparanodal organization was developed and used to study the impact of injury-induced demyelination on axonal signal transmission. Injured axons showed alterations in signal propagation that were consistent with the experimental findings and with the notion of reduced axonal excitability immediately post trauma. Injury-induced demyelination strongly modulated the rate of axonal depolarization, suggesting that trauma-induced damage to paranode myelin can affect axonal transition to degradation. Results of these studies clarify the contribution of paranode demyelination to immediate post trauma alterations in axonal function and suggest that partial paranode demyelination should be considered as another "injury parameter" that is likely to determine the stability of axonal function.	[Volman, Vladislav; Ng, Laurel J.] L 3 Appl Technol Simulat Engn & Testing, San Diego, CA 92121 USA; [Volman, Vladislav] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA; [Volman, Vladislav] Salk Inst Biol Studies, Computat Neurobiol Lab, La Jolla, CA 92037 USA		Volman, V (corresponding author), L 3 Appl Technol Simulat Engn & Testing, 10770 Wateridge Circle,Suite 200, San Diego, CA 92121 USA.	Vladislav.Volman@L-3com.com			US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-11-D-0011]; Direct For Mathematical & Physical ScienNational Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS) [1308264] Funding Source: National Science Foundation	This work was sponsored by the US Army Medical Research and Materiel Command under contract W81XWH-11-D-0011. This document is cleared for all audiences for OPSEC purposes. Cleared 09/18/2013. The opinions or assertions contained herein are private views of the authors, and are not to be construed as official or as reflecting views of the Department of the Army or the Department of Defense. PAO REVIEWED. The authors declare no competing financial interests.	Bhat MA, 2003, CURR OPIN NEUROBIOL, V13, P552, DOI 10.1016/j.conb.2003.09.004; Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; BLACK JA, 1990, TRENDS NEUROSCI, V13, P48, DOI 10.1016/0166-2236(90)90068-L; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BOSTOCK H, 1983, J PHYSIOL-LONDON, V341, P59, DOI 10.1113/jphysiol.1983.sp014792; Boucher PA, 2012, J COMPUT NEUROSCI, V33, P301, DOI 10.1007/s10827-012-0387-7; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; BRILL MH, 1977, J NEUROL NEUROSUR PS, V40, P769, DOI 10.1136/jnnp.40.8.769; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Coggan JS, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/065002; Coggan JS, 2010, P NATL ACAD SCI USA, V107, P20602, DOI 10.1073/pnas.1013798107; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; Gow A, 2008, NEURON GLIA BIOL, V4, P307, DOI 10.1017/S1740925X09990391; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Hille B., 2001, IONS CHANNELS EXCITA; Hines ML, 2000, NEURAL COMPUT, V12, P995, DOI 10.1162/089976600300015475; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Huff TB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017176; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Janigro D, 1997, J NEUROSCI, V17, P2813; Kager H, 2000, J NEUROPHYSIOL, V84, P495, DOI 10.1152/jn.2000.84.1.495; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Krishnan GP, 2011, J NEUROSCI, V31, P8870, DOI 10.1523/JNEUROSCI.6200-10.2011; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Lauger P., 1991, ELECTROGENIC ION PUM; Lopreore CL, 2008, BIOPHYS J, V95, P2624, DOI 10.1529/biophysj.108.132167; Maxwell WL, 1996, MICROSC RES TECHNIQ, V34, P522, DOI 10.1002/(SICI)1097-0029(19960815)34:6<522::AID-JEMT4>3.0.CO;2-L; McIntyre CC, 2002, J NEUROPHYSIOL, V87, P995, DOI 10.1152/jn.00353.2001; MOORE JW, 1978, BIOPHYS J, V21, P147, DOI 10.1016/S0006-3495(78)85515-5; MORAN O, 1983, NATURE, V304, P344, DOI 10.1038/304344a0; Nashmi R, 2001, BRAIN RES REV, V38, P165, DOI 10.1016/S0165-0173(01)00134-5; NG HK, 1994, CLIN NEUROL NEUROSUR, V96, P24, DOI 10.1016/0303-8467(94)90025-6; Nikolaeva MA, 2005, J NEUROSCI, V25, P9960, DOI 10.1523/JNEUROSCI.2003-05.2005; Ouyang H, 2010, J NEUROTRAUM, V27, P1109, DOI 10.1089/neu.2010.1271; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Rasband MN, 2001, DEV BIOL, V236, P5, DOI 10.1006/dbio.2001.0326; Reeves TM, 2010, BRAIN PATHOL, V20, P1055, DOI 10.1111/j.1750-3639.2010.00412.x; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shi R, 2002, NEUROSCIENCE, V110, P765, DOI 10.1016/S0306-4522(01)00596-6; Shi R, 1996, J NEUROPHYSIOL, V76, P1572, DOI 10.1152/jn.1996.76.3.1572; Shi R, 2006, J NEUROPHYSIOL, V95, P3384, DOI 10.1152/jn.00350.2005; Southwood C, 2004, J NEUROSCI, V24, P11215, DOI 10.1523/JNEUROSCI.3479-04.2004; Staal JA, 2010, J NEUROCHEM, V112, P1147, DOI 10.1111/j.1471-4159.2009.06531.x; Steffensen I, 1997, BRAIN RES, V776, P1, DOI 10.1016/S0006-8993(97)00868-8; STEPHANOVA DI, 1995, BIOL CYBERN, V73, P275, DOI 10.1007/BF00201429; Stephanova DI, 2000, BIOL CYBERN, V83, P161, DOI 10.1007/s004220000151; Stephanova DI, 2005, CLIN NEUROPHYSIOL, V116, P2334, DOI 10.1016/j.clinph.2005.07.013; Stephanova DI, 2005, CLIN NEUROPHYSIOL, V116, P1159, DOI 10.1016/j.clinph.2005.01.005; Stephanova DI, 2005, CLIN NEUROPHYSIOL, V116, P1153, DOI 10.1016/j.clinph.2004.12.011; Stephanova DI, 1997, BIOL CYBERN, V76, P311, DOI 10.1007/s004220050342; Stephanova D, 2008, EUR BIOPHYS J BIOPHY, V37, P183, DOI 10.1007/s00249-007-0215-6; Stys PK, 1996, ANN NY ACAD SCI, V779, P366, DOI 10.1111/j.1749-6632.1996.tb44808.x; Stys PK, 2005, J NEUROL SCI, V233, P3, DOI 10.1016/j.jns.2005.03.031; Stys PK, 1998, J CEREBR BLOOD F MET, V18, P2, DOI 10.1097/00004647-199801000-00002; Sun WJ, 2012, J NEUROTRAUM, V29, P611, DOI 10.1089/neu.2011.2086; Sun WJ, 2010, J NEUROPHYSIOL, V103, P469, DOI 10.1152/jn.00154.2009; Vabnick I, 1998, J NEUROBIOL, V37, P80, DOI 10.1002/(SICI)1097-4695(199810)37:1<80::AID-NEU7>3.3.CO;2-U; Volman V, 2012, FRONT COMPUT NEUROSC, V6, P1; Volman V, 2013, NEURAL COMPUT, V25, P2646, DOI 10.1162/NECO_a_00491; von Reyn CR, 2009, J NEUROSCI, V29, P10350, DOI 10.1523/JNEUROSCI.2339-09.2009; Wang JA, 2009, AM J PHYSIOL-CELL PH, V297, pC823, DOI 10.1152/ajpcell.00505.2008; WAXMAN SG, 1972, NATURE-NEW BIOL, V238, P217, DOI 10.1038/newbio238217a0; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Zeng SY, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.061916	70	17	17	0	9	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0929-5313	1573-6873		J COMPUT NEUROSCI	J. Comput. Neurosci.	DEC	2014	37	3					439	457		10.1007/s10827-014-0515-7			19	Mathematical & Computational Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Mathematical & Computational Biology; Neurosciences & Neurology	AT2LZ	WOS:000344767600004	24986633				2022-02-06	
J	Zhao, B; Shang, GW; Chen, J; Geng, XK; Ye, X; Xu, GX; Wang, J; Zheng, JS; Li, HJ; Akbary, F; Li, SL; Lu, J; Ling, F; Ji, XM				Zhao, Bo; Shang, Guowei; Chen, Jian; Geng, Xiaokun; Ye, Xin; Xu, Guoxun; Wang, Ju; Zheng, Jiasheng; Li, Hongjun; Akbary, Fauzia; Li, Shengli; Lu, Jing; Ling, Feng; Ji, Xunming			A more consistent intraluminal rhesus monkey model of ischemic stroke	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; brain injury; rhesus monkeys; model middle cerebral artery; microcoil; infarction; stroke; interventional therapy; digital subtraction angiography; magnetic resonance image; neuroimaging; neuroregeneration	CEREBRAL-ARTERY OCCLUSION; DIFFUSION TENSOR MRI; NONHUMAN PRIMATE; SUBCORTICAL INFARCTS; MACACA-FASCICULARIS; CALORIC RESTRICTION; REPERFUSED STROKE; NXY-059; TERRITORY; MACAQUES	Endovascular surgery is advantageous in experimentally induced ischemic stroke because it causes fewer cranial traumatic lesions than invasive surgery and can closely mimic the pathophysiology in stroke patients. However, the outcomes are highly variable, which limits the accuracy of evaluations of ischemic stroke studies. In this study, eight healthy adult rhesus monkeys were randomized into two groups with four monkeys in each group: middle cerebral artery occlusion at origin segment (M1) and middle cerebral artery occlusion at M2 segment. The blood flow in the middle cerebral artery was blocked completely for 2 hours using the endovascular microcoil placement technique (1 mm x 10 cm) (undetachable), to establish a model of cerebral ischemia. The microcoil was withdrawn and the middle cerebral artery blood flow was restored. A reversible middle cerebral artery occlusion model was identified by hematoxylin-eosin staining, digital subtraction angiography, magnetic resonance angiography, magnetic resonance imaging, and neurological evaluation. The results showed that the middle cerebral artery occlusion model was successfully established in eight adult healthy rhesus monkeys, and ischemic lesions were apparent in the brain tissue of rhesus monkeys at 24 hours after occlusion. The rhesus monkeys had symptoms of neurological deficits. Compared with the MI occlusion group, the M2 occlusion group had lower infarction volume and higher neurological scores. These experimental findings indicate that reversible middle cerebral artery occlusion can be produced with the endovascular microcoil technique in rhesus monkeys. The M2 occluded model had less infarction and less neurological impairment, which offers the potential for application in the field of brain injury research.	[Zhao, Bo; Shang, Guowei; Chen, Jian; Geng, Xiaokun; Ling, Feng; Ji, Xunming] Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, Beijing 100053, Peoples R China; [Ye, Xin; Xu, Guoxun] Capital Med Univ, Xuanwu Hosp, Dept Anesthesiol, Beijing 100053, Peoples R China; [Wang, Ju; Lu, Jing] Capital Med Univ, Dept Lab Anim Sci, Beijing 100053, Peoples R China; [Zheng, Jiasheng; Li, Hongjun] Capital Med Univ, Beijing Youan Hosp, Dept Radiol, Beijing 100053, Peoples R China; [Akbary, Fauzia] Wayne State Univ, Sch Med, Detroit, MI USA; [Ji, Xunming] Beijing Inst Brain Disorders, Ctr Stroke, Beijing, Peoples R China		Ji, XM (corresponding author), Capital Med Univ, Xuanwu Hosp, Ctr Stroke, Beijing Inst Brain Disorders,Dept Neurol, Beijing 100053, Peoples R China.	jixm@ccmu.edu.cn	Ji, Xunming/AAN-3370-2021		National Key Basic Research Program (973 Program) of ChinaNational Basic Research Program of China [2011CB707804]; Beijing Municipal Science and Technology Project [2121100005312016]	This study was financially supported by grants from the National Key Basic Research Program (973 Program) of China, No. 2011CB707804; Beijing Municipal Science and Technology Project, No. 2121100005312016.	Barnes DC, 2012, CAN VET J, V53, P780; Bradley DV, 1999, INVEST OPHTH VIS SCI, V40, P214; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Cook DJ, 2012, NEUROTHERAPEUTICS, V9, P371, DOI 10.1007/s13311-012-0115-z; Cook DJ, 2012, NATURE, V483, P213, DOI 10.1038/nature10841; D'Arceuil HE, 2006, J MED PRIMATOL, V35, P78, DOI 10.1111/j.1600-0684.2006.00147.x; Feigin V, 2006, LANCET NEUROL, V5, P130, DOI 10.1016/S1474-4422(05)70325-2; Frazee JG, 1998, STROKE, V29, P1912, DOI 10.1161/01.STR.29.9.1912; Freret T, 2008, J CEREBR BLOOD F MET, V28, P786, DOI 10.1038/sj.jcbfm.9600575; Fukuda S, 2003, ILAR J, V44, P96, DOI 10.1093/ilar.44.2.96; Gao Huanmin, 2006, J Stroke Cerebrovasc Dis, V15, P202, DOI 10.1016/j.jstrokecerebrovasdis.2006.05.010; GARCIA JH, 1984, STROKE, V15, P5, DOI 10.1161/01.STR.15.1.5; Gauberti M, 2012, CEREBROVASC DIS, V33, P329, DOI 10.1159/000335309; Gauvrit JY, 2006, J NEUROL, V253, P631, DOI 10.1007/s00415-005-0075-x; Gerraty RP, 2002, STROKE, V33, P2019, DOI 10.1161/01.STR.0000020841.74704.5B; Gerriets T, 2004, STROKE, V35, P2372, DOI 10.1161/01.STR.0000142134.37512.a7; Ginsberg MD, 2003, STROKE, V34, P214, DOI 10.1161/01.STR.0000048846.09677.62; Goldstein LB, 2001, STROKE, V32, P280, DOI 10.1161/01.STR.32.1.280; Green AR, 2002, CLIN EXP PHARMACOL P, V29, P1030, DOI 10.1046/j.1440-1681.2002.03767.x; Halkes PHA, 2006, STROKE, V37, P1828, DOI 10.1161/01.STR.0000226993.88307.ff; Heinsius T, 1998, NEUROLOGY, V50, P341, DOI 10.1212/WNL.50.2.341; Hofer S, 2008, CEREB CORTEX, V18, P1079, DOI 10.1093/cercor/bhm141; Huang J, 2000, STROKE, V31, P3054, DOI 10.1161/01.STR.31.12.3054; Huttner HB, 2009, LANCET NEUROL, V8, P949, DOI 10.1016/S1474-4422(09)70224-8; Kaku S, 1998, EUR J PHARMACOL, V345, P185, DOI 10.1016/S0014-2999(98)00005-3; Kumar N, 2009, ANAT REC, V292, P976, DOI 10.1002/ar.20891; Kwiecien TD, 2014, NEUROL RES, V36, P417, DOI 10.1179/1743132814Y.0000000358; Lee KY, 2009, NEUROLOGY, V72, P1134, DOI 10.1212/01.wnl.0000345360.80382.69; Liu S, 2012, J NEUROSCI METH, V209, P90, DOI 10.1016/j.jneumeth.2012.06.009; LIU XG, 1992, STROKE, V23, P40, DOI 10.1161/01.STR.23.1.40; Liu YR, 2007, STROKE, V38, P138, DOI 10.1161/01.STR.0000252127.07428.9c; Mack WJ, 2003, NEUROL RES, V25, P846, DOI 10.1179/016164103771953943; Marshall JWB, 2003, STROKE, V34, P2228, DOI 10.1161/01.STR.0000087790.79851.A8; Marshall JWB, 2003, BRAIN RES, V972, P119, DOI 10.1016/S0006-8993(03)02511-3; Marshall JWB, 2001, STROKE, V32, P190, DOI 10.1161/01.STR.32.1.190; Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432; Min WK, 2000, STROKE, V31, P2055, DOI 10.1161/01.STR.31.9.2055; Neumann AB, 2009, STROKE, V40, P3768, DOI 10.1161/STROKEAHA.108.545368; O'Brien MD, 1973, STROKE, V4, P201, DOI 10.1161/01.STR.4.2.201; Paxinos G., 2000, RHESUS MONKEY BRAIN; Peters A, 2012, NEUROBIOL AGING, V33, P2357, DOI 10.1016/j.neurobiolaging.2011.11.015; Plautz EJ, 2003, NEUROL RES, V25, P801, DOI 10.1179/016164103771953880; Rink C, 2008, P NATL ACAD SCI USA, V105, P14100, DOI 10.1073/pnas.0806678105; Rodriguez-Mercado R, 2012, COMPARATIVE MED, V62, P427; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Sariol CA, 2007, CLIN VACCINE IMMUNOL, V14, P756, DOI 10.1128/CVI.00052-07; Sasaki M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026577; Saver JL, 2009, STROKE, V40, P2594, DOI 10.1161/STROKEAHA.109.552554; Sawada K, 2012, CONGENIT ANOM, V52, P16, DOI 10.1111/j.1741-4520.2011.00352.x; Schwartz AE, 2011, ACTA NEUROCHIR, V153, P327, DOI 10.1007/s00701-010-0816-1; Shuaib A, 2007, NEW ENGL J MED, V357, P562, DOI 10.1056/NEJMoa070240; Shuaib A, 2011, LANCET NEUROL, V10, P909, DOI 10.1016/S1474-4422(11)70195-8; Spetzler R, 1980, NEUROSURGERY, V7, P5; TIGGES J, 1988, AM J PRIMATOL, V15, P263, DOI 10.1002/ajp.1350150308; Valentine LE, 2008, TRENDS MICROBIOL, V16, P605, DOI 10.1016/j.tim.2008.08.010; West GA, 2009, J CEREBR BLOOD F MET, V29, P1175, DOI 10.1038/jcbfm.2009.43; Woods SE, 2013, J AM ASSOC LAB ANIM, V52, P295	57	17	18	0	6	SHENYANG EDITORIAL DEPT NEURAL REGENERATION RES	SHENYANG	PO BOX 1234, SHENYANG, LIAONING 110004, PEOPLES R CHINA	1673-5374			NEURAL REGEN RES	Neural Regen. Res.	DEC	2014	9	23					2087	2094		10.4103/1673-5374.147936			8	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	AZ1SJ	WOS:000348017800018	25657726	Green Published, Green Submitted, gold			2022-02-06	
J	Long, QF; Fan, CR; Kai, W; Luo, Q; Xin, WC; Wang, P; Wang, AS; Wang, ZY; Han, R; Fei, Z; Qiu, BS; Liu, WP				Long, Qianfa; Fan, Cairui; Kai, Wang; Luo, Qiang; Xin, Weichuan; Wang, Ping; Wang, Ansheng; Wang, Zhanyao; Han, Rui; Fei, Zhou; Qiu, Bensheng; Liu, Weiping			Hypoxia inducible factor-1 alpha expression is associated with hippocampal apoptosis during epileptogenesis	BRAIN RESEARCH			English	Article						Hypoxia inducible factor-1 alpha; Hippocampus; Apoptosis; Epilepsy	INDUCED STATUS EPILEPTICUS; LITHIUM-PILOCARPINE MODEL; TEMPORAL-LOBE EPILEPSY; CELL-DEATH; RAT MODEL; HIF-1-ALPHA; SEIZURES; OXYGEN; SPECTROSCOPY; MECHANISM	Cell apoptosis can cause hippocampal neuronal loss after epileptic seizures. Hypoxia inducible factor (HIF)-1 alpha is an important factor mediating apoptosis after brain injuries, such as cerebral ischemia and traumatic brain injures, but little research has been done on its role in the lithium chloride-pilocarpine induced epileptic model. Here, we used a rat model of pilocarpine-induced status epilepticus (SE) to investigate HIF-1 alpha expression and apoptosis in the hippocampus, and to explore their relationship during epileptogenesis. 120 male Sprague Dawley (SD) rats were treated with lithium chloride-pilocarpine injections and divided into an experimental group (administered by MK-801) and a positive control group (administered by saline). Then the HIF-1 alpha expression and hippocampal apoptosis were investigated by histological confirmation and western blotting at 24 h, 3 d, 7 d and 14 d, respectively. The results showed that the administration of MK-801 significantly reduced (P<0.05) HIF-1 alpha expression and hippocampal apoptosis during epileptogenesis in comparison with the positive control. Moreover, the expression of HIP-1 alpha and hippocampal apoptosis presented significant time-dependent changes (P<0.01) within 2 weeks, and their positive correlation (P<0.05) analyzed by Pearson's correlation analysis. Meanwhile, the HIF-1 alpha immunostained cells were distributed in accord with TUNEL immunostained cells and Caspase-3 immunopositive cells in the hippocampus. These results indicate that the HIP-1 alpha expression is associated with hippocampal apoptosis, and suggest that HIF-1 alpha is an important factor during epileptogenesis. (C) 2014 Elsevier B.V. All rights reserved.	[Long, Qianfa; Xin, Weichuan; Wang, Ping; Wang, Ansheng; Wang, Zhanyao] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp, Cent Hosp Xian,Dept Neurosurg, Xian 710003, Peoples R China; [Fan, Cairui; Kai, Wang; Luo, Qiang; Fei, Zhou; Liu, Weiping] Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Peoples R China; [Qiu, Bensheng] Univ Washington, Sch Med, Dept Radiol, Seattle, WA 98195 USA; [Han, Rui] Armed Police Hosp Shaanxi Prov, Dept Pathol, Xian 710054, Peoples R China		Qiu, BS (corresponding author), Univ Washington, Sch Med, Dept Radiol, Box 357115, Seattle, WA 98195 USA.	bqiu@u.washington.edu; liuwp@fmmu.edu.cn	Long, Qianfa/F-6461-2017	Long, Qianfa/0000-0001-8848-9688	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31301216]; Project of Science and Technology Research of Shaanxi Province [2014KJXX-29]	We would like to thank Miss Yue Qiu and Andrius Baskys (MD & PhD, Clinical Professor of Psychiatry UCR SOM, USA) for their editorial help and valuable comments on this article. This work was supported by the National Natural Science Foundation of China (No. 31301216) and the Project of Science and Technology Research of Shaanxi Province (No. 2014KJXX-29). We are also grateful to Juan Li and Xiaoyan Chen for advices and technical assistance in this study.	Ambrogini P., 2014, MOL NEUROBIOL; Barsoum IB, 2014, CANCER RES, V74, P665, DOI 10.1158/0008-5472.CAN-13-0992; Bateman LM, 2008, BRAIN, V131, P3239, DOI 10.1093/brain/awn277; Berger EA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003457; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Cheng YL, 2014, NEUROBIOL DIS, V62, P286, DOI 10.1016/j.nbd.2013.10.009; Costa-Ferro ZS, 2011, SEIZURE, V19, P84; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; Nguyen DK, 2013, EPILEPSIA, V54, P331, DOI 10.1111/epi.12011; Faure JB, 2013, EPILEPSIA, V54, P1203, DOI 10.1111/epi.12219; Feast A, 2012, EPILEPSIA, V53, P1349, DOI 10.1111/j.1528-1167.2012.03591.x; GORCZYCA W, 1993, CANCER RES, V53, P1945; Gualtieri F, 2013, NEUROMOL MED, V15, P133, DOI 10.1007/s12017-012-8203-0; Hao Y, 2012, NEUROL RES, V34, P430, DOI 10.1179/1743132811Y.0000000055; Henshall DC, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00110; Hota KB, 2012, J CEREBR BLOOD F MET, V32, P1046, DOI 10.1038/jcbfm.2012.21; Hu K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-115; Li Y, 2005, EXP NEUROL, V191, P198, DOI 10.1016/j.expneurol.2004.08.036; Liu Y, 2009, BRAIN RES, V1304, P149, DOI 10.1016/j.brainres.2009.09.083; Long QF, 2013, BRAIN RES, V1532, P1, DOI 10.1016/j.brainres.2013.07.020; Mikati MA, 2008, BRAIN DEV-JPN, V30, P513, DOI 10.1016/j.braindev.2008.01.002; Muller L, 2014, EPILEPSY RES, V108, P90, DOI 10.1016/j.eplepsyres.2013.10.017; Northington FJ, 2011, ANN NEUROL, V69, P743, DOI 10.1002/ana.22419; Paquet M, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-9; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Peng BW, 2013, EPILEPSIA, V54, P1223, DOI 10.1111/epi.12150; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P269, DOI 10.1016/0013-4694(72)90176-9; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Semenza GL, 2011, AM J PHYSIOL-CELL PH, V301, pC550, DOI 10.1152/ajpcell.00176.2011; SGONC R, 1994, TRENDS GENET, V10, P41, DOI 10.1016/0168-9525(94)90140-6; Shakarjian MP, 2012, TOXICOL APPL PHARM, V265, P113, DOI 10.1016/j.taap.2012.08.037; Song ZC, 2012, CELL PROLIFERAT, V45, P239, DOI 10.1111/j.1365-2184.2012.00810.x; Southwell DG, 2014, SCIENCE, V344, P167, DOI 10.1126/science.1240622; Trinka E, 2012, EPILEPSIA, V53, P127, DOI 10.1111/j.1528-1167.2012.03622.x; Tzeng TT, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-90; van Eijsden P, 2004, BRAIN RES, V1030, P11, DOI 10.1016/j.brainres.2004.09.025; Zhang C.C., 2013, ANTIOXID REDOX SIGNA	37	17	19	1	12	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	NOV 24	2014	1590						20	30		10.1016/j.brainres.2014.09.028			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AU6ST	WOS:000345732800003	25242614				2022-02-06	
J	Couchman, G; McMahon, G; Kelly, A; Ponsford, J				Couchman, Grace; McMahon, Genevieve; Kelly, Amber; Ponsford, Jennie			A new kind of normal: Qualitative accounts of Multifamily Group Therapy for acquired brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Caregiver; Traumatic brain injury; Family psychoeducation; Family; Experience; Multi-family group; Qualitative	FAMILY GROUP TREATMENT; SELF; PSYCHOEDUCATION; INDIVIDUALS; PEOPLE; RIGOUR	Acquired brain injuries (ABI) can have a major impact on social participation, causing increased social isolation and emotional distress for people with the injury and their family members. Multifamily Group Therapy (MFGT) provides information, resources, problem-solving strategies and opportunities for social networking for families where one member has an illness. By qualitatively examining the experience of group participation from the perspectives of both individuals with ABI and their family members, the present study aimed to elucidate the processes underlying and factors influencing success of facilitated MFG programmes with families impacted by ABI. Following participation in the 12-week MFGT, 29 individuals with brain injury and 30 caregivers participated in 90-minute, semi-structured focus groups. The overarching theme emerging from the transcripts was that of "Finding One's Place", with sub-themes of Connectedness, Identity, and Knowledge and Understanding. The MFGT experience made a contribution to participants' efforts to find their place in the world after an ABI. This was enhanced by connection with others within the group, sharing experiences, the development of self and family identity, and the gaining of knowledge and understanding. These findings consolidate a growing literature, which points to the importance of "Reconstruction of a place in the world" and "Reconstruction of personhood" in ABI recovery.	[Couchman, Grace; McMahon, Genevieve; Kelly, Amber; Ponsford, Jennie] Monash Univ, Sch Psychol & Psychiat, Clayton, Vic, Australia; [Couchman, Grace] Cairnmillar Inst, Sch Psychol Counseling & Psychotherapy, Camberwell, Australia; [Ponsford, Jennie] Epworth Healthcare, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia		Couchman, G (corresponding author), 184 Weston St East, Melbourne, Vic 3057, Australia.	g.couchman@me.com			Victorian Traffic Accident Commission (TAC), Victorian Neurotrauma Initiative [DP145]	The authors received funding from the Victorian Traffic Accident Commission (TAC), Victorian Neurotrauma Initiative to conduct the described research (project DP145). They believe this has in no way influenced their conduct of the research nor the interpretation of the research findings. The researchers received no direct personal benefit of a financial or other kind.	Arenth PM, 2006, BRAIN INJURY, V20, P253, DOI 10.1080/02699050500487662; Becker B. D., 2006, MULTI FAMILY GROUP T; Bradley GM, 2006, PSYCHIAT SERV, V57, P521, DOI 10.1176/appi.ps.57.4.521; Braun V., 2013, SUCCESSFUL QUALITATI; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; Charles N, 2007, NEUROREHABILITATION, V22, P61; Couchman G., 2008, PSYCHOTHERAPIES PSYC, P240; Davey T. T. L., 2004, J HUMAN BEHAV SOCIAL, V9, P129, DOI DOI 10.1300/J137V09N01_09; Dyck DG, 2000, PSYCHIAT SERV, V51, P513, DOI 10.1176/appi.ps.51.4.513; Epston, 1990, NARRATIVE MEANS THER; Fristad MA, 2002, BIPOLAR DISORD, V4, P254, DOI 10.1034/j.1399-5618.2002.09073.x; Geertz C., 1973, INTERPRETATION CULTU; Geist R, 2000, CAN J PSYCHIAT, V45, P173, DOI 10.1177/070674370004500208; Gelech JM, 2011, QUAL HEALTH RES, V21, P62, DOI 10.1177/1049732310377454; good b, 1994, MED RATIONALITY EXPE; Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P627, DOI 10.1080/09602010802041238; Guba EgonG., 1981, EFFECTIVE EVALUATION; Kersten P, 2010, DISABIL REHABIL, V32, P1028, DOI 10.3109/09638281003775568; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; Lemmens GM, 2003, J FAM THER, V25, P41, DOI 10.1111/1467-6427.00234; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; McFarlane W., 2002, MULTIFAMILY GROUPS T, V29; McFarlane W., 2002, FAMILY PCYCHOEDUCATI; MCFARLANE WR, 1995, FAM PROCESS, V34, P127, DOI 10.1111/j.1545-5300.1995.00127.x; McPherson KM, 2010, DISABIL REHABIL, V32, P961, DOI 10.3109/09638281003672393; Medved MI, 2008, QUAL HEALTH RES, V18, P469, DOI 10.1177/1049732308315731; Meezan W, 1998, RES SOCIAL WORK PRAC, V8, P330, DOI 10.1177/104973159800800306; Mihalopoulos C, 2004, AUST NZ J PSYCHIAT, V38, P511, DOI 10.1080/j.1440-1614.2004.01404.x; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; Rodgers ML, 2007, AM J PHYS MED REHAB, V86, P482, DOI 10.1097/PHM.0b013e31805c00a1; Ryan G. W., 2003, FIELD METHOD, V15, P85, DOI [10.1177/1525-822X02239569, DOI 10.1177/1525822X02239569, 10.1177/1525822X02239569]; Seale C, 1997, EUR J PUBLIC HEALTH, V7, P379, DOI 10.1093/eurpub/7.4.379; Strauss A., 1990, BASICS QUALITATIVE R; Tobin GA, 2004, J ADV NURS, V48, P388, DOI 10.1111/j.1365-2648.2004.03207.x	37	17	17	0	17	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	NOV 2	2014	24	6					809	832		10.1080/09602011.2014.912957			24	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	AS4MK	WOS:000344250200001	24824512				2022-02-06	
J	Ciuffreda, KJ; Ludlam, DP; Thiagarajan, P; Yadav, NK; Capo-Aponte, J				Ciuffreda, Kenneth J.; Ludlam, Diana P.; Thiagarajan, Preethi; Yadav, Naveen K.; Capo-Aponte, Jose			Proposed Objective Visual System Biomarkers for Mild Traumatic Brain Injury	MILITARY MEDICINE			English	Article							OCULOMOTOR REHABILITATION; EVOKED POTENTIALS; PROTOCOL; MTBI; DYSFUNCTIONS; POPULATION; CONCUSSION; TRACKING; TBI; VEP	The challenge and search for objectively based biomarkers to assess for the presence of concussion/mild traumatic brain injury is a high priority for the military establishment. We present a documented overview of specific test areas and related targeted, high-yield, objectively based parameters that may be potential "vision biomarkers" for the detection of concussion/mild traumatic brain injury based on results from our laboratory and others, with emphasis on oculomotor aspects. These findings have military relevance with respect to the initial diagnosis in the battlefield and in the far-forward medical facilities, pre-/postdeployment issues, pre-/postvisual rehabilitation evaluation, fitness-for-duty assessment, and establishment of a return-to-duty timeline.	[Ciuffreda, Kenneth J.; Ludlam, Diana P.; Thiagarajan, Preethi; Yadav, Naveen K.] SUNY State Coll Optometry, Dept Biol & Vis Sci, New York, NY 10036 USA; [Capo-Aponte, Jose] Womack Army Med Ctr, Dept Optometry, Ft Bragg, NC 28310 USA		Ciuffreda, KJ (corresponding author), SUNY State Coll Optometry, Dept Biol & Vis Sci, 33 West 42nd St, New York, NY 10036 USA.				Department of Defense (DoD)United States Department of Defense [W81XWH-12-1-0240, W81XWH-10-1-0141]; Langeloth Foundation; College of Optometrists in Vision Development (COVD); William C. Ezell Fellowship	We thank LTC James Truong for his helpful comments during manuscript preparation. Our studies were supported from the following sources: Department of Defense (DoD grants (W81XWH-12-1-0240 and W81XWH-10-1-0141), Langeloth Foundation, College of Optometrists in Vision Development (COVD), and the William C. Ezell Fellowship.	Alvarez TL, 2012, OPTOMETRY VISION SCI, V89, P1740, DOI 10.1097/OPX.0b013e3182772dce; Alvarez TL, 2010, OPTOMETRY VISION SCI, V87, P985, DOI 10.1097/OPX.0b013e3181fef1aa; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Capo-Aponte J.E., 2013, J SPINE, V4, DOI [10.4172/2165-7939.S4-004, DOI 10.4172/2165-7939.S4-004]; Capo-Aponte JE, 2012, J REHABIL RES DEV, V49, P1377, DOI 10.1682/JRRD.2011.07.0128; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Casto KL, 2012, A576370 DTIC; Ciuffreda K. J., 2011, J BEHAV OPTOMETRY, V22, P10; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda KJ, 2006, NEUROREHABILITATION, V21, P9; Ciuffreda KJ, 2013, BRAIN INJURY, V27, P41, DOI 10.3109/02699052.2012.700088; Ciuffreda KJ, 2011, OPTOMETRY, V82, P337, DOI 10.1016/j.optm.2011.03.006; Ciuffreda KJ, 2013, PUPILLARY DYNAMICS L; Ciuffreda KJ, 1995, EYE MOVEMENT BASICS, P72; Deployment Health Clinical Center (DHCC), DEPL SUPP ENH POSTD; Di Battista AP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00044; Gajawelli N, 2013, WORLD NEUROSURG, V80, P824, DOI 10.1016/j.wneu.2013.10.020; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Goodrich GL, 2013, J REHABIL RES DEV, V50, P757, DOI 10.1682/JRRD.2012.10.0184; Green W, 2010, J REHABIL RES DEV, V47, P183, DOI 10.1682/JRRD.2009.04.0041; GUR S, 1992, ISRAEL J MED SCI, V28, P622; Han Y, 2004, BRAIN RES PROTOC, V14, P1, DOI 10.1016/j.brainresprot.2004.06.002; Heitger MH, 2008, IEEE ENG MED BIO, P3570, DOI 10.1109/IEMBS.2008.4649977; Helvie R, 2011, VISION REHABILITATION: MULTIDISCIPLINARY CARE OF THE PATIENT FOLLOWING BRAIN INJURY, P45, DOI 10.1201/b10524-4; Hergenroeder GW, 2008, MOL DIAGN THER, V12, P345, DOI 10.2165/1250444-200812060-00002; Hoffmann M, 2012, BRIT J SURG, V99, P122, DOI 10.1002/bjs.7707; Leong DF, 2014, J SPORT MED PHYS FIT, V54, P70; Marion DW, 2011, J NEUROTRAUM, V28, P517, DOI 10.1089/neu.2010.1638; Maroon Joseph C, 2011, Clin Neurosurg, V58, P51; Mohan K, 2013, INVEST OPHTH VIS SCI, V54, P3440, DOI 10.1167/iovs.12-11522; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; PADULA WV, 1994, BRAIN INJURY, V8, P125, DOI 10.3109/02699059409150964; PAPATHANASOPOULOS P, 1994, EUR NEUROL, V34, P268, DOI 10.1159/000117054; Park JC, 2011, INVEST OPHTH VIS SCI, V52, P6624, DOI 10.1167/iovs.11-7586; Pearson BC, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.036731; Sarno S, 2000, VISION RES, V40, P3029, DOI 10.1016/S0042-6989(00)00137-1; Scheiman M, 2001, VISUAL VESTIBULAR CO, P89; Schmid Kara E, 2012, Front Neurol, V3, P90, DOI 10.3389/fneur.2012.00090; Suchoff IB, 2001, VISUAL VESTIBULAR CO; Suter PS, 2011, VISION REHABILITATION: MULTIDISCIPLINARY CARE OF THE PATIENT FOLLOWING BRAIN INJURY, P1, DOI 10.1201/b10524; Szymanowicz D, 2012, J REHABIL RES DEV, V49, P1083, DOI 10.1682/JRRD.2010.07.0129; Thiagarajan P., 2012, THESIS STATE U NEW Y; Thiagarajan P, 2014, J REHABIL RES DEV, V51, P175, DOI 10.1682/JRRD.2013.01.0027; Thiagarajan P, 2014, BRAIN INJURY, V28, P930, DOI 10.3109/02699052.2014.888761; Thiagarajan P, 2014, NEUROREHABILITATION, V34, P129, DOI 10.3233/NRE-131025; Thiagarajan P, 2013, J REHABIL RES DEV, V50, P1223, DOI 10.1682/JRRD.2012.12.0235; VistaLifeSciences, BETT INF BETT HLTH A; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Zasler N., 2007, BRAIN INJURY MED PRI	49	17	17	1	12	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	NOV	2014	179	11					1212	1217		10.7205/MILMED-D-14-00059			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7LK	WOS:000349098600012	25373043	Bronze			2022-02-06	
J	Hart, T; Kozlowski, AJ; Whyte, J; Poulsen, I; Kristensen, K; Nordenbo, A; Heinemann, AW				Hart, Tessa; Kozlowski, Allan J.; Whyte, John; Poulsen, Ingrid; Kristensen, Karin; Nordenbo, Annette; Heinemann, Allen W.			Functional Recovery After Severe Traumatic Brain Injury: An Individual Growth Curve Approach	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Rehabilitation	LENGTH-OF-STAY; REHABILITATION OUTCOMES; INDEPENDENCE MEASURE; NATIONAL INSTITUTE; MODEL SYSTEMS; DISABILITY; THERAPY; IMPAIRMENT; AGE	Objective: To examine person, injury, and treatment characteristics associated with recovery trajectories of people with severe traumatic brain injury (TBI) during inpatient rehabilitation. Design: Observational prospective longitudinal study. Setting: TBI rehabilitation units. Participants: Adults (N= 206) with severe nonpenetrating TBI admitted directly to inpatient rehabilitation from acute care. Participants were excluded for prior disability and intentional etiology of injury. Interventions: Naturally occurring treatments delivered within comprehensive multidisciplinary teams were recorded daily in 15-minute units provided to patients and family members, separately. Main Outcome Measures: Motor and cognitive FIM were measured on admission, discharge, and every 2 weeks in between and were analyzed with individual growth curve methodology. Results: Inpatient recovery was best modeled with linear, cubic, and quadratic components: relatively steep recovery was followed by deceleration of improvement, which attenuated prior to discharge. Slower recovery was associated with older age, longer coma, and interruptions to rehabilitation. Patients admitted at lower functional levels received more treatment, and more treatment was associated with slower recovery, presumably because treatment was allocated according to need. Therefore, effects of treatment on outcome could not be disentangled from effects of case mix factors. Conclusions: FIM gain during inpatient recovery from severe TBI is not a linear process. In observational studies, the specific effects of treatment on rehabilitation outcomes are difficult to separate from case mix factors that are associated with both outcome and allocation of treatment. (C) 2014 by the American Congress of Rehabilitation Medicine	[Hart, Tessa; Whyte, John] Moss Rehabil Res Inst, Elkins Pk, PA 19027 USA; [Kozlowski, Allan J.] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Poulsen, Ingrid; Kristensen, Karin; Nordenbo, Annette] Univ Copenhagen, Glostrup Hosp, Dept Neurorehabil, Res Unit Brain Injury Rehabil,Traumat Brain Injur, Copenhagen, Denmark; [Heinemann, Allen W.] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Heinemann, Allen W.] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA		Hart, T (corresponding author), Moss Rehabil Res Inst, 50 Township Line Rd, Elkins Pk, PA 19027 USA.	thart@einstein.edu	Heinemann, Allen W./AAI-2790-2021; Poulsen, ingrid/AAH-2052-2019	Heinemann, Allen W./0000-0003-2782-7326; Poulsen, ingrid/0000-0002-0342-017X; Whyte, John/0000-0002-4381-1474			Bode RK, 2004, ARCH PHYS MED REHAB, V85, P1901, DOI 10.1016/j.apmr.2004.02.023; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Forsyth RJ, 2010, ARCH DIS CHILD, V95, P266, DOI 10.1136/adc.2008.147926; Graham JE, 2010, ARCH PHYS MED REHAB, V91, P43, DOI 10.1016/j.apmr.2009.09.017; Granger CV, 1987, UNIFORM DATA SET MED; HEINEMANN AW, 1994, ARCH PHYS MED REHAB, V75, P133; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Kozlowski AJ, 2013, ARCH PHYS MED REHAB, V94; Kozlowski AJ, 2013, ARCH PHYS MED REHAB, V94, P589, DOI 10.1016/j.apmr.2012.08.199; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; National Data and Statistical Center, TRAUM BRAIN INJ MOD; Peiris CL, 2011, ARCH PHYS MED REHAB, V92, P1490, DOI 10.1016/j.apmr.2011.04.005; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P579, DOI 10.1016/j.apmr.2012.08.197; Raudenbush SW., 2002, HIERARCHICAL LINEAR, V1; Shiel A, 2001, CLIN REHABIL, V15, P501, DOI 10.1191/026921501680425225	15	17	17	0	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	NOV	2014	95	11					2103	2110		10.1016/j.apmr.2014.07.001			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	AS3XC	WOS:000344207500015	25010537				2022-02-06	
J	Kretschmer, A; Altgassen, M; Rendell, PG; Bolte, S				Kretschmer, Anett; Altgassen, Mareike; Rendell, Peter G.; Bolte, Sven			Prospective memory in adults with high-functioning autism spectrum disorders: Exploring effects of implementation intentions and retrospective memory load	RESEARCH IN DEVELOPMENTAL DISABILITIES			English	Article						Asperger syndrome; Executive function; Memory for intentions; Implementation intentions; Cognition; Planning abilities; Retrospective memory load	TRAUMATIC BRAIN-INJURY; EXECUTIVE FUNCTION; EMOTIONAL VALENCE; OLDER-ADULTS; VIRTUAL WEEK; FREE-RECALL; PERFORMANCE; DEFICITS; CHILDREN; TIME	This study examined, for the first time, the impact of implementation intentions on Prospective memory (PM) performance in adults with autism spectrum disorders (ASD) and further explored the role of retrospective memory for PM in ASD. PM was assessed with Virtual Week, a computerized game simulating upcoming everyday-life tasks. Twenty-seven adults with ASD and 27 age- and ability-matched controls were included. Half of the participants were, instructed to form implementation intentions (i.e., encoding PM tasks in form of if-then statements), while the rest received simple PM instructions. Results provide first tentative evidence for beneficial effects of implementation intentions and PM tasks with low demands on retrospective memory for adults with ASD's PM. Overall, results point to the importance of planning and retrospective memory for successful prospective remembering in ASD. (C) 2014 Elsevier Ltd. All rights reserved.	[Kretschmer, Anett; Altgassen, Mareike] Tech Univ Dresden, Dept Psychol, D-01062 Dresden, Germany; [Altgassen, Mareike] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Rendell, Peter G.] Australian Catholic Univ, Sch Psychol, Melbourne, Vic, Australia; [Bolte, Sven] Karolinska Inst, Dept Womens & Childrens Hlth, Pediat Neuropsychiat Unit, Ctr Neurodev Disorders KIND, Stockholm, Sweden; [Bolte, Sven] Stockholm Cty Council, Div Child & Adolescent Psychiat, Stockholm, Sweden		Kretschmer, A (corresponding author), Tech Univ Dresden, Dept Psychol, Zellescher Weg 17, D-01062 Dresden, Germany.	anett.kretschmer@tu-dresden.de	Altgassen, Mareike/J-3048-2012; Rendell, Peter/E-7539-2010; Kretschmer-Trendowicz, Anett/L-9513-2016; Bolte, Sven/AAH-8675-2019; Altgassen, Mareike/AAN-1767-2020	Rendell, Peter/0000-0002-4829-4322; Bolte, Sven/0000-0002-4579-4970; Altgassen, Mareike/0000-0002-2644-8298			Aarts H, 1999, EUR J SOC PSYCHOL, V29, P971, DOI 10.1002/(SICI)1099-0992(199912)29:8<971::AID-EJSP963>3.0.CO;2-A; Achenbach T. M., 2003, ADULT SELF REPORT; Altgassen M, 2008, J CLIN EXP NEUROPSYC, V30, P777, DOI 10.1080/13803390701779552; Altgassen M, 2012, J AUTISM DEV DISORD, V42, P2141, DOI 10.1007/s10803-012-1466-3; Altgassen M, 2010, J NEURODEV DISORD, V2, P2, DOI 10.1007/s11689-009-9030-y; Altgassen M, 2009, BRAIN IMPAIR, V10, P52, DOI 10.1375/brim.10.1.52; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Bastin C., 2002, CURRENT PSYCHOL LETT, V7, P105; BEBKO JM, 2000, AUTISM, V4, P299, DOI DOI 10.1177/1362361300004003006; Bennetto L, 1996, CHILD DEV, V67, P1816, DOI 10.1111/j.1467-8624.1996.tb01830.x; Boucher J, 2012, PSYCHOL BULL, V138, P458, DOI 10.1037/a0026869; Bowler DM, 2000, J ABNORM PSYCHOL, V109, P663, DOI 10.1037//0021-843X.109.4.663; BRANDIMONTE MA, 1996, PROSPECTIVE MEMORY T; Brandimonte MA, 2011, MEMORY, V19, P56, DOI 10.1080/09658211.2010.535657; Breneiser J. E, 2009, N AM J PSYCHOL, V11, P401; Chasteen AL, 2001, PSYCHOL SCI, V12, P457, DOI 10.1111/1467-9280.00385; Dunn LM., 2007, PEABODY PICTURE VOCA, VIV; Einstein, 2008, PROSPECTIVE MEMORY C, P283; Einstein, 2002, PSYCHOL BEITR, V44, P303, DOI [10.1037/0012-1649.44.2.612, DOI 10.1037/0012-1649.44.2.612]; EINSTEIN GO, 1992, PSYCHOL AGING, V7, P471, DOI 10.1037/0882-7974.7.3.471; Einstein GO, 2005, CURR DIR PSYCHOL SCI, V14, P286, DOI 10.1111/j.0963-7214.2005.00382.x; EINSTEIN GO, 1995, J EXP PSYCHOL LEARN, V21, P996, DOI 10.1037/0278-7393.21.4.996; Einstein GO, 2003, J EXP PSYCHOL-APPL, V9, P147, DOI 10.1037/1076-898X.9.3.147; Fortin S, 2003, CORTEX, V39, P273, DOI 10.1016/S0010-9452(08)70109-6; Foster ER, 2013, NEUROPSYCHOLOGY, V27, P170, DOI 10.1037/a0031946; Gaigg SB, 2008, NEUROPSYCHOLOGIA, V46, P983, DOI 10.1016/j.neuropsychologia.2007.11.011; Gollwitzer PeterM., 1993, EUR REV SOC PSYCHOL, V4, P141, DOI [10.1080/14792779343000059, DOI 10.1080/14792779343000059]; Gollwitzer PM, 1999, AM PSYCHOL, V54, P493, DOI 10.1037//0003-066X.54.7.493; Gotham K, 2007, J AUTISM DEV DISORD, V37, P613, DOI 10.1007/s10803-006-0280-1; Happe F, 2006, NAT NEUROSCI, V9, P1218, DOI 10.1038/nn1770; Henry J. D., 2014, J EXPT CHILD PSYCHOL; HUGHES C, 1994, NEUROPSYCHOLOGIA, V32, P477, DOI 10.1016/0028-3932(94)90092-2; Jager T, 2008, J GEN PSYCHOL, V135, P4, DOI 10.3200/GENP.135.1.4-22; Jones CRG, 2011, J AUTISM DEV DISORD, V41, P455, DOI 10.1007/s10803-010-1067-y; Kliegel M, 2000, MEM COGNITION, V28, P1041, DOI 10.3758/BF03209352; Kliegel M, 2004, BRAIN COGNITION, V56, P43, DOI 10.1016/j.bandc.2004.05.005; Kliegel M, 2004, MEMORY, V12, P553, DOI 10.1080/09658210344000099; Leitz JR, 2009, PSYCHOPHARMACOLOGY, V205, P379, DOI 10.1007/s00213-009-1546-z; Liu LL, 2004, PSYCHOL AGING, V19, P318, DOI 10.1037/0882-7974.19.2.318; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Mackinlay R, 2006, BRAIN COGNITION, V61, P14, DOI 10.1016/j.bandc.2005.12.006; Mantyla T, 1997, AGING NEUROPSYCHOL C, V4, P81, DOI 10.1080/13825589708256638; Martin M, 2003, INT J PSYCHOL, V38, P195, DOI 10.1080/00207590344000123; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; McDaniel MA, 2008, MEM COGNITION, V36, P716, DOI 10.3758/MC.36.4.716; McFarland CP, 2011, AGING NEUROPSYCHOL C, V18, P633, DOI 10.1080/13825585.2011.613449; Meeks JT, 2010, PSYCHOL RES-PSYCH FO, V74, P82, DOI 10.1007/s00426-008-0223-x; Mioni G, 2013, J CLIN EXP NEUROPSYC, V35, P90, DOI 10.1080/13803395.2012.755151; OZONOFF S, 1994, DEV PSYCHOPATHOL, V6, P415, DOI 10.1017/S0954579400006027; OZONOFF S, 1991, J CHILD PSYCHOL PSYC, V32, P1081, DOI 10.1111/j.1469-7610.1991.tb00351.x; Paraskevaides T, 2010, PSYCHOPHARMACOLOGY, V208, P301, DOI 10.1007/s00213-009-1731-0; Pereira A, 2012, AGING NEUROPSYCHOL C, V19, P549, DOI 10.1080/13825585.2011.638977; PRIOR M, 1990, J AUTISM DEV DISORD, V20, P581, DOI 10.1007/BF02216063; Raskin SA, 2011, NEUROPSYCHOLOGY, V25, P201, DOI 10.1037/a0020999; Raven J.C., 2008, STANDARD PROGR MATRI; Rendell PG, 2012, J CLIN EXP NEUROPSYC, V34, P738, DOI 10.1080/13803395.2012.670388; Rendell PG, 2011, COGNITION EMOTION, V25, P916, DOI 10.1080/02699931.2010.508610; Rendell PG, 2009, BRAIN IMPAIR, V10, P14, DOI 10.1375/brim.10.1.14; Rendell PG, 2000, APPL COGNITIVE PSYCH, V14, pS43, DOI 10.1002/acp.770; Risi, 2001, AUTISM DIAGNOSTIC OB; Rummel J, 2012, MEMORY, V20, P803, DOI 10.1080/09658211.2012.707214; Schnitzspahn K. M., 2014, FUTURE THINKIN UNPUB; Schnitzspahn KM, 2009, EUR J AGEING, V6, P147, DOI 10.1007/s10433-009-0116-x; SCHOPLER E, 1984, EFFECTS AUTISM FAMIL, P65; Smith BJ, 2007, J AUTISM DEV DISORD, V37, P445, DOI 10.1007/s10803-006-0180-4; TERRY WS, 1988, PSYCHOL REP, V62, P299, DOI 10.2466/pr0.1988.62.1.299; Trawley SL, 2014, J COGN PSYCHOL, V26, P39, DOI 10.1080/20445911.2013.852199; Webb TL, 2003, J EXP SOC PSYCHOL, V39, P279, DOI 10.1016/S0022-1031(02)00527-9; WILLIAMS D, 2013, CHEM IND-LONDON, V77, P43, DOI DOI 10.L007/S10803-012-1703-9; Williams DM, 2014, NEUROPSYCHOLOGY, V28, P30, DOI 10.1037/neu0000008; Zimmermann TD, 2010, APPL COGNITIVE PSYCH, V24, P645, DOI 10.1002/acp.1576; Zinke K, 2010, CHILD NEUROPSYCHOL, V16, P229, DOI 10.1080/09297040903559648	72	17	17	4	39	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0891-4222			RES DEV DISABIL	Res. Dev. Disabil.	NOV	2014	35	11					3108	3118		10.1016/j.ridd.2014.07.052			11	Education, Special; Rehabilitation	Social Science Citation Index (SSCI)	Education & Educational Research; Rehabilitation	AO7PY	WOS:000341546300050	25151603				2022-02-06	
J	Mckay, CD; Meeuwisse, WH; Emery, CA				McKay, Carly D.; Meeuwisse, Willem H.; Emery, Carolyn A.			Informing body checking policy in youth ice hockey in Canada: A discussion meeting with researchers and community stakeholders	CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE			English	Article						Policy; injury; ice hockey; knowledge translation	INJURY; RISK	OBJECTIVES: Body checking is a significant risk factor for injury, including concussion, in youth ice hockey. Recent evidence regarding injury rates in youth leagues prompted USA Hockey to institute a national policy change in 2011 that increased the age of body checking introduction from 11-12 years old (Pee Wee) to 13-14 years old (Bantam). Body checking policy was more controversial in Canada, and research evidence alone was insufficient to drive change. The purpose of this paper is to provide an example of one of the knowledge exchange processes that occurred between researchers and community stakeholders, leading up to a national policy change in 2013. PARTICIPANTS: There were 28 stakeholder attendees, representing the research community, youth hockey organizations, and child health advocacy groups. SETTING: A one-day meeting held in Whistler, British Columbia, in April 2013. INTERVENTION: Researchers and stakeholders presented current perspectives on evidence and policy change, and discussion focused on an a priori set of questions designed to elicit facilitators and barriers to policy change. OUTCOMES: Three major factors that can drive policy change in the sport safety context were identified: the need for decision-making leadership, the importance of knowledge translation, and the role of sport culture as a barrier to change. CONCLUSION: There is a critical need for researcher and stakeholder partnership in facilitating ongoing policy discussion and informing evidence-based policy change in sport and recreation injury prevention.	[McKay, Carly D.; Meeuwisse, Willem H.; Emery, Carolyn A.] Univ Calgary, Fac Kinesiol, SIPRC, Calgary, AB T2N 1N4, Canada; [Meeuwisse, Willem H.; Emery, Carolyn A.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 1N4, Canada; [Emery, Carolyn A.] Univ Calgary, Fac Med, Dept Pediat, Alberta Childrens Hosp Res Inst Child & Maternal, Calgary, AB T2N 1N4, Canada; [Emery, Carolyn A.] Univ Calgary, Fac Med, Dept Community Hlth Sci, Calgary, AB T2N 1N4, Canada		Mckay, CD (corresponding author), Univ Calgary, Fac Kinesiol, SIPRC, Calgary, AB T2N 1N4, Canada.	cdmckay@ucalgary.ca	Emery, Carolyn/AAI-2761-2020	McKay, Carly/0000-0001-7664-3211	Alberta Innovates [201201160] Funding Source: researchfish		Emery CA, 2011, CMAJ, V183, P1249; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; Hockey Canada, TEACHING CHECKING A; Houghton KM, 2012, PAED CHILD HEALT-CAN, V17, P509, DOI 10.1093/pch/17.9.509; USA Hockey Coaching Education Program, CHECKING THE RIGHT W; USA Hockey Player Development Committee, SUBCOMMITTEE ON BODY	7	17	17	1	15	CANADIAN PUBLIC HEALTH ASSOC	OTTAWA	1565 CARLING AVE, SUITE 300, OTTAWA, ONTARIO K1Z 8R1, CANADA	0008-4263	1920-7476		CAN J PUBLIC HEALTH	Can. J. Public Health-Rev. Can. Sante Publ.	NOV-DEC	2014	105	6					E445	E449		10.17269/cjph.105.4653			5	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	AZ8QB	WOS:000348478800008	25560891	Green Published, Green Accepted			2022-02-06	
J	Rincon, F; Maltenfort, M; Dey, S; Ghosh, S; Vibbert, M; Urtecho, J; Jallo, J; Ratliff, JK; McBride, JW; Bell, R				Rincon, Fred; Maltenfort, Mitchell; Dey, Saugat; Ghosh, Sayantani; Vibbert, Matthew; Urtecho, Jaqueline; Jallo, Jack; Ratliff, John K.; McBride, John William; Bell, Rodney			The Prevalence and Impact of Mortality of the Acute Respiratory Distress Syndrome on Admissions of Patients With Ischemic Stroke in the United States	JOURNAL OF INTENSIVE CARE MEDICINE			English	Article						epidemiology; outcome; NIS; nationwide inpatient sample; hypoxia	ACUTE LUNG INJURY; TRAUMATIC BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; WEDGE PRESSURE; EPIDEMIOLOGY; OUTCOMES; ARDS; ACCURACY; ICD-9-CM; TRIALS	Purpose: To determine the epidemiology of the acute respiratory distress syndrome (ARDS) and impact on in-hospital mortality in admissions of patients with acute ischemic stroke (AIS) in the United States. Methods: Retrospective cohort study of admissions with a diagnosis of AIS and ARDS from 1994 to 2008 identified through the Nationwide Inpatient Sample. Results: During the 15-year study period, we found 55 58 091 admissions of patients with AIS. The prevalence of ARDS in admissions of patients with AIS increased from 3% in 1994 to 4% in 2008 (P < .001). The ARDS was more common among younger men, nonwhites, and associated with history of congestive heart failure, hypertension, chronic obstructive pulmonary disease, renal failure, chronic liver disease, systemic tissue plasminogen activator, craniotomy, angioplasty or stent, sepsis, and multiorgan failures. Mortality due to AIS and ARDS decreased from 8% in 1994 to 6% in 2008 (P < .001) and 55% in 1994 to 45% in 2008 (P < .001), respectively. The ARDS in AIS increased in-hospital mortality (odds ratio, 14; 95% confidence interval, 13.5-14.3). A significantly higher length of stay was seen in admissions of patients with AIS having ARDS. Conclusion: Our analysis demonstrates that ARDS is rare after AIS. Despite an overall significant reduction in mortality after AIS, ARDS carries a higher risk of death in this patient population.	[Rincon, Fred; Vibbert, Matthew; Urtecho, Jaqueline; McBride, John William; Bell, Rodney] Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA; [Rincon, Fred; Dey, Saugat; Ghosh, Sayantani; Vibbert, Matthew; Urtecho, Jaqueline; Jallo, Jack; Bell, Rodney] Thomas Jefferson Univ, Dept Neurol Surg, Philadelphia, PA 19107 USA; [Maltenfort, Mitchell] Rothman Inst, Dept Biostat, Philadelphia, PA USA; [Ratliff, John K.] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [McBride, John William; Bell, Rodney] Thomas Jefferson Univ, Div Crit Care & Neurotrauma, Philadelphia, PA 19107 USA; [McBride, John William; Bell, Rodney] Thomas Jefferson Univ, Div Cerebrovasc Dis, Philadelphia, PA 19107 USA		Rincon, F (corresponding author), Thomas Jefferson Univ, Div Crit Care & Neurotrauma, Dept Neurol Surg, 909 Walnut St,3rd Floor, Philadelphia, PA 19107 USA.	fred.rincon@jefferson.edu	Dey, Saugat/ABI-5969-2020	Dey, Saugat/0000-0003-4128-3337; Rincon, Fred/0000-0002-8510-118X; Jallo, Jack/0000-0002-5512-1729	American Heart AssociationAmerican Heart Association [AHA 12CRP12050342]	The author(s) disclosed receipt of the following financial support for the research, authorship and/or publication of this article: Dr Rincon has received salary support from the American Heart Association (AHA 12CRP12050342).	ASHBAUGH DG, 1967, LANCET, V2, P319; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Bersten AD, 2002, AM J RESP CRIT CARE, V165, P443, DOI 10.1164/ajrccm.165.4.2101124; Brun-Buisson C, 2004, INTENS CARE MED, V30, P51, DOI 10.1007/s00134-003-2022-6; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Erickson SE, 2009, CRIT CARE MED, V37, P1, DOI 10.1097/CCM.0b013e31819292ea; Ferguson ND, 2002, INTENS CARE MED, V28, P1073, DOI 10.1007/s00134-002-1354-y; Forfia PR, 2005, J AM COLL CARDIOL, V45, P1667, DOI 10.1016/j.jacc.2005.01.046; Goldstein LB, 1998, STROKE, V29, P1602, DOI 10.1161/01.STR.29.8.1602; Goss CH, 2003, CRIT CARE MED, V31, P1607, DOI 10.1097/01.CCM.0000063475.65751.1D; Gruber A, 1999, CRIT CARE MED, V27, P505, DOI 10.1097/00003246-199903000-00026; Halpern NA, 2006, CRIT CARE MED, V34, P2105, DOI 10.1097/01.CCM.0000227174.30337.3E; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Hudson LD, 1999, CHEST, V116, p74S, DOI 10.1378/chest.116.suppl_1.74S-a; Kahn JM, 2006, CRIT CARE MED, V34, P196, DOI 10.1097/01.CCM.0000194540.44020.8E; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; LEIBSON CL, 1994, STROKE, V25, P2348, DOI 10.1161/01.STR.25.12.2348; Luhr OR, 1999, AM J RESP CRIT CARE, V159, P1849, DOI 10.1164/ajrccm.159.6.9808136; Luhr OR, 2000, INTENS CARE MED, V26, P508, DOI 10.1007/s001340051197; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mascia L, 2007, CRIT CARE MED, V35, P1815, DOI 10.1097/01.CCM.0000275269.77467.DF; Moss M, 2000, CRIT CARE MED, V28, P2187, DOI 10.1097/00003246-200007000-00001; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Qureshi AI, 2005, NEUROSURGERY, V57, P647, DOI 10.1227/01.NEU.0000175546.62088.D6; Rana R, 2006, CRIT CARE MED, V34, P1941, DOI 10.1097/01.CCM.0000220492.15645.47; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Reynolds, 1998, Crit Care, V2, P29, DOI 10.1186/cc121; Rincon F, 2012, NEUROSURGERY, V71, P795, DOI 10.1227/NEU.0b013e3182672ae5; Rincon F, 2011, J CRIT CARE, V26, P620, DOI 10.1016/j.jcrc.2011.02.009; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Rubenfeld GD, 2007, CHEST, V131, P554, DOI 10.1378/chest.06-1976; Salim A, 2008, INJURY, V39, P30, DOI 10.1016/j.injury.2007.06.015; Saver JL, 2010, STROKE, V41, P2381, DOI 10.1161/STROKEAHA.110.583807; Silverboard H, 2005, J TRAUMA, V59, P717, DOI 10.1097/01.ta.0000174919.35240.21; THOMSEN GE, 1995, AM J RESP CRIT CARE, V152, P965, DOI 10.1164/ajrccm.152.3.7663811; VILLAR J, 1989, AM REV RESPIR DIS, V140, P814, DOI 10.1164/ajrccm/140.3.814; Wardlaw JM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub2; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	39	17	18	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0885-0666	1525-1489		J INTENSIVE CARE MED	J. Intensive Care Med.	NOV-DEC	2014	29	6					357	364		10.1177/0885066613491919			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AS6LR	WOS:000344375600006	23753254				2022-02-06	
J	Bukovics, P; Czeiter, E; Amrein, K; Kovacs, N; Pal, J; Tamas, A; Bagoly, T; Helyes, Z; Buki, A; Reglodi, D				Bukovics, Peter; Czeiter, Endre; Amrein, Krisztina; Kovacs, Noemi; Pal, Jozsef; Tamas, Andrea; Bagoly, Terez; Helyes, Zsuzsanna; Buki, Andras; Reglodi, Dora			Changes of PACAP level in cerebrospinal fluid and plasma of patients with severe traumatic brain injury	PEPTIDES			English	Article						Endogenous PACAP; Plasma; Cerebrospinal fluid; Traumatic brain injury; Neuroprotective; Blood-brain barrier	CYCLASE-ACTIVATING POLYPEPTIDE; VASOACTIVE-INTESTINAL-PEPTIDE; INDUCED RETINAL LESION; ADENYLATE-CYCLASE; SPINAL-CORD; CEREBRAL-ISCHEMIA; SUBSTANTIA-NIGRA; CELL-DEATH; BLOOD; RATS	PACAP has well-known neuroprotective potential including traumatic brain injury (TBI). Its level is up-regulated following various insults of the CNS in animal models. A few studies have documented alterations of PACAP levels in human serum. The time course of post-ictal PACAP levels, for example, show correlation with migraine severity. Very little is known about the course of PACAP levels following CNS injury in humans and the presence of PACAP has not yet been detected in cerebrospinal fluid (CSF) of subjects with severe TBI (sTBI). The aim of the present study was to determine whether PACAP occurs in the CSF and plasma (PI) of patients that suffered sTBI and to establish a time course of PACAP levels in the CSF and Pl. Thirty eight subjects with sTBI were enrolled with a Glasgow Coma Scale <= 8 on admission. Samples were taken daily, until the time of death or for maximum 10 days. Our results demonstrated that PACAP was detectable in the CSF, with higher concentrations in patients with TBI. PACAP concentrations markedly increased in both PI and CSF in the majority of patients 24-48 h after the injury stayed high thereafter. In cases of surviving patients, Pl and CSF levels displayed parallel patterns, which may imply the damage of the blood-brain barrier. However, in patients, who died within the first week, Pl levels were markedly higher than CSF levels, possibly indicating the prognostic value of high Pl PACAP levels. (C) 2014 Elsevier Inc. All rights reserved.	[Bukovics, Peter; Amrein, Krisztina; Kovacs, Noemi; Pal, Jozsef; Buki, Andras] Univ Pecs, Dept Neurosurg, Pecs, Hungary; [Bukovics, Peter; Czeiter, Endre; Buki, Andras] MTA PTE Clin Neurosci MR Res Grp, Pecs, Hungary; [Czeiter, Endre; Helyes, Zsuzsanna; Buki, Andras] Univ Pecs, Janos Szentagothai Res Ctr, Pecs, Hungary; [Czeiter, Endre; Tamas, Andrea; Reglodi, Dora] MTA PTE Lendulet PACAP Res Grp, Pecs, Hungary; [Czeiter, Endre; Tamas, Andrea; Reglodi, Dora] Univ Pecs, Dept Anat, Pecs, Hungary; [Bagoly, Terez; Helyes, Zsuzsanna] Univ Pecs, Dept Pharmacol & Pharmacotherapy, Pecs, Hungary		Czeiter, E (corresponding author), MTA PTE Clin Neurosci MR Res Grp, Pecs, Hungary.	endre.czeiter@gmail.com	Bukovics, Peter/A-6019-2009; Czeiter, Endre/B-1404-2009	Pal, Jozsef/0000-0001-6468-6409	National Science Research Found [OTKA PD72240, OTKA K104984]; European UnionEuropean Commission; State of Hungary; European Social FundEuropean Social Fund (ESF) [SROP 4.2.4.A/2-11-1-2012-0001, SROP-4.2.2.A-11/1/KONV-2012-0017, SROP-4.2.2.A-11/1/KONV-2012-0024]; National Excellence Program; Magyary Zoltan Scholarship; Arimura Foundation; MTA-PTE "Lendulet" Program; Hungarian Brain Research Program [KTIA_13_NAP-A-III/5, KTIA_13_NAP-A-II/8]	This study was supported by National Science Research Found OTKA PD72240, OTKA K104984, the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of SROP 4.2.4.A/2-11-1-2012-0001, SROP-4.2.2.A-11/1/KONV-2012-0017, SROP-4.2.2.A-11/1/KONV-2012-0024; 'National Excellence Program'; Magyary Zoltan Scholarship; Arimura Foundation; MTA-PTE "Lendulet" Program and Hungarian Brain Research Program Grant No. KTIA_13_NAP-A-III/5 as well as Hungarian Brain Research Program Grant No. KTIA_13_NAP-A-II/8.	Armstrong BD, 2008, NEUROSCIENCE, V151, P63, DOI 10.1016/j.neuroscience.2007.09.084; Atlasz T, 2007, GEN COMP ENDOCR, V153, P108, DOI 10.1016/j.ygcen.2006.12.022; Babai N, 2005, NEUROTOX RES, V8, P227, DOI 10.1007/BF03033976; BANKS WA, 1993, J PHARMACOL EXP THER, V267, P690; Beal MF, 2000, NEUROTOX RES, V2, P71, DOI 10.1007/BF03033786; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI 10.1089/neu.2008-0738; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Chen WH, 2005, NEUROSCI LETT, V384, P117, DOI 10.1016/j.neulet.2005.04.070; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Dash PK, 2010, J NEUROSCI RES, V88, P1719, DOI 10.1002/jnr.22336; Delgado M, 2003, ANN NY ACAD SCI, V992, P141, DOI 10.1111/j.1749-6632.2003.tb03145.x; Delgado M, 1999, J IMMUNOL, V162, P1200; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; DOW RC, 1994, J ENDOCRINOL, V142, pR1, DOI 10.1677/joe.0.142R001; Farkas O, 2004, REGUL PEPTIDES, V123, P69, DOI 10.1016/j.regpep.2004.05.014; Feng SQ, 2005, NEUROTOX RES, V7, P169, DOI 10.1007/BF03033785; de Yebenes JG, 2000, NEUROTOX RES, V2, P115, DOI 10.1007/BF03033789; Gerlach M, 2000, NEUROTOX RES, V2, P99, DOI 10.1007/BF03033788; Helyes Z, 2007, PEPTIDES, V28, P1847, DOI 10.1016/j.peptides.2007.07.001; Katahira M., 2003, Regulatory Peptides, V115, P49; Kim WK, 2000, J NEUROSCI, V20, P3622, DOI 10.1523/JNEUROSCI.20-10-03622.2000; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Li M, 2007, PEPTIDES, V28, P1891, DOI 10.1016/j.peptides.2007.05.002; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Martinez C, 2006, ANN NY ACAD SCI, V1070, P405, DOI 10.1196/annals.1317.053; MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Nemeth J, 2006, NEUROSCIENCE, V143, P223, DOI 10.1016/j.neuroscience.2006.07.028; RACZ B, 2006, INT J NEUROPROT NEUR, V2, P80; Racz B, 2006, REGUL PEPTIDES, V137, P20, DOI 10.1016/j.regpep.2006.02.009; Reglodi D, 2006, NEUROPEPTIDES, V40, P265, DOI 10.1016/j.npep.2006.06.001; Reglodi D, 2004, REGUL PEPTIDES, V123, P85, DOI 10.1016/j.regpep.2004.05.016; Reglodi D, 2002, PEPTIDES, V23, P2227, DOI 10.1016/S0196-9781(02)00262-0; Reglodi D, 2005, NEUROTOX RES, V8, P317; Saw MM, 2014, NEUROCRIT CARE, V20, P209, DOI 10.1007/s12028-013-9933-z; Segura-Aguilar J, 2006, NEUROTOX RES, V10, P263, DOI 10.1007/BF03033362; Shioda S, 1998, ANN NY ACAD SCI, V865, P111, DOI 10.1111/j.1749-6632.1998.tb11169.x; Shioda S, 2006, ANN NY ACAD SCI, V1070, P550, DOI 10.1196/annals.1317.080; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Skoglosa Y, 1999, NEUROSCIENCE, V90, P235, DOI 10.1016/S0306-4522(98)00414-X; Somogyvari-Vigh A, 2004, CURR PHARM DESIGN, V10, P2861, DOI 10.2174/1381612043383548; Tamas A, 2006, ANN NY ACAD SCI, V1070, P570, DOI 10.1196/annals.1317.083; Tamas A, 2006, J NEUROTRAUM, V23, P686, DOI 10.1089/neu.2006.23.686; Tamas A, 2012, INT J MOL SCI, V13, P8430, DOI 10.3390/ijms13078430; Tams JW, 1999, BIOCHEM J, V341, P271, DOI 10.1042/0264-6021:3410271; van Landeghem FKH, 2007, ACTA NEUROPATHOL, V113, P683, DOI 10.1007/s00401-007-0208-7; Vaudry D, 2000, PHARMACOL REV, V52, P269; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370	49	17	18	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0196-9781	1873-5169		PEPTIDES	Peptides	OCT	2014	60						18	22		10.1016/j.peptides.2014.07.001			5	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	AP8YI	WOS:000342364900004	25017241				2022-02-06	
J	Forward, KE; Seabrook, JA; Lynch, T; Lim, R; Poonai, N; Sangha, GS				Forward, Karen E.; Seabrook, Jamie A.; Lynch, Tim; Lim, Rodrick; Poonai, Naveen; Sangha, Gurinder S.			A comparison of the epidemiology of ice hockey injuries between male and female youth in Canada	PAEDIATRICS & CHILD HEALTH			English	Article						Epidemiology; Female; Hockey; Injury; Minor; Youth	RISK-FACTORS	BACKGROUND: Hockey is played by youth across Canada, and its popularity has increased dramatically among females in the past decade. Despite this, there has been little epidemiological research comparing the injury patterns of young female and male hockey players. OBJECTIVE: To describe and compare injuries sustained by female and male youth hockey players using the Canadian Hospitals Injury Reporting and Prevention Program database. METHODS: In the present cross-sectional, retrospective comparison study, the Canadian Hospitals Injury Reporting and Prevention Program database was used to identify all hockey-related injuries sustained by children seven to 17.5 years of age over a 15-year period (January 1995 to December 2009). Exclusion criteria included paid professional players and children with injuries sustained while playing road hockey. RESULTS: Inclusion criteria were met by 33,233 children (2637 [7.9%] females and 30,596 [92.1%] males). Compared with males, females reported proportionately more soft tissue injuries (39.8% versus 32.6%; P<0.01) and sprains/strains (21.1% versus 17.6%; P<0.01). Males experienced more fractures (27.1% versus 18.2%; P<0.01) and were most often injured through body checking (42.8% versus 25.7%; P<0.01). Females showed a trend toward increased concussion with age, and were most often injured through collisions (28.6% versus 24.6%; P<0.01). CONCLUSION: Compared with males, female hockey players sustained proportionately more soft tissue injures and sprains/strains, and showed a trend toward concussions in late adolecence. Males experienced more fractures, shoulder injuries and injuries due to body checking. Further research is required to identify risk factors for injury in female youth hockey players and to target injury prevention.	[Forward, Karen E.; Seabrook, Jamie A.; Lynch, Tim; Lim, Rodrick; Poonai, Naveen; Sangha, Gurinder S.] Western Univ, Dept Paediat, London, ON, Canada; [Seabrook, Jamie A.; Lynch, Tim; Lim, Rodrick] Childrens Hlth Inst, London, ON, Canada		Sangha, GS (corresponding author), Childrens Hosp, London Hlth Sci Ctr, Dept Emergency Med, Room E1-105,800 Commissioners Rd East, London, ON N6C 2V5, Canada.	gurinder.sangha@lhsc.on.ca					Agel J, 2007, J ATHL TRAINING, V42, P249; Agel J, 2010, CAN J SURG, V53, P319; Brainard LL, 2012, MED SCI SPORT EXER, V44, P297, DOI 10.1249/MSS.0b013e31822b0ab4; Canada Hockey, HOCK CAN 94 ANN GEN; Cusimano Michael D, 2011, Open Med, V5, pe57; Darling SR, 2011, BRIT J SPORT MED, V45, P492, DOI 10.1136/bjsm.2009.063693; Decloe MD, 2014, BRIT J SPORT MED, V48, P51, DOI 10.1136/bjsports-2012-091653; Deits J, 2010, J ATHL TRAINING, V45, P467, DOI 10.4085/1062-6050-45.5.467; Dryden D M, 2000, J Sci Med Sport, V3, P140, DOI 10.1016/S1440-2440(00)80076-6; Dryden DM, 2000, MED SCI SPORT EXER, V32, P1378, DOI 10.1097/00005768-200008000-00004; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; Hockey Canada, AG CHANG GEN INF; Hockey Canada, HOCK CAN BAS REG STA; Hockey Canada, FEM HOCK STAT HIST; Houghton KM, 2012, PAED CHILD HEALT-CAN, V17, P509, DOI 10.1093/pch/17.9.509; Keightley M, 2013, INT J SPORTS MED, V34, P756, DOI 10.1055/s-0032-1327574; Macpherson A, 2006, PEDIATRICS, V117, pE143, DOI 10.1542/peds.2005-1163; Public Health Agency of Canada, CHIRPP UN SOURC CHIL	18	17	17	1	10	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1205-7088	1918-1485		PAED CHILD HEALT-CAN	Paediatr. Child Health	OCT	2014	19	8					418	422		10.1093/pch/19.8.418			5	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	AT0OP	WOS:000344635500009	25382998	Green Published			2022-02-06	
J	Veenith, TV; Carter, EL; Grossac, J; Newcombe, VF; Outtrim, JG; Nallapareddy, S; Lupson, V; Correia, MM; Mada, MM; Willianns, GB; Menon, DK; Coles, JP				Veenith, Tonny V.; Carter, Eleanor L.; Grossac, Julia; Newcombe, Virginia F.; Outtrim, Joanne G.; Nallapareddy, Sridhar; Lupson, Victoria; Correia, Marta M.; Mada, Marius M.; Willianns, Guy B.; Menon, David K.; Coles, Jonathan P.			Use of diffusion tensor imaging to assess the impact of normobaric hyperoxia within at-risk pericontusional tissue after traumatic brain injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						contusion; diffusion tensor imaging; normobaric hyperoxia; penumbra; traumatic brain injury	SEVERE HEAD-INJURY; HYPERBARIC-OXYGEN; MITOCHONDRIAL-FUNCTION; INTRACRANIAL-PRESSURE; CEREBRAL METABOLISM; ISCHEMIC BURDEN; CARDIAC-ARREST; THERAPY; RESUSCITATION; IMPROVEMENT	Ischemia and metabolic dysfunction remain important causes of neuronal loss after head injury, and we have shown that normobaric hyperoxia may rescue such metabolic compromise. This study examines the impact of hyperoxia within injured brain using diffusion tensor imaging (DTI). Fourteen patients underwent DTI at baseline and after 1 hour of 80% oxygen. Using the apparent diffusion coefficient (ADC) we assessed the impact of hyperoxia within contusions and a 1 cm border zone of normal appearing pericontusion, and within a rim of perilesional reduced ADC consistent with cytotoxic edema and metabolic compromise. Seven healthy volunteers underwent imaging at 21%, 60%, and 100% oxygen. In volunteers there was no ADC change with hyperoxia, and contusion and pericontusion ADC values were higher than volunteers (P<0.01). There was no ADC change after hyperoxia within,contusion, but an increase within pericontusion (P<0.05). We identified a rim of perilesional cytotoxic edema in 13 patients, and hyperoxia resulted in an ADC increase towards normal (P=0.02). We demonstrate that hyperoxia may result in benefit within the perilesional rim of cytotoxic edema. Future studies should address whether a longer period of hyperoxia has a favorable impact on the evolution of tissue injury.	[Veenith, Tonny V.; Carter, Eleanor L.; Grossac, Julia; Newcombe, Virginia F.; Outtrim, Joanne G.; Nallapareddy, Sridhar; Menon, David K.; Coles, Jonathan P.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge CB2 0QQ, Cambs, England; [Lupson, Victoria; Correia, Marta M.; Mada, Marius M.; Willianns, Guy B.] Univ Cambridge, Addenbrookes Hosp, Wolfson Brain Imaging Ctr, Dept Clin Neurosci, Cambridge CB2 0QQ, Cambs, England		Coles, JP (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Hills Rd, Cambridge CB2 0QQ, Cambs, England.	jpc44@wbic.cam.ac.uk	Veenith, Tonny V/A-9948-2010; Veenith, Tonny/AAI-3067-2020	Veenith, Tonny V/0000-0002-4125-8804; Veenith, Tonny/0000-0002-4125-8804; Morgado Correia, Marta/0000-0002-3231-7040; Coles, Jonathan/0000-0003-4013-679X; Newcombe, Virginia/0000-0001-6044-9035	National Institute of Academic Anaesthesia; Raymond Beverly Sackler studentship; NIHR academic clinical fellowship; Wellcome TrustWellcome TrustEuropean Commission; NIHRNational Institute for Health Research (NIHR); Medical Research Council (UK)UK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390 ID 65883]; UK National Institute of Health Research Biomedical Research Centre at CambridgeNational Institute for Health Research (NIHR); UK Department of Health; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_U105579212, G0600986, G0001237, G9439390, G0701532] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390, G0701532, G0001237, G0600986, MC_U105579212] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327, ACF-2009-14-007, NF-SI-0512-10090] Funding Source: researchfish	TVV was supported by clinical research training fellowship from National Institute of Academic Anaesthesia and Raymond Beverly Sackler studentship. VFN is supported by an NIHR academic clinical fellowship. JPC was supported by Wellcome Trust Project grant. DKM is supported by an NIHR Senior Investigator Award. This work was supported by a Medical Research Council (UK) Program Grant (Acute brain injury: heterogeneity of mechanisms, therapeutic targets and outcome effects (G9439390 ID 65883)), the UK National Institute of Health Research Biomedical Research Centre at Cambridge, and the Technology Platform funding provided by the UK Department of Health.	Ahn ES, 2008, J NEUROSURG, V108, P124, DOI 10.3171/JNS/2008/108/01/0124; Anzai Y, 2004, AM J NEURORADIOL, V25, P274; Bennett MH, 2004, COCHRANE DB SYST REV, V12; Beynon C, 2012, J NEUROTRAUM, V29, P2109, DOI 10.1089/neu.2012.2365; Brown GC, 1997, MOL CELL BIOCHEM, V174, P189, DOI 10.1023/A:1006800322719; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Coles JP, 2009, J CEREBR BLOOD F MET, V29, P965, DOI 10.1038/jcbfm.2009.22; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P191, DOI 10.1097/01.WCB.0000100045.07481.DE; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; Diringer MN, 2007, J NEUROSURG, V106, P526, DOI 10.3171/jns.2007.106.4.526; Hlatky R, 2008, J NEUROSURG, V108, P53, DOI 10.3171/JNS/2008/108/01/0053; Kilgannon JH, 2010, JAMA-J AM MED ASSOC, V303, P2165, DOI 10.1001/jama.2010.707; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; Nangunoori R, 2012, NEUROCRIT CARE, V17, P131, DOI 10.1007/s12028-011-9621-9; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; Newcombe VFJ, 2013, J CEREBR BLOOD F MET, V33, P855, DOI 10.1038/jcbfm.2013.11; Newcombe VFJ, 2011, BRAIN, V134, P759, DOI 10.1093/brain/awq388; Nortje J, 2008, CRIT CARE MED, V36, P273, DOI 10.1097/01.CCM.0000292014.60835.15; Palzur E, 2008, BRAIN RES, V1221, P126, DOI 10.1016/j.brainres.2008.04.078; Pilcher J, 2012, RESUSCITATION, V83, P417, DOI 10.1016/j.resuscitation.2011.12.021; Puccio AM, 2009, J NEUROTRAUM, V26, P1241, DOI [10.1089/neu.2008.0624, 10.1089/neu.2008-0624]; Reinert M, 2004, J NEUROSURG, V101, P323, DOI 10.3171/jns.2004.101.2.0323; Robertson CL, 2004, J BIOENERG BIOMEMBR, V36, P363, DOI 10.1023/B:JOBB.0000041769.06954.e4; ROCKSWOLD GL, 1992, J NEUROSURG, V76, P929, DOI 10.3171/jns.1992.76.6.0929; Rockswold SB, 2013, J NEUROSURG, V118, P1317, DOI 10.3171/2013.2.JNS121468; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Slessarev M, 2006, CRIT CARE MED, V34, P829, DOI 10.1097/01.CCM.0000201877.82049.C3; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Tachtsidis I, 2011, ADV EXP MED BIOL, V701, P9, DOI 10.1007/978-1-4419-7756-4_2; Tisdall MM, 2008, J NEUROSURG, V109, P424, DOI 10.3171/JNS/2008/109/9/0424; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Veenith TV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065941; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vilalta A, 2011, J NEUROTRAUM, V28, P1139, DOI 10.1089/neu.2010.1720; Zhou ZW, 2007, J NEUROSURG, V106, P687, DOI 10.3171/jns.2007.106.4.687	42	17	18	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	OCT	2014	34	10					1622	1627		10.1038/jcbfm.2014.123			6	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	AQ1IV	WOS:000342536000006	25005875	Green Published, hybrid			2022-02-06	
J	Gomez, PA; Castano-Leon, AM; de-la-Cruz, J; Lora, D; Lagares, A				Gomez, Pedro A.; Castano-Leon, Ana M.; de-la-Cruz, Javier; Lora, David; Lagares, Alfonso			Trends in epidemiological and clinical characteristics in severe traumatic brain injury: Analysis of the past 25 years of a single centre data base	NEUROCIRUGIA			English	Article						Severe traumatic brain injury; Epidemiology; Mechanism; GCS	GLASGOW COMA SCALE; PROGNOSTIC VALUE; HEAD-INJURY; MODERATE; IMPACT; CLASSIFICATION; ENROLLMENT; MODELS	Objective: To describe the demographic and clinical profiles of a cohort of environmentally representative severe traumatic brain injury (TBI) cases collected for the past 25 years and to analyse the changes that occurred by dividing the analysis period into 3 equal time periods. Material and methods: This was an observational cohort study of consecutive adult patients (>14 years of age) with severe closed TEI (Glasgow Coma Scale score [GCS] <= 8) who were admitted during the first 48 h after injury to the 12 de Octubre hospital from 1987 to 2012. The most relevant epidemiological and clinical variables reported in the literature were defined and compared in 3 equal time periods (1987-1995,1996-2004 and 2005-2014). Results: There was a 13% reduction in the frequency of severe TBI from the first to the last time period. An increase in the mean age from 35 to 43 years was observed, whereas the frequency of severe TBI according to sex remained approximately the same during the last decades of life. A distinct change was observed in the injury mechanism; traffic accidents decreased from 76% to 55%, particularly those involving 4-wheeled vehicles. However, falls increased significantly, especially in older women, and contusion and subdural haematoma were the most frequent structural injuries. Motor scores could not be reliably assessed for the last time period because of early intubation and sedative drug use. Conclusions: TBI epidemiology in Western countries has changed. This trend was also observed in our environment as an increase in mean age, which reflected the increase in falls among elderly patients. (C) 2014 Sociedad Espanola de Neurocirugia. Published by Elsevier Espana, S.L.U. All rights reserved.	[Gomez, Pedro A.; Castano-Leon, Ana M.; Lagares, Alfonso] Univ Complutense Madrid, Octubre Univ Hosp 12, Dept Neurosurg, Madrid, Spain; [de-la-Cruz, Javier; Lora, David] 12 Octubre Univ Hosp, CIBERESP IMAS12, Clin Res Unit, Madrid, Spain		Gomez, PA (corresponding author), Univ Complutense Madrid, Octubre Univ Hosp 12, Dept Neurosurg, Madrid, Spain.	pedroantonio.gomez@salud.madrid.org	Lagares, Alfonso/B-2969-2011; Gomez, Pedro/N-5051-2019; Castano-Leon, Ana M/ABF-6322-2020	Lagares, Alfonso/0000-0003-3996-0554; Gomez, Pedro/0000-0002-4185-5238; Castano-Leon, Ana M/0000-0002-7918-5049	Mutua Madrilena Foundation (Spain) [2010-007]	This study was funded by grant no. 2010-007 from the Mutua Madrilena Foundation (Spain).	Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Boto GR, 2009, NEUROSURG REV, V32, P343, DOI 10.1007/s10143-008-0178-9; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; Butcher I, 2007, J NEUROTRAUM, V24, P281, DOI 10.1089/neu.2006.0030; Chesnut R., 2000, J NEUROTRAUM, V17, P557; Direccion Generalde Trafico (DGT), 2011, PRINC CIFR SIN VIAL; Faul M, 2010, TRAUMATIC BRAIN INJU; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gomez, 1999, NEUROCIRUGIA, V10, P297; Gomez PA, 2000, ACTA NEUROCHIR, V142, P373, DOI 10.1007/s007010050445; Gomez PA, 1999, CIR ESPAN, V65, P277; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Marion DW, 1994, J TRAUMA, P36; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perez K, 2012, ACCIDENT ANAL PREV, V46, P37, DOI 10.1016/j.aap.2011.12.004; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Roozenbeek B, 2009, J NEUROTRAUM, V26, P1069, DOI 10.1089/neu.2008.0569; Rosso A, 2007, WIEN KLIN WOCHENSCHR, V119, P29, DOI 10.1007/s00508-006-0761-4; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; VAZQUEZBARQUERO A, 1992, EUR J EPIDEMIOL, V8, P832, DOI 10.1007/BF00145328; Vilalta J, 1992, Rev Esp Anestesiol Reanim, V39, P277; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549	38	17	17	0	7	ELSEVIER ESPANA SLU	BARCELONA	AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN	1130-1473	2340-6305		NEUROCIRUGIA	Neurocirugia	SEP-OCT	2014	25	5					199	210		10.1016/j.neucir.2014.05.001			12	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AQ5UB	WOS:000342873000001	24998417				2022-02-06	
J	Moore, H; Gillespie, A				Moore, Helen; Gillespie, Alex			The caregiving bind: Concealing the demands of informal care can undermine the caregiving identity	SOCIAL SCIENCE & MEDICINE			English	Article						UK; Informal care; Acquired brain injury; Disagreement; Misunderstanding; Identity	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; HEALTH; STRESS; PARENT; CANCER; PERSPECTIVES; EXPERIENCES; DISABILITY; DEPRESSION	Disagreements and misunderstandings between informal caregivers and care-receivers have been widely reported, but the causes are unclear. The present article compares the views of people with acquired brain injury and their main informal caregivers (28 dyads, n = 56). First, we report a quantitative analysis finding that the majority of disagreements were about caregivers' identity. Caregivers saw themselves as less confident, less intelligent, more embarrassed, more independent and more overprotective than care-receivers rated them to be. Caregivers understood the care-receivers' ratings but disagreed with them' Second, we report a qualitative analysis focussing on how caregivers felt themselves to be perceived by significant others. Caregivers felt that the care-receiver, family members, the general public, health services and even friends often have negative views of them. The 'caregiving bind' is proposed as a cause of caregivers' negative identity. It arises when caregivers try to protect the care-receiver's identity by concealing the extent of informal care provision, with the unintended consequence of undermining the prospects of the caregiver receiving positive social recognition for the challenging work of caregiving. The caregiving bind has implications for therapy and points to the potential of friends and health services to provide caregivers with positive social recognition. (C) 2014 The Authors. Published by Elsevier Ltd.	[Moore, Helen] Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland; [Gillespie, Alex] London Sch Econ, Dept Social Psychol, London WC2A 2AE, England		Moore, H (corresponding author), Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland.	helenmooreuk@yahoo.co.uk; a.t.gillespie@lse.ac.uk					Ashworth Mark, 2010, Qual Prim Care, V18, P127; Badr H, 2007, PSYCHOL HEALTH, V22, P211, DOI 10.1080/14768320600843077; Bar-Tal Y, 2005, SOC SCI MED, V60, P1459, DOI 10.1016/j.socscimed.2004.08.003; Bevans M, 2012, JAMA-J AM MED ASSOC, V307, P398, DOI 10.1001/jama.2012.29; Bowen C., 2010, RELATIONAL APPROACH; Brain Injury Association of America, 2011, BRAIN INJ BRAIN INJ; Braine ME, 2011, J NEUROSCI NURS, V43, P156, DOI 10.1097/JNN.0b013e3182135bb2; Braun M, 2009, AGING MENT HEALTH, V13, P426, DOI 10.1080/13607860902879441; Brittain KR, 2007, SOC SCI MED, V65, P1274, DOI 10.1016/j.socscimed.2007.04.002; Buckner L., 2011, VALUING CARERS 2011; Carnes S.L., 2005, FAM SYST HEALTH, V23, P186, DOI DOI 10.1037/1091-7527.23.2.186; Croteau C, 2006, APHASIOLOGY, V20, P327, DOI 10.1080/02687030500475051; Emslie C, 2009, SOC SCI MED, V68, P1169, DOI 10.1016/j.socscimed.2009.01.004; Ennis N, 2013, NEUROPSYCHOL REHABIL, V23, P1, DOI 10.1080/09602011.2012.712871; Farmer J.E., 1996, RECOVERY TRAUMATIC B; FLEURIDAS C, 1986, J MARITAL FAM THER, V12, P113, DOI 10.1111/j.1752-0606.1986.tb01629.x; Gaber TAZK, 2008, BRAIN INJURY, V22, P589, DOI 10.1080/02699050802132461; Gill CJ, 2011, J HEAD TRAUMA REHAB, V26, P56, DOI 10.1097/HTR.0b013e3182048ee9; Gillespie A, 2010, APHASIOLOGY, V24, P1559, DOI 10.1080/02687038.2010.500810; Gillespie A, 2010, J THEOR SOC BEHAV, V40, P19, DOI 10.1111/j.1468-5914.2009.00419.x; Godwin EE, 2011, J HEAD TRAUMA REHAB, V26, P43, DOI 10.1097/HTR.0b013e3182048f54; Goffman E., 1963, STIGMA NOTES MANAGEM; Goffman E., 1956, PRESENTATION SELF EV; Gosling J, 1999, BRAIN INJURY, V13, P785; Greenwood N, 2009, INT J NURS STUD, V46, P1122, DOI 10.1016/j.ijnurstu.2009.02.011; HARPER S, 1990, INT J AGING HUM DEV, V30, P241, DOI 10.2190/9BLE-FED4-BRAC-RPX3; Hengst JA, 2008, INT J LANG COMM DIS, V43, P58, DOI 10.1080/13682820701698093; Honneth Axel, 1996, STRUGGLE RECOGNITION; Horowitz A, 2004, GERONTOLOGIST, V44, P532, DOI 10.1093/geront/44.4.532; Howes H, 2005, PSYCHOL HEALTH, V20, P129, DOI 10.1080/0887044042000272903; HSCIC, 2010, SURV CAR HOUS ENGL 2; James W., 1890, PRINCIPLES PSYCHOL; Johansson NO, 2005, SCAND J PSYCHOL, V46, P349, DOI 10.1111/j.1467-9450.2005.00465.x; Jones JM, 2011, PSYCHOL HEALTH, V26, P353, DOI 10.1080/08870440903440699; Jones L, 2013, CLIN REHABIL, V27, P272, DOI 10.1177/0269215512455532; KREFTING L, 1990, SOC SCI MED, V30, P859, DOI 10.1016/0277-9536(90)90213-C; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; Lee AR., 1966, INTERPERSONAL PERCEP; Locock L, 2010, SOC SCI MED, V71, P1498, DOI 10.1016/j.socscimed.2010.06.043; MacIntosh R, 2012, SOC SCI MED, V74, P332, DOI 10.1016/j.socscimed.2011.03.014; Maslow Abraham., 1954, MOTIVATION PERSONALI; McPherson KM, 2000, DISABIL REHABIL, V22, P683, DOI 10.1080/096382800445489; Mead GeorgeHerbert., 1934, MIND SELF SOC; Murphy J., 2000, BRIT J THERAPY REHAB, V7, P454; Newsom JT, 1998, HEALTH PSYCHOL, V17, P172, DOI 10.1037/0278-6133.17.2.172; Noble LM, 2004, CURR OPIN PSYCHIATR, V17, P289, DOI 10.1097/01.yco.0000133832.42167.76; Perrin PB, 2013, PM&R, V5, P839, DOI 10.1016/j.pmrj.2013.05.018; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Pot AM, 1998, PATIENT EDUC COUNS, V34, P43, DOI 10.1016/S0738-3991(98)00048-2; Power A, 2008, SOC SCI MED, V67, P834, DOI 10.1016/j.socscimed.2008.05.023; Reader TW, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-156; RIDLEY B, 1989, SOC SCI MED, V29, P555, DOI 10.1016/0277-9536(89)90201-3; Robinson L, 2007, HEALTH RISK SOC, V9, P389, DOI 10.1080/13698570701612774; Sander AM, 2003, ARCH PHYS MED REHAB, V84, P197, DOI 10.1053/apmr.2003.50105; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; SEMPLE SJ, 1992, GERONTOLOGIST, V32, P648, DOI 10.1093/geront/32.5.648; Sillars A, 2005, HUM COMMUN RES, V31, P102, DOI 10.1093/hcr/31.1.102; Simon C, 2009, SOC SCI MED, V69, P404, DOI 10.1016/j.socscimed.2009.04.007; SKAFF MM, 1992, GERONTOLOGIST, V32, P656, DOI 10.1093/geront/32.5.656; Thomas C, 2002, SOC SCI MED, V54, P529, DOI 10.1016/S0277-9536(01)00048-X; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Turner HA, 1997, AM J COMMUN PSYCHOL, V25, P35, DOI 10.1023/A:1024693707990; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Walsh F., 2006, STRENGTHENING FAMILY; Walsh RS, 2014, HEALTH PSYCHOL REV, V8, P458, DOI 10.1080/17437199.2012.733914; Walters K, 2000, AGE AGEING, V29, P505, DOI 10.1093/ageing/29.6.505; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Wight RG, 2006, SOC SCI MED, V62, P444, DOI 10.1016/j.socscimed.2005.06.004; Yeates G.N., 2013, HDB REAL NEUROPSYCHO, P271; Yeates G, 2007, NEUROPSYCHOL REHABIL, V17, P151, DOI 10.1080/09602010600696423; Yeates GN, 2008, NEUROPSYCHOL REHABIL, V18, P566, DOI 10.1080/09602010802151532	73	17	17	2	20	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0277-9536			SOC SCI MED	Soc. Sci. Med.	SEP	2014	116						102	109		10.1016/j.socscimed.2014.06.038			8	Public, Environmental & Occupational Health; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Biomedical Social Sciences	AN6HN	WOS:000340695700012	24996218	hybrid, Green Accepted			2022-02-06	
J	Solomon, GS; Sills, A				Solomon, Gary S.; Sills, Allen			Chronic Traumatic Encephalopathy and the Availability Cascade	PHYSICIAN AND SPORTSMEDICINE			English	Article						concussion; sports; chronic traumatic encephalopathy; mild traumatic brain injury	INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; SPORTS CONCUSSION; FOOTBALL; TAU; DISEASE; RISK; AFTERMATH; SPECTRUM; POSITION	Chronic traumatic encephalopathy (CTE) in sports has been known for > 85 years, and has experienced a resurgence of interest over the past decade, both in the media and in the scientific community. However, there appears to be a disconnection between the public's perception of CTE and the currently available scientific data. The cognitive bias known as the "availability cascade" has been suggested as a reason to explain this rift in knowledge. This review summarizes and updates the history of CTE in sports, discusses recent epidemiological and autopsy studies, summarizes the evidence base related to CTE in sports, and offers recommendations for future directions.	[Solomon, Gary S.; Sills, Allen] Vanderbilt Univ, Sch Med, Vanderbilt Sports Concuss Ctr, Dept Neurol Surgery,Dept Orthoped Surg & Rehabil, Nashville, TN 37212 USA; [Solomon, Gary S.] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37212 USA		Solomon, GS (corresponding author), Neurosurg Clin, 1500 21st Ave South,Suite 1506, Nashville, TN 37212 USA.	gary.solomon@vanderbilt.edu	Solomon, Gary/K-9011-2019		Rawlings; Nashville Predators and Tennessee Titans	Allen Sills, MD, receives funding (unrestricted educational grant) from Rawlings, the sports equipment manufacturing company. Gary Solomon, PhD, receives funding (unrestricted educational grant) from Rawlings; consulting fees from the Nashville Predators and Tennessee Titans; royalties from book sales; and is a member of the Professional Advisory Board of ImPACT, for which he receives expense reimbursement for attendance at board meetings.	Andrikopoulos J, 2014, JAMA NEUROL, V71, P654, DOI 10.1001/jamaneurol.2013.6408; [Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Baron SL, 2012, AM J CARDIOL, V109, P889, DOI 10.1016/j.amjcard.2011.10.050; Barr WB, 2013, NEUROPSYCHOL REV, V23, P271, DOI 10.1007/s11065-013-9244-3; Casson I, 2010, NEUROLOGY TODAY, V10, P6, DOI DOI 10.1097/01.NT.0000380917.17552.b7; CASSON IR, 1984, JAMA-J AM MED ASSOC, V251, P2663, DOI 10.1001/jama.251.20.2663; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; COURVILLE CYRIL B., 1962, BULL LOS ANGELES NEUROL SOC, V27, P160; Critchley M, 1949, HOMMAGE C VINCENT; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; Iverson GL, 2014, BRIT J SPORT MED, V48, P162, DOI 10.1136/bjsports-2013-092935; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Karantzoulis S, 2013, NEUROPSYCHOL REV, V23, P350, DOI 10.1007/s11065-013-9243-4; Kuran T, 1999, STANFORD LAW REV, V51, P683, DOI 10.2307/1229439; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Lesort M, 1999, J NEURAL TRANSM, V106, P1217, DOI 10.1007/s007020050235; Love S, 2014, AM J SPORTS MED; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; MAWDSLEY C, 1963, LANCET, V2, P795; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2011, CLIN J SPORT MED, V21, P6, DOI 10.1097/JSM.0b013e318204db50; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mietelska-Porowska A, 2014, INT J MOL SCI, V15, P4671, DOI 10.3390/ijms15034671; MILLER H, 1966, P ROY SOC MED, V59, P257, DOI 10.1177/003591576605900327; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Parker HL, 1934, J NEUROL PSYCHOPATHO, V15, P20; Ramage SN, 2005, NEUROPATH APPL NEURO, V31, P439, DOI 10.1111/j.1365-2990.2005.00670.x; Randolph C, 2014, CURR SPORT MED REP, V13, P33, DOI [10.1097/OPX.0000000000000170, 10.1249/JSR.0000000000000022]; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Savica R, 2012, MAYO CLIN PROC, V87, P335, DOI 10.1016/j.mayocp.2011.12.016; Schwenk TL, 2007, MED SCI SPORT EXER, V39, P599, DOI 10.1249/mss.0b013e31802fa679; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Weir D. R., 2009, STUDY RETIRED NFL PL	48	17	17	2	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.	SEP	2014	42	3					26	31		10.3810/psm.2014.09.2072			6	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Orthopedics; Sport Sciences	AR2FQ	WOS:000343399400003	25295763				2022-02-06	
J	Weaver, SM; Portelli, JN; Chau, A; Cristofori, I; Moretti, L; Grafman, J				Weaver, Starla M.; Portelli, Jaclyn N.; Chau, Aileen; Cristofori, Irene; Moretti, Laura; Grafman, Jordan			Genetic polymorphisms and traumatic brain injury: the contribution of individual differences to recovery	BRAIN IMAGING AND BEHAVIOR			English	Article						Genetic polymorphisms; Traumatic brain injury; Polymorphisms	APOLIPOPROTEIN-E GENOTYPE; O-METHYLTRANSFERASE GENE; COMT VAL(108/158) MET; ANGER-RELATED TRAITS; WORKING-MEMORY; DECISION-MAKING; EXECUTIVE FUNCTION; PREFRONTAL CORTEX; MONOAMINE-OXIDASE; RECEPTOR GENE	Recovery after Traumatic Brain Injury (TBI) is variable, even for patients with similar severity of brain injury. Recent research has highlighted the contribution that genetic predisposition plays in determining TBI outcome. This review considers the potential for genetic polymorphisms to influence recovery of cognitive and social processes following TBI. Limitations and considerations that researchers should make when assessing the potential impact of polymorphisms on TBI outcome are also discussed. Understanding the genetic factors that support neuroplasticity will contribute to an understanding of the variation in outcome following injury and help to identify potential targets for rehabilitation.	[Weaver, Starla M.; Portelli, Jaclyn N.; Chau, Aileen; Cristofori, Irene; Moretti, Laura; Grafman, Jordan] Kessler Fdn Res Ctr, Traumat Brain Injury Res Lab, W Orange, NJ 07052 USA		Weaver, SM (corresponding author), Kessler Fdn Res Ctr, Traumat Brain Injury Res Lab, 1199 Pleasant Valley Way, W Orange, NJ 07052 USA.	sweaver@kesslerfoundation.org; jgrafman@ric.org		Weaver, Starla/0000-0002-9559-8337; Grafman, Jordan H./0000-0001-8645-4457; Cristofori, Irene/0000-0003-2339-1457	Kessler Foundation	The preparation of this article was supported by funding from the Kessler Foundation. Portions of this manuscript were previously published (Weaver, Chau, Portelli & Grafman, in press).	Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Anderson DE, 2012, J COGNITIVE NEUROSCI, V24, P1069, DOI 10.1162/jocn_a_00207; Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; Awh E, 2008, NAT NEUROSCI, V11, P5, DOI 10.1038/nn0108-5; Barnett JH, 2008, BIOL PSYCHIAT, V64, P137, DOI 10.1016/j.biopsych.2008.01.005; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Bertolino A, 2006, J NEUROSCI, V26, P3918, DOI 10.1523/JNEUROSCI.4975-05.2006; Beste C, 2011, NEUROPSYCHOLOGIA, V49, P2664, DOI 10.1016/j.neuropsychologia.2011.05.014; Beste C, 2010, NEUROIMAGE, V50, P764, DOI 10.1016/j.neuroimage.2009.11.067; Bevilacqua L, 2011, TRENDS COGN SCI, V15, P401, DOI 10.1016/j.tics.2011.07.009; Bevilacqua L, 2010, NATURE, V468, P1061, DOI 10.1038/nature09629; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Blair KS, 2008, PSYCHOPHARMACOLOGY, V196, P29, DOI 10.1007/s00213-007-0920-y; Borg J, 2009, INT J NEUROPSYCHOPH, V12, P783, DOI 10.1017/S1461145708009759; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; Caldu X, 2007, NEUROIMAGE, V37, P1437, DOI 10.1016/j.neuroimage.2007.06.021; Camara E, 2010, CEREB CORTEX, V20, P1985, DOI 10.1093/cercor/bhp263; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Cerasa A, 2008, BRAIN RES, V1201, P114, DOI 10.1016/j.brainres.2008.01.048; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Channon S, 2010, NEUROPSYCHOL REHABIL, V20, P739, DOI 10.1080/09602011003794583; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chiaruttini C, 2009, P NATL ACAD SCI USA, V106, P16481, DOI 10.1073/pnas.0902833106; Clark L, 2005, PSYCHOPHARMACOLOGY, V182, P570, DOI 10.1007/s00213-005-0104-6; Congdon E, 2009, BIOL PSYCHOL, V81, P144, DOI 10.1016/j.biopsycho.2009.03.005; Conklin HM, 2008, BRAIN INJURY, V22, P847, DOI 10.1080/02699050802403565; Conley YP, 2011, PM&R, V3, pS52, DOI 10.1016/j.pmrj.2011.04.004; Craig IW, 2009, HUM GENET, V126, P101, DOI 10.1007/s00439-009-0695-9; Dardiotis E., 2010, NEUROSURGERY FOCUS, V28, P1; de Frias CM, 2005, J COGNITIVE NEUROSCI, V17, P1018, DOI 10.1162/0898929054475136; Dempster E, 2005, AM J MED GENET B, V134B, P73, DOI 10.1002/ajmg.b.30150; Doll BB, 2011, J NEUROSCI, V31, P6188, DOI 10.1523/JNEUROSCI.6486-10.2011; Dreher JC, 2009, P NATL ACAD SCI USA, V106, P617, DOI 10.1073/pnas.0805517106; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Eisenberger NI, 2007, BIOL PSYCHIAT, V61, P1100, DOI 10.1016/j.biopsych.2006.08.007; Enge S, 2011, NEUROPSYCHOLOGIA, V49, P3776, DOI 10.1016/j.neuropsychologia.2011.09.038; Enoch MA, 2003, PSYCHIAT GENET, V13, P33, DOI 10.1097/00041444-200303000-00006; Erickson KI, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.011.2008; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; FISKE ST, 1993, ANNU REV PSYCHOL, V44, P155, DOI 10.1146/annurev.ps.44.020193.001103; Furman DJ, 2011, SOC COGN AFFECT NEUR, V6, P270, DOI 10.1093/scan/nsq029; Giakoumaki SG, 2008, NEUROPSYCHOPHARMACOL, V33, P3058, DOI 10.1038/npp.2008.82; Giegling I, 2006, J AFFECT DISORDERS, V96, P75, DOI 10.1016/j.jad.2006.05.016; Goel V, 2007, CEREB CORTEX, V17, P2245, DOI 10.1093/cercor/bhl132; Goldberg TE, 2003, ARCH GEN PSYCHIAT, V60, P889, DOI 10.1001/archpsyc.60.9.889; Gonda X, 2009, EUR ARCH PSY CLIN N, V259, P106, DOI 10.1007/s00406-008-0842-7; Gong PY, 2011, CAN J NEUROL SCI, V38, P303, DOI 10.1017/S0317167100011513; GRAFMAN J, 1990, PERCEPT MOTOR SKILL, V71, P1120, DOI 10.2466/PMS.71.7.1120-1122; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Hadjigeorgiou GM, 2005, NEUROLOGY, V65, P1077, DOI 10.1212/01.wnl.0000178890.93795.0e; Hamidovic A, 2009, EXP CLIN PSYCHOPHARM, V17, P374, DOI 10.1037/a0017840; Han SD, 2007, J NEUROL NEUROSUR PS, V78, P1103, DOI 10.1136/jnnp.2006.108183; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Harris SE, 2006, MOL PSYCHIATR, V11, P505, DOI 10.1038/sj.mp.4001799; Ioannidis JPA, 2011, JAMA-J AM MED ASSOC, V305, P2200, DOI 10.1001/jama.2011.713; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Klein TA, 2007, SCIENCE, V318, P1642, DOI 10.1126/science.1145044; Koenigs M, 2008, J NEUROSCI, V28, P12341, DOI 10.1523/JNEUROSCI.2324-08.2008; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; Lane HY, 2008, J PSYCHIATR NEUROSCI, V33, P47; Lee BK, 2011, ARCH GEN PSYCHIAT, V68, P314, DOI 10.1001/archgenpsychiatry.2011.6; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lipsky RH, 2005, J NEUROPSYCH CLIN N, V17, P465, DOI 10.1176/appi.neuropsych.17.4.465; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mah L, 2004, AM J PSYCHIAT, V161, P1247, DOI 10.1176/appi.ajp.161.7.1247; Mah LWY, 2005, J NEUROPSYCH CLIN N, V17, P66, DOI 10.1176/appi.neuropsych.17.1.66; Mani TM, 2007, NEUROCASE, V13, P229, DOI 10.1080/13554790701594862; Manuck SB, 1999, BIOL PSYCHIAT, V45, P603, DOI 10.1016/S0006-3223(98)00375-8; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; McAllister TW, 2008, BRAIN INJURY, V22, P705, DOI 10.1080/02699050802263019; McAllister TW, 2010, PM&R, V2, pS241, DOI 10.1016/j.pmrj.2010.10.005; McAllister TW, 2009, J HEAD TRAUMA REHAB, V24, P65, DOI 10.1097/HTR.0b013e3181996e6b; McAllister TW, 2005, AM J PSYCHIAT, V162, P1749, DOI 10.1176/appi.ajp.162.9.1749; McHugh L, 2008, BRAIN INJURY, V22, P715, DOI 10.1080/02699050802263027; Meyer-Lindenberg A, 2006, MOL PSYCHIATR, V11, P867, DOI 10.1038/sj.mp.4001860; Missitzi J, 2011, J PHYSIOL-LONDON, V589, P297, DOI 10.1113/jphysiol.2010.200600; Nathoo N, 2003, J CLIN PATHOL-MOL PA, V56, P132, DOI 10.1136/mp.56.3.132; Newcombe VFJ, 2011, BRAIN, V134, P759, DOI 10.1093/brain/awq388; Nomura M, 2006, PSYCHOPHARMACOLOGY, V187, P30, DOI 10.1007/s00213-006-0398-z; Pardini M, 2011, NEUROLOGY, V76, P1038, DOI 10.1212/WNL.0b013e318211c33e; Ponsford J, 2007, NEUROLOGY, V68, P619, DOI 10.1212/01.wnl.0000254609.04330.9d; Ptak R, 2004, NEUROCASE, V10, P52, DOI 10.1080/13554790490960495; Ramos A, 1998, NEUROSCI BIOBEHAV R, V22, P33; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Rapoport M, 2008, J NEUROPSYCH CLIN N, V20, P68, DOI 10.1176/jnp.2008.20.1.68; Ready RE, 2011, AM J ALZHEIMERS DIS, V26, P463, DOI 10.1177/1533317511421921; Reeves RR, 2011, J PSYCHOSOC NURS MEN, V49, P42, DOI 10.3928/02793695-20110201-03; Reuter M, 2005, BEHAV BRAIN RES, V164, P93, DOI 10.1016/j.bbr.2005.06.002; Rieger M, 2003, NEUROPSYCHOLOGY, V17, P272, DOI 10.1037/0894-4105.17.2.272; Rochat L, 2011, PSYCHOPATHOLOGY, V44, P158, DOI 10.1159/000322454; Roiser JP, 2009, J NEUROSCI, V29, P5985, DOI 10.1523/JNEUROSCI.0407-09.2009; Rujescu D, 2002, MOL PSYCHIATR, V7, P1023, DOI 10.1038/sj.mp.4001128; Ryan L, 2011, NEUROIMAGE, V54, P1565, DOI 10.1016/j.neuroimage.2010.08.052; Rybakowski JK, 2003, BIPOLAR DISORD, V5, P468, DOI 10.1046/j.1399-5618.2003.00071.x; Rybakowski JK, 2006, PSYCHIAT CLIN NEUROS, V60, P70, DOI 10.1111/j.1440-1819.2006.01462.x; Sabol SZ, 1998, HUM GENET, V103, P273, DOI 10.1007/s004390050816; Sanchez MM, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.47; Sanfey AG, 2003, NEUROPSYCHOLOGIA, V41, P1218, DOI 10.1016/S0028-3932(03)00039-3; SCHWAB K, 1993, NEUROLOGY, V43, P95, DOI 10.1212/WNL.43.1_Part_1.95; Shadli RM, 2011, BRAIN INJURY, V25, P596, DOI 10.3109/02699052.2011.572947; Siegel JA, 2012, NEUROBIOL AGING, V33, P345, DOI 10.1016/j.neurobiolaging.2010.03.002; Small BJ, 2004, PSYCHOL AGING, V19, P592, DOI 10.1037/0882-7974.19.4.592; Soliman A, 2011, PSYCHOL MED, V41, P1051, DOI 10.1017/S0033291710001601; Solis-Ortiz S, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-67; Stablum F, 2007, NEUROPSYCHOL REHABIL, V17, P1, DOI 10.1080/13506280500411111; Stokes PRA, 2011, NEUROPSYCHOPHARMACOL, V36, P763, DOI 10.1038/npp.2010.210; Swan GE, 2005, J GERIATR PSYCH NEUR, V18, P196, DOI 10.1177/0891988705281864; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Uzan M, 2005, ACTA NEUROCHIR, V147, P715, DOI 10.1007/s00701-005-0529-z; Vallat-Azouvi C, 2009, BRAIN INJURY, V23, P585, DOI 10.1080/02699050902970711; Watson KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004156; Wetter SR, 2005, J CLIN EXP NEUROPSYC, V27, P943, DOI 10.1080/13803390490919001; Wilkosc M, 2010, ACTA NEUROBIOL EXP, V70, P86; Wisdom NM, 2011, NEUROBIOL AGING, V32, P63, DOI 10.1016/j.neurobiolaging.2009.02.003; Wishart HA, 2011, J INT NEUROPSYCH SOC, V17, P174, DOI 10.1017/S1355617710001402; Wood RL, 2011, J HEAD TRAUMA REHAB, V26, P202, DOI 10.1097/HTR.0b013e318217b46d; Yurgelun-Todd DA, 2011, J HEAD TRAUMA REHAB, V26, P276, DOI 10.1097/HTR.0b013e31822251dc; Zubieta JK, 2003, SCIENCE, V299, P1240, DOI 10.1126/science.1078546	123	17	17	0	16	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	SEP	2014	8	3			SI		420	434		10.1007/s11682-012-9197-9			15	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AP9ZR	WOS:000342441400011	22878895				2022-02-06	
J	Roach, EB; Bleiberg, J; Lathan, CE; Wolpert, L; Tsao, JW; Roach, RC				Roach, Emma B.; Bleiberg, Joseph; Lathan, Corinna E.; Wolpert, Lawrence; Tsao, Jack W.; Roach, Robert C.			AltitudeOmics: Decreased reaction time after high altitude cognitive testing is a sensitive metric of hypoxic impairment	NEUROREPORT			English	Article						brain hypoxia; cognitive reserve; mild cognitive impairment; military psychology; neuropsychological tests	SPORT-RELATED CONCUSSION; PERFORMANCE; EFFICIENCY; STAY	Humans experiencing hypoxic conditions exhibit multiple signs of cognitive impairment, and high altitude expeditions may be undermined by abrupt degradation in mental performance. Therefore, the development of psychometric tools to quickly and accurately assess cognitive impairment is of great importance in aiding medical decision-making in the field, particularly in situations where symptoms may not be readily recognized. The present study used the Defense Automated Neurobehavioral Assessment (DANA), a ruggedized and portable neurocognitive assessment tool, to examine cognitive function in healthy human volunteers at sea level, immediately after ascending to an elevation over 5000 m, and following 16 days of acclimatization to this high altitude. The DANA battery begins with a simple reaction time test (SRT1) which is followed by a 20-min series of complex cognitive tests and ends with a second test of simple reaction time (SRT2). Tabulating the performance scores from these two tests allows the calculation of an SRT change score (dSRT = SRT1-SRT2) that reflects the potential effect of mental effort spent during the 20-min testing session. We found that dSRT, but not direct SRT in comparison to sea-level baseline performance, is highly sensitive to acute altitude-related performance deficits and the remission of impairment following successful acclimatization. Our results suggest that dSRT is a potentially useful analytical method to enhance the sensitivity of neurocognitive assessment. (C) 2014 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Roach, Emma B.; Lathan, Corinna E.; Wolpert, Lawrence] AnthroTronix Inc, Silver Spring, MD USA; [Bleiberg, Joseph] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Tsao, Jack W.] US Navy Bur Med & Surg, Wounded Ill & Injured Directorate, Falls Church, VA USA; [Roach, Robert C.] Univ Colorado, Altitude Res Ctr, Dept Emergency Med, Denver, CO 80202 USA		Roach, RC (corresponding author), 8737 Colesville Rd,Suite L203, Silver Spring, MD 20910 USA.	emma.roach@atinc.com	Roach, Robert/F-4729-2011	Roach, Robert/0000-0002-7998-8976; Bleiberg, Joseph/0000-0003-0867-5494	BUMED; US Department of DefenseUnited States Department of Defense [W81XWH-11-2-0040 TATRC]; NIH/NCATS Colorado CTSIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000154]; Cardiopulmonary & Respiratory Physiology Laboratory, University of Oregon; Altitude Research Center; Charles S. Houston Endowed Professorship, Department of Emergency Medicine, School of Medicine, University of Colorado Denver; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000154] Funding Source: NIH RePORTER	This study was funded by BUMED; US Department of Defense (W81XWH-11-2-0040 TATRC); NIH/NCATS Colorado CTSI (UL1 TR000154); the Cardiopulmonary & Respiratory Physiology Laboratory, University of Oregon; and the Altitude Research Center and the Charles S. Houston Endowed Professorship, Department of Emergency Medicine, School of Medicine, University of Colorado Denver.	Bartholomew CJ, 1999, INT J AVIAT PSYCHOL, V9, P351, DOI 10.1207/s15327108ijap0904_3; Basnyat B, 2000, High Alt Med Biol, V1, P167; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bolmont B, 2000, PHYSIOL BEHAV, V71, P469, DOI 10.1016/S0031-9384(00)00362-0; Bonnon M, 2000, AVIAT SPACE ENVIR MD, V71, P678; Campbell W, 2007, 132 ANN M AM NEUR AS; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; HORNBEIN TF, 1989, NEW ENGL J MED, V321, P1714, DOI 10.1056/NEJM198912213212505; Lathan C, 2013, MIL MED, V178, P365, DOI 10.7205/MILMED-D-12-00438; Petrassi FA, 2012, AVIAT SPACE ENVIR MD, V83, P975, DOI 10.3357/ASEM.3315.2012; SHARMA VM, 1975, ERGONOMICS, V18, P511, DOI 10.1080/00140137508931485; Stivalet P, 2000, ERGONOMICS, V43, P474, DOI 10.1080/001401300184350; Subudhi AW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092191; Virues-Ortega Javier, 2004, Neuropsychology Review, V14, P197	15	17	18	0	29	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	AUG 6	2014	25	11					814	818		10.1097/WNR.0000000000000169			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AK9UH	WOS:000338772700002	24722229	Green Published			2022-02-06	
J	Dias, C; Maia, I; Cerejo, A; Varsos, G; Smielewski, P; Paiva, JA; Czosnyka, M				Dias, Celeste; Maia, Isabel; Cerejo, Antonio; Varsos, Georgios; Smielewski, Peter; Paiva, Jose-Artur; Czosnyka, Marek			Pressures, Flow, and Brain Oxygenation During Plateau Waves of Intracranial Pressure	NEUROCRITICAL CARE			English	Article						Multimodal brain monitoring; Intracranial pressure; Plateau waves; Cerebral perfusion pressure; Cerebrovascular reactivity; Head injury	CEREBRAL PERFUSION-PRESSURE; HEAD-INJURED PATIENTS; BLOOD-FLOW; CEREBROVASCULAR AUTOREGULATION; TISSUE OXYGEN; REACTIVITY; MODEL; VOLUME	Plateau waves are common in traumatic brain injury. They constitute abrupt increases of intracranial pressure (ICP) above 40 mmHg associated with a decrease in cerebral perfusion pressure (CPP). The aim of this study was to describe plateau waves characteristics with multimodal brain monitoring in head injured patients admitted in neurocritical care. Prospective observational study in 18 multiple trauma patients with head injury admitted to Neurocritical Care Unit of Hospital Sao Joao in Porto. Multimodal systemic and brain monitoring of primary variables [heart rate, arterial blood pressure, ICP, CPP, pulse amplitude, end tidal CO2, brain temperature, brain tissue oxygenation pressure, cerebral oximetry (CO) with transcutaneous near-infrared spectroscopy and cerebral blood flow (CBF)] and secondary variables related to cerebral compensatory reserve and cerebrovascular reactivity were supported by dedicated software ICM+ (www.neurosurg.cam.ac.uk/icmplus). The compiled data were analyzed in patients who developed plateau waves. In this study we identified 59 plateau waves that occurred in 44 % of the patients (8/18). During plateau waves CBF, cerebrovascular resistance, CO, and brain tissue oxygenation decreased. The duration and magnitude of plateau waves were greater in patients with working cerebrovascular reactivity. After the end of plateau wave, a hyperemic response was recorded in 64 % of cases with increase in CBF and brain oxygenation. The magnitude of hyperemia was associated with better autoregulation status and low oxygenation levels at baseline. Multimodal brain monitoring facilitates identification and understanding of intrinsic vascular brain phenomenon, such as plateau waves, and may help the adequate management of acute head injury at bed side.	[Dias, Celeste; Maia, Isabel; Paiva, Jose-Artur] Hosp Sao Joao, Neurocrit Care Unit, Dept Intens Care, Oporto, Portugal; [Cerejo, Antonio] Hosp Sao Joao, Dept Neurosurg, Oporto, Portugal; [Varsos, Georgios; Smielewski, Peter; Czosnyka, Marek] Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge, England		Dias, C (corresponding author), Hosp Sao Joao, Neurocrit Care Unit, Dept Intens Care, Oporto, Portugal.	mceleste.dias@gmail.com	Paiva, Jose-Artur/AAO-9730-2021; Dias, Celeste/L-9901-2014; Dias, Celeste/AAD-8711-2019; Dias, Celeste/AAV-3820-2020	Dias, Celeste/0000-0003-0340-9808; Dias, Celeste/0000-0003-0340-9808; Smielewski, Peter/0000-0001-5096-3938	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986, G9439390, G0001237] Funding Source: Medline; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986, G9439390, G0001237] Funding Source: UKRI		Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Aries MJH, 2012, NEUROCRIT CARE, V17, P67, DOI 10.1007/s12028-012-9687-z; AVEZAAT CJJ, 1979, J NEUROL NEUROSUR PS, V42, P687, DOI 10.1136/jnnp.42.8.687; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Brady KM, 2007, STROKE, V38, P2818, DOI 10.1161/STROKEAHA.107.485706; Brady KM, 2009, ANESTH ANALG, V108, P1278, DOI 10.1213/ane.0b013e3181964848; Brain Trauma Foundation American Association of Neurological Surgeons, 2007, J NEUROTRAUM, V24, P59; Budohoski KP, 2012, BRIT J ANAESTH, V108, P89, DOI 10.1093/bja/aer324; Castellani G, 2009, NEUROCRIT CARE, V11, P143, DOI 10.1007/s12028-009-9235-7; Citerio G, 2004, INTENS CARE MED, V30, P1882, DOI 10.1007/s00134-004-2377-3; Czosnyka M, 1999, J NEUROSURG, V91, P11, DOI 10.3171/jns.1999.91.1.0011; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; HAYASHI M, 1991, BRAIN, V114, P2681, DOI 10.1093/brain/114.6.2681; HAYASHI M, 1984, J NEUROSURG, V61, P30, DOI 10.3171/jns.1984.61.1.0030; Jaeger M, 2006, CRIT CARE MED, V34, P1783, DOI 10.1097/01.CCM.0000218413.51546.9E; JANNY P, 1950, THESIS PARIS; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; MATSUDA M, 1979, J NEUROSURG, V50, P483, DOI 10.3171/jns.1979.50.4.0483; Radolovich DK, 2010, ANESTH ANALG, V110, P165, DOI 10.1213/ANE.0b013e3181c0722f; RENIER D, 1982, J NEUROSURG, V57, P370, DOI 10.3171/jns.1982.57.3.0370; ROSNER MJ, 1984, J NEUROSURG, V60, P312, DOI 10.3171/jns.1984.60.2.0312; Smielewski P, 2005, ACT NEUR S, V95, P43; URSINO M, 1991, ANN BIOMED ENG, V19, P15, DOI 10.1007/BF02368459; Varsos GV, 2013, J CEREBR BLOOD F MET, V33, P235, DOI 10.1038/jcbfm.2012.161	24	17	18	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2014	21	1					124	132		10.1007/s12028-013-9918-y			9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AL7XP	WOS:000339350500019	24072460				2022-02-06	
J	Dziewas, R; Glahn, J; Helfer, C; Ickenstein, G; Keller, J; Lapa, S; Ledl, C; Lindner-Pfleghar, B; Nabavi, D; Prosiegel, M; Riecker, A; Stanschus, S; Warnecke, T; Busse, O				Dziewas, R.; Glahn, J.; Helfer, C.; Ickenstein, G.; Keller, J.; Lapa, S.; Ledl, C.; Lindner-Pfleghar, B.; Nabavi, D.; Prosiegel, M.; Riecker, A.; Stanschus, S.; Warnecke, T.; Busse, O.			FEES for neurogenic dysphagia. Training curriculum of the German Society of Neurology and the German Stroke Society	NERVENARZT			German	Article						Nervous system diseases; Muscular diseases; Stroke; Teaching; Clinical competence	FIBEROPTIC ENDOSCOPIC EVALUATION; TRAUMATIC BRAIN-INJURY; SWALLOWING DISORDERS; LATERAL-SCLEROSIS; ASPIRATION; SAFETY; VIDEOFLUOROSCOPY; RECOMMENDATIONS; COMPLICATIONS; DIAGNOSIS	Neurogenic dysphagia is one of the most frequent and prognostically relevant neurological deficits in a variety of disorders, such as stroke, parkinsonism and advanced neuromuscular diseases. Flexible endoscopic evaluation of swallowing (FEES) is now probably the most frequently used tool for objective dysphagia assessment in Germany. It allows evaluation of the efficacy and safety of swallowing, determination of appropriate feeding strategies and assessment of the efficacy of different swallowing manoeuvres. The literature furthermore indicates that FEES is a safe and well-tolerated procedure. In spite of the huge demand for qualified dysphagia diagnostics in neurology, a systematic FEES education has yet not been established. The structured training curriculum presented in this article aims to close this gap and intends to enforce a robust and qualified FEES service. As management of neurogenic dysphagia is not confined to neurologists, this educational program is applicable to other clinicians and speech language therapists with expertise in dysphagia as well.	[Dziewas, R.; Warnecke, T.] Univ Klinikum Munster, Klin Allgemeine Neurol, D-48129 Munster, Germany; [Glahn, J.] Johannes Wesling Klinikum, Neurol Klin, Minden, Germany; [Helfer, C.] Vivantes Klinikum Neukolln, Kliniken HNO & Neurol, Berlin, Germany; [Ickenstein, G.] HELIOS Klinikum Aue, Neurol Klin, Dusseldorf, Germany; [Ickenstein, G.] HELIOS Klinikum Aue, Stroke Unit, Dusseldorf, Germany; [Keller, J.] St Martinus Krankenhaus, Klin Akut Geriatrie, Dusseldorf, Germany; [Lapa, S.] Univ Klinikum Frankfurt aM, ZNN, Neurol Klin, Ulm, Germany; [Ledl, C.] Schon Klin Bad Aibling, Ulm, Germany; [Lindner-Pfleghar, B.; Riecker, A.] Univ Ulm, Neurol Klin, D-89069 Ulm, Germany; [Lindner-Pfleghar, B.; Riecker, A.] Rehabil Klinikum Ulm RKU, Ulm, Germany; [Nabavi, D.] Vivantes Klinikum Neukolln, Neurol Klin, Berlin, Germany; [Prosiegel, M.] Deutsch Interdisziplinare Gesell Dysphagie, Munich, Germany; [Stanschus, S.] Kreiskliniken Reutlingen, Abt Logopadie, Berlin, Germany; [Stanschus, S.] Kreiskliniken Reutlingen, Schluckzentrum, Berlin, Germany; [Busse, O.] Geschaftsstelle DSG & DGN, Berlin, Germany		Dziewas, R (corresponding author), Univ Klinikum Munster, Klin Allgemeine Neurol, Albert Schweitzer Campus 1, D-48129 Munster, Germany.	Rainer.Dziewas@ukmuenster.de	Dziewas, Rainer/AAX-9505-2020	Dziewas, Rainer/0000-0003-1592-8461			*AM SPEECH LANG HE, 2005, ROL SPEECH  LANG PAT; Aviv JE, 2000, DYSPHAGIA, V15, P39, DOI 10.1007/s004559910008; Aviv JE., 2001, ENDOSCOPIC EVALUATIO, P235; Carnaby-Mann G, 2008, PHYS MED REH CLIN N, V19, P747, DOI 10.1016/j.pmr.2008.05.008; Cohen MA, 2003, LARYNGOSCOPE, V113, P21, DOI 10.1097/00005537-200301000-00004; DEUTSCHMANN MW, 2012, HEAD NECK-J SCI SPEC, V35, P974; Dziewas R, 2013, NERVENARZT, V84, P705, DOI 10.1007/s00115-013-3791-y; Dziewas R, 2003, J NEUROL NEUROSUR PS, V74, P1429, DOI 10.1136/jnnp.74.10.1429; Dziewas R, 2008, CEREBROVASC DIS, V26, P41, DOI 10.1159/000135652; GROB D, 1987, ANN NY ACAD SCI, V505, P472; Hafner G, 2008, EUR ARCH OTO-RHINO-L, V265, P441, DOI 10.1007/s00405-007-0507-6; Hoffmann S, 2012, STROKE, V43, P2617, DOI 10.1161/STROKEAHA.112.653055; HORNER J, 1994, ALZ DIS ASSOC DIS, V8, P177; Kelly AM, 2006, CLIN OTOLARYNGOL, V31, P425, DOI 10.1111/j.1749-4486.2006.01292.x; Kelly AM, 2007, FIBREOPTIC ENDOSCOPI; Kelly AM, 2007, LARYNGOSCOPE, V117, P1723, DOI 10.1097/MLG.0b013e318123ee6a; Kuhnlein P, 2008, NAT CLIN PRACT NEURO, V4, P366, DOI 10.1038/ncpneuro0853; Langmore S E, 1988, Dysphagia, V2, P216, DOI 10.1007/BF02414429; Langmore S. E., 2001, ENDOSCOPIC EVALUATIO; Langmore SE, 2007, ARCH NEUROL-CHICAGO, V64, P58, DOI 10.1001/archneur.64.1.58; Langmore Susan E, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P485, DOI 10.1097/00020840-200312000-00014; Leder SB, 2004, DYSPHAGIA, V19, P177, DOI 10.1007/s00455-004-0009-2; Leder SB, 1999, J HEAD TRAUMA REHAB, V14, P448, DOI 10.1097/00001199-199910000-00005; Leder SB, 1998, DYSPHAGIA, V13, P19, DOI 10.1007/PL00009544; Leder SB, 1997, DYSPHAGIA, V12, P52; Macht M, 2011, CRIT CARE, V15, DOI 10.1186/cc10472; Mackay LE, 1999, J HEAD TRAUMA REHAB, V14, P435, DOI 10.1097/00001199-199910000-00004; Martino R, 2005, STROKE, V36, P2756, DOI 10.1161/01.STR.0000190056.76543.eb; McCullough GH, 2005, J SPEECH LANG HEAR R, V48, P1280, DOI 10.1044/1092-4388(2005/089); Miller N, 2006, AGE AGEING, V35, P614, DOI 10.1093/ageing/afl105; Morgan AS, 1999, J HEAD TRAUMA REHAB, V14, P454, DOI 10.1097/00001199-199910000-00006; Mulcahy KP, 2012, DYSPHAGIA, V27, P64, DOI 10.1007/s00455-011-9338-0; Muller J, 2001, ARCH NEUROL-CHICAGO, V58, P259, DOI 10.1001/archneur.58.2.259; O'Donoghue S, 1999, FOLIA PHONIATR LOGO, V51, P158, DOI 10.1159/000021494; Prosiegel M, 2012, NERVENARZT, V83, P1590, DOI 10.1007/s00115-012-3679-2; Suh MK, 2009, ALZ DIS ASSOC DIS, V23, P178, DOI 10.1097/WAD.0b013e318192a539; Suntrup S, 2012, NERVENARZT, V83, P1619, DOI 10.1007/s00115-012-3611-9; Suntrup S, 2012, J NEUROL, V259, P93, DOI 10.1007/s00415-011-6129-3; Tolep K, 1996, CHEST, V109, P167, DOI 10.1378/chest.109.1.167; Warnecke T, 2009, KLIN NEUROPHYSIOL, V40, P194, DOI 10.1055/s-0029-1220750; Warnecke T, 2010, MOVEMENT DISORD, V25, P1239, DOI 10.1002/mds.23060; Warnecke T, 2009, NEUROMUSCULAR DISORD, V19, P704, DOI 10.1016/j.nmd.2009.06.371; Warnecke T, 2009, STROKE, V40, P482, DOI 10.1161/STROKEAHA.108.520775; Willging J Paul, 2005, Curr Gastroenterol Rep, V7, P240, DOI 10.1007/s11894-005-0041-x; Wu CH, 1997, LARYNGOSCOPE, V107, P396; [No title captured]	46	17	17	0	8	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0028-2804	1433-0407		NERVENARZT	Nervenarzt	AUG	2014	85	8					1006	+		10.1007/s00115-014-4114-7			9	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	AN2EH	WOS:000340396300013	25060752				2022-02-06	
J	Karver, CL; Kurowski, B; Semple, EA; Stancin, T; Taylor, HG; Yeates, KO; Walz, NC; Wade, SL				Karver, Christine L.; Kurowski, Brad; Semple, Erin A.; Stancin, Terry; Taylor, H. Gerry; Yeates, Keith O.; Walz, Nicolay C.; Wade, Shari L.			Utilization of Behavioral Therapy Services Long-Term After Traumatic Brain Injury in Young Children	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Behavior therapy; Rehabilitation	UNITED-STATES; CHILDHOOD; OUTCOMES; AGE; SYMPTOMATOLOGY; ADOLESCENTS; ADAPTATION; PREDICTORS; CAREGIVER; ATTENTION	Objective: To examine associations of clinical need, defined by elevated parent ratings of child behavior problems and utilization of behavioral health services in young children with traumatic brain injury (TBI) and an orthopedic injury (OI) comparison group. Design: Parents completed outcome measures 18 months after injury and at an extended follow-up conducted an average of 38 months postinjury. Setting: Children's hospitals and a general hospital. Participants: Participants included parents of 3 groups of children injured between 3 and 7 years of age (N=139): 47 children with complicated mild to moderate TBI, 18 with severe TBI, and 74 with OI. Interventions: Not applicable. Main Outcome Measures: Parents completed ratings of child behavior, mental health symptomology, and family functioning at both visits; at the extended follow-up, they reported utilization of behavior therapy or counseling services since the 18-month follow-up visit. Results: Children with TBI had more behavior problems than those with OI. Although clinical need at both follow-ups was associated with greater service utilization at the extended follow-up, all groups had unmet needs as defined by a clinical need in the absence of services. Lower socioeconomic status was associated with higher rates of unmet need across groups. Conclusions: The results document unmet long-term behavioral health needs after both TBI and OI in children and underscore the importance of monitoring and treatment of postinjury behavior problems. (C) 2014 by the American Congress of Rehabilitation Medicine	[Karver, Christine L.] Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA; [Karver, Christine L.; Kurowski, Brad; Wade, Shari L.] Cincinnati Childrens Hosp, Dept Phys Med & Rehabil, Cincinnati, OH USA; [Semple, Erin A.] Univ Toledo, Coll Med, Toledo, OH 43606 USA; [Stancin, Terry] Case Western Reserve Univ, Dept Psychiat, Cleveland, OH 44106 USA; [Stancin, Terry] Metrohlth Med Ctr, Cleveland, OH USA; [Taylor, H. Gerry] Case Western Reserve Univ, Univ Hosp, Cleveland, OH 44106 USA; [Yeates, Keith O.] Ohio State Univ, Nationwide Childrens Hosp, Columbus, OH 43210 USA; [Walz, Nicolay C.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH 45221 USA		Karver, CL (corresponding author), Univ Cincinnati, Dept Psychol, Edwards Ctr 1, ML 0376, Cincinnati, OH 45221 USA.	karvercl@mail.uc.edu	Yeates, Keith/AAJ-4223-2020; Stancin, Terry/L-7993-2019	Yeates, Keith/0000-0001-7680-2892	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD42729, K02 HD44099]; United States Public Health Service National Institutes of HealthUnited States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA [M01 RR 08084]; State of Ohio Emergency Medical Services, National Center for Research Resources; National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [8 UL1 TR000077-04, K12 HD001097-16]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074683, R01HD042729, K12HD001097] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K02HD044099] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR008084] Funding Source: NIH RePORTER	Supported in part by the National Institute of Child Health and Human Development (grant nos. R01 HD42729 K02 HD44099), United States Public Health Service National Institutes of Health (grant no. M01 RR 08084), State of Ohio Emergency Medical Services trauma research grants, National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health (grant nos. 8 UL1 TR000077-04 and K12 HD001097-16).	Achenbach T.M., 2000, MANUAL ASEBA PRESCHO; Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Anderson V, 2012, J NEUROTRAUM, V29, P143, DOI 10.1089/neu.2011.2012; Anderson V, 2010, J PEDIATR PSYCHOL, V35, P716, DOI 10.1093/jpepsy/jsp100; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Goldstrohm SL, 2005, ARCH CLIN NEUROPSYCH, V20, P675, DOI 10.1016/j.acn.2005.02.005; Grados MA, 2008, DEPRESS ANXIETY, V25, P398, DOI 10.1002/da.20398; Greenspan AI, 2000, BRAIN INJURY, V14, P417; Jensen PS, 2011, PEDIATRICS, V128, P970, DOI 10.1542/peds.2009-0367; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Kazdin AE, 1997, J CONSULT CLIN PSYCH, V65, P453, DOI 10.1037/0022-006X.65.3.453; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Levi RB, 1999, J CLIN CHILD PSYCHOL, V28, P232, DOI 10.1207/s15374424jccp2802_10; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; Max JE, 1998, J NERV MENT DIS, V186, P589, DOI 10.1097/00005053-199810000-00001; Max JE, 1998, J NERV MENT DIS, V186, P325, DOI 10.1097/00005053-199806000-00001; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Snell-Johns J, 2004, J FAM PSYCHOL, V18, P19, DOI 10.1037/0893-3200.18.1.19; Stancin T, 2010, J DEV BEHAV PEDIATR, V31, P317, DOI 10.1097/DBP.0b013e3181dbaf32; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; TEASDALE G, 1974, LANCET, V2, P81; Vasa RA, 2002, J AM ACAD CHILD PSY, V41, P148, DOI 10.1097/00004583-200202000-00008; Verger K, 2000, BRAIN INJURY, V14, P495; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P629, DOI 10.1001/archpsyc.62.6.629; Wassenberg R, 2004, BRAIN INJURY, V18, P751, DOI 10.1080/02699050410001671775; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514	40	17	17	0	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2014	95	8					1556	1563		10.1016/j.apmr.2014.03.030			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	AM2ND	WOS:000339687200020	24755047	Green Accepted			2022-02-06	
J	Kaufman, DR; Puckett, MJ; Smith, MJ; Wilson, KS; Cheema, R; Landers, MR				Kaufman, Denise R.; Puckett, Mallory J.; Smith, Mitchell J.; Wilson, Kyle S.; Cheema, Rebecca; Landers, Merrill R.			Test-retest reliability and responsiveness of gaze stability and dynamic visual acuity in high school and college football players	PHYSICAL THERAPY IN SPORT			English	Article						Concussion; Vestibulo-ocular reflex; Reliability; responsiveness	TRAUMATIC BRAIN-INJURY; VESTIBULAR DYSFUNCTION; VESTIBULOOCULAR REFLEX; POSTURAL STABILITY; STABILIZATION TEST; HEAD-INJURY; CONCUSSION; DEFICITS; DIZZINESS; PERFORMANCE	Objectives: The purpose of this study was to establish reliability and responsiveness of the dynamic visual acuity test (DVAT) at head speeds of 150-200 degrees per second (deg/s) and the gaze stabilization test (GST) in high school and college football players. Design: Reliability design. Participants: Fifty high school and college football athletes completed the DVAT and GST in both the yaw (horizontal) and pitch (vertical) planes twice within two weeks. Results: Test-retest reliability for the DVAT was good in yaw, Intraclass Correlation Coefficient (ICC) = 0.770, and moderate/good in pitch, ICC = 0.725. Minimal detectable change (MDC) was 0.16 logMAR for yaw and 0.21 logMAR for pitch. GST reliability was moderate in yaw, ICC = 0.634, and poor in pitch, ICC = 0.411. MDCs were 73.4 deg/s (yaw) and 81.2 deg/s (pitch). Conclusions: The DVAT is reliable at high head speeds in high school and college football athletes in both yaw and pitch. GST head speeds were higher than previously reported in the literature, but reliability of this tool for this population was poor to moderate. From a clinical perspective, DVAT may be reliably used in the assessment of high school and college football athletes; however, GST requires further evaluation. (C) 2013 Elsevier Ltd. All rights reserved.	[Kaufman, Denise R.; Puckett, Mallory J.; Smith, Mitchell J.; Landers, Merrill R.] Univ Nevada, Dept Phys Therapy, Las Vegas, NV 89154 USA; [Wilson, Kyle S.] Univ Nevada, Las Vegas, NV 89154 USA; [Cheema, Rebecca] Pima Med Inst, Phys Therapist Assistant Program, Las Vegas, NV USA		Landers, MR (corresponding author), Univ Nevada, Dept Phys Therapy, 4505 Maryland Pkwy,Box 453029, Las Vegas, NV 89154 USA.	merrill.landers@unlv.edu	Landers, Merrill/P-6359-2014	Landers, Merrill/0000-0002-4234-910X			Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Crane BT, 1997, J NEUROPHYSIOL, V78, P2129, DOI 10.1152/jn.1997.78.4.2129; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Goebel JA, 2007, OTOL NEUROTOL, V28, P68, DOI 10.1097/01.mao.0000244351.42201.a7; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Gottshall KR, 2007, MIL MED, V172, P852, DOI 10.7205/MILMED.172.8.852; Gottshall KR, 2010, J NEUROL PHYS THER, V34, P94, DOI 10.1097/NPT.0b013e3181dead12; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hall TD, 2004, OTOL NEUROTOL, V25, P746, DOI 10.1097/00129492-200409000-00017; Herdman SJ, 2003, ARCH OTOLARYNGOL, V129, P819, DOI 10.1001/archotol.129.8.819; Herdman SJ, 2001, ARCH OTOLARYNGOL, V127, P1205, DOI 10.1001/archotol.127.10.1205; Herdman SJ, 1998, AM J OTOL, V19, P790; Honaker JA, 2010, J VESTIBUL RES-EQUIL, V20, P357, DOI 10.3233/VES-2010-0365; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Kisilevski V, 2001, Int Tinnitus J, V7, P118; LaBotz M, 2005, CLIN J SPORT MED, V15, P73, DOI 10.1097/01.jsm.0000157649.99867.fc; LEIGH RJ, 1993, NEUROLOGY, V43, P1288, DOI 10.1212/WNL.43.7.1288; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Mohammad MT, 2011, J VESTIBUL RES-EQUIL, V21, P277, DOI 10.3233/VES-2011-0430; Mulligan I, 2012, J ORTHOP SPORT PHYS, V42, P625, DOI 10.2519/jospt.2012.3798; NeuroCom a division of Natus, 2012, NEUR VOR IMP ASS; NeuroCom International Inc, 2008, INVISION SYST; Peterson MD, 2010, J HEAD TRAUMA REHAB, V25, P193, DOI 10.1097/HTR.0b013e3181dc82fa; Piland SG, 2010, J ATHL TRAINING, V45, P273, DOI 10.4085/1062-6050-45.3.273; Quevedo-Junyent L, 2011, RES Q EXERCISE SPORT, V82, P644, DOI 10.1080/02701367.2011.10599801; Roberts RA, 2007, J AM ACAD AUDIOL, V18, P236, DOI 10.3766/jaaa.18.3.5; Roberts RA, 2006, ANN OTO RHINOL LARYN, V115, P658, DOI 10.1177/000348940611500902; Schneiders AG, 2010, PHYS THER SPORT, V11, P47, DOI 10.1016/j.ptsp.2010.01.001; Slobounov S, 2008, CLIN NEUROPHYSIOL, V119, P281, DOI 10.1016/j.clinph.2007.10.006; U.S. General Services Administration, 2003, FAC STAND P100 EL EN; Ward BK, 2010, J VESTIBUL RES-EQUIL, V20, P363, DOI 10.3233/VES-2010-0371; Ward BK, 2010, OTOL NEUROTOL, V31, P168, DOI 10.1097/MAO.0b013e3181c4c3e2	39	17	17	1	12	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1466-853X			PHYS THER SPORT	Phys. Ther. Sport	AUG	2014	15	3					181	188		10.1016/j.ptsp.2013.10.002			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	AL3NL	WOS:000339035300009	24295546	Green Published			2022-02-06	
J	Leong, DF; Master, CL; Messner, LV; Pang, Y; Smith, C; Starling, AJ				Leong, Danielle F.; Master, Christina L.; Messner, Leonard V.; Pang, Yi; Smith, Craig; Starling, Amaal J.			The Effect of Saccadic Training on Early Reading Fluency	CLINICAL PEDIATRICS			English	Article						eye movements; reading fluency; saccades; remediation	VISUAL SCREENING TOOL; KING-DEVICK TEST; EYE-MOVEMENT; SLEEP-DEPRIVATION; CONCUSSION; VISION; AREA	Background. Eye movements are necessary for the physical act of reading and have been shown to relate to underlying cognitive and visuoattentional processes during reading. The purpose of this study was to determine the effect of saccadic training using the King-Devick remediation software on reading fluency. Methods. In this prospective, single-blinded, randomized, crossover trial, a cohort of elementary students received standardized reading fluency testing pre- and posttreatment. Treatment consisted of in-school training 20 minutes per day, 3 days per week for 6 weeks. Results. The treatment group had significantly higher reading fluency scores after treatment (P < .001), and posttreatment scores were significantly higher than the control group (P < .005). Conclusion. Saccadic training can significantly improve reading fluency. We hypothesize that this improvement in reading fluency is a result of rigorous practice of eye movements and shifting visuospatial attention, which are vital to the act of reading.	[Leong, Danielle F.] King Devick Test LLC, Oak Brook Terrace, IL 60181 USA; [Master, Christina L.] Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Messner, Leonard V.; Pang, Yi] Illinois Coll Optometry, Illinois Eye Inst, Chicago, IL USA; [Smith, Craig] Aegis Creat, Lakewood, CO USA; [Smith, Craig] Bill & Melinda Gates Fdn, Seattle, WA USA; [Starling, Amaal J.] Mayo Clin, Dept Neurol, Phoenix, AZ USA		Leong, DF (corresponding author), King Devick Test LLC, Two Mid America Plaza,Suite 110, Oak Brook Terrace, IL 60181 USA.	dleong@kingdevicktest.com		Master, Christina/0000-0002-6717-4270			Allen M, 2012, M AM OPT ASS OPT JUN; Alliance for Excellence in Education, 2007, HIGH COST HIGH SCH D; Bucci MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033458; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; CASS HD, 1994, ARCH DIS CHILD, V70, P192, DOI 10.1136/adc.70.3.192; Chetwood ASA, 2012, SURG ENDOSC, V26, P2003, DOI 10.1007/s00464-011-2143-x; Cymerman A, 2005, AVIAT SPACE ENVIR MD, V76, P627; Davies EC, 2012, NEUROLOGY, V78, pE103, DOI 10.1212/WNL.0b013e318251833d; Dore-Mazars K, 2004, PSYCHOL RES-PSYCH FO, V69, P67, DOI 10.1007/s00426-003-0166-1; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fielding J, 2009, NEUROPSYCHOLOGIA, V47, P1647, DOI 10.1016/j.neuropsychologia.2009.01.040; FIORAVANTI F, 1995, VISION RES, V35, P3217, DOI 10.1016/0042-6989(95)00152-5; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Gamlin PD, 2000, NATURE, V407, P1003, DOI 10.1038/35039506; Gold DR, 2012, CURR TREAT OPTION NE, V14, P73, DOI 10.1007/s11940-011-0160-7; Goldich Y, 2010, CURR EYE RES, V35, P1135, DOI 10.3109/02713683.2010.507902; Goldstand S, 2005, AM J OCCUP THER, V59, P377, DOI 10.5014/ajot.59.4.377; Jacquin-Courtois S, 2013, CORTEX, V49, P994, DOI 10.1016/j.cortex.2012.03.025; Kastner S, 2000, NEURON, V28, P314; King D, 2013, J NEUROL SCI, V326, P59, DOI 10.1016/j.jns.2013.01.012; King D, 2012, J NEUROL SCI, V320, P16, DOI 10.1016/j.jns.2012.05.049; Lin TP, 2014, PARKINSONISM RELAT D, V20, P226, DOI 10.1016/j.parkreldis.2013.10.009; Luna B, 2008, BRAIN COGNITION, V68, P293, DOI 10.1016/j.bandc.2008.08.019; Markowitz SN, 2006, CAN J OPHTHALMOL, V41, P289, DOI 10.1139/I06-027; Matsumoto H, 2011, MOVEMENT DISORD, V26, P1619, DOI 10.1002/mds.23683; National Reading Panel (US), 2000, REP NAT READ PAN TEA; Prasad S, 2010, NEUROL CLIN, V28, P641, DOI 10.1016/j.ncl.2010.03.006; Puig SM, 2013, PLOS ONE, V8; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Rayner K., 1985, REMEDIAL SPEC ED, V6, P53, DOI 10.1177/074193258500600609; Roth T, 2009, NEUROLOGY, V72, P324, DOI 10.1212/01.wnl.0000341276.65721.f2; Rounds B B, 1991, J Am Optom Assoc, V62, P92; Rouse C, 2005, S SOC COSTS IN ED OC; SAMUELS SJ, 1988, READ TEACH, V41, P756; Schubert MC, 2010, RESTOR NEUROL NEUROS, V28, P9, DOI 10.3233/RNN-2010-0523; Seassau M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070261; Stepanek J, 2013, AVIAT SPACE ENVIR MD, V84, P1017, DOI 10.3357/ASEM.3616.2013; U.S. Department of Education Institute of Education Sciences, NAT ASS ED PROGR NAE	40	17	19	0	14	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0009-9228	1938-2707		CLIN PEDIATR	Clin. Pediatr.	AUG	2014	53	9					858	864		10.1177/0009922814532520			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	AM8LD	WOS:000340125700007	24790022				2022-02-06	
J	Liao, GP; Olson, SD; Kota, DJ; Hetz, RA; Smith, P; Bedi, S; Cox, CS				Liao, George P.; Olson, Scott D.; Kota, Daniel J.; Hetz, Robert A.; Smith, Philippa; Bedi, Supinder; Cox, Charles S., Jr.			Far-red tracer analysis of traumatic cerebrovascular permeability	JOURNAL OF SURGICAL RESEARCH			English	Article						Traumatic brain injury; Blood brain barrier; Fluorescence; Edema; Permeability	CONTROLLED CORTICAL IMPACT; BRAIN-INJURY; CELL THERAPY; BARRIER; CONTUSION; MODEL	Background: Blood brain barrier (BBB) compromise is a key pathophysiological component of secondary traumatic brain injury characterized by edema and neuroinflammation in a previously immune-privileged environment. Current assays for BBB permeability are limited by working size, harsh extraction processes, suboptimal detection via absorbance, and wide excitation fluorescence spectra. In this study, we evaluate the feasibility of AlexaFluor 680, a farred dye bioconjugated to dextran, as an alternative assay to improve resolution and sensitivity. Methods: Alexa Fluor was introduced intravenously on the day of sacrifice to three groups: sham, controlled cortical impact (CCI), and CCI treated with a cell based therapy known to reduce BBB permeability. The brains were sectioned coronally and imaged using an infrared laser scanner to generate intensity plot profiles as well as signal threshold images to distinguish regions with varying degrees of permeability. Results: Linear plot profile analysis demonstrated greater signal intensity from CCI than treated rats at corresponding injury depths. Threshold analysis identified rims of signal at low + narrow threshold ranges. The integrated signals from a treatment group known to preserve the BBB were significantly less than the groups with CCI injury alone. There was no significant difference at high + wide signal intensity threshold ranges. Conclusions: Alexa Fluor 680 infrared photodetection and image analysis can aid in detecting differential degrees of BBB permeability after traumatic brain injury and maybe particularly useful in demonstrating BBB preservation of at-risk regions in response to therapeutic agents. (C) 2014 Elsevier Inc. All rights reserved.	[Liao, George P.; Olson, Scott D.; Kota, Daniel J.; Hetz, Robert A.; Smith, Philippa; Bedi, Supinder; Cox, Charles S., Jr.] Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, Houston, TX 77030 USA		Liao, GP (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, 6431 Fannin,MSB 5-230, Houston, TX 77030 USA.	George.P.Liao@uth.tmc.edu		Olson, Scott/0000-0001-8032-3755	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U44NS077511] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32 GM008792] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U44 NS077511] Funding Source: Medline		Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Imer M, 2009, NEUROL RES, V31, P977, DOI 10.1179/174313209X385617; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Lescot T, 2006, CRIT CARE MED, V34, P3029, DOI 10.1097/01.CCM.0000243797.42346.64; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Menge T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004660; Neuwelt EA, 2011, NAT REV NEUROSCI, V12, P169, DOI 10.1038/nrn2995; Newcombe VFJ, 2013, J CEREBR BLOOD F MET, V33, P855, DOI 10.1038/jcbfm.2013.11; Nuriya M, 2013, CEREB CORTEX, V23, P2118, DOI 10.1093/cercor/bhs198; Pasco A, 2007, J NEUROTRAUM, V24, P1321, DOI 10.1089/neu.2006.0136; Pati S, 2011, STEM CELLS DEV, V20, P89, DOI 10.1089/scd.2010.0013; Saw MM, 2014, NEUROCRIT CARE, V20, P209, DOI 10.1007/s12028-013-9933-z; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Taya K, 2010, J NEUROTRAUM, V27, P229, DOI 10.1089/neu.2009.0933; Terpolilli NA, 2013, J CEREBR BLOOD F MET, V33, P311, DOI 10.1038/jcbfm.2012.176; VANDENBRINK WA, 1990, ACT NEUR S, V51, P261; Walker PA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-228; Walker PA, 2012, SURGERY, V152, P790, DOI 10.1016/j.surg.2012.06.006; Walker PA, 2010, EXP NEUROL, V225, P341, DOI 10.1016/j.expneurol.2010.07.005; Wei XE, 2012, J NEUROTRAUM, V29, P2413, DOI 10.1089/neu.2010.1510	21	17	17	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	AUG	2014	190	2					628	633		10.1016/j.jss.2014.05.011			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	AM4DD	WOS:000339801800037	24906578	Green Accepted			2022-02-06	
J	Schintu, S; Hadj-Bouziane, F; Dal Monte, O; Knutson, KM; Pardini, M; Wassermann, EM; Grafman, J; Krueger, F				Schintu, Selene; Hadj-Bouziane, Fadila; Dal Monte, Olga; Knutson, Kristine M.; Pardini, Matteo; Wassermann, Eric M.; Grafman, Jordan; Krueger, Frank			Object and space perception - Is it a matter of hemisphere?	CORTEX			English	Article						Dorsal stream; Ventral stream; Lateralization; VLSM; Insula	BRAIN-LESIONS; FUNCTIONAL NEUROANATOMY; NEURAL FRAMEWORK; VISUAL OBJECT; RECOGNITION; ATTENTION; NETWORK; ANATOMY; NEGLECT; RTMS	In the 1980s, following Newcombe's observations, Ungerleider and Mishkin put forward the functional subdivision of the visual system into a ventral stream dedicated to object perception and a dorsal stream dedicated to space perception. Ten years after this discovery, the perception-action model re-defined the dorsal stream as responsible for nonconscious visual guidance, and most recently a tripartition has been suggested to account for a variety of visuospatial functions. Here, we investigated the neural underpinnings of object and space perception by combining the administration of the Visual Object Space Perception (VOSP) battery with a voxel-based lesion symptom mapping (VLSM) approach in a large sample of patients with penetrating traumatic brain injury (pTBI). First, our results provided new support for the complementary role of both hemispheres in object recognition. The right lateral occipital complex was found to be critical in early perceptual discrimination, whereas more anterior temporal and frontal regions in the left hemisphere were found to be critical in more complex forms of object discrimination and recognition. Second, our findings confirmed that space perception depended on the integrity of the right inferior parietal lobule (IPL) and revealed that a network linking the right IPL with the right premotor cortex was critical for the perception of spatial relationships in both 2D and 3D representations. Taken together, our results supported the functional subdivision of the visual system and shed new light on the specific processes involved along both the dorsal and the ventral streams. (C) 2014 Elsevier Ltd. All rights reserved.	[Schintu, Selene; Hadj-Bouziane, Fadila] CNRS, INSERM, Lyon Neurosci Res Ctr, ImpAct Team,UMR5292,U1028, Lyon, France; [Schintu, Selene; Hadj-Bouziane, Fadila] Univ UCBL Lyon 1, Lyon, France; [Dal Monte, Olga] Univ Turin, Dept Neuropsychol, Turin, Italy; [Knutson, Kristine M.; Wassermann, Eric M.] Natl Inst Neurol Disorders & Stroke, Behav Neurol Unit, Natl Inst Hlth, Bethesda, MD USA; [Pardini, Matteo] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet, Genoa, Italy; [Grafman, Jordan] Inst Chicago, Cognit Neurosci Lab Rehabil, Chicago, IL USA; [Krueger, Frank] George Mason Univ, Mol Neurosci Dept, Fairfax, VA 22030 USA; [Krueger, Frank] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA		Schintu, S (corresponding author), CRNL, ImpAct Team, 16 Ave Doyen Lepine, F-69676 Bron, France.	selene.schintu@gmail.com; fkrueger@gmu.edu	Hadj-Bouziane, Fadila/A-1180-2013; Wassermann, Eric M./AAC-9064-2020; Dal Monte, Olga/P-3759-2018; Schintu, Selene/ABF-7032-2020; Hadj-Bouziane, Fadila/AAC-7147-2020; Pardini, Matteo/F-8414-2010; Hadj-Bouziane, Fadila/F-6309-2016	Wassermann, Eric M./0000-0003-0628-0210; Dal Monte, Olga/0000-0002-7823-4769; Schintu, Selene/0000-0002-6362-3905; Pardini, Matteo/0000-0002-4740-1982; Knutson, Kristine/0000-0003-4626-4514; Hadj-Bouziane, Fadila/0000-0002-5415-7949	U.S. National Institute of Neurological Disorders and Stroke intramural research programUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); States Army Medical Research and Material Command; Henry M. Jackson Foundation [DAMD17-01-1-0675]; NEURODIS Foundation	The work was supported by the U.S. National Institute of Neurological Disorders and Stroke intramural research program, and a project grant from the United States Army Medical Research and Material Command administrated by the Henry M. Jackson Foundation (Vietnam Head Injury Study Phase III: a 30-year post-injury follow-up study, Grant DAMD17-01-1-0675). Selene Schintu was supported with funding from the Henry M. Jackson Foundation, and Fadila Hadj-Bouziane by the NEURODIS Foundation. The authors are grateful to all the Vietnam veterans who participated in this study and the National Naval Medical Center for their support and provision of facilities, as well as V. Raymont, S. Bonifant, B. Cheon, C. Ngo, A. Greathouse, K. Reding, and G. Tasick for their invaluable help with the testing of participants and organization of this study. Note that the views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, the Department of Defense, nor the U.S. Government. For further information about the Vietnam Head Injury Study, contact J. G. at jgrafman@northwestern.edu. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.	Acres K, 2009, NEUROPSYCHOLOGIA, V47, P1836, DOI 10.1016/j.neuropsychologia.2009.02.024; Baldo JV, 2013, CORTEX, V49, P658, DOI 10.1016/j.cortex.2012.03.001; Bar M, 2001, NEURON, V29, P529, DOI 10.1016/S0896-6273(01)00224-0; Bartolomeo P, 2012, FRONTIERS HUMAN NEUR, V6; Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; Beck AT, 1996, BDI 2 BECK DEPRESSIO; Behrmann M, 2004, CURR OPIN NEUROBIOL, V14, P212, DOI 10.1016/j.conb.2004.03.012; Bonello PJ, 1997, CLIN NEUROPSYCHOL, V11, P436, DOI 10.1080/13854049708400475; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; Brighina F, 2002, NEUROREPORT, V13, P2571, DOI 10.1097/00001756-200212200-00038; Clower DM, 2005, CEREB CORTEX, V15, P913, DOI 10.1093/cercor/bhh190; Clower DM, 2001, J NEUROSCI, V21, P6283, DOI 10.1523/JNEUROSCI.21-16-06283.2001; CORBETTA M, 1993, J NEUROSCI, V13, P1202; De Renzi E, 2000, SEMIN NEUROL, V20, P479, DOI 10.1055/s-2000-13181; De Renzi E., 1982, DISORDERS SPACE EXPL; DERENZI E, 1969, NEUROLOGY, V19, P634; Fattori P, 2010, J NEUROSCI, V30, P342, DOI 10.1523/JNEUROSCI.3800-09.2010; Fattori P, 2009, J NEUROSCI, V29, P1928, DOI 10.1523/JNEUROSCI.4998-08.2009; Fierro B, 2000, NEUROREPORT, V11, P1519, DOI 10.1097/00001756-200005150-00030; Galletti C, 2001, EUR J NEUROSCI, V13, P1572, DOI 10.1046/j.0953-816x.2001.01538.x; Glascher J, 2009, NEURON, V61, P681, DOI 10.1016/j.neuron.2009.01.026; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; GRAFMAN J, 1988, BRAIN, V111, P169, DOI 10.1093/brain/111.1.169; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; HAXBY JV, 1991, P NATL ACAD SCI USA, V88, P1621, DOI 10.1073/pnas.88.5.1621; HEILMAN KM, 1980, NEUROLOGY, V30, P327, DOI 10.1212/WNL.30.3.327; Hilgetag CC, 2001, NAT NEUROSCI, V4, P953, DOI 10.1038/nn0901-953; Ishida H, 2010, J COGNITIVE NEUROSCI, V22, P83, DOI 10.1162/jocn.2009.21185; James TW, 2003, BRAIN, V126, P2463, DOI 10.1093/brain/awg248; KAPLAN E, 1976, BOSTON NAMING TEST; Karnath HO, 2009, J NEUROSCI, V29, P5854, DOI 10.1523/JNEUROSCI.5192-08.2009; Kinsbourne M, 1987, ADV PSYCHOL, V45, P69, DOI [10.1016/S0166-4115(08)61709-4, DOI 10.1016/S0166-4115(08)61709-4]; Konen CS, 2008, NAT NEUROSCI, V11, P224, DOI 10.1038/nn2036; Konen CS, 2011, NEURON, V71, P49, DOI 10.1016/j.neuron.2011.05.030; KOSSLYN SM, 1989, J EXP PSYCHOL HUMAN, V15, P723, DOI 10.1037/0096-1523.15.4.723; Kravitz DJ, 2013, TRENDS COGN SCI, V17, P26, DOI 10.1016/j.tics.2012.10.011; Kravitz DJ, 2011, NAT REV NEUROSCI, V12, P217, DOI 10.1038/nrn3008; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Makale M, 2002, BEHAV RES METH INS C, V34, P6, DOI 10.3758/BF03195419; Martens U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047009; McCarthy R. A., 1990, COGNITIVE NEUROPSYCH, Vx; McNeil M., 1994, REVISED TOKEN TEST; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; Milner AD, 2008, NEUROPSYCHOLOGIA, V46, P774, DOI 10.1016/j.neuropsychologia.2007.10.005; Milner A.D., 2006, VISUAL BRAIN ACTION; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; Muri RM, 2002, EXP BRAIN RES, V143, P426, DOI 10.1007/s00221-002-1009-9; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; NEWCOMBE F, 1971, J NEUROL NEUROSUR PS, V34, P329, DOI 10.1136/jnnp.34.3.329; Newcombe F., 1969, MISSILE WOUNDS BRAIN; Ploran EJ, 2007, J NEUROSCI, V27, P11912, DOI 10.1523/JNEUROSCI.3522-07.2007; Price CJ, 1996, P ROY SOC B-BIOL SCI, V263, P1501, DOI 10.1098/rspb.1996.0219; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Rorden C, 2004, NAT REV NEUROSCI, V5, P813, DOI 10.1038/nrn1521; Rounis E, 2007, J COGNITIVE NEUROSCI, V19, P513, DOI 10.1162/jocn.2007.19.3.513; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; SIRIGU A, 1991, BRAIN, V114, P629, DOI 10.1093/brain/114.1.629; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Sterzer P, 2010, BRAIN STRUCT FUNCT, V214, P611, DOI 10.1007/s00429-010-0252-2; Stewart L, 2001, NEUROPSYCHOLOGIA, V39, P1, DOI 10.1016/S0028-3932(00)00084-1; TAYLOR A M, 1973, Cortex, V9, P82; Thiebaut de Schotten M, 2011, NAT NEUROSCI, V14, P1245, DOI 10.1038/nn.2905; Thompson-Schill SL, 2003, NEUROPSYCHOLOGIA, V41, P280, DOI 10.1016/S0028-3932(02)00161-6; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Ungerleider L.G., 1982, 2 CORTICAL VISUAL SY; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; United States Department of Defense, 1960, ARM FORC QUAL TEST A; VALLAR G, 1986, NEUROPSYCHOLOGIA, V24, P609, DOI 10.1016/0028-3932(86)90001-1; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; Warrington E. K., 1991, VISUAL OBJECT SPACE, V4; WARRINGTON EK, 1978, PERCEPTION, V7, P695, DOI 10.1068/p070695; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004; Xu J, 2009, P NATL ACAD SCI USA, V106, P20664, DOI 10.1073/pnas.0909197106; Zachariou V., 2013, J COGNITIVE NEUROSCI, P1; Zelkowicz BJ, 1998, J INT NEUROPSYCH SOC, V4, P160, DOI 10.1017/S135561779800160X	77	17	17	0	40	ELSEVIER MASSON, CORPORATION OFFICE	PARIS	65 CAMILLE DESMOULINS CS50083 ISSY-LES-MOULINEAUX, 92442 PARIS, FRANCE	0010-9452	1973-8102		CORTEX	Cortex	AUG	2014	57						244	253		10.1016/j.cortex.2014.04.009			10	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychology	AN1BK	WOS:000340317500018	24929474				2022-02-06	
J	Sharma, B; Gupta, R; Anand, R; Ingle, R				Sharma, Bhavana; Gupta, Rachna; Anand, Reena; Ingle, Rashmi			Ocular manifestations of head injury and incidence of post-traumatic ocular motor nerve involvement in cases of head injury: a clinical review	INTERNATIONAL OPHTHALMOLOGY			English	Article								As the eyes are in close proximity to the skull, they can get simultaneously affected in head injuries. This close association warrants careful ocular examination in all cases of head injury. This is a prospective non-randomized analytical study to evaluate various ocular manifestations in cases of head injury with special reference to ocular motor nerve involvement, correlation between pupillary changes, and survival. A total of 1,184 patients with head injury were screened for ocular manifestations. This study comprises 594 patients with ocular manifestations of head injury. All the relevant data was compiled and analyzed as per proforma. Ocular manifestations were evaluated in each patient and appropriate investigations were carried out. Patients with ocular morbidity were analyzed for age, sex, mode of injury, Glasgow Coma Score, and associated injuries in addition to ophthalmic and neurosurgical evaluations. Of the 594 patients, 81.6 % were male and 18.4 % were female, with a male-to-female ratio of 4: 1. The major cause of head injury was road traffic accidents (70.37 %). The most common age group involved was, 21-40-year-olds (67.40 %). Out of 594 patients, ecchymosis was found in 51.85 %, subconjunctival hemorrhage in 44.44 %, lid edema in 41.48 %, lacerated wound in 22.59 %, pupillary involvement in 21.04 %, ptosis in 6.73 %, cranial nerve palsy in 11.62 %, orbital fractures in 10.44 %, optic nerve trauma in 4.04 %, and exposure keratitis in 4.21 %. Patients with bilaterally dilated or pinpoint fixed pupils had a 10 times higher risk of mortality than patients without pupillary involvement. Third nerve involvement was seen 2.85 times more frequently in frontal and parietal region injuries compared to other sites of injury. The involvement of the sixth nerve occurred 4.6 times more frequently in parietal region injuries compared to other sites of injury.			Sharma, B (corresponding author), E-7-545 Arera Colony, Bhopal, Madhya Pradesh, India.	drbhavana_s@yahoo.co.in					ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; BAKER RS, 1991, SURV OPHTHALMOL, V35, P245, DOI 10.1016/0039-6257(91)90046-I; Blakeslee GA, 1929, ARCH OPHTHALMOL-CHIC, V2, P566; Chawla, 1980, MED J ARMED FORCES, V61, P187; Cowan CL, 1983, J NATL MED ASSOC, V31, P789; Cross AG, 1957, TRANS OPHTHAL SURG, V9, P265; Elder Duke, 1957, TEXT BOOK OF OPHTHAL, V4, P39; Falbe Hansen I, 1959, ACTA OPHTHALMOL, V37, P359; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; Herbella FAM, 2001, INJURY, V32, P745, DOI 10.1016/S0020-1383(01)00144-9; KEANE JR, 1989, ARCH NEUROL-CHICAGO, V46, P761, DOI 10.1001/archneur.1989.00520430055017; King AB, 1949, AM J OPHTHALMOL, V1949, P32; KOWAL L, 1992, AUST NZ J OPHTHALMOL, V20, P35, DOI 10.1111/j.1442-9071.1992.tb00701.x; Kulkarni AR, 2005, EYE, V19, P1257, DOI 10.1038/sj.eye.6701753; Kumar A, 2008, INDIAN J NEUROTRAUM, V5, P63, DOI 10.1016/S0973-0508(08)80002-0; Lepore FE, 1995, ARCH NEUROL-CHICAGO, V52, P26; Malik SRK, 1968, INDIAN J OPHTHALMOL, V16, P178; Mariak Z, 1997, Eur J Ophthalmol, V7, P68; Masila F, 2012, OCULAR FINDINGS IN P, P1523; Moster ML, 1999, NEUROLOGY, V52, pA23; Odebode TO, 2005, EYE, V19, P561, DOI 10.1038/sj.eye.6701566; Pathak A, 2003, INDIAN J NEUROTRAUMA, V4, P31; Peden M, 2004, INJURY PREV, V10, P67, DOI 10.1136/ip.2004.005405; Raju N S, 1983, Indian J Ophthalmol, V31, P789; ROWBOTHAM GF, 1954, BRIT MED J, V1, P726, DOI 10.1136/bmj.1.4864.726; SABATES NR, 1991, J CLIN NEURO-OPHTHAL, V11, P273; Shukla B, 1983, Indian J Ophthalmol, V31, P439; Turner JWA, 1943, BRAIN, V66, P140; Van Stavern GP, 2001, J NEURO-OPHTHALMOL, V21, P112, DOI 10.1097/00041327-200106000-00012; WHO Neurological Disorder Survey, 2002, NCMH BACK GROUND PAP	30	17	17	0	4	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0165-5701	1573-2630		INT OPHTHALMOL	Int. Ophthalmol.	AUG	2014	34	4					893	900		10.1007/s10792-014-9898-8			8	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	AP1NV	WOS:000341838400027	24469117				2022-02-06	
J	Williams, SG; Collen, J; Wickwire, E; Lettieri, CJ; Mysliwiec, V				Williams, Scott G.; Collen, Jacob; Wickwire, Emerson; Lettieri, Christopher J.; Mysliwiec, Vincent			The Impact of Sleep on Soldier Performance	CURRENT PSYCHIATRY REPORTS			English	Article						Sleep deprivation; Combat related sleep disorder; Insomnia; Obstructive sleep apnea; Sleep disordered breathing; Posttraumatic stress disorder; Nightmares	POSTTRAUMATIC-STRESS-DISORDER; RANDOMIZED CONTROLLED-TRIAL; TRAUMATIC BRAIN-INJURY; RESTLESS LEGS SYNDROME; COGNITIVE-BEHAVIORAL THERAPY; QUALITY-OF-LIFE; STATES-MILITARY-ACADEMY; SHIFT WORK DISORDER; GENERAL-POPULATION; UNITED-STATES	The military population is particularly vulnerable to a multitude of sleep-related disorders owing to the type of work performed by active duty servicemembers (ADSMs). Inadequate sleep, due to insufficient quantity or quality, is increasingly recognized as a public health concern. Traditionally, ADSMs have been encouraged that they can adapt to insufficient sleep just as the body adapts to physical training, but there is a substantial body of scientific literature which argues that this is not possible. Additionally, the military work environment creates unique challenges with respect to treatment options for common sleep disorders like obstructive sleep apnea, restless legs syndrome, and parasomnias. This review highlights sleep disorders which are prevalent in the modern military force and discusses the impact of poor sleep on overall performance. Medical treatments and recommendations for unit leaders are also discussed.	[Williams, Scott G.] Womack Army Med Ctr, Ft Bragg, NC USA; [Williams, Scott G.; Collen, Jacob; Lettieri, Christopher J.] Uniformed Serv Univ Hlth Sci, Dept Med, Bethesda, MD 20814 USA; [Collen, Jacob] San Antonio Mil Med Ctr, Ft Sam Houston, TX USA; [Wickwire, Emerson] Howard Cty Ctr Lung & Sleep Med, Columbia, MD USA; [Wickwire, Emerson] Johns Hopkins Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD USA; [Lettieri, Christopher J.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Mysliwiec, Vincent] Madigan Army Med Ctr, Joint Base Lewis McChord, Tacoma, WA 98431 USA		Williams, SG (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Med, Room A3060, Bethesda, MD 20814 USA.	scott.g.williams@us.army.mil		Lettieri, Christopher/0000-0001-7950-2908			Alattar M, 2007, J AM BOARD FAM MED, V20, P365, DOI 10.3122/jabfm.2007.04.060153; Allen RP, 2010, SLEEP MED, V11, P31, DOI 10.1016/j.sleep.2009.03.007; Allen RP, 2005, ARCH INTERN MED, V165, P1286, DOI 10.1001/archinte.165.11.1286; American Academy of Sleep Medicine, 2014, INT CLAS SLEEP DID; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Ancoli-Israel S, 1999, SLEEP, V22, pS347; [Anonymous], 2005, NIH Consens State Sci Statements, V22, P1; [Anonymous], 2010, Medical Surveillance Monthly Report, V17, P12; Antic NA, 2011, SLEEP, V34, P111, DOI 10.1093/sleep/34.1.111; Armed Forces Health Surveillance Center, 2010, MSMR, P17; Arnedt JT, 2011, BEHAV RES THER, V49, P227, DOI 10.1016/j.brat.2011.02.003; Babson KA, 2013, J NERV MENT DIS, V201, P48, DOI 10.1097/NMD.0b013e31827ab059; Belleville G, 2009, J NERV MENT DIS, V197, P126, DOI 10.1097/NMD.0b013e3181961d8e; Bjorvatn B, 2010, SLEEP MED, V11, P1031, DOI 10.1016/j.sleep.2010.07.011; Bucks RS, 2013, RESPIROLOGY, V18, P61, DOI 10.1111/j.1440-1843.2012.02255.x; Caldwell JL, 2001, MIL MED, V166, P159, DOI 10.1093/milmed/166.2.159; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Collen J, 2012, CHEST, V142, P622, DOI 10.1378/chest.11-1603; Collen JF, 2012, J CLIN SLEEP MED, V8, P667, DOI 10.5664/jcsm.2260; Crowley SK, 2012, MIL MED, V177, P823, DOI 10.7205/MILMED-D-12-00022; Czeisler Charles A, 2006, Trans Am Clin Climatol Assoc, V117, P159; Di Milia L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055306; Drake CL, 2004, SLEEP, V27, P1453, DOI 10.1093/sleep/27.8.1453; El-Solh AA, 2010, SLEEP, V33, P1495, DOI 10.1093/sleep/33.11.1495; Epstein DR, 2012, J REHABIL RES DEV, V49, P867, DOI 10.1682/JRRD.2011.06.0114; Faestel PM, 2013, J CLIN SLEEP MED, V9, P577, DOI 10.5664/jcsm.2754; Farkas RH, 2013, NEW ENGL J MED, V369, P689, DOI 10.1056/NEJMp1307972; FORD DE, 1989, JAMA-J AM MED ASSOC, V262, P1479, DOI 10.1001/jama.262.11.1479; Garcia-Borreguero D, 2013, SLEEP MED, V14, P675, DOI 10.1016/j.sleep.2013.05.016; Gehrman P, 2013, SLEEP, V36, P1009, DOI 10.5665/sleep.2798; Germain A, 2013, AM J PSYCHIAT, V170, P372, DOI 10.1176/appi.ajp.2012.12040432; Giam G. C. K., 1997, Annals Academy of Medicine Singapore, V26, P88; Harvey AG, 2002, BEHAV RES THER, V40, P869, DOI 10.1016/S0005-7967(01)00061-4; Hening WA, 2009, SLEEP MED, V10, P976, DOI 10.1016/j.sleep.2008.09.015; Huang QR, 2008, J CLIN SLEEP MED, V4, P543; Jacobs GD, 2004, ARCH INTERN MED, V164, P1888, DOI 10.1001/archinte.164.17.1888; Joya FL, 2009, J CLIN SLEEP MED, V5, P377; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Kennedy K., 2010, ARMY TIMES; Kinoshita LM, 2012, SLEEP BREATH, V16, P1201, DOI 10.1007/s11325-011-0632-8; Kolla BP, 2013, J HOSP MED, V8, P1, DOI 10.1002/jhm.1985; Krakow B, 2000, J PSYCHOSOM RES, V49, P291, DOI 10.1016/S0022-3999(00)00147-1; Krakow B, 2001, BIOL PSYCHIAT, V49, P948, DOI 10.1016/S0006-3223(00)01087-8; Kripke DF, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000850; Kushida Clete A., 2000, Sleep Breath, V4, P9, DOI 10.1055/s-2000-11530; LeBlanc M, 2007, J PSYCHOSOM RES, V63, P157, DOI 10.1016/j.jpsychores.2007.03.004; Lee Won, 2008, Expert Rev Respir Med, V2, P349, DOI 10.1586/17476348.2.3.349; Leger D, 2001, PSYCHOSOM MED, V63, P49, DOI 10.1097/00006842-200101000-00006; Lichstein KL, 2006, SLEEP MED REV, V10, P3, DOI 10.1016/j.smrv.2005.10.001; LICHSTEIN KL, 1980, J ABNORM PSYCHOL, V89, P105, DOI 10.1037/0021-843X.89.1.105; Luxton DD, 2011, SLEEP, V34, P1189, DOI 10.5665/SLEEP.1236; Macera CA, 2013, SLEEP, V36, P83, DOI 10.5665/sleep.2306; Mackowiak PA, 2012, AM J MED SCI, V343, P146, DOI 10.1097/MAJ.0b013e31823bbcdd; Maher MJ, 2006, CNS DRUGS, V20, P567, DOI 10.2165/00023210-200620070-00003; MAHOWALD MW, 1990, J FORENSIC SCI, V35, P413; Manber R, 2008, SLEEP, V31, P489, DOI 10.1093/sleep/31.4.489; Marks Fredric A, 2006, Aviat Space Environ Med, V77, P1094; Martin SA, 2004, SLEEP MED REV, V8, P63, DOI 10.1016/j.smrv.2003.08.001; Matheson A, 2014, J CLIN NURS, V23, P3309, DOI 10.1111/jocn.12524; McCrae CS, 2014, J CLIN SLEEP MED, V10, P127, DOI 10.5664/jcsm.3436; McLay RN, 2010, MIL MED, V175, P759, DOI 10.7205/MILMED-D-10-00193; MELLMAN TA, 1995, AM J PSYCHIAT, V152, P110; Miller NL, 2012, SLEEP, V35, P1123, DOI 10.5665/sleep.2002; Miller NL, 2010, SLEEP, V33, P1623, DOI 10.1093/sleep/33.12.1623; Miller NL, 2005, SLEEP, V28, P837, DOI 10.1093/sleep/28.7.837; Morin CM, 2009, JAMA-J AM MED ASSOC, V301, P2005, DOI 10.1001/jama.2009.682; Morin CM, 1999, JAMA-J AM MED ASSOC, V281, P991, DOI 10.1001/jama.281.11.991; Mustafa Masroor, 2005, Sleep Breath, V9, P57, DOI 10.1007/s11325-005-0016-z; Mysliwiec V, 2013, CHEST, V144, P549, DOI 10.1378/chest.13-0088; Newman RA, 2013, PERCEPT MOTOR SKILL, V116, P280, DOI 10.2466/29.22.25.PMS.116.1.280-293; Office of the Surgeon General, 2013, ARM MED 2020 CAMP PL, P12; Ohayon MM, 2000, J NERV MENT DIS, V188, P340, DOI 10.1097/00005053-200006000-00004; Ohayon MM, 2003, J PSYCHIAT RES, V37, P9, DOI 10.1016/S0022-3956(02)00052-3; Ohayon MM, 2002, J PSYCHOSOM RES, V53, P547, DOI 10.1016/S0022-3999(02)00443-9; Oudiette D, 2009, SLEEP, V32, P1621, DOI 10.1093/sleep/32.12.1621; Patrick L, 2007, ALTERN MED REV, V12, P101; Peterson AL, 2008, MIL MED, V173, P230, DOI 10.7205/MILMED.173.3.230; Pressman MR, 2007, SLEEP, V30, P1039, DOI 10.1093/sleep/30.8.1039; Provini F, 1999, BRAIN, V122, P1017, DOI 10.1093/brain/122.6.1017; Rajaratnam SMW, 2011, JAMA-J AM MED ASSOC, V306, P2567, DOI 10.1001/jama.2011.1851; Roberts RE, 2014, SLEEP, V37, P239, DOI 10.5665/sleep.3388; ROSS RJ, 1989, AM J PSYCHIAT, V146, P697; Roth T, 2012, SLEEP MED, V13, P335, DOI 10.1016/j.sleep.2011.11.006; Ruff RL, 2012, J REHABIL RES DEV, V49, P1305, DOI 10.1682/JRRD.2011.12.0251; Rupp TL, 2009, SLEEP, V32, P311, DOI 10.1093/sleep/32.3.311; Schutte-Rodin S, 2008, J CLIN SLEEP MED, V4, P487; Seelig AD, 2010, SLEEP, V33, P1615, DOI 10.1093/sleep/33.12.1615; Sharafkhaneh A, 2004, SLEEP MED, V5, P345, DOI 10.1016/j.sleep.2004.01.019; Siclari F, 2010, BRAIN, V133, P3494, DOI 10.1093/brain/awq296; Silber MH, 2013, MAYO CLIN PROC, V88, P977, DOI 10.1016/j.mayocp.2013.06.016; Sivertsen B, 2006, JAMA-J AM MED ASSOC, V295, P2851, DOI 10.1001/jama.295.24.2851; Sjostrom N, 2007, SLEEP, V30, P91; SPIELMAN AJ, 1987, PSYCHIAT CLIN N AM, V10, P541; Spoormaker VI, 2008, SLEEP MED REV, V12, P169, DOI 10.1016/j.smrv.2007.08.008; Staff RT, 2012, NEUROIMAG CLIN N AM, V22, P99, DOI 10.1016/j.nic.2011.11.006; STOLLER MK, 1994, CLIN THER, V16, P873; Talbot LS, 2014, SLEEP, V37, P327, DOI 10.5665/sleep.3408; Taylor DJ, 2007, SLEEP, V30, P213, DOI 10.1093/sleep/30.2.213; Taylor Daniel J, 2003, Behav Sleep Med, V1, P227, DOI 10.1207/S15402010BSM0104_5; Thomas M, 2000, J SLEEP RES, V9, P335, DOI 10.1046/j.1365-2869.2000.00225.x; Tippin J, 2009, J PSYCHOSOM RES, V67, P143, DOI 10.1016/j.jpsychores.2009.03.015; U.S. Army, 2009, 6225 FM; Vakulin A, 2011, J CLIN SLEEP MED, V7, P243, DOI 10.5664/JCSM.1062; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Van Dongen HPA, 2001, SLEEP, V24, P813, DOI 10.1093/sleep/24.7.813; van Liempt S, 2012, EUR J PSYCHOTRAUMATO, V3, DOI 10.3402/ejpt.v3i0.19142; van Liempt S, 2013, DEPRESS ANXIETY, V30, P469, DOI 10.1002/da.22054; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Vitiello MV, 2013, J AM GERIATR SOC, V61, P947, DOI 10.1111/jgs.12275; Waage S, 2009, SLEEP, V32, P558, DOI 10.1093/sleep/32.4.558; Wallace DM, 2011, 200 PUBL HLTH RES; Wang XS, 2011, OCCUP MED-OXFORD, V61, P78, DOI 10.1093/occmed/kqr001; Webster JB, 2001, ARCH PHYS MED REHAB, V82, P316, DOI 10.1053/apmr.2001.20840; Wesensten Nancy J, 2013, US Army Med Dep J, P109; Wickwire EM, 2010, SLEEP MED, V11, P772, DOI 10.1016/j.sleep.2010.03.012; Williams SG, 2014, SLEEP BREATH; Youakim JM, 1998, PSYCHOSOMATICS, V39, P168, DOI 10.1016/S0033-3182(98)71365-9	117	17	17	1	19	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1523-3812	1535-1645		CURR PSYCHIAT REP	Curr. Psychiatry Rep.	AUG	2014	16	8							459	10.1007/s11920-014-0459-7			13	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	AM4CX	WOS:000339801200003	24942599				2022-02-06	
J	Dekker, SE; Sillesen, M; Bambakidis, T; Andjelkovic, AV; Jin, G; Liu, BL; Boer, C; Johansson, PI; Linzel, D; Halaweish, I; Alam, HB				Dekker, Simone E.; Sillesen, Martin; Bambakidis, Ted; Andjelkovic, Anuska V.; Jin, Guang; Liu, Baoling; Boer, Christa; Johansson, Par I.; Linzel, Durk; Halaweish, Ihab; Alam, Hasan B.			Treatment with a histone deacetylase inhibitor, valproic acid, is associated with increased platelet activation in a large animal model of traumatic brain injury and hemorrhagic shock	JOURNAL OF SURGICAL RESEARCH			English	Article; Proceedings Paper	9th Annual Academic Surgical Congress of the Association-for-Academic-Surgery and the Society-of-University-Surgeons	FEB 04-07, 2014	San Diego, CA	Assoc Acad Surg, Soc Univ Surg		Traumatic brain injury; Hemorrhagic shock; Histone deacetylase inhibitor; Fresh frozen plasma	CELL ADHESION MOLECULE-1; FRESH-FROZEN PLASMA; COAGULATION DISORDERS; DYSFUNCTION; RESUSCITATION; COAGULOPATHY; COLLAGEN	Background: We have previously shown that resuscitation with fresh frozen plasma (FFP) in a large animal model of traumatic brain injury (TBI) and hemorrhagic shock (HS) decreases the size of the brain lesion, and that addition of a histone deacetylase inhibitor, valproic acid (VPA), provides synergistic benefits. In this study, we hypothesized that VPA administration would be associated with a conservation of platelet function as measured by increased platelet activation after resuscitation. Materials and methods: Ten swine (42-50 kg) were subjected to TBI and HS (40% blood loss). Animals were left in shock for 2 h before resuscitation with either FFP or FFP + VPA (300 mg/kg). Serum levels of platelet activation markers transforming growth factor beta, CD40 L, P-selectin, and platelet endothelial cell adhesion molecule (PECAM) 1 were measured at baseline, postresuscitation, and after a 6-h observation period. Platelet activation markers were also measured in the brain whole cell lysates and immunohistochemistry. Results: Circulating P-selectin levels were significantly higher in the FFP + VPA group compared with the FFP alone group (70.85 +/- 4.70 versus 48.44 +/- 7.28 ng/mL; P < 0.01). Likewise, immunohistochemistry data showed elevated P-selectin in the VPA treatment group (22.30 +/- 10.39% versus 8.125 +/- 3.94%, P < 0.01). Serum sCD40L levels were also higher in the FFP + VPA group (3.21 +/- 0.124 versus 2.38 +/- 0.124 ng/mL; P < 0.01), as was brain sCD40L levels (1.41 +/- 0.15 versus 1.22 +/- 0.12 ng/mL; P = 0.05). Circulating transforming growth factor beta levels were elevated in the FFP + VPA group, but this did not reach statistical significance (11.20 +/- 1.46 versus 8.09 +/- 1.41 ng/mL; P = 0.17). Brain platelet endothelial cell adhesion molecule 1 levels were significantly lower in the FFP + VPA group compared with the FFP group (5.22 +/- 2.00 pg/mL versus 7.99 +/- 1.13 pg/mL; P = 0.03). Conclusions: In this clinically relevant large animal model of combined TBI + HS, the addition of VPA to FFP resuscitation results in an early upregulation of platelet activation in the circulation and the brain. The previously observed neuroprotective effects of VPA may be due to a conservation of platelet function as measured by a higher platelet activation response after resuscitation. (C) 2014 Elsevier Inc. All rights reserved.	[Dekker, Simone E.; Bambakidis, Ted; Jin, Guang; Liu, Baoling; Linzel, Durk; Halaweish, Ihab; Alam, Hasan B.] Univ Michigan Hosp, Dept Surg, Ann Arbor, MI 48109 USA; [Dekker, Simone E.; Boer, Christa] Vrije Univ Amsterdam Med Ctr, Inst Cardiovasc Res, Dept Anesthesiol, Amsterdam, Netherlands; [Sillesen, Martin] Harvard Univ, Sch Med, Dept Surg, Massachusetts Gen Hosp,Div Trauma Emergency Surg, Boston, MA 02115 USA; [Sillesen, Martin] Copenhagen Univ Hosp, Dept Surg, Hillerod, Denmark; [Andjelkovic, Anuska V.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Andjelkovic, Anuska V.] Univ Michigan, Sch Med, Dept Neurosurg, Ann Arbor, MI USA; [Johansson, Par I.] Univ Copenhagen, Rigshosp, Capital Reg Blood Bank, DK-1168 Copenhagen, Denmark; [Johansson, Par I.] Univ Texas Med Sch, Ctr Translat Injury Res CeTIR, Dept Surg, Houston, TX USA; [Linzel, Durk] Vrije Univ Amsterdam Med Ctr, Dept Emergency Med, Amsterdam, Netherlands		Alam, HB (corresponding author), Univ Michigan Hosp, Taubman Ctr 2920, Dept Surg, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	alamh@med.umich.edu	Johansson, Par I/P-9283-2015	Johansson, Par I/0000-0001-9778-5964; Sillesen, Martin/0000-0001-9494-5475; Boer, Christa/0000-0002-7781-6951			Anderson GD, 2003, EPILEPSY RES, V57, P111, DOI 10.1016/j.eplepsyres.2003.11.001; Banerjea MC, PRO ANTICOAGULATORY; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Centers for Disease Control and Prevention National Center for Injury Prevention and Control, GLOB TRAUM CAR; Cicmil M, 2002, BLOOD, V99, P137, DOI 10.1182/blood.V99.1.137; Davidson DC, 2011, J IMMUNOL, V186, P584, DOI 10.4049/jimmunol.1001911; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; Falati S, 2006, BLOOD, V107, P535, DOI 10.1182/blood-2005-04-1512; Gesundheit B, 2002, J PEDIAT HEMATOL ONC, V24, P589, DOI 10.1097/00043426-200210000-00022; GIDAL B, 1994, NEUROLOGY, V44, P1418, DOI 10.1212/WNL.44.8.1418; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Imam AM, 2013, SURGERY, V154, P388, DOI 10.1016/j.surg.2013.05.008; Jacoby RC, 2001, J TRAUMA, V51, P639, DOI 10.1097/00005373-200110000-00003; Jin G, 2012, J TRAUMA ACUTE CARE, V73, P1461, DOI 10.1097/TA.0b013e3182782641; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Jones KL, 2001, BLOOD, V98, P1456, DOI 10.1182/blood.V98.5.1456; Kelly JF, 2008, J TRAUMA, V64, pS21, DOI 10.1097/TA.0b013e318160b9fb; Kis B, 1999, EPILEPSIA, V40, P307, DOI 10.1111/j.1528-1157.1999.tb00709.x; Ko C. H., 2001, Hong Kong Medical Journal, V7, P15; Koenig S, 2008, BLOOD COAGUL FIBRIN, V19, P375, DOI 10.1097/MBC.0b013e3282f3f9ec; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P13, DOI 10.1097/TA.0b013e318256deab; Li YQ, 2012, ADV EXP MED BIOL, V710, P107, DOI 10.1007/978-1-4419-5638-5_11; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; Nekludov M, 2007, J NEUROTRAUM, V24, P1699, DOI 10.1089/neu.2007.0322; Nurden AT, 2008, FRONT BIOSCI-LANDMRK, V13, DOI 10.2741/2947; PARETI FI, 1980, AM J MED, V69, P235, DOI 10.1016/0002-9343(80)90383-6; Patil S, 2001, BLOOD, V97, P1727, DOI 10.1182/blood.V97.6.1727; Schnuriger B, 2010, J TRAUMA, V68, P881, DOI 10.1097/TA.0b013e3181d3cc58; Serdaroglu G, 2002, J CHILD NEUROL, V17, P41, DOI 10.1177/088307380201700110; Sillesen M, 2014, J TRAUMA ACUTE CARE, V76, P998, DOI 10.1097/TA.0000000000000193; Sillesen M, 2013, J TRAUMA ACUTE CARE, V74, P1252, DOI 10.1097/TA.0b013e31828c7a6b; Verrotti A, 1999, PEDIATR NEUROL, V21, P611, DOI 10.1016/S0887-8994(99)00060-0; Ward MM, 1996, EPILEPSIA, V37, P98, DOI 10.1111/j.1528-1157.1996.tb00519.x	33	17	18	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JUL	2014	190	1					312	318		10.1016/j.jss.2014.02.049			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	AK5DN	WOS:000338444700047	24694719				2022-02-06	
J	Huang, EYK; Tsai, TH; Kuo, TT; Tsai, JJ; Tsui, PF; Chou, YC; Ma, HI; Chiang, YH; Chen, YH				Huang, Eagle Yi-Kung; Tsai, Tung-Han; Kuo, Tung-Tai; Tsai, Jing-Jr; Tsui, Pi-Fen; Chou, Yu-Ching; Ma, Hsin-I.; Chiang, Yung-Hsiao; Chen, Yuan-Hao			Remote effects on the striatal dopamine system after fluid percussion injury	BEHAVIOURAL BRAIN RESEARCH			English	Article						Fluid percussion injury; Dopamine releasing and reuptake; Fast-Scan Cyclic Voltammetry (FSCV); High-pressure liquid chromatography (HPLC); Neuroinflammation	TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; RAT FRONTAL-CORTEX; INTERFERON-ALPHA; COGNITIVE DYSFUNCTION; SURFACE EXPRESSION; BASAL GANGLIA; INFLAMMATION; TRANSPORTER; AMANTADINE	Purpose: To investigate the effects of traumatic brain injury (TBI) on the dopamine system in the brain at different distances from the impaction site, we compared the release, reuptake, metabolism, and release probability of dopamine on the sides of the brain ipsilateral and contralateral to the injury at different time points after varying severities of fluid percussion injuries. Materials and methods: Tonic (1-pulse evoked) and bursting (10-pulse evoked) dopamine release changes in the ipsilateral and contralateral sides of the striatum resulting from mild (2-Pa) and severe (6-Pa) levels of fluid percussion injury were analyzed at the acute (2 hand 24 h), subacute (1 and 2 weeks), and chronic stages (4, 6, and 8 weeks) after injury by using fast scan cyclic voltammetry to measure brain slices. The metabolic rate of striatal dopamine was surveyed using high-performance liquid chromatography. The microglia reaction was analyzed using immunohistochemistry at each stage. Results: In 6-Pa injured animals, for both tonic and bursting dopamine release, reuptake and release probability were suppressed on both the ipsilateral and contralateral sides of the striatum from the acute to the chronic stage. These neuronal activities were also affected at the subacute stage on both sides of the striatum in 2-Pa injured animals. The turnover rate of dopamine was not affected in the 2-Pa injured animals but increased gradually during the chronic stage in the 6-Pa injured group. Conclusion: TBI suppresses dopamine release and reuptake and affects the metabolic rate and release probability of dopamine on the sides of the nigrostriatal system both ipsilateral and contralateral to the injury during both the acute and subacute stages after the injury. (C) 2014 Elsevier B.V. All rights reserved.	[Huang, Eagle Yi-Kung; Tsui, Pi-Fen] Natl Def Med Ctr, Dept Pharmacol, Taipei 114, Taiwan; [Kuo, Tung-Tai] Natl Taipei Univ Technol, Grad Inst Comp & Commun Engn, Taipei 106, Taiwan; [Tsai, Tung-Han; Tsai, Jing-Jr; Ma, Hsin-I.; Chen, Yuan-Hao] Natl Def Med Ctr, Tri Serv Gen Hosp, Dept Neurol Surg, Taipei 114, Taiwan; [Chou, Yu-Ching] Natl Def Med Ctr, Sch Publ Hlth, Taipei 114, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ, Grad Inst Neural Regenerat Med, PhD Program Neural Regenerat Med, Dept Neurosurg,Taipei Med Univ Hosp, Taipei 110, Taiwan		Chen, YH (corresponding author), Natl Def Med Ctr, Tri Serv Gen Hosp, Dept Neurol Surg, 4F,325,2nd Sec,Cheng Kung Rd, Taipei 114, Taiwan.	chenyh178@gmail.com			National Science Council of TaiwanMinistry of Science and Technology, Taiwan [NSC 102-2314-B-016-030-MY3, NSC102-2314-B-038-023-MY3]; Medical Research Project grants from the Tr-Service General Hospital of Taiwan [TSGH-C102-080, TSGH-C101-084, TSGH-C100-033]	This work was supported by the National Science Council of Taiwan under grant NSC 102-2314-B-016-030-MY3, NSC102-2314-B-038-023-MY3 and by Medical Research Project grants TSGH-C102-080, TSGH-C101-084 and TSGH-C100-033 from the Tr-Service General Hospital of Taiwan.	Bales James W, 2010, Open Drug Discov J, V2, P119; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Baskaran H, 2000, J SURG RES, V93, P88, DOI 10.1006/jsre.2000.5955; Bhatia RK, 2005, INJURY, V36, P956, DOI 10.1016/j.injury.2005.03.009; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Capuron L, 2012, ARCH GEN PSYCHIAT, V69, P1044, DOI 10.1001/archgenpsychiatry.2011.2094; Chen YH, 2008, FASEB J, V22, P261, DOI 10.1096/fj.07-8797com; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Connor TJ, 2008, NEUROSCI LETT, V441, P29, DOI 10.1016/j.neulet.2008.06.007; Cunnington C, 2012, CIRCULATION, V125, P1356, DOI 10.1161/CIRCULATIONAHA.111.038919; Felger JC, 2007, BIOL PSYCHIAT, V62, P1324, DOI 10.1016/j.biopsych.2007.05.026; Felger JC, 2012, FRONT NEUROENDOCRIN, V33, P315, DOI 10.1016/j.yfrne.2012.09.003; Floresco SB, 2003, NAT NEUROSCI, V6, P968, DOI 10.1038/nn1103; Frenette AJ, 2012, J NEUROTRAUM, V29, P1, DOI 10.1089/neu.2011.1812; Gao HM, 2008, TRENDS IMMUNOL, V29, P357, DOI 10.1016/j.it.2008.05.002; GARIANO RF, 1989, BRAIN RES BULL, V22, P511, DOI 10.1016/0361-9230(89)90103-2; Good CH, 2013, J NEUROSCI, V 33, P16853, DOI 10.1523/JNEUROSCI.1844-13.2013; Good CH, 2011, FASEB J, V25, P1333, DOI 10.1096/fj.10-173625; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; Guillemin GJ, 2003, ADV EXP MED BIOL, V527, P105; Haroon E, 2012, NEUROPSYCHOPHARMACOL, V37, P137, DOI 10.1038/npp.2011.205; Huang EYK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086354; Hutson CB, 2011, J NEUROTRAUM, V28, P1783, DOI 10.1089/neu.2010.1723; Janhunen S, 2007, NEUROSCI BIOBEHAV R, V31, P287, DOI 10.1016/j.neubiorev.2006.09.008; Kamata M, 2000, EUR NEUROPSYCHOPHARM, V10, P129, DOI 10.1016/S0924-977X(99)00067-X; Karperien A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00003; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kraus MF, 2005, BRAIN INJURY, V19, P471, DOI 10.1080/02699050400025059; Kraus MF, 1997, J NEUROPSYCH CLIN N, V9, P222; Kulagina NV, 2001, NEUROSCIENCE, V102, P121, DOI 10.1016/S0306-4522(00)00480-2; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Massucci JL, 2004, NEUROSCI LETT, V372, P127, DOI 10.1016/j.neulet.2004.09.026; Matsushita Y, 2000, J NEUROTRAUM, V17, P143, DOI 10.1089/neu.2000.17.143; McDowell S, 1998, BRAIN, V121, P1155, DOI 10.1093/brain/121.6.1155; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Moron JA, 2003, J NEUROSCI, V23, P8480; Nisell M, 1997, J NEURAL TRANSM, V104, P1, DOI 10.1007/BF01271290; Piras F, 2014, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00217; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; Riggio S, 2009, MT SINAI J MED, V76, P163, DOI 10.1002/msj.20097; Riggio S, 2009, MT SINAI J MED, V76, P95, DOI 10.1002/msj.20107; Robinson S, 2004, P NATL ACAD SCI USA, V101, P13329, DOI 10.1073/pnas.0405084101; Sato T, 2006, PSYCHIAT CLIN NEUROS, V60, P499, DOI 10.1111/j.1440-1819.2006.01538.x; Sawyer E, 2008, ANN PHARMACOTHER, V42, P247, DOI 10.1345/aph.1K284; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; Shi WX, 2000, SYNAPSE, V35, P111, DOI 10.1002/(SICI)1098-2396(200002)35:2<111::AID-SYN3>3.3.CO;2-Z; STOCK G, 1973, N-S ARCH PHARMACOL, V278, P347, DOI 10.1007/BF00501479; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Utagawa A, 2008, EXP NEUROL, V211, P283, DOI 10.1016/j.expneurol.2008.02.001; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wagner AK, 2007, J NEUROSURG, V106, P538, DOI 10.3171/jns.2007.106.4.538; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wang T, 2013, J NEUROTRAUMA; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Williamson John B, 2013, Front Neuroeng, V6, P13, DOI 10.3389/fneng.2013.00013; Wu Y, 2000, NEUROSCIENCE, V96, P65, DOI 10.1016/S0306-4522(99)00539-4; Yan HQ, 2002, NEUROREPORT, V13, P1899, DOI 10.1097/00001756-200210280-00013; Yan HQ, 2001, NEUROREPORT, V12, P2323, DOI 10.1097/00001756-200108080-00009; Zhang LF, 2009, MOL PHARMACOL, V76, P396, DOI 10.1124/mol.109.056317; Zhu J, 2005, J NEUROCHEM, V93, P1434, DOI 10.1111/j.1471-4159.2005.03130.x	68	17	17	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	JUL 1	2014	267						156	172		10.1016/j.bbr.2014.03.033			17	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	AI2UK	WOS:000336713400020	24675161				2022-02-06	
J	Hwang, V; Trickey, AW; Lormel, C; Bradford, AN; Griffen, MM; Lawrence, CP; Sturek, C; Stacey, E; Howell, JM				Hwang, Vivian; Trickey, Amber W.; Lormel, Christy; Bradford, Anna N.; Griffen, Margaret M.; Lawrence, Cheryl P.; Sturek, Charles; Stacey, Elizabeth; Howell, John M.			Are pediatric concussion patients compliant with discharge instructions?	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Pediatrics; concussion; emergency department; discharge instructions; compliance	CHRONIC TRAUMATIC ENCEPHALOPATHY; HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; PLAY GUIDELINES; RUGBY PLAYERS; SPORT HELD; RETURN; ZURICH	BACKGROUND: Concussions are commonly diagnosed in pediatric patients presenting to the emergency department (ED). The primary objective of this study was to evaluate compliance with ED discharge instructions for concussion management. METHODS: A prospective cohort study was conducted from November 2011 to November 2012 in a pediatric ED at a regional Level 1 trauma center, serving 35,000 pediatric patients per year. Subjects were aged 8 yetis to 17 years and were discharged from the ED with a diagnosis of concussion. Exclusion criteria included recent (past 3 months) diagnosis of head injury, hospital admission, intracranial injury, skull fracture, suspected nonaccidental trauma, or preexisting neurologic condition. Subjects were administered a baseline survey in the ED and were given standardized discharge instructions for concussion by the treating physician. Telephone follow-up surveys were conducted at 2 weeks and 4 weeks after ED visit. RESULTS: A total of 150 patients were enrolled. The majority (67%) of concussions were sports related. Among sports-related concussions, soccer (30%), football (11%), lacrosse (8%), and basketball (8%) injuries were most common. More than one third (39%) reported return to play (RTP) on the day of the injury. Physician follow-up was equivalent for sport and nonsport concussions (2 weeks, 58%; 4 weeks, 64%). Sports-related concussion patients were more likely to follow up with a trainer (2 weeks, 25% vs. 10%, p = 0.06; 4 weeks, 29% vs. 8%, p < 0.01). Of the patients who did RTP or normal activities at 2 weeks (44%), more than one third (35%) were symptomatic, and most (58%) did not receive medical clearance. Of the patients who had returned to activities at 4 weeks (64%), less than one quarter (23%) were symptomatic, andmost (54%) received medical clearance. CONCLUSION: Pediatric patients discharged from the ED are mostly compliant with concussion instructions. However, a significant number of patients RTP on the day of injury, while experiencing symptoms or without medical clearance. (J Trauma Acute Care Surg. 2014;77: 117-122. Copyright (C) 2014 by Lippincott Williams & Wilkins)	[Hwang, Vivian; Trickey, Amber W.; Lormel, Christy; Bradford, Anna N.; Griffen, Margaret M.; Lawrence, Cheryl P.; Sturek, Charles; Stacey, Elizabeth; Howell, John M.] Inova Fairfax Hosp, Dept Emergency Med, Falls Church, VA 22042 USA		Hwang, V (corresponding author), Inova Fairfax Hosp, Dept Emergency Med, 3300 Gallows Rd, Falls Church, VA 22042 USA.	vivhwang1@gmail.com					[Anonymous], 2014, FAIRF COUNT SPORTS O; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Centers for Disease Control (CDC), 2013, INJ PREV CONTR TRAUM; Echemendia RJ, 2003, APPL NEUROPSYCHOL, V10, P48, DOI 10.1207/S15324826AN1001_7; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; FCPS, 2013, MILD HEAD INJ CONC A; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gagnon I, 2009, J HEAD TRAUMA REHAB, V24, P355, DOI 10.1097/HTR.0b013e3181b97a4e; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Johnston KM, 2000, CLIN J SPORT MED, V10, P209; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Purcell L, 2009, BRIT J SPORT MED, V43, pI51, DOI 10.1136/bjsm.2009.058214; Schatz P, 2011, CLIN NEUROPSYCHOL, V25, P1042, DOI 10.1080/13854046.2011.556669; Sullivan SJ, 2009, CLIN J SPORT MED, V19, P228, DOI 10.1097/JSM.0b013e3181a41e43; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Thomas DG, 2011, ACAD EMERG MED, V18, P246, DOI 10.1111/j.1553-2712.2011.01015.x; Yard EE, 2009, BRAIN INJURY, V23, P888, DOI 10.1080/02699050903283171	26	17	17	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUL	2014	77	1					117	122		10.1097/TA.0000000000000275			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Surgery	AK4IY	WOS:000338389600031	24977765				2022-02-06	
J	Jones, NS; Walter, KD; Caplinger, R; Wright, D; Raasch, WG; Young, C				Jones, Nathaniel S.; Walter, Kevin D.; Caplinger, Roger; Wright, Daniel; Raasch, William G.; Young, Craig			Effect of Education and Language on Baseline Concussion Screening Tests in Professional Baseball Players	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						sociocultural; neuropsychological testing; concussion; baseball	SPORTS-RELATED CONCUSSION; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; FOOTBALL PLAYERS; IMPACT; INJURY; RELIABILITY; PERFORMANCE; ZURICH; ISSUES	Objective: The purpose of the present study was to investigate the possible effects of sociocultural influences, specifically pertaining to language and education, on baseline neuropsychological concussion testing as obtained via immediate postconcussion assessment and cognitive testing (ImPACT) of players from a professional baseball team. Design: A retrospective chart review. Setting: Baseline testing of a professional baseball organization. Participants: Four hundred five professional baseball players. Independent Variables: Age, languages spoken, hometown country location (United States/Canada vs overseas), and years of education. Main Outcome Measures: The 5 ImPACT composite scores (verbal memory, visual memory, visual motor speed, reaction time, impulse control) and ImPACT total symptom score from the initial baseline testing. Results: The result of t tests revealed significant differences (P < 0.05) when comparing native English to native Spanish speakers in many scores. Even when corrected for education, the significant differences (P < 0.05) remained in some scores. Conclusions: Sociocultural differences may result in differences in computer-based neuropsychological testing scores.	[Jones, Nathaniel S.] Loyola Univ, Med Ctr, Dept Family Med, Maywood, IL 60153 USA; [Jones, Nathaniel S.] Loyola Univ, Med Ctr, Dept Orthopaed Surg & Rehabil, Maywood, IL 60153 USA; [Walter, Kevin D.; Raasch, William G.; Young, Craig] Med Coll Wisconsin, Dept Orthopaed Surg, Milwaukee, WI 53226 USA; [Caplinger, Roger; Wright, Daniel] Milwaukee Brewers Baseball Club, Milwaukee, WI USA; [Young, Craig] Med Coll Wisconsin, Dept Family & Community Med, Milwaukee, WI 53226 USA		Jones, NS (corresponding author), Loyola Univ, Med Ctr, Dept Family Med, 2160 S First Ave,Bldg 54,Rm 253, Maywood, IL 60153 USA.	nsjonesy@gmail.com		Jones, Nathaniel/0000-0002-7618-9431			Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Collie A, 2004, BRIT J SPORT MED, V38, P273, DOI 10.1136/bjsm.2003.000293; Collie A, 2003, BRIT J SPORT MED, V37, P556, DOI 10.1136/bjsm.37.6.556; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Granito V.J., 2002, J SPORT BEHAV, V25, P243; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hutchison M, 2011, AM J SPORT MED, V39, P2331, DOI 10.1177/0363546511413375; Iverson G, 2002, ARCH CLIN NEUROPSYCH, V17, P769; Iverson G. L., 2002, IMMEDIATE POSTCONCUS; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Kontos AP, 2010, ARCH CLIN NEUROPSYCH, V25, P734, DOI 10.1093/arclin/acq068; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lezak MD, 2004, NEUROPSYCHOLOGICAL A, P310; Lovell M. R, 2004, IMPACT VERSION 2 0 C; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory Paul, 2005, Clin J Sport Med, V15, P48; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Register-Mihalik JK, 2012, J ATHL TRAINING, V47, P297, DOI 10.4085/1062-6050-47.3.13; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Shuttleworth-Edwards AB, 2004, J CLIN EXP NEUROPSYC, V26, P903, DOI 10.1080/13803390490510824; Shuttleworth-Edwards Ann B, 2009, Phys Sportsmed, V37, P45, DOI 10.3810/psm.2009.12.1741; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039	28	17	17	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JUL	2014	24	4					284	288					5	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	AL3VW	WOS:000339060000003	24184854				2022-02-06	
J	McLay, R; Ram, V; Murphy, J; Spira, J; Wood, DP; Wiederhold, MD; Wiederhold, BK; Johnston, S; Reeves, D				McLay, Robert; Ram, Vasudha; Murphy, Jennifer; Spira, James; Wood, Dennis P.; Wiederhold, Mark D.; Wiederhold, Brenda K.; Johnston, Scott; Reeves, Dennis			Effect of Virtual Reality PTSD Treatment on Mood and Neurocognitive Outcomes	CYBERPSYCHOLOGY BEHAVIOR AND SOCIAL NETWORKING			English	Article							POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; EMOTIONAL STROOP TASK; EXPOSURE THERAPY; IRAQ; DEPLOYMENT; ANXIETY; DUTY; CARE; PERSPECTIVES	Virtual reality (VR) is an emerging tool to help treat posttraumatic stress disorder (PTSD). Previously published studies have shown that VR graded exposure therapy (VR-GET) treatment can result in improvements in PTSD symptoms. Less is known about the impact on depression, general anxiety, and neuropsychological functioning in patients with PTSD. This study examined changes in self-reports of PTSD, depression, and anxiety before and after treatment, and also examined neuropsychological functioning as assessed by a computerized test of simple reaction time, procedural reaction time, and performance on the congruent, incongruent, emotional, and neutral (match the color of the "nonsense word'') Stroop tests. Results showed that subjects treated with VR-GET showed significant reductions in PTSD and anxiety severity and significant improvements on the emotional Stroop test. Changes in depression and other measures of neuropsychological function were not significant. Change scores on the emotional Stroop test did not correlate with changes in self-report measures of PTSD. Overall, these findings support the use of VR-GET as a treatment for PTSD but indicate that benefits may be narrowly focused. Additional treatments may be needed after or alongside VR-GET for service members with neuropsychological impairments.	[McLay, Robert] Naval Med Ctr San Diego, Directorate Mental Hlth, San Diego, CA 92134 USA; [Ram, Vasudha; Murphy, Jennifer; Johnston, Scott] Naval Ctr Combat & Operat Stress Control, San Diego, CA USA; [Spira, James] Natl Ctr PTSD, Honolulu, HI USA; [Wood, Dennis P.; Wiederhold, Mark D.; Wiederhold, Brenda K.] Virtual Real Med Ctr, San Diego, CA USA		McLay, R (corresponding author), Naval Med Ctr San Diego, Directorate Mental Hlth, 34800 Bob Wilson Dr, San Diego, CA 92134 USA.	Robert.McLay@med.navy.mil	Wiederhold, Brenda K/Z-1993-2019	Wiederhold, Brenda K/0000-0002-3320-0303			Baldwin DS, 2010, CURR TOP BEHAV NEURO, V2, P453, DOI 10.1007/7854_2009_2; Barrett DH, 1996, AM J PSYCHIAT, V153, P1492; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Ben-David BM, 2011, J INT NEUROPSYCH SOC, V17, P354, DOI 10.1017/S135561771000175X; Bryan C, 2012, J HEAD TRAUMA REHAB, V27, P45, DOI 10.1097/HTR.0b013e318238f146; Buckley TC, 2000, CLIN PSYCHOL REV, V20, P1041, DOI 10.1016/S0272-7358(99)00030-6; Cisler JM, 2011, CLIN PSYCHOL REV, V31, P817, DOI 10.1016/j.cpr.2011.03.007; Elsmore TF, 2007, ARCH CLIN NEUROPSYCH, V22, pS135, DOI 10.1016/j.acn.2006.10.009; Enns MW, 1998, J AFFECT DISORDERS, V47, P195, DOI 10.1016/S0165-0327(97)00103-1; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Foa E.B., 2007, PROLONGED EXPOSURE T; Foa EB, 2011, DEPRESS ANXIETY, V28, P1043, DOI 10.1002/da.20907; Forbes D, 2001, BEHAV RES THER, V39, P977, DOI 10.1016/S0005-7967(00)00084-X; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Kane RL, 2007, ARCH CLIN NEUROPSYCH, V22, pS115, DOI 10.1016/j.acn.2006.10.006; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Levinson DM, 1997, ARCH CLIN NEUROPSYCH, V12, P155, DOI 10.1016/S0887-6177(96)00026-1; McLay RN, 2011, CYBERPSYCH BEH SOC N, V14, P223, DOI 10.1089/cyber.2011.0003; MCNALLY RJ, 1990, J ABNORM PSYCHOL, V99, P398, DOI 10.1037/0021-843X.99.4.398; Miller MW, 2010, J TRAUMA STRESS, V23, P631, DOI 10.1002/jts.20559; Naudet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020811; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; Reeves DL, 2006, MIL MED, V171, P982, DOI 10.7205/MILMED.171.10.982; Rizzo AA, 2009, STUD HEALTH TECHNOL, V142, P277, DOI 10.3233/978-1-58603-964-6-277; Rothbaum BO, 2001, J CLIN PSYCHIAT, V62, P617, DOI 10.4088/JCP.v62n0808; Schwab KA, 2006, NEUROLOGY, V66, pA235; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Stein DJ, 2009, CNS SPECTRUMS, V14, P25; Sundin J, 2010, PSYCHOL MED, V40, P367, DOI 10.1017/S0033291709990791; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Vincent AS, 2012, MIL MED, V177, P248, DOI 10.7205/MILMED-D-11-00156; Weathers F.W., 1993, ANN CONV INT SOC TRA; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3; Wood DP, 2007, CYBERPSYCHOL BEHAV, V10, P309, DOI 10.1089/cpb.2006.9951; Wood DP, 2011, STUD HEALTH TECHNOL, V163, P696, DOI 10.3233/978-1-60750-706-2-696	39	17	17	4	29	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2152-2715	2152-2723		CYBERPSYCH BEH SOC N	Cyberpsychology Behav. Soc. Netw.	JUL	2014	17	7					439	446		10.1089/cyber.2013.0383			8	Psychology, Social	Social Science Citation Index (SSCI)	Psychology	AL2HN	WOS:000338946700003	24635120				2022-02-06	
J	Naftel, KG; Yust, EM; Nichols, MH; King, WD; Davis, D				Naftel, Kimberly G.; Yust, Elizabeth M.; Nichols, Michele H.; King, William D.; Davis, Drew			Knowledge and Management of Sports Concussions among Coaches and Certified Athletic Trainers in Alabama	SOUTHERN MEDICAL JOURNAL			English	Article						athletes; concussion; head injuries; mild traumatic brain injury; return to play	HIGH-SCHOOL SPORTS; SIDELINE	Objectives: To identify modifiable barriers in resources, knowledge, and management that may improve the care of young athletes with concussions in the state of Alabama. Methods: An electronic survey was distributed to 2668 middle and high school coaches of contact sports in Alabama, and a paper survey was completed by 79 certified athletic trainers (ATCs) in 2010. Questions focused on their resource availability, knowledge of concussions based on the 2008 Consensus Statement on Concussion in Sport: the 3rd International Conference on Concussion in Sport (commonly known as the Zurich consensus statement), and management of concussions. Results: A total of 402 (16% response rate) coaches and 55 ATCs (70% response rate) responded to the survey. This study highlights that ATC coverage often is limited to the high school level, football, and competitions. Both coaches and ATCs primarily use physicians to make return-to-play decisions, although coaches (43.7%) usually refer to primary care physicians, whereas ATCs (43.6%) refer to orthopedic or sports medicine physicians. The study also revealed that coaches and ATCs desire education and could expand concussion awareness by providing education to parents and athletes. No overall difference was seen in the knowledge and management of concussions between coaches and ATCs; however, ATCs were more likely to identify symptoms that are positive for concussions (P = 0.04). Both groups had difficulty recognizing subtle symptoms such as trouble sleeping, personality changes, and dizziness; they also were unaware that strenuous mental activities could delay concussion recovery, although ATCs scored significantly better than coaches (P < 0.001). Neither coaches nor ATCs consistently use standardized measures such as the Sports Concussion Assessment Tool 2 (7.5% vs 56.4%) or neuropsychological testing (5.3% vs 14.5%). Conclusions: This study describes coaches' and ATCs' varying knowledge and management techniques and highlights areas in which targeted interventions and outreach could be useful. These areas include increased ATC availability, coach/ATC concussion education, improved parent/athlete education, increased "return to think'' awareness, and more consistent use of Sports Concussion Assessment Tool 2.	Monroe Carell Jr Childrens Hosp Vanderbilt, Div Pediat Emergency Med, Nashville, TN 37232 USA; Texas Childrens Hosp, Div Pediat Emergency Med, Houston, TX 77030 USA; Univ Alabama Birmingham, Div Pediat Emergency Med, Birmingham, AL USA; Univ Alabama Birmingham, Southeast Child Safety Inst, Childrens Alabama, Birmingham, AL USA; Univ Alabama Birmingham, Div Pediat Rehabil Med, Birmingham, AL USA		Naftel, KG (corresponding author), Monroe Carell Jr Childrens Hosp Vanderbilt, Dept Pediat, Div Emergency Med, 2200 Childrens Way,Suite 1014, Nashville, TN 37232 USA.	kimberly.gran@vanderbilt.edu			Alabama High School Athletic Association; Alabama Athletic Trainers' Association	The authors would like to acknowledge the Alabama High School Athletic Association and the Alabama Athletic Trainers' Association for their support. The authors also thank John Clifton Wellons III, MD and Joseph D. Ackerson, PhD, who assisted with survey development.	Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bay E, 2011, ADV EMERG NURS J, V33, P71, DOI 10.1097/TME.0b013e318207e851; Cohen JS, 2009, CURR OPIN PEDIATR, V21, P288, DOI 10.1097/MOP.0b013e32832b1195; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Eckner JT, 2010, CURR SPORT MED REP, V9, P8, DOI 10.1249/JSR.0b013e3181caa778; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Likert R., 1932, ARCH PSYCHOL, V22, P1; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McCrory Paul, 2005, Clin J Sport Med, V15, P48; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Nesmith J Darrell, 2010, J Ark Med Soc, V107, P111; Patel DR, 2005, SPORTS MED, V35, P671, DOI 10.2165/00007256-200535080-00002; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Sawyer RJ, 2010, HEALTH PROMOT PRACT, V11, P34, DOI 10.1177/1524839907309377; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Stevens Penelope K, 2010, J Trauma Nurs, V17, P178, DOI 10.1097/JTN.0b013e3181ff2789; Williams Nolan, 2012, Front Neurol, V3, P130, DOI 10.3389/fneur.2012.00130	23	17	17	2	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0038-4348	1541-8243		SOUTH MED J	South.Med.J.	JUL	2014	107	7					418	423		10.14423/SMJ.0000000000000136			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ4ZZ	WOS:000342812700006	25010582				2022-02-06	
J	Schoonman, GG; Bakker, DP; Jellema, K				Schoonman, G. G.; Bakker, D. P.; Jellema, K.			Low risk of late intracranial complications in mild traumatic brain injury patients using oral anticoagulation after an initial normal brain computed tomography scan: education instead of hospitalization	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						brain; human; injury; intracranial; oral anticoagulation; trauma	HEAD-INJURY; ADMISSION	Background and purpose Mild traumatic brain injury (mTBI) is a common neurological disorder. Whether oral anticoagulation (OAC) use is a risk factor for secondary deterioration in mTBI patients after a normal computed tomography (CT) scan is unclear. Therefore data were retrospectively collected on patients with mTBI who used OAC to determine the incidence of secondary clinical deterioration after an initial normal head CT scan. Methods This was a retrospective single-centre patient record study. All patients with an mTBI who presented at the emergency department between January 2007 and October 2011 were selected. Inclusion criteria were mTBI and at least 1week of OAC use resulting in an international normalized radio >1.1. CT scans were re-evaluated for this study. Results A total of 211 mTBI patients using OAC and with an initial CT scan without abnormalities were included in the analysis. In five patients a secondary deterioration was found. One patient developed a subdural hematoma after 15h of clinical observation. The other four patients became symptomatic between 2 and 28days after trauma. Conclusions A low risk of secondary deterioration within 24h in mTBI patients taking OAC with a normal first head CT scan was found. Our study does not support the recommendation of the current guidelines that these patients should be clinically observed for at least 24h. The fact that in our series the majority of secondary deteriorations occurred between 2 and 28days after trauma underscores the importance of patient instructions upon discharge from the hospital.	[Schoonman, G. G.] St Elizabeth Hosp, Dept Neurol, Tilburg, Netherlands; [Schoonman, G. G.; Bakker, D. P.; Jellema, K.] Med Ctr Haaglanden, Dept Neurol, NL-2512 VA The Hague, Netherlands		Jellema, K (corresponding author), Med Ctr Haaglanden, Dept Neurol, Lijnbaan 32, NL-2512 VA The Hague, Netherlands.	k.jellema@mchaaglanden.nl					af Geijerstam JL, 2006, BMJ-BRIT MED J, V333, P465, DOI 10.1136/bmj.38918.669317.4F; af Geijerstam JL, 2005, EMERG MED J, V22, P103, DOI 10.1136/emj.2004.015396; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; de Boussard CN, 2006, J TRAUMA, V61, P577, DOI 10.1097/01.ta.0000224901.67930.ce; Engelen Marc, 2009, Cases J, V2, P7587, DOI 10.4076/1757-1626-2-7587; Erly WK, 2003, AM J ROENTGENOL, V180, P1727, DOI 10.2214/ajr.180.6.1801727; Itshayek E, 2006, NEUROSURGERY, V58, P851, DOI 10.1227/01.NEU.0000209653.B2936.96; Kaen A, 2010, J TRAUMA, V68, P895, DOI 10.1097/TA.0b013e3181b28a76; McCarthy DM, 2012, EMERG MED INT, V2012, DOI 10.1155/2012/306859; Menditto VG, 2012, ANN EMERG MED, V59, P451, DOI 10.1016/j.annemergmed.2011.12.003; Parmar K. A., 2006, SMJ Singapore Medical Journal, V47, P676; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Reed D, INITIAL MANAGEMENT C; Tauber M, 2009, J TRAUMA, V67, P521, DOI 10.1097/TA.0b013e3181a7c184; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x	16	17	17	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-5101	1468-1331		EUR J NEUROL	Eur. J. Neurol.	JUL	2014	21	7					1021	1025		10.1111/ene.12429			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AJ4CE	WOS:000337616900014	24684394				2022-02-06	
J	Karason, S; Reynisson, K; Sigvaldason, K; Sigurdsson, GH				Karason, Sigurbergur; Reynisson, Kristbjorn; Sigvaldason, Kristinn; Sigurdsson, Gisli H.			Evaluation of clinical efficacy and safety of cervical trauma collars: differences in immobilization, effect on jugular venous pressure and patient comfort	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Cervical collar; Intracranial pressure; Cervical spine injury; Head trauma; Internal jugular venous pressure	INTRACRANIAL-PRESSURE; RIGID COLLAR; SPINE; HEAD; ORTHOSES; MOTION	Background: Concern has been raised that cervical collars may increase intracranial pressure in traumatic brain injury. The purpose of this study was to compare four types of cervical collars regarding efficacy of immobilizing the neck, effect on jugular venous pressure (JVP), as a surrogate for possible effect on intracranial pressure, and patient comfort in healthy volunteers. Methods: The characteristics of four widely used cervical collars (Laerdal Stifneck (R) (SN), Vista (R) (VI), Miami J Advanced (R) (MJ), Philadelphia (R) (PH)) were studied in ten volunteers. Neck movement was measured with goniometry, JVP was measured directly through an endovascular catheter and participants graded the collars according to comfort on a scale 1-5. Results: The mean age of participants was 27 +/- 5 yr and BMI 26 +/- 5. The mean neck movement (53 +/- 9 degrees) decreased significantly with all the collars (p < 0.001) from 18 +/- 7 degrees to 25 +/- 9 degrees (SN < MJ < PH < VI). There was a significant increase in mean JVP (9.4 +/- 1.4 mmHg) with three of the collars, but not with SN, from 10.5 +/- 2.1 mmHg to 16.3 +/- 3.3 mmHg (SN < MJ < VI < PH). The grade of comfort between collars varied from 4.2 +/- 0.8 to 2.2 +/- 0.8 (VI > MJ > SN > PH). Conclusion: Stifneck and Miami J collars offered the most efficient immobilization of the neck with the least effect on JVP. Vista and Miami J were the most comfortable ones. The methodology used in this study may offer a new approach to evaluate clinical efficacy and safety of neck collars and aid their continued development.	[Karason, Sigurbergur; Sigvaldason, Kristinn; Sigurdsson, Gisli H.] Landspitali Univ Hosp, Dept Anesthesia & Intens Care, Reykjavik, Iceland; [Karason, Sigurbergur; Sigurdsson, Gisli H.] Univ Iceland, Fac Med, Reykjavik, Iceland; [Reynisson, Kristbjorn] Landspitali Univ Hosp, Dept Radiol, Reykjavik, Iceland		Karason, S (corresponding author), Landspitali Univ Hosp, Dept Anesthesia & Intens Care, Reykjavik, Iceland.	skarason@landspitali.is			Ossur Inc, Reykjavik, Iceland	The study was partly supported by unconditional grant from Ossur Inc, Reykjavik, Iceland and from institutional funds.	Bloomfield GL, 1997, CRIT CARE MED, V25, P496, DOI 10.1097/00003246-199703000-00020; Brohi K, 2005, J TRAUMA, V58, P897, DOI 10.1097/01.ta.0000171984.25699.35; Caricato A, 2005, J TRAUMA, V58, P571, DOI 10.1097/01.TA.0000152806.19198.DB; CRAIG GR, 1991, INTENS CARE MED, V17, P504, DOI 10.1007/BF01690778; Davies G, 1996, INJURY, V27, P647, DOI 10.1016/S0020-1383(96)00115-5; Exo J, 2009, Ped Health, V3, P533, DOI 10.2217/phe.09.54; Grande PO, 2006, INTENS CARE MED, V32, P1475, DOI 10.1007/s00134-006-0294-3; Ho AMH, 2002, J TRAUMA, V53, P1185, DOI 10.1097/00005373-200212000-00028; Horodyski M, 2011, J EMERG MED, V41, P513, DOI 10.1016/j.jemermed.2011.02.001; Hostler D, 2009, PREHOSP EMERG CARE, V13, P256, DOI 10.1080/10903120802706195; Hunt K, 2001, ANAESTHESIA, V56, P511, DOI 10.1046/j.1365-2044.2001.02053.x; James CY, 2004, J ATHL TRAINING, V39, P138; Kwan I., 2001, COCHRANE DB SYST REV, DOI [10.1002/14651858.Cd002803, DOI 10.1002/14651858.CD002803]; Kwan I, 2005, PREHOSP DISASTER MED, V20, P47, DOI 10.1017/S1049023X00002144; Malik SA, 2008, EUR SPINE J, V17, P585, DOI 10.1007/s00586-008-0603-3; Mobbs RJ, 2002, ANZ J SURG, V72, P389, DOI 10.1046/j.1445-2197.2002.02462.x; Molinari RW, 2012, EUR SPINE J, V21, P855, DOI 10.1007/s00586-011-2069-y; Muench E, 2005, CRIT CARE MED, V33, P2367, DOI 10.1097/01.CCM.0000181732.37319.DF; PLAISIER B, 1994, J TRAUMA, V37, P714, DOI 10.1097/00005373-199411000-00004; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; Richter D, 2001, J TRAUMA, V50, P848, DOI 10.1097/00005373-200105000-00012; Schneider AM, 2007, SPINE, V32, pE1, DOI 10.1097/01.brs.0000251019.24917.44; Stone MB, 2010, ACAD EMERG MED, V17, P100, DOI 10.1111/j.1553-2712.2009.00624.x; The ATLS Subcommittee ACoSCoT and the International ATLS working group, 2012, ADV TRAUM LIF SUPP A; Zhang SN, 2005, CLIN BIOMECH, V20, P264, DOI 10.1016/j.clinbiomech.2004.09.015	25	17	17	1	10	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	JUN 6	2014	22								37	10.1186/1757-7241-22-37			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	AK3CL	WOS:000338300300001	24906207	gold, Green Published			2022-02-06	
J	Corrigan, JD; Kreider, S; Cuthbert, J; Whyte, J; Dams-O'Connor, K; Faul, M; Harrison-Felix, C; Whiteneck, G; Pretz, CR				Corrigan, John D.; Kreider, Scott; Cuthbert, Jeffrey; Whyte, John; Dams-O'Connor, Kristen; Faul, Mark; Harrison-Felix, Cynthia; Whiteneck, Gale; Pretz, Christopher R.			Components of Traumatic Brain Injury Severity Indices	JOURNAL OF NEUROTRAUMA			English	Article						AIS; Barell matrix; craniocerebral trauma; GCS; MCA; TBI	GLASGOW COMA SCALE; PROGNOSTIC VALUE; MOTOR SCORE; PREDICTION; DIAGNOSIS	The purpose of this study was to determine whether there are underlying dimensions common among traditional traumatic brain injury (TBI) severity indices and, if so, the extent to which they are interchangeable when predicting short-term outcomes. This study had an observational design, and took place in United States trauma centers reporting to the National Trauma Data Bank (NTDB). The sample consisted of 77,470 unweighted adult cases reported to the NTDB from 2007 to 2010, with International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) TBI codes. There were no interventions. Severity indices used were the Emergency Department Glasgow Coma Scale (GCS) Total score and each of the subscales for eye opening (four levels), verbal response (five levels), and motor response (six levels); the worst Abbreviated Injury Scale (AIS) severity score for the head (six levels); and the worst Barell index type (three categories). Prediction models were computed for acute care length of stay (days), intensive care unit length of stay (days), hospital discharge status (alive or dead), and, if alive, discharge disposition (home versus institutional). Multiple correspondence analysis (MCA) indicated a two dimensional relationship among items of severity indexes. The primary dimension reflected overall injury severity. The second dimension seemed to capture volitional behavior without the capability for cogent responding. Together, they defined two vectors around which most of the items clustered. A scale that took advantage of the order of items along these vectors proved to be the most consistent index for predicting short-term health outcomes. MCA provided useful insight into the relationships among components of traditional TBI severity indices. The two vector pattern may reflect the impact of injury on different cortical and subcortical networks. Results are discussed in terms of score substitution and the ability to impute missing values.	[Corrigan, John D.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Kreider, Scott; Cuthbert, Jeffrey; Harrison-Felix, Cynthia; Whiteneck, Gale; Pretz, Christopher R.] Craig Hosp, Res Dept, Englewood, CO USA; [Dams-O'Connor, Kristen] Albert Einstein Healthcare Network, Moss Rehabil Res Inst, Elkins Pk, PA USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Faul, Mark] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA		Corrigan, JD (corresponding author), Ohio State Univ, Dept Phys Med & Rehabil, 480 Med Ctr Dr, Columbus, OH 43210 USA.	corrigan.1@osu.edu		Whyte, John/0000-0002-4381-1474; Faul, Mark/0000-0002-7683-0348	Intramural CDC HHS [CC999999] Funding Source: Medline		American College of Surgeons, NAT TRAUM DAT BANK N; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL; Association for the Advancement of Automotive Medicine, 1998, ABBR INJ SCAL; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Centers for Disease Control and Prevention, 2014, DOD VA COMM DEF TBI; Chen Jeff W, 2011, Surg Neurol Int, V2, P82, DOI 10.4103/2152-7806.82248; *COMM MED ASP AUT, 1971, JAMA-J AM MED ASSOC, V215, P277; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; de Oliveira Thais M. E., 2012, J NEUROPSYCHOL, V8, P125; Faul M, 2012, PREHOSP EMERG CARE, V16, P222, DOI 10.3109/10903127.2011.615013; Gill M, 2005, ANN EMERG MED, V45, P37, DOI 10.1016/j.annemergmed.2004.07.429; Greenacre M. J., 2006, MULTIPLE CORRES ANAL; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Hoffmann M, 2012, BRIT J SURG, V99, P122, DOI 10.1002/bjs.7707; Kung WM, 2011, INJURY, V42, P940, DOI 10.1016/j.injury.2010.09.019; Lesko MM, 2013, J NEUROTRAUM, V30, P17, DOI 10.1089/neu.2012.2438; MACKENZIE E, 1997, ICDMAP 90 SOFTWARE U; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Marr A., 2004, CENTRAL NERVOUS SYST; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McNett Molly, 2007, J Neurosci Nurs, V39, P68; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Ong LC, 1996, PEDIATR NEUROSURG, V24, P285, DOI 10.1159/000121057; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1; Singh B, 2013, BRAIN INJURY, V27, P293, DOI 10.3109/02699052.2012.743182; TEASDALE G, 1974, LANCET, V2, P81; United States Department of Health and Human Services Centers for Disease Control and Prevention and the Centers for Medicare and Medicaid Services, 2005, INT CLASS DIS; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012	28	17	17	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2014	31	11					1000	1007		10.1089/neu.2013.3145			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AJ7RS	WOS:000337895300002	24521197	Green Accepted			2022-02-06	
J	Dalsgaard, S; Leckman, JF; Nielsen, HS; Simonsen, M				Dalsgaard, Soren; Leckman, James F.; Nielsen, Helena Skyt; Simonsen, Marianne			Gender and Injuries Predict Stimulant Medication Use	JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; CHILDHOOD BEHAVIOR DISORDERS; TRAUMATIC BRAIN-INJURY; UNINTENTIONAL INJURY; INCREASED RISK; DRUG-USE; CHILDREN; PREVALENCE; ADOLESCENTS	Objective: The purpose of this article was to examine whether injuries in early childhood and gender predict prescriptions of stimulant medication in three groups of children: With attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder (ASD), and other psychiatric disorders (OPD). Methods: This was a population-based study with prospective and complete follow-up of children with ADHD (n=11,553), ASD (n=9698), and OPD (n=48,468), of whom 61%, 16%, and 3%, respectively, were treated with stimulants. For all 69,719 individual children data on psychiatric diagnoses, injuries, and drug prescriptions were obtained from national registers and merged. Results: Having sustained an injury before 5 years of age increased the likelihood of later stimulant treatment, in children with ADHD (odds ratio [OR]=1.09; 95% confidence interval [CI]=1.01-1.21), ASD (OR=1.19; 95% CI=1.02-1.40), and OPD (OR=1.24; 95% CI=1.08-1.42), with each injury increasing the likelihood by 3%, 10%, and 7%, respectively. Head injury did not increase the likelihood of later stimulant treatment. Within each of the three groups, ADHD, ASD, and OPD boys were more likely than girls to receive stimulant medication, OR=1.17 (95% CI=1.07-1.28); OR=1.71 (95% CI=1.47-2.01), and OR=2.41 (95% CI=2.16-2.71), respectively. Conclusions: To our knowledge, this is the first prospective study assessing early life predictors of later ADHD medication in children with a psychiatric disorder, taken from a national cohort with complete follow-up of all cases. We found that the number of injuries prior to diagnosis was associated with initiation of stimulant treatment in all three groups of patients. In addition, male gender predicted treatment with ADHD medications. Our results suggest that the number of injuries early in life prior to diagnosis is associated with stimulant treatment, and may serve as a proxy for the level of later severity of ADHD symptoms, as it is universally associated with pharmacological treatment for ADHD.	[Dalsgaard, Soren] Aarhus Univ, Dept Econ & Business, Natl Ctr Register Based Res, DK-8210 Aarhus V, Denmark; [Dalsgaard, Soren] Lundbeck Fdn Initiat Integrat Psychiat Res, iPSYCH, Aarhus, Denmark; [Dalsgaard, Soren] Lundbeck Fdn Initiat Integrat Psychiat Res, iPSYCH, Copenhagen, Denmark; [Dalsgaard, Soren] Hosp Telemark, Dept Child & Adolescent Psychiat, Kragero, Norway; [Leckman, James F.] Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06510 USA; [Nielsen, Helena Skyt; Simonsen, Marianne] Aarhus Univ, Sch Business & Social Sci, Deparment Econ & Business, DK-8210 Aarhus V, Denmark		Dalsgaard, S (corresponding author), Aarhus Univ, Natl Ctr Register Ased Res, Fuglesangs Alle 4,Bldg K, DK-8210 Aarhus V, Denmark.	sdalsgaard@ncrr.dk	Leckman, James/O-2426-2015; Dalsgaard, Soren/I-4595-2013; Dalsgaard, Soren/AAA-4475-2020	Dalsgaard, Soren/0000-0003-4659-0969; Dalsgaard, Soren/0000-0003-4659-0969; Simonsen, Marianne/0000-0003-3376-865X; Nielsen, Helena/0000-0003-2577-4734; Leckman, James/0000-0002-3902-4478	Lundbeck FoundationLundbeckfonden; Danish Council for Independent ResearchDet Frie Forskningsrad (DFF) [10-079597]; Slagtermester Max Worzner and Inger Worzners Foundation; Lundbeck FoundationLundbeckfonden [R155-2014-1724] Funding Source: researchfish	The study was funded by grants from the Lundbeck Foundation, the Danish Council for Independent Research (Sapere Aude Starting Grant, 10-079597) and Slagtermester Max Worzner and Inger Worzners Foundation.	Aman MG, 2005, ARCH GEN PSYCHIAT, V62, P1266; Andersen TF, 1999, DAN MED BULL, V46, P263; Brault MC, 2012, CAN J PSYCHIAT, V57, P93, DOI 10.1177/070674371205700206; Brehaut JC, 2003, PEDIATRICS, V111, P262, DOI 10.1542/peds.111.2.262; Bruce B, 2007, PAED CHILD HEALT-CAN, V12, P749, DOI 10.1093/pch/12.9.749; Bruckner TA, 2012, PHARMACOEPIDEM DR S, V21, P442, DOI 10.1002/pds.2264; Byrne JM, 2003, CHILD NEUROPSYCHOL, V9, P142, DOI 10.1076/chin.9.2.142.14501; Castle Lon, 2007, J Atten Disord, V10, P335, DOI 10.1177/1087054707299597; Chen CY, 2011, J CHILD ADOL PSYCHOP, V21, P265, DOI 10.1089/cap.2010.0107; Cox ER, 2003, PEDIATRICS, V111, P237, DOI 10.1542/peds.111.2.237; Dalsgaard S, 2002, BRIT J PSYCHIAT, V181, P416, DOI 10.1192/bjp.181.5.416; Dalsgaard S, 2013, J CHILD ADOL PSYCHOP, V23, P432, DOI 10.1089/cap.2012.0111; DiScala C, 1998, PEDIATRICS, V102, P1415, DOI 10.1542/peds.102.6.1415; FARMER JE, 1995, HEALTH PSYCHOL, V14, P325, DOI 10.1037/0278-6133.14.4.325; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Hodgkins P, 2011, CLIN THER, V33, P188, DOI 10.1016/j.clinthera.2011.03.001; Hurtig T, 2013, J ATTEN DISORD; Kang JH, 2013, ACTA PAEDIATR, V102, P640, DOI 10.1111/apa.12213; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Lang HC, 2010, HEALTH POLICY, V97, P71, DOI 10.1016/j.healthpol.2010.03.005; Lauritsen MB, 2010, J AUTISM DEV DISORD, V40, P139, DOI 10.1007/s10803-009-0818-0; Lee LC, 2008, RES DEV DISABIL, V29, P247, DOI 10.1016/j.ridd.2007.05.002; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Linnet KM, 2009, ACTA PAEDIATR, V98, P173, DOI 10.1111/j.1651-2227.2008.00980.x; Madsen KM, 2002, NEW ENGL J MED, V347, P1477, DOI 10.1056/NEJMoa021134; Maxson RT, 2009, J PEDIATR SURG, V44, P743, DOI 10.1016/j.jpedsurg.2008.08.003; Merrill RM, 2009, ADV MED SCI-POLAND, V54, P20, DOI 10.2478/v10039-009-0022-7; Miller AR, 2004, AMBUL PEDIATR, V4, P174, DOI 10.1367/A03-031R1.1; Mors O, 2011, SCAND J PUBLIC HEALT, V39, P54, DOI 10.1177/1403494810395825; Nosarti C, 2012, ARCH GEN PSYCHIAT, V69, P610, DOI 10.1001/archgenpsychiatry.2011.1374; Novik TS, 2006, EUR CHILD ADOLES PSY, V15, P15, DOI 10.1007/s00787-006-1003-z; Pedersen CB, 2006, DAN MED BULL, V53, P441; Pottegard A, 2012, EUR J CLIN PHARMACOL, V68, P1443, DOI 10.1007/s00228-012-1265-y; Romano E, 2009, J PEDIATR-US, V155, P721, DOI 10.1016/j.jpeds.2009.05.028; Rowe R, 2004, J PEDIATR PSYCHOL, V29, P119, DOI 10.1093/jpepsy/jsh015; Rucklidge JJ, 2001, J AM ACAD CHILD PSY, V40, P530, DOI 10.1097/00004583-200105000-00012; Rucklidge JJ, 2010, PSYCHIAT CLIN N AM, V33, P357, DOI 10.1016/j.psc.2010.01.006; SAS Institute Inc, 2000, SAS REL 9 2; Schwartz A, 2013, NEW YORK TIMES  0331; Sclar DA, 2012, CLIN PEDIATR, V51, P584, DOI 10.1177/0009922812439621; Stephenson CP, 2013, AUST NZ J PSYCHIAT, V47, P74, DOI 10.1177/0004867412466595; Thapar A, 2012, ARCH DIS CHILD, V97, P260, DOI 10.1136/archdischild-2011-300482; Uslu M, 2007, CLIN ORTHOP RELAT R, P192, DOI 10.1097/BLO.0b013e31805002da; van den Ban E, 2014, EUR CHILD ADOLES PSY, V23, P95, DOI 10.1007/s00787-013-0432-8; Witwer A, 2005, J CHILD ADOL PSYCHOP, V15, P671, DOI 10.1089/cap.2005.15.671; World Health Organization, 1993, ICD 10 CLASS MENT BE; Xiang HY, 2005, AM J PUBLIC HEALTH, V95, P1970, DOI 10.2105/AJPH.2004.057505; Zetterqvist J, 2013, ACTA PSYCHIAT SCAND, V128, P70, DOI 10.1111/acps.12004; Zito JM, 1999, ARCH PEDIAT ADOL MED, V153, P1257, DOI 10.1001/archpedi.153.12.1257; Zuvekas SH, 2006, AM J PSYCHIAT, V163, P579, DOI 10.1176/appi.ajp.163.4.579	50	17	17	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1044-5463	1557-8992		J CHILD ADOL PSYCHOP	J. Child Adolesc. Psychopharmacol.	JUN	2014	24	5					253	259		10.1089/cap.2013.0101			7	Pediatrics; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics; Pharmacology & Pharmacy; Psychiatry	AJ9EP	WOS:000338010400004	24813570	Green Published, Green Submitted			2022-02-06	
J	Mandaville, A; Ray, A; Robertson, H; Foster, C; Jesser, C				Mandaville, Amy; Ray, Anjea; Robertson, Henry; Foster, Careen; Jesser, Christine			A Retrospective Review of Swallow Dysfunction in Patients with Severe Traumatic Brain Injury	DYSPHAGIA			English	Article						Deglutition; Deglutition disorders; Clinical prediction model; Long-term dysphagia; Severe traumatic brain injury; Percutaneous gastrostomy tube	PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; HEAD TRAUMA; DYSPHAGIA; TRACHEOSTOMY; DISORDERS; COMPLICATIONS; MANAGEMENT; RECOVERY; STROKE	In the acute-care setting, it is difficult for clinicians to determine which patients with severe traumatic brain injury will have long-term oropharyngeal dysphagia (> 6 weeks) and which patients will begin oral nutrition quickly. Patients frequently remain in the acute-care setting while physicians determine whether to place a percutaneous endoscopic gastrostomy (PEG) tube. To improve the acute-care clinician's ability to predict long-term oropharyngeal dysphagia and subsequent need for PEG tube placement in patients with severe traumatic brain injury [Glascow Coma Scale (GCS) a parts per thousand currency sign8), a novel prediction model was created utilizing clinical information and acute-care swallowing evaluation findings. Five years of retrospective data were obtained from trauma patients at a Level 1 trauma hospital. Of the 375 patients who survived their hospitalization with a GCS a parts per thousand currency sign8, a total of 269 patients received Ranchos Los Amigos (RLA) scores. Of those patients who were scored for RLA, 219 patients underwent swallowing evaluation. Ninety-six of the 219 patients were discharged from the hospital with a feeding tube, and 123 patients were discharged without one. Logistic regression models examined the association between clinical and patient characteristics and whether a patient with severe traumatic brain injury exhibited long-term oropharyngeal dysphagia. Multivariable logistic regression analysis revealed that increased age, low RLA score, tracheostomy tube placement, and aphonia observed on the initial swallowing evaluation significantly increased the odds of being discharged from the acute-care hospital with a feeding tube. The resultant model could be used clinically to guide decision making and to counsel patients and families.	[Mandaville, Amy; Ray, Anjea] Univ Med Ctr Brackenridge, Austin, TX 78701 USA; [Robertson, Henry; Jesser, Christine] Seton Family Hosp Analyt & Hlth Econ, Austin, TX 78723 USA; [Foster, Careen] Trauma Trust, Tacoma, WA 98405 USA		Mandaville, A (corresponding author), Univ Med Ctr Brackenridge, 601 E 15th St, Austin, TX 78701 USA.	amandaville@seton.org; aeray@seton.org; htrobertson@seton.org; cajesser@seton.org					Brain Injury Association of America, 2006, ESS BRAIN INJ GUID; Ciaglia P, 1993, J Trauma, V34, P916; DAMELIO LF, 1994, AM SURGEON, V60, P180; Gomes CAR, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008096.pub2; Gurkin MA, 2002, AM SURGEON, V68, P324; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Halper AS, 1999, J HEAD TRAUMA REHAB, V14, P486, DOI 10.1097/00001199-199910000-00009; Hill K, 2008, INT J STROKE, V3, P120, DOI 10.1111/j.1747-4949.2008.00189.x; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jorgensen HS, 1999, STROKE, V30, P2008, DOI 10.1161/01.STR.30.10.2008; Jung SJ, 2012, ANN REHABIL MED-ARM, V36, P356, DOI 10.5535/arm.2012.36.3.356; LAZARUS C, 1987, ARCH PHYS MED REHAB, V68, P79; Linden P., 1993, Dysphagia, V8, P170, DOI 10.1007/BF01354535; Lockett MA, 2002, AM SURGEON, V68, P117; LOGEMANN JA, 1995, J SPEECH HEAR RES, V38, P556, DOI 10.1044/jshr.3803.556; Mackay LE, 1999, ARCH PHYS MED REHAB, V80, P365, DOI 10.1016/S0003-9993(99)90271-X; Mackay LE, 1999, J HEAD TRAUMA REHAB, V14, P435, DOI 10.1097/00001199-199910000-00004; Mann G, 1999, STROKE, V30, P744, DOI 10.1161/01.STR.30.4.744; MOORE FA, 1992, J TRAUMA, V33, P435, DOI 10.1097/00005373-199209000-00017; Morgan A, 2003, J HEAD TRAUMA REHAB, V18, P239, DOI 10.1097/00001199-200305000-00002; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Nicholson FB, 2000, J GASTROEN HEPATOL, V15, P21, DOI 10.1046/j.1440-1746.2000.02004.x; Robbins J, 1988, Dysphagia, V3, P11, DOI 10.1007/BF02406275; Schroeder MF, 2006, J REHABIL RES DEV, V43, P301, DOI 10.1682/JRRD.2004.12.0154; Shaker R, 2002, GASTROENTEROLOGY, V122, P1314, DOI 10.1053/gast.2002.32999; VAUGHAN JR, 1991, AM SURGEON, V57, P214; VEIS SL, 1985, ARCH PHYS MED REHAB, V66, P372; WINSTEIN CJ, 1983, PHYS THER, V63, P1992, DOI 10.1093/ptj/63.12.1992	28	17	20	0	16	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-051X	1432-0460		DYSPHAGIA	Dysphagia	JUN	2014	29	3					310	318		10.1007/s00455-013-9509-2			9	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	AK2DY	WOS:000338230500003	24414375				2022-02-06	
J	Petrov, A; Wynne, KE; Parsley, MA; Petrov, IY; Petrov, Y; Ruppert, KA; Prough, DS; DeWitt, DS; Esenaliev, RO				Petrov, Andrey; Wynne, Karon E.; Parsley, Margaret A.; Petrov, Irene Y.; Petrov, Yuriy; Ruppert, Katherine A.; Prough, Donald S.; DeWitt, Douglas S.; Esenaliev, Rinat O.			Optoacoustic detection of intra-and extracranial hematomas in rats after blast injury	PHOTOACOUSTICS			English	Article						Optoacoustics; Noninvasive monitoring; Cerebral blood oxygenation; Animal model; Traumatic brain injury; Hematoma; blast	VENOUS-BLOOD OXYGENATION; VOLUNTEERS	Surgical drainage of intracranial hematomas is often required within the first four hours after traumatic brain injury (TBI) to avoid death or severe disability. Although CT and MRI permit hematoma diagnosis, they can be used only at a major health-care facility. This delays hematoma diagnosis and therapy. We proposed to use an optoacoustic technique for rapid, noninvasive diagnosis of hematomas. In this study we developed a near-infrared OPO-based optoacoustic system for hematoma diagnosis and cerebral venous blood oxygenation monitoring in rats. A specially-designed blast device was used to inflict TBI in anesthetized rats. Optoacoustic signals were recorded from the superior sagittal sinus and hematomas that allowed for measurements of their oxygenations. These results indicate that the optoacoustic technique may be used for early diagnosis of hematomas and may provide important information for improving outcomes in patients with TBI. (C) 2014 Published by Elsevier GmbH.	[Petrov, Andrey; Petrov, Irene Y.; Petrov, Yuriy; Esenaliev, Rinat O.] Univ Texas Med Branch, Ctr Biomed Engn, Lab Opt Sensing & Monitoring, Res Bldg 21,301 Univ Blvd, Galveston, TX 77555 USA; [Wynne, Karon E.; Ruppert, Katherine A.; Esenaliev, Rinat O.] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Wynne, Karon E.; Parsley, Margaret A.; Prough, Donald S.; DeWitt, Douglas S.; Esenaliev, Rinat O.] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA		Esenaliev, RO (corresponding author), Univ Texas Med Branch, Ctr Biomed Engn, Lab Opt Sensing & Monitoring, Res Bldg 21,301 Univ Blvd, Galveston, TX 77555 USA.	riesenal@utmb.edu	Prough, Donald S/G-5793-2013; Esenaliev, Rinat/Y-4361-2019	Prough, Donald S/0000-0001-7994-532X; Esenaliev, Rinat/0000-0002-2848-5906	National Institutes of Health (National Institute of Biomedical Imaging and Bioengineering)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [U54EB007954]; DODUnited States Department of Defense [W81XWH-10-1-1048]; NIH from the National Institute of Neurological Disorders and Stroke [R01 NS044345]; National Heart, Lung and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R41HL10309501]; Moody Center for Brain and Spinal Cord Injury Research/Mission Connect of UTMB	This work is supported by the National Institutes of Health Grant # U54EB007954 (from the National Institute of Biomedical Imaging and Bioengineering) and in part by the DOD (Grant # W81XWH-10-1-1048), NIH Grant R01 NS044345 from the National Institute of Neurological Disorders and Stroke, Grant R41HL10309501 from the National Heart, Lung and Blood Institute), and the Moody Center for Brain and Spinal Cord Injury Research/Mission Connect of UTMB. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIBIB or NIH. Drs. Prough and Esenaliev are coowners of Noninvasix, Inc., a UTMB-based startup that has licensed the rights to optoacoustic monitoring technology.	Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS65; Bulters D, 2009, ANAESTHESIA, V64, P277, DOI 10.1111/j.1365-2044.2008.05779.x; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Esenaliev RO, 2000, OSA TRENDS OPT PHOTO, V38, P272; Garner Jeff, 2007, Anesthesiol Clin, V25, P147; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; Petrov A., 2013, P SOC PHOTO-OPT INS, V8581; Petrov IY, 2012, OPT EXPRESS, V20, P4159, DOI 10.1364/OE.20.004159; Petrov IY, 2012, BIOMED OPT EXPRESS, V3, P125, DOI 10.1364/BOE.3.000125; Petrov IY, 2012, P SOC PHOTO-OPT INS, V8223; Petrov Y, 2012, P SOC PHOTO-OPT INS, V8223; Petrov Y., 2013, NONINVASIVE OPTOACOU; Petrova IY, 2009, OPT EXPRESS, V17, P7285, DOI 10.1364/OE.17.007285; Petrova IY, 2009, P SOC PHOTO-OPT INS, V7177; Pollard V, 1996, ANESTH ANALG, V82, P278, DOI 10.1097/00000539-199602000-00011; Pollard V, 1996, ANESTH ANALG, V82, P269, DOI 10.1097/00000539-199602000-00010; Pollard V, 1998, PRINCIPLES PRACTICE, P1019; Prahl Scott, 2015, OREGON MED LASER CTR; Prough D. S., 1999, MISSILE WOUNDS HEAD, P221	20	17	17	1	1	ELSEVIER GMBH	MUNICH	HACKERBRUCKE 6, 80335 MUNICH, GERMANY	2213-5979			PHOTOACOUSTICS	Photoacoustics	JUN	2014	2	2					75	80		10.1016/j.pacs.2014.04.001			6	Acoustics; Engineering, Biomedical; Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Acoustics; Engineering; Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical Imaging	V4F5K	WOS:000218885500003	25302157	Green Published, gold			2022-02-06	
J	Zhang, Y; Zhu, Y; Su, WQ; Zhou, ZF; Jin, Y; Wang, XJ				Zhang, Yu; Zhu, Yuan; Su, Wenqiang; Zhou, Zhifei; Jin, Yan; Wang, Xiaojing			A retrospective study of pediatric traumatic dental injuries in Xi'an, China	DENTAL TRAUMATOLOGY			English	Article						pediatric dentistry; traumatic dental injuries; primary and permanent teeth; children	QUALITY-OF-LIFE; PERMANENT TEETH; PREVALENCE; CHILDREN; UNIVERSITY; ADOLESCENTS; TURKEY; IMPACT	Background/AimPediatric traumatic dental injury is an important public health problem because of its high prevalence, severe physical or psychological impacts, and high prevention and treatment costs. This study aimed to determine the distributive features of pediatric traumatic dental injury in a university dental hospital in Xi'an, China. Materials and methodsChildren (aged 1 to 15years) visiting the hospital from February 2011 to May 2012 as a result of dental trauma were investigated. Trauma-related information was recorded and analyzed. ResultsMost of the traumas occurred in children aged 7 to 12years and affected the maxillary incisors. Of all the children involved, 17.2% had overjet. Concussion, enamel-dentin-pulp fracture, avulsion, and lateral luxation occurred more in the primary dentition (20.9%, 16.5%, 14.3%, and 13.2%, respectively). However, most traumas to the permanent dentition were enamel-dentin-pulp fractures and enamel-dentin fractures (33.7% and 29.1%, respectively). Most traumas were luxations (n=156) in the 1- to 6-year-old group, while fractures were more common in the 7- to 12- and >13-year-old groups (n=549, 84; P<0.001). In total, 357 urban children had access to immediate medical care, whereas only 12 rural children were able to access a clinic within 24h after injury (P<0.001). ConclusionBased on the information presented in this survey, the government should focus on medical development in rural settings and should attempt to balance the distribution of medical resources between urban and rural areas. Educational and preventive programs should also be promoted to enhance the guardians' awareness regarding pediatric traumatic dental injuries.	[Zhang, Yu; Zhu, Yuan; Su, Wenqiang; Zhou, Zhifei; Wang, Xiaojing] Fourth Mil Med Univ, Dept Pediat Dent, Sch Stomatol, Xian 710032, Shanxi, Peoples R China; [Jin, Yan] Fourth Mil Med Univ, Dept Oral Histol & Pathol, Res & Dev Ctr Tissue Engn, Sch Stomatol, Xian 710032, Shanxi, Peoples R China		Jin, Y (corresponding author), Fourth Mil Med Univ, Dept Oral Histol & Pathol, Res & Dev Ctr Tissue Engn, Sch Stomatol, Xian 710032, Shanxi, Peoples R China.	yanjin@fmmu.edu.cn; wxjing@fmmu.edu.cn	Jin, Yan/I-4204-2013		Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81170964]	This study was supported by grants from the Nature Science Foundation of China (81170964). The authors thank the parents and the children who participated in this survey. We also appreciate the collaboration with Dr. Li'an Wu, Lintian Yuan, Jun Fang, Xin Ge, Fen Liu, Jingtao Chen, and Ling Tan during the process of collecting these clinical cases.	Al-Jundi SH, 2002, DENT TRAUMATOL, V18, P181, DOI 10.1034/j.1600-9657.2002.02081.x; Andreasen FM, 2007, TXB COLOR ATLAS TRAU; Beltrao EM, 2007, EUR ARCH PAEDIATR DE, V8, P141, DOI 10.1007/BF03262583; Cardoso M, 2002, DENT TRAUMATOL, V18, P129, DOI 10.1034/j.1600-9657.2002.00030.x; Cortes MID, 2002, COMMUNITY DENT ORAL, V30, P193; Cortes MIS, 2001, DENT TRAUMATOL, V17, P22, DOI 10.1034/j.1600-9657.2001.170105.x; Bonini GADC, 2009, DENT TRAUMATOL, V25, P594, DOI 10.1111/j.1600-9657.2009.00826.x; Ekanayake L, 2008, DENT TRAUMATOL, V24, P471, DOI 10.1111/j.1600-9657.2008.00611.x; Glendor U, 2008, DENT TRAUMATOL, V24, P603, DOI 10.1111/j.1600-9657.2008.00696.x; Gong Y, 2011, DENT TRAUMATOL, V27, P203, DOI 10.1111/j.1600-9657.2010.00938.x; Granville-Garcia AF, 2006, DENT TRAUMATOL, V22, P318, DOI 10.1111/j.1600-9657.2005.00390.x; Jokic NI, 2009, DENT TRAUMATOL, V25, P84, DOI 10.1111/j.1600-9657.2008.00711.x; Kramer PF, 2003, DENT TRAUMATOL, V19, P299, DOI 10.1046/j.1600-9657.2003.00203.x; Malikaew P, 2006, COMMUNITY DENT HLTH, V23, P222; Nicolau B, 2001, DENT TRAUMATOL, V17, P213; Oulis CJ, 1996, ENDOD DENT TRAUMATOL, V12, P60; Petersson EE, 1997, SWED DENT J, V21, P55; Piovesan C, 2012, BRAZ ORAL RES, V26, P464, DOI 10.1590/S1806-83242012000500014; Rajab LD, 2003, DENT TRAUMATOL, V19, P6, DOI 10.1034/j.1600-9657.2003.00131.x; Ramos-Jorge ML, 2008, DENT TRAUMATOL, V24, P159, DOI 10.1111/j.1600-9657.2007.00533.x; Ramos-Jorge ML, 2007, DENT TRAUMATOL, V23, P114, DOI 10.1111/j.1600-9657.2005.00409.x; Robson F, 2009, DENT TRAUMATOL, V25, P118, DOI 10.1111/j.1600-9657.2008.00725.x; Sandalli N, 2005, DENT TRAUMATOL, V21, P188, DOI 10.1111/j.1600-9657.2005.00309.x; Saroglu I, 2002, DENT TRAUMATOL, V18, P299, DOI 10.1034/j.1600-9657.2002.00093.x; Skaare AB, 2005, DENT TRAUMATOL, V21, P315, DOI 10.1111/j.1600-9657.2005.00362.x; Soriano EP, 2007, DENT TRAUMATOL, V23, P232, DOI 10.1111/j.1600-9657.2005.00426.x; Wong FSL, 2004, DENT TRAUMATOL, V20, P327, DOI 10.1111/j.1600-9657.2004.00263.x; Zhang X, 2011, DENT TRAUMATOL, V27, P379, DOI 10.1111/j.1600-9657.2011.01024.x	28	17	21	2	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	JUN	2014	30	3					211	215		10.1111/edt.12075			5	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	AG5OT	WOS:000335469000008	24118923				2022-02-06	
J	Sun, LQ; Gao, JL; Zhao, MM; Jing, XB; Cui, Y; Xu, XY; Wang, KJ; Zhang, WQ; Cui, JZ				Sun, Liqian; Gao, Junling; Zhao, Manman; Jing, Xiaobin; Cui, Ying; Xu, Xiaoyu; Wang, Kaijie; Zhang, Wenqian; Cui, Jianzhong			The effects of BMSCs transplantation on autophagy by CX43 in the hippocampus following traumatic brain injury in rats	NEUROLOGICAL SCIENCES			English	Article						Autophagy; BMSCs; CX43; Hippocampus; Traumatic brain injury	MARROW STROMAL CELLS; COMBINATION THERAPY; MODEL	Traumatic brain injury (TBI) can initiate a series of complicated pathological events, and induce various types of neuronal cell death including autophagy and apoptosis. Currently, the treatment of TBI is one of the main challenges in neurobiology. In this regard, the administration of bone marrow stromal cells (BMSCs) represents a novel treatment modality for TBI. However, the protective mechanism of BMSCs was unknown in the TBI. The aim of the present study was to assess the effects of BMSCs on connexin 43(CX43) and autophagy in the hippocampus following TBI in rats. A rat model of TBI was created using a modified weight-drop device. Double-membrane structures in the process of autophagy formation were frequently observed in injured brain by electron microscopy. The levels of autophagic pathway associated proteins and CX43 were also detected by western blot analysis. Specifically, immunoblotting results showed that BMSCs treatment after TBI could down-regulate light chain 3 (LC3), Beclin-1 and CX43 expression in the hippocampus. Taken together, our results demonstrated that BMSCs were able to significantly suppress TBI-induced autophagy activity, and the potential mechanism by regulating CX43 levels.	[Sun, Liqian; Cui, Ying; Xu, Xiaoyu; Wang, Kaijie; Zhang, Wenqian; Cui, Jianzhong] Tangshan Gongren Hosp, Dept Neurosurg, Tangshan 063000, Peoples R China; [Gao, Junling; Zhao, Manman] Hebei United Univ, Sch Basic Med Sci, Tangshan 063000, Peoples R China; [Jing, Xiaobin] Tangshan Ophthalmol Hosp, Dept Ophthalmol, Tangshan 063000, Peoples R China		Sun, LQ (corresponding author), Tangshan Gongren Hosp, Dept Neurosurg, 27 Wen Hua Rd, Tangshan 063000, Peoples R China.	slq20000@126.com			Natural Science Foundation of Hebei ProvinceNatural Science Foundation of Hebei Province [H2012401071]	The present study was supported by a grant from the Natural Science Foundation of Hebei Province (No. H2012401071).	Bakhtiary Mehrdad, 2010, Iranian Biomedical Journal, V14, P142; Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; Bonilla C, 2009, BRAIN INJURY, V23, P760, DOI 10.1080/02699050903133970; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Kuroda S, 2011, J STEM CELLS REGEN, V7, P2; Lai Y, 2007, J CEREB BLOOD FLOW M, V28, P540; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Mahmood A, 2007, NEUROSURGERY, V60, P546, DOI 10.1227/01.NEU.0000255346.25959.99; Mahmood A, 2008, J NEUROTRAUM, V25, P1441, DOI 10.1089/neu.2007.0495; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Osanai T, 2012, NEUROSURGERY, V70, P435, DOI 10.1227/NEU.0b013e318230a795; Sadasivan S, 2008, BIOCHEM BIOPH RES CO, V373, P478, DOI 10.1016/j.bbrc.2008.05.031; Wang T, 2013, NEUROSCIENCE, V231, P70, DOI 10.1016/j.neuroscience.2012.11.019; Zhang MY, 2012, J MOL NEUROSCI, V46, P631, DOI 10.1007/s12031-011-9651-y	15	17	17	0	10	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	MAY	2014	35	5					677	682		10.1007/s10072-013-1575-6			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AI4BJ	WOS:000336810100005	24221859				2022-02-06	
J	Ottens, AK; Stafflinger, JE; Griffin, HE; Kunz, RD; Cifu, DX; Niemeier, JP				Ottens, Andrew K.; Stafflinger, Jillian E.; Griffin, Hailey E.; Kunz, Richard D.; Cifu, David X.; Niemeier, Janet P.			Post-Acute Brain Injury Urinary Signature: A New Resource for Molecular Diagnostics	JOURNAL OF NEUROTRAUMA			English	Article						rehabilitation; brain injury, mass spectrometry; biomarker; metabolomics; urine	RANDOMIZED CONTROLLED-TRIAL; CEREBROSPINAL-FLUID; BIOMARKERS; REHABILITATION; REORGANIZATION; REHABILOMICS; PROTEINS; RECOVERY; TRAUMA; IMPACT	Heterogeneity within brain injury presents a challenge to the development of informative molecular diagnostics. Recent studies show progress, particularly in cerebrospinal fluid, with biomarker assays targeting one or a few structural proteins. Protein-based assays in peripheral fluids, however, have been more challenging to develop, in part because of restricted and intermittent barrier access. Further, a greater number of molecular variables may be required to inform on patient status given the multi-factorial nature of brain injury. Presented is an alternative approach profiling peripheral fluid for a class of small metabolic by-products rendered by ongoing brain pathobiology. Urine specimens were collected for head trauma subjects upon admission to acute brain injury rehabilitation and non-traumatized matched controls. An innovative data-independent mass spectrometry approach was employed for reproducible molecular quantification across osmolarity-normalized samples. The postacute human traumatic brain injury urinary signature encompassed 2476 discriminant variables reproducibly measured in specimens for subject classification. Multiple subprofiles were then discerned in correlation with injury severity per the Glasgow Comma Scale and behavioral and neurocognitive function per the Patient Competency Rating Scale and Frontal Systems Behavioral Scale. Identified peptide constituents were enriched for outgrowth and guidance, extracellular matrix, and post-synaptic density proteins, which were reflective of ongoing post-acute neuroplastic processes demonstrating pathobiological relevance. Taken together, these findings support further development of diagnostics based on brain injury urinary signatures using either combinatorial quantitative models or pattern-recognition methods. Particularly, these findings espouse assay development to address unmet diagnostic and theragnostic needs in brain injury rehabilitative medicine.	[Ottens, Andrew K.; Stafflinger, Jillian E.; Griffin, Hailey E.] Virginia Commonwealth Univ, Sch Med, Dept Anat & Neurobiol, Richmond, VA 23298 USA; [Kunz, Richard D.; Cifu, David X.; Niemeier, Janet P.] Virginia Commonwealth Univ, Sch Med, Dept Phys Med & Rehabil, Richmond, VA 23298 USA		Ottens, AK (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Anat & Neurobiol, POB 980709, Richmond, VA 23298 USA.	akottens@vcu.edu		Cifu, David/0000-0003-1600-9387; Ottens, Andrew/0000-0002-2118-3796	Virginia Commonwealth University School of Medicine; National Institutes of Health National Center for Medical Rehabilitation Research/National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD052922]; National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TR000058]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD052922] Funding Source: NIH RePORTER	This research was supported in part by the Virginia Commonwealth University School of Medicine and the National Institutes of Health National Center for Medical Rehabilitation Research/National Institute of Child Health and Human Development (grant HD052922) and the National Center for Advancing Translational Sciences (grant TR000058). The authors thank William Korzun for assistance with osmolarity analysis. Many thanks to the nursing staff of the Brain Injury Rehabilitation Unit of Virginia Commonwealth University Health Systems for their crucial assistance on the unit. The authors are grateful to the participants and their families for their voluntary contribution to this research.	Adamczak S, 2012, J NEUROSURG, V117, P1119, DOI 10.3171/2012.9.JNS12815; Bajor M, 2013, NEUROCHEM RES, V38, P1113, DOI 10.1007/s11064-012-0919-6; Berger RP, 2006, J HEAD TRAUMA REHAB, V21, P315, DOI 10.1097/00001199-200607000-00004; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Cifu DX, 2003, ARCH PHYS MED REHAB, V84, P1441, DOI 10.1016/S0003-9993(03)00272-7; Cortes DF, 2012, ELECTROPHORESIS, V33, P3712, DOI 10.1002/elps.201200341; Gabathuler R, 2010, NEUROBIOL DIS, V37, P48, DOI 10.1016/j.nbd.2009.07.028; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Kall L, 2008, J PROTEOME RES, V7, P40, DOI 10.1021/pr700739d; Kobeissy FH, 2011, PM&R, V3, pS139, DOI 10.1016/j.pmrj.2011.02.012; Kochanek PM, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00040; Kusuhara Hiroyuki, 2005, NeuroRx, V2, P73, DOI 10.1602/neurorx.2.1.73; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; Niemeier JP, 2011, BRAIN INJURY, V25, P680, DOI 10.3109/02699052.2011.573520; Nishibe M, 2010, J NEUROTRAUM, V27, P2221, DOI 10.1089/neu.2010.1456; Niyonkuru C, 2013, J NEUROTRAUM, V30, P938, DOI 10.1089/neu.2012.2578; Nudo RJ, 2011, J COMMUN DISORD, V44, P515, DOI 10.1016/j.jcomdis.2011.04.004; Papa L, 2013, J NEUROTRAUM, V30, P324, DOI 10.1089/neu.2012.2545; Berger RP, 2006, PEDIATR CRIT CARE ME, V7, P557, DOI 10.1097/01.PCC.0000244426.37793.23; Pelinka LE, 2005, SHOCK, V24, P119, DOI 10.1097/01.shk.0000168876.68154.43; Ragnarsson KT, 2006, J HEAD TRAUMA REHAB, V21, P379, DOI 10.1097/00001199-200609000-00002; Rajalahti T, 2011, INT J PHARMACEUT, V417, P280, DOI 10.1016/j.ijpharm.2011.02.019; Robin X, 2009, EXPERT REV PROTEOMIC, V6, P675, DOI 10.1586/EPR.09.83; Roozenbeek B, 2012, J NEUROTRAUM, V29, P1306, DOI 10.1089/neu.2011.1988; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Silva JC, 2005, ANAL CHEM, V77, P2187, DOI 10.1021/ac048455k; Siman R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028938; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Wagner AK, 2010, EUR J PHYS REHAB MED, V46, P549; Walder B, 2013, J NEUROTRAUM, V30, P1631, DOI 10.1089/neu.2012.2791; Warren KM, 2012, J NEUROTRAUM, V29, P1922, DOI 10.1089/neu.2012.2383; Witt KA, 2001, PEPTIDES, V22, P2329, DOI 10.1016/S0196-9781(01)00537-X; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zitnay GA, 2008, J NEUROTRAUM, V25, P1135, DOI 10.1089/neu.2008.0599	41	17	18	1	15	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2014	31	8					782	788		10.1089/neu.2013.3116			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AD7PX	WOS:000333457200009	24372380	Green Published, Green Submitted			2022-02-06	
J	Gonzalez, CLR; Mills, KJ; Genee, I; Li, FF; Piquette, N; Rosen, N; Gibb, R				Gonzalez, Claudia L. R.; Mills, Kelly J.; Genee, Inge; Li, Fangfang; Piquette, Noella; Rosen, Nicole; Gibb, Robbin			Getting the right grasp on executive function	FRONTIERS IN PSYCHOLOGY			English	Article						grasping movements; left hemisphere; space use; development; frontal lobe; handedness; assessment; intervention	DEVELOPMENTAL COORDINATION DISORDER; FINE MOTOR-SKILLS; BEHAVIOR RATING INVENTORY; TRAUMATIC BRAIN-INJURY; HAND-USE; HEMISPHERIC-SPECIALIZATION; GENERAL INTELLIGENCE; PREFRONTAL CORTEX; ACADEMIC ABILITY; CHILDREN	Executive Function (EF) refers to important socio-emotional and cognitive skills that are known to be highly correlated with both academic and life success. EF is a blanket term that is considered to include self-regulation, working memory, and planning. Recent studies have shown a relationship between EF and motor control. The emergence of motor control coincides with that of EF, hence understanding the relationship between these two domains could have significant implications for early detection and remediation of later EF deficits. The purpose of the current study was to investigate this relationship in young children. This study incorporated the Behavioral Rating Inventory of Executive Function (BRIEF) and two motor assessments with a focus on precision grasping to test this hypothesis. The BRIEF is comprised of two indices of EF: (1) the Behavioral Regulation Index (BRI) containing three subscales: Inhibit, Shift, and Emotional Control; (2) the Metacognition Index (MI) containing five subscales: Initiate, Working Memory, Plan/Organize, Organization of Materials, and Monitor. A global executive composite (GEC) is derived from the two indices. In this study, right-handed children aged 5-6 and 9-10 were asked to: grasp-to-construct (Lego (R) models); and grasp-to-place (wooden blocks), while their parents completed the BRIEF questionnaire. Analysis of results indicated significant correlations between the strength of right hand preference for grasping and numerous elements of the BRIEF including the BRI, MI, and GEC. Specifically, the more the right hand was used for grasping the better the EF ratings. In addition, patterns of space-use correlated with the GEC in several subscales of the BRIEF Finally and remarkably, the results also showed a reciprocal relationship between hand and space use for grasping and EF These findings are discussed with respect to: (1) the developmental overlap of motor and executive functions; (2) detection of EF deficits through tasks that measure lateralization of hand and space use; and (3) the possibility of using motor interventions to remediate EF deficits.	[Gonzalez, Claudia L. R.; Mills, Kelly J.] Univ Lethbridge, Brain Act Lab, Dept Kinesiol, Lethbridge, AB T1K 3M4, Canada; [Genee, Inge; Rosen, Nicole] Univ Lethbridge, Dept Modern Languages, Lethbridge, AB T1K 3M4, Canada; [Li, Fangfang] Univ Lethbridge, Dept Psychol, Lethbridge, AB T1K 3M4, Canada; [Piquette, Noella] Univ Lethbridge, Dept Educ, Lethbridge, AB T1K 3M4, Canada; [Gibb, Robbin] Univ Lethbridge, Dept Neurosci, Lethbridge, AB T1K 3M4, Canada		Gonzalez, CLR (corresponding author), Univ Lethbridge, Brain Act Lab, Dept Kinesiol, Lethbridge, AB T1K 3M4, Canada.	claudia.gonzalez@uleth.ca	VARRECCHIA, TIWANA/AAJ-8712-2021	Li, Fangfang/0000-0001-7047-6918			Abe M, 2009, BEHAV BRAIN RES, V198, P13, DOI 10.1016/j.bbr.2008.10.046; Barbey AK, 2012, BRAIN, V135, P1154, DOI 10.1093/brain/aws021; Best JR, 2010, CHILD DEV, V81, P1641, DOI 10.1111/j.1467-8624.2010.01499.x; Blair C, 2007, CHILD DEV, V78, P647, DOI 10.1111/j.1467-8624.2007.01019.x; Butcher PR, 2009, J CHILD PSYCHOL PSYC, V50, P920, DOI 10.1111/j.1469-7610.2009.02066.x; Cameron CE, 2012, CHILD DEV, V83, P1229, DOI 10.1111/j.1467-8624.2012.01768.x; Carlson AG, 2013, J GENET PSYCHOL, V174, P514, DOI 10.1080/00221325.2012.717122; Chaddock L, 2011, J INT NEUROPSYCH SOC, V17, P975, DOI 10.1017/S1355617711000567; Cheyne CP, 2010, LATERALITY, V15, P451, DOI 10.1080/13576500902976956; Crow TJ, 1998, NEUROPSYCHOLOGIA, V36, P1275, DOI 10.1016/S0028-3932(98)00039-6; Davis EE, 2011, BRIT J PSYCHOL, V102, P569, DOI 10.1111/j.2044-8295.2011.02018.x; de Bruin N, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00004; Diamond A, 2000, CHILD DEV, V71, P44, DOI 10.1111/1467-8624.00117; Diamond A, 2007, DEVELOPMENTAL SCI, V10, P152, DOI 10.1111/j.1467-7687.2007.00578.x; Diamond A, 2011, SCIENCE, V333, P959, DOI 10.1126/science.1204529; Donders J, 2002, CHILD NEUROPSYCHOL, V8, P229, DOI 10.1076/chin.8.4.229.13508; Dubois J, 2009, CEREB CORTEX, V19, P414, DOI 10.1093/cercor/bhn097; ELIASON MJ, 1986, J DEV BEHAV PEDIATR, V7, P175; Eliasson AC, 2004, DEV MED CHILD NEUROL, V46, P19, DOI 10.1017/S0012162204000040; Fuentes CT, 2009, NEUROLOGY, V73, P1532, DOI 10.1212/WNL.0b013e3181c0d48c; Gallivan JP, 2011, NEUROPSYCHOLOGIA, V49, P3710, DOI 10.1016/j.neuropsychologia.2011.09.027; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Glascher J, 2010, P NATL ACAD SCI USA, V107, P4705, DOI 10.1073/pnas.0910397107; Gonzalez CLR, 2006, J NEUROPHYSIOL, V95, P3496, DOI 10.1152/jn.01187.2005; Gonzalez CLR, 2007, EXP BRAIN RES, V182, P275, DOI 10.1007/s00221-007-1090-1; Gonzalez CLR, 2009, NEUROPSYCHOLOGIA, V47, P3182, DOI 10.1016/j.neuropsychologia.2009.07.019; Hanakawa T, 2011, NEUROSCI RES, V70, P144, DOI 10.1016/j.neures.2011.02.010; Herve PY, 2013, TRENDS COGN SCI, V17, P69, DOI 10.1016/j.tics.2012.12.004; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Iverson JM, 2010, J CHILD LANG, V37, P229, DOI 10.1017/S0305000909990432; Jabusch HC, 2009, HUM MOVEMENT SCI, V28, P74, DOI 10.1016/j.humov.2008.08.001; Jacquet AY, 2012, DEV PSYCHOBIOL, V54, P36, DOI 10.1002/dev.20572; Johnson LJ, 1995, J EARLY INTERVENTION, V19, P315, DOI 10.1177/105381519501900406; Jongbloed-Pereboom M, 2013, J EXP CHILD PSYCHOL, V114, P295, DOI 10.1016/j.jecp.2012.08.008; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; KARNI A, 1995, LANCET, V345, P395, DOI 10.1016/S0140-6736(95)90386-0; Kirby A, 2008, DYSLEXIA, V14, P197, DOI 10.1002/dys.367; Kolb B., 2009, FUNDAMENTALS HUMAN N; Lalonde G, 2013, J NEUROSCI METH, V219, P76, DOI 10.1016/j.jneumeth.2013.07.005; Lin W, 2008, AM J NEURORADIOL, V29, P1883, DOI 10.3174/ajnr.A1256; Luo Z, 2007, BRIT J DEV PSYCHOL, V25, P595, DOI 10.1348/026151007X185329; Masten AS, 2012, EDUC RESEARCHER, V41, P363, DOI [10.3102/0013189X12467366, 10.3102/0013189X12459883]; Mayringer H, 2002, NEUROPSYCHOLOGIA, V40, P701, DOI 10.1016/S0028-3932(01)00191-9; Michel GF, 2006, DEV PSYCHOBIOL, V48, P436, DOI 10.1002/dev.20161; Momennejad I, 2013, J NEUROSCI, V33, P17342, DOI 10.1523/JNEUROSCI.0492-13.2013; Moriguchi Y, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00867; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pangelinan MM, 2011, NEUROIMAGE, V54, P3093, DOI 10.1016/j.neuroimage.2010.11.021; Pennequin V, 2010, BRAIN COGNITION, V74, P107, DOI 10.1016/j.bandc.2010.07.003; Piek JP, 2008, HUM MOVEMENT SCI, V27, P668, DOI 10.1016/j.humov.2007.11.002; Racine MB, 2008, J CHILD NEUROL, V23, P399, DOI 10.1177/0883073807309244; Ratnarajah N, 2013, NEUROIMAGE, V75, P187, DOI 10.1016/j.neuroimage.2013.02.052; Roebers CM, 2009, DEVELOPMENTAL SCI, V12, P175, DOI 10.1111/j.1467-7687.2008.00755.x; Rosenbaum DA, 2012, PSYCHOL BULL, V138, P924, DOI 10.1037/a0027839; Rosenblum S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00357; ROTH M, 1993, EXCEPT CHILDREN, V59, P348, DOI 10.1177/001440299305900407; Sacrey LAR, 2013, DEV PSYCHOBIOL, V55, P902, DOI 10.1002/dev.21083; Sacrey LAR, 2012, INFANT BEHAV DEV, V35, P543, DOI 10.1016/j.infbeh.2012.05.006; Schmahmann JD, 2008, CORTEX, V44, P1037, DOI 10.1016/j.cortex.2008.04.004; Stone KD, 2014, EXP BRAIN RES, V232, P385, DOI 10.1007/s00221-013-3746-3; Stone KD, 2013, EXP BRAIN RES, V224, P455, DOI 10.1007/s00221-012-3325-z; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Sugden D, 2008, INT J DISABIL DEV ED, V55, P173, DOI 10.1080/10349120802033691; Thibaut JP, 2010, J EXP CHILD PSYCHOL, V105, P116, DOI 10.1016/j.jecp.2009.10.003; van der Meulen M, 2014, HUM BRAIN MAPP, V35, P455, DOI 10.1002/hbm.22192; van Swieten LM, 2010, J EXP PSYCHOL HUMAN, V36, P493, DOI 10.1037/a0017177; Waber DP, 2006, DEV NEUROPSYCHOL, V29, P459, DOI 10.1207/s15326942dn2903_5; Willcutt EG, 2000, J LEARN DISABIL, V33, P179, DOI 10.1177/002221940003300206; WOLFF PH, 1985, DEV MED CHILD NEUROL, V27, P344	71	17	17	1	81	FRONTIERS RESEARCH FOUNDATION	LAUSANNE	PO BOX 110, LAUSANNE, 1015, SWITZERLAND	1664-1078			FRONT PSYCHOL	Front. Psychol.	APR 7	2014	5									10.3389/fpsyg.2014.00285			11	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	AE1VK	WOS:000333758800001	24778624	gold, Green Published			2022-02-06	
J	Nishijima, DK; Sena, M; Galante, JM; Shahlaie, K; London, J; Melnikow, J; Holmes, JF				Nishijima, Daniel K.; Sena, Matthew; Galante, Joseph M.; Shahlaie, Kiarash; London, Jason; Melnikow, Joy; Holmes, James F.			Derivation of a Clinical Decision Instrument to Identify Adult Patients With Mild Traumatic Intracranial Hemorrhage at Low Risk for Requiring ICU Admission	ANNALS OF EMERGENCY MEDICINE			English	Article							INTENSIVE-CARE-UNIT; INJURY SEVERITY SCORE; BRAIN-INJURY; HEAD-INJURY; TREE ANALYSIS; UTILITY; TOMOGRAPHY; IMPACT	Study objective: The objective of this study is to derive a clinical decision instrument with a sensitivity of at least 95% (with upper and lower bounds of the 95% confidence intervals [CIs] within a 5% range) to identify adult emergency department patients with mild traumatic intracranial hemorrhage who are at low risk for requiring critical care resources during hospitalization and thus may not need admission to the ICU. Methods: This was a prospective, observational study of adult patients with mild traumatic intracranial hemorrhage (initial Glasgow Coma Scale [GCS] score 13 to 15, with traumatic intracranial hemorrhage) presenting to a Level I trauma center from July 2009 to February 2013. The need for ICU admission was defined as the presence of an acute critical care intervention (intubation, neurosurgical intervention, blood product transfusion, vasopressor or inotrope administration, invasive monitoring for hemodynamic instability, urgent treatment for arrhythmia or cardiopulmonary resuscitation, and therapeutic angiography). We derived the clinical decision instrument with binary recursive partitioning (with a misclassification cost of 20 to 1). The accuracy of the decision instrument was compared with the treating physician's (emergency medicine faculty) clinical impression. Results: A total of 600 patients with mild traumatic intracranial hemorrhage were enrolled; 116 patients (19%) had a critical care intervention. The derived instrument consisted of 4 predictor variables: admission GCS score less than 15, nonisolated head injury, aged 65 years or older, and evidence of swelling or shift on initial cranial computed tomography scan. The decision instrument identified 114 of 116 patients requiring an acute critical care intervention (sensitivity 98.3%; 95% Cl 93.9% to 99.5%) if at least 1 variable was present and 192 of 484 patients who did not have an acute critical care intervention (specificity 39.7%; 95% Cl 35.4% to 44.1%) if no variables were present. Physician clinical impression was slightly less sensitive (90.1%; 95% Cl 83.1% to 94.4%) but overall similar to the clinical decision instrument. Conclusion: We derived a clinical decision instrument that identifies a subset of patients with mild traumatic intracranial hemorrhage who are at low risk for acute critical care intervention and thus may not require ICU admission. Physician clinical impression had test characteristics similar to those of the decision instrument. Because the results are based on single-center data without a validation cohort, external validation is required.	[Nishijima, Daniel K.; Holmes, James F.] UC Davis Sch Med, Dept Emergency Med, Sacramento, CA 95616 USA; [Galante, Joseph M.] UC Davis Sch Med, Div Trauma Surg, Sacramento, CA USA; [Shahlaie, Kiarash] UC Davis Sch Med, Dept Neurol Surg, Sacramento, CA USA; [Melnikow, Joy] UC Davis Sch Med, Ctr Healthcare Policy & Res, Sacramento, CA USA; [Melnikow, Joy] UC Davis Sch Med, Dept Family & Community Med, Sacramento, CA USA; [Sena, Matthew; London, Jason] Kaiser Permanente South Sacramento, Div Trauma Surg, Sacramento, CA USA		Nishijima, DK (corresponding author), UC Davis Sch Med, Dept Emergency Med, Sacramento, CA 95616 USA.	daniel.nishijima@ucdmc.ucdavis.edu			National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000002, KL2TR000134]; NIH Roadmap for Medical ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org). The authors have stated that no such relationships exist and provided the following details: Dr. Nishijima was supported through a Mentored Clinical Research Training Program Award (grant UL1TR000002 and linked award KL2TR000134) from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research.	Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; [Anonymous], 1999, CRIT CARE MED, V27, P633; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Brieman L., 1984, CLASSIFICATION REGRE; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Chalfin DB, 2007, CRIT CARE MED, V35, P1477, DOI 10.1097/01.CCM.0000266585.74905.5A; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; ESCARCE JJ, 1990, JAMA-J AM MED ASSOC, V264, P2389, DOI 10.1001/jama.264.18.2389; Escher M, 2006, BMJ-BRIT MED J, V329, P425; Frost SA, 2009, RESUSCITATION, V80, P224, DOI 10.1016/j.resuscitation.2008.10.030; Goldhill DR, CRIT CARE MED; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; GROEGER JS, 1993, CRIT CARE MED, V21, P279, DOI 10.1097/00003246-199302000-00022; Hillman KM, 2002, INTENS CARE MED, V28, P1629, DOI 10.1007/s00134-002-1496-y; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hukkelhoven CWPM, 2005, INTENS CARE MED, V31, P799, DOI 10.1007/s00134-005-2628-y; Huynh T, 2006, AM SURGEON, V72, P1162; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Marion DW, 2006, NEUROSURGERY, V58, P655; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nishijima DK, 2013, ANN EMERG MED, V61, P509, DOI 10.1016/j.annemergmed.2012.08.024; Nishijima DK, 2012, INJURY, V43, P1827, DOI 10.1016/j.injury.2011.07.020; Nishijima DK, 2012, J TRAUMA ACUTE CARE, V72, P1658, DOI 10.1097/TA.0b013e318256dfc5; Nishijima DK, 2011, J TRAUMA, V70, pE101, DOI 10.1097/TA.0b013e3181e88bcb; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; SAX FL, 1987, CRIT CARE MED, V15, P510, DOI 10.1097/00003246-198705000-00012; Sifri ZC, 2004, AM J SURG, V187, P338, DOI 10.1016/j.amjsurg.2003.12.015; Stiell IG, 1999, ANN EMERG MED, V33, P437, DOI 10.1016/S0196-0644(99)70309-4; Truog RD, 2006, CRIT CARE MED, V34, P958, DOI 10.1097/01.CCM.0000206116.10417.D9; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Wang MC, 2006, J TRAUMA, V61, P226, DOI 10.1097/01.ta.0000197385.18452.89	37	17	17	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-0644			ANN EMERG MED	Ann. Emerg. Med.	APR	2014	63	4					448	456		10.1016/j.annemergmed.2013.11.003			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	AF3XZ	WOS:000334647300016	24314900	Green Accepted			2022-02-06	
J	Hosseini, H; Moosavi-Nejad, S; Akiyama, H; Menezes, V				Hosseini, H.; Moosavi-Nejad, S.; Akiyama, H.; Menezes, V.			Shock wave interaction with interfaces between materials having different acoustic impedances	APPLIED PHYSICS LETTERS			English	Article							THERAPY; INCREASE; BRAIN	We experimentally examined interaction of blast waves with water-air/air-water interfaces through high-speed-real-time visualization and measurement of pressure across the waves. The underwater shock wave, which was expected to reflect totally at the water-air interface, was observed transmitting a shock front to air. Transmission of a blast wave from air to water was also visualized and evaluated. Underwater shock waves are used in several medical/biological procedures, where such unforeseen transmissions can result in detriments. The details provide a guideline to evaluate blast wave transmissions, which can induce tissue and brain injuries. The results explain mechanisms behind blast-induced traumatic brain injury. (C) 2014 AIP Publishing LLC.	[Hosseini, H.; Moosavi-Nejad, S.; Akiyama, H.] Kumamoto Univ, Inst Pulsed Power Sci, Bioelect Dept, Kumamoto 8608555, Japan; [Moosavi-Nejad, S.] Fukuoka Univ, Fac Med, Dept Anat, Fukuoka 8140180, Japan; [Menezes, V.] Indian Inst Technol, Dept Aerosp Engn, Bombay 400076, Maharashtra, India		Hosseini, H (corresponding author), Kumamoto Univ, Inst Pulsed Power Sci, Bioelect Dept, Kumamoto 8608555, Japan.	hosseini@kumamoto-u.ac.jp		Akiyama, Hidenori/0000-0002-9675-1209	Ministry of Education, Culture, Sports, Science and Technology of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [24540539]	This work was supported in part by Grant-in-Aid for Scientific Research No. 24540539 from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Baker W.E., 1973, EXPLOSIONS AIR; Catalano MG, 2007, THYROID, V17, P91, DOI 10.1089/thy.2006.0142; CHAUSSY C, 1980, LANCET, V2, P1265; Chen H, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.034301; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; Christensen DA., 1988, ULTRASONIC BIOINSTRU, V1; Cole R. H., 1965, UNDERWATER EXPLOSION, P55; Haake M, 2003, BRIT MED J, V327, P75, DOI 10.1136/bmj.327.7406.75; Hosseini SHR, 2006, MINIM INVASIV THER, V15, P230, DOI 10.1080/13645700600836315; Hosseini SHR, 2005, J FLUID MECH, V530, P223, DOI 10.1017/S0022112005003587; Ito K, 2011, AM J CARDIOVASC DRUG, V11, P295, DOI 10.2165/11592760-000000000-00000; Ivings MJ, 1998, INT J NUMER METH FL, V28, P395, DOI 10.1002/(SICI)1097-0363(19980915)28:3<395::AID-FLD718>3.0.CO;2-S; Kato K, 2007, J NEUROSURG, V106, P667, DOI 10.3171/jns.2007.106.4.667; Kuo YR, 2007, J SURG RES, V143, P385, DOI 10.1016/j.jss.2006.12.552; Menezes V, 2008, SHOCK WAVES, V18, P393, DOI 10.1007/s00193-008-0163-9; Menezes V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050823; Menezes V, 2009, J APPL PHYS, V106, DOI 10.1063/1.3245320; Moosavi-Nejad SF, 2006, CANCER SCI, V97, P296, DOI 10.1111/j.1349-7006.2006.00172.x; Nagayama K, 2002, J APPL PHYS, V91, P476, DOI 10.1063/1.1421630; Nakada M, 2008, JPN J APPL PHYS, V47, P1522, DOI 10.1143/JJAP.47.1522; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Saito T, 2003, SHOCK WAVES, V13, P139, DOI 10.1007/s00193-003-0201-6; Schimizze B, 2013, APPL ACOUST, V74, P1, DOI 10.1016/j.apacoust.2012.05.011; Speed CA, 2004, J BONE JOINT SURG BR, V86B, P165, DOI 10.1302/0301-620X.86B2.14253; Takiya T., 2012, ADV STUD THEOR PHYS, V6, P233; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7	26	17	17	2	34	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0003-6951	1077-3118		APPL PHYS LETT	Appl. Phys. Lett.	MAR 10	2014	104	10							103701	10.1063/1.4867883			5	Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Physics	AD2RM	WOS:000333082800085					2022-02-06	
J	Bressan, S; Daverio, M; Martinolli, F; Dona, D; Mario, F; Steiner, IP; Da Dalt, L				Bressan, Silvia; Daverio, Marco; Martinolli, Francesco; Dona, Daniele; Mario, Federica; Steiner, Ivan P.; Da Dalt, Liviana			The use of handheld near-infrared device (Infrascanner) for detecting intracranial haemorrhages in children with minor head injury	CHILDS NERVOUS SYSTEM			English	Article						Minor head injury; Near-infrared spectroscopy; CTscan; Children	COMPUTED-TOMOGRAPHY; ADVERSE EVENTS; DECISION RULE; SPECTROSCOPY; CHILDHOOD; SEDATION; ADULTS; SCANS; RISK; CT	A handheld device using near-infrared technology (Infrascanner) has shown good accuracy for detection of traumatic intracranial haemorrhages in adults. This study aims to determine the feasibility of use of Infrascanner in children with minor head injury (MHI) in the Emergency Department (ED). Secondary aim was to assess its potential usefulness to reduce CT scan rate. Prospective pilot study conducted in two paediatric EDs, including children at high or intermediate risk for clinically important traumatic brain injury (ciTBI) according to the adapted PECARN rule in use. Completion of Infrascanner measurements and time to completion were recorded. Decision on CT scan and CT scan reporting were performed independently and blinded to Infrascanner results. Completion of the Infrascanner measurement was successfully achieved in 103 (94 %) of 110 patients enrolled, after a mean of 4.4 +/- 2.9 min. A CT scan was performed in 18 (17.5 %) children. Only one had an intracranial haemorrhage that was correctly identified by the Infrascanner. The exploratory analysis showed a specificity of 93 % (95 % CI, 86.5-96.6) and a negative predictive value of 100 % (95 % CI, 81.6-100) for ciTBI. The use of Infrascanner would have led to avoid ten CT scan, reducing the CT scan rate by 58.8 %. Infrascanner seems an easy-to-use tool for children presenting to the ED following a MHI, given the high completion rate and short time to completion. Our preliminary results suggest that Infrascanner is worthy of further investigation as a potential tool to decrease the CT scan rate in children with MHI.	[Bressan, Silvia; Daverio, Marco; Martinolli, Francesco; Dona, Daniele; Mario, Federica; Da Dalt, Liviana] Univ Padua, Dept Womans & Childs Hlth, I-35128 Padua, Italy; [Daverio, Marco; Martinolli, Francesco; Da Dalt, Liviana] Osped Ca Foncello, Pediat Unit, Treviso, Italy; [Steiner, Ivan P.] Univ Alberta, Fac Med & Dent, Edmonton, AB, Canada; [Bressan, Silvia] Univ Padua, Div Pediat Emergency Med, Dept Womans & Childs Hlth, I-35128 Padua, Italy		Bressan, S (corresponding author), Univ Padua, Div Pediat Emergency Med, Dept Womans & Childs Hlth, Via Giustiniani 3, I-35128 Padua, Italy.	silviabress@gmail.com	Daverio, Marco/AAB-1646-2019; Dona, Daniele/W-7088-2019	Daverio, Marco/0000-0002-3127-8836; Dona, Daniele/0000-0001-7105-2105			Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Bressan S, 2012, ACAD EMERG MED, V19, P801, DOI 10.1111/j.1553-2712.2012.01384.x; Coskun F, 2010, SCI RES ESSAYS, V5, P1911; Cravero JP, 2006, PEDIATRICS, V118, P1087, DOI 10.1542/peds.2006-0313; Da Dalt L, 2006, EUR J PEDIATR, V165, P142, DOI 10.1007/s00431-005-0019-6; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Faul M, 2010, TRAUMATIC BRAIN INJU; Francis SV, 2005, J CLIN NEUROSCI, V12, P291, DOI 10.1016/j.jocn.2004.06.009; Ghalenoui H, 2008, PREHOSP DISASTER MED, V23, P558, DOI 10.1017/S1049023X00006415; GOPINATH SP, 1995, J NEUROSURG, V83, P438, DOI 10.3171/jns.1995.83.3.0438; GOPINATH SP, 1993, J NEUROSURG, V79, P43, DOI 10.3171/jns.1993.79.1.0043; Kahraman S, 2006, J TRAUMA, V61, P1480, DOI 10.1097/01.ta.0000197616.10279.48; Kessel B, 2007, INJURY, V38, P1065, DOI 10.1016/j.injury.2007.05.009; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Leon-Carrion J, 2010, BRAIN INJURY, V24, P1193, DOI 10.3109/02699052.2010.506636; Lyttle MD, 2012, EMERG MED J, V29, P785, DOI 10.1136/emermed-2011-200225; Malviya S, 2000, BRIT J ANAESTH, V84, P743, DOI 10.1093/oxfordjournals.bja.a013586; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Pandor A, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15270; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Robertson C S, 1997, J Biomed Opt, V2, P31, DOI 10.1117/12.261680; Robertson CS, 2010, J NEUROTRAUM, V27, P1597, DOI 10.1089/neu.2010.1340; Salonia R, 2012, J NEUROTRAUM, V29, P1047, DOI 10.1089/neu.2011.1890; Strangman G, 2002, BIOL PSYCHIAT, V52, P679, DOI 10.1016/S0006-3223(02)01550-0	26	17	18	1	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	MAR	2014	30	3					477	484		10.1007/s00381-013-2314-2			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	AC2HA	WOS:000332319200013	24469947				2022-02-06	
J	Fleming, J; Nalder, E; Alves-Stein, S; Cornwell, P				Fleming, Jennifer; Nalder, Emily; Alves-Stein, Serena; Cornwell, Petrea			The Effect of Environmental Barriers on Community Integration for Individuals With Moderate to Severe Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						environmental factors; participation; rehabilitation; traumatic brain injury	REHABILITATION; OUTCOMES; PEOPLE; ADULTS; PERSPECTIVES; PRODUCTIVITY; OUTPATIENT; PREDICTION; SCALE; HOME	Objective: To describe environmental barriers endorsed by individuals with traumatic brain injury during the first 6 months after discharge and determine their effect on community integration. Design: Prospective longitudinal study with data collected at predischarge and at 1, 3, and 6 months postdischarge. Participants: One hundred thirty-five individuals with a diagnosis of traumatic brain injury discharged from a large metropolitan hospital to a home/community environment. Measures: Sydney Psychosocial Reintegration Scale; Craig Hospital Inventory of Environmental Factors; and Mayo-Portland Adaptability Inventory-4. Results: Multiple regression analyses indicated that environmental barriers arising during the transition from hospital to home had a negative association with community integration outcomes. Physical barriers were most commonly endorsed, but attitudinal barriers were significantly correlated with relationship changes. Conclusion: Environmental barriers should be addressed in rehabilitation and considered in policy development for people with traumatic brain injury. Future research on the measurement of environmental barriers is recommended.	[Fleming, Jennifer; Nalder, Emily; Alves-Stein, Serena] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [Fleming, Jennifer] Queensland Hlth, Ctr Functioning & Hlth Res, Brisbane, Qld 4102, Australia; [Fleming, Jennifer] Princess Alexandra Hosp, Occupat Therapy Dept, Brisbane, Qld 4102, Australia; [Cornwell, Petrea] Metro North Hosp & Hlth Serv, Brisbane, Qld, Australia; [Cornwell, Petrea] Griffith Univ, Griffith Hlth Inst, Behav Basis Hlth Program, Brisbane, Qld 4111, Australia		Fleming, J (corresponding author), Queensland Hlth, Ctr Functioning & Hlth Res, POB 6053, Brisbane, Qld 4102, Australia.	j.fleming@uq.edu.au	Cornwell, Petrea/AAE-5547-2019	Alves-Stein, Serena/0000-0002-3457-4438	Australian Research CouncilAustralian Research Council [LP0776294]; Department of Communities (Disability Services); Acquired Brain Injury Outreach Service	This project is supported by an Australian Research Council Linkage grant (LP0776294) and partner organizations, Department of Communities (Disability Services) and Acquired Brain Injury Outreach Service.	Bier N, 2009, J HEAD TRAUMA REHAB, V24, P187, DOI 10.1097/HTR.0b013e3181a0b15a; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Conneeley AL., 2002, BRIT J OCCUP THER, V65, P356; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; Dawson DR, 2009, CAN J OCCUP THER, V76, P115, DOI 10.1177/000841740907600209; Devitt R, 2006, DISABIL REHABIL, V28, P547, DOI 10.1080/00222930500219258; Doig E, 2011, BRAIN INJURY, V25, P1114, DOI 10.3109/02699052.2011.607788; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Fleming J, 1999, BRAIN INJURY, V13, P417; Fleming J, 2009, DISABIL REHABIL, V31, P1666, DOI 10.1080/09638280902738425; Gan C, 2010, NEUROREHABILITATION, V27, P5, DOI 10.3233/NRE-2010-0577; Gentleman D, 2001, TRAUMA, V3, P193; Guscia R, 2006, J POLICY PRACT INTEL, V3, P173, DOI DOI 10.1111/J.1741-1130.2006.00077.X; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kim YJ, 2011, J CLIN NURS, V20, P1518, DOI 10.1111/j.1365-2702.2010.03618.x; Malec J. F., 2003, MANUAL MAYO PORTLAND; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Marrosszeky N, 1998, PTA PROTOCOL GUIDELI; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; McLellan T, 2010, J INT NEUROPSYCH SOC, V16, P705, DOI 10.1017/S1355617710000524; Nalder E, 2012, J REHABIL MED, V44, P837, DOI 10.2340/16501977-1033; Sloan S., 2007, BRAIN IMPAIR, V8, P251, DOI [10.1375/brim.8.3.251, DOI 10.1375/BRIM.8.3.251]; *STATACORP LP, 2009, STAT STAT SOFTW REL; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; TATE RL, 2003, 26 ANN BRAIN IMP C S; TEASDALE G, 1974, LANCET, V2, P81; Togher L, 2011, TBI EXPRESS SOCIAL C; TOGLIA JP, 1991, AM J OCCUP THER, V45, P505, DOI 10.5014/ajot.45.6.505; Turner BJ, 2011, DISABIL REHABIL, V33, P818, DOI 10.3109/09638288.2010.513422; Whiteneck GG, 2004, ARCH PHYS MED REHAB, V85, P1324, DOI 10.1016/j.apmr.2003.09.027; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001; WILLER B, 1994, BRAIN INJURY, V8, P647, DOI 10.3109/02699059409151017; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; World Health Organization, 2007, INT CLASS FUNCT DIS; Ylvisaker M, 2009, DEV NEUROREHABIL, V12, P370, DOI 10.3109/17518420903087533	37	17	17	0	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2014	29	2					125	135		10.1097/HTR.0b013e318286545d			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AH9ZH	WOS:000336504600006	23474885				2022-02-06	
J	Lumba-Brown, A; Harley, J; Lucio, S; Vaida, F; Hilfiker, M				Lumba-Brown, Angela; Harley, Jim; Lucio, Simon; Vaida, Florin; Hilfiker, Mary			Hypertonic Saline as a Therapy for Pediatric Concussive Pain	PEDIATRIC EMERGENCY CARE			English	Article						concussion; pediatric mild traumatic brain injury; hypertonic saline; pediatric head injury; mild traumatic brain injury; pediatric concussion; concussion therapy; concussion treatment; closed-head injury; mTBI; TBI; HTS	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; PRESSURE; VALIDATION; REACTIVITY; CHILDREN; SCALE	Objective Three-percent hypertonic saline (HTS) is a hyperosmotic therapy used in pediatric traumatic brain injury to treat increased intracranial pressure and cerebral edema. It also promotes plasma volume expansion and cerebral perfusion pressure, immunomodulation, and anti-inflammatory response. We hypothesized that HTS will improve concussive symptoms of mild traumatic brain injury. Methods The study was a prospective, double-blind, randomized controlled trial. Children, 4 to 7 years of age with a Glasgow Coma Scale score greater than 13, were enrolled from a pediatric emergency department following closed-head injury upon meeting Acute Concussion Evaluation criteria with head pain. Patients were randomized to receive 10 mL/kg of HTS or normal saline (NS) over 1 hour. Self-reported pain values were obtained using the Wong-Baker FACES Pain Rating Scale initially, immediately following fluids, and at 2 to 3 days of discharge. The primary outcome measure was change in self-reported pain following fluid administration. Secondary outcome measures were a change in pain and postconcussive symptoms within 2 to 3 days of fluid administration. We used an intention-to-treat analysis. Results Forty-four patients, ranging from 7 to 16 years of age with comparable characteristics, were enrolled in the study; 23 patients (52%) received HTS, and 21 (48%) received NS. There was a significant difference (P < 0.001) identified in the self-reported improvement of pain following fluid administration between the HTS group (mean improvement = 3.5) and the NS group (mean improvement = 1.1). There was a significant difference (P = 0.01) identified in the self-reported improvement of pain at 2 to 3 days after treatment between the HTS group (mean improvement = 4.6) and the NS group (mean improvement = 3.0). We were unable to determine a difference in other postconcussive symptoms following discharge. Conclusions Three-percent HTS is more effective than NS in acutely reducing concussion pain in children.	[Lumba-Brown, Angela] Washington Univ, Sch Med, St Louis, MO 63110 USA; [Lumba-Brown, Angela; Harley, Jim; Lucio, Simon] Univ Calif San Diego, Dept Emergency Med, Div Pediat Emergency Med, San Diego, CA 92103 USA; [Vaida, Florin] Univ Calif San Diego, Dept Family & Prevent Med, Div Biostat & Bioinformat, San Diego, CA 92103 USA; [Vaida, Florin] HIV Neurobehav Res Program, Stat Unit, San Diego, CA USA; [Hilfiker, Mary] Univ Calif San Diego, Rady Childrens Hosp, San Diego, CA 92103 USA		Lumba-Brown, A (corresponding author), Washington Univ, Sch Med, 660 S Euclid Ave,Campus Box 8116, St Louis, MO 63110 USA.	alumba@aol.com		Lumba-Brown, Angela/0000-0002-9102-8791	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001442] Funding Source: NIH RePORTER; NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR001442] Funding Source: Medline		Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Blume HK, 2012, PEDIATRICS, V129, pE31, DOI 10.1542/peds.2011-1742; Bosenberg A, 2003, PAEDIATR ANAESTH, V13, P708, DOI 10.1046/j.1460-9592.2003.01142.x; CDC, 2003, REP C MILD TRAUM BRA; Centers for Disease Control, HEADS FACTS PHYS MIL; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Faul M, 2010, TRAUMATIC BRAIN INJU; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; Garra G, 2010, ACAD EMERG MED, V17, P50, DOI 10.1111/j.1553-2712.2009.00620.x; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Isayama K, 2012, J SURG RES, V172, P137, DOI 10.1016/j.jss.2010.07.042; Kelly JP, 1997, NEUROLOGY, V48, P581; Khan R, 2011, SHOCK, V36, P440, DOI 10.1097/SHK.0b013e3182336bda; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Lee JH, 2001, J NEUROSURG, V95, P222, DOI 10.3171/jns.2001.95.2.0222; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; MOSS GS, 1988, AM J SURG, V155, P425, DOI 10.1016/S0002-9610(88)80106-5; NAKAYAMA SI, 1985, J SURG RES, V38, P180, DOI 10.1016/0022-4804(85)90025-3; Richards HK, 2001, J CEREBR BLOOD F MET, V21, P779, DOI 10.1097/00004647-200107000-00002; Schulz KF, 2011, INT J SURG, V9, P672, DOI [10.7326/0003-4819-152-11-201006010-00232, 10.1016/j.ijsu.2011.09.004]; Suazo JAC, 2000, CRIT CARE MED, V28, P3268, DOI 10.1097/00003246-200009000-00024; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Weed LH, 1919, AM J PHYSIOL, V48, P531, DOI 10.1152/ajplegacy.1919.48.4.531	30	17	18	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	MAR	2014	30	3					139	145		10.1097/PEC.0000000000000084			7	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	AC6OR	WOS:000332644000001	24583571	Green Accepted			2022-02-06	
J	Murnane, O; Mabrey, H; Pearson, A; Byrd, S; Akin, F				Murnane, Owen; Mabrey, Heather; Pearson, Amber; Byrd, Stephanie; Akin, Faith			Normative Data and Test-Retest Reliability of the SYNAPSYS Video Head Impulse Test	JOURNAL OF THE AMERICAN ACADEMY OF AUDIOLOGY			English	Article						Head impulse test; semicircular canal; vestibulo-ocular reflex; video head impulse test	HORIZONTAL VESTIBULOOCULAR REFLEX; SEMICIRCULAR-CANAL FUNCTION; VESTIBULAR DYSFUNCTION; RESTING DISCHARGE; SQUIRREL-MONKEY; OCULOGRAPHY; NEURECTOMY; DEFICITS; NEURONS	Background: The observation or measurement of eye movement can aid in the detection and localization of vestibular pathology due to the relationship between the function of the vestibular sensory receptors in the inner ear and the eye movements produced by the vestibulo-ocular reflex (VOR). The majority of bedside and laboratory tests of vestibular function involve the observation or measurement of horizontal eye movements (i.e., horizontal VOR) produced by stimuli that activate the horizontal semicircular canals (SCCs) and the superior vestibular nerve. The video head impulse test (vHIT) is a new clinical test of dynamic SCC function that uses a high-speed digital video camera to record head and eye movement during and immediately after passive head rotations. The SYNAPSYS Inc. vHIT device measures the "canal deficit" (deviation in gaze) during passive head impulses in the horizontal and diagonal (vertical) planes. There is, however, a paucity of data that has been reported using this device. Purpose: The purpose of this study was to obtain normative data and assess the test-retest reliability of the SYNAPSYS vHIT (version 2.0). Research Design: A prospective repeated measures design was utilized. Study Sample: Thirty young adults with normal hearing, normal caloric test results, and a negative history of vestibular disorder, neurological disease, open or closed head injury, or cervical spine injury participated in the study. Data Collection and Analysis: A single examiner manually rotated each participant's head in the horizontal and diagonal planes in two directions (left and right in the horizontal plane; downward and upward in each diagonal plane) resulting in the stimulation of each of the six SCCs. Each participant returned for repeat testing to assess test-retest reliability. The effects of ear, session, and semicircular canal (horizontal, anterior, posterior) on the magnitude of canal deficit during the vHIT were assessed using repeated measures analysis of variance. Results: The mean canal deficit of the horizontal canals (8.3%) was significantly lower than the mean canal deficit of the anterior canals (16.5%) and the posterior canals (15.2%); there was no significant difference between the mean canal deficits of the anterior and posterior canals. The main effects of session and ear on canal deficit were not,significant, and there were no significant interaction effects. There was no significant difference between the mean canal deficit for session 1 and session 2 for the horizontal, anterior, and posterior canals. The 95th percentiles for canal deficit were 19, 26, and 22% for the horizontal, anterior, and posterior SCCs, respectively. Conclusions: Testing of all six SCCs was completed in most participants in similar to 10 min and was well-tolerated. The vHIT has some important advantages relative to more established laboratory tests of horizontal SCC function including the ability to assess the vertical SCCs, lower cost, shorter test time, greater portability, minimal space requirements, and increased patient comfort. Additional data, however, should be obtained from older participants with normal vestibular function and from patients with vestibular disorders. Within-subject comparisons between the results of the vHIT and the caloric and rotary chair tests will be important in determining the role of the vHIT in the vestibular test battery.	[Murnane, Owen; Pearson, Amber; Byrd, Stephanie; Akin, Faith] VA Med Ctr, Vestibular Balance Res Lab, Mountain Home, TN 37604 USA; [Murnane, Owen; Mabrey, Heather; Akin, Faith] E Tennessee State Univ, Dept Audiol & Speech Language Pathol, Johnson City, TN 37614 USA		Murnane, O (corresponding author), VA Med Ctr, Audiol 126, Mountain Home, TN 37604 USA.	owen.murnane@va.gov			Auditory and Vestibular Dysfunction Research Enhancement Award Program - Rehabilitation Research and Development Service, Department of Veterans Affairs, Washington, DC	This work was supported by the Auditory and Vestibular Dysfunction Research Enhancement Award Program sponsored by the Rehabilitation Research and Development Service, Department of Veterans Affairs, Washington, DC.	BALOH RW, 1977, ACTA OTO-LARYNGOL, V83, P475, DOI 10.3109/00016487709128874; Barin K., 2008, BALANCE FUNCTION ASS, P229; Bartl K, 2009, ANN NY ACAD SCI, V1164, P331, DOI 10.1111/j.1749-6632.2009.03850.x; Bartolomeo M, 2014, EUR ARCH OTO-RHINO-L, V271, P681, DOI 10.1007/s00405-013-2451-y; Beynon GJ, 1998, CLIN OTOLARYNGOL, V23, P117; Blodow A, 2013, AURIS NASUS LARYNX, V40, P348, DOI 10.1016/j.anl.2012.11.002; BOHMER A, 1985, BRAIN RES, V326, P291, DOI 10.1016/0006-8993(85)90038-1; Cremer PD, 1998, BRAIN, V121, P699, DOI 10.1093/brain/121.4.699; ESTES MS, 1975, J NEUROPHYSIOL, V38, P1232, DOI 10.1152/jn.1975.38.5.1232; EWALD EJR, 1892, PHYSL UNTERSUCHUNGEN; FOSTER CA, 1994, LARYNGOSCOPE, V104, P473; GOLDBERG JM, 1971, J NEUROPHYSIOL, V34, P635, DOI 10.1152/jn.1971.34.4.635; GROSSMAN GE, 1988, EXP BRAIN RES, V70, P470; HALMAGYI GM, 1988, ARCH NEUROL-CHICAGO, V45, P737, DOI 10.1001/archneur.1988.00520310043015; HALMAGYI GM, 1990, EXP BRAIN RES, V81, P479, DOI 10.1007/BF02423496; HAMID MA, 1991, OTOLARYNG HEAD NECK, V105, P40, DOI 10.1177/019459989110500106; HAMID MA, 1987, VESTIBULAR SYSTEM NE, P115; Harvey SA, 1996, LARYNGOSCOPE, V106, P6, DOI 10.1097/00005537-199601000-00002; Harvey SA, 1997, AM J OTOL, V18, P207; Herdman SJ, 1998, AM J OTOL, V19, P790; Kessler P, 2008, ACTA OTO-LARYNGOL, V128, P29, DOI 10.1080/00016480701299642; Kirkwood B, 2003, ESSENTIALS MED STAT; Lehnen N, 2004, NEUROLOGY, V62, P2294, DOI 10.1212/WNL.62.12.2294; MacDougall HG, 2009, NEUROLOGY, V73, P1134, DOI 10.1212/WNL.0b013e3181bacf85; Mahringer A, 2014, EUR ARCH OTO-RHINO-L, V271, P463, DOI 10.1007/s00405-013-2376-5; McCaslin DL, EAR HEAR IN PRESS; Minor LB, 1999, J NEUROPHYSIOL, V82, P1254, DOI 10.1152/jn.1999.82.3.1254; Murnane OD, 2009, EAR HEARING, V30, P313, DOI 10.1097/AUD.0b013e31819c3ec7; Perez N, 2003, OTOL NEUROTOL, V24, P913, DOI 10.1097/00129492-200311000-00016; Perez-Fernandez N, 2012, ACTA OTORRINOLAR ESP, V63, P429, DOI 10.1016/j.otorri.2012.04.010; Prepageran N, 2005, ACTA OTO-LARYNGOL, V125, P48, DOI 10.1080/00016480410017981; Schubert MC, 2004, PHYS THER, V84, P151, DOI 10.1093/ptj/84.2.151; Ulmer E, 2005, Ann Otolaryngol Chir Cervicofac, V122, P84, DOI 10.1016/S0003-438X(05)82329-1; Ulmer E, 2011, EUR ANN OTORHINOLARY, V128, P278, DOI 10.1016/j.anorl.2011.05.005; Weber KP, 2009, ANN NY ACAD SCI, V1164, P486, DOI 10.1111/j.1749-6632.2008.03730.x; Weber KP, 2008, NEUROLOGY, V70, P454	36	17	17	0	13	AMER ACAD AUDIOLOGY	RESTON	11730 PLAZA DR, STE 300, RESTON, VA 20190 USA	1050-0545	2157-3107		J AM ACAD AUDIOL	J. Am. Acad. Audiol.	MAR	2014	25	3			SI		244	252		10.3766/jaaa.25.3.3			9	Audiology & Speech-Language Pathology; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Otorhinolaryngology	AL5CL	WOS:000339151000003	25032968				2022-02-06	
J	Baylor, C; McAuliffe, MJ; Hughes, LE; Yorkston, K; Anderson, T; Kim, J; Amtmann, D				Baylor, Carolyn; McAuliffe, Megan J.; Hughes, Louise E.; Yorkston, Kathryn; Anderson, Tim; Kim, Jiseon; Amtmann, Dagmar			A Differential Item Functioning (DIF) Analysis of the Communicative Participation Item Bank (CPIB): Comparing Individuals With Parkinson's Disease From the United States and New Zealand	JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH			English	Article						communicative participation; Parkinson's disease; dysarthria; outcomes measurement; item response theory; cultural and linguistic diversity	ORDINAL LOGISTIC-REGRESSION; TRAUMATIC BRAIN-INJURY; RESPONSE THEORY; SPEECH; OUTCOMES; LIFE; CALIBRATION; SYMPTOMS; SCALE	Purpose: To examine the cross-cultural applicability of the Communicative Participation Item Bank (CPIB) through a comparison of respondents with Parkinson's disease (PD) from the United States and New Zealand. Method: A total of 428 respondents-218 from the United States and 210 from New Zealand-completed the self-report CPIB and a series of demographic questions. Differential item functioning (DIF) analyses were conducted to examine whether response bias was present across the 2 groups. Results: No items were identified as having statistically significant DIF across the U.S. and N.Z. cohorts. Conclusion: The current CPIB items and scoring parameters are also suitable for use with respondents from New Zealand.	[Baylor, Carolyn; Yorkston, Kathryn; Kim, Jiseon; Amtmann, Dagmar] Univ Washington, Seattle, WA 98195 USA; [McAuliffe, Megan J.; Hughes, Louise E.] Univ Canterbury, Christchurch 1, New Zealand; [Anderson, Tim] New Zealand Brain Res Inst, Christchurch, New Zealand		Baylor, C (corresponding author), Univ Washington, Seattle, WA 98195 USA.	cbaylor@u.washington.edu		McAuliffe, Megan/0000-0003-3827-2215	National Institute on Deafness and Other Communication DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [1R03DC010044]; New Zealand Institute of Language, Brain and Behaviour; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R03DC010044] Funding Source: NIH RePORTER	This study was made possible by funding from the National Institute on Deafness and Other Communication Disorders (Grant 1R03DC010044; principal investigator Carolyn Baylor) and the New Zealand Institute of Language, Brain and Behaviour. We thank subjects for their time and efforts participating in this study. We would also like to acknowledge student research assistants in the United States who assisted with data collection, Christina Gray and Brittney Skrupky, and the Washington Parkinson's Disease Registry at the University of Washington. Assistance with participant recruitment in New Zealand was provided by Parkinson's New Zealand, the New Zealand Brain Research Institute, and speech therapists from district health boards across New Zealand.	Battle D., 2011, COMMUNICATION DISORD; Baylor C, 2013, J SPEECH LANG HEAR R, V56, P1190, DOI 10.1044/1092-4388(2012/12-0140); Baylor C, 2011, AM J SPEECH-LANG PAT, V20, P243, DOI 10.1044/1058-0360(2011/10-0079); Baylor CR, 2009, J SPEECH LANG HEAR R, V52, P1302, DOI 10.1044/1092-4388(2009/07-0275); Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Choi SW, 2011, J STAT SOFTW, V39, P1; Cook KF, 2011, ARCH PHYS MED REHAB, V92, P818, DOI 10.1016/j.apmr.2010.12.008; Cook KF, 2005, HEALTH SERV RES, V40, P1694, DOI 10.1111/j.1475-6773.2005.00446.x; Crane PK, 2007, QUAL LIFE RES, V16, P69, DOI 10.1007/s11136-007-9185-5; Crane PK, 2006, MED CARE, V44, pS115, DOI 10.1097/01.mlr.0000245183.28384.ed; Crane PK, 2004, STAT MED, V23, P241, DOI 10.1002/sim.1713; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Eadie TL, 2006, AM J SPEECH-LANG PAT, V15, P307, DOI 10.1044/1058-0360(2006/030); Embretson S.E., 2013, ITEM RESPONSE THEORY; Embretson SE, 1996, PSYCHOL ASSESSMENT, V8, P341, DOI 10.1037/1040-3590.8.4.341; HARTELIUS L, 1994, FOLIA PHONIATR LOGO, V46, P9, DOI 10.1159/000266286; JOHNSON JA, 1990, BRIT J DISORD COMMUN, V25, P183; Larkins BM, 2004, BRAIN INJURY, V18, P691, DOI 10.1080/02699050310001617389; Law M, 2002, AM J OCCUP THER, V56, P640, DOI 10.5014/ajot.56.6.640; McLellan K, 2011, NEW ZEAL MED J, V124, P48; Miller N, 2006, AGE AGEING, V35, P235, DOI 10.1093/ageing/afj053; Perenboom RJM, 2003, DISABIL REHABIL, V25, P577, DOI 10.1080/0963828031000137081; Reeve BB, 2007, MED CARE, V45, pS22, DOI 10.1097/01.mlr.0000250483.85507.04; Samejima F., 1969, PSYCHOMETRIC MONOGRA; Statistics New Zealand, 2006, 2006 CENS POP DWELL; WHITENECK GG, 1994, ARCH PHYS MED REHAB, V75, P1073, DOI 10.1016/0003-9993(94)90080-9; World Health Organization, 2007, INT CLASS FUNCT DIS; Yorkston KM, 2008, DISABIL REHABIL, V30, P425, DOI 10.1080/09638280701625328; Yorkston KM, 2007, FOLIA PHONIATR LOGO, V59, P107, DOI 10.1159/000101769	30	17	17	1	6	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	10801 ROCKVILLE PIKE, ROCKVILLE, MD 20852-3279 USA	1092-4388	1558-9102		J SPEECH LANG HEAR R	J. Speech Lang. Hear. Res.	FEB	2014	57	1					90	95		10.1044/1092-4388(2013/12-0414)			6	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	AZ0EM	WOS:000347919100008	24687470	Green Accepted			2022-02-06	
J	Head, J; Helton, WS				Head, James; Helton, William S.			Practice does not make perfect in a modified sustained attention to response task	EXPERIMENTAL BRAIN RESEARCH			English	Article						Attention; Response inhibition; Speed-accuracy trade-offs; Sustained attention; Vigilance	TRAUMATIC BRAIN-INJURY; REPEATED SESSIONS; SIGNAL; MIND; PERFORMANCE; VARIABILITY; SENSITIVITY; ENGAGEMENT; EXPERIENCE; DECREMENT	In the current investigation, we examined the changes in performance, task-related thoughts (TRT), and task-unrelated thoughts (TUT) over four sessions of a modified sustained attention to response task (SART). Eighteen participants completed a clockwise manual selection SART (Head and Helton in Conscious Cogn 22:913-919, 2013) and a conscious thought questionnaire once a week for four weeks. Response times and errors of commission oscillated over sessions in line with a motor strategy interpretation of the SART. As participants became faster in the task, they made more commission errors. The conscious thought questionnaire failed to show a relationship between errors of commission and TRT and TUT on the SART at either a between-subject or within-subject level of analysis. Commission errors in the SART may be better measures of executive motor control and response strategy than perceptual decoupling.	[Head, James; Helton, William S.] Univ Canterbury, Dept Psychol, Christchurch 1, New Zealand		Helton, WS (corresponding author), Univ Canterbury, Dept Psychol, Private Bag 4800, Christchurch 1, New Zealand.	deak.helton@canterbury.ac.nz					BAKAN P, 1955, J EXP PSYCHOL, V50, P387, DOI 10.1037/h0044041; Beilock SL, 2004, PSYCHON B REV, V11, P373, DOI 10.3758/BF03196585; BINFORD JR, 1966, J EXP PSYCHOL, V72, P339, DOI 10.1037/h0023633; COLE TB, 1988, AM J PUBLIC HEALTH, V78, P1585, DOI 10.2105/AJPH.78.12.1585; Dockree PM, 2006, EXP BRAIN RES, V168, P218, DOI 10.1007/s00221-005-0079-x; Dockree PM, 2004, COGNITIVE BRAIN RES, V20, P403, DOI 10.1016/j.cogbrainres.2004.03.019; Green AL, 2011, EXP BRAIN RES, V215, P307, DOI 10.1007/s00221-011-2898-2; Grier RA, 2003, HUM FACTORS, V45, P349, DOI 10.1518/hfes.45.3.349.27253; Hancock PA, 2013, AM PSYCHOL, V68, P97, DOI 10.1037/a0030214; He JB, 2011, HUM FACTORS, V53, P13, DOI 10.1177/0018720810391530; Head J, 2013, CONSCIOUS COGN, V22, P913, DOI 10.1016/j.concog.2013.06.003; Head J, 2012, CONSCIOUS COGN, V21, P1617, DOI 10.1016/j.concog.2012.08.009; Head J, 2012, EXP BRAIN RES, V216, P103, DOI 10.1007/s00221-011-2914-6; Helton W.S., 2013, P HUM FACTOR ERGON S, V57, No. 1, P1244, DOI [10.1177/1541931213571276, DOI 10.1177/1541931213571276]; Helton WS, 2008, ACTA PSYCHOL, V129, P18, DOI 10.1016/j.actpsy.2008.04.002; Helton WS, 2014, HUM FACTORS, V56, P322, DOI 10.1177/0018720813490727; Helton WS, 2011, EXP BRAIN RES, V212, P429, DOI 10.1007/s00221-011-2749-1; Helton WS, 2011, EXP BRAIN RES, V209, P401, DOI 10.1007/s00221-011-2563-9; Helton WS, 2011, PSYCHOL RES-PSYCH FO, V75, P384, DOI 10.1007/s00426-010-0316-1; Helton WS, 2009, CONSCIOUS COGN, V18, P600, DOI 10.1016/j.concog.2009.06.002; Helton WS, 2009, J CLIN EXP NEUROPSYC, V31, P39, DOI 10.1080/13803390801978856; Helton WS, 2005, BRIT J PSYCHOL, V96, P249, DOI 10.1348/000712605X38369; Johnson KA, 2007, NEUROPSYCHOLOGIA, V45, P630, DOI 10.1016/j.neuropsychologia.2006.03.034; Manly T, 1999, NEUROPSYCHOLOGIA, V37, P661, DOI 10.1016/S0028-3932(98)00127-4; Manly T, 2004, NEUROPSYCHOL REHABIL, V14, P89, DOI 10.1080/09602010343000110; Matthews G, 2002, EMOTION, V2, P315, DOI 10.1037//1528-3542.2.4.315; Maxwell S., 2004, DESIGNING EXPT ANAL; McAvinue L, 2005, NEUROPSYCHOL REHABIL, V15, P569, DOI 10.1080/09602010443000119; McVay JC, 2012, J EXP PSYCHOL GEN, V141, P302, DOI 10.1037/a0025250; Ossowski U, 2011, CONSCIOUS COGN, V20, P1649, DOI 10.1016/j.concog.2011.08.015; Peebles D, 2004, PROCEEDINGS OF THE SIXTH INTERNATIONAL CONFERENCE ON COGNITIVE MODELING, P231; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Seli P, 2013, BEHAV RES METHODS, V45, P355, DOI 10.3758/s13428-012-0266-1; Seli P, 2012, CONSCIOUS COGN, V21, P277, DOI 10.1016/j.concog.2011.09.017; Shaw TH, 2013, BRAIN COGNITION, V82, P265, DOI 10.1016/j.bandc.2013.05.003; Smallwood J, 2004, CONSCIOUS COGN, V13, P657, DOI 10.1016/j.concog.2004.06.003; Smallwood J, 2003, CONSCIOUS COGN, V12, P169, DOI 10.1016/S1053-8100(02)00003-X; Smallwood J, 2007, PSYCHON B REV, V14, P527, DOI 10.3758/BF03194102; Smallwood J, 2013, CAN J EXP PSYCHOL, V67, P32, DOI 10.1037/a0030760; Stevenson H, 2011, BRAIN COGNITION, V77, P215, DOI 10.1016/j.bandc.2011.08.007; THURMOND JB, 1970, PERCEPT PSYCHOPHYS, V7, P100, DOI 10.3758/BF03210142; WIENER EL, 1964, PERCEPT MOTOR SKILL, V18, P104, DOI 10.2466/pms.1964.18.1.104; Yanko MR, 2013, ACCIDENT ANAL PREV, V57, P80, DOI 10.1016/j.aap.2013.04.003; Zelenski JM, 2000, J RES PERS, V34, P178, DOI 10.1006/jrpe.1999.2275	44	17	17	0	5	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	FEB	2014	232	2					565	573		10.1007/s00221-013-3765-0			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	AA0GG	WOS:000330773000020	24247591				2022-02-06	
J	Rodriguez, RA; Bussiere, M; Froeschl, M; Nathan, HJ				Rodriguez, Rosendo A.; Bussiere, Miguel; Froeschl, Michael; Nathan, Howard J.			Auditory-evoked potentials during coma: Do they improve our prediction of awakening in comatose patients?	JOURNAL OF CRITICAL CARE			English	Article						Coma; Cardiac arrest; Auditory-evoked potentials; Awakening; Consciousness	EVENT-RELATED POTENTIALS; TRAUMATIC BRAIN-INJURY; CARDIAC-ARREST; MISMATCH NEGATIVITY; FUNCTIONAL OUTCOMES; STEM RESPONSES; RESUSCITATION; CONSCIOUSNESS; GUIDELINES; PROGNOSIS	Objective: The mismatch negativity (MMN), an auditory event-related potential, has been identified as a good indicator of recovery of consciousness during coma. We explored the predictive value of the MMN and other auditory-evoked potentials including brainstem and middle-latency potentials for predicting awakening in comatose patients after cardiac arrest or cardiogenic shock. Materials and Methods: Auditory brainstem, middle-latency (Pa wave), and event-related potentials (N100 and MMN waves) were recorded in 17 comatose patients and 9 surgical patients matched by age and coronary artery disease. Comatose patients were followed up daily to determine recovery of consciousness and classified as awakened and nonawakened. Results: Among the auditory-evoked potentials, the presence or absence of MMN best discriminated between patients who awakened or those who did not. Mismatch negativity was present during coma in all patients who awakened (7/7) and in 2 of those (2/10) who did not awaken. In patients who awakened and in whom MMN was detected, 3 of those awakened between 2 and 3 days and 4 between 9 and 21 days after evoked potential examination. All awakened patients had intact N100 waves and identifiable brainstem and middle-latency waves. In nonawakened patients, N100 and Pa waves were detected in 5 cases (50%) and brainstem waves in 9 (90%). Conclusions: The MMN is a good predictor of awakening in comatose patients after cardiac arrest and cardiogenic shock and can be measured days before awakening encouraging ongoing life support. (C) 2014 Elsevier Inc. All rights reserved.	[Rodriguez, Rosendo A.] Univ Ottawa, Inst Heart, Div Cardiac Surg, Ottawa, ON, Canada; [Rodriguez, Rosendo A.] Ottawa Hosp, Res Inst, Ottawa, ON K1H 8L6, Canada; [Bussiere, Miguel] Ottawa Hosp, Dept Med, Div Neurol, Ottawa, ON K1H 8L6, Canada; [Froeschl, Michael] Univ Ottawa, Inst Heart, Div Cardiol, Ottawa, ON, Canada; [Nathan, Howard J.] Univ Ottawa, Inst Heart, Div Cardiac Anesthesia, Ottawa, ON, Canada		Rodriguez, RA (corresponding author), Ottawa Hosp, Room L-2217,Box 180,501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.	rrodriguez@toh.on.ca					Bassetti C, 1996, J NEUROL NEUROSUR PS, V61, P610, DOI 10.1136/jnnp.61.6.610; Booth CM, 2004, JAMA-J AM MED ASSOC, V291, P870, DOI 10.1001/jama.291.7.870; CHIAPPA KH, 1983, EVOKED POTENTIALS CL, P105; Cullen NK, 2011, BRAIN INJURY, V25, P35, DOI 10.3109/02699052.2010.531691; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; Daltrozzo J, 2007, CLIN NEUROPHYSIOL, V118, P606, DOI 10.1016/j.clinph.2006.11.019; Fischer C, 2000, AUDIOL NEURO-OTOL, V5, P192, DOI 10.1159/000013880; Fischer C, 1999, CLIN NEUROPHYSIOL, V110, P1601, DOI 10.1016/S1388-2457(99)00131-5; Fischer C, 2006, CRIT CARE MED, V34, P1520, DOI 10.1097/01.CCM.0000215823.36344.99; FISCHER C, 1994, NEUROSURGERY, V35, P45, DOI 10.1227/00006123-199407000-00007; Guerit JM, 1999, CLIN NEUROPHYSIOL, V110, P1260, DOI 10.1016/S1388-2457(99)00061-9; HOMAN RW, 1987, ELECTROEN CLIN NEURO, V66, P376, DOI 10.1016/0013-4694(87)90206-9; Houlden DA, 2010, CRIT CARE MED, V38, P167, DOI 10.1097/CCM.0b013e3181c031b3; KAGA K, 1985, LARYNGOSCOPE, V95, P321; Luaute J, 2005, ARCH PHYS MED REHAB, V86, P917, DOI 10.1016/j.apmr.2004.08.011; NAATANEN R, 1995, EAR HEARING, V16, P6; Parkkonen L, 2009, HUM BRAIN MAPP, V30, P1772, DOI 10.1002/hbm.20788; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1111/1469-8986.3720127; PICTON TW, 1985, HUMAN COMMUNICATION, V9, P127; Pratt H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P69; Puettgen HA, 2007, J NEUROL SCI, V261, P108, DOI 10.1016/j.jns.2007.04.041; Rodriguez RA, 2013, ANN THORAC SURG, V95, P884, DOI 10.1016/j.athoracsur.2012.09.032; Rodriguez Rosendo A, 2004, Semin Cardiothorac Vasc Anesth, V8, P85, DOI 10.1177/108925320400800203; Schielke E, 2005, J NEUROL, V252, P648, DOI 10.1007/s00415-005-0711-5; TEASDALE G, 1974, LANCET, V2, P81; UZIEL A, 1978, ELECTROEN CLIN NEURO, V45, P515, DOI 10.1016/0013-4694(78)90295-X; Whyte J, 2001, ARCH PHYS MED REHAB, V82, P1355, DOI 10.1053/apmr.2001.26091; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; Wityk RJ, 2001, ARCH NEUROL-CHICAGO, V58, P571, DOI 10.1001/archneur.58.4.571; Young GB, 2009, NEW ENGL J MED, V361, P605, DOI 10.1056/NEJMcp0903466	30	17	21	0	11	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	FEB	2014	29	1					93	100		10.1016/j.jcrc.2013.08.020			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275QT	WOS:000328693000017	24125771				2022-02-06	
J	Huang, EYK; Tsui, PF; Kuo, TT; Tsai, JJ; Chou, YC; Ma, HI; Chiang, YH; Chen, YH				Huang, Eagle Yi-Kung; Tsui, Pi-Fen; Kuo, Tung-Tai; Tsai, Jing-Jr; Chou, Yu-Ching; Ma, Hsin-I; Chiang, Yung-Hsiao; Chen, Yuan-Hao			Amantadine Ameliorates Dopamine-Releasing Deficits and Behavioral Deficits in Rats after Fluid Percussion Injury	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; PLACEBO-CONTROLLED TRIAL; WATER MAZE PERFORMANCE; OXIDATIVE STRESS; BASAL GANGLIA; HEAD-INJURY; STRIATUM; METHYLPHENIDATE; TRANSPORTER	Aims: To investigate the role of dopamine in cognitive and motor learning skill deficits after a traumatic brain injury (TBI), we investigated dopamine release and behavioral changes at a series of time points after fluid percussion injury, and explored the potential of amantadine hydrochloride as a chronic treatment to provide behavioral recovery. Materials and Methods: In this study, we sequentially investigated dopamine release at the striatum and behavioral changes at 1, 2, 4, 6, and 8 weeks after fluid percussion injury. Rats subjected to 6-Pa cerebral cortical fluid percussion injury were treated by using subcutaneous infusion pumps filled with either saline (sham group) or amantadine hydrochloride, with a releasing rate of 3.6mg/kg/hour for 8 weeks. The dopamine-releasing conditions and metabolism were analyzed sequentially by fast scan cyclic voltammetry (FSCV) and high-pressure liquid chromatography (HPLC). Novel object recognition (NOR) and fixed-speed rotarod (FSRR) behavioral tests were used to determine treatment effects on cognitive and motor deficits after injury. Results: Sequential dopamine-release deficits were revealed in 6-Pa-fluid-percussion cerebral cortical injured animals. The reuptake rate (tau value) of dopamine in injured animals was prolonged, but the tau value became close to the value for the control group after amantadine therapy. Cognitive and motor learning impairments were shown evidenced by the NOR and FSRR behavioral tests after injury. Chronic amantadine therapy reversed dopamine-release deficits, and behavioral impairment after fluid percussion injuries were ameliorated in the rats treated by using amantadine-pumping infusion. Conclusion: Chronic treatment with amantadine hydrochloride can ameliorate dopamine-release deficits as well as cognitive and motor deficits caused by cerebral fluid-percussion injury.	[Huang, Eagle Yi-Kung; Tsui, Pi-Fen] Natl Def Med Ctr, Dept Pharmacol, Taipei, Taiwan; [Kuo, Tung-Tai] Natl Taipei Univ Technol, Grad Inst Comp & Commun Engn, Taipei 106, Taiwan; [Tsai, Jing-Jr; Ma, Hsin-I; Chen, Yuan-Hao] Triserv Gen Hosp, Natl Def Med Ctr, Dept Neurol Surg, Taipei, Taiwan; [Chou, Yu-Ching] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ, Taipei Med Univ Hosp, PhD Program Neural Regenerat Med, Dept Neurosurg,Grad Inst Neural Regenerat Med, Taipei, Taiwan		Chen, YH (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Dept Neurol Surg, Taipei, Taiwan.	nova.chenyuanhao@gmail.com	Chen, Yuan-Hao/U-6870-2019	Chen, Yuan-Hao/0000-0002-0570-4328	National Science Council of TaiwanMinistry of Science and Technology, Taiwan [NSC 101-2314-B-016-008]; Tri-Service General Hospital of Taiwan [TSGH-C101-084, TSGH-C100-033]	This work was supported by the National Science Council of Taiwan under grant NSC 101-2314-B-016-008, and by Medical Research Project grants TSGH-C101-084, and TSGH-C100-033 from the Tri-Service General Hospital of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOKI FY, 1988, CLIN PHARMACOKINET, V14, P35, DOI 10.2165/00003088-198814010-00003; Bales JW, 2011, EXP NEUROL, V229, P300, DOI 10.1016/j.expneurol.2011.02.013; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Bates G, 2006, DEV MED CHILD NEUROL, V48, P697, DOI 10.1017/S0012162206001472; Berman SB, 1996, J NEUROCHEM, V67, P593; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; CHAPMAN AG, 1989, NEUROSCI LETT, V107, P256, DOI 10.1016/0304-3940(89)90827-6; Chen YH, 2008, FASEB J, V22, P261, DOI 10.1096/fj.07-8797com; Chudasama Y, 2006, BIOL PSYCHOL, V73, P19, DOI 10.1016/j.biopsycho.2006.01.005; Crosson B, 2003, J INT NEUROPSYCH SOC, V9, P1061, DOI 10.1017/S135561770397010X; DIETRICH WD, 1994, J NEUROTRAUM, V11, P629, DOI 10.1089/neu.1994.11.629; Ding YC, 2001, NEUROL RES, V23, P193, DOI 10.1179/016164101101198334; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Felger JC, 2012, FRONT NEUROENDOCRIN, V33, P315, DOI 10.1016/j.yfrne.2012.09.003; FILLOUX F, 1991, SYNAPSE, V8, P281, DOI 10.1002/syn.890080406; FRITSCHY JM, 1992, J COMP NEUROL, V321, P421, DOI 10.1002/cne.903210309; Furman CA, 2009, J NEUROSCI, V29, P3328, DOI 10.1523/JNEUROSCI.5386-08.2009; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Goldstein LB, 2003, BRAIN INJURY, V17, P685, DOI 10.1080/0269905031000107179; Good CH, 2011, FASEB J, V25, P1333, DOI 10.1096/fj.10-173625; GRACE AA, 1983, NEUROSCIENCE, V10, P333, DOI 10.1016/0306-4522(83)90137-9; Granado N, 2008, CEREB CORTEX, V18, P1, DOI 10.1093/cercor/bhm026; Gualtieri C T, 1988, Brain Inj, V2, P101, DOI 10.3109/02699058809150936; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; HEIKKILA RE, 1972, EUR J PHARMACOL, V20, P156, DOI 10.1016/0014-2999(72)90144-6; Huang EYK, 2003, N-S ARCH PHARMACOL, V368, P386, DOI 10.1007/s00210-003-0803-7; KAWAGOE KT, 1993, J NEUROSCI METH, V48, P225, DOI 10.1016/0165-0270(93)90094-8; KLINE AE, 1994, PHARMACOL BIOCHEM BE, V48, P773, DOI 10.1016/0091-3057(94)90345-X; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; Kraus MF, 1997, J NEUROPSYCH CLIN N, V9, P222; Lemon N, 2006, J NEUROSCI, V26, P7723, DOI 10.1523/JNEUROSCI.1454-06.2006; Massucci JL, 2004, NEUROSCI LETT, V372, P127, DOI 10.1016/j.neulet.2004.09.026; Matsushita Y, 2000, ACTA NEUROCHIR SUPPL, V76, P207; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McMillan TM, 1997, CURR OPIN NEUROL, V10, P479, DOI 10.1097/00019052-199712000-00008; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; MIZOGUCHI K, 1994, BRAIN RES, V662, P255, DOI 10.1016/0006-8993(94)90821-4; OLNEY JW, 1990, EXP NEUROL, V108, P269, DOI 10.1016/0014-4886(90)90134-E; ONN SP, 1986, BRAIN RES, V376, P8, DOI 10.1016/0006-8993(86)90894-2; PHILLIPS LL, 1994, J NEUROTRAUM, V11, P641, DOI 10.1089/neu.1994.11.641; Pristupa ZB, 1998, SYNAPSE, V30, P79, DOI 10.1002/(SICI)1098-2396(199809)30:1<79::AID-SYN10>3.3.CO;2-I; Ridley RM, 2006, BEHAV BRAIN RES, V166, P253, DOI 10.1016/j.bbr.2005.08.007; Sabeti J, 2002, J NEUROSCI METH, V121, P41, DOI 10.1016/S0165-0270(02)00229-7; Sawyer E, 2008, ANN PHARMACOTHER, V42, P247, DOI 10.1345/aph.1K284; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Shin SS, 2011, BRAIN RES, V1369, P208, DOI 10.1016/j.brainres.2010.10.096; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; Shojo H, 2006, BRAIN RES, V1078, P198, DOI 10.1016/j.brainres.2006.01.063; Takahashi T, 1996, BRAIN RES BULL, V41, P363, DOI 10.1016/S0361-9230(96)00211-0; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Von Voigtlander P F, 1971, Science, V174, P408, DOI 10.1126/science.174.4007.408; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Wang T, 2013, J NEUROTRAUMA; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; Williams SE, 1998, J HEAD TRAUMA REHAB, V13, P73, DOI 10.1097/00001199-199806000-00007; Williams SE, 2007, BRAIN INJURY, V21, P885, DOI 10.1080/02699050701553213; Wilson MS, 2005, J NEUROSCI RES, V80, P85, DOI 10.1002/jnr.20419; Yan HQ, 2002, NEUROREPORT, V13, P1899, DOI 10.1097/00001756-200210280-00013; Zafonte RD, 1998, BRAIN INJURY, V12, P617; Zhuang XX, 2001, P NATL ACAD SCI USA, V98, P1982, DOI 10.1073/pnas.98.4.1982	63	17	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86354	10.1371/journal.pone.0086354			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	WOS:000330617100013	24497943	Green Published, gold, Green Submitted			2022-02-06	
J	Torrente, D; Mendes-Da-Silva, RF; Lopes, AAC; Gonzalez, J; Barreto, GE; Guedes, RCA				Torrente, Daniel; Mendes-da-Silva, Rosangela Figueiredo; Cunha Lopes, Andreia Albuquerque; Gonzalez, Janneth; Barreto, George E.; Araujo Guedes, Rubem Carlos			Increased calcium influx triggers and accelerates cortical spreading depression in vivo in male adult rats	NEUROSCIENCE LETTERS			English	Article						Ca2+ influx; Ionophore; Cortical spreading depression; Rat	BRAIN; CELLS; CHANNELS; A23187; CA2+	Cortical spreading depression (CSD) is a depolarization wave associated with neurological disorders such as migraine, cerebral ischemia and traumatic brain injury. The mechanism of action of this phenomenon still remains unclear. Although it is suggested that extracellular K+ accumulation contributes to CSD, other ions may play a relevant role in the mechanism of propagation of the wave. In this context, we hypothesize that Ca2+ may play an important function in the wave propagation. Our results demonstrate that enhancing Ca2+ influx into the cells by topical cortical application of the ionophore A23187 (10 mu M, 50 mu M and 100 mu M solutions) increases the velocity of CSD propagation in a dose-dependent manner, and a much higher dose of this compound (2 mM) triggers CSD. In conclusion, increased Ca2+ influx can be a key element in the induction mechanism of the CSD, and should be assessed in further experimental strategies targeting brain disorders related to CSD. (C) 2013 Elsevier Ireland Ltd. All rights reserved.	[Torrente, Daniel; Gonzalez, Janneth; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia; [Mendes-da-Silva, Rosangela Figueiredo; Cunha Lopes, Andreia Albuquerque; Araujo Guedes, Rubem Carlos] Univ Fed Pernambuco, Dept Nutr, Ctr Ciencias Saude, BR-50670901 Recife, PE, Brazil		Guedes, RCA (corresponding author), Univ Fed Pernambuco, Dept Nutr, Ctr Ciencias Saude, Rua Prof Moraes Rego,S-N Cidade Univ, BR-50670901 Recife, PE, Brazil.	guedes.rca@gmail.com	Guedes, Rubem C. A./A-3246-2008; Barreto, George E./B-5747-2014; Barreto, George E./AAD-7420-2020; GONZALEZ, JANNETH/AAB-9948-2020; Guedes, Rubem/AAF-3426-2020	Guedes, Rubem C. A./0000-0002-2396-4019; Barreto, George E./0000-0002-6644-1971; Barreto, George E./0000-0002-6644-1971; GONZALEZ, JANNETH/0000-0003-2009-3374; Guedes, Rubem/0000-0002-2396-4019; Morais, Andreia/0000-0002-9351-2552; Mendes da Silva, Rosangela/0000-0002-4659-1534; Gonzalez, Janneth/0000-0003-4482-256X	PUJ [5024, 4367]; PROLAB IBRO/LARC CNPq - Convenio Brazil/ColombiaConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); CNPq (INCT de Neurociencia Translacional) [573604/2008-8]; Edital MCT/CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [477456/2010-3]; IBN-Net/FinepFinanciadora de Inovacao e Pesquisa (Finep) [4191]	This work was supported in part by PUJ grants IDs 5024 and 4367, and PROLAB IBRO/LARC CNPq - Convenio Brazil/Colombia to GEB, and by CNPq (INCT de Neurociencia Translacional; No. 573604/2008-8); Edital MCT/CNPq 14/2010 (No. 477456/2010-3) and IBN-Net/Finep (No. 4191) to RCAG.	Amancio-dos-Santos A, 2013, EUR J PHARMACOL, V706, P70, DOI 10.1016/j.ejphar.2013.02.047; AMEMORI T, 1987, NEUROSCIENCE, V22, P29, DOI 10.1016/0306-4522(87)90195-3; Brittain MK, 2012, NEUROBIOL DIS, V46, P109, DOI 10.1016/j.nbd.2011.12.051; COLQUHOUN D, 1981, NATURE, V294, P752, DOI 10.1038/294752a0; Erdahl WL, 1995, BIOPHYS J, V69, P2350, DOI 10.1016/S0006-3495(95)80104-9; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; KRAIG RP, 1978, NEUROSCIENCE, V3, P1045, DOI 10.1016/0306-4522(78)90122-7; Kuge Y, 2000, J NEUROL SCI, V176, P114, DOI 10.1016/S0022-510X(00)00327-0; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; MARTINA M, 1994, J MEMBRANE BIOL, V142, P209, DOI 10.1007/BF00234942; PARTRIDGE LD, 1988, TRENDS NEUROSCI, V11, P69, DOI 10.1016/0166-2236(88)90167-1; Racay P, 1996, GEN PHYSIOL BIOPHYS, V15, P273; Shi Y, 2007, BRIT J PHARMACOL, V150, P624, DOI 10.1038/sj.bjp.0706999; SIESJO BK, 1989, J CEREBR BLOOD F MET, V9, P127, DOI 10.1038/jcbfm.1989.20; Smith JM, 2006, BIOL REV, V81, P457, DOI 10.1017/S1464793106007081; Smith MI, 2000, CEPHALALGIA, V20, P546, DOI 10.1046/j.1468-2982.2000.00092.x; Van Harreveld A., 1970, BIBL PSYCHIAT, V143, P62; WANG XY, 1994, J BIOCHEM-TOKYO, V116, P858, DOI 10.1093/oxfordjournals.jbchem.a124607; YOUNG W, 1992, J NEUROTRAUM, V9, pS9	20	17	17	0	9	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JAN 13	2014	558						87	90		10.1016/j.neulet.2013.11.004			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AK5QO	WOS:000338481300017	24246901	hybrid			2022-02-06	
J	Andersen, J; Kot, N; Ennis, N; Colantonio, A; Ouchterlony, D; Cusimano, MD; Topolovec-Vranic, J				Andersen, Jackie; Kot, Nadine; Ennis, Naomi; Colantonio, Angela; Ouchterlony, Donna; Cusimano, Michael D.; Topolovec-Vranic, Jane			Traumatic brain injury and cognitive impairment in men who are homeless	DISABILITY AND REHABILITATION			English	Article						Cognitive symptoms; homeless persons; men; traumatic brain injury	RELIABILITY; VALIDITY; SAMPLE; HEALTH; DEFICITS; BATTERY; HOSTEL; MEMORY; ADULTS; RBANS	Purpose: To examine cognitive performance among a sample of men in a residential unit of an urban homeless shelter and to compare cognitive performance between those with and without a history of traumatic brain injury (TBI). Methods: An exploratory, quantitative study of participants recruited through convenience sampling. Participants were screened for TBI using the Brain Injury Screening Questionnaire, and cognitive function using the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). Data were analyzed to examine associations between TBI status and cognitive performance. Results: Thirty-four participants were recruited for the study: n = 12 with a positive and n = 22 with a negative screen for TBI. Both groups performed below norms in all cognitive domains measured by the RBANS. Those with a positive screen for TBI performed significantly worse on attention tasks than those with a negative screen for TBI (p = 0.026). RBANS scores were not associated with either mental health or substance abuse status. Conclusions: A history of TBI was associated with generally poorer cognitive performance in the study sample. An improved awareness of TBI and cognitive dysfunction among service providers and routine TBI screening could improve treatment and service delivery for this population.	[Andersen, Jackie; Kot, Nadine; Colantonio, Angela; Topolovec-Vranic, Jane] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Ennis, Naomi; Ouchterlony, Donna; Cusimano, Michael D.; Topolovec-Vranic, Jane] St Michaels Hosp, Trauma & Neurosurg Program, Toronto, ON M5B 1W8, Canada; [Colantonio, Angela] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Ouchterlony, Donna] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [Cusimano, Michael D.] Univ Toronto, Div Neurosurg, Toronto, ON, Canada; [Cusimano, Michael D.; Topolovec-Vranic, Jane] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada		Topolovec-Vranic, J (corresponding author), St Michaels Hosp, Trauma & Neurosurg Program, 30 Bond St,Bond 3-012, Toronto, ON M5B 1W8, Canada.	topolovec-vranicj@smh.ca	Topolovec-Vranic, Jane/A-5293-2013; Cusimano, Michael/X-4059-2019	Topolovec-Vranic, Jane/0000-0001-7695-4212; Colantonio, Angela/0000-0003-2094-4765; Cusimano, Michael/0000-0002-9989-0650	St. Michael's Hospital Head Injury Clinic; Canadian Institutes of Health Research (CIHR) Traumatic Brain Injury and Violence Research TeamCanadian Institutes of Health Research (CIHR) [TIR-103946]; CIHR Chair in Gender, Work and HealthCanadian Institutes of Health Research (CIHR) [CGW-126580]; Saunderson Family Chair in Acquired Brain Injury Research, Toronto Rehabilitation Institute	The authors report no declarations of interest. Funding for this project was provided by the St. Michael's Hospital Head Injury Clinic, and the Canadian Institutes of Health Research (CIHR) Traumatic Brain Injury and Violence Research Team (# TIR-103946). Support for Dr Colantonio was obtained from the CIHR Chair in Gender, Work and Health (#CGW-126580) and the Saunderson Family Chair in Acquired Brain Injury Research, Toronto Rehabilitation Institute.	Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Backer Thomas Earl, 2007, J Prim Prev, V28, P375, DOI 10.1007/s10935-007-0100-1; Bremner AJ, 1996, BRIT J PSYCHIAT, V169, P434, DOI 10.1192/bjp.169.4.434; Burra TA, 2009, CAN J PSYCHIAT, V54, P123, DOI 10.1177/070674370905400210; Cantor JB, 2006, J HEAD TRAUMA REHAB, V21, P424, DOI 10.1097/00001199-200609000-00039; CDC, 2003, REP C MILD TRAUM BRA; Cicerone KD, 2002, BRAIN INJURY, V16, P185, DOI 10.1080/02699050110103959; COHEN CI, 1988, J GERONTOL, V43, pS121, DOI 10.1093/geronj/43.4.S121; COHEN CI, 1988, GERONTOLOGIST, V28, P58, DOI 10.1093/geront/28.1.58; COHEN CI, 1988, J AM GERIATR SOC, V36, P492, DOI 10.1111/j.1532-5415.1988.tb04018.x; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cowan N., 1995, ATTENTION MEMORY INT; Department for Children Schools and Families, 2008, TRANSF SOC CAR, P1; Der G, 2010, AGING NEUROPSYCHOL C, V17, P55, DOI 10.1080/13825580903009071; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; Eslinger PJ, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P990; Faul M, TRAUMATIC BRAIN INJU; Fichter MM, 1996, EUR ARCH PSY CLIN N, V246, P185, DOI 10.1007/BF02188952; Gilchrist G, 2005, EUR J PUBLIC HEALTH, V15, P587, DOI 10.1093/eurpub/cki036; Gillen G., 2009, COGNITIVE PERCEPTUAL; Gonzalez EA, 2001, J NERV MENT DIS, V189, P176, DOI 10.1097/00005053-200103000-00006; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; Gordon WA, 2010, BRAIN INJURY SCREENI; GRIEVE J, 2000, NEUROPSYCHOLOGY OCCU; HCH Clinicians' Network, 2003, HEALING HANDS, V7, P1; Highley JL, 2008, NASHVILLE HLTH CARE; Hodges JR, 2012, COGNITIVE ASSESSMENT; Hux K, 2009, BRAIN INJURY, V23, P8, DOI 10.1080/02699050802590353; Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341; Lafferty B, 2010, JNP-J NURSE PRACT, V6, P358; Lehmkul D, 1988, TIRR SYMPTOM CHECKLI; LEVIN HS, 1982, NEUROBEHAVIOURAL CON; Mateer C.A., 1987, J HEAD TRAUMA REHAB, V2, P74, DOI DOI 10.1097/00001199-198709000-00009; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; Mckay C, 2008, CLIN NEUROPSYCHOL, V22, P228, DOI 10.1080/13854040701260370; McKay C, 2007, ARCH CLIN NEUROPSYCH, V22, P91, DOI 10.1016/j.acn.2006.11.003; Picard M, 1991, HELPS BRIEF SCREENIN; Randolph C., 1998, REPEATABLE BATTERY A; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Sacks AL, 2009, J DUAL DIAGN, V5, P404, DOI 10.1080/15504260903182755; Seidman LJ, 2003, PSYCHIAT SERV, V54, P905, DOI 10.1176/appi.ps.54.6.905; Sohlberg M., 2001, COGNITIVE REHABILITA; Solliday-McRoy C, 2004, J NERV MENT DIS, V192, P471, DOI 10.1097/01.nmd.0000131962.30547.26; Spence S, 2004, J ROY SOC MED, V97, P375, DOI 10.1258/jrsm.97.8.375; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Wald M. M., 2008, BRAIN INJURY PROFESS, V5, P22	48	17	17	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2014	36	26					2210	2215		10.3109/09638288.2014.895870			6	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	AW4MS	WOS:000346255900003	24621413				2022-02-06	
J	Block, C; Fabrizio, K; Bagley, B; Hannah, J; Camp, S; Mindingall, N; Labbe, D; Lokken, K				Block, Cady; Fabrizio, Katherine; Bagley, Beau; Hannah, Joanna; Camp, Susan; Mindingall, Nazaren; Labbe, Don; Lokken, Kristine			Assessment of Veteran and Caregiver Knowledge About Mild Traumatic Brain Injury in a VA Medical Center	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						attitudes; knowledge; practice; health knowledge; veterans; military personnel; brain injuries	POSTCONCUSSION SYNDROME; INFORMATIONAL CASCADES; WAR VETERANS; MISCONCEPTIONS; CONCUSSION; IRAQ; AFGHANISTAN; SURVIVORS; TERMINOLOGY; DEPLOYMENT	Objective: To examine the accuracy of knowledge about mild traumatic brain injury (TBI) of veterans and their friends/family members. Setting: VA Medical Center. Participants: One hundred veterans and 50 of their friends/family members. Design: Cross-sectional survey. Main Measures: A 60-item questionnaire was created by drawing both from the Neurobehavioral Symptom Inventory and from a brain injury knowledge survey developed for use with the general public. Results: Both groups were equally able to identify true mild TBI items, but both also endorsed numerous items not typical of a mild injury. Self-reported prior TBI and receipt of TBI education were unrelated to the level of knowledge. For both groups, knowing another individual with TBI was unrelated to other aspects of mild TBI knowledge. Only 1 in 5 veterans endorsed receiving brain injury education while in the military. Conclusion: Results of this study may assist in the development of targeted TBI educational interventions for veterans and their friends/family members within the Veterans Affairs system. Ultimately, increased knowledge about mild TBI improves the likelihood that veterans receive care congruent with their needs and may potentially improve outcomes for those with mild TBI.	[Block, Cady; Fabrizio, Katherine; Labbe, Don] Univ Alabama Birmingham, Div Med Clin Psychol, Dept Psychol, Birmingham, AL 35294 USA; [Bagley, Beau; Hannah, Joanna; Camp, Susan; Mindingall, Nazaren; Lokken, Kristine] Birmingham Vet Affairs Med Ctr, Dept Phys Med & Rehabil, Birmingham, AL USA		Block, C (corresponding author), Univ Alabama Birmingham, Div Med Clin Psychol, CH 201,1530 3rd Ave S, Birmingham, AL 35294 USA.	cblock@uab.edu	Block, Cady/I-3078-2014	Block, Cady/0000-0001-7168-6116			Ahmed OH, 2010, DISABIL REHABIL, V32, P1877, DOI 10.3109/09638281003734409; [Anonymous], 2010, SOCIAL LIFE HLTH INF; Baxendale S, 2004, BMJ-BRIT MED J, V329, P1480, DOI 10.1136/bmj.329.7480.1480; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; BIKHCHANDANI S, 1992, J POLIT ECON, V100, P992, DOI 10.1086/261849; Bikhchandani S, 1998, J ECON PERSPECT, V12, P151, DOI 10.1257/jep.12.3.151; Binder LM, 1999, ARCH CLIN NEUROPSYCH, V14, P531, DOI 10.1016/S0887-6177(98)00047-X; Bush NE, 2012, TELEMED E-HEALTH, V18, P253, DOI 10.1089/tmj.2011.0131; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Deidan C, 2002, STUD NEUROPSYCHOL DE, P281; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Evans K, 2009, CONT ISSUES COMMUN S, V36, P166; Faul M, 2010, TRAUMATIC BRAIN INJU; Gordon KE, 2010, PEDIATR NEUROL, V43, P253, DOI 10.1016/j.pediatrneurol.2010.05.012; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P331; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Hux K, 2006, BRAIN INJURY, V20, P547, DOI 10.1080/02699050600676784; Jackson H, 2001, NEUROREHABILITATION, V16, P27; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; LEZAK MD, 1978, AM J PHYS MED REHAB, V57, P9; Linden MA, 2006, ARCH CLIN NEUROPSYCH, V21, P763, DOI 10.1016/j.acn.2006.08.010; Linden MA, 2010, BRAIN INJURY, V24, P642, DOI 10.3109/02699051003601689; Linden MA, 2005, BRAIN INJURY, V19, P1011, DOI 10.1080/02699050500110314; McClure J, 2011, REHABIL PSYCHOL, V56, P85, DOI 10.1037/a0023354; McCrea M., 2008, MILD TRAUMATIC BRAIN; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; MORROW KA, 1992, J COUNS DEV, V70, P571, DOI 10.1002/j.1556-6676.1992.tb01663.x; O'Jile JR., 1997, INT J REHABILITATION, V3, P61, DOI [10.1007/BF02766798, DOI 10.1007/BF02766798]; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Risher P, 2000, PUBLIC PERCEPTIONS B; Ruff RM, 2009, PSYCHOL INJ LAW, V2, P34, DOI 10.1007/s12207-009-9029-4; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Springer JA, 1997, J HEAD TRAUMA REHAB, V12, P41, DOI 10.1097/00001199-199706000-00005; Sullivan SJ, 2012, BRIT J SPORT MED, V46, P258, DOI 10.1136/bjsm.2010.080341; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; U.S. Department of Defense Task Force on Mental Health, 2007, ACH VIS REP DEP DEF; US Centers for Disease Control and Prevention, 2012, TRAUMATIC BRAIN INJU; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weber M, 2010, BRAIN INJURY, V24, P1364, DOI 10.3109/02699052.2010.507110; WILLER B, 1993, ARCH CLIN NEUROPSYCH, V8, P461, DOI 10.1016/0887-6177(93)90009-P; [No title captured]	48	17	17	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2014	29	1					76	88		10.1097/HTR.0b013e3182886d78			13	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AH1OC	WOS:000335889400013	23524877				2022-02-06	
J	Cotrena, C; Branco, LD; Zimmermann, N; Cardoso, CO; Grassi-Oliveira, R; Fonseca, RP				Cotrena, Charles; Branco, Laura Damiani; Zimmermann, Nicolle; Cardoso, Caroline Oliveira; Grassi-Oliveira, Rodrigo; Fonseca, Rochele Paz			Impaired decision-making after traumatic brain injury: The Iowa Gambling Task	BRAIN INJURY			English	Article						Decision-making; executive functions; Iowa Gambling Task; traumatic brain injury	DIFFUSE AXONAL INJURY; PREFRONTAL CORTEX; NEUROPSYCHIATRIC COMPLICATIONS; FUTURE CONSEQUENCES; HEAD-INJURY; PERFORMANCE; DAMAGE; DIAGNOSIS; SEQUELAE; LESIONS	The Summary: The aim of the present study was to use the Iowa Gambling Task (IGT) to investigate differences in decision-making (DM) between patients who sustained TBI and healthy subjects, while controlling for age, education and gender. Methods: A hundred and ten participants, half of whom had severe or mild TBI, completed the IGT. Results: Differences between control participants and patients with TBI were found regarding total net score, block score, number of selections from each deck and classification of performance as impaired or unimpaired. No significant differences in IGT performance were found between patients with and without frontal lesions and between patients with mild and severe TBI. Conclusions: Results indicate poor DM on the IGT in patients with TBI, regardless of lesion location and severity. The instrument proved to be equally sensitive to both frontal and extrafrontal lesions and did not differentiate between patients with mild and severe TBI.	[Cotrena, Charles; Branco, Laura Damiani; Zimmermann, Nicolle; Cardoso, Caroline Oliveira; Grassi-Oliveira, Rodrigo; Fonseca, Rochele Paz] Pontificia Univ Catolica Rio Grande do Sul, Dept Psychol, Porto Alegre, RS, Brazil		Cotrena, C (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Dept Psychol, Clin & Expt Neuropsychol Res Grp, Av Ipiranga,6681 Predio 11-9 Andar,Sala 932, Porto Alegre, RS, Brazil.	c.cotrena@gmail.com	Cotrena, Charles/J-7979-2014; Branco, Laura Damiani/I-7438-2019; Grassi-Oliveira, R/G-2623-2012	Cotrena, Charles/0000-0002-3573-7809; Grassi-Oliveira, R/0000-0001-9911-5921; ZIMMERMANN, NICOLLE/0000-0003-4771-4070; Branco, Laura Damiani/0000-0001-7967-7142; Cardoso, Caroline/0000-0002-3720-0845			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Anderson CV, 1995, J CLIN EXP NEUROPSYC, V17, P900, DOI 10.1080/01688639508402438; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bechara A, 2002, NEUROPSYCHOLOGIA, V40, P1675, DOI 10.1016/S0028-3932(02)00015-5; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Bechara A., 2007, IOWA GAMBLING TASK P; Bonatti E, 2008, COGN BEHAV NEUROL, V21, P164, DOI 10.1097/WNN.0b013e318184e688; Bootes K, 2010, WORK, V36, P207, DOI [10.3233/WOR-2010-01021, 10.3233/WOR-2010-1021]; CHAVES MLF, 1992, ACTA NEUROL SCAND, V85, P378; DAMASIO A. R.=, 1996, ERRO DESCARTES EMOCA; Fellows LK, 2007, CEREB CORTEX, V17, P2669, DOI 10.1093/cercor/bhl176; Fonseca R. P., 2012, METODOS NEUROCIENCIA, P300; Fonseca Rochele Paz, 2012, Psychol. Neurosci., V5, P183, DOI 10.3922/j.psns.2012.2.08; Fonseca Rochele Paz, 2008, Psychol. Neurosci., V1, P55, DOI 10.1590/S1983-32882008000100009; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; Garcia-Molina A, 2007, NEUROLOGIA, V22, P206; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Hanten G, 2006, NEUROCASE, V12, P247, DOI 10.1080/13554790600910490; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P663, DOI 10.1007/978-0-387-76978-3_21; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Levine B, 2005, COGN BEHAV NEUROL, V18, P45, DOI 10.1097/01.wnn.0000152227.13001.c3; LEZAK MD, 1998, NEUROPSYCHOLOGICAL A; Li XR, 2010, HUM BRAIN MAPP, V31, P410, DOI 10.1002/hbm.20875; MacPherson SE, 2009, CLIN NEUROPSYCHOL, V23, P510, DOI 10.1080/13854040802396586; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Reeves RR, 2011, J PSYCHOSOC NURS MEN, V49, P42, DOI 10.3928/02793695-20110201-03; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Schneider Daniela Di Giorgio, 2006, Psicol. Reflex. Crit., V19, P442, DOI 10.1590/S0102-79722006000300013; Sigurdardottir S, 2010, NEUROPSYCHOLOGY, V24, P504, DOI 10.1037/a0018934; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; TEASDALE G, 1974, LANCET, V2, P81; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; van Noordt S, 2011, BRAIN INJURY, V25, P707, DOI 10.3109/02699052.2011.580312; Wiederkehr S, 2005, REV NEUROL-FRANCE, V161, P201, DOI 10.1016/S0035-3787(05)85023-4; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Yacubian J, 2007, NEUROIMAGE, V38, P557, DOI 10.1016/j.neuroimage.2007.08.007; Zgaljardic DJ, 2010, APPL NEUROPSYCHOL, V17, P283, DOI 10.1080/09084282.2010.525118	40	17	18	1	7	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	8					1070	1075		10.3109/02699052.2014.896943			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AI6KP	WOS:000336983200007	24654680				2022-02-06	
J	Ekici, MA; Uysal, O; Cikriklar, HI; Ozbek, Z; Cosan, DT; Baydemir, C; Kazanci, B; Hafizoglu, D				Ekici, M. A.; Uysal, O.; Cikriklar, H. I.; Ozbek, Z.; Cosan, D. Turgut; Baydemir, C.; Kazanci, B.; Hafizoglu, D.			Effect of etanercept and lithium chloride on preventing secondary tissue damage in rats with experimental diffuse severe brain injury	EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES			English	Article						Traumatic brain injury; Etanercept; Lithium chloride; TNF-alpha	NECROSIS-FACTOR-ALPHA; SPINAL-CORD-INJURY; FIBRILLARY ACIDIC PROTEIN; FOCAL CEREBRAL-ISCHEMIA; TAU-PROTEIN; RHEUMATOID-ARTHRITIS; NEURONAL DAMAGE; TNF-ALPHA; EXPRESSION; MODEL	OBJECTIVE: Studies in animals have provided key evidence that antagonizing TNF-alpha is a viable therapeutic strategy for diffuse severe brain injury. This study is planned to prevent post-traumatic secondary tissue damages in rat diffuse severe brain injury model, which is induced by alone or combined administration of Etanercept and lithium chloride (LiCl). MATERIALS AND METHODS: Male SpragueDawley rats were used in the current study. Rats were divided into 5 groups. Trauma was not induced and treatment was not applied to rats of Sham group. For rats of Trauma+Saline group, saline 0.9% was administered via intraperitoneal (i.p.) route at dose of 1 mg/100 g body weight 1 hour after trauma. For rats of Trauma+Etanercept group, Etanercept was administered via i.p. route at dose of 5 mg/kg body weight 1 hour after trauma. For rats of Trauma+LiCl group, LiCl was administered via i.p. route at dose of 50 mg/kg body weight 1 hour after trauma. For rats of Etanercept+LiCl group, Etanercept and LiCl were administered via i.p. route at dose of 5 mg/kg body weight and 50 mg/kg body weight, respectively, 1 hour after trauma. Serum glial fibrillary acidic protein (GFAP) and Tau levels were analyzed with ELISA. For analyses H&E, TUNEL, GFAP and TNF-alpha staining methods were used. RESULTS: We demonstrate that Etanercept treatment reduced the TBI-induced brain tissues alteration, reduced the expression of TNF-alpha and improve edema and axonal swelling. We observed a significant decrease in TNF-alpha and GFAP positivity after LiCl was administered. CONCLUSIONS: The findings obtained in this study suggest that the combination therapy with Etanercept and LiCl decreased neuronal degeneration and alleviated secondary tissue damage in post-traumatic period.	[Ekici, M. A.] Sevket Yilmaz Res & Training Hosp, Neurosurg Clin, Minist Hlth, Bursa, Turkey; [Uysal, O.] Eskisehir Osmangazi Univ, Vocat Sch Hlth Serv, Eskisehir, Turkey; [Cikriklar, H. I.] Sevket Yilmaz Res & Training Hosp, Emergency Clin, Minist Hlth, Bursa, Turkey; [Ozbek, Z.] Eskisehir Osmangazi Univ, Fac Med, Dept Neurosurg, Eskisehir, Turkey; [Cosan, D. Turgut] Eskisehir Osmangazi Univ, Fac Med, Dept Med Biol, Eskisehir, Turkey; [Baydemir, C.] Eskisehir Osmangazi Univ, Fac Med, Dept Biostat, Eskisehir, Turkey; [Kazanci, B.] Ufuk Univ, Fac Med, Dept Neurosurg, Ankara, Turkey; [Hafizoglu, D.] Uludag Univ, Fac Med, Dept Pediat Immunol, Bursa, Turkey		Uysal, O (corresponding author), Eskisehir Osmangazi Univ, Vocat Sch Hlth Serv, Eskisehir, Turkey.	ouysal1971@gmail.com	Cosan, Didem Turgut/ABC-1466-2020; cikriklar, halil ibrahim/AAH-8714-2021; UYSAL, ONUR/W-4144-2017; Ekici, Mehmet Ali/ABE-1571-2020	Cosan, Didem Turgut/0000-0002-8488-6405; UYSAL, ONUR/0000-0001-6800-5607; 			Albert-WeiSSenberger Christiane, 2012, Exp Transl Stroke Med, V4, P1, DOI 10.1186/2040-7378-4-1; Ananiadou Olga G, 2005, Interact Cardiovasc Thorac Surg, V4, P597; Campbell SJ, 2007, J NEUROCHEM, V103, P2245, DOI 10.1111/j.1471-4159.2007.04928.x; Chen G, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/716458; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Chio CC, 2010, J NEUROCHEM, V115, P921, DOI 10.1111/j.1471-4159.2010.06969.x; Conroy BP, 2001, ANN THORAC SURG, V71, P1325, DOI 10.1016/S0003-4975(01)02401-8; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Fix AS, 1996, TOXICOL PATHOL, V24, P291, DOI 10.1177/019262339602400305; Genovese T, 2007, NEUROSCIENCE, V150, P168, DOI 10.1016/j.neuroscience.2007.06.059; Genovese T, 2006, J PHARMACOL EXP THER, V316, P1006, DOI 10.1124/jpet.105.097188; Gong C, 1998, BRAIN RES, V801, P1, DOI 10.1016/S0006-8993(98)00489-2; Hang CH, 2004, BRAIN RES, V1026, P23, DOI 10.1016/j.brainres.2004.07.090; Hausmann R, 2000, INT J LEGAL MED, V113, P70, DOI 10.1007/PL00007711; Herrera DG, 1998, BRAIN RES, V784, P71, DOI 10.1016/S0006-8993(97)01162-1; Hortobagyi T, 2008, ACNR, V8, P16; Irazuzta JE, 2001, BRAIN RES, V913, P95, DOI 10.1016/S0006-8993(01)02764-0; Isaksson J, 2001, ACTA NEUROPATHOL, V102, P246; Kalayci M, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-75; Kato K, 2010, J NEUROSCI RES, V88, P360, DOI 10.1002/jnr.22202; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Kita T, 1997, INT J LEGAL MED, V110, P305, DOI 10.1007/s004140050093; Lafuente JV, 2007, NEUROSCI RES, V57, P354, DOI 10.1016/j.neures.2006.11.005; Lee EJ, 2010, ANN DERMATOL, V22, P138, DOI 10.5021/ad.2010.22.2.138; Li FH, 2002, AM J NEURORADIOL, V23, P180; Liliang PC, 2010, RESUSCITATION, V81, P1205, DOI 10.1016/j.resuscitation.2010.05.016; Lin HW, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-15; LIU T, 1994, STROKE, V25, P1481, DOI 10.1161/01.STR.25.7.1481; Lopez NE, 2012, J TRAUMA ACUTE CARE, V72, P1562, DOI 10.1097/TA.0b013e3182569875; Lopez NE, 2012, J NEUROTRAUM, V29, P385, DOI 10.1089/neu.2011.2053; Mao M, 2006, NEUROSCI LETT, V403, P227, DOI 10.1016/j.neulet.2006.03.078; Marchand F, 2009, EUR J PAIN, V13, P673, DOI 10.1016/j.ejpain.2008.08.001; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Moreland LW, 1997, NEW ENGL J MED, V337, P141, DOI 10.1056/NEJM199707173370301; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Neher MD, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-90; Oshima T, 2009, BRAIN RES, V1290, P102, DOI 10.1016/j.brainres.2009.07.022; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Pettigrew LC, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-47; Sairanen T, 2001, STROKE, V32, P1750, DOI 10.1161/01.STR.32.8.1750; Schmidt O.I., 2004, EUR J TRAUMA, V30, P135, DOI DOI 10.1007/S00068-004-1394-9; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Shojo H, 2006, BRAIN RES, V1078, P198, DOI 10.1016/j.brainres.2006.01.063; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sriram K, 2006, FASEB J, V20, P670, DOI 10.1096/fj.05-5106com; Su HX, 2009, J NEUROCHEM, V108, P1385, DOI 10.1111/j.1471-4159.2009.05902.x; Tweedie D, 2007, CURR ALZHEIMER RES, V4, P378, DOI 10.2174/156720507781788873; Umeda N, 2010, INTERNAL MED, V49, P187, DOI 10.2169/internalmedicine.49.2439; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Woiciechowsky C, 2004, MED SCI MONITOR, V10, pBR325; Wong YW, 2011, SPINAL CORD, V49, P94, DOI 10.1038/sc.2010.69; Wunderlich MT, 2006, CLIN NEUROL NEUROSUR, V108, P558, DOI 10.1016/j.clineuro.2005.12.006; Yang LQ, 2005, J CLIN NEUROSCI, V12, P276, DOI 10.1016/j.jocn.2004.06.011; Young W, 2009, CELL TRANSPLANT, V18, P951, DOI 10.3727/096368909X471251; Yu CH, 2011, J VET SCI, V12, P299, DOI 10.4142/jvs.2011.12.3.299; Yu HM, 2004, NEUROPATHOLOGY, V24, P136, DOI 10.1111/j.1440-1789.2003.00539.x; Zurek J, 2012, ACTA NEUROCHIR, V154, P93, DOI 10.1007/s00701-011-1175-2	59	17	18	0	8	VERDUCI PUBLISHER	ROME	VIA GREGORIO VII, ROME, 186-00165, ITALY	1128-3602			EUR REV MED PHARMACO	Eur. Rev. Med. Pharmacol. Sci.	JAN	2014	18	1					10	27					18	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	AA9TV	WOS:000331436700002	24452937				2022-02-06	
J	Liston, DB; Stone, LS				Liston, Dorion B.; Stone, Leland S.			Oculometric assessment of dynamic visual processing	JOURNAL OF VISION			English	Article						oculometrics; pursuit; screening; assessment; clinical	PURSUIT EYE-MOVEMENTS; MOTION PERCEPTION DEFICITS; TRAUMATIC BRAIN-INJURY; HUMAN SMOOTH-PURSUIT; MIDLINE CEREBELLAR LESIONS; DIRECTION DISCRIMINATION; APPARENT MOTION; MACAQUE MONKEY; TIME-COURSE; TRACKING	Eye movements are the most frequent (similar to 3/s), shortest-latency (similar to 150-250 ms), and biomechanically simplest (one joint, no inertial complexities) voluntary motor behavior in primates, providing a model system to assess sensorimotor disturbances arising from trauma, fatigue, aging, or disease states. We have developed a 15-min behavioral tracking protocol consisting of randomized Rashbass (1961) step-ramp radial target motion to assess several aspects of the behavioral response to visual motion, including pursuit initiation, steady-state tracking, direction tuning, and speed tuning. We show how oculomotor data can be converted into direction- and speed-tuning oculometric functions, with large increases in efficiency over traditional button-press psychophysics. We also show how the latter two can be converted into standard visual psychometric thresholds. To assess our paradigm, we first tested for the psychometric criterion of repeatability, and report that our metrics are reliable across repeated sessions. Second, we tested for the psychometric criterion of validity, and report that our metrics show the anticipated changes as the motion stimulus degrades due to spatiotemporal undersampling. Third, we documented the distribution of these metrics across a population of 41 normal observers to provide a thorough quantitative picture of normal human ocular tracking performance, with practice and expectation effects minimized. Our method computes 10 metrics that quantify various aspects of the eye-movement response during a simple 15-min clinical test, which could be used as a screening or assessment tool for disorders affecting sensorimotor processing, including degenerative retinal disease; developmental, neurological or psychiatric disorders; strokes; and traumatic brain injury.	[Liston, Dorion B.; Stone, Leland S.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Liston, Dorion B.] San Jose State Univ, San Jose, CA 95192 USA		Liston, DB (corresponding author), NASA, Ames Res Ctr, Moffett Field, CA 94035 USA.	dorion.b.liston@nasa.gov			NASA's Human Health and Performance Program [111-10-10]; NASA's Human Factors Engineering Program [131-20-30]; National Science Foundation's Program in Perception, Action, and Cognition Program [NSF 0924841]; National Space Biomedical Research Institute [SA 2002]; U.S. Air Force School of Aerospace Medicine; NASA Ames Research Center Director's Innovation Fund Award; Office of Naval ResearchOffice of Naval Research [SAA2-402925]	The development of this methodology has been supported over the past 10 years by NASA's Human Health and Performance Program (111-10-10), NASA's Human Factors Engineering Program (131-20-30), the National Science Foundation's Program in Perception, Action, and Cognition Program (NSF 0924841), the National Space Biomedical Research Institute (SA 2002), the U.S. Air Force School of Aerospace Medicine, a NASA Ames Research Center Director's Innovation Fund Award, and the Office of Naval Research (SAA2-402925).	Adler SA, 2002, J VISION, V2, P627, DOI 10.1167/2.9.5; Anderson TJ, 2013, NAT REV NEUROL, V9, P74, DOI 10.1038/nrneurol.2012.273; Antoniades C, 2013, VISION RES, V84, P1, DOI 10.1016/j.visres.2013.02.007; Bach M, 1996, OPTOMETRY VISION SCI, V73, P49, DOI 10.1097/00006324-199601000-00008; Beutter BR, 2000, VISUAL NEUROSCI, V17, P139, DOI 10.1017/S0952523800171147; Beutter BR, 1998, VISION RES, V38, P1273, DOI 10.1016/S0042-6989(97)00276-9; Beutter BR, 2003, J OPT SOC AM A, V20, P1341, DOI 10.1364/JOSAA.20.001341; Blanke O, 2003, EUR J NEUROSCI, V18, P709, DOI 10.1046/j.1460-9568.2003.02771.x; CARL JR, 1987, J NEUROPHYSIOL, V57, P1446, DOI 10.1152/jn.1987.57.5.1446; Carpenter R. H. S., 1981, EYE MOVEMENTS COGNIT, P237; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Churchland MM, 2000, J NEUROPHYSIOL, V84, P216, DOI 10.1152/jn.2000.84.1.216; de Brouwer S, 2002, J NEUROPHYSIOL, V87, P1646, DOI 10.1152/jn.00432.2001; DEBRUYN B, 1988, VISION RES, V28, P1323, DOI 10.1016/0042-6989(88)90064-8; Diefendorf AR, 1908, BRAIN, V31, P451, DOI 10.1093/brain/31.3.451; Dodge R, 1901, PSYCHOL REV, V8, P145, DOI 10.1037/h0076100; Dodge R, 1903, AM J PHYSIOL, V8, P307, DOI 10.1152/ajplegacy.1903.8.4.307; DURSTELER MR, 1987, J NEUROPHYSIOL, V57, P1262, DOI 10.1152/jn.1987.57.5.1262; Gegenfurtner KR, 2003, J VISION, V3, P865, DOI 10.1167/3.11.19; GREEN DM, 1964, PSYCHOL REV, V71, P392, DOI 10.1037/h0044520; Handel B, 2009, J NEUROSCI, V29, P15126, DOI 10.1523/JNEUROSCI.3972-09.2009; Heitger MH, 2008, IEEE ENG MED BIO, P3570, DOI 10.1109/IEMBS.2008.4649977; Horton JC, 1999, AM J OPHTHALMOL, V128, P530, DOI 10.1016/S0002-9394(99)00177-4; Huang X, 2011, J VISION, V11, DOI 10.1167/11.4.7; KOWLER E, 1987, VISION RES, V27, P993, DOI 10.1016/0042-6989(87)90014-9; Krauzlis RJ, 2001, VISUAL NEUROSCI, V18, P365, DOI 10.1017/S0952523801183033; Krauzlis RJ, 1996, J NEUROPHYSIOL, V76, P2822, DOI 10.1152/jn.1996.76.5.2822; Krukowski AE, 2003, J VISION, V3, P831, DOI 10.1167/3.11.16; Krukowski AE, 2005, NEURON, V45, P315, DOI 10.1016/j.neuron.2005.01.005; Kuroki Y., 2006, SOC INF DISPLAY, V37, P14; Leigh RJ, 2004, BRAIN, V127, P460, DOI 10.1093/brain/awh035; Leigh RJ, 2006, NEUROLOGY EYE MOVEME; LEVIN S, 1988, J PSYCHIAT RES, V22, P195, DOI 10.1016/0022-3956(88)90005-2; Levy DL, 2010, CURR TOP BEHAV NEURO, V4, P311, DOI 10.1007/7854_2010_60; Lisberger SG, 1998, J NEUROPHYSIOL, V79, P1918, DOI 10.1152/jn.1998.79.4.1918; LISBERGER SG, 1985, J NEUROSCI, V5, P1662; LISBERGER SG, 1981, J NEUROPHYSIOL, V46, P229, DOI 10.1152/jn.1981.46.2.229; Liston D, 2005, J VISION, V5, P678, DOI 10.1167/5.9.3; Liston D, 2003, J NEUROSCI, V23, P11305; Liston DB, 2013, DISPLAYS, V34, P171, DOI 10.1016/j.displa.2012.10.002; Liston DB, 2008, J NEUROSCI, V28, P13866, DOI 10.1523/JNEUROSCI.3120-08.2008; Liu J, 2005, J NEUROSCI, V25, P711, DOI 10.1523/JNEUROSCI.4034-04.2005; Luce RD, 1986, RESPONSE TIMES THEIR; Madelain L, 2003, J VISION, V3, P642, DOI 10.1167/3.11.1; Madelain L, 2003, J NEUROPHYSIOL, V90, P972, DOI 10.1152/jn.00869.2002; MCKEE SP, 1981, VISION RES, V21, P491, DOI 10.1016/0042-6989(81)90095-X; Nawrot M, 1998, VISION RES, V38, P2219, DOI 10.1016/S0042-6989(97)00297-6; NAWROT M, 1995, VISION RES, V35, P723, DOI 10.1016/0042-6989(94)00168-L; NEWSOME WT, 1988, J NEUROPHYSIOL, V60, P604, DOI 10.1152/jn.1988.60.2.604; NEWSOME WT, 1985, J NEUROSCI, V5, P825; NICKERSON RA, 1969, J EXP PSYCHOL, V79, P452, DOI 10.1037/h0026889; Nunnally J., 1994, PSYCHOMETRIC THEORY; Osborne LC, 2005, NATURE, V437, P412, DOI 10.1038/nature03961; Osborne LC, 2007, J NEUROSCI, V27, P2987, DOI 10.1523/JNEUROSCI.5072-06.2007; Oswal A, 2007, J NEUROPHYSIOL, V97, P2722, DOI 10.1152/jn.01238.2006; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; Pearson BC, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.036731; Pelak VS, 2005, NEURO-OPHTHALMOLOGY, V29, P137, DOI 10.1080/01658100500218046; RASHBASS C, 1961, J PHYSIOL-LONDON, V159, P326, DOI 10.1113/jphysiol.1961.sp006811; ROBINSON DA, 1965, J PHYSIOL-LONDON, V180, P569, DOI 10.1113/jphysiol.1965.sp007718; SCHALEN L, 1980, ACTA OTO-LARYNGOL, V90, P404, DOI 10.3109/00016488009131742; Schutz AC, 2011, J VISION, V11, DOI 10.1167/11.5.9; Stone L. S., 2009, ENCY NEUROSCIENCE, V7, P503; Stone LS, 2000, PERCEPTION, V29, P771, DOI 10.1068/p2979; Stone LS, 2003, J VISION, V3, P725, DOI 10.1167/3.11.7; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Sweet B. T., 2008, IMAGR SOC ST LOUIS M; Takarae Y, 2004, BRAIN, V127, P2584, DOI 10.1093/brain/awh307; THIER P, 1991, ANN NEUROL, V29, P443, DOI 10.1002/ana.410290419; THURSTON SE, 1988, ANN NEUROL, V23, P266, DOI 10.1002/ana.410230309; TURANO K, 1992, INVEST OPHTH VIS SCI, V33, P2411; TYCHSEN L, 1986, J NEUROPHYSIOL, V56, P953, DOI 10.1152/jn.1986.56.4.953; van Zoest W, 2011, VISION RES, V51, P111, DOI 10.1016/j.visres.2010.10.013; Watamaniuk SNJ, 1999, VISION RES, V39, P59, DOI 10.1016/S0042-6989(98)00128-X; Watson A. B., 2013, SOC MOTION PICTURE T, V122, P18, DOI DOI 10.5594/J18266; Wessel K, 1998, ARCH NEUROL-CHICAGO, V55, P949, DOI 10.1001/archneur.55.7.949; Winn BJ, 2007, ARCH OPHTHALMOL-CHIC, V125, P1137, DOI 10.1001/archopht.125.8.1137; Zee DS, 2012, BIOCYBERN BIOMED ENG, V32, P65; ZIHL J, 1983, BRAIN, V106, P313, DOI 10.1093/brain/106.2.313	79	17	18	0	10	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	1534-7362			J VISION	J. Vision		2014	14	14							12	10.1167/14.14.12			17	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	AX8TR	WOS:000347181800012	25527150	Green Submitted, gold			2022-02-06	
J	Quinn, AC; Bhargava, D; Al-Tamimi, YZ; Clark, MJ; Ross, SA; Tennant, A				Quinn, Audrey C.; Bhargava, Deepti; Al-Tamimi, Yahia Z.; Clark, Matthew J.; Ross, Stuart A.; Tennant, Alan			Self-perceived health status following aneurysmal subarachnoid haemorrhage: a cohort study	BMJ OPEN			English	Article						Stroke Medicine	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; INTRACRANIAL ANEURYSMS; OUTCOME MEASURES; POPULATION; MODEL; TRIAL; MOOD; QUESTIONNAIRE	Objective The objective of the study was to assess the long-term self-reported health status and quality of life (QoL) of patients following an aneurysmal subarachnoid haemorrhage (ASAH) using a self-completed questionnaire booklet. Design A two-cohort study. Setting A regional tertiary neurosurgical centre. Participants 2 cohorts of patients with ASAH treated between 1998 and 2008 and followed up at approximately 1year. Interventions Routine care. Primary and secondary outcomes A range of standardised scales included: AKC Short Sentences Test, the Barthel Index, the Self-Report Dysexecutive Questionnaire, the Everyday Memory Questionnaire, Stroke Symptom Checklist, Wimbledon Self-Report Scale, Modified Rankin Score (MRS) and a new Stroke-QoL. The data from summated scales were fit to the Rasch measurement model to validate the summed score. Results 214 patients (48%) returned the questionnaires; the majority (76%) had a World Federation of Neurosurgeons grade of 1 or 2. The most frequent aneurysm type was that of the anterior communicating artery (28%) with approximately 90% of aneurysms of the anterior circulation. Of those previously in full or part-time employment, 48.9% were unemployed at follow-up. All summated scales satisfied the Rasch measurement model requirements, such that their summed scores were a sufficient statistic. Given this, one-third of patients were noted to have a significant mood disorder and 25% had significant dysexecutive function. Patients with an MRS of 3, 4 or 5 had significantly worse scores on most outcome measures, but a significant minority of those with a score of zero had failed to return to work and displayed significant mood disorder. Conclusions A range of self-reported cognitive and physical deficits have been highlighted in a cohort of patients with ASAH. While the MRS has been shown to provide a reasonable indication of outcome, in routine clinical follow-up it requires supplementation by instruments assessing dysexecutive function, memory and mood.	[Quinn, Audrey C.; Clark, Matthew J.] Leeds Gen Infirm, Dept Anaesthesia, Leeds, W Yorkshire, England; [Bhargava, Deepti] Walton Ctr Neurol & Neurosurg, Liverpool, Merseyside, England; [Al-Tamimi, Yahia Z.] Hope Hosp, Dept Neurosurg, Manchester, Lancs, England; [Ross, Stuart A.] Leeds Gen Infirm, Dept Neurosurg, Leeds, W Yorkshire, England; [Tennant, Alan] Univ Leeds, LIRMM, Fac Med & Hlth, Leeds, W Yorkshire, England		Quinn, AC (corresponding author), Leeds Gen Infirm, Dept Anaesthesia, Leeds, W Yorkshire, England.	a.c.quinn@leeds.ac.uk		Tennant, Alan/0000-0002-0728-2130			Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; Andrich D., 2009, RUMM 2030; Barker S, 2007, CLIN REHABIL, V22, P667; Bellebaum C, 2004, J CLIN EXP NEUROPSYC, V26, P1081, DOI 10.1080/13803390490515342; Bent N, 2002, LANCET, V360, P1280, DOI 10.1016/S0140-6736(02)11316-X; Bowen A, 1998, BRAIN INJURY, V12, P177, DOI 10.1080/026990598122656; Bowen A, 1999, BRAIN INJURY, V13, P547; Christiensen KB, 2013, RASCH MODELS HLTH; Coughlan AK, 1988, CLIN REHABIL, V2, P207, DOI DOI 10.1177/026921558800200305; da Rocha NS, 2013, J PSYCHIATR RES, V47, P141, DOI 10.1016/j.jpsychires.2012.09.014; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; FARRELL B, 1991, J NEUROL NEUROSUR PS, V54, P1044, DOI 10.1136/jnnp.54.12.1044; Fertl E, 1999, ACTA NEUROCHIR, V141, P571, DOI 10.1007/s007010050345; Gerstorf D, 2008, AGING NEUROPSYCHOL C, V15, P424, DOI 10.1080/13825580701640374; Gomertz P, 1994, CLIN REHABIL, V8, P233; Hackett ML, 2000, NEUROLOGY, V55, P658, DOI 10.1212/WNL.55.5.658; Hellawell DJ, 1999, CLIN REHABIL, V13, P333, DOI 10.1191/026921599669500092; Hop JW, 1998, STROKE, V29, P798, DOI 10.1161/01.STR.29.4.798; Hutter B.O., 1993, NEUROSURGERY, V33, P1005; HUTTER BO, 1993, NEUROSURGERY, V33, P999; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kapapa T, 2012, WORLD NEUROSURG; Kim DH, 2005, STROKE, V36, P792, DOI 10.1161/01.STR.0000157594.58180.97; Krajewski K, 2014, NEUROSURG REV, V37, P55, DOI 10.1007/s10143-013-0489-3; Kreiter KT, 2002, STROKE, V33, P200, DOI 10.1161/hs0102.101080; Kreiter KT, 2013, J NEUROL SCI, V335, P64, DOI 10.1016/j.jns.2013.08.024; Lees KR, 2012, STROKE, V43, P1163, DOI 10.1161/STROKEAHA.111.641423; LONGSTRETH WT, 1993, NEUROLOGY, V43, P712, DOI 10.1212/WNL.43.4.712; MASTERS GN, 1982, PSYCHOMETRIKA, V47, P149, DOI 10.1007/BF02296272; McKenna SP, 2004, VALUE HEALTH, V7, pS1, DOI 10.1111/j.1524-4733.2004.7s101.x; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; Passier PECA, 2010, CEREBROVASC DIS, V29, P557, DOI 10.1159/000306642; Passier PECA, 2011, J STROKE CEREBROVASC, V20, P324, DOI 10.1016/j.jstrokecerebrovasdis.2010.02.001; Pedrero-Perez EJ, 2011, REV NEUROLOGIA, V52, P394, DOI 10.33588/rn.5207.2010731; Rinkel GJE, 2011, LANCET NEUROL, V10, P349, DOI 10.1016/S1474-4422(11)70017-5; Sandvei MS, 2011, NEUROLOGY, V77, P1833, DOI 10.1212/WNL.0b013e3182377de3; Stienen MN, 2013, ACTA NEUROCHIR, V155, P2045, DOI 10.1007/s00701-013-1823-9; SUNDERLAND A, 1984, J CLIN NEUROPSYCHOL, V6, P127, DOI 10.1080/01688638408401204; Sunderland A., 1983, J VERB LEARN VERB BE, V22, P727, DOI [10.1016/S0022-5371(83)90229-3, DOI 10.1093/BRAIN/AWU207]; TENNANT A, 1995, ANN RHEUM DIS, V54, P439, DOI 10.1136/ard.54.6.439; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; Vetkas A, 2013, ACTA NEUROCHIR, V155, P1107, DOI 10.1007/s00701-013-1683-3; Visser-Meily JMA, 2013, CEREBROVASC DIS, V36, P126, DOI 10.1159/000353642; WAINER H, 1987, J EDUC MEAS, V24, P185, DOI 10.1111/j.1745-3984.1987.tb00274.x; Wilburn J, 2013, J HAND SURG-AM, V38A, P1209, DOI 10.1016/j.jhsa.2013.03.036; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59; Wong GKC, 2014, J CLIN NEUROSCI, V21, P954, DOI 10.1016/j.jocn.2013.09.010; World Health Organization, 1980, INT CLASS IMP DIS HA; World Health Organization, 2007, INT CLASS FUNCT DIS	51	17	17	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2014	4	4							e003932	10.1136/bmjopen-2013-003932			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH0SL	WOS:000335830500003	24699459	gold, Green Published			2022-02-06	
J	Tator, CH				Tator, Charles H.			Chronic traumatic encephalopathy: How serious a sports problem is it?	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article						Concussion; Head injuries; Contact sports	INTERNATIONAL-CONFERENCE; CONCUSSION; STATEMENT	It is now recognised that there is a spectrum of concussion disorders ranging from acute concussion at one end to various forms of brain degeneration at the other end. The spectrum includes acute concussion, second impact syndrome or acute cerebral swelling, postconcussion syndrome, depression or anxiety, chronic traumatic encephalopathy (CTE) and possibly other forms of central nervous system degeneration. It is essential to carefully evaluate the clinical and neuropathological correlations of CTE that have been published. This has been accomplished in an excellent paper on this subject by Gardner and colleagues in this issue. There have been significant advances in our knowledge of the clinical and neuropathological features of CTE in athletes in the past 10years. However, we are just at the beginning of our appreciation of this entity due to the paucity of research and the inability to diagnose CTE during life. At present, it is not possible to assess the validity of the proposed methods of classification and grading of the severity of the disease. Additional studies of large numbers of at-risk athletes are essential, especially prospective longitudinal studies. Obviously, such studies would be even more effective if reliable in vivo biomarkers were discovered, especially non-invasive ones such as advanced MRI or MR spectroscopy or invasive ones such as blood or cerebrospinal fluid tests. The major questions that remain unanswered include the frequency of CTE in various collision sports, the causal or otherwise relationship between concussions and CTE, the number of concussions that need to be involved and their management.	Univ Toronto, Div Neurosurg, Toronto Western Hosp, Toronto, ON M5T 2S8, Canada		Tator, CH (corresponding author), Univ Toronto, Div Neurosurg, Toronto Western Hosp, 399 Bathurst St,Room 4W-422, Toronto, ON M5T 2S8, Canada.	charles.tator@uhn.ca			Canadian Sports Concussion Project at the Toronto Western Hospital, Toronto, Ontario Canada	This work was supported by the Canadian Sports Concussion Project at the Toronto Western Hospital, Toronto, Ontario Canada.	American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Tator CH, 2013, CAN MED ASSOC J, V185, P975, DOI 10.1503/cmaj.120039; Tator CH, 2009, CAN J NEUROL SCI, V36, P405, DOI 10.1017/S031716710000771X	16	17	18	0	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	JAN	2014	48	2					81	83		10.1136/bjsports-2013-093040			3	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	276KK	WOS:000328749000006	24273309				2022-02-06	
J	Xing, GQ; Ren, M; Verma, A				Xing, Guoqiang; Ren, Ming; Verma, Ajay			Divergent temporal expression of hyaluronan metabolizing enzymes and receptors with craniotomy vs. controlled-cortical impact injury in rat brain: a pilot study	FRONTIERS IN NEUROLOGY			English	Article						TBI; secondary injury factors; hyaluronic acid; receptor; synthesis; degradation; hyaluronidase; rat brain		Traumatic brain injury (TBI) triggers many secondary changes in tissue biology, which ultimately determine the extent of injury and clinical outcome. Hyaluronan [hyaluronic acid (HA)] is a protective cementing gel present in the intercellular spaces whose degradation has been reported as a causative factor in tissue damage. Yet little is known about the expression and activities of genes involved in HA catabolism after TBI. Young adult male Sprague-Dawley rats were assigned to three groups: naive control, craniotomy, and controlled-cortical impact-induced TBI (CCI-TBI). Four animals per group were sacrificed at 4 h, 1, 3, and 7 days post-CCI. The mRNA expression of hyaluronan synthases (HAS1-3), hyaluronidases (enzymes for HA degradation, HYAL 1-4, and PH20), and CD44 and RHAMM (membrane receptors for HA signaling and removal) were determined using real-time PCR. Compared to the naive controls, expression of HAS1 and HAS2 mRNA, but not HAS3 mRNA increased significantly following craniotomy alone and following CCI with differential kinetics. Expression of HAS2 mRNA increased significantly in the ipsilateral brain at 1 and 3 days post-CCI. HYAL1 mRNA expression also increased significantly in the craniotomy group and in the contralateral CCI at 1 and 3 days post-CCI. CD44 mRNA expression increased significantly in the ipsilateral CCI at 4 h, 1, 3, and 7 days post-CCI (up to 25-fold increase). These data suggest a dynamic regulation and role for HA metabolism in secondary responses to TBI.	[Xing, Guoqiang; Ren, Ming; Verma, Ajay] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA		Xing, GQ (corresponding author), Johns Hopkins Univ, MCC, Lotus Biotech Com, 9601 Med Ctr Dr,Suite 227, Rockville, MD 20850 USA.	gxing99@yahoo.com	Xing, Guoqiang/ABA-8450-2020		Lotus Biotech.com; GEMI Fund; Henry Jackson Foundation DBSCIP	This work was supported in part by, Lotus Biotech.com, GEMI Fund and Henry Jackson Foundation DBSCIP. Daniel Xing proofread the manuscript.	Agren UM, 1997, FREE RADICAL BIO MED, V23, P996, DOI 10.1016/S0891-5849(97)00098-1; Al Qteishat A, 2006, NEUROREPORT, V17, P1111, DOI 10.1097/01.wnr.0000227986.69680.20; Al'Qteishat A, 2006, BRAIN, V129, P2158, DOI 10.1093/brain/awl139; Andhare RA, 2009, OSTEOARTHR CARTILAGE, V17, P906, DOI 10.1016/j.joca.2008.12.007; Ariyoshi W, 2012, ARTHRITIS RHEUM-US, V64, P187, DOI 10.1002/art.33329; Averbeck M, 2007, J INVEST DERMATOL, V127, P687, DOI 10.1038/sj.jid.5700614; Aya KL, 2014, WOUND REPAIR REGEN, V22, P579, DOI 10.1111/wrr.12214; BERG S, 1988, SCAND J CLIN LAB INV, V48, P727, DOI 10.3109/00365518809088752; Bertrand P, 2005, INT J CANCER, V113, P207, DOI 10.1002/ijc.20562; Bifone A, 2010, MAGN RESON IMAGING, V28, P1200, DOI 10.1016/j.mri.2010.07.001; Bugiani M, 2013, BRAIN, V136, P209, DOI 10.1093/brain/aws320; Cabrera PV, 2000, MEDICINA-BUENOS AIRE, V60, P940; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Campo GM, 2012, J CELL BIOCHEM, V113, P1852, DOI 10.1002/jcb.24054; Casalino-Matsuda SM, 2009, AM J RESP CELL MOL, V40, P277, DOI 10.1165/rcmb.2008-0073OC; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Cortivo R, 1996, SEMIN ARTHRITIS RHEU, V26, P492, DOI 10.1016/S0049-0172(96)80030-8; Csoka AB, 1999, GENOMICS, V60, P356, DOI 10.1006/geno.1999.5876; Csoka AB, 2001, MATRIX BIOL, V20, P499, DOI 10.1016/S0945-053X(01)00172-X; CULTY M, 1992, J CELL BIOL, V116, P1055, DOI 10.1083/jcb.116.4.1055; Deguine V, 1998, INT J BIOL MACROMOL, V22, P17, DOI 10.1016/S0141-8130(97)00084-6; Dixon CE, 1997, J NEUROTRAUM, V14, P161, DOI 10.1089/neu.1997.14.161; Ekici S, 2004, INT J CANCER, V112, P121, DOI 10.1002/ijc.20368; Fang XJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-290; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Flugge LA, 1999, CHEM BIOL, V6, pR157, DOI 10.1016/S1074-5521(99)80043-X; Forteza RM, 2012, J BIOL CHEM, V287, P42288, DOI 10.1074/jbc.M112.387795; Fox JW, 2013, TOXICON, V62, P75, DOI 10.1016/j.toxicon.2012.09.009; Fukuda K, 2001, OSTEOARTHR CARTILAGE, V9, P390, DOI 10.1053/joca.2000.0400; Gritsenko PG, 2012, J PATHOL, V226, P185, DOI 10.1002/path.3031; GROOTVELD M, 1991, BIOCHEM J, V273, P459, DOI 10.1042/bj2730459; Hanley WD, 2006, FASEB J, V20, P337, DOI 10.1096/fj.05-4574fje; HodgeDufour J, 1997, J IMMUNOL, V159, P2492; HOLMES MWA, 1988, BIOCHEM J, V250, P435, DOI 10.1042/bj2500435; Horton MR, 1999, CHEST, V116, p17S, DOI 10.1016/S0012-3692(15)30642-5; Horton MR, 1998, J BIOL CHEM, V273, P35088, DOI 10.1074/jbc.273.52.35088; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Jacobson A, 2000, BIOCHEM J, V348, P29, DOI 10.1042/0264-6021:3480029; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Jiang DH, 2010, ANAT REC, V293, P982, DOI 10.1002/ar.21102; Jong A, 2012, J BIOL CHEM, V287, P15298, DOI 10.1074/jbc.M112.353375; Josefsson A, 2011, AM J PATHOL, V179, P1961, DOI 10.1016/j.ajpath.2011.06.005; Karousou E, 2010, J BIOL CHEM, V285, P23647, DOI 10.1074/jbc.M110.127050; Kashima Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058760; Kaya G, 1997, GENE DEV, V11, P996, DOI 10.1101/gad.11.8.996; KEHRER JP, 1993, CRIT REV TOXICOL, V23, P21, DOI 10.3109/10408449309104073; Kim E, 2005, P NATL ACAD SCI USA, V102, P18028, DOI 10.1073/pnas.0506825102; Knepper PA, 2005, INVEST OPHTH VIS SCI, V46, P2829, DOI 10.1167/iovs.04-1472; Knudson W, 2002, MATRIX BIOL, V21, P15, DOI 10.1016/S0945-053X(01)00186-X; KONTTINEN YT, 1990, CLIN CHIM ACTA, V193, P39, DOI 10.1016/0009-8981(90)90005-D; Krasinski R, 2009, POSTEP HIG MED DOSW, V63, P205; Krasinski Rafal, 2007, Postepy Hig Med Dosw (Online), V61, P683; LAURENT UBG, 1992, MATRIX, V12, P130, DOI 10.1016/S0934-8832(11)80054-5; Lepperdinger G, 1998, J BIOL CHEM, V273, P22466, DOI 10.1074/jbc.273.35.22466; Lepperdinger G, 2001, MATRIX BIOL, V20, P509, DOI 10.1016/S0945-053X(01)00170-6; Li JM, 2013, ENVIRON MOL MUTAGEN, V54, P429, DOI 10.1002/em.21794; Li YJ, 2000, AM J RESP CELL MOL, V23, P411, DOI 10.1165/ajrcmb.23.3.4102; MARGOLIS RU, 1975, BIOCHEMISTRY-US, V14, P85, DOI 10.1021/bi00672a014; Matsumoto T, 2012, NEUROSCI LETT, V520, P115, DOI 10.1016/j.neulet.2012.05.048; McKallip RJ, 2013, TOXINS, V5, P1814, DOI 10.3390/toxins5101814; McKee CM, 1997, J BIOL CHEM, V272, P8013, DOI 10.1074/jbc.272.12.8013; Michael DR, 2011, J BIOL CHEM, V286, P19523, DOI 10.1074/jbc.M111.233916; Miki Y, 2010, INFLAMM RES, V59, P471, DOI 10.1007/s00011-009-0147-y; Monzon ME, 2010, J BIOL CHEM, V285, P26126, DOI 10.1074/jbc.M110.135194; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; MORALES TI, 1988, J BIOL CHEM, V263, P3632; Moseley R, 1997, BBA-MOL BASIS DIS, V1362, P221, DOI 10.1016/S0925-4439(97)00083-5; Moseley R, 2002, BIOMATERIALS, V23, P2255, DOI 10.1016/S0142-9612(01)00360-X; NAGY JI, 1995, J NEUROSCI, V15, P241; NG CK, 1992, ARCH BIOCHEM BIOPHYS, V298, P70, DOI 10.1016/0003-9861(92)90095-E; Nishida Y, 2005, EXP CELL RES, V307, P194, DOI 10.1016/j.yexcr.2005.03.026; Nishida Y, 1999, J BIOL CHEM, V274, P21893, DOI 10.1074/jbc.274.31.21893; Nishida Y, 2014, J BIOL CHEM, V289, P18121, DOI 10.1074/jbc.A114.021893; Noble Paul W, 2006, Proc Am Thorac Soc, V3, P401, DOI 10.1513/pats.200604-097AW; Noble PW, 1996, J EXP MED, V183, P2373, DOI 10.1084/jem.183.5.2373; NOBLE PW, 1993, J CLIN INVEST, V91, P2368, DOI 10.1172/JCI116469; Noble PW, 2002, MATRIX BIOL, V21, P25, DOI 10.1016/S0945-053X(01)00184-6; Piao JH, 2013, GLIA, V61, P361, DOI 10.1002/glia.22438; Ramnani N, 2004, BIOL PSYCHIAT, V56, P613, DOI 10.1016/j.biopsych.2004.02.004; Recklies AD, 2001, BIOCHEM J, V354, P17, DOI 10.1042/bj3540017; SAARI H, 1991, ANN RHEUM DIS, V50, P389, DOI 10.1136/ard.50.6.389; Schaller B, 2004, BRAIN RES PROTOC, V12, P125, DOI 10.1016/j.brainresprot.2003.09.003; Schaller B, 2003, BRAIN RES, V982, P31, DOI 10.1016/S0006-8993(03)02900-7; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; Schmidt EP, 2014, J BIOL CHEM, V289, P8194, DOI 10.1074/jbc.M113.539452; Schulz T, 2007, J BIOL CHEM, V282, P20999, DOI 10.1074/jbc.M700915200; Sironen RK, 2011, EXP CELL RES, V317, P383, DOI 10.1016/j.yexcr.2010.11.017; SOKOLOFF L, 1981, FED PROC, V40, P2311; Sokoloff L, 2008, COGN NEURODYNAMICS, V2, P1, DOI 10.1007/s11571-007-9033-x; Soltes L, 2006, BIOMACROMOLECULES, V7, P659, DOI 10.1021/bm050867v; Struve J, 2005, GLIA, V52, P16, DOI 10.1002/glia.20215; Sugahara KN, 2006, J BIOL CHEM, V281, P5861, DOI 10.1074/jbc.M506740200; Takahashi N, 2010, ARTHRITIS RHEUM-US, V62, P1338, DOI 10.1002/art.27410; Temiz A, 2010, OTOLARYNG HEAD NECK, V143, P772, DOI 10.1016/j.otohns.2010.07.007; Trabucchi E, 2002, INT J TISSUE REACT, V24, P65; Triggs-Raine B, 1999, P NATL ACAD SCI USA, V96, P6296, DOI 10.1073/pnas.96.11.6296; TURLEY EA, 1994, GLIA, V12, P68, DOI 10.1002/glia.440120109; van der Windt GJW, 2011, AM J RESP CELL MOL, V44, P377, DOI 10.1165/rcmb.2010-0158OC; Ventura CL, 2006, MOL MICROBIOL, V61, P723, DOI 10.1111/j.1365-2958.2006.05259.x; Wakao N, 2011, NEUROSCI LETT, V488, P299, DOI 10.1016/j.neulet.2010.11.051; WEST DC, 1989, EXP CELL RES, V183, P179, DOI 10.1016/0014-4827(89)90428-X; WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340; Xing GQ, 2012, EXP NEUROL, V234, P31, DOI 10.1016/j.expneurol.2011.12.007; Yamazaki Kenji, 2003, Pathophysiology, V9, P215, DOI 10.1016/S0928-4680(03)00024-5; Yu HM, 2011, MOL CELL BIOCHEM, V352, P65, DOI 10.1007/s11010-011-0740-6; Zhang NY, 2010, J NEUROSCI METH, V189, P186, DOI 10.1016/j.jneumeth.2010.04.001; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200	108	17	17	0	2	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.		2014	5								173	10.3389/fneur.2014.00173			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	V42QW	WOS:000209629300162	25309501	Green Published, gold			2022-02-06	
J	Xue, FT; Stoica, BA; Hanscom, M; Kabadi, SV; Faden, AI				Xue, Fengtian; Stoica, Bogdan A.; Hanscom, Marie; Kabadi, Shruti V.; Faden, Alan I.			Positive Allosteric Modulators (PAMs) of Metabotropic Glutamate Receptor 5 (mGluR5) Attenuate Microglial Activation	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						Metabotropic glutamate receptor 5; microglial activation; neuroinflammation; neuroprotection; positive allosteric modulator; traumatic brain injury	PROTEIN-COUPLED RECEPTORS; IN-VIVO; BRAIN-INJURY; DRUG DEVELOPMENT; CELL-DEATH; RAT; DISCOVERY; VITRO; SUBTYPE-5; APOPTOSIS	Traumatic brain injury causes progressive neurodegeneration associated with chronic microglial activation. Recent studies show that neurodegeneration and neuroinflammation after traumatic brain injury can be inhibited as late as one month in animals by the activation of the metabotropic glutamate receptor 5 in microglia using (RS)-2-chloro-5-hydroxy-phenylglycine. However, the therapeutic potential of this agonist is limited due to its relatively weak potency and brain permeability. To address such concerns, we evaluated the anti-inflammatory activities of several positive allosteric modulators using various in vitro assays, and found that 3,3'-difluorobenzaldazine, 3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl) benzamide and 4-nitro-N-(1-(2-fluorophenyl)-3-phenyl-1H-pyrazol-5-yl) benzamide showed significantly improved potency which makes them potential lead compounds for further development of positive allosteric modulators for the treatment of traumatic brain injury.	[Xue, Fengtian; Stoica, Bogdan A.; Hanscom, Marie; Kabadi, Shruti V.; Faden, Alan I.] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; [Xue, Fengtian] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA		Xue, FT (corresponding author), Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, 20 Penn St, Baltimore, MD 21201 USA.	fxue@rx.umaryland.edu	STOICA, BOGDAN/H-9782-2013	STOICA, BOGDAN/0000-0002-2501-6434; Hanscom, Marie/0000-0001-8308-135X; Faden, Alan I./0000-0003-0128-2348			Allen JW, 1999, NEUROPHARMACOLOGY, V38, P1243, DOI 10.1016/S0028-3908(99)00044-1; Allen JW, 2000, CELL DEATH DIFFER, V7, P470, DOI 10.1038/sj.cdd.4400678; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Arkhipov V. I., 2011, Eksperimental'naya i Klinicheskaya Farmakologiya, V74, P46; Ayala JE, 2009, NEUROPSYCHOPHARMACOL, V34, P2057, DOI 10.1038/npp.2009.30; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Cleva RM, 2011, MOLECULES, V16, P2097, DOI 10.3390/molecules16032097; Conigrave AD, 2010, PHARMACOL THERAPEUT, V127, P252, DOI 10.1016/j.pharmthera.2010.04.007; de Paulis T, 2006, J MED CHEM, V49, P3332, DOI 10.1021/jm051252j; Doherty AJ, 1997, NEUROPHARMACOLOGY, V36, P265, DOI 10.1016/S0028-3908(97)00001-4; Engers DW, 2009, CHEMMEDCHEM, V4, P505, DOI 10.1002/cmdc.200800357; Enz R, 2012, CURR DRUG TARGETS, V13, P145, DOI 10.2174/138945012798868452; Fei Z, 2006, J CLIN NEUROSCI, V13, P1023, DOI 10.1016/j.jocn.2005.11.042; Gass JT, 2009, BIOL PSYCHIAT, V65, P717, DOI 10.1016/j.biopsych.2008.11.001; Gravius A, 2008, J NEURAL TRANSM, V115, P1609, DOI 10.1007/s00702-008-0098-4; Homayoun H, 2004, NEUROPSYCHOPHARMACOL, V29, P1259, DOI 10.1038/sj.npp.1300417; Homayoun H, 2010, EUR J PHARMACOL, V639, P33, DOI 10.1016/j.ejphar.2009.12.042; Kinney GG, 2005, J PHARMACOL EXP THER, V313, P199, DOI 10.1124/jpet.104.079244; Kinney GG, 2003, J PHARMACOL EXP THER, V306, P116, DOI 10.1124/jpet.103.048702; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Lamb JP, 2011, BIOORG MED CHEM LETT, V21, P2711, DOI 10.1016/j.bmcl.2010.11.119; Lecourtier L, 2007, BIOL PSYCHIAT, V62, P739, DOI 10.1016/j.biopsych.2006.12.003; Lindsley CW, 2004, J MED CHEM, V47, P5825, DOI 10.1021/jm049400d; Loane DJ, 2009, J BIOL CHEM, V284, P15629, DOI 10.1074/jbc.M806139200; Maeda J, 2007, BRAIN RES, V1157, P100, DOI 10.1016/j.brainres.2007.04.054; Molcanyi M, 2007, J NEUROTRAUM, V24, P625, DOI 10.1089/neu.2006.0180; Movsesyan VA, 2004, J NEUROCHEM, V89, P1528, DOI 10.1111/j.1471-4159.2004.02451.x; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; O'Brien JA, 2004, J PHARMACOL EXP THER, V309, P568, DOI 10.1124/jpet.103.061747; O'Brien JA, 2003, MOL PHARMACOL, V64, P731, DOI 10.1124/mol.64.3.731; Olive MF, 2010, EUR J PHARMACOL, V639, P47, DOI 10.1016/j.ejphar.2010.01.029; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Piers TM, 2011, NEUROSCI LETT, V505, P140, DOI 10.1016/j.neulet.2011.10.007; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; Recasens M, 2007, CURR DRUG TARGETS, V8, P651, DOI 10.2174/138945007780618544; Sharma S, 2009, J MED CHEM, V52, P4103, DOI 10.1021/jm900654c; Shindo T, 2006, J MED INVESTIG, V53, P42, DOI 10.2152/jmi.53.42; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Stauffer SR, 2011, ACS CHEM NEUROSCI, V2, P450, DOI 10.1021/cn2000519; Szydlowska K, 2007, EUR J PHARMACOL, V554, P18, DOI 10.1016/j.ejphar.2006.09.061; Tharmalingam S, 2012, NEUROPHARMACOLOGY, V63, P667, DOI 10.1016/j.neuropharm.2012.05.029; Vilhardt F, 2005, INT J BIOCHEM CELL B, V37, P17, DOI 10.1016/j.biocel.2004.06.010; Wilms H, 2003, NEUROBIOL DIS, V14, P417, DOI 10.1016/j.nbd.2003.07.002; Yasuhara Akito, 2010, Open Med Chem J, V4, P20, DOI 10.2174/1874104501004020020; Zhao ZJ, 2007, BIOORG MED CHEM LETT, V17, P1386, DOI 10.1016/j.bmcl.2006.11.081; Zhou Y, 2010, ACS MED CHEM LETT, V1, P433, DOI 10.1021/ml100181a	47	17	17	0	1	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets		2014	13	4					558	566		10.2174/18715273113126660199			9	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	AN8EO	WOS:000340836200004	24168364				2022-02-06	
J	Yadav, NK; Thiagarajan, P; Ciuffreda, KJ				Yadav, Naveen K.; Thiagarajan, Preethi; Ciuffreda, Kenneth J.			Effect of oculomotor vision rehabilitation on the visual-evoked potential and visual attention in mild traumatic brain injury	BRAIN INJURY			English	Article						Alpha band power; attenuation ratio; mild traumatic brain injury; oculomotor vision rehabilitation; visual attention; visual-evoked potential amplitude; visual-evoked potential latency	EEG ALPHA; VEP; ACCOMMODATION; PERFORMANCE; PROTOCOL; TBI	Primary objective: The purpose of the experiment was to investigate the effect of oculomotor vision rehabilitation (OVR) on the visual-evoked potential (VEP) and visual attention in the mTBI population. Research design and methods: Subjects (n = 7) were adults with a history of mild traumatic brain injury (mTBI). Each received 9 hours of OVR over a 6-week period. The effects of OVR on VEP amplitude and latency, the attention-related alpha band (8-13 Hz) power (mu V-2) and the clinical Visual Search and Attention Test (VSAT) were assessed before and after the OVR. Results: After the OVR, the VEP amplitude increased and its variability decreased. There was no change in VEP latency, which was normal. Alpha band power increased, as did the VSAT score, following the OVR. Conclusions: The significant changes in most test parameters suggest that OVR affects the visual system at early visuo-cortical levels, as well as other pathways which are involved in visual attention.	[Yadav, Naveen K.; Thiagarajan, Preethi; Ciuffreda, Kenneth J.] SUNY State Coll Optometry, Dept Biol & Vis Sci, New York, NY 10036 USA		Yadav, NK (corresponding author), SUNY State Coll Optometry, Dept Biol & Vis Sci, 33 West 42nd St, New York, NY 10036 USA.	nyadav@sunyopt.edu					Alvarez TL, 2010, OPTOMETRY VISION SCI, V87, P985, DOI 10.1097/OPX.0b013e3181fef1aa; Briggs F, 2013, NATURE, V499, P476, DOI 10.1038/nature12276; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Ciuffreda K. J., 2011, J BEHAV OPTOMETRY, V22, P10; Ciuffreda KJ, 2013, BRAIN INJURY, V27, P41, DOI 10.3109/02699052.2012.700088; Ciuffreda KJ, 2011, OPTOMETRY, V82, P337, DOI 10.1016/j.optm.2011.03.006; Ciuffreda KJ, 2011, OPTOMETRY, V82, P61, DOI 10.1016/j.optm.2010.11.011; Ciuffreda Kenneth J, 2008, Optometry, V79, P18, DOI 10.1016/j.optm.2007.10.004; Ciuffreda Kenneth J, 2002, Optometry, V73, P735; Ciuffreda KJ, 2001, VISUAL VESTIBULAR CO, P77; Cohen A H, 1992, J Am Optom Assoc, V63, P569; DUMERMUTH G, 1987, NEUROPSYCHOBIOLOGY, V17, P85, DOI 10.1159/000118345; Faul M, 2010, TRAUMATIC BRAIN INJU; Freed S, 1997, BRAIN INJURY, V11, P25, DOI 10.1080/026990597123782; FULLER PW, 1978, J LEARN DISABIL-US, V11, P303, DOI 10.1177/002221947801100507; Gomarus HK, 2009, CLIN NEUROPHYSIOL, V120, P73, DOI 10.1016/j.clinph.2008.10.017; Green W, 2010, OPTOMETRY, V81, P129, DOI 10.1016/j.optm.2009.07.015; Green W, 2010, J REHABIL RES DEV, V47, P183, DOI 10.1682/JRRD.2009.04.0041; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Helvie R, 2011, VISION REHABILITATION: MULTIDISCIPLINARY CARE OF THE PATIENT FOLLOWING BRAIN INJURY, P45, DOI 10.1201/b10524-4; Hurley RA, 2004, J NEUROPSYCH CLIN N, V16, P1, DOI 10.1176/appi.neuropsych.16.1.1; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Kapoor N, 2004, ARCH PHYS MED REHAB, V85, P1667, DOI 10.1016/j.apmr.2003.12.044; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Lachapelle J, 2008, BRAIN INJURY, V22, P265, DOI 10.1080/02699050801938983; LEGEWIE H, 1969, ELECTROEN CLIN NEURO, V27, P470, DOI 10.1016/0013-4694(69)90187-4; Ludlam WM, 1996, NEUROREHABILITATION, V6, P183, DOI 10.3233/NRE-1996-6304; LUDLAM WM, 1979, J AM OPTOM ASSOC, V50, P111; Luria, 1996, HIGHER CORTICAL FUNC; Mendez CV, 2005, J NEUROPSYCH CLIN N, V17, P297, DOI 10.1176/appi.neuropsych.17.3.297; MILLODOT M, 1981, BRIT J OPHTHALMOL, V65, P294, DOI 10.1136/bjo.65.4.294; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; PADULA WV, 1994, BRAIN INJURY, V8, P125, DOI 10.3109/02699059409150964; REDING MJ, 1988, STROKE, V19, P1354, DOI 10.1161/01.STR.19.11.1354; Scheiman M, 2005, OPTOMETRY VISION SCI, V82, P583, DOI 10.1097/01.opx.0000171331.36871.2f; Scheiman M, 2001, VISUAL VESTIBULAR CO, P89; Schnabel R, 2012, CLIN NEUROPSYCHOL, V26, P769, DOI 10.1080/13854046.2012.693541; Shelley-Trembley J, 2012, J CORRECTIONAL ED, V63, P49; Solan HA, 2003, J LEARN DISABIL-US, V36, P556, DOI 10.1177/00222194030360060601; Solan HA, 2001, J LEARN DISABIL-US, V34, P107, DOI 10.1177/002221940103400202; Solan Harold A, 2004, Optometry, V75, P640, DOI 10.1016/S1529-1839(04)70211-0; Steinman S. B., 2000, FDN BINOCULAR VISION; Suchoff IB, 2001, VISUAL VESTIBULAR CO; Szymanowicz D, 2012, J REHABIL RES DEV, V49, P1083, DOI 10.1682/JRRD.2010.07.0129; Thiabault LE, 1990, 34 ANN P ASS ADV AUT, V34, P337; Thiagarajan P, NEUROREHABI IN PRESS; Thiagarajan P., 2012, THESIS STATE U NEW Y; Thiagarajan P, 2013, J REHABIL RES DEV, V50, P1223, DOI 10.1682/JRRD.2012.12.0235; Thiagarajan P, 2011, OPHTHAL PHYSL OPT, V31, P456, DOI 10.1111/j.1475-1313.2011.00831.x; Trenerry MR, 1989, PROFESSIONAL MANUAL; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wick B., 2008, CLIN MANAGEMENT BINO; Willeford KT, 2013, DOC OPHTHALMOL, V126, P105, DOI 10.1007/s10633-012-9363-9; Willeford KT, 2013, DOC OPHTHALMOL, V126, P29, DOI 10.1007/s10633-012-9357-7; Yadav NK, 2012, DOC OPHTHALMOL, V124, P177, DOI 10.1007/s10633-012-9319-0	59	17	17	0	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	7					922	929		10.3109/02699052.2014.887227			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AH9XL	WOS:000336498600006	24564831				2022-02-06	
J	Zhu, LH; Bai, X; Wang, SY; Hu, Y; Wang, T; Qian, LJ; Jiang, L				Zhu, Lihua; Bai, Xiang; Wang, Shiyu; Hu, Yan; Wang, Ting; Qian, Lijuan; Jiang, Li			Recombinant Human Erythropoietin Augments Angiogenic Responses in a Neonatal Rat Model of Cerebral Unilateral Hypoxia-Ischemia	NEONATOLOGY			English	Article						Erythropoietin; Premature brain; Hypoxia-ischemia; Angiogenesis factor; Vascular endothelial growth factor; Angiopoietin-1	TRAUMATIC BRAIN-INJURY; ENDOTHELIAL PROGENITOR-CELL; THERAPEUTIC ANGIOGENESIS; PREMATURE-INFANTS; PRETERM INFANTS; GROWTH-FACTOR; PROTECTS	Background: Recombinant human erythropoietin (rh-EPO) has been used as a drug to treat premature infant anemia for over a decade. In addition to its erythropoietic effect, rh-EPO has also been reported to have protective effects against brain injury. Objectives: Our aim was to evaluate the levels of angiogenesis-related cells (CD34+ cells) and angiogenic factors (vascular endothelial growth factor, VEGF, and angiopoietin-1, Ang-1) in a neonatal rat model of cerebral unilateral hypoxia-ischemia (HI) and to identify the effects of rh-EPO on angiogenic responses. Methods: Postnatal day 3 (PD3) rats underwent permanent ligation of the right common carotid artery followed by 6% O-2 for 4 h (HI) or sham operation and normoxic exposure (sham). Immediately after HI, the rats received a single intraperitoneal injection of rh-EPO (5 U/g) or saline. Angiogenesis-related cells (CD34+ cells) and angiogenic factors (VEGF and Ang-1) were examined on PD5, 7, 10 and 14. Results: Compared with the sham rats, the number of CD34+ cells in HI rats increased from PD5 to 7 but decreased from PD10 to 14. VEGF and Ang-1 mRNA levels both increased from PD5 to 14. CD34+ cells, VEGF and Ang-1 were all upregulated in rh-EPO-treated rats compared with HI rats. Conclusions: In the present study, we show the angiogenic effects of rh-EPO in a rat model of neonatal cerebral unilateral HI. Our results highlight the powerful therapeutic potential of rh-EPO treatment of HI premature brain for the enhancement of angiogenic responses. (C) 2014 S. Karger AG, Basel	[Zhu, Lihua] Southeast Univ, Res Ctr Learning Sci, Nanjing 210009, Jiangsu, Peoples R China; [Zhu, Lihua; Bai, Xiang; Wang, Shiyu] Southeast Univ, Clin Med Coll, Div Pediat, Nanjing 210009, Jiangsu, Peoples R China; [Hu, Yan] Southeast Univ, Zhongda Hosp, Dept Obstet & Gynaecol, Nanjing 210009, Jiangsu, Peoples R China; [Wang, Ting] Southeast Univ, Sch Biol Sci & Med Engn, Nanjing 210009, Jiangsu, Peoples R China; [Qian, Lijuan; Jiang, Li] Southeast Univ, Zhongda Hosp, Dept Pediat, Nanjing 210009, Jiangsu, Peoples R China		Jiang, L (corresponding author), Southeast Univ, Zhongda Hosp, Dept Pediat, Nanjing 210009, Jiangsu, Peoples R China.	jiangli77777@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81370739]; Science and Innovation Funds of Jiangsu Province [CXLX12_0123]	This work was supported by grants from the National Natural Science Foundation of China (81370739) and the Science and Innovation Funds of Jiangsu Province (CXLX12_0123).	Back SA, 2002, J NEUROSCI, V22, P455, DOI 10.1523/JNEUROSCI.22-02-00455.2002; Brines M, 2008, J INTERN MED, V264, P405, DOI 10.1111/j.1365-2796.2008.02024.x; Brown MS, 2009, PEDIATRICS, V124, pE681, DOI 10.1542/peds.2008-2701; Fan YF, 2007, J NEUROIMMUNE PHARM, V2, P284, DOI 10.1007/s11481-007-9073-3; Fan YF, 2010, ANN NEUROL, V67, P488, DOI 10.1002/ana.21919; Guo XB, 2009, J NEUROTRAUM, V26, P1337, DOI [10.1089/neu.2008.0733, 10.1089/neu.2008-0733]; Kato S, 2011, J NEUROSCI RES, V89, P1566, DOI 10.1002/jnr.22702; Lu JJ, 2014, J NANOSCI NANOTECHNO, V14, P5614, DOI 10.1166/jnn.2014.8728; Mammis A, 2009, SURG NEUROL, V71, P527, DOI 10.1016/j.surneu.2008.02.040; Mazur M, 2010, J NEUROSURG-PEDIATR, V6, P206, DOI 10.3171/2010.5.PEDS1032; McPherson RJ, 2007, NEONATOLOGY, V91, P36, DOI 10.1159/000096969; McPherson RJ, 2010, CURR OPIN PEDIATR, V22, P139, DOI 10.1097/MOP.0b013e328336eb57; Ning RZ, 2011, BRAIN RES, V1384, P140, DOI 10.1016/j.brainres.2011.01.099; Okada S, 2008, DIABETES CARE, V31, P157, DOI 10.2337/dc07-1125; PHIBBS RH, 1995, J PERINAT MED, V23, P127, DOI 10.1515/jpme.1995.23.1-2.127; Rayjada N, 2012, NEONATOLOGY, V102, P287, DOI 10.1159/000341615; Rees S, 2010, J NEUROPATH EXP NEUR, V69, P306, DOI 10.1097/NEN.0b013e3181d27138; Shin SH, 2013, PHARM RES-DORDR, V30, P2157, DOI 10.1007/s11095-013-1076-6; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; van Velthoven CTJ, 2010, BRAIN BEHAV IMMUN, V24, P387, DOI 10.1016/j.bbi.2009.10.017; Volpe J. J., 2008, NEUROLOGY NEWBORN; Volpe JJ, 2001, NEUROLOGY NEWBORN, V4th, P217; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Wan T, 2012, INT J PHARMACEUT, V422, P462; Westenbrink BD, 2007, EUR HEART J, V28, P2018, DOI 10.1093/eurheartj/ehm177; Yang YJ, 2005, CHIN J CONT PEDIAT, V7, P25; Zhu LH, 2007, J CLIN PEDIAT, V25, P784	27	17	23	1	20	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1661-7800	1661-7819		NEONATOLOGY	Neonatology		2014	106	2					143	148		10.1159/000362262			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	AM9WO	WOS:000340231900011	24969821				2022-02-06	
J	Edlow, BL; Giacino, JT; Hirschberg, RE; Gerrard, J; Wu, O; Hochberg, LR				Edlow, Brian L.; Giacino, Joseph T.; Hirschberg, Ronald E.; Gerrard, Jason; Wu, Ona; Hochberg, Leigh R.			Unexpected Recovery of Function After Severe Traumatic Brain Injury: The Limits of Early Neuroimaging-Based Outcome Prediction	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Coma; Magnetic resonance imaging; Traumatic axonal injury; Diffusion-weighted imaging; Apparent diffusion coefficient; Diffusion tensor imaging	DIFFUSE AXONAL INJURY; MINIMALLY CONSCIOUS STATE; DISABILITY RATING-SCALE; SEVERE HEAD-INJURY; PERSISTENT VEGETATIVE STATE; WHITE-MATTER INJURY; PROGNOSTIC VALUE; WEIGHTED MR; CORPUS-CALLOSUM; CARDIAC-ARREST	Prognostication in the early stage of traumatic coma is a common challenge in the neuro-intensive care unit. We report the unexpected recovery of functional milestones (i.e., consciousness, communication, and community reintegration) in a 19-year-old man who sustained a severe traumatic brain injury. The early magnetic resonance imaging (MRI) findings, at the time, suggested a poor prognosis. During the first year of the patient's recovery, MRI with diffusion tensor imaging and T2*-weighted imaging was performed on day 8 (coma), day 44 (minimally conscious state), day 198 (post-traumatic confusional state), and day 366 (community reintegration). Mean apparent diffusion coefficient (ADC) and fractional anisotropy values in the corpus callosum, cerebral hemispheric white matter, and thalamus were compared with clinical assessments using the Disability Rating Scale (DRS). Extensive diffusion restriction in the corpus callosum and bihemispheric white matter was observed on day 8, with ADC values in a range typically associated with neurotoxic injury (230-400 x 10(-6) mm(2)/s). T2*-weighted MRI revealed widespread hemorrhagic axonal injury in the cerebral hemispheres, corpus callosum, and brainstem. Despite the presence of severe axonal injury on early MRI, the patient regained the ability to communicate and perform activities of daily living independently at 1 year post-injury (DRS = 8). MRI data should be interpreted with caution when prognosticating for patients in traumatic coma. Recovery of consciousness and community reintegration are possible even when extensive traumatic axonal injury is demonstrated by early MRI.	[Edlow, Brian L.; Hochberg, Leigh R.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Edlow, Brian L.; Wu, Ona] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Giacino, Joseph T.; Hirschberg, Ronald E.] Harvard Univ, Sch Med, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02114 USA; [Giacino, Joseph T.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Hirschberg, Ronald E.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Phys Med & Rehabil, Boston, MA 02114 USA; [Gerrard, Jason] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Wu, Ona] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Hochberg, Leigh R.] Brown Univ, Sch Engn, Providence, RI 02912 USA; [Hochberg, Leigh R.] Brown Univ, Inst Brain Sci, Providence, RI 02912 USA; [Hochberg, Leigh R.] Ctr Neurorestorat & Neurotechnol, Dept Vet Affairs Med Ctr, Providence, RI USA		Edlow, BL (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol, 175 Cambridge St,Suite 300, Boston, MA 02114 USA.	bedlow@partners.org	Viani, Rafael/V-1196-2018; Giacino, Joseph/AAF-1952-2021; Hochberg, Leigh/R-6872-2019	Giacino, Joseph/0000-0002-7916-9698; Hochberg, Leigh/0000-0003-0261-2273; Gerrard, Jason/0000-0001-6971-1407; Wu, Ona/0000-0002-5509-9461	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R25NS065743, P41EB015896]; National Institute on Disability and Rehabilitation Research [H133A120085]; Center for Integration of Medicine and Innovative Technology (Boston, MA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R25NS065743] Funding Source: NIH RePORTER	This study was supported in part by grants from the National Institutes of Health (R25NS065743 and P41EB015896), the National Institute on Disability and Rehabilitation Research (H133A120085), and the Center for Integration of Medicine and Innovative Technology (Boston, MA). The views in this article represent those of the authors alone, and do not necessarily represent the views of the Department of Veterans Affairs or the U.S. Government.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Betz J, 2012, J NEUROTRAUM, V29, P1292, DOI 10.1089/neu.2011.2215; Edlow BL, 2012, SEMIN NEUROL, V32, P374, DOI 10.1055/s-0032-1331810; Edlow BL, 2012, J NEUROPATH EXP NEUR, V71, P531, DOI 10.1097/NEN.0b013e3182588293; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Fernandez-Espejo D, 2011, NEUROIMAGE, V54, P103, DOI 10.1016/j.neuroimage.2010.08.035; Firsching R, 1998, J NEUROSURG, V89, P707, DOI 10.3171/jns.1998.89.5.0707; Galanaud D, 2012, ANESTHESIOLOGY, V117, P1300, DOI 10.1097/ALN.0b013e3182755558; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GENTRY LR, 1989, RADIOLOGY, V171, P177, DOI 10.1148/radiology.171.1.2928523; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GENTRY LR, 1994, RADIOLOGY, V191, P1; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Grandin C, 2002, J NEURORADIOLOGY, V29, P68; GRAY FD, 1970, J AMER MED ASSOC, V211, P1815, DOI 10.1001/jama.211.11.1815; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Greer D, 2011, NEUROCRIT CARE, V14, P61, DOI 10.1007/s12028-010-9457-8; Greer DM, 2006, SEMIN NEUROL, V26, P373, DOI 10.1055/s-2006-948317; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; Hinson HE, 2012, CURR OPIN CRIT CARE, V18, P139, DOI 10.1097/MCC.0b013e3283513290; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; JENNETT B, 1972, LANCET, V1, P734; Jones DK, 2004, MAGNET RESON MED, V51, P807, DOI 10.1002/mrm.20033; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Kidwell CS, 2003, STROKE, V34, P2729, DOI 10.1161/01.STR.0000097608.38779.CC; KINNEY HC, 1994, NEW ENGL J MED, V330, P1469, DOI 10.1056/NEJM199405263302101; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Lagares A, 2009, ACTA NEUROCHIR, V151, P341, DOI 10.1007/s00701-009-0194-8; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Ling GSF, 2008, NEUROL CLIN, V26, P409, DOI 10.1016/j.ncl.2008.02.001; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Marino S, 2007, J NEUROL NEUROSUR PS, V78, P501, DOI 10.1136/jnnp.2006.099796; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Melhem ER, 2000, AM J NEURORADIOL, V21, P1813; Mlynash M, 2010, STROKE, V41, P1665, DOI 10.1161/STROKEAHA.110.582452; Muccio CF, 2009, BRAIN INJURY, V23, P466, DOI 10.1080/02699050902841912; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nakahara M, 2001, ACTA RADIOL, V42, P365, DOI 10.1080/028418501127346990; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Parvizi J, 2003, BRAIN, V126, P1524, DOI 10.1093/brain/awg166; Parvizi J, 2001, COGNITION, V79, P135, DOI 10.1016/S0010-0277(00)00127-X; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Schlaug G, 1997, NEUROLOGY, V49, P113, DOI 10.1212/WNL.49.1.113; Schwamm LH, 1998, STROKE, V29, P2268, DOI 10.1161/01.STR.29.11.2268; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Skandsen T, 2011, J NEUROTRAUM, V28, P691, DOI 10.1089/neu.2010.1590; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sorensen AG, 1999, RADIOLOGY, V212, P785, DOI 10.1148/radiology.212.3.r99se24785; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Takayama H, 2000, CLIN NEUROL NEUROSUR, V102, P135, DOI 10.1016/S0303-8467(00)00079-2; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Tovar-Moll F, 2009, AM J NEURORADIOL, V30, P1380, DOI 10.3174/ajnr.A1564; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Wijman CAC, 2009, ANN NEUROL, V65, P394, DOI 10.1002/ana.21632; Wu O, 2009, RADIOLOGY, V252, P173, DOI 10.1148/radiol.2521081232; Yanagawa Y, 2000, J TRAUMA, V49, P272, DOI 10.1097/00005373-200008000-00013; Zheng WB, 2007, NEURORADIOLOGY, V49, P271, DOI 10.1007/s00234-006-0187-8	76	17	17	0	15	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	DEC	2013	19	3					364	375		10.1007/s12028-013-9870-x			12	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	257OB	WOS:000327393200015	23860665	Green Accepted			2022-02-06	
J	Hwabejire, JO; Imam, AM; Jin, G; Liu, BL; Li, YQ; Sillesen, M; Jepsen, CH; Lu, J; deMoya, MA; Alam, HB				Hwabejire, John O.; Imam, Ayesha M.; Jin, Guang; Liu, Baoling; Li, Yongqing; Sillesen, Martin; Jepsen, Cecilie H.; Lu, Jennifer; deMoya, Marc A.; Alam, Hasan B.			Differential effects of fresh frozen plasma and normal saline on secondary brain damage in a large animal model of polytrauma, hemorrhage and traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	43rd Annual Meeting of the Western-Trauma-Association	MAR 03-08, 2013	Snowmass, CO	Western Trauma Assoc		Brain; trauma; hemorrhage; metabolism; swine	HYPOTENSION; HYPOXIA	BACKGROUND: We have previously shown that the extent of traumatic brain injury (TBI) in large animal models can be reduced with early infusion of fresh frozen plasma (FFP), but the precise mechanisms remain unclear. In this study, we investigated whether resuscitation with FFP or normal saline differed in their effects on cerebral metabolism and excitotoxic secondary brain injury in a model of polytrauma, TBI, and hemorrhagic shock. METHODS: Yorkshire swine (n = 10) underwent Grade III liver injury, rib fracture, standardized TBI, and volume-controlled hemorrhage, (40% +/- 5%) and were randomly resuscitated with either FFP or normal saline. Hemodynamic parameters and brain oxygenation were continuously monitored, while microdialysis was used to measure the brain concentrations of pyruvate, lactate, glutamate, and glycerol at baseline; 1 hour and 2 hours after shock; immediate postresuscitation (PR); as well as 2, 4, and 6 hours PR. Cells from the injured hemisphere were separated into mitochondrial and cytosolic fractions and analyzed for activity of the pyruvate dehydrogenase complex (PDH). RESULTS: There were no baseline differences in cerebral perfusion pressure, brain oxygenation, as well as concentrations of pyruvate, lactate, glutamate, and glycerol between the groups. At 2 hours and 4 hours PR, the FFP group had significantly higher cerebral perfusion pressures (52 [5] mm Hg vs. 43 [2] mm Hg, p = 0.016; and 50 [7] mm Hg vs. 37 [1] mm Hg, p = 0.008, respectively). There was a sustained and significant (p < 0.05) drop in the glutamate and glycerol levels in the FFP group, implying a decrease in excitotoxicity and brain damage, respectively. Mitochondrial PDH activity was significantly higher (2,666.2 [638.2] adjusted volume INT x mm(2) vs. 1,293.4 [88.8] adjusted volume INT x mm(2), p = 0.008), and cytosolic PDH activity was correspondingly lower (671.4 [209.2] adjusted volume INT x mm(2) vs. 3070.7 [484.3] adjusted volume INT x mm(2), p < 0.001) in the FFP group, suggesting an attenuation of mitochondrial dysfunction and permeability. CONCLUSION: In this model of TBI, polytrauma, and hemorrhage, FFP resuscitation confers neuroprotection by improving cerebral perfusion, diminishing glutamate-mediated excitotoxic secondary brain injury and reducing mitochondrial dysfunction. (Copyright (C) 2013 by Lippincott Williams & Wilkins)	[Hwabejire, John O.; Imam, Ayesha M.; Jin, Guang; Liu, Baoling; Li, Yongqing; Sillesen, Martin; Jepsen, Cecilie H.; Lu, Jennifer; deMoya, Marc A.; Alam, Hasan B.] Massachusetts Gen Hosp, Div Trauma Emergency Surg & Surg Crit Care, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; [Jin, Guang; Liu, Baoling; Alam, Hasan B.] Univ Michigan Hosp, Dept Surg, Ann Arbor, MI 48109 USA		Alam, HB (corresponding author), Univ Michigan Hosp, Taubman Ctr 5331 2920, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	alamh@med.umich.edu		Sillesen, Martin/0000-0001-9494-5475			Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; DeGraba TJ, 2000, NEUROL CLIN, V18, P475, DOI 10.1016/S0733-8619(05)70203-6; Faden AI, 2001, ARCH NEUROL-CHICAGO, V58, P1553, DOI 10.1001/archneur.58.10.1553; Frykholm P, 2001, J NEUROL NEUROSUR PS, V71, P455, DOI 10.1136/jnnp.71.4.455; Jin G, 2012, J TRAUMA ACUTE CARE, V73, P1461, DOI 10.1097/TA.0b013e3182782641; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Olson DA, 2013, HEAD INJURY E MED; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Robertson CL, 2004, J BIOENERG BIOMEMBR, V36, P363, DOI 10.1023/B:JOBB.0000041769.06954.e4; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131	18	17	17	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	DEC	2013	75	6					968	974		10.1097/TA.0b013e31829a021a			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	300IR	WOS:000330458100008	24256668				2022-02-06	
J	Martinez-Vargas, M; Morales-Gomez, J; Gonzalez-Rivera, R; Hernandez-Enriquez, C; Perez-Arredondo, A; Estrada-Rojo, F; Navarro, L				Martinez-Vargas, Marina; Morales-Gomez, Julio; Gonzalez-Rivera, Ruben; Hernandez-Enriquez, Carla; Perez-Arredondo, Adan; Estrada-Rojo, Francisco; Navarro, Luz			Does the Neuroprotective Role of Anandamide Display Diurnal Variations?	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						cannabinoid receptor; anandamide; circadian rhythms; cerebral cortex; neuroprotection	CANNABINOID BINDING-SITES; TRAUMATIC BRAIN-INJURY; RAT-BRAIN; CIRCADIAN-RHYTHMS; CEREBRAL-ISCHEMIA; RECEPTOR-BINDING; TEMPORAL-CHANGES; DOWN-REGULATION; MESSENGER-RNA; CB1	The endocannabinoid system is a component of the neuroprotective mechanisms that an organism displays after traumatic brain injury (TBI). A diurnal variation in several components of this system has been reported. This variation may influence the recovery and survival rate after TBI. We have previously reported that the recovery and survival rate of rats is higher if TBI occurs at 1:00 than at 13:00. This could be explained by a diurnal variation of the endocannabinoid system. Here, we describe the effects of anandamide administration in rats prior to the induction of TBI at two different times of the day: 1:00 and 13:00. We found that anandamide reduced the neurological damage at both times. Nevertheless, its effects on bleeding, survival, food intake, and body weight were dependent on the time of TBI. In addition, we analyzed the diurnal variation of the expression of the cannabinoid receptors CB1R and CB2R in the cerebral cortex of both control rats and rats subjected to TBI. We found that CB1R protein was expressed more during the day, whereas its mRNA level was higher during the night. We did not find a diurnal variation for the CB2R. In addition, we also found that TBI increased CB1R and CB2R in the contralateral hemisphere and disrupted the CB1R diurnal cycle.	[Martinez-Vargas, Marina; Morales-Gomez, Julio; Gonzalez-Rivera, Ruben; Hernandez-Enriquez, Carla; Perez-Arredondo, Adan; Estrada-Rojo, Francisco; Navarro, Luz] Univ Nacl Autonoma Mexico, Dept Physiol, Sch Med, Mexico City 04510, DF, Mexico		Navarro, L (corresponding author), Univ Nacl Autonoma Mexico, Dept Physiol, Sch Med, AP 70-250, Mexico City 04510, DF, Mexico.	marvar_69@yahoo.com.mx; julio_macaco181@hotmail.com; rubengonzalezrivera@yahoo.com.mx; medicosita.06@gmail.com; aparredondo23@yahoo.com.mx; fesro@hotmail.com; lnavarro@unam.mx	Navarro, Luz/Q-9086-2019	Perez-Arredondo, Adan/0000-0002-0479-6734; MARTINEZ-VARGAS, MARINA/0000-0002-3729-2161	PAPIITPrograma de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) [IN222209, IN221212]; CONACyTConsejo Nacional de Ciencia y Tecnologia (CONACyT) [152510]	Supported by grants PAPIIT IN222209, IN221212 and CONACyT 152510.	Acuna-Goycolea C, 2010, J NEUROSCI, V30, P10061, DOI 10.1523/JNEUROSCI.5838-09.2010; Llompart-Pou JA, 2010, NEUROCRIT CARE, V13, P211, DOI 10.1007/s12028-010-9399-1; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Borner C, 2007, J LEUKOCYTE BIOL, V81, P336, DOI 10.1189/jlb.0306224; Boone DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046204; Braud S, 2000, FEBS LETT, V471, P12, DOI 10.1016/S0014-5793(00)01359-4; BRUININK A, 1983, LIFE SCI, V33, P31, DOI 10.1016/0024-3205(83)90708-7; BURBACH JPH, 1988, MOL BRAIN RES, V4, P157, DOI 10.1016/0169-328X(88)90007-1; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; Coutts AA, 2001, J NEUROSCI, V21, P2425; DEFONSECA FR, 1994, PHARMACOL BIOCHEM BE, V47, P33, DOI 10.1016/0091-3057(94)90108-2; Garcia-Ovejero D, 2009, NEUROBIOL DIS, V33, P57, DOI 10.1016/j.nbd.2008.09.015; Glaser ST, 2009, NEUROSCIENCE, V163, P594, DOI 10.1016/j.neuroscience.2009.06.043; Heller Joshua E, 2009, Clin Neurosurg, V56, P84; Hunter AJ, 2000, NEUROPHARMACOLOGY, V39, P806, DOI 10.1016/S0028-3908(99)00262-2; Jin KL, 2000, ANN NEUROL, V48, P257, DOI 10.1002/1531-8249(200008)48:2<257::AID-ANA18>3.3.CO;2-G; Kazanis I, 2003, BRAIN RES, V991, P34, DOI 10.1016/S0006-8993(03)03525-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Maccarrone M, 1999, FEBS LETT, V447, P277, DOI 10.1016/S0014-5793(99)00308-7; Marco EM, 2009, BRAIN RES, V1257, P25, DOI 10.1016/j.brainres.2008.12.037; MARSHALL J, 1977, STROKE, V8, P230, DOI 10.1161/01.STR.8.2.230; Martinez-Vargas M, 2003, NEUROSCIENCE, V117, P197, DOI 10.1016/S0306-4522(02)00820-5; Martinez-Vargas M, 2006, NEUROSCI LETT, V400, P21, DOI 10.1016/j.neulet.2006.02.010; Mechoulam R, 2007, MOL NEUROBIOL, V36, P68, DOI 10.1007/s12035-007-8008-6; Mechoulam R, 2002, TRENDS MOL MED, V8, P58, DOI 10.1016/S1471-4914(02)02276-1; Montagnana M, 2009, SEMIN THROMB HEMOST, V35, P23, DOI 10.1055/s-0029-1214145; MULLER JE, 1985, NEW ENGL J MED, V313, P1315, DOI 10.1056/NEJM198511213132103; Murillo-Rodniguez E, 2006, LIFE SCI, V79, P30, DOI 10.1016/j.lfs.2005.12.028; Murillo-Rodriguez E, 1998, BRAIN RES, V812, P270, DOI 10.1016/S0006-8993(98)00969-X; NABER D, 1981, BIOL PSYCHIAT, V16, P831; Nagayama T, 1999, J NEUROSCI, V19, P2987; OVIEDO A, 1993, BRAIN RES, V616, P293, DOI 10.1016/0006-8993(93)90220-H; Panikashvili D, 2006, NEUROBIOL DIS, V22, P257, DOI 10.1016/j.nbd.2005.11.004; Panikashvili D, 2005, J CEREBR BLOOD F MET, V25, P477, DOI 10.1038/sj.jcbfm.9600047; Paul T, 2007, CHRONOBIOL INT, V24, P45, DOI 10.1080/07420520601142569; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Perron RR, 2001, NEUROREPORT, V12, P3791, DOI 10.1097/00001756-200112040-00038; Romero J, 1998, SYNAPSE, V30, P298, DOI 10.1002/(SICI)1098-2396(199811)30:3<298::AID-SYN7>3.0.CO;2-6; ROMERO J, 1995, PHARMACOL BIOCHEM BE, V51, P731, DOI 10.1016/0091-3057(95)00023-P; Rueda-Orozco PE, 2008, PSYCHOPHARMACOLOGY, V198, P565, DOI 10.1007/s00213-007-0911-z; Sanford AE, 2008, BRAIN RES, V1222, P141, DOI 10.1016/j.brainres.2008.05.048; SCHMID PC, 1995, FEBS LETT, V375, P117, DOI 10.1016/0014-5793(95)01194-J; Schomacher M, 2006, ACTA NEUROPATHOL, V111, P8, DOI 10.1007/s00401-005-1109-2; Schomacher M, 2008, BRAIN RES, V1240, P213, DOI 10.1016/j.brainres.2008.09.019; Shen MX, 1998, MOL PHARMACOL, V54, P459, DOI 10.1124/mol.54.3.459; SOLOMON GD, 1992, CLEV CLIN J MED, V59, P326, DOI 10.3949/ccjm.59.3.326; SOULBAN G, 1989, LIFE SCI, V45, P2485, DOI 10.1016/0024-3205(89)90015-5; Sritharan K, 2009, BRIT J HOSP MED, V70, pM156, DOI 10.12968/hmed.2009.70.Sup10.44641; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; TOMINAGA K, 1992, NEUROREPORT, V3, P809, DOI 10.1097/00001756-199209000-00022; TONI D, 1991, CHRONOBIOL INT, V8, P321, DOI 10.3109/07420529109059168; Torner C, 1998, BIOL RHYTHM RES, V29, P538, DOI 10.1076/brhm.29.5.538.4817; TURNERWARWICK M, 1988, AM J MED, V85, P6, DOI 10.1016/0002-9343(88)90231-8; Valenti M, 2004, CELL MOL LIFE SCI, V61, P945, DOI 10.1007/s00018-003-3453-5; Vickers SP, 2005, CURR DRUG TARGETS, V6, P215, DOI 10.2174/1389450053174514; Vinall PE, 2000, J NEUROSURG, V93, P82, DOI 10.3171/jns.2000.93.1.0082; White TE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-282; Wittmann G, 2007, J COMP NEUROL, V503, P270, DOI 10.1002/cne.21383; Zhang M, 2008, NEUROSCIENCE, V152, P753, DOI 10.1016/j.neuroscience.2008.01.022; Zhuang SY, 1998, MOL BRAIN RES, V62, P141, DOI 10.1016/S0169-328X(98)00232-0	61	17	17	0	20	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	DEC	2013	14	12					23341	23355		10.3390/ijms141223341			15	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	296XX	WOS:000330219800011	24287910	gold, Green Submitted, Green Published			2022-02-06	
J	Norman, RS; Jaramillo, CA; Amuan, M; Wells, MA; Eapen, BC; Pugh, MJ				Norman, Rocio S.; Jaramillo, Carlos A.; Amuan, Megan; Wells, Margaret Ann; Eapen, Blessen C.; Pugh, Mary Jo			Traumatic brain injury in veterans of the wars in Iraq and Afghanistan: Communication disorders stratified by severity of brain injury	BRAIN INJURY			English	Article						aphasia; epidemiology; fluency disorder; TBI severity; Veterans Health Administration; voice disorder	POSTTRAUMATIC-STRESS-DISORDER; HEAD-INJURY; VOICE DISORDERS; MILD; LANGUAGE; SYMPTOMS; REHABILITATION; IMPAIRMENT; MANAGEMENT; ABILITIES	Objective: To describe the prevalence of communication disorders in veterans of the wars in Iraq and Afghanistan with traumatic brain injury (TBI). Design: Retrospective study of the prevalence of aphasia, fluency and voice disorders among veterans with different severity levels of TBI. Data was obtained from the VA National repository for OEF/OIF/OND veterans who received VA care in Fiscal Years 2010 and 2011. Results: Among the 303 716 veterans in this study, 1848 were diagnosed with a communication disorder; 40% of these were also diagnosed with a TBI. Voice disorders were the most prevalent diagnosis (3.5 per 1000) followed by aphasia (1.9 per 1000) and fluency disorder (0.7 per 1000). Individuals with a TBI diagnosis were more likely to have a diagnosis of aphasia, followed by fluency and then voice disorder. The odds ratio (OR) of aphasia with TBI was 11.09-252.75 (95% CI = 8.78-441.52, p < 0.01). OR for fluency disorders with TBI was 3.58-10.41 (95% CI = 2.56-42.40, p < 0.01) and association of voice disorders with TBI was significant for all levels of TBI severity (OR = 1.5-6.61, 95% CI = 1.24-14.05, p < 0.01). Conclusions: Veterans who sustained a TBI were more likely to have a diagnosis of a communication disorder, regardless of TBI severity. Those with TBI, including mild TBI, should be screened and evaluated for communication disorders.	[Norman, Rocio S.; Jaramillo, Carlos A.] South Texas Vet Hlth Care Syst, Polytrauma Rehabil Ctr, San Antonio, TX USA; [Amuan, Megan] Edith Nourse Rogers Mem VA Hosp, Ctr Hlth Qual Outcomes & Econ Res, Bedford, MA USA; [Wells, Margaret Ann] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Eapen, Blessen C.] South Texas Vet Hlth Care Syst, Polytrauma Transit Rehabil Program, San Antonio, TX USA; [Pugh, Mary Jo] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, South Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA		Norman, RS (corresponding author), Univ Wisconsin, Dept Commun Sci & Disorders, 1975 Willow Dr, Madison, WI 53706 USA.	rnorman2@wisc.edu	Pugh, Mary Jo/K-5336-2019	Pugh, Mary Jo/0000-0003-4196-7763	South Texas Veterans Healthcare System/Audie L. Murphy Division; Edith Nourse Rogers VA Memorial Hospital; Veterans AffairsUS Department of Veterans Affairs [I01HX000329] Funding Source: NIH RePORTER	The authors acknowledge and appreciate support from the South Texas Veterans Healthcare System/Audie L. Murphy Division and the Edith Nourse Rogers VA Memorial Hospital. We also acknowledge assistance with manuscript preparation by Barbara Elizondo and Kathleen Franklin as well as valuable input by Dr Juan Cabrera at the initial stages of the manuscript process. The views expressed in this article are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs.	Alm PA, 2004, J COMMUN DISORD, V37, P325, DOI 10.1016/j.jcomdis.2004.03.001; Belanger HG, 2012, ARCH PHYS MED REHAB, V93, P1234, DOI 10.1016/j.apmr.2012.03.003; BERKER EA, 1986, ARCH NEUROL-CHICAGO, V43, P1065, DOI 10.1001/archneur.1986.00520100069017; BOHNEN NI, 1995, BRAIN INJURY, V9, P27, DOI 10.3109/02699059509004568; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Cherney LR, 2010, J HEAD TRAUMA REHAB, V25, P219, DOI 10.1097/HTR.0b013e3181dc82c1; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Coelho CA, 1996, J SPEECH HEAR RES, V39, pS5, DOI 10.1044/jshr.3905.s5; Department of Defense, 2010, DEP DEF ICD 9 COD GU; Dion GR, 2013, J VOICE, V27, P57, DOI 10.1016/j.jvoice.2012.08.001; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Ezrati-Vinacour R, 2004, J FLUENCY DISORD, V29, P135, DOI 10.1016/j.jfludis.2004.02.003; Faul M, 2010, TRAUMATIC BRAIN INJU; Fischer H., 2013, US MILITARY CASUALTY; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoofien D, 2001, BRAIN INJURY, V15, P189; Huang SJ, 2010, BRAIN INJURY, V24, P1606, DOI 10.3109/02699052.2010.523056; Isaki E, 2000, BRAIN INJURY, V14, P441; Iverach L, 2009, J ANXIETY DISORD, V23, P928, DOI 10.1016/j.janxdis.2009.06.003; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Levin HS, 2003, BRAIN INJURY, V17, P665, DOI 10.1080/0269905031000107151; Ludlow CL, 2003, J FLUENCY DISORD, V28, P273, DOI 10.1016/j.jfludis.2003.07.001; LUDLOW CL, 1987, ANN NEUROL, V22, P60, DOI 10.1002/ana.410220114; Lundgren K, 2010, J NEUROLINGUIST, V23, P447, DOI 10.1016/j.jneuroling.2009.08.008; LURIA AR, 1970, SCI AM, V222, P66, DOI 10.1038/scientificamerican0370-66; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Management of Concussion/mTBI Working Group, 2009, J REHABILITATION RES, V46; Mao H, 2007, J NEUROIMAGING, V17, P292, DOI 10.1111/j.1552-6569.2007.00146.x; McHenry M, 2000, LARYNGOSCOPE, V110, P1157, DOI 10.1097/00005537-200007000-00017; Messenger M, 2004, J FLUENCY DISORD, V29, P201, DOI 10.1016/j.jfludis.2004.06.002; MOHR JP, 1980, NEUROLOGY, V30, P1273, DOI 10.1212/WNL.30.12.1273; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; O'Mara W, 2000, J La State Med Soc, V152, P218; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; REILLY S, 2004, EVIDENCE BASED PRACT; Roy N, 2005, LARYNGOSCOPE, V115, P1988, DOI 10.1097/01.mlg.0000179174.32345.41; Roy N, 2000, J SPEECH LANG HEAR R, V43, P737, DOI 10.1044/jslhr.4303.737; Ruben RJ, 2000, LARYNGOSCOPE, V110, P241, DOI 10.1097/00005537-200002010-00010; Russell KC, 2012, BRAIN INJURY, V26, P984, DOI 10.3109/02699052.2012.660513; Saunders GH, 2012, J REHABIL RES DEV, V49, P1043, DOI 10.1682/JRRD.2010.08.0157; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Togher L., 2010, ISL PALMS SC CLIN AP; Togher L, 1999, CODE C COMMUNICATION; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Verschueren DS, 2006, J ORAL MAXIL SURG, V64, P203, DOI 10.1016/j.joms.2005.10.034; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Yairi E, 2004, ASHA LEADER, V9, p[4, 14]	50	17	17	0	17	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2013	27	13-14					1623	1630		10.3109/02699052.2013.834380			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	259BW	WOS:000327503400018	24131337				2022-02-06	
J	Sakai, K; Fukuda, T; Iwadate, K				Sakai, Kentaro; Fukuda, Takahiro; Iwadate, Kimiharu			Beading of the astrocytic processes (clasmatodendrosis) following head trauma is associated with protein degradation pathways	BRAIN INJURY			English	Article						Astrocyte; autophagy; clasmatodendrosis; traumatic brain injury; ubiquitin	SELECTIVE AUTOPHAGY; DISEASE PATIENTS; UBIQUITIN; P62/SQSTM1; ISCHEMIA; SYSTEM; BRAIN; DEATH; MICE; P62	Objectives: To present the incidence of clasmatodendrosis (injured astrocytic processes) and analyse the association between clasmatodendrosis and the ubiquitin proteasome system (UPS) and autophagy lysosome system (autophagy). Methods: The injured cerebral cortices of 36 autopsy cases were analysed by light microscopy by immunohistochemistry using an anti-glial fibrillary acidic protein (GFAP) antibody and UPS marker antibodies (ubiquitin and lysine 48-linked polyubiquitin chains (K-48) and autophagy marker (lysine 63-linked polyubiquitin chains (K-63), p62/sequestosome 1 and microtubule-associated protein 1 light chain 3 [LC3]). Double-immunofluorescence staining was used to detect the relationships between p62-K-48, p62-K-63 and GFAP-K-48. Results: Clasmatodendrosis that was immunoreactive to GFAP or K-48 was detected by 1 hour up to 14 days following head trauma. The survival time of cases with clasmatodendrosis was significantly shorter than that in cases without clasmatodendrosis (p<0.01). Involvement of contusion or oedema was significantly frequent in cases with clasmatodendrosis (p<0.01). There was no significant age difference between cases with clasmatodendrosis and cases without clasmatodendrosis (p=0.18). Double-immunofluorescence staining for p62-K-48 and GFAP-K-48 demonstrated clasmatodendrosis with overlapping fluorescence signals. Conclusion: Clasmatodendrosis is associated with UPS-mediated, autophagy and relatively acute pathological findings after traumatic intracranial injury.	[Sakai, Kentaro; Iwadate, Kimiharu] Jikei Univ, Sch Med, Dept Forens Med, Minato Ku, Tokyo 1058461, Japan; [Fukuda, Takahiro] Jikei Univ, Sch Med, Res Ctr Med Sci,Dept Neurosci,Div Neuropathol, Minato Ku, Tokyo 1058461, Japan		Sakai, K (corresponding author), Jikei Univ, Sch Med, Dept Forens Med, Minato Ku, 3-25-8 Nishi Shimbashi, Tokyo 1058461, Japan.	kentaro.sakai@jikei.ac.jp					Akiguchi I, 1997, STROKE, V28, P1423, DOI 10.1161/01.STR.28.7.1423; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bjorkoy G, 2006, AUTOPHAGY, V2, P138, DOI 10.4161/auto.2.2.2405; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; CAVANAGH JB, 1993, NEUROPATH APPL NEURO, V19, P240, DOI 10.1111/j.1365-2990.1993.tb00434.x; Ciechanover A, 2006, NEUROLOGY, V66, pS7, DOI 10.1212/01.wnl.0000192261.02023.b8; Duchen L. W., 1992, GREENFIELDS NEUROPAT, P1; FRIEDE RL, 1961, EXP NEUROL, V4, P197, DOI 10.1016/0014-4886(61)90041-3; Gelot A, 2009, DEV NEUROSCI-BASEL, V31, P459, DOI 10.1159/000232564; Hulse RE, 2001, GLIA, V33, P169, DOI 10.1002/1098-1136(200102)33:2<169::AID-GLIA1016>3.0.CO;2-B; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Koehler RC, 2006, J APPL PHYSIOL, V100, P307, DOI 10.1152/japplphysiol.00938.2005; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; KRAIG RP, 1990, J CEREBR BLOOD F MET, V10, P104, DOI 10.1038/jcbfm.1990.13; Leesthma JE, 1988, FORENSIC NEUROPATHOL; Lehman NL, 2009, ACTA NEUROPATHOL, V118, P329, DOI 10.1007/s00401-009-0560-x; Lim KL, 2011, NEUROBIOL DIS, V43, P9, DOI 10.1016/j.nbd.2010.08.001; LOBERG EM, 1989, MED SCI LAW, V29, P109, DOI 10.1177/002580248902900205; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Qiao YL, 2003, J CEREBR BLOOD F MET, V23, P1113, DOI 10.1097/01.WCB.0000088765.02615.FE; Qin AP, 2010, AUTOPHAGY, V6, P738, DOI 10.4161/auto.6.6.12573; Rafalowska Janina, 1992, Neuropatologia Polska, V30, P73; Ryu HJ, 2011, CELL MOL NEUROBIOL, V31, P1071, DOI 10.1007/s10571-011-9706-1; Seibenhener ML, 2007, FEBS LETT, V581, P175, DOI 10.1016/j.febslet.2006.12.027; Tan JMM, 2008, AUTOPHAGY, V4, P251, DOI 10.4161/auto.5444; Tomimoto H, 1997, ACTA NEUROPATHOL, V94, P146, DOI 10.1007/s004010050686; Uchiyama Y, 2008, HISTOCHEM CELL BIOL, V129, P407, DOI 10.1007/s00418-008-0406-y; Vinters HV, 2008, GREENFIELDS NEUROPAT, V1, P1	30	17	17	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2013	27	13-14					1692	1697		10.3109/02699052.2013.837198			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	259BW	WOS:000327503400027	24111565				2022-02-06	
J	Xiang, J; Shi, JX; Wheeler, KK; Yeates, KO; Taylor, HG; Smith, GA				Xiang, Joe; Shi, Junxin; Wheeler, Krista Kurz; Yeates, Keith Owen; Taylor, H. Gerry; Smith, Gary A.			Paediatric patients with abusive head trauma treated in US Emergency Departments, 2006-2009	BRAIN INJURY			English	Article						Abuse; children; emergency department; head trauma; traumatic brain injury	BRAIN-INJURY; CHILD-ABUSE; INFANTS	Objective: To study characteristics and outcomes of paediatric patients with abusive head trauma (AHT) treated in emergency departments. Methods: Nationwide Emergency Department Sample (NEDS) data were analysed. The CDC recommended AHT definition was used to classify children <= 4 years with head trauma into AHT and non-AHT groups. Outcomes were compared between patients with AHT and patients with non-AHT. Logistic models were fitted to identify risk factors. Results: An estimated 10 773 paediatric patients with AHT were treated in EDs in 2006-2009. The average annual rate was 12.83 per 100 000 for children <= 4 years. Children < 1 year of age accounted for most AHT cases (60.6%) and males had a significantly higher AHT rate than females. Medicaid was the primary payer for 66.1% of AHT injuries and 40.3% of non-AHT injuries. The case mortality rate was 53.9 (95% CI = 41.0-66.7) per 1000 patients with AHT compared with 1.6 (95% CI = 1.4-1.9) per 1000 patients with non-AHT. Conclusions: Child caregivers should be educated about the serious consequences of AHT and proper techniques for caring for infants. Unbiased and accurate documentation of AHT by physicians and medical coders is crucial for monitoring AHT injuries.	[Xiang, Joe; Shi, Junxin; Wheeler, Krista Kurz; Yeates, Keith Owen; Smith, Gary A.] Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, Columbus, OH 43205 USA; [Xiang, Joe; Taylor, H. Gerry] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Yeates, Keith Owen; Smith, Gary A.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA		Smith, GA (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA.	gary.smith@nationwidechildrens.org	Yeates, Keith/AAJ-4223-2020	Wheeler, Krista/0000-0003-3728-8928; Yeates, Keith/0000-0001-7680-2892			Agency for Healthcare Research and Quality, 2011, OV NAT EM DEP SAMPL; Baker SP, 1992, THE INJURY FACT BOOK, VSecond; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Barr RG, 2009, CAN MED ASSOC J, V180, P727, DOI 10.1503/cmaj.081419; Barth RP, 2009, FUTURE CHILD, V19, P95, DOI 10.1353/foc.0.0031; Berger RP, 2011, PEDIATRICS, V128, P637, DOI 10.1542/peds.2010-2185; Dias MS, 2005, PEDIATRICS, V115, DOI 10.1542/peds.2004-1896; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; Ellingson KD, 2008, AM J PREV MED, V34, pS157, DOI 10.1016/j.amepre.2007.12.021; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Flaherty EG, 2008, PEDIATRICS, V122, P611, DOI 10.1542/peds.2007-2311; GOLDSTEIN B, 1993, CRIT CARE MED, V21, P1328, DOI 10.1097/00003246-199309000-00016; Herman BE, 2011, PEDIATR EMERG CARE, V27, P65, DOI 10.1097/PEC.0b013e31820349db; Hooft A, 2013, J PEDIATR-US, V162, P80, DOI 10.1016/j.jpeds.2012.06.037; Huang MI, 2011, J NEUROSURG-PEDIATR, V8, P171, DOI 10.3171/2011.5.PEDS1139; Jenny C, 2013, JAMA-J AM MED ASSOC, V281, P621; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Leventhal JM, 2010, PEDIATRICS, V126, pE104, DOI 10.1542/peds.2009-1076; Libby AM, 2003, PEDIATRICS, V112, P58, DOI 10.1542/peds.112.1.58; McKenzie K, 2009, INJURY PREV, V15, P60, DOI 10.1136/ip.2008.019935; National Center for Injury Prevention and Control, 2012, PREV SHAK BAB SYNDR; Oluigbo CO, 2012, J NEUROSURG-PEDIATR, V9, P125, DOI 10.3171/2011.11.PEDS09449; Parks S, 2012, INJURY PREVENTION, V18; Parks S, 2012, PEDIAT ABUSE HEAD TR; Parks SE, 2012, INJURY PREV, V18, P193, DOI 10.1136/injuryprev-2011-040128; Prasad MR, 2005, ARCH DIS CHILD, V90, P82, DOI 10.1136/adc.2003.045583; Runyan DK, 2008, AM J PREV MED, V34, pS163, DOI 10.1016/j.amepre.2008.01.010; Runyan DK, 2008, AM J PREV MED, V34, pS112, DOI 10.1016/j.amepre.2008.01.011; Sills MR, 2005, ARCH PEDIAT ADOL MED, V159, P665, DOI 10.1001/archpedi.159.7.665; U.S. Census Bureau, 2010, TABL 1 ANN EST RES P; Wright RJ, 1999, PEDIATR EMERG CARE, V15, P376, DOI 10.1097/00006565-199912000-00002	32	17	17	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2013	27	13-14					1555	1561		10.3109/02699052.2013.831126			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	259BW	WOS:000327503400009	24102484				2022-02-06	
J	Ding, J; Guo, JY; Yuan, Q; Yuan, F; Chen, H; Tian, H				Ding, Jun; Guo, Jianyi; Yuan, Qiang; Yuan, Fang; Chen, Hao; Tian, Hengli			Inhibition of Phosphatase and Tensin Homolog Deleted on Chromosome 10 Decreases Rat Cortical Neuron Injury and Blood-Brain Barrier Permeability, and Improves Neurological Functional Recovery in Traumatic Brain Injury Model	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; PTEN; PATHWAY; SURVIVAL; AKT; PHOSPHORYLATION; STROKE; MICE; ANGIOGENESIS; OUTGROWTH	Background and Purpose: Recent evidence has supported the neuroprotective effect of bpV (pic), an inhibitor of phosphatase and tensin homolog deleted on chromosome 10 (PTEN), in models of ischemic stroke. However, whether PTEN inhibitors improve long-term functional recovery after traumatic brain injury (TBI) and whether PTEN affects blood brain barrier (BBB) permeability need further elucidation. The present study was performed to address these issues. Methods: Adult Sprague-Dawley rats were subjected to fluid percussion injury (FPI) after treatment with a well-established PTEN inhibitor bpV (pic) or saline starting 24 h before FPI. Western blotting, real-time quantitative PCR, or immunostaining was used to measure PTEN, p-Akt, or MMP-9 expression. We determined the presence of neuron apoptosis by TUNEL assay. Evans Blue dye extravasation was measured to evaluate the extent of BBB disruption. Functional recovery was assessed by the neurological severity score (NSS), and Kaplan-Meier analysis was used for survival analysis. Results: PTEN expression was up-regulated after TBI. After bpV (pic) treatment, p-Akt was also up-regulated. We found that bpV (pic) significantly decreased BBB permeability and reduced the number of TUNEL-positive cells. We further demonstrated that PTEN inhibition improved neurological function recovery in the early stage after TBI. Conclusion: These data suggest that treatment with the PTEN inhibitor bpV (pic) has a neuroprotective effect in TBI rats.	[Ding, Jun; Guo, Jianyi; Yuan, Qiang; Yuan, Fang; Chen, Hao; Tian, Hengli] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Neurosurg, Shanghai 200030, Peoples R China		Tian, H (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Neurosurg, Shanghai 200030, Peoples R China.	tianhlsh@126.com			National Nature and Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271383]; Shanghai Science and Technique Committee [13411951400, 13411951401, 10JC1412500]	Grant support was provided by National Nature and Science Foundation of China (grant No. 81271383) and the Shanghai Science and Technique Committee (grant No. 13411951400, 13411951401 and 10JC1412500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck H, 2009, ACTA NEUROPATHOL, V117, P481, DOI 10.1007/s00401-009-0483-6; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cai QY, 2009, ANAT REC, V292, P498, DOI 10.1002/ar.20834; Cao L, 2011, INVEST OPHTH VIS SCI, V52, P2272, DOI 10.1167/iovs.10-5972; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chopp M, 2008, ACTA NEUROCHIR SUPPL, V105, P79; Christie KJ, 2010, J NEUROSCI, V30, P9306, DOI 10.1523/JNEUROSCI.6271-09.2010; Dasari VR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010350; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Guo JY, 2013, INT J MOL SCI; Guo SZ, 2009, STROKE, V40, pS4, DOI 10.1161/STROKEAHA.108.534388; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Huang JH, 2002, ARTERIOSCL THROM VAS, V22, P745, DOI 10.1161/01.ATV.0000016358.05294.8D; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Keyes KT, 2010, AM J PHYSIOL-HEART C, V298, pH1198, DOI 10.1152/ajpheart.00915.2009; Kini V, 2010, J BIOL CHEM, V285, P33082, DOI 10.1074/jbc.M110.142034; Lakhan SE, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00032; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Li PP, 2012, MOL BIOL CELL, V23, P4109, DOI 10.1091/mbc.E12-05-0367; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Liu C, 2010, J NEUROCHEM, V112, P1500, DOI 10.1111/j.1471-4159.2009.06561.x; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Lok J, 2007, NEUROCHEM RES, V32, P2032, DOI 10.1007/s11064-007-9342-9; Mao L, 2013, NEUROSCIENCE, V231, P272, DOI 10.1016/j.neuroscience.2012.11.050; Marin D, 2005, LEUKEMIA, V19, P507, DOI 10.1038/sj.leu.2403664; Martelli AM, 2011, LEUKEMIA, V25, P1064, DOI 10.1038/leu.2011.46; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Sanchez T, 2005, P NATL ACAD SCI USA, V102, P4312, DOI 10.1073/pnas.0409784102; Sedding DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055445; Tamguney T, 2007, J CELL SCI, V120, P4071, DOI 10.1242/jcs.015230; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Walker CL, 2012, PLOS ONE, V7, P315, DOI 10.1371/journal.pone.0030012; Walker CL, 2013, FRONT BIOL; Wang XJ, 2008, CELL RES, V18, P807, DOI 10.1038/cr.2008.83; Woodgett JR, 2005, CURR OPIN CELL BIOL, V17, P150, DOI 10.1016/j.ceb.2005.02.010; Yuan Q, 2012, INJURY, V43, P2094, DOI 10.1016/j.injury.2012.03.028; Zhang QG, 2007, FEBS LETT, V581, P495, DOI 10.1016/j.febslet.2006.12.055; Zhang S, 2013, J NEUROSCI, V33, P7997, DOI 10.1523/JNEUROSCI.5661-12.2013; Zhang YJ, 2012, BRAIN, V135, P2736, DOI 10.1093/brain/aws196; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104; Zu LY, 2011, EUR J PHARMACOL, V650, P298, DOI 10.1016/j.ejphar.2010.09.069	44	17	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e80429	10.1371/journal.pone.0080429			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	WOS:000327657900007	24312220	Green Submitted, Green Published, gold			2022-02-06	
J	Barz, H; Schreiber, A; Barz, U				Barz, Helmut; Schreiber, Almut; Barz, Ulrich			Impulses and pressure waves cause excitement and conduction in the nervous system	MEDICAL HYPOTHESES			English	Article							MECHANISM	It is general accepted, that nerval excitement and conduction is caused by voltage changes. However, the influx of fluid into an elastical tube releases impulses or pressure waves. Therefore an influx of ion currents, respectively fluid motions into the elastic neuronal cells and fibres also induce impulses. This motion of charge carriers are measured by voltage devices as oscillations or action potentials, but the voltage changes may be an epiphenomenon of the (mechanical) impulses. Impulse waves can have a high speed. As stiffer or inelastic a tube wall, the greater is the speed of the impulse. Myelin sheaths cause a significant stiffening of the nerve fibre wall and myelinated fibres have a conduction velocity up to 120 m/s. The influx of fluid at the nodes of Ranvier intensifies periodically the impulse wave in the nerve fibres. The authors suggest that also the muscle end-plate acts as a conductor of axonal impulses to the inner of the muscle fibres and that the exocytosis of acetylcholine into the synaptic cleft may be an amplifier of the axonal impulse. It is discussed that intracellular actin filaments may also influence motions at the neuronal membrane. Many sensory nerve cells are excited due to exogenous or endogenous mechanical impulses. It may plausible that such impulses are conducted directly to the sensory nerve cell bodies in the dorsal root ganglia without the transformation in electric energy. Excitation conduction happens without noteworthy energy consumption because the flow of ion currents through the membranes takes place equivalent to the concentration gradient. Impulse waves cause short extensions of the lipid membranes of the cell- and fibres walls and therefore they can induce opening and closing of the included ion channels. This mechanism acts to "voltage gated" and "ligand-gated" channels likewise. The concept of neuronal impulses can be helpful to the understanding of other points of neurophysiology or neuronal diseases. This includes e.g., the brain concussion and pathohistological findings in Alzheimer dementia. To verify the concept of (mechanical) impulses in the nervous system it is necessary to carry out biophysical or mechanical investigations in very small dimensions and the authors hope to give for this a sufficient stimulus. (C) 2013 The Authors. Published by Elsevier Ltd. All rights reserved.	[Barz, Helmut] Dietrich Bonhoeffer Hosp, Dept Neuropathol, D-17022 Neubrandenburg, Germany; [Schreiber, Almut] Inst Arbeits & Sozialhyg, D-01069 Dresden, Saxony, Germany; [Barz, Ulrich] Univ Halle Wittenberg, D-06108 Halle, Saxony Anhalt, Germany		Barz, H (corresponding author), Holunderweg 17, D-18209 Bad Doberan, Germany.	HelmutBarz@gmx.de; almut.schreiber@fit-for-work.eu; UlrichBarz@yahoo.de					Adams JH, 1992, GREENFIELDS NEUROPAT, P106; Bamburg J. R., 1991, NEURONAL CYTOSKELETO, P121; Barz H, 1992, Acta Histochem Suppl, V42, P77; Barz H., 1992, ZEREBRALEN DURCHBLUT, VII, P554; Berg JM, 2013, BIOCHIMIE, P374; Beyder A, 2010, J PHYSL, V24, P4569; Cole KS, 1939, J GEN PHYSIOL, V22, P649, DOI 10.1085/jgp.22.5.649; Corry B, 2006, BIOPHYS J, V90, P799, DOI 10.1529/biophysj.105.067868; Dudel J., 1996, NEUROWISSENSCHAFT MO, P87; Dudel J., 1996, NEUROWISSENSCHAFTEN, P115; FIFKOVA E, 1985, CELL MOL NEUROBIOL, V5, P47, DOI 10.1007/BF00711085; Forbes M., 2012, CELL PHYSL SOURCE BO, P67; Freedman JC, 2012, CELL PHYSL SOURCE BO, P3; French AS, 2012, CELL PHYSL SOURCE BO, P633; Gekle M, 2010, TASCHENLEHRBUCH PHYS, P191; Giza CC, 2001, J ATHL TRAINING, V36, P228; Graeber MB, 2002, GREENFIELDS NEUROPAT, VI, P123; Guckenheimer J, 2002, SIAM J APPL DYN SYST, V1, P105, DOI 10.1137/S1111111101394040; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Kandel ER, 1995, ESSENTIALS NEURAL SC, P197; Koester J, 1995, ESSENTIALS NEURAL SC, P115; Lambert S., 2012, CELL PHYSL SOURCE BO, P475; Mirra S. S., 2002, GREENFIELDS NEUROPAT, V2, P195; Morris CE, 2007, BIOPHYS J, V93, P822, DOI 10.1529/biophysj.106.101246; Morris CE, 2012, CELL PHYSL SOURCE BO, P493; Perozo E, 2002, NAT STRUCT BIOL, V9, P696, DOI 10.1038/nsb827; Rudel R, 1996, NEUROWISSENSCHAFT MO, P145; Sperelakis N, 2012, CELL PHYSL SOURCE BO, P325; Suszkiw J B., 2012, CELL PHYSL SOURCE BO, P563; Unwin N, 2012, J MOL BIOL, V422, P617, DOI 10.1016/j.jmb.2012.07.010	30	17	18	0	10	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	NOV	2013	81	5					768	772		10.1016/j.mehy.2013.07.049			5	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	257DI	WOS:000327363400006	23953966	hybrid			2022-02-06	
J	Jackson, TC; Verrier, JD; Drabek, T; Janesko-Feldman, K; Gillespie, DG; Uray, T; Dezfulian, C; Clark, RS; Bayir, H; Jackson, EK; Kochanek, PM				Jackson, Travis C.; Verrier, Jonathan D.; Drabek, Tomas; Janesko-Feldman, Keri; Gillespie, Delbert G.; Uray, Thomas; Dezfulian, Cameron; Clark, Robert S.; Bayir, Huelya; Jackson, Edwin K.; Kochanek, Patrick M.			Pharmacological Inhibition of Pleckstrin Homology Domain Leucine-Rich Repeat Protein Phosphatase Is Neuroprotective: Differential Effects on Astrocytess	JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS			English	Article							SIGNAL-REGULATED KINASE; TRAUMATIC BRAIN-INJURY; GLOBAL CEREBRAL-ISCHEMIA; CELL-DEATH; HIPPOCAMPAL-NEURONS; CARDIAC-ARREST; SUPRACHIASMATIC NUCLEUS; CIRCULATORY ARREST; RAT HIPPOCAMPUS; ACTIVATION	Pleckstrin homology domain and leucine-rich repeat protein phosphatase 1 (PHLPP1) inhibits protein kinase B (AKT) survival signaling in neurons. Small molecule pan-PHLPP inhibitors (selective for PHLPP1 and PHLPP2) may offer a translatable method to induce AKT neuroprotection. We tested several recently discovered PHLPP inhibitors (NSC117079 and NSC45586; benzoic acid, 5-[2-[4-[2-(2,4-diamino-5-methylphenyl)diazenyl]phenyl]diazenyl]-2-hydroxy-, sodium salt.) in rat cortical neurons and astrocytes and compared the biochemical response of these agents with short hairpin RNA (shRNA)-mediated PHLPP1 knockdown (KD). In neurons, both PHLPP1 KD and experimental PHLPP inhibitors activated AKT and ameliorated staurosporine (STS)-induced cell death. Unexpectedly, in astrocytes, both inhibitors blocked AKT activation, and NSC117079 reduced viability. Only PHLPP2 KD mimicked PHLPP inhibitors on astrocyte biochemistry. This suggests that these inhibitors could have possible detrimental effects on astrocytes by blocking novel PHLPP2-mediated prosurvival signaling mechanisms. Finally, because PHLPP1 levels are reportedly high in the hippocampus (a region prone to ischemic death), we characterized hippocampal changes in PHLPP and several AKT targeting prodeath phosphatases after cardiac arrest (CA)-induced brain injury. PHLPP1 levels increased in rat brains subjected to CA. None of the other AKT inhibitory phosphatases increased after global ischemia (i.e., PHLPP2, PTEN, PP2A, and PP1). Selective PHLPP1 inhibition (such as by shRNA KD) activates AKT survival signaling in neurons and astrocytes. Nonspecific PHLPP inhibition (by NSC117079 and NSC45586) only activates AKT in neurons. Taken together, these results suggest that selective PHLPP1 inhibitors should be developed and may yield optimal strategies to protect injured hippocampal neurons and astrocytes-namely from global brain ischemia.	[Jackson, Travis C.; Janesko-Feldman, Keri; Uray, Thomas; Dezfulian, Cameron; Clark, Robert S.; Bayir, Huelya; Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Verrier, Jonathan D.; Gillespie, Delbert G.; Jackson, Edwin K.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Drabek, Tomas] Presbyterian Hosp, Dept Anesthesiol, Pittsburgh, PA USA		Kochanek, PM (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, Safar Ctr Resuscitat Res, 3434 5th Ave, Pittsburgh, PA 15260 USA.	kochanekpm@ccm.upmc.edu	Kochanek, Patrick M/D-2371-2015; Drabek, Tomas/AAJ-1595-2021	Kochanek, Patrick M/0000-0002-2627-913X; Drabek, Tomas/0000-0002-5702-4498; Jackson, Edwin/0000-0002-8101-6009; Dezfulian, Cameron/0000-0002-4486-0446; Uray, Thomas/0000-0002-8869-1912	American Heart AssociationAmerican Heart Association [11POST7320018]; National Institutes of Health National Institute of Diabetes and Digestive and Kidney DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK079307]; Laerdal Foundation; National Institutes of Health National Institutes of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08-NS069817]; Max Kade Foundation; US ArmyUnited States Department of Defense [W81XWH-10-1-0623]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P30DK079307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS069817] Funding Source: NIH RePORTER	This work was supported by the American Heart Association [Research Grant 11POST7320018]; National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases [Grant DK079307]; Laerdal Foundation; National Institutes of Health National Institutes of Neurological Disorders and Stroke [Grant K08-NS069817]; the Max Kade Foundation; and the US Army [Grant W81XWH-10-1-0623].	Aharon AS, 2004, EUR J CARDIO-THORAC, V26, P912, DOI 10.1016/j.ejcts.2004.05.040; Beiser DG, 2010, AM J PHYSIOL-HEART C, V298, pH1761, DOI 10.1152/ajpheart.00187.2010; Mai BK, 2010, J CHEM INF MODEL, V50, P2236, DOI 10.1021/ci100346s; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Chen B, 2013, J CEREBR BLOOD F MET, V33, P196, DOI 10.1038/jcbfm.2012.150; Cho DG, 2004, J THORAC CARDIOV SUR, V127, P1033, DOI 10.1016/j.jtcvs.2003.09.038; Clausen F, 2004, J NEUROTRAUM, V21, P1168, DOI 10.1089/neu.2004.21.1168; Dash PK, 2002, NEUROSCIENCE, V114, P755, DOI 10.1016/S0306-4522(02)00277-4; Endo H, 2006, J CEREBR BLOOD F MET, V26, P1479, DOI 10.1038/sj.jcbfm.9600303; Fukunaga K, 2003, J PHARMACOL SCI, V92, P317; Gabryel B, 2004, EUR J PHARMACOL, V494, P111, DOI 10.1016/j.ejphar.2004.04.042; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Ho Y, 2007, NEUROSCIENCE, V145, P248, DOI 10.1016/j.neuroscience.2006.11.039; Horstmann A, 2010, NEUROLOGY, V74, P306, DOI 10.1212/WNL.0b013e3181cbcd6f; Isaeva E, 2010, EUR J NEUROSCI, V32, P1889, DOI 10.1111/j.1460-9568.2010.07468.x; Ito M, 2009, J NEUROTRAUM, V26, P41, DOI 10.1089/neu.2008.0646; Jackson TC, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.187; Jackson TC, 2009, CELL DEATH DIFFER, V16, P439, DOI 10.1038/cdd.2008.171; Jackson TC, 2010, J NEUROCHEM, V115, P941, DOI 10.1111/j.1471-4159.2010.06984.x; Janata A, 2013, CRIT CARE MED, V41, pE211, DOI 10.1097/CCM.0b013e318287f51e; Jo H, 2012, P NATL ACAD SCI USA, V109, P10581, DOI 10.1073/pnas.1202810109; Li X, 2009, MOL CELL BIOL, V29, P6192, DOI 10.1128/MCB.00681-09; Lim JH, 2007, BRAIN RES, V1164, P1, DOI 10.1016/j.brainres.2007.06.020; Lin YC, 2002, J NEUROSCI RES, V67, P484, DOI 10.1002/jnr.10077; Lobert VH, 2013, EMBO REP, V14, P10, DOI 10.1038/embor.2012.188; Lu K, 2010, J NEUROCHEM, V114, P237, DOI 10.1111/j.1471-4159.2010.06747.x; Lu KT, 2005, NEUROSCI LETT, V386, P40, DOI 10.1016/j.neulet.2005.05.057; Luo HR, 2003, P NATL ACAD SCI USA, V100, P11712, DOI 10.1073/pnas.1634990100; Mandell JW, 1999, NEUROREPORT, V10, P3567, DOI 10.1097/00001756-199911260-00019; Mateen FJ, 2011, NEUROLOGY, V77, P1438, DOI 10.1212/WNL.0b013e318232ab33; Miyawaki T, 2009, NAT NEUROSCI, V12, P618, DOI 10.1038/nn.2299; Murga C, 1998, J BIOL CHEM, V273, P19080, DOI 10.1074/jbc.273.30.19080; Namura S, 2000, J CEREBR BLOOD F MET, V20, P1301, DOI 10.1097/00004647-200009000-00004; Nawashiro H, 2000, J CEREBR BLOOD F MET, V20, P1040, DOI 10.1097/00004647-200007000-00003; Ozawa H, 1999, NEUROSCI LETT, V262, P57, DOI 10.1016/S0304-3940(99)00034-8; Raghupathi R, 2003, EXP NEUROL, V183, P438, DOI 10.1016/S0014-4886(03)00166-3; Schwindinger WF, 2001, ONCOGENE, V20, P1653, DOI 10.1038/sj.onc.1204181; Shimizu K, 2003, J BIOL CHEM, V278, P14920, DOI 10.1074/jbc.M213214200; Shimizu K, 1999, FEBS LETT, V458, P363, DOI 10.1016/S0014-5793(99)01190-4; Shimizu K, 2007, CELL, V128, P1219, DOI 10.1016/j.cell.2006.12.047; Sierecki E, 2010, J MED CHEM, V53, P6899, DOI 10.1021/jm100331d; Takuma K, 2000, EUR J PHARMACOL, V399, P1, DOI 10.1016/S0014-2999(00)00334-4; Verrier JD, 2011, J NEUROCHEM, V118, P979, DOI 10.1111/j.1471-4159.2011.07392.x; Zhan LX, 2012, NEUROPHARMACOLOGY, V63, P873, DOI 10.1016/j.neuropharm.2012.06.035; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283	47	17	18	0	1	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0022-3565	1521-0103		J PHARMACOL EXP THER	J. Pharmacol. Exp. Ther.	NOV	2013	347	2					516	528		10.1124/jpet.113.206888			13	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	238HE	WOS:000325934400026	24023368	Green Published			2022-02-06	
J	Jacobsson, L; Lexell, J				Jacobsson, Lars; Lexell, Jan			LIFE SATISFACTION 6-15 YEARS AFTER A TRAUMATIC BRAIN INJURY	JOURNAL OF REHABILITATION MEDICINE			English	Article						long-term outcome; outcome assessment; traumatic brain injury; quality of life; questionnaires	QUALITY-OF-LIFE; 18-TO 64-YEAR-OLD SWEDES; PSYCHOSOCIAL ADJUSTMENT; FOLLOW-UP; DISABILITY; SYMPTOMS; HEALTH; COMA	Objectives: To assess satisfaction with life as a whole and 10 domains of life satisfaction in Swedish individuals after a traumatic brain injury, to describe the relationship with demographic, social and injury related variables, and to compare the level of life satisfaction with a Swedish reference sample. Subjects: Fifty-one men and sixteen women, 6-15 years after a traumatic brain injury. Methods: Life Satisfaction Questionnaire (LiSat-11). Results: Many of the participants were, to some degree, satisfied with life as a whole and with all 10 domains of life satisfaction, but significantly less satisfied with life as whole and with 6 of the other 10 domains of life satisfaction in comparison with the Swedish reference sample. The participants' sex, injury severity or years post-injury was not related to any domains in LiSat-11, whereas age at time of injury, marital status and vocational situation were significantly related to a few of the domains. Conclusion: This study shows that life satisfaction can be affected several years after a traumatic brain injury. It appears that individuals who are married or cohabiting and productive had higher life satisfaction. This implies that regaining social participation is an important factor for life satisfaction many years after a traumatic brain injury.	[Jacobsson, Lars] Kalix Hosp, Dept Gen Med, Med Rehabil Sect, SE-95282 Kalix, Sweden; [Jacobsson, Lars; Lexell, Jan] Lund Univ, Dept Hlth Sci, Lund, Sweden; [Lexell, Jan] Dept Rehabil Med, Lund, Sweden; [Lexell, Jan] Skane Univ Hosp, Lund, Sweden		Jacobsson, L (corresponding author), Kalix Hosp, Dept Gen Med, SE-95282 Kalix, Sweden.	lars.jacobsson@nll.se		Jacobsson, Lars/0000-0002-1127-1178			Andersson EE, 2011, J REHABIL MED, V43, P323, DOI 10.2340/16501977-0666; Anke AGW, 2003, CLIN REHABIL, V17, P431, DOI 10.1191/0269215503cr629oa; Bezner JR, 2001, ARCH PHYS MED REHAB, V82, P787, DOI 10.1053/apmr.2001.23269; Brown AW, 2011, J NEUROTRAUM, V28, P167, DOI 10.1089/neu.2010.1400; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; DIENER E, 1995, SOC INDIC RES, V34, P7, DOI 10.1007/BF01078966; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Eriksson G, 2009, J REHABIL MED, V41, P187, DOI 10.2340/16501977-0307; Fugl-Meye KS., 1991, CLIN REHABIL, V5, P25, DOI [10.1177/026921559100500105, DOI 10.1177/026921559100500105]; Fugl-Meyer AR, 2002, J REHABIL MED, V34, P239, DOI 10.1080/165019702760279242; Geyh S, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-94; Jacobsson LJ, 2007, ACTA NEUROL SCAND, V116, P300, DOI 10.1111/j.1600-0404.2007.00896.x; Jacobsson LJ, 2011, NEUROPSYCHOL REHABIL, V21, P383, DOI 10.1080/09602011.2011.566711; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; Jacobsson LJ, 2009, ACTA NEUROL SCAND, V120, P389, DOI 10.1111/j.1600-0404.2009.01238.x; Johansson U, 2003, BRAIN INJURY, V17, P991, DOI 10.1080/0269905031000110508; Johansson Ulla, 2007, Scand J Occup Ther, V14, P116, DOI 10.1080/11038120601095093; JOHNSTONE AJ, 1993, BRAIN INJURY, V7, P501, DOI 10.3109/02699059309008177; Lund ML, 2011, DISABIL REHABIL-ASSI, V6, P402, DOI 10.3109/17483107.2011.574309; Lund ML, 2011, APPL RES QUAL LIFE, V6, P71, DOI 10.1007/s11482-010-9116-4; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; Melin R, 2003, J REHABIL MED, V35, P84, DOI 10.1080/16501970306119; Merrick Daniel, 2010, BMC Res Notes, V3, P190, DOI 10.1186/1756-0500-3-190; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Roding J, 2010, J REHABIL MED, V42, P155, DOI 10.2340/16501977-0497; Sorbo AK, 2009, INT J REHABIL RES, V32, P139, DOI 10.1097/MRR.0b013e328325a5d1; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; Stalnacke BM, 2007, J REHABIL MED, V39, P405, DOI 10.2340/16501977-0057; Stalnacke BM, 2009, J REHABIL MED, V41, P353, DOI 10.2340/16501977-0349; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Wood RL, 2008, EUR J ANAESTH, V25, P115, DOI 10.1017/S0265021507003432; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540	37	17	17	0	6	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	NOV	2013	45	10					1010	1015		10.2340/16501977-1204			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	251TE	WOS:000326952800004	23995834	gold, Green Published			2022-02-06	
J	Logan, BW; Goldman, S; Zola, M; Mackey, A				Logan, Bret W.; Goldman, Sarah; Zola, Marc; Mackey, Angela			Concussive Brain Injury in the Military: September 2001 to the Present	BEHAVIORAL SCIENCES & THE LAW			English	Article							SYMPTOMS	Since the terrorist attacks of September 11, 2001, 1,348,405 citizens have been deployed to combat in Operation Iraqi Freedom (OIF), Operation New Dawn in Iraq, and Operation Enduring Freedom in Afghanistan (OEF). During this same period 266,810 (20%) of these individuals have been diagnosed with a traumatic brain injury (TBI). The majority of these were Army soldiers, with 155,282 (58%) receiving the diagnosis. Mild TBI comprised 82% of the total, with the remainder being moderate to severe. Over this same period the Department of Defense (DoD) has invested $374.9 million to enhance access and quality of care services, including 57 TBI treatment centers in the combat theater and throughout the U.S. The Army's medical research division, the Medical Research and Material Command (MRMC), has invested an additional $700 million to TBI research during this time. The effort has faced a number of challenges, including limited human subject basic and translational research, limited epidemiological data on combat-related injuries, limited capacity and standards for data acquisition, and a lack of standardized evidenced-based protocols for treatment. All these areas have undergone significant growth and development, leading to the comprehensive system of care present today. A further challenge in this patient population has been the clinical co-morbidity of TBI, post-traumatic stress disorder, and chronic pain syndrome. The Army and the DoD have created treatment programs that are interdisciplinary in clinical approach, targeting particular neuropsychological domains of dysfunction rather than diagnostic category or etiology of injury. This article presents the history of this effort, the challenges to accurate and adequate diagnosis and care that remain, and the future of brain injury clinical and research efforts in the military. Copyright (c) 2013 John Wiley & Sons, Ltd.	[Logan, Bret W.] Intrepid Spirit III NICOE Satellite Ft Campbell, Ft Campbell, KY 42223 USA; [Zola, Marc] NICOE Satellite, Intrepid Spirit 3, Rehabil Serv, Ft Campbell, KY USA; [Mackey, Angela] NICOE Satellite, Intrepid Spirit 3, Ft Campbell, KY USA		Logan, BW (corresponding author), Intrepid Spirit III NICOE Satellite Ft Campbell, 650 Joel Dr,BLDG 2543, Ft Campbell, KY 42223 USA.	Bret.W.Logan.civ@mail.mil					[Anonymous], 2012, CONCUSSION MANAGEMEN; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; Crooks Carol Y, 2007, Phys Med Rehabil Clin N Am, V18, P681, DOI 10.1016/j.pmr.2007.06.005; Defense Manpower Data Center, 2013, US CAS STAT OIF OND; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Office of the Surgeon General U. A., 2013, TBI TALK POINTS 2013; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Turner RC, 2013, FRONT NEUROL, V3, DOI 10.3389/fneur.2012.00186; Vanderploeg R. D., 2013, J HEAD TRAUMA REHABI, DOI 10.1097/HTR.0b013e318281966e.	12	17	19	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0735-3936	1099-0798		BEHAV SCI LAW	Behav. Sci. Law	NOV	2013	31	6			SI		803	813		10.1002/bsl.2092			11	Psychology, Applied; Law	Social Science Citation Index (SSCI)	Psychology; Government & Law	262KI	WOS:000327733400009	24130079				2022-02-06	
J	Tu, TW; Kim, JH; Yin, FQ; Jakeman, LB; Song, SK				Tu, Tsang-Wei; Kim, Joong H.; Yin, Feng Qin; Jakeman, Lyn B.; Song, Sheng-Kwei			The impact of myelination on axon sparing and locomotor function recovery in spinal cord injury assessed using diffusion tensor imaging	NMR IN BIOMEDICINE			English	Article						diffusion tensor imaging; myelin; dysmyelination; white matter; spinal cord injury	WHITE-MATTER CHANGES; TRAUMATIC BRAIN-INJURY; IN-VIVO; MOUSE MODEL; MULTIPLE-SCLEROSIS; WALLERIAN DEGENERATION; CONTUSION INJURY; SHIVERER MICE; DEMYELINATION; GLYCOPROTEIN	The dysmyelinated axons of shiverer mice exhibit impaired conduction characteristics, similar to early postnatal axons before myelination, whereas the patterns of neuronal activity and connectivity are relatively comparable with those of wild-type myelinated axons. This unique dysmyelination pattern is exploited in the present study to determine the role of compact myelin in the loss and recovery of function following traumatic spinal cord injury (SCI). We applied in vivo diffusion tensor imaging (DTI) and post-mortem immunohistochemistry analysis to examine changes in myelin and axonal integrity, and evaluated these changes in concert with the analysis of locomotor function from 1 to 4 weeks following a mid-thoracic contusion injury in homozygous shiverer and heterozygous littermate mice. The DTI biomarkers, axial and radial diffusivities, are noninvasive indicators of axon and myelin integrity in response to SCI of both myelinated and dysmyelinated spinal cord. We show that myelin is critical for normal hind limb function in open field locomotion. However, when the functional outcome is limited during chronic SCI, the extent of recovery is associated with residual axonal integrity and independent of the extent of intact myelin at the lesion epicenter. Copyright (c) 2013 John Wiley & Sons, Ltd.	[Tu, Tsang-Wei] Washington Univ, Dept Mech Engn & Mat Sci, St Louis, MO 63110 USA; [Kim, Joong H.; Song, Sheng-Kwei] Washington Univ, Dept Radiol, St Louis, MO 63110 USA; [Yin, Feng Qin; Jakeman, Lyn B.] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Yin, Feng Qin; Jakeman, Lyn B.] Ohio State Univ, Ctr Brain & Spinal Cord Repair, Columbus, OH 43210 USA		Song, SK (corresponding author), Washington Univ, Sch Med, Dept Radiol, 4525 Scott Ave, St Louis, MO 63110 USA.	ssong@wustl.edu		Jakeman, Lyn/0000-0002-1760-8819	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS047592, R01 NS054194, P01 NS059560]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS047592, R01NS054194, P01NS059560] Funding Source: NIH RePORTER	This study was supported in part by National Institute of Health R01 NS047592, R01 NS054194, and P01 NS059560.	Andrews EM, 2012, EXP NEUROL, V235, P174, DOI 10.1016/j.expneurol.2011.09.008; Andrews H, 2006, J NEUROSCI RES, V83, P1533, DOI 10.1002/jnr.20842; Bando Y, 2008, EUR J NEUROSCI, V28, P1731, DOI 10.1111/j.1460-9568.2008.06474.x; Barkhof F, 2009, NAT REV NEUROL, V5, P256, DOI 10.1038/nrneurol.2009.41; Bartzokis G, 2004, NEUROBIOL AGING, V25, P5, DOI 10.1016/j.neurobiolaging.2003.03.001; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; Biddle F, 1973, MOUSE NEWS LETT, V48; Bilgen M, 2000, MAGN RESON MED, V43, P594; Blight A, 1988, J Am Paraplegia Soc, V11, P26; Brady ST, 1999, J NEUROSCI, V19, P7278, DOI 10.1523/JNEUROSCI.19-17-07278.1999; Budde MD, 2009, J NEUROSCI, V29, P2805, DOI 10.1523/JNEUROSCI.4605-08.2009; Chabriat H, 1999, STROKE, V30, P2637, DOI 10.1161/01.STR.30.12.2637; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; CHERNOFF GF, 1981, J HERED, V72, P128, DOI 10.1093/oxfordjournals.jhered.a109442; Clark CA, 2000, MAGN RESON MED, V43, P133; Cohen-Adad J, 2011, NEUROIMAGE, V57, P1068, DOI 10.1016/j.neuroimage.2011.04.068; Cohen-Adad J, 2011, NEUROIMAGE, V55, P1024, DOI 10.1016/j.neuroimage.2010.11.089; Concha L, 2006, NEUROIMAGE, V32, P1090, DOI 10.1016/j.neuroimage.2006.04.187; Deo AA, 2006, J NEUROSCI RES, V83, P801, DOI 10.1002/jnr.20783; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Drobyshevsky A, 2007, DEV NEUROSCI-BASEL, V29, P289, DOI 10.1159/000105470; Edgar JM, 2004, J CELL BIOL, V166, P121, DOI 10.1083/jcb.200312012; Eftekharpour E, 2007, J NEUROSCI, V27, P3416, DOI 10.1523/JNEUROSCI.0273-07.2007; Ellingson BM, 2008, ANN BIOMED ENG, V36, P224, DOI 10.1007/s10439-007-9415-6; Ellingson BM, 2010, MAGN RESON IMAGING, V28, P1353, DOI 10.1016/j.mri.2010.06.006; Ellingson BM, 2008, J MAGN RESON IMAGING, V28, P1068, DOI 10.1002/jmri.21578; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Freund P, 2010, MULT SCLER J, V16, P1193, DOI 10.1177/1352458510376180; FRUTTIGER M, 1995, EUR J NEUROSCI, V7, P511, DOI 10.1111/j.1460-9568.1995.tb00347.x; Griffiths I, 1998, SCIENCE, V280, P1610, DOI 10.1126/science.280.5369.1610; Gulani V, 2001, MAGNET RESON MED, V45, P191, DOI 10.1002/1522-2594(200102)45:2<191::AID-MRM1025>3.0.CO;2-9; Harsan LA, 2006, J NEUROSCI RES, V83, P392, DOI 10.1002/jnr.20742; Harsan LA, 2007, J NEUROSCI RES, V85, P935, DOI 10.1002/jnr.21201; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Huppi PS, 1998, PEDIATR RES, V44, P584; Jakeman LB, 2000, J NEUROTRAUM, V17, P299, DOI 10.1089/neu.2000.17.299; Kim JH, 2006, NEUROBIOL DIS, V21, P626, DOI 10.1016/j.nbd.2005.09.009; Kim JH, 2007, MAGN RESON MED, V58, P253, DOI 10.1002/mrm.21316; Kim JH, 2010, J NEUROTRAUM, V27, P587, DOI 10.1089/neu.2009.1063; Kim JH, 2009, J NEUROTRAUM, V26, P1395, DOI [10.1089/neu.2008.0728, 10.1089/neu.2008-0728]; Kirkpatrick LL, 2001, J NEUROSCI, V21, P2288, DOI 10.1523/JNEUROSCI.21-07-02288.2001; Klingberg T, 2000, NEURON, V25, P493, DOI 10.1016/S0896-6273(00)80911-3; Klingberg T, 1999, NEUROREPORT, V10, P2817, DOI 10.1097/00001756-199909090-00022; Kottis V, 2002, J NEUROCHEM, V82, P1566, DOI 10.1046/j.1471-4159.2002.01146.x; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Li SX, 2004, J NEUROSCI, V24, P10511, DOI 10.1523/JNEUROSCI.2828-04.2004; Loy DN, 2007, J NEUROTRAUM, V24, P979, DOI 10.1089/neu.2006.0253; Ludeman NA, 2008, NEUROLOGY, V71, P1676, DOI 10.1212/01.wnl.0000304084.59964.e2; Ma MH, 2004, J COMP NEUROL, V474, P469, DOI 10.1002/cne.20149; Ma MH, 2001, EXP NEUROL, V169, P239, DOI 10.1006/exnr.2001.7679; McDonald JW, 2006, J NEUROTRAUM, V23, P345, DOI 10.1089/neu.2006.23.345; McGavern DB, 1999, J NEUROSCI RES, V58, P492, DOI 10.1002/(SICI)1097-4547(19991115)58:4<492::AID-JNR3>3.0.CO;2-P; McGavern DB, 2000, BRAIN, V123, P519, DOI 10.1093/brain/123.3.519; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Mi S, 2007, NAT MED, V13, P1228, DOI 10.1038/nm1664; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Mohamed FB, 2011, AM J NEURORADIOL, V32, P339, DOI 10.3174/ajnr.A2334; Nair G, 2005, NEUROIMAGE, V28, P165, DOI 10.1016/j.neuroimage.2005.05.049; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Nave KA, 2010, NAT REV NEUROSCI, V11, P275, DOI 10.1038/nrn2797; Neil JJ, 1998, RADIOLOGY, V209, P57, DOI 10.1148/radiology.209.1.9769812; Nevo U, 2001, MAGN RESON MED, V45, P1, DOI 10.1002/1522-2594(200101)45:1<1::AID-MRM1001>3.0.CO;2-I; NOMURA Y, 1994, AM J NEURORADIOL, V15, P231; OKA A, 1993, J NEUROSCI, V13, P1441; ONO J, 1995, BRAIN RES, V671, P141, DOI 10.1016/0006-8993(94)01335-F; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; Paus T, 2010, BRAIN COGNITION, V72, P26, DOI 10.1016/j.bandc.2009.06.002; Pitt D, 2003, NEUROLOGY, V61, P1113, DOI 10.1212/01.WNL.0000090564.88719.37; Pitt D, 2010, BRAIN RES, V1309, P146, DOI 10.1016/j.brainres.2009.10.066; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Rasband MN, 1999, J NEUROCYTOL, V28, P319, DOI 10.1023/A:1007057512576; READHEAD C, 1987, CELL, V48, P703, DOI 10.1016/0092-8674(87)90248-0; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Schwartz ED, 2005, NEUROREPORT, V16, P73, DOI 10.1097/00001756-200501190-00017; Schwartz ED, 2003, EXP NEUROL, V184, P570, DOI 10.1016/S0014-4886(03)00295-4; Sinha K, 2006, J NEUROPHYSIOL, V95, P1683, DOI 10.1152/jn.00899.2005; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2004, NEUROBIOL DIS, V15, P640, DOI 10.1016/j.nbd.2003.12.003; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Tu TW, 2010, J NEUROTRAUM, V27, P253, DOI 10.1089/neu.2009.1026; Werring DJ, 2000, BRAIN, V123, P1667, DOI 10.1093/brain/123.8.1667; Werring DJ, 1999, NEUROLOGY, V52, P1626, DOI 10.1212/WNL.52.8.1626; WIMBERGER DM, 1995, J COMPUT ASSIST TOMO, V19, P28, DOI 10.1097/00004728-199501000-00005; Yin XH, 1998, J NEUROSCI, V18, P1953, DOI 10.1523/jneurosci.18-06-01953.1998; Zhang JY, 2009, J NEUROSCI, V29, P3160, DOI 10.1523/JNEUROSCI.3941-08.2009	91	17	18	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0952-3480	1099-1492		NMR BIOMED	NMR Biomed.	NOV	2013	26	11					1484	1495		10.1002/nbm.2981			12	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	283DK	WOS:000329225200016	23775778	Green Accepted			2022-02-06	
J	Sullivan, S; Friess, SH; Ralston, J; Smith, C; Propert, KJ; Rapp, PE; Margulies, SS				Sullivan, Sarah; Friess, Stuart H.; Ralston, Jill; Smith, Colin; Propert, Kathleen J.; Rapp, Paul E.; Margulies, Susan S.			Improved Behavior, Motor, and Cognition Assessments in Neonatal Piglets	JOURNAL OF NEUROTRAUMA			English	Article						cognition; neurobehavioral assessment; pediatric brain injury; porcine; traumatic brain injury	TRAUMATIC BRAIN-INJURY; MATURATION-DEPENDENT RESPONSE; ROTATIONAL HEAD-INJURY; IMMATURE BRAIN; AXONAL INJURY; ANIMAL-MODELS; GROSS MOTOR; SUS-SCROFA; CHILDREN; PIG	The alterations of animal behavior after traumatic brain injury (TBI) can be subtle, and their quantitative characterization can present significant methodological challenges. Meeting these challenges is a critical need, because quantitative measures are required in studies that compare the efficacy of different clinical interventions. We developed a battery of assessments to quantify behavioral, motor, and cognitive changes in neonatal piglets with good sensitivity and specificity to the detection of persistent deficits that correlate with axonal injury severity after a rapid non-impact head rotation with a diffuse pattern of axonal injury. The battery of measures developed included open field behaviors of sniffing and moving a toy, locomotion measures of Lempel-Ziv complexity and the probability of remaining in the current location, and a novel metric for evaluating motor performance. Our composite porcine disability score was able to detect brain injury with a sensitivity of 100% and specificity of 85.7% at day +4 post-injury for n=8 injured and n=7 sham piglets and significantly correlated with the percent axonal injury in these animals (day +4: =0.76, p=0.0011). A significant improvement over our previous assessments, this new porcine disability score has potential use in a wide variety of porcine disease and injury models.	[Sullivan, Sarah; Ralston, Jill; Margulies, Susan S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Friess, Stuart H.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Smith, Colin] Univ Edinburgh, Dept Pathol, Edinburgh, Midlothian, Scotland; [Propert, Kathleen J.] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Rapp, Paul E.] Uniformed Serv Univ Hlth Sci, Dept Mil & Emergency Med, Bethesda, MD 20814 USA		Margulies, SS (corresponding author), Univ Penn, Dept Bioengn, 240 Skirkanich Hall,210 South 33rd St, Philadelphia, PA 19104 USA.	margulie@seas.upenn.edu		Smith, Colin/0000-0002-4507-5132	NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039679, U01NS069545, K08NS064051]; Traumatic Injury Research Program of the Uniformed Services University of the Health Sciences; Defense Medical Research and Development Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS064051, U01NS069545, R01NS039679] Funding Source: NIH RePORTER	The authors would like to acknowledge Benjamin Bruins, Erica Hummel, James Butler, and Sohaib Hashmi for their contributions in conducting and rating the assessments. This study was made possible by the support of NIH/NINDS grants R01NS039679, U01NS069545, and K08NS064051. PER would like to acknowledge support of the Traumatic Injury Research Program of the Uniformed Services University of the Health Sciences and the Defense Medical Research and Development Program. The opinions and assertions contained herein are the private opinions of the authors and are not to be construed as official or reflecting the views of their respective commands, the U. S. Navy or the Department of Defense.	Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Bolhuis JE, 2004, BEHAV BRAIN RES, V152, P351, DOI 10.1016/j.bbr.2003.10.024; Bona E, 1997, PEDIATR RES, V42, P678, DOI 10.1203/00006450-199711000-00021; Conrad MS, 2012, DEV NEUROSCI-BASEL, V34, P291, DOI 10.1159/000339311; Dilger RN, 2010, BRAIN BEHAV IMMUN, V24, P1156, DOI 10.1016/j.bbi.2010.05.008; Ding YC, 2001, NEUROL RES, V23, P193, DOI 10.1179/016164101101198334; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Duhaime AC, 2006, DEV NEUROSCI-BASEL, V28, P380, DOI 10.1159/000094164; Durham SR, 2007, J NEUROTRAUM, V24, P5, DOI 10.1089/neu.2006.0054; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Fang MR, 2005, NEUROSIGNALS, V14, P102, DOI 10.1159/000086292; Faul M, 2010, TRAUMATIC BRAIN INJU; FLYNN TJ, 1984, NEUROCHEM RES, V9, P935, DOI 10.1007/BF00964525; Friess SH, 2007, EXP NEUROL, V204, P234, DOI 10.1016/j.expneurol.2006.10.010; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; Gieling ET, 2011, CURR TOP BEHAV NEURO, V7, P359, DOI 10.1007/7854_2010_112; Gieling ET, 2011, ANIM COGN, V14, P151, DOI 10.1007/s10071-010-0364-3; Hagberg H, 2002, DEV NEUROSCI-BASEL, V24, P364, DOI 10.1159/000069040; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Katz-Leurer M, 2008, BRAIN INJURY, V22, P153, DOI 10.1080/02699050801895399; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kornum BR, 2011, NEUROSCI BIOBEHAV R, V35, P437, DOI 10.1016/j.neubiorev.2010.05.004; Kuhtz-Buschbeck JP, 2003, ARCH PHYS MED REHAB, V84, P424, DOI 10.1053/apmr.2003.50017; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Kuluz J, 2010, J SPINAL CORD MED, V33, P43, DOI 10.1080/10790268.2010.11689673; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; Linder-Lucht M, 2007, PEDIATRICS, V120, P880, DOI 10.1542/peds.2006-2258; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Naim MY, 2010, DEV NEUROSCI-BASEL, V32, P466, DOI 10.1159/000322448; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; Rossi C, 1996, ARCH PHYS MED REHAB, V77, P1062, DOI 10.1016/S0003-9993(96)90069-6; Sullivan S, 2013, J NEUROTRAUM, V30, P538, DOI 10.1089/neu.2012.2594; Tanaka Y, 2008, STROKE, V39, P205, DOI 10.1161/STROKEAHA.107.489906; Wallen MA, 2001, ARCH PHYS MED REHAB, V82, P642, DOI 10.1053/apmr.2001.22620; Wang B, 2007, AM J CLIN NUTR, V85, P561, DOI 10.1093/ajcn/85.2.561	39	17	17	0	16	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2013	30	20					1770	1779		10.1089/neu.2013.2913			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	232JW	WOS:000325491000010	23758416	Green Published, Green Submitted			2022-02-06	
J	Eifert, B; Maurer-Karattup, P; Schorl, M				Eifert, Bernd; Maurer-Karattup, Petra; Schorl, Martin			Integration of Intensive Care Treatment and Neurorehabilitation in Patients With Disorders of Consciousness: A Program Description and Case Report	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Consciousness disorders; Persistent vegetative state; Rehabilitation	TRAUMATIC BRAIN-INJURY; MINIMALLY RESPONSIVE PATIENTS; EARLY REHABILITATION; VEGETATIVE STATE; HEAD-INJURY; RECOVERY; COMA; CONSORTIUM; GUIDELINES; MANAGEMENT	Severe brain injuries frequently result in disorders of consciousness, requiring intensive care unit treatment. We present a rehabilitative system that integrates neurorehabilitation into intensive care treatment. The system will be described using the case report of a young man who was in a vegetative state after a severe traumatic brain injury that resulted in major medical problems and complications. Despite these challenges, interdisciplinary therapies can be applied throughout the rehabilitative process. The patient in our case report showed significant improvements and functional gains during the course of treatment. Additional data from other patients support the feasibility of this system and show that integrating neurorehabilitation into intensive care treatment is possible and can lead to improved outcomes in this patient population. We will discuss the advantages, special features, and limitations of the system. Additional studies are needed to further demonstrate the efficacy of this approach compared with standard treatment. (c) 2013 by the American Congress of Rehabilitation Medicine	[Eifert, Bernd; Maurer-Karattup, Petra; Schorl, Martin] SRH Fachkrankenhaus Neresheim, Clin Neurorehabil Severe Head Injuries, Neresheim, Germany		Maurer-Karattup, P (corresponding author), SRH Fachkrankenhaus Neresheim GmbH, Kosinger St 11, D-73450 Neresheim, Germany.	petra.maurer@fkne.srh.de					ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Baguley IJ, 2008, SEMIN NEUROL, V28, P716, DOI 10.1055/s-0028-1105971; BAR [German workforce for rehabilitation], 1995, REC NEUR REH PAT SEV; Bertram M, 2007, NERVENARZT, V78, P1160, DOI 10.1007/s00115-007-2269-1; Choi JH, 2008, J TRAUMA, V65, P1028, DOI 10.1097/TA.0b013e31815eba9b; Dolce G, 2002, POST-TRAUMATIC VEGETATIVE STATE, P11; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199708000-00008; Giacino JT, 2005, NEUROPSYCHOL REHABIL, V15, P166, DOI 10.1080/09602010443000498; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; Gianutsos R, 1990, Neuropsychol Rev, V1, P21, DOI 10.1007/BF01108857; GOBIET W, 1989, Neurosurgical Review, V12, P143, DOI 10.1007/BF01790637; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; Hendricks HT, 2010, EUR J NEUROL, V17, P1172, DOI 10.1111/j.1468-1331.2010.02989.x; Hildebrandt H., 2002, Z NEUROSPYCHOL, V13, P91; Hopkins RO, 2009, AACN ADV CRIT CARE, V20, P277, DOI 10.1097/NCI.0b013e3181acaef0; Jennett B, 2001, NEUROLOGY, V56, P486, DOI 10.1212/WNL.56.4.486; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; Lippert-Gruner M, 2002, ACT NEUR S, V79, P21; Lippert-Gruner M, 2002, J REHABIL MED, V34, P211, DOI 10.1080/165019702760279198; Maurer-Karattup P., 2010, THESIS U TUBINGEN TU; McFetridge Brian, 2011, Intensive Crit Care Nurs, V27, P57, DOI 10.1016/j.iccn.2011.02.003; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Piguet O, 1999, BRAIN INJURY, V13, P829, DOI 10.1080/026990599121223; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Salter K, 2006, J REHABIL MED, V38, P113, DOI 10.1080/16501970500314350; SAZBON L, 1991, J NEUROL NEUROSUR PS, V54, P149, DOI 10.1136/jnnp.54.2.149; Schorl M, 2009, CENT EUR NEUROSURG, V70, P68, DOI 10.1055/s-0028-1093355; Schorl M, 2012, NEUROL REHABIL, V18, P99; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Sherburne E, 1986, J Neurosci Nurs, V18, P140; Sorbo A, 2005, BRAIN INJURY, V19, P493, DOI 10.1080/02699050400013709; Spranger M, 2005, NEUROL REHABIL, V11, P317; Stier-Jarmer M, 2002, PHYS MED REHAB KUROR, V12, P260, DOI 10.1055/s-2002-35154; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; WHYTE J, 1995, ARCH PHYS MED REHAB, V76, P804, DOI 10.1016/S0003-9993(95)80543-5; Whyte John, 1986, J HEAD TRAUMA REHAB, V1, P1; Zieger A, 1992, Zentralbl Neurochir, V53, P92; Zieger A., 2005, NEUR REH CTR ZIHLSCH; [No title captured]	43	17	17	2	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	2013	94	10					1924	1933		10.1016/j.apmr.2013.03.030			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	231TU	WOS:000325442100010	23810352				2022-02-06	
J	Hanson, HR; Pomerantz, WJ; Gittelman, M				Hanson, Holly R.; Pomerantz, Wendy J.; Gittelman, Mike			ED Utilization Trends in Sports-Related Traumatic Brain Injury	PEDIATRICS			English	Article						traumatic brain injury; sports; pediatrics; admission; severity	PROFESSIONAL FOOTBALL PLAYERS; RECURRENT CONCUSSION; UNITED-STATES; US CHILDREN; MILD; HOSPITALIZATIONS; ASSOCIATION; SYMPTOMS	BACKGROUND: Emergency department (ED) visits for sports-related traumatic brain injuries (TBIs) have risen. This study evaluated how the number and severity of admissions have changed as ED visits for sports-related TBIs have increased. METHODS: A retrospective study of children aged 0 to 19 years at a level 1 trauma center was performed. Patients from 2002 to 2011 with a primary or secondary diagnosis of TBI were identified from the hospital's inpatient and outpatient trauma registries. Frequencies were used to characterize the population, chi(2) analysis was performed to determine differences between groups, and regression analysis looked at relationship between year and injury severity score or length of stay. RESULTS: Sport was responsible for injury in 3878 (15.4%) cases during the study period; 3506 (90.4%) were discharged from the hospital, and 372 (9.6%) were admitted. Seventy-three percent were male patients and 78% Caucasian; mean age was 13 +/- 3.5 years. ED visits for sports-related TBIs increased 92% over the study period, yet there was no significant change (chi(2) = 9.8, df = 9, P = .37) in the percentage of children admitted. Mean injury severity score for those admitted decreased from 7.8 to 4.8 (beta = -0.46; P = .006); length of stay trended downward (beta = -0.05; P = .05). CONCLUSIONS: The percentage of children being admitted from the ED with sports-related TBI has not changed over the past 10 years. The severity of admitted sports-related TBI is decreasing. Additional research is needed to correlate these trends with other TBI mechanisms.	[Hanson, Holly R.; Pomerantz, Wendy J.; Gittelman, Mike] Cincinnati Childrens Hosp Med Ctr, Div Emergency Med, Cincinnati, OH 45229 USA		Hanson, HR (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Emergency Med, 3333 Burnet Ave,MLC 2008, Cincinnati, OH 45229 USA.	holly.hanson@cchmc.org			NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000077] Funding Source: NIH RePORTER; NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000077] Funding Source: Medline		Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Bener A, 2010, BRAIN INJURY, V24, P74, DOI 10.3109/02699050903508192; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Centers for Disease Control and Prevention, 2011, MMWR-MORBID MORTAL W, V60, P1137; Centers for Disease Control and Prevention, 2010, HEADS CONC; Faigenbaum AD, 2009, J STRENGTH COND RES, V23, pS60, DOI 10.1519/JSC.0b013e31819df407; Faul M, 2010, TRAUMATIC BRAIN INJU; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Metzl JD, 2006, PEDIATRICS, V117, P1813, DOI 10.1542/peds.2006-0480; Monaghan S, 2012, HIGH SCH SPORTS PART; *NAT CTR INJ PREV, 1999, TRAUM BRAIN INJ US R; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Sosin DM, 1996, BRAIN INJURY, V10, P47; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Yang J, 2008, BRIT J SPORT MED, V42, P664, DOI 10.1136/bjsm.2007.040923	21	17	17	0	3	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	OCT	2013	132	4					E859	E864		10.1542/peds.2013-1704			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	227FI	WOS:000325095400007	24081999	Green Published			2022-02-06	
J	Thomas, AG; Hegde, SV; Dineen, RA; Jaspan, T				Thomas, A. G.; Hegde, S. V.; Dineen, R. A.; Jaspan, T.			Patterns of accidental craniocerebral injury occurring in early childhood	ARCHIVES OF DISEASE IN CHILDHOOD			English	Article							TRAUMATIC HEAD-INJURY; SHORT-DISTANCE FALLS; YOUNG-CHILDREN; INFANTS; DEATH; BED; CONTROVERSIES	Objective To describe the range of intracranial injuries encountered in 0-2-year-olds in cases of accidental head injury where the mechanism of trauma was well characterised and to assess the clinical consequences. Design A retrospective review of imaging and clinical data. Setting Two tertiary paediatric referral centres. Patients All children aged 0-2 undergoing cranial CT as indicated by National Institute for Health and Clinical Excellence guidance for head injury from 2006 to 2011. After exclusion criteria, 149 patients were included. Main outcome measures Rates of skull fracture, intracranial haemorrhage, parenchymal injuries and ischaemic change per type of mechanism of injury. Rates of neurological sequelae on follow-up. Results Skull fractures were demonstrated in 54 (36%) patients of whom 17 (11%) had thin underlying subdural haemorrhage (SDH). Extradural haemorrhage complicated one fracture and two cases of isolated subdural haematomas were seen without skull fracture. Radiologically evident brain parenchymal injuries were present in three patients, all with mechanisms of injury involving high levels of force; severe neurological sequelae were only seen in one patient, who had diffuse hypoxic-ischaemic damage at presentation and whose (accidental) mechanism of injury involved extensive acceleration/deceleration/translational forces. Conclusions Skull fractures and focal SDH are relatively common following minor trauma in this age group but in the vast majority of cases there are no long-term neurological sequelae. Conversely, diffuse brain injury with severe subsequent neurological impairment was only seen in patients with a correspondingly severe mechanism of injury.	[Thomas, A. G.] Leicester Royal Infirm, Univ Hosp Leicester NHS Trust, Dept Radiol, Leicester LE1 5WW, Leics, England; [Hegde, S. V.] Arkansas Childrens Hosp, Dept Radiol, Little Rock, AR 72202 USA; [Dineen, R. A.] Univ Nottingham, Dept Radiol & Imaging Sci, Nottingham NG7 2RD, England; [Dineen, R. A.; Jaspan, T.] Nottingham Univ Hosp NHS Trust, Dept Neuroradiol, Nottingham, England		Thomas, AG (corresponding author), Leicester Royal Infirm, Univ Hosp Leicester NHS Trust, Dept Radiol, Infirm Sq, Leicester LE1 5WW, Leics, England.	adam.thomas@doctors.org.uk	Dineen, Robert/S-7192-2019	Dineen, Robert/0000-0002-9523-2546			Case ME, 2008, BRAIN PATHOL, V18, P583, DOI 10.1111/j.1750-3639.2008.00203.x; Chadwick DL, 2008, PEDIATRICS, V121, P1213, DOI 10.1542/peds.2007-2281; CHADWICK DL, 1991, J TRAUMA, V31, P1353, DOI 10.1097/00005373-199110000-00006; CHADWICK DL, 1993, J TRAUMA, V35, P968, DOI 10.1097/00005373-199312000-00031; Ciurea AV, 2007, CHILD NERV SYST, V23, P335, DOI 10.1007/s00381-006-0230-4; Datta S, 2005, ARCH DIS CHILD, V90, P947, DOI 10.1136/adc.2002.021154; Demaerel P, 2002, EUR RADIOL, V12, P849, DOI 10.1007/s00330-001-1145-9; Denton S, 2003, AM J FOREN MED PATH, V24, P371, DOI 10.1097/01.paf.0000097851.18478.16; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Ehsani JP, 2010, AM J FOREN MED PATH, V31, P287, DOI 10.1097/PAF.0b013e3181db7eb5; Ewing-Cobbs L, 2000, CHILD NERV SYST, V16, P25, DOI 10.1007/s003810050006; Fernando S, 2008, PEDIATR RADIOL, V38, P827, DOI 10.1007/s00247-007-0729-1; HALL JR, 1989, J TRAUMA, V29, P1273, DOI 10.1097/00005373-198909000-00015; Hedlund GL, 2009, FORENSIC SCI MED PAT, V5, P280, DOI 10.1007/s12024-009-9132-6; HELFER RE, 1977, PEDIATRICS, V60, P533; Hymel KP, 1997, PEDIATR RADIOL, V27, P743, DOI 10.1007/s002470050215; Jaspan T, 2008, PEDIATR RADIOL, V38, pS378, DOI 10.1007/s00247-008-0896-8; Kim KA, 2000, NEUROSURG FOCUS, V8, P1; Kuppermann N, 2008, PEDIATR RADIOL, V38, pS670, DOI 10.1007/s00247-008-0996-5; LYONS TJ, 1993, PEDIATRICS, V92, P125; National Institute for Clinical Excellence (NICE), 2003, CG4 NICE; National Institute for Clinical Excellence (NICE), 2007, CG56 NICE; NIMITYONGSKUL P, 1987, J PEDIATR ORTHOPED, V7, P184, DOI 10.1097/01241398-198703000-00014; Plunkett J, 2001, AM J FOREN MED PATH, V22, P1, DOI 10.1097/00000433-200103000-00001; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; REIBER GD, 1993, AM J FOREN MED PATH, V14, P201, DOI 10.1097/00000433-199309000-00005; RIVARA FP, 1993, PEDIATRICS, V92, P61; *ROYAL COLL RAD, 2008, STAND RAD INV SUSP N; Spivack B, 2001, AM J FOREN MED PATH, V22, P332, DOI 10.1097/00000433-200109000-00028; Tarantino CA, 1999, PEDIATR EMERG CARE, V15, P5, DOI 10.1097/00006565-199902000-00002; Thompson AK, 2011, ACCIDENT ANAL PREV, V43, P143, DOI 10.1016/j.aap.2010.07.020; Tung GA, 2006, PEDIATRICS, V118, P626, DOI 10.1542/peds.2006-0130; Vezina G, 2009, PEDIATR RADIOL, V39, P586, DOI 10.1007/s00247-009-1212-y; Warrington SA, 2001, ARCH DIS CHILD, V85, P104, DOI 10.1136/adc.85.2.104; WILLIAMS RA, 1991, J TRAUMA, V31, P1350, DOI 10.1097/00005373-199110000-00005	35	17	20	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0003-9888	1468-2044		ARCH DIS CHILD	Arch. Dis. Child.	OCT	2013	98	10					787	792		10.1136/archdischild-2013-304267			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	218FX	WOS:000324419300015	23922057				2022-02-06	
J	Olivier, J; Walter, SR				Olivier, Jake; Walter, Scott R.			Bicycle Helmet Wearing Is Not Associated with Close Motor Vehicle Passing: A Re-Analysis of Walker, 2007	PLOS ONE			English	Article							NEW-SOUTH-WALES; RISK COMPENSATION; HEAD; AUSTRALIA; SELECTION; TRIALS; INJURY; IMPACT; POWER	Objectives: To re-analyse bicycle overtaking data collected by Walker (2007) with a view to assess factors associated with close passing (<1 m), to adjust for other observed factors in a multivariable analysis, and to assess the extent to which the sample size in the original analysis may have contributed to spurious results. Method: A re-analysis of 2,355 motor vehicle passing events recorded by Walker that includes information on cyclist's distance to the kerb, vehicle size and colour, city of observation, time of day, whether the event occurred while in a bikelane and helmet wearing. Each variable was considered for a final, multivariable model using purposeful selection of variables. The analysis was repeated using multiple logistic regression with passing distance dichotomised by the one metre rule. Bootstrap p-values were computed using sample sizes computed from conventional values of power and effect size. Results: The previously observed significant association between passing distance and helmet wearing was not found when dichotomised by the one metre rule. Other factors were found to be significantly associated with close passing including cyclists' distance to the kerb, vehicle size and city of observation (Salisbury or Bristol, UK). P-values from bootstrap samples indicate the significance of helmet wearing resulted from an overly large sample size. Conclusions: After re-analysis of Walker's data, helmet wearing is not associated with close motor vehicle passing. The results, however, highlight other more important factors that may inform effective bicycle safety strategies.	[Olivier, Jake] Univ New S Wales, Sch Math & Stat, Sydney, NSW, Australia; [Walter, Scott R.] Univ New S Wales, Ctr Hlth Syst & Safety Res, Australian Inst Hlth Innovat, Sydney, NSW, Australia		Olivier, J (corresponding author), Univ New S Wales, Sch Math & Stat, Sydney, NSW, Australia.	j.olivier@unsw.edu.au	Olivier, Jake/D-2034-2012	Olivier, Jake/0000-0002-3144-4507			Amoros E, 2012, INJURY PREV, V18, P27, DOI 10.1136/ip.2011.031815; Amy Gillett Foundation, MET MATT; [Anonymous], 2011, ALBERTAS HELMET LAW; Attewell RG, 2001, ACCIDENT ANAL PREV, V33, P345, DOI 10.1016/S0001-4575(00)00048-8; Bambach MR, 2013, ACCIDENT ANAL PREV, V53, P78, DOI 10.1016/j.aap.2013.01.005; Basford L, 2002, TRL549; Bell ML, 2013, PSYCHO-ONCOLOGY, V22, P499, DOI 10.1002/pon.3046; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; CAMERON MH, 1994, ACCIDENT ANAL PREV, V26, P325, DOI 10.1016/0001-4575(94)90006-X; Case L. Douglas, 2007, V404, P377, DOI 10.1007/978-1-59745-530-5_19; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J., 2013, STAT POWER ANAL BEHA; Efron B., 1993, INTRO BOOTSTRAP; Ewald B, 2006, J CLIN EPIDEMIOL, V59, P798, DOI 10.1016/j.jclinepi.2005.11.025; Foot Rule, LIST US STAT HAV 3 F; Fox T, 2010, J AUSTRALAS COLL ROA, V21, P22; Hosmer D. W., 2004, APPL LOGISTIC REGRES; Johnson M, 2011, ACCIDENT ANAL PREV, V43, P323, DOI 10.1016/j.aap.2010.08.030; Johnston MF, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-1; Julious SA, 2004, STAT MED, V23, P1921, DOI 10.1002/sim.1783; Khan A.M., 1995, TRANSP RES REC J TRA, V1502, P8; Lardelli-Claret P, 2003, INJURY PREV, V9, P128, DOI 10.1136/ip.9.2.128; Love DC, 2012, ACCIDENT ANAL PREV, V48, P451, DOI 10.1016/j.aap.2012.03.002; Lumley T, 2002, ANNU REV PUBL HEALTH, V23, P151, DOI 10.1146/annurev.publhealth.23.100901.140546; Macpherson A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005401.pub2; Messiah A, 2012, AM J PUBLIC HEALTH, V102, pS204, DOI 10.2105/AJPH.2012.300711; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Nolan R, 2010, COMMUNICATION; Nova Scotia Government, FREQ ASK QUEST ON ME; O'Reilly M, 2012, SYDNEY MORNING HERAL; Olivier J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058777; Olivier J, 2013, ACCIDENT ANAL PREV, V50, P1128, DOI 10.1016/j.aap.2012.09.003; Phillips RO, 2011, RISK ANAL, V31, P1187, DOI 10.1111/j.1539-6924.2011.01589.x; Safe Cycling Australia, CAMP; Stone M, 2003, ACCIDENT ANAL PREV, V35, P549, DOI 10.1016/S0001-4575(02)00032-5; Thompson DC., 1999, COCHRANE DB SYST REV, V308, DOI 10.1002/14651858.CD001855; Walker I, BICYCLE OVERTAKING S; Walker I, 2007, ACCIDENT ANAL PREV, V39, P417, DOI 10.1016/j.aap.2006.08.010; Walter SR, 2011, ACCIDENT ANAL PREV, V43, P2064, DOI 10.1016/j.aap.2011.05.029; Wiltshire Council, CHILDC SUFF 2011 201	40	17	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75424	10.1371/journal.pone.0075424			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228VC	WOS:000325218700085	24086528	gold, Green Submitted, Green Published			2022-02-06	
J	Kreuzer, PM; Landgrebe, M; Frank, E; Langguth, B				Kreuzer, Peter Michael; Landgrebe, Michael; Frank, Elmar; Langguth, Berthold			Repetitive Transcranial Magnetic Stimulation for the Treatment of Chronic Tinnitus After Traumatic Brain Injury: A Case Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						affective disorder; alcohol abuse; depression; repetitive transcranial magnetic stimulation; rTMS; TBI; tinnitus; traumatic brain injury	SEVERITY; INHIBIT; RETURN	Tinnitus is a frequent symptom of traumatic brain injury, which is difficult to treat. Repetitive transcranial magnetic stimulation has shown beneficial effects in some forms of tinnitus. However, traumatic brain injury in the past has been considered as a relative contraindication for repetitive transcranial magnetic stimulation because of the increased risk of seizures. Here we present the case of a 53-year-old male patient suffering from severe tinnitus after traumatic brain injury with comorbid depression and alcohol abuse, who received 5 treatment series of repetitive transcranial magnetic stimulation (1 Hz stimulation protocol over left primary auditory cortex, 10 sessions of 2000 stimuli each, stimulation intensity 110% resting motor threshold). Repetitive transcranial magnetic stimulation was tolerated without any side effects and tinnitus complaints (measured by a validated tinnitus questionnaire and numeric rating scales) were improved in a replicable way throughout 5 courses of transcranial magnetic stimulation up to now.	[Kreuzer, Peter Michael; Landgrebe, Michael; Frank, Elmar; Langguth, Berthold] Univ Regensburg, Dept Psychiat & Psychotherapy, D-93053 Regensburg, Germany		Kreuzer, PM (corresponding author), Univ Regensburg, Dept Psychiat & Psychotherapy, Univ Str 84, D-93053 Regensburg, Germany.	peter.kreuzer@medbo.de	Langguth, Berthold/AAP-2638-2021				Bayar N, 2001, J OTOLARYNGOL, V30, P300, DOI 10.2310/7070.2001.19597; Bernabeu M, 2004, CLIN NEUROPHYSIOL, V115, P1714, DOI 10.1016/j.clinph.2004.02.021; Cosentino G, 2010, NEUROCASE, V16, P267, DOI 10.1080/13554790903456191; Demirtas-Tatlidede A, 2012, J HEAD TRAUMA REHAB, V27, P274, DOI 10.1097/HTR.0b013e318217df55; Fagelson Marc A, 2007, Am J Audiol, V16, P107, DOI 10.1044/1059-0889(2007/015); Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Fitzgerald PB, 2011, J ECT, V27, P38, DOI 10.1097/YCT.0b013e3181eb30c6; Folmer RL, 2003, LARYNGOSCOPE, V113, P821, DOI 10.1097/00005537-200305000-00010; Frank G, 2010, EUR J NEUROL, V17, P951, DOI 10.1111/j.1468-1331.2010.02956.x; GOEBEL G, 1994, HNO, V42, P166; Hinton DE, 2006, J TRAUMA STRESS, V19, P541, DOI 10.1002/jts.20138; Jury MA, 2001, NEW ZEAL MED J, V114, P286; Kreuzer PM, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00088; Langguth B, 2010, J PSYCHOPHARMACOL, V24, P1273, DOI 10.1177/0269881109106929; Langguth B, 2008, LARYNGOSCOPE, V118, P2264, DOI 10.1097/MLG.0b013e318182c325; Mennemeier M, 2008, LARYNGOSCOPE, V118, P1228, DOI 10.1097/MLG.0b013e318170f8ac; Moller A, 2011, TXB TINNITUS, P511; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Sindhusake Doungkamol, 2004, J Am Acad Audiol, V15, P269; Tergau F, 1999, LANCET, V353, P2209, DOI 10.1016/S0140-6736(99)01301-X; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004	24	17	20	1	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2013	28	5					386	389		10.1097/HTR.0b013e318254736e			4	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	298ZU	WOS:000330364600085	22688213				2022-02-06	
J	Newsome, MR; Scheibel, RS; Mayer, AR; Chu, ZLD; Wilde, EA; Hanten, G; Steinberg, JL; Lin, XD; Li, XQ; Merkley, TL; Hunter, JV; Vasquez, AC; Cook, L; Lu, HZ; Vinton, K; Levin, HS				Newsome, Mary R.; Scheibel, Randall S.; Mayer, Andrew R.; Chu, Zili D.; Wilde, Elisabeth A.; Hanten, Gerri; Steinberg, Joel L.; Lin, Xiaodi; Li, Xiaoqi; Merkley, Tricia L.; Hunter, Jill V.; Vasquez, Ana C.; Cook, Lori; Lu, Hanzhang; Vinton, Kami; Levin, Harvey S.			How Functional Connectivity between Emotion Regulation Structures Can Be Disrupted: Preliminary Evidence from Adolescents with Moderate to Severe Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Resting state; fMRI; Adolescents; Empathy; TBI; Anterior cingulate	GENERALIZED ANXIETY DISORDER; DEFAULT MODE; HEAD-INJURY; CORTICAL THICKNESS; NEURAL SYSTEMS; VISUAL-CORTEX; GLOBAL SIGNAL; AMYGDALA; NETWORK; ACTIVATION	Outcome of moderate to severe traumatic brain injury (TBI) includes impaired emotion regulation. Emotion regulation has been associated with amygdala and rostral anterior cingulate (rACC). However, functional connectivity between the two structures after injury has not been reported. A preliminary examination of functional connectivity of rACC and right amygdala was conducted in adolescents 2 to 3 years after moderate to severe TBI and in typically developing (TD) control adolescents, with the hypothesis that the TBI adolescents would demonstrate altered functional connectivity in the two regions. Functional connectivity was determined by correlating fluctuations in the blood oxygen level dependent (BOLD) signal of the rACC and right amygdala with that of other brain regions. In the TBI adolescents, the rACC was found to be significantly less functionally connected to medial prefrontal cortices and to right temporal regions near the amygdala (height threshold T = 2.5, cluster level p < .05, FDR corrected), while the right amygdala showed a trend in reduced functional connectivity with the rACC (height threshold T = 2.5, cluster level p = .06, FDR corrected). Data suggest disrupted functional connectivity in emotion regulation regions. Limitations include small sample sizes. Studies with larger sample sizes are necessary to characterize the persistent neural damage resulting from moderate to severe TBI during development.	[Newsome, Mary R.; Scheibel, Randall S.; Wilde, Elisabeth A.; Hanten, Gerri; Lin, Xiaodi; Li, Xiaoqi; Merkley, Tricia L.; Vasquez, Ana C.; Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Mayer, Andrew R.] Mind Res Network, Albuquerque, NM USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA; [Chu, Zili D.; Wilde, Elisabeth A.; Hunter, Jill V.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Chu, Zili D.; Hunter, Jill V.] Texas Childrens Hosp, Dept Pediat Radiol, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Levin, Harvey S.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Steinberg, Joel L.] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA; [Merkley, Tricia L.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Cook, Lori; Vinton, Kami] Univ Texas Dallas, Ctr Brain Hlth, Dallas, TX 75230 USA; [Lu, Hanzhang] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [Levin, Harvey S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA		Newsome, MR (corresponding author), Baylor Coll Med, Cognit Neurosci Lab, 1709 Dryden Rd,Ste 12-59, Houston, TX 77030 USA.	mnewsome@bcm.edu	Merkley, Tricia L./AAN-2989-2020	Merkley, Tricia/0000-0002-0897-8391	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS21889]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER	This work was supported by NINDS grant R01-NS21889 "Neurobehavioral outcome of head injury in children," Harvey S. Levin, PI. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. There are no potential conflicts of interest, including financial, between any of the authors and the work presented in this manuscript. We are grateful to the youth and their families for taking part in the research, to the South Central Mental Illness Research, Education, and Clinical Center (MIRECC) for providing facilities that allowed analyses of the fMRI data, to the Editor, Associate Editor, and to three anonymous reviewers who provided valuable feedback. Zachary Dorsey and Isaiah Tate aided in the preparation of the manuscript.	Adolphs R, 2000, J NEUROSCI, V20, P2683; Alstott J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000408; Ansari AHJ, 2011, IEEE ENG MED BIO, P5056, DOI 10.1109/IEMBS.2011.6091252; Asemota AO, 2013, J NEUROTRAUM, V30, P67, DOI 10.1089/neu.2012.2605; Bigler ED, 2010, NEUROIMAGE, V50, P1017, DOI 10.1016/j.neuroimage.2010.01.003; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Corbetta M, 2012, DEV PSYCHOBIOL, V54, P239, DOI 10.1002/dev.20507; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Crowe LM, 2012, J PEDIATR PSYCHOL, V37, P745, DOI 10.1093/jpepsy/jss070; de Sousa A, 2012, J CLIN EXP NEUROPSYC, V34, P606, DOI 10.1080/13803395.2012.667067; Decety J, 2008, NEUROPSYCHOLOGIA, V46, P2607, DOI 10.1016/j.neuropsychologia.2008.05.026; Decety J, 2012, CEREB CORTEX, V22, P209, DOI 10.1093/cercor/bhr111; Dyck M, 2011, NEUROIMAGE, V54, P2503, DOI 10.1016/j.neuroimage.2010.10.013; Egner T, 2008, CEREB CORTEX, V18, P1475, DOI 10.1093/cercor/bhm179; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Etkin A, 2010, AM J PSYCHIAT, V167, P545, DOI 10.1176/appi.ajp.2009.09070931; Etkin A, 2009, ARCH GEN PSYCHIAT, V66, P1361, DOI 10.1001/archgenpsychiatry.2009.104; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Faul M, 2010, TRAUMATIC BRAIN INJU; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Franco AR, 2009, HUM BRAIN MAPP, V30, P2293, DOI 10.1002/hbm.20668; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Ganesalingam K, 2006, J INT NEUROPSYCH SOC, V12, P609, DOI 10.1017/S1355617706060796; Glascher J, 2003, J NEUROSCI, V23, P10274; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Hare TA, 2008, BIOL PSYCHIAT, V63, P927, DOI 10.1016/j.biopsych.2008.03.015; Hinvest NS, 2011, NEUROPSYCHOLOGIA, V49, P2311, DOI 10.1016/j.neuropsychologia.2011.02.023; Johnson CP, 2011, J INT NEUROPSYCH SOC, V17, P663, DOI 10.1017/S1355617711000464; Jolliffe D, 2006, J ADOLESCENCE, V29, P589, DOI 10.1016/j.adolescence.2005.08.010; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lenroot RK, 2007, NEUROIMAGE, V36, P1065, DOI 10.1016/j.neuroimage.2007.03.053; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; Merkley TL, 2008, J NEUROTRAUM, V25, P1343, DOI 10.1089/neu.2008.0615; Mervaala E, 2000, PSYCHOL MED, V30, P117, DOI 10.1017/S0033291799001567; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Newsome MR, 2010, NEUROPSYCHOLOGY, V24, P139, DOI 10.1037/a0017432; Nummenmaa L, 2008, NEUROIMAGE, V43, P571, DOI 10.1016/j.neuroimage.2008.08.014; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rapson R., 1993, CURR DIR PSYCHOL SCI, V2, P96, DOI [DOI 10.1111/1467-8721.EP10770953, 10.1111/1467-8721.ep10770953]; Ruby P, 2004, J COGNITIVE NEUROSCI, V16, P988, DOI 10.1162/0898929041502661; Scheibel RS, 2011, SOC NEUROSCI-UK, V6, P582, DOI 10.1080/17470919.2011.588844; Schmidt AT, 2010, NEUROPSYCHOLOGIA, V48, P2869, DOI 10.1016/j.neuropsychologia.2010.05.029; Schreiber LRN, 2012, J PSYCHIATR RES, V46, P651, DOI 10.1016/j.jpsychires.2012.02.005; Schultz RT, 2003, PHILOS T R SOC B, V358, P415, DOI 10.1098/rstb.2002.1208; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shmuel A, 2008, HUM BRAIN MAPP, V29, P751, DOI 10.1002/hbm.20580; Slawik H, 2009, J NEUROTRAUM, V26, P1891, DOI 10.1089/neu.2009.0942; Somerville LH, 2010, BRAIN COGNITION, V72, P124, DOI 10.1016/j.bandc.2009.07.003; Szabo CA, 2001, AM J NEURORADIOL, V22, P1342; Talairach J., 1988, COPLANAR STEREOTAXIC; TEASDALE G, 1974, LANCET, V2, P81; Tonks J, 2008, BRAIN INJURY, V22, P325, DOI 10.1080/02699050801968303; van Marle HJF, 2010, NEUROIMAGE, V53, P348, DOI 10.1016/j.neuroimage.2010.05.070; Weisskoff RM, 1996, MAGNET RESON MED, V36, P643, DOI 10.1002/mrm.1910360422; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003; Wilde EA, 2011, INT J PSYCHOPHYSIOL, V82, P86, DOI 10.1016/j.ijpsycho.2011.04.006; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wood RL, 2008, J INT NEUROPSYCH SOC, V14, P289, DOI 10.1017/S1355617708080326; Xia Jun, 2004, J Huazhong Univ Sci Technolog Med Sci, V24, P500	72	17	18	2	15	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	SEP	2013	19	8					911	924		10.1017/S1355617713000817			14	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	209AQ	WOS:000323725800008	23981357				2022-02-06	
J	Hubel, KA; Yund, EW; Herron, TJ; Woods, DL				Hubel, Kerry A.; Yund, E. William; Herron, Timothy J.; Woods, David L.			Computerized measures of finger tapping: Reliability, malingering and traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Finger oscillation; Symptom validity; Traumatic brain injury; Tapping rate; Motor speed; Tap failure; Index finger; Effort; Test-retest	HEAD-INJURY; PARKINSONS-DISEASE; MOTOR-PERFORMANCE; SEX-DIFFERENCES; PTSD CHECKLIST; TEST BATTERY; HANDEDNESS; TESTS; SPEED; HAND	We analyzed computerized finger tapping metrics in four experiments. Experiment 1 showed tapping-rate differences associated with hand dominance, digits, sex, and fatigue that replicated those seen in a previous, large-scale community sample. Experiment 2 revealed test-retest correlations (r = .91) that exceeded those reported in previous tapping studies. Experiment 3 investigated subjects simulating symptoms of traumatic brain injury (TBI); 62% of malingering subjects produced abnormally slow tapping rates. A tapping-rate malingering index, based on rate-independent tapping patterns, provided confirmatory evidence of malingering in 48% of the subjects with abnormal tapping rates. Experiment 4 compared tapping in 24 patients with mild TBI (mTBI) and a matched control group; mTBI patients showed slowed tapping without evidence of malingering. Computerized finger tapping measures are reliable measures of motor speed, useful in detecting subjects performing with suboptimal effort, and are sensitive to motor abnormalities following mTBI.	[Hubel, Kerry A.; Yund, E. William; Herron, Timothy J.; Woods, David L.] Martinez Clin, Human Cognit Neurophysiol Lab, Martinez, CA USA; [Woods, David L.] Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA; [Woods, David L.] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Woods, David L.] Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA		Woods, DL (corresponding author), VANCHCS, Neurol Serv 127E, 150 Muir Rd, Martinez, CA 94553 USA.	dlwoods@ucdavis.edu		Yund, E./0000-0002-6833-0052; Herron, Timothy/0000-0002-4297-014X; Woods, David/0000-0002-8804-3587	VA Research Service Grant [6119R]	This research was supported by the VA Research Service Grant 6119R to D. L. W. The content is solely the responsibility of the authors and does not necessarily represent the official views of the agencies.	Aoki T, 2003, EXP BRAIN RES, V152, P270, DOI 10.1007/s00221-003-1552-z; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Ashendorf L, 2009, APPL NEUROPSYCHOL, V16, P171, DOI 10.1080/09084280903098562; BARNSLEY RH, 1970, PERCEPT MOTOR SKILL, V30, P343, DOI 10.2466/pms.1970.30.2.343; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; BROWN MB, 1975, BIOMETRICS, V31, P987, DOI 10.2307/2529826; Cameron A., 1998, REGRESSION ANAL COUN; Christianson MK, 2004, NEW ZEAL J PSYCHOL, V33, P44; Commodari E, 2008, AGING CLIN EXP RES, V20, P578; CROSSLEY M, 1992, PSYCHOL AGING, V7, P499, DOI 10.1037/0882-7974.7.4.499; de Groot-Driessen D, 2006, ARCH PHYS MED REHAB, V87, P40, DOI 10.1016/j.apmr.2005.09.022; De Monte VE, 2005, J CLIN EXP NEUROPSYC, V27, P224, DOI 10.1080/13803390490515766; Dikmen SS, 1999, J INT NEUROPSYCH SOC, V5, P346, DOI 10.1017/S1355617799544056; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Fan LZ, 2010, BRAIN RES, V1353, P60, DOI 10.1016/j.brainres.2010.07.031; Foo S. C., 1994, Annals Academy of Medicine Singapore, V23, P650; GARDNER W, 1995, PSYCHOL BULL, V118, P392, DOI 10.1037/0033-2909.118.3.392; GILL DM, 1986, PERCEPT MOTOR SKILL, V62, P675, DOI 10.2466/pms.1986.62.2.675; Greiffenstein MF, 2008, CLIN NEUROPSYCHOL, V22, P565, DOI 10.1080/13854040701377810; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; HAALAND KY, 1994, J CLIN EXP NEUROPSYC, V16, P448, DOI 10.1080/01688639408402655; Haaxma CA, 2010, MOVEMENT DISORD, V25, P1150, DOI 10.1002/mds.23100; Halstead W.C., 1947, BRAIN INTELLIGENCE; Heaton R. K., 2004, REVISED COMPREHENSIV; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; Herve PV, 2005, NEUROIMAGE, V25, P1133, DOI 10.1016/j.neuroimage.2004.12.062; Hinton SC, 2007, J INT NEUROPSYCH SOC, V13, P539, DOI 10.1017/S1355617707070671; Hubel KA., 2013, PERCEPT MOT SKILLS M, V116, P1; Jarvis PE., 1994, HALSTEAD REITAN NEUR; Jimenez-Jimenez FJ, 2010, EUR J NEUROL, V17, P152, DOI 10.1111/j.1468-1331.2009.02784.x; Kang XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045582; Koeneke S, 2009, J MOTOR BEHAV, V41, P347, DOI 10.3200/JMBR.41.4.347-356; Lang AJ, 2003, J TRAUMA STRESS, V16, P257, DOI 10.1023/A:1023796007788; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Lee MS, 2010, MOVEMENT DISORD, V25, P2531, DOI 10.1002/mds.23304; Massman PJ, 1996, J CLIN EXP NEUROPSYC, V18, P110, DOI 10.1080/01688639608408267; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P271, DOI 10.1016/0887-6177(95)00040-2; MORRISON MW, 1979, PERCEPT MOTOR SKILL, V48, P139, DOI 10.2466/pms.1979.48.1.139; MURELIUS O, 1991, ACTA NEUROL SCAND, V83, P9; Nalcaci E, 2001, CORTEX, V37, P493, DOI 10.1016/S0010-9452(08)70589-6; PALMER RD, 1974, J CLIN PSYCHOL, V30, P545, DOI 10.1002/1097-4679(197410)30:4<545::AID-JCLP2270300424>3.0.CO;2-I; PETERS M, 1980, CAN J PSYCHOL, V34, P62, DOI 10.1037/h0081014; Peters M, 1996, J EXP PSYCHOL HUMAN, V22, P1107; Prigatano GP, 2003, J INT NEUROPSYCH SOC, V9, P128, DOI 10.1017/S1355617703000134; Prigatano GP, 1997, ARCH PHYS MED REHAB, V78, P847, DOI 10.1016/S0003-9993(97)90198-2; PROVINS KA, 1972, NEUROPSYCHOLOGIA, V10, P199, DOI 10.1016/0028-3932(72)90060-7; Reitan R, 1985, HALSTEAD REITAN NEUR; REITAN RM, 1994, CLIN NEUROPSYCHOL, V8, P193, DOI 10.1080/13854049408401557; ROBINSON LR, 1993, ARCH PHYS MED REHAB, V74, P1134; RUFF RM, 1993, PERCEPT MOTOR SKILL, V76, P1219, DOI 10.2466/pms.1993.76.3c.1219; Schmidt SL, 2000, NEUROPSYCHOLOGIA, V38, P529, DOI 10.1016/S0028-3932(99)00120-7; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Tanner BA, 2003, J CLIN PSYCHOL, V59, P123, DOI 10.1002/jclp.10122; TANNER BA, 1995, BEHAV RES METH INSTR, V27, P160, DOI 10.3758/BF03204722; Teixeira LA, 2008, CORTEX, V44, P707, DOI 10.1016/j.cortex.2006.10.002; Tobimatsu S, 1998, J NEUROL, V245, P256, DOI 10.1007/s004150050215; TODOR JI, 1987, ACTA PSYCHOL, V65, P65, DOI 10.1016/0001-6918(87)90047-3; Tsushima WT, 2009, BRAIN INJURY, V23, P809, DOI 10.1080/02699050903200530; Wells FL, 1908, AM J PSYCHOL, V19, P437, DOI 10.2307/1413393; Western Psychological Services, 1998, WPS ELECT TAPPING TE; Wolfson, 1993, HALSTEAD REITAN NEUR; Woods DL, 2011, J CLIN EXP NEUROPSYC, V33, P101, DOI 10.1080/13803395.2010.493149; Zelaznik HN, 2010, J SPEECH LANG HEAR R, V53, P383, DOI 10.1044/1092-4388(2009/08-0204)	63	17	17	2	13	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	AUG 19	2013	35	7					745	758		10.1080/13803395.2013.824070			14	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	219NG	WOS:000324513100007	23947782				2022-02-06	
J	Prodam, F; Gasco, V; Caputo, M; Zavattaro, M; Pagano, L; Marzullo, P; Belcastro, S; Busti, A; Perino, C; Grottoli, S; Ghigo, E; Aimaretti, G				Prodam, F.; Gasco, V.; Caputo, M.; Zavattaro, M.; Pagano, L.; Marzullo, P.; Belcastro, S.; Busti, A.; Perino, C.; Grottoli, S.; Ghigo, E.; Aimaretti, G.			Metabolic alterations in patients who develop traumatic brain injury (TBI)-induced hypopituitarism	GROWTH HORMONE & IGF RESEARCH			English	Article						Hypopituitarism; Traumatic brain injury; Glucose metabolism; Lipids	GROWTH-HORMONE DEFICIENCY; BODY-COMPOSITION; PREVALENCE; RISK; ADULTS; DYSFUNCTION; DISEASE; PROFILE	Objective: Hypopituitarism is associated with metabolic alterations but in TBI-induced hypopituitarism data are scanty. The aim of our study was to evaluate the prevalence of naive hypertension, dyslipidemia, and altered glucose metabolism in TBI-induced hypopituitarism patients. Design: Cross-sectional retrospective study in a tertiary care endocrinology center. 54 adult patients encountering a moderate or severe TBI were evaluated in the chronic phase (at least 12 months after injury) after-trauma. Presence of hypopituitarism, BMI, hypertension, fasting blood glucose and insulin levels, oral glucose tolerance test (if available) and a lipid profile were evaluated. Results: The 27.8% of patients showed various degrees of hypopituitarism. In particular, 9.3% had total, 7.4% multiple and 11.1% isolated hypopituitarism. GHD was present in 22.2% of patients. BMI was similar between the two groups. Hypopituitaric patients presented a higher prevalence of dyslipidemia (p < 0.01) and altered glucose metabolism (p < 0.005) with respect to non hypopituitaric patients. In particular, triglycerides (p < 0.05) and HOMA-IR (p < 0.02) were higher in hypopituitaric TB! patients. Conclusions: We showed that long-lasting TBI patients who develop hypopituitarism frequently present metabolic alterations, in particular altered glucose levels, insulin resistance and hypertriglyceridemia. In view of the risk of premature cardiovascular death in hypopituitaric patients, major attention has to been paid in those who encountered a TBI, because they suffer from the same comorbidities and may present other deterioration factors due to complex pharmacological treatments and restriction in participation in life activities and healthy lifestyle. (C) 2013 Elsevier Ltd. All rights reserved.	[Prodam, F.; Caputo, M.; Zavattaro, M.; Pagano, L.; Marzullo, P.; Belcastro, S.; Busti, A.; Aimaretti, G.] Univ Piemonte Orientale Amedeo Avogadro, Dept Translat Med, I-28100 Novara, Italy; [Prodam, F.] Univ Piemonte Orientale, Dept Hlth Sci, SCDU Pediat, I-28100 Novara, Italy; [Prodam, F.] Univ Piemonte Orientale, ICSO, I-28100 Novara, Italy; [Gasco, V.; Grottoli, S.; Ghigo, E.] Univ Turin, I-10124 Turin, Italy; [Perino, C.] Don Gnocchi Rehabil Ctr, Turin, Italy		Aimaretti, G (corresponding author), Univ Piemonte Orientale Amedeo Avogadro, Dept Translat Med, Via Solaroli 17, I-28100 Novara, Italy.	gianluca.aimaretti@med.unipmn.it	Caputo, Marina/AAC-6707-2022; pagano, livio/J-3020-2018; Marzullo, Paolo/K-6371-2016	pagano, livio/0000-0001-8287-928X; Marzullo, Paolo/0000-0003-3215-5747; Prodam, Flavia/0000-0001-9660-5335	Regione PiemonteRegione Piemonte [2827]; University of Eastern Piedmont, Ministero dell'Universita e della Ricerca Scientifica [20082P8CCE]	This study was supported by Regione Piemonte (grant no. 2827, 2008), and University of Eastern Piedmont, Ministero dell'Universita e della Ricerca Scientifica (grant no. 20082P8CCE, 2008).	Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Amer Diabet Assoc, 2006, DIABETES CARE, V29, pS43; Attanasio AF, 2010, J CLIN ENDOCR METAB, V95, P74, DOI 10.1210/jc.2009-1326; Barter P, 2011, ATHEROSCLEROSIS SUPP, V12, P265, DOI [10.1016/S1567-5688(11)00035-3, DOI 10.1016/S1567-5688(11)00035-3]; Cannavo S, 2011, J ENDOCRINOL INVEST, V34, P32, DOI [10.1007/BF03346692, 10.3275/7076]; Colao A, 2013, CLIN ENDOCRINOL, V79, P211, DOI 10.1111/cen.12122; Corneli G, 2005, EUR J ENDOCRINOL, V153, P257, DOI 10.1530/eje.1.01967; Evans LM, 1999, CLIN ENDOCRINOL, V50, P457; Klose M, 2007, J CLIN ENDOCR METAB, V92, P3861, DOI 10.1210/jc.2007-0901; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; Lauer MS, 2001, JAMA-J AM MED ASSOC, V285, P2508, DOI 10.1001/jama.285.19.2508; Leonsson M, 2002, CLIN ENDOCRINOL, V57, P751, DOI 10.1046/j.1365-2265.2002.01663.x; Lombardi G, 2012, J ENDOCRINOL INVEST, V35, P1021, DOI 10.3275/8717; Luque RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015767; MARKUSSIS V, 1992, LANCET, V340, P1188, DOI 10.1016/0140-6736(92)92892-J; Mersebach H, 2003, CLIN ENDOCRINOL, V58, P65, DOI 10.1046/j.1365-2265.2003.01675.x; Murray RD, 2010, CLIN ENDOCRINOL, V73, P508, DOI 10.1111/j.1365-2265.2009.03754.x; Nyenwe EA, 2009, AM J MED SCI, V338, P190, DOI 10.1097/MAJ.0b013e3181a84bde; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Sesmilo G, 2001, J CLIN ENDOCR METAB, V86, P5774, DOI 10.1210/jc.86.12.5774; Srinivasan S, 2004, J CLIN ENDOCR METAB, V89, P81, DOI 10.1210/jc.2003-030442; Tanriverdi F, 2011, J ENDOCRINOL INVEST, V34, P541, DOI 10.3275/7805; Tanriverdi F, 2008, ANN INTERN MED, V148, P827, DOI 10.7326/0003-4819-148-11-200806030-00005; Tanriverdi F, 2010, PITUITARY, V13, P146, DOI 10.1007/s11102-009-0215-x; TEASDALE G, 1974, LANCET, V2, P81; Tomlinson JW, 2001, LANCET, V357, P425, DOI 10.1016/S0140-6736(00)04006-X; Verhelst J, 2011, EUR J ENDOCRINOL, V165, P881, DOI 10.1530/EJE-11-0599; Verhelst J, 2009, EUR J ENDOCRINOL, V161, pS41, DOI 10.1530/EJE-09-0291	29	17	17	0	10	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1096-6374	1532-2238		GROWTH HORM IGF RES	Growth Horm. IGF Res.	AUG	2013	23	4					109	113		10.1016/j.ghir.2013.04.001			5	Cell Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Endocrinology & Metabolism	174KT	WOS:000321155000004	23660372				2022-02-06	
J	Tisdall, MM; Rejdak, K; Kitchen, ND; Smith, M; Petzold, A				Tisdall, Martin M.; Rejdak, Konrad; Kitchen, Neil D.; Smith, Martin; Petzold, Axel			The Prognostic Value of Brain Extracellular Fluid Nitric Oxide Metabolites After Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Microdialysis; Nitric oxide; Neurocritical care; Neuromonitoring	SEVERE HEAD-INJURY; CEREBROSPINAL-FLUID; MICRODIALYSIS; NITRATE	Nitric oxide (NO) is a compound with both protective and damaging effects on neurons. Quantification of NO metabolites in humans is limited by sample contamination with blood. In vivo cerebral microdialysis may offer an alternative approach as sampling of extracellular fluid (ECF) adjacent to neurons becomes possible. We investigate the prognostic value of brain ECF NO metabolites in patients with traumatic brain injury (TBI). A prospective case cohort of 195 ECF samples collected from 11 cases over 4 days following TBI was collected. Nitrate and nitrite concentrations ([NO (x) ]) were quantified using a vanadium-based colorimetric assay. Early ECF [NO (x) ] (< 48 h post TBI) were significantly higher in non-survivors (median 59.2 mu mol/l, n = 7) compared to survivors (23.3 mu mol/l, n = 4) (P = 0.04). Late (48-96 h) ECF [NO (x) ] remained higher in non-survivors (47.9 mu mol/l) compared to survivors (23.0 mu mol/l) but this was not significant (P = 0.29). Receiver operator characteristic analysis shows an optimized cutoff level for ECF [NO (x) ] of 26.5 mu mol/l measured < 48 h post TBI for predicting non-survival (sensitivity 100%, specificity 75%). Early ECF NO (x) concentrations are of prognostic value after TBI. ECF NO (x) may be a useful biomarker for treatment trials targeted at nitric oxide metabolism.	[Tisdall, Martin M.; Smith, Martin; Petzold, Axel] Natl Hosp Neurol & Neurosurg, Dept Neuroanaesthesia, London WC1N 3BG, England; [Tisdall, Martin M.; Smith, Martin; Petzold, Axel] Natl Hosp Neurol & Neurosurg, Dept Neurocrit Care, London WC1N 3BG, England; [Tisdall, Martin M.; Kitchen, Neil D.] Natl Hosp Neurol & Neurosurg, Victor Horsley Dept Neurosurg, London WC1N 3BG, England; [Rejdak, Konrad] Med Univ Lublin, Dept Neurol, Lublin, Poland; [Petzold, Axel] Vrije Univ Amsterdam, Med Ctr, Dept Neurol, Amsterdam, Netherlands		Tisdall, MM (corresponding author), Natl Hosp Neurol & Neurosurg, Victor Horsley Dept Neurosurg, Queen Sq, London WC1N 3BG, England.	martin.tisdall@uclh.nhs.uk	Petzold, Axel/C-1090-2009; Smith, Martin/B-2616-2009	Petzold, Axel/0000-0002-0344-9749; Tisdall, Martin/0000-0001-8880-8386; Rejdak, Konrad/0000-0002-7019-6681	Wellcome Clinical Research Training Fellowship Grant [075608]; Department of Health's National Institute for Health Research Centres via the UCLH/UCL Comprehensive Biomedical Research Centre; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0701458] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0701458] Funding Source: researchfish	MT is supported by a Wellcome Clinical Research Training Fellowship Grant, Grant No 075608. MS is partially funded by the Department of Health's National Institute for Health Research Centres funding scheme via the UCLH/UCL Comprehensive Biomedical Research Centre.	Bellander BM, 2004, INTENS CARE MED, V30, P2166, DOI 10.1007/s00134-004-2461-8; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Clark RSB, 1996, CRIT CARE MED, V24, P1243, DOI 10.1097/00003246-199607000-00030; Hlatky R, 2003, J CEREBR BLOOD F MET, V23, P582, DOI 10.1097/01.WCB.0000059586.71206.F3; Hlatky R, 2002, ACT NEUR S, V81, P331; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Moncada S, 2006, J NEUROCHEM, V97, P1676, DOI 10.1111/j.1471-4159.2006.03988.x; Petzold A, 2011, BRAIN, V134, P464, DOI 10.1093/brain/awq360; Rejdak K, 2004, J NEUROL SCI, V219, P71, DOI 10.1016/j.jns.2003.12.011; Tisdall MM, 2006, BRIT J ANAESTH, V97, P18, DOI 10.1093/bja/ael109; Uzan M, 2001, SURG NEUROL, V56, P350, DOI 10.1016/S0090-3019(01)00633-4	11	17	17	1	9	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933			NEUROCRIT CARE	Neurocrit. Care	AUG	2013	19	1					65	68		10.1007/s12028-011-9633-5			4	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	187SP	WOS:000322140000010	22002154	Green Submitted			2022-02-06	
J	Wang, B; Dawson, H; Wang, HC; Kernagis, D; Kolls, BJ; Yao, L; Laskowitz, DT				Wang, Bo; Dawson, Hana; Wang, Haichen; Kernagis, Dawn; Kolls, Brad J.; Yao, Lucy; Laskowitz, Daniel T.			Lacosamide Improves Outcome in a Murine Model of Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Lacosamide; Neuroprotection; Inflammation; Microglial activation	CLOSED-HEAD INJURY; SPINAL-CORD-INJURY; SUBARACHNOID HEMORRHAGE; ANTICONVULSANT PROPHYLAXIS; FUNCTIONAL RECOVERY; SODIUM-CHANNELS; ONSET SEIZURES; PHENYTOIN; PRESSURE; LEVETIRACETAM	Use of antiepileptic drugs (AED's) is common in the neurocritical care setting. However, there remains a great deal of controversy regarding the optimal agent. Studies associating the prophylactic use of AED's with poor outcomes are heavily biased by the prevalent use of phenytoin, an agent highly associated with deleterious effects. In the current study, we evaluate lacosamide for neuroprotective properties in a murine model of closed head injury. Mice were subjected to moderate closed head injury using a pneumatic impactor, and then treated with either low-dose (6 mg/kg) or high-dose (30 mg/kg) lacosamide or vehicle at 30 min post-injury, and twice daily for 3 days after injury. Motor and cognitive functional assessments were performed following injury using rotarod and Morris Water Maze, respectively. Neuronal injury and microglial activation were measured by flourojade-B, NeuN, and F4/80 staining at 1 and 7 days post-injury. Timm's staining was also performed to assess lacosamide effects on mossy fiber axonal sprouting. To evaluate possible mechanisms of lacosamide effects on the inflammatory response to injury, an RNA expression array was used to evaluate for alterations in differential gene expression patterns in injured mice following lacosamide or vehicle treatments. High-dose lacosamide was associated with improved functional outcome on both the rotarod and Morris Water Maze. High-dose lacosamide was also associated with a reduction of neuronal injury at 24 h post-injury. However, the reduction in neuronal loss observed early did not result in greater neuronal density at 31 days post-injury based on unbiased stereology of NeuN staining. High-dose lacosamide was also associated with a significant reduction in microglial activation at 7 days post-injury. The therapeutic effects of lacosamide are associated with a delay in injury-related changes in RNA expression of a subset of inflammatory mediator genes typically seen at 24 h post-injury. Administration of lacosamide improves functional performance, and reduces histological evidence of acute neuronal injury and neuroinflammation in a murine model of closed head injury. Lacosamide effects appear to be mediated via a reduction or delay in the acute inflammatory response to injury. Prior clinical and animal studies have found antiepileptic treatment following injury to be detrimental, though these studies are biased by the common use of older medications such as phenytoin. Our current results as well as prior work on levetiracetam suggest the newer AED's may be beneficial in the setting of acute brain injury.	[Wang, Bo] Shandong Univ, Shandong Prov Hosp, Dept Anesthesiol, Jinan 250021, Shandong, Peoples R China; [Wang, Bo; Dawson, Hana; Wang, Haichen; Kernagis, Dawn; Kolls, Brad J.; Yao, Lucy; Laskowitz, Daniel T.] Duke Univ, Med Ctr, Brain Injury Translat Res Ctr, Durham, NC 27710 USA; [Wang, Bo; Dawson, Hana; Wang, Haichen; Kolls, Brad J.; Yao, Lucy; Laskowitz, Daniel T.] Duke Univ, Med Ctr, Dept Med Neurol, Durham, NC 27710 USA; [Kernagis, Dawn] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA		Laskowitz, DT (corresponding author), Duke Univ, Med Ctr, Dept Med Neurol, Durham, NC 27710 USA.	danl@neuro.duke.edu	Kolls, Brad/R-9154-2019	Kolls, Brad/0000-0002-8704-8749			BAKER CJ, 1995, NEUROSURGERY, V37, P863, DOI 10.1227/00006123-199511000-00003; Baker CJ, 1995, NEUROSURGERY, V37, P870; Beydoun A, 2009, EXPERT REV NEUROTHER, V9, P33, DOI 10.1586/14737175.9.1.33; Biton V, 2012, EXPERT REV NEUROTHER, V12, P645, DOI [10.1586/ern.12.50, 10.1586/ERN.12.50]; Bladin CF, 2000, ARCH NEUROL-CHICAGO, V57, P1617, DOI 10.1001/archneur.57.11.1617; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS83; Butzkueven H, 2000, NEUROLOGY, V55, P1315, DOI 10.1212/WNL.55.9.1315; CAVAZOS JE, 1991, J NEUROSCI, V11, P2795; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Cronin M, 2008, MOL CELL NEUROSCI, V39, P152, DOI 10.1016/j.mcn.2008.06.005; DANSCHER G, 1978, HISTOCHEMISTRY, V55, P27, DOI 10.1007/BF00496691; Darrah SH, 2011, J NEUROTRAUM, V28, P43, DOI 10.1089/neu.2010.1521; Dawson HN, 2010, NEUROSCIENCE, V169, P516, DOI 10.1016/j.neuroscience.2010.04.037; Edwards HB, 2012, ACTA NEUROL SCAND, V125, P228, DOI 10.1111/j.1600-0404.2011.01619.x; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; FOY PM, 1981, ACTA NEUROCHIR, V55, P253, DOI 10.1007/BF01808441; GOLDSTEIN LB, 1995, J NEUROL NEUROSUR PS, V58, P753, DOI 10.1136/jnnp.58.6.753; Guekht Alla, 2012, Handb Clin Neurol, V108, P569, DOI 10.1016/B978-0-444-52899-5.00016-2; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Hanell A, 2010, J NEUROTRAUM, V27, P1297, DOI 10.1089/neu.2009.1255; HASAN D, 1993, ANN NEUROL, V33, P286; Hoofien D, 2001, BRAIN INJURY, V15, P189; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Lanzino G, 2011, NEUROCRIT CARE, V15, P247, DOI 10.1007/s12028-011-9584-x; Laskowitz DT, 2007, J NEUROTRAUM, V24, P1093, DOI 10.1089/neu.2006.0192; Laskowitz DT, 2010, J NEUROTRAUM, V27, P1983, DOI 10.1089/neu.2010.1396; Lynch JR, 2002, ANN NEUROL, V51, P113, DOI 10.1002/ana.10098; Maxwell WL, 1999, J NEUROTRAUM, V16, P273, DOI 10.1089/neu.1999.16.273; McNamara B, 2003, BRIT J ANAESTH, V90, P39, DOI 10.1093/bja/aeg008; Naidech AM, 2005, STROKE, V36, P583, DOI 10.1161/01.STR.0000141936.36596.1e; Naidech AM, 2009, STROKE, V40, P3810, DOI 10.1161/STROKEAHA.109.559948; Pinder C, 2011, BRAIN INJURY, V25, P634, DOI 10.3109/02699052.2011.572946; Pineda JA, 2001, J NEUROTRAUM, V18, P625, DOI 10.1089/089771501750291864; Rao V, 2002, PSYCHIAT CLIN N AM, V25, P43, DOI 10.1016/S0193-953X(03)00052-2; Rhoney DH, 2000, NEUROLOGY, V55, P258, DOI 10.1212/WNL.55.2.258; Riazi K, 2008, P NATL ACAD SCI USA, V105, P17151, DOI 10.1073/pnas.0806682105; Rosengart AJ, 2007, J NEUROSURG, V107, P253, DOI 10.3171/JNS-07/08/0253; Skelton RW, 2006, BRAIN INJURY, V20, P189, DOI 10.1080/02699050500456410; Slapo Geir D, 2006, Expert Rev Neurother, V6, P1801, DOI 10.1586/14737175.6.12.1801; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Vespa P, 2005, J CLIN NEUROPHYSIOL, V22, P99, DOI 10.1097/01.WNP.0000154919.54202.E0; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Vezzani A, 2011, EXP NEUROL; Vezzani A, 2008, EPILEPSIA, V49, P24, DOI 10.1111/j.1528-1167.2008.01490.x; Vezzani Annamaria, 2012, Handb Clin Neurol, V107, P163, DOI 10.1016/B978-0-444-52898-8.00010-0; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Wang HC, 2006, NEUROCRIT CARE, V5, P71, DOI 10.1385/NCC:5:1:71; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001	52	17	17	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933			NEUROCRIT CARE	Neurocrit. Care	AUG	2013	19	1					125	134		10.1007/s12028-012-9808-8			10	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	187SP	WOS:000322140000020	23269559				2022-02-06	
J	Liu, P; Li, YS; Quartermain, D; Boutajangout, A; Ji, Y				Liu, Ping; Li, Yong-Sheng; Quartermain, David; Boutajangout, Allal; Ji, Yong			Inhaled nitric oxide improves short term memory and reduces the inflammatory reaction in a mouse model of mild traumatic brain injury	BRAIN RESEARCH			English	Article						Inhaled nitric oxide (INO); Mild traumatic brain injury (mTBI); Short term memory (STM); Inflammatory reaction; Mouse	CLOSED-HEAD INJURY; CELL-DEATH; CONSEQUENCES; ASTROCYTES; EXPRESSION; LEVEL; RATS	Although the mechanisms underlying mild traumatic brain injury (mTBI) are becoming well understood, treatment options are still limited. In the present study, mTBI was induced by a weight drop model to produce a closed head injury to mice and the effect of inhaled nitric oxide (INO) was evaluated by a short term memory task (object recognition task) and immunohistochemical staining of glial fibrillary acidic protein (GFAP) and CD45 for the detection of reactive astrocytes and microglia. Results showed that mTBI model did not produce brain edema, skull fracture or sensorimotor coordination dysfunctions. Mice did however exhibit a significant deficit in short term memory (STM) and strong inflammatory reaction in the ipsilateral cortex and hippocampus compared to sham-injured controls 24 h after mTBI. Additional groups of untreated mice tested 3 and 7 days later, demonstrated that recognition memory had recovered to normal levels by Day 3. Mice treated with 10 ppm INO for 4 or 8 h, beginning immediately after TBI demonstrated significantly improved STM at 24 h when compared with room air controls (p < 0.05). Whereas mice treated with 10 ppm INO for 24 h showed no improvement in STM. Mice treated with INO 10 ppm for 8 h exhibited significantly reduced microglia and astrocyte activation compared with room air controls. These data demonstrate that mTBI produces a disruption of STM which is evident 24 h after injury and persists for 2-3 days. Treatment with low concentration or short durations of INO prevents this memory loss and also attenuates the inflammatory response. These findings may have relevance for the treatment of patients diagnosed with concussion. (c) 2013 Elsevier B.V. All rights reserved.	[Liu, Ping; Ji, Yong] Huanhu Hosp, Dept Neurol, Tianjin, Peoples R China; [Liu, Ping; Li, Yong-Sheng; Quartermain, David] NYU, Sch Med, Dept Neurol, Lab Behav Neurol, New York, NY 10003 USA; [Boutajangout, Allal] NYU, Sch Med, Dept Physiol & Neurosci & Psychiat, New York, NY 10003 USA		Liu, P (corresponding author), Huanhu Hosp, Dept Neurol, Tianjin, Peoples R China.	ping.liu@nyumc.org					Baldus S, 2001, AM J RESP CRIT CARE, V163, P308, DOI 10.1164/ajrccm.163.2.ed2000c; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Bloomfield GL, 1997, CRIT CARE MED, V25, P584, DOI 10.1097/00003246-199704000-00006; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; Da JP, 2007, CRIT CARE MED, V35, P26, DOI 10.1097/01.CCM.0000250319.91575.BB; Dempsey RJ, 2000, NEUROSURGERY, V47, P399, DOI 10.1097/00006123-200008000-00024; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; GROSS SS, 1995, ANNU REV PHYSIOL, V57, P737, DOI 10.1146/annurev.ph.57.030195.003513; Ichinose F, 2004, CIRCULATION, V109, P3106, DOI 10.1161/01.CIR.0000134595.80170.62; Israelsson C, 2009, J NEUROTRAUM, V26, P1307, DOI [10.1089/neu.2008.0676, 10.1089/neu.2008-0676]; Laroux FS, 2001, ACTA PHYSIOL SCAND, V173, P113, DOI 10.1046/j.1365-201X.2001.00891.x; Laufs U, 1998, J BIOL CHEM, V273, P24266, DOI 10.1074/jbc.273.37.24266; Leinhase I, 2006, EXP NEUROL, V199, P454, DOI 10.1016/j.expneurol.2006.01.033; Li B, 2009, NEUROSURGERY, V65, P179, DOI 10.1227/01.NEU.0000346272.76537.DC; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Mautes AEM, 1996, NEUROSCI LETT, V214, P95, DOI 10.1016/0304-3940(96)12916-5; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; Miguel-Hidalgo JJ, 2005, ALCOHOL CLIN EXP RES, V29, P766, DOI 10.1097/01.ALC.0000164378.92680.FA; MONCADA S, 1991, PHARMACOL REV, V43, P109; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Pan WH, 2003, EXP BRAIN RES, V149, P195, DOI 10.1007/s00221-002-1355-7; Papadimos TJ, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-5; Papadimos Thomas J, 2008, J Trauma Manag Outcomes, V2, P1, DOI 10.1186/1752-2897-2-1; Peillon D, 1999, ANN FR ANESTH, V18, P225, DOI 10.1016/S0750-7658(99)80073-2; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rick A.B., 2006, NAT PROTOC, V3, P1306; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Sehba FA, 2011, ACTA NEUROCHIR SUPPL, V110, P99, DOI 10.1007/978-3-7091-0353-1_18; Shay M., 2011, J NEUROL RES, V1, P1; Sironi L, 2003, ARTERIOSCL THROM VAS, V23, P322, DOI 10.1161/01.ATV.0000044458.23905.3B; Sittipunt C, 2001, AM J RESP CRIT CARE, V163, P503, DOI 10.1164/ajrccm.163.2.2004187; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; STRUGAR J, 1993, J TRAUMA, V34, P555, DOI 10.1097/00005373-199304000-00012; Tapia-Perez JH, 2008, J NEUROTRAUM, V25, P1011, DOI 10.1089/neu.2008.0554; Vavilala MS, 2001, ANESTH ANALG, V93, P351, DOI 10.1097/00000539-200108000-00023; Wachtel M, 2001, J NEUROCHEM, V78, P155, DOI 10.1046/j.1471-4159.2001.00399.x; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36; Zohar O, 2011, NEUROBIOL DIS, V41, P329, DOI 10.1016/j.nbd.2010.10.001	47	17	20	0	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUL 19	2013	1522						67	75		10.1016/j.brainres.2013.05.032			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	198NU	WOS:000322930400007	23743262				2022-02-06	
J	Al-Habib, A; A-shail, A; Alaqeel, A; Zamakhshary, M; Al-Bedah, K; AlQunai, M; Al-enazi, S				Al-Habib, Amro; A-shail, Abdulaziz; Alaqeel, Ahmed; Zamakhshary, Mohammed; Al-bedah, Khalid; AlQunai, Mansur; Al-enazi, Saleem			Causes and patterns of adult traumatic head injuries in Saudi Arabia: implications for injury prevention	ANNALS OF SAUDI MEDICINE			English	Article							BRAIN-INJURY; UNITED-STATES; HELMET USE; EPIDEMIOLOGY; DEATHS	BACKGROUND AND OBJECTIVES: Data on the epidemiology of traumatic head injuries (THI) is essential for any organized prevention program. Such data are few in the developing world. Our primary goal was to study the causes, descriptive features, and outcomes of THI in adults in Saudi Arabia. DESIGN AND SETTINGS: The present study is a retrospective review. METHODS: This retrospective review included all consecutive cases of adults with THI (>18 years) who were admitted to a major trauma centre in Riyadh, Saudi Arabia, from May 2001 to July 2010. Patients were identified through a trauma database, which includes cases that required hospital admission or died in the emergency department. RESULTS: A total of 1870 patients met the inclusion criteria with a mean age of 32.6 years and a male predominance (91.2%). Most injuries were secondary to motor vehicle collisions (MVC; 69.4%). Pedestrian injuries were second (16.8%) and had 40% risk of mortality (odds ratio 0.62, 95% CI 0.48-0.8). Most patients (56.7%) had a severe THI (Glasgow coma score, GCS < 8). The overall mortality rate was 30%. Mortality was significantly associated with older age (P=.0001), lower GCS (P=.0001), and a higher injury severity score (ISS; P=.0001). CONCLUSION: The most common causes of hospital admission following injury were MVC and pedestrian injuries. Both were also the most common causes for injury-related deaths. Safety on the roads should be the primary target for any organized injury prevention programs to be successful.	[Al-Habib, Amro; A-shail, Abdulaziz; Alaqeel, Ahmed; Al-enazi, Saleem] King Saud Univ, Coll Med, Dept Surg, Div Neurosurg, Riyadh 11323, Saudi Arabia; [Zamakhshary, Mohammed; Al-bedah, Khalid] King Abdul Aziz Med City, Dept Surg, Riyadh, Saudi Arabia; [AlQunai, Mansur] Aljouf Univ, Dept Surg, Aljouf, Saudi Arabia		Alaqeel, A (corresponding author), King Saud Univ, Coll Med, Dept Surg, Div Neurosurg, Riyadh 11323, Saudi Arabia.	ahmedalaqeel@hotmail.com	Alhabib, Amro F/F-1778-2018; Alqunai, Mansur/ABC-9756-2021	Alqunai, Mansur/0000-0002-6365-4904; Zamakhshary, Mohammed/0000-0001-8870-8684			Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; Al-Habib A, 2012, J TRAUMA ACUTE CARE, V72, P1356, DOI 10.1097/TA.0b013e318250b537; Al-Kuwaiti A, 2012, ULUS TRAVMA ACIL CER, V18, P213, DOI 10.5505/tjtes.2012.03710; Alaranta H, 2000, Wien Med Wochenschr, V150, P444; Arregui-Dalmases C, 2010, ACCIDENT ANAL PREV, V42, P1164, DOI 10.1016/j.aap.2010.01.005; Bener A, 2010, BRAIN INJURY, V24, P74, DOI 10.3109/02699050903508192; Chakravarthy B, 2007, PEDIATR EMERG CARE, V23, P738, DOI 10.1097/PEC.0b013e318156acea; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Committee EEV-s, 1998, IMPR TEST METH EV PE, P17; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Crankson SJ, 2006, PEDIATR SURG INT, V22, P641, DOI 10.1007/s00383-006-1715-7; Faul M, 2010, TRAUMATIC BRAIN INJU; Finnoff JT, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.1.e4; Hefny AF, 2012, ACCIDENT ANAL PREV, V49, P245, DOI 10.1016/j.aap.2011.05.003; Hillier SL, 1997, BRAIN INJURY, V11, P649; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; Kay A, 2001, WORLD J SURG, V25, P1210, DOI 10.1007/s00268-001-0084-6; Kleiven Svein, 2003, Inj Control Saf Promot, V10, P173, DOI 10.1076/icsp.10.3.173.14552; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Krug, 2002, INJURY LEADING CAUSE; National Institute for Health and Clinical Excellence, 2007, HEAT INJ TRIAG ASS I; Nogueira LD, 2009, REV LAT-AM ENFERM, V17, P1037, DOI 10.1590/S0104-11692009000600017; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; SERVADEI F, 1989, Neurosurgical Review, V12, P429, DOI 10.1007/BF01790686; SOSIN DM, 1989, JAMA-J AM MED ASSOC, V262, P2251, DOI 10.1001/jama.262.16.2251; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; United States. Central Intelligence Agency, WORLD FACTB WASH	30	17	17	0	2	K FAISAL SPEC HOSP RES CENTRE	RIYADH	PUBLICATIONS OFFICE PO BOX 3354, RIYADH 11211, SAUDI ARABIA	0256-4947	1319-9226		ANN SAUDI MED	Ann. Saudi Med.	JUL-AUG	2013	33	4					351	355		10.5144/0256-4947.2013.351			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA3PB	WOS:000331003700005	24060713	Green Published, gold, Green Submitted			2022-02-06	
J	Du, JM; Sang, G; Jiang, CM; He, XJ; Han, Y				Du, Jian-Min; Sang, Gao; Jiang, Chun-Ming; He, Xiao-Jun; Han, Yong			Relationship between plasma copeptin levels and complications of community-acquired pneumonia in preschool children	PEPTIDES			English	Article						Copeptin; Children; Community-acquired pneumonia; Complication; Pleural effusion; Biomarker	CORTICOTROPIN-RELEASING HORMONE; ACUTE RESPIRATORY-INFECTIONS; TRAUMATIC BRAIN-INJURY; REGULATORY MECHANISMS; EMERGENCY-DEPARTMENT; VASOPRESSIN; PEPTIDE; RISK; PRECURSOR; BIOMARKER	High plasma copeptin level has been associated with clinical outcomes after acute illness. The present study was undertaken to investigate the plasma copeptin concentrations in preschool children with community-acquired pneumonia (CAP) and to analyze the correlations of copeptin with CAP-related complications and pleural effusion. Plasma copeptin concentrations of 100 healthy children and 165 preschool children with CAP were measured. 35 children (21.2%) presented with complicated CAP and 28 children (17.0%) presented with pleural effusion. The admission copeptin levels were significantly increased in all patients (49.7 +/- 21.4 pmol/L), children with complicated CAP (73.0 +/- 16.9 pmol/L), those with uncomplicated CAP (43.4 +/- 17.8 pmol/L), those with pleural effusion (70.9 +/- 17.4 pmol/L) and those without pleural effusion (45.3 +/- 19.5 pmol/L) compared with healthy control individuals (9.0 +/- 2.7 pmol/L, all P < 0.001). Multivariate logistic regression analysis showed that plasma copeptin levels were independently related to CAP-related complications (odds ratio 1.214, 95% confidence interval 1.104-1.872, P < 0.001) and pleural effusion (odds ratio 1.226, 95% confidence interval 1.109-1.917, P < 0.001). A receiver operating characteristic curve analysis showed plasma copeptin level better predicted CAP-related complications (area under curve 0.876, 95% confidence interval 0.815-0.922) and pleural effusion (area under curve 0.831, 95% confidence interval 0.765-0.885). Thus, plasma copeptin level may represent a novel biomarker for predicting CAP-related complications in preschool children. (c) 2013 Elsevier Inc. All rights reserved.	[Du, Jian-Min; Jiang, Chun-Ming; He, Xiao-Jun; Han, Yong] Nanjing Med Univ, Peoples Hosp Hangzhou 1, Dept Paediat, Hangzhou 310006, Zhejiang, Peoples R China; [Sang, Gao] Tongde Hosp Zhejiang Prov, Dept Paediat, Hangzhou 310012, Zhejiang, Peoples R China		Jiang, CM (corresponding author), Nanjing Med Univ, Peoples Hosp Hangzhou 1, Dept Paediat, 261 Huansha Rd, Hangzhou 310006, Zhejiang, Peoples R China.	hanrdxcb@163.com					Asfar P, 2006, CRIT CARE CLIN, V22, P131, DOI 10.1016/j.ccc.2005.08.007; Christ-Crain Mirjam, 2008, Expert Rev Respir Med, V2, P565, DOI 10.1586/17476348.2.5.565; Dong XQ, 2011, J TRAUMA, V71, P1194, DOI 10.1097/TA.0b013e31821283f2; Dong XQ, 2011, PEPTIDES, V32, P253, DOI 10.1016/j.peptides.2010.11.021; Francois P, 2010, ACTA PAEDIATR, V99, P861, DOI 10.1111/j.1651-2227.2010.01734.x; Itoi K, 2004, J NEUROENDOCRINOL, V16, P348, DOI 10.1111/j.0953-8194.2004.01172.x; Itoi K, 1998, ENDOCR J, V45, P13, DOI 10.1507/endocrj.45.13; Jochberger S, 2006, J CLIN ENDOCR METAB, V91, P4381, DOI 10.1210/jc.2005-2830; Katan M, 2008, NEUROENDOCRINOL LETT, V29, P341; Katan M, 2010, SWISS MED WKLY, V140, P11, DOI 10.4414/smw.2010.13101; Katan M, 2009, ANN NEUROL, V66, P799, DOI 10.1002/ana.21783; Kolditz M, 2012, RESP MED, V106, P1320, DOI 10.1016/j.rmed.2012.06.008; Kunyoshi V, 2006, PEDIATR SURG INT, V22, P186, DOI 10.1007/s00383-005-1620-5; Masia M, 2007, CLIN CHEM, V53, P2193, DOI 10.1373/clinchem.2007.085688; Morgenthaler NG, 2006, CLIN CHEM, V52, P112, DOI 10.1373/clinchem.2005.060038; Muller B, 2007, EUR J CLIN INVEST, V37, P145, DOI 10.1111/j.1365-2362.2007.01762.x; Mulholland K, 2003, PEDIATR PULM, V36, P469, DOI 10.1002/ppul.10344; Neuman MI, 2011, PEDIATRICS, V128, P246, DOI 10.1542/peds.2010-3367; Nickel CH, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-7; Pinto KDBPC, 2004, REV PANAM SALUD PUBL, V15, P104, DOI 10.1590/S1020-49892004000200005; Purhonen AK, 2012, PEPTIDES, V36, P129, DOI 10.1016/j.peptides.2012.05.001; Seligman R, 2008, CRIT CARE, V12, DOI 10.1186/cc6780; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; Yu GF, 2012, PEPTIDES, V33, P164, DOI 10.1016/j.peptides.2011.11.017; Zhu XD, 2011, CRIT CARE, V15, DOI 10.1186/cc10575	25	17	20	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0196-9781			PEPTIDES	Peptides	JUL	2013	45						61	65		10.1016/j.peptides.2013.04.015			5	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	170KW	WOS:000320850300009	23659862				2022-02-06	
J	Steel, J; Ferguson, A; Spencer, E; Togher, L				Steel, Joanne; Ferguson, Alison; Spencer, Elizabeth; Togher, Leanne			Speech pathologists' current practice with cognitive-communication assessment during post-traumatic amnesia: A survey	BRAIN INJURY			English	Article						Acute; cognitive communication assessment; inpatient; PTA; rehabilitation; speech pathology; traumatic brain injury	TRAUMATIC BRAIN-INJURY; REHABILITATION; INTERVENTION; PERFORMANCE; EMERGENCE; CONFUSION; SEVERITY; BATTERY; ADULTS	Primary objective: To investigate speech pathologists' current practice with adults who are in post-traumatic amnesia (PTA). Method: Speech pathologists with experience of adults in PTA were invited to take part in an online survey through Australian professional email/internet-based interest groups. Results: Forty-five speech pathologists responded to the online survey. The majority of respondents (78%) reported using informal, observational assessment methods commencing at initial contact with people in PTA or when patients' level of alertness allowed and initiating formal assessment on emergence from PTA. Seven respondents (19%) reported undertaking no assessment during PTA. Clinicians described using a range of techniques to monitor cognitive-communication during PTA, including static, dynamic, functional and impairment-based methods. Conclusions: The study confirmed that speech pathologists have a key role in the multidisciplinary team caring for the person in PTA, especially with family education and facilitating interactions with the rehabilitation team and family. Decision-making around timing and means of assessment of cognitive-communication during PTA appeared primarily reliant on speech pathologists' professional experience and the culture of their workplace. The findings support the need for further research into the nature of cognitive-communication disorder and resolution over this period.	[Steel, Joanne; Ferguson, Alison; Spencer, Elizabeth] Univ Newcastle, Newcastle, NSW 2308, Australia; [Togher, Leanne] Univ Sydney, Sydney, NSW 2006, Australia		Steel, J (corresponding author), Univ Newcastle, Sch Humanities & Social Sci, Sch Off, 1st Floor,McMullin Bldg,Callaghan Campus, Newcastle, NSW 2308, Australia.	joanne.steel@uon.edu.au	Steel, Joanne/M-2585-2018; Steel, Joanne/AAA-2744-2022; Togher, Leanne/AAC-7083-2019	Steel, Joanne/0000-0002-5478-5865; Steel, Joanne/0000-0002-5478-5865; Togher, Leanne/0000-0002-4518-6748			Adamovich B. B., 1992, SCALES COGNITIVE ABI; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; ANSELL BJ, 1989, ARCH PHYS MED REHAB, V70, P104; Armstrong E, 2003, ADV SPEECH LANGUAGE, V5, P137, DOI DOI 10.1080/14417040510001669171; Babcock H, 1940, MEASUREMENT EFFICIEN; Bittner RM, 2007, BRAIN INJURY, V21, P709, DOI 10.1080/02699050701468917; Bloomberg K., 2009, TRIPLE C CHECKLIST C; Blyth T, 2012, BRAIN INJURY, V26, P234, DOI 10.3109/02699052.2012.654587; Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; Body R., 2006, BRAIN IMPAIR, V7, P212, DOI DOI 10.1375/BRIM.7.3.212; Bragge P, 2011, J NEUROTRAUM, V29, P1; Buchanan EA, 2009, J EMPIR RES HUM RES, V4, P37, DOI 10.1525/jer.2009.4.2.37; Burns M. S., 1985, RIC EVALUATION COMMU; Butt P., 2004, BUTT NONVERBAL REASO; Christie J, 1986, MT WILGA HIGH LEVEL; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Couper MP, 2000, PUBLIC OPIN QUART, V64, P464, DOI 10.1086/318641; Cullen N, 2013, MODULE3 EFFICACY MOD; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); Duff MC, 2002, BRAIN INJURY, V16, P773, DOI 10.1080/02699050210128870; Frank EM, 1996, J MED SPEECH-LANG PA, V4, P81; Giacino JT, 2004, COMA RECOVERY SCALE; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Harradine PG, 2004, MED J AUSTRALIA, V181, P130, DOI 10.5694/j.1326-5377.2004.tb06202.x; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Hartley L. L, 1995, COGNITIVE COMMUNICAT; Helm-Estabrooks N, 1991, BRIEF TEST HEAD INJU; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; Holland A., 1980, COMMUNICATIVE ABILIT; Howard D, 1992, PYRAMIDS PALM TREES; Kaczmirek L., 2011, EUROPEAN ASS METHODO, P11; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; Kaplan E, 1983, BOSTON NAMING TEST; Kertesz A., 1982, W APHASIA BATTERY; Langhorn L, 2010, J CLIN NURS, V19, P2959, DOI 10.1111/j.1365-2702.2010.03330.x; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Marsh NV, 1991, NEUROPSYCHOLOGY, V5, P107, DOI 10.1037/0894-4105.5.2.107; Marshall, 2013, EVIDENCE BASED REV M; McDonald S., 2002, AWARENESS SOCIAL INF; McGhee H, 2006, BRAIN INJURY, V20, P1307, DOI 10.1080/02699050601081851; Menachemi N., 2010, EVALUATION RES ED, V24, P5; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Niemeier JP, 2011, BRAIN INJURY, V25, P680, DOI 10.3109/02699052.2011.573520; Nott MT, 2008, BRAIN INJURY, V22, P669, DOI 10.1080/02699050802227170; O'Callaghan AM, 2010, INT J SPEECH-LANG PA, V12, P107, DOI 10.3109/17549500903431774; O'Halloran R, 2009, INT J SPEECH-LANG PA, V11, P438, DOI 10.3109/17549500902741363; Pastorek NJ, 2004, J INT NEUROPSYCH SOC, V10, P807, DOI 10.1017/S1355617704106012; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Sherer M, 2008, ARCH PHYS MED REHAB, V89, P42, DOI 10.1016/j.apmr.2007.08.128; Smith VH, 2001, BRAIN IMPAIR, V2, P29, DOI DOI 10.1375/BRIM.2.1.29; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Snow P, 1995, TRAUMATIC BRAIN INJU, P33; Sue V., 2007, CONDUCTING ONLINE SU; Syder D, 1993, SHEFFIELD SCREENING; Tate R.L., 2000, BRAIN IMPAIR, V1, P116, DOI [10.1375/brim.1.2.116, DOI 10.1375/BRIM.1.2.116]; Taylor CM, 2007, ARCH PHYS MED REHAB, V88, P521, DOI 10.1016/j.apmr.2007.01.013; Togher L, 2009, BRAIN IMPAIR, V10, P188, DOI 10.1375/brim.10.2.188; Tomoeda C., 1993, ARIZONA BATTERY COMM; Turkstra L, 2005, J MED SPEECH-LANG PA, V13, pIX; Turkstra Lyn S., 2005, Seminars in Speech and Language, V26, P215, DOI 10.1055/s-2005-922101; Weir N, 2006, BRAIN INJURY, V20, P927, DOI 10.1080/02699050600832684; Wiig E. H., 1989, TEST LANGUAGE COMPET; Ylvisaker Mark, 1995, Seminars in Speech and Language, V16, P32, DOI 10.1055/s-2008-1064109	66	17	17	1	16	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2013	27	7-8					819	830		10.3109/02699052.2013.775492			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	169UO	WOS:000320806200008	23758272	Green Accepted			2022-02-06	
J	Bodanapally, UK; Kathirkamanathan, S; Geraymovych, E; Mirvis, SE; Choi, AY; McMillan, AB; Zhuo, JC; Shin, RK				Bodanapally, Uttam K.; Kathirkamanathan, Shanmuganathan; Geraymovych, Elena; Mirvis, Stuart E.; Choi, Andrew Y.; McMillan, Alan B.; Zhuo, Jiachen; Shin, Robert K.			Diagnosis of Traumatic Optic Neuropathy: Application of Diffusion Tensor Magnetic Resonance Imaging	JOURNAL OF NEURO-OPHTHALMOLOGY			English	Article							INJURY	Background: Using diffusion tensor imaging, we evaluated the directional diffusivities of the optic nerve in patients with traumatic optic neuropathy (TON). Methods: Our study consisted of 12 patients with unilateral TON, 6 patients with severe traumatic brain injury (comparison group A), and 6 patients with normal conventional brain magnetic resonance imaging (comparison group B). The contralateral optic nerve in patients with TON also was evaluated (comparison group C). Two trauma radiologists, blinded to the clinical diagnosis, independently obtained the directional diffusivities. The intraorbital optic nerve was divided into anterior and posterior segments to evaluate intersegmental differences in directional diffusivities. Results: The mean axial diffusivity (AD) in both optic nerve segments and the mean diffusivity (ADC) in the posterior segment on the affected side were significantly lower and differentiated subjects with TON from those in comparison groups A and B. Area under the receiver operating characteristic curve was 0.762, 0.746, and 0.737 for posterior AD, anterior AD, and posterior ADC, respectively. The mean AD, mean diffusivity, and radial diffusivity were lower in the affected nerves in comparison to the contralateral nerve (comparison group C), but the values did not reach statistical significance. Conclusion: Decreased AD and mean diffusivity in the posterior segment of the optic nerve may serve as a bio-marker of axonal damage in patients with TON and merits further investigation as a predictor of initial visual acuity and potential visual recovery. (C) 2013 by North American Neuro-Ophthalmology Society	[Bodanapally, Uttam K.; Kathirkamanathan, Shanmuganathan; Mirvis, Stuart E.; Choi, Andrew Y.; McMillan, Alan B.; Zhuo, Jiachen] Univ Maryland, Med Ctr, Dept Radiol, Baltimore, MD 21201 USA; [Geraymovych, Elena; Shin, Robert K.] Univ Maryland, Med Ctr, Dept Ophthalmol & Visual Sci, Baltimore, MD 21201 USA; [Choi, Andrew Y.] Air Force Sch Aerosp Med, Dept Radiol, Wright Patterson AFB, OH USA		Bodanapally, UK (corresponding author), Univ Maryland, Med Ctr, Dept Radiol, 22S Greene St, Baltimore, MD 21201 USA.	ubodanapally@umm.edu					Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Cockerham KP, 2003, OPHTHALMIC CARE COMB, P395; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; CROMPTON M R, 1970, Brain Behavior and Evolution, V93, P785, DOI 10.1093/brain/93.4.785; Hosmer DW, 2000, WILEY PS TX, V2nd, P147; Hoyt CS, 2007, EYE, V21, P1285, DOI 10.1038/sj.eye.6702849; Lee V, 2010, EYE, V24, P240, DOI 10.1038/eye.2009.79; Levin LA, 2007, CAN J OPHTHALMOL, V42, P403, DOI 10.3129/i07-046; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; NAU HE, 1987, ACTA NEUROCHIR, V89, P16, DOI 10.1007/BF01406662; Sorensen AG, 1999, RADIOLOGY, V212, P785, DOI 10.1148/radiology.212.3.r99se24785; Steinsapir K, 2005, COMPR OPHTHALMOL UPD, V6, P11; STEINSAPIR KD, 1994, SURV OPHTHALMOL, V38, P487, DOI 10.1016/0039-6257(94)90145-7; WALSH FRANK B., 1966, INVEST OPHTHALMOL, V5, P433; Yang QT, 2011, ORL-J OTO-RHIN-LARYN, V73, P301, DOI 10.1159/000330723	15	17	18	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1070-8022	1536-5166		J NEURO-OPHTHALMOL	J. Neuro-Ophthal.	JUN	2013	33	2					128	133		10.1097/WNO.0b013e3182842553			6	Clinical Neurology; Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Ophthalmology	299FT	WOS:000330382000009	23528798				2022-02-06	
J	Cao, Y; Selassie, AW; Krause, JS				Cao, Yue; Selassie, Anbesaw W.; Krause, James S.			Risk of Death After Hospital Discharge With Traumatic Spinal Cord Injury: A Population-Based Analysis, 1998-2009	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Mortality; Rehabilitation; Risk; Spinal cord injuries	VENOUS THROMBOEMBOLISM; CARE SERVICES; MORTALITY; SURVIVAL; TRENDS; PEOPLE; ACCESS; BRAIN	Objective: To investigate risk factors associated with mortality among people with traumatic spinal cord injury (TSCI) after discharge from acute care hospitals in South Carolina and to compare their mortality experiences with the general population. Design: Retrospective cohort study. Setting: Sixty-two acute care, nonfederal hospitals. Participants: Persons (N=2685) with TSCI. Interventions: Not applicable. Main Outcome Measures: Death after TSCI from all causes within 4288 days of observation after discharge from acute care facilities. Results: The crude annual mortality rate during the period was 33 per 1000 person-years. Number of comorbidities, admission into trauma centers, advancing age, type of insurance, injury level and completeness, and being a man were significantly associated (P<.05) with the risk of death after discharge from acute care facilities. The overall mortality rate of our cohort is 3.6 times (95% confidence interval, 3.3-3.9) higher than the general population. Conclusions: The causes of postdischarge deaths are multifactorial, and more emphasis should be placed on managing and monitoring chronic diseases throughout the recovery process to improve the survivorship of people with TSCI. (C) 2013 by the American Congress of Rehabilitation Medicine	[Cao, Yue; Krause, James S.] Med Univ S Carolina, Dept Hlth Sci & Res, Charleston, SC 29425 USA; [Selassie, Anbesaw W.] Med Univ S Carolina, Div Biostat & Epidemiol, Charleston, SC 29425 USA		Cao, Y (corresponding author), Dept Hlth Sci & Res, 77 President St,Room 207,MSC 700, Charleston, SC 29425 USA.	caoyu@musc.edu			Department of Education, National Institute on Disability and Rehabilitation Research [H133B090005]; South Carolina Spinal Cord Injury Research Fund [SCIRF 11-006, SCIRF 11-004]	Supported by the Department of Education, National Institute on Disability and Rehabilitation Research (grant no. H133B090005) and the South Carolina Spinal Cord Injury Research Fund (grant nos. SCIRF 11-006 and SCIRF 11-004).	Ahoniemi E, 2008, SPINAL CORD, V46, P781, DOI 10.1038/sc.2008.53; Alander DH, 1997, SPINE, V22, P1189, DOI 10.1097/00007632-199706010-00003; Allison PD, 2010, SURVIVAL ANAL USING, V2nd; Banja J D, 2001, J Spinal Cord Med, V24, P230; BIERINGSORENSEN F, 1990, PARAPLEGIA, V28, P105, DOI 10.1038/sc.1990.13; BURSTIN HR, 1993, JAMA-J AM MED ASSOC, V270, P845, DOI 10.1001/jama.270.7.845; BURSTIN HR, 1992, JAMA-J AM MED ASSOC, V268, P2383, DOI 10.1001/jama.268.17.2383; Bushnik T, 2002, TOPICS SPINAL CORD I, V7, P17; CDC National Center for Health Statistics, 2012, UND CAUS DEATH 1999; Chaovipoch P, 2006, J NEUROTRAUM, V23, P830, DOI 10.1089/neu.2006.23.830; Chen Y., 2010, ESSENTIALS SPINAL CO; Claridge JA, 2006, J TRAUMA, V60, P178, DOI 10.1097/01.ta.0000198804.74514.0c; DeVivo MJ, 2010, SPINAL CORD MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P78; DeVivo MJ, 2011, ARCH PHYS MED REHAB, V92, P332, DOI 10.1016/j.apmr.2010.08.031; DeVivo Michael J, 2002, J Spinal Cord Med, V25, P335; DeVivo MJ, 1999, ARCH PHYS MED REHAB, V80, P1411, DOI 10.1016/S0003-9993(99)90252-6; DEVIVO MJ, 1987, ARCH NEUROL-CHICAGO, V44, P872, DOI 10.1001/archneur.1987.00520200074023; DEVIVO MJ, 1992, ARCH PHYS MED REHAB, V73, P156; Dixon L, 2001, PSYCHIAT SERV, V52, P786, DOI 10.1176/appi.ps.52.6.786; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fee DB, 2007, BRAIN RES, V1137, P146, DOI 10.1016/j.brainres.2006.12.024; Frankel HL, 1998, SPINAL CORD, V36, P266, DOI 10.1038/sj.sc.3100638; Fu ES, 2005, CURR OPIN ANESTHESIO, V18, P181, DOI 10.1097/01.aco.0000162838.56344.88; GARCIARENESES J, 1991, PARAPLEGIA, V29, P180, DOI 10.1038/sc.1991.26; Georgiou C, 2009, WORLD J SURG, V33, P1087, DOI 10.1007/s00268-009-9923-7; Giskes K, 2009, J EPIDEMIOL COMMUN H, V63, P113, DOI 10.1136/jech.2008.078352; Gittler J, 2008, RES GERONTOL NURS, V1, P264, DOI 10.3928/19404921-20081001-08; Golob JF, 2008, J TRAUMA, V64, P311, DOI 10.1097/TA.0b013e3181627625; GRIFFIN MR, 1985, J CHRON DIS, V38, P643, DOI 10.1016/0021-9681(85)90018-9; Guilcher SJT, 2010, SPINAL CORD, V48, P45, DOI 10.1038/sc.2009.78; Hagglund K J, 1999, Mo Med, V96, P447; Hall KM, 1999, ARCH PHYS MED REHAB, V80, P1507, DOI 10.1016/S0003-9993(99)90265-4; Jones T, 2005, ARCH PHYS MED REHAB, V86, P2240, DOI 10.1016/j.apmr.2005.07.286; Kao LS, 2006, AM J SURG, V192, P710, DOI 10.1016/j.amjsurg.2006.08.031; KARAMEHMETOGLU SS, 1995, PARAPLEGIA, V33, P469, DOI 10.1038/sc.1995.102; Kelz RR, 2004, CANCER-AM CANCER SOC, V101, P2187, DOI 10.1002/cncr.20624; KIWERSKI J, 1981, PARAPLEGIA, V19, P347, DOI 10.1038/sc.1981.66; KRAUS JF, 1975, J CHRON DIS, V28, P471, DOI 10.1016/0021-9681(75)90057-0; Krause JS, 2009, SPINAL CORD, V47, P592, DOI 10.1038/sc.2009.15; Krause JS, 2008, ARCH PHYS MED REHAB, V89, P1482, DOI 10.1016/j.apmr.2007.11.062; Krause JS, 2011, ARCH PHYS MED REHAB, V92, P339, DOI 10.1016/j.apmr.2010.09.032; Krause JS, 2009, ARCH PHYS MED REHAB, V90, P95, DOI 10.1016/j.apmr.2008.07.012; Krause JS, 2009, ARCH PHYS MED REHAB, V90, P628, DOI 10.1016/j.apmr.2008.10.014; Krause JS, 2004, ARCH PHYS MED REHAB, V85, P1764, DOI 10.1016/j.apmr.2004.06.062; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; MILZMAN DP, 1992, J TRAUMA, V32, P236, DOI 10.1097/00005373-199202000-00021; Moore L, 2008, ANN EMERG MED, V52, P356, DOI 10.1016/j.annemergmed.2007.09.007; Murphy SL, 2012, NATL VITAL STAT REPO, V60; National Spinal Cord Injury Statistical Center, 2010, J Spinal Cord Med, V33, P439; NSCISC, 2011, SPIN CORD INJ FACTS; O'Connor PJ, 2005, ARCH PHYS MED REHAB, V86, P48, DOI 10.1016/j.apmr.2004.07.346; Saunders LL, 2009, J TRAUMA, V66, P184, DOI 10.1097/TA.0b013e31815644e5; Segrin C, 2007, PERS INDIV DIFFER, V43, P637, DOI 10.1016/j.paid.2007.01.017; Selassie AW, 2013, SPINAL CORD, V51, P48, DOI 10.1038/sc.2012.88; Selassie AW, 2011, ARCH PHYS MED REHAB, V92, P1534, DOI 10.1016/j.apmr.2011.04.018; Shigaki CL, 2002, REHABIL PSYCHOL, V47, P204, DOI 10.1037//0090-5550.47.2.204; Shoko T, 2010, J AM COLL SURGEONS, V211, P338, DOI 10.1016/j.jamcollsurg.2010.04.010; Smedley BD, 2003, UNEQUAL TREATMENT CO; Stover SL, 1999, ARCH PHYS MED REHAB, V80, P1365, DOI 10.1016/S0003-9993(99)90246-0; Strauss DJ, 2000, J INSURANCE MED, V32, P11; Surkin J, 2000, SPINE, V25, P716, DOI 10.1097/00007632-200003150-00011; Suzuki R, 2007, REHABIL PSYCHOL, V52, P338, DOI 10.1037/0090-5550.52.3.338; Swartz KR, 2007, J NEUROTRAUM, V24, P473, DOI 10.1089/neu.2006.0167; The Henry Kaiser Foundation, 2008, EX SOURC COV MED BEN; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ., 1995, GUIDELINES SURVEILLA; Varma A, 2010, SPINE, V35, P778, DOI 10.1097/BRS.0b013e3181ba1359; Warren S, 1995, Alaska Med, V37, P11; WOODRUFF BA, 1994, AM J PREV MED, V10, P10, DOI 10.1016/S0749-3797(18)30640-8	69	17	17	0	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUN	2013	94	6					1054	1061		10.1016/j.apmr.2013.01.022			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	158FH	WOS:000319954400007	23391523				2022-02-06	
J	Durazzo, TC; Abadjian, L; Kincaid, A; Bilovsky-Muniz, T; Boreta, L; Gauger, GE				Durazzo, Timothy C.; Abadjian, Linda; Kincaid, Adam; Bilovsky-Muniz, Tobias; Boreta, Lauren; Gauger, Grant E.			The Influence of Chronic Cigarette Smoking on Neurocognitive Recovery after Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cigarette smoking; cognition; mild traumatic brain injury; recovery	ALCOHOL-DEPENDENT INDIVIDUALS; OXIDATIVE STRESS; NICOTINE ADDICTION; ANTIOXIDANT STATUS; TOBACCO-SMOKE; TEENAGE GIRLS; VITAMIN-C; IN-VITRO; HISTORY; DAMAGE	The majority of the approximately 1.7 million civilians in the United States who seek emergency care for traumatic brain injury (TBI) are classified as mild (MTBI). Premorbid and comorbid conditions that commonly accompany MTBI may influence neurocognitive and functional recovery. This study assessed the influence of chronic smoking and hazardous alcohol consumption on neurocognitive recovery after MTBI. A comprehensive neurocognitive battery was administered to 25 non-smoking MTBI participants (nsMTBI), 19 smoking MTBI (sMTBI) 38 +/- 22 days (assessment point 1: AP1) and 230 +/- 36 (assessment point 2: AP2) days after injury. Twenty non-smoking light drinkers served as controls (CON). At AP1, nsMTBI and sMTBI were inferior to CON on measures of auditory-verbal learning and memory; nsMTBI performed more poorly than CON on processing speed and global neurocognition, and sMTBI performed worse than CON on working memory measures; nsMTBI were inferior to sMTBI on visuospatial memory. Over the AP1-AP2 interval, nsMTBI showed significantly greater improvement than sMTBI on measures of processing speed, visuospatial learning and memory, visuospatial skills, and global neurocognition, whereas sMTBI only showed significant improvement on executive skills. At AP2, sMTBI remained inferior to CON on auditory-verbal learning and auditory-verbal memory; there were no significant differences between nsMTBI and CON or among nsMTBI and sMTBI on any domain at AP2. Hazardous alcohol consumption was not significantly associated with change in any neurocognitive domain. For sMTBI, over the AP1-AP2 interval, greater lifetime duration of smoking and pack-years were related to significantly less improvement on multiple domains. Results suggest consideration of the effects of chronic cigarette smoking is necessary to understand the potential factors influencing neurocognitive recovery after MTBI.	[Durazzo, Timothy C.; Abadjian, Linda; Bilovsky-Muniz, Tobias; Boreta, Lauren; Gauger, Grant E.] San Francisco VA Med Ctr, Ctr Imaging Neurodegenerat Dis, San Francisco, CA 94121 USA; [Durazzo, Timothy C.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Kincaid, Adam; Gauger, Grant E.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA		Durazzo, TC (corresponding author), San Francisco VA Med Ctr, Ctr Imaging Neurodegenerat Dis 114M, 4150 Clement St, San Francisco, CA 94121 USA.	timothy.durazzo@ucsf.edu			Department of DefenseUnited States Department of Defense [W81XWII-05-2-0094]; National Institute on Drug AbuseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [DA24136]; National Institute on Alcohol and AlcoholismUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [AA10788]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA010788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [K01DA024136] Funding Source: NIH RePORTER	This material is the result of work supported by the Department of Defense (W81XWII-05-2-0094 to TCD and GEG), National Institute on Drug Abuse (DA24136 to TCD), National Institute on Alcohol and Alcoholism (AA10788 to Dieter J. Meyerhoff), and with resources and the use of facilities at the San Francisco Veterans Affairs Medical Center, San Francisco, CA. We thank Dr. Geoffrey Manley and Michelle Meeker for invaluable assistance in recruitment, Hana Lee for assistance with neurocognitive assessment, and Dr. Dieter J. Meyerhoff for providing a portion of the neurocognitive data for control participants. We also wish to extend our gratitude to the study participants, who made this research possible.	Alonso JR, 2004, EUR RESPIR J, V23, P214, DOI 10.1183/09031936.03.00038203; Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Anbarasi K, 2006, LIFE SCI, V78, P1378, DOI 10.1016/j.lfs.2005.07.030; Azizian Allen, 2009, Handb Exp Pharmacol, P113, DOI 10.1007/978-3-540-69248-5_5; Babor T.F., 2001, AUDIT THE ALCOHOL US; Bartal M, 2001, Monaldi Arch Chest Dis, V56, P545; Bates C, 1999, TOBACCO ADDITIVES CI; Beck A.T., 1978, DEPRESSION INVENTORY; Benedict R., 1997, BRIEF VISUOSPATIAL M; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bloomer RJ, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-39; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Bouchery EE, 2011, AM J PREV MED, V41, P516, DOI 10.1016/j.amepre.2011.06.045; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cohen J., 2013, STAT POWER ANAL BEHA; Dani JA, 2001, PHARMACOL BIOCHEM BE, V70, P439, DOI 10.1016/S0091-3057(01)00652-9; Delis D.C., 2000, CALIFORNIA VERBAL LE; Deveci SE, 2004, RESP MED, V98, P551, DOI 10.1016/j.rmed.2003.11.018; DIKMEN SS, 1995, ANN EMERG MED, V26, P167, DOI 10.1016/S0196-0644(95)70147-8; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Dube S. R., 2010, VITAL SINGS CURRENT; Durazzo TC, 2004, ALCOHOL CLIN EXP RES, V28, P1849, DOI 10.1097/01.ALC.0000148112.92525.AC; Durazzo TC, 2008, ALCOHOL, V42, P439, DOI 10.1016/j.alcohol.2008.06.001; Durazzo TC, 2007, ALCOHOL CLIN EXP RES, V31, P1114, DOI 10.1111/j.1530-0277.2007.00398.x; Durazzo TC, 2007, FRONT BIOSCI-LANDMRK, V12, P4079, DOI 10.2741/2373; Durazzo TC, 2012, ALZHEIMERS DEMENT, V8, P513, DOI 10.1016/j.jalz.2011.10.006; Durazzo TC, 2012, DRUG ALCOHOL DEPEN, V122, P105, DOI 10.1016/j.drugalcdep.2011.09.019; Durazzo TC, 2010, INT J ENV RES PUB HE, V7, P3760, DOI 10.3390/ijerph7103760; Durazzo TC, 2010, ALCOHOL ALCOHOLISM, V45, P507, DOI 10.1093/alcalc/agq057; FAGERSTROM KO, 1991, ENT-EAR NOSE THROAT, V69, P763; Fowles J., 2000, CHEM CONSTITUENTS CI; Gibbon M, 1998, STRUCTURED CLIN INTE; GOLDEN CJ, 1978, J CONSULT CLIN PSYCH, V46, P1258, DOI 10.1037/0022-006X.46.6.1258; Golden CJ, 1978, STROOP COLOR WORD TE; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; GROBER E, 1991, J CLIN EXP NEUROPSYC, V13, P933, DOI 10.1080/01688639108405109; Haustein KO, 1999, INT J CLIN PHARM TH, V37, P76; Heaton RK, 1991, COMPREHENSIVE NORMS; John U, 2003, ALCOHOL ALCOHOLISM, V38, P606, DOI 10.1093/alcalc/agg122; Jorge RE, 2005, ARCH GEN PSYCHIAT, V62, P742, DOI 10.1001/archpsyc.62.7.742; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; Kim SH, 2004, NUTRITION, V20, P437, DOI 10.1016/j.nut.2004.01.008; Kim SH, 2003, NUTRITION, V19, P240, DOI 10.1016/S0899-9007(02)01002-X; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Mansvelder HD, 2003, EUR J PHARMACOL, V480, P117, DOI 10.1016/j.ejphar.2003.08.099; Mansvelder HD, 2006, PSYCHOPHARMACOLOGY, V184, P292, DOI 10.1007/s00213-005-0070-z; Mazzone P, 2010, INT J ENV RES PUB HE, V7, P4111, DOI 10.3390/ijerph7124111; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McKee SA, 2007, ARCH INTERN MED, V167, P716, DOI 10.1001/archinte.167.7.716; Mendez-Alvarez E, 1998, J APPL TOXICOL, V18, P443, DOI 10.1002/(SICI)1099-1263(199811/12)18:6<443::AID-JAT530>3.3.CO;2-G; Mertens JR, 2005, ALCOHOL CLIN EXP RES, V29, P989, DOI 10.1097/01.ALC.0000167958.68586.3D; Meyerhoff DJ, 2013, CURR TOP BEHAV NEURO, V13, P511, DOI 10.1007/7854_2011_131; Moriarty SE, 2003, FREE RADICAL BIO MED, V35, P1582, DOI 10.1016/j.freeradbiomed.2003.09.006; Northrop-Clewes CA, 2007, CLIN CHIM ACTA, V377, P14, DOI 10.1016/j.cca.2006.08.028; Panda K, 2000, FREE RADICAL BIO MED, V29, P115, DOI 10.1016/S0891-5849(00)00297-5; Petraglia AL, 2012, NEUROSURGERY, V70, P1520, DOI 10.1227/NEU.0b013e31824cebe8; Reitan R, 1985, HALSTEAD REITAN NEUR; Robertson Jr E., 1994, ASSESSMENT MILD BRAI; Rourke S. B., 2009, NEUROPSYCHOLOGICAL A, P398; Sankoh AJ, 1997, STAT MED, V16, P2529, DOI 10.1002/(SICI)1097-0258(19971130)16:22<2529::AID-SIM692>3.0.CO;2-J; SKINNER HA, 1982, J STUD ALCOHOL, V43, P1157, DOI 10.15288/jsa.1982.43.1157; Swan GE, 2007, NEUROPSYCHOL REV, V17, P259, DOI 10.1007/s11065-007-9035-9; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Valavanidis A, 2009, INT J ENV RES PUB HE, V6, P445, DOI 10.3390/ijerph6020445; Vallejo YF, 2005, J NEUROSCI, V25, P5563, DOI 10.1523/JNEUROSCI.5240-04.2005; Vickery CD, 2008, ARCH PHYS MED REHAB, V89, P48, DOI 10.1016/j.apmr.2007.07.047; Volkow N D, 1999, Nicotine Tob Res, V1 Suppl 2, pS127; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Yang YM, 2003, BIOMED ENVIRON SCI, V16, P256; [No title captured], DOI DOI 10.1037/0894-4105.7.3.296; [No title captured]; [No title captured]	74	17	17	0	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2013	30	11					1013	1022		10.1089/neu.2012.2676			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	166WD	WOS:000320589300012	23421788	Green Published			2022-02-06	
J	Reynolds, JC; Rittenberger, JC; Callaway, CW				Reynolds, Joshua C.; Rittenberger, Jon C.; Callaway, Clifton W.			Methylphenidate and amantadine to stimulate reawakening in comatose patients resuscitated from cardiac arrest	RESUSCITATION			English	Article						Cardiac arrest; Resuscitation; Coma; Methylphenidate; Amantadine	TRAUMATIC BRAIN-INJURY; AMERICAN-HEART-ASSOCIATION; EMERGENCY CARDIOVASCULAR CARE; CARDIOPULMONARY-RESUSCITATION; STROKE-FOUNDATION; CONTROLLED-TRIAL; ISCHEMIA; NEUROPROTECTION; CONSCIOUSNESS; HYPOTHERMIA	Background: Despite critical-care packages including therapeutic hypothermia (TH), neurologic injury is common after cardiac arrest (CA) resuscitation. Methylphenidate and amantadine have treated coma in traumatically-brain-injured patients with mixed success, but have not been explored in post-arrest patients. Objective: Compare the outcome of comatose post-arrest patients treated with neurostimulants to a matched cohort. Methods: Retrospective cohort study from 6/2008 to 12/2011 in a tertiary university hospital. We included adult patients treated with methylphenidate or amantadine after resuscitation from in-hospital or out-of-hospital CA (OHCA) of any rhythm, excluding patients with traumatic/surgical etiology of arrest, terminal re-arrest within 6 h, or withdrawal of care by family within 6 h. Primary outcome was following commands; secondary outcomes included survival to hospital discharge, cerebral performance category (CPC), and modified Rankin scale (mRS). We compared characteristics and outcomes to a control cohort matched on TH and 72 h FOUR score +/- 1. Results: Of 588 patients, 8 received methylphenidate, 6 received amantadine, and 2 both. Most were female suffering OHCA with median age 61 years. All received TH and a multi-modal neurological evaluation. Initial exam revealed median GCS 6 and FOUR 7, which was unchanged at 72 h. Six patients (38%) followed commands prior to discharge at median 2.5 days (range: 1-18 days) after treatment. Patients receiving neurostimulants trended toward improved rate of following commands, survival to hospital discharge, and distribution of CPC and mRS scores. Conclusions: Neurostimulants may be considered to stimulate wakefulness in selected post-cardiac arrest patients, but a prospective trial is needed to evaluate this therapy. (C) 2012 Elsevier Ireland Ltd. All rights reserved.	[Reynolds, Joshua C.; Rittenberger, Jon C.; Callaway, Clifton W.] Univ Pittsburgh, Dept Emergency Med, Pittsburgh, PA USA		Reynolds, JC (corresponding author), Iroquois Bldg,Suite 400 A,3600 Forbes Ave, Pittsburgh, PA 15261 USA.	reynoldsjc@upmc.edu		Callaway, Clifton/0000-0002-3309-1573; Reynolds, Joshua/0000-0002-5482-3569	National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [2 U01 HL07787-07]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [F32HL007787] Funding Source: NIH RePORTER	Dr. Callaway is supported in part by 2 U01 HL07787-07 from the National Heart, Lung, and Blood Institute.	Castro CC, 2012, BRAIN RES, V1474, P82, DOI 10.1016/j.brainres.2012.07.025; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; DeMarchi R, 2005, CAN J NEUROL SCI, V32, P4, DOI 10.1017/S0317167100016826; Donnino MW, 2011, RESUSCITATION, V82, P974, DOI 10.1016/j.resuscitation.2011.03.021; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Hughes S, 2005, BRAIN INJURY, V19, P1197, DOI 10.1080/02699050500309296; Kelley MH, 2011, NEUROPHARMACOLOGY, V61, P724, DOI 10.1016/j.neuropharm.2011.05.017; Knapp J, 2011, RESUSCITATION, V82, P1076, DOI 10.1016/j.resuscitation.2011.03.038; Laver S, 2004, INTENS CARE MED, V30, P2126, DOI 10.1007/s00134-004-2425-z; Metter RB, 2011, RESUSCITATION, V82, P1180, DOI 10.1016/j.resuscitation.2011.04.001; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Moein H, 2006, CLIN NEUROL NEUROSUR, V108, P539, DOI 10.1016/j.clineuro.2005.09.003; Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652; Patrick PD, 2006, J CHILD NEUROL, V21, P879, DOI 10.1177/08830738060210100901; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; Quintard H, 2011, NEUROPHARMACOLOGY, V61, P622, DOI 10.1016/j.neuropharm.2011.05.003; Reynolds JC, 2012, J EMERG MED; Rittenberger JC, 2012, NEUROCRIT CARE, V16, P114, DOI 10.1007/s12028-011-9565-0; Rittenberger JC, 2011, RESUSCITATION, V82, P1399, DOI 10.1016/j.resuscitation.2011.06.024; Rittenberger JC, 2010, RESUSCITATION, V81, P1128, DOI 10.1016/j.resuscitation.2010.05.011; Rittenberger JC, 2008, RESUSCITATION, V79, P198, DOI 10.1016/j.resuscitation.2008.08.014; Saniova B, 2004, J NEURAL TRANSM, V111, P511, DOI 10.1007/s00702-004-0112-4; Sawyer E, 2008, ANN PHARMACOTHER, V42, P247, DOI 10.1345/aph.1K284; Sunde K, 2007, RESUSCITATION, V73, P29, DOI 10.1016/j.resuscitation.2006.08.016; Taguchi N, 2012, RESUSCITATION, V83, P652, DOI 10.1016/j.resuscitation.2011.11.004; TEASDALE G, 1974, LANCET, V2, P81; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Volkow ND, 1998, AM J PSYCHIAT, V155, P1325, DOI 10.1176/ajp.155.10.1325; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Wu O, 2009, RADIOLOGY, V252, P173, DOI 10.1148/radiol.2521081232; Yang ZJ, 2011, NEUROBIOL DIS, V43, P446, DOI 10.1016/j.nbd.2011.04.018	34	17	19	0	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572			RESUSCITATION	Resuscitation	JUN	2013	84	6					818	824		10.1016/j.resuscitation.2012.11.014			7	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	172IV	WOS:000320996800033	23178867				2022-02-06	
J	Sebastian, V; Diallo, A; Ling, DSF; Serrano, PA				Sebastian, Veronica; Diallo, Aissatou; Ling, Douglas S. F.; Serrano, Peter A.			Robust training attenuates TBI-induced deficits in reference and working memory on the radial 8-arm maze	FRONTIERS IN BEHAVIORAL NEUROSCIENCE			English	Article						traumatic brain injury; radial arm maze; working memory; reference memory; robust training	TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; TERM COGNITIVE DEFICITS; MORRIS WATER MAZE; SPATIAL MEMORY; PREFRONTAL CORTEX; ENVIRONMENTAL ENRICHMENT; CELL-DEATH; RAT; HIPPOCAMPAL	Globally, it is estimated that nearly 10 million people sustain severe brain injuries leading to hospitalization and/or death every year. Amongst survivors, traumatic brain injury (TBI) results in a wide variety of physical, emotional and cognitive deficits. The most common cognitive deficit associated with TBI is memory loss, involving impairments in spatial reference and working memory. However, the majority of research thus far has characterized the deficits associated with TBI on either reference or working memory systems separately, without investigating how they interact within a single task. Thus, we examined the effects of TBI on short-term working and long-term reference memory using the radial 8-arm maze (RAM) with a sequence of four baited and four unbaited arms. Subjects were given 10 daily trials for 6 days followed by a memory retrieval test 2 weeks after training. Multiple training trials not only provide robust training, but also test the subjects' ability to frequently update short-term memory while learning the reference rules of the task. Our results show that TBI significantly impaired short-term working memory function on previously acquired spatial information but has little effect on long-term reference memory. Additionally, TBI significantly increased working memory errors during acquisition and reference memory errors during retention testing 2 weeks later. With a longer recovery period after TBI, the robust RAM training mitigated the reference memory deficit in retention but not the short-term working memory deficit during acquisition. These results identify the resiliency and vulnerabilities of short-term working and long-term reference memory to TBI in the context of robust training. The data highlight the role of cognitive training and other behavioral remediation strategies implicated in attenuating deficits associated with TBI.	[Sebastian, Veronica; Diallo, Aissatou; Serrano, Peter A.] CUNY Hunter Coll, Dept Psychol, New York, NY 10065 USA; [Ling, Douglas S. F.] Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; [Ling, Douglas S. F.] Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Brooklyn, NY 11203 USA; [Serrano, Peter A.] CUNY, Grad Ctr, Dept Psychol, New York, NY USA		Serrano, PA (corresponding author), CUNY Hunter Coll, Dept Psychol, 695 Pk Ave, New York, NY 10065 USA.	serrano@genectr.hunter.cuny.edu			RCMI from the National Center for Research Resources (NCRR) [RR003037]; Department of DefenseUnited States Department of Defense [W81XWH-08-1-0243]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [G12RR003037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R25NS080686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R24DA012136] Funding Source: NIH RePORTER	This study was funded in part by the RCMI grant number RR003037 from the National Center for Research Resources (NCRR) and the Department of Defense W81XWH-08-1-0243 to Peter A. Serrano.	Abrahams S, 1997, NEUROPSYCHOLOGIA, V35, P11, DOI 10.1016/S0028-3932(96)00051-6; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Atkins CM, 2011, TRANSL STROKE RES, V2, P546, DOI 10.1007/s12975-011-0123-z; Baddeley A.D., 1994, NEUROPSYCHOLOGY, V8, P485, DOI [10.1037/0894-4105.8.4.485, DOI 10.1037/0894-4105.8.4.485]; BEATTY WW, 1985, NEUROBIOL AGING, V6, P219, DOI 10.1016/0197-4580(85)90053-3; Bimonte HA, 2003, NEUROBIOL AGING, V24, P37, DOI 10.1016/S0197-4580(02)00015-5; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Bramlett HM, 1997, BRAIN RES, V762, P195, DOI 10.1016/S0006-8993(97)00387-9; Chen M. F., 2012, J PHYSL, V591, P985; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Cheng JP, 2012, J NEUROTRAUM, V29, P2684, DOI 10.1089/neu.2012.2560; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; DASH PK, 1995, J NEUROSCI, V15, P2030, DOI 10.1523/JNEUROSCI.15-03-02030.1995; Daumas S, 2008, LEARN MEMORY, V15, P625, DOI 10.1101/lm.990208; Dikmen S, 2001, J NEUROTRAUM, V18, P127, DOI 10.1089/08977150150502578; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Floresco SB, 1997, J NEUROSCI, V17, P1880; Gong QZ, 1999, J NEUROTRAUM, V16, P893, DOI 10.1089/neu.1999.16.893; GOODMAN JC, 1994, J NEUROTRAUM, V11, P587, DOI 10.1089/neu.1994.11.587; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; Honig WK, 1978, COGNITIVE PROCESS, P213; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Hu BR, 2004, J CEREBR BLOOD F MET, V24, P934, DOI 10.1097/01.WCB.0000125888.56462.A1; JARRARD LE, 1978, J COMP PHYSIOL PSYCH, V92, P1119, DOI 10.1037/h0077516; Joel D, 1997, BRAIN RES, V765, P37, DOI 10.1016/S0006-8993(97)00334-X; Kobori N, 2006, J NEUROSCI, V26, P4236, DOI 10.1523/JNEUROSCI.4687-05.2006; KOLB B, 1982, BEHAV BRAIN RES, V6, P365, DOI 10.1016/0166-4328(82)90018-3; Lagraoui Mouna, 2012, Front Neurol, V3, P155, DOI 10.3389/fneur.2012.00155; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Markgraf CG, 2001, J NEUROTRAUM, V18, P175, DOI 10.1089/08977150150502604; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; Monaco C. M, 2013, EXP NEUROL, DOI [10.1016/j.expneurol.2013.01.007, DOI 10.1016/J.EXPNEUR0L.2013.01.007.[]; Newcomb JK, 1999, EXP NEUROL, V158, P76, DOI 10.1006/exnr.1999.7071; OLTON DS, 1979, BEHAV BRAIN SCI, V2, P313, DOI 10.1017/S0140525X00062713; OLTON DS, 1976, J EXP PSYCHOL-ANIM B, V2, P97, DOI 10.1037/0097-7403.2.2.97; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; Piot-Grosjean O, 2001, NEUROBIOL DIS, V8, P1082, DOI 10.1006/nbdi.2001.0450; Ramos BP, 2003, NEURON, V40, P835, DOI 10.1016/S0896-6273(03)00694-9; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sanders MJ, 1999, J NEUROTRAUM, V16, P915, DOI 10.1089/neu.1999.16.915; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Schrott LM, 2008, BRAIN RES, V1198, P132, DOI 10.1016/j.brainres.2008.01.020; Serrano P, 2008, PLOS BIOL, V6, P2698, DOI 10.1371/journal.pbio.0060318; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Soblosky JS, 1996, BEHAV BRAIN RES, V79, P79, DOI 10.1016/0166-4328(95)00264-2; Soblosky JS, 1996, BEHAV BRAIN RES, V80, P185, DOI 10.1016/0166-4328(96)00034-4; STEWART J, 1989, NEUROBIOL AGING, V10, P669, DOI 10.1016/0197-4580(89)90003-1; Tyagi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057945; Vallat-Azouvi C, 2007, J INT NEUROPSYCH SOC, V13, P770, DOI 10.1017/S1355617707070993; WALLACE JE, 1980, J GERONTOL, V35, P355, DOI 10.1093/geronj/35.3.355; Whiting MD, 2008, BRAIN RES, V1213, P69, DOI 10.1016/j.brainres.2008.01.107; Willmott C, 2009, NEUROPSYCHOLOGY, V23, P424, DOI 10.1037/a0015058; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872; Xia XW, 2012, WORLD NEUROSURG, V78, P689, DOI 10.1016/j.wneu.2011.07.042; Yang L, 2010, J NEUROTRAUM, V27, P1541, DOI 10.1089/neu.2009.1244; Ying Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052998; Yoshihara T, 2004, NEUROSCIENCE, V129, P1, DOI 10.1016/j.neuroscience.2004.07.030; Zhang M, 2011, J NEUROSCI, V31, P10174, DOI 10.1523/JNEUROSCI.0009-11.2011; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	67	17	17	1	17	FRONTIERS RESEARCH FOUNDATION	LAUSANNE	PO BOX 110, LAUSANNE, 1015, SWITZERLAND	1662-5153			FRONT BEHAV NEUROSCI	Front. Behav. Neurosci.	MAY 3	2013	7								38	10.3389/fnbeh.2013.00038			9	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	136BV	WOS:000318335400001	23653600	gold, Green Published			2022-02-06	
J	Danaila, L; Popescu, I; Pais, V; Riga, D; Riga, S; Pais, E				Danaila, L.; Popescu, I.; Pais, V.; Riga, D.; Riga, S.; Pais, E.			Apoptosis, Paraptosis, Necrosis, and Cell Regeneration in Posttraumatic Cerebral Arteries	CHIRURGIA			English	Article						posttraumatic cerebral arteries; apoptosis; paraptosis; necrosis; cell regeneration; ultrastructure	BRAIN-INJURY; DEATH; PATHOPHYSIOLOGY; MECHANISMS; ISCHEMIA	This study is to understand the nature and functional significance of the activated cell death programs and rehabilitation signs during late vascular changes after brain injury. We used light and transmission electron microscopy to describe changes of cells within the vascular endothelium and tunica media of the cortical arteries four weeks after craniocerebral traumatism. Within tunica media of the posttraumatic damaged artery, apoptotic and paraptotic phenotypes were identified as well as some early ultrastructural signs of smooth muscle cells regeneration, these cell highlighting a remarkable degree of plasticity. Surprisingly, some endothelial cells showed an extensive rough endoplasmic reticulum development, whereas other endothelial cells showed typical necrosis. In conclusion, two groups of suicidal cells - apoptotic and paraptotic cells - were encountered in the same lesional vascular wall after neurotrauma, showing also signs of cell regeneration. The pathophysiologic significance of the coexisting double cell death programs and cell regeneration seems to be in relation with late cell survival, after arterial damage when some cells disappear and other cells try to survive undergoing reversible injury.	[Danaila, L.; Pais, V.] Natl Inst Neurol & Neurovasc Dis, Dept Neurosurg, Bucharest, Romania; [Popescu, I.] Fundeni Clin Inst, Dept Gen Surg & Liver Transplantat Dan Setlacec, Bucharest, Romania; [Riga, D.; Riga, S.] Al Obregia Clin Hosp Psychiat, Dept Stress Res & Prophylaxis, Bucharest, Romania; [Pais, E.] Spectral Mol Imaging Inc, Los Angeles, CA USA		Danaila, L (corresponding author), Natl Inst Neurol & Neurovasc Dis, Dept Neurosurg, Bucharest, Romania.	leondanaila@neuroch.info	Riga, Dan/AAL-5762-2021; POPESCU, IRINEL/B-3048-2008; Pais, Emil Sebastian/H-7155-2013	Pais, Emil Sebastian/0000-0002-0245-671X			Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Bredesen DE, 2004, AGING CELL, V3, P255, DOI 10.1111/j.1474-9728.2004.00121.x; Conti AC, 1998, J NEUROSCI, V18, P5663; Crisby M, 1997, ATHEROSCLEROSIS, V130, P17, DOI 10.1016/S0021-9150(96)06037-6; Danaila L, 2005, PROGRAMMED CELL DEAT; Danaila L, 2008, PROGRAMMED CELL DEAT; Diederich M, 2003, ANN NEW YORK ACAD SC, V1010; Fujikawa DG, 2002, TRENDS PHARMACOL SCI, V23, P309, DOI 10.1016/S0165-6147(02)02042-4; Geng YJ, 2001, CELL RES, V11, P253, DOI 10.1038/sj.cr.7290094; Gremmels H, 2011, ANTIOXID REDOX SIGN, V15, P1029, DOI 10.1089/ars.2010.3594; Grimes R, 2011, J BONE MINER RES, V26, P2597, DOI 10.1002/jbmr.486; LI Y, 1995, AM J PATHOL, V146, P1045; Lizard G, 1999, ARTERIOSCL THROM VAS, V19, P1190, DOI 10.1161/01.ATV.19.5.1190; Mayr M, 2001, EXP GERONTOL, V36, P969, DOI 10.1016/S0531-5565(01)00090-0; Pais V, 2011, ULTRASTRUCTURE DYING; Pais V, 2009, PROGRAMMED CELL DEAT; Pais V, 2012, ULTRASTRUCT PATHOL, V36, P166, DOI 10.3109/01913123.2012.655856; Povlishock J T, 1985, Cent Nerv Syst Trauma, V2, P285; Riga D, 2009, 13 IABG INT ASS BIOM; Riga D., 2007, ANTIAGING MED LONGEV, P199; Sperandio S, 2004, CELL DEATH DIFFER, V11, P1066, DOI 10.1038/sj.cdd.4401465; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zhu C, 2005, CELL DEATH DIFFER, V12, P162, DOI 10.1038/sj.cdd.4401545	23	17	17	0	15	EDITURA CELSIUS	BUCHAREST	STR LITOVOI VOIEVOD NR 1, BL OD7A, SC A, AP 20, SECTOR 2, BUCHAREST, 00000, ROMANIA	1221-9118			CHIRURGIA-BUCHAREST	Chirurgia	MAY-JUN	2013	108	3					319	324					6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	168GY	WOS:000320694900005	23790779				2022-02-06	
J	Esquivel, A; Haque, S; Keating, P; Marsh, S; Lemos, S				Esquivel, Amanda; Haque, Sadiq; Keating, Patrick; Marsh, Stephanie; Lemos, Stephen			Concussion Management, Education, and Return-to-Play Policies in High Schools: A Survey of Athletic Directors, Athletic Trainers, and Coaches	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						concussion; return-to-play; concussion awareness; high school athletics		Background: Concussions represent 8.9% to 13.2% of all high school athletic injuries. How these injuries are managed is currently unknown. Hypothesis: There are differences in concussion management and awareness among boys football, boys ice hockey, and boys and girls soccer. Study Design: Descriptive epidemiologic study. Methods: High school athletic directors were contacted via e-mail and asked to complete, and request that their staff complete, an online survey with 4 sections aimed at athletic directors, head coaches, team physicians, and certified athletic trainers. Results: According to coaches, concussion awareness education was provided for football (97%), hockey (65%), and boys and girls soccer (57% and 47%, respectively) (P < 0.01). Use of sideline screening tools was significantly greater for football (P = 0.03). All participants agreed that a player who has suffered a concussion cannot return to play the same day. Conclusion: There is a difference in concussion management and awareness among the 4 sports. Concussion education is well promoted in football but should be expanded in soccer and hockey. Players are not allowed to return to play the same day, and the majority are referred to a physician. Clinical Relevance: Study results highlight the differences in concussion education among sports. Health care providers should address these gaps.	[Esquivel, Amanda; Haque, Sadiq; Keating, Patrick; Marsh, Stephanie; Lemos, Stephen] Detroit Med Ctr Sports Med, 24495 Cavendish Ave E, Novi, MI 48375 USA		Haque, S (corresponding author), Detroit Med Ctr Sports Med, 24495 Cavendish Ave E, Novi, MI 48375 USA.	sadiqhaque@yahoo.com		Esquivel, Amanda/0000-0002-0793-4581			Byard RW, 2009, FORENSIC SCI MED PAT, V5, P36, DOI 10.1007/s12024-008-9063-7; Covassin T, 2011, CLIN SPORT MED, V30, P125, DOI 10.1016/j.csm.2010.08.001; Covassin T, 2009, J ATHL TRAINING, V44, P400, DOI 10.4085/1062-6050-44.4.400; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Deits J, 2010, J ATHL TRAINING, V45, P467, DOI 10.4085/1062-6050-45.5.467; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; Michigan High School Athletic Association, HLTH SAF; National Federation of State High School Associations, CONC SPORTS WHAT YOU; National Federation of State High School Associations, HIGH SCH SPORTS PART; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Yard EE, 2009, BRAIN INJURY, V23, P888, DOI 10.1080/02699050903283171	21	17	17	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	MAY-JUN	2013	5	3					258	262		10.1177/1941738113476850			5	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	V19ZL	WOS:000214856800009	24427398	Green Published			2022-02-06	
J	Ewing-Cobbs, L; Prasad, MR; Mendez, D; Barnes, MA; Swank, P				Ewing-Cobbs, Linda; Prasad, Mary R.; Mendez, Donna; Barnes, Marcia A.; Swank, Paul			Social Interaction in Young Children with Inflicted and Accidental Traumatic Brain Injury: Relations with Family Resources and Social Outcomes	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Joint attention; Gaze; Developmental outcome; Social cognition; High risk; Child abuse; Communication; Adaptive behavior; Cognition; Infants	INFANT JOINT ATTENTION; VISUAL-ATTENTION; SKILLS; COMPETENCE; ADOLESCENTS; COGNITION; MODERATE; AUTISM	Core social interaction behaviors were examined in young children 0-36 months of age who were hospitalized for accidental (n = 61) or inflicted (n = 64) traumatic brain injury (TBI) in comparison to typically developing children (n = 60). Responding to and initiating gaze and joint attention (JA) were evaluated during a semi-structured sequence of social interactions between the child and an examiner at 2 and 12 months after injury. The accidental TBI group established gaze less often and had an initial deficit initiating JA that resolved by the follow-up. Contrary to expectation, children with inflicted TBI did not have lower rates of social engagement than other groups. Responding to JA was more strongly related than initiating JA to measures of injury severity and to later cognitive and social outcomes. Compared to complicated-mild/moderate TBI, severe TBI in young children was associated with less responsiveness in social interactions and less favorable caregiver ratings of communication and social behavior. JA response, family resources, and group interacted to predict outcomes. Children with inflicted TBI who were less socially responsive and had lower levels of family resources had the least favorable outcomes. Low social responsiveness after TBI may be an early marker for later cognitive and adaptive behavior difficulties.	[Ewing-Cobbs, Linda; Prasad, Mary R.; Barnes, Marcia A.; Swank, Paul] Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Houston, TX USA; [Ewing-Cobbs, Linda; Prasad, Mary R.; Barnes, Marcia A.; Swank, Paul] Univ Texas Hlth Sci Ctr Houston, Childrens Learning Inst, Houston, TX USA; [Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, Dept Psychiat & Behav Sci, Houston, TX USA; [Mendez, Donna] Baylor Coll Med, Dept Emergency Med, Houston, TX 77030 USA		Ewing-Cobbs, L (corresponding author), Childrens Learning Inst, Dept Pediat, 7000 Fannin,Suite 2401, Houston, TX 77030 USA.	linda.ewing-cobbs@uth.tmc.edu			National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS029462]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS029462] Funding Source: NIH RePORTER	This publication was supported by Grant Number R01 NS029462 from the National Institute of Neurological Disorders and Stroke. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke or the National Institutes of Health. The participation of the children and families, as well as the assistance of the Texas Department of Protective and Regulatory Services, is gratefully acknowledged. The authors report no financial or other conflict of interest.	Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Bayley N., 2006, BAYLEY SCALES INFANT, V3rd; Beauchamp MH, 2009, J NEUROTRAUM, V26, P1645, DOI [10.1089/neu.2009.0916, 10.1089/neu.2009-0916]; Bernard K, 2010, ARCH PEDIAT ADOL MED, V164, P438, DOI 10.1001/archpediatrics.2010.54; BRUCE DA, 1989, PEDIATR ANN, V18, P482, DOI 10.3928/0090-4481-19890801-07; Butterworth G., 1995, JOINT ATTENTION ITS, P29; Carpenter M, 1998, MONOGR SOC RES CHILD, V63, pV; Carpenter M, 2002, J AUTISM DEV DISORD, V32, P91, DOI 10.1023/A:1014836521114; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Charman T, 2000, COGNITIVE DEV, V15, P481, DOI 10.1016/S0885-2014(01)00037-5; Ciccetti D., 1984, VINELAND ADAPTIVE BE; D'Entremont B, 2007, CHILD DEV, V78, P723, DOI 10.1111/j.1467-8624.2007.01026.x; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; DUNST CJ, 1987, CHILD CARE HLTH DEV, V13, P111, DOI 10.1111/j.1365-2214.1987.tb00528.x; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Ewing-Cobbs L, 2000, CHILD NERV SYST, V16, P25, DOI 10.1007/s003810050006; Ewing-Cobbs L, 2012, INT J DEV NEUROSCI, V30, P247, DOI 10.1016/j.ijdevneu.2011.07.004; Frischen A, 2007, PSYCHOL BULL, V133, P694, DOI 10.1037/0033-2909.133.4.694; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Goldstrohm SL, 2005, ARCH CLIN NEUROPSYCH, V20, P675, DOI 10.1016/j.acn.2005.02.005; HAHN YS, 1988, CHILD NERV SYST, V4, P34; Hirotani M, 2009, NEUROREPORT, V20, P600, DOI 10.1097/WNR.0b013e32832a0a7c; Hoehl S, 2009, CHILD DEV, V80, P968, DOI 10.1111/j.1467-8624.2009.01311.x; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; Hymel KP, 1997, PEDIATR RADIOL, V27, P743, DOI 10.1007/s002470050215; Keenan HT, 2007, PEDIATRICS, V119, pE616, DOI 10.1542/peds.2006-2313; Keenan HT, 2006, PEDIATRICS, V117, P317, DOI 10.1542/peds.2005-0979; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Landry SH, 2004, DEV NEUROPSYCHOL, V26, P707, DOI 10.1207/s15326942dn2603_4; Landry SH, 2002, DEV NEUROPSYCHOL, V21, P15, DOI 10.1207/S15326942DN2101_2; LEUNG EHL, 1981, DEV PSYCHOL, V17, P215, DOI 10.1037/0012-1649.17.2.215; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Mundy P, 2003, J CHILD PSYCHOL PSYC, V44, P793, DOI 10.1111/1469-7610.00165; Mundy P, 2010, NEURAL NETWORKS, V23, P985, DOI 10.1016/j.neunet.2010.08.009; Nybo T, 2004, J INT NEUROPSYCH SOC, V10, P719, DOI 10.1017/S1355617704105109; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; SCAIFE M, 1975, NATURE, V253, P265, DOI 10.1038/253265a0; Sheinkopf SI, 2004, DEV PSYCHOPATHOL, V16, P273, DOI 10.1017/S0954579404044517; St James-Roberts I, 1979, Adv Child Dev Behav, V14, P253, DOI 10.1016/S0065-2407(08)60116-0; TEASDALE G, 1974, LANCET, V2, P81; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; Van Hecke AV, 2007, CHILD DEV, V78, P53; Van Hecke AV, 2012, INFANT BEHAV DEV, V35, P303, DOI 10.1016/j.infbeh.2011.12.001; Vygotsky L.S., 1978, MIND SOC; Walz NC, 2009, J PEDIATR REHAB MED, V2, P285, DOI 10.3233/PRM-2009-0094; Walz NC, 2010, J NEUROPSYCHOL, V4, P181, DOI 10.1348/174866410X488788; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387	52	17	17	1	13	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAY	2013	19	5					497	507		10.1017/S1355617713000210			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	136OB	WOS:000318370100002	23507345	Green Accepted			2022-02-06	
J	Wolffbrandt, MM; Poulsen, I; Engberg, AW; Hornnes, N				Wolffbrandt, Mia M.; Poulsen, Ingrid; Engberg, Aase W.; Hornnes, Nete			Occurrence and Severity of Agitated Behavior After Severe Traumatic Brain Injury	REHABILITATION NURSING			English	Article						Agitated behavior; sub-acute rehabilitation; traumatic brain injury	OVERT AGGRESSION SCALE; HEAD-INJURY; RELIABILITY; OUTCOMES; REHABILITATION; PATIENT; UNIT; CARE	Purpose To investigate the occurrence and severity of agitation in patients after severe traumatic brain injury (TBI), to identify predictors of agitation and to study interrater reliability for a translated version of the Agitated Behavior Scale (ABS). Design Prospective observational study. From November 1, 2006, through October 2007, 46 consecutive patients with TBI were included in the early rehabilitation phase following neurosurgical intervention. Agitated behavior was assessed by the ABS, which was implemented in clinical practice. Logistic regression analysis identified predictors of agitated behavior and Intra Class Correlation was used to analyze reliability. Findings Agitated behavior occurred in 41% of patients, of whom one third exhibited severely agitated behavior. The interrater reliability between three nurses was good to excellent. Conclusions Using ABS as a tool in care of patients with agitated behavior may be effective through working as a common language. Clinical Relevance We recommend the use of ABS as a routine assessment in early rehabilitation of patients with TBI.	[Wolffbrandt, Mia M.; Poulsen, Ingrid; Engberg, Aase W.] Copenhagen Univ Hosp, Dept Neurorehabil TBI Unit, Glostrup, Denmark; [Hornnes, Nete] Copenhagen Univ Hosp, Dept Neurol, Herlev, Denmark		Poulsen, I (corresponding author), Copenhagen Univ Hosp, Glostrup, Denmark.	Ingrid.Poulsen@regionh.dk	Poulsen, ingrid/AAH-2052-2019	Poulsen, ingrid/0000-0002-0342-017X	Copenhagen University Hospital Hvidovre	We thank the staff of the Department of Neurorehabilitation, TBI Unit, especially the key persons, the nursing staff, occupational therapists and physiotherapists for their contribution to the data collection. We also thank the management of the department for their support, the neurologist Annette Liebach and Ph.D. Carla Caetano for translation and backtranslation of ABS. and DMSc Lars Peter Kammersgaard for performing the data analysis. We thank John Corrigan and Jennifer Bogner for their interest and helpful comments. Finally we thank Copenhagen University Hospital Hvidovre for funding MMW, during the data collection and - analyzing.	Alderman N, 1997, BRAIN INJURY, V11, P503, DOI 10.1080/713802182; Amato S, 2012, REHABIL NURS, V37, P19, DOI 10.1002/RNJ.00001; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; BARTKO JJ, 1976, J NERV MENT DIS, V163, P307, DOI 10.1097/00005053-197611000-00003; Beaulieu C, 2008, J HEAD TRAUMA REHAB, V23, P304, DOI 10.1097/01.HTR.0000336843.60961.b7; Becker C, 2012, REHABIL NURS, V37, P171, DOI 10.1002/rnj.50; Bogner JA, 1999, J HEAD TRAUMA REHAB, V14, P91, DOI 10.1097/00001199-199902000-00012; Bogner JA, 2001, AM J PHYS MED REHAB, V80, P636, DOI 10.1097/00002060-200109000-00002; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; CORRIGAN JD, 1994, J CLIN EXP NEUROPSYC, V16, P386, DOI 10.1080/01688639408402649; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; Fleminger S, 2006, COCHRANE DATABASE SY, V18; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Granger CV, 1998, ARCH PHYS MED REHAB, V79, P235, DOI 10.1016/S0003-9993(98)90000-4; Heck S., 2000, NEUROLOGISCHEN REHAB, V6, P125; Jennett B., 1983, REHABILITATION HEAD, P3; Kadyan V, 2004, AM J PHYS MED REHAB, V83, P747, DOI 10.1097/01.PHM.0000140790.30468.F4; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Linn Shai, 1995, Annals of Epidemiology, V5, P440, DOI 10.1016/1047-2797(95)00059-3; Lombard LA, 2005, AM J PHYS MED REHAB, V84, P797, DOI 10.1097/01.phm.0000179438.22235.08; McNett M, 2012, BRAIN INJURY, V26, P1155, DOI 10.3109/02699052.2012.667587; Norup A, 2010, BRAIN INJURY, V24, P81, DOI 10.3109/02699050903508200; Nott MT, 2006, BRAIN INJURY, V20, P1175, DOI 10.1080/02699050601049114; Nott MT, 2010, BRAIN INJURY, V24, P1214, DOI 10.3109/02699052.2010.506858; Sandel ME, 1996, ARCH PHYS MED REHAB, V77, P617, DOI 10.1016/S0003-9993(96)90306-8; SECHREST L, 1972, J CROSS CULT PSYCHOL, V3, P41, DOI 10.1177/002202217200300103; YUDOFSKY SC, 1986, AM J PSYCHIAT, V143, P35	28	17	18	0	9	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0278-4807			REHABIL NURS	Rehabil. Nurs.	MAY-JUN	2013	38	3					133	141		10.1002/rnj.82			9	Nursing; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing; Rehabilitation	141ZI	WOS:000318764800004	23658127				2022-02-06	
J	Zhuang, YF; Li, JE				Zhuang, Yan-Feng; Li, Jie			Serum EGF and NGF levels of patients with brain injury and limb fracture	ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE			English	Article						Fracture healing; Traumatic brain injury; EGF; NGF		OBJECTIVE: To explore the expression and significance of human epidermal growth factor (EGF) and nerve growth factor (NGF) in patients with knee osteoarthritis. METHODS: RT-PCR and enzyme-linked immunosorbent assay were used to measure the serum EGF and NGF expression levels of patients with limb fracture and brain trauma injurry after 1 d, 3 d, 7 d, 14 d and the relationship between them was analyzed. The level was compared among the simple fracture group, traumatic brain injury group and the normal control group, with 40 cases in each group. RESULTS: The serum NGF levels were significantly different among three groups. Serum NGF, EGF mRNA and protein levels gradually decreased with the increasing injury time in the limb fracture combined with brain injury group, traumatic brain injury group, the simple fracture group and the health control group (P<0.05). CONCLUSIONS: The serum of NGF, EGF levels significantly increased when limb fracture combined with brain injury, so EGF and NGF may be involved in the process of fracture healing.	[Zhuang, Yan-Feng; Li, Jie] Fuzhou Gen Hosp, Dept Orthoped, Fuzhou 350000, Fujian Province, Peoples R China		Li, JE (corresponding author), 156 North Rd West 2nd Ring, Fuzhou, Fujian Province, Peoples R China.	boban10@126.com					Boes M, 2006, J BONE JOINT SURG AM, V88A, P738, DOI 10.2106/JBJS.D.02648; Cadosch D, 2010, J BONE JOINT SURG AM, V92A, P645, DOI 10.2106/JBJS.I.00097; Cadosch D, 2009, J BONE JOINT SURG AM, V91A, P282, DOI 10.2106/JBJS.G.01613; Gautschi OP, 2009, ANZ J SURG, V79, P449, DOI 10.1111/j.1445-2197.2008.04803.x; Katsios C, 2013, EXPERT REV GASTROENT, V7, P5, DOI [10.1586/EGH.12.60, 10.1586/egh.12.60]; Kong QL, 2007, CHIN J TISSUE ENG, V11, P247; Morley J, 2005, INJURY, V36, P363, DOI 10.1016/j.injury.2004.08.028; Onodera S, 2004, HISTOCHEM CELL BIOL, V121, P209, DOI 10.1007/s00418-004-0624-x; Schnitzler AC, 2010, J NEUROSCI, V30, P8221, DOI 10.1523/JNEUROSCI.5611-09.2010; Tan Y, 2012, CYTOTECHNOLOGY, V64, P635, DOI 10.1007/s10616-012-9439-0; Yang HL, 2012, CHIN J MODERN MED, V22, P45	11	17	25	0	8	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1995-7645	2352-4146		ASIAN PAC J TROP MED	Asian Pac. J. Trop. Med.	MAY	2013	6	5					383	386		10.1016/S1995-7645(13)60043-7			4	Public, Environmental & Occupational Health; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Tropical Medicine	136AU	WOS:000318332600008	23608378	gold			2022-02-06	
J	Riegler, LJ; Neils-Strunjas, J; Boyce, S; Wade, SL; Scheifele, PM				Riegler, Lindsay James; Neils-Strunjas, Jean; Boyce, Suzanne; Wade, Shari L.; Scheifele, Peter M.			Cognitive intervention results in web-based videophone treatment adherence and improved cognitive scores	MEDICAL SCIENCE MONITOR			English	Article						rehabilitation; traumatic brain injury; veterans; telehealth; cognitive	TELEHEALTH DELIVERY; REHABILITATION; PROGRAM; OUTCOMES; ADULTS	Background: We report findings from an intervention study using telehealth modalities to determine whether provision of telehealth services can improve access to care and increase adherence to cognitive therapy in veterans with mild traumatic brain injury (TBI) while matching traditional care in terms of outcomes. Material/Methods: Veterans who were initially non-adherent to clinic-based cognitive therapy were offered a newly developed treatment. The control participants were selected from patient records of veterans who had completed cognitive treatment and matched to MOPS-VI participants on the basis of age, marital or relationship status, and composite memory index score. Baseline and post-treatment cognitive functioning as assessed by the Test of Memory and Learning 2nd Edition (TOMAL-2) was obtained for all participants. The MOPS-VI modules were designed to increase understanding of TBI and elicit problem-solving skills for attention and memory impairment. Results: Sixty-seven percent of veterans (who were assigned to the MOPS-VI treatment group because they were initially non-adherent with the clinic-based treatment) completed the MOPS-VI telemedicine treatment. Results of a two-way analysis of Variance (ANOVA) comparing baseline and follow-up scores on the TOMAL-2 in the MOPS-VI and control groups revealed there was a significant pre-post assessment effect, indicating that participant's memory and learning improved after treatment for both MOPS-VI and standard treatment groups. There was no significant difference between clinic-based treatment and MOPS-VI therapy. Conclusions: Preliminary evidence supports the efficacy of the treatment, defined as increased compliance in completing the treatment program, and improvements in standardized memory and learning test results comparable to those following clinic-based treatment.	[Riegler, Lindsay James; Neils-Strunjas, Jean; Boyce, Suzanne; Scheifele, Peter M.] Univ Cincinnati, Dept Commun Sci & Disorders, Cincinnati, OH 45221 USA; [Riegler, Lindsay James] Cincinnati Vet Med Ctr, Cincinnati, OH USA; [Neils-Strunjas, Jean] Armstrong Atlantic State Univ, Dept Rehabil Sci, Commun Sci & Disorders Program, Savannah, GA USA; [Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH USA		Riegler, LJ (corresponding author), Univ Cincinnati, Dept Commun Sci & Disorders, Cincinnati, OH 45221 USA.	jamesls@mail.us.edu		Boyce, Suzanne/0000-0003-2105-2486	Veterans AdministrationUS Department of Veterans Affairs	Support for this study was provided by grants from the Veterans Administration	Adams W, AS KAUFMAN NL KAUFMA; Barak A, 2009, ANN BEHAV MED, V38, P4, DOI 10.1007/s12160-009-9130-7; Bergquist TF, 2010, TELEMED J E-HEALTH, V16, P417, DOI 10.1089/tmj.2009.0118; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Darkins A, 2006, TELEMEDICINE STANDAR; Department of Defense, TRAUM BRAIN INJ CAR; Dunn L.M., 1997, PEABODY PICTURE VOCA, V3rd Edition; Girard P, 2007, J REHABIL RES DEV, V44, P1017, DOI 10.1682/JRRD.2006.12.0174; Godleski L, 2008, BEHAV SCI LAW, V26, P271, DOI 10.1002/bsl.811; Lewis C, 2008, AM J SPEECH-LANG PAT, V17, P139, DOI 10.1044/1058-0360(2008/014); O'Brian S, 2008, J SPEECH LANG HEAR R, V51, P184, DOI 10.1044/1092-4388(2008/014); REYNOLDS C. R., 2007, TEST MEMORY LEARNING; Rose VL, 1999, AM FAM PHYSICIAN, V59, P1051; Schoenberg MR, 2008, PROF PSYCHOL-RES PR, V39, P169, DOI 10.1037/0735-7028.39.2.169; SPSS Inc, 1998, SPSS BAS 8 0 WIND US; Tindall LR, 2008, TELEMED J E-HEALTH, V14, P1070, DOI 10.1089/tmj.2008.0040	18	17	17	0	7	INT SCIENTIFIC INFORMATION, INC	MELVILLE	150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	APR 15	2013	19						269	275		10.12659/MSM.883885			7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine	159OM	WOS:000320055100001	23584165	Green Published, Green Submitted			2022-02-06	
J	Aboulafia-Brakha, T; Buschbeck, CG; Rochat, L; Annoni, JM				Aboulafia-Brakha, T.; Buschbeck, C. Greber; Rochat, L.; Annoni, J. -M.			Feasibility and initial efficacy of a cognitive-behavioural group programme for managing anger and aggressiveness after traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; Cognitive behavioural therapy; Anger; Neurorehabilitation	HIGH-FUNCTIONING AUTISM; ASPERGER-SYNDROME; FOLLOW-UP; MANAGEMENT; PSYCHOTHERAPY; IMPULSIVITY; QUESTIONNAIRE; IRRITABILITY; DEPRESSION; PEOPLE	This study assesses the feasibility of a cognitive-behavioural group programme for treating anger and aggressiveness after a traumatic brain injury (TBI). Five feasibility criteria were considered: demand, implementation, practicality, acceptability and initial efficacy. A self-report questionnaire of aggressiveness (AQ-12) was administered before the intervention (T1), one week following the intervention (T2) and at a four months follow-up (T3). Ten patients with moderate to severe chronic TBI completed the programme through eight once-a-week sessions. The analysis of the feasibility outcomes suggests that: (1) The recruitment, the process of grouping participants and the characterisation of anger and aggressiveness at baseline need to be re-evaluated and improved for future designs. (2) The use of specific strategies for bypassing cognitive and other behavioural dysfunctions related to TBI is crucial for the success of this intervention and merits special attention. (3) The high retention rate, the convenient meeting schedule, cost advantages and the good acceptability by participants are positive arguments for the implementation of a larger trial. (4) The significant reduction of AQ-12 scores at T3 and the high effect size constitute a change in the expected direction and support the initial efficacy of the programme.	[Aboulafia-Brakha, T.; Annoni, J. -M.] Univ Hosp Geneva, Dept Clin Neurosci, Div Neurol, CH-1211 Geneva, Switzerland; [Aboulafia-Brakha, T.; Buschbeck, C. Greber] Univ Hosp Geneva, Dept Clin Neurosci, Div Neurorehabil, CH-1211 Geneva, Switzerland; [Aboulafia-Brakha, T.; Rochat, L.] Univ Geneva, Cognit Psychopathol & Neuropsychol Unit, CH-1211 Geneva 4, Switzerland; [Rochat, L.] Univ Geneva, Swiss Ctr Affect Sci, CH-1211 Geneva 4, Switzerland; [Aboulafia-Brakha, T.; Annoni, J. -M.] Univ Fribourg, Dept Med, Neurol Unit, CH-1700 Fribourg, Switzerland		Aboulafia-Brakha, T (corresponding author), Univ Hosp Geneva, Dept Neurol, Neuropsychol Unit, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva, Switzerland.	Tatiana.Aboulafia@hcuge.ch		Rochat, Lucien/0000-0002-9992-2720	Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [32-138497]	The study was partly supported by the Swiss National Science Foundation (32-138497 to JMA). We would like to thank Blaise Christe and Ann Travis for their comments on the manuscript as well as the Clinical Research Centre of the Geneva University Hospitals for their statistical advices (T Perneger).	Adair JC, 1996, NEUROLOGY, V46, P842; Alderman N, 2003, NEUROPSYCHOL REHABIL, V13, P211, DOI 10.1080/09602010244000327; Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Bazin N, 2009, PSYCHIAT RES, V167, P28, DOI 10.1016/j.psychres.2007.12.010; Bowen DJ, 2009, AM J PREV MED, V36, P452, DOI 10.1016/j.amepre.2009.02.002; Bryant FB, 2001, J RES PERS, V35, P138, DOI 10.1006/jrpe.2000.2302; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; CARROLL KM, 1994, ARCH GEN PSYCHIAT, V51, P989; Cattelani R, 2010, NEUROPSYCHOL REV, V20, P52, DOI 10.1007/s11065-009-9125-y; Ciurli P, 2010, J INT NEUROPSYCH SOC, V16, P360, DOI 10.1017/S135561770999141X; Coetzer R, 2009, CNS SPECTRUMS, V14, P632, DOI 10.1017/S1092852900023877; Couillet J, 2010, NEUROPSYCHOL REHABIL, V20, P321, DOI 10.1080/09602010903467746; Denson TF, 2009, SYD SYM SOC PSYCHOL, P233; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Genoud P., 2009, FRENCH VERSION 12 IT; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; Hart T, 2008, NEUROPSYCHOL REHABIL, V18, P1, DOI 10.1080/09602010601082359; Hart T, 2012, J HEAD TRAUMA REHAB, V27, P113, DOI 10.1097/HTR.0b013e31820e686c; Huntley AL, 2012, BRIT J PSYCHIAT, V200, P184, DOI 10.1192/bjp.bp.111.092049; Johansson SH, 2008, BRAIN INJURY, V22, P999, DOI 10.1080/02699050802530573; KAGAN J, 1966, J ABNORM PSYCHOL, V71, P17, DOI 10.1037/h0022886; Kalechstein AD, 2003, J CLIN EXP NEUROPSYC, V25, P1186, DOI 10.1076/jcen.25.8.1186.16723; Kangas M, 2011, NEUROPSYCHOL REHABIL, V21, P250, DOI 10.1080/09602011.2010.540920; Kertzman S, 2010, EUR ADDICT RES, V16, P23, DOI 10.1159/000253861; Kim SH, 1999, J NERV MENT DIS, V187, P327, DOI 10.1097/00005053-199906000-00001; LEVIN HS, 1995, J NEUROTRAUM, V12, P913, DOI 10.1089/neu.1995.12.913; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; Mayne TJ, 1999, J CLIN PSYCHOL, V55, P353, DOI 10.1002/(SICI)1097-4679(199903)55:3<353::AID-JCLP7>3.0.CO;2-B; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; O'Connor C, 2005, PSYCHOL REP, V97, P169, DOI 10.2466/PR0.97.5.169-179; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Padesky, 1995, MIND MOOD COGNITIVE; Padesky C., 1995, CLIN GUIDE MIND MOOD; Rochat L, 2010, NEUROPSYCHOL REHABIL, V20, P778, DOI 10.1080/09602011.2010.495245; Salmond CH, 2005, CURR OPIN CRIT CARE, V11, P111, DOI 10.1097/01.ccx.0000155358.31983.37; TEASDALE G, 1974, LANCET, V2, P81; Walker AJ, 2010, BRAIN INJURY, V24, P517, DOI 10.3109/02699051003601721; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wechsler D., 1997, WECHSLER MEMORY SCAL; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zimmermann P, 1995, TEST ATTENTIONAL PER	46	17	17	0	20	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	APR 1	2013	23	2					216	233		10.1080/09602011.2012.747443			18	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	105KU	WOS:000316068800004	23259694	Green Submitted			2022-02-06	
J	Gardner, CJ; Javadpour, M; Stoneley, C; Purthuran, M; Biswas, S; Daousi, C; MacFarlane, IA; Cuthbertson, DJ				Gardner, Chris J.; Javadpour, Mohsen; Stoneley, Catherine; Purthuran, Mani; Biswas, Shubhabrata; Daousi, Christina; MacFarlane, Ian A.; Cuthbertson, Daniel J.			Low prevalence of hypopituitarism after subarachnoid haemorrhage using confirmatory testing and with BMI-specific GH cut-off levels	EUROPEAN JOURNAL OF ENDOCRINOLOGY			English	Article							HORMONE (GH)-RELEASING HORMONE; GLUCAGON STIMULATION TEST; TRAUMATIC BRAIN-INJURY; BODY-MASS INDEX; GROWTH-HORMONE; PITUITARY-FUNCTION; ENDOCRINE-SOCIETY; DEFICIENCY; DYSFUNCTION; DIAGNOSIS	Objective: Hypopituitarism following subarachnoid haemorrhage (SAH) has been reported to be a frequent occurrence. However, there is considerable heterogeneity between studies with differing patient populations and treatment modalities and most importantly employing differing endocrine protocols and (normal) reference ranges of GH. We aimed to examine prospectively a cohort of SAH survivors for development of hypopituitarism post-SAH using rigorous endocrine testing and compare GH response to glucagon stimulation with a cohort of healthy controls of a similar BMI. Design and methods: Sixty-four patients were investigated for evidence of hypopituitarism 3 months post-SAH with 50 patients tested again at 12 months. Glucagon stimulation testing (GST), with confirmation of deficiencies by GHRH/arginine testing for GH deficiency (GHD) and short synacthen testing for ACTH deficiency, was used. Basal testing of other hormonal axes was undertaken. Results: Mean age of patients was 53 +/- 11.7 years and mean BMI was 27.5 +/- 5.7 kg/m(2). After confirmatory testing, the prevalence of hypopituitarism was 12% (GHD 10%, asymptomatic hypocortisolaemia 2%). There was no association between hypopituitarism and post-SAH vasospasm, presence of cerebral infarction, Fisher grade, or clinical grading at presentation. There was a significant correlation between BMI and peak GH to glucagon stimulation in both patients and controls. Conclusions: Identification of 'true' GHD after SAH requires confirmatory testing with an alternative stimulation test and application of BMI-specific cut-offs. Using such stringent criteria, we found a prevalence of hypopituitarism of 12% in our population. European Journal of Endocrinology 168 473-481	[Gardner, Chris J.; Daousi, Christina; MacFarlane, Ian A.; Cuthbertson, Daniel J.] Aintree Univ Hosp NHS Fdn Trust, Aintree Univ Hosp NHS Fdn Trust, Univ Dept Obes & Endocrinol, Floor Clin Sci Ctr 3, Liverpool L9 7AL, Merseyside, England; [Javadpour, Mohsen; Stoneley, Catherine; Purthuran, Mani; Biswas, Shubhabrata] Walton Ctr Neurol & Neurosurg NHS Fdn Trust, Dept Neurosurg, Liverpool, Merseyside, England; [Javadpour, Mohsen; Stoneley, Catherine; Purthuran, Mani; Biswas, Shubhabrata] Walton Ctr Neurol & Neurosurg NHS Fdn Trust, Dept Radiol, Liverpool, Merseyside, England		Cuthbertson, DJ (corresponding author), Aintree Univ Hosp NHS Fdn Trust, Aintree Univ Hosp NHS Fdn Trust, Univ Dept Obes & Endocrinol, Floor Clin Sci Ctr 3, Longmoor Lane, Liverpool L9 7AL, Merseyside, England.	daniel.cuthbertson@liverpool.ac.uk	Javadpour, Mohsen/AAX-4657-2020	Javadpour, Mohsen/0000-0001-9836-1741; Cuthbertson, Daniel/0000-0002-6128-0822	PfizerPfizer; Weight Matters; medical research charity	The study was funded jointly by an investigator-initiated research award to D J Cuthbertson from Pfizer and by the medical research charity, Weight Matters.	Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Bellebaum C, 2004, J CLIN EXP NEUROPSYC, V26, P1081, DOI 10.1080/13803390490515342; BJERRE P, 1986, NEUROSURGERY, V19, P1012, DOI 10.1227/00006123-198612000-00018; Bonert VS, 2004, J CLIN ENDOCR METAB, V89, P3397, DOI 10.1210/jc.2003-032213; Conceicao FL, 2003, J ENDOCRINOL INVEST, V26, P1065, DOI 10.1007/BF03345251; Cordido F, 2003, EUR J ENDOCRINOL, V149, P117, DOI 10.1530/eje.0.1490117; Corneli G, 2005, EUR J ENDOCRINOL, V153, P257, DOI 10.1530/eje.1.01967; CROMPTON MR, 1963, BRAIN, V86, P301, DOI 10.1093/brain/86.2.301; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Gardner CJ, 2011, BRIT J NEUROSURG, V25, P337, DOI 10.3109/02688697.2010.546900; Gomez JM, 2002, CLIN ENDOCRINOL, V56, P329, DOI 10.1046/j.1365-2265.2002.01472.x; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; IRANMANESH A, 1991, J CLIN ENDOCR METAB, V73, P1081, DOI 10.1210/jcem-73-5-1081; Karaca Z, 2013, PITUITARY, V16, P76, DOI 10.1007/s11102-012-0377-9; Kelestimur F, 2006, CLIN ENDOCRINOL, V64, P667, DOI 10.1111/j.1365-2265.2006.02525.x; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Klose M, 2010, CLIN ENDOCRINOL, V73, P95, DOI 10.1111/j.1365-2265.2010.03791.x; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Kreitschmann-Andermahr Ilonka, 2005, Pituitary, V8, P219, DOI 10.1007/s11102-006-6044-2; Lammert A, 2012, PITUITARY, V15, P505, DOI 10.1007/s11102-011-0357-5; Leong KS, 2001, CLIN ENDOCRINOL, V54, P463, DOI 10.1046/j.1365-2265.2001.01169.x; Lissett CA, 1999, CLIN ENDOCRINOL, V51, P551, DOI 10.1046/j.1365-2265.1999.00836.x; LITTLEY MD, 1989, CLIN ENDOCRINOL, V31, P527, DOI 10.1111/j.1365-2265.1989.tb01276.x; McKenna SP, 1999, QUAL LIFE RES, V8, P373, DOI 10.1023/A:1008987922774; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; Orme SM, 1998, CLIN ENDOCRINOL, V49, P773, DOI 10.1046/j.1365-2265.1998.00610.x; OSTERMAN PO, 1975, ACTA NEUROL SCAND, V52, P56, DOI 10.1111/j.1600-0404.1975.tb02827.x; RAO RH, 1987, METABOLISM, V36, P658, DOI 10.1016/0026-0495(87)90150-8; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Tanriverdi F, 2007, CLIN ENDOCRINOL, V67, P931, DOI 10.1111/j.1365-2265.2007.02989.x; TEASDALE GM, 1988, J NEUROL NEUROSUR PS, V51, P1457, DOI 10.1136/jnnp.51.11.1457; Toogood A, 2007, HORM RES, V68, P66, DOI 10.1159/000110479; Tzanela M, 2010, EUR J ENDOCRINOL, V162, P29, DOI 10.1530/EJE-09-0390; van der Schaaf I, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003085.pub2; Veldhuis JD, 2011, J CLIN ENDOCR METAB, V96, P2874, DOI 10.1210/jc.2011-0084; Yuen KCJ, 2009, J CLIN ENDOCR METAB, V94, P2702, DOI 10.1210/jc.2009-0299	38	17	18	0	3	BIOSCIENTIFICA LTD	BRISTOL	EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT, ENGLAND	0804-4643	1479-683X		EUR J ENDOCRINOL	Eur. J. Endocrinol.	APR	2013	168	4					473	481		10.1530/EJE-12-0849			9	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	124PY	WOS:000317478700004	23258271	Bronze			2022-02-06	
J	Nickele, CM; Kamps, TK; Medow, JE				Nickele, Christopher M.; Kamps, Timothy K.; Medow, Joshua E.			Safety of a DVT Chemoprophylaxis Protocol Following Traumatic Brain Injury: A Single Center Quality Improvement Initiative	NEUROCRITICAL CARE			English	Article						Clinical protocols; Craniocerebral trauma; Intracranial hemorrhages; Prevention and control; Quality improvement; Venous thrombosis	VENOUS THROMBOSIS PROPHYLAXIS; INTRACRANIAL HEMORRHAGIC INJURIES; MOLECULAR-WEIGHT HEPARIN; DEEP-VEIN THROMBOSIS; ENOXAPARIN PROPHYLAXIS; COMPRESSION STOCKINGS; MAJOR TRAUMA; THROMBOEMBOLISM; PREVENTION; THROMBOPROPHYLAXIS	Venous thromboembolism (VTE) is a complication that affects approximately 30 % of moderate and severe traumatic brain injury (TBI) patients when pharmacologic prophylaxis is not used. Following TBI, specifically in the case of contusions, the safety and efficacy of pharmacologic thromboembolism prophylaxis (PTP) has been studied only in small sample sizes. In this study, we attempt to assess the safety and efficacy of a PTP protocol for TBI patients, as a quality improvement (QI) initiative, in the neuroscience intensive care unit (NSICU). Between January 1st and December 31st, 2009, consecutive patients discharged from the University of Wisconsin NSICU after > a 48 h minimum stay were evaluated as part of a QI project. A protocol for the initiation of PTP was designed and implemented for NSICU patients. The protocol did not vary based on type of intracranial injury. The rate of VTE was reported as was heparin-induced thrombocytopenia and PTP-related expansion of intracranial hemorrhage (IH) requiring reoperation. The number of patients receiving PTP and the timing of therapy were tracked. Patients were excluded for persistent coagulopathy, other organ system bleeding (such as the gastrointestinal tract), or pregnancy. Faculty could opt out of the protocol without reason. Using the same criteria, patients discharged during the preceding 6 months, from July 1st to December 31st, 2008, were evaluated as controls as the PTP protocol was not in effect during this time. During the control period, there were 48 head trauma admissions who met the inclusion criteria. In 22 patients (45.8 %), PTP was initiated at an average of 4.9 +/- A 5.4 days after admission. During the protocol period, there were 87 head trauma admissions taken from 1,143 total NSICU stays who met criteria. In 63 patients (72.4 %), the care team in the NSICU successfully initiated PTP, at an average of 3.4 +/- A 2.8 days after admission. All 87 trauma patients were analyzed, and the rate of clinically significant deep venous thrombosis (DVT) was 6.9 % (6 of 87). Three protocol patients (3.45 %) went to the operating room for surgery after the initiation of PTP; none of these patients had a measurable change in hemorrhage size on head CT. The change in percentage of patients receiving PTP was significantly increased by the protocol (p < 0.0001); while the average days to first PTP dose trended down with institution of the protocol, this change was not statistically significant. A PTP protocol in the NSICU is useful in controlling the number of complications from DVT and pulmonary embolism while avoiding additional IH. This protocol, based on a published body of literature, allowed for VTE rates similar to published rates, while having no PTP-related hemorrhage expansion. The protocol significantly changed physician behavior, increasing the percentage of patients receiving PTP during their hospitalization; whether long-term patient outcomes are affected is a potential goal for future study.	[Nickele, Christopher M.; Medow, Joshua E.] Univ Wisconsin Hosp & Clin, Dept Neurol Surg, Madison, WI 53792 USA; [Kamps, Timothy K.] Univ Wisconsin, Dept Qual Resources, Madison, WI USA		Medow, JE (corresponding author), Univ Wisconsin Hosp & Clin, Dept Neurol Surg, 600 Highland Ave,CSC K4-822, Madison, WI 53792 USA.	medow@neurosurgery.wisc.edu					Agnelli G, 1998, NEW ENGL J MED, V339, P80, DOI 10.1056/NEJM199807093390204; Arnold JD, 2010, AM SURGEON, V76, P563; DENNIS JW, 1993, J TRAUMA, V35, P132, DOI 10.1097/00005373-199307000-00021; Dickinson LD, 1998, NEUROSURGERY, V43, P1074, DOI 10.1097/00006123-199811000-00039; Ekeh AP, 2010, J TRAUMA, V68, P912, DOI 10.1097/TA.0b013e3181b21cad; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; Kim J, 2002, J TRAUMA, V53, P38, DOI 10.1097/00005373-200207000-00008; Koehler DM, 2011, J TRAUMA, V70, P324, DOI 10.1097/TA.0b013e31820b5d22; KUDSK KA, 1989, AM J SURG, V158, P515, DOI 10.1016/0002-9610(89)90182-7; Levy AS, 2010, J TRAUMA, V68, P886, DOI 10.1097/TA.0b013e3181d27dd5; Norwood SH, 2008, J TRAUMA, V65, P1021, DOI 10.1097/TA.0b013e31818a0e74; Norwood SH, 2002, ARCH SURG-CHICAGO, V137, P696, DOI 10.1001/archsurg.137.6.696; Nurmohamed MT, 1996, THROMB HAEMOSTASIS, V75, P233; Paffrath T, 2010, INJURY, V41, P97, DOI 10.1016/j.injury.2009.06.010; Scudday T, 2011, J AM COLL SURGEONS, V213, P53; Scudday T, 2011, J AM COLL SURGEONS, V213, P148, DOI 10.1016/j.jamcollsurg.2011.02.027; Tominaga GT, 2002, ARCH SURG-CHICAGO, V137, P701; Velmahos GC, 1998, J AM COLL SURGEONS, V187, P529, DOI 10.1016/S1072-7515(98)00223-3	19	17	17	0	9	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2013	18	2					184	192		10.1007/s12028-012-9786-x			9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	105PR	WOS:000316084700005	23099845				2022-02-06	
J	Nakajima, T; Barss, T; Klarner, T; Komiyama, T; Zehr, EP				Nakajima, Tsuyoshi; Barss, Trevor; Klarner, Taryn; Komiyama, Tomoyoshi; Zehr, E. Paul			Amplification of interlimb reflexes evoked by stimulating the hand simultaneously with conditioning from the foot during locomotion	BMC NEUROSCIENCE			English	Article						Reflex; Interlimb; Propriospinal; Central pattern generator; Afferent feedback; Rehabilitation; Walking; Cycling; Arm swing	RHYTHMIC ARM MOVEMENT; CUTANEOUS REFLEXES; SPINAL-CORD; ELECTRICAL-STIMULATION; LEG MOVEMENT; WALKING; COORDINATION; AFFERENTS; MUSCLES; PATHWAY	Background: Widespread interlimb reflexes evoked in leg muscles by cutaneous stimulation of the hand are phase-modulated and behaviorally relevant to produce functional changes in ankle trajectory during walking. These reflexes are complementary to the segmental responses evoked by stimulation at the ankle. Despite differences in the expression of reflex amplitude based upon site of nerve stimulation, there are some common features as well, suggesting the possibility of shared interneuronal pathways. Currently little is known about integration or shared reflex systems from interlimb cutaneous networks during human locomotion. Here we investigated convergent reflex effects following cutaneous stimulation of the hand and foot during arm and leg cycling (AL) by using spatial facilitation. Participants performed AL cycling and static activation of the target muscle knee extensor vastus lateralis (VL) in 3 different randomly ordered nerve stimulation conditions: 1) superficial radial nerve (SR; input from hand); 2) superficial peroneal nerve (SP; input from foot); and, 3) combined stimulation (SR + SP). Stimuli were applied around the onset of rhythmic EMG bursts in VL corresponding to the onset of the power or leg extension phase. Results: During AL cycling, small inhibitory (similar to 80 ms) and large facilitatory reflexes (similar to 100 similar to 150 ms) were seen in VL. The amplitudes of the facilitatory responses with SR + SP stimulation were significantly larger than those for SP or SR stimulation alone. The facilitation was also significantly larger than the simple mathematical summation of amplitudes from SP and SR trials. This indicates extra facilitation beyond what would be accounted for by serial neuronal processing and was not observed during static activation. Conclusions: We conclude that AL cycling activates shared interneurons in convergent reflex pathways from cutaneous inputs innervating the hand and leg. This enhanced activity has functional implications for corrective responses during locomotion and for translation to rehabilitation after neurotrauma.	[Nakajima, Tsuyoshi] Kyorin Univ, Sch Med, Dept Integrat Physiol, Mitaka, Tokyo 181, Japan; [Barss, Trevor; Klarner, Taryn; Zehr, E. Paul] Univ Victoria, Rehabil Neurosci Lab, Victoria, BC V8W 3P1, Canada; [Komiyama, Tomoyoshi] Chiba Univ, Fac Educ, Dept Hlth & Sports Sci, Chiba, Japan; [Zehr, E. Paul] Int Collaborat Repair Discoveries ICORD, Vancouver, BC, Canada; [Zehr, E. Paul] Univ Victoria, Ctr Biomed Res, Victoria, BC, Canada; [Zehr, E. Paul] Univ Victoria, Div Med Sci, Victoria, BC, Canada; [Zehr, E. Paul] Univ Victoria, Sch Exercise Sci Phys & Hlth Educ, Victoria, BC, Canada		Zehr, EP (corresponding author), Univ Victoria, Rehabil Neurosci Lab, POB 3010 STN CSC, Victoria, BC V8W 3P1, Canada.	pzehr@uvic.ca	Barss, Trevor/L-7045-2019	Barss, Trevor/0000-0003-3466-2750	Natural Sciences and Engineering Research Council (NSERC) of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC); Japanese Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [22500525] Funding Source: KAKEN	This work was supported by a Discovery grant from the Natural Sciences and Engineering Research Council (NSERC) of Canada to EPZ and a Research Fellowships for Young Scientists from the Japanese Society for the Promotion of Science to TN.	Baldiserra F, 1981, HDB PHYSL, P509; Balter JE, 2007, J NEUROPHYSIOL, V97, P1809, DOI 10.1152/jn.01038.2006; Borgmann A, 2009, J NEUROSCI, V29, P2972, DOI 10.1523/JNEUROSCI.3155-08.2009; Calancie B, 1996, ELECTROMYOGR MOTOR C, V101, P304, DOI 10.1016/0924-980X(96)95194-2; Christensen LOD, 1999, EXP BRAIN RES, V124, P59, DOI 10.1007/s002210050600; Dietz V, 2002, TRENDS NEUROSCI, V25, P462, DOI 10.1016/S0166-2236(02)02229-4; Dietz V, 2011, J NEUROL, V258, P1406, DOI 10.1007/s00415-011-6063-4; Falgairolle M, 2007, J PHYSL PAR IN PRESS; Falgairolle M, 2006, J PHYSIOL-PARIS, V100, P304, DOI 10.1016/j.jphysparis.2007.05.003; Frigon A, 2004, J NEUROPHYSIOL, V91, P1516, DOI 10.1152/jn.00695.2003; Haridas C, 2003, J NEUROPHYSIOL, V90, P2850, DOI 10.1152/jn.00531.2003; Juvin L, 2005, J NEUROSCI, V25, P6025, DOI 10.1523/JNEUROSCI.0696-05.2005; Kagamihara Y, 2003, EXP BRAIN RES, V151, P136, DOI 10.1007/s00221-003-1436-2; Kawashima N, 2008, J NEUROPHYSIOL, V99, P2946, DOI 10.1152/jn.00020.2008; LABELLA LA, 1990, J NEUROPHYSIOL, V64, P403, DOI 10.1152/jn.1990.64.2.403; Lamont EV, 2007, J NEUROPHYSIOL, V98, P433, DOI 10.1152/jn.00002.2007; Lamont EV, 2006, EXP BRAIN RES, V173, P185, DOI 10.1007/s00221-006-0586-4; Lloyd DPC, 1942, J NEUROPHYSIOL, V5, P435; LUNDBERG A, 1975, BRAIN RES, V87, P81, DOI 10.1016/0006-8993(75)90783-0; Lundberg A, 1979, Prog Brain Res, V50, P11; Mezzarane RA, 2011, EXP BRAIN RES, V208, P157, DOI 10.1007/s00221-010-2467-0; Nakajima T, 2011, J NEUROPHYSIOL, V106, P1679, DOI 10.1152/jn.01049.2010; Sakamoto M, 2007, EXP BRAIN RES, V176, P188, DOI 10.1007/s00221-006-0742-x; Sakamoto M, 2006, CLIN NEUROPHYSIOL, V117, P1301, DOI 10.1016/j.clinph.2006.03.005; Sasada S, 2010, J NEUROPHYSIOL, V104, P210, DOI 10.1152/jn.00774.2009; Sherrington CS, 1903, J PHYSIOL-LONDON, V29, P58; Sherrington CS, 1910, J PHYSIOL-LONDON, V40, P28; Wannier T, 2001, EXP BRAIN RES, V141, P375, DOI 10.1007/s002210100875; Zehr EP, 2007, J NEUROPHYSIOL, V98, P1810, DOI 10.1152/jn.00562.2007; Zehr EP, 2007, J PHYSIOL-LONDON, V582, P209, DOI 10.1113/jphysiol.2007.133843; Zehr EP, 2012, CLIN NEUROPHYSIOL, V123, P796, DOI 10.1016/j.clinph.2011.07.049; Zehr EP, 2009, EXERC SPORT SCI REV, V37, P102, DOI 10.1097/JES.0b013e31819c2ed6; Zehr EP, 2004, EXP BRAIN RES, V159, P382, DOI 10.1007/s00221-004-2092-x; Zehr EP, 2004, NEUROSCIENTIST, V10, P347, DOI 10.1177/1073858404264680; Zehr EP, 2001, EXP BRAIN RES, V140, P495	35	17	18	0	12	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2202			BMC NEUROSCI	BMC Neurosci.	MAR 13	2013	14								28	10.1186/1471-2202-14-28			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	112AB	WOS:000316562500001	23497331	gold, Green Published			2022-02-06	
J	Fenerty, L; Thibault-Halman, G; Bruce, BS; Landry, J; Young, J; Walling, S; Clarke, DB				Fenerty, Lynne; Thibault-Halman, Ginette; Bruce, Beth S.; Landry, Jacob; Young, Julian; Walling, Simon; Clarke, David B.			Helmets for skiing and snowboarding: Who is using them and why	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Helmet; skiing; snowboarding; traumatic brain injury; epidemiology	HEAD-INJURIES; SKIERS; LEGISLATION; RISK; PREVALENCE; ATTITUDES; TRENDS; IMPACT; AREAS; WEAR	BACKGROUND: In Canada, winter sports injuries are responsible for significant health care burden, with estimates of $400 million in direct and indirect annual health care costs. For ski-related injuries, helmets have been shown to provide significant protection. Current common practice in Canada, including the Province of Nova Scotia, is to leave the decision of whether to wear a helmet to the individual. The purposes of this study were to document skiers' and snowboarders' use of helmets and to isolate factors associated with helmet use and nonuse. METHODS: A mixed methods approach was used to collect data during a 2-month period at the province's three ski hills. Naturalistic observations documented helmet use and falls, whereas interviews identified factors influencing helmet use or nonuse. RESULTS: Helmets were used by most skiers (74%) and snowboarders (72%); the use varied significantly between ski hills, ranging from 69% to 79%. Females were more likely to wear helmets compare with males (80% vs. 70%). The highest rates of use were found among 4-year-old to 12-year-old children, with helmet use declining as age increases. Qualitative data revealed that helmet users were most influenced by the protective benefits of helmets (77%), personal choice (46%), family (44%), and rules (44%), while non-helmet users cited personal choice (29%), comfort (26%), rules (14%), and cost (11%) as reasons for nonuse. CONCLUSION: More than 25% of skiers and snowboarders remain at increased risk of a serious brain injury by not wearing a helmet. Changes in regulations may be required to ensure widespread use of helmets on ski hills. (J Trauma Acute Care Surg. 2013;74: 895-900. Copyright (c) 2013 by Lippincott Williams & Wilkins)	[Fenerty, Lynne; Thibault-Halman, Ginette; Bruce, Beth S.; Landry, Jacob; Walling, Simon; Clarke, David B.] Dalhousie Univ, Div Neurosurg, Halifax, NS B3H 3A7, Canada; [Young, Julian] Govt Nova Scotia, Dept Hlth & Wellness, Halifax, NS, Canada		Clarke, DB (corresponding author), Dalhousie Univ, Div Neurosurg, Halifax Infirm, 1796 Summer St,Suite 3807, Halifax, NS B3H 3A7, Canada.	d.clarke@dal.ca			Nova Scotia Department of Health and Wellness; Dalhousie University Division of Neurosurgery	Funding for this project was provided by the Nova Scotia Department of Health and Wellness as well as Dalhousie University Division of Neurosurgery.	Ackery A, 2007, INJURY PREV, V13, P368, DOI 10.1136/ip.2007.017285; Andersen PA, 2004, INJURY PREV, V10, P358, DOI 10.1136/ip.2004.005967; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Cundy TP, 2010, J TRAUMA, V69, P1486, DOI 10.1097/TA.0b013e3181fee31c; Cusimano MD, 2010, BRIT J SPORT MED, V44, P781, DOI 10.1136/bjsm.2009.070573; Forjuoh SN, 2002, ARCH PEDIAT ADOL MED, V156, P656, DOI 10.1001/archpedi.156.7.656; Greve MW, 2009, WILD ENVIRON MED, V20, P234, DOI 10.1580/08-WEME-OR-244R1.1; Hagel B, 2005, ACCIDENT ANAL PREV, V37, P103, DOI 10.1016/j.aap.2004.04.003; Hagel BE, 2010, AM J EPIDEMIOL, V171, P1134, DOI 10.1093/aje/kwq039; Josefson D, 1998, BRIT MED J, V316, P172; King WD, 2007, J TRAUMA, V63, pS25, DOI 10.1097/TA.0b013e31812f5e7a; LeBlanc JC, 2002, CAN MED ASSOC J, V166, P592; Levy AS, 2002, J TRAUMA, V53, P695, DOI 10.1097/00005373-200210000-00013; Lincoln Yvonna S., 1985, NATURALISTIC INQUIRY; Macnab AJ, 2002, INJURY PREV, V8, P324, DOI 10.1136/ip.8.4.324; Macpherson AK, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.5.e60; McBeth PB, 2009, AM J SURG, V197, P560, DOI [10.1016/j.amjsurg.2008.12.016, 10.1016/j.amjsurg.2008.08.010]; Miles M. B., 1994, QUALITATIVE DATA ANA, V2nd; Moffat C, 2009, WEST J EMERG MED, V10, P257; Public Health Agency of Canada Health Surveillance and Epidemiology Division, 2003, INJ ASS IC SNOW SPOR; Ruedl G, 2012, INJURY PREV, V18, P182, DOI 10.1136/injuryprev-2011-040042; Russell K, 2010, CAN MED ASSOC J, V182, P333, DOI 10.1503/cmaj.091080; Sacco DE, 1998, J TRAUMA, V44, P654, DOI 10.1097/00005373-199804000-00016; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; Wesson DE, 2008, PEDIATRICS, V122, P605, DOI 10.1542/peds.2007-1776; Xiang H, 2004, INJURY PREV, V10, P99, DOI 10.1136/ip.2003.004655	26	17	17	0	22	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAR	2013	74	3					895	900		10.1097/TA.0b013e31827e19ca			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	108UO	WOS:000316321900036	23425754				2022-02-06	
J	Ornstein, TJ; Max, JE; Schachar, R; Dennis, M; Barnes, M; Ewing-Cobbs, L; Levin, HS				Ornstein, Tisha J.; Max, Jeffrey E.; Schachar, Russell; Dennis, Maureen; Barnes, Marcia; Ewing-Cobbs, Linda; Levin, Harvey S.			Response inhibition in children with and without ADHD after traumatic brain injury	JOURNAL OF NEUROPSYCHOLOGY			English	Article							ATTENTION-DEFICIT HYPERACTIVITY; CLOSED-HEAD-INJURY; DEFICIT/HYPERACTIVITY DISORDER; PSYCHIATRIC-DISORDERS; STOP TASK; TBI; CLASSIFICATION; NEUROSCIENCE; ADOLESCENTS; CHILDHOOD	Children with attention-deficit hyperactivity disorder (ADHD) and traumatic brain injury (TBI) show deficient response inhibition. ADHD itself is a common consequence of TBI, known as secondary ADHD (S-ADHD). Similarity in inhibitory control in children with TBI, S-ADHD, and ADHD would implicate impaired frontal-striatal systems; however, it is first necessary to delineate similarities and differences in inhibitory control in these conditions. We compared performance of children with ADHD and those with TBI without pre-injury ADHD on a stop signal, response inhibition task. Participants were 274 children aged 614 years. There were 92 children with ADHD, 103 children with TBI, and 79 typically developing children who served as controls. Among the TBI participants, injury severity ranged from mild to severe. Children with ADHD and TBI showed deficient inhibition. The deficit in children with ADHD was as great as or greater than that in children with TBI, regardless of degree of TBI severity or the presence of S-ADHD. The finding indicates that TBI results in deficient inhibition regardless of the development of S-ADHD.	[Ornstein, Tisha J.] Ryerson Univ, Dept Psychol, Toronto, ON M5B 2K3, Canada; [Max, Jeffrey E.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Max, Jeffrey E.] Rady Childrens Hosp, San Diego, CA USA; [Schachar, Russell] Hosp Sick Children, Dept Psychiat, Toronto, ON M5G 1X8, Canada; [Schachar, Russell] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Dennis, Maureen] Hosp Sick Children, Dept Psychol, Toronto, ON M5G 1X8, Canada; [Barnes, Marcia] Univ Texas Med Sch, Dept Pediat, Houston, TX USA; [Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr, Dept Pediat, Houston, TX USA; [Levin, Harvey S.] Baylor Coll Med, Cognit Neurosci Lab, Houston, TX 77030 USA		Ornstein, TJ (corresponding author), Ryerson Univ, Dept Psychol, Off 816 Jorgenson Hall,350 Victoria St, Toronto, ON M5B 2K3, Canada.	tjornste@psych.ryerson.ca		Schachar, Russell/0000-0002-2015-4395	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP44070]; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K-08-MH01800]; National Institute of Health, NINDS division [NS-21889]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR002558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K08MH001800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER	This study was supported by grants from the Canadian Institutes of Health Research (No. MOP44070), the National Institute of Mental Health (No. K-08-MH01800), and the National Institute of Health, NINDS division (No. NS-21889).	Anderson V, 1998, BRAIN INJURY, V12, P937, DOI 10.1080/026990598121990; Aron AR, 2005, BIOL PSYCHIAT, V57, P1285, DOI 10.1016/j.biopsych.2004.10.026; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Biederman J, 2005, BIOL PSYCHIAT, V57, P1215, DOI 10.1016/j.biopsych.2004.10.020; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Boyle MH, 1996, J AM ACAD CHILD PSY, V35, P1440, DOI 10.1097/00004583-199611000-00012; Casey BJ, 2002, DEV PSYCHOBIOL, V40, P237, DOI 10.1002/dev.10030; Castellanos FX, 1997, CHILD ADOL PSYCH CL, V6, P383, DOI 10.1016/S1056-4993(18)30310-9; Chambers CD, 2009, NEUROSCI BIOBEHAV R, V33, P631, DOI 10.1016/j.neubiorev.2008.08.016; Crosbie J, 2001, AM J PSYCHIAT, V158, P1884, DOI 10.1176/appi.ajp.158.11.1884; Crosbie J, 2008, NEUROSCI BIOBEHAV R, V32, P40, DOI 10.1016/j.neubiorev.2007.05.002; Dennis M, 2008, J INT NEUROPSYCH SOC, V14, P673, DOI 10.1017/S1355617708080983; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Ickowicz A, 2006, CAN J PSYCHIAT, V51, P325, DOI 10.1177/070674370605100508; Konrad KN, 2000, BRAIN INJURY, V14, P859; Leblanc N, 2005, DEV NEUROPSYCHOL, V28, P829, DOI 10.1207/s15326942dn2803_5; Levin H. S., 1994, NEUROPSYCHOLOGY, V87, P171, DOI DOI 10.1037/0894-4105.8.2.171; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Logan Gordon D., 1994, P189; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; Max JE, 1998, J AM ACAD CHILD PSY, V37, P841, DOI 10.1097/00004583-199808000-00014; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Max JE, 1997, BRAIN INJURY, V11, P699; Nigg JT, 1999, J ABNORM CHILD PSYCH, V27, P393, DOI 10.1023/A:1021980002473; Oosterlaan J, 1998, J CHILD PSYCHOL PSYC, V39, P411, DOI 10.1111/1469-7610.00336; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Power T, 2007, BRAIN INJURY, V21, P279, DOI 10.1080/02699050701253095; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schachar R, 2000, J ABNORM CHILD PSYCH, V28, P227, DOI 10.1023/A:1005140103162; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; Schachar R, 2007, J ABNORM CHILD PSYCH, V35, P229, DOI 10.1007/s10802-006-9075-2; Slaats-Willemse D, 2003, J AM ACAD CHILD PSY, V42, P1242, DOI 10.1097/00004583-200310000-00016; Slomine BS, 2005, J INT NEUROPSYCH SOC, V11, P645, DOI 10.1017/S1355617705050769; Stewart JAL, 1999, BRAIN COGNITION, V41, P411, DOI 10.1006/brcg.1999.1141; Tamm L, 2002, J AM ACAD CHILD PSY, V41, P1231, DOI 10.1097/00004583-200210000-00013; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	37	17	18	1	19	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1748-6645	1748-6653		J NEUROPSYCHOL	J. Neuropsychol.	MAR	2013	7	1					1	11		10.1111/j.1748-6653.2012.02027.x			11	Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	103MN	WOS:000315921200001	23464806	Green Accepted			2022-02-06	
J	Dubendorfer, C; Billeter, AT; Seifert, B; Keel, M; Turina, M				Duebendorfer, C.; Billeter, A. T.; Seifert, B.; Keel, M.; Turina, M.			Serial lactate and admission SOFA scores in trauma: an analysis of predictive value in 724 patients with and without traumatic brain injury	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Trauma; Infection; Sepsis; Lactate; Base excess; SOFA score	GLASGOW COMA SCALE; ORGAN FAILURE; BASE DEFICIT; OCCULT HYPOPERFUSION; SERUM LACTATE; MORTALITY; SEPSIS; SURVIVAL; MULTICENTER; CLEARANCE	Objective Arterial lactate, base excess (BE), lactate clearance, and Sequential Organ Failure Assessment (SOFA) score have been shown to correlate with outcome in severely injured patients. The goal of the present study was to separately assess their predictive value in patients suffering from traumatic brain injury (TBI) as opposed to patients suffering from injuries not related to the brain. Materials and methods A total of 724 adult trauma patients with an Injury Severity Score (ISS) >= 16 were grouped into patients without TBI (non-TBI), patients with isolated TBI (isolated TBI), and patients with a combination of TBI and non-TBI injuries (combined injuries). The predictive value of the above parameters was then analyzed using both uni- and multivariate analyses. Results The mean age of the patients was 39 years (77 % males), with a mean ISS of 32 (range 16-75). Mortality ranged from 14 % (non-TBI) to 24 % (combined injuries). Admission and serial lactate/BE values were higher in non-survivors of all groups (all p < 0.01), but not in patients with isolated TBI. Admission SOFA scores were highest in non-survivors of all groups (p = 0.023); subsequently septic patients also showed elevated SOFA scores (p < 0.01), except those with isolated TBI. In this group, SOFA score was the only parameter which showed significant differences between survivors and non-survivors. Receiver operating characteristic (ROC) analysis revealed lactate to be the best overall predictor for increased mortality and further septic complications, irrespective of the leading injury. Conclusion Lactate showed the best performance in predicting sepsis or death in all trauma patients except those with isolated TBI, and the differences were greatest in patients with substantial bleeding. Following isolated TBI, SOFA score was the only parameter which could differentiate survivors from non-survivors on admission, although the SOFA score, too, was not an independent predictor of death following multivariate analysis.	[Duebendorfer, C.] Kantonsspital Winterthur, Dept Anesthesiol, CH-8401 Winterthur, Switzerland; [Duebendorfer, C.; Billeter, A. T.] Univ Zurich Hosp, Div Trauma Surg, Dept Surg, CH-8091 Zurich, Switzerland; [Billeter, A. T.] Univ Louisville, Price Inst Surg Res, Sch Med, Louisville, KY 40202 USA; [Seifert, B.] Univ Zurich, Biostat Unit, Inst Social & Prevent Med, CH-8001 Zurich, Switzerland; [Keel, M.] Inselspital Bern, Dept Orthopaed Surg, Univ Hosp Bern, CH-3002 Bern, Switzerland; [Turina, M.] Cleveland Clin Fdn, Dept Colorectal Surg, Cleveland, OH 44195 USA		Billeter, AT (corresponding author), Univ Zurich Hosp, Div Trauma Surg, Dept Surg, Ramistr 100, CH-8091 Zurich, Switzerland.	adrianbilleter@bluewin.ch	Billeter, Adrian/O-2185-2019				ABRAMSON D, 1993, J TRAUMA, V35, P584, DOI 10.1097/00005373-199310000-00014; Antonelli M, 1999, INTENS CARE MED, V25, P389, DOI 10.1007/s001340050863; Arnold RC, 2009, SHOCK, V32, P35, DOI 10.1097/SHK.0b013e3181971d47; Aslar AK, 2004, INJURY, V35, P746, DOI 10.1016/j.injury.2003.09.030; Bakker J, 1996, AM J SURG, V171, P221, DOI 10.1016/S0002-9610(97)89552-9; Billeter A, 2009, WORLD J SURG, V33, P558, DOI 10.1007/s00268-008-9896-y; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bota DP, 2002, INTENS CARE MED, V28, P1619, DOI 10.1007/s00134-002-1491-3; Chamoun RB, 2009, J NEUROSURG, V111, P683, DOI 10.3171/2009.2.JNS08817; Claridge JA, 2000, J TRAUMA, V48, P8, DOI 10.1097/00005373-200001000-00003; Cureton EL, 2010, J SURG RES, V159, P468, DOI 10.1016/j.jss.2009.04.020; DAVIS JW, 1988, J TRAUMA, V28, P1464, DOI 10.1097/00005373-198810000-00010; Davis JW, 1996, J TRAUMA, V41, P769, DOI 10.1097/00005373-199611000-00001; DAVIS JW, 1991, SURG GYNECOL OBSTET, V173, P473; DAVIS JW, 1991, ANN EMERG MED, V20, P842, DOI 10.1016/S0196-0644(05)81423-4; Demetriades D, 2006, J TRAUMA, V61, P868, DOI 10.1097/01.ta.0000219135.33398.f3; Ikossi DG, 2006, J TRAUMA, V61, P780, DOI 10.1097/01.ta.0000239500.71419.58; Jackson EV, 1997, CRIT CARE MED, V25, P1840, DOI 10.1097/00003246-199711000-00022; Jansen TC, 2009, CRIT CARE MED, V37, P2827, DOI 10.1097/CCM.0b013e3181a98899; Jansen TC, 2009, CRIT CARE MED, V37, P2369, DOI 10.1097/CCM.0b013e3181a0f919; KENNEDY F, 1993, J TRAUMA, V35, P75, DOI 10.1097/00005373-199307000-00013; LANDOW L, 1994, J TRAUMA, V37, P869; Lee TT, 1997, ACTA NEUROCHIR, V139, P1042, DOI 10.1007/BF01411558; MANIKIS P, 1995, AM J EMERG MED, V13, P619, DOI 10.1016/0735-6757(95)90043-8; Meregalli A, 2004, CRIT CARE, V8, pR60, DOI 10.1186/cc2423; Mikkelsen ME, 2009, CRIT CARE MED, V37, P1670, DOI 10.1097/CCM.0b013e31819fcf68; Mikulaschek A, 1996, J TRAUMA, V40, P218, DOI 10.1097/00005373-199602000-00008; Namendys-Silva SA, 2009, AM J HOSP PALLIAT ME, V26, P341, DOI 10.1177/1049909109333041; Neumann F, 2008, ANN HEMATOL, V87, P299, DOI 10.1007/s00277-008-0440-9; RUTHERFORD EJ, 1992, J TRAUMA, V33, P417, DOI 10.1097/00005373-199209000-00014; Schulman AM, 2004, J TRAUMA, V57, P795, DOI 10.1097/01.TA.0000140835.65944.54; TEASDALE G, 1974, LANCET, V2, P81; Tien HC, 2006, J TRAUMA, V60, P274, DOI 10.1097/01.ta.0000197177.13379.f4; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Zehtabchi S, 2007, EMERG MED J, V24, P333, DOI 10.1136/emj.2006.044578	37	17	17	0	6	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	FEB	2013	39	1					25	34		10.1007/s00068-012-0212-z			10	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	119FK	WOS:000317083000005	26814920	Green Submitted, Green Accepted			2022-02-06	
J	Green, JA; Pellegrini, DC; Vanderkolk, WE; Figueroa, BE; Eriksson, EA				Green, Joel A.; Pellegrini, Daniela C.; Vanderkolk, Wayne E.; Figueroa, Bryan E.; Eriksson, Evert A.			Goal Directed Brain Tissue Oxygen Monitoring Versus Conventional Management in Traumatic Brain Injury: An Analysis of In Hospital Recovery	NEUROCRITICAL CARE			English	Article						Trauma; pBtO2; Traumatic brain injury; Brain tissue oxygenation; Intracranial pressure; Intracranial monitor; Outcome	TENSION	Brain tissue oxygen monitoring (pBtO2) has been advocated in the treatment of patients with severe traumatic brain injuries (TBI); however, controversy exists regarding the improvements that pBtO2 monitoring provides. The objective of our study was to evaluate our experience and effect on mortality with goal directed pBtO2 monitoring for severe TBI compared to traditional ICP/CPP monitoring. All patients admitted with severe TBI (GCS < 8) to our Level 1 trauma center from June 2007 through June 2009 were retrospectively analyzed. All patients had ICP monitoring and pBtO2 monitors were placed based on the current practices of the attending neurosurgeon producing two temporally matched cohorts of patients with and without pBtO2 monitors. Exclusion criteria were age < 18 years and survival < 24 h. Goal-directed therapy was utilized in all patients to maintain ICP < 20 mmHg and CPP > 60 mmHg. Patients with pBtO2 monitors were managed to maintain a level > 20 mmHg. 74 patients were treated for severe TBI over the 2-year study period with 37 patients in each group. Both groups were similar in age, sex, and admission Glascow Coma Score(GCS).The pBtO2-monitored group did, however, have significantly lower injury severity score [26 (25-30) vs. 30 (26-36), p = 0.03] and AIS Chest [0 (0-0) vs. 2 (0-3), p = 0.02]. There was no survival difference found (64.9 vs. 54.1 %, p = 0.34). No difference with respect to discharge GCS or discharge Functional Independence Measure score was identified. Compared with ICP/CPP-directed therapy alone, the addition of pBtO2 monitoring did not provide a survival or functional status improvement at discharge. The true clinical benefit of pBtO2 monitoring will require further study.	[Green, Joel A.; Vanderkolk, Wayne E.] St Marys Hlth Care, Dept Trauma, Grand Rapids, MI USA; [Pellegrini, Daniela C.] Univ Wisconsin, Dept Internal Med, Madison, WI USA; [Figueroa, Bryan E.] Spectrum Hlth, Dept Neurosurg, Grand Rapids, MI USA; [Eriksson, Evert A.] Med Univ S Carolina, Dept Gen Surg, Charleston, SC 29425 USA		Eriksson, EA (corresponding author), Med Univ S Carolina, Dept Gen Surg, 96 Jonathan Lucas St,Suite 420, Charleston, SC 29425 USA.	joelgreenmd@gmail.com; pellegrd@gmail.com; waynshell@aol.com; bfigueroa@greatlakesneuro.com; evsurgery@gmail.com		Eriksson, Evert/0000-0002-4099-325X			Bardt TF, 1998, ACT NEUR S, V71, P153; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS3; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Eriksson EA, 2012, CLIN NEUROPHYSIOL, V123, P1255, DOI 10.1016/j.clinph.2011.08.035; Eriksson EA, 2012, J TRAUMA ACUTE CARE, V72, P1345, DOI 10.1097/TA.0b013e318249a0f4; Fletcher JJ, 2010, NEUROCRIT CARE, V13, P47, DOI 10.1007/s12028-010-9345-2; Martin MJ, 2005, J TRAUMA, V59, P860, DOI 10.1097/01.ta.0000187964.47703.e9; Martini RP, 2009, J NEUROSURG, V111, P644, DOI 10.3171/2009.2.JNS08998; McCarthy MC, 2009, SURGERY, V146, P585, DOI 10.1016/j.surg.2009.06.059; Nangunoori R, 2012, NEUROCRIT CARE, V17, P131, DOI 10.1007/s12028-011-9621-9; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Rosenthal G, 2009, CRIT CARE MED, V37, P379, DOI 10.1097/CCM.0b013e318193265f; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; van Santbrink H, 2003, ACTA NEUROCHIR, V145, P429, DOI 10.1007/s00701-003-0032-3	19	17	19	0	9	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2013	18	1					20	25		10.1007/s12028-012-9797-7			6	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	086SY	WOS:000314708500004	23138547				2022-02-06	
J	Lai, WJ; Wu, J; Zou, X; Xie, J; Zhang, LW; Zhao, XY; Zhao, MZ; Wang, QS; Ji, JG				Lai, Wenjia; Wu, Jing; Zou, Xiao; Xie, Jian; Zhang, Liwei; Zhao, Xuyang; Zhao, Minzhi; Wang, Qingsong; Ji, Jianguo			Secretome Analyses of A beta(1-42) Stimulated Hippocampal Astrocytes Reveal that CXCL10 is Involved in Astrocyte Migration	JOURNAL OF PROTEOME RESEARCH			English	Article						cell migration; secreted protein; reactive astrocytes; Alzheimer's disease; amyloid-beta; LC-MS/MS	ONSET ALZHEIMERS-DISEASE; TRAUMATIC BRAIN-INJURY; SHOTGUN PROTEOMICS; MTT REDUCTION; CANCER-CELLS; A-BETA; EXPRESSION; PROTEIN; RAT; IDENTIFICATION	Amyloid-beta (A beta) aggregation plays an important role in the development of Alzheimer's disease (AD). In the AD brain, amyloid plaques are surrounded by reactive astrocytes, and many essential functions of astrocytes have been reported to be mediated by protein secretion. However, the roles of activated astrocytes in AD progression are under intense debate. To provide an in-depth view of the secretomes of activated astrocytes, we present in this study a quantitative profile of rat hippocampal astrocyte secretomes at multiple time points after both brief and sustained A beta(1-42) stimulation. Using SILAC labeling and LC-MS/MS analyses, we identified 19 up-regulated secreted proteins after A beta(1-42) treatment. These differentially expressed proteins have been suggested to be involved in key aspects of biological processes, such as cell recruitment, A beta clearance, and regulation of neurogenesis. Particularly, we validated the role played by CXCL10 in promoting astrocyte aggregation around amyloid plagues through in vitro cell migration analysis. This research provides global, quantitative profiling of astrocyte secretomes produced on A beta stimulation and hence provides a detailed molecular basis for the relationship between amyloid plaques and astrocyte aggregation; the findings thus have important implications for further investigations into AD development and therapy.	[Lai, Wenjia; Wu, Jing; Zou, Xiao; Zhao, Xuyang; Zhao, Minzhi; Wang, Qingsong; Ji, Jianguo] Peking Univ, Coll Life Sci, Natl Lab Prot Engn & Plant Genet Engn, Beijing 100871, Peoples R China; [Xie, Jian; Zhang, Liwei] Capital Med Univ, Beijing TianTan Hosp, Dept Neurosurg, Beijing 100875, Peoples R China		Ji, JG (corresponding author), Peking Univ, Coll Life Sci, Natl Lab Prot Engn & Plant Genet Engn, Beijing 100871, Peoples R China.	jijg@pku.edu.cn	wu, jing/C-4576-2015		National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31270872, 30970652]; National Key Basic Research Program of ChinaNational Basic Research Program of China [2010CB912203, 2011CB915504]	This work was supported by grants from the National Natural Science Foundation of China (Nos. 31270872 and 30970652) and the National Key Basic Research Program of China (Nos. 2010CB912203 and 2011CB915504).	Abe K, 1998, NEUROSCI RES, V31, P295, DOI 10.1016/S0168-0102(98)00055-8; Ahlemeyer B, 2013, J NEUROSCI METH, V212, P156, DOI 10.1016/j.jneumeth.2012.09.016; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Bonneh-Barkay D, 2010, J NEUROTRAUM, V27, P1215, DOI 10.1089/neu.2010.1310; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Brazil MI, 2000, J BIOL CHEM, V275, P16941, DOI 10.1074/jbc.M000937200; Camon Evelyn, 2004, In Silico Biology, V4, P5; Chen YJ, 2005, NUCLEIC ACIDS RES, V33, pD169; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Crespo-Biel Natalia, 2012, Int J Alzheimers Dis, V2012, P251426, DOI 10.1155/2012/251426; Di Fede G, 2012, PROG NEUROBIOL, V99, P281, DOI 10.1016/j.pneurobio.2012.06.004; Dowell JA, 2009, J PROTEOME RES, V8, P4135, DOI 10.1021/pr900248y; Du JL, 2012, PROTEIN ENG DES SEL, V25, P337, DOI 10.1093/protein/gzs026; Duan RS, 2008, NEUROCHEM RES, V33, P1085, DOI 10.1007/s11064-007-9554-z; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Enderlin M, 2009, CANCER GENE THER, V16, P149, DOI 10.1038/cgt.2008.62; Endo T, 2005, CURR DRUG TARGETS, V6, P427, DOI 10.2174/1389450054021909; Fotopoulou S, 2010, DEV BIOL, V339, P451, DOI 10.1016/j.ydbio.2010.01.007; Fu HJ, 2012, GLIA, V60, P993, DOI 10.1002/glia.22331; Gongidi V, 2004, NEURON, V41, P57, DOI 10.1016/S0896-6273(03)00818-3; Greco TM, 2010, J PROTEOME RES, V9, P2764, DOI 10.1021/pr100134n; Hamel MG, 2005, J NEUROCHEM, V93, P1533, DOI 10.1111/j.1471-4159.2005.03144.x; Han H, 2011, ARCH ORTHOP TRAUM SU, V131, P829, DOI 10.1007/s00402-010-1233-x; Han NK, 2012, PROTEOMICS, V12, P2822, DOI 10.1002/pmic.201100419; Hickman SE, 2013, ADV ALZH DIS, V3, P295, DOI 10.3233/978-1-61499-154-0-295; HOFFMANN MC, 1992, NEUROSCIENCE, V49, P397, DOI 10.1016/0306-4522(92)90105-B; Ishibashi S, 2007, EXP NEUROL, V207, P302, DOI 10.1016/j.expneurol.2007.06.024; Israelsson C, 2010, EUR J NEUROSCI, V31, P852, DOI 10.1111/j.1460-9568.2010.07105.x; Jia JX, 2010, MOL CELL BIOCHEM, V335, P127, DOI 10.1007/s11010-009-0249-4; Kanekiyo T, 2007, P NATL ACAD SCI USA, V104, P6412, DOI 10.1073/pnas.0701585104; Kang WF, 2011, MOL NEUROBIOL, V43, P147, DOI 10.1007/s12035-011-8163-7; Kanno M, 2005, J NEUROIMMUNOL, V167, P72, DOI 10.1016/j.jneuroim.2005.06.028; Keene SD, 2009, PROTEOMICS, V9, P768, DOI 10.1002/pmic.200800385; Lafon-Cazal M, 2003, J BIOL CHEM, V278, P24438, DOI 10.1074/jbc.M211980200; Lee JH, 2012, CANCER RES, V72, P3175, DOI 10.1158/0008-5472.CAN-12-0481; Lee S, 2011, J BIOL CHEM, V286, P43855, DOI 10.1074/jbc.M111.299248; Li XY, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-79; Liu YB, 1997, J NEUROCHEM, V69, P2285; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loeffler DA, 2001, FREE RADICAL RES, V35, P111, DOI 10.1080/10715760100300651; Luan KL, 2013, AGEING RES REV, V12, P174, DOI 10.1016/j.arr.2012.06.002; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; McKimmie CS, 2010, BIOCHEM BIOPH RES CO, V394, P1006, DOI 10.1016/j.bbrc.2010.03.111; Miura T, 2004, CELL DEATH DIFFER, V11, P1076, DOI 10.1038/sj.cdd.4401462; Moon LDF, 2003, J NEUROSCI RES, V71, P23, DOI 10.1002/jnr.10449; Moore NH, 2009, J NEUROCHEM, V108, P891, DOI 10.1111/j.1471-4159.2008.05836.x; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; Nielsen HM, 2010, GLIA, V58, P1235, DOI 10.1002/glia.21004; Nishitsuji K, 2011, J BIOL CHEM, V286, P6393, DOI 10.1074/jbc.M110.172106; Noda Mariko, 2012, Int J Alzheimers Dis, V2012, P891087, DOI 10.1155/2012/891087; Omari KM, 2005, BRAIN, V128, P1003, DOI 10.1093/brain/awh479; Parpura V, 2012, J NEUROCHEM, V121, P4, DOI 10.1111/j.1471-4159.2012.07664.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Piacentini S, 2012, J NEUROL SCI, V317, P137, DOI 10.1016/j.jns.2012.01.026; Pinhel MAS, 2008, CLIN CHEM LAB MED, V46, P439, DOI 10.1515/CCLM.2008.102; Pocernich CB, 2005, MOL BRAIN RES, V133, P307, DOI 10.1016/j.molbrainres.2004.10.023; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Romagnani P, 2012, CLIN CHIM ACTA, V413, P1364, DOI 10.1016/j.cca.2012.02.009; Sasaki T, 2004, GLYCOBIOLOGY, V14, P357, DOI 10.1093/glycob/cwh043; Satoh K, 2005, BIOCHEM BIOPH RES CO, V335, P631, DOI 10.1016/j.bbrc.2005.07.117; Savaskan NE, 2007, CELL MOL LIFE SCI, V64, P230, DOI 10.1007/s00018-006-6412-0; Shwartsman A L, 2011, Tsitologiia, V53, P772; Sidahmed AME, 2012, CYTOKINE, V59, P433, DOI 10.1016/j.cyto.2012.05.002; Skalnikova H, 2011, PROTEOMICS, V11, P691, DOI 10.1002/pmic.201000402; Spisni E, 2009, NEUROTOXICOLOGY, V30, P605, DOI 10.1016/j.neuro.2009.03.005; Squitti Rosanna, 2009, Recent Pat CNS Drug Discov, V4, P209; Stroombergen MCMJ, 1999, HUM EXP TOXICOL, V18, P141, DOI 10.1191/096032799678839815; Sui YJ, 2006, EUR J NEUROSCI, V23, P957, DOI 10.1111/j.1460-9568.2006.04631.x; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Takanashi Masashi, 2012, Nihon Rinsho, V70, P94; Takata T, 2012, ONCOL REP, V28, P1968, DOI 10.3892/or.2012.2020; Thal DR, 2012, EXP NEUROL, V236, P1, DOI 10.1016/j.expneurol.2012.04.021; Thomas Saskia, 2012, Inflammopharmacology, V20, P1, DOI 10.1007/s10787-011-0104-6; Tirotta E, 2012, STEM CELL RES, V9, P208, DOI 10.1016/j.scr.2012.06.005; Umemura K, 2006, NEUROSCI LETT, V400, P97, DOI 10.1016/j.neulet.2006.02.008; Vafadar-Isfahani B, 2012, J ALZHEIMERS DIS, V28, P625, DOI 10.3233/JAD-2011-111505; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Yamamori H, 2012, NEUROSCI LETT, V513, P204, DOI 10.1016/j.neulet.2012.02.039; Yang LL, 2012, ONCOL LETT, V3, P383, DOI 10.3892/ol.2011.472; Yates-Binder CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040812	83	17	20	0	18	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1535-3893	1535-3907		J PROTEOME RES	J. Proteome Res.	FEB	2013	12	2					832	843		10.1021/pr300895r			12	Biochemical Research Methods	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	084SG	WOS:000314558800026	23270423				2022-02-06	
J	Shin, SS; Bales, JW; Yan, HQ; Kline, AE; Wagner, AK; Lyons-Weiler, J; Dixon, CE				Shin, Samuel S.; Bales, James W.; Yan, Hong Q.; Kline, Anthony E.; Wagner, Amy K.; Lyons-Weiler, James; Dixon, C. Edward			The Effect of Environmental Enrichment on Substantia Nigra Gene Expression after Traumatic Brain Injury in Rats	JOURNAL OF NEUROTRAUMA			English	Article						dopamine; EE; microarray; TBI	MEDIATED FUNCTIONAL IMPROVEMENT; CONTROLLED CORTICAL IMPACT; WATER MAZE PERFORMANCE; PARKINSONS-DISEASE; MESSENGER-RNA; AXONAL INJURY; NEUROBEHAVIORAL RECOVERY; COGNITIVE DEFICITS; ATTENTION DEFICITS; CYCLOSPORINE-A	Experimental investigations into the effects of traumatic brain injury (TBI) have demonstrated significant alterations in dopaminergic systems. Dopaminergic fibers originating within the substantia nigra and ventral tegmental area (VTA) are important for reward learning, addiction, movement, and behavior. However, little is known about the effect of TBI on substantia nigra and VTA function. Environmental enrichment (EE) has been shown to improve functional outcome after TBI, and a number of studies suggest that it may exert some benefits via dopaminergic signaling. To better understand the role of dopamine in chronic TBI pathophysiology and the effect of EE, we examined the mRNA expression profile within the substantia nigra and VTA at 4 weeks post-injury. Specifically, three comparisons were made: 1) TBI versus sham, 2) sham + EE versus sham + standard (STD) housing, and 3) TBI + EE versus TBI + STD. There were differential expressions of 25, 4, and 40 genes in these comparisons, respectively. Chronic alterations in genes post-injury within the substantia nigra and VTA included genes important for cellular membrane homeostasis and transcription. EE-induced gene alterations after TBI included genes important for signal transduction, in particular calcium signaling pathways, membrane homeostasis, and metabolism. Elucidation of these alterations in gene expression within the substantia nigra and VTA provides new insights into chronic changes in dopamine signaling post-TBI, and the potential role of EE in TBI rehabilitation.	[Shin, Samuel S.; Bales, James W.; Yan, Hong Q.; Dixon, C. Edward] Univ Pittsburgh, Brain Trauma Res Ctr, Pittsburgh, PA 15260 USA; [Shin, Samuel S.; Bales, James W.; Yan, Hong Q.; Kline, Anthony E.; Wagner, Amy K.; Dixon, C. Edward] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Shin, Samuel S.; Bales, James W.; Yan, Hong Q.; Dixon, C. Edward] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Shin, Samuel S.; Bales, James W.; Yan, Hong Q.; Kline, Anthony E.; Wagner, Amy K.; Dixon, C. Edward] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Kline, Anthony E.] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA; [Kline, Anthony E.; Wagner, Amy K.; Dixon, C. Edward] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15260 USA; [Lyons-Weiler, James] Univ Pittsburgh, Genom & Prote Core Labs Bioinformat Anal Core, Pittsburgh, PA 15260 USA; [Dixon, C. Edward] Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA USA		Dixon, CE (corresponding author), Univ Pittsburgh, 201 Hill Bldg,3434 Fifth Ave, Pittsburgh, PA 15260 USA.	dixonec@upmc.edu	Lyons-Weiler, James/Q-4948-2019	Lyons-Weiler, James/0000-0001-9343-7508	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21NS047919, P01NS030318, R01NS060672, 5F30NS067731-03]; Pittsburgh Copeland Foundation;  [R01NS060005]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS047919, P01NS030318, R01NS060005, R01NS060672, F30NS067731] Funding Source: NIH RePORTER	This research was supported by National Institutes of Health (NIH) grants R21NS047919, P01NS030318, R01NS060672, NIH F30 grant 5F30NS067731-03, and the Pittsburgh Copeland Foundation (CED), and R01NS060005 (AEK).	Alerte TNM, 2008, NEUROSCI LETT, V435, P24, DOI 10.1016/j.neulet.2008.02.014; Bales JW, 2011, EXP NEUROL, V229, P300, DOI 10.1016/j.expneurol.2011.02.013; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; BARDO MT, 1995, PHARMACOL BIOCHEM BE, V51, P397, DOI 10.1016/0091-3057(94)00413-D; Barembaum M, 2000, NAT CELL BIOL, V2, P219, DOI 10.1038/35008643; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BINDER LM, 1987, J NEUROSURG, V67, P785; Bomze HM, 2001, NAT NEUROSCI, V4, P38, DOI 10.1038/82881; Burke WJ, 2003, BRAIN RES, V989, P205, DOI 10.1016/S0006-8993(03)03354-7; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Caleo M, 2009, EXP NEUROL, V216, P515, DOI 10.1016/j.expneurol.2008.12.016; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; Chang PY, 2005, J NEUROSCI RES, V79, P788, DOI 10.1002/jnr.20409; Chao CCK, 2003, J NEUROSCI RES, V74, P248, DOI 10.1002/jnr.10763; Chen DY, 2011, NATURE, V469, P491, DOI 10.1038/nature09667; Chen SJ, 1997, BRAIN RES, V749, P181, DOI 10.1016/S0006-8993(96)01159-6; COULTER PM, 1993, J NEUROCHEM, V61, P756; Cramer SC, 2000, TRENDS NEUROSCI, V23, P265, DOI 10.1016/S0166-2236(00)01562-9; Dahlqvist P, 2004, EUR J NEUROSCI, V19, P2288, DOI 10.1111/j.0953-816X.2004.03248.x; de Castro IP, 2011, MOL NEUROBIOL, V43, P80, DOI 10.1007/s12035-010-8150-4; de Witt BW, 2011, NEUROREHAB NEURAL RE, V25, P343, DOI 10.1177/1545968310390520; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; During Matthew J., 2006, Current Alzheimer Research, V3, P29, DOI 10.2174/156720506775697133; Founds SA, 2009, PLACENTA, V30, P15, DOI 10.1016/j.placenta.2008.09.015; Frey D, 2000, J CELL BIOL, V149, P1443, DOI 10.1083/jcb.149.7.1443; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gelfo F, 2011, NEUROREHAB NEURAL RE, V25, P243, DOI 10.1177/1545968310380926; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Herb A, 1997, MOL CELL NEUROSCI, V8, P367, DOI 10.1006/mcne.1996.0594; Hicks RR, 2002, NEUROSCIENCE, V112, P631, DOI 10.1016/S0306-4522(02)00104-5; Hoffman AN, 2008, NEUROSCI LETT, V431, P226, DOI 10.1016/j.neulet.2007.11.042; Hoffmann LC, 2009, NEUROSCIENCE, V158, P1589, DOI 10.1016/j.neuroscience.2008.11.035; Hsu E, 2011, ARTHRITIS RHEUM-US, V63, P783, DOI 10.1002/art.30159; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; Jadavji NM, 2006, NEUROSCIENCE, V140, P1127, DOI 10.1016/j.neuroscience.2006.03.027; Jankowsky JL, 2005, J NEUROSCI, V25, P5217, DOI 10.1523/JNEUROSCI.5080-04.2005; Diez-Guerra FJ, 2010, IUBMB LIFE, V62, P597, DOI 10.1002/iub.357; Johansson BB, 1996, STROKE, V27, P324, DOI 10.1161/01.STR.27.2.324; Jordan R, 2008, CANCER INFORM, V6, P389; Ju YT, 1998, P NATL ACAD SCI USA, V95, P11423, DOI 10.1073/pnas.95.19.11423; Kadenbach B, 2004, BBA-BIOENERGETICS, V1655, P400, DOI 10.1016/j.bbabio.2003.06.005; Khatri P, 2007, NUCLEIC ACIDS RES, V35, pW206, DOI 10.1093/nar/gkm327; Kim J, 2012, PSYCHOPHARMACOLOGY, V222, P47, DOI 10.1007/s00213-011-2622-8; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; Kline AE, 2004, J NEUROTRAUM, V21, P1712, DOI 10.1089/0897715042664849; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Kline AE, 2012, J NEUROTRAUM, V29, P1960, DOI 10.1089/neu.2012.2385; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Kremerskothen J, 2006, J NEUROCHEM, V96, P1659, DOI 10.1111/j.1471-4159.2006.03679.x; Kuroda S, 1999, BIOCHEM BIOPH RES CO, V265, P79, DOI 10.1006/bbrc.1999.1638; Lee SW, 2003, NAT MED, V9, P900, DOI 10.1038/nm889; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LEVIN HS, 1988, SCAND J REHABIL MED, P33; LEVIN HS, 1988, BRAIN COGNITION, V7, P283, DOI 10.1016/0278-2626(88)90003-6; Li HH, 2004, J NEUROTRAUM, V21, P1141, DOI 10.1089/0897715041953777; Li SW, 2001, MOL BRAIN RES, V93, P1, DOI 10.1016/S0169-328X(01)00120-6; Lin XY, 1996, J BIOL CHEM, V271, P28430, DOI 10.1074/jbc.271.45.28430; Marciano PG, 2002, NEUROCHEM RES, V27, P1147, DOI 10.1023/A:1020973308941; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Moreno TA, 2001, DEV BIOL, V240, P340, DOI 10.1006/dbio.2001.0472; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Okonkwo DO, 2003, NEUROREPORT, V14, P463, DOI 10.1097/01.wnr.0000058958.85541.d3; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Overton PG, 1999, NEUROREPORT, V10, P221, DOI 10.1097/00001756-199902050-00004; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Patel Satish, 2004, Appl Bioinformatics, V3, P49; Rall JM, 2003, NEUROPATH APPL NEURO, V29, P118, DOI 10.1046/j.1365-2990.2003.00439.x; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; SAARI MJ, 1990, NEUROTOXICOL TERATOL, V12, P29, DOI 10.1016/0892-0362(90)90109-P; Segovia G, 2010, J NEURAL TRANSM, V117, P1123, DOI 10.1007/s00702-010-0447-y; Shiel A, 2001, CLIN REHABIL, V15, P501, DOI 10.1191/026921501680425225; Shin SS, 2011, BRAIN RES, V1369, P208, DOI 10.1016/j.brainres.2010.10.096; Singleton RH, 2001, J NEUROTRAUM, V18, P607, DOI 10.1089/089771501750291846; Solinas M, 2009, NEUROPSYCHOPHARMACOL, V34, P1102, DOI 10.1038/npp.2008.51; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Tehranian R, 2006, J NEUROCHEM, V99, P1188, DOI 10.1111/j.1471-4159.2006.04146.x; Tomarev SI, 2009, MOL NEUROBIOL, V40, P122, DOI 10.1007/s12035-009-8076-x; Wagner AK, 2005, EXP NEUROL, V195, P475, DOI 10.1016/j.expneurol.2005.06.009; Wagner AK, 2002, NEUROSCI LETT, V334, P165, DOI 10.1016/S0304-3940(02)01103-5; Wanger AK, 2009, J NEUROCHEM, V110, P801, DOI 10.1111/j.1471-4159.2009.06155.x; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 2008, AM J PHYS MED REHAB, V87, P85, DOI 10.1097/PHM.0b013e3181619609; Yan HQ, 2007, BRAIN RES, V1134, P171, DOI 10.1016/j.brainres.2006.11.087; Yan HQ, 2000, BRAIN RES, V887, P134, DOI 10.1016/S0006-8993(00)03002-X; Zhu XL, 2007, BRAIN INJURY, V21, P681, DOI 10.1080/02699050701468941	92	17	18	0	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2013	30	4					259	270		10.1089/neu.2012.2462			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	093CM	WOS:000315169300003	23094804	Green Published			2022-02-06	
J	Bali, N; Morgan, TE; Finch, CE				Bali, N.; Morgan, T. E.; Finch, C. E.			Pgrmc1: new roles in the microglial mediation of progesterone-antagonism of estradiol-dependent neurite sprouting and in microglial activation	FRONTIERS IN NEUROSCIENCE			English	Article						Prgmc1; microglia; progesterone; sprouting; S2R	MEMBRANE COMPONENT 1; TRAUMATIC BRAIN-INJURY; GENE-EXPRESSION; BINDING PROTEIN; RECEPTORS; RAT; INCREASES; OUTGROWTH; MOUSE; 25-DX	Pgrmc1 (progesterone receptor membrane component 1) is a multifunctional 22 kDa protein with heme-binding and P450-activating capacity which was recognized under different names for roles in cell motility during neural development and in cancer, and apoptosis. Pgrmc1 expression in microglia was recently shown by the present authors to mediate estrogen-progesterone interactions during axonal sprouting and to mediate microglial activation itself. We also discuss other functions of Pgramc1 in the nervous system and its possible relationship to the 18 kDa sigma-2 receptor (S2R).	[Bali, N.; Morgan, T. E.; Finch, C. E.] Univ So Calif, Davis Sch Gerontol, Los Angeles, CA 90089 USA; [Bali, N.; Morgan, T. E.; Finch, C. E.] Univ So Calif, Dornsife Coll Letters Arts & Sci, Los Angeles, CA 90089 USA		Finch, CE (corresponding author), Univ So Calif, Davis Sch Gerontol, 3715 McClintock Ave, Los Angeles, CA 90089 USA.	cefinch@usc.edu	Finch, Caleb/AAA-7250-2022		NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [2P01 AG026572-06]; Project 2; Animal Core; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG026572] Funding Source: NIH RePORTER	This work was supported by NIH grant 2P01 AG026572-06 to Roberta D. Brinton; Project 2 to C. E. Finch and T. E. Morgan; Animal Core to T. E. Morgan. We also thank John Peluso, Javier Cuevas, and Arnold E. Ruoho for helpful comments.	Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Ahmed IS, 2010, J PHARMACOL EXP THER, V333, P564, DOI 10.1124/jpet.109.164210; Bali N, 2013, ENDOCRINOLOGY, V154, P2468, DOI 10.1210/en.2012-2109; Bashour NM, 2012, ENDOCRINOLOGY, V153, P4457, DOI 10.1210/en.2012-1122; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Brinton RD, 2008, FRONT NEUROENDOCRIN, V29, P313, DOI 10.1016/j.yfrne.2008.02.001; Cahill MA, 2007, J STEROID BIOCHEM, V105, P16, DOI 10.1016/j.jsbmb.2007.02.002; Chen ZH, 2012, J NEUROSCI, V32, P11706, DOI 10.1523/JNEUROSCI.0730-12.2012; Cuevas J, 2011, J PHARMACOL EXP THER, V339, P161, DOI 10.1124/jpet.111.182816; Gatson JW, 2011, ENDOCRINOLOGY, V152, P207, DOI 10.1210/en.2010-0724; Intlekofer KA, 2011, NEUROSCIENCE, V172, P55, DOI 10.1016/j.neuroscience.2010.10.051; Johannessen M, 2011, AM J PHYSIOL-CELL PH, V300, pC328, DOI 10.1152/ajpcell.00383.2010; Kimura I, 2012, CURR PROTEIN PEPT SC, V13, P687, DOI 10.2174/138920312804142110; Krebs CJ, 2000, P NATL ACAD SCI USA, V97, P12816, DOI 10.1073/pnas.97.23.12816; Labombarda F, 2010, NEUROSCIENCE, V166, P94, DOI 10.1016/j.neuroscience.2009.12.012; Liu LF, 2009, ENDOCRINOLOGY, V150, P3186, DOI 10.1210/en.2008-1447; Meffre D, 2005, J NEUROCHEM, V93, P1314, DOI 10.1111/j.1471-4159.2005.03127.x; Meffre D, 2013, NEUROSCIENCE, V231, P111, DOI 10.1016/j.neuroscience.2012.11.039; Mir SUR, 2012, INT J CANCER, V131, pE1, DOI 10.1002/ijc.26432; Peluso JJ, 2010, MOL CELL ENDOCRINOL, V320, P153, DOI 10.1016/j.mce.2010.02.005; Peluso JJ, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00099; Ruoho A. E., 2013, SOC NEUR ABSTR, V631; RUOHO AE, 2013, SOC NEUR ABSTR, V631, P8; Sierra A, 2008, GLIA, V56, P659, DOI 10.1002/glia.20644; Stein DG, 2011, NEUROSCIENCE, V191, P101, DOI 10.1016/j.neuroscience.2011.04.013; Su C, 2012, ENDOCRINOLOGY, V153, P4389, DOI 10.1210/en.2011-2177; Wong AM, 2009, ENDOCRINOLOGY, V150, P324, DOI 10.1210/en.2008-0988; WOOLLEY CS, 1992, J NEUROSCI, V12, P2549; Xu JB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1386	29	17	18	0	3	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-453X			FRONT NEUROSCI-SWITZ	Front. Neurosci.		2013	7								157	10.3389/fnins.2013.00157			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AW9HF	WOS:000346567300156	24027494	Green Published, gold			2022-02-06	
J	Dukes, SF; Bridges, E; Johantgen, M				Dukes, Susan F.; Bridges, Elizabeth; Johantgen, Meg			Occurrence of Secondary Insults of Traumatic Brain Injury in Patients Transported by Critical Care Air Transport Teams From Iraq/Afghanistan: 2003-2006	MILITARY MEDICINE			English	Article							INTRACRANIAL-PRESSURE; IRAQI FREEDOM; HYPERGLYCEMIA; TEMPERATURE; HYPOTHERMIA; MORTALITY; IMPACT; HYPERTHERMIA; HYPOTENSION; HYPOXIA	Traumatic brain injury patients are susceptible to secondary insults to the injured brain. A retrospective cohort study was conducted to describe the occurrence of secondary insults in 63 combat casualties with severe isolated traumatic brain injury who were transported by the U.S. Air Force Critical Care Air Transport Teams (CCATT) from 2003 through 2006. Data were obtained from the Wartime Critical Care Air Transport Database, which describes the patient's physiological state and care as they are transported across the continuum of care from the area of responsibility (Iraq/Afghanistan) to Germany and the United States. Fifty-three percent of the patients had at least one documented episode of a secondary insult. Hyperthermia was the most common secondary insult and was associated with severity of injury. The hyperthermia rate increased across the continuum, which has implications for en route targeted temperature management. Hypoxia occurred most frequently within the area of responsibility, but was rare during CCATT flights, suggesting that concerns for altitude-induced hypoxia may not be a major factor in the decision when to move a patient. Similar research is needed for polytrauma casualties and analysis of the association between physiological status and care across the continuum and long-term outcomes.	[Dukes, Susan F.] US Air Force, Sch Aerosp Med, Wright Patterson AFB, OH 45433 USA; [Bridges, Elizabeth] Univ Washington, Seattle, WA 98195 USA; [Johantgen, Meg] Univ Maryland, Sch Nursing, Baltimore, MD 21201 USA		Dukes, SF (corresponding author), US Air Force, Sch Aerosp Med, 2510 5th St, Wright Patterson AFB, OH 45433 USA.						Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Badjatia N, 2009, CRIT CARE MED, V37, pS250, DOI 10.1097/CCM.0b013e3181aa5e8d; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1025; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Beninati W, 2008, CRIT CARE MED, V36, pS370, DOI 10.1097/CCM.0b013e31817e3143; Bridges E, 2009, MIL MED, V174, P370, DOI 10.7205/MILMED-D-03-9607; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Choi HA, 2012, NAT REV NEUROL, V8, P214, DOI 10.1038/nrneurol.2012.21; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Diringer MN, 2004, CRIT CARE MED, V32, P1489, DOI 10.1097/01.CCM.0000129484.61912.84; Duckworth JL, 2012, PATHOPHYSIO IN PRESS; Elf K, 2008, NEUROL RES, V30, P1097, DOI 10.1179/174313208X319125; Fang R, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1043; Fox JL, 2010, CAN J EMERG MED, V12, P355; Franschman G, 2011, J TRAUMA, V71, P826, DOI 10.1097/TA.0b013e31820cebf0; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Goodman MD, 2011, J SURG RES, V165, P30, DOI 10.1016/j.jss.2010.05.055; Goodman MD, 2010, J SURG RES, V164, P286, DOI 10.1016/j.jss.2009.07.040; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Kim YJ, 2011, J CLIN NURS, V20, P1518, DOI 10.1111/j.1365-2702.2010.03618.x; Liu-DeRyke X, 2009, NEUROCRIT CARE, V11, P151, DOI 10.1007/s12028-009-9228-6; Mason PE, 2011, J EMERG MED, V41, P8, DOI 10.1016/j.jemermed.2008.06.032; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Prisco L, 2012, J NEUROSURG SCI, V56, P131; Puccio AM, 2009, NEUROCRIT CARE, V11, P82, DOI 10.1007/s12028-009-9213-0; Richardson MW, 2007, J TRAUMA, V62, pS64, DOI 10.1097/TA.0b013e318065adf3; Rossi S, 2001, J NEUROL NEUROSUR PS, V71, P448, DOI 10.1136/jnnp.71.4.448; Sadaka F, 2012, BRAIN INJURY, V26, P899, DOI 10.3109/02699052.2012.661120; Salim A, 2009, AM SURGEON, V75, P25; Shafi S, 2005, J TRAUMA, V59, P830, DOI 10.1097/01.ta.0000188147.36232.c0; Shafi S, 2005, J TRAUMA, V59, P1081, DOI 10.1097/01.ta.0000188647.03665.fd; Soukup J, 2002, J NEUROTRAUM, V19, P559, DOI 10.1089/089771502753754046; Stahel PF, 2008, INTENS CARE MED, V34, P402, DOI 10.1007/s00134-007-0889-3; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X; Vespa P, 2012, CRIT CARE MED, V40, P1923, DOI 10.1097/CCM.0b013e31824e0fcc; Wang HE, 2005, CRIT CARE MED, V33, P1296, DOI 10.1097/01.CCM.0000165965.31895.80; Whitcomb BW, 2005, CRIT CARE MED, V33, P2772, DOI 10.1097/01.CCM.0000189741.44071.25	40	17	17	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN	2013	178	1					11	17		10.7205/MILMED-D-12-00177			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7TV	WOS:000340804800007	23356112	Bronze			2022-02-06	
J	Lesko, MM; Jenks, T; O'Brien, SJ; Childs, C; Bouamra, O; Woodford, M; Lecky, F				Lesko, Mehdi Moazzez; Jenks, Tom; O'Brien, Sara J.; Childs, Charmaine; Bouamra, Omar; Woodford, Maralyn; Lecky, Fiona			Comparing Model Performance for Survival Prediction Using Total Glasgow Coma Scale and Its Components in Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						GCS; Glasgow Coma Scale; outcome; prognosis; traumatic brain injury	ADMISSION CHARACTERISTICS; RELIABILITY; VALIDATION; SCORES; IMPACT; CARE	The Glasgow Coma Scale (GCS) score is used in clinical practice for patient assessment and communication among clinicians and also in outcome prediction models such as the Trauma and Injury Severity Score (TRIS). The objective of this study is to determine which GCS subscore is best associated with outcome, taking time of assessment into account. Records of patients with brain injury who presented after 1989 were extracted from the Trauma Audit and Research Network (TARN) database. Using logistic regression, a baseline model was derived with age, Injury Severity Score (ISS), and year of injury as covariates and survival at discharge as the dependent variable. Total GCS, its subscores, and their combinations at various time points were separately added to the baseline model to compare their effect on model performance. The dataset contained 21,657 cases. The total GCS score at scene and its subscores had significantly lower predictive power compared with those recorded on arrival at the Emergency Department (ED) (scene total GCS: Area Under the Curve-AUC: 0.89; 95% confidence interval [CI]: 0.89-0.90) and Nagelkerke R-2 of 0.55, admission total GCS: AUC of 0.91; 95% CI: 0.91-0.91, and Nagelkerke R-2 of 0.59). Eye and verbal subscores had significantly lower performances compared with total GCS, motor subscore, and various combinations of subscores. Motor subscore and total GCS appeared to have similar predictive performance (admission total and motor GCS both had AUC of 0.91 (95% CI: 0.91-0.92) and Nagelkerke R-2 of 0.59 and 0.58, respectively). Motor subscore contains most of the predictive power of the total score. GCS on arrival is a significantly better predictor of outcome than that recorded at scene.	[Lesko, Mehdi Moazzez; Jenks, Tom; Bouamra, Omar; Woodford, Maralyn; Lecky, Fiona] Salford Royal Hosp, TARN, Salford M6 8HD, Lancs, England; [O'Brien, Sara J.] Univ Liverpool, Inst Infect & Global Hlth, Natl Ctr Zoonosis Res, Neston, England; [Childs, Charmaine] Natl Univ Singapore, Yong Loo Lin Sch Med, Alice Lee Ctr Nursing Studies, Clin Res Ctr, Singapore 117595, Singapore		Lesko, MM (corresponding author), Salford Royal Hosp, TARN, Clin Sci Bldg Eccles Old Rd, Salford M6 8HD, Lancs, England.	mehdimlesko@gmail.com		bouamra, omar/0000-0002-3155-4634; O'Brien, Sarah Jane/0000-0003-2896-8999	Trauma Audit and Research Network (TARN); Overseas Research Students (ORS) Award Scheme, University of Manchester	We would like to thank TARN members of staff and participating hospitals for the collection and submission of the data. This work was in part funded by the Trauma Audit and Research Network (TARN) and Overseas Research Students (ORS) Award Scheme, University of Manchester.	Arbabi S, 2004, J TRAUMA, V56, P1029, DOI 10.1097/01.TA.0000123036.20919.4B; Association for the Advancement of Automatic Medicine, 2001, ABBR INJ SCAL; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; David W.H., 2000, APPL LOGISTIC REGRES; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Intercollegiate Group of Trauma Standards, 2009, REG TRAUM SYST INT G; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Ross SE, 1998, J TRAUMA, V45, P42, DOI 10.1097/00005373-199807000-00008; ROWLEY G, 1991, LANCET, V337, P535, DOI 10.1016/0140-6736(91)91309-I; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; TEASDALE G, 1974, LANCET, V2, P81	20	17	19	0	7	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JAN	2013	30	1					17	22		10.1089/neu.2012.2438			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	061GU	WOS:000312837300004	22931390				2022-02-06	
J	Saxton, ME; Younan, SS; Lah, S				Saxton, Melissa E.; Younan, Shameran Slewa; Lah, Suncica			Social behaviour following severe traumatic brain injury: Contribution of emotion perception deficits	NEUROREHABILITATION			English	Article						Brain injuries; emotions; social behaviour; rehabilitation	STRESS SCALES DASS; COMMUNICATION ABILITIES; PSYCHOMETRIC PROPERTIES; DEPRESSION; ANXIETY; VALIDITY; SKILLS; OUTCOMES; ADJUSTMENT; VERSION	OBJECTIVE: This theoretically driven study aimed to determine contribution of emotional perception impairments to social behaviour following traumatic brain injury (TBI). METHODS: Adults with severe TBI (n = 24) participated. Emotion perception predictors included: (i) appraisal: Montreal Set of Facial Displays of Emotion, The Adapted Story Task, (ii) affective state: Depression, Anxiety and Stress Scale (DASS-21), Interpersonal Reactivity Index (IRI) and (iii) regulation: Delis Kaplan Executive Function System -Colour Word Interference and Word Fluency. Social behavioural outcomes were (i) interpersonal: Key Behaviors Change Inventory (KBCI) - Interpersonal Difficulties and (ii) communication: KBCI - Communication Problems. RESULTS: Social behaviours correlated with affective state, but not appraisal or regulation. Simultaneous regression analyses revealed significant independent contributions of affective state: (i) the IRI Perspective Taking to the KBCI Interpersonal Difficulties and (ii) the DASS-21 (composite) and IRI Perspective Taking to the KBCI Communication Problems. The models explained 52% and 72% of the variance of the KBCI Interpersonal Difficulties and Communication Problems respectively. CONCLUSIONS: This study provides evidence that impairments in certain aspects of emotion perception: affective state [empathy (perspective taking) and mood], but not appraisal and regulation, contribute to social behaviour difficulties in patients with severe TBI, which has important implications for rehabilitation.	[Saxton, Melissa E.; Lah, Suncica] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia; [Younan, Shameran Slewa] Univ Western Sydney, Sch Med, Sydney, NSW, Australia		Lah, S (corresponding author), Univ Sydney, Sch Psychol, Mungo Mac Callum Bldg A19, Sydney, NSW 2006, Australia.	suncica.lah@sydney.edu.au		Lah, Suncica/0000-0003-2282-4812			Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Baker KA, 1998, REHABIL PSYCHOL, V43, P30, DOI 10.1037/0090-5550.43.1.30; Barlow D., 2001, CLIN HDB PSYCHOL DIS, V3rd; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Beaupre M.G., 2000, MONTREAL SET FACIAL; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bracy C., 2005, BRAIN IMPAIR, V6, P1, DOI DOI 10.1375/brim.6.1.1.65476; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Brown TA, 1997, BEHAV RES THER, V35, P79, DOI 10.1016/S0005-7967(96)00068-X; Channon Shelley, 2003, Cogn Neuropsychiatry, V8, P243, DOI 10.1080/135468000344000002; CHRISTOPHER FS, 1993, J MARRIAGE FAM, V55, P469, DOI 10.2307/352816; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Davis M.H., 1980, JSAS CATALOG SELECTE, V10, P85; Delis D.C., 2001, EXAMINERS MANUAL; GODFREY HPD, 1989, PSYCHOL MED, V19, P175, DOI 10.1017/S0033291700011120; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Higgins E. T., 1992, J LANG SOC PSYCHOL, V11, P107, DOI DOI 10.1177/0261927X92113001; HODGSON J, 2005, BRAIN IMPAIR, V6, P169, DOI DOI 10.1375/BRIM.2005.6.3.169; Hoofien D, 2001, BRAIN INJURY, V15, P189; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kolitz BP, 2003, ARCH PHYS MED REHAB, V84, P277, DOI 10.1053/apmr.2003.50100; Kraus JF, 2005, TXB TRAUMATIC BRAIN, P3; KRAUSS RM, 1991, SOC COGNITION, V9, P2, DOI 10.1521/soco.1991.9.1.2; Long E, 2008, BRAIN IMPAIR, V9, P274, DOI 10.1375/brim.9.3.274; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Maguire P, 2002, BRIT MED J, V325, P697, DOI 10.1136/bmj.325.7366.697; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; MILLER WR, 1975, PSYCHOL BULL, V82, P238, DOI 10.1037/h0076367; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; Ownsworth T, 2008, BRAIN INJURY, V22, P858, DOI 10.1080/02699050802446697; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; Radice-Neumann D, 2009, J HEAD TRAUMA REHAB, V24, P313, DOI 10.1097/HTR.0b013e3181b09160; REDMOND MV, 1995, J RES PERS, V29, P35, DOI 10.1006/jrpe.1995.1003; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; Scattone D, 2007, PSYCHOL SCHOOLS, V44, P717, DOI 10.1002/pits.20260; Schonberger M, 2011, J INT NEUROPSYCH SOC, V17, P781, DOI 10.1017/S1355617711000701; Schutte NS, 2001, J SOC PSYCHOL, V141, P523, DOI 10.1080/00224540109600569; SHEAN GD, 1995, J NERV MENT DIS, V183, P485, DOI 10.1097/00005053-199507000-00011; Sherron P., 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [DOI 10.1097/00001199-199109000-00004, https://doi.org/10.1097/00001199-199109000-00004]; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Snow PC, 1999, APHASIOLOGY, V13, P529, DOI 10.1080/026870399401993; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P4, DOI 10.1097/HTR.0b013e3182048e98; Struchen MA, 2008, BRAIN INJURY, V22, P940, DOI 10.1080/02699050802425410; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; TEASDALE G, 1974, LANCET, V2, P81; Topolovec-Vranic J, 2010, BRAIN INJURY, V24, P762, DOI 10.3109/02699051003709599; Vanderploeg RD, 2007, J REHABIL RES DEV, V44, P937, DOI 10.1682/JRRD.2006.12.0163; Watts AJ, 2006, APHASIOLOGY, V20, P707, DOI 10.1080/02687030500489953; Youse KM, 2005, BRAIN INJURY, V19, P1001, DOI 10.1080/02699050500109951	56	17	17	2	26	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2013	33	2					263	271		10.3233/NRE-130954			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	228IO	WOS:000325179600011	23949062				2022-02-06	
S	Yenari, MA; Han, HS		Naritomi, H; Krieger, DW		Yenari, M. A.; Han, H. S.			Influence of Therapeutic Hypothermia on Regeneration after Cerebral Ischemia	CLINICAL RECOVERY FROM CNS DAMAGE	Frontiers of Neurology and Neuroscience		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; ENDOTHELIAL GROWTH-FACTOR; NEUROTROPHIC FACTOR; MILD HYPOTHERMIA; CARDIAC-ARREST; ADULT NEUROGENESIS; GLOBAL-ISCHEMIA; RAT HIPPOCAMPUS; ANGIOGENESIS; CELLS	The protective effect of therapeutic hypothermia in cerebral ischemia is well accepted in experimental models, and some clinical studies show that there is benefit in humans as well. Long-term observations in animal and clinical studies have documented recovery of neurological function following hypothermia treatment. Diminished damage by hypothermic protection should contribute to the recovery in many ways, but hypothermia appears to enhance regeneration of brain tissue as well. Since regeneration of the brain after damage initiates within hours and is active days and weeks after stroke, prolonged hypothermia might affect regenerative processes which have been documented to occur in these time frames. As there is a lack of data at the basic and clinical levels, the mechanism of neuroregeneration by hypothermia is unclear. Yet, we speculate that hypothermia enhances regeneration by positively influencing neurogenesis, angiogenesis, gliogenesis and synapse/circuit formation after stroke. In this chapter, we will provide up-to-date data from experimental studies and clinical reports on the effect of therapeutic hypothermia on neuroregeneration, with perspectives on future research. Copyright (C) 2013 S. Karger AG, Basel	[Yenari, M. A.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94121 USA; [Yenari, M. A.] San Francisco VA Med Ctr, San Francisco, CA 94121 USA; [Han, H. S.] Kyungpook Natl Univ, Sch Med, Dept Physiol, Taegu, South Korea		Yenari, MA (corresponding author), Univ Calif San Francisco, Dept Neurol, 4150 Clement St, San Francisco, CA 94121 USA.	yenari@alum.mit.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS040516] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS040516] Funding Source: Medline		Bennet L, 2007, J PHYSIOL-LONDON, V578, P491, DOI 10.1113/jphysiol.2006.119602; Boris-Moller F, 1998, MOL BRAIN RES, V63, P163, DOI 10.1016/S0169-328X(98)00286-1; Bregy A, 2012, EXP NEUROL, V233, P821, DOI 10.1016/j.expneurol.2011.12.008; Coassin M, 2010, BRIT J OPHTHALMOL, V94, P1678, DOI 10.1136/bjo.2009.168864; D'Cruz BJ, 2002, J CEREBR BLOOD F MET, V22, P843, DOI 10.1097/00004647-200207000-00009; Feng JF, 2010, NEUROSURGERY, V67, P730, DOI 10.1227/01.NEU.0000378023.81727.6E; Geocadin RG, 2012, NAT REV NEUROL, V8, P5, DOI 10.1038/nrneurol.2011.201; Hermann DM, 2012, LANCET NEUROL, V11, P369, DOI 10.1016/S1474-4422(12)70039-X; Imada S, 2010, J NEUROSCI RES, V88, P3457, DOI 10.1002/jnr.22520; Jinno S, 2011, J COMP NEUROL, V519, P451, DOI 10.1002/cne.22527; Kanagawa T, 2006, BRAIN RES, V1111, P36, DOI 10.1016/j.brainres.2006.06.112; Kao CH, 2011, J TRAUMA, V70, P885, DOI 10.1097/TA.0b013e3181e7456d; Kuo JR, 2010, J TRAUMA, V69, P1467, DOI 10.1097/TA.0b013e3181f31b06; Lasarzik I, 2009, ANESTH ANALG, V109, P1632, DOI 10.1213/ANE.0b013e3181bab451; Li L, 2010, GLIA, V58, P1610, DOI 10.1002/glia.21033; Lotocki G, 2011, NEUROSCI LETT, V499, P143, DOI 10.1016/j.neulet.2011.05.056; Manoonkitiwongsa PS, 2004, J CEREBR BLOOD F MET, V24, P693, DOI 10.1097/01.WCB.0000126236.54306.21; Navarro-Sobrino M, 2011, ATHEROSCLEROSIS, V216, P205, DOI 10.1016/j.atherosclerosis.2011.01.030; Oddo M, 2011, CURR OPIN CRIT CARE, V17, P254, DOI 10.1097/MCC.0b013e328344f2ae; Petcu EB, 2010, VASC CELL, V2, DOI 10.1186/2040-2384-2-26; Saito K, 2010, BRAIN RES, V1358, P20, DOI 10.1016/j.brainres.2010.08.048; Schmidt KM, 2004, NEUROSCI LETT, V368, P135, DOI 10.1016/j.neulet.2004.06.071; Schmitt KRL, 2007, NEUROSCI RES, V59, P68, DOI 10.1016/j.neures.2007.05.011; Schmitt KRL, 2010, BRAIN PATHOL, V20, P771, DOI 10.1111/j.1750-3639.2009.00358.x; Shruster A, 2010, APOPTOSIS, V15, P1415, DOI 10.1007/s10495-010-0491-y; Silasi G, 2012, J CEREBR BLOOD F MET, V32, P1525, DOI 10.1038/jcbfm.2012.38; Silasi G, 2011, J CEREBR BLOOD F MET, V31, P1725, DOI 10.1038/jcbfm.2011.25; Trendelenburg G, 2005, GLIA, V50, P307, DOI 10.1002/glia.20204; Vosler PS, 2005, MOL BRAIN RES, V135, P21, DOI 10.1016/j.molbrainres.2004.11.006; Xie YC, 2007, NEUROSCI LETT, V422, P87, DOI 10.1016/j.neulet.2007.03.072; Xiong M, 2011, NEUROCHEM INT, V58, P625, DOI 10.1016/j.neuint.2011.01.026; Yenari MA, 2012, NAT REV NEUROSCI, V13, P267, DOI 10.1038/nrn3174; Yoneyama M, 2011, J PHARMACOL SCI, V115, P425, DOI 10.1254/jphs.11R02CP	33	17	17	0	3	KARGER	BASEL	POSTFACH, CH-4009 BASEL, SWITZERLAND	1660-4431	1662-2804	978-3-318-02309-1; 978-3-318-02308-4	FRONT NEUROL NEUROSC	Front. Neurol. Neurosci.		2013	32						122	128		10.1159/000346428			7	Clinical Neurology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BGG55	WOS:000322844300015	23859971	Green Accepted, Green Published			2022-02-06	
J	Shao, JB; Zhu, HP; Yao, HY; Stallones, L; Yeates, K; Wheeler, K; Xiang, HY				Shao, Jianbo; Zhu, Huiping; Yao, Hongyan; Stallones, Lorann; Yeates, Keith; Wheeler, Krista; Xiang, Huiyun			Characteristics and Trends of Pediatric Traumatic Brain Injuries Treated at a Large Pediatric Medical Center in China, 2002-2011	PLOS ONE			English	Article							COMMON OUTCOME MEASURES; UNIQUE FEATURES; YOUNG-CHILDREN; UNITED-STATES; HEAD TRAUMA; EPIDEMIOLOGY; HOSPITALIZATION; RECOMMENDATIONS; COMPLICATIONS; MECHANISMS	Background: Pediatric traumatic brain injuries (TBIs) have not been well studied in China. This study investigated characteristics and trends of hospitalized TBIs sustained by Chinese children. Methods and Findings: We analyzed 2002-2011 hospitalized TBI patients (0-17 years of age) treated at a large pediatric medical center in China. TBIs were defined using the International Classification of Diseases, Tenth Revision (ICD-10) codes. We examined age patterns across external causes of TBIs. We reported the trend of traffic-related TBIs for each year from 2002 to 2011. Of 4,230 TBI patients, 67.1% (95% CI: 65.4%-68.8%) were city residents and 28.8% (95% CI: 26.3%-31.3%) came from rural villages. Males had disproportionately more TBIs than females (65.2% vs. 34.8%). Falls, struck by/against objects, and traffic collisions were the top three external causes of TBIs for all age groups. Falls were the leading cause of TBI for all ages but peaked at 2 years of age. There were 125 TBIs in 0-2 year olds (5.9% of all TBIs in this age group) that were caused by suspected child abuse. Suspected child abuse was significantly more likely to occur in 0-1 year olds. The proportion of traffic -related TBIs increased significantly from 12.99% in 2002 to 19.68% in 2008 but dropped each subsequent year until it reached a level of 8.91% in 2011. Conclusions: Our study confirms that falls, struck by/against objects and traffic collisions are the top external causes of TBIs in Chinese children. When compared with national data from the developed countries, gender patterns are similar, but the ranking of external causes is different. This is the first study to highlight the important role of suspected child abuse in causing TBIs in infants in China. TBIs caused by child abuse warrant further research and government attention as a social and medical problem in China.	[Shao, Jianbo] Wuhan Childrens Hosp, Dept CT MRI, Wuhan, Hubei, Peoples R China; [Zhu, Huiping] Capital Med Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth & Family Med, Beijing, Peoples R China; [Yao, Hongyan] Chinese Ctr Dis Control & Prevent, Off Epidemiol, Beijing, Peoples R China; [Stallones, Lorann] Colorado State Univ, Dept Psychol, Colorado Injury Control Res Ctr, Ft Collins, CO 80523 USA; [Yeates, Keith] Ohio State Univ, Ctr Biobehav Hlth, Res Inst, Natl Childrens Hosp, Columbus, OH 43210 USA; [Yeates, Keith; Wheeler, Krista; Xiang, Huiyun] Ohio State Univ, Ctr Injury Res & Policy, Res Inst, Natl Childrens Hosp, Columbus, OH 43210 USA		Shao, JB (corresponding author), Wuhan Childrens Hosp, Dept CT MRI, Wuhan, Hubei, Peoples R China.	jbshao2005@yahoo.com.cn; huiyun.xiang@nationwidechildrens.org	Yeates, Keith/AAJ-4223-2020; Stallones, Lorann/AAC-6248-2021; Xiang, Huiyun/E-4335-2011	Stallones, Lorann/0000-0001-7616-582X; Yeates, Keith/0000-0001-7680-2892; Wheeler, Krista/0000-0003-3728-8928	USA-China Agricultural Injury Research Training Project; National Institutes of Health Fogarty International CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [1D43TW007257-01A2]; FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [D43TW007257] Funding Source: NIH RePORTER	Drs. Stallones and Xiang were supported by the USA-China Agricultural Injury Research Training Project, funded by the National Institutes of Health Fogarty International Center (PIs: L Stallones and H Xiang; Grant #: 1D43TW007257-01A2). The views expressed here are those of the authors and do not necessarily reflect the official views of the funding agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson EE, 2012, DEV NEUROREHABIL, V15, P26, DOI 10.3109/17518423.2011.633570; Bo Liu, 2005, J NEURO NEUROREHABIL, V2, P179; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen Hui, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P307; Cole TB, 2004, JAMA-J AM MED ASSOC, V291, P2531, DOI 10.1001/jama.291.21.2531; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; D'Ambrosio R, 2004, CURR OPIN NEUROL, V17, P731, DOI 10.1097/00019052-200412000-00014; Deb S, 1999, AM J PSYCHIAT, V156, P374; Eisele JA, 2006, J HEAD TRAUMA REHAB, V21, P537, DOI 10.1097/00001199-200611000-00008; Harris JE, 2012, BRAIN INJURY, V26, P177, DOI 10.3109/02699052.2011.635361; Harrison J E, 2012, BRAIN INJ, P1; Hu GQ, 2011, B WORLD HEALTH ORGAN, V89, P41, DOI 10.2471/BLT.10.080317; Jellinger K A, 2001, BMC Neurol, V1, P3, DOI 10.1186/1471-2377-1-3; Jiang JY, 2007, SURG NEUROL, V68, P2, DOI 10.1016/j.surneu.2007.09.016; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kuang JG, 2011, JIANGXI MED J, V46, P299; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Minns RA, 2008, AM J PREV MED, V34, pS126, DOI 10.1016/j.amepre.2008.01.016; Murgio A, 1999, CHILD NERV SYST, V15, P318, DOI 10.1007/s003810050401; Pinto PS, 2012, J NEUROIMAGING, V22, pe18, DOI 10.1111/j.1552-6569.2011.00690.x; Pinto PS, 2012, J NEUROIMAGING, V22, pe1, DOI 10.1111/j.1552-6569.2011.00688.x; Polinder S, 2007, B WORLD HEALTH ORGAN, V85, P27, DOI 10.2471/BLT.06.030973; Redelmeier DA, 2003, LANCET, V361, P2177, DOI 10.1016/S0140-6736(03)13770-1; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; SAS, 1999, SAS STAT US GUID VER, V10th; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shi JX, 2009, BRAIN INJURY, V23, P602, DOI 10.1080/02699050903014907; Sun Y, 2006, INJURY, V37, P416, DOI 10.1016/j.injury.2005.12.002; Tieves Kelly S, 2005, WMJ, V104, P22; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; WANG CC, 1986, ARCH NEUROL-CHICAGO, V43, P570, DOI 10.1001/archneur.1986.00520060034013; Wang SY, 2008, LANCET, V372, P1765, DOI 10.1016/S0140-6736(08)61367-7; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; World Health Organization, 1994, INT CLASS DIS REL HL; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Yang SZ, 2002, CHIN J CLIN NEUROSCI, V10, P155; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5; Zhang XJ, 2011, TRAFFIC INJ PREV, V12, P614, DOI 10.1080/15389588.2011.609925; Zhao YD, 2001, WORLD J SURG, V25, P1202	46	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51634	10.1371/journal.pone.0051634			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	066QV	WOS:000313236200151	23251600	Green Published, gold, Green Submitted			2022-02-06	
J	Echlin, PS; Skopelja, EN; Worsley, R; Dadachanji, SB; Lloyd-Smith, DR; Taunton, JA; Forwell, LA; Johnson, AM				Echlin, Paul S.; Skopelja, Elaine N.; Worsley, Rachel; Dadachanji, Shiroy B.; Lloyd-Smith, D. Rob; Taunton, Jack A.; Forwell, Lorie A.; Johnson, Andrew M.			A prospective study of physician-observed concussion during a varsity university ice hockey season: incidence and neuropsychological changes. Part 2 of 4	NEUROSURGICAL FOCUS			English	Article						concussion; ice hockey; incidence; neuropsychological testing; sex; Canada	SCHOOL FOOTBALL PLAYERS; CHRONIC TRAUMATIC ENCEPHALOPATHY; INJURY SURVEILLANCE SYSTEM; SPORT-RELATED CONCUSSION; BASE-LINE VALUES; RECURRENT CONCUSSION; PROFESSIONAL FOOTBALL; DESCRIPTIVE EPIDEMIOLOGY; INTERNATIONAL-CONFERENCE; BRAIN-FUNCTION	Object. The primary objective of this study was to measure the incidence of concussion according to a relative number of athlete exposures among 25 male and 20 female varsity ice hockey players. The secondary objective was to present neuropsychological test results between preseason and postseason play and at 72 hours, 2 weeks, and 2 months after concussion. Methods. Every player underwent baseline assessments using the Sport Concussion Assessment Tool-2 (SCAT2), Immediate Post-Concussion Assessment and Cognitive Test (ImPACT), and MRI. Each regular season and postseason game was observed by 2 independent observers (a physician and a nonphysician observer). Players with a diagnosed concussion were removed from the game, examined in the team physician's office using the SCAT2 and ImPACT, and sent to undergo MRI. Results. Eleven concussions occurred during the 55 physician-observed games (20%). The incidence of concussion, expressed as number of concussions per 1000 athlete exposures, was 10.70 for men and women combined in regular season play, 11.76 for men and women combined across both the regular season and playoff season, 7.50 for men and 14.93 for women in regular season play, and 8.47 for men across both the regular season and playoff season. One male player experienced repeat concussions. No concussions were reported during practice sessions, and 1 concussion was observed and diagnosed in an exhibition game. Neuropsychological testing suggested no statistically significant preseason/postseason differences between athletes who sustained a physician-diagnosed concussion and athletes who did not sustain a physician-diagnosed concussion on either the ImPACT or SCAT2. The athletes who sustained a physician-diagnosed concussion demonstrated few reliable changes postinjury. Conclusions. Although the incidence of game-related concussions per 1000 athlete exposures in this study was half the highest rate reported in the authors' previous research, it was 3 times higher than the incidence reported by other authors within the literature concerning men's collegiate ice hockey and 5 times higher than the highest rate previously reported for woman's collegiate ice hockey. Interestingly, the present results suggest a substantively higher incidence of concussion among women (14.93) than men (7.50). The reproducible and significantly higher incidence of concussion among both men and woman ice hockey players, when compared with nonphysician-observed games, suggests a significant underestimation of sports concussion in the scientific literature. (http://thejns.org/doi/abs/10.3171/2012.10.FOCUS12286)	[Echlin, Paul S.] Elliott Sports Med Clin, Burlington, ON L7N 2G3, Canada; [Skopelja, Elaine N.] Indiana Univ, Sch Med Lib, Indianapolis, IN 46204 USA; [Worsley, Rachel] Univ British Columbia, Sch Phys Therapy, Vancouver, BC V5Z 1M9, Canada; [Dadachanji, Shiroy B.; Taunton, Jack A.] Univ British Columbia, Sch Kinesiol, Vancouver, BC V5Z 1M9, Canada; [Lloyd-Smith, D. Rob] Univ British Columbia, Dept Family Med, Vancouver, BC V5Z 1M9, Canada; [Forwell, Lorie A.] Univ Western Ontario, Fowler Kennedy Sport Med Clin, London, ON, Canada; [Forwell, Lorie A.] Univ Western Ontario, Sch Phys Therapy, London, ON, Canada; [Johnson, Andrew M.] Univ Western Ontario, Sch Hlth Studies, London, ON, Canada		Echlin, PS (corresponding author), Elliott Sports Med Clin, 1100 Walkers Line,Suite 2, Burlington, ON L7N 2G3, Canada.	psechlin@gmail.com	Johnson, Andrew M/B-2048-2012	Johnson, Andrew M./0000-0002-7269-3016; Skopelja, Elaine/0000-0002-2847-8909			Agel J, 2007, J ATHL TRAINING, V42, P241; Agel J, 2007, J ATHL TRAINING, V42, P249; Agel J, 2010, CAN J SURG, V53, P319; Amen DG, 2011, J NEUROPSYCH CLIN N, V23, P98, DOI 10.1176/appi.neuropsych.23.1.98; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Benson BW, 2002, BRIT J SPORT MED, V36, P27, DOI 10.1136/bjsm.36.1.27; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Cusimano M, 2002, CAN J NEUROL SCI S1, V29, pS25; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Delaney JS, 2001, CLIN J SPORT MED, V11, P234, DOI 10.1097/00042752-200110000-00005; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10210; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10187; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.10.FOCUS10222; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Flik K, 2005, AM J SPORT MED, V33, P183, DOI 10.1177/0363546504267349; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Honey CR, 1998, CLIN J SPORT MED, V8, P43, DOI 10.1097/00042752-199801000-00010; Jinguji TM, 2012, BRIT J SPORT MED, V46, P365, DOI 10.1136/bjsports-2011-090526; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Keating P, ESPN MAGAZINE; Langburt W, 2001, J CHILD NEUROL, V16, P83, DOI 10.1177/088307380101600203; Lehman EJ, 2012, NEUROLOGY; Mayers LB, 2012, J CLIN EXP NEUROPSYC, V34, P235, DOI 10.1080/13803395.2011.630655; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; O'Kane JW, 2011, CLIN J SPORT MED, V21, P486, DOI 10.1097/JSM.0b013e31822e89a8; Pinto M, 1999, CLIN J SPORT MED, V9, P70, DOI 10.1097/00042752-199904000-00005; Randolph C, 2005, J ATHL TRAINING, V40, P139; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; Rishiraj N, 2009, J SPORT MED PHYS FIT, V49, P159; Schneider KJ, 2010, BRIT J SPORT MED, V44, P1112, DOI 10.1136/bjsm.2009.071266; Shehata N, 2009, BRIT J SPORT MED, V43, P730, DOI 10.1136/bjsm.2009.059832; Shuttleworth-Edwards AB, 2008, ARCH CLIN NEUROPSYCH, V23, P479, DOI 10.1016/j.acn.2008.07.002; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596; Wessels KK, 2012, ARCH PHYS MED REHAB, V93, P275, DOI 10.1016/j.apmr.2011.09.009; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Yard EE, 2008, AM J SPORT MED, V36, P1930, DOI 10.1177/0363546508318047; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	57	17	17	0	15	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	DEC	2012	33	6							E2	10.3171/2012.10.FOCUS12286			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	048GI	WOS:000311898500003	23199425	Bronze			2022-02-06	
J	Malec, JF; Kean, J; Altman, IM; Swick, S				Malec, James F.; Kean, Jacob; Altman, Irwin M.; Swick, Shannon			Mayo-Portland Adaptability Inventory: Comparing Psychometrics in Cerebrovascular Accident to Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Outcome assessment (health care); Rehabilitation; Stroke	POSTACUTE REHABILITATION; SAMPLE	Malec JF, Kean J, Altman IM, Swick S. Mayo-Portland Adaptability Inventory: comparing psychometrics in cerebrovascular accident to traumatic brain injury. Arch Phys Med Rehabil 2012;93:2271-5. Objectives: (1) To evaluate the measurement reliability and construct validity of the Mayo-Portland Adaptability Inventory, 4th revision (MPAI-4) in a sample consisting exclusively of patients with cerebrovascular accident (CVA) using single parameter (Rasch) item-response methods; (2) to examine the differential item functioning (DIF) by sex within the CVA population; and (3) to examine DIF and differential test functioning (DTF) across traumatic brain injury (TB!) and CVA samples. Design: Retrospective psychometric analysis of rating scale data. Setting: Home- and community-based brain injury rehabilitation program. Participants: Individuals post-CVA (n=861) and individuals with TBI (n=603). Interventions: Not applicable. Main Outcome Measure: MPAI-4. Results: Item data on admission to community-based rehabilitation were submitted to Rasch, DIF, and DTF analyses. The final calibration in the CVA sample revealed satisfactory reliability/separation for persons (.91/3.16) and items (1.00/23.64). DIF showed that items for pain, anger, audition, and memory were associated with higher levels of disability for CVA than TBI patients; whereas, self-care, mobility, and use of hands indicated greater overall disability for TBI patients. DTF analyses showed a high degree of association between the 2 sets of items (R=.92; R-2=.85) and, at most, a 3.7 point difference in raw scores. Conclusions: The MPAI-4 demonstrates satisfactory psychometric properties for use with individuals with CVA applying for interdisciplinary posthospital rehabilitation. DIF reveals clinically meaningful differences between CVA and TBI groups that should be considered in results at the item and subscale level.	[Malec, James F.; Kean, Jacob] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46254 USA; [Malec, James F.; Kean, Jacob] Rehabil Hosp Indiana, Indianapolis, IN 46254 USA; [Altman, Irwin M.] Rehab Walls, Phoenix, AZ USA; [Swick, Shannon] Rehab Walls, Marshall, AZ USA		Malec, JF (corresponding author), Indiana Univ Sch Med, Dept Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46254 USA.	jmalec@rhin.com		Kean, Jacob/0000-0002-8577-0586	National Institute for Neurological Diseases and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [3R42NS059133-02]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R42NS059133] Funding Source: NIH RePORTER	Supported by the National Institute for Neurological Diseases and Stroke by a Small Business Technology Transfer Research grant (no. 3R42NS059133-02).	Altman IM, 2010, ARCH PHYS MED REHAB, V91, P1697, DOI 10.1016/j.apmr.2010.08.001; Badia X., 2002, RASCH MEAS T, V16, P889; Bohac DL, 1997, BRAIN INJURY, V11, P469, DOI 10.1080/713802185; Bond T. G., 2007, APPL RASCH MODEL FUN, V2; Constantinidou F, 2005, J HEAD TRAUMA REHAB, V20, P143, DOI 10.1097/00001199-200503000-00003; Kean J, 2011, J NEUROTRAUM, V28, P745, DOI 10.1089/neu.2010.1573; Linacre J.M., 2002, RASCH MEAS T, V16; Malec J. F., 1994, J HEAD TRAUMA REHAB, V9, P1, DOI [10. 1097/ 00001199- 199412000- 00003, DOI 10.1097/00001199-199412000-00003]; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Malec JF, 2000, J HEAD TRAUMA REHAB, V15, P670, DOI 10.1097/00001199-200002000-00006; Malec JF, 2001, ARCH PHYS MED REHAB, V82, P885, DOI 10.1053/apmr.2001.23895; Malec JF, 2000, ARCH PHYS MED REHAB, V81, P1007, DOI 10.1053/apmr.2000.6980; Malec JF., MANUAL MAYO PORTLAND; Smith AB, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-33; Wyse AE, 2011, APPL PSYCH MEAS, V35, P217, DOI 10.1177/0146621610377082	15	17	18	0	16	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	2012	93	12					2271	2275		10.1016/j.apmr.2012.06.013			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	051IX	WOS:000312121000020	22743410				2022-02-06	
J	McIntosh, SE; Campbell, A; Weber, D; Dow, J; Joy, E; Grissom, CK				McIntosh, Scott E.; Campbell, Aaron; Weber, David; Dow, Jennifer; Joy, Elizabeth; Grissom, Colin K.			Mountaineering Medical Events and Trauma on Denali, 1992-2011	HIGH ALTITUDE MEDICINE & BIOLOGY			English	Article						Denali; Mt. McKinley; injury; illness; rescue	SEVERE FROSTBITE; PREVENTION; GUIDELINES	Scott E. McIntosh, Aaron Campbell, David Weber, Jennifer Dow, Elizabeth Joy, and Colin K. Grissom. Mountaineering Medical Events and Trauma on Denali, 1992-2011. High Alt Med Biol 13:275-280, 2012.-Denali (Mt. McKinley) is the tallest mountain in North America and a popular climbing destination for high altitude mountaineering expeditions. National Park Service (NPS) personnel care for and manage medical incidences and traumatic injuries for mountaineers each year. We retrospectively examined NPS medical reports from the climbing seasons of 1992-2011. Medical complaints, diagnoses, treatment, provider training, and overall numbers of injuries and illness were analyzed. Fatalities were included only if they were cared for by NPS medical personnel prior to death. Of the 24,079 climbers on Denali during this period, 831 (3.5%) required medical assistance from the NPS. There were 819 diagnoses; 502 were due to medical illness and 317 were traumatic injuries. Patient encounters occurred most frequently (71%) at the 4328m camp. Frostbite was the most common individual diagnosis (18.1%), while altitude-related syndromes were the most common illness category (29%). Most patients (84%) were treated and released to descend without additional intervention, whereas 11% needed air evacuation, and 4% needed another type of NPS assistance to descend. The only fatality in this series was caused by traumatic brain injury due to a climbing fall. A broad variety of medical complaints were evaluated and treated by NPS personnel, most commonly altitude related problems and frostbite. The results of the study will enhance the awareness of potential illness and injuries encountered by medical providers participating in high altitude mountaineering expeditions. Additionally, providers responsible for evaluating mountaineers prior to their expeditions can educate them on the spectrum of physical and environmental conditions that increase the chances of illness or injury. This ideally will decrease the incidence of morbidity on both Denali and other high altitude mountaineering destinations.	[McIntosh, Scott E.] Univ Utah, Div Emergency Med, Salt Lake City, UT 84132 USA; [Campbell, Aaron] Adventist Hlth Med Grp, Sandy, OR USA; [Weber, David] Talkeetna Ranger Stn, Denali Natl Pk, Talkeetna, AK USA; [Weber, David] Univ Utah, Remote Rescue Training, Salt Lake City, UT 84132 USA; [Dow, Jennifer] Alaska Reg Hosp, Natl Pk Serv Alaska Reg, Girdwood, AK USA; [Joy, Elizabeth] Intermt Healthcare, Clin Outcomes Res, Salt Lake City, UT USA; [Grissom, Colin K.] Intermt Med Ctr, Shock Trauma ICU, Murray, UT USA		McIntosh, SE (corresponding author), Univ Utah, Div Emergency Med, 30 N Med Dr, Salt Lake City, UT 84132 USA.	Scott.mcintosh@hsc.utah.edu					Bruen KJ, 2007, ARCH SURG-CHICAGO, V142, P546, DOI 10.1001/archsurg.142.6.546; Cauchy E, 2011, NEW ENGL J MED, V364, P189, DOI 10.1056/NEJMc1000538; Harirchi I, 2005, BRIT J SPORT MED, V39, P898, DOI 10.1136/bjsm.2004.016097; Jenabzadeh K, 2006, J BURN CARE RES, V30, pS103; Leigh-Smith S, 2004, WILD ENVIRON MED, V15, P157, DOI 10.1580/1080-6032(2004)15[157:CMPITR]2.0.CO;2; Lischke V, 2001, WILD ENVIRON MED, V12, P74, DOI 10.1580/1080-6032(2001)012[0074:MAITEA]2.0.CO;2; Luks AM, 2010, WILD ENVIRON MED, V21, P146, DOI 10.1016/j.wem.2010.03.002; Mcintosh SE, 2008, HIGH ALT MED BIOL, V9, P89, DOI 10.1089/ham.2008.1047; McIntosh SE, 2011, WILD ENVIRON MED, V22, P156, DOI 10.1016/j.wem.2011.03.003; McIntosh SE, 2010, WILD ENVIRON MED, V21, P103, DOI 10.1016/j.wem.2009.12.024; McLaughlin JB, 2005, WILD ENVIRON MED, V16, P92, DOI 10.1580/1080-6032(2005)16[92:GOAMCT]2.0.CO;2; Mort A, 2011, CLIN J SPORT MED, V21, P530, DOI 10.1097/JSM.0b013e318234be97; National Park Service, 2005, MOUNT DEN NAT PARK R; Roscoe C, 2006, WILD ENVIRON MED, V17, P75, DOI 10.1580/PR03-05.1; Schoffl V, 2011, WILD ENVIRON MED, V22, P46, DOI 10.1016/j.wem.2010.11.008; Smith Larry O, 2006, Phys Med Rehabil Clin N Am, V17, P633, DOI 10.1016/j.pmr.2006.05.003; Twomey JA, 2005, J TRAUMA, V59, P1350, DOI 10.1097/01.ta.0000195517.50778.2e	17	17	18	0	4	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1527-0297			HIGH ALT MED BIOL	High Alt. Med. Biol.	DEC	2012	13	4					275	280		10.1089/ham.2012.1027			6	Biophysics; Public, Environmental & Occupational Health; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Public, Environmental & Occupational Health; Sport Sciences	063LZ	WOS:000313001900008	23270445				2022-02-06	
J	Rogachev, B; Ohayon, S; Saad, A; Vorobiovsky, V; Gruenbaum, BF; Leibowitz, A; Boyko, M; Shapira, Y; Shnaider, A; Zlotnik, M; Azab, AN; Zlotnik, A				Rogachev, Boris; Ohayon, Sharon; Saad, Amit; Vorobiovsky, Victoria; Gruenbaum, Benjamin F.; Leibowitz, Akiva; Boyko, Matthew; Shapira, Yoram; Shnaider, Alla; Zlotnik, Moshe; Azab, Abed N.; Zlotnik, Alexander			The effects of hemodialysis on blood glutamate levels in chronic renal failure: Implementation for neuroprotection	JOURNAL OF CRITICAL CARE			English	Article						Brain injury; Glutamate; Glutamate oxaloacetate transaminase (GOT); Glutamate pyruvate transaminase (GPT); Hemodialysis	AMINO-ACID LOSSES; CLOSED-HEAD INJURY; SCAVENGING ACTIVITY; CLINICAL-TRIALS; ISCHEMIC-STROKE; RAT MODEL; BRAIN; DIALYSIS; PLASMA; COMPARTMENTS	Purpose: The purpose of the present study is to investigate whether hemodialysis (HD) is effective in lowering blood glutamate levels. In addition, we examined the effect of HD on glutamate oxaloacetate transaminase (GOT) and glutamate pyruvate transaminase (GPT) levels in the blood and described the rate and pattern of blood glutamate clearance during HD. Materials and Methods: Blood samples were taken from 45 patients with stage V chronic kidney disease immediately after initiation of HD and hourly, for a total of 5 blood samples. Samples were sent for determination of glutamate, glucose, GOT, GPT, hemoglobin, hematocrit, urea, and creatinine levels. A blood sample from 25 healthy volunteers without chronic renal failure was used as a control for the determination of baseline blood levels of glutamate, GOT, and GPT. Results: Glutamate and GPT levels in patients on HD were higher at baseline compared with healthy controls (P < .001). In the first 3 hours after HD, there was a decrease in blood glutamate levels compared with baseline levels (P < .00001). At the fourth hour, there was an increase in blood glutamate levels compared with the third hour (P < .05). Conclusions: Hemodialysis may be a promising method of reducing blood glutamate levels. (C) 2012 Elsevier Inc. All rights reserved.	[Zlotnik, Alexander] Soroka Med Ctr, Div Anesthesiol, Dept Anesthesiol & Crit Care, IL-84101 Beer Sheva, Israel; [Rogachev, Boris; Shnaider, Alla; Zlotnik, Moshe] Soroka Med Ctr, Dept Nephrol, IL-84101 Beer Sheva, Israel; [Rogachev, Boris; Ohayon, Sharon; Vorobiovsky, Victoria; Gruenbaum, Benjamin F.; Leibowitz, Akiva; Boyko, Matthew; Shapira, Yoram; Shnaider, Alla; Zlotnik, Moshe; Zlotnik, Alexander] Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel; [Saad, Amit] Univ Haifa, Dept Philosophy, IL-31999 Haifa, Israel; [Azab, Abed N.] Ben Gurion Univ Negev, Fac Hlth Sci Ben Gur, Sch Community Hlth Profess, IL-84105 Beer Sheva, Israel		Zlotnik, A (corresponding author), Soroka Med Ctr, Div Anesthesiol, Dept Anesthesiol & Crit Care, IL-84101 Beer Sheva, Israel.	zlotnika@bgu.ac.il		Boyko, Matthew/0000-0003-3116-1643; Leibowitz, Akiva/0000-0003-4244-1915			BERGSTROM J, 1989, ADV EXP MED BIOL, V260, P1; BERL S, 1961, J NEUROCHEM, V7, P186, DOI 10.1111/j.1471-4159.1961.tb13503.x; BERL S, 1962, J BIOL CHEM, V237, P2562; Boyko M, 2011, EUR J NEUROSCI, V34, P1432, DOI 10.1111/j.1460-9568.2011.07864.x; Boyko M, 2010, J NEUROSCI METH, V193, P246, DOI 10.1016/j.jneumeth.2010.08.026; Campos F, 2011, J CEREB BLOOD FLOW M; Campos F, 2011, CLIN SCI LOND; Castillo J, 1997, LANCET, V349, P79, DOI 10.1016/S0140-6736(96)04453-4; Castillo J, 1996, STROKE, V27, P1060, DOI 10.1161/01.STR.27.6.1060; Castro MCM, 2001, NEPHROL DIAL TRANSPL, V16, P1814, DOI 10.1093/ndt/16.9.1814; Choi JY, NEPHROL DIAL TRANSPL; COHEN GA, 1976, ANN INTERN MED, V84, P275, DOI 10.7326/0003-4819-84-3-275; CRAWFORD DR, 1978, NEPHRON, V22, P418, DOI 10.1159/000181484; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Divino JC, 1998, J ENDOCRINOL, V156, P519, DOI 10.1677/joe.0.1560519; Divino JC, 1997, NEPHROL DIAL TRANSPL, V12, P2339; Garred LJ, 1997, NEPHROL DIAL TRANSPL, V12, P535, DOI 10.1093/ndt/12.3.535; Gil HW, 2007, J KOREAN MED SCI, V22, P598, DOI 10.3346/jkms.2007.22.4.598; GIORDANO C, 1980, CLIN NEPHROL, V14, P230; Gottlieb M, 2003, J NEUROCHEM, V87, P119, DOI 10.1046/j.1471-4159.2003.01972.x; GRAHAM LT, 1966, ANAL BIOCHEM, V15, P487, DOI 10.1016/0003-2697(66)90110-2; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; IKIZLER TA, 1994, KIDNEY INT, V46, P830, DOI 10.1038/ki.1994.339; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Johnston MV, 2001, PEDIATR RES, V49, P735, DOI 10.1203/00006450-200106000-00003; KOPPLE JD, 1982, AM J CLIN NUTR, V36, P395, DOI 10.1093/ajcn/36.3.395; Mate M, 2009, EUR J PHARMACOL, V604, P51, DOI 10.1016/j.ejphar.2008.12.022; McIntyre CW, 2010, SEMIN DIALYSIS, V23, P449, DOI 10.1111/j.1525-139X.2010.00782.x; MCLAGGAN D, 1994, J BIOL CHEM, V269, P1911; Morris GF, 1998, NEUROSURGERY, V43, P1369, DOI 10.1097/00006123-199812000-00063; Muir KW, 2006, CURR OPIN PHARMACOL, V6, P53, DOI 10.1016/j.coph.2005.12.002; MUIR KW, 1995, STROKE, V26, P503, DOI 10.1161/01.STR.26.3.503; Nagy D, 2010, CELL MOL NEUROBIOL, V30, P1101, DOI 10.1007/s10571-010-9542-8; O'Kane RL, 1999, J BIOL CHEM, V274, P31891, DOI 10.1074/jbc.274.45.31891; Pakfetrat M, 2010, SAUDI J KIDNEY DIS T, V21, P707; Soupart A, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017903.77985.CD; Sulowicz Wladyslaw, 2007, Med Pregl, V60 Suppl 2, P14; Teichberg VI, 2009, NEUROSCIENCE, V158, P301, DOI 10.1016/j.neuroscience.2008.02.075; Teichberg VI, 2008, NEUROSCIENCE; WOLFSON M, 1982, KIDNEY INT, V21, P500, DOI 10.1038/ki.1982.52; Zauner A, 1996, ACT NEUR S, V67, P40; Zlotnik A, 2010, EXP NEUROL; Zlotnik A, 2010, BIOL REPROD; Zlotnik A, 2011, ANESTHESIOL IN PRESS; Zlotnik A, J NEUROSURG ANESTHES, V23, P45; Zlotnik A, 2009, AM SOC AN ANN M LA U; Zlotnik A, NEUROCHEM RES; Zlotnik A, 2008, AM SOC AN ANN M FL U; Zlotnik A, 2007, NEUROCHEM RES; Zlotnik A, 2008, NEUROCHEM RES, V33, P1044, DOI 10.1007/s11064-007-9548-x; Zlotnik A, 2007, EXP NEUROL, V203, P213, DOI 10.1016/j.expneurol.2006.08.021; Zlotnik A, 2012, INTENS CARE MED, V38, P137, DOI 10.1007/s00134-011-2401-3; Zlotnik A, 2011, BIOL REPROD, V84, P581, DOI 10.1095/biolreprod.110.088120; Zlotnik A, 2011, NEUROCHEM RES, V36, P732, DOI 10.1007/s11064-010-0388-8; Zlotnik A, 2009, J NEUROSURG ANESTH, V21, P235, DOI 10.1097/ANA.0b013e3181a2bf0b	55	17	17	2	11	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	DEC	2012	27	6							743.e1	10.1016/j.jcrc.2012.07.002			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057YF	WOS:000312599800041	23084134				2022-02-06	
J	Yu, ZQ; Zha, JH				Yu, Zheng-Quan; Zha, Ji-Hui			Genetic Ablation of Toll-Like Receptor 2 Reduces Secondary Brain Injury Caused by Cortical Contusion in Mice	ANNALS OF CLINICAL AND LABORATORY SCIENCE			English	Article						Traumatic brain injury; Cerebral inflammation; Toll-like receptor 2	RAT MODEL; ACTIVATION; PROGESTERONE; INFLAMMATION; HEMORRHAGE; EXPRESSION; CYTOKINES	Previous studies have shown that Toll-like receptor 2 (TLR2) was up-regulated after traumatic brain injury (TBI), but the potential contribution of TLR2 to TBI still remains unclear. The present study investigated the role of TLR2 in modulating TBI-induced secondary brain injury in mice. Wild-type TLR2(+/+) and TLR2(-/-)-deficient mice were subjected to a moderately severe weight-drop impact head injury. Brain samples were extracted at 24 hours after trauma. We measured TLR2 by western blot; motor function by Grip test; brain edema by wet/dry method; cortical apoptosis by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) method; and IL-1 beta, TNF-alpha and IL-6 by enzyme-linked immunosorbent assay (ELISA). We found the absence of TLR2 function in mice resulted in ameliorating brain injury as shown by the reduced severity of neurological deficit, apoptosis, and brain edema at 24 hours after TBI, which was associated with the decreased expression of inflammatory cytokines such as tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), and interleukin-6 (IL-6), compared with their wild-type counterparts after TBI. In combination, these results suggest that TLR2 might play an important aggravating role in the pathogenesis of TBI-induced secondary brain injury, possibly by regulating inflammatory cytokines in the cortex.	[Yu, Zheng-Quan] Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou 215006, Jiangsu, Peoples R China; [Zha, Ji-Hui] Xuzhou Med Coll, Dept Neurosurg, Xuzhou 221002, Jiangsu, Peoples R China		Yu, ZQ (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou 215006, Jiangsu, Peoples R China.	yuzhengquan1964@gmail.com					Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Chen G, 2008, ANN CLIN LAB SCI, V38, P65; Chen G, 2007, NEUROSCI LETT, V425, P177, DOI 10.1016/j.neulet.2007.08.022; Chen G, 2009, CYTOKINE, V45, P162, DOI 10.1016/j.cyto.2008.11.015; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; Hang CH, 2005, NEUROL INDIA, V53, P312, DOI 10.4103/0028-3886.16930; Hellal F, 2004, NEUROSCI LETT, V357, P21, DOI 10.1016/j.neulet.2003.12.036; Hua F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-42; Johnson GB, 2003, CRIT REV IMMUNOL, V23, P15, DOI 10.1615/CritRevImmunol.v23.i12.20; Johnson Pauline, 2009, Crit Rev Immunol, V29, P347; Kenny EF, 2008, CYTOKINE, V43, P342, DOI 10.1016/j.cyto.2008.07.010; Kupina NC, 2001, J NEUROTRAUM, V18, P1229, DOI 10.1089/089771501317095269; Lee Sung Joong, 2002, Current Drug Targets - Inflammation and Allergy, V1, P181; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Mallard C, 2009, CLIN PERINATOL, V36, P763, DOI 10.1016/j.clp.2009.07.009; Merrill JE, 1996, TRENDS NEUROSCI, V19, P331, DOI 10.1016/0166-2236(96)10047-3; Palsson-McDermott EM, 2007, IRISH J MED SCI, V176, P253, DOI 10.1007/s11845-007-0103-1; Park C, 2008, NEUROSCI LETT, V431, P123, DOI 10.1016/j.neulet.2007.11.057; RAMILO O, 1990, J EXP MED, V172, P497, DOI 10.1084/jem.172.2.497; Sen O, 2011, TURK NEUROSURG, V21, P203, DOI 10.5137/1019-5149.JTN.3646-10.1; Yuan TM, 2010, J NEUROIMMUNOL, V229, P16, DOI 10.1016/j.jneuroim.2010.08.008	23	17	17	0	9	ASSOC CLINICAL SCIENTISTS	MIDDLEBURY	PO BOX 1287, MIDDLEBURY, VT 05753 USA	0091-7370	1550-8080		ANN CLIN LAB SCI	Ann. Clin. Lab. Sci.	WIN	2012	42	1					26	33					8	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	980SR	WOS:000306913900005	22371907				2022-02-06	
J	Kucherov, Y; Hubler, GK; DePalma, RG				Kucherov, Yan; Hubler, Graham K.; DePalma, Ralph G.			Blast induced mild traumatic brain injury/concussion: A physical analysis	JOURNAL OF APPLIED PHYSICS			English	Article							WATER; BRILLOUIN; SPECTRUM; INJURY	Currently, a consensus exists that low intensity non-impact blast wave exposure leads to mild traumatic brain injury (mTBI). Considerable interest in this "invisible injury" has developed in the past few years but a disconnect remains between the biomedical outcomes and possible physical mechanisms causing mTBI. Here, we show that a shock wave travelling through the brain excites a phonon continuum that decays into specific acoustic waves with intensity exceeding brain tissue strength. Damage may occur within the period of the phonon wave, measured in tens to hundreds of nanometers, which makes the damage difficult to detect using conventional modalities. [http://dx.doi.org/10.1063/1.4765727]	[Kucherov, Yan; Hubler, Graham K.] USN, Div Mat Sci & Technol, Res Lab, Washington, DC 20375 USA; [DePalma, Ralph G.] Dept Vet Affairs, Washington, DC 20420 USA		Hubler, GK (corresponding author), USN, Div Mat Sci & Technol, Res Lab, Code 6360,4555 Overlook Ave SW, Washington, DC 20375 USA.	graham.hubler@nrl.navy.mil			US Marine Corps Systems Command; PM Infantry Combat Equipment; US Veterans Administration ORD	We thank Jeffrey Byers for useful comments. This work was sponsored by the US Marine Corps Systems Command, PM Infantry Combat Equipment, and US Veterans Administration ORD. The authors report no conflicts of interest and no commercial sponsorships as they pertain to this topic. The opinions expressed herein are those of the authors. They do not and should not be interpreted as belonging to or being endorsed by the Department of Veterans Affairs, Department of Defense, or the Government of the United States.	Boteler JM, 2004, J APPL PHYS, V96, P6919, DOI 10.1063/1.1810635; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Garai J., 2009, J FLUID PHASE EQUILI, V283, P89; Graham, 1997, MODERN SUPERABSORBEN; Granacher R. P., 2007, TRAUMATIC BRAIN INJU, P6; Hrapko M, 2008, BIORHEOLOGY, V45, P663, DOI 10.3233/BIR-2008-0512; Kucherov Y, 2012, J APPL PHYS, V111, DOI 10.1063/1.3675274; LEIRO JA, 1989, SURF SCI, V211, P350, DOI 10.1016/0039-6028(89)90789-9; Lin A. P., 2012, METAB IMAGING BEHAV, V6, P208; Ling GSF, 2011, CURR OPIN ANESTHESIO, V24, P124, DOI 10.1097/ACO.0b013e32834458da; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mott D.R., 2008, P 20 INT S MIL ASP B; NOVIKOV AG, 1990, J STRUCT CHEM+, V31, P77, DOI 10.1007/BF00752017; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Park E, 2011, J NEUROTRAUM, V28, P343, DOI 10.1089/neu.2009.1050; PRATESI G, 1995, MEAS SCI TECHNOL, V6, P41, DOI 10.1088/0957-0233/6/1/008; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Scarcelli G, 2008, NAT PHOTONICS, V2, P39, DOI 10.1038/nphoton.2007.250; Shah NJ, 2011, METHODS MOL BIOL, V711, P29, DOI 10.1007/978-1-61737-992-5_3; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Taraskin SN, 2000, PHYS REV B, V61, P12031, DOI 10.1103/PhysRevB.61.12031; Topolovec-Vranic J, 2011, J TRAUMA, V71, pS478, DOI 10.1097/TA.0b013e318232fa70; WALRAFEN GE, 1990, J PHYS CHEM-US, V94, P2237, DOI 10.1021/j100369a008; Weinberger S, 2011, NATURE, V477, P390, DOI 10.1038/477390a; Zeldovich Y., 2002, PHYS SHOCK WAVES HIG, P705	28	17	17	0	17	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	0021-8979	1089-7550		J APPL PHYS	J. Appl. Phys.	NOV 15	2012	112	10							104701	10.1063/1.4765727			5	Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Physics	049GF	WOS:000311969800158					2022-02-06	
J	Burke, MJ; Chundamala, J; Tator, CH				Burke, Matthew J.; Chundamala, Josie; Tator, Charles H.			Deficiencies in Concussion Education in Canadian Medical Schools	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article							KNOWLEDGE	Background: Recent reports raise concern that physician knowledge of the identification and management of concussion may be deficient. There is little information known about the adequacy of concussion education provided to physicians or medical students. The present study assesses the concussion curriculum offered at medical schools in Canada. Methods: We asked all 17 Canadian medical schools to complete a questionnaire on their concussion curriculum, including the following: year of medical school offered; format/setting; and estimated teaching hours. The responses were organized into three categories: ( I) concussion-specific education; (2) head injury education incorporating a concussion component; and (3) no concussion education. Results: Replies were received from 14 (82%) of the 17 medical schools in Canada. Of the 14 responding schools, four (29%) provided concussion-specific education, six (43%) offered head injury education that incorporated a concussion component, and four (29%) reported no concussion teaching in their curriculum. Conclusion: We found deficiencies in the concussion education curriculum provided in the majority of Canadian medical schools. To address this issue, we recommend that all medical schools should, at a minimum, include a one-hour formal concussion-specific teaching session in an early year of their curriculum to be followed by clinical exposure to concussed patients in the later years of medical school. Future studies will be necessary to evaluate if these recommended curricular enhancements are effective in remedying the reported gaps in physicians' concussion knowledge and whether the improved curriculum translates into better care for patients suffering concussion.	Univ Toronto, Toronto, ON M5T 2S8, Canada; Toronto Western Hosp, Toronto, ON M5T 2S8, Canada		Tator, CH (corresponding author), Univ Toronto, ThinkFirst Canada Toronto Western Hosp, 399 Bathurst St,Ste 4W-433, Toronto, ON M5T 2S8, Canada.	charles.tator@uhn.ca			Ontario Neurotrauma Foundation	This research study was supported by funding from the Ontario Neurotrauma Foundation.	Boggild M, 2012, CAN J NEUROL SCI, V39, P361, DOI 10.1017/S0317167100013524; Colantonio A, 2010, CAN J NEUROL SCI, V37, P783, DOI 10.1017/S0317167100051441; Covassin T, 2009, J ATHL TRAINING, V44, P400, DOI 10.4085/1062-6050-44.4.400; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Demorest RA, 2005, PEDIATRICS, V115, P28, DOI 10.1542/peds.2004-0266; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Medical Council of Canada, OBJ QUAL EX; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180	9	17	17	1	6	CANADIAN JOURNAL NEUROLOGICAL SCIENCES INC	CALGARY	709-7015 MACLEOD TRAIL SW, CALGARY, AB T2H 2K6, CANADA	0317-1671			CAN J NEUROL SCI	Can. J. Neurol. Sci.	NOV	2012	39	6					763	766		10.1017/S0317167100015584			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	034FX	WOS:000310859000009	23230614	Bronze			2022-02-06	
J	Costine, BA; Quebeda-Clerkin, PB; Dodge, CP; Harris, BT; Hillier, SC; Duhaime, AC				Costine, Beth A.; Quebeda-Clerkin, Patricia B.; Dodge, Carter P.; Harris, Brent T.; Hillier, Simon C.; Duhaime, Ann-Christine			Neuron-Specific Enolase, but Not S100B or Myelin Basic Protein, Increases in Peripheral Blood Corresponding to Lesion Volume after Cortical Impact in Piglets	JOURNAL OF NEUROTRAUMA			English	Article						age; biomarkers; controlled cortical impact	TRAUMATIC BRAIN-INJURY; SERUM-LEVELS; CEREBROSPINAL-FLUID; INFANTS; MARKERS	A peripheral indicator of the presence and magnitude of brain injury has been a sought-after tool by clinicians. We measured neuron-specific enolase (NSE), myelin basic protein (MBP), and S100B, prior to and after scaled cortical impact in immature pigs, to determine if these purported markers increase after injury, correlate with the resulting lesion volume, and if these relationships vary with maturation. Scaled cortical impact resulted in increased lesion volume with increasing age. Concentrations of NSE, but not S100B or MBP, increased after injury in all age groups. The high variability of S100B concentrations prior to injury may have precluded detection of an increase due to injury. Total serum markers were estimated, accounting for the allometric growth of blood volume, and resulted in a positive correlation of both NSE and S100B with lesion volume. Even with allometric scaling of blood volume and a uniform mechanism of injury, NSE had only a fair to poor predictive value. In a clinical setting, where the types of injuries are varied, more investigation is required to yield a panel of serum markers that can reliably predict the extent of injury. Allometric scaling may improve estimation of serum marker release in pediatric populations.	[Costine, Beth A.; Duhaime, Ann-Christine] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurosurg, Boston, MA USA; [Quebeda-Clerkin, Patricia B.] Childrens Hosp Cent Calif, Dept Neurosurg, Madera, CA USA; [Dodge, Carter P.; Hillier, Simon C.] Dartmouth Hitchcock Med Ctr, Dept Anesthesiol, Dartmouth Med Sch, Lebanon, NH 03766 USA; [Harris, Brent T.] Georgetown Univ, Med Ctr, Dept Pathol, Washington, DC 20007 USA; [Harris, Brent T.] Georgetown Univ, Med Ctr, Dept Neurol, Washington, DC 20007 USA		Costine, BA (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurosurg, 149 13th St,Room 3-405, Charlestown, MA 02129 USA.	bcostine@partners.org			NIH's National Institute of Child Health and Human Development [R01 (HD45364-5)]; Pediatric Neurosurgery Research Fund from the Children's Hospital at Dartmouth; Nicolas T. Zervas Endowed Chair Fund of Massachusetts General Hospital Department of Neurosurgery; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD045364] Funding Source: NIH RePORTER	This study was supported by an R01 (HD45364-5) from the NIH's National Institute of Child Health and Human Development, the Pediatric Neurosurgery Research Fund from the Children's Hospital at Dartmouth, and the Nicolas T. Zervas Endowed Chair Fund of Massachusetts General Hospital Department of Neurosurgery.	Abraham H, 2010, INT J DEV NEUROSCI, V28, P401, DOI 10.1016/j.ijdevneu.2010.03.004; Bechtel K, 2009, PEDIATRICS, V124, pE697, DOI 10.1542/peds.2008-1493; Berger RP, 2006, PEDIATRICS, V117, P325, DOI 10.1542/peds.2005-0711; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI 10.1089/neu.2008-0738; BUSH JA, 1955, AM J PHYSIOL, V181, P9, DOI 10.1152/ajplegacy.1955.181.1.9; Cata JP, 2011, BRIT J ANAESTH, V107, P844, DOI 10.1093/bja/aer338; Costine B.A., 2011, ISOFLURANE SOLE ANES; Darrow DC, 1928, J CLIN INVEST, V5, P243, DOI 10.1172/JCI100156; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Geyer C, 2009, J NEUROS-PEDIATR, V4, P339, DOI 10.3171/2009.5.PEDS08481; Gyorgy A, 2011, J NEUROTRAUM, V28, P1121, DOI 10.1089/neu.2010.1561; HANSEN TWR, 1992, PEDIATR RES, V32, P524, DOI 10.1203/00006450-199211000-00005; Harauz G, 2009, BIOCHEMISTRY-US, V48, P8094, DOI 10.1021/bi901005f; HARDEMARK HG, 1988, STROKE, V19, P1140, DOI 10.1161/01.STR.19.9.1140; HULLIN DA, 1980, BIOCHIM BIOPHYS ACTA, V628, P98, DOI 10.1016/0304-4165(80)90355-4; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Kleindienst A, 2005, J NEUROTRAUM, V22, P645, DOI 10.1089/neu.2005.22.645; Knibbe CAJ, 2005, BRIT J CLIN PHARMACO, V59, P705, DOI 10.1111/j.1365-2125.2005.02239.x; Missios S, 2009, J NEUROTRAUM, V26, P1943, DOI [10.1089/neu.2009.0956, 10.1089/neu.2009-0956]; Nemergut M, 2011, ANN M SOC PED AN SAN; Nylen K, 2008, ACTA NEUROCHIR, V150, P221, DOI 10.1007/s00701-007-1489-2; OLIVA D, 1989, GENE, V79, P355, DOI 10.1016/0378-1119(89)90217-5; Pelinka LE, 2005, SHOCK, V24, P119, DOI 10.1097/01.shk.0000168876.68154.43; Piazza O, 2007, PEDIATR NEUROSURG, V43, P258, DOI 10.1159/000103304; Portela LVC, 2002, CLIN CHEM, V48, P950; Rainey T, 2009, RESUSCITATION, V80, P341, DOI 10.1016/j.resuscitation.2008.11.021; Rizzi S, 2010, ANN NY ACAD SCI, V1199, P43, DOI 10.1111/j.1749-6632.2009.05173.x; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Rothoerl RD, 2000, ACTA NEUROCHIR, V142, P199, DOI 10.1007/s007010050024; Woertgen C, 2001, J NEUROTRAUM, V18, P569, DOI 10.1089/089771501300227378; YAMAZAKI Y, 1995, SURG NEUROL, V43, P267, DOI 10.1016/0090-3019(95)80012-6; Zhao H, 2012, RESUSCITATION, V83, P913, DOI 10.1016/j.resuscitation.2012.01.001	35	17	20	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2012	29	17					2689	2695		10.1089/neu.2012.2428			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	047QU	WOS:000311856400010	22867012	Green Published			2022-02-06	
J	Hu, HT; Xiao, F; Yan, YQ; Wen, SQ; Zhang, L				Hu, Hai-Tao; Xiao, Feng; Yan, Yu-Qing; Wen, Shu-Qun; Zhang, Liang			The prognostic value of serum tau in patients with intracerebral hemorrhage	CLINICAL BIOCHEMISTRY			English	Article						Intracerebral hemorrhage; Outcome; Stroke; Tau	TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; CEREBROSPINAL-FLUID; NEUROFIBRILLARY TANGLES; ALZHEIMERS-DISEASE; PROTEIN; PREDICT; LOCALIZATION; MORTALITY; MARKER	Objectives: This study aimed to investigate the relationship between serum tau concentrations and 3-month clinical outcomes in patients with intracerebral hemorrhage. Design and methods: Serum tau concentrations of 176 patients were quantified by enzyme-linked immunosorbent assay. The end points were mortality and poor outcome (modified Rankin Scale score > 2) after 3 months. Results: 110 patients (62.5%) had a poor outcome at 3 months. The 3-month mortality rate was 36.4% (64/176). A forward stepwise logistic regression selected serum tau concentration as an independent predictor for 3-month mortality (P = 0.002) and poor outcomes (P = 0.009) of patients. A receiver operating characteristic curve analysis showed that serum tau concentration predicted 3-month mortality (P = 0.001) and poor outcomes (P = 0.001) statistically significantly. The area under curve of tau was similar to that of the National Institutes of Health Stroke Scale score for 3-month mortality (P = 0.715) and poor outcomes (P = 0.315). In a combined logistic-regression model, tau statistically significantly improved the area under curve of the National Institutes of Health Stroke Scale score for the prediction of 3-month poor outcome (P = 0.039), but not for the prediction of 3-month mortality (P = 0.106). Conclusions: Serum tau concentration represents a novel biomarker for predicting mortality and poor outcomes at 3 months in patients with intracerebral hemorrhage. (C) 2012 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.	[Hu, Hai-Tao; Yan, Yu-Qing; Wen, Shu-Qun; Zhang, Liang] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurol, Hangzhou 310000, Zhejiang, Peoples R China; [Xiao, Feng] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Neurosurg, Hangzhou 310000, Zhejiang, Peoples R China		Zhang, L (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurol, 88 Jiefang Rd, Hangzhou 310000, Zhejiang, Peoples R China.	haohaowangwan@126.com					Andersen KK, 2009, STROKE, V40, P2068, DOI 10.1161/STROKEAHA.108.540112; Ariesen MJ, 2005, J NEUROL NEUROSUR PS, V76, P839, DOI 10.1136/jnnp.2004.048223; Bielewicz J, 2011, J MOL NEUROSCI, V43, P241, DOI 10.1007/s12031-010-9403-4; Bitsch A, 2002, EUR NEUROL, V47, P45, DOI 10.1159/000047946; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Cheung C. M., 2008, Hong Kong Medical Journal, V14, P367; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Hesse Camilla, 2000, Journal of Alzheimer's Disease, V2, P199; HIMMLER A, 1989, MOL CELL BIOL, V9, P1381, DOI 10.1128/MCB.9.4.1381; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Kurzepa J, 2010, J CLIN NEUROSCI, V17, P997, DOI 10.1016/j.jocn.2010.01.005; Liliang PC, 2010, J SURG RES, V160, P302, DOI 10.1016/j.jss.2008.12.022; Otto M, 2003, RESTOR NEUROL NEUROS, V21, P191; Shiiya N, 2004, ANN THORAC SURG, V77, P2034, DOI 10.1016/j.athoracsur.2003.12.057; Tapiola T, 1997, NEUROREPORT, V8, P3961, DOI 10.1097/00001756-199712220-00022; Tashiro K, 1997, NEUROREPORT, V8, P2797, DOI 10.1097/00001756-199708180-00029; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Wunderlich MT, 2006, CLIN NEUROL NEUROSUR, V108, P558, DOI 10.1016/j.clineuro.2005.12.006; Zanier ER, 2008, ACTA NEUROCHIR SUPPL, V102, P339, DOI 10.1007/978-3-211-85578-2_65	20	17	17	0	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0009-9120	1873-2933		CLIN BIOCHEM	Clin. Biochem.	NOV	2012	45	16-17					1320	1324		10.1016/j.clinbiochem.2012.06.003			5	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	036WY	WOS:000311064200009	22705449				2022-02-06	
J	Yanuck, D; Mihos, CG; Santana, O				Yanuck, Danielle; Mihos, Christos G.; Santana, Orlando			Mechanisms and Clinical Evidence of the Pleiotropic Effects of the Hydroxy-Methyl-Glutaryl-CoA Reductase Inhibitors in Central Nervous System Disorders: A Comprehensive Review	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						brain; CNS; neurology; non-lipid lowering; statins	AMYOTROPHIC-LATERAL-SCLEROSIS; TRAUMATIC BRAIN-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; RANDOMIZED CONTROLLED-TRIAL; TRANSIENT ISCHEMIC ATTACK; GUILLAIN-BARRE-SYNDROME; MULTIPLE-SCLEROSIS; STATIN USE; ALZHEIMERS-DISEASE; INTRACEREBRAL HEMORRHAGE	The hydroxy-methyl-glutaryl-CoA reductase inhibitors, better known as statins, are principally used in the treatment of hyperlipidemia and play a pivotal role in the primary and secondary prevention of atherosclerotic heart disease and stroke. Evidence also exists for the potential benefits from statin use in a variety of other disease processes, conferred via their non-lipid lowering properties, which are known as pleiotropic effects. Our paper serves as a focused and updated discussion on the pleiotropic effects of statins in neurological disorders. Emphasis is placed on the discussion of randomized, placebo-controlled trials, and their importance in further elucidating this interesting phenomenon.	[Santana, Orlando] Columbia Univ, Div Cardiol, Mt Sinai Heart Inst, Echocardiog Lab, Miami Beach, FL 33140 USA; [Yanuck, Danielle] Mt Sinai Med Ctr, Dept Internal Med, Miami Beach, FL 33140 USA		Santana, O (corresponding author), Columbia Univ, Div Cardiol, Mt Sinai Heart Inst, Echocardiog Lab, 4300 Alton Rd, Miami Beach, FL 33140 USA.	osantana@msmc.com					Abellan-Miralles I, 2006, REV NEUROLOGIA, V43, P659, DOI 10.33588/rn.4311.2006100; Abrahamson EE, 2009, ANN NEUROL, V66, P407, DOI 10.1002/ana.21731; Amarenco P, 2009, LANCET NEUROL, V8, P453, DOI 10.1016/S1474-4422(09)70058-4; Amarenco P, 2006, NEW ENGL J MED, V355, P549; Bar EE, 2008, EXPERT OPIN INV DRUG, V17, P185, DOI 10.1517/13543784.17.2.185; Bar-On P, 2008, J NEUROCHEM, V105, P1656, DOI 10.1111/j.1471-4159.2008.05254.x; Beltowski J, 2010, MED SCI MONITOR, V16, pRA73; Bessler H, 1999, BIOMED PHARMACOTHER, V53, P141, DOI 10.1016/S0753-3322(99)80079-1; Beziaud T, 2011, CRIT CARE MED, V39, P2300, DOI 10.1097/CCM.0b013e3182227e4a; Biffi A, 2011, NEUROLOGY, V76, P1581, DOI 10.1212/WNL.0b013e3182194be9; Birnbaum G, 2008, NEUROLOGY, V71, P1390, DOI 10.1212/01.wnl.0000319698.40024.1c; Blanco M, 2007, NEUROLOGY, V69, P904, DOI 10.1212/01.wnl.0000269789.09277.47; Boimel M, 2009, J NEUROPATH EXP NEUR, V68, P314, DOI 10.1097/NEN.0b013e31819ac3cb; Carlsson CM, EVALUATE SAFETY EFFE; Carlsson CM, 2008, J ALZHEIMERS DIS, V13, P187; Cemeus C, 2008, J NEURO-ONCOL, V90, P9, DOI 10.1007/s11060-008-9627-0; Chen JL, 2003, ANN NEUROL, V53, P743, DOI 10.1002/ana.10555; Chroinin DN, 2011, STROKE, V42, P1021, DOI 10.1161/STROKEAHA.110.596734; Collins R, 2004, LANCET, V363, P757; Correale J, 2007, AUTOIMMUNITY, V40, P148, DOI 10.1080/08916930601183522; Damier P, SAFETY EFFICACY PRAV; Diringer M, STATINS CEREBRAL BLO; Edwards IR, 2007, DRUG SAFETY, V30, P515, DOI 10.2165/00002018-200730060-00005; Endres M, 1998, P NATL ACAD SCI USA, V95, P8880, DOI 10.1073/pnas.95.15.8880; Everett BM, 2010, CIRCULATION, V121, P143, DOI 10.1161/CIRCULATIONAHA.109.874834; Feldman HH, 2010, NEUROLOGY, V74, P956, DOI 10.1212/WNL.0b013e3181d6476a; Figueiredo E, ROLE STATINS PREVENT; Flint AC, 2012, STROKE, V43, P147, DOI 10.1161/STROKEAHA.111.627729; Frederiksen JL, SIMVASTATIN TREATMEN; Frederiksen JL, SIMVASTATIN ADD ON T; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Gao X, 2012, ARCH NEUROL-CHICAGO, V69, P380, DOI 10.1001/archneurol.2011.1060; Ghosh A, 2009, J NEUROSCI, V29, P13543, DOI 10.1523/JNEUROSCI.4144-09.2009; Goldstein LB, 2008, NEUROLOGY, V70, P2364, DOI 10.1212/01.wnl.0000296277.63350.77; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Golomb BA, 2009, DRUG SAFETY, V32, P649, DOI 10.2165/00002018-200932080-00004; Haag MDM, 2009, J NEUROL NEUROSUR PS, V80, P13, DOI 10.1136/jnnp.2008.150433; Hackam DG, 2011, CIRCULATION, V124, P2233, DOI 10.1161/CIRCULATIONAHA.111.055269; Harris JR, 2010, SUBCELL BIOCHEM, V51, P47, DOI 10.1007/978-90-481-8622-8_2; Hoe Heo J, EFFECTS VERY EARLY U; Ifergan I, 2006, ANN NEUROL, V60, P45, DOI 10.1002/ana.20875; Indraswari F, 2012, J NEUROTRAUM, V29, P1388, DOI 10.1089/neu.2011.2117; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Kazui H, CLIN STUDY PITAVASTA; Koob AO, 2010, EXP NEUROL, V221, P267, DOI 10.1016/j.expneurol.2009.11.015; Kramer AH, 2010, NEUROCRIT CARE, V12, P285, DOI 10.1007/s12028-009-9306-9; Kurinami H, 2008, INT J MOL MED, V21, P531; Lanzillo R, 2010, MULT SCLER J, V16, P450, DOI 10.1177/1352458509358909; Lapchak PA, 2009, BRAIN RES, V1303, P144, DOI 10.1016/j.brainres.2009.09.064; Li G, 2007, NEUROLOGY, V69, P878, DOI 10.1212/01.wnl.0000277657.95487.1c; Li G, 2010, J AM GERIATR SOC, V58, P1311, DOI 10.1111/j.1532-5415.2010.02906.x; Li XL, 2011, CELL IMMUNOL, V271, P455, DOI 10.1016/j.cellimm.2011.08.015; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Markovic-Plese S, 2008, FUTUR NEUROL, V3, P153, DOI 10.2217/14796708.3.2.153; Matsumoto M, JAPAN STATIN TREATME; Miesbach W, 2005, J NEUROL SCI, V238, P93, DOI 10.1016/j.jns.2005.06.008; Migrino R, CAROTID PLAQUE REGRE; Mihos CG, 2012, RHEUMATOL INT, V32, P287, DOI 10.1007/s00296-011-2008-6; Mihos CG, 2011, INT J GEN MED, V4, P261, DOI 10.2147/IJGM.S16779; Mihos CG, 2010, CARDIOL REV, V18, P298, DOI 10.1097/CRD.0b013e3181f52a7f; Miron VE, 2007, GLIA, V55, P130, DOI 10.1002/glia.20441; Miron VE, 2009, AM J PATHOL, V174, P1880, DOI 10.2353/ajpath.2009.080947; Mutez E, 2009, PHARMACOL RES, V60, P41, DOI 10.1016/j.phrs.2009.03.010; Paintlia AS, 2009, GLIA, V57, P182, DOI 10.1002/glia.20745; Patassini S, 2008, NEUROSCI LETT, V448, P166, DOI 10.1016/j.neulet.2008.10.023; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Pugh MJV, 2009, J AM GERIATR SOC, V57, P237, DOI 10.1111/j.1532-5415.2008.02124.x; Putaala J, 2011, NEUROLOGY, V77, P426, DOI 10.1212/WNL.0b013e318227b1c2; Rajabally YA, 2004, MUSCLE NERVE, V30, P663, DOI 10.1002/mus.20112; Rockwood K, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-26; Rojas-Fernandez CH, 2012, ANN PHARMACOTHER, V46, P549, DOI 10.1345/aph.1Q620; Rosand J, 2000, NEUROLOGY, V55, P947, DOI 10.1212/WNL.55.7.947; Roy A, 2011, NEUROSCIENTIST, V17, P244, DOI 10.1177/1073858410385006; Rudick RA, 2009, NEUROLOGY, V72, P1989, DOI 10.1212/WNL.0b013e3181a92b96; Sarkey JP, 2007, J NEUROCHEM, V100, P1265, DOI 10.1111/j.1471-4159.2006.04309.x; Schneider EB, 2011, J TRAUMA, V71, P815, DOI 10.1097/TA.0b013e3182319de5; Scola RH, 2004, ARQ NEURO-PSIQUIAT, V62, P540, DOI 10.1590/S0004-282X2004000300031; Serbanescu I, 2004, J LIPID RES, V45, P2038, DOI 10.1194/jlr.M400097-JLR200; Sillberg VAH, 2008, STROKE, V39, P2622, DOI 10.1161/STROKEAHA.107.508341; Sironi L, 2003, ARTERIOSCL THROM VAS, V23, P322, DOI 10.1161/01.ATV.0000044458.23905.3B; Smith SC, 2006, CIRCULATION, V113, P2363, DOI 10.1161/CIRCULATIONAHA.106.174516; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; Sorensen HT, 2010, CIRC-CARDIOVASC QUAL, V3, P413, DOI 10.1161/CIRCOUTCOMES.110.936278; Sorensen PS, 2011, LANCET NEUROL, V10, P691, DOI 10.1016/S1474-4422(11)70144-2; Sparks DL, 2006, ACTA NEUROL SCAND, V114, P3, DOI 10.1111/j.1600-0404.2006.00690.x; Squizzato A, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007551.pub2; Sterzer P, 2001, STROKE, V32, P2817, DOI 10.1161/hs1201.099663; Sugawara T, 2008, ACTA NEUROCHIR SUPPL, V104, P287; Tandon V., 2005, Indian Journal of Pharmacology, V37, P77; Tapia-Perez JH, 2008, J NEUROTRAUM, V25, P1011, DOI 10.1089/neu.2008.0554; Togha M, 2010, MULT SCLER J, V16, P848, DOI 10.1177/1352458510369147; Trompet S, 2010, J NEUROL, V257, P85, DOI 10.1007/s00415-009-5271-7; Tsakiri A, 2010, EXP NEUROL, V221, P320, DOI 10.1016/j.expneurol.2009.11.014; Valone F, IMMUNOTHERAPY BHT 30; Vergouwen MDI, 2008, STROKE, V39, P497, DOI 10.1161/STROKEAHA.107.488791; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Wang Q, 2011, EXP NEUROL, V230, P27, DOI 10.1016/j.expneurol.2010.04.006; Weber MS, 2008, CURR TOP MICROBIOL, V318, P313; Westover MB, 2011, ARCH NEUROL-CHICAGO, V68, P573, DOI 10.1001/archneurol.2010.356; Whitfield JF, 2006, EXPERT OPIN INV DRUG, V15, P1479, DOI 10.1517/13543784.15.12.1479; Whitmer RA, 2005, NEUROLOGY, V64, P277, DOI 10.1212/01.WNL.0000149519.47454.F2; Wolozin B, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-20; Woo D, 2002, STROKE, V33, P1190, DOI 10.1161/01.STR.0000014774.88027.22; Yan JQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020945; Zinman L, 2008, AMYOTROPH LATERAL SC, V9, P223, DOI 10.1080/17482960802031092	105	17	17	0	10	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0020-7454			INT J NEUROSCI	Int. J. Neurosci.	NOV	2012	122	11					619	629		10.3109/00207454.2012.704455			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	019PK	WOS:000309751600001	22720798				2022-02-06	
J	Garland, P; Broom, LJ; Quraishe, S; Dalton, PD; Skipp, P; Newman, TA; Perry, VH				Garland, Patrick; Broom, Lucy J.; Quraishe, Shmma; Dalton, Paul D.; Skipp, Paul; Newman, Tracey A.; Perry, V. Hugh			Soluble Axoplasm Enriched from Injured CNS Axons Reveals the Early Modulation of the Actin Cytoskeleton	PLOS ONE			English	Article							SPINAL-CORD-INJURY; RAT PERIPHERAL-NERVE; WALLERIAN DEGENERATION; OPTIC-NERVE; CELL-DEATH; NEURONS; TRANSPORT; REGENERATION; HIPPOCAMPAL; RETROGRADE	Axon injury and degeneration is a common consequence of diverse neurological conditions including multiple sclerosis, traumatic brain injury and spinal cord injury. The molecular events underlying axon degeneration are poorly understood. We have developed a novel method to enrich for axoplasm from rodent optic nerve and characterised the early events in Wallerian degeneration using an unbiased proteomics screen. Our detergent-free method draws axoplasm into a dehydrated hydrogel of the polymer poly(2-hydroxyethyl methacrylate), which is then recovered using centrifugation. This technique is able to recover axonal proteins and significantly deplete glial contamination as confirmed by immunoblotting. We have used iTRAQ to compare axoplasm-enriched samples from naive vs injured optic nerves, which has revealed a pronounced modulation of proteins associated with the actin cytoskeleton. To confirm the modulation of the actin cytoskeleton in injured axons we focused on the RhoA pathway. Western blotting revealed an augmentation of RhoA and phosphorylated cofilin in axoplasm-enriched samples from injured optic nerve. To investigate the localisation of these components of the RhoA pathway in injured axons we transected axons of primary hippocampal neurons in vitro. We observed an early modulation of filamentous actin with a concomitant redistribution of phosphorylated cofilin in injured axons. At later time-points, RhoA is found to accumulate in axonal swellings and also colocalises with filamentous actin. The actin cytoskeleton is a known sensor of cell viability across multiple eukaryotes, and our results suggest a similar role for the actin cytoskeleton following axon injury. In agreement with other reports, our data also highlights the role of the RhoA pathway in axon degeneration. These findings highlight a previously unexplored area of axon biology, which may open novel avenues to prevent axon degeneration. Our method for isolating CNS axoplasm also represents a new tool to study axon biology.	[Garland, Patrick; Broom, Lucy J.; Perry, V. Hugh] Univ Southampton, Southampton Gen Hosp, Ctr Biol Sci, Southampton, Hants, England; [Dalton, Paul D.] Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai 200030, Peoples R China		Garland, P (corresponding author), Univ Southampton, Southampton Gen Hosp, Ctr Biol Sci, Southampton, Hants, England.	pg1p07@soton.ac.uk	Dalton, Paul/AAO-9805-2021; Perry, V. Hugh/Y-2935-2019; Newman, Tracey A/I-8884-2012	Dalton, Paul/0000-0001-9602-4151; Newman, Tracey A/0000-0002-3727-9258; Garland, Patrick/0000-0002-7679-6426	(EU) NeuroproMiSe [LSHM-CT-2005-018637]; Multiple Sclerosis Society (United Kingdom); Kerkut Trust (United Kingdom)	(EU) NeuroproMiSe: LSHM-CT-2005-018637. Multiple Sclerosis Society (United Kingdom). Kerkut Trust (United Kingdom). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin D, 2010, J NEUROTRAUM, V27, P349; Arundell M, 2011, LAB CHIP, V11, P3001, DOI 10.1039/c1lc20120d; Beirowski B, 2010, J NEUROPATH EXP NEUR, V69, P455, DOI 10.1097/NEN.0b013e3181da84db; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; BRADY ST, 1982, SCIENCE, V218, P1129, DOI 10.1126/science.6183745; BUCKMASTER EA, 1995, EUR J NEUROSCI, V7, P1596, DOI 10.1111/j.1460-9568.1995.tb01155.x; CAMPENOT RB, 1994, J NEUROBIOL, V25, P599, DOI 10.1002/neu.480250603; Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248; Conrad S, 2005, J COMP NEUROL, V487, P166, DOI 10.1002/cne.20561; Fath T, 2009, NAT PROTOC, V4, P78, DOI 10.1038/nprot.2008.199; Franklin-Tong VE, 2008, BIOCHEM J, V413, P389, DOI 10.1042/BJ20080320; Hejcl A, 2008, PHYSIOL RES, V57, pS121, DOI 10.33549/physiolres.931606; Hemphill MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022899; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Larsen AK, 2008, BIOCHEM J, V411, P657, DOI 10.1042/BJ20070522; LAWSON LJ, 1994, J NEUROCYTOL, V23, P729, DOI 10.1007/BF01268086; LUNN ER, 1989, EUR J NEUROSCI, V1, P27, DOI 10.1111/j.1460-9568.1989.tb00771.x; Madura T, 2004, EMBO REP, V5, P412, DOI 10.1038/sj.embor.7400117; MARQUIS JK, 1974, J NEUROCHEM, V23, P1085, DOI 10.1111/j.1471-4159.1974.tb10763.x; Masiero L, 1999, J CELL SCI, V112, P3205; Michaelevski I, 2010, MOL CELL PROTEOMICS, V9, P976, DOI 10.1074/mcp.M900369-MCP200; Minamide LS, 2000, NAT CELL BIOL, V2, P628, DOI 10.1038/35023579; Morley SC, 2003, J CELL BIOCHEM, V88, P1066, DOI 10.1002/jcb.10449; Paul C, 2002, MOL CELL BIOL, V22, P816, DOI 10.1128/MCB.22.3.816-834.2002; Perlson E, 2004, MOL CELL PROTEOMICS, V3, P510, DOI 10.1074/mcp.M400004-MCP200; PERRY VH, 1991, EUR J NEUROSCI, V3, P102, DOI 10.1111/j.1460-9568.1991.tb00815.x; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rishal I, 2010, DEV NEUROBIOL, V70, P126, DOI 10.1002/dneu.20755; Saxena S, 2007, PROG NEUROBIOL, V83, P174, DOI 10.1016/j.pneurobio.2007.07.007; SCHLAEPFER WW, 1979, BRAIN RES, V168, P299, DOI 10.1016/0006-8993(79)90171-9; SCHLAEPFER WW, 1974, BRAIN RES, V78, P71, DOI 10.1016/0006-8993(74)90354-0; SCHMIED R, 1993, J NEUROSCI, V13, P4064; Taylor AM, 2009, J NEUROSCI, V29, P4697, DOI 10.1523/JNEUROSCI.6130-08.2009; Thomas SG, 2006, J CELL BIOL, V174, P221, DOI 10.1083/jcb.200604011; VERONESI B, 1988, EXP NEUROL, V101, P176, DOI 10.1016/0014-4886(88)90002-7; Waller, 1850, PHILOS T R SOC LOND, VI, P423, DOI [10.1098/rspl.1843.0224, DOI 10.1098/RSTL.1850.0021]; Wu CH, 2012, NATURE, V488, P499, DOI 10.1038/nature11280; Yamagishi S, 2005, J BIOL CHEM, V280, P20384, DOI 10.1074/jbc.M501945200	39	17	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47552	10.1371/journal.pone.0047552			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	WOS:000310310200049	23115653	Green Submitted, Green Published, Green Accepted, gold			2022-02-06	
J	Chew, BG; Spearman, CM; Quigley, MR; Wilberger, JE				Chew, Brandon G.; Spearman, Christopher M.; Quigley, Matthew R.; Wilberger, James E.			The prognostic significance of traumatic brainstem injury detected on T2-weighted MRI Clinical article	JOURNAL OF NEUROSURGERY			English	Article						trauma; brainstem injury; MRI; volumetric analysis; outcome; traumatic brain injury	SEVERE HEAD-INJURY; GLASGOW COMA SCALE; MAGNETIC-RESONANCE; DATA-BANK; CLASSIFICATION; TOMOGRAPHY; MECHANISM; SEVERITY; LESIONS; SCORE	Object. Magnetic resonance imaging is frequently used to evaluate patients with traumatic brain injury in the acute and subacute setting, and it can detect injuries to the brainstem, which are often associated with poor outcomes. This study was undertaken to determine which MRI and clinical factors provide prognostic information in patients with traumatic brainstem injuries. Methods. The authors performed a retrospective analysis of cases involving patients admitted to a Level I trauma center who were identified in a prospective database as having suffered traumatic brainstem injury identified on MRI. Patient outcomes were dichotomized to dead/vegetative versus functional groups. Standard demographic data, admission Glasgow Coma Scale (GCS) scores, results of the motor component of the GCS examination at admission and 24 hours later, CT scan findings, and peak intracranial pressure were collected from medical records. Volumetric analysis of each patient's injuries was performed with T2-weighted and gradient echo sequences. The T2-weighted MRI sequence for each patient was reviewed to determine the anatomical location of injury within the brainstem and whether the injury crossed the midline. Results. Thirty-six patients who met the study inclusion criteria were identified. At 6-month follow-up, 53% of these patients had poor outcomes and 47% had recovered. Patients with injuries to the medulla or deep bilateral injuries to the pons did not recover. The T2 volumes were found superior to gradient echo sequences in regard to predicting survival (ROC/AUC 0.67, p = 0.07 vs 0.60, p = 0.29, respectively), but neither reached statistical significance. The timing of MR image acquisition did not influence the findings. The time from admission to MRI did not differ significantly between the recovered group and the poor-outcome group (p = 0.52, Mann-Whitney test), and lesion size as measured by T2 volume did not vary with time to scan (R-2 = 0.03, p = 0.3, linear regression). Performing a stepwise logistic regression with all the variables yielded the following factors related to recovery: crossing midline, p = 0.0156, OR 0.075; and 24-hour GCS motor score, p = 0.0045, OR = 2.25, c-statistic 0.913. Further examination of these 2 factors disclosed the following: none of 15 patients with midline-crossing lesions and a 24-hour GCS motor score of 4 or less recovered; conversely, 12 of 13 patients with lesions that did not cross midline recovered, regardless of GCS motor score. Conclusions. Bilateral injury to the pons and medulla as detected on T2-weighted MRI sequences was associated with poor outcome in patients with brainstem injuries; T2 volumes were found superior to gradient echo sequences in regard to predicting survival, but neither reached statistical significance. When MRI findings were coupled with clinical examination findings, a strong correlation existed between poor outcome and the combination of bilateral brainstem injury and a motor GCS score of 4 or less 24 hours after admission. (http://thejns.org/doi/abs/10.3171/2012.6.JNS111736)	[Chew, Brandon G.; Spearman, Christopher M.; Quigley, Matthew R.; Wilberger, James E.] Allegheny Gen Hosp, Dept Neurosurg, Pittsburgh, PA 15212 USA		Chew, BG (corresponding author), Allegheny Gen Hosp, Dept Neurosurg, 420 East North Ave,Suite 302, Pittsburgh, PA 15212 USA.	bgcneuromd@gmail.com					CORDOBES F, 1986, ACTA NEUROCHIR, V81, P27, DOI 10.1007/BF01456261; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; Firsching R, 1998, J NEUROSURG, V89, P707, DOI 10.3171/jns.1998.89.5.0707; Gerber DJ, 2004, BRAIN INJURY, V18, P1083, DOI 10.1080/02699050410001672341; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; Lagares A, 2006, NEUROCIRUGIA, V17, P105; LOBATO RD, 1986, J NEUROSURG, V65, P784, DOI 10.3171/jns.1986.65.6.0784; Mannion RJ, 2007, J NEUROTRAUM, V24, P128, DOI 10.1089/neu.2006.0127; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Ross SE, 1998, J TRAUMA, V45, P42, DOI 10.1097/00005373-199807000-00008; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; Shibata Y, 2000, CLIN NEUROL NEUROSUR, V102, P124, DOI 10.1016/S0303-8467(00)00095-0; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Wedekind C, 2002, BRIT J NEUROSURG, V16, P256, DOI 10.1080/02688690220148842; WILBERGER JE, 1987, NEUROSURGERY, V20, P571, DOI 10.1227/00006123-198704000-00011; Woischneck D, 2003, CHILD NERV SYST, V19, P174, DOI 10.1007/s00381-002-0703-z	23	17	17	0	6	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085			J NEUROSURG	J. Neurosurg.	OCT	2012	117	4					722	728		10.3171/2012.6.JNS111736			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	015YZ	WOS:000309485600021	22860606				2022-02-06	
J	Song, KS; Ramnani, K; Bae, KC; Cho, CH; Lee, KJ; Son, ES				Song, Kwang Soon; Ramnani, Kirti; Bae, Ki Cheor; Cho, Chul Hyun; Lee, Kyung Jae; Son, Eun Seok			Indirect Reduction of the Radial Head in Children With Chronic Monteggia Lesions	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						chronic Monteggia lesion; ulna osteotomy; closed reduction; children	ANNULAR LIGAMENT RECONSTRUCTION; ANTERIOR DISLOCATION; FRACTURE-DISLOCATIONS; ULNAR OSTEOTOMY	Objective: The purpose of this study was to report the long-term follow-up results of chronic Monteggia fractures treated with angulation-translation osteotomy of ulna and closed reduction of the radial head. Design: Retrospective. Setting: Level 1 trauma center. Patients: We retrospectively reviewed 10 missed Monteggia fractures in children. The mean age of the patients was 7.5 years (range, 6-10 years), and there were 2 girls and 8 boys. The mean duration of time between initial injury and initial presentation was 1.7 years (range, 6 weeks to 5 years). Intervention: Closed reduction with ulna osteotomy or lengthening was performed in all 10 cases. Annular ligament reconstruction (ALR) was done in 2 cases. Final follow-up ranged from 3 to 20 years (mean 10 years). Main Outcome Measurement: We assessed preoperative and postoperative radiographs to evaluate the quality of the radial head reduction. Clinical results were assessed according to the functional elbow score devised by Kim et al. Results: Radial head reduction was achieved and maintained in 8 of 10 cases after primary or secondary surgery. The radial head was mildly subluxated in one case and dislocated in another case at final follow-up. ALR was performed in only 2 cases. Open reduction and ALR is not required in every case, and its need should depend on intraoperative stability of radial head.	[Song, Kwang Soon; Ramnani, Kirti; Bae, Ki Cheor; Cho, Chul Hyun; Lee, Kyung Jae; Son, Eun Seok] Keimyung Univ, Dept Orthoped Surg, Taegu 700712, South Korea		Song, KS (corresponding author), Keimyung Univ, Dept Orthoped Surg, 194 Dongsandong, Taegu 700712, South Korea.	skspos@dsmc.or.kr		Song, Kwang Soon/0000-0001-6029-1901; Cho, Chul-Hyun/0000-0003-0252-8741			Bell Tawse A J, 1965, J Bone Joint Surg Br, V47, P718; BEST TN, 1994, J PEDIATR ORTHOPED, V14, P193, DOI 10.1097/01241398-199403000-00012; Bhaskar A, 2010, J CHILD ORTHOP, V4, P479, DOI 10.1007/s11832-010-0286-2; Cappellino A, 1998, J PEDIATR ORTHOPED, V18, P410, DOI 10.1097/00004694-199805000-00026; De Boeck H, 2000, CLIN ORTHOP RELAT R, P215; Degreff I, 2004, J ORTHOP TRAUMA, V18, P375, DOI 10.1097/00005131-200407000-00008; Devnani AS, 1997, INJURY, V28, P131, DOI 10.1016/S0020-1383(96)00160-X; Exner GU, 2001, J BONE JOINT SURG BR, V83B, P547, DOI 10.1302/0301-620X.83B4.11103; FREEDMAN L, 1988, J BONE JOINT SURG BR, V70, P846, DOI 10.1302/0301-620X.70B5.3192599; Gyr BM, 2004, J PEDIATR ORTHOP B, V13, P402, DOI 10.1097/01202412-200411000-00011; Hasler CC, 2005, J BONE JOINT SURG BR, V87B, P88, DOI 10.1302/0301-620X.87B1.14669; HIRAYAMA T, 1987, J BONE JOINT SURG BR, V69, P639, DOI 10.1302/0301-620X.69B4.3611173; Hui JHP, 2005, J PEDIATR ORTHOPED, V25, P501, DOI 10.1097/01.bpo.0000158812.37225.b3; Kim HT, 2002, J PEDIATR ORTHOPED, V22, P583, DOI 10.1097/00004694-200209000-00004; Kim HT, 2002, J PEDIATR ORTHOPED, V22, P591, DOI 10.1097/01.BPO.0000023140.69745.72; LLOYDROBERTS GC, 1977, J BONE JOINT SURG BR, V59, P402, DOI 10.1302/0301-620X.59B4.925049; Nakamura K, 2009, J BONE JOINT SURG AM, V91A, P1394, DOI 10.2106/JBJS.H.00644; ONER FC, 1993, J BONE JOINT SURG BR, V75, P577, DOI 10.1302/0301-620X.75B4.8331112; Rodgers WB, 1996, J BONE JOINT SURG AM, V78A, P1322, DOI 10.2106/00004623-199609000-00005; Slongo TF, 2008, OPER ORTHOPADE TRAUM, V20, P435, DOI 10.1007/s00064-008-1414-8; STOLL TM, 1992, J BONE JOINT SURG BR, V74, P436, DOI 10.1302/0301-620X.74B3.1587897; Wang MN, 2006, J ORTHOP TRAUMA, V20, P1, DOI 10.1097/01.bot.0000189881.75421.92	22	17	21	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0890-5339	1531-2291		J ORTHOP TRAUMA	J. Orthop. Trauma	OCT	2012	26	10					597	601		10.1097/BOT.0b013e3182548981			5	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	022LV	WOS:000309961800016	22495527				2022-02-06	
J	Ding, J; Yuan, F; Guo, Y; Chen, SW; Gao, WW; Wang, G; Cao, HL; Ju, SM; Chen, H; Zhang, PQ; Tian, HL				Ding, Jun; Yuan, Fang; Guo, Yan; Chen, Shi-Wen; Gao, Wen -Wei; Wang, Gan; Cao, He-Li; Ju, Shi-Ming; Chen, Hao; Zhang, Peng-Qi; Tian, Heng-Li			A prospective clinical study of routine repeat computed tomography (CT) after traumatic brain injury (TBI)	BRAIN INJURY			English	Article						Traumatic brain injury; routine computed tomography; progressive haemorrhage	MINIMAL HEAD-INJURY; RISK-FACTORS; HEMORRHAGE; MODERATE	Purpose: To discuss the repeated CT scanning in patients with traumatic brain injury (TBI) and to identify the conditions under which this approach is necessary. Methods: One hundred and seventy-one patients who suffered TBI but were not surgically treated were divided into two groups: the routine-repeat CT group (n=89) and the non-routine-repeat CT group (n=82). The patients' clinical characteristics were compared. T-tests and stepwise logistic regression were used for analysis. Patients in the routine-repeat CT group were divided into three groups according to GCS scores to determine the need for routinely repeated CT scans. Results: The results revealed statistically significant differences between the two groups in terms of neuro-ICU-LOS and LOS (p<0.01). No significant differences emerged with respect to hospital charges and GCS scores at discharge (p>0.05). AGE, international normalized ratio (INR), D-dimer concentration (DD), GCS scores and number of hours between the first CT scan and the injury (HCT1) were influential factors of developing progressive haemorrhage. Conclusion: The routine-repeat CT group fared better than did the non-routine-repeat CT group. Routinely repeated CTs were minimally effective among those with mild TBI, whereas this procedure demonstrated a significant effect on patients with moderate and severe TBI.	[Ding, Jun; Yuan, Fang; Guo, Yan; Chen, Shi-Wen; Gao, Wen -Wei; Wang, Gan; Cao, He-Li; Ju, Shi-Ming; Chen, Hao; Zhang, Peng-Qi; Tian, Heng-Li] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Neurosurg, Shanghai 200233, Peoples R China		Tian, HL (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Neurosurg, Shanghai 200233, Peoples R China.	tianhengli1964@yahoo.com.cn			Shanghai Science and Technology CommitteeShanghai Science & Technology Committee [10JC1412500]	This work was supported by a grant from the Shanghai Science and Technology Committee (No. 10JC1412500). The authors report no conflicts of interest.	Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chao A, 2001, J TRAUMA, V51, P870, DOI 10.1097/00005373-200111000-00008; Falimirski ME, 2003, J TRAUMA, V55, P1, DOI 10.1097/01.TA.0000071295.67263.A2; Figg RE, 2003, J TRAUMA, V55, P1061, DOI 10.1097/01.TA.0000096712.90133.5C; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Patel NY, 2000, J TRAUMA, V48, P367, DOI 10.1097/00005373-200003000-00001; Sifri ZC, 2004, AM J SURG, V187, P338, DOI 10.1016/j.amjsurg.2003.12.015; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Stein SC, 2008, J TRAUMA, V65, P66, DOI 10.1097/TA.0b013e318068d75f; Tabori U, 2000, CRIT CARE MED, V28, P840, DOI 10.1097/00003246-200003000-00038; Tian HL, 2008, NEUROSURG REV, V31, P431, DOI 10.1007/s10143-008-0153-5; Tian HL, 2008, SURG NEUROL, V69, P241, DOI 10.1016/j.surneu.2007.02.032; Valadka A, 2000, TRAUMA, P377; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d	19	17	18	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2012	26	10					1211	1216		10.3109/02699052.2012.667591			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	984GR	WOS:000307178600006	22571813				2022-02-06	
J	Frankenfield, DC; Ashcraft, CM				Frankenfield, David C.; Ashcraft, Christine M.			Description and prediction of resting metabolic rate after stroke and traumatic brain injury	NUTRITION			English	Article						Brain injury; Stroke; Critical illness; Energy metabolism	CRITICALLY-ILL PATIENTS; ENERGY-EXPENDITURE; MECHANICAL VENTILATION; BODY-TEMPERATURE; VALIDATION; MODERATE; OBESE; HYPERMETABOLISM; HEMORRHAGE; SEVERITY	Objective: To compare the effect of stroke on the metabolic rate compared with the effect of traumatic brain injury and to determine whether the metabolic rate is predictable in both types of brain injury. Methods: Indirect calorimetry was conducted prospectively in mechanically ventilated patients within the first 6 d of admission to a critical care unit owing to ischemic stroke, hemorrhagic stroke, isolated traumatic brain injury, or traumatic brain injury with collateral injuries. Clinical data were collected simultaneously and a predicted value of the resting metabolic rate was calculated using the Penn State equation (using body size, body temperature, and minute ventilation). Results: One hundred thirty patients were measured. Ischemic stroke showed a lower incidence of fever, a lower body temperature, and a lower resting metabolic rate than the other groups; whereas in hemorrhagic stroke, these variables were similar to the trauma groups. Sedation decreased the resting metabolic rate, but this effect seemed particular to the trauma patients. The Penn State equation predicted the resting metabolic rate accurately 72% of the time, and when its component variables of body temperature and minute ventilation were controlled in an analysis of variance, all the differences among the brain injury and sedation groups were eliminated. Conclusion: Stroke is a hypermetabolic event most of the time. Body size, temperature, and minute ventilation explain most of the variation in the resting metabolic rate after traumatic and nontraumatic brain injuries. The Penn State equation therefore predicts the resting metabolic rate in brain-injured patients no matter the mechanism of injury. (C) 2012 Elsevier Inc. All rights reserved.	[Frankenfield, David C.] Penn State Milton S Hershey Med Ctr, Dept Clin Nutr, Hershey, PA USA; Penn State Milton S Hershey Med Ctr, Dept Nursing, Hershey, PA USA		Frankenfield, DC (corresponding author), Penn State Milton S Hershey Med Ctr, Dept Clin Nutr, Hershey, PA USA.	Dfrankenfield@hmc.psu.edu					Audebert HJ, 2004, STROKE, V35, P2128, DOI 10.1161/01.STR.0000137607.61697.77; Bardutzky J, 2004, INTENS CARE MED, V30, P151, DOI 10.1007/s00134-003-1988-4; Bardutzky J, 2004, J NEUROSURG, V100, P266, DOI 10.3171/jns.2004.100.2.0266; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boysen G, 2001, STROKE, V32, P413, DOI 10.1161/01.STR.32.2.413; Bruder N, 1998, CRIT CARE MED, V26, P568, DOI 10.1097/00003246-199803000-00033; CHIOLERO RL, 1993, METABOLIC SUPPORT CR, P95; Compher C, 2006, J AM DIET ASSOC, V106, P881, DOI 10.1016/j.jada.2006.02.009; Esper DH, 2006, JPEN-PARENTER ENTER, V30, P71, DOI 10.1177/014860710603000271; Finestone HM, 2003, STROKE, V34, P502, DOI 10.1161/01.STR.0000053031.12332.FB; Foley N, 2008, J NEUROTRAUM, V25, P1415, DOI 10.1089/neu.2008.0628; Frankenfield D, 2011, JPEN-PARENTER ENTER, V35, P264, DOI 10.1177/0148607110377903; Frankenfield DC, 2009, JPEN-PARENTER ENTER, V33, P27, DOI 10.1177/0148607108322399; Frankenfield DC, 2003, J AM DIET ASSOC, V103, P1152, DOI 10.1016/S0002-8223(03)00982-9; Frankenfield DC, 1997, INJURY, V28, P617, DOI 10.1016/S0020-1383(97)00117-4; GARREL DR, 1994, AM J CLIN NUTR, V59, P971, DOI 10.1093/ajcn/59.5.971; HEYMSFIELD SB, 1987, AM J CLIN NUTR, V45, P526, DOI 10.1093/ajcn/45.3.526; Kasuya H, 1998, NEUROSURGERY, V42, P1268, DOI 10.1097/00006123-199806000-00038; Krakau K, 2006, BRAIN INJURY, V20, P345, DOI 10.1080/02699050500487571; KRONMAL RA, 1993, J ROY STAT SOC A STA, V156, P379, DOI 10.2307/2983064; MIFFLIN MD, 1990, AM J CLIN NUTR, V51, P241, DOI 10.1093/ajcn/51.2.241; PHANG PT, 1990, JPEN-PARENTER ENTER, V14, P259, DOI 10.1177/0148607190014003259; RAUBENHEIMER D, 1995, FUNCT ECOL, V9, P21, DOI 10.2307/2390086; Raurich JM, 2007, JPEN-PARENTER ENTER, V31, P58, DOI 10.1177/014860710703100158; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Vizzini A, 2011, NUTRITION, V27, P129, DOI 10.1016/j.nut.2010.05.004; WEEKES E, 1992, CLIN NUTR, V11, P18, DOI 10.1016/0261-5614(92)90058-X; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363	28	17	17	0	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0899-9007			NUTRITION	Nutrition	SEP	2012	28	9					906	911		10.1016/j.nut.2011.12.008			6	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	994DQ	WOS:000307911500015	22464552				2022-02-06	
J	Leonardo, CC; Musso, J; Das, M; Rowe, DD; Collier, LA; Mohapatra, S; Pennypacker, KR				Leonardo, Christopher C.; Musso, James; Das, Mahasweta; Rowe, Derrick D.; Collier, Lisa A.; Mohapatra, Shyam; Pennypacker, Keith R.			CCL20 Is Associated with Neurodegeneration Following Experimental Traumatic Brain Injury and Promotes Cellular Toxicity In Vitro	TRANSLATIONAL STROKE RESEARCH			English	Article						Chemokine; Hypoxia; Inflammation; Ischemia; MIP-3 alpha; Rodent	ISCHEMIA-REPERFUSION; LIVER; ISCHEMIA/REPERFUSION; MECHANISMS; EXPRESSION; STROKE; DEATH; RATS	Traumatic brain injury (TBI) is complex and involves multiple processes that contribute to functional decline. Progressive neuropathies result from delayed cellular death following the initial impact. Although the precise mechanisms responsible for delayed injury are unknown, numerous data implicate a role for the peripheral immune system in perpetuating neuroinflammation after TBI. A previous report demonstrated that splenic CCL20 chemokine expression was upregulated 24 h after lateral fluid percussive impact (LFPI), prior to neuronal expression but consistent with neurodegeneration. Here, we expand on those data to report increased CCL20 protein expression in white matter 48 h after LFPI and demonstrate that CCL20 is directly toxic to primary neurons and oligodendrocytes subjected to oxygen glucose deprivation. The temporal expression profile of CCL20, coupled with in vitro toxicity to primary cells, suggests that this chemokine exerts deleterious effects on cell viability following TBI. These findings warrant further investigations into the use of CCL20 as a potential biomarker and/or therapeutic target.	[Pennypacker, Keith R.] Univ S Florida, Dept Mol Pharmacol & Physiol, Sch Biomed Sci, Morsani Coll Med, Tampa, FL 32612 USA; [Mohapatra, Shyam] Univ S Florida, Coll Med, Dept Internal Med, Sch Biomed Sci, Tampa, FL 32612 USA; [Leonardo, Christopher C.; Musso, James; Rowe, Derrick D.; Collier, Lisa A.; Pennypacker, Keith R.] Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 32612 USA; [Das, Mahasweta; Mohapatra, Shyam] Univ S Florida, Morsani Coll Med, Dept Internal Med, Tampa, FL 32612 USA		Pennypacker, KR (corresponding author), Univ S Florida, Dept Mol Pharmacol & Physiol, Sch Biomed Sci, Morsani Coll Med, Tampa, FL 32612 USA.	smohapat@health.usf.edu; kpennypa@health.usf.edu	Mohapatra, Shyam/C-2500-2012; Pennypacker, Keith/I-5092-2012		NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 NS052839]	This work was supported by NIH RO1 NS052839. We want to thank Dr. Christopher Katnik and Jesus Recio for their effort with the primary neuronal cultures. There are no conflicts of interest.	Ajmo CT, 2008, J NEUROSCI RES, V86, P2227, DOI 10.1002/jnr.21661; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Das M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-148; Duckworth EAM, 2005, BRAIN RES, V1042, P29, DOI 10.1016/j.brainres.2005.02.021; Fan CG, 1999, J MOL MED, V77, P577, DOI 10.1007/s001099900029; Freyaldenhoven TE, 1997, BRAIN RES, V759, P9, DOI 10.1016/S0006-8993(97)00045-0; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hall AA, 2009, J NEUROSCI RES, V87, P333, DOI 10.1002/jnr.21857; Jaeschke H, 2000, J GASTROEN HEPATOL, V15, P718, DOI 10.1046/j.1440-1746.2000.02207.x; Jiang HC, 2007, SURGERY, V141, P32, DOI 10.1016/j.surg.2006.03.024; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Li M, 2011, J TRAUMA, V71, P141, DOI [10.1097/TA.0b013e3181f30fc9, 10.1088/1742-5468/2011/12/P12001]; Okuaki Y, 1996, LIVER, V16, P188; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rowe DD, 2010, BRAIN RES, V1366, P172, DOI 10.1016/j.brainres.2010.09.078; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Savas MC, 2003, J PEDIATR SURG, V38, P1465, DOI 10.1016/S0022-3468(03)00497-4; Shimizu Y, 2001, HEPATOLOGY, V34, P311, DOI 10.1053/jhep.2001.26631; Walker PA, 2010, EXP NEUROL, V225, P341, DOI 10.1016/j.expneurol.2010.07.005	19	17	17	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1868-4483			TRANSL STROKE RES	Transl. Stroke Res.	SEP	2012	3	3			SI		357	363		10.1007/s12975-012-0203-8			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	992FK	WOS:000307760800009	24323811				2022-02-06	
J	Schuur, JD; Brown, MD; Cheung, DS; Graff, L; Griffey, RT; Hamedani, AG; Kelly, JJ; Klauer, K; Phelan, M; Sierzenski, PR; Raja, AS				Schuur, Jeremiah D.; Brown, Michael D.; Cheung, Dickson S.; Graff, Louis; Griffey, Richard T.; Hamedani, Azita G.; Kelly, John J.; Klauer, Kevin; Phelan, Michael; Sierzenski, Paul R.; Raja, Ali S.			Assessment of Medicare's Imaging Efficiency Measure for Emergency Department Patients With Atraumatic Headache	ANNALS OF EMERGENCY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; QUALITY-OF-CARE; RADIATION-EXPOSURE; UNITED-STATES; FREQUENCY; VISITS; CT	Study objective: Computed tomography (CT) use has increased rapidly, raising concerns about radiation exposure and cost. The Centers for Medicare & Medicaid Services (CMS) developed an imaging efficiency measure (Outpatient Measure 15 [OP-15]) to evaluate the use of brain CT in the emergency department (ED) for atraumatic headache. We aim to determine the reliability, validity, and accuracy of OP-15. Methods: This was a retrospective record review at 21 US EDs. We identified 769 patient visits that CMS labeled as including an inappropriate brain CT to identify clinical indications for CT and reviewed the 748 visits with available records. The primary outcome was the reliability of OP-15 as determined by CMS from administrative data compared with medical record review. Secondary outcomes were the measure's validity and accuracy. Outcome measures were defined according to the testing protocol of the American Medical Association's Physician Consortium for Performance Improvement. Results: On record review, 489 of 748 ED brain CTs identified as inappropriate by CMS had a measure exclusion documented that was not identified by administrative data; the measure was 34.6% reliable (95% confidence interval [CI] 31.2% to 38.0%). Among the 259 patient visits without measure exclusions documented in the record, the measure's validity was 47.5% (95% CI 41.4% to 53.6%), according to a consensus list of indications for brain CT. Overall, 623 of the 748 ED visits had either a measure exclusion or a consensus indication for CT; the measure's accuracy was 16.7% (95% CI 14% to 19.4%). Hospital performance as reported by CMS did not correlate with the proportion of CTs with a documented clinical indication (r=-0.11; P=.63). Conclusion: The CMS imaging efficiency measure for brain CTs (OP-15) is not reliable, valid, or accurate and may produce misleading information about hospital ED performance. [Ann Emerg Med. 2012;60:280-290.]	[Schuur, Jeremiah D.; Raja, Ali S.] Brigham & Womens Hosp, Dept Emergency Med, Boston, MA 02115 USA; [Raja, Ali S.] Brigham & Womens Hosp, Ctr Evidence Based Imaging, Boston, MA 02115 USA; [Schuur, Jeremiah D.; Raja, Ali S.] Harvard Univ, Sch Med, Boston, MA USA; [Brown, Michael D.] Spectrum Hlth, Dept Emergency Med, Grand Rapids, MI USA; [Brown, Michael D.] Michigan State Univ, Coll Human Med, Grand Rapids, MI USA; [Cheung, Dickson S.] Carepoint PC, Denver, CO USA; [Graff, Louis] Hosp Cent Connecticut, Dept Emergency Med, New Britain, CT USA; [Graff, Louis] Univ Connecticut, Sch Med, Farmington, CT USA; [Griffey, Richard T.] Washington Univ, Sch Med, Inst Publ Hlth, St Louis, MO USA; [Griffey, Richard T.] Barnes Jewish Hosp, St Louis, MO 63110 USA; [Hamedani, Azita G.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA; [Kelly, John J.] Albert Einstein Med Ctr, Dept Emergency Med, Philadelphia, PA 19141 USA; [Kelly, John J.] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA; [Klauer, Kevin] Emergency Med Phys Ltd, Canton, OH USA; [Klauer, Kevin] Michigan State Univ, Coll Osteopath Med, Barberton, OH USA; [Klauer, Kevin] Michigan State Univ, Coll Osteopath Med, Wadsworth, OH USA; [Klauer, Kevin] Summa Hlth Syst, Barberton, OH USA; [Klauer, Kevin] Summa Hlth Syst, Wadsworth, OH USA; [Phelan, Michael] Cleveland Clin, Emergency Serv Inst, Qual & Patients Safety Inst, Cleveland, OH 44106 USA; [Sierzenski, Paul R.] Christiana Care Hlth Syst, Dept Emergency Med, Newark, DE USA		Schuur, JD (corresponding author), Brigham & Womens Hosp, Dept Emergency Med, 75 Francis St, Boston, MA 02115 USA.	jschuur@partners.org	Raja, Ali S./AAE-5103-2019	Griffey, Richard/0000-0002-6279-7380	Brigham and Women's Physician Organization (BWPO); HealthONE, LLC; Hospital Corporation of America	By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org). Dr. Schuur received a performance improvement grant from the Brigham and Women's Physician Organization (BWPO), which supported this project. The BWPO had no role in the study design, analysis of the data, or publication. Dr. Schuur developed a performance measure of appropriate head CT imaging in adults with acute atraumatic headache that was reviewed by the same National Quality Forum (NQF) panel that reviewed Outpatient Measure 15 (OP-15). This measure was rejected by the NQF committee and Dr. Schuur receives no financial benefit from this measure. Dr. Schuur serves as a member of the American College of Emergency Physicians (ACEP) Quality and Performance Committee. As a member of this committee, Dr. Schuur has drafted comments to the NQF and Centers for Medicare & Medicaid Services (CMS) during public comment periods on OP-15. Dr. Cheung receives consulting fees from HealthONE, LLC and the Hospital Corporation of America and serves as a member of the ACEP Quality and Performance Committee. As a member of this committee, he has drafted comments to the NQF and CMS during public comment periods on OP-15.	[Anonymous], CONTR REP; Baumann BM, 2011, ANN EMERG MED, V58, P1, DOI 10.1016/j.annemergmed.2010.10.018; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Centers for Medicare & Medicaid Services (CMS) HHS, 2011, Fed Regist, V76, P74122; Department of Health and Human Services Centers for Medicare & Medicaid Services, 2011, FED REGISTER, V76, P42170; Drescher FS, 2011, ANN EMERG MED, V57, P613, DOI 10.1016/j.annemergmed.2010.09.018; Friedman BW, 2007, ANN EMERG MED, V49, P409, DOI 10.1016/j.annemergmed.2006.11.004; Frishberg B, EVIDENCE BASED GUIDE; Gilbert EH, 1996, ANN EMERG MED, V27, P305, DOI 10.1016/S0196-0644(96)70264-0; Gilbert JW, 2011, EMERG MED J; Goldstein JN, 2006, CEPHALALGIA, V26, P684, DOI 10.1111/j.1468-2982.2006.01093.x; *HOSP COMP, HOSP COMP QUAL TOOL; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Jain S, 2010, PEDIATR EMERG CARE, V26, P902, DOI 10.1097/PEC.0b013e3181fe9108; Jordan JE, ACR APPROPRIATENESS; Korley FK, 2010, JAMA-J AM MED ASSOC, V304, P1465, DOI 10.1001/jama.2010.1408; Krumholz HM, 2008, CIRCULATION, V118, P1885, DOI 10.1161/CIRCULATIONAHA.108.190500; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Larson DB, 2011, RADIOLOGY, V259, P793, DOI 10.1148/radiol.11101939; Larson DB, 2011, RADIOLOGY, V258, P164, DOI 10.1148/radiol.10100640; Measures Implementation and Evaluation (MIE) Advisory Committee, 2010, MEAS TEST PROT PHYS; *MEDPAC, 2010, HLTH CAR SPEND MED P; Mettler FA, 2009, RADIOLOGY, V253, P520, DOI 10.1148/radiol.2532082010; *NAT QUAL FOR, EFF IM EFF; National Quality Forum, MEAS EV CRIT; Prevedello LM, AM J MED IN PRESS; QualityNet, IM EFF MEAS; Raja AS, 2011, ARCH INTERN MED, V171, P260, DOI 10.1001/archinternmed.2010.520; Raja AS, 2010, ANN EMERG MED, V56, P597, DOI 10.1016/j.annemergmed.2010.09.013; Raja AS, RADIOLOGY IN PRESS; Raosoft, SAMPL SIZ CALC; Scottish Intercollegiate Guidelines Network, 2008, SIGN PUBL; Sodickson A, 2009, RADIOLOGY, V251, P175, DOI 10.1148/radiol.2511081296; Studdert DM, 2006, NEW ENGL J MED, V354, P2024, DOI 10.1056/NEJMsa054479; Sun ZH, 2011, J MED IMAG HEALTH IN, V1, P21, DOI 10.1166/jmihi.2011.1003; Thijs RD, 2004, CLIN AUTON RES, V14, P4, DOI 10.1007/s10286-004-1002-4	37	17	17	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-0644			ANN EMERG MED	Ann. Emerg. Med.	SEP	2012	60	3					280	290		10.1016/j.annemergmed.2011.12.025			11	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	003OF	WOS:000308620500008	22364867				2022-02-06	
J	Colak, T; Cine, N; Bamac, B; Kurtas, O; Ozbek, A; Bicer, U; Sunnetci, D; Savli, H				Colak, T.; Cine, N.; Bamac, B.; Kurtas, O.; Ozbek, A.; Bicer, U.; Sunnetci, D.; Savli, H.			Microarray-based gene expression analysis of an animal model for closed head injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Rats; Craniocerebral trauma; Microarray	TRAUMATIC BRAIN-INJURY; C1Q FAMILY PROTEINS; MATRIX METALLOPROTEINASES; ENDOTHELIAL-CELLS; GROWTH-FACTOR; ANGIOGENESIS; ISCHEMIA; DEATH; PATHOPHYSIOLOGY; MECHANISMS	Objective: Traumatic brain injury (TBI) is a major cause of death and disability in both children and the elderly. Mortality from TBI is said account for 1-2% of all deaths. One-third to one-half of all traumatic deaths is due to head injury. Of those who survive, the majority is left with significant disabilities, including 3% who remain in a vegetative state and only approximately 30% who make a good recovery. Microarray studies and other genomic techniques facilitate the discovery of new targets for the treatment of diseases, which aids in drug development, immunotherapeutics and gene therapy. Gene expression profiling or microarray analysis enables the measurement of thousands of genes in a single RNA sample. Methods: In this study, adult Wistar-albino rats underwent TBI using a trauma device. Brain tissues and blood samples were taken for gene expression at 1, 12 and 48 h post-trauma and were then analysed via microarray. Total RNA was isolated using an RNeasy Mini Kit (QIAGEN-Sample & Assay Technologies, Hilden, Germany) and tested using a 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA). Overall changes in gene expression were evaluated using Agilent Whole Rat Genome 4 x 44 K oligonucleotide arrays and analysed with GeneSpring (GeneSpring 6.1, Silicon Genetics, Redwood City, CA) software. Only genes with a signal-to-noise ratio of above 2 in the experiments were included in the statistical analysis. Results: ANOVA (p < 0.05) was performed to identify differentially expressed probe sets. Additional filtering (minimum 2-fold change) was applied to extract the most differentially expressed genes based on the study groups (Control vs. 1st hour, Control vs. 12th hour, Control vs. 48th hour). Differentially expressed genes were detected via microarray analysis. A gene interaction-based network investigation of the genes that were identified via traditional microarray data analysis describes a significantly relevant gene network that includes the C1ql2, Cbnl, Sdc1, Bdnf, MMP9, and Cd47 genes, which were differentially expressed compared with the controls. Conclusions: In this study, we will review the current understanding of the genetic susceptibility of TBI with microarrays. Our results highlight the importance of genes that control the response of the brain to injury as well as the suitability of microarrays for identifying specific targets for further study. (C) 2012 Elsevier Ltd. All rights reserved.	[Colak, T.; Bamac, B.; Ozbek, A.] Kocaeli Univ, Sch Med, Dept Anat, TR-41380 Kocaeli, Turkey		Colak, T (corresponding author), Kocaeli Univ, Sch Med, Dept Anat, TR-41380 Kocaeli, Turkey.	tuncaycolak@live.com	Cine, Naci/M-5957-2019; Ozbek, Aydin/J-4519-2018; Bamac, Belgin/F-7373-2018; Colak, Tuncay/F-5749-2018; Ozbek, Aydin/AAV-6294-2020; Cine, Naci/F-7299-2018	Colak, Tuncay/0000-0002-9483-3243; Ozbek, Aydin/0000-0001-5864-8166; Bicer, Umit/0000-0002-2242-3894; Cine, Naci/0000-0001-9063-1073			Akdemir G, 2008, TURKIYE KLIN J NEURO, V1, P6; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Bekman ZM, 2007, TURKIYE KLIN J INT M, V3, P35; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Chen JL, 2003, ANN NEUROL, V53, P743, DOI 10.1002/ana.10555; Chopp M, 2007, STROKE, V38, P827, DOI 10.1161/01.STR.0000250235.80253.e9; Colak T, 2010, TURK KLIN TIP BILIM, V30, P1171, DOI 10.5336/medsci.2009-11356; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; de Vries HE, 2002, J IMMUNOL, V168, P5832, DOI 10.4049/jimmunol.168.11.5832; Del Bigio MR, 1999, NEUROPATH APPL NEURO, V25, P54; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gennarelli, 1998, Semin Clin Neuropsychiatry, V3, P160; Iijima T, 2010, EUR J NEUROSCI, V31, P1606, DOI 10.1111/j.1460-9568.2010.07202.x; Isenberg JS, 2008, BLOOD, V111, P613, DOI 10.1182/blood-2007-06-098392; Jaakkola P, 2000, PROG NUCLEIC ACID RE, V63, P109; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; Jin G, 2009, EXP NEUROL, V217, P165, DOI 10.1016/j.expneurol.2009.02.004; Kamei N, 2007, SPINE, V32, P1272, DOI 10.1097/BRS.0b013e318059afab; KIEFER MC, 1990, P NATL ACAD SCI USA, V87, P6985, DOI 10.1073/pnas.87.18.6985; Koshimizu H, 2002, J NEUROCHEM, V82, P249, DOI 10.1046/j.1471-4159.2002.00965.x; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Murshid WR, 1998, ACTA NEUROCHIR, V140, P56, DOI 10.1007/s007010050058; Nabika S, 2007, PEDIATR NEUROSURG, V43, P312, DOI 10.1159/000103313; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Oh JH, 2009, GYNECOL ONCOL, V114, P509, DOI 10.1016/j.ygyno.2009.05.027; Oh LYS, 1999, J NEUROSCI, V19, P8464; REINHOLD MI, 1995, J CELL SCI, V108, P3419; Sasaki M, 2009, J NEUROSCI, V29, P14932, DOI 10.1523/JNEUROSCI.2769-09.2009; SLEMMON JR, 1985, P NATL ACAD SCI USA, V82, P7145, DOI 10.1073/pnas.82.20.7145; Son BC, 2000, ACT NEUR S, V76, P13; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun CY, 2006, CHINESE MED J-PEKING, V119, P589, DOI 10.1097/00029330-200604010-00013; Ucar T, 2006, J TRAUMA, V60, P558, DOI 10.1097/01.ta.0000209172.75637.db; URADE Y, 1991, P NATL ACAD SCI USA, V88, P1069, DOI 10.1073/pnas.88.3.1069; Voller B, 1999, BRAIN INJURY, V13, P821, DOI 10.1080/026990599121214; Voller B, 2001, BRAIN INJURY, V15, P107, DOI 10.1080/026990501458344; Xing CH, 2009, J NEUROSCI RES, V87, P2571, DOI 10.1002/jnr.22076; Xing CH, 2009, J NEUROCHEM, V108, P430, DOI 10.1111/j.1471-4159.2008.05777.x; Xiong Y, 2008, J NEUROSURG, V109, P510, DOI 10.3171/JNS/2008/109/9/0510; Yong VW, 1998, TRENDS NEUROSCI, V21, P75; Yuzaki M, 2008, CELL MOL LIFE SCI, V65, P1698, DOI 10.1007/s00018-008-7550-3; Yuzaki M, 2010, EUR J NEUROSCI, V32, P191, DOI 10.1111/j.1460-9568.2010.07346.x; Zhang YL, 2009, BRAIN RES, V1294, P153, DOI 10.1016/j.brainres.2009.07.077; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4; Zucker S, 1998, INT J CANCER, V75, P780, DOI 10.1002/(SICI)1097-0215(19980302)75:5<780::AID-IJC19>3.3.CO;2-N	46	17	18	0	22	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	AUG	2012	43	8					1264	1270		10.1016/j.injury.2012.01.021			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	970FG	WOS:000306112900006	22341557				2022-02-06	
J	Hocomb, EM; Millis, SR; Hanks, RA				Hocomb, Erin M.; Millis, Scott R.; Hanks, Robin A.			Comorbid Disease in Persons With Traumatic Brain Injury: Descriptive Findings Using the Modified Cumulative Illness Rating Scale	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Comorbidity; Rehabilitation	INPATIENT REHABILITATION; METHODOLOGIC CONSIDERATIONS; CO-MORBIDITY; RESOURCE USE; AGE; POPULATION; VALIDATION; LENGTH; STAY; HYPERTENSION	Holcomb EM, Millis SR, Hanks RA. Comorbid disease in persons with traumatic brain injury: descriptive findings using the Modified Cumulative Illness Rating Scale. Arch Phys Med Rehabil 2012;93:1338-42. Objective: To provide descriptive findings regarding the overall health status and prevalence of medical comorbidities experienced by traumatic brain injury (TBI) patients. Design: Inception cohort design with cross-sectional follow-up at 1 to 15 years. Setting: Rehabilitation hospital. Participants: Adults (N = 258) with moderate to severe TBI. Interventions: Not applicable. Main Outcome Measure: The Modified Cumulative Illness Rating Scale is a 14-item rating scale used to indicate health status by rating impairment across 14 different domains. Results: The TBI sample had lower rates of comorbidities compared with other rehabilitation populations, including stroke and orthopedic samples. The most commonly encountered medical conditions within our sample were eyes, ears, nose, and throat problems, psychiatric or behavioral disturbances, hypertension, and musculoskeletal injury at mild to moderate severity. Prevalence of conditions did not differ by sex, race, or cause of TBI. Conclusions: The current TBI sample was relatively healthy with few medical comorbidities. Further, the Modified Cumulative Illness Rating Scale may better be used as a standardized checklist to assess for the presence of co-occurring conditions, given the near absence of conditions in the higher range of severity.	[Hocomb, Erin M.] Wayne State Univ, Dept Psychol, Detroit, MI 48202 USA; [Millis, Scott R.; Hanks, Robin A.] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI USA		Hocomb, EM (corresponding author), Wayne State Univ, Dept Psychol, 5057 Woodward Ave,7th Fl, Detroit, MI 48202 USA.	du0878@wayne.edu			U.S. Department of Education-National Institute of Disability Research and Rehabilitation-The Traumatic Brain Injury Model Systems Project [H133A020515]	Supported by the U.S. Department of Education-National Institute of Disability Research and Rehabilitation-The Traumatic Brain Injury Model Systems Project (grant no. H133A020515).	BOONE KB, 1993, DEMENTIA, V4, P232; Brady CB, 2001, J GERONTOL B-PSYCHOL, V56, pP340, DOI 10.1093/geronb/56.6.P340; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Dahmer ER, 1993, J HEAD TRAUMA REHAB, V8, P13; de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1; Deb S, 1999, AM J PSYCHIAT, V156, P374; ELIAS MF, 1995, EXP AGING RES, V21, P369, DOI 10.1080/03610739508253991; Fahlander K, 2000, J GERONTOL B-PSYCHOL, V55, pP259, DOI 10.1093/geronb/55.5.P259; Giaquinto S, 2003, EUR J NEUROL, V10, P235, DOI 10.1046/j.1468-1331.2003.00563.x; Giaquinto S, 2001, DISABIL REHABIL, V23, P296; Golding EM, 2002, BRAIN RES REV, V38, P377, DOI 10.1016/S0165-0173(02)00141-8; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Imamura K, 1997, J CLIN EPIDEMIOL, V50, P1011, DOI 10.1016/S0895-4356(97)00128-5; KAPLAN MH, 1974, J CHRON DIS, V27, P387, DOI 10.1016/0021-9681(74)90017-4; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Lew HL, 2002, AM J PHYS MED REHAB, V81, P830, DOI 10.1097/00002060-200211000-00005; Ley EJ, 2011, J TRAUMA, V70, P1141, DOI 10.1097/TA.0b013e3182146d66; LINN BS, 1968, J AM GERIATR SOC, V16, P622, DOI 10.1111/j.1532-5415.1968.tb02103.x; Manolio TA, 2003, CURR HYPERTENS REP, V5, P255, DOI 10.1007/s11906-003-0029-6; Miller M., 1991, MANUAL GUIDELINES SC; MILLER MD, 1992, PSYCHIAT RES, V41, P237, DOI 10.1016/0165-1781(92)90005-N; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; PARMELEE PA, 1995, J AM GERIATR SOC, V43, P130, DOI 10.1111/j.1532-5415.1995.tb06377.x; Reistetter TA, 2011, DIABETES CARE, V34, P1375, DOI 10.2337/dc10-2220; Rochon PA, 1996, MED CARE, V34, P1093, DOI 10.1097/00005650-199611000-00004; Salvi F, 2008, J AM GERIATR SOC, V56, P1926, DOI 10.1111/j.1532-5415.2008.01935.x; Sondik EJ, 2010, SUMMARY HLTH STAT US; Stineman MG, 2000, ARCH PHYS MED REHAB, V81, P549, DOI 10.1016/S0003-9993(00)90033-9; Tamari K, 2010, ARCH PHYS MED REHAB, V91, P1363, DOI 10.1016/j.apmr.2010.06.014; Tan WS, 2009, ARCH PHYS MED REHAB, V90, P1202, DOI 10.1016/j.apmr.2009.01.027; The Eastern Association for the Surgery of Trauma, 2005, EAST PRACT MAN GUID; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; van Dijk GM, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-95; WALDSTEIN SR, 1991, PSYCHOL BULL, V110, P451, DOI 10.1037/0033-2909.110.3.451; Weeks DL, 2009, ARCH PHYS MED REHAB, V90, P1937, DOI 10.1016/j.apmr.2009.06.008; WONG DT, 1991, CAN J ANAESTH, V38, P374, DOI 10.1007/BF03007629	38	17	17	0	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2012	93	8					1338	1342		10.1016/j.apmr.2012.04.029			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	983XJ	WOS:000307151700007	22840832				2022-02-06	
J	Itoh, T; Imano, M; Nishida, S; Tsubaki, M; Mizuguchi, N; Hashimoto, S; Ito, A; Satou, T				Itoh, Tatsuki; Imano, Motohiro; Nishida, Shozo; Tsubaki, Masahiro; Mizuguchi, Nobuyuki; Hashimoto, Shigeo; Ito, Akihiko; Satou, Takao			(-)-Epigallocatechin-3-gallate increases the number of neural stem cells around the damaged area after rat traumatic brain injury	JOURNAL OF NEURAL TRANSMISSION			English	Article						Neural stem cell; Traumatic brain injury; Nestin; Neurosphere; Catechin	CENTRAL-NERVOUS-SYSTEM; GREEN TEA POLYPHENOL; EXPERIMENTAL-ISCHEMIA; OXIDATIVE STRESS; NEURONAL DAMAGE; CEREBRAL-CORTEX; OXYGEN RADICALS; DEATH; PROLIFERATION; PROTECTS	A major component of green tea is (-)-epigallocatechin gallate (EGCG), which has strong antioxidant properties. Here, we investigated the effect of EGCG on neural stem cell (NSC) proliferation around the damaged area following traumatic brain injury (TBI). In this study, male Wistar rats that had access to normal drinking water, or water containing 0.1% (w/v) EGCG, ad libitum received TBI at 10 weeks of age. Immunohistochemistry revealed that the number of nestin-positive cells around the damaged area after TBI in the EGCG treatment group increased significantly compared with the normal water group (P < 0.05). However, the number of 8-hydroxy-2'-deoxyguanosine-, 4-hydroxy-2-nonenal-, single-stranded DNA (ssDNA)-positive cells and the level of peroxidation around the damaged area after TBI significantly decreased in the EGCG treatment group when compared with the water group (P < 0.05). Furthermore, in contrast to the EGCG group, almost all ssDNA-positive cells in the water group co-localized with NeuN and nestin-staining. Ex vivo studies revealed that spheres could only be isolated from injured brain tissue in the water group at 3 days following TBI. However, in the EGCG group, spheres could be isolated at both 3 and 7 days following TBI. A greater number of spheres could be isolated from the EGCG group, which differentiated into neurons and glia in culture without basic fibroblast growth factor. These results indicate that consumption of water containing EGCG pre- and post-TBI inhibits free radical-induced degradation of NSCs, which have the potential to differentiate into neurons and glia around the area of damage following TBI.	[Itoh, Tatsuki; Ito, Akihiko; Satou, Takao] Kinki Univ, Fac Med, Dept Pathol, Osaka 5898511, Japan; [Imano, Motohiro] Kinki Univ, Sch Med, Dept Surg, Osaka 5898511, Japan; [Nishida, Shozo; Tsubaki, Masahiro] Kinki Univ, Fac Pharmaceut Sci, Osaka 5898511, Japan; [Mizuguchi, Nobuyuki] Kinki Univ, Life Sci Res Inst, Osaka 5898511, Japan; [Hashimoto, Shigeo] PL Hosp, Div Hosp, Osaka, Japan; [Satou, Takao] Kinki Univ Hosp, Div Hosp Pathol, Fac Med, Osaka, Japan		Itoh, T (corresponding author), Kinki Univ, Fac Med, Dept Pathol, 377-2 Ohno Higashi, Osaka 5898511, Japan.	tatsuki@med.kindai.ac.jp			 [21500803]; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [24501009] Funding Source: KAKEN	This work was supported by the Grant-in-Aid for Scientific Research (21500803). The authors thank Mari Yachi for technical assistance.	Aktas O, 2004, J IMMUNOL, V173, P5794, DOI 10.4049/jimmunol.173.9.5794; Amemiya S, 2005, EUR J PHARMACOL, V516, P125, DOI 10.1016/j.ejphar.2005.04.036; Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; CHAN PH, 1985, PROG BRAIN RES, V63, P227; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Clausen F, 2004, J NEUROTRAUM, V21, P1168, DOI 10.1089/neu.2004.21.1168; Douen AG, 2004, BRAIN RES, V1008, P139, DOI 10.1016/j.brainres.2003.08.070; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; Hata R, 1999, METAB BRAIN DIS, V14, P117, DOI 10.1023/A:1020709814456; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; Hong JT, 2000, BRAIN RES BULL, V53, P743, DOI 10.1016/S0361-9230(00)00348-8; Irving EA, 2002, J CEREBR BLOOD F MET, V22, P631, DOI 10.1097/00004647-200206000-00001; Itoh T, 2005, NEUROREPORT, V16, P1687, DOI 10.1097/01.wnr.0000183330.44112.ab; Itoh T, 2007, NEUROL RES, V29, P734, DOI 10.1179/016164107X208086; Itoh T, 2006, NEUROCHEM RES, V31, P1381, DOI 10.1007/s11064-006-9186-8; Itoh T, 2011, NEUROMOL MED, V13, P300, DOI 10.1007/s12017-011-8162-x; Itoh T, 2009, NEUROTOX RES, V16, P378, DOI 10.1007/s12640-009-9081-6; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Kim CY, 2009, ARCH PHARM RES, V32, P869, DOI 10.1007/s12272-009-1609-z; Koh SH, 2004, NEUROTOXICOLOGY, V25, P793, DOI 10.1016/j.neuro.2004.02.001; KONTOS HA, 1985, CIRC RES, V57, P508, DOI 10.1161/01.RES.57.4.508; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lee SR, 2000, NEUROSCI LETT, V287, P191, DOI 10.1016/S0304-3940(00)01159-9; Lee SY, 2003, BRAIN RES BULL, V61, P399, DOI 10.1016/S0361-9230(03)00139-4; Lin HJ, 2004, FEBS LETT, V570, P102, DOI 10.1016/j.febslet.2004.06.019; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Mandel S, 2004, J NEUROCHEM, V88, P1555, DOI 10.1046/j.1471-4159.2003.02291.x; Mandel SA, 2005, NEUROSIGNALS, V14, P46, DOI 10.1159/000085385; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; Moon C, 2004, BRAIN RES, V1028, P238, DOI 10.1016/j.brainres.2004.09.022; Parent JM, 1997, J NEUROSCI, V17, P3727; Picard-Riera N, 2004, J NEUROSCI RES, V76, P223, DOI 10.1002/jnr.20040; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Sugawara T, 2002, J NEUROSCI, V22, P209, DOI 10.1523/JNEUROSCI.22-01-00209.2002; Suzuki M, 2004, MED SCI MONITOR, V10, pBR166; Tsuji M, 2000, NEUROSCI LETT, V282, P41, DOI 10.1016/S0304-3940(00)00844-2; Walton KM, 1998, J NEUROCHEM, V70, P1764; Weinreb O, 2009, GENES NUTR, V4, P283, DOI 10.1007/s12263-009-0143-4; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Yamamoto S, 2001, EXP NEUROL, V172, P115, DOI 10.1006/exnr.2001.7798; Yu JX, 2010, FEBS LETT, V584, P2921, DOI 10.1016/j.febslet.2010.05.011	44	17	23	0	15	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0300-9564			J NEURAL TRANSM	J. Neural Transm.	AUG	2012	119	8					877	890		10.1007/s00702-011-0764-9			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	977XR	WOS:000306698700001	22212485				2022-02-06	
J	Rivara, FP; Ennis, SK; Mangione-Smith, R; MacKenzie, EJ; Jaffe, KM				Rivara, Frederik P.; Ennis, Stephanie K.; Mangione-Smith, Rita; MacKenzie, Ellen J.; Jaffe, Kenneth M.			Variation in Adherence to New Quality-of-Care Indicators for the Acute Rehabilitation of Children With Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Adolescent; Child; Quality of health care; Rehabilitation; Traumatic brain injuries	HEALTH-CARE; IMPROVEMENT	Objective: To determine variations in care provided by 9 inpatient rehabilitation units for children with traumatic brain injury (TBI) using newly developed quality indicators. Design Retrospective cohort study. Setting: Nine inpatient rehabilitation units. Participants: Children (N = 174; age range, 0-17y) admitted for the inpatient rehabilitation of moderate to severe TBI. Interventions: Not applicable. Main Outcome Measures: Adherence to 119 newly developed quality-of-care indicators in 7 different domains: general care, family-centered care, cognitive-communication, motor, neuropsychological, school, and community integration. Results: There was substantial variation both within and between institutions in the percentage of patients receiving recommended care in the 7 domains. The lowest scores were found for the school domain. Only 5 institutions scored above 50% for all quality indicators, and only 1 institution scored above 70% overall. Greater adherence to quality indicators was found for facilities with a higher proportion of therapists with pediatric training and for facilities that only admitted children. Patient volume was not associated with adherence to quality indicators. Conclusions: The results indicate a tremendous variability and opportunity for improvement in the care of children with TBI.	[Rivara, Frederik P.; Ennis, Stephanie K.; Jaffe, Kenneth M.] Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; [Rivara, Frederik P.; Mangione-Smith, Rita; Jaffe, Kenneth M.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Rivara, Frederik P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Ennis, Stephanie K.; Jaffe, Kenneth M.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Rivara, Frederik P.; Mangione-Smith, Rita] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA; [MacKenzie, Ellen J.] Johns Hopkins B Oomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [MacKenzie, Ellen J.] Johns Hopkins B Oomberg Sch Publ Hlth, Ctr Injury Res & Policy, Baltimore, MD USA		Rivara, FP (corresponding author), Harborview Injury Prevent & Res Ctr, Box 359960,325 9th Ave, Seattle, WA 98104 USA.	fpr@uw.edu			Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21 HD059049-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD059049] Funding Source: NIH RePORTER	Supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (grant no. R21 HD059049-01A1).	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Asch Steven M, 2005, BMC Cardiovasc Disord, V5, P1, DOI 10.1186/1471-2261-5-1; Brook RH, 1996, NEW ENGL J MED, V335, P966, DOI 10.1056/NEJM199609263351311; Brook RH, 2000, INT J QUAL HEALTH C, V12, P281, DOI 10.1093/intqhc/12.4.281; DONABEDIAN A, 1966, MILBANK FUND Q, V44, P166, DOI 10.2307/3348969; Fountain NB, 2011, NEUROLOGY, V76, P94, DOI 10.1212/WNL.0b013e318203e9d1; Mangione-Smith R, 2005, AMBUL PEDIATR, V5, P75, DOI 10.1367/A04-106R.1; Mangione-Smith R, 2007, NEW ENGL J MED, V357, P1515, DOI 10.1056/NEJMsa064637; O'Callaghan AM, 2010, INT J SPEECH-LANG PA, V12, P107, DOI 10.3109/17549500903431774; Rivara FP, 2012, ARCH PHYS MED REHAB, V93, P381, DOI 10.1016/j.apmr.2011.08.015; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Zumsteg JM, 2012, ARCH PHYS MED REHAB, V93, P386, DOI 10.1016/j.apmr.2011.08.018	12	17	17	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2012	93	8					1371	1376		10.1016/j.apmr.2012.02.031			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	983XJ	WOS:000307151700012	22446294	Green Accepted			2022-02-06	
J	Tong, WS; Zheng, P; Zeng, JS; Guo, YJ; Yang, WJ; Li, GY; He, B; Yu, H; Li, YS; Tang, XF; Lin, TS; Xu, JF				Tong, Wu-Song; Zheng, Ping; Zeng, Jing-Song; Guo, Yi-Jun; Yang, Wen-Jin; Li, Gao-Yi; He, Bin; Yu, Hui; Li, Yong-Sheng; Tang, Xin-Fen; Lin, Tong-Shun; Xu, Jun-Fa			Prognosis analysis and risk factors related to progressive intracranial haemorrhage in patients with acute traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury (TBI); progressive intracranial haemorrhage (PIH); risk factor; prognosis	HEAD-INJURY; COAGULOPATHY; THROMBOCYTOPENIA; PREDICTORS; LESIONS	Background: Since progressive intracranial haemorrhage (PIH) was introduced in neurosurgical literatures, several studies have been performed. PIH has been shown to be associated with a high increase in the risk of clinical worsening and related to morbidity and mortality as well. So, early detection and prediction of PIH is practically important in a clinical situation. Objectves: To investigate the risk factors related to PIH in patients with acute traumatic brain injury (TBI) and analyse their clinical significances. Methods: PIH was confirmed by comparing the first and repeated CT scans. Data compared included gender, age, mechanism of injury, Glasgow Coma Score (GCS) at admission, timing from injury to the first CT, the signs of the initial CT scan, prothrombin time (PT), activated partial thromboplastin time (APTT), fibrinogen (Fg), thrombin time (TT), platelet (PLT) and D-dimer (D-D) values. Logistic regression analysis was used to show the risk factors related to PIH. Results: A cohort of 498 patients with TBI was evaluated, and there were 139 (27.91%) patients who suffered from PIH. The differences between PIHs and non-PIHs were significant in age, GCS at admission, the signs of the initial CT scan (fracture, subarachnoid haemorrhage, brain contusion and primary haematoma), PT, Fg and D-D values (p<0.001). Logistic regression analysis was used to identify that CT scans (subarachnoid haemorrhage, brain contusion and primary haematoma) and plasma D-D values as the most important predictors of PIH (p<0.001). Conclusions: For patients with the initial CT scan showing subarachnoid haemorrhage, brain contusion and primary haematoma with abnormal D-D levels, an earlier and dynamic CT scan should be performed, for the detection of PIH as early as possible and the medical intervention would be enforced in time.	[Tong, Wu-Song; Zheng, Ping; Zeng, Jing-Song; Guo, Yi-Jun; Yang, Wen-Jin; Li, Gao-Yi; He, Bin; Yu, Hui; Li, Yong-Sheng; Xu, Jun-Fa] Pudong New Area Peoples Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Tang, Xin-Fen; Lin, Tong-Shun] Pudong New Area Peoples Hosp, Dept Lab Examine, Shanghai, Peoples R China		Tong, WS (corresponding author), Pudong New Area Peoples Hosp, Dept Neurosurg, 490 S Chuanhuan Rd, Shanghai, Peoples R China.	tongws001@yahoo.com.cn					BULLOCK R, 1990, J NEUROSURG, V72, P9, DOI 10.3171/jns.1990.72.1.0009; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Engstrom M, 2005, J NEUROTRAUM, V22, P291, DOI 10.1089/neu.2005.22.291; Halpern CH, 2008, J NEUROTRAUM, V25, P997, DOI 10.1089/neu.2008.0548; Jiang JY, 2008, CLIN GUIDELINES MANA; KLAUBER MR, 1985, J NEUROSURG, V62, P528, DOI 10.3171/jns.1985.62.4.0528; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Pahatouridis D, 2010, BRAIN INJURY, V24, P1189, DOI 10.3109/02699052.2010.490510; Patel NY, 2000, J TRAUMA, V48, P367, DOI 10.1097/00005373-200003000-00001; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Sanus GZ, 2004, NEUROSURG QUART, V14, P97, DOI 10.1097/01.wnq.0000127718.06183.12; Selladurai BM, 1997, BRIT J NEUROSURG, V11, P398; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; SHACKFORD SR, 1987, ARCH SURG-CHICAGO, V122, P523; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Takahashi H, 1997, J NEUROSURG, V86, P768, DOI 10.3171/jns.1997.86.5.0768; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0	21	17	25	1	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	2012	26	9					1136	1142		10.3109/02699052.2012.666437			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	971GI	WOS:000306191400011	22630115				2022-02-06	
J	Lin, TK; Tsai, HC; Hsieh, TC				Lin, Tzu-Kang; Tsai, Hong-Chieh; Hsieh, Tsung-Che			The impact of traumatic subarachnoid hemorrhage on outcome: A study with grouping of traumatic subarachnoid hemorrhage and transcranial Doppler sonography	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Classification; outcome; transcranial Doppler sonography; traumatic subarachnoid hemorrhage	CEREBRAL BLOOD-FLOW; BRAIN-INJURY; HEAD-INJURY; INTRAVENTRICULAR HEMORRHAGE; VASOSPASM; MULTICENTER; ULTRASOUND; ADMISSION; VELOCITY; SCAN	BACKGROUND: To clarify the clinical role of traumatic subarachnoid hemorrhage (tSAH), stratified analysis with grouping of tSAH was performed. Their blood flow changes and correlations with outcome were assayed. METHODS: One hundred seventeen tSAH patients were classified into several groups according to their initial computerized tomography scans. Group I included patients with tSAH only in the posterior interhemispheric fissure, whereas Group II contained patients with tSAH located elsewhere. Group II was further subdivided into IIa, little SAH; IIb, extensive SAH; IIc, little SAH with intraventricular hemorrhage (IVH); and IId, extensive SAH with IVH. The cerebral blood flow velocity was monitored using transcranial Doppler sonography (TCD). RESULTS: Both age and initial coma scale were independent predictors of poor outcome. The poor outcome rates in various subgroups of tSAH increased stepwise from group I to group IId (I, 7.4%; IIa, 18.4%; IIb, 33.3%; IIc, 62.5%; and IId, 90.9%) (p = 0.0010). Stratified analyses revealed that patients with extensive tSAH (group IIb + IId) were more likely to have unfavorable outcomes (47.7%) than patients with little tSAH (group IIa + IIc) (26.1%) (p = 0.0185); patients with IVH (group IIc + IId) also displayed a higher incidence (78.9%) of poor outcomes than patients without IVH (group IIa + IIb) (25.4%) (p = 0.0030). TCD study demonstrated that patients with extensive tSAH (group IIb + IId) were more likely to have the vasospasm based on TCD criteria than did patients in group I and group IIa + IIc (37.5% vs. 5.9% and 7.7%, p = 0.0105). Notably, there was a tendency of worse outcome in patients with vasospasm on the basis of TCD-derived criteria than those without, with the unfavorable outcome rates being 47.4% and 24.7% (p = 0.0799). CONCLUSIONS: Age, initial coma scale, extensive tSAH, and IVH are independent predictors of poor outcome in the cohort of tSAH patients. Statistically, patients with extensive tSAH are significantly more likely to have vasospasm. (J Trauma Acute Care Surg. 2012; 73: 131-136. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Lin, Tzu-Kang; Tsai, Hong-Chieh] Chang Gung Univ, Chang Gung Mem Hosp, Dept Neurosurg, Tao Yuan 333, Taiwan; [Hsieh, Tsung-Che] St Pauls Hosp, Dept Neurosurg, Tao Yuan, Taiwan		Lin, TK (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Dept Neurosurg, 5 Fu Hsing St, Tao Yuan 333, Taiwan.	tklin100@cgmh.org.tw		Tsai, Hong-Chieh/0000-0003-3994-1601	National Science Council, TaiwanMinistry of Science and Technology, Taiwan [NSC 88-2314-B-182A-099]	Supported by grant NSC 88-2314-B-182A-099 from the National Science Council, Taiwan.	AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; CHAN KH, 1992, NEUROSURGERY, V30, P697; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Compagnone C, 2009, NEUROSURGERY, V64, P690, DOI 10.1227/01.NEU.0000340796.18738.F7; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; FUJITSU K, 1988, NEUROSURGERY, V23, P423, DOI 10.1227/00006123-198810000-00003; GAETANI P, 1995, J NEUROL NEUROSUR PS, V59, P635, DOI 10.1136/jnnp.59.6.635; GREENE KA, 1995, J NEUROSURG, V83, P445, DOI 10.3171/jns.1995.83.3.0445; Harders A, 1996, J NEUROSURG, V85, P82, DOI 10.3171/jns.1996.85.1.0082; HASHIMOTO T, 1992, Neurological Surgery, V20, P209; KAKARIEKA A, 1994, ACTA NEUROCHIR, V129, P1, DOI 10.1007/BF01400864; Lee JH, 1997, J NEUROSURG, V87, P221, DOI 10.3171/jns.1997.87.2.0221; LEE JP, 1991, CAN J NEUROL SCI, V18, P458, DOI 10.1017/S0317167100032157; LEE JP, 1991, ACTA NEUROL SCAND, V84, P85, DOI 10.1111/j.1600-0404.1991.tb04913.x; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; Mattioli C, 2003, J NEUROSURG, V98, P37, DOI 10.3171/jns.2003.98.1.0037; Morris GF, 1997, ACTA NEUROCHIR S, V71, P382; Nahed BV, 2009, J NEUROSURG-PEDIATR, V3, P311, DOI 10.3171/2008.12.PEDS08206; SANDER D, 1993, J NEUROL SCI, V119, P1, DOI 10.1016/0022-510X(93)90185-2; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Vergouwen MDI, 2006, LANCET NEUROL, V5, P1029, DOI 10.1016/S1474-4422(06)70582-8; WEBER M, 1990, NEUROSURGERY, V27, P106, DOI 10.1227/00006123-199007000-00015; Zubkov ZY, 2000, SURG NEUROL, V53, P126	25	17	18	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUL	2012	73	1					131	136		10.1097/TA.0b013e31824aff74			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	979JU	WOS:000306814100019	22743382				2022-02-06	
J	Chen, Y; Huang, W; Constantini, S				Chen, Yun; Huang, Wei; Constantini, Shlomi			Blast Shock Wave Mitigation Using the Hydraulic Energy Redirection and Release Technology	PLOS ONE			English	Article							INJURY; TSUNAMIS; PRESSURE; PHYSICS	A hydraulic energy redirection and release technology has been developed for mitigating the effects of blast shock waves on protected objects. The technology employs a liquid-filled plastic tubing as a blast overpressure transformer to transfer kinetic energy of blast shock waves into hydraulic energy in the plastic tubings. The hydraulic energy is redirected through the plastic tubings to the openings at the lower ends, and then is quickly released with the liquid flowing out through the openings. The samples of the specifically designed body armor in which the liquid-filled plastic tubings were installed vertically as the outer layer of the body armor were tested. The blast test results demonstrated that blast overpressure behind the body armor samples was remarkably reduced by 97% in 0.2 msec after the liquid flowed out of its appropriate volume through the openings. The results also suggested that a volumetric liquid surge might be created when kinetic energy of blast shock wave was transferred into hydraulic energy to cause a rapid physical movement or displacement of the liquid. The volumetric liquid surge has a strong destructive power, and can cause a noncontact, remote injury in humans (such as blast-induced traumatic brain injury and post-traumatic stress disorder) if it is created in cardiovascular system. The hydraulic energy redirection and release technology can successfully mitigate blast shock waves from the outer surface of the body armor. It should be further explored as an innovative approach to effectively protect against blast threats to civilian and military personnel.	[Chen, Yun] BrightstarTech Inc, Clarksburg, MD USA; [Huang, Wei] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Constantini, Shlomi] Tel Aviv Univ, Tel Aviv Med Ctr, Dana Childrens Hosp, Dept Pediat Neurosurg, IL-69978 Tel Aviv, Israel		Chen, Y (corresponding author), BrightstarTech Inc, Clarksburg, MD USA.	yun.chen@brightstartechinc.com			BrightstarTech, Inc.	This work was supported in part by BrightstarTech, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Azenkot A, 2004, IRRIGATION SYSTEM DE; Bailey JL, 2006, ADA443885 DTIC; Beattie MS, 2000, J NEUROTRAUM, V17, P915, DOI 10.1089/neu.2000.17.915; Cannon L, 2001, J R Army Med Corps, V147, P87; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chen HX, 2011, US patent, Patent No. [13/285049, 13285049]; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; Choe SH, 2010, NY TIMES; Courtney AC, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3702803; Elsayed NM, 1997, TOXICOLOGY, V121, P1, DOI 10.1016/S0300-483X(97)03651-2; Glasstone S., 1977, EFFECTS NUCL WEAPONS, V3; Haugen KB, 2005, MAR PETROL GEOL, V22, P209, DOI 10.1016/j.marpetgeo.2004.10.016; HIRSCH AE, 1972, J NEUROSURG, V37, P95, DOI 10.3171/jns.1972.37.1.0095; Kailasanath K, 2002, ADA400620 DTIC; Krehl POK, 2011, EUR PHYS J H, V36, P85, DOI 10.1140/epjh/e2011-10037-x; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Margaritondo G, 2005, EUR J PHYS, V26, P401, DOI 10.1088/0143-0807/26/3/007; Pudasaini SP, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.041308; Reid WD, 1996, DSTOGD0109 DEP DEF S; Rice D, 2000, TACTICAL EDGE J  SUM, P53; Rinehart SA, 2010, DESIGN CONSIDERATION; Ritenour AE, 2008, CRIT CARE MED, V36, pS311, DOI 10.1097/CCM.0b013e31817e2a8c; Schwer D, 2006, ADA452669 DTIC; Stuhmiller JH, 2008, BIQPJHSCH10 ARM MED; VOIT SS, 1987, ANNU REV FLUID MECH, V19, P217, DOI 10.1146/annurev.fl.19.010187.001245; Willauer HD, 2009, J HAZARD MATER, V165, P1068, DOI 10.1016/j.jhazmat.2008.10.130	26	17	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2012	7	6							e39353	10.1371/journal.pone.0039353			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KK	WOS:000305693200067	22745740	Green Published, gold			2022-02-06	
J	Donders, J; Levitt, T				Donders, Jacobus; Levitt, Terry			Criterion Validity of the Neuropsychological Assessment Battery after Traumatic Brain Injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Neuropsychological assessment; Executive functioning; Clinical utility	COGNITIVE IMPAIRMENT; SCREENING MODULE; UTILITY; SAMPLE	The performance of 54 patients with complicated mildsevere traumatic brain injury (TBI) was evaluated on the Attention, Executive Functions, and Memory modules of the Neuropsychological Assessment Battery (NAB) and compared with that of 54 demographically matched healthy controls. All three NAB indices demonstrated statistically significant group differences and negative covariances with the duration of coma, with large effect sizes. The Numbers and Letters and Mazes subtests had the most consistent evidence for sensitivity to brain injury. The findings provide preliminary support for the criterion validity of the NAB in the assessment of patients with complicated mildsevere TBI.	[Donders, Jacobus] Mary Free Bed Rehabil Hosp, Psychol Serv, Grand Rapids, MI 49503 USA		Donders, J (corresponding author), Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy SE, Grand Rapids, MI 49503 USA.	jacobus.donders@maryfreebed.com					[American Educational Research Association American Psychological Association National Council on Measurement in Education], 1999, STAND ED PSYCH TESTS; Anderson TM, 2010, J CLIN EXP NEUROPSYC, V32, P1074, DOI 10.1080/13803391003733560; Banos J, 2010, PRINCIPLES PRACTICE, P329; DeJong J, 2010, J CLIN EXP NEUROPSYC, V32, P953, DOI 10.1080/13803391003645640; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Gavett BE, 2009, J INT NEUROPSYCH SOC, V15, P121, DOI 10.1017/S1355617708090176; Green P., 2003, GREENS WORD MEMORY T; Grohman K, 2004, EXP CLIN PSYCHOPHARM, V12, P200, DOI 10.1037/1064-1297.12.3.200; Hanks RA, 2004, DIFFERENTIAL DIAGNOSIS IN ADULT NEUROPSYCHOLOGICAL ASSESSMENT, P218; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Stern RA, 2003, NEUROPSYCHOLOGICAL A; Stricker NH, 2010, J INT NEUROPSYCH SOC, V16, P813, DOI 10.1017/S1355617710000652; Strong CAH, 2008, J CLIN EXP NEUROPSYC, V30, P885, DOI 10.1080/13803390701858224; Strong CAH, 2011, J INT NEUROPSYCH SOC, V17, P230, DOI 10.1017/S1355617710001451; Willmott C, 2009, NEUROPSYCHOLOGY, V23, P424, DOI 10.1037/a0015058; Zgaljardic DJ, 2010, APPL NEUROPSYCHOL, V17, P27, DOI 10.1080/09084280903297909	19	17	18	0	11	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JUN	2012	27	4					440	445		10.1093/arclin/acs043			6	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	944JX	WOS:000304198300007	22532153	Bronze			2022-02-06	
J	Sonig, A; Thakur, JD; Chittiboina, P; Khan, IS; Nanda, A				Sonig, Ashish; Thakur, Jai Deep; Chittiboina, Prashant; Khan, Imad Saeed; Nanda, Anil			Is posttraumatic cerebrospinal fluid fistula a predictor of posttraumatic meningitis? A US Nationwide Inpatient Sample database study	NEUROSURGICAL FOCUS			English	Article						cerebrospinal fluid fistula; meningitis; head injury	NOSOCOMIAL BACTERIAL-MENINGITIS; HIGH-RESOLUTION CT; ANTIBIOTIC-PROPHYLAXIS; HEAD-INJURY; ANTIMICROBIAL PROPHYLAXIS; RISK-FACTORS; CSF LEAKS; NEUROSURGERY; METAANALYSIS; RHINORRHEA	Object. Various factors have been reported in literature to be associated with the development of posttraumatic meningitis. There is a paucity of data regarding skull fractures and facial fractures leading to CSF leaks and their association with the development of meningitis. The primary objective of this study was to analyze the US Nationwide Inpatient Sample (NIS) database to elucidate the factors associated with the development of posttraumatic meningitis. A secondary goal was to analyze the overall hospitalization cost related to posttraumatic meningitis and factors associated with that cost. Methods. The NIS database was analyzed to identify patients admitted to hospitals with a diagnosis of head injury from 2005 through 2009. This data set was analyzed to assess the relationship of various clinical parameters that may affect the development of posttraumatic meningitis using binary logistic regression models. Additionally, the overall hospitalization cost for the head injury patients who did not undergo any neurosurgical intervention was further categorized into quartile groups, and a regression model was created to analyze various factors responsible for escalating the overall cost of the hospital stay. Results. A total of 382,267 inpatient admissions for head injury were analyzed for the 2005-2009 period. Meningitis was reported in 0.2% of these cases (708 cases). Closed skull base fractures, open skull base fractures, cranial vault fractures, and maxillofacial fractures were reported in 20,524 (5.4%), 1089 (0.3%), 5064 (1.3%), and 88,649 (23.2%) patients, respectively. Among these patients with fractures, meningitis was noted in 0.17%, 0.18%, 0.05%, and 0.10% admissions, respectively. Cerebrospinal fluid rhinorrhea was reported in 453 head injury patients (0.1%) and CSF otorrhea in 582 (0.2%). Of the patients reported to have CSF rhinorrhea, 35 (7.7%) developed meningitis, whereas in the cohort with CSF otorrhea, 15 patients (2.6%) developed meningitis. Cerebrospinal fluid rhinorrhea (p < 0.001, OR 22.8, 95% CI 15.6-33.3), CSF otorrhea (p < 0.001, OR 9.2, 95% CI 5.2-16.09), and major neurosurgical procedures (p < 0.001, OR 5.6, 95% CI 4.8-6.5) were independent predictors of meningitis. Further, CSF rhinorrhea (p < 0.001, OR 2.0, 95% CI 1.6-2.7), CSF otorrhea (p < 0.001, OR 2.3, 95% CI 1.9-2.7), and posttraumatic meningitis (p < 0.001, OR 3.1, 95% CI 2.5-3.8) were independent factors responsible for escalating the cost of head injury in cases not requiring any major neurosurgical intervention. Conclusions. Cerebrospinal fluid rhinorrhea and CSF otorrhea are independent predictors of posttraumatic meningitis. Furthermore, meningitis and CSF fistulas may independently lead to significantly increased cost of hospitalization in head injury patients not undergoing any major neurosurgical intervention. (http://thejns.org/doi/abs/10.3171/2012.5.FOCUS1269)	[Sonig, Ashish; Thakur, Jai Deep; Chittiboina, Prashant; Khan, Imad Saeed; Nanda, Anil] Louisiana State Univ, Dept Neurosurg, Hlth Sci Ctr Shreveport, Shreveport, LA 71130 USA		Nanda, A (corresponding author), Louisiana State Univ, Dept Neurosurg, Hlth Sci Ctr Shreveport, 1501 Kings Highway,POB 33932, Shreveport, LA 71130 USA.	ananda@lsuhsc.edu	Chittiboina, Prashant/T-7177-2017; Chittiboina, Prashant/AAE-3799-2020	Chittiboina, Prashant/0000-0001-9349-4756; Chittiboina, Prashant/0000-0001-9349-4756			APPELBAUM E, 1960, JAMA-J AM MED ASSOC, V173, P1818, DOI 10.1001/jama.1960.03020340036010; BALTAS I, 1994, NEUROSURGERY, V35, P422, DOI 10.1227/00006123-199409000-00009; Brodie HA, 1997, ARCH OTOLARYNGOL, V123, P749; BROWN EM, 1994, LANCET, V344, P1547; Bullock M Ross, 2006, Neurosurgery, V58, pS56; Choi D, 1996, BRIT J NEUROSURG, V10, P571, DOI 10.1080/02688699646880; COOPER MA, 1995, LANCET, V345, P515, DOI 10.1016/S0140-6736(95)90610-X; Dagi T F, 1983, Am J Emerg Med, V1, P295, DOI 10.1016/0735-6757(83)90109-2; Eftekhar B, 2004, J NEUROSURG, V101, P757, DOI 10.3171/jns.2004.101.5.0757; ELJAMEL MS, 1993, BRIT J NEUROSURG, V7, P501, DOI 10.3109/02688699308995072; Friedman J A, 2000, Neurosurg Focus, V9, pe1, DOI 10.3171/foc.2000.9.1.1; HAND WL, 1970, ANN INTERN MED, V73, P862, DOI 10.7326/0003-4819-73-5-862; HELLING TS, 1988, J TRAUMA, V28, P1575, DOI 10.1097/00005373-198811000-00009; JONES SR, 1973, J TRAUMA, V13, P895, DOI 10.1097/00005373-197313100-00009; Kaufman B A, 1990, Infect Dis Clin North Am, V4, P677; Korinek AM, 2006, NEUROSURGERY, V59, P126, DOI 10.1227/01.NEU.0000220477.47323.92; La Fata V, 2008, AM J NEURORADIOL, V29, P536, DOI 10.3174/ajnr.A0885; LUI TN, 1989, PEDIATR NEUROSCI, V15, P85, DOI 10.1159/000120448; MACGEE EE, 1970, J NEUROSURG, V33, P312, DOI 10.3171/jns.1970.33.3.0312; Palabiyikoglu I, 2006, J HOSP INFECT, V62, P94, DOI 10.1016/j.jhin.2005.06.010; PAPPAS DG, 1993, CLIN INFECT DIS, V17, P364, DOI 10.1093/clinids/17.3.364; PARK JI, 1983, LARYNGOSCOPE, V93, P1294; Plaisier B. R., 2005, INTERNET J NEUROSURG, V2; Prosser JD, 2011, OTOLARYNG CLIN N AM, V44, P857, DOI 10.1016/j.otc.2011.06.007; Prosser JD, 2011, OTOLARYNGOL CLIN N A, V44, pvii; Ratilal BO, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004884, 10.1002/14651858.CD004884.pub3]; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; SPONSEL C, 1994, POSTGRAD MED, V95, P109, DOI 10.1080/00325481.1994.11945784; Stone JA, 1999, AM J NEURORADIOL, V20, P706; van de Beek D, 2010, NEW ENGL J MED, V362, P146, DOI 10.1056/NEJMra0804573; Villalobos T, 1998, CLIN INFECT DIS, V27, P364, DOI 10.1086/514666; Weisfelt M, 2007, J HOSP INFECT, V66, P71, DOI 10.1016/j.jhin.2007.02.017; Yilmazlar S, 2006, NEUROSURG REV, V29, P64, DOI 10.1007/s10143-005-0396-3	33	17	17	0	5	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	JUN	2012	32	6							E4	10.3171/2012.5.FOCUS1269			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	954DQ	WOS:000304927100006	22655693				2022-02-06	
J	Anderson, V; Eren, S; Dob, R; Le Brocque, R; Iselin, G; Davern, TJ; McKinlay, L; Kenardy, J				Anderson, Vicki; Eren, Senem; Dob, Rian; Le Brocque, Robyne; Iselin, Greg; Davern, Timothy J.; McKinlay, Lynne; Kenardy, Justin			Early Attention Impairment and Recovery Profiles After Childhood Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						child; traumatic brain injury; attention; recovery	PEDIATRIC HEAD-INJURY; CHILDREN; SKILLS; DEFICITS; PERFORMANCE; SAMPLE	Objectives: To examine recovery of attention from 3 to 6 months postinjury; to identify effects of injury severity and time since injury on performance; to explore whether complex attention skills (eg, shifting, divided attention, attentional control) are more vulnerable to traumatic brain injury (TBI), and slower to recover than simple attention skills (eg, attentional capacity, selective attention, sustained attention). Design: Prospective longitudinal investigation. Participants: A total of 205 school-aged children with TBI were divided into groups according to injury severity (mild = 63%, moderate = 27%, severe = 10%). Setting: Emergency departments of 3 metropolitan children's hospitals across Australia. Main Measures: Standardized clinical measures of both simple and complex attention were administered at 3 months and 6 months postinjury. Results: Attention skills were vulnerable to the impact of TBI. More severe injury affected attention skills most negatively. Significant recovery was observed over time. There were few interaction effects, with severity groups exhibiting similar levels of recovery over the 6 months post-TBI. No differences in recovery trajectories were detected for simple and complex attention. Conclusions: These findings have important clinical and educational implications, suggesting that children with TBI, and particularly those with more serious injuries, are most vulnerable to attention deficits in the acute stages postinjury. It is important that schools and families are aware of these limitations and structure expectations accordingly. For example, gradual return to school should be considered, and in the early stages of recovery, children should be provided with sufficient rest time, with reduced expectations for tasks such as homework.	[Anderson, Vicki; Eren, Senem] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Anderson, Vicki; Eren, Senem] Univ Melbourne, Melbourne, Vic, Australia; [Anderson, Vicki] Royal Childrens Hosp, Dept Psychol, Melbourne, Vic 3052, Australia; [Davern, Timothy J.] Monash Univ, Melbourne, Vic 3004, Australia; [Dob, Rian] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Le Brocque, Robyne; Iselin, Greg; Kenardy, Justin] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [McKinlay, Lynne] Royal Childrens Hosp, Queensland Paediat Rehabil Serv, Brisbane, Qld, Australia		Anderson, V (corresponding author), Royal Childrens Hosp, Dept Psychol, Flemington Rd, Parkville, Vic 3052, Australia.	vicki.anderson@rch.org.au	Kenardy, Justin/F-2085-2010; Le Brocque, Robyne/F-4848-2010; Kenardy, Justin A/H-6603-2014	Le Brocque, Robyne/0000-0002-4574-1254; Kenardy, Justin A/0000-0001-9475-8450; McKinlay, Lynne/0000-0002-6677-0628			Achenbach TM, 1991, MANUAL CHILD BEHAV C; Anderson V, 1998, BRAIN INJURY, V12, P937, DOI 10.1080/026990598121990; Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P283; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Catroppa C, 1999, J INT NEUROPSYCH SOC, V5, P48, DOI 10.1017/S1355617799511077; Catroppa C, 2003, DEV NEUROPSYCHOL, V23, P359, DOI 10.1207/S15326942DN2303_3; Catroppa C, 1999, CHILD NEUROPSYCHOL, V5, P251, DOI 10.1076/0929-7049(199912)05:04;1-R;FT251; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Ciccetti D., 1984, VINELAND ADAPTIVE BE; COOLEY EL, 1990, DEV NEUROPSYCHOL, V6, P239, DOI 10.1080/87565649009540465; Crowe L, 2009, JPCH, V45, P345; Ewing-Cobbs L, 1998, CHILD NEUROPSYCHOL, V4, P35, DOI 10.1076/chin.4.1.35.3194; Fenwick T, 1999, CHILD NEUROPSYCHOL, V5, P213, DOI 10.1076/0929-7049(199912)05:04;1-R;FT213; Ginstfeldt T, 2010, BRAIN INJURY, V24, P1123, DOI 10.3109/02699052.2010.506853; Gioia GA IP, 2000, BEHAV RATING INVENTO; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; Kraus JF., 1995, TRAUMATIC HEAD INJUR, P117; Manly T, 2001, J CHILD PSYCHOL PSYC, V42, P1065, DOI 10.1111/1469-7610.00806; Manly T., 1999, TEST EVERYDAY ATTENT; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; MCLENNAN W, 1997, AUSTR STANDARD CLASS; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; MURRAY R, 1992, BRAIN COGNITION, V18, P99, DOI 10.1016/0278-2626(92)90072-T; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Posner M, 1990, ANNU REV NEUROSCI, V15, P25; Stuss DT, 1995, ANN NY ACAD SCI, V769, P191, DOI 10.1111/j.1749-6632.1995.tb38140.x; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; TAYLOR HG, 1990, NEW ENGL J MED, V323, P1657, DOI 10.1056/NEJM199012133232403; TEASDALE G, LANCET, V2, P81; Timmermans SR, 1991, COGNITIVE REHABILITA, V9, P26; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; Vriezen ER, 2000, BRAIN COGNITION, V44, P67; Walsh K. W., 1978, NEUROPSYCHOLOGY CLIN; Warchausky S, 1996, ARCH CLIN NEUROPSYCH, V11, P147; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D., 2011, WECHSLER ABBREVIATED; Willmott C, 2000, DEV NEUROPSYCHOL, V17, P361, DOI 10.1207/S15326942DN1703_5; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; [No title captured]	42	17	17	0	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2012	27	3					199	209		10.1097/HTR.0b013e31821a9d2b			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	941CV	WOS:000303941500008	21691214				2022-02-06	
J	Armstead, WM; Riley, J; Vavilala, MS				Armstead, William M.; Riley, John; Vavilala, Monica S.			TBI Sex Dependently Upregulates ET-1 To Impair Autoregulation, which Is Aggravated by Phenylephrine in Males but Is Abrogated in Females	JOURNAL OF NEUROTRAUMA			English	Article						cerebral autoregulation; endothelin; K channels; signal transduction; TBI	TRAUMATIC BRAIN-INJURY; K+ CHANNEL FUNCTION; PROTEIN-KINASE-C; INTRACRANIAL-PRESSURE; ATP; AGE; HYPOTENSION; ACTIVATION; CHILDREN; NEWBORN	Traumatic brain injury (TBI) contributes to morbidity in children, and boys are disproportionately represented. Endothelin-1 (ET-1) contributes to impaired autoregulation via oxygen (O-2(-)) after TBI in piglets, but its relative role in males compared with females has not been previously investigated. Increased cerebral perfusion pressure (CPP) via phenylephrine (Phe) sex dependently improves impairment of autoregulation after TBI through modulation of extracellular signal-related kinase (ERK) mitogen-activated protein kinase (MAPK) upregulation, aggravated in males, but blocked in females. Activation of adenosine-5'-triphosphate (ATP) and Ca sensitive K channels produce vasodilation, contributing to autoregulation. We hypothesized that ET-1 upregulation is greater in males after TBI and that disturbed autoregulation will be prevented by Phe in a sex-dependent manner through modulation of ET-1, O-2(-), and ERK. Results show that ET-1 release was greater in males after fluid percussion injury (FPI), blunted by Phe in females, but aggravated in males. K channel vasodilation was impaired more in males than in females after TBI. Phe prevented reductions in K channel vasodilation in females, but further reduced dilation in males after TBI. Co-administration of BQ-123, U0126, or PEG-SOD (ET-1, ERK antagonist, and O-2(-) scavenger) with Phe restored dilation to K agonists and hypotension in males after TBI. ERK upregulation was blocked by BQ-123 and PEG-SOD. These data indicate that TBI upregulates ET-1 more in males than in females. Elevation of CPP with Phe sex dependently prevents impairment of cerebral autoregulation after TBI through modulation of ET-1, O-2(-), and ERK mediated impairment of K channel vasodilation. These observations advocate for the consideration of development of sex-based therapies for the treatment of hemodynamic sequelae of pediatric TBI.	[Armstead, William M.; Riley, John] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Armstead, William M.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol Pediat & Neurol Surg, Seattle, WA 98195 USA		Armstead, WM (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care, 3620 Hamilton Walk,JM3, Philadelphia, PA 19104 USA.	armsteaw@uphs.upenn.edu		Riley, John/0000-0002-7932-8935	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD57355]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD057355] Funding Source: NIH RePORTER	This research was supported by grant HD57355 from the National Institutes of Health.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS12; Armstead WM, 2007, J CEREBR BLOOD F MET, V27, P1702, DOI 10.1038/sj.jcbfm.9600473; Armstead William M, 2005, Pathophysiology, V12, P5, DOI 10.1016/j.pathophys.2005.01.002; Armstead WM, 2011, NEUROL RES, V33, P127, DOI 10.1179/016164111X12881719352138; Armstead WM, 2011, J NEUROTRAUM, V28, P105, DOI 10.1089/neu.2010.1581; Armstead WM, 2010, CRIT CARE MED, V38, P1868, DOI 10.1097/CCM.0b013e3181e8ac1a; Armstead WM, 2010, J NEUROTRAUM, V27, P391, DOI 10.1089/neu.2009.1094; Armstead WM, 2009, J CEREBR BLOOD F MET, V29, P524, DOI 10.1038/jcbfm.2008.142; Armstead WM, 1999, STROKE, V30, P153, DOI 10.1161/01.STR.30.1.153; Armstead WM, 1999, AM J PHYSIOL-HEART C, V277, pH1884; Armstead WM, 1999, BRAIN RES, V816, P158, DOI 10.1016/S0006-8993(98)01146-9; Armstead WM, 1997, STROKE, V28, P2273, DOI 10.1161/01.STR.28.11.2273; Armstead WM, 2000, MICROCIRCULATION, V7, P225, DOI 10.1080/713773978; Bratton SL, 2007, J NEUROTRAUMA, V24, pS7; Catala-Temprano A, 2007, J NEUROSURG, V106, P463, DOI 10.3171/ped.2007.106.6.463; Coles JP, 2004, BRAIN, V127, P2479, DOI 10.1093/brain/awh268; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Di Gennaro JL, 2010, DEV NEUROSCI-BASEL, V32, P420, DOI 10.1159/000322083; EDVINSSON L, 1987, J CEREBR BLOOD F MET, V7, P720, DOI 10.1038/jcbfm.1987.126; Faraci FM, 1998, PHYSIOL REV, V78, P53, DOI 10.1152/physrev.1998.78.1.53; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; Ishikawa S, 2009, ANESTH ANALG, V108, P1631, DOI 10.1213/ane.0b013e31819d94e3; Keenan Heather T, 2005, Pediatr Crit Care Med, V6, P537, DOI 10.1097/01.PCC.0000164638.44600.67; Laher I, 2001, J CEREBR BLOOD F MET, V21, P887, DOI 10.1097/00004647-200108000-00001; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006	25	17	18	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2012	29	7					1483	1490		10.1089/neu.2011.2248			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	933TC	WOS:000303384600020	22335188	Green Published			2022-02-06	
J	Eriksson, EA; Barletta, JF; Figueroa, BE; Bonnell, BW; Sloffer, CA; Vanderkolk, WE; McAllen, KJ; Ott, M				Eriksson, Evert A.; Barletta, Jeffrey F.; Figueroa, Bryan E.; Bonnell, Bruce W.; Sloffer, Chris A.; Vanderkolk, Wayne E.; McAllen, Karen J.; Ott, Mickey			The first 72 hours of brain tissue oxygenation predicts patient survival with traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Trauma; pBtO(2); traumatic brain injury; brain tissue oxygenation; intracranial pressure	PO-2	BACKGROUND: Utilization of brain tissue oxygenation (pBtO(2)) is an important but controversial variable in the treatment of traumatic brain injury. We hypothesize that pBtO(2) values over the first 72 hours of monitoring are predictive of mortality. METHODS: Consecutive, adult patients with severe traumatic brain injury and pBtO(2) monitors were retrospectively identified. Time-indexed measurements of pBtO(2), cerebral perfusion pressure (CPP), and intracranial pressure (ICP) were collected, and average values over 4-hour blocks were determined. Patients were stratified according to survival, and repeated measures analysis of variance was used to compare pBtO(2), CPP, and ICP. The pBtO(2) threshold most predictive for survival was determined. RESULTS: There were 8,759 time-indexed data points in 32 patients. The mean age was 39 years +/- 16.5 years, injury severity score was 27.7 +/- 10.7, and Glasgow Coma Scale score was 6.6 +/- 3.4. Survival was 68%. Survivors consistently demonstrated higher pBtO(2) values compared with nonsurvivors including age as a covariate (F +/- 12.898, p < 0.001). Individual pBtO(2) was higher at the time points 8 hours, 12 hours, 20 hours to 44 hours, 52 hours to 60 hours, and 72 hours of monitoring (p < 0.05). There was no difference in ICP (F = 1.690, p = 0.204) and CPP (F = 0.764, p = 0.389) values between survivors and nonsurvivors including age as a covariate. Classification and regression tree analysis identified 29 mm Hg as the threshold at which pBtO(2) was most predictive for mortality. CONCLUSION: The first 72 hours of pBtO(2) neurologic monitoring predicts mortality. When the pBtO(2) monitor remains below 29 mm Hg in the first 72 hours of monitoring, mortality is increased. This study challenges the brain oxygenation threshold of 20 mm Hg that has been used conventionally and delineates a time for monitoring pBtO(2) that is predictive of outcome. (J Trauma. 2012;72: 1345-1349. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Eriksson, Evert A.] Med Univ S Carolina, Dept Gen Surg, Div Gen Trauma Surg, Charleston, SC 29425 USA; [Barletta, Jeffrey F.] Midwestern Univ, Coll Pharm, Dept Pharm Practice, Glendale, AZ USA; [Figueroa, Bryan E.] Spectrum Hlth, Dept Neurosurg, Grand Rapids, MI USA; [Bonnell, Bruce W.] Spectrum Hlth, Dept Surg Crit Care, GRMEC MSU Surg Crit Care, Grand Rapids, MI USA; [Sloffer, Chris A.] Bronson Neurosci Ctr, Dept Neurosurg, Kalamazoo, MI USA; [Vanderkolk, Wayne E.] St Marys Hlth Care, Dept Trauma, Grand Rapids, MI USA; [McAllen, Karen J.] Spectrum Hlth, Dept Pharm, Acute Crit Care, Grand Rapids, MI USA; [Ott, Mickey] Vanderbilt Univ, Med Ctr, Div Trauma & Surg Crit Care, Nashville, TN USA		Eriksson, EA (corresponding author), Med Univ S Carolina, Dept Gen Surg, Div Gen Trauma Surg, 96 Jonathan Lucas St,Suite 420, Charleston, SC 29425 USA.	evsurgery@gmail.com	Barletta, Jeffrey F./B-2644-2013	Eriksson, Evert/0000-0002-4099-325X			Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS55; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS65; Chang JJJ, 2009, CRIT CARE MED, V37, P283, DOI 10.1097/CCM.0b013e318192fbd7; Dings J, 1998, NEUROL RES, V20, pS71; Eriksson EA, 2011, CLIN NEUROPHYSI 1118; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hoelper BM, 2005, ACTA NEUROCHIR, V147, P767, DOI 10.1007/s00701-005-0512-8; LeRoux PD, 1997, J NEUROSURG, V87, P1, DOI 10.3171/jns.1997.87.1.0001; Martini RP, 2009, J NEUROSURG, V111, P644, DOI 10.3171/2009.2.JNS08998; McCarthy MC, 2009, SURGERY, V146, P585, DOI 10.1016/j.surg.2009.06.059; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007	19	17	18	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAY	2012	72	5					1345	1349		10.1097/TA.0b013e318249a0f4			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	944JD	WOS:000304195100043	22673264				2022-02-06	
J	Harris, NG; Mironova, YA; Chen, SF; Richards, HK; Pickard, JD				Harris, Neil G.; Mironova, Yevgeniya A.; Chen, Szu-Fu; Richards, Hugh K.; Pickard, John D.			Preventing Flow-Metabolism Uncoupling Acutely Reduces Axonal Injury after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						autoradiography; blood flow; cortical contusion injury; glucose metabolism; uncoupling	CEREBRAL-BLOOD-FLOW; CONTROLLED CORTICAL IMPACT; POSITRON-EMISSION-TOMOGRAPHY; HEAD-INJURY; NEUROFILAMENT COMPACTION; AXOLEMMAL PERMEABILITY; CEREBROVASCULAR REACTIVITY; CYTOCHEMICAL EVIDENCE; STRETCH INJURY; NERVE-FIBERS	We have previously presented evidence that the development of secondary traumatic axonal injury is related to the degree of local cerebral blood flow (LCBF) and flow-metabolism uncoupling. We have now tested the hypothesis that augmenting LCBF in the acute stages after brain injury prevents further axonal injury. Data were acquired from rats with or without acetazolamide (ACZ) that was administered immediately following controlled cortical impact injury to increase cortical LCBF. Local cerebral metabolic rate for glucose (LCMRglc) and LCBF measurements were obtained 3 h post-trauma in the same rat via F-18-fluorodeoxyglucose and C-14-iodoantipyrine co-registered autoradiographic images, and compared to the density of damaged axonal profiles in adjacent sections, and in additional groups at 24 h used to assess different populations of injured axons stereologically. ACZ treatment significantly and globally elevated LCBF twofold above untreated-injured rats at 3 h (p < 0.05), but did not significantly affect LCMRglc. As a result, ipsilateral LCMRglc: LCBF ratios were reduced by twofold to sham-control levels, and the density of beta-APP-stained axons at 24 h was significantly reduced in most brain regions compared to the untreated-injured group (p < 0.01). Furthermore, early LCBF augmentation prevented the injury-associated increase in the number of stained axons from 3-24 h. Additional robust stereological analysis of impaired axonal transport and neurofilament compaction in the corpus callosum and cingulum underlying the injury core confirmed the amelioration of beta-APP axon density, and showed a trend, but no significant effect, on RMO14-positive axons. These data underline the importance of maintaining flow-metabolism coupling immediately after injury in order to prevent further axonal injury, in at least one population of injured axons.	[Harris, Neil G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Brain Injury Res Ctr, Los Angeles, CA 90095 USA; [Chen, Szu-Fu] Cheng Hsin Gen Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Chen, Szu-Fu] Natl Def Med Ctr, Dept Physiol, Taipei, Taiwan; [Richards, Hugh K.; Pickard, John D.] Univ Cambridge, Ctr Brain Repair, Cambridge, England; [Richards, Hugh K.; Pickard, John D.] Univ Cambridge, Wolfson Brain Imaging Ctr, Cambridge, England		Harris, NG (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Brain Injury Res Ctr, Box 957039, Los Angeles, CA 90095 USA.	ngharris@mednet.ucla.edu	Chen, Szu-Fu/K-5040-2012	Harris, Neil/0000-0002-1965-6750	Medical Research Council of the United KingdomUK Research & Innovation (UKRI)Medical Research Council UK (MRC); National Institutes of Health/National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS055910]; UCLA Brain Injury Research Center; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986, G0001237, G9439390] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0001237, G0600986, G9439390] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055910] Funding Source: NIH RePORTER	This work was supported by the Medical Research Council of the United Kingdom, National Institutes of Health/National Institute of Neurological Disorders and Stroke award no. NS055910 and the UCLA Brain Injury Research Center. The Overseas Research Council and Merck Sharp & Dohme funded S. F. C. and N.G.H., respectively. We would also like to thank Ms. Marcia Nogueira for her assistance with the experiments.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Belayev L, 1999, J NEUROTRAUM, V16, P445, DOI 10.1089/neu.1999.16.445; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; BICKLER PE, 1988, J APPL PHYSIOL, V65, P422, DOI 10.1152/jappl.1988.65.1.422; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Buki A, 2000, J NEUROSCI, V20, P2825; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chen SF, 2004, J CEREBR BLOOD F MET, V24, P1025, DOI 10.1097/01.WCB.0000129415.34520.47; Chen T, 2000, BRAIN RES, V861, P281, DOI 10.1016/S0006-8993(00)01992-2; Cherian L, 1999, CRIT CARE MED, V27, P2512, DOI 10.1097/00003246-199911000-00031; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Forbes ML, 1997, J CEREBR BLOOD F MET, V17, P865, DOI 10.1097/00004647-199708000-00005; Gallyas F, 2006, ACTA NEUROPATHOL, V111, P229, DOI 10.1007/s00401-006-0034-3; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Ginsberg MD, 2001, J NEUROSURG, V94, P499, DOI 10.3171/jns.2001.94.3.0499; GRADY MS, 1993, J NEUROPATH EXP NEUR, V52, P143, DOI 10.1097/00005072-199303000-00007; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Hamm RJ, 1996, J NEUROTRAUM, V13, P325, DOI 10.1089/neu.1996.13.325; Harris N, 2009, J NEUROTRAUM, V26, pA37; Harris NG, 2001, NEUROIMAGE, V13, P339, DOI 10.1006/nimg.2000.0689; Harris NG, 2000, J CEREBR BLOOD F MET, V20, P28, DOI 10.1097/00004647-200001000-00006; HOSSMANN KA, 1994, ANN NEUROL, V36, P557, DOI 10.1002/ana.410360404; INGVAR M, 1991, J CEREBR BLOOD F MET, V11, P926, DOI 10.1038/jcbfm.1991.157; Kelley BJ, 2006, EXP NEUROL, V198, P350, DOI 10.1016/j.expneurol.2005.12.017; Kelly DF, 2000, J NEUROTRAUM, V17, P261, DOI 10.1089/neu.2000.17.261; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; LEAR JL, 1989, METAB BRAIN DIS, V4, P95, DOI 10.1007/BF00999387; Marion DW, 1996, J NEUROTRAUM, V13, P139, DOI 10.1089/neu.1996.13.139; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; Marklund N, 2002, J NEUROTRAUM, V19, P1139, DOI 10.1089/08977150260337958; Marmarou CR, 2006, EXP NEUROL, V197, P353, DOI 10.1016/j.expneurol.2005.10.003; Marmarou CR, 2005, J NEUROTRAUM, V22, P1066, DOI 10.1089/neu.2005.22.1066; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Maxwell WL, 1995, J NEUROCYTOL, V24, P925, DOI 10.1007/BF01215643; Maxwell WL, 1999, J NEUROTRAUM, V16, P273, DOI 10.1089/neu.1999.16.273; MAXWELL WL, 1993, ACTA NEUROPATHOL, V86, P136, DOI 10.1007/BF00334880; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Moro N, 2010, EXP NEUROL, V225, P391, DOI 10.1016/j.expneurol.2010.07.013; MUIR JK, 1995, J NEUROTRAUM, V12, P179, DOI 10.1089/neu.1995.12.179; NIXON RA, 1994, NEUROCHEM RES, V19, P1445, DOI 10.1007/BF00972474; NIXON RA, 1994, J CELL BIOL, V126, P1031, DOI 10.1083/jcb.126.4.1031; Okonkwo DO, 1998, BRAIN RES, V784, P1, DOI 10.1016/S0006-8993(97)01075-5; Paxinos G, 1997, RAT BRAIN STEREOTAXI; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; Povlishock JT, 1996, ACT NEUR S, V66, P81; Reeves TM, 2007, BRAIN RES, V1154, P225, DOI 10.1016/j.brainres.2007.04.002; Richards HK, 2001, J CEREBR BLOOD F MET, V21, P779, DOI 10.1097/00004647-200107000-00002; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; Rockswold SB, 2001, J NEUROSURG, V94, P403, DOI 10.3171/jns.2001.94.3.0403; Saatman KE, 2003, J CEREBR BLOOD F MET, V23, P34, DOI 10.1097/01.WCB.0000035040.10031.B0; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; Schurr A, 1999, J NEUROSCI, V19, P34, DOI 10.1523/JNEUROSCI.19-01-00034.1999; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; Stone JR, 2000, BRAIN RES, V871, P288, DOI 10.1016/S0006-8993(00)02485-9; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; SUNAMI, 1989, NEUROSURG REV, V12, P400; SUTTON RL, 1994, ACTA NEUROCHIR, P446; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; Yang JT, 2001, NEUROREPORT, V12, P3589, DOI 10.1097/00001756-200111160-00043; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zhao WZ, 1999, J NEUROSURG, V90, P510, DOI 10.3171/jns.1999.90.3.0510	69	17	17	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2012	29	7					1469	1482		10.1089/neu.2011.2161			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	933TC	WOS:000303384600019	22321027	Green Published			2022-02-06	
J	Namdari, S; Alosh, H; Baldwin, K; Mehta, S; Keenan, MA				Namdari, Surena; Alosh, Hassan; Baldwin, Keith; Mehta, Samir; Keenan, Mary Ann			Outcomes of tendon fractional lengthenings to improve shoulder function in patients with spastic hemiparesis	JOURNAL OF SHOULDER AND ELBOW SURGERY			English	Article						Tendon lengthening; spasticity; hemiparesis	UPPER-LIMB SPASTICITY; BRAIN-INJURED ADULTS; DYNAMIC ELECTROMYOGRAPHY; ORTHOPEDIC MANAGEMENT; SURGICAL-TREATMENT; BOTULINUM TOXIN; STROKE; DEFORMITY; CONTRACTURE; REDUCTION	Background: Patients with spastic hemiparesis after upper motor neuron (UMN) injury often exhibit limited shoulder movement. We evaluated the outcomes of shoulder tendon fractional lengthenings in patients with spasticity and preserved volitional control. Methods: A consecutive series of 34 adults with spastic hemiparesis from UMN injury (23 post-stroke, 11 post-traumatic brain injury) and limited shoulder movement with preserved volitional motor control who underwent shoulder tendon fractional lengthenings (pectoralis major, latissimus dorsi, teres major) were evaluated. Active and passive shoulder motion, spasticity, pain, and satisfaction were considered pre- and postoperatively. Results: There were 15 males and 19 females with a mean age of 44.1 years. Mean follow-up was 12.2 months. Mean Modified Ashworth spasticity score was 2.4 preoperatively compared to 1.9 postoperatively (P = .001). Active flexion, abduction, and external rotation improved compared to the normal contralateral side (P < .001) with most dramatic gains in external rotation. Similarly, passive extension, flexion, abduction, and external rotation improved compared to the normal contralateral side (P < .01). Ninety-four percent (15/16) with preoperative pain had improved pain relief postoperatively with 14 (88%) being pain-free. Thirty-one (92%) were satisfied with the outcome. Conclusion: Shoulder tendon lengthenings can be an effective means of pain-relief, improved motion, enhanced active motor function, and decreased spasticity in patients with spastic hemiparesis from UMN injury. (c) 2012 Journal of Shoulder and Elbow Surgery Board of Trustees.	[Namdari, Surena; Alosh, Hassan; Baldwin, Keith; Mehta, Samir; Keenan, Mary Ann] Hosp Univ Penn, Dept Orthopaed Surg, Philadelphia, PA 19104 USA		Keenan, MA (corresponding author), Hosp Univ Penn, Dept Orthopaed Surg, 2 Silverstein,3400 Spruce St, Philadelphia, PA 19104 USA.	MaryAnn.Keenan@uphs.upenn.edu	Keenan, Mary Ann/ABB-1551-2020				Aldwell C B, 1969, Clin Orthop Relat Res, V63, P69; Bertelli JA, 2009, J BONE JOINT SURG BR, V91B, P943, DOI 10.1302/0301-620X.91B7.21795; Bhakta BB, 1996, J NEUROL NEUROSUR PS, V61, P30, DOI 10.1136/jnnp.61.1.30; Botte M J, 1988, Orthop Rev, V17, P891; BOTTE MJ, 1988, J HAND SURG-AM, V13A, P147, DOI 10.1016/0363-5023(88)90220-1; BRAUN RM, 1971, J BONE JOINT SURG AM, VA 53, P1307, DOI 10.2106/00004623-197153070-00006; Braun RM, 1999, CLIN ORTHOP RELAT R, P54; GARLAND DE, 1978, CLIN ORTHOP RELAT R, P111; KAPLAN PE, 1977, ARCH PHYS MED REHAB, V58, P415; Keenan MA, 2010, GREENS OPERATIVE HAN, P1178; Keenan MAE, 2004, J HEAD TRAUMA REHAB, V19, P143, DOI 10.1097/00001199-200403000-00006; Keenan MAE, 2002, CUR CLIN NEUROL, P197; KOZIN SH, 1993, CLIN ORTHOP RELAT R, P109; Namdari S, 2011, J SHOULDER ELB SURG, V20, P802, DOI 10.1016/j.jse.2010.10.023; Namdari S, 2010, J BONE JOINT SURG AM, V92A, P2589, DOI 10.2106/JBJS.I.01390; PILL SG, 2008, SPASTICITY OTHER FOR, P119; PINZUR MS, 1993, CLIN ORTHOP RELAT R, P118; Posteraro F, 2010, J REHABIL MED, V42, P279, DOI 10.2340/16501977-0500; RHOADES ME, 1978, CLIN ORTHOP RELAT R, P104; Shaw L, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14260; van der Sluijs JA, 2004, J PEDIATR ORTHOP B, V13, P218, DOI 10.1097/00009957-200405000-00015; Waters PM, 2009, J BONE JOINT SURG AM, V91A, P213, DOI 10.2106/JBJS.I.00501; Yelnik A. P., 2009, Annals of Physical and Rehabilitation Medicine, V52, P746, DOI 10.1016/j.rehab.2009.09.005	23	17	17	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1058-2746			J SHOULDER ELB SURG	J. Shoulder Elbow Surg.	MAY	2012	21	5					691	698		10.1016/j.jse.2011.03.026			8	Orthopedics; Sport Sciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences; Surgery	944HU	WOS:000304190700024	21719314				2022-02-06	
J	Holmes, J; Peng, J; Bair, A				Holmes, James; Peng, James; Bair, Aaron			ABNORMAL END-TIDAL CARBON DIOXIDE LEVELS ON EMERGENCY DEPARTMENT ARRIVAL IN ADULT AND PEDIATRIC INTUBATED PATIENTS	PREHOSPITAL EMERGENCY CARE			English	Article; Proceedings Paper	ACEP Scientific Assembly	OCT, 2010	Boston, MA			prehospital intubation; trauma; ETCO2	TRAUMATIC BRAIN-INJURY; ENDOTRACHEAL INTUBATION; PREHOSPITAL INTUBATION; VENTILATION; FIELD; SURVIVAL; IMPACT; TIME	Background. The utility of prehospital intubation is controversial, as uncontrolled studies in trauma patients suggest adverse outcomes with prehospital intubation, perhaps secondary to inappropriate ventilation once intubation is accomplished. Objectives. The objectives were 1) to establish, immediately upon arrival to the emergency department (ED), the prevalence of abnormal end-tidal carbon dioxide (ETCO2) levels in patients with prehospital intubation and 2) to describe the relationship between abnormal ETCO2 levels on ED arrival and mortality. Methods. This was a prospective, observational cohort study of patients with prehospital intubation. Patients were excluded if they underwent prehospital cardiopulmonary resuscitation (CPR). On ED arrival, the initial ETCO2 measurement from the patient's endotracheal tube was immediately obtained prior to purposeful intervention in the patient's ventilation by using an Oridion Surestream Sure VentLine H Set with a Welch Allyn Propaq CS monitor. For each patient, the treating physician documented the ETCO2 measurement, patient demographics, and details of the transport. The primary outcome was an abnormal ETCO2 value (<30 mmHg or >45 mmHg). The secondary outcome was mortality. Results. One hundred eligible patients were enrolled, with a median age of 30 years (interquartile range [IQR] 15, 48 years). Esophageal intubations were identified in four cases, and those cases were excluded from further analysis. Mechanisms included trauma, 74; medical, 12; and burn, 10. The median ETCO2 value was 32 mmHg (IQR 27, 38 mmHg), range 18-80 mmHg. Forty-six of 96 (48%, 95% confidence interval [CI] 38%, 58%) patients had abnormal ETCO2 values, including 37 (39%, 95% CI 29%, 49%) with low ETCO2 levels and nine (9%, 95% CI 4%, 17%) with high ETCO2 levels. Death was higher in those trauma patients with abnormal ETCO2 levels (10/33, 30%, 95% CI 16%, 49%) than in those with normal ETCO2 levels (2/41, 5%, 95% CI 0.6%, 17%), relative risk = 6.2 (95% CI 1.5, 26.4), p = 0.004. Conclusion. Nearly half of all patients transported by prehospital providers had abnormal ETCO2 measurements on initial ED presentation, suggesting an area for potential improvement. Trauma patients with abnormal initial ETCO2 levels were more likely to die.	[Holmes, James; Peng, James; Bair, Aaron] Univ Calif Davis, Sch Med, Dept Emergency Med, Sacramento, CA 95817 USA		Holmes, J (corresponding author), Univ Calif Davis, Sch Med, Dept Emergency Med, 2315 Stockton Blvd,PSSB 2100, Sacramento, CA 95817 USA.	jfholmes@ucdavis.edu					Bair AE, 2005, J EMERG MED, V28, P403, DOI 10.1016/j.jemermed.2004.12.008; Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; Carr BG, 2008, PREHOSP EMERG CARE, V12, P327, DOI 10.1080/10903120802096928; Caulfield EV, 2009, J TRAUMA, V66, P1577, DOI 10.1097/TA.0b013e3181a3931d; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Cobas MA, 2009, ANESTH ANALG, V109, P489, DOI 10.1213/ane.0b013e3181aa3063; Colwell CB, 2009, PREHOSP EMERG CARE, V13, P304, DOI 10.1080/10903120902935280; Cooper A, 2001, Semin Pediatr Surg, V10, P3, DOI 10.1053/spsu.2001.19379; Cudnik MT, 2007, PREHOSP EMERG CARE, V11, P224, DOI 10.1080/10903120701205208; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Davis DP, 2005, NEUROCRIT CARE, V2, P165, DOI 10.1385/NCC:2:2:165; Davis DP, 2004, J TRAUMA, V56, P808, DOI 10.1097/01.TA.0000100217.05066.87; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Deakin CD, 2009, EMERG MED J, V26, P888, DOI 10.1136/emj.2008.064642; DiRusso SM, 2005, J TRAUMA, V59, P84, DOI 10.1097/01.TA.0000171462.28379.F3; Dumont TM, 2010, J NEUROTRAUM, V27, P1233, DOI 10.1089/neu.2009.1216; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; Kupas DF, 2010, PREHOSP EMERG CARE, V14, P26, DOI 10.3109/10903120903144932; Lecky F, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001429.pub2; Lyon RM, 2010, EMERG MED J, V27, P321, DOI 10.1136/emj.2009.076737; Murray JA, 2000, J TRAUMA, V49, P1065, DOI 10.1097/00005373-200012000-00015; Stiell IG, 2008, CAN MED ASSOC J, V178, P1141, DOI 10.1503/cmaj.071154; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Wang HE, 2003, ACAD EMERG MED, V10, P717, DOI 10.1197/aemj.10.7.717; Wang HE, 2010, ANN EMERG MED, V55, P527, DOI 10.1016/j.annemergmed.2009.12.020; Warner KJ, 2008, J TRAUMA, V64, P341, DOI 10.1097/TA.0b013e318160dfb3; Warner KJ, 2010, PREHOSP EMERG CARE, V14, P103, DOI 10.3109/10903120903144858	27	17	17	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1090-3127	1545-0066		PREHOSP EMERG CARE	Prehosp. Emerg. Care	APR-JUN	2012	16	2					210	216		10.3109/10903127.2011.640416			7	Emergency Medicine; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Emergency Medicine; Public, Environmental & Occupational Health	899BU	WOS:000300788700004	22217189				2022-02-06	
J	Menuet, C; Borghgraef, P; Voituron, N; Gestreau, C; Gielis, L; Devijver, H; Dutschmann, M; Van Leuven, F; Hilaire, G				Menuet, Clement; Borghgraef, Peter; Voituron, Nicolas; Gestreau, Christian; Gielis, Lies; Devijver, Herman; Dutschmann, Mathias; Van Leuven, Fred; Hilaire, Gerard			Isoflurane anesthesia precipitates tauopathy and upper airways dysfunction in pre-symptomatic Tau.P301L mice: Possible implication for neurodegenerative diseases	NEUROBIOLOGY OF DISEASE			English	Article						Tauopathy; Anesthesia; Upper airways; Memantine; Isoflurane; NMDA receptors; Mice; Brainstem; Alzheimer's disease	TRAUMATIC BRAIN-INJURY; D-ASPARTATE RECEPTORS; ALZHEIMERS-DISEASE; TAU PHOSPHORYLATION; MEMORY IMPAIRMENT; PREMOTOR NEURONS; TRANSGENIC MICE; STEM NUCLEI; PROTEIN-TAU; C-FOS	The postoperative cognitive decline resulting from volatile anesthesia is gaining acceptance as a major health problem. The common anesthetic isoflurane is suspected to precipitate neurodegeneration in Alzheimer's disease by unknown mechanisms. We previously validated that 8 month old Tau.P301L mice suffer upper airways defects related to tauopathy within the Kolliker-Fuse nucleus that controls upper airways function. We now report that isoflurane anesthesia in young, pre-symptomatic Tau.P301L mice triggered precocious upper airways defects and tauopathy in several brainstem nuclei, including the nucleus ambiguus that contains upper airways motor neurons and the Kolliker-Fuse. The prescription drug memantine, identified as an NMDA receptor antagonist, prevented the post-anesthesia upper airways dysfunction and alleviated tauopathy in the nucleus ambiguus and Kolliker-Fuse. We further identified protocols of anesthesia in young Tau.P301L mice that mitigated adverse effects of isoflurane anesthesia. Thus, our experimental findings in a validated mouse model for tauopathy demonstrate the link between isoflurane anesthesia, earlier onset of tauopathy and earlier onset of functional deficits, highlight the implication of NMDA-receptors in the mechanisms mediating the adverse effects of isoflurane, and potentially identify safer protocols for anesthesia in patients with tauopathy. (C) 2012 Elsevier Inc. All rights reserved.	[Menuet, Clement; Voituron, Nicolas; Gestreau, Christian; Hilaire, Gerard] Fac Sci & Tech St Jerome, Resp Team MP3, Unite Mixte Rech 6231, Ctr Rech Neurobiol & Neurophysiol Marseille,Serv, F-13397 Marseille 20, France; [Borghgraef, Peter; Gielis, Lies; Devijver, Herman; Van Leuven, Fred] KULeuven, Expt Genet Grp, LEGTEGG, Dept Human Genet, B-3000 Louvain, Belgium; [Dutschmann, Mathias] Univ Leeds, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England		Hilaire, G (corresponding author), Fac Sci & Tech St Jerome, Resp Team MP3, Unite Mixte Rech 6231, Ctr Rech Neurobiol & Neurophysiol Marseille,Serv, F-13 Marseille, France.	gerard.hilaire@univ-cezanne.fr	Gestreau, Christian/K-5161-2017	Gestreau, Christian/0000-0001-5069-482X; Dutschmann, Mathias/0000-0002-0692-746X; Menuet, Clement/0000-0002-7419-6427	Unite Mixte de Recherche [6231]; Fonds Wetenschappelijk Onderzoek-Vlaanderen (FWO-Vlaanderen)FWO; Instituut voor Wetenschap en Techniek (IWT)Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT); KULeuven-Research Fund (BOF)KU Leuven; KULeuven-Research&Development and EEC Framework programs; NHLBIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)	This work was supported by the Unite Mixte de Recherche 6231, the Fonds Wetenschappelijk Onderzoek-Vlaanderen (FWO-Vlaanderen), Instituut voor Wetenschap en Techniek (IWT), KULeuven-Research Fund (BOF), KULeuven-Research&Development and EEC Framework programs FP6 & FP7 and NHLBI. The authors thank Luc Quintin, MD, PhD, for his invaluable comments and advices about the translation of our data obtained in Tau.P301L mice to human anesthesia.	Alonso AD, 2004, J BIOL CHEM, V279, P34873, DOI 10.1074/jbc.M405131200; Arrich Jasmin, 2010, Anesth Analg, V110, P1239, DOI 10.1213/ANE.0b013e3181ce8d34; Baranov D, 2009, ANESTH ANALG, V108, P1627, DOI 10.1213/ane.0b013e318199dc72; Benumof J.L., 1986, ANESTHESIA, V2, P1115; Bhatnagar S, 1998, NEUROSCIENCE, V84, P1025, DOI 10.1016/S0306-4522(97)00577-0; Bilotta F, 2010, J ALZHEIMERS DIS, V22, pS81, DOI 10.3233/JAD-2010-100825; Bonis JM, 2011, RESP PHYSIOL NEUROBI, V175, P272, DOI 10.1016/j.resp.2010.12.002; BRAAK H, 1994, NEUROBIOL AGING, V15, P355, DOI 10.1016/0197-4580(94)90032-9; BRION JP, 1986, LANCET, V2, P1098, DOI 10.1016/S0140-6736(86)90495-2; CAILLE D, 1979, RESP PHYSIOL, V36, P201, DOI 10.1016/0034-5687(79)90025-2; Chen HSV, 2006, J NEUROCHEM, V97, P1611, DOI 10.1111/j.1471-4159.2006.03991.x; Chohan MO, 2006, FEBS LETT, V580, P3973, DOI 10.1016/j.febslet.2006.06.021; Cooke JR, 2009, J CLIN SLEEP MED, V5, P305; Daulatzai MA, 2010, J ALZHEIMERS DIS, V20, P355, DOI 10.3233/JAD-2010-1374; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; Dutschmann M, 1998, BRAIN RES, V809, P221, DOI 10.1016/S0006-8993(98)00885-3; Dutschmann M, 1998, J PHYSIOL-LONDON, V510, P793, DOI 10.1111/j.1469-7793.1998.793bj.x; Dutschmann M, 2006, EUR J NEUROSCI, V24, P1071, DOI 10.1111/j.1460-9568.2006.04981.x; Dutschmann M, 2010, J NEUROSCI, V30, P1810, DOI 10.1523/JNEUROSCI.5261-09.2010; Froessler B, 2010, ANAESTHESIST, V59, P1003, DOI 10.1007/s00101-010-1764-0; FUNG ML, 1994, RESP PHYSIOL, V96, P177, DOI 10.1016/0034-5687(94)90125-2; Gestreau C, 2005, RESP PHYSIOL NEUROBI, V147, P159, DOI 10.1016/j.resp.2005.03.015; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Guo ZL, 2002, NEUROSCIENCE, V113, P435, DOI 10.1016/S0306-4522(02)00173-2; Guthman A, 1999, J COMP NEUROL, V415, P501; Hansen MLH, 2011, ALZ DIS ASSOC DIS, V25, P269, DOI 10.1097/WAD.0b013e3182096624; Harris MB, 2003, RESP PHYSIOL NEUROBI, V134, P191, DOI 10.1016/S1569-9048(02)00223-9; Horiuchi J, 1999, NEUROSCIENCE, V89, P1319, DOI 10.1016/S0306-4522(98)00399-6; HORNER J, 1994, ALZ DIS ASSOC DIS, V8, P177; Humbert IA, 2010, J ALZHEIMERS DIS, V19, P1185, DOI 10.3233/JAD-2010-1316; Kuna ST, 1999, RESP PHYSIOL, V117, P85, DOI 10.1016/S0034-5687(99)00058-4; Liang L, 2004, FEBS LETT, V566, P261, DOI 10.1016/j.febslet.2004.04.047; LING LM, 1994, J APPL PHYSIOL, V76, P1138, DOI 10.1152/jappl.1994.76.3.1138; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Lipton SA, 2007, CURR DRUG TARGETS, V8, P621, DOI 10.2174/138945007780618472; Martinez-Coria H, 2010, AM J PATHOL, V176, P870, DOI 10.2353/ajpath.2010.090452; Menuet C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025770; Menuet C, 2011, RESP PHYSIOL NEUROBI, V178, P290, DOI 10.1016/j.resp.2011.06.030; NUNEZABADES PA, 1990, J ANAT, V172, P1; Pan CX, 2011, ANESTH ANALG, V113, P145, DOI 10.1213/ANE.0b013e3182185fee; Paxinos GFK., 2001, MOUSE BRAIN STEREOTA, V2nd ed.; Planel E, 2007, J NEUROSCI, V27, P3090, DOI 10.1523/JNEUROSCI.4854-06.2007; Planel E, 2009, FASEB J, V23, P2595, DOI 10.1096/fj.08-122424; Priefer BA, 1997, DYSPHAGIA, V12, P212, DOI 10.1007/PL00009539; Rahman A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006344; Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128; Roda F, 2004, J COMP NEUROL, V468, P571, DOI 10.1002/cne.10974; Rohrer JD, 2011, CURR ALZHEIMER RES, V8, P266; Run XQ, 2009, J ALZHEIMERS DIS, V16, P619, DOI 10.3233/JAD-2009-1003; Saab BJ, 2010, ANESTHESIOLOGY, V113, P1061, DOI 10.1097/ALN.0b013e3181f56228; Sakata DJ, 2007, ANESTH ANALG, V104, P587, DOI 10.1213/01.ane.0000255074.96657.39; Sinclair HL, 2010, CRIT CARE, V14, DOI 10.1186/cc8220; Song MS, 2008, EUR J NEUROSCI, V28, P1989, DOI 10.1111/j.1460-9568.2008.06498.x; Subramanian HH, 2008, J NEUROSCI, V28, P12274, DOI 10.1523/JNEUROSCI.4168-08.2008; Suh MK, 2009, ALZ DIS ASSOC DIS, V23, P178, DOI 10.1097/WAD.0b013e318192a539; Tang JXX, 2011, ANESTHESIOLOGY, V115, P727, DOI 10.1097/ALN.0b013e31822e9306; Teppema LJ, 1997, J COMP NEUROL, V388, P169, DOI 10.1002/(SICI)1096-9861(19971117)388:2<169::AID-CNE1>3.0.CO;2-#; Terwel D, 2005, J BIOL CHEM, V280, P3963, DOI 10.1074/jbc.M409876200; Terwel D, 2008, AM J PATHOL, V172, P786, DOI 10.2353/ajpath.2008.070904; Tokutomi T, 2009, J TRAUMA, V66, P166, DOI 10.1097/TA.0b013e318157dbec; Vanderweyde T, 2010, J ALZHEIMERS DIS, V22, pS91, DOI 10.3233/JAD-2010-100843; VILLARD MF, 1984, J PHYSIOL-PARIS, V79, P11; Wada H, 2001, GERONTOLOGY, V47, P271, DOI 10.1159/000052811; Yamazaki H, 2009, BIOL PHARM BULL, V32, P293, DOI 10.1248/bpb.32.293	66	17	17	0	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	APR	2012	46	1					234	243		10.1016/j.nbd.2012.01.012			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	913SQ	WOS:000301898100025	22316605				2022-02-06	
J	Ward, AB; Gutenbrunner, C; Giustini, A; Delarque, A; Fialka-Moser, V; Kiekens, C; Berteanu, M; Christodoulou, N				Ward, Anthony B.; Gutenbrunner, Christoph; Giustini, Alessandro; Delarque, Alain; Fialka-Moser, Veronika; Kiekens, Carlotte; Berteanu, Mihai; Christodoulou, Nicolas			A POSITION PAPER ON PHYSICAL & REHABILITATION MEDICINE PROGRAMMES IN POST-ACUTE SETTINGS	JOURNAL OF REHABILITATION MEDICINE			English	Article						rehabilitation; post acute settings; physical & rehabilitation medicine programmes; clinical pathways	INPATIENT NEUROREHABILITATION SERVICES; TRAUMATIC BRAIN-INJURY; CARE PATHWAYS PATIENTS; ACTION PLAN; SPECIALIST REHABILITATION; WHITE BOOK; PRM; SECTION; UK; EFFICIENCY	Physical & Rehabilitation Medicine (PRM) programmes in post-acute settings cover interventions for the rehabilitation of people with a variety of disabling health conditions. The setting of the intervention is more important than the timing and these programmes can be carried out in a variety of facilities. This paper describes the role of PRM services and of PRM specialists in delivering rehabilitation programmes to people, who have initially been admitted to hospital. The emphasis is on improving patients' activities and addressing participation issues. PRM programmes in post-acute settings provide a range of treatments and have a major influence in the long-term on the pace and extent of return of function and recovery from ill-health. This paper will define the meaning of post-acute settings and will describe the patient's journey through the post-acute setting. In particular, it addresses the standards of care across Europe that patients should expect. This paper also examines the general principles of funding such programmes within the context of different health care systems across Europe. Coordinated care improves outcomes and economic profiles for both payers and providers of services. This paper describes the value of PRM interventions and PRM specialist-led teams in promoting better outcomes for people with disabilities with complex needs.	[Ward, Anthony B.] Haywood Hosp, N Staffordshire Rehabil Ctr, UEMS Sect PRM, Stoke On Trent ST6 7AG, Staffs, England; [Gutenbrunner, Christoph] Hannover Med Sch, Profess Practice Comm, UEMS Sect PRM, Dept Rehabil Med, D-30623 Hannover, Germany; [Giustini, Alessandro] Rehabil Hosp San Pancrazio KosGrp Santo, European Soc PRM, Arco Felice Napoli, Trento, Italy; [Delarque, Alain] CHU Timone, UEMS Sect PRM, Dept Med Phys & Readaptat, Marseille, France; [Fialka-Moser, Veronika] Allgemeines Krankenhaus Stadt Wien, UEMS Sect PRM, Univ Klin Phys Med & Rehabil, Vienna, Austria; [Berteanu, Mihai] Univ Hosp Elias, Profess Practice Comm, UEMS Sect PRM, Dept Phys & Rehabil Med, Bucharest, Romania; [Christodoulou, Nicolas] European Univ Cyprus, Sch Sci, UEMS Sect PRM, Nicosia, Cyprus		Ward, AB (corresponding author), Haywood Hosp, N Staffordshire Rehabil Ctr, UEMS Sect PRM, High Lane, Stoke On Trent ST6 7AG, Staffs, England.	anthony@bward2.freeserve.co.uk	Kiekens, Carlotte/V-7545-2018	Kiekens, Carlotte/0000-0001-8500-7751; Gutenbrunner, Christoph/0000-0002-6522-1942			[Anonymous], 2004, 2004280 DHOSSDO01DGS; [Anonymous], 2011, NAT STROK REH PROGR; [Anonymous], 1998, MIN HLTH OFF B; [Anonymous], 2010, REH FOLL ACQ BRAIN I; [Anonymous], 2011, ITALIAN REPUBLIC OFF, V50-S.O.; Bade MJ, 2011, J ORTHOP SPORT PHYS, V41, P932, DOI 10.2519/jospt.2011.3734; Barnes M. D., 2000, TXB REHABILITATION M; British Society of Rehabilitation Medicine, 2009, BSRM STAND REH SERV; Calmels P., 2011, Annals of Physical and Rehabilitation Medicine, V54, P501, DOI 10.1016/j.rehab.2011.10.001; Cannon S, 2002, J INTEGRATED CARE S1, V5, P2; Collin C, 2010, REHABILITATION MED 2; De Korvin G., 2010, Annals of Physical and Rehabilitation Medicine, V53, P352, DOI 10.1016/j.rehab.2010.03.008; Delarque A, 2010, EUR J PHYS REHAB MED, V46, P1; Delarque A, 2009, EUR J PHYS REHAB MED, V45, P265; Delarque A, 2010, J REHABIL MED, V42, P1, DOI 10.2340/16501977-0494; Department of Health, 2009, SPEC SERV NAT DEF SE; Department of Health, 2005, NAT SERV FRAM LONG T; DeVivo MJ., 2011, TOP SPINAL CORD INJ, V16, P1, DOI DOI 10.1310/SCI1604-1; *FEDMER, 1999, CHART MPR SIGN 15 OC; [FEDMER Groupe-Rhone-Alpes], 2005, CRIT PRIS CHARG MED; Grill E, 2011, J REHABIL MED, V43, P1131; Grill E, 2007, J REHABIL MED, V39, P591, DOI 10.2340/16501977-0093; Gutenbrunner C., 2011, Annals of Physical and Rehabilitation Medicine, V54, P298, DOI 10.1016/j.rehab.2011.05.001; Gutenbrunner C, 2010, Ann Phys Rehabil Med, V53, P593, DOI 10.1016/j.rehab.2010.10.005; Gutenbrunner C, 2009, EUR J PHYS REHAB MED, V45, P275; Gutenbrunner C, 2007, J REHABIL MED S45, pS1; GUTENBRUNNER C, 2006, EURA MEDICOPHYS, V40, P287; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Krokowski GD, 2009, EUR J PHYS REHAB MED, V45, P281; Lohmann S, 2011, J REHABIL MED, V43, P151, DOI 10.2340/16501977-0657; Lysens R, 2011, TOP SPINAL CORD INJ, V16, P43; MAHONEY F I, 1965, Md State Med J, V14, P61; McElligott J, 2011, AM J PHYS MED REHAB, V90, P74, DOI 10.1097/PHM.0b013e318201744e; Moslavac S, 2010, Ann Phys Rehabil Med, V53, P451, DOI 10.1016/j.rehab.2010.07.004; Neumann V, 2010, J REHABIL MED, V42, P4, DOI 10.2340/16501977-0483; Ribinik P., 2011, Annals of Physical and Rehabilitation Medicine, V54, P496, DOI 10.1016/j.rehab.2011.09.007; Sandhaug M, 2010, BRAIN INJURY, V24, P740, DOI 10.3109/02699051003652849; Shiel A, 2001, CLIN REHABIL, V15, P501, DOI 10.1191/026921501680425225; Stier-Jarmer M, 2011, J REHABIL MED, V43, P113, DOI [10.2340/16501977-0617, 10.2340/16501977-0659]; STUCKI G, 2007, J REHABIL MED, V39, P278; Teasell Robert, 2005, Top Stroke Rehabil, V12, P46; Turner Stokes L, 2002, CLIN REHABIL S1, V16, P9; Turner-Stokes L, 2000, CLIN REHABIL, V14, P468, DOI 10.1191/0269215500cr349oa; Turner-Stokes L, 2006, J NEUROL NEUROSUR PS, V77, P634, DOI 10.1136/jnnp.2005.073411; Turner-Stokes L, 2005, CLIN MED, V5, P203, DOI 10.7861/clinmedicine.5-3-203; Turner-Stokes L, 1999, CLIN REHABIL, V13, P277, DOI 10.1191/026921599676896799; Turner-Stokes L, 1999, CLIN REHABIL, V13, P3, DOI 10.1191/026921599673346206; Turner-Stokes L, 2007, CLIN MED, V7, P593, DOI 10.7861/clinmedicine.7-6-593; Turner-Stokes L, 2007, BRAIN INJURY, V21, P1015, DOI 10.1080/02699050701591445; Turner-Stokes L, 2012, CLIN REHABIL, V26, P264, DOI 10.1177/0269215511417467; Turner-Stokes L, 2012, CLIN REHABIL, V26, P256, DOI 10.1177/0269215511417469; Viton JM, 2009, EUR J PHYS REHAB MED, V45, P271; Ward AB, 1993, ADVICE PURCHASERS RE; Ward AB, 2010, J REHABIL MED, V42, P417, DOI 10.2340/16501977-0565; World Health Organization, 2007, INT CLASS FUNCT DIS; Yelnik A. -P., 2011, Annals of Physical and Rehabilitation Medicine, V54, P506, DOI 10.1016/j.rehab.2011.09.004	56	17	17	0	8	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	APR	2012	44	4					289	298		10.2340/16501977-0960			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	939WS	WOS:000303850800001	22453770	gold, Green Submitted			2022-02-06	
J	Gong, DS; Hao, M; Liu, L; Liu, CX; Dong, JF; Cui, Z; Sun, L; Su, SB; Zhang, JN				Gong, Dasen; Hao, Mu; Liu, Li; Liu, Chunxiang; Dong, Jingfei; Cui, Zhuang; Sun, Lin; Su, Shaobo; Zhang, Jianning			Prognostic relevance of circulating endothelial progenitor cells for severe traumatic brain injury	BRAIN INJURY			English	Article						EPCs; TBI; VEGF; MMP-9; prognosis	ACUTE MYOCARDIAL-INFARCTION; PERIPHERAL-BLOOD; CD34(+) CELLS; PRACTICAL SCALE; NEOVASCULARIZATION; TRANSPLANTATION; ANGIOGENESIS; MOBILIZATION; VASCULOGENESIS; RECRUITMENT	Objective: Traumatic brain injury (TBI) promotes the recruitment of endothelial progenitor cells (EPCs) into the injured tissue where EPCs play an important role in repairing injured vasculature. However, the repair mechanism and prognostic significance of EPCs after TBI remain poorly understood. Methods: Blood samples were collected from 21 patients with severe TBI and 20 healthy subjects. EPCs were quantified by flow cytometry and serum VEGF and MMP-9 level measured by ELISA on days 1, 4, 7, 14 and 21 after TBI. Results: EPCs in the patients decreased originally, then increased to the peak level at 7 days and was significantly correlated with GOS scores 6 months after TBI. VEGF and MMP-9 were significantly increased during the follow-up period after TBI. EPCs was also positively correlated with GCS score 1 day after TBI and with MMP-9 and VEGF 7 days and 14 days after TBI. Conclusion: The data demonstrate that TBI led to an increase of EPCs, VEGF and MMP-9, suggesting that increased VEGF and MMP-9 may mediate the recruitment of bone marrow-derived EPCs into the circulation. The association of EPCs with nerve functional recovery in patients provides evidence that EPCs may be a potential biomarker to monitor TBI angiogenesis and prognosis.	[Gong, Dasen; Liu, Li; Liu, Chunxiang; Sun, Lin; Su, Shaobo; Zhang, Jianning] Tianjin Med Univ Gen Hosp, Dept Neurosurg, Tianjin Neurol Inst,Minist Educ,Tianjin Key Lab I, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin 300052, Peoples R China; [Hao, Mu] Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Tianjin, Peoples R China; [Hao, Mu] Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China; [Hao, Mu] Peking Union Med Coll, Tianjin, Peoples R China; [Dong, Jingfei] Baylor Coll Med, Dept Med, Thrombosis Res Sect, Houston, TX 77030 USA; [Cui, Zhuang] Tianjin Med Univ, Coll Publ Hyg, Tianjin, Peoples R China		Zhang, JN (corresponding author), Tianjin Med Univ Gen Hosp, Dept Neurosurg, Tianjin Neurol Inst,Minist Educ,Tianjin Key Lab I, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin 300052, Peoples R China.	jianningzhang@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30772229]; 973 ProjectNational Basic Research Program of China [2005CB522600]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HL71895]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL071895] Funding Source: NIH RePORTER	The work is supported by grants from the National Natural Science Foundation of China 30772229, 973 Project 2005CB522600 and NIH grant HL71895. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Beaudry P, 2005, CLIN CANCER RES, V11, P3514, DOI 10.1158/1078-0432.CCR-04-2271; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Fan YF, 2010, ANN NEUROL, V67, P488, DOI 10.1002/ana.21919; Fujiyama S, 2003, CIRC RES, V93, P980, DOI 10.1161/01.RES.0000099245.08637.CE; Guo XB, 2009, J NEUROTRAUM, V26, P1337, DOI [10.1089/neu.2008.0733, 10.1089/neu.2008-0733]; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Hristov M, 2004, J CELL MOL MED, V8, P498, DOI 10.1111/j.1582-4934.2004.tb00474.x; Huang PH, 2009, ARTERIOSCL THROM VAS, V29, P1179, DOI 10.1161/ATVBAHA.109.189175; JENNETT B, 1975, LANCET, V1, P480; Jeon O, 2007, J BIOMED SCI, V14, P323, DOI 10.1007/s11373-007-9145-7; Jung S, 2006, J NEURO-ONCOL, V76, P257, DOI 10.1007/s11060-005-6876-z; Li B, 2006, FASEB J, V20, P1495, DOI 10.1096/fj.05-5137fje; Li B, 2010, BRAIN RES, V1327, P91, DOI 10.1016/j.brainres.2010.02.030; Liu L, 2007, J NEUROTRAUM, V24, P936, DOI 10.1089/neu.2006.0250; Nakayama D, 2010, EUR J NEUROSCI, V31, P90, DOI 10.1111/j.1460-9568.2009.07043.x; Paczkowska E, 2005, EUR J HAEMATOL, V75, P461, DOI 10.1111/j.1600-0609.2005.00536.x; Rookmaaker MB, 2005, ARTERIOSCL THROM VAS, V25, P1843, DOI 10.1161/01.ATV.0000177808.92494.14; Shintani S, 2001, CIRCULATION, V103, P2776, DOI 10.1161/hc2301.092122; Shintani S, 2001, CIRCULATION, V103, P897, DOI 10.1161/01.CIR.103.6.897; TEASDALE G, 1974, LANCET, V2, P81; Tei K, 2008, STEM CELLS, V26, P819, DOI 10.1634/stemcells.2007-0671; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Wojakowski W, 2004, CIRCULATION, V110, P3213, DOI 10.1161/01.CIR.0000147609.39780.02; Xu Qing-Bo, 2005, Shengli Xuebao, V57, P1; Xue S, 2010, NEUROSCI LETT, V473, P186, DOI 10.1016/j.neulet.2010.02.035; Yatsushige H, 2007, J NEUROSCI RES, V85, P1436, DOI 10.1002/jnr.21281	27	17	21	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR	2012	26	3					291	297		10.3109/02699052.2011.648710			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	899XD	WOS:000300849100009	22372416				2022-02-06	
J	Grabiec, U; Koch, M; Kallendrusch, S; Kraft, R; Hill, K; Merkwitz, C; Ghadban, C; Lutz, B; Straiker, A; Dehghani, F				Grabiec, Urszula; Koch, Marco; Kallendrusch, Sonja; Kraft, Robert; Hill, Kerstin; Merkwitz, Claudia; Ghadban, Chalid; Lutz, Beat; Straiker, Alex; Dehghani, Faramarz			The endocannabinoid N-arachidonoyldopamine (NADA) exerts neuroprotective effects after excitotoxic neuronal damage via cannabinoid receptor 1 (CB1)	NEUROPHARMACOLOGY			English	Article						CB1 cannabinoid receptor 1; NADA N-arachidonoyldopamine; NMDA N-methyl-D-aspartate; OHSC organotypic hippocampal slice cultures; CB2 cannabinoid receptor 2; TRPV1 transient receptor potential channel V1; TRPA1 transient receptor potential channel A1	TRAUMATIC BRAIN-INJURY; HIPPOCAMPAL SLICE CULTURES; ACTIVATED MICROGLIAL CELLS; ACID AMIDE HYDROLASE; IN-VITRO; INTERNATIONAL UNION; LIPID MEDIATORS; RAT-BRAIN; ANANDAMIDE; DOPAMINE	Endocannabinoids exert numerous effects in the CNS under physiological and pathological conditions. The aim of the present study was to examine whether the endocannabinoid N-arachidonoyldopamine (NADA) may protect neurons in excitotoxically lesioned organotypic hippocampal slice cultures (OHSC). OHSC were excitotoxically lesioned by application of N-methyl-D-aspartate (NMDA, 50 mu M) for 4 h and subsequently treated with different NADA concentrations (0.1 pM-50 mu M) alone or in combination with cannabinoid receptor antagonists. NADA protected dentate gyrus granule cells and caused a slight reduction in the number of microglial cells. The number of degenerated neurons significantly decreased between 100 pM and 10 mu M NADA (p < 0.05). To identify the responsive receptor type of NADA mediated neuroprotection, we applied the cannabinoid (CB) receptor 1 (CB1) inverse agonist/antagonist AM251, CB2 inverse agonist/antagonist AM630, abnormal-cannabidiol (abn-CBD)-sensitive receptor antagonist O-1918, transient receptor potential channel V1 (1'RPV1) antagonist 6-iodonordihydrocapsaicin and Al (TRPA1) antagonist HC-030031. Neuroprotective properties of low (1 nM) but not high (10 mu M) NADA concentrations were solely blocked by AM251 and were absent in CB1-/- mice. AM630, O-1918, 6-iodonordihydrocapsaicin and HC-030031 showed no effects at all NADA concentrations applied. Our findings demonstrate that NADA protects dentate gyrus granule cells by acting via CB1. NADA reduced the number of microglial cells at distinct concentrations. TRPV1 and TRPA1 were not involved in NADA mediated neuroprotection. Thus, our data implicate that NADA mediated activation of neuronal CB1 may serve as a novel pharmacological target to mitigate symptoms of neuronal damage. (c) 2011 Elsevier Ltd. All rights reserved.	[Grabiec, Urszula; Koch, Marco; Kallendrusch, Sonja; Merkwitz, Claudia; Ghadban, Chalid; Dehghani, Faramarz] Univ Leipzig, Inst Anat, D-04103 Leipzig, Germany; [Kraft, Robert] Univ Leipzig, Carl Ludwig Inst Physiol, D-04103 Leipzig, Germany; [Hill, Kerstin] Rudolf Boehm Inst Pharmakol & Toxikol, D-04107 Leipzig, Germany; [Lutz, Beat] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, D-55128 Mainz, Germany; [Straiker, Alex] Gill Ctr Biomol Med, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA		Dehghani, F (corresponding author), Univ Leipzig, Inst Anat, Liebigstr 13, D-04103 Leipzig, Germany.	Faramarz.Dehghani@medizin.uni-leipzig.de	Kallendrusch, Sonja/AAV-7179-2020; Kallendrusch, Sonja/ABG-1789-2021; Hohmann, Urszula/ABB-7323-2020; Kraft, Robert/E-9199-2011	Kallendrusch, Sonja/0000-0003-2474-8307; Kraft, Robert/0000-0002-5774-6001	BMBFFederal Ministry of Education & Research (BMBF); DFGGerman Research Foundation (DFG)European Commission [KR 3408/2-1]	The authors would like to thank Oliver Ullrich for providing the BV2 cell line. The authors would further like to thank Dana Tschierske, Angela Ehrlich and Constanze Hobusch for excellent technical assistance and Ingo Bechmann for continuous support. This study was supported by BMBF project Tierversuchsersatzmethoden. R.K. is supported by a grant from the DFG (KR 3408/2-1).	BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Benito C, 2008, BRIT J PHARMACOL, V153, P277, DOI 10.1038/sj.bjp.0707505; Bisogno T, 2000, BIOCHEM J, V351, P817, DOI 10.1042/0264-6021:3510817; Bjorklund E, 2010, BRIT J PHARMACOL, V161, P1512, DOI 10.1111/j.1476-5381.2010.00974.x; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Bobrov MY, 2008, NEUROSCI LETT, V431, P6, DOI 10.1016/j.neulet.2007.11.010; Bradshaw HB, 2005, BRIT J PHARMACOL, V144, P459, DOI 10.1038/sj.bjp.0706093; Bradshaw HB, 2006, AM J PHYSIOL-REG I, V291, pR349, DOI 10.1152/ajpregu.00933.2005; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cavanaugh DJ, 2011, J NEUROSCI, V31, P5067, DOI 10.1523/JNEUROSCI.6451-10.2011; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Crawford DC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008166; Cristino L, 2008, NEUROSCIENCE, V151, P955, DOI 10.1016/j.neuroscience.2007.11.047; Cui M, 2006, J NEUROSCI, V26, P9385, DOI 10.1523/JNEUROSCI.1246-06.2006; Davies JW, 2010, BRIT J ANAESTH, V104, P596, DOI 10.1093/bja/aeq067; Dehghani F, 2003, EUR J NEUROSCI, V18, P1061, DOI 10.1046/j.1460-9568.2003.02821.x; Egertova M, 1998, P ROY SOC B-BIOL SCI, V265, P2081, DOI 10.1098/rspb.1998.0543; Eljaschewitsch E, 2006, NEURON, V49, P67, DOI 10.1016/j.neuron.2005.11.027; Gibson HE, 2008, NEURON, V57, P746, DOI 10.1016/j.neuron.2007.12.027; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Harrison S, 2003, EUR J PHARMACOL, V475, P107, DOI 10.1016/S0014-2999(03)02114-9; Heppner FL, 1998, EUR J NEUROSCI, V10, P3284, DOI 10.1046/j.1460-9568.1998.00379.x; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Hu SSJ, 2009, PROSTAG LEUKOTR ESS, V81, P291, DOI 10.1016/j.plefa.2009.05.026; Huang SM, 2002, P NATL ACAD SCI USA, V99, P8400, DOI 10.1073/pnas.122196999; Katona I, 1999, J NEUROSCI, V19, P4544; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Kim SR, 2006, J IMMUNOL, V177, P4322, DOI 10.4049/jimmunol.177.7.4322; Koch M, 2011, HIPPOCAMPUS, V21, P554, DOI 10.1002/hipo.20772; Koch M, 2011, NEUROTOX RES, V19, P330, DOI 10.1007/s12640-010-9166-2; Kreutz S, 2007, EXP NEUROL, V203, P246, DOI 10.1016/j.expneurol.2006.08.010; Kreutz S, 2009, GLIA, V57, P286, DOI 10.1002/glia.20756; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Ludanyi A, 2011, NEUROSCIENCE, V174, P50, DOI 10.1016/j.neuroscience.2010.10.062; Maresz K, 2005, J NEUROCHEM, V95, P437, DOI 10.1111/j.1471-4159.2005.03380.x; Maresz K, 2007, NAT MED, V13, P492, DOI 10.1038/nm1561; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Mechoulam R, 2007, MOL NEUROBIOL, V36, P68, DOI 10.1007/s12035-007-8008-6; Millns PJ, 2006, EUR J NEUROSCI, V24, P3489, DOI 10.1111/j.1460-9568.2006.05236.x; Missale C, 2010, J RECEPT SIG TRANSD, V30, P347, DOI 10.3109/10799893.2010.506192; Moesgaard B, 2003, LIPIDS, V38, P387, DOI 10.1007/s11745-003-1073-1; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Navarrete CM, 2010, BIOCHEM PHARMACOL, V79, P1805, DOI 10.1016/j.bcp.2010.02.014; Navarrete CM, 2009, J NEUROCHEM, V109, P452, DOI 10.1111/j.1471-4159.2009.05966.x; O'Sullivan SE, 2004, BRIT J PHARMACOL, V141, P803, DOI 10.1038/sj.bjp.0705643; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Sagar DR, 2004, EUR J NEUROSCI, V20, P175, DOI 10.1111/j.1460-9568.2004.03481.x; Sasamura T, 1998, NEUROREPORT, V9, P2045, DOI 10.1097/00001756-199806220-00025; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Sinor AD, 2000, NEUROSCI LETT, V278, P157, DOI 10.1016/S0304-3940(99)00922-2; Starowicz K, 2007, PHARMACOL THERAPEUT, V114, P13, DOI 10.1016/j.pharmthera.2007.01.005; Stella N, 2010, GLIA, V58, P1017, DOI 10.1002/glia.20983; Stella N, 2009, NEUROPHARMACOLOGY, V56, P244, DOI 10.1016/j.neuropharm.2008.07.037; Straiker A, 2005, J PHYSIOL-LONDON, V569, P501, DOI 10.1113/jphysiol.2005.091918; Straiker A, 2011, BRIT J PHARMACOL, V164, P1672, DOI 10.1111/j.1476-5381.2011.01486.x; Sun Y, 2007, BRIT J PHARMACOL, V152, P734, DOI 10.1038/sj.bjp.0707478; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Wang J, 2009, PROSTAG OTH LIPID M, V89, P112, DOI 10.1016/j.prostaglandins.2008.12.002; White R, 2001, BRIT J PHARMACOL, V134, P921, DOI 10.1038/sj.bjp.0704333	65	17	17	0	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	MAR	2012	62	4					1797	1807		10.1016/j.neuropharm.2011.11.023			11	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	904TT	WOS:000301221500021	22186081				2022-02-06	
J	Hunt, RF; Haselhorst, LA; Schoch, KM; Bach, EC; Rios-Pilier, J; Scheff, SW; Saatman, KE; Smith, BN				Hunt, Robert F.; Haselhorst, Laura A.; Schoch, Kathleen M.; Bach, Eva C.; Rios-Pilier, Jennifer; Scheff, Stephen W.; Saatman, Kathryn E.; Smith, Bret N.			Posttraumatic mossy fiber sprouting is related to the degree of cortical damage in three mouse strains	EPILEPSY RESEARCH			English	Article						Contusion; Dentate gyrus; Epileptogenesis; Epilepsy model; Seizure; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; DENTATE GYRUS; TREATED RATS; MODEL; EPILEPSY; MICE; IMPACT; REORGANIZATION; SUSCEPTIBILITY; SEIZURES	Controlled cortical impact injury was used to examine relationships between focal posttraumatic cortical damage and mossy fiber sprouting (MFS) in the dentate gyrus in three mouse strains. Posttraumatic MFS was more robust when cortical injury impinged upon the hippocampus, versus contusions restricted to neocortex, and was qualitatively similar among CD-1, C57BL/6, and FVB/N background strains. Impact parameters influencing injury severity may be critical in reproducing epilepsy-related changes in neurotrauma models. (C) 2011 Elsevier B.V. All rights reserved.	[Smith, Bret N.] Univ Kentucky, Coll Med, Dept Physiol, Chandler Med Ctr MS508, Lexington, KY 40536 USA; [Scheff, Stephen W.] Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA; [Scheff, Stephen W.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Schoch, Kathleen M.; Scheff, Stephen W.; Saatman, Kathryn E.; Smith, Bret N.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA		Smith, BN (corresponding author), Univ Kentucky, Coll Med, Dept Physiol, Chandler Med Ctr MS508, 800 Rose St, Lexington, KY 40536 USA.	bret.smith@uky.edu		Hunt, Robert/0000-0003-4490-8718	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS052302, AG21981, P01 NS058484]; USAMRMCU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-11-1-0502]; Epilepsy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS058484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG021981] Funding Source: NIH RePORTER	This research was supported by NIH NS052302 and USAMRMC W81XWH-11-1-0502 to B.N.S., NIH AG21981 to S.W.S., NIH P01 NS058484 to K.E.S., and an Epilepsy Foundation Training Fellowship to R.F.H.	Bolkvadze T., 2009, J NEUROTRAUMA; Buckmaster PS, 1997, J COMP NEUROL, V385, P385; Chrzaszcz M, 2010, J NEUROTRAUM, V27, P1283, DOI 10.1089/neu.2009.1227; Hanell A, 2010, J NEUROTRAUM, V27, P1297, DOI 10.1089/neu.2009.1255; Hunt RF, 2011, J NEUROSCI, V31, P6880, DOI 10.1523/JNEUROSCI.0032-11.2011; Hunt RF, 2010, J NEUROPHYSIOL, V103, P1490, DOI 10.1152/jn.00957.2009; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharatishvili I, 2007, BRAIN, V130, P3155, DOI 10.1093/brain/awm268; Kharatishvili I, 2009, EXP NEUROL, V217, P154, DOI 10.1016/j.expneurol.2009.01.026; Mao HJ, 2010, BIOMECH MODEL MECHAN, V9, P763, DOI 10.1007/s10237-010-0212-z; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; Schauwecker PE, 1997, P NATL ACAD SCI USA, V94, P4103, DOI 10.1073/pnas.94.8.4103; Shibley H, 2002, EPILEPSY RES, V49, P109, DOI 10.1016/S0920-1211(02)00012-8; Statler KD, 2009, EPILEPSY RES, V86, P221, DOI 10.1016/j.eplepsyres.2009.05.006; Swartz BE, 2006, EPILEPSIA, V47, P1373, DOI 10.1111/j.1528-1167.2006.00602.x; TAUCK DL, 1985, J NEUROSCI, V5, P1016	19	17	18	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-1211			EPILEPSY RES	Epilepsy Res.	MAR	2012	99	1-2					167	170		10.1016/j.eplepsyres.2011.10.011			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	920TV	WOS:000302431700021	22047981	Green Accepted			2022-02-06	
J	Juranek, J; Johnson, CP; Prasad, MR; Kramer, LA; Saunders, A; Filipek, PA; Swank, PR; Cox, CS; Ewing-Cobbs, L				Juranek, Jenifer; Johnson, Chad P.; Prasad, Mary R.; Kramer, Larry A.; Saunders, Ann; Filipek, Pauline A.; Swank, Paul R.; Cox, Charles S., Jr.; Ewing-Cobbs, Linda			Mean diffusivity in the amygdala correlates with anxiety in pediatric TBI	BRAIN IMAGING AND BEHAVIOR			English	Article						Anxiety; Amygdala; DTI; TBI; Children	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; CLOSED-HEAD INJURY; QUALITY-OF-LIFE; PSYCHIATRIC-DISORDERS; HIPPOCAMPAL VOLUME; CHILDREN; ADOLESCENTS; SYMPTOMS; TENSOR	Traumatic brain injury (TBI) and orthopedic injury (OI) patients are prone to anxiety and mood disorders. In the present study, we integrated anatomical and diffusion tensor neuroimaging to investigate structural properties of the amygdala and hippocampus, gray matter regions implicated in anxiety and mood disorders. Children and adolescents were evaluated during the late sub-acute phase of recovery following trauma resulting from either moderate to severe TBI or OI. Mean diffusivity (MD) of the amygdala and hippocampus was elevated following TBI. An interaction of hemisphere, structure, and group revealed that MD of the right amygdala was elevated in females with TBI. Self-reported anxiety scores were not related to either volume or microstructure of the hippocampus, or to volume or fractional anisotropy of the amygdala. Left amygdala MD in the TBI group accounted for 17.5% of variance in anxiety scores. Anxiety symptoms may be mediated by different mechanisms in patients with TBI or OI.	[Juranek, Jenifer; Prasad, Mary R.; Filipek, Pauline A.; Swank, Paul R.; Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Childrens Learning Inst, Houston, TX 77030 USA; [Kramer, Larry A.] Univ Texas Hlth Sci Ctr Houston, Dept Radiol, Houston, TX 77030 USA; [Saunders, Ann; Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Cox, Charles S., Jr.] Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, Houston, TX 77030 USA; [Johnson, Chad P.] Univ Houston, Dept Psychol, Houston, TX USA		Juranek, J (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Childrens Learning Inst, 7000 Fannin,Ste 2411, Houston, TX 77030 USA.	Jenifer.Juranek@uth.tmc.edu			Department of Pediatrics;  [NIH-NINDS-R01-NS046308]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS046308] Funding Source: NIH RePORTER	This work was funded by NIH-NINDS-R01-NS046308 awarded to LEC. Additional intramural funding from the Department of Pediatrics awarded to JJ.	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bigler ED, 2010, NEUROIMAGE, V50, P1017, DOI 10.1016/j.neuroimage.2010.01.003; Birmaher B, 1999, J AM ACAD CHILD PSY, V38, P1230, DOI 10.1097/00004583-199910000-00011; Birmaher B, 1997, J AM ACAD CHILD PSY, V36, P545, DOI 10.1097/00004583-199704000-00018; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Bock AS, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00149; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Campbell-Sills L, 2011, NEUROIMAGE, V54, P689, DOI 10.1016/j.neuroimage.2010.07.041; Carrion VG, 2002, J AM ACAD CHILD PSY, V41, P166, DOI 10.1097/00004583-200202000-00010; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Di Stefano G, 2000, J NEUROL NEUROSUR PS, V69, P210, DOI 10.1136/jnnp.69.2.210; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Gerring JP, 2002, J AM ACAD CHILD PSY, V41, P157, DOI 10.1097/00004583-200202000-00009; Grados MA, 2008, DEPRESS ANXIETY, V25, P398, DOI 10.1002/da.20398; Hajek CA, 2010, BRAIN INJURY, V24, P100, DOI 10.3109/02699050903508226; Hasan K., 2005, MEDICAMUNDI, V49; Holbrook TL, 2005, J TRAUMA, V59, P1126, DOI 10.1097/01.ta.0000196433.61423.f2; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Johansen-Berg H, 2008, CEREB CORTEX, V18, P1374, DOI 10.1093/cercor/bhm167; Jonovska S, 2008, COLLEGIUM ANTROPOL, V32, P1121; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Jorge RE, 2007, BIOL PSYCHIAT, V62, P332, DOI 10.1016/j.biopsych.2006.07.024; Kantarci K, 2005, NEUROLOGY, V64, P902, DOI 10.1212/01.WNL.0000153076.46126.E9; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kim MJ, 2009, J NEUROSCI, V29, P11614, DOI 10.1523/JNEUROSCI.2335-09.2009; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Langer DA, 2010, CHILD PSYCHIAT HUM D, V41, P549, DOI 10.1007/s10578-010-0187-0; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Levi RB, 1999, J CLIN CHILD PSYCHOL, V28, P232, DOI 10.1207/s15374424jccp2802_10; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Maller JJ, 2010, BRAIN RES REV, V64, P213, DOI 10.1016/j.brainresrev.2010.04.003; Manassis K, 2009, J CAN ACAD CHILD ADO, V18, P103; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; Monk CS, 2008, DEV PSYCHOPATHOL, V20, P1231, DOI 10.1017/S095457940800059X; Mukherjee P, 2006, NEUROIMAG CLIN N AM, V16, P19, DOI 10.1016/j.nic.2005.11.004; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Pine DS, 2008, J AM ACAD CHILD PSY, V47, P1217, DOI 10.1097/CHI.0b013e318185dad0; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Slemmer JE, 2008, AM J PATHOL, V173, P1795, DOI 10.2353/ajpath.2008.080168; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Tasker RC, 2005, PEDIATR RES, V58, P302, DOI 10.1203/01.PDR.0000169965.08854.25; Tateno A, 2004, J NEUROPSYCH CLIN N, V16, P426, DOI 10.1176/appi.neuropsych.16.4.426; TEASDALE G, 1974, LANCET, V2, P81; Vasa RA, 2004, BIOL PSYCHIAT, V55, P208, DOI 10.1016/S0006-3223(03)00708-X; Vasa RA, 2002, J AM ACAD CHILD PSY, V41, P148, DOI 10.1097/00004583-200202000-00008; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Winston FK, 2005, ARCH PEDIAT ADOL MED, V159, P1074, DOI 10.1001/archpedi.159.11.1074; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	60	17	17	0	11	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	MAR	2012	6	1					36	48		10.1007/s11682-011-9140-5			13	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	896OC	WOS:000300576500004	21979818	Green Accepted			2022-02-06	
J	Kim, S; Scalzo, F; Bergsneider, M; Vespa, P; Martin, N; Hu, X				Kim, Sunghan; Scalzo, Fabien; Bergsneider, Marvin; Vespa, Paul; Martin, Neil; Hu, Xiao			Noninvasive Intracranial Pressure Assessment Based on a Data-Mining Approach Using a Nonlinear Mapping Function	IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING			English	Article						Data mining; kernel spectral regression (KSR); noninvasive ICP (NICP); nonlinear mapping function; ordinary least squares (OLS); quadratic programming (QP); recursive weighted least squares (RWL)	TRANSCRANIAL DOPPLER ULTRASONOGRAPHY; CEREBRAL PERFUSION-PRESSURE; FULMINANT HEPATIC-FAILURE; TRAUMATIC BRAIN-INJURY; TECHNICAL NOTE; CLASSIFICATION; AUTOREGULATION	The current gold standard to determine intracranial pressure (ICP) involves an invasive procedure for direct access to the intracranial compartment. The risks associated with this invasive procedure include intracerebral hemorrhage, infection, and discomfort. We previously proposed an innovative data-mining framework of noninvasive ICP (NICP) assessment. The performance of the proposed framework relies on designing a good mapping function. We attempt to achieve performance gain by adopting various linear and nonlinear mapping functions. Our results demonstrate that a nonlinear mapping function based on the kernel spectral regression technique significantly improves the performance of the proposed data-mining framework for NICP assessment in comparison to other linear mapping functions.	[Kim, Sunghan; Scalzo, Fabien; Hu, Xiao] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Neural Syst & Dynam Lab, Los Angeles, CA 90095 USA; [Martin, Neil] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, UCLA Stroke Ctr, Los Angeles, CA 90095 USA; [Vespa, Paul] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Neurocrit Care Program, Los Angeles, CA 90095 USA; [Bergsneider, Marvin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, UCLA Adult Hydrocephalus Ctr, Los Angeles, CA 90095 USA		Hu, X (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Neural Syst & Dynam Lab, Los Angeles, CA 90095 USA.	visionsk@gmail.com; fscalzo@mednet.ucla.edu; mbergsneider@mednet.ucla.edu; pvespa@mednet.ucla.edu; nmartin@mednet.ucla.edu; xhu@mednet.ucla.edu	Scalzo, Fabien/AAM-6328-2020	Scalzo, Fabien/0000-0001-9755-8104; Martin, Neil/0000-0002-6565-4131	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS066008] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS066008-03, R01 NS066008-02, R01 NS066008] Funding Source: Medline		Aaslid R., 1986, P 6 INT S INTR PRESS, P226; Aggarwal S, 2008, LIVER TRANSPLANT, V14, P1048, DOI 10.1002/lt.21499; Belfort MA, 2000, HYPERTENS PREGNANCY, V19, P331, DOI 10.1081/PRG-100101995; Cai D., 2007, UIUCDCSR20072888; Czosnyka M, 1998, J NEUROSURG, V88, P802, DOI 10.3171/jns.1998.88.5.0802; Detry O, 1999, TRANSPLANTATION, V67, P767, DOI 10.1097/00007890-199903150-00024; Detry O, 2006, WORLD J GASTROENTERO, V12, P7405, DOI 10.3748/wjg.v12.i46.7405; Efron B., 1993, INTRO BOOTSTRAP; Hu X, 2004, CLIN NEUROPHYSIOL, V115, P1276, DOI 10.1016/j.clinph.2003.12.030; Hu X, 2010, J BIOMED INFORM, V43, P190, DOI 10.1016/j.jbi.2009.11.002; Hu X, 2006, BIOMED SIGNAL PROCES, V1, P64, DOI 10.1016/j.bspc.2006.05.003; Kim S, 2011, PHYSIOL MEAS, V32, P319, DOI 10.1088/0967-3334/32/3/004; Larsen FS, 2000, CRIT CARE MED, V28, P996, DOI 10.1097/00003246-200004000-00014; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Michaeli D, 2002, J NEUROSURG, V96, P1132, DOI 10.3171/jns.2002.96.6.1132; Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5; Panerai RB, 1999, AM J PHYSIOL-HEART C, V277, pH1089, DOI 10.1152/ajpheart.1999.277.3.H1089; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Scalzo F, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-61; Schmidt B, 2003, STROKE, V34, P84, DOI 10.1161/01.STR.0000047849.01376.AE; Schmidt B, 2000, J NEUROSURG, V92, P793, DOI 10.3171/jns.2000.92.5.0793; Sherman RW, 2002, BRIT J ANAESTH, V89, P687, DOI 10.1093/bja/aef247; Ueno T, 1998, ACT NEUR S, V71, P66; Ueno T, 2005, J NEUROSURG, V103, P361, DOI 10.3171/jns.2005.103.2.0361; Zhang F., 2000, P IEEE INT S CIRC SY, V5, P45	26	17	17	0	2	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9294			IEEE T BIO-MED ENG	IEEE Trans. Biomed. Eng.	MAR	2012	59	3					619	626		10.1109/TBME.2010.2093897			8	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	895PK	WOS:000300508400004	21097375	Green Accepted			2022-02-06	
J	Liu, H; Yang, M; Qiu, GP; Zhuo, F; Yu, WH; Sun, SQ; Xiu, Y				Liu, Hui; Yang, Mei; Qiu, Guo-ping; Zhuo, Fei; Yu, Wei-hua; Sun, Shan-quan; Xiu, Yun			Aquaporin 9 in rat brain after severe traumatic brain injury	ARQUIVOS DE NEURO-PSIQUIATRIA			English	Article						aquaporin-9; traumatic brain injury; brain edema	ENERGY-METABOLISM; CATECHOLAMINERGIC NEURONS; EXPRESSION; ROLES; CELLS; AQP9	Objective: To reveal the expression and possible roles of aquaporin 9 (AQP9) in rat brain, after severe traumatic brain injury (TBI). Methods: Brain water content (BWC), tetrazolium chloride staining, Evans blue staining, immunohistochemistry (IHC), immunofluorescence (IF), western blot, and real-time polymerase chain reaction were used. Results: The BWC reached the first and second (highest) peaks at 6 and 72 hours, and the blood brain barrier (BBB) was severely destroyed at six hours after the TBI. The worst brain ischemia occurred at 72 hours after TBI. Widespread AQP9-positive astrocytes and neurons in the hypothalamus were detected by means of IHC and IF after TBI. The abundance of AQP9 and its mRNA increased after TBI and reached two peaks at 6 and 72 hours, respectively, after TBI. Conclusions: Increased AQP9 might contribute to clearance of excess water and lactate in the early stage of TBI. Widespread AQP9-positive astrocytes might help lactate move into neurons and result in cellular brain edema in the later stage of TBI. AQP9-positive neurons suggest that AQP9 plays a role in energy balance after TBI.	[Liu, Hui; Yang, Mei; Qiu, Guo-ping; Zhuo, Fei; Yu, Wei-hua; Sun, Shan-quan] Chongqing Med Univ, Inst Neurosci, Chongqing 400016, Peoples R China; [Xiu, Yun] Chongqing Med Univ, Inst Life Sci, Chongqing 400016, Peoples R China		Sun, SQ (corresponding author), Chongqing Med Univ, Inst Neurosci, Chongqing 400016, Peoples R China.	19659179@qq.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30470608, 81000566]; Ministry of Education of China for New Teacher [20105503120009]; Chongqing Natural Science FoundationNatural Science Foundation of Chongqing [cstc2011jjA10093]	This research was supported by the National Natural Science Foundation of China (No. 30470608 and 81000566), Ph.D. Programs Foundation of Ministry of Education of China for New Teacher (No. 20105503120009) and Chongqing Natural Science Foundation (cstc2011jjA10093).	Badaut J, 2008, BRAIN RES, V1188, P17, DOI 10.1016/j.brainres.2007.10.087; Badaut J, 2004, NEUROSCIENCE, V129, P971, DOI 10.1016/j.neuroscience.2004.06.035; Badaut J, 2004, NEUROSCIENCE, V128, P27, DOI 10.1016/j.neuroscience.2004.05.042; Badaut J, 2010, NEUROSCIENCE, V168, P1047, DOI 10.1016/j.neuroscience.2009.10.030; Dibas A, 2007, PHARMACOL RES, V55, P378, DOI 10.1016/j.phrs.2007.01.021; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Finnie JW, 2002, VET PATHOL, V39, P679, DOI 10.1354/vp.39-6-679; Hwang IK, 2007, J NEUROSCI RES, V85, P2470, DOI 10.1002/jnr.21381; Magistretti PJ, 1999, PHILOS T R SOC B, V354, P1155, DOI 10.1098/rstb.1999.0471; Marmarou A., 2007, NEUROSURG FOCUS, V22, P1; Ribeiro MD, 2006, J NEUROSCI RES, V83, P1231, DOI 10.1002/jnr.20819; Schurr A, 2002, INT J MOL MED, V10, P131, DOI 10.3892/ijmm.10.2.131; Tsukaguchi H, 1998, J BIOL CHEM, V273, P24737, DOI 10.1074/jbc.273.38.24737; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Verkman AS, 2005, J CELL SCI, V118, P3225, DOI 10.1242/jcs.02519; Verweij BH, 2007, PROG BRAIN RES, V161, P111, DOI 10.1016/S0079-6123(06)61008-X	16	17	18	2	3	ASSOC ARQUIVOS NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X			ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.	MAR	2012	70	3					214	220		10.1590/S0004-282X2012000300012			7	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	902YO	WOS:000301080300012	22392116	gold, Green Submitted			2022-02-06	
J	Mikkonen, K; Pekkala, N; Pokka, T; Romner, B; Uhari, M; Rantala, H				Mikkonen, Kirsi; Pekkala, Niina; Pokka, Tytti; Romner, Bertil; Uhari, Matti; Rantala, Heikki			S100B proteins in febrile seizures	SEIZURE-EUROPEAN JOURNAL OF EPILEPSY			English	Article						S100B; Febrile seizure; Children	TRAUMATIC BRAIN-INJURY; NEURON-SPECIFIC ENOLASE; BLOOD	S100B protein concentrations correlate with the severity and outcome of brain damage after brain injuries, and have been shown to be markers of blood-brain barrier damage. In children elevated Si 008 values are seen as a marker of damage to astrocytes even after mild head injuries. S100B proteins may also give an indication of an ongoing pathological process in the brain with respect to febrile seizures (FS) and the likelihood of their recurrence. To evaluate this, we measured S100B protein concentrations in serum and cerebrospinal fluid from 103 children after their first FS. 33 children with acute infection without FS served as controls for the serum concentrations. In the FS patients the mean S100B concentration in the cerebrospinal fluid samples was 0.21 mu g/L and that in the serum samples 0.12 mu g/L. The mean serum concentration in the controls was 0.11 mu g/L (difference 0.01 mu g/L, 95% confidence interval -0.02 to 0.04 mu g/L, P = 0.46). There was a correlation between age and serum S100B concentration (r= -0.28, P = 0.008) in children under four years, but S100B concentrations did not predict the clinical severity of the FS nor their recurrence. There was no correlation between time of arrival at the hospital after FS and S100B concentration in serum (r = -0.130, P = 0.28) or in cerebrospinal fluid samples (r = -0.091, P = 0.52). Our findings indicate that FS does not cause significant blood-brain barrier openings, and increase the evidence that these seizures are relatively harmless for the developing brain. (C) 2011 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.	[Mikkonen, Kirsi; Pekkala, Niina; Pokka, Tytti; Uhari, Matti; Rantala, Heikki] Univ Oulu, Dept Pediat, FIN-90014 Oulu, Finland; [Romner, Bertil] Rigshosp, Dept Neurosurg, DK-2100 Copenhagen, Denmark		Mikkonen, K (corresponding author), Univ Oulu, Dept Pediat, POB 5000, FIN-90014 Oulu, Finland.	kirsi.mikkonen@oulu.fi			Special State Grants for Health Research in the Department of Pediatrics and Adolescence, Oulu University Hospital, Finland	This study was supported by Special State Grants for Health Research in the Department of Pediatrics and Adolescence, Oulu University Hospital, Finland.	[Anonymous], 1989, EPILEPSIA, V30, P389; Bellander BM, 2011, ACTA NEUROCHIR, V153, P90, DOI 10.1007/s00701-010-0737-z; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Burgess DL, 2005, EPILEPSIA, V46, P51, DOI 10.1111/j.1528-1167.2005.00359.x; Gazzolo D, 2003, CLIN CHEM, V49, P967, DOI 10.1373/49.6.967; Geyer C, 2009, J NEUROS-PEDIATR, V4, P339, DOI 10.3171/2009.5.PEDS08481; Heizmann CW, 2005, J PEDIATR-US, V147, P731, DOI 10.1016/j.jpeds.2005.08.046; Marchi N, 2004, CLIN CHIM ACTA, V342, P1, DOI 10.1016/j.cccn.2003.12.008; Marchi N, 2011, CARDIOVASC PSYCHIAT, V2011; NELSON KB, 1978, PEDIATRICS, V61, P720; Palmio J, 2001, J NEUROL SCI, V183, P27, DOI 10.1016/S0022-510X(00)00478-0; Sandler SJI, 2010, CHILD NERV SYST, V26, P205, DOI 10.1007/s00381-009-1009-1; Schulpis KH, 2006, SCAND J CLIN LAB INV, V66, P733, DOI 10.1080/00365510600977737; Strengell T, 2009, ARCH PEDIAT ADOL MED, V163, P799, DOI 10.1001/archpediatrics.2009.137; Tomkins O, 2011, CARDIOVASC PSYCHIAT, V2011	15	17	19	1	6	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1059-1311			SEIZURE-EUR J EPILEP	Seizure	MAR	2012	21	2					144	146		10.1016/j.seizure.2011.10.006			3	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	900ER	WOS:000300869900013	22130006	Bronze			2022-02-06	
J	Praeger, AJ; Westbrook, AJ; Nichol, AD; Wijemunige, R; Davies, AR; Lyon, SM; Wills, JL; Bailey, M; Rosenfeld, JV; Cooper, DJ				Praeger, Adrian J.; Westbrook, Andrew J.; Nichol, Alistair D.; Wijemunige, Ruwan; Davies, Andrew R.; Lyon, Stuart M.; Wills, Judy L.; Bailey, Michael; Rosenfeld, Jeffrey V.; Cooper, D. James			Deep vein thrombosis and pulmonary embolus in patients with traumatic brain injury: a prospective observational study	CRITICAL CARE AND RESUSCITATION			English	Article							VENOUS THROMBOEMBOLISM; MAJOR TRAUMA; PROPHYLAXIS; HEPARIN	Background: Intensive care patients with traumatic brain injury (TBI) are at high risk of developing deep vein thrombosis (DVT). A high rate of DVT was reported before routine thromboprophylaxis, but the current DVT rate in TBI patients receiving best-practice mechanical and pharmacological prophylaxis is unknown. Objectives: To determine the prevalence of DVT among TBI patients. Design, participants and setting: A prospective observational pilot study of adult patients admitted to the intensive care unit of a level 1 trauma centre within 72 hours of sustaining a TBI (Glasgow Coma Scale score <= 14). Main outcome measures: Rate of DVT determined using twice-weekly compression ultrasound; rate of pulmonary embolism (PE) and length of stay. Results: 36 patients (28 men; mean age, 40.3 years) were included. Six had moderate and 21 had severe TBI. Two patients (6%) developed a DVT and two patients (6%) developed a PE. The proximal leg DVT rate was 3%, but the overall venous thromboembolism rate was 11% (4 patients). Conclusions: Mechanical and pharmacological prophylaxis appeared to be effective. The incidence of clinically identified PE is of concern and suggests that thromboembolic sources other than large leg veins may not be being adequately controlled by modern thromboprophylaxis regimens.	[Praeger, Adrian J.; Westbrook, Andrew J.; Nichol, Alistair D.; Wijemunige, Ruwan; Davies, Andrew R.; Bailey, Michael; Cooper, D. James] Monash Univ, Dept Epidemiol & Prevent Med, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic 3004, Australia; [Praeger, Adrian J.; Wijemunige, Ruwan; Rosenfeld, Jeffrey V.] Alfred Hosp, Dept Neurosurg, Melbourne, Vic, Australia; [Nichol, Alistair D.] Alfred Hosp, Dept Intens Care & Hyperbar Med, Melbourne, Vic, Australia; [Lyon, Stuart M.; Wills, Judy L.] Alfred Hosp, Dept Radiol, Melbourne, Vic, Australia; [Rosenfeld, Jeffrey V.] Monash Univ, Dept Surg, Melbourne, Vic 3004, Australia		Cooper, DJ (corresponding author), Monash Univ, Dept Epidemiol & Prevent Med, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic 3004, Australia.	jamie.cooper@monash.edu	Rosenfeld, Jeffrey V/B-7249-2011; Bailey, Michael J/A-4499-2012; Cooper, D. James/G-7961-2013	Bailey, Michael J/0000-0002-5551-1401; Cooper, D. James/0000-0002-5872-9051; Praeger, Adrian/0000-0003-0010-6238; Nichol, Alistair/0000-0002-4689-1238; Nichol, Alistair Dualta/0000-0002-4771-5615	Intensive Care Foundation (Australia); Tattersall's George Adams Foundation - National Trauma Research Institute Foundation	We acknowledge the financial support of the Intensive Care Foundation (Australia) and a Tattersall's George Adams Foundation - National Trauma Research Institute Foundation Fellowship.	Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS32, DOI 10.1089/neu.2007.9991; Cook D, 2011, NEW ENGL J MED, V364, P1305, DOI 10.1056/NEJMoa1014475; Denson K, 2007, AM J SURG, V193, P380, DOI 10.1016/j.amjsurg.2006.12.004; Ekeh AP, 2010, J TRAUMA, V68, P912, DOI 10.1097/TA.0b013e3181b21cad; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; HIRSCH DR, 1995, JAMA-J AM MED ASSOC, V274, P335, DOI 10.1001/jama.274.4.335; KAKKAR VV, 1969, LANCET, V2, P230; Kim J, 2002, J TRAUMA, V53, P38, DOI 10.1097/00005373-200207000-00008; Moore EM, 2011, ANAESTH INTENS CARE, V39, P356, DOI 10.1177/0310057X1103900306; Norwood SH, 2008, J TRAUMA, V65, P1021, DOI 10.1097/TA.0b013e31818a0e74; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Rogers Frederick, 2007, J Intensive Care Med, V22, P26, DOI 10.1177/0885066606295291	14	17	19	1	4	AUSTRALASIAN MED PUBL CO LTD	PYRMONT	LEVEL 2, 26-32 PYRMONT BRIDGE RD, PYRMONT, NSW 2009, AUSTRALIA	1441-2772			CRIT CARE RESUSC	Crit Care Resusc.	MAR	2012	14	1					10	13					4	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904PL	WOS:000301210300003	22404055				2022-02-06	
J	Reeves, RR; Laizer, JT				Reeves, Roy R.; Laizer, Janet T.			Traumatic Brain Injury and Suicide	JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MAJOR DEPRESSION; PSYCHIATRIC-DISORDERS; BEHAVIOR; ASSOCIATION; POPULATION; PEOPLE; POSTINJURY; SYMPTOMS; VETERANS	A number of psychiatric and neurological problems may occur following traumatic brain injury (TBI). Anxiety and depression are common. There is evidence that there may be a correlation between TBI and increased risk of suicide. This article will explore current literature on the risk of suicidal behavior in people who have experienced TBI. Risk factors for suicide, recognition and assessment of suicidal behavior, and treatment issues will be discussed.	[Reeves, Roy R.; Laizer, Janet T.] GV Sonny Montgomery Vet Affairs Med Ctr, Jackson, MS 39216 USA; [Reeves, Roy R.; Laizer, Janet T.] Univ Mississippi, Sch Med, Jackson, MS 39216 USA		Reeves, RR (corresponding author), GV Sonny Montgomery Vet Affairs Med Ctr, 1500 E Woodrow Wilson Dr, Jackson, MS 39216 USA.	roy.reeves@va.gov					Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Brenner LA, 2011, SUICIDE LIFE-THREAT, V41, P416, DOI 10.1111/j.1943-278X.2011.00041.x; Brenner LA, 2011, J CLIN PSYCHOL MED S, V18, P116, DOI 10.1007/s10880-011-9240-9; Breshears RE, 2010, J PERS ASSESS, V92, P349, DOI 10.1080/00223891.2010.482011; Bryan C, 2011, J CLIN PSYCHOL, V67, P856, DOI 10.1002/jclp.20808; Coco K, 2011, J NEUROSCI NURS, V43, P337, DOI 10.1097/JNN.0b013e318234ea0b; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kuipers P, 2000, J HEAD TRAUMA REHAB, V15, P1275, DOI 10.1097/00001199-200012000-00007; Mainio A, 2007, BRAIN INJURY, V21, P851, DOI 10.1080/02699050701504265; Morey L.C., 2004, COMPREHENSIVE HDB PS, V2, P15; Oquendo MA, 2004, J NERV MENT DIS, V192, P430, DOI 10.1097/01.nmd.0000126706.53615.7b; Oquendo MA, 2003, AM J PSYCHIAT, V160, P580, DOI 10.1176/appi.ajp.160.3.580; Reeves RR, 2009, TERROR HOT SPOTS CON, P105; Satz P, 1998, BRAIN INJURY, V12, P555, DOI 10.1080/026990598122322; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Simpson G, 2003, J HEAD TRAUMA REHAB, V18, P445, DOI 10.1097/00001199-200309000-00006; Simpson G, 2005, J NERV MENT DIS, V193, P680, DOI 10.1097/01.nmd.0000180743.65943.c8; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Simpson GK, 2007, MED J AUSTRALIA, V187, P229, DOI 10.5694/j.1326-5377.2007.tb01206.x; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Thibault JM, 2004, AM FAM PHYSICIAN, V70, P1101; TREVENA L, 2004, CLIN PRACTICE GUIDEL; Wasserman L, 2008, BRAIN INJURY, V22, P811, DOI 10.1080/02699050802372166; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246	35	17	18	0	8	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0279-3695			J PSYCHOSOC NURS MEN	J. Psychosoc. Nurs. Ment. Health Serv.	MAR	2012	50	3					32	38		10.3928/02793695-20120207-02			7	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	905VA	WOS:000301302800011	22329620				2022-02-06	
J	Liddle, J; Fleming, J; McKenna, K; Turpin, M; Whitelaw, P; Allen, S				Liddle, Jacki; Fleming, Jennifer; McKenna, Kryss; Turpin, Merrill; Whitelaw, Penny; Allen, Shelley			Adjustment to loss of the driving role following traumatic brain injury: A qualitative exploration with key stakeholders	AUSTRALIAN OCCUPATIONAL THERAPY JOURNAL			English	Article						automobile driving; community	OUTCOMES; DRIVERS; RETURN	Background/aims: Community mobility is affected by an interruption to or cessation of driving following traumatic brain injury (TBI). This study aimed to examine loss of the driving role and to explore the outcomes associated with driving cessation from the perspectives of key people involved within the process: people with TBI, their family members and involved health professionals. Methods: A qualitative methodology was used, employing semi-structured interviews with 15 individuals with TBI who had experienced driving cessation, 10 family members and 10 health professionals working with this population. Results: This article focuses on two themes, each with three subthemes. Being stuck: needs related to driving cessation had subthemes: (i) an emotional time, (ii) being normal and (iii) participation without driving. The second theme, A better way: suggestions to improve outcomes had subthemes: (i) information, (ii) support and trying it out and (iii) their family member's roles and needs. Conclusions: Driving cessation following TBI is associated with emotional, identity, transport and participation-related needs. An ongoing, individualised approach involving information, support and practical experiences may improve outcomes of driving cessation for people with TBI and their family members.	[Liddle, Jacki] Univ Queensland, Sch Hlth & Rehabil Sci, Div Occupat Therapy, Brisbane, Qld 4072, Australia; [Fleming, Jennifer] Princess Alexandra Hosp, Occupat Therapy Dept, Woolloongabba, Qld, Australia; [Fleming, Jennifer] Queensland Hlth, MetroS Hlth Serv Dist, Ctr Functioning & Hlth Res, Brisbane, Qld, Australia		Liddle, J (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Div Occupat Therapy, Brisbane, Qld 4072, Australia.	j.liddle@uq.edu.au	Liddle, Jacki/F-6872-2010	Liddle, Jacki/0000-0002-6336-9898; Turpin, Merrill/0000-0001-7946-0883	School of Health and Rehabilitation Motor Accident Insurance Commission (MAIC)	This project was funded by a School of Health and Rehabilitation Motor Accident Insurance Commission (MAIC) Rehabilitation Research Grant. The authors would like to thank the staff, patients and families involved in the study for their assistance.	Austroads, 2003, ASS FITN DRIV; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Doig E, 2009, AM J OCCUP THER, V63, P559, DOI 10.5014/ajot.63.5.559; EISENHANDLER SA, 1990, INT J AGING HUM DEV, V30, P1, DOI 10.2190/0MF5-HQ1L-7EBY-XNXV; Fleming JM, 2006, NEUROPSYCHOL REHABIL, V16, P474, DOI 10.1080/09602010500505518; Harradine PG, 2004, MED J AUSTRALIA, V181, P130, DOI 10.5694/j.1326-5377.2004.tb06202.x; Hawley CA, 2001, J NEUROL NEUROSUR PS, V70, P761, DOI 10.1136/jnnp.70.6.761; Hoffmann T, 2008, AUST OCCUP THER J, V55, P239, DOI 10.1111/j.1440-1630.2007.00693.x; JENSEN M, 1999, TRANSP POLICY, V0006, P00019; Jumisko E, 2007, DISABIL REHABIL, V29, P1535, DOI 10.1080/09638280601055816; Langdridge D., 2007, PHENOMENOLOGICAL PSY; Liddle J., 2003, BRIT J OCCUPATIONAL, V66, P125, DOI DOI 10.1177/030802260306600307; Liddle J, 2007, AUST OCCUP THER J, V54, P303, DOI 10.1111/j.1440-1630.2006-00614.x; Liddle J, 2011, DISABIL REHABIL, V33, P2574, DOI 10.3109/09638288.2011.582922; Lister R, 1999, BRIT J OCCUPATIONAL, V62, P514; Lundqvist A, 2008, BRAIN INJURY, V22, P295, DOI 10.1080/02699050801966133; Marottoli RA, 2000, J GERONTOL B-PSYCHOL, V55, pS334, DOI 10.1093/geronb/55.6.S334; Molnar L. J., 2008, PROMISING APPROACHES; Oxley J, 2008, TRAFFIC INJ PREV, V9, P367, DOI 10.1080/15389580801895285; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; Pietrapiana P, 2005, BRAIN INJURY, V19, P197, DOI 10.1080/02699050400017197; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; Qualitative Solutions and Research, 1999, NVIVO REF GUID SOFTW; Ragland DR, 2005, J GERONTOL A-BIOL, V60, P399, DOI 10.1093/gerona/60.3.399; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; Schanke AK, 2000, SCAND J PSYCHOL, V41, P113, DOI 10.1111/1467-9450.00179; Turner B, 2007, BRAIN INJURY, V21, P1119, DOI 10.1080/02699050701651678; Turner B, 2009, AM J OCCUP THER, V63, P609, DOI 10.5014/ajot.63.5.609	28	17	17	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0045-0766	1440-1630		AUST OCCUP THER J	Aust. Occup. Ther. J.	FEB	2012	59	1			SI		79	88		10.1111/j.1440-1630.2011.00978.x			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	880NY	WOS:000299415300011	22272886				2022-02-06	
J	Qi, L; Cui, XX; Dong, WF; Barrera, R; Nicastro, J; Coppa, GF; Wang, P; Wu, RQ				Qi, Lei; Cui, Xiaoxuan; Dong, Weifeng; Barrera, Rafael; Nicastro, Jeffrey; Coppa, Gene F.; Wang, Ping; Wu, Rongqian			Ghrelin Attenuates Brain Injury after Traumatic Brain Injury and Uncontrolled Hemorrhagic Shock in Rats	MOLECULAR MEDICINE			English	Article							SECRETAGOGUE RECEPTOR; HEAD-INJURY; ACYLATED PEPTIDE; STIMULATES GH; HORMONE; APOPTOSIS; STOMACH; SEPSIS; CELLS; PATHOPHYSIOLOGY	Traumatic brain injury (TBI) and hemorrhagic shock often occur concomitantly due to multiple injuries. Gastrointestinal dysfunction occurs frequently in patients with TBI. However, whether alterations in the gastrointestinal system are involved in modulating neuronal damage and recovery after TBI is largely neglected. Ghrelin is a "gut-brain" hormone with multiple functions including antiinflammation and antiapoptosis. The purpose of this study was to determine whether ghrelin attenuates brain injury in a rat model of TBI and uncontrolled hemorrhage (UH). To study this, brain injury was induced by dropping a 450-g weight from 1.5 m onto a steel helmet attached to the skull of male adult rats. Immediately after TBI, a midline laparotomy was performed and both lumbar veins were isolated and severed at the junction with the vena cava. At 45 min after TBI/UH, ghrelin (4,8 or 16 nmol/rat) or 1 mL normal saline (vehicle) was intravenously administered. Brain levels of TNF-alpha and IL-6, and cleaved PARP-1 levels in the cortex were measured at 4 h after TBI/UH. Beam balance test, forelimb placing test and hindlimb placing test were used to assess sensorimotor and reflex function. In additional groups of animals, ghrelin (16 nmol/rat) or vehicle was subcutaneously (s.c.) administered daily for 10 d after TBI/UH. The animals were monitored for 28 d to record body weight changes, neurological severity scale and survival. Our results showed that ghrelin downregulated brain levels of TNF-a and IL-6, reduced cortical levels of cleaved PARP-1, improved sensorimotor and reflex functions, and decreased mortality after TBI/UH. Thus, ghrelin has a great potential to be further developed as an effective resuscitation approach for the trauma victims with brain injury and severe blood loss. Online address: http://www.molmed.org doi: 10.2119/molmed.2011.00390	[Wu, Rongqian] Feinstein Inst Med Res, Surg Res Lab, Manhasset, NY 11030 USA; [Qi, Lei; Cui, Xiaoxuan; Dong, Weifeng; Barrera, Rafael; Nicastro, Jeffrey; Coppa, Gene F.; Wang, Ping; Wu, Rongqian] N Shore Univ Hosp, Dept Surg, Manhasset, NY USA; [Qi, Lei; Cui, Xiaoxuan; Dong, Weifeng; Barrera, Rafael; Nicastro, Jeffrey; Coppa, Gene F.; Wang, Ping; Wu, Rongqian] Long Isl Jewish Med Ctr, Manhasset, NY USA; [Qi, Lei] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Neurosurg, Xian 710049, Shaanxi, Peoples R China		Wu, RQ (corresponding author), Feinstein Inst Med Res, Surg Res Lab, 350 Community Dr, Manhasset, NY 11030 USA.	rwu@nshs.edu	Wu, Rongqian/I-3614-2012; Qi, Lei/A-2980-2009	Wu, Rongqian/0000-0003-0993-4531; Wang, Ping/0000-0002-1557-0394; Qi, Lei/0000-0002-9525-9132	DoD/DRMRP [DR080669]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21 NS072608]	This study was supported by a DoD/DRMRP Grant DR080669 (R Wu) and an NIH grant R21 NS072608 (R Wu).	Ammori JB, 2008, SURGERY, V144, P159, DOI 10.1016/j.surg.2008.03.008; Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Arvat E, 2000, J ENDOCRINOL INVEST, V23, P493, DOI 10.1007/BF03343763; Bansal V, 2012, INFLAMMATION, V35, P214, DOI 10.1007/s10753-011-9307-7; Bansal V, 2010, J NEUROTRAUM, V27, P2255, DOI 10.1089/neu.2010.1372; Bilotta F, 2009, J NEUROSURG ANESTH, V21, P2, DOI 10.1097/ANA.0b013e31818f8a5c; Boulanger L, 2007, AM SURGEON, V73, P1269; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cheyuo C, 2011, SHOCK, V35, P258, DOI 10.1097/SHK.0b013e3181f48a37; Chung H, 2007, ENDOCRINOLOGY, V148, P148, DOI 10.1210/en.2006-0991; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Cowley MA, 2004, ENDOCRINOLOGY, V145, P2604, DOI 10.1210/en.2004-0346; Date Y, 2000, BIOCHEM BIOPH RES CO, V275, P477, DOI 10.1006/bbrc.2000.3342; Davis KL, 2007, J TRAUMA, V62, P622, DOI 10.1097/TA.0b013e318031afe3; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Dezaki K, 2008, PHARMACOL THERAPEUT, V118, P239, DOI 10.1016/j.pharmthera.2008.02.008; Dressler J, 2007, INT J LEGAL MED, V121, P365, DOI 10.1007/s00414-006-0126-6; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Godoy DA, 2010, NEUROCRIT CARE, V13, P425, DOI 10.1007/s12028-010-9404-8; Hattori N, 2001, J CLIN ENDOCR METAB, V86, P4284, DOI 10.1210/jc.86.9.4284; Jacka MJ, 2009, CAN J NEUROL SCI, V36, P436, DOI 10.1017/S0317167100007757; Katsaragakis S, 2010, BRAIN INJURY, V24, P871, DOI 10.3109/02699051003789237; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; Krakau K, 2006, BRAIN INJURY, V20, P345, DOI 10.1080/02699050500487571; Luo Chun, 2002, Chin J Traumatol, V5, P24; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Miao YY, 2007, BIOCHEM BIOPH RES CO, V359, P795, DOI 10.1016/j.bbrc.2007.05.192; Nass R, 2000, J NEUROENDOCRINOL, V12, P1194, DOI 10.1046/j.1365-2826.2000.00586.x; Papotti M, 2000, J CLIN ENDOCR METAB, V85, P3803, DOI 10.1210/jc.85.10.3803; Sakata I, 2003, NEUROSCI LETT, V342, P183, DOI 10.1016/S0304-3940(03)00294-5; Sangiao-Alvarellos S, 2010, INT J PEPT, V2010; Savitz SI, 1998, NEUROSURGERY, V42, P555, DOI 10.1097/00006123-199803000-00026; Shuto YJ, 2001, LIFE SCI, V68, P991, DOI 10.1016/S0024-3205(00)01001-8; van der Lely AJ, 2004, ENDOCR REV, V25, P426, DOI 10.1210/er.2002-0029; Wang GY, 2002, REGUL PEPTIDES, V105, P75, DOI 10.1016/S0167-0115(02)00012-5; Wong J, 2005, NEUROCRIT CARE, V3, P177, DOI 10.1385/NCC:3:2:177; Wu R, 2007, AM J PHYSIOL-ENDOC M, V293, pE1697, DOI 10.1152/ajpendo.00098.2007; Wu R, 2007, AM J RESP CRIT CARE, V176, P805, DOI 10.1164/rccm.200604-511OC; Wu RQ, 2007, CRIT CARE MED, V35, P912, DOI 10.1097/01.CCM.0000257327.61829.34; Wu RQ, 2007, ANN SURG, V245, P480, DOI 10.1097/01.sla.0000251614.42290.ed; Wu RQ, 2009, ANN SURG, V250, P126, DOI 10.1097/SLA.0b013e3181ad85d6; Wu RQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002026; Wu RQ, 2005, CARDIOVASC RES, V68, P318, DOI 10.1016/j.cardiores.2005.06.011; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	52	17	20	0	3	FEINSTEIN INST MED RES	MANHASSET	350 COMMUNITY DR, MANHASSET, NY 11030 USA	1076-1551			MOL MED	Mol. Med.	FEB	2012	18	2					186	193		10.2119/molmed.2011.00390			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	941KS	WOS:000303962700005	22160303	gold, Green Published, Green Submitted			2022-02-06	
J	Veech, RL; Valeri, CR; VanItallie, TB				Veech, Richard L.; Valeri, C. Robert; VanItallie, Theodore B.			The mitochondrial permeability transition pore provides a key to the diagnosis and treatment of traumatic brain injury	IUBMB LIFE			English	Article						TBI; ketone bodies; mPTP; cyclosporine A; brain energetics	CYCLOSPORINE-A; METABOLISM; GLUCOSE; PYROPHOSPHATE; DYSFUNCTION; APOPTOSIS; DAMAGE	The pathological consequences of traumatic head injury result largely from the opening of the mitochondrial permeability transition pore (mPTP). The mPTP opens due to a decrease in brain phosphorylation energy resulting in a further decrease in brain ATP production and a measurable increase in brain heat generation and temperature. The increase in brain temperature can be measured transcranially by near infrared spectroscopy which can be used to diagnose traumatic brain injury (TBI) and to monitor treatment. Effective therapy of TBI can be achieved by closure of the mPTP by administration of cyclosporine A or by oral administration of ketone body esters. While ketosis has previously been known to prevent damage from TBI, the availability of oral ketone esters presents the first practical modality of achieving therapeutic levels of ketone bodies. (c) 2012 IUBMB Life, 2012	[Veech, Richard L.] NIAAA, Lab Metab Control, NIH, Rockville, MD 20852 USA; [Valeri, C. Robert] Naval Blood Res Lab Inc, Boston, MA USA; [VanItallie, Theodore B.] Columbia Univ, Dept Med, St Lukes Roosevelt Hosp Ctr, Coll Phys & Surg, New York, NY USA		Veech, RL (corresponding author), NIAAA, Lab Metab Control, NIH, Rockville, MD 20852 USA.	rveech@mail.nih.gov			Defense Research Project Administration, DARPA; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [ZIDAA000112, ZIAAA000110] Funding Source: NIH RePORTER	Support for development of the ketone ester from the Defense Research Project Administration, DARPA, is gratefully acknowledged.	Albensi BC, 2000, EXP NEUROL, V162, P385, DOI 10.1006/exnr.1999.7338; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Hu ZG, 2009, ANN CLIN LAB SCI, V39, P76; Kashiwaya Y, 2010, J BIOL CHEM, V285, P25950, DOI 10.1074/jbc.M110.138198; Kelly J. J., 1995, SPIE, V2389, P818; Li L, 2009, TRENDS ENDOCRIN MET, V20, P429, DOI 10.1016/j.tem.2009.06.004; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mazzeo AT, 2009, J NEUROTRAUM, V26, P2195, DOI 10.1089/neu.2009.1012; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; O'Rourke B, 2007, ANNU REV PHYSIOL, V69, P19, DOI 10.1146/annurev.physiol.69.031905.163804; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Prins ML, 2008, J CEREBR BLOOD F MET, V28, P1, DOI 10.1038/sj.jcbfm.9600543; Rumana CS, 1998, CRIT CARE MED, V26, P562, DOI 10.1097/00003246-199803000-00032; SATO K, 1995, FASEB J, V9, P651, DOI 10.1096/fasebj.9.8.7768357; Sharma Pushpa, 2009, J Emerg Trauma Shock, V2, P67, DOI 10.4103/0974-2700.50739; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Veech R L, 1986, Adv Exp Med Biol, V194, P617; VEECH RL, 1980, FEBS LETT, V117, pK65, DOI 10.1016/0014-5793(80)80571-0; Veech RL, 2002, IUBMB LIFE, V54, P241, DOI 10.1080/15216540215678; YAMADA T, 1988, J BIOCHEM-TOKYO, V104, P847, DOI 10.1093/oxfordjournals.jbchem.a122561; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739	25	17	19	0	6	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1521-6543			IUBMB LIFE	IUBMB Life	FEB	2012	64	2					203	207		10.1002/iub.590			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	875OE	WOS:000299039800013	22241645	Green Accepted, Bronze			2022-02-06	
J	Lafuente, JV; Sharma, A; Patnaik, R; Muresanu, DF; Sharma, HS				Vicente Lafuente, Jose; Sharma, Aruna; Patnaik, Ranjana; Muresanu, Dafin Fior; Sharma, Hari Shanker			Diabetes Exacerbates Nanoparticles Induced Brain Pathology	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						Nanoparticles; SiO2; Cu; Ag; Blood-brain barrier; brain edema; neuronal injury; myelin damage; diabetes; streptozotocine; electron microscopy; cerebral blood flow; neurotoxicity; sensory-motor function; cognitive disturbances; hyperglycemia	CEREBRAL-BLOOD-FLOW; ANTIOXIDANT COMPOUND H-290/51; SPINAL-CORD-INJURY; ACUTE METHAMPHETAMINE INTOXICATION; ACUTE HEAT EXPOSURE; BARRIER PERMEABILITY; EDEMA FORMATION; YOUNG-RATS; ENGINEERED NANOPARTICLES; POSSIBLE NEUROPROTECTION	Long term exposure of nanoparticles e.g., silica dust (SiO2) from desert environments, or engineered nanoparticles from metals viz., Cu, Al or Ag from industry, ammunition, military equipment and related products may lead to adverse effects on mental health. However, it is unclear whether these nanoparticles may further adversely affect human health in cardiovascular or metabolic diseases e.g., hypertension or diabetes. It is quite likely that in diabetes or hypertension where the body immune system is already compromised there will be greater adverse effects following nanoparticles exposure on human health as compared to their exposure to healthy individuals. Previous experiments from our laboratory showed that diabetic or hypertensive animals are more susceptible to heat stress-induced neurotoxicity. Furthermore, traumatic injury to the spinal cord in SiO2 exposed rats resulted in exacerbation of cord pathology. However, whether nanoparticles such as Cu, Ag or SiO2 exposure will lead to enhanced neurotoxicity in diabetic animals are still not well investigated. Previous data from our laboratory showed that Cu or Ag intoxication (50 mg/kg, i.p. per day for 7 days) in streptozotocine induced diabetic rats exhibited enhanced neurotoxicity and exacerbation of sensory, motor and cognitive function as compared to normal animals under identical conditions. Thus the diabetic animals showed exacerbation of regional blood-brain barrier (BBB) disruption, edema formation and cell injuries along with greater reduction in the local cerebral blood flow (CBF) as compared to normal rats. These observations suggest that diabetic animals are more vulnerable to nanoparticles induced brain damage than healthy rats. The possible mechanisms and functional significance of these findings are discussed in this review largely based on our own investigations.	[Sharma, Aruna; Sharma, Hari Shanker] Uppsala Univ, Univ Hosp, Dept Surg Sci Anesthesiol & Intens Care Med, Lab Cerebrovasc Res, SE-75185 Uppsala, Sweden; [Vicente Lafuente, Jose] Univ Basque Country, Dept Neurosci, Lab Clin & Expt Neurosci LaCEN, Bilbao 48080, Spain; [Patnaik, Ranjana] Banaras Hindu Univ, Inst Technol, Sch Biomed Engn, Deaprtment Biomat, Varanasi 221005, Uttar Pradesh, India; [Muresanu, Dafin Fior] Univ Med & Pharm Iuliu Hatieganu, Dept Neurosci, Cluj Napoca, Romania		Sharma, HS (corresponding author), Uppsala Univ, Univ Hosp, Dept Surg Sci Anesthesiol & Intens Care Med, Lab Cerebrovasc Res, SE-75185 Uppsala, Sweden.	Sharma@surgsci.uu.se	Patnaik, Ranjana/AAZ-4440-2020; Muresanu, Fior-Dafin/AAI-8120-2021; Lafuente, Jose-Vicente/O-6395-2014	Patnaik, Ranjana/0000-0002-8131-177X; Lafuente, Jose-Vicente/0000-0001-7246-0987	Air Force Office of Scientific Research (London), Air Force Material Command, USAFUnited States Department of DefenseAir Force Office of Scientific Research (AFOSR) [FA8655-05-1-3065]; EOARD, London office; Swedish Medical Research Council, SwedenSwedish Medical Research Council (SMRC) [2710]; Astra-Zeneca, Molndal, SwedenAstraZeneca; Alexander von Humboldt Foundation, GermanyAlexander von Humboldt Foundation; University Grants Commission, Govt. of India, New DelhiUniversity Grants Commission, India; Amity Science & Technology Foundation, New Delhi, India; Indian Medical Research Council, Govt. of India, New Delhi; Department of Science & Technology, Govt. of IndiaDepartment of Science & Technology (India); SAIOTEK; (Basque Gov.), Spain [IT491-10]	This investigation is partially supported by the Air Force Office of Scientific Research (London), Air Force Material Command, USAF, under grant number FA8655-05-1-3065. The U.S. Government is authorized to reproduce and distribute reprints for Government purpose notwithstanding any copyright notation thereon. The views and conclusions contained herein are those of the authors and should not be interpreted as necessarily representing the official policies or endorsements, either expressed or implied, of the Air Force Office of Scientific Research or the U.S. Government. We express sincere gratitude to Dr Robert N Kang, EOARD, London office for all necessary support and help during this investigation and several laboratories where a part of the work is done or some data is recorded and evaluated. Financial support from Swedish Medical Research Council (2710 HSS), Sweden; Astra-Zeneca (HSS). Molndal, Sweden; Alexander von Humboldt Foundation (HSS), Germany; University Grants Commission, Govt. of India, New Delhi (HSS/AS), Amity Science & Technology Foundation, New Delhi, India (AS/HSS), Indian Medical Research Council (HSS), Govt. of India, New Delhi, Department of Science & Technology, Govt. of India (HSS/AS); SAIOTEK and IT491-10 (Basque Gov.), Spain (JV) is gratefully acknowledged. Technical assistance of Mari-Anne Carlsson, Ingmarie Olsson, Karstin Flink, Margaretta Butler of Uppsala University is highly appreciated. The authors have no conflict of interest with any financial agencies mentioned above.	Berger M, 2006, MILITARY NANOTECHNOL; Beurskens-Comuth PAWV, 2011, ANN OCCUP HYG, V55, P937, DOI 10.1093/annhyg/mer060; Bi R, 2009, J BIOMED NANOTECHNOL, V5, P84, DOI 10.1166/jbn.2009.036; Chen X, 2008, TOXICOL LETT, V176, P1, DOI 10.1016/j.toxlet.2007.10.004; Chow JC, 2005, J AIR WASTE MANAGE, V55, P1411, DOI 10.1080/10473289.2005.10464743; Ding CN, 2005, J NEUROIMMUNOL, V161, P61, DOI 10.1016/j.jneuroim.2004.12.011; Drews G., 2010, PFLUGERS ARCH; Eisen EA, 2011, J OCCUP ENVIRON MED, V53, pS57, DOI 10.1097/JOM.0b013e31821bde98; Fenoglio I, 2006, FREE RADICAL BIO MED, V40, P1227, DOI 10.1016/j.freeradbiomed.2005.11.010; Glaser N, 2009, PEDIATR DIABETES, V10, P534, DOI 10.1111/j.1399-5448.2009.00511.x; Heng BC, 2011, ARCH TOXICOL, V85, P1517, DOI 10.1007/s00204-011-0722-1; Hillman KL, 2010, J NEUROSCI, V30, P7705, DOI 10.1523/JNEUROSCI.1273-10.2010; Hirano Seishiro, 2009, Environmental Health and Preventive Medicine, V14, P223, DOI 10.1007/s12199-008-0064-7; Hoffman WH, 2009, BRAIN RES, V1254, P138, DOI 10.1016/j.brainres.2008.11.100; Jachak A, 2011, NANOTOXICOLOGY; Jankord R, 2010, AM J PHYSIOL-REG I, V299, pR343, DOI 10.1152/ajpregu.00131.2010; Kelly E, 2010, EXPERT REV NEUROTHER, V10, P1045, DOI [10.1586/ern.10.81, 10.1586/ERN.10.81, 10.1586/ern.10.79]; Kim JH, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/50/505101; Kiyatkin EA, 2009, NEUROSCIENCE, V161, P926, DOI 10.1016/j.neuroscience.2009.04.004; Kiyatkin EA, 2007, EUR J NEUROSCI, V26, P1242, DOI 10.1111/j.1460-9568.2007.05741.x; Kiyatkin EA, 2009, INT REV NEUROBIOL, V88, P65, DOI 10.1016/S0074-7742(09)88004-5; Konczol M, 2011, CHEM RES TOXICOL, V24, P1460, DOI 10.1021/tx200051s; Kreyling Wolfgang G, 2009, Inhal Toxicol, V21 Suppl 1, P55, DOI 10.1080/08958370902942517; Leppanen M., 2011, NANOTOXICOLOGY; Li N, 2011, J OCCUP ENVIRON MED, V53, pS74, DOI 10.1097/JOM.0b013e31821b1bf2; Li PA, 1998, BRAIN RES, V804, P36, DOI 10.1016/S0006-8993(98)00651-9; Long TC, 2006, ENVIRON SCI TECHNOL, V40, P4346, DOI 10.1021/es060589n; Lucchini RG, 2011, NEUROTOXICOLOGY; Manna SK, 2005, NANO LETT, V5, P1676, DOI 10.1021/nl0507966; Muresanu DF, 2007, ANN NY ACAD SCI, V1122, P1, DOI 10.1196/annals.1403.001; Muresanu DF, 2010, ANN NY ACAD SCI, V1199, P15, DOI 10.1111/j.1749-6632.2009.05328.x; Muresanu DF, 2010, ACTA NEUROCHIR SUPPL, V106, P327, DOI 10.1007/978-3-211-98811-4_61; Oberdorster G, 2009, J NANOSCI NANOTECHNO, V9, P4996, DOI 10.1166/jnn.2009.GR02; Oberdorster G, 2010, J INTERN MED, V267, P89, DOI 10.1111/j.1365-2796.2009.02187.x; OLSSON Y, 1990, ACTA NEUROPATHOL, V79, P595, DOI 10.1007/BF00294236; Peters A, 2011, J OCCUP ENVIRON MED, V53, pS8, DOI 10.1097/JOM.0b013e31821ad5c0; PETTERSSON CAV, 1990, ACTA NEUROPATHOL, V81, P148, DOI 10.1007/BF00334503; Powers CM, 2010, ENVIRON HEALTH PERSP, V118, P73, DOI 10.1289/ehp.0901149; Rahman MF, 2009, TOXICOL LETT, V187, P15, DOI 10.1016/j.toxlet.2009.01.020; Rushton EK, 2010, J TOXICOL ENV HEAL A, V73, P445, DOI 10.1080/15287390903489422; Schubauer-Berigan MK, 2011, J OCCUP ENVIRON MED, V53, pS62, DOI 10.1097/JOM.0b013e31821b1e2c; Sharma H. S., 2009, HDB NEUROCHEMISTRY M, P363, DOI DOI 10.1007/978-0-387-30375-8_17; Sharma HS, 2009, INT REV NEUROBIOL, V88, P297, DOI 10.1016/S0074-7742(09)88011-2; Sharma HS, 2009, J NANOSCI NANOTECHNO, V9, P5014, DOI 10.1166/jnn.2009.GR04; Sharma HS, 2009, J NANOSCI NANOTECHNO, V9, P5055, DOI 10.1166/jnn.2009.GR09; Sharma HS, 2009, J CHEM NEUROANAT, V37, P18, DOI 10.1016/j.jchemneu.2008.08.002; Sharma HS, 2007, ANN NY ACAD SCI, V1122, P197, DOI 10.1196/annals.1403.014; Sharma HS, 2007, NANOMEDICINE-UK, V2, P753, DOI 10.2217/17435889.2.6.753; Sharma HS, 2007, PROG BRAIN RES, V162, P245, DOI 10.1016/S0079-6123(06)62013-X; Sharma HS, 2007, CURR PHARM DESIGN, V13, P1903; Sharma HS, 2012, WIRES NANOMED NANOBI, V4, P184, DOI 10.1002/wnan.172; Sharma HS, 2011, J NANOSCI NANOTECHNO, V11, P7549, DOI 10.1166/jnn.2011.5114; Sharma HS, 2011, J NEURAL TRANSM, V118, P155, DOI 10.1007/s00702-010-0514-4; Sharma HS, 2010, J NANOSCI NANOTECHNO, V10, P7931, DOI 10.1166/jnn.2010.3616; Sharma HS, 2010, BRAIN PROTECTION IN SCHIZOPHRENIA, MOOD AND COGNITIVE DISORDERS, P243, DOI 10.1007/978-90-481-8553-5_9; Sharma HS, 2009, PROG BRAIN RES, V180, P155, DOI 10.1016/S0079-6123(08)80009-X; Sharma Hari Shanker, 2010, Nanomedicine (Lond), V5, P533, DOI 10.2217/nnm.10.25; Sharma HS, 2010, ACTA NEUROCHIR SUPPL, V106, P351, DOI 10.1007/978-3-211-98811-4_64; Sharma HS, 2010, ACTA NEUROCHIR SUPPL, V106, P359, DOI 10.1007/978-3-211-98811-4_65; Sharma HS, 2010, ACTA NEUROCHIR SUPPL, V106, P61, DOI 10.1007/978-3-211-98811-4_10; Sharma HS, 2009, J NANOSCI NANOTECHNO, V9, P5073, DOI 10.1166/jnn.2009.GR10; Sharma HS, 2009, J NANOSCI NANOTECHNO, V9, P4970, DOI 10.1166/jnn.2009.1717; Sharma HS, 2009, J NANOSCI NANOTECHNO, V9, P4992, DOI 10.1166/jnn.2009.GR01; Sharma HS, 2008, ANN NY ACAD SCI, V1139, P242, DOI 10.1196/annals.1432.052; SHARMA HS, 1990, BRAIN RES, V517, P215, DOI 10.1016/0006-8993(90)91029-G; Sharma HS, 2006, J NEURAL TRANSM, V113, P521, DOI 10.1007/s00702-005-0405-2; Sharma HS, 1998, PROG BRAIN RES, V115, P351; SHARMA HS, 1986, NEUROPHARMACOLOGY, V25, P161, DOI 10.1016/0028-3908(86)90037-7; SHARMA HS, 1987, NEUROPHARMACOLOGY, V26, P85, DOI 10.1016/0028-3908(87)90049-9; Sharma HS, 2009, PROG BRAIN RES, V180, P1; SHARMA HS, 1991, NEUROREPORT, V2, P155, DOI 10.1097/00001756-199103000-00012; Sharma HS, 2002, AMINO ACIDS, V23, P261, DOI 10.1007/s00726-001-0137-z; Sharma HS, 1997, ANN NY ACAD SCI, V813, P559, DOI 10.1111/j.1749-6632.1997.tb51747.x; SHARMA HS, 1990, ACT NEUR S, V51, P383; SHARMA HS, 1987, BRAIN RES, V424, P153, DOI 10.1016/0006-8993(87)91205-4; SHARMA HS, 1988, NEUROSCI RES, V5, P224, DOI 10.1016/0168-0102(88)90051-X; SHARMA HS, 1992, NEUROSCIENCE, V50, P445, DOI 10.1016/0306-4522(92)90436-6; SHARMA HS, 1990, ACTA NEUROPATHOL, V79, P604, DOI 10.1007/BF00294237; Sheikpranbabu S, 2010, BIOMATERIALS, V31, P2260, DOI 10.1016/j.biomaterials.2009.11.076; Shvedova AA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P23, DOI 10.1023/B:BIRY.0000016347.35373.39; Sonaje K, 2010, BIOMATERIALS, V31, P3384, DOI 10.1016/j.biomaterials.2010.01.042; Song YG, 2011, THESCIENTIFICWORLDJO, V11, P1821, DOI 10.1100/2011/794801; Stone V, 2006, NAT NANOTECHNOL, V1, P23, DOI 10.1038/nnano.2006.69; Sun J, 2011, CELL BIOL TOXICOL, V27, P333, DOI 10.1007/s10565-011-9191-9; Sun SP, 2010, J MICROENCAPSUL, V27, P471, DOI 10.3109/02652040903515490; Ting JHY, 2006, CURR GENE THER, V6, P193, DOI 10.2174/156652306776359487; van Berlo D, 2010, ARCH TOXICOL, V84, P553, DOI 10.1007/s00204-010-0551-7; Vanwinkle BA, 2009, NANOTOXICOLOGY, V3, P307, DOI 10.3109/17435390903121949; Win-Shwe TT, 2009, INHAL TOXICOL, V21, P828, DOI 10.1080/08958370802538068; Yuen N, 2008, DIABETES, V57, P2588, DOI 10.2337/db07-1410; Zhang L, 2011, NANOTOXICOLOGY; Zhang R., 2011, J HAZARD MAT	92	17	19	0	17	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets	FEB	2012	11	1					26	39					14	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	934MW	WOS:000303449400005	22229323				2022-02-06	
J	Agbeko, RS; Pearson, S; Peters, MJ; McNames, J; Goldstein, B				Agbeko, Rachel S.; Pearson, Sean; Peters, Mark J.; McNames, James; Goldstein, Brahm			Intracranial pressure and cerebral perfusion pressure responses to head elevation changes in pediatric traumatic brain injury	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						brain injury; intracranial pressure; cerebral perfusion pressure; child; head of bed elevation	BODY POSITION; HYPERTENSION; MANAGEMENT; CHILDREN; OUTFLOW; SYSTEM; CPP; ICP	Objectives: To determine the effect of and dynamic interaction between head elevation on intracranial pressure and cerebral perfusion pressure in severe pediatric traumatic head injury. Design: Prospective, randomized, interventional cohort study. Setting: Two tertiary pediatric critical care referral units. Patients: Ten children admitted with severe traumatic brain injury defined as Glasgow Coma Score <= 8 necessitating intracranial pressure monitoring (10 yrs +/- 5 SD; range 2-16 yrs). Interventions: Head elevation was randomly increased or decreased between 0 and 40 degrees from baseline level (30 degrees) in increments or decrements of 10 degrees. Measurements and Main Results: Intracranial pressure and arterial blood pressure were continuously recorded in combination with time-stamped clinical notations. Data were available for analysis in eight subjects (seven males and one female; mean age, 10 yrs +/- SD 5; range, 2-16 yrs) during 18 protocol sessions. This resulted in a total of 66 head-of-the-bed challenges. To compare results for a given change in head-of-the-bed elevation across age, we transformed head-of-the-bed angle to change in height (cm) at the level of Monro's foramen. An increase in head elevation of 10 cm resulted in an average change in intracranial pressure of -3.9 mm Hg (SD +/- 3.2 mm Hg; p < .001), whereas cerebral perfusion pressure remained unchanged (0.1 +/- 5.6 mm Hg; p = .957). Individual subjects showed marked variability in intracranial pressure change (range, -8.4 to +1.9 mm Hg/10 cm). The overall regression analysis for intracranial pressure response was change in intracranial pressure = -0.39/cm Delta h, r(2) = 0.42, and p < .001, where Delta h is the change in vertical height at the level of foramen of Monro attributable to a change in the head of the bed. Conclusions: In severe pediatric traumatic brain injury, the relationship between change in head of the bed and change in intracranial pressure was negative and linear. The lowest intracranial pressure was usually, but not always, achieved at highest head-of-the-bed angles. The effect size of a head-of-the-bed angle change depended, in part, on the subject's height. In contrast, cerebral perfusion pressure was mostly unaffected by head-of-the-bed changes. (Pediatr Crit Care Med 2012; 13:e39-e47)	[Goldstein, Brahm] Ikaria Inc, Clinton, NJ USA; [Agbeko, Rachel S.] Newcastle Hosp NHS Fdn Trust, Great N Childrens Hosp, Paediat Intens Care Unit, Newcastle Upon Tyne, Tyne & Wear, England; [Peters, Mark J.] UCL, Crit Care Grp 9RSA, Portex Unit, Inst Child Hlth, London, England; [Pearson, Sean; McNames, James] Portland State Univ, Dept Elect & Comp Engn, Portland, OR 97207 USA; [Peters, Mark J.] Great Ormond St Hosp NHS Trust, Paediat Intens Care Unit, London, England		Goldstein, B (corresponding author), Ikaria Inc, Clinton, NJ USA.	brahm.goldstein@ikaria.com	Peters, Mark/AAD-7518-2019	Peters, Mark/0000-0003-3653-4808	Thrasher Research Fund; Department of Health's NIHR Biomedical Research CentreNational Institute for Health Research (NIHR); Special Trustees Great Ormond Street Hospital	Supported, in part, by the Thrasher Research Fund.; This work was undertaken at Great Ormond Street Hospital/UCL Institute of Child Health, which received a proportion of funding from the Department of Health's NIHR Biomedical Research Centre's funding scheme.; Rachel S. Agbeko was supported by the Special Trustees Great Ormond Street Hospital. The remaining authors have not disclosed any potential conflicts of interest.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS31; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS25; Brady KM, 2009, PEDIATRICS, V124, pE1205, DOI 10.1542/peds.2009-0550; Carter BG, 2008, CHILD NERV SYST, V24, P245, DOI 10.1007/s00381-007-0461-z; Chambers IR, 2005, CHILD NERV SYST, V21, P195, DOI 10.1007/s00381-004-1060-x; Cunitz G, 1994, INT S INTR PRESS NAG, P674; DURWARD QJ, 1983, J NEUROSURG, V59, P938, DOI 10.3171/jns.1983.59.6.0938; EMERY JR, 1983, J PEDIATR-US, V103, P950, DOI 10.1016/S0022-3476(83)80728-8; FELDMAN Z, 1992, J NEUROSURG, V76, P207, DOI 10.3171/jns.1992.76.2.0207; Huh JW, 2003, CRIT CARE MED, V31, pA91; Jones HA, 2009, NURS CRIT CARE, V14, P303, DOI 10.1111/j.1478-5153.2009.00352.x; KENNING JA, 1981, SURG NEUROL, V15, P148, DOI 10.1016/0090-3019(81)90037-9; Lovell AT, 2000, ANESTH ANALG, V90, P372, DOI 10.1097/00000539-200002000-00025; MAGNAES B, 1976, J NEUROSURG, V44, P687, DOI 10.3171/jns.1976.44.6.0687; MARMAROU A, 1975, J NEUROSURG, V43, P523, DOI 10.3171/jns.1975.43.5.0523; McCann YG, 2001, CHEST, V120, P1322, DOI 10.1378/chest.120.4.1322; Meixensberger J, 1997, NEUROL RES, V19, P249, DOI 10.1080/01616412.1997.11740808; Munis JR, 2000, J NEUROSURG ANESTH, V12, P290, DOI 10.1097/00008506-200007000-00029; Ng I, 2004, NEUROSURGERY, V54, P593, DOI 10.1227/01.NEU.0000108639.16783.39; ROPPER AH, 1982, NEUROLOGY, V32, P1288, DOI 10.1212/WNL.32.11.1288; ROSNER MJ, 1986, J NEUROSURG, V65, P636, DOI 10.3171/jns.1986.65.5.0636; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; SCHNEIDER GH, 1993, ACTA NEUROCHIR, P107; Schulz-Stubner S, 2006, EUR J ANAESTH, V23, P177, DOI 10.1017/S0265021505232118; Segui-Gomez M, 2003, EPIDEMIOL REV, V25, P3, DOI 10.1093/epirev/mxg007; Vinecore K, 2007, PEDIATR CRIT CARE ME, V8, P563, DOI 10.1097/01.PCC.0000288715.66726.64; White H, 2008, ANESTH ANALG, V107, P979, DOI 10.1213/ane.0b013e31817e7b1a; Winkelman C, 2000, Am J Crit Care, V9, P373; Winkelman C., 2000, AM J CRIT CARE, V9, P381; WOISCHNECK D, 1992, J NEUROSURG, V77, P651	31	17	18	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JAN	2012	13	1					E39	E47		10.1097/PCC.0b013e31820ac2ad			9	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	875YT	WOS:000299073000007	21242856				2022-02-06	
J	Antonini, TN; Raj, SP; Oberjohn, KS; Wade, SL				Antonini, Tanya N.; Raj, Stacey P.; Oberjohn, Karen S.; Wade, Shari L.			An online positive parenting skills programme for paediatric traumatic brain injury: feasibility and parental satisfaction	JOURNAL OF TELEMEDICINE AND TELECARE			English	Article							CHILD INTERACTION THERAPY; YOUNG-CHILDREN; EFFICACY; BEHAVIOR; OUTCOMES	We examined the feasibility of and parental satisfaction with a training programme for parents with children who had suffered traumatic brain injury (TBI). Families who did not have a home computer and/or webcam were loaned the necessary equipment. Skype was used for videoconferencing. After the initial treatment session in the family's home, the remaining nine sessions were conducted online. Each session had two parts: (1) a self-guided web session with information about a particular skill; (2) a videoconference session with the therapist. Three of the 20 families (15%) dropped out prior to the final 6-month follow-up visit. Of the remaining 17 families, 13 (65% of those enrolled) completed 9-14 sessions. Almost all of the caregivers (87%) said that the Skype sessions were helpful compared to a conventional office visit. Almost all parents were satisfied with the programme and the technology that was used. Parental satisfaction with the programme was not influenced by prior computer ownership or comfort with technology. The programme appears to be feasible for a wide range of parents of children with TBI and provides an alternative to conventional office-based sessions that may not be accessible to all families.	[Antonini, Tanya N.; Raj, Stacey P.; Oberjohn, Karen S.; Wade, Shari L.] Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA; [Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Antonini, Tanya N.] Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA; [Raj, Stacey P.] Miami Univ, Dept Psychol, Oxford, OH 45056 USA		Wade, SL (corresponding author), Childrens Hosp, Med Ctr, 3333 Burnet Ave,ML 4009, Cincinnati, OH 45229 USA.	shari.wade@cchmc.org			National Institute on Disability and Rehabilitation Research, Department of Education [H133G060167, H133B090010]	The work was supported by grants H133G060167 and H133B090010 from the National Institute on Disability and Rehabilitation Research, Department of Education. Part of this work was presented at the 2011 annual meeting of the Society for Computers in Psychology in Seattle, Washington and at the 2011 Federal Interagency Conference on Traumatic Brain Injury in Washington, DC.	Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Bodenmann G, 2008, BEHAV RES THER, V46, P411, DOI 10.1016/j.brat.2008.01.001; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Eyberg S., 1988, CHILD FAMILY BEHAV T, V10, P33, DOI [10.1300/J019v10n01_04, DOI 10.1300/J019V10N01_04]; Feeney T, 2006, BRAIN INJURY, V20, P629, DOI 10.1080/02699050600744194; JENNETT B, 1975, LANCET, V1, P480; Kaminski JW, 2008, J ABNORM CHILD PSYCH, V36, P567, DOI 10.1007/s10802-007-9201-9; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Newman MG, 2004, J CLIN PSYCHOL, V60, P141, DOI 10.1002/jclp.10240; Ruskin PE, 2004, AM J PSYCHIAT, V161, P1471, DOI 10.1176/appi.ajp.161.8.1471; Schuhmann EM, 1998, J CLIN CHILD PSYCHOL, V27, P34, DOI 10.1207/s15374424jccp2701_4; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wade SL, 2009, J HEAD TRAUMA REHAB, V24, P239, DOI 10.1097/HTR.0b013e3181ad6680; Wade SL, 1996, J LEARN DISABIL, V29, P652, DOI 10.1177/002221949602900609; Webster-Stratton C, 2008, J CHILD PSYCHOL PSYC, V49, P471, DOI 10.1111/j.1469-7610.2007.01861.x; Werba BE, 2006, BEHAV MODIF, V30, P618, DOI 10.1177/0145445504272977	18	17	17	2	16	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1357-633X	1758-1109		J TELEMED TELECARE	J. Telemed. Telecare		2012	18	6					333	338		10.1258/jtt.2012.120404			6	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	014KU	WOS:000309375400006	22941332				2022-02-06	
J	Carlson, KF; Meis, LA; Jensen, AC; Simon, AB; Gravely, AA; Taylor, BC; Bangerter, A; Schaaf, KW; Griffin, JM				Carlson, Kathleen F.; Meis, Laura A.; Jensen, Agnes C.; Simon, Alisha Baines; Gravely, Amy A.; Taylor, Brent C.; Bangerter, Ann; Schaaf, Katy Wilder; Griffin, Joan M.			Caregiver Reports of Subsequent Injuries Among Veterans With Traumatic Brain Injury After Discharge From Inpatient Polytrauma Rehabilitation Programs	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						caregivers; health services; rehabilitation; traumatic brain injury; trauma; injury	RISK; MORTALITY; BEHAVIOR; DEATH; INDIVIDUALS; CHILDREN; OUTCOMES; BURDEN; CARE	Objective: We examined prevalence of, and potential risk factors for, nonfatal injuries among Veterans with traumatic brain injury (TBI) postdischarge from Veterans Affairs inpatient polytrauma rehabilitation programs. Methods: We surveyed caregivers of patients who had military service anytime from 2001 to 2009, sustained polytrauma including TBI, received Veterans Affairs inpatient care from 2001 to 2009, were discharged at least 3 months before the study, and were alive when the study was fielded about caregiver and patient health, including patients' medically treated "accidents/new injuries" since discharge. We examined prevalence and source(s) of subsequent injuries and estimated patients' injury risk in reference to hypothesized risk factors. Odds ratios and 95% confidence intervals were calculated using multivariate logistic regression. Results: Caregivers reported that nearly one-third (32%) of patients incurred medically treated injuries after discharge; most were associated with falls (49%) and motor vehicles (37%). Odds of subsequent injury were associated with select demographics, initial injury characteristics, and postdischarge health and functioning. Characteristics of caregivers, including physical and mental health, were also associated with patients' odds of subsequent injury. Conclusions: A significant number of caregivers reported subsequent nonfatal injuries among patients treated for TBI/polytrauma in inpatient rehabilitation settings. Enhanced injury prevention efforts may be beneficial for this population.	[Carlson, Kathleen F.] Portland VA Med Ctr, Portland Ctr Study Chron Comorbid Mental & Phys D, Portland, OR USA; [Carlson, Kathleen F.] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97201 USA; [Meis, Laura A.; Jensen, Agnes C.; Simon, Alisha Baines; Gravely, Amy A.; Taylor, Brent C.; Bangerter, Ann; Griffin, Joan M.] Minneapolis VA Hlth Care Syst, Ctr Chron Dis Outcomes Res, Minneapolis, MN USA; [Taylor, Brent C.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Meis, Laura A.; Taylor, Brent C.; Griffin, Joan M.] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; [Schaaf, Katy Wilder] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Sch Med, Neuropsychol & Rehabil Psychol Serv, Richmond, VA USA; [Schaaf, Katy Wilder] Hunter Holmes McGuire VA Med Ctr, Richmond, VA USA		Carlson, KF (corresponding author), Portland VA Med Ctr R&D 66, Portland Ctr Study Chron Comorbid Mental & Phys D, 3715 SW US Vet Hosp Rd, Portland, OR 97239 USA.	kathleen.carlson@va.gov	Taylor, Brent C/A-8069-2009	Taylor, Brent C/0000-0002-2140-8377	Veterans Health Administration Health Services Research and Development ServiceUS Department of Veterans Affairs [SDR 07-044, CDA 08-025]	This work was supported by grants from the Veterans Health Administration Health Services Research and Development Service (SDR 07-044; CDA 08-025). The opinions expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government.	Adams Patricia F, 2009, Vital Health Stat 10, P1; Anderson MI, 2009, BRAIN INJURY, V23, P931, DOI 10.3109/02699050903302336; Brophy M, 2008, EPIDEMIOLOGY, V19, P465, DOI 10.1097/EDE.0b013e31816932ba; Brotherton SS, 2007, SPINAL CORD, V45, P37, DOI 10.1038/sj.sc.3101909; Carlson KF, 2011, INJURY PREV, V17, P343, DOI 10.1136/ip.2010.030213; Carlson KF, 2005, AM J IND MED, V47, P254, DOI 10.1002/ajim.20135; Carruth A K, 2001, J Am Med Womens Assoc (1972), V56, P15; Centers for Disease Control and Prevention, 2008, BEH RISK FACT SURV S; Chen JR, 2007, PEDIATRICS, V119, pE958, DOI [10.1542/peds.2006-1605, 10.1542/peds.2006-2140]; CHRISTOFFEL T, 2006, INJURY PREVENTION PU; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dischinger PC, 2001, J TRAUMA, V51, P877, DOI 10.1097/00005373-200111000-00009; Friedemann-Sanchez G, 2008, REHABIL NURS, V33, P206, DOI 10.1002/j.2048-7940.2008.tb00229.x; Gentilello LM, 1999, ANN SURG, V230, P473, DOI 10.1097/00000658-199910000-00003; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Griffin JM, J HEAD TRAUMA REHABI; Hall C, 2010, J GEN INTERN MED, V25, P18, DOI 10.1007/s11606-009-1125-3; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Hernan MA, 2002, AM J EPIDEMIOL, V155, P176, DOI 10.1093/aje/155.2.176; Hoffer Michael E, 2007, Int Tinnitus J, V13, P69; Johnston BD, 2002, PEDIATRICS, V110, P267, DOI 10.1542/peds.110.2.267; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kazis LE, 2006, VETERANS RAND 12 ITE; Krause JS, 2010, ARCH PHYS MED REHAB, V91, P1741, DOI 10.1016/j.apmr.2010.07.219; Krause JS, 2004, ARCH PHYS MED REHAB, V85, P1503, DOI 10.1016/j.apmr.2004.01.017; Krause JS, 2000, ARCH PHYS MED REHAB, V81, P924, DOI 10.1053/apmr.2000.5618; LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; National Alliance for Caregiving AARP, 2010, CAR US 2009; Pentland B, 2005, J NEUROL NEUROSUR PS, V76, P395, DOI 10.1136/jnnp.2004.037861; Preece MHW, 2011, J NEUROL NEUROSUR PS, V82, P447, DOI 10.1136/jnnp.2010.215228; Probst C, 2009, J TRAUMA, V66, P1212, DOI 10.1097/TA.0b013e318197b97c; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Schanke AK, 2008, J REHABIL MED, V40, P733, DOI 10.2340/16501977-0256; Schwebel DC, 2010, J PEDIATR PSYCHOL, V35, P45, DOI 10.1093/jpepsy/jsp033; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; Sigford BJ, 2008, ARCH PHYS MED REHAB, V89, P160, DOI 10.1016/j.apmr.2007.09.015; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Sohn Min-Woong, 2006, Popul Health Metr, V4, P2, DOI 10.1186/1478-7954-4-2; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; van Ryn M, 2011, PSYCHO-ONCOLOGY, V20, P44, DOI 10.1002/pon.1703; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Vladutiu CJ, 2008, INJURY PREV, V14, P302, DOI 10.1136/ip.2008.018838; WAXWEILER RJ, 1995, J NEUROTRAUM, V12, P509, DOI 10.1089/neu.1995.12.509; Weightman MM, 2010, J HEAD TRAUMA REHAB, V25, P206, DOI 10.1097/HTR.0b013e3181dc82d3; WEISBESKI D, 1989, J TRAUMA, V29, P940, DOI 10.1097/00005373-198907000-00006; Williams GP, 2010, J HEAD TRAUMA REHAB, V25, P164, DOI 10.1097/HTR.0b013e3181dc120b; Wright J, 2000, INTRO FIM TM	50	17	17	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2012	27	1					14	25		10.1097/HTR.0b013e318236bd86			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	879JV	WOS:000299326400002	22218200				2022-02-06	
J	Hawley, CA				Hawley, Carol A.			Self-esteem in children after traumatic brain injury: An exploratory study	NEUROREHABILITATION			English	Article						Self-esteem; paediatrics; brain injury; stress	ACADEMIC-ACHIEVEMENT; BEHAVIOR; SCHOOL; DEPRESSION	Children with a traumatic brain injury (TBI) often have difficulties in adjusting to their injury and altered abilities, and may be at risk of low self-esteem and loss of confidence. However, few studies have examined self-esteem in this client group. The current study measured the self-esteem of a group of children who were, on average, two years post-TBI and compared this to their performance on other psychometric measures. Participants were 96 children with TBI and 31 peer controls, their parents and teachers. Self-esteem was measured using the Coopersmith Self-esteem Inventory (CSEI). CSEI scores were compared with performance on Wechsler Intelligence Scales (WISC-III), Hospital Anxiety and Depression Scale (HADS); Children's Memory Scale (CMS), Vineland Adaptive Behaviour Scales (VABS) and Parental Stress Index (PSI). Self-esteem was highly correlated with IQ; HADS anxiety and depression; and parental stress (p < 0.001). Children with TBI had significantly lower self-esteem than controls and population norms (p = 0.015). Many children with TBI demonstrate low self-esteem and this is closely linked with anxiety and depression. This may hamper academic performance and could lead to further psychosocial problems. It is recommended that self-esteem is routinely assessed after brain injury and rehabilitation strategies implemented to promote a sense of self-worth.	Univ Warwick, Warwick Med Sch, Div Mental Hlth & Wellbeing, Coventry CV4 7AL, W Midlands, England		Hawley, CA (corresponding author), Univ Warwick, Warwick Med Sch, Div Mental Hlth & Wellbeing, Coventry CV4 7AL, W Midlands, England.	c.a.hawley@warwick.ac.uk	Hawley, Carol/AAG-3830-2019				Abidin, 1995, PARENTING STRESS IND; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; Appleton R, 1998, MANAGEMENT BRAIN INJ; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; *BRIT SOC REH MED, 1998, REH TRAUM BRAIN INJ; Ciccetti D., 1984, VINELAND ADAPTIVE BE; Cobb J. C., 1998, CHILD STUDY J, V28, P291; COHEN B, 1997, CHILDRENS MEMORY SCA; Coopersmith, 1967, ANTECEDENTS SELF EST; Coopersmith S., 1981, SELF ESTEEM INVENTOR; Eccles JS, 1999, FUTURE CHILD, V9, P30, DOI 10.2307/1602703; FELSON RB, 1989, J MARRIAGE FAM, V51, P727, DOI 10.2307/352171; GECAS V, 1986, J MARRIAGE FAM, V48, P37, DOI 10.2307/352226; Gillett J, 2004, NEUROREHABILITATION, V19, P207; Glia F., 2010, J CHILD FAM STUD, V19, P738; Harter S., 1999, CONSTRUCTION SELF; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Marsh HW, 2008, PERS SOC PSYCHOL B, V34, P542, DOI 10.1177/0146167207312313; MARSH HW, 1988, J EDUC PSYCHOL, V80, P366, DOI 10.1037/0022-0663.80.3.366; Meyer A., 1983, TOPICS LEARNIGN LEAR, V3, P59; Miller P., 2002, THEORIES DEV PSYCHOL; Nilsson KK, 2010, BIPOLAR DISORD, V12, P585, DOI 10.1111/j.1399-5618.2010.00856.x; OPENSHAW DK, 1984, J EARLY ADOLESC, V4, P259; Orth U, 2008, J PERS SOC PSYCHOL, V95, P695, DOI 10.1037/0022-3514.95.3.695; Ross CE, 2000, SOCIOL EDUC, V73, P270, DOI 10.2307/2673234; Sigelman C., 2003, LIFE SPAN HUMAN DEV; Stanley PD, 1997, J ADOLESCENCE, V20, P219, DOI 10.1006/jado.1996.0079; Taylor LM, 2010, EDUC PSYCHOL-UK, V30, P191, DOI 10.1080/01443410903494478; Townsend P, 1986, INEQUALITIES HLTH NO; TREMBLAY RE, 1992, J CONSULT CLIN PSYCH, V60, P64, DOI 10.1037/0022-006X.60.1.64; Wechsler D., 1991, MANUAL WECHSLER INTE, V3rd; Ylvisaker M. E., 1998, TRAUMATIC BRAIN INJU; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	37	17	17	3	22	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2012	30	3					173	181		10.3233/NRE-2012-0742			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	948CD	WOS:000304480300003	22635121	Green Submitted			2022-02-06	
J	Hayes, JP; Morey, RA; Tupler, LA				Hayes, Jasmeet Pannu; Morey, Rajendra A.; Tupler, Larry A.			A case of frontal neuropsychological and neuroimaging signs following multiple primary-blast exposure	NEUROCASE			English	Article						Blast-induced neurotrauma; Closed-head injury; Diffusion-tensor imaging; Executive control; Explosive Ordnance Disposal Service; Fractional anisotropy; Primary blast; Traumatic brain injury; White matter	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; VERBAL-LEARNING TEST; AXONAL INJURY; HEAD-INJURY; PERFORMANCE; SOLDIERS; CONCUSSION; DEFICITS; RISK	Blast-related traumatic brain injury (TBI) from the Afghanistan and Iraq wars represents a significant medical concern for troops and veterans. To better understand the consequences of primary-blast injury in humans, we present a case of a Marine exposed to multiple primary blasts during his 14-year military career. The neuropsychological profile of this formerly high-functioning veteran suggested primarily executive dysfunction. Diffusion-tensor imaging revealed white-matter pathology in long fiber tracks compared with a composite fractional-anisotropy template derived from a veteran reference control group without TBI. This study supports the existence of primary blast-induced neurotrauma in humans and introduces a neuroimaging technique with potential to discriminate multiple-blast TBI.	[Hayes, Jasmeet Pannu] VA Boston Healthcare Syst, Natl Ctr PTSD, Boston, MA 02130 USA; [Hayes, Jasmeet Pannu] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Hayes, Jasmeet Pannu; Morey, Rajendra A.] Duke Univ, Duke UNC Brain Imaging & Anal Ctr, Durham, NC USA; [Hayes, Jasmeet Pannu; Morey, Rajendra A.; Tupler, Larry A.] Durham VA Med Ctr, Mental Illness Res Educ & Clin Ctr Postdeployment, Durham, NC USA; [Hayes, Jasmeet Pannu; Morey, Rajendra A.; Tupler, Larry A.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA		Hayes, JP (corresponding author), VA Boston Healthcare Syst, Natl Ctr PTSD 116B 2, 150 S Huntington Ave, Boston, MA 02130 USA.	jphayes@bu.edu	Hayes, Jasmeet/AAN-4150-2020; Morey, Rajendra A/P-3079-2018	Hayes, Jasmeet/0000-0002-5157-0666; Morey, Rajendra A/0000-0002-6517-6969	 [NIMH K23 MH084013];  [K23 MH073091];  [VHA 101RX000389];  [VISN6 MIRECC]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K23MH073091, K23MH084013] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX000389] Funding Source: NIH RePORTER	We would like to thank J.G. for sharing his story with us, Elizabeth Selgrade and Gregory McCarthy for helpful discussions regarding the project, and Christopher Lascola for providing a neuroradiology consult. We would also like to acknowledge the contributions of the Mid-Atlantic Mental Illness Research, Education, and Clinical Center workgroup (members include Jean C. Beckham, Patrick S. Calhoun, Rita M. Davison, A. Meade Eggleston, John A. Fairbank, Kimberly T. Green, Angela C. Kirby, Harold Kudler, Jeffrey M. Hoerle, Christine E. Marx, Scott D. Moore, Victoria Payne, Mary C. Pender, Jennifer L. Strauss, Kristy K. Straits-Troster, and Richard D. Weiner). This work was supported by grants NIMH K23 MH084013 and K23 MH073091, VHA 101RX000389, and the VISN6 MIRECC. The views expressed herein are those of the authors and do not necessarily reflect the views of the Department of Veterans Affairs.	Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Benzinger TLS, 2009, J NEUROTRAUM, V26, P2127, DOI [10.1089/neu.2009.0885, 10.1089/neu.2009-0885]; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Bigler ED, 2010, NEUROLOGY, V74, P626, DOI 10.1212/WNL.0b013e3181d3e43a; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Brewin CR, 2007, J ABNORM PSYCHOL, V116, P448, DOI 10.1037/0021-843X.116.3.448; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; Chappell MH, 2008, MAGN RESON IMAGING, V26, P1398, DOI 10.1016/j.mri.2008.04.004; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Clausen H, 2005, BRIT J SPORT MED, V39, P661, DOI 10.1136/bjsm.2004.017046; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; Dedert EA, 2009, J PSYCHIATR RES, V43, P830, DOI 10.1016/j.jpsychires.2009.01.004; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Di Russo F, 2010, PSYCHOPHYSIOLOGY, V47, P425, DOI 10.1111/j.1469-8986.2009.00950.x; DREW RH, 1986, J CLIN PSYCHOL, V42, P520, DOI 10.1002/1097-4679(198605)42:3<520::AID-JCLP2270420319>3.0.CO;2-6; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Finkel MF, 2006, J NEUROL SCI, V249, P63, DOI 10.1016/j.jns.2006.06.005; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Gaylord KM, 2008, J TRAUMA, V64, pS200, DOI 10.1097/TA.0b013e318160ba42; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Hogan J., 1985, PSYCHOL PHYS PERFORM; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hurley RA, 2004, J NEUROPSYCH CLIN N, V16, P1, DOI 10.1176/appi.neuropsych.16.1.1; Kinnunen K., 2010, BRAIN; Kizilbash AH, 2002, ARCH CLIN NEUROPSYCH, V17, P57, DOI 10.1016/S0887-6177(00)00101-3; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lew HL, 2005, AM J PHYS MED REHAB, V84, P393, DOI 10.1097/01.phm.0000163703.91647.a7; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Madrid R., 1992, INN APPL ART INT SAN; Martin EM, 2008, AM J NURS, V108, P40, DOI 10.1097/01.NAJ.0000315260.92070.3f; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MCLATCHIE G, 1987, J NEUROL NEUROSUR PS, V50, P96, DOI 10.1136/jnnp.50.1.96; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; POLLOCK BE, 1995, NEUROSURGERY, V36, P215, DOI 10.1227/00006123-199501000-00036; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; Power JD, 2010, NEURON, V67, P735, DOI 10.1016/j.neuron.2010.08.017; Rosso SM, 2003, J NEUROL NEUROSUR PS, V74, P1574, DOI 10.1136/jnnp.74.11.1574; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Stuhmiller J, 1991, TXB MILITARY MED CON; Sweet JJ, 2000, ARCH CLIN NEUROPSYCH, V15, P105, DOI 10.1016/S0887-6177(98)00153-X; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Vanden Brook T, 2009, US TODAY; Warden DL, 2009, NEUROIMAGE, V47, pT152, DOI 10.1016/j.neuroimage.2009.01.060; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925; Wightman JM, 2001, ANN EMERG MED, V37, P664, DOI 10.1067/mem.2001.114906; Yilmaz S, 2007, AM J EMERG MED, V25, P97, DOI 10.1016/j.ajem.2006.04.014; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161; Zhang L, 2006, AM J NEURORADIOL, V27, P2000; Zoroya G, 2010, US TODAY	65	17	17	0	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1355-4794	1465-3656		NEUROCASE	Neurocase		2012	18	3					258	269		10.1080/13554794.2011.588181			12	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	936BH	WOS:000303565400009	21879996	Green Accepted, Green Submitted			2022-02-06	
J	Kuni, BJ; Banwell, BL; Till, C				Kuni, Bravina J.; Banwell, Brenda L.; Till, Christine			Cognitive and Behavioral Outcomes in Individuals With a History of Acute Disseminated Encephalomyelitis (ADEM)	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							PERFORMANCE-TEST PERFORMANCE; TRAUMATIC BRAIN-INJURY; MULTIPLE-SCLEROSIS; CHILDREN; FEATURES; DEFICITS; IMPACT; MRI; AGE; MS	We describe cognitive and behavioral outcomes in 12 males and 7 females diagnosed with acute disseminated encephalomyelitis (ADEM) in childhood. Age at assessment ranged from 6 to 23 years and all participants were at least 2 years post-ADEM presentation (mean 5.4 years). Performance was compared with 18 control subjects. Three of 19 ADEM patients met criteria for cognitive impairment, defined as performance falling <= 1.5 SD on at least three tests. Age at ADEM-onset was not associated with outcome. Despite the transient nature of the illness and absence of persistent physical disability, cognitive sequelae occur in some individuals following childhood ADEM.	[Kuni, Bravina J.; Till, Christine] York Univ, Dept Psychol, Toronto, ON M3J 1P3, Canada; [Banwell, Brenda L.; Till, Christine] Univ Toronto, Hosp Sick Children, Neurosci & Mental Hlth Program, Toronto, ON M5G 1X8, Canada; [Banwell, Brenda L.] Univ Toronto, Hosp Sick Children, Div Neurol, Toronto, ON M5G 1X8, Canada		Till, C (corresponding author), York Univ, Dept Psychol, 4700 Keele St, Toronto, ON M3J 1P3, Canada.	ctill@yorku.ca		Till, Christine/0000-0001-5030-3155	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Multiple Sclerosis Society of Canada; Canadian Multiple Sclerosis Scientific Research Foundation	Funding for this research was provided in part by the Canadian Institutes of Health Research (CIHR), Multiple Sclerosis Society of Canada, and the Canadian Multiple Sclerosis Scientific Research Foundation. No conflict of interest is declared.	Anderson PJ, 2004, DEV MED CHILD NEUROL, V46, P230, DOI [10.1017/S0012162204000386, 10.1017/S001212204000386]; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Banwell B, 2009, NEUROLOGY, V72, P232, DOI 10.1212/01.wnl.0000339482.84392.bd; BEERY KE, 1997, BEERY BUKTENICA DEV; Callen DJA, 2009, NEUROLOGY, V72, P968, DOI 10.1212/01.wnl.0000338630.20412.45; Conners C. K., 2000, CONNERS CONTINUOUS P; Conners CK, 2003, J ABNORM CHILD PSYCH, V31, P555, DOI 10.1023/A:1025457300409; Dale RC, 2000, BRAIN, V123, P2407, DOI 10.1093/brain/123.12.2407; Deery B, 2010, DEV NEUROPSYCHOL, V35, P506, DOI 10.1080/87565641.2010.494921; Edgin JO, 2008, J INT NEUROPSYCH SOC, V14, P90, DOI 10.1017/S1355617708080053; Epstein JN, 2003, J ABNORM CHILD PSYCH, V31, P543, DOI 10.1023/A:1025405216339; Gioia GA, 2005, PSYCHOL ASSESS RESOU; Gioia GA IP, 2000, BEHAV RATING INVENTO; Hahn CD, 2003, PEDIATR NEUROL, V29, P117, DOI 10.1016/S0887-8994(03)00143-7; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Hynson JL, 2001, NEUROLOGY, V56, P1308, DOI 10.1212/WNL.56.10.1308; Idrissova ZR, 2003, EUR J NEUROL, V10, P537, DOI 10.1046/j.1468-1331.2003.00639.x; Ingraham LJ, 1996, NEUROPSYCHOLOGY, V10, P120, DOI 10.1037/0894-4105.10.1.120; Jacobs RK, 2004, PEDIATR NEUROL, V31, P191, DOI 10.1016/j.pediatrneurol.2004.03.008; Jayakrishnan MP, 2010, J PEDIATR NEUROSCI, V5, P111, DOI 10.4103/1817-1745.76098; Krupp LB, 2007, NEUROLOGY, V68, pS7, DOI 10.1212/01.wnl.0000259422.44235.a8; Morey L.C., 2007, PERSONALITY ASSESSME; Mulhern RK, 2001, J CLIN ONCOL, V19, P472, DOI 10.1200/JCO.2001.19.2.472; Murthy SNK, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.2.e21; Pohl D, 2007, NEUROLOGY, V68, pS54, DOI 10.1212/01.wnl.0000259407.40023.ab; Reddick WE, 2006, CANCER-AM CANCER SOC, V106, P941, DOI 10.1002/cncr.21679; Reitan R, 1959, MANUAL ADM SCORING T; REYNOLDS C. R., 2007, TEST MEMORY LEARNING; Reynolds C. R., 2004, BEHAV ASSESSMENT SYS, V2nd; Rostasy K, 2009, NEUROPEDIATRICS, V40, P211, DOI 10.1055/s-0030-1247518; Ryland H. K., 2010, CHILD ADOLESCENT PSY, V4, P1; Smith A., 1991, SYMBOL DIGIT MODALIT; Tenembaum S, 2002, NEUROLOGY, V59, P1224, DOI 10.1212/WNL.59.8.1224; Till C, 2011, NEUROPSYCHOLOGY, V25, P319, DOI 10.1037/a0022051; Varier S, 2011, J INT NEUROPSYCH SOC, V17, P1030, DOI 10.1017/S1355617711000993; Wechsler D., 2011, WECHSLER ABBREVIATED; Woodcock R. W., 2001, WOODCOCK JOHNSON 3 N; Woodcock RW, 2007, WOODCOCK JOHNSON 3 W; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Young NP, 2008, SEMIN NEUROL, V28, P84, DOI 10.1055/s-2007-1019130	40	17	17	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.		2012	37	8					682	696		10.1080/87565641.2012.690799			15	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	041NE	WOS:000311407700003	23145566				2022-02-06	
J	Leibowitz, A; Klin, Y; Gruenbaum, BF; Gruenbaum, SE; Kuts, R; Dubilet, M; Ohayon, S; Boyko, M; Sheiner, E; Shapira, Y; Zlotnik, A				Leibowitz, Akiva; Klin, Yael; Gruenbaum, Benjamin F.; Gruenbaum, Shaun E.; Kuts, Ruslan; Dubilet, Michael; Ohayon, Sharon; Boyko, Matthew; Sheiner, Eyal; Shapira, Yoram; Zlotnik, Alexander			Effects of strong physical exercise on blood glutamate and its metabolite 2-ketoglutarate levels in healthy volunteers	ACTA NEUROBIOLOGIAE EXPERIMENTALIS			English	Article						exercise; glutamate; hyperthermia; muscle damage; neurotoxicity; stress	TRAUMATIC BRAIN-INJURY; HUMAN HEAD-INJURY; EXCITATORY AMINO-ACIDS; CEREBROSPINAL-FLUID; ISCHEMIC-STROKE; CREATINE-PHOSPHOKINASE; SCAVENGING ACTIVITY; RELEASE; STRESS; PLASMA	Excessive concentrations of L-glutamate (glutamate) have been found to posses neurotoxic properties. This study investigates how stress induced by strong physical exercise effects blood glutamate, 2-ketoglutarate, Alanine aminotransferase (ALT) and Aspartate Aminotransferase (AST) levels. The relationship between muscle damage caused by strong physical exercise and blood glutamate levels was also examined. Twenty-two healthy volunteers engaged in intense veloergometry ("spinning") for a duration of 60 minutes. Two 10 minute peaks of extremely intense exercise were performed at 10 minutes and 50 minutes after the start of exercise. After 60 minutes of exercise, volunteers were monitored for an additional 180 minutes in resting conditions. Blood samples for determination of glutamate and 2-ketoglutarate levels were collected prior to exercise and then every 30 min for entire experiment. Blood samples were also taken at those time points to measure glutamate, 2-ketoglutarate, AST, ALT, creatine phosphokinase (CPK), myoglobin, lactate and venous blood gas levels. Blood glutamate levels were significantly elevated throughout the exercise session (P<0.001) and then returned to baseline levels at the cessation of exercise. 2-ketoglutarate, a product of glutamate metabolism, reached significantly elevated levels at 30 minutes (P<0.01) from the start of exercise and remained elevated up to 240 minutes post exercise initiation (P<0.001). AST and ALT levels were elevated at 60 minutes when compared to baseline. AST levels remained elevated at 240 minutes, unlike ALT levels which returned to baseline values at 240 minutes. Strong physical exercise leads to a significant elevation in blood glutamate, most likely as a result of skeletal muscle damage. 2-ketoglutarate was also found to be elevated for long periods of time, reflecting an ongoing process of glutamate breakdown. Elevated concentrations of AST and ALT in plasma reflect the importance of these enzymes in the maintenance of stable blood glutamate concentrations.	[Leibowitz, Akiva; Gruenbaum, Benjamin F.; Kuts, Ruslan; Dubilet, Michael; Ohayon, Sharon; Boyko, Matthew; Shapira, Yoram; Zlotnik, Alexander] Ben Gurion Univ Negev, Soroka Univ, Dept Anesthesiol & Crit Care, Med Ctr, IL-84105 Beer Sheva, Israel; [Klin, Yael] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Gruenbaum, Shaun E.] Yale Univ, Sch Med, Dept Anesthesiol, New Haven, CT 06510 USA; [Sheiner, Eyal] Ben Gurion Univ Negev, Soroka Univ, Dept Obstet & Gynecol, Med Ctr, IL-84105 Beer Sheva, Israel		Leibowitz, A (corresponding author), Ben Gurion Univ Negev, Soroka Univ, Dept Anesthesiol & Crit Care, Med Ctr, IL-84105 Beer Sheva, Israel.	akival@bgu.ac.il	SHEINER, EYAL/F-1488-2012	Boyko, Matthew/0000-0003-3116-1643; Leibowitz, Akiva/0000-0003-4244-1915			APPLE JK, 1993, J ANIM SCI, V71, P71, DOI 10.2527/1993.71171x; Arakawa H, 1997, J PHARMACOL EXP THER, V280, P1296; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; BERL S, 1961, J NEUROCHEM, V7, P186, DOI 10.1111/j.1471-4159.1961.tb13503.x; BLOMSTRAND E, 1988, ACTA PHYSIOL SCAND, V133, P115, DOI 10.1111/j.1748-1716.1988.tb08388.x; Blomstrand E, 2009, AMINO ACIDS, V37, P629, DOI 10.1007/s00726-008-0182-y; Boyko M, 2012, NEUROCHEM RES, V37, P2198, DOI 10.1007/s11064-012-0843-9; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Camacho A, 2006, ARCH MED RES, V37, P11, DOI 10.1016/j.arcmed.2005.05.014; Castillo J, 1997, LANCET, V349, P79, DOI 10.1016/S0140-6736(96)04453-4; Castillo J, 1996, STROKE, V27, P1060, DOI 10.1161/01.STR.27.6.1060; Castillo J, 2002, NEUROLOGY, V58, P624, DOI 10.1212/WNL.58.4.624; Chio A, 2009, AMYOTROPH LATERAL SC, V10, P205, DOI 10.1080/17482960902721634; Cohen-Kashi-Malina K, 2012, J CEREBR BLOOD F MET, V32, P177, DOI 10.1038/jcbfm.2011.121; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Davalos A, 1997, STROKE, V28, P708, DOI 10.1161/01.STR.28.4.708; Espey MG, 2002, NEUROLOGY, V58, P1439, DOI 10.1212/WNL.58.9.1439; Fu FH, 2002, PERCEPT MOTOR SKILL, V95, P1171, DOI 10.2466/PMS.95.8.1171-1178; Gottlieb M, 2003, J NEUROCHEM, V87, P119, DOI 10.1046/j.1471-4159.2003.01972.x; GRAHAM LT, 1966, ANAL BIOCHEM, V15, P487, DOI 10.1016/0003-2697(66)90110-2; Hammarqvist F, 2001, CLIN PHYSIOL, V21, P44, DOI 10.1046/j.1365-2281.2001.00291.x; Hediger MA, 1999, AM J PHYSIOL-RENAL, V277, pF477, DOI 10.1152/ajprenal.1999.277.4.F477; Helms HC, 2012, GLIA, V60, P882, DOI 10.1002/glia.22321; Johnston MV, 2001, PEDIATR RES, V49, P735, DOI 10.1203/00006450-200106000-00003; KAYASHIMA S, 1995, EUR J APPL PHYSIOL O, V70, P413, DOI 10.1007/BF00618492; Klin Y, 2010, BIOCHEM BIOPH RES CO, V399, P694, DOI 10.1016/j.bbrc.2010.07.144; Koura SS, 1998, ACT NEUR S, V71, P244; Kratz A, 2002, AM J CLIN PATHOL, V118, P856, DOI 10.1092/BTWQ5YMYVQ67QK9L; Leibowitz A, 2012, INT J MOL SCI, V13, P10041, DOI 10.3390/ijms130810041; MARLISS EB, 1971, J CLIN INVEST, V50, P814, DOI 10.1172/JCI106552; MELTZER HY, 1971, AM J PHYSIOL, V221, P896, DOI 10.1152/ajplegacy.1971.221.3.896; Mitani H, 2006, PROG NEURO-PSYCHOPH, V30, P1155, DOI 10.1016/j.pnpbp.2006.03.036; MUKHERJEE K, 1987, AVIAT SPACE ENVIR MD, V58, P18; Newsholme EA, 1996, EXPERIENTIA, V52, P413, DOI 10.1007/BF01919308; O'Callaghan RM, 2007, BEHAV BRAIN RES, V176, P362, DOI 10.1016/j.bbr.2006.10.018; O'Kane RL, 1999, J BIOL CHEM, V274, P31891, DOI 10.1074/jbc.274.45.31891; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Paul P, 2012, AMINO ACIDS, V43, P1823, DOI 10.1007/s00726-012-1385-9; Resende NM, 2011, OMICS, V15, P695, DOI 10.1089/omi.2011.0010; Richards DA, 2003, PHARMACOL RES, V48, P101, DOI 10.1016/S1043-6618(03)00081-1; Rose ME, 2002, BRAIN RES, V943, P15, DOI 10.1016/S0006-8993(02)02471-X; ROSS JH, 1983, Q J MED, V52, P268; ROTI S, 1981, J SPORT MED PHYS FIT, V21, P113; SEN CK, 1992, J APPL PHYSIOL, V73, P1265, DOI 10.1152/jappl.1992.73.4.1265; Sen P., 1992, Indian Journal of Experimental Biology, V30, P1170; Serena J, 2001, STROKE, V32, P1154, DOI 10.1161/01.STR.32.5.1154; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Sutedja NA, 2009, AMYOTROPH LATERAL SC, V10, P295, DOI 10.3109/17482960802430799; Teichberg VI, 2009, NEUROSCIENCE, V158, P301, DOI 10.1016/j.neuroscience.2008.02.075; Tong LQ, 2001, NEUROBIOL DIS, V8, P1046, DOI 10.1006/nbdi.2001.0427; Tran TY, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E8; Vesce S, 2007, INT REV NEUROBIOL, V82, P57, DOI 10.1016/S0074-7742(07)82003-4; Wu CW, 2008, J APPL PHYSIOL, V105, P1585, DOI 10.1152/japplphysiol.90775.2008; Yamamoto T, 1999, ACT NEUR S, V75, P17; Yan B, 2009, J APPL PHYSIOL, V106, P531, DOI 10.1152/japplphysiol.90816.2008; Zauner A, 1996, ACT NEUR S, V67, P40; Zhang H, 2001, CLIN CHEM, V47, P1458; Zlotnik A, 2008, NEUROCHEM RES, V33, P1044, DOI 10.1007/s11064-007-9548-x; Zlotnik A, 2007, EXP NEUROL, V203, P213, DOI 10.1016/j.expneurol.2006.08.021; Zlotnik A, 2012, ANESTHESIOLOGY, V116, P73, DOI 10.1097/ALN.0b013e31823d7731; Zlotnik A, 2012, INTENS CARE MED, V38, P137, DOI 10.1007/s00134-011-2401-3; Zlotnik A, 2011, NEUROCHEM RES, V36, P732, DOI 10.1007/s11064-010-0388-8; Zlotnik A, 2010, ANESTH ANALG, V111, P1497, DOI 10.1213/ANE.0b013e3181fc0112; Zlotnik A, 2010, EXP NEUROL, V224, P465, DOI 10.1016/j.expneurol.2010.05.009; Zlotnik A, 2009, J NEUROSURG ANESTH, V21, P235, DOI 10.1097/ANA.0b013e3181a2bf0b	66	17	18	1	8	NENCKI INST EXPERIMENTAL BIOLOGY	WARSAW	UL PASTEURA 3, 02-093 WARSAW, POLAND	0065-1400			ACTA NEUROBIOL EXP	Acta Neurobiol. Exp.		2012	72	4					385	396					12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	087CI	WOS:000314738500007	23377269				2022-02-06	
J	Lewis, JD; Wassermann, EM; Chao, WD; Ramage, AE; Robin, DA; Clauw, DJ				Lewis, Jeffrey D.; Wassermann, Eric M.; Chao, Wendy; Ramage, Amy E.; Robin, Donald A.; Clauw, Daniel J.			Central sensitization as a component of post-deployment syndrome	NEUROREHABILITATION			English	Article						Chronic widespread pain; post-deployment; mild traumatic brain injury	CHRONIC-FATIGUE-SYNDROME; IRRITABLE-BOWEL-SYNDROME; PERSIAN-GULF-WAR; POSTINJURY PAIN HYPERSENSITIVITY; POSTTRAUMATIC-STRESS-DISORDER; CHRONIC WIDESPREAD PAIN; POSTCONCUSSIVE SYMPTOMS; FIBROMYALGIA SYNDROME; MUSCULOSKELETAL PAIN; SOMATIC SYMPTOMS	Many service members and veterans report chronic unexplained symptoms such as pain, fatigue and memory complaints, which have most recently been characterized as post-deployment syndrome (PDS). Chronic widespread pain is a component of this syndrome, producing significant disability and considerable health care costs. The similarity between the nature of these complaints and other medically unexplained illnesses such as fibromyalgia, irritable bowel syndrome, and chronic fatigue syndrome suggest that they may share a common mechanism. Here, we provide support for PDS as a consequence of pain and sensory amplification secondary to neuroplastic changes within the central nervous system, a phenomenon often termed central sensitization. We also discuss how factors such as stress and genetics may promote chronic widespread pain in veterans and service members who develop PDS.	[Lewis, Jeffrey D.; Wassermann, Eric M.] NINDS, Behav Neurol Unit, Bethesda, MD 20892 USA; [Lewis, Jeffrey D.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Chao, Wendy] Brooke Army Med Ctr, Dept Neurol, Ft Sam Houston, TX 78234 USA; [Ramage, Amy E.] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA; [Robin, Donald A.] Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, San Antonio, TX 78229 USA; [Clauw, Daniel J.] Univ Michigan, Chron Pain & Fatigue Ctr, Ann Arbor, MI 48109 USA		Wassermann, EM (corresponding author), Behav Neurol Univ, NINDS, 10 Ctr Dr,MSC 1440,Bldg 10,Room 7D43, Bethesda, MD 20892 USA.	Wassermanne@ninds.nih.gov	Wassermann, Eric M./AAC-9064-2020; Ramage, Amy/S-9227-2018	Wassermann, Eric M./0000-0003-0628-0210; Ramage, Amy/0000-0001-8554-555X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [ZIANS002977] Funding Source: NIH RePORTER; Intramural NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [Z99 NS999999] Funding Source: Medline		Ablin JN, 2010, CLIN EXP RHEUMATOL, V28, pS15; Ablin K, 2009, RHEUM DIS CLIN N AM, V35, P233, DOI 10.1016/j.rdc.2009.06.006; Afari N, 2003, AM J PSYCHIAT, V160, P221, DOI 10.1176/appi.ajp.160.2.221; Association A. P., 1994, DIAGN STAT MAN MENT; Azari P, 2012, CNS DRUGS, V26, P215, DOI 10.2165/11595200-000000000-00000; Benison AM, 2011, J NEUROSCI, V31, P6317, DOI 10.1523/JNEUROSCI.0076-11.2011; Bonds T., 2010, ARMY DEPLOYMENTS OIF; Brody AL, 2001, BIOL PSYCHIAT, V50, P171, DOI 10.1016/S0006-3223(01)01117-9; Buskila D, 2008, AUTOIMMUN REV, V8, P41, DOI 10.1016/j.autrev.2008.07.023; Choy E, 2011, SEMIN ARTHRITIS RHEU, V41, P335, DOI 10.1016/j.semarthrit.2011.06.003; Cifu D, 2011, OVERCOMING POSTDEPLO; Cifu D. X., 2011, COMMUNICATION; Clauw D, 2003, BMJ-BRIT MED J, V327, P1357, DOI 10.1136/bmj.327.7428.1357; Cook DB, 2010, J PAIN, V11, P764, DOI 10.1016/j.jpain.2009.11.010; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Dunphy RC, 2003, PAIN, V102, P79, DOI 10.1016/S0304-3959(02)00342-1; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; Fulton J. F., 1942, NEW ENGL J MED, V226, P1; Gale JD, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00028; Garza Ivan, 2006, Neuropsychiatr Dis Treat, V2, P281, DOI 10.2147/nedt.2006.2.3.281; Geisser ME, 2008, J PAIN, V9, P417, DOI 10.1016/j.jpain.2007.12.006; Geisser ME, 2008, PSYCHOSOMATICS, V49, P235, DOI 10.1176/appi.psy.49.3.235; Gironda RJ, 2006, PAIN MED, V7, P339, DOI 10.1111/j.1526-4637.2006.00146.x; GOLDENBERG DL, 1987, JAMA-J AM MED ASSOC, V257, P2782, DOI 10.1001/jama.257.20.2782; Gracely RH, 2002, ARTHRITIS RHEUM-US, V46, P1333, DOI 10.1002/art.10225; Green PG, 2011, J PAIN, V12, P811, DOI 10.1016/j.jpain.2011.01.006; Hassett AL, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3024; Helmer DA, 2009, PAIN MED, V10, P1174, DOI 10.1111/j.1526-4637.2009.00723.x; Hickie I, 2006, BRIT MED J, V333, P575, DOI 10.1136/bmj.38933.585764.AE; Hollins M, 2009, PAIN, V141, P215, DOI 10.1016/j.pain.2008.10.003; HOLMES GP, 1988, ANN INTERN MED, V108, P387, DOI 10.7326/0003-4819-108-3-387; Ismail K, 2008, PSYCHOL MED, V38, P953, DOI 10.1017/S0033291707001560; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Jason LA, 1999, ARCH INTERN MED, V159, P2129, DOI 10.1001/archinte.159.18.2129; Jones E, 2002, BMJ-BRIT MED J, V324, P321, DOI 10.1136/bmj.324.7333.321; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Jones G. T., 2011, ARTHRITIS CARE RES H; Kang HK, 2000, J OCCUP ENVIRON MED, V42, P491, DOI 10.1097/00043764-200005000-00006; Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Mailis A, 1997, PAIN, V70, P69, DOI 10.1016/S0304-3959(96)03300-3; Maixner W, 1995, PAIN, V63, P341, DOI 10.1016/0304-3959(95)00068-2; May A, 2008, PAIN, V137, P7, DOI 10.1016/j.pain.2008.02.034; McBeth J, 2001, RHEUMATOLOGY, V40, P95, DOI 10.1093/rheumatology/40.1.95; McFarlane AC, 2007, BEST PRACT RES CL RH, V21, P549, DOI 10.1016/j.berh.2007.03.008; McLean SA, 2005, PSYCHOSOM MED, V67, P783, DOI 10.1097/01.psy.0000181276.49204.bb; MERTZ H, 1995, GASTROENTEROLOGY, V109, P40, DOI 10.1016/0016-5085(95)90267-8; N-Hoffmant VLF, 2007, J PAIN, V8, P954, DOI 10.1016/j.jpain.2007.07.003; Naliboff BD, 2001, PSYCHOSOM MED, V63, P365, DOI 10.1097/00006842-200105000-00006; Obermann M, 2009, NEUROLOGY, V73, P978, DOI 10.1212/WNL.0b013e3181b8791a; Pae CU, 2009, EXPERT OPIN PHARMACO, V10, P1561, DOI 10.1517/14656560902988510; Rahimi R, 2009, WORLD J GASTROENTERO, V15, P1548, DOI 10.3748/wjg.15.1548; Raphael KG, 2002, PAIN, V100, P131, DOI 10.1016/S0304-3959(02)00273-7; Rau V, 2005, NEUROSCI BIOBEHAV R, V29, P1207, DOI 10.1016/j.neubiorev.2005.04.010; Ravindran MK, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-30; Reeser JC, 2011, PM&R, V3, P193, DOI 10.1016/j.pmrj.2010.12.009; Reid S, 2001, AM J EPIDEMIOL, V153, P604, DOI 10.1093/aje/153.6.604; Rodriguez-Raecke R, 2010, J NEUROSCI, V30, P11363, DOI 10.1523/JNEUROSCI.2197-10.2010; Soros P, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-48; Stimpson NJ, 2006, MIL MED, V171, P1181, DOI 10.7205/MILMED.171.12.1181; Turk DC, 2002, CLIN J PAIN, V18, P355, DOI 10.1097/00002508-200211000-00003; Unwin C, 1999, LANCET, V353, P169, DOI 10.1016/S0140-6736(98)11338-7; Valdes M, 2010, ARTHRITIS RHEUM-US, V62, P1829, DOI 10.1002/art.27430; Veterans Administration Office of Public Health and Environmental Hazards Briefing, 2010, AN VA HLTH CAR UT OP; Williams DA, 2003, JAMA-J AM MED ASSOC, V289, P1637, DOI 10.1001/jama.289.13.1637; Williams DA, 2003, BEST PRACT RES CL RH, V17, P649, DOI 10.1016/S1521-6942(03)00034-2; Williams DA, 2009, J PAIN, V10, P777, DOI 10.1016/j.jpain.2009.06.001; WOOLF CJ, 1983, NATURE, V306, P686, DOI 10.1038/306686a0; WOOLF CJ, 1991, PAIN, V44, P293, DOI 10.1016/0304-3959(91)90100-C; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Woolfolk RL, 2012, PAIN RES TREAT, V2012, DOI 10.1155/2012/937873; YUNUS M, 1981, SEMIN ARTHRITIS RHEU, V11, P151, DOI 10.1016/0049-0172(81)90096-2; Yunus M B, 1989, J Rheumatol Suppl, V19, P62; Yunus MB, 2007, SEMIN ARTHRITIS RHEU, V36, P339, DOI 10.1016/j.semarthrit.2006.12.009	76	17	17	0	10	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2012	31	4					367	372		10.3233/NRE-2012-00805			6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	052GV	WOS:000312186600004	23232159	Green Accepted			2022-02-06	
J	Morris, CE; Boucher, PA; Joos, B				Morris, Catherine E.; Boucher, Pierre-Alexandre; Joos, Bela			Left-shifted Nav channels in injured bilayer: primary targets for neuroprotective Nav antagonists?	FRONTIERS IN PHARMACOLOGY			English	Article						traumatic brain injury; spinal; riluzole; ranolazine; simulation; modeling	GATED SODIUM-CHANNELS; LIPID-COMPOSITION; NEUROPATHIC PAIN; DRUG-BINDING; TETRODOTOXIN; CHOLESTEROL; MODULATION; MECHANOSENSITIVITY; CONDUCTANCE; INHIBITION	Mechanical, ischemic, and inflammatory injuries to voltage-gated sodium channel (Nav)-rich membranes of axon initial segments and nodes of Ranvier render Nav channels dangerously leaky. By what means? The behavior of recombinant Nav1.6 (Wang et al., 2009) leads us to postulate that, in neuropathologic conditions, structural degradation of axolemmal bilayer fosters chronically left-shifted Nay channel operation, resulting in E-Na rundown. This "sick excitable cell Nav-leak" would encompass left-shifted fast- and slow-mode based persistent /(Na) (i.e., /(window) and slow-inactivating /(Na)). Bilayer-damage-induced electrophysiological dysfunctions of native-Nay channels, and effects on inhibitors on those channels, should, we suggest, be studied in myelinated axons, exploiting /(Na)(V, t) hysteresis data from sawtooth ramp clamp. We hypothesize that (like dihydropyridines for Ca channels), protective lipophilic Nay antagonists would partition more avidly into disorderly bilayers than into the well-packed bilayers characteristic of undamaged, healthy plasma membrane. Whereas inhibitors using aqueous routes would access all Navs equally, differential partitioning into "sick bilayer" would co-localize lipophilic antagonists with "sick-Nav channels," allowing for more specific targeting of impaired cells. Molecular fine-tuning of Nav antagonists to favor more avid partitioning into damaged than into intact bilayers could reduce side effects. In potentially salvageable neurons of traumatic and/or ischemic penumbras, in inflammatory neuropathies, in muscular dystrophy, in myocytes of cardiac infarct borders, Nav-leak driven excitotoxicity overwhelms cellular repair mechanisms. Precision-tuning of a lipophilic Nav antagonist for greatest efficacy in mildly damaged membranes could render it suitable for the prolonged continuous administration needed to allow for the remodeling of the excitable membranes, and thus functional recovery.	[Morris, Catherine E.] Ottawa Hosp Res Inst, Ottawa, ON K1H 8M5, Canada; [Boucher, Pierre-Alexandre; Joos, Bela] Univ Ottawa, Inst Phys Ottawa Carleton, Ottawa, ON, Canada		Morris, CE (corresponding author), Ottawa Hosp Res Inst, 450 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	cmorris@uottawa.ca		Joos, Bela/0000-0001-8576-5579; Morris, Catherine/0000-0002-7401-6545	NSERCNatural Sciences and Engineering Research Council of Canada (NSERC); CIHR, CanadaCanadian Institutes of Health Research (CIHR)	Support for this work is from NSERC and CIHR, Canada.	Ali MH, 2010, J PHARM PHARMACOL, V62, P1646, DOI 10.1111/j.2042-7158.2010.01090.x; Allen DG, 2011, INT J BIOCHEM CELL B, V43, P290, DOI 10.1016/j.biocel.2010.11.005; Antzelevitch C, 2011, HEART RHYTHM, V8, P1281, DOI 10.1016/j.hrthm.2011.03.045; Armstrong SC, 2001, J MOL CELL CARDIOL, V33, P1165, DOI 10.1006/jmcc.2001.1380; Ates O, 2007, J CLIN NEUROSCI, V14, P658, DOI 10.1016/j.jocn.2006.03.023; Baenziger JE, 2008, MOL PHARMACOL, V73, P880, DOI 10.1124/mol.107.039008; Banderali U, 2010, CHANNELS, V4, P12, DOI 10.4161/chan.4.1.10260; Benabdellah F, 2009, NEUROBIOL DIS, V36, P252, DOI 10.1016/j.nbd.2009.07.013; BENOIT E, 1991, PFLUG ARCH EUR J PHY, V419, P603, DOI 10.1007/BF00370302; Beyder A, 2010, J PHYSIOL-LONDON, V588, P4969, DOI 10.1113/jphysiol.2010.199034; Boucher P.-A., 2011, THESIS U OTTAWA OTTA; Boucher P. A., 2012, J COMPUT NE IN PRESS; Browne SE, 2006, NEUROBIOL DIS, V22, P599, DOI 10.1016/j.nbd.2006.01.001; Cadotte DW, 2011, CLIN ORTHOP RELAT R, V469, P732, DOI 10.1007/s11999-010-1674-0; Catterall WA, 2008, J NEUROSCI, V28, P11768, DOI 10.1523/JNEUROSCI.3901-08.2008; Charras GT, 2009, J CELL SCI, V122, P3233, DOI 10.1242/jcs.049262; Chatelier A., 2010, PFLUGERS ARCH, V460, P1; Chen SB, 2011, J NEUROSCI METH, V195, P222, DOI 10.1016/j.jneumeth.2010.12.018; Chisari M, 2009, J NEUROPHYSIOL, V102, P1254, DOI 10.1152/jn.00346.2009; Coggan JS, 2010, P NATL ACAD SCI USA, V107, P20602, DOI 10.1073/pnas.1013798107; CONTI F, 1976, J PHYSIOL-LONDON, V262, P729, DOI 10.1113/jphysiol.1976.sp011617; Dib-Hajj SD, 2010, NEUROSCI LETT, V486, P84, DOI 10.1016/j.neulet.2010.08.077; Dong CJ, 2005, DOC OPHTHALMOL, V110, P15, DOI 10.1007/s10633-005-7339-8; Douglas HA, 2011, J NEUROPHYSIOL, V105, P1482, DOI 10.1152/jn.00817.2010; Eckford PDW, 2008, BIOCHEMISTRY-US, V47, P13686, DOI 10.1021/bi801409r; Finol-Urdaneta RK, 2010, BIOPHYS J, V98, P762, DOI 10.1016/j.bpj.2009.10.053; Fu Y, 2011, J PHYSIOL-LONDON, V589, P525, DOI 10.1113/jphysiol.2010.199430; Haeseler G, 2008, CRIT CARE MED, V36, P1239, DOI 10.1097/CCM.0b013e31816a02cf; Henry MA, 2009, J PAIN, V10, P750, DOI 10.1016/j.jpain.2009.01.264; HERBETTE LG, 1989, J MOL CELL CARDIOL, V21, P187, DOI 10.1016/0022-2828(89)90861-4; Hirn C, 2008, J GEN PHYSIOL, V132, P199, DOI 10.1085/jgp.200810024; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Jastrzebska B, 2011, PROG LIPID RES, V50, P267, DOI 10.1016/j.plipres.2011.03.002; Jo S, 2011, MOL PHARMACOL, V80, P247, DOI 10.1124/mol.110.070276; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; Khanal G, 2011, ANALYST, V136, P3519, DOI 10.1039/c0an00845a; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Kole MHP, 2011, NEURON, V71, P671, DOI 10.1016/j.neuron.2011.06.024; Krepkiy D, 2009, NATURE, V462, P473, DOI 10.1038/nature08542; Kuwabara S, 2006, CLIN NEUROPHYSIOL, V117, P810, DOI 10.1016/j.clinph.2005.11.018; Kuwabara Satoshi, 2008, Curr Mol Pharmacol, V1, P61; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Lenkey N, 2011, NEUROPHARMACOLOGY, V60, P191, DOI 10.1016/j.neuropharm.2010.08.005; Letienne R, 2009, EUR J PHARMACOL, V624, P16, DOI 10.1016/j.ejphar.2009.09.032; Levental I, 2011, P NATL ACAD SCI USA, V108, P11411, DOI 10.1073/pnas.1105996108; Lin W, 2007, BIOPHYS J, V92, P1559, DOI 10.1529/biophysj.106.092478; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lombardi D, 2009, EUR J PHARM SCI, V38, P533, DOI 10.1016/j.ejps.2009.10.001; Lopez-Marques RL, 2011, BIOL CHEM, V392, P67, DOI 10.1515/BC.2011.015; Mantegazza M, 2010, LANCET NEUROL, V9, P413, DOI 10.1016/S1474-4422(10)70059-4; Martinez V, 2008, EUR J PAIN, V12, P934, DOI 10.1016/j.ejpain.2007.12.011; MASON RP, 1993, BIOCHEM PHARMACOL, V45, P2173, DOI 10.1016/0006-2952(93)90186-Z; MASON RP, 1992, MOL PHARMACOL, V41, P315; Maxwell WL, 1996, MICROSC RES TECHNIQ, V34, P522, DOI 10.1002/(SICI)1097-0029(19960815)34:6<522::AID-JEMT4>3.0.CO;2-L; McGinn MJ, 2009, J NEUROPATH EXP NEUR, V68, P241, DOI 10.1097/NEN.0b013e3181996bfe; Milescu M, 2009, NAT STRUCT MOL BIOL, V16, P1080, DOI 10.1038/nsmb.1679; MILTON RL, 1990, J NEUROSCI, V10, P885; Misawa S, 2009, J PERIPHER NERV SYST, V14, P279, DOI 10.1111/j.1529-8027.2009.00239.x; Morris C.E., 2011, CELL PHYSL SOURCE BO, P493; Morris C. E., 2011, CARDIAC MECHANOELECT, P43; Morris CE, 2007, BIOPHYS J, V93, P822, DOI 10.1529/biophysj.106.101246; Morris Catherine E., 2006, V322, P315; Morris CE, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00025; Morris CE, 2001, J MEMBRANE BIOL, V179, P79, DOI 10.1007/s002320010040; Muddana HS, 2012, BIOPHYS J, V102, P489, DOI 10.1016/j.bpj.2011.12.033; MUSTERS RJP, 1993, CIRC RES, V73, P514, DOI 10.1161/01.RES.73.3.514; Nesterenko VV, 2011, AM J PHYSIOL-HEART C, V301, pH1615, DOI 10.1152/ajpheart.00243.2011; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Novak KR, 2009, J CLIN INVEST, V119, P1150, DOI 10.1172/JCI36570; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; Pieri M, 2009, EXP NEUROL, V215, P368, DOI 10.1016/j.expneurol.2008.11.002; Rajendran L, 2010, NAT REV DRUG DISCOV, V9, P29, DOI 10.1038/nrd2897; Ritter AM, 2009, NEUROSCI LETT, V452, P28, DOI 10.1016/j.neulet.2008.12.051; Rusinova R, 2011, J GEN PHYSIOL, V138, P249, DOI 10.1085/jgp.201010529; Schafer DP, 2009, J NEUROSCI, V29, P13242, DOI 10.1523/JNEUROSCI.3376-09.2009; Schlegel RA, 2001, CELL DEATH DIFFER, V8, P551, DOI 10.1038/sj.cdd.4400817; Schmidt D, 2008, P NATL ACAD SCI USA, V105, P19276, DOI 10.1073/pnas.0810187105; Schwarz JR, 2006, J PHYSIOL-LONDON, V573, P17, DOI 10.1113/jphysiol.2006.106815; SCHWARZ JR, 1995, PFLUG ARCH EUR J PHY, V430, P283, DOI 10.1007/BF00374660; Shcherbatko A, 1999, BIOPHYS J, V77, P1945, DOI 10.1016/S0006-3495(99)77036-0; Sheetz MP, 2006, ANNU REV BIOPH BIOM, V35, P417, DOI 10.1146/annurev.biophys.35.040405.102017; Shevchenko A, 2010, NAT REV MOL CELL BIO, V11, P593, DOI 10.1038/nrm2934; Song JH, 1997, J PHARMACOL EXP THER, V282, P707; STYS PK, 1993, P NATL ACAD SCI USA, V90, P6976, DOI 10.1073/pnas.90.15.6976; Sun GC, 2006, ACTA PHARMACOL SIN, V27, P1537, DOI 10.1111/j.1745-7254.2006.00452.x; Tabarean IV, 1999, BIOPHYS J, V77, P758, DOI 10.1016/S0006-3495(99)76930-4; Taddese A, 2002, NEURON, V33, P587, DOI 10.1016/S0896-6273(02)00574-3; Tejwani RW, 2011, J PHARM SCI-US, V100, P2136, DOI 10.1002/jps.22441; Underhill SM, 2007, NEUROBIOL DIS, V25, P284, DOI 10.1016/j.nbd.2006.09.011; van Genderen HO, 2008, BBA-MOL CELL RES, V1783, P953, DOI 10.1016/j.bbamcr.2008.01.030; Villalba-Galea CA, 2008, P NATL ACAD SCI USA, V105, P17600, DOI 10.1073/pnas.0807387105; Vucic S, 2010, J NEUROL NEUROSUR PS, V81, P222, DOI 10.1136/jnnp.2009.183079; Wang JA, 2009, AM J PHYSIOL-CELL PH, V297, pC823, DOI 10.1152/ajpcell.00505.2008; Waxman SG, 2008, NAT CLIN PRACT NEURO, V4, P159, DOI 10.1038/ncpneuro0735; Webb J, 2009, PFLUG ARCH EUR J PHY, V457, P1253, DOI 10.1007/s00424-008-0600-8; Weiss S, 2010, BRIT J PHARMACOL, V160, P1072, DOI 10.1111/j.1476-5381.2010.00766.x; Weston RM, 2009, NEUROCHEM RES, V34, P1816, DOI 10.1007/s11064-009-0012-y; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161; Zhang JZ, 2007, BIOPHYS J, V92, P3988, DOI 10.1529/biophysj.106.102434; Zuliani V, 2010, EXPERT OPIN THER PAT, V20, P755, DOI 10.1517/13543771003774118	102	17	17	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1663-9812			FRONT PHARMACOL	Front. Pharmacol.		2012	3								19	10.3389/fphar.2012.00019			13	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	V35XE	WOS:000209177700019	22375118	Green Published, gold			2022-02-06	
J	Vakil, E				Vakil, Eli			Neuropsychological assessment: Principles, rationale, and challenges	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Neuropsychological; Assessment; Review	TRAUMATIC BRAIN-INJURY; MILD COGNITIVE IMPAIRMENT; FRONTAL-LOBE DAMAGE; SEVERE HEAD-INJURY; PREMORBID INTELLIGENCE; COMPUTERIZED ASSESSMENT; ECOLOGICAL VALIDITY; EXECUTIVE FUNCTION; VIRTUAL-REALITY; EVERYDAY MEMORY	Neuropsychological assessments are increasingly in demand for a wide range of patients. This paper offers a survey of the basic aspects of neuropsychological assessment that are of greatest importance for professionals (e. g., psychologists, psychiatrists, social workers, and lawyers) who are not trained in neuropsychological testing, but who refer clients for neuropsychological assessment. This survey could also serve neuropsychologists in their early stages of training, by addressing some of the major issues related to the assessment process. The range of goals that neuropsychological assessment may attain is first outlined. Next, a model is presented that explains the rationale enabling generalization from assessment to real-world functions that are the focus of interest and the target of prediction. Issues that need to be considered before deciding to conduct a neuropsychological evaluation are then introduced, and sources of information available to the assessor are described. A description is provided of what a neuropsychological assessment includes, with an emphasis on its cognitive aspects. Finally, mention is made of some of the difficulties and challenges that must be confronted in the course of a neuropsychological assessment.	[Vakil, Eli] Bar Ilan Univ, Dept Psychol, IL-52900 Ramat Gan, Israel; [Vakil, Eli] Bar Ilan Univ, Gonda Multidisciplinary Brain Res Ctr, IL-52900 Ramat Gan, Israel		Vakil, E (corresponding author), Bar Ilan Univ, Dept Psychol, IL-52900 Ramat Gan, Israel.	vakile@mail.biu.ac.il					ADAMS KM, 1985, J CONSULT CLIN PSYCH, V53, P790, DOI 10.1037/0022-006X.53.6.790; ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; *AM PSYCH ASS, 1986, GUID COMP BAS TESTS; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Baade LE, 2004, ARCH CLIN NEUROPSYCH, V19, P227, DOI 10.1016/S0887-6177(03)00092-1; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bercaw EL, 2011, CLIN NEUROPSYCHOL, V25, P72, DOI 10.1080/13854046.2010.532813; Bilder RM, 2011, J INT NEUROPSYCH SOC, V17, P7, DOI 10.1017/S1355617710001396; Bond M. R., 1986, NEUROPSYCHOLOGICAL A; BRANDT J, 1988, CLIN ASSESSMENT MALI; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Bruner J. S., 1957, CONT APPROACHES COGN, P41; Burgess P, 1996, BEHAV ASSESSMENT DYS; Cernich AN, 2007, ARCH CLIN NEUROPSYCH, V22, pS39, DOI 10.1016/j.acn.2006.10.004; Chaytor N, 2007, J INT NEUROPSYCH SOC, V13, P377, DOI 10.1017/S1355617707070592; Christensen AL, 1979, LURIAS NEUROPSYCHOLO; de Jager CA, 2003, PSYCHOL MED, V33, P1039, DOI 10.1017/S0033291703008031; Deb S, 1999, AM J PSYCHIAT, V156, P374; Dikmen SS, 1999, J INT NEUROPSYCH SOC, V5, P346, DOI 10.1017/S1355617799544056; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Erlanger DM, 2002, J HEAD TRAUMA REHAB, V17, P458, DOI 10.1097/00001199-200210000-00007; Evans CC, 2005, J HEAD TRAUMA REHAB, V20, P488, DOI 10.1097/00001199-200511000-00002; Farah MJ, 2003, INT J CLIN NEUROPSYC, V4th, P146; Feldstein SN, 1999, CLIN NEUROPSYCHOL, V13, P303, DOI 10.1076/clin.13.3.303.1744; Geary EK, 2011, J INT NEUROPSYCH SOC, V17, P709, DOI 10.1017/S1355617711000646; Geary EK, 2010, J INT NEUROPSYCH SOC, V16, P506, DOI 10.1017/S135561771000010X; Golden C. J., 1976, LURIA NEBRASKA NEURO; Greiffenstein M., 2008, CLIN NEUROPSYCHOL, V22, P1; Greiffenstein MF, 2002, PSYCHOL ASSESSMENT, V14, P202, DOI 10.1037//1040-3590.14.2.202; Hoofien D, 2000, J CLIN EXP NEUROPSYC, V22, P305, DOI 10.1076/1380-3395(200006)22:3;1-V;FT305; Jagaroo V, 2009, NEUROINFORMATICS FOR NEUROPSYCHOLOGY, P1, DOI 10.1007/978-1-4419-0060-9_1; JANOWSKY JS, 1989, BEHAV NEUROSCI, V103, P548, DOI 10.1037/0735-7044.103.3.548; Kaplan E, 1988, CLIN NEUROPSYCHOLOGY; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Lehrner J., 2008, EUROPEAN J GERIATRIC, V10, P59; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Long, 1996, ECOLOGICAL VALIDITY, P15; Luciana M, 2003, J CHILD PSYCHOL PSYC, V44, P649, DOI 10.1111/1469-7610.00152; Luis CA, 2011, INT J ALZHEIMERS DIS, V2011; Luria A.R., 1966, HIGHER CORTICAL FUNC; Mateer CA, 1996, J HEAD TRAUMA REHAB, V11, P1; MCCARTHY RA, 1990, COGNITIVE NEUROPSYCH; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Nelson AP, 2008, CNS SPECTRUMS, V13, P56, DOI 10.1017/S1092852900016163; Parkin A. J., 1997, MEMORY AMNESIA INTRO; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Quraishi S, 2002, J AFFECT DISORDERS, V72, P209, DOI 10.1016/S0165-0327(02)00091-5; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Reitan R M, 1989, Arch Clin Neuropsychol, V4, P385, DOI 10.1016/0887-6177(89)90029-2; Reitan RM, 2000, ARCH CLIN NEUROPSYCH, V15, P433, DOI 10.1016/S0887-6177(99)00038-4; Rizzo AA, 2004, NEUROPSYCHOL REHABIL, V14, P207, DOI 10.1080/09602010343000183; Robbins TW, 1998, J INT NEUROPSYCH SOC, V4, P474, DOI 10.1017/s1355617798455073; RUSSELL EW, 1995, NEUROPSYCHOL REV, V5, P1, DOI 10.1007/BF02214929; Schatz P, 2002, J HEAD TRAUMA REHAB, V17, P395, DOI 10.1097/00001199-200210000-00003; Schlegel RE, 2007, ARCH CLIN NEUROPSYCH, V22, pS49, DOI 10.1016/j.acn.2006.10.005; Schulenberg SE, 2004, COMPUT HUM BEHAV, V20, P477, DOI 10.1016/j.chb.2003.10.006; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P378, DOI 10.1097/00001199-200210000-00002; SCHWARTZ AF, 1989, CORTEX, V25, P665, DOI 10.1016/S0010-9452(89)80026-7; Selverstein SM, 2007, BEHAV RES METHODS, V39, P940, DOI 10.3758/BF03192989; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Shallice T, 1990, NEUROPSYCHOLOGY MENT; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Silver CH, 2000, J HEAD TRAUMA REHAB, V15, P973, DOI 10.1097/00001199-200008000-00002; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Teng E, 2009, DEMENT GERIATR COGN, V28, P168, DOI 10.1159/000235732; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; TRANEL D, 1994, HDB NEUROPSYCHOLOGY, P125; Vakil E, 1997, CLIN NEUROPSYCHOL, V11, P356, DOI 10.1080/13854049708400464; Vakil E., 2006, QUANTIFIED PROCESS A; Vakil E, 2010, CLIN NEUROPSYCHOL, V24, P662, DOI 10.1080/13854040903493522; Wechsler D, 1997, WESCHSLER ADULT INTE; WELSH MC, 1990, CHILD DEV, V61, P1697, DOI 10.1111/j.1467-8624.1990.tb03560.x; Wieshmann UC, 1999, LANCET, V353, P1242, DOI 10.1016/S0140-6736(99)00248-2; Wilson, 1993, APPL PREV PSYCHOL, V2, P209, DOI DOI 10.1016/S0962-1849(05)80091-5; WILSON B, 1989, J CLIN EXP NEUROPSYC, V11, P855, DOI 10.1080/01688638908400940; Wilson B., 1999, BEHAVIOURAL INATTENT BEHAV INATTENTION TE; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO; Wilson BA, 2000, J INT NEUROPSYCH SOC, V6, P469, DOI 10.1017/S1355617700644053; WILSON BA, 1991, NEUROPSYCHOLOGY, V5, P281; WILSON BA, 1991, NEUROPSYCHOL REHABIL, V1, P117, DOI DOI 10.1080/09602019108401386; Wolfson, 1993, HALSTEAD REITAN NEUR	90	17	20	1	38	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2012	34	2					135	150		10.1080/13803395.2011.623121			16	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	916EC	WOS:000302079900003	22087572				2022-02-06	
J	Wells, DL; Swanson, JM; Wood, GC; Magnotti, LJ; Boucher, BA; Croce, MA; Harrison, CG; Muhlbauer, MS; Fabian, TC				Wells, Diana L.; Swanson, Joseph M.; Wood, G. Christopher; Magnotti, Louis J.; Boucher, Bradley A.; Croce, Martin A.; Harrison, Charles G.; Muhlbauer, Michael S.; Fabian, Timothy C.			The relationship between serum sodium and intracranial pressure when using hypertonic saline to target mild hypernatremia in patients with head trauma	CRITICAL CARE			English	Article							BRAIN-INJURY; CEREBRAL EDEMA; MANNITOL; HYPERTENSION; MANAGEMENT; INFUSION; CHLORIDE; IMPACT	Introduction: Limited data suggest mild hypernatremia may be related to lower intracranial pressure (ICP) in patients with traumatic brain injury (TBI). The practice at the study center has been to use hypertonic saline (HTS) to generate a targeted serum sodium of 145 to 155 mEq/l in patients with TBI. The purpose of this study was to determine the relationship between serum sodium values and ICP, and to evaluate the acute effect of HTS on ICP. Methods: A retrospective review of patients who were admitted to the trauma ICU for TBI, had an ICP monitor placed, and received at least one dose of HTS between January 2006 and March 2011 was performed. Data were collected for up to 120 hours after ICP monitor placement. The primary outcome was the relationship between serum sodium and maximum ICP. Secondary outcomes were the relationship between serum sodium and the mean number of daily interventions for ICP control, and the acute effect of HTS on ICP during the 6 hours after each dose. Linear regression was used to analyze the primary outcome. Analysis of variance on ranks and repeated measures analysis of variance were used to evaluate the number of interventions and the acute effect of HTS on ICP, respectively. Results: Eighty-one patients were enrolled with mean +/- standard deviation age of 36 +/- 15 years and median Glasgow Coma Scale score of 7 (interquartile range, 4 to 7). A total of 1,230 serum sodium values (range, 118 to 174 mEq/l) and 7,483 ICP values (range, 0 to 159 mmHg) were collected. There was no correlation between serum sodium and maximum ICP (R-2 = 0.0052). The overall mean +/- standard deviation number of interventions for elevated ICP per day was 4.2 +/- 2.9, 2.9 +/- 2.0, and 2.6 +/- 2.3 for patients with a mean serum sodium of < 145, 145 to 155, and > 155 mEq/l, respectively (P < 0.001). Regarding the acute effect of HTS on ICP, there was no statistical difference in mean ICP compared with baseline during hours 1 through 6 following HTS doses (baseline, 13.7 +/- 8.4 mmHg; hour 1, 13.6 +/- 8.3 mmHg; hour 2, 13.5 +/- 8.8 mmHg; hour 3, 13.3 +/- 8.7 mmHg; hour 4, 13.4 +/- 8.7 mmHg; hour 5, 13.4 +/- 8.3 mmHg; hour 6, 13.5 +/- 8.3 mmHg; P = 0.84). Conclusions: Serum sodium concentrations did not correlate with ICP values. These results warrant further evaluation and possible reassessment of sodium goals for ICP management in patients with TBI.	[Wells, Diana L.] Auburn Univ, Harrison Sch Pharm, Dept Pharm Practice, Auburn, AL 36849 USA; [Swanson, Joseph M.; Wood, G. Christopher; Boucher, Bradley A.; Harrison, Charles G.] Univ Tennessee, Hlth Sci Ctr, Dept Clin Pharm, Memphis, TN 38163 USA; [Magnotti, Louis J.; Croce, Martin A.; Fabian, Timothy C.] Univ Tennessee, Hlth Sci Ctr, Dept Surg, Memphis, TN 38163 USA; [Muhlbauer, Michael S.] Univ Tennessee, Hlth Sci Ctr, Dept Neurosurg, Memphis, TN 38163 USA		Wells, DL (corresponding author), Auburn Univ, Harrison Sch Pharm, Dept Pharm Practice, 1321 Walker Bldg, Auburn, AL 36849 USA.	dlw0022@auburn.edu					Aiyagari V, 2006, J CRIT CARE, V21, P163, DOI 10.1016/j.jcrc.2005.10.002; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Farahvar A, 2011, J NEUROSURG, V114, P1471, DOI 10.3171/2010.11.JNS101116; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Froelich M, 2009, CRIT CARE MED, V37, P1433, DOI 10.1097/CCM.0b013e31819c1933; Ichai C, 2009, INTENS CARE MED, V35, P471, DOI 10.1007/s00134-008-1283-5; Kerwin AJ, 2009, J TRAUMA, V67, P277, DOI 10.1097/TA.0b013e3181acc726; KOFKE WA, 1993, J NEUROSURG ANESTH, V5, P1; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lindsey KA, 2010, NUTRITION, V26, P784, DOI 10.1016/j.nut.2009.08.013; Maggiore U, 2009, CRIT CARE, V13, DOI 10.1186/cc7953; Qureshi AI, 1999, J TRAUMA, V47, P659, DOI 10.1097/00005373-199910000-00009; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; Roquilly A, 2011, CRIT CARE, V15, DOI 10.1186/cc10522; Sakellaridis N, 2011, J NEUROSURG, V114, P545, DOI 10.3171/2010.5.JNS091685; Schroeppel TJ, 2010, J TRAUMA, V69, P776, DOI 10.1097/TA.0b013e3181e981b8; Shackford SR, 1998, J TRAUMA, V44, P50, DOI 10.1097/00005373-199801000-00004; Stocchetti N, 1999, INTENS CARE MED, V25, P371, DOI 10.1007/s001340050860; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; Williams RF, 2009, J TRAUMA, V66, P1570, DOI 10.1097/TA.0b013e3181a594c4	22	17	18	1	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care		2012	16	5							R193	10.1186/cc11678			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	124WT	WOS:000317499900030	23068293	gold, Green Published			2022-02-06	
J	Whiteside, DM; Galbreath, J; Brown, M; Turnbull, J				Whiteside, Douglas M.; Galbreath, Jennifer; Brown, Michelle; Turnbull, Jane			Differential response patterns on the Personality Assessment Inventory (PAI) in compensation-seeking and non-compensation-seeking mild traumatic brain injury patients	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Personality Assessment Inventory; Mild traumatic brain injury; Neuropsychological assessment; Personality assessment; Compensation seeking	CLOSED-HEAD INJURY; VALIDITY SCALES; MMPI-2 VALIDITY; INDIVIDUALS; PERFORMANCE; SYMPTOMS; SPECIFICITY; SENSITIVITY; INDICATORS; OFFENDERS	There is relatively little research on the Personality Assessment Inventory (PAI) with mild traumatic brain injury (MTBI) populations. There is also little research on how compensation-seeking status affects personality assessment results in MTBI patients. The current study examined the PAI scales and subscales in two MTBI groups, one composed of compensation-seeking MTBI patients and the other consisting of non-compensation-seeking MTBI patients. Results indicated significant differences on several scales and subscales between the two MTBI groups, with the compensation-seeking MTBI patients having significantly higher elevations on scales related to somatic preoccupation (Somatic Complaint Scale, SOM), emotional distress (Anxiety Scale, ANX; Anxiety Related Disorders Scale, ARD; Depression Scale, DEP), and the Negative Impression Management, NIM, validity scale. All the SOM subscales and the Anxiety Cognitive (ANX-C) and ANX Affective, ANX-A, subscales were also elevated in the compensation-seeking group. Results indicated that several scales on the PAI were sensitive to group differences in compensation-seeking status in MTBI patients.	[Whiteside, Douglas M.] Adler Sch Profess Psychol, Dept Clin Psychol, Chicago, IL 60602 USA; [Galbreath, Jennifer; Brown, Michelle; Turnbull, Jane] Argosy Univ, Washington Sch Profess Psychol, Seattle, WA USA		Whiteside, DM (corresponding author), Adler Sch Profess Psychol, Dept Clin Psychol, 17 N Dearborn St, Chicago, IL 60602 USA.	dwhiteside@adler.edu	Whiteside, Douglas/AAK-6396-2020	Whiteside, Douglas/0000-0002-8454-4413			ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Berry DTR, 1995, PSYCHOL ASSESSMENT, V7, P517; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BLACK FW, 1974, J CLIN PSYCHOL, V30, P571, DOI 10.1002/1097-4679(197410)30:4<571::AID-JCLP2270300432>3.0.CO;2-W; Boccaccini MT, 2010, PSYCHOL ASSESSMENT, V22, P142, DOI 10.1037/a0017818; Caperton JD, 2004, PSYCHOL ASSESSMENT, V16, P187, DOI 10.1037/1040-3590.16.2.187; Cohen J., 1988, STAT POWER BEHAV SCI; Demakis GJ, 2007, ARCH CLIN NEUROPSYCH, V22, P123, DOI 10.1016/j.acn.2006.09.004; FalsStewart W, 1996, PSYCHOL ASSESSMENT, V8, P60; Greiffenstein MF, 2008, CLIN NEUROPSYCHOL, V22, P565, DOI 10.1080/13854040701377810; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P491, DOI 10.1080/13854040590967144; Hessen E, 2008, BRAIN INJURY, V22, P39, DOI 10.1080/02699050701846179; Hessen E, 2009, BRAIN INJURY, V23, P234, DOI 10.1080/02699050902748349; Hopwood CJ, 2008, J PERS ASSESS, V90, P76, DOI 10.1080/00223890701693785; Hopwood CJ, 2007, REHABIL PSYCHOL, V52, P443, DOI 10.1037/0090-5550.52.4.443; Kaemmer, 1989, MINNESOTA MULTIPHASI; Karlin BE, 2005, J CLIN PSYCHOL, V61, P1571, DOI 10.1002/jclp.20209; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; Kurcharski L. T., 2007, J PERS ASSESS, V88, P25; Kurtz JE, 2007, J PERS ASSESS, V88, P66, DOI 10.1207/s15327752jpa8801_09; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; LaChapelle DL, 2005, APPL NEUROPSYCHOL, V12, P143, DOI 10.1207/S15324826AN1203_4; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Mathias JL, 1999, J CLIN EXP NEUROPSYC, V21, P200, DOI 10.1076/jcen.21.2.200.930; McCrea M., 2008, MILD TRAUMATIC BRAIN; Meyers JE, 2002, ARCH CLIN NEUROPSYCH, V17, P157, DOI 10.1016/S0887-6177(00)00107-4; Morey, 1991, PERSONALITY ASSESSME; Morey L., 1996, INTERPRETATIVE GUIDE; Morey LC, 2002, INT J OFFENDER THER, V46, P333, DOI 10.1177/0306624X02046003007; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; Piotrowski C, 2000, PSYCHOL REP, V86, P65, DOI 10.2466/PR0.86.1.65-66; Rayls KR, 2000, CLIN NEUROPSYCHOL, V14, P546, DOI 10.1076/clin.14.4.546.7194; Ross SR, 2006, J CLIN EXP NEUROPSYC, V28, P111, DOI 10.1080/13803390590929270; Ruttan LA, 2003, J CLIN EXP NEUROPSYC, V25, P407, DOI 10.1076/jcen.25.3.407.13812; SHAW DJ, 1965, J CLIN PSYCHOL, V21, P405, DOI 10.1002/1097-4679(196510)21:4<405::AID-JCLP2270210416>3.0.CO;2-I; Thomas ML, 2009, CLIN NEUROPSYCHOL, V23, P1067, DOI 10.1080/13854040902795000; Till C, 2009, BRAIN INJURY, V23, P655, DOI 10.1080/02699050902970794; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Wang EW, 1997, BEHAV SCI LAW, V15, P469, DOI 10.1002/(SICI)1099-0798(199723/09)15:4<469::AID-BSL279>3.0.CO;2-A; Warriner EM, 2003, J CLIN EXP NEUROPSYC, V25, P904, DOI 10.1076/jcen.25.7.904.16494; Whiteside DM, 2009, CLIN NEUROPSYCHOL, V23, P523, DOI 10.1080/13854040802389169	42	17	17	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2012	34	2					172	182		10.1080/13803395.2011.630648			11	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	916EC	WOS:000302079900006	22136511				2022-02-06	
J	Moreira, MS; Velasco, IT; Ferreira, LS; Ariga, SKK; Abatepaulo, F; Grinberg, LT; Marques, MM				Moreira, Maria S.; Velasco, Irineu T.; Ferreira, Leila S.; Ariga, Suely K. K.; Abatepaulo, Fatima; Grinberg, Lea Tenenholz; Marques, Marcia M.			Effect of laser phototherapy on wound healing following cerebral ischemia by cryogenic injury	JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY			English	Article						Brain injury; Leukocytes; Low power laser; Lymphocytes; Macrophages; Glial cells	TRAUMATIC BRAIN-INJURY; ADHESION MOLECULES; 780 NM; THERAPY; IRRADIATION; REGENERATION; STROKE; MECHANISMS; EXPRESSION; INCREASES	Laser phototherapy emerges as an alternative or auxiliary therapy for acute ischemic stroke, traumatic brain injury, degenerative brain disease, spinal cord injury, and peripheral nerve regeneration, but its effects are still controversial. We have previously found that laser phototherapy immunomodulates the response to focal brain damage. Following direct cortical cryogenic injury the effects of laser phototherapy on inflammation and repair was assessed after cryogenic injury (Cl) to the central nervous system (CNS) of rats. The laser phototherapy was carried out with a 780 nm AlGaAs diode laser. The irradiation parameters were: power of 40 mW, beam area of 0.04 cm(2), energy density of 3 J/cm(2) (3 s) in two points (0.12 J per point). Two irradiations were performed at 3 h-intervals, in contact mode. Rats (20 non-irradiated - controls and 20 irradiated) were used. The wound healing in the CNS was followed in 6 h, 1,7 and 14 days after the last irradiation. The size of the lesions, the neuron cell viability percentages and the amount of positive GFAP labeling were statistically compared by ANOVA complemented by Tukey's test (p < 0.05). The distribution of lymphocytes, leukocytes and macrophages were also analyzed. Cl created focal lesions in the cortex represented by necrosis, edema, hemorrhage and inflammatory infiltrate. The most striking findings were: lased lesions showed smaller tissue loss than control lesions in 6 h. During the first 24 h the amount of viable neurons was significantly higher in the lased group. There was a remarkable increase in the amount of GFAP in the control group by 14 days. Moreover, the lesions of irradiated animals had fewer leukocytes and lymphocytes in the first 24 h than controls. Considering the experimental conditions of this study it was concluded that laser phototherapy exerts its effect in wound healing following Cl by controlling the brain damage, preventing neuron death and severe astrogliosis that could indicate the possibility of a better clinical outcome. (C) 2011 Elsevier B.V. All rights reserved.	[Moreira, Maria S.; Ferreira, Leila S.; Marques, Marcia M.] Univ Sao Paulo, Sch Dent, BR-05508000 Sao Paulo, Brazil; [Moreira, Maria S.; Velasco, Irineu T.; Ariga, Suely K. K.; Abatepaulo, Fatima] Univ Sao Paulo, Sch Med, LIM 51, BR-05508000 Sao Paulo, Brazil; [Moreira, Maria S.] Ibirapuera Univ UNIB, Postgrad Program Biodent, Sao Paulo, Brazil; [Grinberg, Lea Tenenholz] FMUSP, Discipline Expt Physiopathol, Sao Paulo, Brazil; [Grinberg, Lea Tenenholz] UCSF San Francisco, Dept Neurol, Sao Paulo, Brazil		Marques, MM (corresponding author), Univ Sao Paulo, Sch Dent, BR-05508000 Sao Paulo, Brazil.	mmmarques@usp.br	Moreira, Maria Stella N A/F-8054-2014; Marques, Marcia M/F-3780-2012	Moreira, Maria Stella N A/0000-0002-4533-4544; Marques, Marcia M/0000-0002-9398-1252; grinberg, lea/0000-0002-6809-0618	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Sao Paulo, BrazilFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brasilia, DF, BrazilConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)	We thank the staffs of the Labs: LIM51 at the Medicine School and LELO (Special Laboratory of Lasers in Dentistry) at the School of Dentistry, University of Sao Paulo, Brazil. We also thank Professor Livia Ribeiro de Assis for your suggestions. We are also grateful to ours grants sponsors Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Sao Paulo, Brazil and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brasilia, DF, Brazil.	Ad N, 2001, INT J CARDIOL, V80, P109, DOI 10.1016/S0167-5273(01)00503-4; Anders JJ, 2004, NEUROL RES, V26, P233, DOI 10.1179/016164104225013914; Aronowski J, 1999, J CEREBR BLOOD F MET, V19, P652, DOI 10.1097/00004647-199906000-00008; Avni D, 2005, PHOTOMED LASER SURG, V23, P273, DOI 10.1089/pho.2005.23.273; Back T, 1998, CELL MOL NEUROBIOL, V18, P621, DOI 10.1023/A:1020265701407; Benedicenti S, 2008, PHOTOMED LASER SURG, V26, P451, DOI 10.1089/pho.2007.2218; Boschi ES, 2008, LASER SURG MED, V40, P500, DOI 10.1002/lsm.20658; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Clausen F, 2007, J NEUROTRAUM, V24, P1295, DOI 10.1089/neu.2006.0258; Damante CA, 2009, LASER MED SCI, V24, P885, DOI 10.1007/s10103-008-0582-y; de Lima FM, 2011, LASER MED SCI, V26, P389, DOI 10.1007/s10103-010-0874-x; del Zoppo G, 2000, BRAIN PATHOL, V10, P95; DeTaboada L, 2006, LASER SURG MED, V38, P70, DOI 10.1002/lsm.20256; Eduardo FD, 2008, LASER SURG MED, V40, P433, DOI 10.1002/lsm.20646; Eduardo FP, 2007, LASER SURG MED, V39, P365, DOI 10.1002/lsm.20481; Engel S, 1996, ACT NEUR S, V66, P87; Feuerstein GZ, 1998, NEUROIMMUNOMODULAT, V5, P143, DOI 10.1159/000026331; Fujihara NA, 2006, LASER SURG MED, V38, P332, DOI 10.1002/lsm.20298; GebickeHaerter PJ, 1996, NEUROCHEM INT, V29, P1; GIULIAN D, 1989, J NEUROSCI, V9, P4416; HAMA T, 1989, NEUROSCI LETT, V104, P340, DOI 10.1016/0304-3940(89)90600-9; Hashmi JT, 2010, PM&R, V2, pS292, DOI 10.1016/j.pmrj.2010.10.013; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; HOLMIN S, 1995, NEUROSCI LETT, V194, P97, DOI 10.1016/0304-3940(95)11737-H; Iadecola C, 1997, ANN NY ACAD SCI, V835, P203, DOI 10.1111/j.1749-6632.1997.tb48631.x; Kaufmann AM, 1999, STROKE, V30, P93, DOI 10.1161/01.STR.30.1.93; KOCHANEK PM, 1992, STROKE, V23, P1367, DOI 10.1161/01.STR.23.9.1367; Kujawa J, 2004, J CLIN LASER MED SUR, V22, P111, DOI 10.1089/104454704774076163; KUMAR V, 2005, ROBBINS COTRAN PATHO, P1525; Lampl Y, 2007, STROKE, V38, P1843, DOI 10.1161/STROKEAHA.106.478230; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Leung MCP, 2002, LASER SURG MED, V31, P283, DOI 10.1002/lsm.10096; MEANS ED, 1983, J NEUROPATH EXP NEUR, V42, P707, DOI 10.1097/00005072-198311000-00009; Meneguzzo DT, 2008, PROC SPIE, V6846, DOI 10.1117/12.761220; Meneguzzo DT, 2007, PROC SPIE, V6428, DOI 10.1117/12.702252; Mirsky N, 2002, ANTIOXID REDOX SIGN, V4, P785, DOI 10.1089/152308602760598936; Moreira MS, 2009, J PHOTOCH PHOTOBIO B, V97, P145, DOI 10.1016/j.jphotobiol.2009.09.002; Moriyama Y, 2009, LASER SURG MED, V41, P227, DOI 10.1002/lsm.20745; Oron A, 2007, J NEUROTRAUM, V24, P651, DOI 10.1089/neu.2006.0198; Oron A, 2006, STROKE, V37, P2620, DOI 10.1161/01.STR.0000242775.14642.b8; Oron U, 2007, PHOTOMED LASER SURG, V25, P180, DOI 10.1089/pho.2007.2064; Oron U, 2010, PHOTOMED LASER SURG, V28, P675, DOI 10.1089/pho.2009.2756; Leal ECP, 2010, EUR J APPL PHYSIOL, V108, P1083, DOI 10.1007/s00421-009-1321-1; Rochkind S, 2007, PHOTOMED LASER SURG, V25, P436, DOI 10.1089/pho.2007.2093; Sawasaki I, 2009, LASER MED SCI, V24, P113, DOI 10.1007/s10103-007-0531-1; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; SCHOTT RJ, 1989, ANN EMERG MED, V18, P517, DOI 10.1016/S0196-0644(89)80836-4; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Soares HD, 1995, J NEUROSCI, V15, P8223; Sousa LR, 2009, PHOTOMED LASER SURG, V27, P37, DOI 10.1089/pho.2007.2220; Stoll G, 2002, ADV EXP MED BIOL, V513, P87; Streeter J, 2004, MITOCHONDRION, V4, P569, DOI 10.1016/j.mito.2004.07.037; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Tuby H, 2006, LASER SURG MED, V38, P682, DOI 10.1002/lsm.20377; Yaakobi T, 2001, J APPL PHYSIOL, V90, P2411, DOI 10.1152/jappl.2001.90.6.2411	58	17	17	0	6	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	1011-1344			J PHOTOCH PHOTOBIO B	J. Photochem. Photobiol. B-Biol.	DEC 2	2011	105	3					207	215		10.1016/j.jphotobiol.2011.09.005			9	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	859QV	WOS:000297891800007	22024356				2022-02-06	
J	Eckner, JT; Chandran, S; Richardson, JK				Eckner, James T.; Chandran, SriKrishna; Richardson, James K.			Investigating the Role of Feedback and Motivation in Clinical Reaction Time Assessment	PM&R			English	Article							COMMUNITY-DWELLING WOMEN; TRAUMATIC BRAIN-INJURY; OLDER-PEOPLE; SENSORIMOTOR FUNCTION; PERFORMANCE; CONCUSSION; FALLS; KNOWLEDGE; ASSOCIATION; STATEMENT	Objective: To investigate the influence of performance feedback and motivation during 2 tests of simple visuomotor reaction time (RT). Design: Cross-sectional, observational study. Setting: Outpatient academic physiatry clinic. Participants: Thirty-one healthy adults (mean [SD], 54 +/- 15 years). Methods: Participants completed a clinical test of RT (RTclin) and a computerized test of RT with and without performance feedback (RTcompFB and RTcompNoFB, respectively) in randomly assigned order. They then ranked their degree of motivation during each test. RTclin measured the time required to catch a suspended vertical shaft by hand closure after release of the shaft by the examiner. RTcompFB and RTcompNoFB both measured the time required to press a computer key in response to a visual cue displayed on a computer monitor. Performance feedback (visual display of the previous trial and summary results) was provided for RTcompFB, but not for RTcompNoFB. Main Outcome Measurements: Means and standard deviations of RTclin, RTcompFB, and RTcompNoFB and participants' self-reported motivation on a 5-point Likert scale for each test. Results: There were significant differences in both the means and standard deviations of RTclin, RTcompFB, and RTcompNoFB (F-2,F-60 = 81.66, P < .0001; F-2,F-60 = 32.46, P < .0001, respectively), with RTclin being both the fastest and least variable of the RT measurements. RTclin was more strongly correlated with RTcompFB = 0.449, P = .0011) than with RTcompNoFB (r = 0.314, P = .086). The participants reported similar levels of motivation between RTclin and RTcompFB both of which were reported to be more motivating than RTcompNoFB. Conclusions: The stronger correlation between RTclin and RTcompFB as well as the higher reported motivation during RTclin and RTcompFB testing suggest that performance feedback ;is a positive motivating factor that is inherent to RTclin testing. RTclin is a simple, inexpensive technique for measuring RT and appears to be an intrinsically motivating task. This motivation may promote faster, more consistent RT performance compared with currently available computerized programs, which do not typically provide performance feedback. PM R 2011;3:1092-1097	[Eckner, James T.; Richardson, James K.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48108 USA; [Chandran, SriKrishna] Johns Hopkins Univ, Dept Phys Med & Rehabil, Baltimore, MD USA		Eckner, JT (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, 325 E Eisenhower Pkwy, Ann Arbor, MI 48108 USA.	jeckner@med.umich.edu			University of Michigan Patent application; Foundation for Physical Medicine and Rehabilitation; University of Michigan Bone and Joint Injury Prevention and Rehabilitation Center (pilot grant); NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [k-12/RMSTP]; University of Michigan Biostatistics Core [UL1RR024986]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD001097] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR024986] Funding Source: NIH RePORTER	4A, University of Michigan Patent application; 8A, Foundation for Physical Medicine and Rehabilitation (2007 New Investigator Award) and the University of Michigan Bone and Joint Injury Prevention and Rehabilitation Center (pilot grant), k-12/RMSTP Fellowship (NIH funded).; The authors thank the University of Michigan Biostatistics Core (UL1RR024986 CTSA funded) for statistical advice.	Bailey CM, 2006, J INT NEUROPSYCH SOC, V12, P475, DOI 10.1017/S1355617706060619; Bulmash EL, 2006, J AFFECT DISORDERS, V93, P213, DOI 10.1016/j.jad.2006.01.015; Callisaya ML, 2009, AGE AGEING, V38, P290, DOI 10.1093/ageing/afp017; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Chudler EH, 2007, NEUROSCIENCE KIDS RE; CHURCH RM, 1965, AM J PSYCHOL, V78, P102, DOI 10.2307/1421087; Collie A, 2005, SPORTS NEUROPSYCHOLO, P240; CRABTREE DA, 1988, PERCEPT MOTOR SKILL, V66, P363, DOI 10.2466/pms.1988.66.2.363; Deary IJ, 2005, PSYCHOL SCI, V16, P64, DOI 10.1111/j.0956-7976.2005.00781.x; Eckner JT, 2011, PM&R, V3, P212, DOI 10.1016/j.pmrj.2010.12.003; Eckner JT, 2011, MED SCI SPORT EXER, V43, P382, DOI 10.1249/MSS.0b013e3181f1cc51; Eckner JT, 2010, J ATHL TRAINING, V45, P327, DOI 10.4085/1062-6050-45.4.327; Eckner JT, 2009, PERCEPT MOTOR SKILL, V108, P717, DOI 10.2466/PMS.108.3.717-720; Eckner JT, 2011, J ATHL TRAI IN PRESS, V46, P415; FERRIS S, 1976, J AM GERIATR SOC, V24, P529, DOI 10.1111/j.1532-5415.1976.tb03277.x; Gorus E, 2007, J CLIN PSYCHOPHARM, V27, P182, DOI 10.1097/JCP.0b013e318032eadb; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Lajoie Y, 2004, ARCH GERONTOL GERIAT, V38, P11, DOI 10.1016/S0167-4943(03)00082-7; LOCKE EA, 1968, AM J PSYCHOL, V81, P566, DOI 10.2307/1421061; LORD SR, 1994, J AM GERIATR SOC, V42, P1110, DOI 10.1111/j.1532-5415.1994.tb06218.x; Lord SR, 1996, AGE AGEING, V25, P292, DOI 10.1093/ageing/25.4.292; LORD SR, 1991, J AM GERIATR SOC, V39, P1194, DOI 10.1111/j.1532-5415.1991.tb03574.x; Lord SR, 2001, J GERONTOL A-BIOL, V56, pM627, DOI 10.1093/gerona/56.10.M627; MCCORMACK P D, 1963, Percept Mot Skills, V17, P279; MCCORMACK P D, 1963, Percept Mot Skills, V17, P565; MCCORMACK PD, 1962, PERCEPT MOTOR SKILL, V14, P367; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Menz HB, 2004, ARCH PHYS MED REHAB, V85, P245, DOI 10.1016/j.apmr.2003.06.015; Miscio G, 2006, NEUROL SCI, V26, P402, DOI 10.1007/s10072-005-0523-0; O'Neill WM, 2000, PAIN, V85, P209, DOI 10.1016/S0304-3959(99)00274-2; ODENHEIMER GL, 1994, J GERONTOL, V49, pM153, DOI 10.1093/geronj/49.4.M153; PERETTI PO, 1970, PERCEPT MOTOR SKILL, V30, P838, DOI 10.2466/pms.1970.30.3.838; Pichel F, 2006, RESP MED, V100, P1020, DOI 10.1016/j.rmed.2005.09.036; REBOK GW, 1994, ALZ DIS ASSOC DIS, V8, P228, DOI 10.1097/00002093-199408040-00002; Rebok GW, 1995, MOVEMENT DISORD, V10, P778, DOI 10.1002/mds.870100611; Richerson SJ, 2005, BIOMED ENG ONLINE, V4, DOI 10.1186/1475-925X-4-12; Smeesters C, 2001, J BIOMECH, V34, P589, DOI 10.1016/S0021-9290(01)00005-7; Tiedemann AC, 2007, J GERONTOL A-BIOL, V62, P1259, DOI 10.1093/gerona/62.11.1259; Turner C, 2006, J PSYCHOPHARMACOL, V20, P506, DOI 10.1177/0269881106059804; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Wood JM, 2008, J AM GERIATR SOC, V56, P986, DOI 10.1111/j.1532-5415.2008.01709.x	43	17	19	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482			PM&R	PM&R	DEC	2011	3	12					1092	1097		10.1016/j.pmrj.2011.04.022			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	966YG	WOS:000305872700003	21852221	Green Accepted, Green Published			2022-02-06	
J	Giebel, S; Kothari, R; Koestner, A; Mohney, G; Baker, R				Giebel, Stephen; Kothari, Rashmi; Koestner, Amy; Mohney, Gretchen; Baker, Robert			FACTORS INFLUENCING EMERGENCY MEDICINE PHYSICIANS' MANAGEMENT OF SPORTS-RELATED CONCUSSIONS: A COMMUNITY-WIDE STUDY	JOURNAL OF EMERGENCY MEDICINE			English	Article						sports medicine; concussion; management	HIGH-SCHOOL; INTERNATIONAL-CONFERENCE; STATEMENT; RECOVERY	Background: Numerous guidelines to grade and manage sports-related concussions have been published. However, little is known about how frequently they are implemented in the emergency department. This study evaluates the current practices of emergency physicians (EPs) in managing sports-related concussions. Objectives: To evaluate the current practice of EP evaluation and management of sports-related concussions. Methods: All EPs and emergency medicine residents in Kalamazoo County were surveyed regarding their management of sports-related concussions. The surveys obtained demographic data, participants' use of guidelines, and the importance of clinical and non-clinical factors in deciding when to allow a player to return to play. Results: Of the 73 EP respondents, only 23% used a nationally recognized guideline, with no significant difference between attending and resident EPs. The symptomatic complaints of loss of consciousness, amnesia of the event, and difficulty concentrating were ranked most important by EPs in assessing patients with sports-related concussions. Among non-clinical factors, residents were significantly more likely than attendings to report that medical-legal, parental, and players' concerns were more likely to influence their decision in allowing a patient to return to play. Conclusion: EPs take into consideration important clinical factors in assessing patients with sports-related concussion. However, almost 75% do not use any nationally recognized guideline in their evaluation. Residents are more likely than attendings to be influenced by non-clinical factors. (C) 2011 Elsevier Inc.	[Giebel, Stephen; Kothari, Rashmi] Michigan State Univ, Kalamazoo Ctr Med Studies, Dept Emergency Med, Kalamazoo, MI 49008 USA; [Kothari, Rashmi; Koestner, Amy] Borgess Med Ctr, Kalamazoo, MI USA; [Mohney, Gretchen] Kalamazoo Valley Orthoped, Kalamazoo, MI USA; [Baker, Robert] Michigan State Univ, Kalamazoo Ctr Med Studies, Dept Family Med, Kalamazoo, MI 49008 USA		Kothari, R (corresponding author), Michigan State Univ, Kalamazoo Ctr Med Studies, Dept Emergency Med, 1000 Oakland Dr, Kalamazoo, MI 49008 USA.			Mohney, Gretchen/0000-0001-8600-9070			CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; Cantu RC, 2001, J ATHL TRAINING, V36, P244; *CDCP, 2007, MORTALITY MORBIDITY, V0056; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P224; Collins Michael W, 2002, Curr Sports Med Rep, V1, P12; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Covassin T, 2009, J ATHL TRAINING, V44, P400, DOI 10.4085/1062-6050-44.4.400; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Ferrara Michael S., 2001, J Athl Train, V36, P145; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P581; Lovell M, 2009, CLIN SPORT MED, V28, P95, DOI 10.1016/j.csm.2008.08.008; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538	19	17	17	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	DEC	2011	41	6					649	654		10.1016/j.jemermed.2011.03.021			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	869BZ	WOS:000298572000013	21550754				2022-02-06	
J	McCartney, A; Butler, C; Acreman, S				McCartney, Aileen; Butler, Claire; Acreman, Sue			Exploring access to rehabilitation services from allied health professionals for patients with primary high-grade brain tumours	PALLIATIVE MEDICINE			English	Article						Allied health professionals; brain tumours; health services access; rehabilitation	INPATIENT REHABILITATION; LUNG-CANCER; FUNCTIONAL OUTCOMES; BREATHLESSNESS; INTERVENTION; BARRIERS; INJURY; UK	Primary brain tumours account for less than 2% of cancer diagnoses in the UK but more people under 40 die from a brain tumour than from any other cancer. Despite developments in some treatment options, survival remains poor and patients suffer with considerable functional and cognitive deficits. Rehabilitation for patients with primary brain tumours produces statistically and clinically significant improvements in function. When compared, similar functional gains are made following rehabilitation for brain tumour patients and for those following stroke and traumatic brain injury. There have been very few studies looking at access to rehabilitation for this group of patients as a primary objective. However, existing studies and clinical experience suggest that patients with brain tumours do not access rehabilitation services frequently or easily, either locally or nationally. Therefore, this qualitative study addressed the reasons for this through semi-structured interviews of healthcare professionals, investigating their experiences of rehabilitation for this patient group and describing commonly identified barriers under key themes. The interviews gauged the views of eight healthcare professionals representing three professions in different settings, including hospital and community based. The resultant barriers fell under the following themes: professional knowledge and behaviours; services and systems; and the disease and its effects. Suggested solutions were wide ranging and included education, multidisciplinary meetings and specialist clinicians to co-ordinate care. The barriers to accessing rehabilitation for this group of patients are complex, but some of the solutions could be reached through education and co-ordination of services. Further research into the benefits of, and access to, rehabilitation for this group of patients is essential to ensure that patients with brain tumours are given opportunity to gain from the benefits of rehabilitation in the same way as other diagnoses, both cancer and non-cancer.	[McCartney, Aileen] Wisdom Hosp, Rochester ME1 2NU, Kent, England; [Acreman, Sue] Velindre Canc Ctr, Cardiff, S Glam, Wales		McCartney, A (corresponding author), Wisdom Hosp, Rochester ME1 2NU, Kent, England.	aileenmccartney@nhs.net		McCartney, Aileen/0000-0002-3726-0573			Bell KR, 1998, ARCH PHYS MED REHAB, V79, pS37, DOI 10.1016/S0003-9993(98)90120-4; BERGLUND G, 1994, EUR J CANCER, V30A, P1744, DOI 10.1016/0959-8049(94)00330-8; Bredin M, 1999, BMJ-BRIT MED J, V318, P901, DOI 10.1136/bmj.318.7188.901; *CANC RES UK, 2004, CANC STATS MON 2004; *CANC RES UK, 2008, BRAIN TUM RISKS CAUS; Cheville AL, 2007, J SURG ONCOL, V95, P409, DOI 10.1002/jso.20782; Corner J, 2006, SOC SCI MED, V62, P1381, DOI 10.1016/j.socscimed.2005.08.012; Corner J, 1996, PALLIATIVE MED, V10, P299, DOI 10.1177/026921639601000405; Cramp F, 2008, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD006145.PUB2; Ezzy D, 2002, QUALITATIVE ANAL PRA; Geler-Kulcu D, 2009, J CLIN NEUROSCI, V16, P74, DOI 10.1016/j.jocn.2008.04.014; GUERRERO D, 1998, NEUROONCOLOGY NURSES; Hackman D, 2011, PHYSIOTHER RES INT, V16, P201, DOI 10.1002/pri.506; Holley S, 2001, Oncol Nurs Forum, V28, P1393; Huang ME, 1998, ARCH PHYS MED REHAB, V79, P1386, DOI 10.1016/S0003-9993(98)90232-5; Huang ME, 2000, AM J PHYS MED REHAB, V79, P327, DOI 10.1097/00002060-200007000-00003; Kirshblum S, 2001, CANCER, V92, P1029, DOI 10.1002/1097-0142(20010815)92:4+<1029::AID-CNCR1416>3.0.CO;2-P; Marciniak CM, 2001, ARCH PHYS MED REHAB, V82, P457, DOI 10.1053/apmr.2001.21862; Miller M, 2000, Eur J Oncol Nurs, V4, P233, DOI 10.1054/ejon.2000.0109; MUKAND JA, 2001, AM J PHYS MED REHAB, V80, P346; Mulholland PJ, 2004, MIMS ADV NEURO ONCOL, V1, P1; *NAT I HLTH, 2006, SERV GUID IMPR OUTC; National Council for Hospice and Specialist Palliative Care Services (NCHSPCS), 2000, FULF LIV REH PALL CA; National Institute for Health and Clinical Excellence, 2004, IMPR SUPP PALL CAR A; O'Dell MW, 1998, ARCH PHYS MED REHAB, V79, P1530, DOI 10.1016/S0003-9993(98)90414-2; Osoba D, 2000, NEURO-ONCOLOGY, V2, P221, DOI 10.1093/neuonc/2.4.221; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; Rodriguez-Bigas MA, 2007, J SURG ONCOL, V95, P400, DOI 10.1002/jso.20778; Rubin H., 1995, QUALITATIVE INTERVIE; Salander P, 2002, PALLIATIVE MED, V16, P305, DOI 10.1191/0269216302pm569oa; Sherer M, 1997, CANCER, V80, P250, DOI 10.1002/(SICI)1097-0142(19970715)80:2<250::AID-CNCR13>3.3.CO;2-T; Stevinson C, 2005, EUR J CANCER CARE, V14, P63, DOI 10.1111/j.1365-2354.2005.00514.x	32	17	17	0	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2163			PALLIATIVE MED	Palliat. Med.	DEC	2011	25	8			SI		788	796		10.1177/0269216311398699			9	Health Care Sciences & Services; Public, Environmental & Occupational Health; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Public, Environmental & Occupational Health; General & Internal Medicine	854EP	WOS:000297478100009	21393353				2022-02-06	
J	Sun, LJ; Wang, L; Jiang, MH; Huang, JX; Lin, H				Sun, Lingjun; Wang, Lin; Jiang, Minghu; Huang, Juxiang; Lin, Hong			Glycogen Debranching Enzyme 6 (AGL), Enolase 1 (ENOSF1), Ectonucleotide Pyrophosphatase 2 (ENPP2_1), Glutathione S-Transferase 3 (GSTM3_3) and Mannosidase (MAN2B2) Metabolism Computational Network Analysis Between Chimpanzee and Human Left Cerebrum	CELL BIOCHEMISTRY AND BIOPHYSICS			English	Article						AGL, ENOSF1, ENPP2_1, GSTM3_3 and MAN2B2 computational network; Metabolism; Chimpanzee left cerebrum; Human left cerebrum	NEURON-SPECIFIC ENOLASE; TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE SYNTHASE; ALPHA-MANNOSIDASE; GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; MESSENGER-RNA; K562 CELLS; MU CLASS; IN-VIVO	We identified significantly higher expression of the genes glycogen debranching enzyme 6 (AGL), enolase 1 (ENOSF1), ectonucleotide pyrophosphatase 2 (ENPP2_1), glutathione S-transferase 3 (GSTM3_3) and mannosidase (MAN2B2) from human left cerebrums versus chimpanzees. Yet the distinct low- and high-expression AGL, ENOSF1, ENPP2_1, GSTM3_3 and MAN2B2 metabolism networks between chimpanzee and human left cerebrum remain to be elucidated. Here, we constructed low- and high-expression activated and inhibited upstream and downstream AGL, ENOSF1, ENPP2_1, GSTM3_3 and MAN2B2 metabolism network between chimpanzee and human left cerebrum in GEO data set by gene regulatory network inference method based on linear programming and decomposition procedure, under covering AGL, ENOSF1, ENPP2_1, GSTM3_3 and MAN2B2 pathway and matching metabolism enrichment analysis by CapitalBio MAS 3.0 integration of public databases, including Gene Ontology, KEGG, BioCarta, GenMapp, Intact, UniGene, OMIM, etc. Our results show that the AGL, ENOSF1, ENPP2_1, GSTM3_3 and MAN2B2 metabolism network has more activated and less inhibited molecules in chimpanzee, but less activated and more inhibited in the human left cerebrum. We inferred stronger carbohydrate, glutathione and proteoglycan metabolism, ATPase activity, but weaker base excision repair, arachidonic acid and drug metabolism as a result of inducing cell growth in low-expression AGL, ENOSF1, ENPP2_1, GSTM3_3 and MAN2B2 metabolism network of chimpanzee left cerebrum; whereas stronger lipid metabolism, amino acid catabolism, DNA repair but weaker inflammatory response, cell proliferation, glutathione and carbohydrate metabolism as a result of inducing cell differentiation in high-expression AGL, ENOSF1, ENPP2_1, GSTM3_3 and MAN2B2 metabolism network of human left cerebrum. Our inferences are consistent with recent reports and computational activation and inhibition gene number patterns, respectively.	[Sun, Lingjun; Wang, Lin; Huang, Juxiang; Lin, Hong] Beijing Univ Posts & Telecommun, Biomed Ctr, Sch Elect Engn, Beijing 100876, Peoples R China; [Jiang, Minghu] Tsinghua Univ, Lab Computat Linguist, Sch Humanities & Social Sci, Beijing 100084, Peoples R China		Wang, L (corresponding author), Beijing Univ Posts & Telecommun, Biomed Ctr, Sch Elect Engn, Beijing 100876, Peoples R China.	wanglin98@tsinghua.org.cn		Wang, Lin/0000-0003-2433-8594	National Natural Science Foundation in ChinaNational Natural Science Foundation of China (NSFC) [60871100]; Returned Overseas Chinese Scholars for Scientific research Foundation of State Education Ministry [2009ZX08012-001B]; State Key Lab of Pattern Recognition Open Foundation	This work was supported by the National Natural Science Foundation in China (No.60871100), the Returned Overseas Chinese Scholars for Scientific research Foundation of State Education Ministry, Significant Science and Technology Project for New Transgenic Biological Species (2009ZX08012-001B), and State Key Lab of Pattern Recognition Open Foundation.	Agarwal V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002337; Baroukh NN, 2009, FEBS J, V276, P6509, DOI 10.1111/j.1742-4658.2009.07353.x; Baumforth KRN, 2005, BLOOD, V106, P2138, DOI 10.1182/blood-2005-02-0471; Brody F, 2007, SURG ENDOSC, V21, P941, DOI 10.1007/s00464-006-9098-3; Buxhoeveden DP, 2002, BRAIN BEHAV EVOLUT, V60, P125, DOI 10.1159/000065935; Caceres M, 2003, P NATL ACAD SCI USA, V100, P13030, DOI 10.1073/pnas.2135499100; CAMMER W, 1992, J COMP NEUROL, V321, P33, DOI 10.1002/cne.903210104; Charrueau C, 2009, J NEUROTRAUM, V26, P1911, DOI 10.1089/neu.2008.0737; DALY JM, 1991, CARCINOGENESIS, V12, P1237, DOI 10.1093/carcin/12.7.1237; Deloulme JC, 1996, J NEUROCHEM, V66, P936; Deng XG, 2000, CHINESE MED J-PEKING, V113, P198; Deng YQ, 2009, AM J PATHOL, V175, P2089, DOI 10.2353/ajpath.2009.090157; Farias S, 2009, J NEUROTRAUM, V26, P1977, DOI 10.1089/neu.2009.0877; Fiaux H, 2005, J MED CHEM, V48, P4237, DOI 10.1021/jm0409019; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; GRIGNON DJ, 1994, MODERN PATHOL, V7, P186; Gu JY, 2003, TRENDS GENET, V19, P63, DOI 10.1016/S0168-9525(02)00040-9; Han SH, 2010, MOL BIOL REP, V37, P467, DOI 10.1007/s11033-009-9644-x; Helbok R, 2009, CRIT CARE MED, V37, pA155; Hiramoto S, 1997, BIOCHEM BIOPH RES CO, V241, P439, DOI 10.1006/bbrc.1997.7768; HUANG J, 2010, OPEN GENOMICS J, V3, P1; Huang JX, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-50; Huang RQ, 2009, J CEREBR BLOOD F MET, V29, P1914, DOI 10.1038/jcbfm.2009.104; Inoue H, 1997, EXP HEMATOL, V25, P935; Jawaid A, 2009, NEURODEGENER DIS, V6, P219, DOI 10.1159/000258704; Jiang Dong-dong, 2007, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V29, P528; Jowsey IR, 2003, BIOCHEM BIOPH RES CO, V312, P1226, DOI 10.1016/j.bbrc.2003.11.068; Kaminsky Y, 2009, BRAIN RES, V1294, P193, DOI 10.1016/j.brainres.2009.07.082; Koebmann B, 2006, IEE P SYST BIOL, V153, P346, DOI 10.1049/ip-syb:20060022; Koike S, 2006, GENES CELLS, V11, P133, DOI 10.1111/j.1365-2443.2006.00924.x; LAMANDE N, 1995, MOL REPROD DEV, V41, P306, DOI 10.1002/mrd.1080410305; Li QA, 2006, BIOCHEM BIOPH RES CO, V340, P845, DOI 10.1016/j.bbrc.2005.12.067; MATRANGA V, 1993, CELL MOL NEUROBIOL, V13, P137, DOI 10.1007/BF00735370; Odetallah NH, 2002, POULTRY SCI, V81, P1322, DOI 10.1093/ps/81.9.1322; OKAMURA N, 1995, MOL REPROD DEV, V42, P141, DOI 10.1002/mrd.1080420203; PETERSON CA, 1992, DEV BIOL, V151, P626, DOI 10.1016/0012-1606(92)90201-Q; Preuss TM, 2002, CEREB CORTEX, V12, P671, DOI 10.1093/cercor/12.7.671; Racanicchi L, 2008, MOL CELL BIOCHEM, V308, P17, DOI 10.1007/s11010-007-9606-3; Scharmach E, 2009, TOXICOLOGY, V265, P122, DOI 10.1016/j.tox.2009.09.017; SCHILLING K, 1989, J NEUROSCI RES, V24, P347, DOI 10.1002/jnr.490240302; Schnekenburger M, 2006, LEUKEMIA RES, V30, P561, DOI 10.1016/j.leukres.2005.08.023; Schnekenburger M, 2004, BIOCHEM PHARMACOL, V68, P1269, DOI 10.1016/j.bcp.2004.03.047; Sha J, 2003, MICROB PATHOGENESIS, V34, P195, DOI 10.1016/S0882-4010(03)00028-7; Shield AJ, 2001, ENVIRON MOL MUTAGEN, V37, P285, DOI 10.1002/em.1034; Stefan C, 1998, HEPATOLOGY, V28, P1497, DOI 10.1002/hep.510280608; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Sun T, 2006, NAT REV NEUROSCI, V7, P655, DOI 10.1038/nrn1930; SUN Y, 2008, FRONTIERS ELECT ELEC, V3, P381, DOI DOI 10.1007/SCIENCE11460-008-0086-3; Sun Y, 2010, CELL BIOCHEM BIOPHYS, V56, P59, DOI 10.1007/s12013-009-9071-6; Tamura Y, 2007, NEUROSCIENCE, V148, P535, DOI 10.1016/j.neuroscience.2007.06.026; Teste MA, 2000, FEMS MICROBIOL LETT, V193, P105, DOI 10.1016/S0378-1097(00)00468-7; Tian Y, 2008, CANCER SCI, V99, P2428, DOI 10.1111/j.1349-7006.2008.01019.x; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; Van Den Heuvel RL, 1999, TOXICOL IN VITRO, V13, P605, DOI 10.1016/S0887-2333(99)00019-3; Vecchini F, 1997, CELL GROWTH DIFFER, V8, P261; Wang L, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/726728; Wang L, 2011, J CELL BIOCHEM, V112, P1286, DOI 10.1002/jcb.23030; Wang L, 2010, CELL PHYSIOL BIOCHEM, V26, P303, DOI 10.1159/000320553; Wang L, 2010, TUMOR BIOL, V31, P417, DOI 10.1007/s13277-010-0050-8; Wang L, 2009, CANCER INVEST, V27, P816, DOI 10.1080/07357900802672753; Wang Y, 2006, BIOINFORMATICS, V22, P2413, DOI 10.1093/bioinformatics/btl396; Yu IT, 2008, CHEM-BIOL INTERACT, V174, P118, DOI 10.1016/j.cbi.2008.05.011; Yue W, 2004, INT J CANCER, V108, P189, DOI 10.1002/ijc.11536; Zhu LA, 2009, EXP MOL PATHOL, V87, P27, DOI 10.1016/j.yexmp.2009.05.002	64	17	17	0	9	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1085-9195	1559-0283		CELL BIOCHEM BIOPHYS	Cell Biochem. Biophys.	DEC	2011	61	3					493	505		10.1007/s12013-011-9232-2			13	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Cell Biology	849ZE	WOS:000297163300004	21735130				2022-02-06	
J	Toglia, J; Goverover, Y; Johnston, MV; Dain, B				Toglia, Joan; Goverover, Yael; Johnston, Mark V.; Dain, Barry			Application of the Multicontextual Approach in Promoting Learning and Transfer of Strategy Use in an Individual With TBI and Executive Dysfunction	OTJR-OCCUPATION PARTICIPATION AND HEALTH			English	Article						metacognition; strategy use; cognitive rehabilitation	TRAUMATIC BRAIN-INJURY; COGNITIVE REHABILITATION; OCCUPATIONAL-THERAPY; SELF-REGULATION; AWARENESS; INTERVENTIONS; ADULTS; SKILLS	The multicontext approach addresses strategy use and self-monitoring skills within activities and contexts that are systematically varied to facilitate transfer of learning. This article illustrates the application of the multicontext approach by presenting a case study of an adult who is 5 years post-traumatic brain injury with executive dysfunction and limited awareness. A single case study design with repeated pre-post measures was used. Methods to monitor strategy generation and specific awareness within intervention are described. Findings suggest improved functional performance and generalization of use of an external strategy despite absence of changes in general self-awareness of deficits. This case describes the multicontext intervention process and provides clinical suggestions for working with individuals with serious deficits in awareness and executive dysfunction following traumatic brain injury.	[Toglia, Joan] Mercy Coll, Dobbs Ferry, NY 10522 USA; [Goverover, Yael] NYU, Dept Occupat Therapy, New York, NY USA; [Johnston, Mark V.] Univ Wisconsin, Coll Hlth Sci, Milwaukee, WI 53201 USA; [Dain, Barry] Helen Hayes Hosp, Post Acute TBI Serv, W Haverstraw, NY USA		Toglia, J (corresponding author), Mercy Coll, Dobbs Ferry, NY 10522 USA.	JToglio@mercy.edu	Toglia, Joan/AAN-6674-2021	Toglia, Joan/0000-0002-6902-6853			Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; Baum CM, 2008, TEST MANUAL EXECUTIV; BURKE W H, 1991, Brain Injury, V5, P241, DOI 10.3109/02699059109008095; *CDCP, 2003, TBI REP C MILD TRAUM; CICERONE KD, 1992, NEUROREHABILITATION, V2, P12, DOI DOI 10.3233/NRE-1992-2304; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; ESLINGER P, 2007, BRAIN INJURY MED PRI, P770; Giles GM, 2005, COGNITION OCCUPATION, P139; Gioia GA, 2005, PSYCHOL ASSESS RESOU; Goverover Y, 2007, BRAIN INJURY, V21, P913, DOI 10.1080/02699050701553205; Johnston MV, 2009, OTJR-OCCUP PART HEAL, V29, P4; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Martelli MF, 2008, NEUROREHABILITATION, V23, P115; MAYER NH, 1986, CLIN NEUROPSYCHOLOGY, P205; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Nelson DL, 1996, AM J OCCUP THER, V50, P223, DOI 10.5014/ajot.50.3.223; Ownsworth T., 2009, NEUROPSYCHOL REHABIL, V20, P59, DOI 10.1080/09602010902949223; Ownsworth TL, 2000, CLIN NEUROPSYCHOL, V14, P76, DOI 10.1076/1385-4046(200002)14:1;1-8;FT076; Parish L, 2007, NEUROPSYCHOL REHABIL, V17, P230, DOI 10.1080/09602010600750675; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Roley S., 2008, AM OCCUPATIONAL THER, V62, P625, DOI [10.5014/ajot.62.6.625, DOI 10.5014/AJOT.62.6.625]; SCHWARTZ SM, 1995, AM J OCCUP THER, V49, P655, DOI 10.5014/ajot.49.7.655; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sosin DM, 1996, BRAIN INJURY, V10, P47; Toglia J, 2010, BRAIN INJURY, V24, P664, DOI 10.3109/02699051003610474; Toglia JP, 1998, COGNITION AND OCCUPATION IN REHABILITATION, P5; TOGLIA JP, 1991, AM J OCCUP THER, V45, P505, DOI 10.5014/ajot.45.6.505; TOGLIA JP, 2003, WILLARD SPACKMANS OC, P264	29	17	17	0	13	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1539-4492	1938-2383		OTJR-OCCUP PART HEAL	OTJR-Occup. Particip. Health	WIN	2011	31	1		S	SI		S53	S60		10.3928/15394492-20101108-09			8	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	707ME	WOS:000286289900009	24650265				2022-02-06	
J	Wade, SL; Oberjohn, K; Conaway, K; Osinska, P; Bangert, L				Wade, Shari L.; Oberjohn, Karen; Conaway, Kathryn; Osinska, Paulina; Bangert, Lauren			Live Coaching of Parenting Skills Using the Internet: Implications for Clinical Practice	PROFESSIONAL PSYCHOLOGY-RESEARCH AND PRACTICE			English	Article						acquired brain injury; parenting; telehealth; parent-child interaction; therapeutic alliance	TRAUMATIC BRAIN-INJURY; BEHAVIORAL FAMILY INTERVENTION; CHILD INTERACTION THERAPY; YOUNG-CHILDREN; SHORT-TERM; OUTCOMES; PROGRAM; CAREGIVERS; EFFICACY; AREAS	Many parents who would benefit from parenting skills training via live coaching do not receive it due to barriers such as time, distance, and the unavailability of skilled providers. This report describes an innovative web-based parenting skills program for families of young children with traumatic brain injury (TBI)-Internet-Based Interacting Together Everyday, Recovery After Childhood TBI (I-InTERACT). I-InTERACT is a web-based parenting skills program of 10-14 sessions that combines self-guided web modules with live coaching via videoconferencing. We describe the feasibility and utility of this approach, as well as the unique nature of the therapeutic process, detailing the perspectives of 13 parents of children with TBI who participated in the program and 6 therapists who delivered the program. Nine of 13 parents preferred the web-based coaching to traditional treatment; they cited its ease of use and the comfort of doing it at home. Therapists uniformly liked coaching over the web despite the need to address boundaries and troubleshoot technological difficulties. Therapeutic alliance was comparable to traditional therapy with nearly all families expressing a strong connection to the therapist. Individuals with less computer experience particularly liked the program because it gave them access to the web and a sense of empowerment. These preliminary findings support the utility of web-based parenting skills training for families from diverse backgrounds, while underscoring the potential for clinical use with other underserved populations.	[Wade, Shari L.; Oberjohn, Karen; Osinska, Paulina; Bangert, Lauren] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, Cincinnati, OH 45229 USA; [Wade, Shari L.] Univ Cincinnati, Cincinnati, OH 45221 USA		Wade, SL (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA.	shari.wade@cchmc.org					Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Bauer WM, 2003, J REHABIL, V69, P18; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Connell S, 1997, BEHAV MODIF, V21, P379, DOI 10.1177/01454455970214001; Elliott TR, 2008, BEHAV RES THER, V46, P1220, DOI 10.1016/j.brat.2008.08.004; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Eyberg S., 1988, CHILD FAMILY BEHAV T, V10, P33, DOI [10.1300/J019v10n01_04, DOI 10.1300/J019V10N01_04]; EYBERG SM, 1995, PSYCHOPHARMACOL BULL, V31, P83; Feeney TJ, 2003, J HEAD TRAUMA REHAB, V18, P33, DOI 10.1097/00001199-200301000-00006; Ganesalingam K, 2007, J INT NEUROPSYCH SOC, V13, P298, DOI 10.1017/S1355617707070324; Gilkey SL, 2009, FAM SOC, V90, P37, DOI 10.1606/1044-3894.3843; Kaminski JW, 2008, J ABNORM CHILD PSYCH, V36, P567, DOI 10.1007/s10802-007-9201-9; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Mayheu M. M, 2011, SKYPE HIPAA WHAT ARE; Sander AM, 2009, J HEAD TRAUMA REHAB, V24, P248, DOI 10.1097/HTR.0b013e3181ad593a; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Thomas R, 2007, J ABNORM CHILD PSYCH, V35, P475, DOI 10.1007/s10802-007-9104-9; Wade SL, 2006, REHABIL PSYCHOL, V51, P179, DOI 10.1037/0090-5550.51.3.179; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wade SL, 2010, J HEAD TRAUMA REHAB, V25, P409, DOI 10.1097/HTR.0b013e3181fb900d; Wade SL, 2009, J HEAD TRAUMA REHAB, V24, P239, DOI 10.1097/HTR.0b013e3181ad6680; Wade SL, 2006, J CONSULT CLIN PSYCH, V51, P178; Webster-Stratton C., 2010, EVIDENCE BASED PSYCH; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	25	17	17	1	18	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0735-7028	1939-1323		PROF PSYCHOL-RES PR	Prof. Psychol.-Res. Pract.	DEC	2011	42	6			SI		487	493		10.1037/a0025222			7	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	860CI	WOS:000297924400012					2022-02-06	
J	Wheaton, P; Mathias, JL; Vink, R				Wheaton, P.; Mathias, J. L.; Vink, R.			Impact of pharmacological treatments on outcome in adult rodents after traumatic brain injury: a meta-analysis	JOURNAL OF PSYCHOPHARMACOLOGY			English	Article						Adult rodents; meta-analysis; outcome; pharmacological treatments; traumatic brain injury	CLOSED-HEAD INJURY; IMPROVES FUNCTIONAL RECOVERY; REDUCES NEUROLOGICAL DEFICIT; REGIONAL CEREBRAL EDEMA; NITRIC-OXIDE SYNTHASE; ACETYLCHOLINESTERASE INHIBITOR; NEUROBEHAVIORAL DEFICITS; COGNITIVE DEFICITS; MAGNESIUM THERAPY; CONTUSION VOLUME	Pharmacological treatments have been widely investigated in pre-clinical animal trials to evaluate their usefulness in reducing cognitive, behavioural and motor problems after traumatic brain injury (TBI). However, the relative efficacy of these agents has yet to be evaluated, making it difficult to assess the strength of evidence for their use in a clinical population. A meta-analytic review of research (1980-2009) was therefore conducted to examine the impact of pharmacological treatments administered to adult male rodents after experimental TBI on cognitive, behavioural, and motor outcome. The PubMed and PsycInfo databases were searched using 35 terms. Weighted Cohen's d effect sizes, percent overlap, Fail-Safe N statistics and confidence intervals were calculated for each treatment. In total, 91 treatments were evaluated in 223 pre-clinical trials, comprising 5988 rodents. Treatments that were investigated by multiple studies and showed large and significant treatment effects were of greatest interest. Of the 16 treatments that were efficacious, six improved cognition, 10 improved motor function and no treatment improved behaviour (depression/anxiety, aggression, zoosociat behaviour). Treatment benefits were found across a range of TBI models. Drug dosage and treatment interval impacted on treatment effects.	[Wheaton, P.; Mathias, J. L.] Univ Adelaide, Sch Psychol, Adelaide, SA 5005, Australia; [Vink, R.] Univ Adelaide, Sch Med Sci, Adelaide, SA 5005, Australia		Mathias, JL (corresponding author), Univ Adelaide, Sch Psychol, Adelaide, SA 5005, Australia.	jane.mathias@adelaide.edu.au	Vink, Robert/J-7351-2012; Vink, Robert/S-5616-2019; Mathias, J L/L-6295-2013	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667; Mathias, Jane/0000-0001-8957-8594	Neurosurgical Foundation of Australia; Faculty of Health Sciences of The University of Adelaide	This research was supported by the Neurosurgical Foundation of Australia and the Faculty of Health Sciences of The University of Adelaide.	Arlinghaus KA, 2005, TXB TRAUMATIC BRAIN; Ashley M. J., 2004, TRAUMATIC BRAIN INJU, V2nd; Barbre AB, 2006, BRAIN RES BULL, V69, P639, DOI 10.1016/j.brainresbull.2006.03.009; Bareyre FM, 1999, J NEUROCHEM, V73, P271, DOI 10.1046/j.1471-4159.1999.0730271.x; Barone FC, 2000, J CARDIOVASC PHARM, V36, pS357, DOI 10.1097/00005344-200036001-00104; Belayev L, 1999, J NEUROTRAUM, V16, P445, DOI 10.1089/neu.1999.16.445; Berman RF, 2000, J NEUROSURG, V93, P821, DOI 10.3171/jns.2000.93.5.0821; Besson VC, 2005, NEUROSCI LETT, V388, P7, DOI 10.1016/j.neulet.2005.06.019; Brauze Damian, 2002, Journal of Applied Genetics, V43, P371; Browne KD, 2004, J NEUROSCI RES, V77, P878, DOI 10.1002/jnr.20215; Chen Y, 1998, BRAIN RES, V784, P18, DOI 10.1016/S0006-8993(97)00982-7; Chen Y, 1998, J NEUROTRAUM, V15, P231, DOI 10.1089/neu.1998.15.231; Cheng JP, 2007, NEUROSCI LETT, V416, P165, DOI 10.1016/j.neulet.2007.02.006; Clark RSB, 2007, J NEUROTRAUM, V24, P1399, DOI 10.1089/neu.2007.0305; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J, 1977, STAT POWER ANAL BEHA; Cooper J.R., 2003, BIOCH BASIS NEUROPHA; DELATORRE JC, 1995, NEUROSURGERY, V37, P273, DOI 10.1227/00006123-199508000-00012; Dempsey RJ, 2003, J NEUROSURG, V98, P867, DOI 10.3171/jns.2003.98.4.0867; Dixon CE, 1997, EXP NEUROL, V146, P479, DOI 10.1006/exnr.1997.6557; Dixon CE, 1997, J NEUROTRAUM, V14, P161, DOI 10.1089/neu.1997.14.161; Faden AI, 1999, AM J PHYSIOL-REG I, V277, pR1196, DOI 10.1152/ajpregu.1999.277.4.R1196; Faden AI, 2003, J CEREBR BLOOD F MET, V23, P342, DOI 10.1097/01.WCB.0000046143.31247.FD; FADEN AI, 1993, J NEUROTRAUM, V10, P91, DOI 10.1089/neu.1993.10.91; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Feng Dong-fu, 2004, Chin J Traumatol, V7, P148; Finnie JW, 2002, VET PATHOL, V39, P679, DOI 10.1354/vp.39-6-679; Finnie JW, 2001, AUST VET J, V79, P628, DOI 10.1111/j.1751-0813.2001.tb10785.x; Flunter JE, 1982, METAANALYSIS CUMULAT, V4; Fromm L, 2004, J AM COLL NUTR, V23, p529S, DOI 10.1080/07315724.2004.10719396; HAMM RJ, 1993, COGNITIVE BRAIN RES, V1, P223, DOI 10.1016/0926-6410(93)90006-Q; Hamm RJ, 1996, J NEUROTRAUM, V13, P325, DOI 10.1089/neu.1996.13.325; Heath DL, 1998, SCAND J CLIN LAB INV, V58, P161, DOI 10.1080/00365519850186751; Heath DL, 1998, J NEUROTRAUM, V15, P183, DOI 10.1089/neu.1998.15.183; Heath DL, 1999, J NEUROSURG, V90, P504, DOI 10.3171/jns.1999.90.3.0504; Hedges L.V., 1985, STAT METHODS META AN; Hinson J, 1996, BRAIN RES BULL, V39, P311, DOI 10.1016/0361-9230(96)00025-1; Hoane MR, 2006, J NEUROTRAUM, V23, P1535, DOI 10.1089/neu.2006.23.1535; Hoane MR, 2005, J NEUROTRAUM, V22, P1112, DOI 10.1089/neu.2005.22.1112; Hoane MR, 2005, RESTOR NEUROL NEUROS, V23, P67; Hoane MR, 2003, J NEUROTRAUM, V20, P1189, DOI 10.1089/089771503770802871; Hoane MR, 2003, BRAIN RES BULL, V60, P105, DOI 10.1016/S0361-9230(03)00022-4; Hoffman AN, 2008, LIFE SCI, V83, P602, DOI 10.1016/j.lfs.2008.08.007; Huang W, 1999, EUR J PHARMACOL, V366, P127, DOI 10.1016/S0014-2999(98)00929-7; Hunter J.E., 2004, METHODS META ANAL CO, V2nd ed.; Ji BA, 2000, J BIOL CHEM, V275, P19115, DOI 10.1074/jbc.M001685200; Ji YC, 2005, J KOREAN MED SCI, V20, P291, DOI 10.3346/jkms.2005.20.2.291; Kline AE, 2002, NEUROSCI LETT, V333, P179, DOI 10.1016/S0304-3940(02)01101-1; Kline AE, 2001, NEUROSCIENCE, V106, P547, DOI 10.1016/S0306-4522(01)00300-1; Kline AE, 2004, J NEUROTRAUM, V21, P1712, DOI 10.1089/0897715042664849; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Knoblach SM, 2002, J NEUROTRAUM, V19, P1039, DOI 10.1089/089771502760341956; Knoller N, 2002, CRIT CARE MED, V30, P548, DOI 10.1097/00003246-200203000-00009; Lee LL, 2004, EXP NEUROL, V190, P70, DOI 10.1016/j.expneurol.2004.07.003; Lipsey M. W., 2001, PRACTICAL METAANALYS, V49; Longhi L, 2009, CRIT CARE MED, V37, P659, DOI 10.1097/CCM.0b013e318195998a; Louin G, 2006, NEUROPHARMACOLOGY, V50, P182, DOI 10.1016/j.neuropharm.2005.08.020; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; Lu DY, 2003, J NEUROSURG, V99, P351, DOI 10.3171/jns.2003.99.2.0351; Lu DY, 2004, J NEUROSURG, V101, P813, DOI 10.3171/jns.2004.101.5.0813; Marklund N, 2001, J NEUROTRAUM, V18, P821, DOI 10.1089/089771501316919184; Marklund N, 2007, J NEUROSURG, V107, P844, DOI 10.3171/JNS-07/10/0844; Mbye LH, 2009, J CEREBR BLOOD F MET, V29, P87, DOI 10.1038/jcbfm.2008.93; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; O'Connor CA, 2003, J NEUROTRAUM, V20, P533, DOI 10.1089/089771503767168465; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; Okiyama K, 1998, BRAIN RES, V792, P291, DOI 10.1016/S0006-8993(98)00158-9; Okiyama K, 1997, J NEUROTRAUM, V14, P211, DOI 10.1089/neu.1997.14.211; Okuyama S, 1997, NEUROL RES, V19, P300, DOI 10.1080/01616412.1997.11740816; Olga NK, 2006, BEHAV BRAIN RES, V170, P233, DOI 10.1016/j.bbr.2006.02.026; PAPPIUS HM, 1991, NEUROCHEM RES, V16, P941, DOI 10.1007/BF00965837; Pascual JM, 2007, J NEUROTRAUM, V24, P944, DOI 10.1089/neu.2006.0190; Pike BR, 1997, PHARMACOL BIOCHEM BE, V57, P785, DOI 10.1016/S0091-3057(96)00453-4; Pillay NS, 2007, BRAIN RES, V1153, P158, DOI 10.1016/j.brainres.2007.03.056; ROSENTHAL R, 1995, PSYCHOL BULL, V118, P183, DOI 10.1037/0033-2909.118.2.183; Rothstein HR, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P1, DOI 10.1002/0470870168; Schmanke T, 1997, J NEUROTRAUM, V14, P459, DOI 10.1089/neu.1997.14.459; SHAPIRA Y, 1995, J NEUROSURG ANESTH, V7, P17, DOI 10.1097/00008506-199501000-00004; Shohami E, 2003, J CEREBR BLOOD F MET, V23, P728, DOI 10.1097/01.WCB.0000067704.86573.83; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; Sindhu F, 1997, J ADV NURS, V25, P1262, DOI 10.1046/j.1365-2648.1997.19970251262.x; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Smith JM, 2007, BRAIN, V130, P915, DOI 10.1093/brain/awl393; Tan AA, 2009, J NEUROTRAUM, V26, P539, DOI 10.1089/neu.2008.0611; Temple MD, 1996, BRAIN RES, V741, P246, DOI 10.1016/S0006-8993(96)00940-7; Tilley A.J., 1996, INTRO PSYCHOL RES ST; Turner RJ, 2004, J AM COLL NUTR, V23, p534S, DOI 10.1080/07315724.2004.10719397; Vales K, 2006, NEUROSCI RES, V55, P383, DOI 10.1016/j.neures.2006.04.007; Wagner AK, 2007, BEHAV BRAIN RES, V181, P200, DOI 10.1016/j.bbr.2007.04.006; Wahl F, 1997, BRAIN RES, V756, P247, DOI 10.1016/S0006-8993(97)00144-3; Webster RA, 2003, NEUROTRANSMITTERS DR; Yaka R, 2007, FASEB J, V21, P2033, DOI 10.1096/fj.06-7856com; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Yatsiv I, 2002, J CEREBR BLOOD F MET, V22, P971, DOI 10.1097/00004647-200208000-00008; Zakzanis K. K., 1999, STUD NEUROPSYCHOL DE; Zakzanis KK, 2001, ARCH CLIN NEUROPSYCH, V16, P653, DOI 10.1016/S0887-6177(00)00076-7; Zamudio S, 2005, BRAIN RES BULL, V65, P339, DOI 10.1016/j.brainresbull.2005.01.009; Zarubina IV, 2003, B EXP BIOL MED+, V136, P56, DOI 10.1023/A:1026040930146; Zhu J, 2000, EXP NEUROL, V166, P136, DOI 10.1006/exnr.2000.7484; [No title captured]	105	17	17	1	6	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-8811	1461-7285		J PSYCHOPHARMACOL	J. Psychopharmacol.	DEC	2011	25	12					1581	1599		10.1177/0269881110388331			19	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	869AW	WOS:000298569000001	21300634				2022-02-06	
J	Yang, CJ; Hsiao, KY; Su, IC; Chen, IC				Yang, Chia-Jung; Hsiao, Kuang-Yu; Su, I-Chun; Chen, I-Chuan			The Association Between Anemia and the Mortality of Severe Traumatic Brain Injury in Emergency Department	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Anemia; Traumatic brain injury; Transfusion; Emergency department	CRITICALLY-ILL PATIENTS; SEVERE HEAD-INJURY; HYPOTENSION INCREASES MORTALITY; BLOOD-CELL TRANSFUSION; PREHOSPITAL HYPOTENSION; CARDIOPULMONARY BYPASS; CEREBRAL OXYGENATION; VALID INDICATOR; TEAM ACTIVATION; BRIEF EPISODE	Background: Anemia is a common medical problem for critically ill patients. Blood transfusion to augment oxygen delivery for these patients has been a traditional therapy. However, few studies have identified the impact of anemia on individuals suffering from severe traumatic brain injury (TBI). Hence, this study aims to evaluate the effects of initial anemia on patients with severe TBI admitted to the Emergency Unit. Methods: We reviewed the medical records of patients with isolated severe TBI admitted to the Emergency Unit of a university hospital from July 2003 to June 2008. Patients were divided into two groups based on their initial anemia data taken while in the Emergency Unit. The anemia datum is defined as hemoglobin (Hb) <10 mg/dL. The t test was used to identify the differences between the two groups, while logistic regression was applied to determine any significant differences found in the statistical analysis. Results: A total of 234 patients were signed up in our study. Based on their initial hemoglobin at emergency department, 23 patients (9.8%) comprised the anemia group, 17 patients (7.3%) comprised the nonanemia group, whereas 112 patients (47.9%) belonging to the nonanemia group were deceased. There is no significant difference between the two groups (p = 0.076; odds ratio, 0.97; confidence interval, 0.78-1.05). Conclusion: This study shows that initial anemia is not a mortality risk factor for patients with isolated severe blunt TBI.	[Yang, Chia-Jung; Hsiao, Kuang-Yu; Su, I-Chun; Chen, I-Chuan] Chang Gung Mem Hosp, Dept Emergency Med, Puzih City 613, Chiayi County, Taiwan; [Yang, Chia-Jung; Hsiao, Kuang-Yu; Su, I-Chun; Chen, I-Chuan] Chang Gung Univ, Coll Med, Dept Med, Gueishan Township, Taoyuan County, Taiwan		Chen, IC (corresponding author), Chang Gung Mem Hosp, Dept Emergency Med, 6 W Sec,Jiapu Rd, Puzih City 613, Chiayi County, Taiwan.	giomacky@gmail.com					Bjerke HS, 2000, J TRAUMA, V48, P1037; Carlson AP, 2006, J TRAUMA, V61, P567, DOI 10.1097/01.ta.0000231768.44727.a2; Chesnut RM, 1997, J TRAUMA, V42, pS4, DOI 10.1097/00005373-199705001-00002; Diringer MN, 2000, J NEUROSURG, V92, P7, DOI 10.3171/jns.2000.92.1.0007; Dorsch N W, 1994, J Clin Neurosci, V1, P19, DOI 10.1016/0967-5868(94)90005-1; Duane TM, 2008, J SURG RES, V147, P163, DOI 10.1016/j.jss.2008.02.044; Ely EW, 1999, NEW ENGL J MED, V340, P467, DOI 10.1056/NEJM199902113400610; Franklin GA, 2000, J TRAUMA, V48, P1034, DOI 10.1097/00005373-200006000-00006; George ME, 2008, NEUROCRIT CARE, V8, P337, DOI 10.1007/s12028-008-9066-y; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; Habib RH, 2003, J THORAC CARDIOV SUR, V125, P1438, DOI 10.1016/S0022-5223(02)73291-1; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hebert PC, 1997, AM J RESP CRIT CARE, V155, P1618, DOI 10.1164/ajrccm.155.5.9154866; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Jonas RA, 2003, J THORAC CARDIOV SUR, V126, P1765, DOI 10.1016/j.jtcvs.2003.04.003; KASSELL NF, 1990, J NEUROSURG, V73, P18, DOI 10.3171/jns.1990.73.1.0018; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; KRAUS JF, 2005, TXB TRAUMATIC BRAIN, P3; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Malone DL, 2006, J TRAUMA, V60, pS91, DOI 10.1097/01.ta.0000199549.80731.e6; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; McCrossan L, 2002, BRIT J ANAESTH, V88, P6, DOI 10.1093/bja/88.1.6; McIntyre LA, 2006, NEUROCRIT CARE, V5, P4, DOI 10.1385/NCC:5:1:4; Leal-Noval SR, 2008, CRIT CARE MED, V36, P1290, DOI 10.1097/CCM.0b013e3181692dfc; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Salim A, 2008, J AM COLL SURGEONS, V207, P398, DOI 10.1016/j.jamcollsurg.2008.03.013; Sena MJ, 2009, INTENS CARE MED, V35, P480, DOI 10.1007/s00134-008-1289-z; Shapiro MB, 2002, J TRAUMA, V53, P236; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Walsh TS, 2004, CRIT CARE MED, V32, P364, DOI 10.1097/01.CCM.0000108878.23703.E0; Zenati MS, 2002, J TRAUMA, V53, P232, DOI 10.1097/00005373-200208000-00007; Zygun DA, 2005, CAN J NEUROL SCI, V32, P87, DOI 10.1017/S0317167100016930; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	35	17	18	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2011	71	6					E132	E135		10.1097/TA.0b013e31820ea36b			4	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	869RT	WOS:000298616400003	21427611				2022-02-06	
J	Cullen, DK; Browne, KD; Xu, YA; Adeeb, S; Wolf, JA; McCarron, RM; Yang, S; Chavko, M; Smith, DH				Cullen, D. Kacy; Browne, Kevin D.; Xu, Yongan; Adeeb, Saleena; Wolf, John A.; McCarron, Richard M.; Yang, Shu; Chavko, Mikulas; Smith, Douglas H.			Blast-Induced Color Change in Photonic Crystals Corresponds with Brain Pathology	JOURNAL OF NEUROTRAUMA			English	Article						blast exposure; blast injury detection; blast injury dosimeter; blast neuropathology; blast sensor; mild traumatic brain injury; nanomaterial	DIFFUSE AXONAL INJURY; ADULT-RAT BRAIN; MULTIBEAM INTERFERENCE; INDUCED NEUROTRAUMA; OXIDATIVE STRESS; AMYLOID-BETA; EXPOSURE; OVERPRESSURE; ACCUMULATION; MECHANISMS	A high incidence of blast exposure is a 21st century reality in counter-insurgency warfare. However, thresholds for closed-head blast-induced traumatic brain injury (bTBI) remain unknown. Moreover, without objective information about relative blast exposure, warfighters with bTBI may not receive appropriate medical care and may remain in harm's way. Accordingly, we have engineered a blast injury dosimeter (BID) using a photonic crystalline material that changes color following blast exposure. The photonic crystals are fabricated using SU-8 via multi-beam interference laser lithography. The final BID is similar in appearance to an array of small colored stickers that may be affixed to uniforms or helmets in multiple locations. Although durable under normal conditions, the photonic crystalline micro- and nano-structure are precisely altered by blast to create a color change. These BIDs were evaluated using a rat model of bTBI, for which blast shockwave exposure was generated via a compressed air-driven shock tube. With prototype BID arrays affixed to the animals, we found that BID color changes corresponded with subtle brain pathologies, including neuronal degeneration and reactive astrocytosis. These subtle changes were most notable in the dentate gyrus of the hippocampus, cerebral cortex, and cerebellum. These data demonstrate the feasibility of using a materials-based, power-free colorimetric BID as the first self-contained blast sensor calibrated to correspond with brain pathology.	[Cullen, D. Kacy; Browne, Kevin D.; Wolf, John A.; Smith, Douglas H.] Univ Penn, Ctr Brain Injury & Repair, Dept Neurosurg, Philadelphia, PA 19104 USA; [Xu, Yongan; Yang, Shu] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA; [Adeeb, Saleena; McCarron, Richard M.; Chavko, Mikulas] USN, Trauma & Resuscitat Med Dept, Med Res Ctr, Silver Spring, MD USA		Smith, DH (corresponding author), Univ Penn, Ctr Brain Injury & Repair, Dept Neurosurg, 105 Hayden Hall,3320 Smith Walk, Philadelphia, PA 19104 USA.	smithdou@mail.med.upenn.edu	Wolf, John A/A-1034-2007; Xu, Yongan/A-7078-2011; Yang, Shu/D-9758-2011	Wolf, John A/0000-0002-6950-2303; Yang, Shu/0000-0001-8834-3320	Nanotechnology Institute of Philadelphia; Office of Naval Research (ONR)Office of Naval Research [N00014-05-0303]; Air Force Office of Scientific Research (AFOSR)United States Department of DefenseAir Force Office of Scientific Research (AFOSR) [FA9550-06-1-0228]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS038104, NS056202, NS043126]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS056202, R01NS038104, T32NS043126] Funding Source: NIH RePORTER	This work was supported by the Nanotechnology Institute of Philadelphia Proof-of-Concept (PoC) Fund, the Office of Naval Research (ONR) (grant # N00014-05-0303), the Air Force Office of Scientific Research (AFOSR) (grant # FA9550-06-1-0228), and the National Institutes of Health (NIH) (grants # NS038104, # NS056202, and # NS043126). The authors thank Constance J. Mietus and William Lane for technical contributions.	Agoston DV, 2009, J NEUROTRAUM, V26, P901, DOI 10.1089/neu.2008.0724; Campbell M, 2000, NATURE, V404, P53, DOI 10.1038/35003523; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Chavko M, 2008, J TRAUMA, V65, P1140, DOI 10.1097/TA.0b013e3181870a8c; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chavko M, 2006, J TRAUMA, V61, P933, DOI 10.1097/01.ta.0000233742.75450.47; Chavko M, 2009, SHOCK, V32, P325, DOI 10.1097/SHK.0b013e31819c38f1; Chen XH, 1999, J NEUROPATH EXP NEUR, V58, P588, DOI 10.1097/00005072-199906000-00003; Cullen DK, 2011, NEUROIMAGE, V54, pS37, DOI 10.1016/j.neuroimage.2010.10.076; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Elsayed NM, 2007, TOXICOL SCI, V95, P289, DOI 10.1093/toxsci/kfl138; Elsayed NM, 2003, TOXICOLOGY, V189, P63, DOI 10.1016/S0300-483X(03)00153-7; Elsayed NM, 1997, TOXICOLOGY, V121, P81, DOI 10.1016/S0300-483X(97)03657-3; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; GHIRADELLA H, 1972, SCIENCE, V178, P1214, DOI 10.1126/science.178.4066.1214; Gorbunov NV, 1997, AM J PHYSIOL-LUNG C, V272, pL320, DOI 10.1152/ajplung.1997.272.2.L320; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Kato K, 2007, J NEUROSURG, V106, P667, DOI 10.3171/jns.2007.106.4.667; Kaur C., 1997, Annals Academy of Medicine Singapore, V26, P27; KAUR C, 1995, NEUROPATH APPL NEURO, V21, P369, DOI 10.1111/j.1365-2990.1995.tb01073.x; Kinoshita S, 2005, CHEMPHYSCHEM, V6, P1442, DOI 10.1002/cphc.200500007; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Leung Lai Yee, 2008, Molecular & Cellular Biomechanics, V5, P155; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Li YZ, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.010902; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Martin E.M, 2008, J TRAUMA NURS, V15, P100; Martin Elisabeth Moy, 2008, J Trauma Nurs, V15, P94, DOI 10.1097/01.JTN.0000337149.29549.28; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; Meagher Sean, 2008, Mil Med, V173, pxx; Miklyaev YV, 2003, APPL PHYS LETT, V82, P1284, DOI 10.1063/1.1557328; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Moochhala SM, 2004, J TRAUMA, V56, P393, DOI 10.1097/01.TA.0000066181.50879.7A; Moon JH, 2005, J MACROMOL SCI-POL R, VC45, P351, DOI 10.1080/15321790500304163; Noh H, 2010, OPT EXPRESS, V18, P11942, DOI 10.1364/OE.18.011942; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; PHILLIPS YY, 1991, CONVENTIONAL WARFARE, P221; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Saljo A, 2002, J NEUROTRAUM, V19, P985, DOI 10.1089/089771502320317131; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Saljo Annette, 2001, Pathophysiology, V8, P105, DOI 10.1016/S0928-4680(01)00067-0; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Svetlov SI, 2009, J NEUROTRAUM, V26, P913, DOI 10.1089/neu.2008.0609; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Van Boven RW, 2009, J REHABIL RES DEV, V46, P717, DOI 10.1682/JRRD.2008.12.0161; Vukusic P, 2003, NATURE, V424, P852, DOI 10.1038/nature01941; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Xu Y, 2008, CHEM MATER, V20, P1816, DOI 10.1021/cm702511k; Yang S, 2002, CHEM MATER, V14, P2831, DOI 10.1021/cm0256007; Zi J, 2003, P NATL ACAD SCI USA, V100, P12576, DOI 10.1073/pnas.2133313100	57	17	17	1	20	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	NOV	2011	28	11			SI		2307	2318		10.1089/neu.2010.1718			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	849VY	WOS:000297154600009	22082449	Green Published			2022-02-06	
J	Magou, GC; Guo, Y; Choudhury, M; Chen, L; Hususan, N; Masotti, S; Pfister, BJ				Magou, George C.; Guo, Yi; Choudhury, Mridusmita; Chen, Linda; Hususan, Nicholae; Masotti, Stephanie; Pfister, Bryan J.			Engineering a High Throughput Axon Injury System	JOURNAL OF NEUROTRAUMA			English	Article						diffuse axonal injury; high throughput; in vitro model; stretch injury; traumatic axonal injury	TRAUMATIC BRAIN-INJURY; IN-VITRO MODEL; SQUID GIANT-AXON; MECHANICAL INJURY; CORTICAL-NEURONS; HEAD-INJURY; DELAYED DEPOLARIZATION; HIPPOCAMPAL-NEURONS; CALCIUM RESPONSE; SODIUM-CHANNELS	Several key biological mechanisms of traumatic injury to axons have been elucidated using in vitro stretch injury models. These models, however, are based on the experimentation of single cultures keeping productivity slow. Indeed, low yield has hindered important and well-founded investigations requiring high throughput methods such as proteomic analyses. To meet this need, we engineered a multi-well high throughput injury device to accelerate and accommodate the next generation of traumatic brain injury research. This modular system stretch injures neuronal cultures in either a 24-well culture plate format or 6 individual wells simultaneously. Custom software control allows the user to accurately program the pressure pulse parameters to achieve the desired substrate deformation and injury parameters. Analysis of the pressure waveforms showed that peak pressure was linearly related to input pressure and valve open times and that the 6- and 24-well modules displayed rise times, peak pressures, and decays with extremely small standard deviations. Data also confirmed that the pressure pulse was distributed evenly throughout the pressure chambers and therefore to each injury well. Importantly, the relationship between substrate deformation and applied pressure was consistent among the multiple wells and displayed a predictable linear behavior in each module. These data confirm that this multi-well system performs as well as currently used stretch injury devices and can undertake high throughput studies that are needed across the field of neurotrauma research.	[Magou, George C.; Guo, Yi; Choudhury, Mridusmita; Chen, Linda; Hususan, Nicholae; Masotti, Stephanie; Pfister, Bryan J.] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA		Pfister, BJ (corresponding author), New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA.	pfister@njit.edu		Guo, Yi/0000-0003-3103-6447	New Jersey Commission on Brain Injury Research [07-3204-BIR-E-0]; NSFNational Science Foundation (NSF) [CBET-0747615]	This work was supported by the New Jersey Commission on Brain Injury Research (07-3204-BIR-E-0) and the NSF CAREER (CBET-0747615). We thank Mr. John Hoinowski of the Biomedical Engineering Design Studio for his ingenuity and construction of the device components. Also we would like to express our gratitude to Drs. Douglas H. Smith and David F. Meaney for their continued mentorship and support.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Cargill RS, 1996, J NEUROTRAUM, V13, P395, DOI 10.1089/neu.1996.13.395; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464; Gallant PE, 1997, J NEUROTRAUM, V14, P811, DOI 10.1089/neu.1997.14.811; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1; Geddes DM, 2001, J BIOMECH ENG-T ASME, V123, P247, DOI 10.1115/1.1374201; Goforth PB, 2004, J NEUROTRAUM, V21, P719, DOI 10.1089/0897715041269704; Graham D I, 1988, Prog Clin Biol Res, V264, P159; GRAHAM DI, 1988, J CLIN PATHOL, V41, P34, DOI 10.1136/jcp.41.1.34; GRAHAM DI, 1993, HEAD INJURY, P91; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147, DOI 10.1093/oxfordjournals.bmb.a071895; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Kao CQ, 2004, J NEUROTRAUM, V21, P259, DOI 10.1089/089771504322972059; Kraus JF, 1993, HEAD INJURY, P1; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; LaPlaca MC, 1997, ANN BIOMED ENG, V25, P665, DOI 10.1007/BF02684844; LaPlaca MC, 1998, J NEUROSCI RES, V52, P220, DOI 10.1002/(SICI)1097-4547(19980415)52:2<220::AID-JNR10>3.0.CO;2-B; Lea PM, 2003, J NEUROTRAUM, V20, P1233, DOI 10.1089/089771503770802907; Lee AA, 1996, AM J PHYSIOL-CELL PH, V271, pC1400, DOI 10.1152/ajpcell.1996.271.4.C1400; Levin HS, 1998, CURR OPIN NEUROL, V11, P643, DOI 10.1097/00019052-199812000-00006; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; LUCAS JH, 1992, J NEUROTRAUM, V9, P117, DOI 10.1089/neu.1992.9.117; Lusardi TA, 2004, ANN BIOMED ENG, V32, P1546, DOI 10.1114/B:ABME.0000049038.75368.75; Lusardi TA, 2004, J NEUROTRAUM, V21, P61, DOI 10.1089/089771504772695959; Lusardi TA, 2003, BIORHEOLOGY, V40, P401; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; MARGULIES SS, 1985, P INT RES COUNCIL BI, P223; Meaney D.F., 1998, FRONTIERS HEAD NECK; Meaney D.F., 1990, INT C BIOMECHANICS I; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Meaney DF, 1993, ASME CRASHWORTHINESS, V25, P169; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Miller WJ, 2009, J NEUROTRAUM, V26, P789, DOI [10.1089/neu.2008.0727, 10.1089/neu.2008-0727]; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Morrison B, 1998, ANN BIOMED ENG, V26, P381, DOI 10.1114/1.61; Pfister B.J., 2001, THESIS J HOPKINS U; Pfister BJ, 2003, ANN BIOMED ENG, V31, P589, DOI 10.1114/1.1566445; Pfister Bryan, 2004, Mech Chem Biosyst, V1, P233; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Prado GR, 2005, J NEURAL ENG, V2, P148, DOI 10.1088/1741-2560/2/4/011; Rzigalinski BA, 1998, J NEUROCHEM, V70, P2377; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 1999, J NEUROSCI, V19, P4263; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Sosin DM, 1996, BRAIN INJURY, V10, P47; Sotoudeh M, 1998, ANN BIOMED ENG, V26, P181, DOI 10.1114/1.88; Spaethling JM, 2008, J NEUROTRAUM, V25, P1207, DOI 10.1089/neu.2008.0532; STRICH SJ, 1961, LANCET, V2, P443; Tavalin SJ, 1997, J NEUROPHYSIOL, V77, P632, DOI 10.1152/jn.1997.77.2.632; Tavalin SJ, 1995, J NEUROPHYSIOL, V74, P2767, DOI 10.1152/jn.1995.74.6.2767; von Reyn CR, 2009, J NEUROSCI, V29, P10350, DOI 10.1523/JNEUROSCI.2339-09.2009; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161	61	17	17	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2011	28	11			SI		2203	2218		10.1089/neu.2010.1596			16	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	849VY	WOS:000297154600002	21787172				2022-02-06	
J	Ogilvie, MP; Pereira, BMT; Ryan, ML; Gomez-Rodriguez, JC; Pierre, EJ; Livingstone, AS; Proctor, KG				Ogilvie, Michael P.; Pereira, Bruno M. T.; Ryan, Mark L.; Gomez-Rodriguez, Juan Carlos; Pierre, Edgar J.; Livingstone, Alan S.; Proctor, Kenneth G.			Bispectral Index to Monitor Propofol Sedation in Trauma Patients	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Electroencephalography; Electromyography; Heart rate variability; Fentanyl; Midazolam	INTENSIVE-CARE-UNIT; CRITICALLY-ILL PATIENTS; DEXMEDETOMIDINE/REMIFENTANIL; MIDAZOLAM/REMIFENTANIL; ELECTROENCEPHALOGRAM; ISOFLURANE; POTENTIALS; MIDAZOLAM; DEPTH; EEG	Background: This study tested the hypothesis that the bispectral index (BIS) is reliable relative to clinical judgment for estimating sedation level during daily propofol spontaneous awakening trials (SATs) in trauma patients. Methods: This was a prospective observational trial with waiver of consent conducted in the intensive care unit of Level I trauma center in 94 mechanically ventilated trauma patients sedated with propofol alone or in combination with midazolam. BIS, Richmond Agitation Sedation Scale (RASS), electromyography, and heart rate variability, as a test of autonomic function, were measured for 45 minutes during daily SATs. Data were evaluated with analysis of variance, linear regression, and nonparametric tests. Results: The BIS wave form coincided almost exactly with propofol on/off. Steady-state BIS correlated with RASS (p < 0.0001) and with propofol dose (p < 0.0001), but the strengths of association were relatively low (all r(2) < 0.5). BIS wave form was not altered by age, heart rate, or heart rate variability and was similar with propofol alone or propofol plus midazolam, but the presence of brain injury or the use of paralytics shifted the curve downward (both p < 0.001). The overall test characteristics for BIS versus RASS without neuromuscular blockade were sensitivity: 90% versus 77% (p = 0.034); specificity: 90% versus 75% (p = 0.021); positive predictive value: 90% versus 76% (p = 0.021), and negative predictive value: 90% versus 76% (p = 0.021). Conclusions: In the first trial in trauma patients and largest trial in any surgical population, the (1) BIS was reliable and has advantages over RASS of being continuous and objective, at least during a propofol SAT; (2) BIS interpretation remains somewhat subjective in patients receiving paralytic agents or with traumatic brain injury.	Univ Miami, Miller Sch Med, Daughtry Family Dept Surg, Div Trauma, Miami, FL 33136 USA; Univ Miami, Miller Sch Med, Daughtry Family Dept Surg, Div Surg Crit Care, Miami, FL 33136 USA		Proctor, KG (corresponding author), Univ Miami, Miller Sch Med, Dept Surg & Anesthesiol, Ryder Trauma Ctr, 1800 NW 10th Ave, Miami, FL 33136 USA.	kproctor@miami.edu	Livingstone, Alan/AAA-4026-2019; Proctor, Kenneth/AAA-2199-2022; Pereira, Bruno M/D-4542-2015	Proctor, Kenneth/0000-0003-1326-6628; Pereira, Bruno M/0000-0003-3763-1749; Gomez-Rodriguez, Juan Carlos/0000-0002-3617-1763	Office of Naval ResearchOffice of Naval Research [N140610670]	Supported, in part, by Grant no. N140610670 from the Office of Naval Research.	Arbour R, 2009, HEART LUNG, V38, P336, DOI 10.1016/j.hrtlng.2008.10.010; Consales G, 2006, MINERVA ANESTESIOL, V72, P329; Consales G, 2007, MINERVA ANESTESIOL, V73, P609; Cooke SE, 2002, AM J HEALTH-SYST PH, V59, P150; Ely EW, 2004, INTENS CARE MED, V30, P1537, DOI 10.1007/s00134-004-2298-1; Glass PS, 1997, ANESTHESIOLOGY, V86, P836, DOI 10.1097/00000542-199704000-00014; Haenggi M, 2006, ANESTH ANALG, V103, P1163, DOI 10.1213/01.ane.0000237394.21087.85; Haenggi M, 2009, ANESTH ANALG, V109, P807, DOI 10.1213/ane.0b013e3181acc85d; Haenggi M, 2009, CRIT CARE, V13, DOI 10.1186/cc7723; Hernandez-Gancedo Carmen, 2007, J Clin Monit Comput, V21, P295, DOI 10.1007/s10877-007-9087-7; Jacobi J, 2002, CRIT CARE MED, V30, P119, DOI 10.1097/00003246-200201000-00020; King DR, 2009, J TRAUMA, V67, P436, DOI 10.1097/TA.0b013e3181ad67de; LeBlanc JM, 2006, ANN PHARMACOTHER, V40, P490, DOI 10.1345/aph.1E491; Lu CH, 2008, ANESTH ANALG, V107, P1290, DOI 10.1213/ane.0b013e31818061ae; Marino PL, 2006, ICU BOOK; McKeage K, 2003, CNS DRUGS, V17, P235, DOI 10.2165/00023210-200317040-00003; Mondello Epifanio, 2002, J Clin Monit Comput, V17, P271, DOI 10.1023/A:1021250320103; Nasraway  SA, 2002, AM J HEALTH-SYST PH, V59, P147, DOI 10.1093/ajhp/59.2.147; Ostermann ME, 2000, JAMA-J AM MED ASSOC, V283, P1451, DOI 10.1001/jama.283.11.1451; Riker RR, 2003, PHARMACOTHERAPY, V23, P1087, DOI 10.1592/phco.23.10.1087.32766; Roustan JP, 2005, ANESTH ANALG, V101, P1141, DOI 10.1213/01.ane.0000167782.47957.e1; Sackey PV, 2007, ANAESTH INTENS CARE, V35, P348, DOI 10.1177/0310057X0703500305; Sackey PV, 2008, CRIT CARE, V12, DOI 10.1186/cc7029; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Tonner PH, 2005, CRIT CARE MED, V33, P580, DOI 10.1097/01.ccm.0000156291.04287.7F; Trope RM, 2005, CHEST, V128, P303, DOI 10.1378/chest.128.1.303; Tukenmez Baris, 2008, J Opioid Manag, V4, P34; Weatherburn C, 2007, ANAESTH INTENS CARE, V35, P204, DOI 10.1177/0310057X0703500208	28	17	18	1	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	NOV	2011	71	5					1415	1421		10.1097/TA.0b013e3182178b8b			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	849IG	WOS:000297118600062	21768900				2022-02-06	
J	Volman, V; Sejnowski, TJ; Bazhenov, M				Volman, Vladislav; Sejnowski, Terrence J.; Bazhenov, Maxim			Topological basis of epileptogenesis in a model of severe cortical trauma	JOURNAL OF NEUROPHYSIOLOGY			English	Article						homeostatic plasticity; paroxysmal discharge; seizure	NECROSIS-FACTOR-ALPHA; IN-VITRO; CORTEX; NETWORKS; EPILEPSY; DEAFFERENTATION; CONNECTIVITY; TRANSITION; NEOCORTEX; NEURONS	Volman V, Sejnowski TJ, Bazhenov M. Topological basis of epileptogenesis in a model of severe cortical trauma. J Neurophysiol 106:1933-1942, 2011. First published July 20, 2011; doi:10.1152/jn.00458.2011.-Epileptic activity often arises after a latent period following traumatic brain injury. Several factors contribute to the emergence of post-traumatic epilepsy, including disturbances to ionic homeostasis, pathological action of intrinsic and synaptic homeostatic plasticity, and remodeling of anatomical network synaptic connectivity. We simulated a large-scale, biophysically realistic computational model of cortical tissue to study the mechanisms underlying the genesis of post-traumatic paroxysmal epileptic-like activity in the deafferentation model of a severely traumatized cortical network. Post-traumatic generation of paroxysmal events did not require changes of the structural connectivity. Rather, network bursts were induced following the action of homeostatic synaptic plasticity, which selectively influenced functionally dominant groups of intact neurons with preserved inputs. This effect critically depended on the spatial density of intact neurons. Thus in the deafferentation model of post-traumatic epilepsy, a trauma-induced change in functional (rather than anatomical) connectivity might be sufficient for epileptogenesis.	[Bazhenov, Maxim] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; [Volman, Vladislav; Sejnowski, Terrence J.; Bazhenov, Maxim] Salk Inst Biol Studies, Howard Hughes Med Inst, Computat Neurobiol Lab, La Jolla, CA 92037 USA; [Sejnowski, Terrence J.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Volman, Vladislav; Sejnowski, Terrence J.] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA		Bazhenov, M (corresponding author), Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA.	Maksim.Bazhenov@ucr.edu	Sejnowski, Terrence/AAV-5558-2021		National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS-059740, R01-NS-060870]; Howard Hughes Medical InstituteHoward Hughes Medical Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS059740, R01NS060870] Funding Source: NIH RePORTER	This research was supported by the National Institute of Neurological Disorders and Stroke Grants R01-NS-059740 and R01-NS-060870 and the Howard Hughes Medical Institute.	Avramescu S, 2008, J NEUROSCI, V28, P6760, DOI 10.1523/JNEUROSCI.0643-08.2008; Bogaard A, 2009, J NEUROSCI, V29, P1677, DOI 10.1523/JNEUROSCI.5218-08.2009; Butz M, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.010.2009; de Curtis M, 2001, PROG NEUROBIOL, V63, P541, DOI 10.1016/S0301-0082(00)00026-5; Dorogovtsev S. N., 2013, EVOLUTION NETWORKS B; Dyhrfjeld-Johnsen J, 2007, J NEUROPHYSIOL, V97, P1566, DOI 10.1152/jn.00950.2006; Dzhala VI, 2003, J NEUROSCI, V23, P7873; Edelstein-Keshet L, 2002, J THEOR BIOL, V216, P301, DOI 10.1006/jtbi.2002.2540; Frohlich F, 2008, J NEUROSCI, V28, P1709, DOI 10.1523/JNEUROSCI.4263-07.2008; GRAFSTEIN B, 1957, ELECTROEN CLIN NEURO, V9, P723, DOI 10.1016/0013-4694(57)90096-2; Houweling AR, 2005, CEREB CORTEX, V15, P834, DOI 10.1093/cercor/bhh184; Jin XM, 2006, J NEUROSCI, V26, P4891, DOI 10.1523/JNEUROSCI.4361-05.2006; Keller CJ, 2010, BRAIN, V133, P1668, DOI 10.1093/brain/awq112; Lau LT, 2001, J NEUROTRAUM, V18, P351, DOI 10.1089/08977150151071035; Morgan RJ, 2008, P NATL ACAD SCI USA, V105, P6179, DOI 10.1073/pnas.0801372105; Netoff TI, 2004, J NEUROSCI, V24, P8075, DOI 10.1523/JNEUROSCI.1509-04.2004; Pitkanen A, 2006, MODELS OF SEIZURES AND EPILEPSY, P1; Prescott SA, 2006, J NEUROSCI, V26, P9084, DOI 10.1523/JNEUROSCI.1388-06.2006; PRINCE DA, 1993, J NEUROPHYSIOL, V69, P1276, DOI 10.1152/jn.1993.69.4.1276; Srinivas KV, 2007, EUR J NEUROSCI, V25, P3276, DOI 10.1111/j.1460-9568.2007.05559.x; Steinmetz CC, 2010, J NEUROSCI, V30, P14685, DOI 10.1523/JNEUROSCI.2210-10.2010; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Timofeev I, 2010, NEUROSCIENTIST, V16, P19, DOI 10.1177/1073858409333545; Topolnik L, 2003, CEREB CORTEX, V13, P883, DOI 10.1093/cercor/13.8.883; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Wendling F, 2005, J CLIN NEUROPHYSIOL, V22, P343	26	17	17	0	15	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077			J NEUROPHYSIOL	J. Neurophysiol.	OCT	2011	106	4					1933	1942		10.1152/jn.00458.2011			10	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	836EJ	WOS:000296092000029	21775725	Green Published			2022-02-06	
J	Harned, ME; Salles, SS; Grider, JS				Harned, Michael E.; Salles, Sara S.; Grider, Jay S.			An Introduction to Trialing Intrathecal Baclofen in Patients with Hemiparetic Spasticity: A Description of 3 Cases	PAIN PHYSICIAN			English	Article						Baclofen; intrathecal drug delivery; spasticity; multiple sclerosis; traumatic brain injury	CEREBRAL-PALSY; THERAPY; MANAGEMENT; CHILDREN; PUMP; METHYLPREDNISOLONE; GUIDELINES; WITHDRAWAL; ZICONOTIDE; EFFICACY	Background: Intrathecal baclofen has been an effective therapy in the management of spasticity. As interventional pain physicians are rapidly becoming the experts in intrathecal drug delivery, they are now frequently asked to trial and implant intrathecal baclofen therapy. While some physicians might be very comfortable with the process of trialing and implanting, others will have next to no experience until the first consult appears on their desks. While uncomplicated lower extremity spasticity can usually be trialed with a single-shot bolus injection, more complicated cases of upper and lower extremities or hemiparetic spasticity need a more delicate approach. This is the first case series in the literature reporting a trial using an indwelling temporary catheter and inpatient admission. Moreover, while the technical aspects of intrathecal therapy trialing and implantation might be familiar for the interventional physician, we review the indications and goals of therapy, about which the physician may be less familiar. Objective: To present a technique for trialing intrathecal baclofen in patients with severe upper and lower extremities spasticity complication for which a single shot technique may be inadequate. Design: Case report of three patients. Setting: Tertiary-care referral medical center. Patients: A 30-year-old man with severe spasticity of the right upper and lower extremities with preserved left-sided function due to diffuse axonal injury. A 45-year-old woman with traumatic brain injury and severe spasticity of the left upper extremity with minimal dysfunction in the right upper extremity. A 34-year-old woman with Multiple Sclerosis and severe spasticity in the right upper extremity and bilateral lower extremities. Intervention: Placement of a temporary intrathecal catheter and an inpatient trial of intrathecal baclofen. Results: In all patients, there was significant improvement in spasticity as documented by decreased Modified Ashworth Scale scores while preserving motor strength and coordination in the unaffected extremities. Limitations: Retrospective review of 3 cases in a single center. Conclusions: Trialing for baclofen is usually performed as a single shot bolus. For patients with severe hemiparetic spasticity or in patients where weakness in the unaffected limb might significantly affect quality of life, this trialing technique may be inadequate. In these patients, placement of a temporary intrathecal catheter and inpatient admission may be a more effective trial method.	[Harned, Michael E.] Univ Kentucky, Coll Med, Dept Anesthesiol, Div Pain Med, Lexington, KY 40536 USA; [Salles, Sara S.] Univ Kentucky, Dept Phys Med & Rehabil, Lexington, KY 40536 USA		Harned, ME (corresponding author), Univ Kentucky, Coll Med, Dept Anesthesiol, Div Pain Med, 800 Rose St,Suite N 201, Lexington, KY 40536 USA.	meharn2@email.uky.edu					ALBRIGHT AL, 1991, JAMA-J AM MED ASSOC, V265, P1418, DOI 10.1001/jama.265.11.1418; ALBRIGHT AL, 1995, CNS DRUGS, V4, P17, DOI 10.2165/00023210-199504010-00003; ALBRIGHT AL, 1993, JAMA-J AM MED ASSOC, V270, P2475, DOI 10.1001/jama.270.20.2475; ASHWORTH B, 1964, PRACTITIONER, V192, P540; Awaad Y, 2003, J CHILD NEUROL, V18, P26, DOI 10.1177/08830738030180010701; Burton AW, 2010, PAIN PHYSICIAN, V13, P23; Coffey RJ, 2002, ARCH PHYS MED REHAB, V83, P735, DOI 10.1053/apmr.2002.32820; Damiano DL, 2002, DEV MED CHILD NEUROL, V44, P112, DOI 10.1017/S0012162201001761; Deer T, 2009, PAIN PHYSICIAN, V12, pE291; Deer TR, 2011, PAIN PHYSICIAN, V14, pE283; Deer TR, 2010, PAIN PHYSICIAN, V13, pE1750; Dureja GP, 2010, PAIN PHYSICIAN, V13, P213; Fluckiger B, 2008, SPINAL CORD, V46, P639, DOI 10.1038/sc.2008.24; Grabb PA, 1999, NEUROSURGERY, V45, P833, DOI 10.1097/00006123-199910000-00020; Green LB, 1999, ARCH PHYS MED REHAB, V80, P1600, DOI 10.1016/S0003-9993(99)90337-4; Haley SM, 1990, PRACTICAL MANAGEMENT, P115; Hayek SM, 2011, PAIN PHYSICIAN, V14, P219; Kapoor R, 2010, PAIN PHYSICIAN, V13, pE321; Krach LE, 2001, J CHILD NEUROL, V16, P31, DOI 10.1177/088307380101600106; Lima RM, 2010, PAIN PHYSICIAN, V13, P493; Manchikanti L, 2009, PAIN PHYSICIAN, V12, P699; Murphy NA, 2002, ARCH PHYS MED REHAB, V83, P1721, DOI 10.1053/apmr.2002.36068; Patel VB, 2009, PAIN PHYSICIAN, V12, P345; PENN RD, 1984, LANCET, V1, P1078; PENN RD, 1989, NEW ENGL J MED, V320, P1517, DOI 10.1056/NEJM198906083202303; Raffaeli W, 2011, PAIN PHYSICIAN, V14, P15; Rawicki B, 1999, J NEUROSURG, V91, P733, DOI 10.3171/jns.1999.91.5.0733; Ruan XL, 2010, PAIN PHYSICIAN, V13, P337; Steinbok P, 2000, Clin Neurosurg, V47, P440; Wilkes D, 2010, PAIN PHYSICIAN, V13, P151	30	17	17	0	1	AM SOC INTERVENTIONAL PAIN PHYSICIANS	PADUCAH	81 LAKEVIEW DR, PADUCAH, KY 42001 USA	1533-3159			PAIN PHYSICIAN	Pain Physician	SEP-OCT	2011	14	5					483	489					7	Anesthesiology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology	885MW	WOS:000299784100017	21927053				2022-02-06	
J	Hollis, SJ; Stevenson, MR; McIntosh, AS; Li, L; Heritier, S; Shores, EA; Collins, MW; Finch, CF				Hollis, Stephanie J.; Stevenson, Mark R.; McIntosh, Andrew S.; Li, Ling; Heritier, Stephane; Shores, E. Arthur; Collins, Michael W.; Finch, Caroline F.			Mild traumatic brain injury among a cohort of rugby union players: predictors of time to injury	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							RISK-FACTORS; HIGH-SCHOOL; CONCUSSION; FOOTBALL; EPIDEMIOLOGY; MATCH	This study reports the time to sustain a mild traumatic brain injury (mTBI) among a cohort of community rugby union players. Demographic and player characteristics were collected and players followed up for between one and three playing seasons. 7% of the cohort sustained an mTBI within 10 h of game time, increasing twofold to 14% within 20 h. The mean time to first mTBI was 8 h with an SD of 6.2 (median 6.8 h; IQR: 2.9-11.7 h). Players reporting a recent history of concussion were 20% more likely to sustain an mTBI after 20 h of game time compared with those with no recent history of concussion. Players were likely to sustain an mTBI in shorter time if they trained for <3 h/week (HR= 1.48, p=0.03) or had a body mass index <27 (HR=1.77, p=0.007). The findings highlight modifiable characteristics to reduce the likelihood of shortened time to mTBI.	[Hollis, Stephanie J.; Heritier, Stephane] George Inst Global Hlth, Sydney, NSW, Australia; [Hollis, Stephanie J.; Heritier, Stephane] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Stevenson, Mark R.] Monash Univ, Monash Injury Res Inst, Accid Res Ctr, Melbourne, Vic 3004, Australia; [Stevenson, Mark R.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia; [McIntosh, Andrew S.] Univ New S Wales, Sch Risk & Safety Sci, Sydney, NSW, Australia; [Li, Ling] Univ New S Wales, Ctr Hlth Syst & Safety Res, Sydney, NSW, Australia; [Shores, E. Arthur] Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia; [Collins, Michael W.] Univ Pittsburgh, UPMC Ctr Sports Med, Pittsburgh, PA USA; [Finch, Caroline F.] Monash Univ, Monash Injury Res Inst, Australian Ctr Res Injury Sport & Its Prevent, Melbourne, Vic 3004, Australia		Hollis, SJ (corresponding author), Univ Sydney, Sydney Med Sch, 25 Nichols Parade, Mt Riverview, NSW 2774, Australia.	shollis@georgeinstitute.org.au	Hollis, Stephanie J/B-5977-2011; stevenson, mark/AAE-9706-2019; Li, Ling/E-1222-2012	stevenson, mark/0000-0003-3166-5876; Li, Ling/0000-0002-1642-142X; Shores, Edwin A/0000-0003-1553-5131	Australian Government's National Health and Medical Research CouncilNational Health and Medical Research Council of Australia; NSW Sporting Injuries Committee; New South Wales Health Biostatistical Training Program; US Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [5R49CE323155]; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE323155] Funding Source: NIH RePORTER	SJH was supported by postgraduate scholarship funding from the Australian Government's National Health and Medical Research Council, and scholarship funding from the NSW Sporting Injuries Committee. MRS was also supported by funding from the Australian Government's National Health and Medical Research Council. LL was funded by the New South Wales Health Biostatistical Training Program. This study was supported by the US Centers for Disease Control and Prevention grant 5R49CE323155 to the University of Pittsburgh Center for Injury Research and Control.	Brooks JHM, 2005, BRIT J SPORT MED, V39, P757, DOI 10.1136/bjsm.2005.018135; Brooks JHM, 2008, J SPORT SCI, V26, P863, DOI 10.1080/02640410701832209; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Cantu RC, 2009, CURR SPORT MED REP, V8, P6, DOI 10.1249/JSR.0b013e31819677db; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Kerr HA, 2008, BRIT J SPORT MED, V42, P595, DOI 10.1136/bjsm.2007.035881; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Lee AJ, 2001, BRIT J SPORT MED, V35, P412, DOI 10.1136/bjsm.35.6.412; MacQueen AE, 2010, CURR SPORT MED REP, V9, P139, DOI 10.1249/JSR.0b013e3181df124c; McIntosh AS, 2010, BRIT J SPORT MED, V44, P188, DOI 10.1136/bjsm.2007.041400; Quarrie KL, 2001, BRIT J SPORT MED, V35, P157, DOI 10.1136/bjsm.35.3.157; SAS Institute, 2009, SAS STAT SOFTW; Schneiders AG, 2009, PHYS THER SPORT, V10, P85, DOI 10.1016/j.ptsp.2009.05.001; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; StataCorp LP, 2007, STAT STAT SOFTW; Takemura M, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.035568	18	17	18	0	14	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674			BRIT J SPORT MED	Br. J. Sports Med.	SEP	2011	45	12					997	999		10.1136/bjsm.2010.079707			3	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	816PM	WOS:000294614600015	21482546				2022-02-06	
J	Ranaivo, HR; Zunich, SM; Choi, N; Hodge, JN; Wainwright, MS				Ranaivo, Hantamalala Ralay; Zunich, Samantha M.; Choi, Nicole; Hodge, Jessica N.; Wainwright, Mark S.			Mild Stretch-Induced Injury Increases Susceptibility to Interleukin-1 beta-Induced Release of Matrix Metalloproteinase-9 from Astrocytes	JOURNAL OF NEUROTRAUMA			English	Article						astrocyte; interleukin-1 beta; mechanical stretch; metalloproteinease-9; mitogen protein-activated kinase	TRAUMATIC BRAIN-INJURY; FOCAL CEREBRAL-ISCHEMIA; ACTIVATED PROTEIN-KINASE; GENE KNOCK-OUT; MATRIX METALLOPROTEINASES; PROINFLAMMATORY CYTOKINE; CULTURED ASTROCYTES; REACTIVE ASTROCYTES; EXTRACELLULAR ATP; BARRIER	Traumatic brain injury (TBI) results in the activation of glia and the release of proinflammatory cytokines, including interleukin (IL)-1 beta. The response of astrocytes to mild TBI has not been well studied. We used an in vitro model of cell stretch to investigate the effects of mild mechanical insult on astrocyte injury (lactate dehydrogenase and propidium iodide), and on mediators of inflammation including IL-1 beta, the chemokine CX3CL1, and nitrite. Here, we tested the hypothesis that a mild mechanical insult would increase susceptibility of astrocytes to delayed exposure to IL-1 beta, including enhanced release of the matrix metalloproteinease-9 (MMP-9). We investigated the role of the mitogen protein-activated kinase (MAPK) pathway in these responses. Cells subjected to a mild stretch show an increase in activation of the ERK1/2 and JNK pathways, and an increase in lactate dehydrogenase (LDH), but no change in the levels of inflammatory mediators. An early increase in LDH was dependent on ERK activation. Exposure to IL-1 beta, or to stretch alone, did not increase MMP-9. In contrast, the combination of mild stretch followed by IL-1 beta resulted in greater activation of the ERK pathway compared to either stimulus alone, and also resulted in an increase in the production of MMP-9 by astrocytes. Inhibition of the ERK pathway suppressed the increase in MMP-9 induced by the combination of stretch and IL-1 beta treatment. These results suggest that a primary mild mechanical injury renders astrocytes more susceptible to a secondary exposure to a proinflammatory cytokine such as IL-1 beta via the activation of the ERK pathway, and suggest a mechanism by which a mild head injury may confer increased susceptibility to neurologic injury caused by a subsequent insult.	[Ranaivo, Hantamalala Ralay; Zunich, Samantha M.; Choi, Nicole; Hodge, Jessica N.; Wainwright, Mark S.] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Div Neurol, Chicago, IL 60611 USA; [Wainwright, Mark S.] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Div Crit Care Med, Chicago, IL 60611 USA; [Ranaivo, Hantamalala Ralay; Zunich, Samantha M.; Choi, Nicole; Hodge, Jessica N.; Wainwright, Mark S.] Northwestern Univ, Feinberg Sch Med, Ctr Interdisciplinary Res Pediat Crit Illness & I, Chicago, IL 60611 USA		Wainwright, MS (corresponding author), Childrens Mem Hosp, Div Neurol 51, 2300 Childrens Plaza, Chicago, IL 60614 USA.	m-wainwright@northwestern.edu			Medical Research Junior Board Foundation; Lyndsey Whittingham Foundation	Dr. Wainwright is supported by the Medical Research Junior Board Foundation, and by the Lyndsey Whittingham Foundation.	Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.0741951.x; Arai K, 2003, GLIA, V43, P254, DOI 10.1002/glia.10255; Arundine M, 2004, J NEUROSCI, V24, P8106, DOI 10.1523/JNEUROSCI.1362-04.2004; Arundine M, 2003, J NEUROTRAUM, V20, P1377, DOI 10.1089/089771503322686166; Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Asahi M, 2000, J CEREBR BLOOD F MET, V20, P1681, DOI 10.1097/00004647-200012000-00007; Birukov KG, 2003, AM J PHYSIOL-LUNG C, V285, pL785, DOI 10.1152/ajplung.00336.2002; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Chen WQ, 2009, J NEUROCHEM, V111, P726, DOI 10.1111/j.1471-4159.2009.06362.x; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Chrzaszcz M, 2010, J NEUROTRAUM, V27, P1283, DOI 10.1089/neu.2009.1227; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Fassbender K, 2000, NEUROSCI LETT, V284, P135, DOI 10.1016/S0304-3940(00)00977-0; Floyd CL, 2004, J NEUROTRAUM, V21, P205, DOI 10.1089/089771504322778668; Fujimura M, 1999, BRAIN RES, V842, P92, DOI 10.1016/S0006-8993(99)01843-0; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; Hayashi T, 2009, BRAIN RES, V1280, P172, DOI 10.1016/j.brainres.2009.05.040; Heida JG, 2005, EPILEPSIA, V46, P1906, DOI 10.1111/j.1528-1167.2005.00294.x; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Hooper C, 2009, J NEUROCHEM, V109, P694, DOI 10.1111/j.1471-4159.2009.05953.x; Hsu HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012470; Huang TT, 2009, J NEUROTRAUM, V26, P1535, DOI [10.1089/neu.2008.0743, 10.1089/neu.2008-0743]; Jayakumar AR, 2008, J NEUROPATH EXP NEUR, V67, P417, DOI 10.1097/NEN.0b013e31816fc9d4; Kumaria A, 2008, BRIT J NEUROSURG, V22, P200, DOI 10.1080/02688690701772413; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Lee J, 2002, NEUROMOL MED, V2, P29; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mori T, 2002, J NEUROTRAUM, V19, P1411, DOI 10.1089/089771502320914642; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Neary JT, 2005, IUBMB LIFE, V57, P711, DOI 10.1080/15216540500319143; Neary JT, 2005, J NEUROTRAUM, V22, P491, DOI 10.1089/neu.2005.22.491; Neary JT, 2003, J NEUROSCI, V23, P2348, DOI 10.1523/jneurosci.23-06-02348.2003; Ranaivo HR, 2010, EXP NEUROL, V226, P310, DOI 10.1016/j.expneurol.2010.09.005; Ranaivo HR, 2010, BRAIN RES, V1313, P222, DOI 10.1016/j.brainres.2009.11.063; Ravizza T, 2008, NEUROBIOL DIS, V29, P142, DOI 10.1016/j.nbd.2007.08.012; Rosenberg GA, 1996, J CEREBR BLOOD F MET, V16, P360, DOI 10.1097/00004647-199605000-00002; Rosenberg GA, 1997, NEUROLOGY, V48, P921, DOI 10.1212/WNL.48.4.921; Rosenberg GA, 1998, STROKE, V29, P2189, DOI 10.1161/01.STR.29.10.2189; Rzigalinski BA, 1998, J NEUROCHEM, V70, P2377; Somera-Molina KC, 2007, EPILEPSIA, V48, P1785, DOI 10.1111/j.1528-1167.2007.01135.x; Somera-Molina KC, 2009, BRAIN RES, V1282, P162, DOI 10.1016/j.brainres.2009.05.073; Tejima E, 2007, J CEREBR BLOOD F MET, V27, P460, DOI 10.1038/sj.jcbfm.9600354; TOTH M, 2001, METASTASIS RES PROTO, P163; Vilalta A, 2008, INTENS CARE MED, V34, P1384, DOI 10.1007/s00134-008-1056-1; von Gertten C, 2003, J NEUROSCI RES, V73, P803, DOI 10.1002/jnr.10729; Wang XY, 2002, J NEUROTRAUM, V19, P615, DOI 10.1089/089771502753754082; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Wilczynski GM, 2008, J CELL BIOL, V180, P1021, DOI 10.1083/jcb.200708213; Willoughby KA, 2004, J NEUROCHEM, V91, P1284, DOI 10.1111/j.1471-4159.2004.02812.x; Wu CY, 2004, J NEUROCHEM, V90, P1477, DOI 10.1111/j.1471-4159.2004.02682.x; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Zhou H, 2011, NEUROCHEM RES, V36, P17, DOI 10.1007/s11064-010-0254-8; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	55	17	18	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2011	28	9					1757	1766		10.1089/neu.2011.1799			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	821AK	WOS:000294947000009	21732764				2022-02-06	
J	Ryan, PB; Lee-Wilk, T; Kok, BC; Wilk, JE				Ryan, Patricia B.; Lee-Wilk, Terry; Kok, Brian C.; Wilk, Joshua E.			Interdisciplinary rehabilitation of mild TBI and PTSD: A case report	BRAIN INJURY			English	Article						Concussion; post-concussive symptoms; post-traumatic stress disorder; veterans; blast injuries; iatrogenic effects	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; GOOD OLD DAYS; HEAD-INJURY; SYMPTOMS; VETERANS; EXPECTATION; PERFORMANCE; HEALTH; IRAQ	Background: Prevalence of mild traumatic brain injury (mTBI) or concussion on the battlefield in Iraq/Afghanistan has resulted in its designation as a 'signature injury'. Civilian studies have shown that negative expectations for recovery may lead to worse outcomes. While there is concern that concussion screening procedures in the Veteran's Affairs Healthcare System and the Department of Defence could fuel negative expectations, leading to negative iatrogenic effects, it has been difficult to document this in clinical settings. The aim of this report is to describe the case of a veteran with comorbid mTBI/PTSD with persistent symptoms of unknown aetiology and the effects of provider communications on the patient's recovery. Methods: Case report of a veteran with reported mTBI, including provider communications, neuropsychological test results and report of functioning after changes in provider messages. Results: Two-years post-mTBI, the patient attributed cognitive difficulties to his brain injury, but neuropsychological assessment found that his cognitive profile was consistent with psychological rather than neurological dysfunction. After providers systematically emphasized expectations of recovery, the patient's daily functioning improved. Conclusions: This case illustrates difficulties in mass screening for and treating mTBI. Recommendations for improvement include clinician training in effectively communicating positive expectations of recovery after concussion.	[Ryan, Patricia B.; Lee-Wilk, Terry] Baltimore VA Med Ctr, VA Maryland Hlth Care Syst, Baltimore, MD USA; [Kok, Brian C.; Wilk, Joshua E.] Walter Reed Army Inst Res, Silver Spring, MD USA		Wilk, JE (corresponding author), 503 Robert Grant Dr, Silver Spring, MD 20910 USA.	joshua.wilk@amedd.army.mil					BATTEN S, 2009, CONS C COGN REH MILD; *BATTL TRANS OFF, 2010, CONC MTBI INF US 1 M; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Cooper DB, 2010, NEUROREHABILITATION, V26, P233, DOI 10.3233/NRE-2010-0559; Delis D.C., 2000, CALIFORNIA VERBAL LE; Department of Veterans Affairs/Department of Defense, 2009, VA DOD CLIN PRACT GU; Ferguson RJ, 1999, NEUROPSYCHOLOGY, V13, P582, DOI 10.1037/0894-4105.13.4.582; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Golden CJ, 1978, STROOP COLOR WORD TE; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Howe LLS, 2009, CLIN NEUROPSYCHOL, V23, P1315, DOI 10.1080/13854040903266928; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Jaycox, 2008, INVISIBLE WOUNDS WAR; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Malec J., 2005, MAYO PORTLAND ADAPTA; Marx BP, 2009, J INT NEUROPSYCH SOC, V15, P840, DOI 10.1017/S1355617709990488; McCrea M., 2008, MILD TRAUMATIC BRAIN; McDermott LM, 2009, J AFFECT DISORDERS, V119, P1, DOI 10.1016/j.jad.2009.04.022; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; MEYERS J, 1995, MEYERS SCORING SYSTE; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Mittenberg W, 2008, TXB CLIN NEUROPSYCHO, P430; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Smith, 1973, SYMBOL DIGIT MODALIT; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; *US ARM PHYS DIS A, 2008, TEMP DIS RET LIST TD, P1; *US DEP DEF TASK F, 2009, ACH VIS REP DEP DEF; *US GOV ACC OFF, 2008, GAO08276; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WechslerD, 2001, WECHSLER TEST ADULT; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f	43	17	17	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2011	25	10					1019	1025		10.3109/02699052.2011.597044			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	801TZ	WOS:000293464800013	21812588				2022-02-06	
J	Shi, J; Tu, JL; Gale, SD; Baxter, L; Vollmer, TL; Campagnolo, DI; Tyry, TM; Zhuang, Y; Kuniyoshi, SM				Shi, Jiong; Tu, Jiang-Long; Gale, Shawn D.; Baxter, Leslie; Vollmer, Timothy L.; Campagnolo, Denise I.; Tyry, Tuula M.; Zhuang, Yi; Kuniyoshi, Sandra M.			APOE epsilon 4 Is Associated With Exacerbation of Cognitive Decline in Patients With Multiple Sclerosis	COGNITIVE AND BEHAVIORAL NEUROLOGY			English	Article						multiple sclerosis; cognition; apolipoprotein E; neuroimmunology	APOLIPOPROTEIN-E EPSILON-4; TRAUMATIC BRAIN-INJURY; GREY-MATTER PATHOLOGY; DEEP GRAY-MATTER; ALZHEIMERS-DISEASE; VOLUME CHANGES; E GENOTYPE; FOLLOW-UP; IMPAIRMENT; ATROPHY	Background: In previous studies we and others have demonstrated an association with apolipoprotein (APOE) epsilon 4 genotype and the presence of cognitive deficits in multiple sclerosis (MS). In this follow-up study, we have assessed whether APOE epsilon 4 status exacerbates progression of cognitive deficits in MS. Methods: A total of 197 patients with MS were assessed for APOE genotype, and baseline cognitive performance was measured using a standardized battery of tests. One hundred seventy patients (86.3%) were clinically followed up for 1 year and were assessed for progression of cognitive deficits. Results: The APOE epsilon 4 allele was present in 24.7% of patients. During 1-year follow-up, significant progression of cognitive deficits was found in APOE epsilon 4 carriers (P = 0.001) after logistic regression analysis controlling for sex, ethnicity, age, education, disease duration, severity, and subtype. Conclusions: APOE epsilon 4 carriers with MS have worsening progression of cognitive deficits than noncarriers. APOE epsilon 4 carrier status predicts cognitive decline in verbal learning and memory.	[Shi, Jiong; Tu, Jiang-Long; Campagnolo, Denise I.; Tyry, Tuula M.] St Josephs Hosp, Barrow Neurol Inst, Div Neurol, Phoenix, AZ 85013 USA; [Gale, Shawn D.; Baxter, Leslie] St Josephs Hosp, Barrow Neurol Inst, Div Neuropsychol, Phoenix, AZ 85013 USA; Med Ctr, Phoenix, AZ 85013 USA; [Shi, Jiong; Zhuang, Yi; Kuniyoshi, Sandra M.] Arizona State Univ, Dept Biostat, Tempe, AZ 85287 USA; [Vollmer, Timothy L.] Univ Colorado Hlth Sci, Dept Neurol, Denver, CO USA		Shi, J (corresponding author), St Josephs Hosp, Barrow Neurol Inst, Div Neurol, 500 W Thomas Rd,Suite 720, Phoenix, AZ 85013 USA.	jiong.shi@chw.edu	Gale, Shawn/M-3144-2013	Gale, Shawn/0000-0002-8989-0964; Baxter, Leslie/0000-0002-3971-863X	National Multiple Sclerosis SocietyNational Multiple Sclerosis Society; Barrow Neurological Foundation	Supported by a Pilot Research Award from the National Multiple Sclerosis Society and Barrow Neurological Foundation.	Achiron A, 2005, J NEUROL NEUROSUR PS, V76, P744, DOI 10.1136/jnnp.2004.045518; Agosta F, 2009, P NATL ACAD SCI USA, V106, P2018, DOI 10.1073/pnas.0812697106; Amato MP, 2008, NEUROLOGY, V70, P1891, DOI 10.1212/01.wnl.0000312276.23177.fa; Amato MP, 2007, ARCH NEUROL-CHICAGO, V64, P1157, DOI 10.1001/archneur.64.8.1157; AMATO MP, 1995, ARCH NEUROL-CHICAGO, V52, P168, DOI 10.1001/archneur.1995.00540260072019; Ashford JW, 2004, J MOL NEUROSCI, V23, P157, DOI 10.1385/JMN:23:3:157; Bakshi R, 2002, ARCH NEUROL-CHICAGO, V59, P62, DOI 10.1001/archneur.59.1.62; Ballard CG, 2004, NEUROLOGY, V63, P1399; Bircher A U, 1975, Nurs Forum, V14, P11; Bo L, 2003, J NEUROPATH EXP NEUR, V62, P723, DOI 10.1093/jnen/62.7.723; Bo L, 2003, MULT SCLER, V9, P323, DOI 10.1191/1352458503ms917oa; Bo L, 2007, ARCH NEUROL-CHICAGO, V64, P76, DOI 10.1001/archneur.64.1.76; Burwick RM, 2006, NEUROLOGY, V66, P1373, DOI 10.1212/01.wnl.0000210531.19498.3f; Caselli RJ, 2007, ARCH NEUROL-CHICAGO, V64, P1306, DOI 10.1001/archneur.64.9.1306; Caselli RJ, 2009, NEW ENGL J MED, V361, P255, DOI 10.1056/NEJMoa0809437; Chard DT, 2003, J NEUROL NEUROSUR PS, V74, P1551, DOI 10.1136/jnnp.74.11.1551; Corona T, 2010, REV NEUROLOGIA, V50, P19, DOI 10.33588/rn.5001.2008129; Cosentino S, 2008, NEUROLOGY, V70, P1842, DOI 10.1212/01.wnl.0000304038.37421.cc; Degenhardt A, 2009, NAT REV NEUROL, V5, P672, DOI 10.1038/nrneurol.2009.178; Devanand DP, 2005, ARCH NEUROL-CHICAGO, V62, P975, DOI 10.1001/archneur.62.6.975; Duquin JA, 2008, J INT NEUROPSYCH SOC, V14, P494, DOI 10.1017/S1355617708080624; Ely EW, 2007, CRIT CARE MED, V35, P112, DOI 10.1097/01.CCM.0000251925.18961.CA; Evangelou N, 1999, J NEUROL NEUROSUR PS, V67, P203, DOI 10.1136/jnnp.67.2.203; Fazekas F, 2001, NEUROLOGY, V57, P853, DOI 10.1212/WNL.57.5.853; Fisher E, 2008, ANN NEUROL, V64, P255, DOI 10.1002/ana.21436; FISNIKU LK, 2008, ANN NEUROL; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Geurts JJG, 2008, LANCET NEUROL, V7, P841, DOI 10.1016/S1474-4422(08)70191-1; Ghaffar O, 2010, NEUROLOGY, V74, P1611, DOI 10.1212/WNL.0b013e3181e074a7; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Guerrero AL, 2008, ACTA NEUROL SCAND, V117, P21, DOI 10.1111/j.1600-0404.2007.00908.x; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; HIXSON JE, 1990, J LIPID RES, V31, P545; Hoe HS, 2005, J NEUROCHEM, V93, P145, DOI 10.1111/j.1471-4159.2004.03007.x; Hoyt BD, 2005, ARCH NEUROL-CHICAGO, V62, P454, DOI 10.1001/archneur.62.3.454; Koutsis G, 2007, NEUROLOGY, V68, P546, DOI 10.1212/01.wnl.0000254468.51973.44; MacPherson D, 2007, CANCER RES, V67, P7547, DOI 10.1158/0008-5472.CAN-07-0276; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Marrie RA, 2007, MULT SCLER, V13, P770, DOI 10.1177/1352458506075031; Martins CAR, 2005, NEUROLOGY, V65, P1888, DOI 10.1212/01.wnl.0000188871.74093.12; Mosconi L, 2004, NEUROLOGY, V63, P2332, DOI 10.1212/01.WNL.0000147469.18313.3B; Parmenter BA, 2007, MULT SCLER J, V13, P25, DOI 10.1177/1352458506070682; Peterson LK, 2007, J NEUROIMMUNOL, V184, P37, DOI 10.1016/j.jneuroim.2006.11.015; Pham T, 2005, BIOCHEMISTRY-US, V44, P7577, DOI 10.1021/bi0472696; Pirko I, 2007, NEUROLOGY, V68, P634, DOI 10.1212/01.wnl.0000250267.85698.7a; Portaccio E, 2009, ACTA NEUROL SCAND, V120, P439, DOI 10.1111/j.1600-0404.2009.01278.x; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; RAO SM, 1995, CURR OPIN NEUROL, V8, P216, DOI 10.1097/00019052-199506000-00010; RAO SM, 1991, NEUROLOGY, V41, P692, DOI 10.1212/WNL.41.5.692; Roosendaal SD, 2009, MULT SCLER, V15, P708, DOI 10.1177/1352458509102907; Rudick RA, 2009, J NEUROL SCI, V282, P106, DOI 10.1016/j.jns.2008.11.018; Sedano MJ, 2006, MULT SCLER J, V12, P13, DOI 10.1191/135248506ms1243oa; Shi J, 2008, NEUROLOGY, V70, P185, DOI 10.1212/01.wnl.0000264004.62612.44; Stadelmann C, 2008, CURR OPIN NEUROL, V21, P229, DOI 10.1097/01.wco.0000318863.65635.9a; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Tiberio M, 2005, NEUROLOGY, V64, P1001, DOI 10.1212/01.WNL.0000154526.22878.30; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Tu JL, 2009, BIOCHEM BIOPH RES CO, V384, P466, DOI 10.1016/j.bbrc.2009.04.153; van der Walt A, 2009, NEUROLOGY, V73, P1018, DOI 10.1212/WNL.0b013e3181b9c85e; Vercellino M, 2005, J NEUROPATH EXP NEUR, V64, P1101, DOI 10.1097/01.jnen.0000190067.20935.42; Vercellino M, 2009, J NEUROPATH EXP NEUR, V68, P489, DOI 10.1097/NEN.0b013e3181a19a5a; Wagle J, 2009, DEMENT GERIATR COGN, V27, P525, DOI 10.1159/000223230; Weisgraber KH, 1996, FASEB J, V10, P1485, DOI 10.1096/fasebj.10.13.8940294; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489; Zivadinov R, 2001, J NEUROL NEUROSUR PS, V70, P773, DOI 10.1136/jnnp.70.6.773	66	17	20	2	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1543-3633			COGN BEHAV NEUROL	Cogn. Behav. Neurol.	SEP	2011	24	3					128	133		10.1097/WNN.0b013e31823380b5			6	Behavioral Sciences; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	823YB	WOS:000295162800004	21945984				2022-02-06	
J	Shichinohe, H; Kuroda, S; Sugiyama, T; Ito, M; Kawabori, M; Nishio, M; Takeda, Y; Koike, T; Houkin, K				Shichinohe, Hideo; Kuroda, Satoshi; Sugiyama, Taku; Ito, Masaki; Kawabori, Masahito; Nishio, Mitsufumi; Takeda, Yukari; Koike, Takao; Houkin, Kiyohiro			Biological Features of Human Bone Marrow Stromal Cells (hBMSC) Cultured with Animal Protein-Free Medium-Safety and Efficacy of Clinical Use for Neurotransplantation	TRANSLATIONAL STROKE RESEARCH			English	Article						Bone marrow stromal cells; Platelet lysate; Cell culture; Neurotransplantation; Autologous graft; Central nervous system disorders	MESENCHYMAL STEM-CELLS; TRAUMATIC BRAIN INJURY; SERUM-FREE MEDIUM; INTRACEREBRAL TRANSPLANTATION; CEREBRAL-ISCHEMIA; TGF-BETA; DIFFERENTIATE; EXPANSION; RATS; EXPRESSION	The donor cell culture in animal serum-free medium is quite important for the clinical application of cell transplantation therapy. This study was aimed to test the hypothesis that the human bone marrow stromal cells (hBMSC) expanded with fetal calf serum (FCS)-free, platelet lysate (PL)-containing medium retain their biological features favoring central nervous system regeneration. The hBMSC were cultured with 5% PL or 10% FCS. Their phenotypes were analyzed with flow cytometry, and their production of growth factors was quantified with enzyme-linked immunosorbent assay. Their capacity of neural differentiation was verified by immunocytochemistry. There was no significant difference in morphology and cell surface marker between the hBMSC-FCS and hBMSC-PL. Both of them were positive for CD44, CD90, CD105, and CD166 and were negative for CD34, CD45, and CD271. The production of human brain-derived neurotrophic factor, human hepatocyte growth factor, human beta-nerve growth factor, and human platelet-derived growth factor-BB did not differ between the two groups, although the hBMSC-PL produced significantly more amount of TGF-beta 1 than the hBMSC-FCS. There was no significant difference in their in vitro differentiation into the neurons and astrocytes between the two groups. The hBMSC expanded with PL-containing medium retain their biological capacity of neural differentiation and neuroprotection. The PL may be a clinically valuable and safe substitute for FCS in expanding the hBMSC for cell therapy.	[Shichinohe, Hideo; Kuroda, Satoshi; Sugiyama, Taku; Ito, Masaki; Kawabori, Masahito; Houkin, Kiyohiro] Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Nishio, Mitsufumi; Takeda, Yukari; Koike, Takao] Hokkaido Univ, Grad Sch Med, Dept Med 2, Sapporo, Hokkaido 0608638, Japan		Kuroda, S (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Kita Ku, North 15,West 7, Sapporo, Hokkaido 0608638, Japan.	skuroda@med.hokudai.ac.jp	Kawabori, Masahito/AAH-7117-2020; Houkin, Kiyohiro/G-5364-2012; Shichinohe, Hideo/G-5367-2012; Sugiyama, Taku/U-9482-2018	Kawabori, Masahito/0000-0002-3574-8380; Sugiyama, Taku/0000-0003-0398-225X	Ministry of Education, Science and Culture of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [19390371, 20390377, 20591701, 21390400]; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [21390400, 23390342] Funding Source: KAKEN	This study was supported by grant-in-aids from the Ministry of Education, Science and Culture of Japan (nos. 19390371, 20390377, 20591701, and 21390400).	Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; Bernardo ME, 2007, J CELL PHYSIOL, V211, P121, DOI 10.1002/jcp.20911; Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; Borlongan CV, 2004, BRAIN RES, V1010, P108, DOI 10.1016/j.brainres.2004.02.072; Chen JL, 2001, J NEUROL SCI, V189, P49, DOI 10.1016/S0022-510X(01)00557-3; Chen Q, 2005, J NEUROSCI RES, V80, P611, DOI 10.1002/jnr.20494; Chiba Y, 2009, NEUROSURGERY, V64, P991, DOI 10.1227/01.NEU.0000341905.57162.1D; Doucet C, 2005, J CELL PHYSIOL, V205, P228, DOI 10.1002/jcp.20391; Englund U, 2002, P NATL ACAD SCI USA, V99, P17089, DOI 10.1073/pnas.252589099; Gu Y, 2010, J MOL NEUROSCI, V40, P332, DOI 10.1007/s12031-009-9304-6; He XY, 2011, CYTOTHERAPY, V13, P46, DOI 10.3109/14653249.2010.510505; Hokari M, 2008, J NEUROSCI RES, V86, P1024, DOI 10.1002/jnr.21572; Hokari M, 2009, CYTOKINE, V46, P260, DOI 10.1016/j.cyto.2009.02.008; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Kortesidis A, 2005, BLOOD, V105, P3793, DOI 10.1182/blood-2004-11-4349; Lange C, 2007, J CELL PHYSIOL, V213, P18, DOI 10.1002/jcp.21081; Lee JB, 2003, NEUROPATHOLOGY, V23, P169, DOI 10.1046/j.1440-1789.2003.00496.x; Lee PH, 2008, CLIN PHARMACOL THER, V83, P723, DOI 10.1038/sj.clpt.6100386; Lepperdinger G, 2008, EXP GERONTOL, V43, P1018, DOI 10.1016/j.exger.2008.07.004; Li Y, 2001, NEUROSCI LETT, V316, P67, DOI 10.1016/S0304-3940(01)02384-9; Liu S, 2000, P NATL ACAD SCI USA, V97, P6126, DOI 10.1073/pnas.97.11.6126; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Maruichi K, 2009, NEUROPATHOLOGY, V29, P422, DOI 10.1111/j.1440-1789.2008.00995.x; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; Neuhuber B, 2005, BRAIN RES, V1035, P73, DOI 10.1016/j.brainres.2004.11.055; Ng F, 2008, BLOOD, V112, P295, DOI 10.1182/blood-2007-07-103697; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Pittenger Mark F., 2008, V449, P27, DOI 10.1007/978-1-60327-169-1_2; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Reger Roxanne L., 2008, V449, P93, DOI 10.1007/978-1-60327-169-1_7; Rezaee F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009690; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Saporta S, 1999, NEUROSCIENCE, V91, P519, DOI 10.1016/S0306-4522(98)00610-1; Schallmoser K, 2007, TRANSFUSION, V47, P1436, DOI 10.1111/j.1537-2995.2007.01220.x; Shichinohe H, 2004, BRAIN RES PROTOC, V13, P166, DOI 10.1016/j.brainresprot.2004.04.004; Shichinohe H, 2008, NEUROREHAB NEURAL RE, V22, P447, DOI 10.1177/1545968308315596; Shichinohe H, 2007, BRAIN RES, V1183, P138, DOI 10.1016/j.brainres.2007.08.091; Shichinohe H, 2010, NEUROPATHOLOGY, V30, P113, DOI 10.1111/j.1440-1789.2009.01050.x; Sugiyama T, 2011, NEUROSURGERY, V68, P1733, DOI 10.1227/NEU.0b013e31820edd63; Sykova E, 2006, CELL TRANSPLANT, V15, P675, DOI 10.3727/000000006783464381; Wilkins A, 2009, STEM CELL RES, V3, P63, DOI 10.1016/j.scr.2009.02.006; Wolfe Margaret, 2008, V449, P3, DOI 10.1007/978-1-60327-169-1_1; Yamaguchi S, 2006, BRAIN RES, V1087, P15, DOI 10.1016/j.brainres.2006.02.127; YAMAMOTO H, 1990, J NEUROSCI, V10, P3469; Yano S, 2005, J NEUROTRAUM, V22, P907, DOI 10.1089/neu.2005.22.907	49	17	17	0	14	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1868-4483	1868-601X		TRANSL STROKE RES	Transl. Stroke Res.	SEP	2011	2	3					307	315		10.1007/s12975-011-0088-y			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	943YH	WOS:000304163500010	24323651				2022-02-06	
J	Wildner, G; Pauker, N; Archan, S; Gemes, G; Rigaud, M; Pocivalnik, M; Prause, G				Wildner, Gernot; Pauker, Nina; Archan, Sylvia; Gemes, Geza; Rigaud, Marcel; Pocivalnik, Mirjam; Prause, Gerhard			Arterial line in prehospital emergency settings - A feasibility study in four physician-staffed emergency medical systems	RESUSCITATION			English	Article						Advanced life support (ALS); Shock; Blood pressure; Blood gases; Monitoring; Emergency medical services	TRAUMATIC BRAIN-INJURY; RAPID-SEQUENCE INTUBATION; HOSPITAL CARDIAC-ARREST; VENTILATION; CATHETERS; HYPOXIA; IMPACT; CARE; HYPERVENTILATION; CANNULATION		[Wildner, Gernot; Archan, Sylvia; Gemes, Geza; Rigaud, Marcel; Prause, Gerhard] Med Univ Graz, Dept Anaesthesiol & Intens Care Med, A-8036 Graz, Austria; [Pauker, Nina; Pocivalnik, Mirjam] Austrian Red Cross, Med Corps Graz, A-8010 Graz, Austria		Wildner, G (corresponding author), Med Univ Graz, Dept Anaesthesiol & Intens Care Med, Auenbruggerpl 29, A-8036 Graz, Austria.	gernot.wildner@medunigraz.at		Rigaud, Marcel/0000-0003-4015-0006			Abella BS, 2007, RESUSCITATION, V73, P54, DOI 10.1016/j.resuscitation.2006.10.027; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barone JE, 2006, J TRAUMA, V61, P468, DOI 10.1097/01.ta.0000229815.43871.59; Belpomme V, 2005, AM J EMERG MED, V23, P852, DOI 10.1016/j.ajem.2005.04.011; Brzezinski M, 2009, ANESTH ANALG, V109, P1763, DOI 10.1213/ANE.0b013e3181bbd416; Davis DP, 2008, RESUSCITATION, V76, P333, DOI 10.1016/j.resuscitation.2007.08.004; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; Gerber DR, 1996, CHEST, V109, P761, DOI 10.1378/chest.109.3.761; GRONBECK C, 1993, CHEST, V104, P1716, DOI 10.1378/chest.104.6.1716; Konrad C, 1998, ANESTH ANALG, V86, P635; McSwain NE, 2004, J TRAUMA, V57, P8; Nolan JP, 2005, RESUSCITATION, V67, pS39, DOI 10.1016/j.resuscitation.2005.10.009; PETERSON LH, 1949, AM HEART J, V37, P771, DOI 10.1016/0002-8703(49)90175-1; Prause G, 1998, ANAESTHESIST, V47, P400, DOI 10.1007/s001010050576; Prause G, 2001, RESUSCITATION, V51, P297, DOI 10.1016/S0300-9572(01)00424-5; Prause G, 1997, RESUSCITATION, V35, P145, DOI 10.1016/S0300-9572(97)00043-9; PRAUSE G, 2010, AM J EMERG MED, V28; Scheer BV, 2002, CRIT CARE, V6, P198, DOI 10.1186/cc1489; Shiver S, 2006, ACAD EMERG MED, V13, P1275, DOI 10.1197/j.aem.2006.07.015; Stahel PF, 2008, INTENS CARE MED, V34, P402, DOI 10.1007/s00134-007-0889-3; Tegtmeyer Ken, 2006, N Engl J Med, V354, pe13, DOI 10.1056/NEJMvcm044149; Warner KJ, 2008, J TRAUMA, V64, P341, DOI 10.1097/TA.0b013e318160dfb3; Warner KJ, 2007, J TRAUMA, V62, P1330, DOI 10.1097/TA.0b013e31804a8032; Warner KJ, 2009, J TRAUMA, V66, P26, DOI 10.1097/TA.0b013e3181957a25; Wildner G, 2008, NOTFALL RETTUNGSMED, V11, P353, DOI 10.1007/s10049-008-1091-z; Yeung J, 2009, RESUSCITATION, V80, P743, DOI 10.1016/j.resuscitation.2009.04.012	26	17	18	0	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572			RESUSCITATION	Resuscitation	SEP	2011	82	9					1198	1201		10.1016/j.resuscitation.2011.05.002			4	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	820MO	WOS:000294910200020	21621893				2022-02-06	
J	Lingsma, HF; Roozenbeek, B; Perel, P; Roberts, I; Maas, AIR; Steyerberg, EW				Lingsma, Hester F.; Roozenbeek, Bob; Perel, Pablo; Roberts, Ian; Maas, Andrew I. R.; Steyerberg, Ewout W.			Between-centre differences and treatment effects in randomized controlled trials: A case study in traumatic brain injury	TRIALS			English	Article							HEAD-INJURY; CLINICAL-TRIAL; HYPOTHERMIA; QUALITY; ADULTS	Background: In Traumatic Brain Injury (TBI), large between-centre differences in outcome exist and many clinicians believe that such differences influence estimation of the treatment effect in randomized controlled trial (RCTs). The aim of this study was to assess the influence of between-centre differences in outcome on the estimated treatment effect in a large RCT in TBI. Methods: We used data from the MRC CRASH trial on the efficacy of corticosteroid infusion in patients with TBI. We analyzed the effect of the treatment on 14 day mortality with fixed effect logistic regression. Next we used random effects logistic regression with a random intercept to estimate the treatment effect taking into account between-centre differences in outcome. Between-centre differences in outcome were expressed with a 95% range of odds ratios (OR) for centres compared to the average, based on the variance of the random effects (tau(2)). A random effects logistic regression model with random slopes was used to allow the treatment effect to vary by centre. The variation in treatment effect between the centres was expressed in a 95% range of the estimated treatment ORs. Results: In 9978 patients from 237 centres, 14-day mortality was 19.5%. Mortality was higher in the treatment group (OR = 1.22, p = 0.00010). Using a random effects model showed large between-centre differences in outcome (95% range of centre effects: 0.27-3.71), but did not substantially change the estimated treatment effect (OR = 1.24, p = 0.00003). There was limited, although statistically significant, between-centre variation in the treatment effect (OR = 1.22, 95% treatment OR range: 1.17-1.26). Conclusion: Large between-centre differences in outcome do not necessarily affect the estimated treatment effect in RCTs, in contrast to current beliefs in the clinical area of TBI.	[Lingsma, Hester F.; Roozenbeek, Bob; Steyerberg, Ewout W.] Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; [Roozenbeek, Bob; Maas, Andrew I. R.] Univ Antwerp Hosp, Dept Neurosurg, B-2650 Edegem, Belgium; [Perel, Pablo; Roberts, Ian] London Sch Hyg & Trop Med, Epidemiol & Populat Hlth Dept, London WC1E 7HT, England		Lingsma, HF (corresponding author), Erasmus MC, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	h.lingsma@erasmusmc.nl	Maas, Andrew IR/C-5584-2013; Steyerberg, Ewout/C-1509-2018	Maas, Andrew IR/0000-0003-1612-1264; Steyerberg, Ewout/0000-0002-7787-0122; /0000-0002-2342-301X	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS-01923521]	This work was supported by the National Institutes of Health [NS-01923521]	Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; Clifton GL, 2009, J NEUROTRAUM, V26, P393, DOI 10.1089/neu.2008.0556; Dickinson K, 2000, BMJ-BRIT MED J, V320, P1308, DOI 10.1136/bmj.320.7245.1308; Finkelstein E., 2006, INCIDENCE EC BURDEN; Kirkpatrick PJ, 1997, J NEUROL NEUROSUR PS, V62, P109, DOI 10.1136/jnnp.62.2.109; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Rothwell PM, 2005, LANCET, V365, P256; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Timbie JW, 2008, STAT MED, V27, P1351, DOI 10.1002/sim.3082	14	17	18	0	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1745-6215			TRIALS	Trials	AUG 25	2011	12								201	10.1186/1745-6215-12-201			6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	817OY	WOS:000294684900001	21867540	gold, Green Published, Green Accepted			2022-02-06	
J	Al Nimer, F; Beyeen, AD; Lindblom, R; Strom, M; Aeinehband, S; Lidman, O; Piehl, F				Al Nimer, Faiez; Beyeen, Amennai Daniel; Lindblom, Rickard; Strom, Mikael; Aeinehband, Shahin; Lidman, Olle; Piehl, Fredrik			Both MHC and non-MHC genes regulate inflammation and T-cell response after traumatic brain injury	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Traumatic brain injury; MHC class II; T-cells; Inflammation; Genes; Ciita; Rat strains	CENTRAL-NERVOUS-SYSTEM; MAJOR HISTOCOMPATIBILITY COMPLEX; SPINAL-CORD-INJURY; CLASS-II; MULTIPLE-SCLEROSIS; HEAD-INJURY; ACTIVE IMMUNIZATION; PARKINSONS-DISEASE; CNS; NEUROPROTECTION	Genetic regulation of autoimmune neuroinflammation is a well known phenomenon, but genetic influences on inflammation following traumatic nerve injuries have received little attention. In this study we examined the inflammatory response in a rat traumatic brain injury (TBI) model, with a particular focus on major histocompatibility class II (MHC II) presentation, in two inbred rat strains that have been extensively characterized in experimental autoimmune encephalomyelitis (EAE); DA and PVC. In addition, MHC and Vra4 congenic strains on these backgrounds were studied to give information on MHC and non-MHC gene contribution. Thus, allelic differences in Vra4, harboring the Ciita gene, was found to regulate expression of the invariant chain at the mRNA level, with a much smaller effect exerted by the MHC locus itself. Notably, however, at the protein level the MHC congenic PVG-RT1(av1) strain displayed much stronger MHCII+ presentation, as shown both by immunolabeling and flow cytometry, than the PVC strain, dwarfing the effect of Ciita. The PVG-RT1(av1) strain had significantly more T-cell influx than both DA and PVC, suggesting regulation both by MHC and non-MHC genes. Finally, in terms of outcome, the EAE susceptible DA strain displayed a significantly smaller resulting lesion volume than the resistant PVG-RT1(av1) strain. These results provide additional support for a role of adaptive immune response after neurotrauma and demonstrate that outcome is significantly affected by host genetic factors. (C) 2010 Elsevier Inc. All rights reserved.	[Al Nimer, Faiez; Beyeen, Amennai Daniel; Lindblom, Rickard; Strom, Mikael; Aeinehband, Shahin; Lidman, Olle; Piehl, Fredrik] Karolinska Univ Hosp, Neuroimmunol Unit, Dept Clin Neurosci, S-17176 Stockholm, Sweden		Al Nimer, F (corresponding author), Karolinska Univ Hosp, Neuroimmunol Unit, Dept Clin Neurosci, S-17176 Stockholm, Sweden.	faiez.al.nimer@ki.se	Piehl, Fredrik/E-3451-2013; Nimer, Faiez Al/ABB-9465-2020	Al Nimer, Faiez/0000-0003-0937-5995; Lindblom, Rickard/0000-0001-7913-4981	European UnionEuropean Commission [LSHM-CT-2005-018637, LSHG-CT-2005019015]; Swedish Research CouncilSwedish Research CouncilEuropean Commission; Swedish Brain Foundation; GV80 Foundation; Swedish Association of Persons with Neurological Disabilities	We would like to thank Professor Tomas Olsson for expert scientific advice. This study was supported by the 6'th Framework Program of the European Union, NeuroproMiSe, LSHM-CT-2005-018637 and EURATools, LSHG-CT-2005019015, the Swedish Research Council, the Swedish Brain Foundation, the GV80 Foundation and the Swedish Association of Persons with Neurological Disabilities.	Abrams MB, 2007, EUR J NEUROSCI, V26, P1118, DOI 10.1111/j.1460-9568.2007.05725.x; Aloisi F, 2000, IMMUNOL TODAY, V21, P141, DOI 10.1016/S0167-5699(99)01512-1; Aloisi F, 1998, J IMMUNOL, V160, P4671; Angelov DN, 2003, P NATL ACAD SCI USA, V100, P4790, DOI 10.1073/pnas.0530191100; Ankeny DP, 2007, EUR J NEUROSCI, V25, P2053, DOI 10.1111/j.1460-9568.2007.05458.x; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Becher B, 2000, GLIA, V29, P293; Benner EJ, 2004, P NATL ACAD SCI USA, V101, P9435, DOI 10.1073/pnas.0400569101; Bronson PG, 2010, HUM MOL GENET, V19, P2331, DOI 10.1093/hmg/ddq101; Brynskikh A, 2008, BRAIN BEHAV IMMUN, V22, P861, DOI 10.1016/j.bbi.2007.12.008; Butovsky O, 2006, P NATL ACAD SCI USA, V103, P11784, DOI 10.1073/pnas.0604681103; Clausen F, 2007, J NEUROTRAUM, V24, P1295, DOI 10.1089/neu.2006.0258; Cox AL, 2006, J NEUROIMMUNOL, V174, P180, DOI 10.1016/j.jneuroim.2006.01.007; Diez M, 2009, J NEUROIMMUNOL, V212, P82, DOI 10.1016/j.jneuroim.2009.05.004; Dominguez CA, 2008, PAIN, V136, P313, DOI 10.1016/j.pain.2007.07.009; Fee D, 2003, J NEUROIMMUNOL, V136, P54, DOI 10.1016/S0165-5728(03)00008-0; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hammarberg H, 2000, J NEUROSCI, V20, P5283, DOI 10.1523/JNEUROSCI.20-14-05283.2000; Harnesk K, 2008, J IMMUNOL, V180, P3289, DOI 10.4049/jimmunol.180.5.3289; Harnesk K, 2009, J NEUROIMMUNOL, V212, P44, DOI 10.1016/j.jneuroim.2009.04.019; Hauben E, 2000, J NEUROSCI, V20, P6421, DOI 10.1523/JNEUROSCI.20-17-06421.2000; Holmin S, 1997, J NEUROSURG, V86, P493, DOI 10.3171/jns.1997.86.3.0493; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; Jones TB, 2004, J NEUROSCI, V24, P3752, DOI 10.1523/JNEUROSCI.0406-04.2004; Kipnis J, 2000, P NATL ACAD SCI USA, V97, P7446, DOI 10.1073/pnas.97.13.7446; Kipnis J, 2003, J NEUROTRAUM, V20, P559, DOI 10.1089/089771503767168483; Kipnis J, 2002, P NATL ACAD SCI USA, V99, P15620, DOI 10.1073/pnas.232565399; Kipnis J, 2002, J NEUROIMMUNOL, V130, P78, DOI 10.1016/S0165-5728(02)00219-9; Kipnis J, 2001, J NEUROSCI, V21, P4564, DOI 10.1523/JNEUROSCI.21-13-04564.2001; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Lidman O, 2003, J NEUROSCI, V23, P9817; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Oehmichen M., 2009, Legal Medicine, V11, P118, DOI 10.1016/j.legalmed.2008.11.003; OLSSON T, 1993, J NEUROL SCI, V117, P130, DOI 10.1016/0022-510X(93)90165-U; OLSSON T, 1992, AUTOIMMUNITY, V13, P117, DOI 10.3109/08916939209001912; Piehl F, 1999, J NEUROIMMUNOL, V101, P87, DOI 10.1016/S0165-5728(99)00136-8; Popovich PG, 1996, J NEUROSCI RES, V45, P349, DOI 10.1002/(SICI)1097-4547(19960815)45:4<349::AID-JNR4>3.0.CO;2-9; Rudehill S, 2006, ACTA NEUROCHIR, V148, P199, DOI 10.1007/s00701-005-0673-5; Sanchez-Guajardo V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008784; Schwartz M, 2009, NEUROSCIENCE, V158, P1133, DOI 10.1016/j.neuroscience.2008.12.013; Swanberg M, 2005, NAT GENET, V37, P486, DOI 10.1038/ng1544; Villadangos JA, 2005, IMMUNOL REV, V207, P191, DOI 10.1111/j.0105-2896.2005.00317.x; Weissert R, 1998, J CLIN INVEST, V102, P1265, DOI 10.1172/JCI3022; Wolf SA, 2002, J NEUROIMMUNOL, V133, P72, DOI 10.1016/S0165-5728(02)00367-3; Zota V, 2009, J IMMUNOL, V183, P3522, DOI 10.4049/jimmunol.0900620	48	17	17	0	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	JUL	2011	25	5			SI		981	990		10.1016/j.bbi.2010.10.017			10	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology; Psychiatry	780EF	WOS:000291836600019	20974248				2022-02-06	
J	Giannantoni, A; Silvestro, D; Siracusano, S; Azicnuda, E; D'Ippolito, M; Rigon, J; Sabatini, U; Bini, V; Formisano, R				Giannantoni, Antonella; Silvestro, Daniela; Siracusano, Salvatore; Azicnuda, Eva; D'Ippolito, Mariagrazia; Rigon, Jessica; Sabatini, Umberto; Bini, Vittorio; Formisano, Rita			Urologic Dysfunction and Neurologic Outcome in Coma Survivors After Severe Traumatic Brain Injury in the Postacute and Chronic Phase	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Coma; Rehabilitation; Urinary bladder disorder; neurogenic	URINARY-INCONTINENCE; DAMAGE	Giannantoni A, Silvestro D, Siracusano S, Azicnuda E, D'Ippolito M, Rigon J, Sabatini U, Bini V, Formisano R. Urologic dysfunction and neurologic outcome in coma survivors after severe traumatic brain injury in the postacute and chronic phase. Arch Phys Med Rehabil 2011;92:1134-8. Objectives: To investigate voiding dysfunction and upper urinary tract status in survivors of coma resulting from traumatic brain injury (TBI), and to compare clinical and urodynamic results with neurologic and psychological features as well as functional outcomes. Design: Observational study focused on urologic dysfunction and neurologic outcome in coma survivors after traumatic brain injury in the postacute and chronic phase. Setting: A postcoma unit in a rehabilitation hospital. Participants: Consecutive patients (N=57) who recovered from coma of traumatic etiology and who were admitted during a 1-year period to a postcoma unit of a rehabilitation hospital. Interventions: Patients underwent clinical urologic assessment, urodynamics with the assessment of the Schafer nomogram and the projected isovolumetric detrusor pressure to evaluate detrusor contractility, ultrasound assessment of the lower and upper urinary tract and voiding cystourethrography, routinely performed, according to the International Continence Society Standards. Neurologic variables assessed were brain injury and disability severity, and neuropsychological status. Neuroimaging identified the site of cerebral lesions. Main Outcome Measures: Urinary symptoms, disability by means of the Glasgow Outcome Scale (GOS), and neuropsychological status by means of the Neurobehavioral Rating Scale (NBRS), and the relationships among them. Results: Of the 57 patients studied, 30 had overactive bladder (urge incontinence) symptoms, 28 had detrusor overactivity, and 18 had detrusor underactivity with associated pseudodyssynergia in 15 of these patients. Eleven patients had hypertrophic bladder; 3, bilateral pyelectasia; and 2, vesicoureteral reflux. Disability measured by GOS was severe in 8 patients and moderate in 27, while recovery was good in 22 patients. The mean NBRS total score indicated a mild cognitive impairment. Neuroimaging showed diffuse brain injury in all patients. Statistically significant relationships were found between urge incontinence, detrusor overactivity, and poor neurologic functional outcome, between detrusor overactivity and right hemisphere damage (P=.0001), and between impaired detrusor contractility and left hemisphere injuries (P=.0001). Conclusions: Most patients who recovered from coma resulting from TBI have symptoms of overactive bladder syndrome and voiding difficulties. These urinary problems correlate with cerebral involvement and neurologic functional outcome.	[Giannantoni, Antonella; Bini, Vittorio] Univ Perugia, Osped S Maria della Misericordia, Dept Urol & Androl, I-06100 Perugia, Italy; [Silvestro, Daniela; Azicnuda, Eva; D'Ippolito, Mariagrazia; Formisano, Rita] Santa Lucia Fdn, Post Coma Unit, Rome, Italy; [Sabatini, Umberto] Santa Lucia Fdn, Dept Radiol, Rome, Italy; [Siracusano, Salvatore] Univ Trieste, Osped Gattinara, Dept Urol, Trieste, Italy; [Rigon, Jessica] San Camillo Hosp, Lido Venice, Italy		Giannantoni, A (corresponding author), Univ Perugia, Osped S Maria della Misericordia, Dept Urol & Androl, I-06100 Perugia, Italy.	agianton@libero.it	D'Ippolito, Mariagrazia/K-4010-2016; Azicnuda, Eva/K-9010-2016; Bini, Vittorio/AAA-1104-2019; Sabatini, Umberto/K-4659-2016; Bini, Vittorio/F-5134-2010	D'Ippolito, Mariagrazia/0000-0001-7818-7352; Bini, Vittorio/0000-0001-8404-2918; Sabatini, Umberto/0000-0001-5321-8626; Bini, Vittorio/0000-0001-8404-2918; Siracusano, Salvatore/0000-0002-1709-9823			ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; Arena M G, 1992, Funct Neurol, V7, P47; AUERBACK ALFRED, 1952, CALIFORNIA MED, V76, P23; CARDOZO L, 2009, INCONTINENCE INT CON; Chase J, 2010, J UROLOGY, V183, P1296, DOI 10.1016/j.juro.2009.12.059; Chua K, 2003, BRAIN INJURY, V17, P469, DOI 10.1080/02699050210154268; Damasio H., 1989, LESION ANAL NEUROPSY; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Formisano R, 2004, BRAIN INJURY, V18, P103, DOI 10.1080/0269905031000149470; Fowler CJ, 2008, NAT REV NEUROSCI, V9, P453, DOI 10.1038/nrn2401; Giugni E, 2005, AM J NEURORADIOL, V26, P1140; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Griffiths DJ, 2004, SCAND J UROL NEPHROL, V38, P93, DOI 10.1080/03008880410015426; JENNETT B, 1975, LANCET, V1, P480; Krimchansky BZ, 1999, BRAIN INJURY, V13, P899; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Marinkovic SP, 2001, J UROLOGY, V165, P359, DOI 10.1097/00005392-200102000-00003; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Moiyadi AV, 2007, NEUROREHABILITATION, V22, P93; Nour S, 2000, BRAIN, V123, P781, DOI 10.1093/brain/123.4.781; Oostra K, 1996, BRAIN INJURY, V10, P459, DOI 10.1080/026990596124313; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; SCHAFER W, 1990, UROL CLIN N AM, V17, P553; Stohrer M, 2009, EUR UROL, V56, P81, DOI 10.1016/j.eururo.2009.04.028; TEASDALE G, 1974, LANCET, V2, P81; Wong SYS, 2006, J AFFECT DISORDERS, V96, P83, DOI 10.1016/j.jad.2006.05.013; WYNDAELE JJ, 1990, NEUROUROL URODYNAM, V9, P43, DOI 10.1002/nau.1930090106	27	17	17	0	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUL	2011	92	7					1134	1138		10.1016/j.apmr.2011.02.013			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	790UU	WOS:000292615900017	21704794				2022-02-06	
J	O'Connor, C; Robertson, IH; Levine, B				O'Connor, Charlene; Robertson, Ian H.; Levine, Brian			The Prosthetics of Vigilant Attention: Random Cuing Cuts Processing Demands	NEUROPSYCHOLOGY			English	Article						fMRI; alerting tones; SART; DLPFC; sustained attention; arousal	TRAUMATIC BRAIN-INJURY; EVENT-RELATED FMRI; SUSTAINED ATTENTION; PREFRONTAL CORTEX; RESPONSE-INHIBITION; GOAL MANAGEMENT; FRONTOPARIETAL NETWORK; INTRINSIC ALERTNESS; EXECUTIVE FUNCTIONS; VISUAL-ATTENTION	Objective: Engagement in tasks requiring vigilant attention is susceptible to modulation by exogenous stimulation, reflected in changes in performance accuracy and speed. The shift from endogenous to exogenous control may be observed not only when the external cue is meaningful to the task, but also when it holds no information about the task or performance. The purpose of this study was to examine how the shift to exogenous engagement is reflected in changes to the well-documented, right-lateralized, frontal-parietal-thalamic vigilant attention network. Method: Using functional magnetic resonance imaging, healthy participants were scanned as they performed the Sustained Attention to Response Task (SART) in 60-s blocks, some of which were presented with brief, random, auditory tones. The SART requires participants to overcome the tendency to respond in an automatic, task-driven manner in response to infrequent no-go stimuli. Results: Despite no overall effect on performance, and only a transient increase in response times immediately following the tones, the SART with alerting tones was associated with a diminished pattern of activation in key nodes of the network. The pattern of right-lateralized activity observed with the SART was attenuated with the tones, and activity in the right middle frontal gyrus was significantly diminished, as revealed by region-of-interest analyses. Conclusions: Alerting tones provided the stimulation to cue the maintenance of the goal-state, reducing reliance on prefrontal control mechanisms and demonstrating the shift from endogenous top-down control to exogenous control. These findings suggest a neural mechanism for the facilitatory effects of exogenous engagement for patients with damaged top-down attentional brain systems.	[O'Connor, Charlene; Levine, Brian] Rotman Res Inst, Toronto, ON M6A 2E1, Canada; [O'Connor, Charlene; Levine, Brian] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [O'Connor, Charlene] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON M5S 1A1, Canada; [Levine, Brian] Univ Toronto, Dept Med Neurol, Toronto, ON M5S 1A1, Canada; [Robertson, Ian H.] Trinity Coll Dublin, Dept Psychol, Dublin, Ireland; [Robertson, Ian H.] Trinity Coll Dublin, Inst Neurosci, Dublin, Ireland		Levine, B (corresponding author), Rotman Res Inst, 3560 Bathurst St, Toronto, ON M6A 2E1, Canada.	blevine@rotman-baycreston.ca	Levine, Brian/O-2725-2019; Levine, Brian/G-4328-2010	Levine, Brian/0000-0003-4343-811X; Levine, Brian/0000-0003-4343-811X; Robertson, Ian H/0000-0001-8637-561X	Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD42385-01]; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP-202037]; Heart and Stroke Foundation of Ontario Centre for Stroke RecoveryHeart & Stroke Foundation of Ontario; Ontario Neurotrauma Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD042385] Funding Source: NIH RePORTER	This work was supported by Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant HD42385-01, Canadian Institutes of Health Research Grant MOP-202037, the Heart and Stroke Foundation of Ontario Centre for Stroke Recovery; and the Ontario Neurotrauma Foundation Studentship Grant.	Cohen RM, 1988, NEUROPSY NEUROPSY BE, V1, P3; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Coull JT, 1996, NEUROPSYCHOLOGIA, V34, P1085, DOI 10.1016/0028-3932(96)00029-2; Cox RW, 1997, NMR BIOMED, V10, P171, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<171::AID-NBM453>3.0.CO;2-L; De Pisapia N, 2006, NEUROCOMPUTING, V69, P1322, DOI 10.1016/j.neucom.2005.12.100; Dockree PM, 2005, NEUROIMAGE, V27, P587, DOI 10.1016/j.neuroimage.2005.05.044; Dockree PM, 2004, COGNITIVE BRAIN RES, V20, P403, DOI 10.1016/j.cogbrainres.2004.03.019; Dodds CM, 2008, NEUROPSYCHOLOGY, V22, P545, DOI 10.1037/0894-4105.22.4.545; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fassbender C, 2006, J PSYCHOPHYSIOL, V20, P286, DOI 10.1027/0269-8803.20.4.286; Fassbender C, 2004, COGNITIVE BRAIN RES, V20, P132, DOI 10.1016/j.cogbrainres.2004.02.007; Fernandez-Duque D, 2001, J CLIN EXP NEUROPSYC, V23, P74, DOI 10.1076/jcen.23.1.74.1217; Fish J, 2007, NEUROPSYCHOLOGIA, V45, P1318, DOI 10.1016/j.neuropsychologia.2006.09.015; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Gobbele R, 2000, EXP BRAIN RES, V133, P506, DOI 10.1007/s002210000435; GOLDMANRAKIC PS, 1985, J COMP NEUROL, V242, P535, DOI 10.1002/cne.902420406; Hager F, 1998, EUR ARCH PSY CLIN N, V248, P161; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kelly AMC, 2004, EUR J NEUROSCI, V19, P3105, DOI 10.1111/j.0953-816X.2004.03429.x; Kinomura S, 1996, SCIENCE, V271, P512, DOI 10.1126/science.271.5248.512; Kubler A, 2006, J COGNITIVE NEUROSCI, V18, P1331, DOI 10.1162/jocn.2006.18.8.1331; LaBerge D, 2005, BRAIN RES REV, V50, P86, DOI 10.1016/j.brainresrev.2005.04.004; Laberge D, 1990, J Cogn Neurosci, V2, P358, DOI 10.1162/jocn.1990.2.4.358; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; LEVINE B, 2011, REHABILITATION UNPUB; Levine B, 2007, J INT NEUROPSYCH SOC, V13, P143, DOI 10.1017/S1355617707070178; Liddle PF, 2001, HUM BRAIN MAPP, V12, P100, DOI 10.1002/1097-0193(200102)12:2<100::AID-HBM1007>3.0.CO;2-6; Manly T, 2005, NEUROPSYCHOLOGIA, V43, P1721, DOI 10.1016/j.neuropsychologia.2005.02.009; Manly T, 2004, NEUROPSYCHOL REHABIL, V14, P89, DOI 10.1080/09602010343000110; Manly T, 2003, NEUROCASE, V9, P340, DOI 10.1076/neur.9.4.340.15553; Manly T, 2002, NEUROPSYCHOLOGIA, V40, P271, DOI 10.1016/S0028-3932(01)00094-X; Manly T., 1997, METHODOL FRONTAL EXE, P135; Marklund P, 2007, CORTEX, V43, P22, DOI 10.1016/S0010-9452(08)70443-X; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Mottaghy FM, 2006, NEUROIMAGE, V29, P225, DOI 10.1016/j.neuroimage.2005.07.034; NORMAN DA, 1986, CONSCIOUSNESS SELF R, V4, P4; O'Keeffe FM, 2004, COGNITIVE BRAIN RES, V22, P101, DOI 10.1016/j.cogbrainres.2004.07.012; Parasuraman R, 1998, ATTENTIVE BRAIN, P221; PARDO JV, 1991, NATURE, V349, P61, DOI 10.1038/349061a0; Paus T, 1997, J COGNITIVE NEUROSCI, V9, P392, DOI 10.1162/jocn.1997.9.3.392; Portas CM, 1998, J NEUROSCI, V18, P8979; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Roberts AC, 2000, CEREB CORTEX, V10, P252, DOI 10.1093/cercor/10.3.252; Robertson IH, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P631; Robertson IH, 1997, NEUROPSYCHOLOGY, V11, P290, DOI 10.1037/0894-4105.11.2.290; Robertson IH, 1998, NATURE, V395, P169, DOI 10.1038/25993; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Robertson IH, 1999, PSYCHOL BULL, V125, P544, DOI 10.1037/0033-2909.125.5.544; Romanski LM, 1997, J COMP NEUROL, V379, P313; Rueckert L, 1996, NEUROPSYCHOLOGIA, V34, P953, DOI 10.1016/0028-3932(96)00016-4; Rueckert L, 1998, NEUROPSYCHOLOGIA, V36, P653, DOI 10.1016/S0028-3932(97)00150-4; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Schneider W., 2001, E PRIME USERS GUIDE; Sherman SM, 1996, J NEUROPHYSIOL, V76, P1367, DOI 10.1152/jn.1996.76.3.1367; Shipp S, 2004, TRENDS COGN SCI, V8, P223, DOI 10.1016/j.tics.2004.03.004; Smallwood J, 2008, J COGNITIVE NEUROSCI, V20, P458, DOI 10.1162/jocn.2008.20037; Smith A, 1996, NATURE, V380, P291, DOI 10.1038/380291a0; Sturm W, 1999, NEUROPSYCHOLOGIA, V37, P797, DOI 10.1016/S0028-3932(98)00141-9; Sturm W, 2001, NEUROIMAGE, V14, pS76, DOI 10.1006/nimg.2001.0839; Stuss DT, 2005, NEUROPSYCHOLOGIA, V43, P396, DOI 10.1016/j.neuropsychologia.2004.06.010; Talairach J., 1988, COPLANAR STEREOTAXIC; WHITEHEAD R, 1991, J COGNITIVE NEUROSCI, V3, P329, DOI 10.1162/jocn.1991.3.4.329; Zordan L, 2008, BRAIN COGNITION, V66, P57, DOI 10.1016/j.bandc.2007.05.005	65	17	17	0	9	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105			NEUROPSYCHOLOGY	Neuropsychology	JUL	2011	25	4					535	543		10.1037/a0022767			9	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	787WQ	WOS:000292407800011	21463046				2022-02-06	
J	Stoddard, SA; Zimmerman, MA				Stoddard, Sarah A.; Zimmerman, Marc A.			Association of Interpersonal Violence With Self-Reported History of Head Injury	PEDIATRICS			English	Article						head injury; traumatic brain injury; violent behavior; longitudinal; emerging adulthood	TRAUMATIC BRAIN-INJURY; UNITED-STATES; REHABILITATION; BEHAVIOR; DEATH	OBJECTIVE: The purpose of this study was to examine differences in interpersonal violence among individuals who reported a head injury compared with those who did not report a head injury. METHODS: We used data from an 8-year longitudinal study of youth selected by their grade point average to study those at-risk for high school dropout in 4 public high schools in a Midwestern city (N = 850). Participants were followed up from mid-adolescence to the transition into young adulthood. One-way analyses of variance were used to test for differences in levels of interpersonal violence, and repeated measures multivariate analyses of variance were used to assess differences in levels of violence over time among participants based on reports of head injury. A series of multivariate regression analyses examined whether head injury was associated with subsequent violent behavior. RESULTS: Participants who had ever experienced a head injury before young adulthood reported more interpersonal violence in young adulthood than participants who had never had a head injury. In multivariate analyses, respondents who had a head injury in the past year reported more subsequent interpersonal violence than respondents who had not had a head injury. CONCLUSION: Our findings support other studies that link history of head injury to later interpersonal violence. Pediatrics 2011; 127:1074-1079	[Stoddard, Sarah A.] Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA; [Zimmerman, Marc A.] Univ Michigan, Sch Publ Hlth, Dept Hlth Behav & Hlth Educ, Ann Arbor, MI 48109 USA		Stoddard, SA (corresponding author), Univ Michigan, Sch Nursing, 400 N Ingalls,Suite 4320, Ann Arbor, MI 48109 USA.	sastodda@umich.edu			National Institute of Drug AbuseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R01-DA07484]; University of Michigan School of Nursing's Health Promotion/Risk Reduction Interventions [5T32NR007073-18]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [T32NR007073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA007484] Funding Source: NIH RePORTER	This research was supported by a National Institute of Drug Abuse grant (R01-DA07484; Principal Investigator, Dr Zimmerman). Dr Stoddard is a Research Fellow supported by the University of Michigan School of Nursing's Health Promotion/Risk Reduction Interventions with Vulnerable Populations Training Program (Project No. 5T32NR007073-18; Principal Investigator, Antonia M. Villarruel).; Funded by the National Institutes of Health (NIH)	*CDCP, FACTS TRAUM BRAIN IN; Centers for Disease Control and Prevention, 2003, C MILD TRAUM BRAIN I; Centers for Disease Control and Prevention, INJ PREV CONTR VIOL; Centers for Disease Control and Prevention (CDC), 2008, MMWR Morb Mortal Wkly Rep, V57, P33; Cohen R A, 1999, Violence Vict, V14, P397; Faul M, 2010, TRAUMATIC BRAIN INJU; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Graham J., 1995, YOUNG PEOPLE CRIME; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; JOHNSTON LD, 2002, NIH PUBL, V1; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leon-Carrion J, 2003, BRAIN INJURY, V17, P207, DOI 10.1080/0269905021000010249; LEWIS DO, 1988, AM J PSYCHIAT, V145, P584; LEWIS DO, 1986, AM J PSYCHIAT, V143, P838; National Institute of Neurological Disorders and Stroke, 2002, NIH PUBL, V02-158; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Raine A, 2002, J ABNORM CHILD PSYCH, V30, P311, DOI 10.1023/A:1015754122318; Raine A, 1993, PSYCHOPATHOLOGY CRIM; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Volkow ND, 1995, PSYCHIAT RES-NEUROIM, V61, P243, DOI 10.1016/0925-4927(95)02671-J	22	17	17	0	5	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005			PEDIATRICS	Pediatrics	JUN	2011	127	6					1074	1079		10.1542/peds.2010-2453			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	771GV	WOS:000291146100048	21624875	Green Published			2022-02-06	
J	Zhao, W; Yang, J; Shi, W; Wu, XJ; Shao, B; Wu, QY; Chen, J; Ni, LC				Zhao, Wei; Yang, Jiao; Shi, Wei; Wu, Xiujie; Shao, Bai; Wu, Qiyun; Chen, Jian; Ni, Lanchun			Upregulation of p21-activated Kinase 6 in rat brain cortex after traumatic brain injury	JOURNAL OF MOLECULAR HISTOLOGY			English	Article						Traumatic brain injury; PAK6; Glial cells; Proliferation; Apoptotic; Rats	ANDROGEN RECEPTOR; REACTIVE ASTROCYTES; GLIAL PROLIFERATION; MECHANISMS; NEUROPROTECTION; NEUROGENESIS; INHIBITION; ACTIVATION; ROLES; ALPHA	p21-activated Kinase 6 (PAK6) is a serine/threonine kinase belonging to the p21-activated kinase (PAK) family. PAK kinases are well-known regulators of a wide variety of cellular functions, including regulation of cytoskeleton rearrangement, cell survival, apoptosis and the mitogen-activated protein kinase signaling pathway. To elucidate the expressions and possible functions of PAK6 in central nervous system (CNS) lesion and repair, we performed a traumatic brain injury (TBI) model in adult rats. Western blot analysis revealed that PAK6 level significantly increased at day 3 after damage, and then declined during the following days. Besides, double immunofluorescence staining showed PAK6 was primarily expressed in the neurons and a few of glial cells in the normal group. While after injury, the expression of PAK6 was increased significantly in the astrocytes and neurons, and the astrocytes had largely proliferated. We also examined the expression of proliferating cell nuclear antigen (PCNA) whose change was correlated with the expression of PAK6. Importantly, double immunofluorescence staining revealed that cell proliferation evaluated by PCNA appeared in many PAK6-expressing cells at day 3 after injury. In addition, injury-induced expression of PAK6 was co-labeled by active caspase-3 during neuronal apoptosis after injury. Collectively, we hypothesized PAK6 may play important roles in CNS pathophysiology after TBI and further research is needed to have a good understanding of its function and mechanism.	[Zhao, Wei; Yang, Jiao; Shi, Wei; Wu, Xiujie; Shao, Bai; Wu, Qiyun; Chen, Jian; Ni, Lanchun] Nantong Univ, Dept Neurosurg, Affiliated Hosp, Nantong 226001, Peoples R China		Chen, J (corresponding author), Nantong Univ, Dept Neurosurg, Affiliated Hosp, Nantong 226001, Peoples R China.	chenjian0100@163.com; Nilangchun@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30770488, 30870320, 31070723, 81070275]; Natural Science Foundation of Jiangsu provinceNatural Science Foundation of Jiangsu Province [BK2009156, BK2009157, BK2009161, BK2010169]; Nature Science Foundation of Jiangsu Colleges and Universities [09KJB320011]	This work was supported by the National Natural Science Foundation of China (No. 30770488, No. 30870320, No. 31070723 and No. 81070275); Natural Science Foundation of Jiangsu province (No. BK2009156, No. BK2009157, No. BK2009161, and No. BK2010169); Nature Science Foundation of Jiangsu Colleges and Universities Grant (09KJB320011).	Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bredesen DE, 1995, ANN NEUROL, V38, P839, DOI 10.1002/ana.410380604; Chen SH, 2009, CRIT CARE MED, V37, P3097, DOI 10.1097/CCM.0b013e3181bc7986; Chen XH, 2003, J NEUROTRAUM, V20, P623, DOI 10.1089/089771503322144545; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1997, J NEUROSCI, V17, P9172; Dan C, 2002, MOL CELL BIOL, V22, P567, DOI 10.1128/MCB.22.2.567-577.2002; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Elzer JG, 2010, J CEREBR BLOOD F MET, V30, P935, DOI 10.1038/jcbfm.2009.258; Erhardt L, 1996, EUR HEART J, V17, P1781; Hammond J, 2001, J NEUROCHEM, V77, P1319, DOI 10.1046/j.1471-4159.2001.00345.x; Hofmann C, 2004, J CELL SCI, V117, P4343, DOI 10.1242/jcs.01392; Jaffer ZM, 2002, INT J BIOCHEM CELL B, V34, P713, DOI 10.1016/S1357-2725(01)00158-3; Kaur R, 2005, J BIOL CHEM, V280, P3323, DOI 10.1074/jbc.M406701200; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; KNAUS UG, 1995, SCIENCE, V269, P221, DOI 10.1126/science.7618083; Konigsmark B.W., 1970, CONT RES METHODS NEU, P315, DOI DOI 10.1007/978-3-642-85986-1_14; Kumar R, 2002, J CELL PHYSIOL, V193, P133, DOI 10.1002/jcp.10167; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Lee SR, 2002, MOL ENDOCRINOL, V16, P85, DOI 10.1210/me.16.1.85; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Li LZ, 2011, NEUROCHEM INT, V58, P126, DOI 10.1016/j.neuint.2010.11.006; Liu YH, 2010, J NEUROTRAUM, V27, P361, DOI 10.1089/neu.2008.0581; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MARTIN GA, 1995, EMBO J, V14, P1970, DOI 10.1002/j.1460-2075.1995.tb07189.x; MORRIS GF, 1989, J BIOL CHEM, V264, P13856; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nadeau S, 2005, MOL CELL NEUROSCI, V29, P525, DOI 10.1016/j.mcn.2005.04.004; Nekrasova T, 2008, DEV BIOL, V322, P95, DOI 10.1016/j.ydbio.2008.07.006; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Patel T, 1996, FASEB J, V10, P587, DOI 10.1096/fasebj.10.5.8621058; Pearl-Yafe M, 2004, BIOCHEM PHARMACOL, V67, P539, DOI 10.1016/j.bcp.2003.09.024; Pike CJ, 2009, FRONT NEUROENDOCRIN, V30, P239, DOI 10.1016/j.yfrne.2009.04.015; Qu J, 2003, MOL CELL BIOL, V23, P7122, DOI 10.1128/MCB.23.20.7122-7133.2003; Schrantz N, 2004, J BIOL CHEM, V279, P1922, DOI 10.1074/jbc.M311145200; Tatsumi K, 2005, NEUROCHEM INT, V46, P381, DOI 10.1016/j.neuint.2004.12.007; Trivedi AK, 2007, ONCOGENE, V26, P1789, DOI 10.1038/sj.onc.1209964; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; Wells CM, 2010, BIOCHEM J, V425, P465, DOI 10.1042/BJ20091173; Wen XQ, 2009, UROLOGY, V73, P1407, DOI 10.1016/j.urology.2008.09.041; Yang F, 2001, J BIOL CHEM, V276, P15345, DOI 10.1074/jbc.M010311200; Zhao ZS, 2005, BIOCHEM J, V386, P201, DOI 10.1042/BJ20041638	46	17	19	0	3	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1567-2379	1567-2387		J MOL HISTOL	J. Mol. Histol.	JUN	2011	42	3					195	203		10.1007/s10735-011-9324-8			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	793QP	WOS:000292838500001	21541790				2022-02-06	
J	Domowicz, MS; Henry, JG; Wadlington, N; Navarro, A; Kraig, RP; Schwartz, NB				Domowicz, Miriam S.; Henry, Judith G.; Wadlington, Natasha; Navarro, Antonia; Kraig, Richard P.; Schwartz, Nancy B.			Astrocyte precursor response to embryonic brain injury	BRAIN RESEARCH			English	Article						Astrocyte precursor; Gliogenesis; Brain stab-wound injury; Ventricular zone; Optic tectum	PERINATAL WHITE-MATTER; OLIGODENDROCYTE LINEAGE MATURATION; DEVELOPING NERVOUS-SYSTEM; DEVELOPING SPINAL-CORD; DEVELOPING RAT-BRAIN; CHICK OPTIC TECTUM; PERIVENTRICULAR LEUKOMALACIA; DEVELOPMENTAL NEUROPATHOLOGY; INTRAUTERINE ENVIRONMENT; CORTICAL GLIOGENESIS	Penetrating traumatic insult during pregnancy is a leading cause of human fetal demise; in particular, trauma to the brain may lead to devastating long-term cognitive sequelae. Perinatal brain injury involves glial precursors, but the neural mechanisms controlling astrocyte ontogeny after injury remain incompletely understood, partly due to a lack of appropriate markers and animal models. We analyzed astrocyte precursor response to injury at the beginning (E11) and peak (E15) of gliogenesis in an avian tectal model of penetrating embryonic brain trauma, without confounding maternal and sibling effects. At both ages, lateral ventricular dilatation, necrotic foci, periventricular cysts and intraventricular hemorrhages were observed distal to stab wounds two days after a unilateral stab injury to optic tecta. Neuronal (TUBB3) and oligodendrocyte precursor (PLP) markers were down-regulated, even far-removed from the wound site. In contrast, the mature astrocyte marker, GFAP, was up-regulated at the wound site, around necrotic areas and cysts, plus in usual areas of GFAP expression. Increased inflammatory response and apoptotic cell death were also confirmed in the injured tecta. Increased expression of NFIA, SOX9 and GLAST at the wound site and in the ventricular zone (VZ) of the injured tecta indicated an astroglial precursor response. However, cell division increased in the VZ only in early (Ell) injury, but not later (E15), indicating that in late injury the astrogliogenesis occurring after acute injury is predominantly due to precursor differentiation rather than precursor proliferation. The inability to replenish the glial precursor pool during the critical period of vulnerability to injury may be an important cause of subsequent developmental abnormalities. (C) 2011 Elsevier B.V. All rights reserved.	[Domowicz, Miriam S.; Henry, Judith G.; Wadlington, Natasha; Navarro, Antonia; Schwartz, Nancy B.] Univ Chicago, Med Ctr, Dept Pediat, Chicago, IL 60637 USA; [Kraig, Richard P.] Univ Chicago, Med Ctr, Dept Neurol, Chicago, IL 60637 USA; [Schwartz, Nancy B.] Univ Chicago, Med Ctr, Dept Biochem & Mol Biol, Chicago, IL 60637 USA		Domowicz, MS (corresponding author), Univ Chicago, Med Ctr, Dept Pediat, 5481 S Maryland Ave,MC 5058, Chicago, IL 60637 USA.	mdxx@uchicago.edu		Domowicz, Miriam/0000-0001-7860-4427; Wadlington, Natasha/0000-0002-4380-7838; Kraig, Richard/0000-0003-4584-1017	National Institute of Child Health and Human Disorders [HD 09402, P30 HD054275]; National Institute of General Medical ScienceUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25 GM066522-06]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-19108]; White Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01HD009402] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD054275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25GM066522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS019108] Funding Source: NIH RePORTER	This work was supported by grants from the National Institute of Child Health and Human Disorders (HD 09402; P30 HD054275), the National Institute of General Medical Science (R25 GM066522-06), the National Institute of Neurological Disorders and Stroke (NS-19108), and the White Foundation.	Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; Back SA, 2007, STROKE, V38, P724, DOI 10.1161/01.STR.0000254729.27386.05; Bayly PV, 2006, BRAIN RES, V1107, P70, DOI 10.1016/j.brainres.2006.05.102; Billiards SS, 2006, J COMP NEUROL, V497, P199, DOI 10.1002/cne.20991; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; Burns KA, 2009, GLIA, V57, P1115, DOI 10.1002/glia.20835; Caggiano AO, 1996, J COMP NEUROL, V376, P447, DOI 10.1002/(SICI)1096-9861(19961216)376:3<447::AID-CNE7>3.0.CO;2-2; CEPKO CL, 1997, MOL CELLULAR APPROAC, P391; Chapman SB, 2003, PEDIATR NEUROL, V29, P34, DOI 10.1016/S0887-8994(03)00012-2; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Clancy B, 2007, NEUROTOXICOLOGY, V28, P931, DOI 10.1016/j.neuro.2007.01.014; Cuadros MA, 1997, J COMP NEUROL, V389, P390; Cuadros MA, 2000, J COMP NEUROL, V423, P659, DOI 10.1002/1096-9861(20000807)423:4<659::AID-CNE10>3.0.CO;2-S; DAMBSKA M, 1989, J CHILD NEUROL, V4, P291, DOI 10.1177/088307388900400408; Deneen B, 2006, NEURON, V52, P953, DOI 10.1016/j.neuron.2006.11.019; Domowicz MS, 2009, DEV BIOL, V329, P242, DOI 10.1016/j.ydbio.2009.02.024; Dornowicz MS, 2008, DEV BIOL, V315, P114, DOI 10.1016/j.ydbio.2007.12.014; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Fagel DM, 2006, EXP NEUROL, V199, P77, DOI 10.1016/j.expneurol.2005.04.006; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; Folkerth RD, 2005, J CHILD NEUROL, V20, P940, DOI 10.1177/08830738050200120301; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; Gotts JE, 2005, J NEUROSCI RES, V80, P160, DOI 10.1002/jnr.20434; GRAY GE, 1991, NEURON, V6, P211, DOI 10.1016/0896-6273(91)90357-6; Gris P, 2007, GLIA, V55, P1145, DOI 10.1002/glia.20537; Hampton DW, 2004, NEUROSCIENCE, V127, P813, DOI 10.1016/j.neuroscience.2004.05.028; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Ikonomidou C, 1996, PEDIATR RES, V39, P1020, DOI 10.1203/00006450-199606000-00015; JAWORSKI DM, 1995, J NEUROSCI, V15, P1352; Johnston MV, 2002, NEUROSCIENTIST, V8, P212, DOI 10.1177/1073858402008003007; Johnston MV, 2001, PEDIATR RES, V49, P735, DOI 10.1203/00006450-200106000-00003; Kazanis I, 2003, BRAIN RES, V991, P34, DOI 10.1016/S0006-8993(03)03525-X; Kim DW, 2006, BRAIN RES, V1076, P16, DOI 10.1016/j.brainres.2006.01.010; King LA, 2009, J NEUROSCI METH, V177, P30, DOI 10.1016/j.jneumeth.2008.09.019; KURTZ A, 1994, DEVELOPMENT, V120, P2637; Laflamme N, 1999, J NEUROSCI, V19, P10923, DOI 10.1523/JNEUROSCI.19-24-10923.1999; LAVAIL JH, 1971, BRAIN RES, V28, P421; LAVAIL JH, 1971, BRAIN RES, V28, P391, DOI 10.1016/0006-8993(71)90053-9; LAWSON LJ, 1995, EUR J NEUROSCI, V7, P1584, DOI 10.1111/j.1460-9568.1995.tb01154.x; Lea PM, 2001, MENT RETARD DEV D R, V7, P235, DOI 10.1002/mrdd.1033; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; Leviton A, 2007, TRENDS NEUROSCI, V30, P473, DOI 10.1016/j.tins.2007.05.009; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; Marin-Padilla M, 1999, J NEUROPATH EXP NEUR, V58, P407, DOI 10.1097/00005072-199905000-00001; MarinPadilla M, 1997, J NEUROPATH EXP NEUR, V56, P219, DOI 10.1097/00005072-199703000-00001; McClure MM, 2008, J CEREBR BLOOD F MET, V28, P995, DOI 10.1038/sj.jcbfm.9600597; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; MILLIGAN CE, 1991, J COMP NEUROL, V314, P136, DOI 10.1002/cne.903140113; Minghetti L, 2004, J NEUROPATH EXP NEUR, V63, P901, DOI 10.1093/jnen/63.9.901; Moses P, 2002, DEV PSYCHOBIOL, V40, P266, DOI 10.1002/dev.10031; NAKAMURA Y, 1994, J NEUROPATH EXP NEUR, V53, P582, DOI 10.1097/00005072-199411000-00005; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453; Petrone P, 2011, INJURY, V42, P47, DOI 10.1016/j.injury.2010.06.026; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; PRICE J, 1988, DEVELOPMENT, V104, P473; REDDY P, 1986, CELL, V46, P53, DOI 10.1016/0092-8674(86)90859-7; Rees S, 2004, NEUROSCI LETT, V361, P111, DOI 10.1016/j.neulet.2004.02.002; Rees S, 2008, INT J DEV NEUROSCI, V26, P3, DOI 10.1016/j.ijdevneu.2007.08.020; Rezaie P, 2002, NEUROPATHOLOGY, V22, P106, DOI 10.1046/j.1440-1789.2002.00438.x; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.1289/ehp.00108s3511; Riddle A, 2006, J NEUROSCI, V26, P3045, DOI 10.1523/JNEUROSCI.5200-05.2006; Robinson S, 2005, NEUROBIOL DIS, V18, P568, DOI 10.1016/j.nbd.2004.10.024; Rodricks CL, 2008, INT J DEV NEUROSCI, V26, P113, DOI 10.1016/j.ijdevneu.2007.08.006; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; Sauvageot CM, 2002, CURR OPIN NEUROBIOL, V12, P244, DOI 10.1016/S0959-4388(02)00322-7; Segovia KN, 2008, ANN NEUROL, V63, P520, DOI 10.1002/ana.21359; Sellers DL, 2009, J NEUROSCI, V29, P6722, DOI 10.1523/JNEUROSCI.4538-08.2009; Sent E, 2006, MENT RETARD DEV D R, V12, P97, DOI 10.1002/mrdd.20106; Seo J.H., 2008, NEUROCHEM RES; Shibata T, 1997, J NEUROSCI, V17, P9212; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Stiles J, 2000, DEV NEUROPSYCHOL, V18, P237, DOI 10.1207/S15326942DN1802_5; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Svedin P, 2005, J CHILD NEUROL, V20, P960, DOI 10.1177/08830738050200120501; Tan S, 2005, J CHILD NEUROL, V20, P972, DOI 10.1177/08830738050200120801; Vardeh D, 2009, J CLIN INVEST, V119, P287, DOI 10.1172/JCI37098; Volpe JJ, 2001, PEDIATR RES, V50, P553, DOI 10.1203/00006450-200111000-00003; Wang XB, 2008, BIOCHEM BIOPH RES CO, V371, P283, DOI 10.1016/j.bbrc.2008.04.055; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; WIGGINS RC, 1986, NEUROTOXICOLOGY, V7, P103; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; Yakovlev AG, 2001, J NEUROSCI, V21, P7439, DOI 10.1523/JNEUROSCI.21-19-07439.2001; Yamagata M, 2006, MOL CELL NEUROSCI, V33, P296, DOI 10.1016/j.mcn.2006.08.001	85	17	17	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAY 10	2011	1389						35	49		10.1016/j.brainres.2011.03.006			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	767VK	WOS:000290886300005	21396923	Green Accepted			2022-02-06	
J	La Fountaine, MF; Gossett, JD; De Meersman, RE; Bauman, WA				La Fountaine, Michael F.; Gossett, James D.; De Meersman, Ronald E.; Bauman, William A.			Increased QT Interval Variability in 3 Recently Concussed Athletes: An Exploratory Observation	JOURNAL OF ATHLETIC TRAINING			English	Article						autonomic nervous system; heart; cardiovascular system; return to play	HEART-RATE-VARIABILITY; AUTONOMIC NERVOUS-SYSTEM; POWER SPECTRAL-ANALYSIS; EXERCISE; MODULATION; CASCADE	Context: The QT interval variability index (QTVI) is a noninvasive measure of beat-to-beat fluctuations of the QT interval as seen from a single electrocardiographic lead. It represents the relationship between the respective variabilities of the QT and R-R intervals. Recently, the QTVI was demonstrated to be an index of vagal cardiac autonomic modulation in resting conditions. Objective: To determine whether QTVI varied in athletes at 48 hours, 1 week, and 2 weeks after a concussive head injury. Design: Case series. Setting: Testing facility. Patients or Other Participants: Three athletes with recent concussions and 3 uninjured athletes with similar demographic factors. Main Outcome Measure(s): Continuous 3-lead electrocardiograms were obtained in a seated, resting position over 2 successive weeks. Separate, unpaired t tests were performed to determine whether group-visit differences were present in the QTVI at 48 hours, 1 week, or 2 weeks. Results: No demographic differences were present between groups. At 48 hours, the QTVI was greater in the concussion group than in the matched controls. At weeks 1 and 2, the QTVI in the concussion group was lower than at 48 hours and not different from that of the control group. Conclusions: Vagal cardiac autonomic modulation, as quantified by the QTVI, appeared to be negatively affected in concussed athletes within 48 hours of injury, resolved within 1 week, and remained at control group levels 2 weeks later. Serial assessments of QTVI may be of clinical utility in identifying suspected cases of acute concussion and may provide helpful information for determining when an athlete can return to play safely.	[La Fountaine, Michael F.; Bauman, William A.] James J Peters VA Med Ctr, Ctr Excellence Med Consequences Spinal Cord Injur, Bronx, NY 10468 USA; [La Fountaine, Michael F.; Bauman, William A.] James J Peters VA Med Ctr, SCI Serv, Bronx, NY 10468 USA; [La Fountaine, Michael F.; Bauman, William A.] Mt Sinai Sch Med, Dept Med, New York, NY USA; [Gossett, James D.] Columbia Univ, Dept Sports Med, New York, NY USA; [De Meersman, Ronald E.] Columbia Univ, Teachers Coll, Dept Biobehav Sci, New York, NY 10027 USA; [Bauman, William A.] Mt Sinai Sch Med, Dept Rehabil Med, New York, NY USA		La Fountaine, MF (corresponding author), James J Peters VA Med Ctr, Ctr Excellence Med Consequences Spinal Cord Injur, Room 7A-13M,130 W Kingsbridge Rd, Bronx, NY 10468 USA.	michael.lafountaine@va.gov	La Fountaine, Michael/Q-6769-2019				AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; ARAI Y, 1989, AM J PHYSIOL, V256, pH132, DOI 10.1152/ajpheart.1989.256.1.H132; Atiga WL, 1998, J CARDIOVASC ELECTR, V9, P899, DOI 10.1111/j.1540-8167.1998.tb00130.x; Berger RD, 2009, J AM COLL CARDIOL, V54, P851, DOI 10.1016/j.jacc.2009.06.007; Borresen J, 2008, SPORTS MED, V38, P633, DOI 10.2165/00007256-200838080-00002; BREUER HWM, 1993, BRIT HEART J, V70, P144; BROWNE KF, 1982, AM J CARDIOL, V50, P1099, DOI 10.1016/0002-9149(82)90425-8; Gall B, 2004, BRIT J SPORT MED, V38, P773, DOI 10.1136/bjsm.2003.009530; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; La Fountaine MF, 2009, AUTON NEUROSCI-BASIC, V148, P101, DOI 10.1016/j.autneu.2009.03.001; Laowattana S, 2006, NEUROLOGY, V66, P477, DOI 10.1212/01.wnl.0000202684.29640.60; MaisonBlanche P, 1997, PACE, V20, P2614, DOI 10.1111/j.1540-8159.1997.tb06111.x; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; Mine T, 2008, ANN NONINVAS ELECTRO, V13, P228, DOI 10.1111/j.1542-474X.2008.00225.x; Moak JP, 2007, HEART RHYTHM, V4, P1523, DOI 10.1016/j.hrthm.2007.07.019; NAKAMURA Y, 1993, J APPL PHYSIOL, V74, P875, DOI 10.1152/jappl.1993.74.2.875; OPPENHEIMER S, 1993, STROKE, V24, pI3; Oppenheimer SM, 1996, CLIN AUTON RES, V6, P131, DOI 10.1007/BF02281899; OPPENHEIMER SM, 1992, NEUROLOGY, V42, P1727, DOI 10.1212/WNL.42.9.1727; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; PERINI R, 1990, EUR J APPL PHYSIOL O, V61, P143, DOI 10.1007/BF00236709; Piccirillo G, 2001, CLIN SCI, V101, P429, DOI 10.1042/CS20000310; Piccirillo G, 2007, EUR HEART J, V28, P1344, DOI 10.1093/eurheartj/ehl367; Piccirillo G, 2009, J AM COLL CARDIOL, V54, P840, DOI 10.1016/j.jacc.2009.06.008; SHIN K, 1995, CLIN CARDIOL, V18, P664, DOI 10.1002/clc.4960181114; Vanravenswaaijarts CMA, 1993, ANN INTERN MED, V118, P436, DOI 10.7326/0003-4819-118-6-199303150-00008; Verberne AJM, 1998, PROG NEUROBIOL, V54, P149, DOI 10.1016/S0301-0082(97)00056-7; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103; ZAMRINI EY, 1990, NEUROLOGY, V40, P1408, DOI 10.1212/WNL.40.9.1408	32	17	17	0	6	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	MAY-JUN	2011	46	3					230	233					4	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	770YC	WOS:000291123400002	21669090				2022-02-06	
J	Wagner, BP; Ammann, RA; Bachmann, DCG; Born, S; Schibler, A				Wagner, Bendicht P.; Ammann, Roland A.; Bachmann, Denis C. G.; Born, Susanne; Schibler, Andreas			Rapid Assessment of Cerebral Autoregulation by Near-Infrared Spectroscopy and a Single Dose of Phenylephrine	PEDIATRIC RESEARCH			English	Article							BOLUS TRANSIT DETECTION; TRAUMATIC BRAIN-INJURY; BLOOD-FLOW ASSESSMENT; INDOCYANINE GREEN; CEREBROVASCULAR AUTOREGULATION; SPONTANEOUS FLUCTUATIONS; INTRACRANIAL-PRESSURE; PERFUSION-PRESSURE; HEAD-INJURY; REACTIVITY	Rapid bedside determination of cerebral blood pressure autoregulation (AR) may improve clinical utility. We tested the hypothesis that cerebral Hb oxygenation (Hb(Diff)) and cerebral Hb volume (Hb(Total)) measured by near-infrared spectroscopy (NIRS) would correlate with cerebral blood flow (CBF) after single dose phenylephrine (PE). Critically ill patients requiring artificial ventilation and arterial lines were eligible. During rapid blood pressure rise induced by i.v. PE bolus, Delta Hb(Diff) and Delta Hb(Total) were calculated by subtracting values at baseline (normotension) from values at peak blood pressure elevation (hypertension). With the aid of NIRS and bolus injection of indocyanine green, relative measures of CBF, called blood flow index (BFI), were determined during normotension and during hypertension. BFI during hypertension was expressed as percentage from BFI during normotension (BFI%). Autoregulation indices (ARIs) were calculated by dividing BFI%, Delta Hb(Diff), and Delta Hb(Total) by the concomitant change in blood pressure. In 24 patients (11 newborns and 13 children), significant correlations between BFI% and Delta Hb(Diff) (or Delta Hb(Total)) were found. In addition, the associations between Hb-based ARI and BFI%-based ART were significant with correlation coefficients of 0.73 (or 0.72). Rapid determination of dynamic AR with the aid of cerebral Hb signals and PE bolus seems to be reliable. (Pediatr Res 69: 436-441, 2011)	[Wagner, Bendicht P.] Univ Bern, Inselspital, Dept Pediat, Div Pediat Intens Care, CH-3010 Bern, Switzerland; [Schibler, Andreas] Mater Misericordiae Univ Hosp, Mater Childrens Hosp Mater, Dept Pediat, Brisbane, Qld 4101, Australia		Wagner, BP (corresponding author), Univ Bern, Inselspital, Dept Pediat, Div Pediat Intens Care, CH-3010 Bern, Switzerland.	bendicht.wagner@insel.ch	Schibler, Andreas/C-3503-2012; Ammann, Roland A/I-4716-2019; Schibler, Andreas/D-8876-2015	Ammann, Roland A/0000-0002-1902-2352; Schibler, Andreas/0000-0002-0791-5938	Department of Clinical Research; University of Berne; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [32-51078.97]	Supported by the Department of Clinical Research, University of Berne, and the Swiss National Science Foundation (grant 32-51078.97).	Al-Rawi PG, 2001, STROKE, V32, P2492, DOI 10.1161/hs1101.098356; Bayliss WM, 1902, J PHYSIOL-LONDON, V28, P220; Bein B, 2006, CRIT CARE, V10, DOI 10.1186/cc3980; Brady KM, 2007, STROKE, V38, P2818, DOI 10.1161/STROKEAHA.107.485706; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2008, ANESTH ANALG, V106, P234, DOI 10.1213/01.ane.0000295802.89962.13; De Visscher G, 2002, COMP BIOCHEM PHYS A, V132, P87, DOI 10.1016/S1095-6433(01)00533-5; GODDARD J, 1980, J PEDIATR-US, V96, P1057, DOI 10.1016/S0022-3476(80)80641-X; GREEN HD, 1964, CIRC RES, V15, pS11; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Hudetz AG, 1998, ADV EXP MED BIOL, V454, P551; Keller E, 2002, J NEUROSCI METH, V117, P23, DOI 10.1016/S0165-0270(02)00044-4; Kuebler WM, 1998, J CEREBR BLOOD F MET, V18, P445, DOI 10.1097/00004647-199804000-00013; Kuebler WM, 2008, J APPL PHYSIOL, V104, P905, DOI 10.1152/japplphysiol.00106.2008; Kurth CD, 2002, J CEREBR BLOOD F MET, V22, P335, DOI 10.1097/00004647-200203000-00011; Lang EW, 2003, J NEUROTRAUM, V20, P69, DOI 10.1089/08977150360517191; Lee JK, 2009, STROKE, V40, P1820, DOI 10.1161/STROKEAHA.108.536094; Meybohm P, 2008, ANESTH ANALG, V106, P795, DOI 10.1213/ane.0b013e31816173b4; Oertel M, 2002, J NEUROSURG, V97, P1045, DOI 10.3171/jns.2002.97.5.1045; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; PERBECK L, 1985, CLIN PHYSIOL, V5, P281; Pryds A, 2005, PEDIATR RES, V57, P294, DOI 10.1203/01.PDR.0000148714.51310.5E; Schytz HW, 2009, EUR J NEUROL, V16, P461, DOI 10.1111/j.1468-1331.2008.02398.x; Soul JS, 2007, PEDIATR RES, V61, P467, DOI 10.1203/pdr.0b013e31803237f6; Soul JS, 2000, PEDIATR RES, V48, P445, DOI 10.1203/00006450-200010000-00005; Steiner LA, 2003, STROKE, V34, P2404, DOI 10.1161/01.STR.0000089014.59668.04; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Steiner LA, 2009, NEUROCRIT CARE, V10, P122, DOI 10.1007/s12028-008-9140-5; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; Tsuji M, 1998, PEDIATR RES, V44, P591, DOI 10.1203/00006450-199810000-00020; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Wagner BP, 2003, INTENS CARE MED, V29, P196, DOI 10.1007/s00134-002-1592-z; Wagner BP, 2002, CRIT CARE MED, V30, P2014, DOI 10.1097/00003246-200209000-00010; Wolf M, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2804899; Wong FY, 2008, PEDIATRICS, V121, pE604, DOI 10.1542/peds.2007-1487	36	17	17	0	2	INT PEDIATRIC RESEARCH FOUNDATION, INC	BALTIMORE	351 W CAMDEN ST, BALTIMORE, MD 21201-2436 USA	0031-3998			PEDIATR RES	Pediatr. Res.	MAY	2011	69	5	1				436	441		10.1203/PDR.0b013e3182110177			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	753WN	WOS:000289811000012	21258266	Bronze			2022-02-06	
J	Moro, N; Ghavim, SS; Hovda, DA; Sutton, RL				Moro, Nobuhiro; Ghavim, Sima S.; Hovda, David A.; Sutton, Richard L.			Delayed sodium pyruvate treatment improves working memory following experimental traumatic brain injury	NEUROSCIENCE LETTERS			English	Article						Cerebral metabolism; Cortical contusion injury; Plus-maze; Pyruvate; Rat; Spatial alternation	CEREBRAL GLUCOSE-UTILIZATION; HIPPOCAMPAL ACETYLCHOLINE-RELEASE; CYTOCHROME-OXIDASE HISTOCHEMISTRY; POSITRON-EMISSION-TOMOGRAPHY; FLUID-PERCUSSION INJURY; CORTICAL CONTUSION; VISUAL-CORTEX; WATER MAZE; FDG-PET; METABOLISM	Prior work indicates that cerebral glycolysis is impaired following traumatic brain injury (TBI) and that pyruvate treatment acutely after TBI can improve cerebral metabolism and is neuroprotective. Since extracellular levels of glucose decrease during periods of increased cognitive demand and exogenous glucose improves cognitive performance, we hypothesized that pyruvate treatment prior to testing could ameliorate cognitive deficits in rats with TBI. Based on pre-surgical spatial alternation performance in a 4-arm plus-maze, adult male rats were randomized to receive either sham injury or unilateral (left) cortical contusion injury (CCI). On days 4,9 and 14 after surgery animals received an intraperitoneal injection of either vehicle (Sham-Veh, n = 6; CCI-Veh, n = 7) or 1000 mg/kg of sodium pyruvate (CCI-SP, n = 7). One hour after each injection rats were retested for spatial alternation performance. Animals in the CCI-SP group showed no significant working memory deficits in the spatial alternation task compared to Sham-Veh controls. The percent four/five alternation scores for CCI-Veh rats were significantly decreased from Sham-Veh scores on days 4 and 9(p < 0.01) and from CCI-SP scores on days 4,9 and 14(p < 0.05). Measures of cortical contusion volume, regional cerebral metabolic rates of glucose and regional cytochrome oxidase activity at day 15 post-injury did not differ between CCI-SP and CCI-Veh groups. These results show that spatial alternation testing can reliably detect temporal deficits and recovery of working memory after TBI and that delayed pyruvate treatment can ameliorate TBI-induced cognitive impairments. (C) 2011 Elsevier Ireland Ltd. All rights reserved.	[Moro, Nobuhiro; Ghavim, Sima S.; Hovda, David A.; Sutton, Richard L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Moro, Nobuhiro; Ghavim, Sima S.; Hovda, David A.; Sutton, Richard L.] Univ Calif Los Angeles, David Geffen Sch Med, Brain Injury Res Ctr, Los Angeles, CA 90095 USA; [Hovda, David A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA		Moro, N (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Box 957039, Los Angeles, CA 90095 USA.	nmoro@mednet.ucla.edu; sghavim@mednet.ucla.edu; dhovda@mednet.ucla.edu; rsutton@mednet.ucla.edu			UCLA Brain Injury Research Center; National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS058489]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS058489] Funding Source: NIH RePORTER	Supported by the UCLA Brain Injury Research Center and Award Number P01NS058489 from the National Institute of Neurological Disorders and Stroke (NINDS). The content is the sole responsibility of the authors and does not necessarily represent official views of the NINDS or the National Institutes of Health.	Bartnik BL, 2005, J NEUROTRAUM, V22, P1052, DOI 10.1089/neu.2005.22.1052; Bartnik BL, 2007, J NEUROTRAUM, V24, P1079, DOI 10.1089/neu.2006.0210; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Bontempi B, 1996, EUR J NEUROSCI, V8, P2348, DOI 10.1111/j.1460-9568.1996.tb01198.x; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; Conejo NM, 2007, NEUROSCIENCE, V145, P403, DOI 10.1016/j.neuroscience.2006.11.057; Dai W, 2009, BRAIN RES, V1251, P287, DOI 10.1016/j.brainres.2008.11.034; DUNNMEYNELL AA, 1995, BRAIN RES, V675, P143, DOI 10.1016/0006-8993(95)00050-Z; Fukushima M, 2009, J NEUROTRAUM, V26, P1095, DOI 10.1089/neu.2008.0771; Harrison FE, 2009, BEHAV BRAIN RES, V198, P247, DOI 10.1016/j.bbr.2008.10.015; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; HOVDA DA, 1987, EXP NEUROL, V97, P391, DOI 10.1016/0014-4886(87)90099-9; HUMAYUN MS, 1989, NUCL MED COMMUN, V10, P335, DOI 10.1097/00006231-198905000-00004; Huttemann M, 2008, NEUROSCIENCE, V151, P148, DOI 10.1016/j.neuroscience.2007.09.029; Izumi Y, 2010, NEUROSCI LETT, V478, P131, DOI 10.1016/j.neulet.2010.04.078; Kokiko ON, 2007, BRAIN INJURY, V21, P259, DOI 10.1080/02699050701209964; Kokiko-Cochran ON, 2008, NEUROSCI LETT, V436, P27, DOI 10.1016/j.neulet.2008.02.046; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee SM, 1999, ANN NY ACAD SCI, V893, P337, DOI 10.1111/j.1749-6632.1999.tb07849.x; Lin AL, 2010, P NATL ACAD SCI USA, V107, P8446, DOI 10.1073/pnas.0909711107; McNay EC, 2006, PHYSIOL BEHAV, V87, P298, DOI 10.1016/j.physbeh.2005.10.016; McNay EC, 2001, J GERONTOL A-BIOL, V56, pB66, DOI 10.1093/gerona/56.2.B66; McNay EC, 2001, NEUROBIOL LEARN MEM, V75, P325, DOI 10.1006/nlme.2000.3976; McNay EC, 2000, P NATL ACAD SCI USA, V97, P2881, DOI 10.1073/pnas.050583697; Messier C, 2004, EUR J PHARMACOL, V490, P33, DOI 10.1016/j.ejphar.2004.02.043; Moore AH, 2000, J CEREBR BLOOD F MET, V20, P1492, DOI 10.1097/00004647-200010000-00011; Moro N, 2010, EXP NEUROL, V225, P391, DOI 10.1016/j.expneurol.2010.07.013; Nakashima T, 2007, AM J NEURORADIOL, V28, P236; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.080523; Prins ML, 2009, J NEUROTRAUM, V26, P1083, DOI 10.1089/neu.2008-0769; Prins ML, 2001, J NEUROTRAUM, V18, P31, DOI 10.1089/089771501750055758; Queen SA, 1996, BRAIN RES, V724, P246, DOI 10.1016/0006-8993(96)00308-3; RAGOZZINO ME, 1995, NEUROSCIENCE, V68, P981, DOI 10.1016/0306-4522(95)00204-V; Ragozzino ME, 1998, J NEUROSCI, V18, P1595; Ragozzino ME, 1996, P NATL ACAD SCI USA, V93, P4693, DOI 10.1073/pnas.93.10.4693; Ragozzino ME, 1995, BEHAV NEUROSCI, V109, P1074; Sanchez-Carrion R, 2008, J NEUROTRAUM, V25, P479, DOI 10.1089/neu.2007.0417; Sharma Pushpa, 2009, J Emerg Trauma Shock, V2, P67, DOI 10.4103/0974-2700.50739; Soane L, 2007, J NEUROSCI RES, V85, P3407, DOI 10.1002/jnr.21498; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Sutton RL, 2000, NEURAL PLAST, V7, P109, DOI 10.1155/NP.2000.109; SUTTON RL, 1994, ACTA NEUROCHIR, P446; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; Wrubel KM, 2007, PHARMACOL BIOCHEM BE, V86, P712, DOI 10.1016/j.pbb.2007.02.018; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zeng JY, 2007, J CEREBR BLOOD F MET, V27, P304, DOI 10.1038/sj.jcbfm.9600335; Zlotnik A, 2008, NEUROCHEM RES, V33, P1044, DOI 10.1007/s11064-007-9548-x	48	17	18	0	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAR 17	2011	491	2					158	162		10.1016/j.neulet.2011.01.029			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	739QF	WOS:000288732200014	21241774	Green Accepted			2022-02-06	
J	Krpan, KM; Stuss, DT; Anderson, ND				Krpan, Katherine M.; Stuss, Donald T.; Anderson, Nicole D.			Planful versus Avoidant Coping: Behavior of Individuals With Moderate-to-Severe Traumatic Brain Injury During a Psychosocial Stress Test	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Traumatic brain injury; Coping; Stress; Methods; Adjustment; Rehabilitation	EXECUTIVE FUNCTION; STRATEGIES; INTERVENTION; PREDICTORS; RECOVERY	Many people who sustain traumatic brain injuries (TBI) have poor psychosocial outcomes that have been related to the use of avoidant coping. A major obstacle to understanding the mechanisms of this relationship are the self-report measures by which coping has been traditionally evaluated. The purpose of the present study was to compare coping behavior during a simulated real-world stress test with self-reported coping. People with moderate-to-severe TBI and matched controls completed the Baycrest Psychosocial Stress Test (BPST) where coping behavior was evaluated, and also completed the Ways of Coping Questionnaire (WOC). While there were no group differences in self- or significant-other-reported behavior on the WOC, the TBI group engaged in more avoidant than planful behavior on the BPST, while the control group displayed the opposite pattern of behavior. Moreover, in the control group there were positive relations between behavior on the BPST and self-reported coping on the WOC, but no such relation within the TB I group. Secondary analyses allowed for TBI participants to be characterized as "planners" or "avoiders." This is the first study, to our knowledge, to report behavioral differences in coping post-TBI. Future work investigating the moderators of these differences may have significant implications for rehabilitative intervention. (JINS, 2011, 17, 248-255)	[Krpan, Katherine M.; Stuss, Donald T.; Anderson, Nicole D.] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Stuss, Donald T.] Rotman Res Inst, Toronto, ON, Canada; [Stuss, Donald T.] Univ Toronto, Fac Med Neurol Rehabil Sci, Toronto, ON M5S 1A1, Canada; [Anderson, Nicole D.] Univ Toronto, Fac Med Psychiat, Toronto, ON M5S 1A1, Canada; [Krpan, Katherine M.; Anderson, Nicole D.] Kunin Lunenfeld Appl Res Unit, Toronto, ON, Canada		Anderson, ND (corresponding author), KLARU Baycrest, 3560 Bathurst St, Toronto, ON M6A 2E1, Canada.	nanderson@klaru-baycrest.on.ca	Anderson, Nicole D/E-9101-2011	Anderson, Nicole D/0000-0002-5979-2220	NSERCNatural Sciences and Engineering Research Council of Canada (NSERC); CIHRCanadian Institutes of Health Research (CIHR); Ontario Research Coalition; Toronto Rehabilitation InstituteUniversity of Toronto; Max and Ruth Wiseman Award; Mary Gertrude l'Anson Scholarship	We thank Dr. M. Binns for his statistical advice on this project, and S. Blackwood, A. Chaudhry, S. Gillingham, A. Maione, C. Nguyen, S. Priselac, and S. Waters-Schulte for all their help with the study. Funding: There are no financial or other relationships that could be interpreted as a conflict of interest affecting this manuscript. This work was supported by an NSERC grant to N.D. Anderson. K.M. Krpan was a doctoral student in the Department of Psychology at the University of Toronto during the project, and was funded by CIHR Doctoral Fellowship, Ontario Research Coalition, Toronto Rehabilitation Institute, Max and Ruth Wiseman Award and the Mary Gertrude l'Anson Scholarship.	Anson K, 2006, BRAIN INJURY, V20, P1, DOI 10.1080/02699050500309791; Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; Dawson DR, 2006, BRAIN COGNITION, V60, P214; Dawson DR, 2004, BRAIN INJURY, V18, P221, DOI 10.1080/02699050310001617406; Dawson M. E., 1990, PRINCIPLES PSYCHOPHY, P295; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Finset A, 2000, BRAIN INJURY, V14, P887; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; Fleming AS, 1997, HORM BEHAV, V32, P85, DOI 10.1006/hbeh.1997.1407; Folkman S., 1984, STRESS; Folkman S., 1988, WAYS COPING QUESTION; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; Krpan KM, 2005, HORM BEHAV, V47, P112, DOI 10.1016/j.yhbeh.2004.08.006; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Levine B., 2008, COGNITIVE NEUROREHAB, V2nd, P464, DOI [10.1017/CBO9781316529898.033, DOI 10.1017/CBO9781316529898.033]; Mateer CA, 2006, NEUROREHABILITATION, V21, P315; O'Keeffe FM, 2004, COGNITIVE BRAIN RES, V22, P101, DOI 10.1016/j.cogbrainres.2004.07.012; PRIGATANO GP, 2005, AWARENESS DEFICIT BR, P111; Spielberger CD., 1983, STATE TRAIT ANXIETY; Stuss D., 1991, AWARENESS DEFICIT BR, P63; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; ZACHARY RA, 1982, SHIPLEY I LIVING SCA	33	17	17	0	6	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAR	2011	17	2					248	255		10.1017/S1355617710001499			8	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	738DY	WOS:000288620900005	21205331				2022-02-06	
J	Lotocki, G; Vaccari, JD; Alonso, O; Molano, JS; Nixon, R; Dietrich, WD; Bramlett, HM				Lotocki, George; Vaccari, Juan de Rivero; Alonso, Ofelia; Molano, Juliana Sanchez; Nixon, Ryan; Dietrich, W. Dalton; Bramlett, Helen M.			Oligodendrocyte Vulnerability Following Traumatic Brain Injury in Rats: Effect of Moderate Hypothermia	THERAPEUTIC HYPOTHERMIA AND TEMPERATURE MANAGEMENT			English	Article								The purpose of this study was to document patterns of oligodendrocyte vulnerability to traumatic brain injury (TBI) and determine whether post-traumatic hypothermia prevents oligodendrocyte cell loss. Sprague-Dawley rats underwent moderate fluid percussion brain injury. Thirty minutes after TBI, brain temperature was reduced to 33 degrees C for 4 hours or maintained at normothermic levels (37 degrees C). Animals were perfusion-fixed for quantitative immunohistochemical analysis at 3 (n = 9) or 7 (n = 9) days post-TBI. Within the cerebral cortex, external capsule, and corpus callosum, numbers of APC-CC1 immunoreactive oligodendrocytes at 3 and 7 days following TBI were significantly decreased compared with sham-operated rats (p < 0.02). Double-labeling studies showed that vulnerable oligodendrocytes expressed increased Caspase 3 activation compared with sham. Post-traumatic hypothermia significantly reduced the number of CC1-positive oligodendrocytes lost after normothermia TBI in white matter tracts (p < 0.01). This model of TBI leads to quantifiable regional patterns of oligodendrocyte vulnerability. Post-traumatic hypothermia protects oligodendrocytes by interfering with Caspase 3-mediated cell death mechanisms. Therapeutic hypothermia may improve functional outcome by attenuating trauma-induced oligodendrocyte cell death, subsequent demyelination, and circuit dysfunction.	[Lotocki, George; Vaccari, Juan de Rivero; Alonso, Ofelia; Molano, Juliana Sanchez; Nixon, Ryan; Dietrich, W. Dalton; Bramlett, Helen M.] Univ Miami Miller Sch Med, Miami Project Cure Paralysis, Miami, FL USA; [Vaccari, Juan de Rivero; Dietrich, W. Dalton; Bramlett, Helen M.] Univ Miami Miller Sch Med, Dept Neurol Surg, Miami, FL USA; [Bramlett, Helen M.] Bruce W Carter Dept Vet Affairs, Med Ctr, Miami, FL USA		Bramlett, HM (corresponding author), Univ Miami Miller Sch Med, Dept Neurol Surg, 1095 NW 14th Terrace LPLC 3-18, Miami, FL 33136 USA.	hbramlett@miami.edu		de Rivero Vaccari, Juan Pablo/0000-0002-5460-8834	 [NS030291];  [NS042133]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030291, R01NS042133] Funding Source: NIH RePORTER	The authors thank Jeremy Lytle for help and editorial assistance with the article. This work was supported by NS030291 and NS042133.	ANDERSON CV, 1995, J NEUROPSYCH CLIN N, V7, P42; Bhat RV, 1996, GLIA, V17, P169; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Buki A, 1999, EXP NEUROL, V159, P319, DOI 10.1006/exnr.1999.7139; Clark RSB, 1996, J CEREBR BLOOD F MET, V16, P253, DOI 10.1097/00004647-199603000-00010; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Conti AC, 1998, J NEUROSCI, V18, P5663; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; CULLUM CM, 1986, J CLIN EXP NEUROPSYC, V8, P437, DOI 10.1080/01688638608401333; Dewar D, 2003, J CEREBR BLOOD F MET, V23, P263, DOI 10.1097/01.WCB.0000053472.41007.F9; Dietrich WD, 2009, J NEUROTRAUM, V26, P301, DOI 10.1089/neu.2008.0806; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; Dietrich WD, 1996, ADV NEUROL, V71, P177; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Domercq M, 2010, GLIA, V58, P730, DOI 10.1002/glia.20958; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Fuss B, 2000, DEV BIOL, V218, P259, DOI 10.1006/dbio.1999.9574; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; Gootjes L, 2004, DEMENT GERIATR COGN, V18, P180, DOI 10.1159/000079199; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kujala P, 1997, BRAIN, V120, P289, DOI 10.1093/brain/120.2.289; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; Lotocki G, 2006, EUR J NEUROSCI, V24, P2283, DOI 10.1111/j.1460-9568.2006.05123.x; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; LYETH BG, 1993, J NEUROTRAUM, V10, P57, DOI 10.1089/neu.1993.10.57; Mabbott DJ, 2006, NEUROIMAGE, V33, P936, DOI 10.1016/j.neuroimage.2006.07.024; McDonald JW, 1996, ANN NEUROL, V40, P750, DOI 10.1002/ana.410400511; McDonald JW, 2002, NEUROSCIENCE, V115, P931, DOI 10.1016/S0306-4522(02)00342-1; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; Salter MG, 2005, NATURE, V438, P1167, DOI 10.1038/nature04301; Schulz R, 2008, CELL TISSUE RES, V334, P327, DOI 10.1007/s00441-008-0714-5; Shaw K, 2001, CLIN NEUROPATHOL, V20, P106; Suzuki T, 2004, J NEUROTRAUM, V21, P842, DOI 10.1089/0897715041526186; Suzuki T, 2003, EXP NEUROL, V184, P1017, DOI 10.1016/S0014-4886(03)00389-3; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Yu WR, 2009, NEUROBIOL DIS, V33, P149, DOI 10.1016/j.nbd.2008.09.024	49	17	18	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2153-7658	2153-7933		THER HYPOTHERMIA TEM	Ther. Hypothermia Temp. Manag.	MAR 1	2011	1	1								10.1089/ther.2010.0011			10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V38PS	WOS:000209355900003	23336085	Green Accepted, Green Published			2022-02-06	
J	Saban, KL; Smith, BM; Collins, EG; Pape, TLB				Saban, Karen L.; Smith, Bridget M.; Collins, Eileen G.; Pape, Theresa Louise-Bender			Sex Differences in Perceived Life Satisfaction and Functional Status One Year After Severe Traumatic Brain Injury	JOURNAL OF WOMENS HEALTH			English	Article							QUALITY-OF-LIFE; GENDER-DIFFERENCES; INDEPENDENCE MEASURE; CEREBRAL-ISCHEMIA; SELF-EFFICACY; 1ST YEAR; PROGESTERONE; OUTCOMES; FEMALE; ESTROGEN	Aims: The primary aim of this study was to describe and compare perceived life satisfaction and perceived functional motor and cognitive status 1 year after severe traumatic brain injury (TBI) in males and females, adjusting for demographics and severity of injury. Methods: Data of 297 participants were abstracted from the National Institute on Disability Rehabilitation and Research (NIDRR)-funded Traumatic Brain Injury Model Systems (TBIMS). Participants were aged 16-50, enrolled in the TBIMS study between the years 1998 and 2008, diagnosed with severe TBI (defined as having an initial Glasgow Coma Scale [GCS] score between 3 and 8), and with perceived life satisfaction and functional status data available at 1 year postinjury. Multiple linear regression models were used to estimate the association between sex, demographic variables, severity of injury, and the outcome variables. Results: Our findings indicate that sex did not significantly influence perceived satisfaction with life or motor function 1 year after severe TBI. However, females had significantly better (p = 0.031) cognitive outcomes compared to males 1 year after severe TBI, after controlling for demographics and severity of injury. Conclusions: Findings suggest that females may have better perceived cognitive functional outcomes than males 1 year after severe TBI. Further longitudinal research, including measurement of hormonal levels, is needed to determine if hormones influence outcomes of severe TBI as well as the trajectory of these outcomes. A better understanding of sex differences in outcomes after TBI will help clinicians improve strategies for rehabilitation.	[Saban, Karen L.] Loyola Univ Chicago, Marcella Niehoff Sch Nursing, Dept Hlth Management & Risk Reduct, Maywood, IL 60153 USA; [Saban, Karen L.; Smith, Bridget M.; Collins, Eileen G.; Pape, Theresa Louise-Bender] Edward Hines Jr VA Hosp, Ctr Management Complex Chron Care, Hines, IL USA; [Smith, Bridget M.] Loyola Univ Chicago, Stritch Sch Med, Hlth Serv Res Program, Maywood, IL 60153 USA; [Collins, Eileen G.] Univ Illinois, Coll Nursing, Dept Biobehav Hlth Sci, Chicago, IL USA; [Pape, Theresa Louise-Bender] Northwestern Univ, Feinburg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA		Saban, KL (corresponding author), Loyola Univ Chicago, Marcella Niehoff Sch Nursing, Dept Hlth Management & Risk Reduct, Maguire Bldg,Room 2840,2160 S 1st Ave, Maywood, IL 60153 USA.	ksaban@luc.edu	Saban, Karen/H-4837-2011	Saban, Karen/0000-0001-5767-5453; Bender Pape, Theresa/0000-0001-7738-5963	Veterans Affairs (VA) Health Service Research and Development (HSRD)US Department of Veterans Affairs [TPN-42-001]; Rehabilitation Research & Development (RR&D), Department of Veterans AffairsUS Department of Veterans Affairs; VA RR&D Career Development Transition Award; VA HSRD	The TBIMS National Database was supported by the U.S. Department of Education, NIDRR, in collaboration with the TBIMS Centers. However, these contents do not necessarily reflect the opinions or views of the TBIMS Centers, NIDRR, or the U. S. Department of Education.; K. L. S. is supported by a 3-year Veterans Affairs (VA) Health Service Research and Development (HSR&D) Postdoctoral Fellowship (TPN-42-001). B. M. S. is supported by funding through VAHSR&D. E. G. C. is supported by a Research Career Scientist Award, Rehabilitation Research & Development (RR&D), Department of Veterans Affairs. T.L.-B.P. is supported by a 3-year VA RR&D Career Development Transition Award and an RR&D merit grant as well as a VA HSR&D merit grant. The views expressed do not necessarily reflect the position or policy of the Department of Veterans Affairs. The authors thank the blinded reviewers for their thoughtful suggestions that strengthened the article.	Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Arango-Lasprilla JC, 2008, ARCH PHYS MED REHAB, V89, P988, DOI 10.1016/j.apmr.2008.02.012; Arvin B, 1996, NEUROSCI BIOBEHAV R, V20, P445, DOI 10.1016/0149-7634(95)00026-7; Beal CC, 2010, J NEUROSCI NURS, V42, P80, DOI 10.1097/JNN.0b013e3181ce5c70; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cain KC, 2009, DIGEST DIS SCI, V54, P1542, DOI 10.1007/s10620-008-0516-3; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P418, DOI 10.1016/j.apmr.2007.01.010; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Dahmer E., 1993, J HEAD TRAUMA REHAB, V8, P12, DOI [10.1097/00001199-199308020-00004, DOI 10.1097/00001199-199308020-00004]; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; DISCALA C, 1992, AM J PHYS MED REHAB, V71, P145, DOI 10.1097/00002060-199206000-00004; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Frisch M.B., 1994, MANUAL TREATMENT GUI; Graham JE, 2010, ARCH PHYS MED REHAB, V91, P43, DOI 10.1016/j.apmr.2009.09.017; Grossman KJ, 2004, BRAIN RES, V1008, P29, DOI 10.1016/j.brainres.2004.02.022; Gulinello M, 2006, HORM BEHAV, V49, P246, DOI 10.1016/j.yhbeh.2005.07.010; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; HURN PD, 1995, J CEREBR BLOOD F MET, V15, P666, DOI 10.1038/jcbfm.1995.82; Kraus J F, 2000, Neurosurg Focus, V8, pe5; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; KumeKick J, 1996, BRAIN RES, V738, P8, DOI 10.1016/0006-8993(96)00744-5; Lin MR, 2010, ARCH PHYS MED REHAB, V91, P474, DOI 10.1016/j.apmr.2009.10.031; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Lippert-Gruner M, 2007, BRAIN INJURY, V21, P451, DOI 10.1080/02699050701343961; Lippert-Gruner M, 2003, BRAIN INJURY, V17, P49, DOI 10.1080/0269905021000010230; Liu R, 2005, BRAIN RES, V1060, P55, DOI 10.1016/j.brainres.2005.08.048; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; MENDELSON ME, 1994, CURR OPIN CARDIOL, V9, P619, DOI 10.1097/00001573-199409000-00018; Merrill SS, 1997, J GERONTOL A-BIOL, V52, pM19, DOI 10.1093/gerona/52A.1.M19; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Niemeier JP, 2007, NEUROPSYCHOL REHABIL, V17, P293, DOI 10.1080/09602010600814729; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Resch JA, 2009, REHABIL PSYCHOL, V54, P51, DOI 10.1037/a0015051; Slewa-Younan S, 2008, J NEUROL NEUROSUR PS, V79, P1197, DOI 10.1136/jnnp.2008.147983; Slewa-Younan S, 2008, BRAIN INJURY, V22, P183, DOI 10.1080/02699050801888808; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Stein DG, 2008, ANN EMERG MED, V51, P164, DOI 10.1016/j.annemergmed.2007.05.001; Suzuki S, 2007, J COMP NEUROL, V500, P1064, DOI 10.1002/cne.21240; TEASDALE G, 1974, LANCET, V2, P81; Thomas MD, 2009, BRAIN INJURY, V23, P516, DOI 10.1080/02699050902926333; Tsaousides T, 2009, REHABIL PSYCHOL, V54, P299, DOI 10.1037/a0016807; von Elm E, 2008, SWISS MED WKLY, V138, P327, DOI 2008/23/smw-12025; Wen Y, 2004, BRAIN RES, V1008, P147, DOI 10.1016/j.brainres.2004.02.019; WHITLOCK JA, 1995, ARCH PHYS MED REHAB, V76, P1103, DOI 10.1016/S0003-9993(95)80117-0; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887	49	17	19	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1540-9996	1931-843X		J WOMENS HEALTH	J. Womens Health	FEB	2011	20	2					179	186		10.1089/jwh.2010.2334			8	Public, Environmental & Occupational Health; Medicine, General & Internal; Obstetrics & Gynecology; Women's Studies	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; General & Internal Medicine; Obstetrics & Gynecology; Women's Studies	720TU	WOS:000287306100003	21314444	Green Submitted			2022-02-06	
J	Yunusova, Y; Green, JR; Wang, J; Pattee, G; Zinman, L				Yunusova, Yana; Green, Jordan R.; Wang, Jun; Pattee, Gary; Zinman, Lorne			A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis (ALS)	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Medicine; Issue 48; speech; assessment; subsystems; bulbar function; amyotrophic lateral sclerosis	NASALANCE; SPEECH; JUDGMENTS	Improved methods for assessing bulbar impairment are necessary for expediting diagnosis of bulbar dysfunction in ALS, for predicting disease progression across speech subsystems, and for addressing the critical need for sensitive outcome measures for ongoing experimental treatment trials. To address this need, we are obtaining longitudinal profiles of bulbar impairment in 100 individuals based on a comprehensive instrumentation-based assessment that yield objective measures. Using instrumental approaches to quantify speech-related behaviors is very important in a field that has primarily relied on subjective, auditory-perceptual forms of speech assessment(1). Our assessment protocol measures performance across all of the speech subsystems, which include respiratory, phonatory (laryngeal), resonatory (velopharyngeal), and articulatory. The articulatory subsystem is divided into the facial components (jaw and lip), and the tongue. Prior research has suggested that each speech subsystem responds differently to neurological diseases such as ALS. The current protocol is designed to test the performance of each speech subsystem as independently from other subsystems as possible. The speech subsystems are evaluated in the context of more global changes to speech performance. These speech system level variables include speaking rate and intelligibility of speech. The protocol requires specialized instrumentation, and commercial and custom software. The respiratory, phonatory, and resonatory subsystems are evaluated using pressure-flow (aerodynamic) and acoustic methods. The articulatory subsystem is assessed using 3D motion tracking techniques. The objective measures that are used to quantify bulbar impairment have been well established in the speech literature and show sensitivity to changes in bulbar function with disease progression. The result of the assessment is a comprehensive, across-subsystem performance profile for each participant. The profile, when compared to the same measures obtained from healthy controls, is used for diagnostic purposes. Currently, we are testing the sensitivity and specificity of these measures for diagnosis of ALS and for predicting the rate of disease progression. In the long term, the more refined endophenotype of bulbar ALS derived from this work is expected to strengthen future efforts to identify the genetic loci of ALS and improve diagnostic and treatment specificity of the disease as a whole. The objective assessment that is demonstrated in this video may be used to assess a broad range of speech motor impairments, including those related to stroke, traumatic brain injury, multiple sclerosis, and Parkinson disease.	[Yunusova, Yana] Univ Toronto, Dept Speech Language Pathol, Toronto, ON M5S 1A1, Canada; [Yunusova, Yana; Zinman, Lorne] Sunnybrook Hlth Sci Ctr, ALS MN Clin, Toronto, ON, Canada; [Green, Jordan R.; Wang, Jun] Univ Nebraska Lincoln, Dept Special Educ & Commun Disorders, Lincoln, NE USA; [Pattee, Gary] Univ Nebraska Med Ctr, Munroe Meyer Inst, Dept Neurol, Lincoln, NE USA; [Zinman, Lorne] Univ Toronto, Dept Neurol, Toronto, ON M5S 1A1, Canada		Yunusova, Y (corresponding author), Univ Toronto, Dept Speech Language Pathol, Toronto, ON M5S 1A1, Canada.	yana.yunusova@utoronto.ca	Wang, Jun/G-8572-2015; Yunusova, Yana/E-3428-2010; Green, Jordan/N-3585-2019	Yunusova, Yana/0000-0002-2353-2275; Green, Jordan/0000-0002-1464-1373	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Institute on Deafness and Other Communication DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DCO09890-02]; Canadian Foundation for InnovationCanada Foundation for Innovation [15704]; Connaught FoundationUniversity of Toronto; University of TorontoUniversity of Toronto	This work has been supported by the National Institute of Health, National Institute on Deafness and Other Communication Disorders, Grant R01DCO09890-02, Canadian Foundation for Innovation (CFI-LOF #15704), and Connaught Foundation, University of Toronto. The authors would like to thank Cynthia Didion, Mili Kuruvilla, Krista Rudy, and Lori Synhorst for assistance with data collection and analysis; and Cara Ullman for creating video clips.	Baken RJ, 2000, CLIN MEASUREMENT SPE; Ball LJ, 2001, J NEUROL SCI, V191, P43, DOI 10.1016/S0022-510X(01)00623-2; Beukelman D. R., 2007, SPEECH INTELLIGIBILI; Bressmann T, 2000, CLEFT PALATE-CRAN J, V37, P248, DOI 10.1597/1545-1569(2000)037<0248:NDARTN>2.3.CO;2; Delorey R, 1999, J MED SPEECH-LANG PA, V7, P19; FLETCHER SG, 1976, CLEFT PALATE J, V13, P31; Gauster A, 2010, CLIN LINGUIST PHONET, V24, P576, DOI 10.3109/02699200903581042; Green JR, 2006, DEV PSYCHOBIOL, V48, P16, DOI 10.1002/dev.20112; Green JR, 2004, J MED SPEECH-LANG PA, V12, P149; Hakkesteegt M. M., 2007, J VOICE, V4, P529; Hakkesteegt MM, 2006, FOLIA PHONIATR LOGO, V58, P264, DOI 10.1159/000093183; HARDIN MA, 1992, CLEFT PALATE-CRAN J, V29, P346, DOI 10.1597/1545-1569(1992)029<0346:CBNSAL>2.3.CO;2; Lyall RA, 2001, BRAIN, V124, P2000, DOI 10.1093/brain/124.10.2000; Robert D, 1999, ACTA OTO-LARYNGOL, V119, P724; Sapienza CM, 1997, J VOICE, V11, P195, DOI 10.1016/S0892-1997(97)80078-1; SMITHERAN JR, 1981, J SPEECH HEAR DISORD, V46, P138, DOI 10.1044/jshd.4602.138; STATHOPOULOS ET, 1986, J SPEECH HEAR RES, V29, P71, DOI 10.1044/jshr.2901.71; Tasko SM, 2004, J PHONETICS, V32, P65, DOI 10.1016/S0095-4470(03)00006-8; Wang Y., BEHAV RES M IN PRESS; Yunusova Y, 2010, J COMMUN DISORD, V43, P6, DOI 10.1016/j.jcomdis.2009.07.003; Yunusova Y, 2009, J SPEECH LANG HEAR R, V52, P547, DOI 10.1044/1092-4388(2008/07-0218)	21	17	18	0	1	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	FEB	2011		48							e2422	10.3791/2422			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V36LG	WOS:000209212900016	21372794	Green Published, Bronze			2022-02-06	
J	Cullen, DK; Xu, YA; Reneer, DV; Browne, KD; Geddes, JW; Yang, S; Smith, DH				Cullen, D. Kacy; Xu, Yongan; Reneer, Dexter V.; Browne, Kevin D.; Geddes, James W.; Yang, Shu; Smith, Douglas H.			Color changing photonic crystals detect blast exposure	NEUROIMAGE			English	Article							TRAUMATIC BRAIN-INJURY; HEAD-INJURY; MULTIBEAM INTERFERENCE; RECURRENT CONCUSSION; ALZHEIMERS-DISEASE; AFGHANISTAN; FABRICATION; FREQUENCY; DEMENTIA; ONSET	Blast-induced traumatic brain injury (bTBI) is the "signaturewound" of the current wars in Iraq and Afghanistan. However, with no objective information of relative blast exposure, warfighters with bTBI may not receive appropriate medical care and are at risk of being returned to the battlefield. Accordingly, we have created a colorimetric blast injury dosimeter (BID) that exploits material failure of photonic crystals to detect blast exposure. Appearing like a colored sticker, the BID is fabricated in photosensitive polymers via multi-beam interference lithography. Although very stable in the presence of heat, cold or physical impact, sculpted micro -and nano-structures of the BID are physically altered in a precise manner by blast exposure, resulting in color changes that correspond with blast intensity. This approach offers a lightweight, power-free sensor that can be readily interpreted by the naked eye. Importantly, with future refinement this technology may be deployed to identify soldiers exposed to blast at levels suggested to be supra-threshold for non-impact blast-induced mild TBI. (C) 2010 Elsevier Inc. All rights reserved.	[Cullen, D. Kacy; Browne, Kevin D.; Smith, Douglas H.] Univ Penn, Dept Neurosurg, Sch Med, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA; [Xu, Yongan; Yang, Shu] Univ Penn, Dept Mat Sci & Engn, Sch Engn & Appl Sci, Philadelphia, PA 19104 USA; [Reneer, Dexter V.; Geddes, James W.] Univ Kentucky, Coll Med,Dept Anat & Neurobiol, Albert B Chandler Med Ctr, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA		Smith, DH (corresponding author), Univ Penn, Dept Neurosurg, Sch Med, Ctr Brain Injury & Repair, 105 Hayden Hall,3320 Smith Walk, Philadelphia, PA 19104 USA.	shuyang@seas.upenn.edu; smithdou@mail.med.upenn.edu	Xu, Yongan/A-7078-2011; Yang, Shu/D-9758-2011	Yang, Shu/0000-0001-8834-3320	Nanotechnology Institute Proof-of-Concept (PoC) Fund; Office of Naval Research (ONR)Office of Naval Research [N00014-05-0303]; Air Force Office of Scientific Research (AFOSR)United States Department of DefenseAir Force Office of Scientific Research (AFOSR) [FA9550-06-1-0228]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS038104, NS048949, NS043126]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS048949, R01NS038104, T32NS043126] Funding Source: NIH RePORTER	This work was supported in part by the Nanotechnology Institute Proof-of-Concept (PoC) Fund, the Office of Naval Research (ONR) (grant #N00014-05-0303), the Air Force Office of Scientific Research (AFOSR) (grant # FA9550-06-1-0228), and the National Institutes of Health (NIH) (grant #NS038104, #NS048949, and #NS043126). The funding sources had no involvement in any aspects of this work or the decision to publish.	Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Campbell M, 2000, NATURE, V404, P53, DOI 10.1038/35003523; Cantu RC, 2003, CLIN SPORT MED, V22, P593, DOI 10.1016/S0278-5919(02)00095-9; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Erlanger DM, 1999, CLIN NEUROPSYCHOL, V13, P193, DOI 10.1076/clin.13.2.193.1963; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jellinger KA, 2001, EUR J NEUROL, V8, P707, DOI 10.1046/j.1468-1331.2001.00322.x; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Kato K, 2007, J NEUROSURG, V106, P667, DOI 10.3171/jns.2007.106.4.667; LEE KY, 1994, J VAC SCI TECHNOL B, V12, P3425, DOI 10.1116/1.587525; LING G, 2008, 26 ANN NAT NEUR S OR; Lorenz H, 1997, J MICROMECH MICROENG, V7, P121, DOI 10.1088/0960-1317/7/3/010; Loubeau A, 2006, J ACOUST SOC AM, V120, pEL29, DOI 10.1121/1.2234518; Martin E.M, 2008, J TRAUMA NURS, V15, P100; Martin Elisabeth Moy, 2008, J Trauma Nurs, V15, P94, DOI 10.1097/01.JTN.0000337149.29549.28; McMurtray A, 2006, DEMENT GERIATR COGN, V21, P59, DOI 10.1159/000089546; Miklyaev YV, 2003, APPL PHYS LETT, V82, P1284, DOI 10.1063/1.1557328; Moochhala SM, 2004, J TRAUMA, V56, P393, DOI 10.1097/01.TA.0000066181.50879.7A; Moon JH, 2006, POLYM ADVAN TECHNOL, V17, P83, DOI 10.1002/pat.663; Moon JH, 2005, J MACROMOL SCI-POL R, VC45, P351, DOI 10.1080/15321790500304163; Mori T, 2006, ACTA NEUROCHIR SUPPL, V96, P40; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Ribeiro JC, 2005, SENSOR ACTUAT A-PHYS, V123-24, P77, DOI 10.1016/j.sna.2005.03.032; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; TOKUDA T, 1991, ACTA NEUROPATHOL, V82, P280, DOI 10.1007/BF00308813; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Warden DL, 2005, J NEUROTRAUM, V22, P1178; Xu Y, 2008, CHEM MATER, V20, P1816, DOI 10.1021/cm702511k; Yang S, 2002, CHEM MATER, V14, P2831, DOI 10.1021/cm0256007	37	17	18	1	25	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	JAN	2011	54			1			S37	S44		10.1016/j.neuroimage.2010.10.076			8	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	813ZF	WOS:000294408600006	21040795	Green Accepted			2022-02-06	
J	Echemendia, RJ; Iverson, GL; McCrea, M; Broshek, DK; Gioia, GA; Sautter, SW; Macciocchi, SN; Barr, WB				Echemendia, Ruben J.; Iverson, Grant L.; McCrea, Michael; Broshek, Donna K.; Gioia, Gerard A.; Sautter, Scott W.; Macciocchi, Stephen N.; Barr, William B.			Role of Neuropsychologists in the Evaluation and Management of Sport-related Concussion: An Inter-Organization Position Statement	CLINICAL NEUROPSYCHOLOGIST			English	Article						Concussion; Traumatic Brain Injury; Children; Legislation	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; FOOTBALL PLAYERS; NEUROCOGNITIVE PERFORMANCE; INTERNATIONAL-CONFERENCE; SEX-DIFFERENCES; RECOVERY; SYMPTOMS; IMPACT; DEFICITS	Over the past 20 years, clinical neuropsychologists have been at the forefront of both scientific and clinical initiatives aimed at developing evidence-based approaches to the evaluation and management of sport-related concussion. These efforts have directly impacted current policy on strategies for injury assessment and return-to-play by athletes after concussion. Many states are considering legislation requiring (a) education of athletes, parents, coaches, and school/organization officials on the recognition, evaluation, and management of sport-related concussions; (b) removal from play of any youth athlete that is suspected of having sustained a concussion; and (c) not allowing the student to return to participation until the student is evaluated and cleared for return to participation in writing by an appropriate healthcare professional. It is the official position of the American Academy of Clinical Neuropsychology (AACN), American Board of Neuropsychology (ABN), Division 40 (Neuropsychology) of the American Psychological Association (APA), and the National Academy of Neuropsychology (NAN) that neuropsychologists should be included among the licensed health care professionals authorized to evaluate, clinically manage, and provide return to play clearance for athletes who sustain a sport-related concussion.	[Echemendia, Ruben J.] Psychol & Neurobehav Associates Inc, State Coll, PA USA; [Iverson, Grant L.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [McCrea, Michael] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Broshek, Donna K.] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA; [Gioia, Gerard A.] Childrens Natl Med Ctr, Rockville, MD USA; [Gioia, Gerard A.] George Washington Univ, Sch Med, Rockville, MD USA; [Sautter, Scott W.] Hampton Rd Neuropsychol Inc, Virginia Beach, VA USA; [Macciocchi, Stephen N.] Shepherd Ctr, Atlanta, GA USA; [Barr, William B.] NYU, Sch Med, New York, NY 10003 USA		Echemendia, RJ (corresponding author), 204 E Calder Way,Ste 205, State Coll, PA 16801 USA.	rechemendia@comcast.net	Broshek, Donna/ABA-4208-2021; Echemendia, Ruben/R-6939-2019	Broshek, Donna/0000-0002-7175-7815; Barr, William/0000-0001-7711-7758; Iverson, Grant/0000-0001-7348-9570; Echemendia, Ruben/0000-0001-6116-8462			Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Barth JT, 2003, ARCH CLIN NEUROPSYCH, V18, P551, DOI 10.1016/S0887-6177(02)00146-4; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Bruce JM, 2003, NEUROPSYCHOLOGY, V17, P622, DOI 10.1037/0894-4105.17.4.622; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; DeKosky ST, 2007, ARCH NEUROL-CHICAGO, V64, P541, DOI 10.1001/archneur.64.4.541; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Echemendia R., 2006, SPORTS NEUROPSYCHOLO; Echemendia RJ, 2009, BRIT J SPORT MED, V43, pI32, DOI 10.1136/bjsm.2009.058164; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kelly JP, 1999, JAMA-J AM MED ASSOC, V282, P989, DOI 10.1001/jama.282.10.989; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lovell M, 1999, SPORTS RELATED CONCU; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; LOVELL MR, 1996, NEW DEV SPORTS REL C; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Sosnoff JJ, 2007, NEUROPSYCHOLOGY, V21, P796, DOI 10.1037/0894-4105.21.6.796; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677	43	17	17	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2011	25	8					1289	1294		10.1080/13854046.2011.618466			6	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	882JM	WOS:000299559900001	22171535	Bronze			2022-02-06	
J	Garnock-Jones, KP				Garnock-Jones, Karly P.			Dextromethorphan/Quinidine In Pseudobulbar Affect	CNS DRUGS			English	Article							EMOTIONAL EXPRESSION DISORDER; MULTIPLE-SCLEROSIS; QUINIDINE INHIBITION; PHARMACOKINETICS; PATHOPHYSIOLOGY; HUMANS; TRIAL	Pseudobulbar affect is characterized by uncontrollable, inappropriate laughing and/or crying that is either unrelated or out of proportion to the emotions felt by the patient and occurs in patients with neurological disorders, such as amyotrophic lateral sclerosis (ALS), multiple sclerosis or traumatic brain injury. Dextromethorphan/quinidine is indicated in the US for the treatment of pseudobulbar affect. Dextromethorphan, when its metabolism is inhibited by the coadministration of quinidine, has been shown to have a positive effect on the symptoms of pseudobulbar affect. Dextromethorphan/quinidine 20 mg/10 mg twice daily was associated with a significantly greater decrease in the rate of pseudobulbar affect episodes per day (primary endpoint) than placebo in the 12-week, randomized, double-blind, placebo-controlled, multicentre STAR trial (Safety, Tolerability, And efficacy Results trial of AVP-923 in PBA [pseudobulbar affect]) involving patients with pseudobulbar affect and ALS or multiple sclerosis. Moreover, the mean change from baseline in Center for Neurologic Study-Lability Scale score at 12 weeks was significantly greater among recipients of dextromethorphan/quinidine 20 mg/10 mg twice daily than those receiving placebo. Dextromethorphan/quinidine 20 mg/10 mg twice daily was generally well tolerated. The drug has been shown to cause dosage-dependent corrected QT interval (QTc) prolongation; however, in the STAR trial, dextromethorphan/quinidine 20 mg/10 mg twice daily appeared to be well tolerated with regard to QTc prolongation.	Adis Int Ltd, Auckland 0754, New Zealand		Garnock-Jones, KP (corresponding author), Adis Int Ltd, 41 Centorian Dr,Private Bag 65901, Auckland 0754, New Zealand.	demail@adis.co.nz		Garnock-Jones, Karly/0000-0002-1109-9945			*AV PHARM INC NEUD, DEXTR HYDR QUIN SULF; Brooks BR, 2004, NEUROLOGY, V63, P1364; BROOKS BR, 2009, 20 INT S AM LAT SCLE; Capon DA, 1996, CLIN PHARMACOL THER, V60, P295, DOI 10.1016/S0009-9236(96)90056-9; Haiman G, 2009, J CLIN PSYCHOPHARM, V29, P444, DOI 10.1097/JCP.0b013e3181b5ae5c; Martin Caren McHenry, 2007, Consult Pharm, V22, P732, DOI 10.4140/TCP.n.2007.732; Miller A, 2006, J NEUROL SCI, V245, P153, DOI 10.1016/j.jns.2005.09.018; Moghadamnia AA, 2003, BRIT J CLIN PHARMACO, V56, P57, DOI 10.1046/j.1365-2125.2003.01853.x; Panitch HS, 2006, ANN NEUROL, V59, P780, DOI 10.1002/ana.20828; Pioro E, 2010, NEUROLOGY, V75, P380; Pioro EP, 2010, ANN NEUROL, V68, P693, DOI 10.1002/ana.22093; POPE L, 2010, 163 ANN M AM PSYCH A; Pope LE, 2004, J CLIN PHARMACOL, V44, P1132, DOI 10.1177/0091270004269521; Rabins PV, 2007, CNS SPECTRUMS, V12, P17, DOI 10.1017/S1092852900025979; Rosen H, 2008, DRUG TODAY, V44, P661, DOI 10.1358/dot.2008.44.9.1258664; Rosen HJ, 2007, ANN NEUROL, V61, P92, DOI 10.1002/ana.21056; SCHADEL M, 1995, J CLIN PSYCHOPHARM, V15, P263, DOI 10.1097/00004714-199508000-00005; Strowd RE, 2010, J NEUROL, V257, P1382, DOI 10.1007/s00415-010-5550-3; Werling LL, 2007, EXP NEUROL, V207, P248, DOI 10.1016/j.expneurol.2007.06.013; Werling LL, 2007, NEUROLOGIST, V13, P272, DOI 10.1097/NRL.0b013e3180f60bd8; Wortzel HS, 2008, CNS DRUGS, V22, P531, DOI 10.2165/00023210-200822070-00001; WYNN D, 2010, 135 ANN M AM NEUR AS; WYNN D, 2010, 24 ANN M CONS MULT S; Zawertailo LA, 2010, HUM PSYCHOPHARM CLIN, V25, P71, DOI 10.1002/hup.1086	24	17	18	0	7	ADIS INT LTD	AUCKLAND	41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND 1311, NEW ZEALAND	1172-7047			CNS DRUGS	CNS Drugs		2011	25	5					435	445		10.2165/11207260-000000000-00000			11	Clinical Neurology; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	772ZH	WOS:000291276300007	21476614				2022-02-06	
J	Monroe, KW; Thrash, C; Sorrentino, A; King, WD				Monroe, Kathy W.; Thrash, Chris; Sorrentino, Annalise; King, William D.			Most Common Sports-Related Injuries in a Pediatric Emergency Department	CLINICAL PEDIATRICS			English	Article						sports; football; basketball; injuries; emergency department	CHILDREN	Background: Participation in sports is a popular activity for children across the country. Prevention of sports-related injuries can be improved if details of injuries are documented and studied. Methods: A retrospective medical record review of injuries that occurred as a direct result of sports participation (both organized and non-organized play) from November 2006 to November 2007. Because the vast majority of injuries were a result of participation in football or basketball, these injuries were focused upon. The injuries specifically examined were closed head injury (CHI), lacerations and fractures. Results: There were 350 football and 196 basketball injuries (total 546). Comparing injuries between the two groups fractures were found to be more prevalent in football compared to basketball (z = 2.14; p = 0.03; 95%CI (0.01, 0.16)). Lacerations were found to be less prevalent among helmeted patients than those without helmets. (z = 2.39; p = 0.02; 95%CI (-0.17,-0.03)). CHI was more prevalent among organized play compared to non-organized (z = 3.9; p<0.001; 95%CI (0.06, 0.16)). Among basketball related visits, non-organized play had a higher prevalence of injury compared to organized play. (z = 2.87; p = 0.004; 95%CI (0.04, 0.21)). Among football related visits, organized play had a higher prevalence of injury compared to non-organized play (z = 2.87; p = 0.004; 95%CI (0.04,. 0.21)). No differences in fracture or laceration prevalence were found between organized and non-organized play. Conclusions: Football and basketball related injuries are common complaints in a pediatric Emergency Department. Frequently seen injuries include CHI, fractures and lacerations. In our institution, fractures were more prevalent among football players and CHI was more prevalent among organized sports participants.			Monroe, KW (corresponding author), Univ Alabama, Childrens Hosp, Suite 210 CPP,1600 7th Ave S, Birmingham, AL 35233 USA.	kmonroe@peds.uab.edu					Babul S, 2007, Int J Inj Contr Saf Promot, V14, P192, DOI 10.1080/17457300701440659; Committee on Trauma Research, 1985, INJ AM CONT PUBL HLT; Halperin W, 1998, PUBLIC HEALTH REP, V113, P424; JINGZHEN Y, 2007, PEDIATRICS, V119, pE813; Moll EK, 2002, INJ PREV, V8, P165, DOI 10.1136/ip.8.2.165; Monroe K, 2008, PEDIATR EMERG CARE, V24, P448, DOI 10.1097/PEC.0b013e31817de348; Ni H, 2002, INJURY PREV, V8, P60, DOI 10.1136/ip.8.1.60; *NIH, 1992, SPORTS INJ YOUTH SUR; Radelet MA, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.3.e28; Simon TD, 2006, PEDIATR EMERG CARE, V22, P309, DOI 10.1097/01.pec.0000215139.29039.5c; 2002, US TODAY KIDS S 1018	11	17	17	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0009-9228			CLIN PEDIATR	Clin. Pediatr.	JAN	2011	50	1					17	20		10.1177/0009922810378735			4	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	693CV	WOS:000285203100003	20837621				2022-02-06	
J	Ownsworth, T; Fleming, J; Haines, T; Cornwell, P; Kendall, M; Nalder, E; Gordon, C				Ownsworth, Tamara; Fleming, Jennifer; Haines, Terry; Cornwell, Petrea; Kendall, Melissa; Nalder, Emily; Gordon, Cassandra			Development of Depressive Symptoms During Early Community Reintegration After Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Traumatic brain injury; Depressive symptoms; Community reintegration; Perceived functioning; Transition events	PSYCHOSOCIAL ADJUSTMENT; EMOTIONAL STATUS; REHABILITATION; IMPAIRMENT; PREDICTORS; STRESS; MODEL	The early onset of depression following traumatic brain injury (TBI) is associated with poorer psychosocial outcomes; however, the direction of this relationship is unclear. This study investigated the relationship between progress in resuming preinjury lifestyle (transition events), change in perceived functioning and level of depressive symptoms at discharge and 3-months postdischarge. As part of a prospective longitudinal study of brain injury outcomes, 96 consecutively discharged patients with TBI completed measures of transition events (Sentinel Events Questionnaire) and perceived functioning (Mayo-Portland Adaptability Inventory-4 Ability and Adjustment indices) at discharge and 3-months follow-up. Level of depressive symptoms was assessed at discharge and 3-months follow-up using the Depression Anxiety Stress Scale 21. After controlling for age and discharge depressive symptoms, change in perceived functioning was found to mediate the relationship between total transition events and depressive symptoms at 3-months postdischarge (beta reduced from .21 to .14), with a significant indirect effect observed. The present findings indicate that lack of progress in resuming preinjury lifestyle contributes to postdischarge depressive symptoms through an influence on perceived functioning, thus providing an improved conceptualization of reactive depression in the context of brain injury. (JINS, 2011, 17, 112-119)	[Ownsworth, Tamara; Cornwell, Petrea; Gordon, Cassandra] Griffith Univ, Sch Psychol, Mt Gravatt, Qld 4122, Australia; [Ownsworth, Tamara; Cornwell, Petrea; Gordon, Cassandra] Griffith Univ, Griffith Inst Hlth & Med Res, Mt Gravatt, Qld 4122, Australia; [Fleming, Jennifer; Nalder, Emily] Univ Queensland, Sch Hlth & Rehabil Sci, St Lucia, Qld, Australia; [Haines, Terry] Monash Univ, Sch Physiotherapy, Clayton, Vic 3800, Australia; [Haines, Terry] Southern Hlth, Allied Hlth Clin Res Unit, Clayton, Vic 3168, Australia		Ownsworth, T (corresponding author), Griffith Univ, Sch Psychol, Mt Gravatt, Qld 4122, Australia.	t.own-sworth@griffith.edu.au	Fleming, Jennifer M/B-4436-2011; Ownsworth, Tamara/ABB-6961-2021; Cornwell, Petrea/AAE-5547-2019; Haines, Terrence/E-9372-2015	Ownsworth, Tamara/0000-0003-1835-7094; Haines, Terrence/0000-0003-3150-6154			BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bombardier CH, 2009, J HEAD TRAUMA REHAB, V24, P230, DOI 10.1097/HTR.0b013e3181ad65f0; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; Gracey F, 2009, NEUROPSYCHOL REHABIL, V19, P867, DOI 10.1080/09602010903027763; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kendall E, 2008, SOC SCI MED, V67, P1217, DOI 10.1016/j.socscimed.2008.05.033; KOLB B, 2003, FUNDAMENTALS HUMAN N; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; MACKINNON DP, 1995, MULTIVAR BEHAV RES, V30, pR2; Malec J., 2005, MAYO PORTLAND ADAPTA; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; NALDER E, 2010, 8 WORLD C BRAIN INJ; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; Ownsworth T, 2008, BRAIN INJURY, V22, P858, DOI 10.1080/02699050802446697; Ownsworth TL, 1998, BRAIN INJURY, V12, P735, DOI 10.1080/026990598122133; OWNSWORTH TL, 2009, J INT NEUROPSYCH SOC, V15, P102; Riley GA, 2004, BRAIN INJURY, V18, P871, DOI 10.1080/02699050410001671829; Robertson IH, 1999, PSYCHOL BULL, V125, P544, DOI 10.1037/0033-2909.125.5.544; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; Rutterford NA, 2006, J INT NEUROPSYCH SOC, V12, P359, DOI 10.1017/S1355617706060450; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; Turner B, 2009, AM J OCCUP THER, V63, P609, DOI 10.5014/ajot.63.5.609; Williams WH, 2003, NEUROPSYCHOL REHABIL, V13, P1, DOI [10.1016/S0960-9822(02)01374-X, 10.1080/09602010244000444]	28	17	17	0	9	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JAN	2011	17	1					112	119		10.1017/S1355617710001311			8	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	702KX	WOS:000285894700013	21083964	Green Submitted, Green Published			2022-02-06	
J	Fabrizio, KS; Keltner, NL				Fabrizio, Katherine S.; Keltner, Norman L.			Traumatic Brain Injury in Operation Enduring Freedom/Operation Iraqi Freedom: A Primer	NURSING CLINICS OF NORTH AMERICA			English	Article						Brain injury; Blast; Military; Veterans	POSTTRAUMATIC-STRESS-DISORDER; PSYCHIATRIC-DISORDERS; PART II; AFGHANISTAN; SOLDIERS; WAR; CONSEQUENCES; DEPRESSION; RECOVERY; LONG	In greater numbers than in prior conflicts, service members deployed as part of Operation Enduring Freedom and Operation Iraqi Freedom have an increased risk of experiencing a traumatic brain injury (TBI). The basics of TBI are discussed, with particular attention paid to blast-related events, as this is a common mechanism of injury in this population. Particular attention is focused on the pharmacologic treatment of the sequlae of TBI and common comorbid conditions.	[Fabrizio, Katherine S.] Birmingham Vet Affairs Med Ctr, Birmingham, AL 35233 USA; [Keltner, Norman L.] Univ Alabama, Sch Nursing, Birmingham, AL 35294 USA		Fabrizio, KS (corresponding author), Birmingham Vet Affairs Med Ctr, Phys Med & Rehabil 117,700 S 19th St, Birmingham, AL 35233 USA.	Katherine.Fabrizio@va.gov					Anderson MI, 2009, BRAIN INJURY, V23, P931, DOI 10.3109/02699050903302336; Ashman TA, 2006, MT SINAI J MED, V73, P999; Bate AJ, 2001, CLIN NEUROPSYCHOL, V15, P405, DOI 10.1076/clin.15.3.405.10279; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; Cooke BB, 2008, PERSPECT PSYCHIATR C, V44, P54, DOI 10.1111/j.1744-6163.2008.00148.x; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; Davidson JRT, 2006, J CLIN PSYCHIAT, V67, P34; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Dowben JS, 2007, PERSPECT PSYCHIATR C, V43, P146, DOI 10.1111/j.1744-6163.2007.00124.x; Fischer J. S., 2004, NEUROPSYCHOLOGICAL A; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P43; JORGE RE, 1993, AM J PSYCHIAT, V150, P916; KELTNER NL, 2011, PSYCHIAT NURSING, P489; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Martin EM, 2008, AM J NURS, V108, P40, DOI 10.1097/01.NAJ.0000315260.92070.3f; McCrea M., 2008, MILD TRAUMATIC BRAIN; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Okie S, 2006, NEW ENGL J MED, V355, P2609, DOI 10.1056/NEJMp068235; PARKER RS, 2001, CONCUSSIVE BRAIN TRA; Richardson JTE., 2000, CLIN NEUROPSYCHOLOGI; Schwab KA, 2007, J REHABIL RES DEV, V44, pXIII; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Sohlberg M., 2001, COGNITIVE REHABILITA; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Swaine BR, 1996, BRAIN INJURY, V10, P347, DOI 10.1080/026990596124368; Tanielian T., 2008, INVISIBLE WOUNDS WAR; TEESDALE G, 1974, LANCET, V2, P81; TENOVUO O, 2006, TRAUMA REHABILITATIO, V52, P2; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Zec RF, 2001, J CLIN EXP NEUROPSYC, V23, P671, DOI 10.1076/jcen.23.5.671.1247	39	17	17	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0029-6465			NURS CLIN N AM	Nurs. Clin. North Am.	DEC	2010	45	4					569	+		10.1016/j.cnur.2010.06.003			13	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	683AI	WOS:000284443700006	20971337				2022-02-06	
J	Kraus, MF; Little, DM; Wojtowicz, SM; Sweeney, JA				Kraus, Marilyn F.; Little, Deborah M.; Wojtowicz, Sydney M.; Sweeney, John A.			Procedural Learning Impairments Identified via Predictive Saccades in Chronic Traumatic Brain Injury	COGNITIVE AND BEHAVIORAL NEUROLOGY			English	Article						traumatic brain injury; oculomotor function; predictive saccades; reflexive guided saccades	EXECUTIVE FUNCTION; WORKING-MEMORY; AXONAL INJURY; HEAD-INJURY; SCHIZOPHRENIA; MILD; NEUROANATOMY; REFLEXIVE; DEFICITS; TASK	Objective: To characterize integrity of fronto-striatal circuitry in chronic traumatic brain injury (TBI). Background: Due to both direct and indirect effects, TBI is hypothesized to affect frontal and striatal function. On the basis of elegant animal, lesion, and neuroimaging literatures, oculomotor testing can provide a useful tool for in vivo assessments of neurophysiologic function. The predictive saccade paradigm in oculomotor function is well established to provide assessment of this fronto-striatal circuit. Methods: Sixty patients with a history of chronic TBI completed 2 specific tests of oculomotor function, including a test of reflexive visually guided saccades to assess basic oculomotor function and a predictive saccade test to assess procedural learning. Results: TBI (mild and moderate/severe) was associated with a decrease in rates of procedural learning, with degree of impairment increasing with injury severity. This was observed as a decrease in the proportion of anticipatory saccades (primary measure of learning). Conclusions: This abnormal oculomotor performance supports the hypothesis that TBI results in chronic impairment of frontal-striatal functions proportionally to injury severity and demonstrate that oculomotor testing is sensitive to all severities of closed-head injury.	[Kraus, Marilyn F.; Sweeney, John A.] Univ Illinois, Ctr Cognit Med, Coll Med, Chicago, IL 60612 USA; [Kraus, Marilyn F.; Sweeney, John A.] Univ Illinois, Dept Psychiat, Coll Med, Chicago, IL 60612 USA; [Kraus, Marilyn F.; Sweeney, John A.] Univ Illinois, Dept Neurol, Coll Med, Chicago, IL 60612 USA; [Little, Deborah M.] Univ Illinois, Ctr Stroke Res, Chicago, IL 60612 USA; [Wojtowicz, Sydney M.] Univ Illinois, Dept Ophthalmol, Chicago, IL 60612 USA; [Wojtowicz, Sydney M.] Univ Illinois, Dept Psychol, Chicago, IL 60612 USA		Kraus, MF (corresponding author), Univ Illinois, Ctr Cognit Med, Coll Med, 912 S Wood St MC 913, Chicago, IL 60612 USA.	mkraus@psych.uic.edu		Sweeney, John/0000-0003-1752-2828	National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K23 MH068787]; Marshall Goldberg Traumatic Brain Injury Research Fund; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K23MH068787] Funding Source: NIH RePORTER	Supported by NIH grant K23 MH068787 from the National Institute of Mental Health, and The Marshall Goldberg Traumatic Brain Injury Research Fund.	ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Basso MR, 2003, J CLIN EXP NEUROPSYC, V25, P893, DOI 10.1076/jcen.25.7.893.16489; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bearden CE, 2004, AM J PSYCHIAT, V161, P1700, DOI 10.1176/appi.ajp.161.9.1700; Benedict R., 1997, BRIEF VISUOSPATIAL M; Bozikas VP, 2004, COMPR PSYCHIAT, V45, P392, DOI 10.1016/j.comppsych.2004.03.006; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chey J, 2002, PSYCHIAT RES, V110, P259, DOI 10.1016/S0165-1781(02)00105-1; CONNERS DK, 2000, CONNERS CONTINUOUS P; Crevits L, 2005, NEUROPSYCHOBIOLOGY, V51, P39, DOI 10.1159/000082854; Culbertson WC., 2001, TOWER LONDON DREXEL; Delis D.C., 2000, CALIFORNIA VERBAL LE; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Golden CJ., 2002, STROOP COLOR WORD TE; GRAHAM DI, 2002, GREENFIELDS NEUROPAT, V2; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Hamsher K., 1989, MULTILINGUAL APHASIA; Hubert V, 2007, HUM BRAIN MAPP, V28, P1415, DOI 10.1002/hbm.20354; Jefferson AL, 2006, ARCH CLIN NEUROPSYCH, V21, P311, DOI 10.1016/j.acn.2006.03.007; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kraus MF, 2007, COGN BEHAV NEUROL, V20, P170, DOI 10.1097/WNN.0b013e318142badb; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; Little DM, 2000, PSYCHOL AGING, V15, P9, DOI 10.1037//0882-7974.15.1.9; Matthews CG., 1964, INSTRUCTION MANUAL A; McDowell JE, 2008, BRAIN COGNITION, V68, P255, DOI 10.1016/j.bandc.2008.08.016; Miranda MC, 2008, J ATTEN DISORD, V11, P588, DOI 10.1177/1087054707299412; Newman SD, 2003, NEUROPSYCHOLOGIA, V41, P1668, DOI 10.1016/S0028-3932(03)00091-5; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; REITAN RM, 1995, CLIN NEUROPSYCHOL, V9, P50, DOI 10.1080/13854049508402057; Ruff RM, 1988, RUFF FIGURAL FLUENCY; Simo LS, 2005, CEREB CORTEX, V15, P1982, DOI 10.1093/cercor/bhi073; Snitz BE, 2006, SCHIZOPHRENIA BULL, V32, P179, DOI 10.1093/schbul/sbi048; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Van der Elst W, 2006, ASSESSMENT, V13, P62, DOI 10.1177/1073191105283427; Wechsler D., 1997, WECHSLER MEMORY SCAL; WechslerD, 2001, WECHSLER TEST ADULT	39	17	18	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1543-3633	1543-3641		COGN BEHAV NEUROL	Cogn. Behav. Neurol.	DEC	2010	23	4					210	217		10.1097/WNN.0b013e3181cefe2e			8	Behavioral Sciences; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	692OC	WOS:000285161100001	21150346	Green Accepted			2022-02-06	
J	Lo, TYM; Jones, PA; Minns, RA				Lo, Tsz-Yan M.; Jones, Patricia A.; Minns, Robert A.			Combining Coma Score and Serum Biomarker Levels To Predict Unfavorable Outcome following Childhood Brain Trauma	JOURNAL OF NEUROTRAUMA			English	Article						biomarkers; Glasgow Coma Scale (GCS); outcome prediction; pediatrics; traumatic brain injury	NEURON-SPECIFIC ENOLASE; SEVERE HEAD-INJURY; CEREBROSPINAL-FLUID; PROGNOSTIC-FACTORS; YOUNG-CHILDREN; MOTOR SCORE; SCALE SCORE; DAMAGE; PROTEIN; INTERLEUKIN-6	This study aims to determine if pairing the Glasgow Coma Scale (GCS) with serum biomarker levels may achieve higher outcome predictive values than using either the GCS or biomarker levels alone in childhood brain trauma. Twenty-eight critically ill children with isolated accidental brain trauma were studied in a prospective observational study. The GCS was recorded at various time points post injury. Enzyme-linked immunosorbent assay (ELISA) was used to quantify eight different serum biomarker levels (S100b, NSE, IL-6, IL-8, IL-10, L-selectin, SICAM, and endothelin) on day 1 post injury. The Glasgow Outcome Score (GOS) was used to assess global outcome at 6 months post injury. Outcome predictive values of the GCS, individual biomarker levels, and paired combinations of the GCS and biomarkers were compared using receiver operator characteristic (ROC) curve analysis and its multivariate extension, multivariate ROC curve (MultiROC). When using either the GCS or individual biomarker levels alone to predict unfavorable outcome, only the PICU discharge summated GCS achieved an area under the ROC curve (AUC) of more than 0.95. This high degree of outcome predictability was also achieved by pairing the GCS with a single biomarker level. The most pronounced improvement in outcome prediction was observed by pairing the post-resuscitation summated GCS with the day-1 serum IL-8 level, which increased the AUC from 0.78 to 0.98 and the sensitivity and specificity from 75% to 100% and 96% respectively. Paired combinations of the GCS and serum biomarker levels greatly enhanced the accuracy of post-traumatic unfavorable outcome prediction than may be achieved using either the GCS or individual biomarker levels alone.	[Lo, Tsz-Yan M.] Royal Hosp Sick Children, Dept Paediat Intens Care Med, Edinburgh EH9 1LF, Midlothian, Scotland; [Minns, Robert A.] Royal Hosp Sick Children, Dept Paediat Neurosci, Edinburgh EH9 1LF, Midlothian, Scotland; [Lo, Tsz-Yan M.; Jones, Patricia A.; Minns, Robert A.] Univ Edinburgh, Edinburgh, Midlothian, Scotland		Lo, TYM (corresponding author), Royal Hosp Sick Children, Dept Paediat Intens Care Med, Sciennes Rd, Edinburgh EH9 1LF, Midlothian, Scotland.	mils.lo@doctors.org.uk					Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Bahloul M, 2009, INJURY, V40, P535, DOI 10.1016/j.injury.2008.04.018; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; Cantais E, 2001, INTENS CARE MED, V27, P1511, DOI 10.1007/s001340101039; Cho DY, 1997, INTENS CARE MED, V23, P77, DOI 10.1007/s001340050294; Ergun R, 1998, NEUROL RES, V20, P418; Fandino J, 2000, J CLIN NEUROSCI, V7, P226, DOI 10.1054/jocn.1999.0202; Gill M, 2005, ANN EMERG MED, V45, P37, DOI 10.1016/j.annemergmed.2004.07.429; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Haukoos JS, 2007, ANN EMERG MED, V50, P18, DOI 10.1016/j.annemergmed.2006.10.004; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Jacobs B, 2010, J NEUROTRAUM, V27, P331, DOI 10.1089/neu.2009.1105; Jagannathan J, 2008, J NEUROSURG-PEDIATR, V2, P240, DOI 10.3171/PED.2008.2.10.240; Joosse P, 2009, J CLIN NEUROSCI, V16, P925, DOI 10.1016/j.jocn.2008.06.014; Liliang PC, 2010, J SURG RES, V160, P302, DOI 10.1016/j.jss.2008.12.022; Lo T, 2009, J NEUROTRAUM, V26, pA46; MCCLAIN C, 1991, J LAB CLIN MED, V118, P225; McKeating EG, 1998, ANESTH ANALG, V86, P759, DOI 10.1097/00000539-199804000-00016; Meric E, 2010, J EMERG MED, V38, P297, DOI 10.1016/j.jemermed.2007.11.032; PERSSON L, 1987, STROKE, V18, P911, DOI 10.1161/01.STR.18.5.911; Pleines UE, 1998, J NEUROTRAUM, V15, P399, DOI 10.1089/neu.1998.15.399; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; Raabe A, 1999, BRIT J NEUROSURG, V13, P56, DOI 10.1080/02688699944195; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; REILLY PL, 1988, CHILD NERV SYST, V4, P30; Ross SE, 1998, J TRAUMA, V45, P42, DOI 10.1097/00005373-199807000-00008; SKOGSEID IM, 1992, ACTA NEUROCHIR, V115, P106, DOI 10.1007/BF01406367; Suominen P, 1998, INJURY, V29, P425; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; WALKER PJ, 1987, AUST NZ J SURG, V57, P715, DOI 10.1111/j.1445-2197.1987.tb01249.x; Whalen MJ, 1998, J NEUROTRAUM, V15, P777, DOI 10.1089/neu.1998.15.777; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; Wiesmann M, 2010, ACTA NEUROL SCAND, V121, P178, DOI 10.1111/j.1600-0404.2009.01196.x; Woertgen C, 1997, ACTA NEUROCHIR, V139, P1161, DOI 10.1007/BF01410977; YAMAURA A, 1981, Neurologia Medico-Chirurgica, V21, P685; YAMAZAKI Y, 1995, SURG NEUROL, V43, P267, DOI 10.1016/0090-3019(95)80012-6	39	17	18	0	0	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	DEC	2010	27	12					2139	2145		10.1089/neu.2010.1387			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	691PN	WOS:000285093400003	20858121				2022-02-06	
J	Nathanson, AT; Baird, J; Mello, M				Nathanson, Andrew T.; Baird, Janette; Mello, Michael			Sailing Injury and Illness: Results of an Online Survey	WILDERNESS & ENVIRONMENTAL MEDICINE			English	Article						sailing; injury; illness; injury prevention	OLYMPIC CLASS SAILORS; EPIDEMIOLOGY; PERFORMANCE; PATTERNS; MEDICINE; INTERNET; WORLD	Objective.-The purpose of this study was to describe the relative frequency, patterns, and mechanisms of sailing-related injuries in dinghies and keelboats. Data were also collected on risky and risk-averse behaviors of sailors, as well as on sailing-related illnesses. Methods.-A web-based, logic-driven, multiple-choice survey was developed and links were posted on sailing-related websites. Data were collected from March through November 2006 on any injuries or illnesses sailors sustained over the prior 12 months. Results.-From 1188 respondents, a total of 1715 injuries and 559 illnesses was reported. The top 3 injuries for keel boats were leg contusions (11%), hand lacerations (8%), and arm contusions (6%), and in dinghies they were leg contusions (13%), knee contusions (6%), and leg lacerations (6%). The most common mechanisms of injury were "trip/fall," "hit by object," and "caught in lines." Tacking, heavy weather, and jibing were the most common factors contributing to injury. The rates of injury and severe injury in this internet-based survey were 4.6 and 0.57 per 1000 days of sailing, respectively. Of the 70 severe injuries, 25% were fractures, 16% were torn tendons or cartilage, 14% were concussions, and 8% were dislocations. The median rate of lifejacket use was 30%, and median rate of sunscreen use was 80%. Sixteen percent of sailors reported sunburn over the prior 12 months. Seven percent of sailors reported use of alcohol within the 2 hours preceding injury. Conclusions.-The most common injuries in both keel boats and dinghies are soft-tissue injuries to the extremities. Severe injuries and illnesses in sailing are uncommon in this study population.	[Nathanson, Andrew T.] Rhode Isl Hosp, Dept Emergency Med, Injury Prevent Ctr, Providence, RI 02903 USA; Brown Univ, Dept Emergency Med, Alpert Med Sch, Providence, RI 02912 USA		Nathanson, AT (corresponding author), Rhode Isl Hosp, Dept Emergency Med, Injury Prevent Ctr, 593 Eddy St, Providence, RI 02903 USA.	Anathanson@lifespan.org			Bonnell Cove Foundation	Funding was obtained from the Bonnell Cove Foundation.	Aagaard P, 1998, SCAND J MED SCI SPOR, V8, P138; Allen JB, 2006, BRIT J SPORT MED, V40, P587, DOI 10.1136/bjsm.2002.001669; Allen J B, 1999, Phys Med Rehabil Clin N Am, V10, P49; Allen J.B., 2005, NZ J SPORTS MED, V33, P43; Branth S, 1996, MED SCI SPORT EXER, V28, P1272, DOI 10.1097/00005768-199610000-00010; Howland J, 2001, ACCIDENT ANAL PREV, V33, P257, DOI 10.1016/S0001-4575(00)00040-3; Jacobs M. E., 2007, WILDERNESS MED, P1780; Legg S, 1999, J SPORT MED PHYS FIT, V39, P315; Legg SJ, 1997, J SPORT MED PHYS FIT, V37, P41; Legg SJ, 1997, J SPORT MED PHYS FIT, V37, P213; McCormick D P, 1988, Br J Sports Med, V22, P95; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Nathanson AT, 2008, WILD ENVIRON MED, V19, P129, DOI 10.1580/07-WEME-BR-1471.1; Nathanson AT, 1999, WILD ENVIRON MED, V10, P218, DOI 10.1580/1080-6032(1999)010[0218:WIROAP]2.3.CO;2; Neville V, 2009, SPORTS MED, V39, P129, DOI 10.2165/00007256-200939020-00003; Neville VJ, 2006, BRIT J SPORT MED, V40, P304, DOI 10.1136/bjsm.2005.021477; NEWTON F, 1989, PRACTITIONER, V233, P1032; Price CJS, 2002, BRIT J SPORT MED, V36, P457, DOI 10.1136/bjsm.36.6.457; Reimers S, 2007, ARCH SEX BEHAV, V36, P147, DOI 10.1007/s10508-006-9143-2; Schaefer O, 2000, SPORTVERLETZ SPORTSC, V14, P25, DOI 10.1055/s-2000-3819; Shephard RJ, 1997, SPORTS MED, V23, P350, DOI 10.2165/00007256-199723060-00002; Shoveller J A, 2001, Chronic Dis Can, V22, P83; 2007, RECREATIONAL BOATING; 2007, NATL LIFE JACKET WEA	24	17	18	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1080-6032			WILD ENVIRON MED	Wildern. Environ. Med.	WIN	2010	21	4					291	297		10.1016/j.wem.2010.06.006			7	Public, Environmental & Occupational Health; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Sport Sciences	700AE	WOS:000285703700003	21168780	Bronze			2022-02-06	
J	Thaler, NS; Bello, DT; Randall, C; Goldstein, G; Mayfield, J; Allen, DN				Thaler, Nicholas S.; Bello, Danielle T.; Randall, Carol; Goldstein, Gerald; Mayfield, Joan; Allen, Daniel N.			IQ Profiles Are Associated with Differences in Behavioral Functioning Following Pediatric Traumatic Brain Injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Assessment; Childhood brain insult; Intelligence; Statistical methods	WECHSLER INTELLIGENCE SCALE; INDEX SCORE PATTERNS; GLASGOW COMA SCALE; WISC-III; EXECUTIVE FUNCTION; PROCESSING SPEED; CLUSTER SUBTYPES; YOUNG-CHILDREN; HEAD-INJURY; PERFORMANCE	Research suggests that IQ profiles identify subgroups of children with traumatic brain injury (TBI) based on sparing and impairment of cognitive abilities, but little information is available regarding whether these subgroups are differentiated on variables that are important for TBI outcome, such as behavioral functioning. The current study examined behavioral disturbances in 123 children with TBI in association with profiles of intellectual abilities identified using cluster analysis. On the basis of prior research, four clusters were hypothesized. Consistent with the hypothesis, cluster analysis identified four IQ clusters in the current sample. Comparisons among the clusters on behavior variables assessed from the Behavioral Assessment System for Children parent ratings indicated significant differences among the four IQ clusters, with the most impaired cluster exhibiting the severest disturbances. Results of the current study indicate that subgroups of children with TBI can be identified using IQ tests and that these subgroups are stable across different samples, and more importantly are moderately associated with behavioral disturbances that persist during the recovery period.	[Allen, Daniel N.] Univ Nevada, Neuropsychol Res Program, Dept Psychol, Las Vegas, NV 89154 USA; [Goldstein, Gerald] VA Pittsburgh Healthcare Syst, MIRECC, Pittsburgh, PA USA; [Mayfield, Joan] Our Childrens House Baylor, Dallas, TX USA		Allen, DN (corresponding author), Univ Nevada, Neuropsychol Res Program, Dept Psychol, 4505 Maryland Pkwy, Las Vegas, NV 89154 USA.	daniel.allen@unlv.edu		Allen, Daniel/0000-0003-4868-2242			Allen DN, 2010, PSYCHOL ASSESSMENT, V22, P57, DOI 10.1037/a0016056; ALLEN DN, ARCH CLIN N IN PRESS; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; BARNEY SJ, CLIN NEUROP IN PRESS; BASSON MD, 1991, J TRAUMA, V31, P1363, DOI 10.1097/00005373-199110000-00008; Bishop D, 2008, DEV MED CHILD NEUROL, V50, P324, DOI 10.1111/j.1469-8749.2008.00324.x; Blashfield R.K., 1984, CLUSTER ANAL; Calhoun SL, 2005, PSYCHOL SCHOOLS, V42, P333, DOI 10.1002/pits.20067; Crawford JR, 1997, CLIN NEUROPSYCHOL, V11, P249, DOI 10.1080/13854049708400453; Curtiss G, 2001, J INT NEUROPSYCH SOC, V7, P574, DOI 10.1017/S1355617701755051; DEBILDT A, 2005, J INTELL DISABIL RES, V49, P572; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Dietz KR, 1997, J CLIN CHILD PSYCHOL, V26, P99, DOI 10.1207/s15374424jccp2601_10; Donders J, 1996, PSYCHOL ASSESSMENT, V8, P312, DOI 10.1037/1040-3590.8.3.312; Donders J, 1997, CHILD NEUROPSYCHOL, V3, P71, DOI 10.1080/09297049708401369; Donders J, 2008, J INT NEUROPSYCH SOC, V14, P651, DOI 10.1017/S1355617708080752; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Ganesalingam K, 2008, J PEDIATR PSYCHOL, V33, P621, DOI 10.1093/jpepsy/jsm133; Gary KW, 2009, ARCH PHYS MED REHAB, V90, P1699, DOI 10.1016/j.apmr.2009.04.014; Ghosh A, 2009, BRAIN INJURY, V23, P228, DOI 10.1080/02699050802672789; Hackbarth RM, 2002, CRIT CARE MED, V30, P1630, DOI 10.1097/00003246-200207000-00038; Hanten G, 2009, TOP LANG DISORD, V29, P236, DOI 10.1097/TLD.0b013e3181b531f0; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; Heaton RK, 1991, COMPREHENSIVE NORMS; Hiekkanen H, 2009, BRAIN INJURY, V23, P396, DOI 10.1080/02699050902926259; Holm S, 2009, NEUROPSYCHOL REHABIL, V19, P444, DOI 10.1080/09602010802296402; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jansen PW, 2007, AM J MED GENET A, V143A, P574, DOI 10.1002/ajmg.a.31623; Kirkwood M, 2000, CHILD NEUROPSYCHOL, V6, P195, DOI 10.1076/chin.6.3.195.3157; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Levin HS., 1982, NEUROBEHAVIORAL CONS; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; Love PF, 2009, J TRAUMA, V67, pS12, DOI 10.1097/TA.0b013e3181ac7f22; Mathias JL, 2007, BRIT J CLIN PSYCHOL, V46, P457, DOI 10.1348/014466507X190197; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Mayes SD, 2004, CLIN NEUROPSYCHOL, V18, P559, DOI 10.1080/13854040490888530; Mottram L, 2006, DEV NEUROPSYCHOL, V30, P865, DOI 10.1207/s15326942dn3003_6; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; Naglieri JA, 2005, ARCH CLIN NEUROPSYCH, V20, P385, DOI 10.1016/j.acn.2004.09.008; Rees L, 2007, BRAIN INJURY, V21, P161, DOI 10.1080/02699050701201813; Reynolds C.R., 1994, TEST MEMORY LEARNING; Reynolds C.R., 2004, BEHAV ASSESSMENT SYS, V2; Reynolds CR., 1992, BEHAV ASSESSMENT SYS; Romesburg CH., 1984, CLUSTER ANAL RES; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Smith RJ, 1998, HUMAN BRAIN FUNCT, P135; Stancin T, 2008, J DEV BEHAV PEDIATR, V29, P253, DOI 10.1097/DBP.0b013e31816b6b0f; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; TEASDALE G, 1974, LANCET, V2, P81; TONKS J, 2007, BRAIN IMPAIR, V8, P143, DOI DOI 10.1375/BRIM.8.2.143; Tramontana M G, 1988, Arch Clin Neuropsychol, V3, P369; van der Heijden P, 2003, ASSESSMENT, V10, P115, DOI 10.1177/1073191103010002001; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; Wechsler D., 2003, WISC 4 TECHNICAL INT; Wechsler D., 1991, MANUAL WECHSLER INTE, V3rd; Wells R, 2009, DEV NEUROREHABIL, V12, P12, DOI 10.1080/17518420902773109; Wood RL, 2006, J NEUROPSYCH CLIN N, V18, P333, DOI 10.1176/appi.neuropsych.18.3.333; Worthington A., 2008, PSYCHOL APPROACHES R; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Young S, 2005, BRIT J CLIN PSYCHOL, V44, P47, DOI 10.1348/014466504X197769; [No title captured]	64	17	17	0	17	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	DEC	2010	25	8					781	790		10.1093/arclin/acq073			10	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	679KE	WOS:000284159500008	20876194	Green Published, Bronze			2022-02-06	
J	Arciniegas, DB; Frey, KL; Newman, J; Wortzel, HS				Arciniegas, David B.; Frey, Kimberly L.; Newman, Jody; Wortzel, Hal S.			Evaluation and Management of Posttraumatic Cognitive Impairments	PSYCHIATRIC ANNALS			English	Article							TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; FRONTAL ASSESSMENT BATTERY; MINI-MENTAL-STATE; EFNS TASK-FORCE; HEAD-INJURY; RATING-SCALE; SUSTAINED ATTENTION; CONFUSIONAL STATE; PRACTICAL SCALE		[Arciniegas, David B.; Frey, Kimberly L.; Newman, Jody; Wortzel, Hal S.] Univ Colorado, Sch Med, Dept Psychiat, Neurobehav Disorders Program, Aurora, CO 80045 USA; [Arciniegas, David B.] Univ Colorado, Sch Med, Dept Neurol, Behav Neurol Sect, Aurora, CO 80045 USA; [Wortzel, Hal S.] Denver Vet Affairs Med Center, VISN Mental Illness Res Educ & Clin Ctr MIRECC 19, Denver, CO USA		Arciniegas, DB (corresponding author), Univ Colorado, Sch Med, Dept Psychiat, Neurobehav Disorders Program, 13001 E 17th Pl,Campus Box F546, Aurora, CO 80045 USA.	David.Arciniegas@UCDenver.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD047242] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD047242, R01 HD047242-04S1, R01 HD047242-05] Funding Source: Medline		Anderson GD, 2009, EPILEPSY BEHAV, V16, P501, DOI 10.1016/j.yebeh.2009.08.025; Appollonio I, 2005, NEUROL SCI, V26, P108, DOI 10.1007/s10072-005-0443-4; Arciniegas DB, 2008, CRIT CARE CLIN, V24, P737, DOI 10.1016/j.ccc.2008.06.001; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Arciniegas DB, 2006, BEHAV NEUROL, V17, P25, DOI 10.1155/2006/460592; Arciniegas David B, 2004, Phys Med Rehabil Clin N Am, V15, P177, DOI 10.1016/S1047-9651(03)00104-9; Arciniegas DB, 2010, NEUROPSYCHIATRIC DISORDERS, P125, DOI 10.1007/978-4-431-53871-4_10; Bloomfield ILM, 2010, J INT NEUROPSYCH SOC, V16, P17, DOI 10.1017/S1355617709990798; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Cappa SF, 2005, EUR J NEUROL, V12, P665; Cappa SF, 2003, EUR J NEUROL, V10, P11, DOI 10.1046/j.1468-1331.2003.00537.x; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frey KL, 2007, BRAIN INJURY, V21, P513, DOI 10.1080/02699050701311026; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kean J, 2010, BRAIN INJURY, V24, P1222, DOI 10.3109/02699052.2010.498008; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Kim YW, 2009, CLIN NEUROPHARMACOL, V32, P63, DOI 10.1097/WNF.0b013e31816f1bc1; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; Larson EB, 2008, PERCEPT MOTOR SKILL, V106, P725, DOI 10.2466/PMS.106.3.725-736; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Marion Donald W, 2006, Prog Neurol Surg, V19, P171, DOI 10.1159/000095191; Marr A, 2002, CENTRAL NERVOUS SYST; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McCauley SR, 2001, J NEUROL NEUROSUR PS, V71, P643, DOI 10.1136/jnnp.71.5.643; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Meyer MJ, 2010, BRAIN INJURY, V24, P722, DOI 10.3109/02699051003692134; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Royall DR, 2007, J NEUROPSYCH CLIN N, V19, P249, DOI 10.1176/appi.neuropsych.19.3.249; Sherer M, 2009, ARCH PHYS MED REHAB, V90, P1749, DOI 10.1016/j.apmr.2009.05.011; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Silver JM, 2006, NEUROLOGY, V67, P748, DOI 10.1212/01.wnl.0000234062.98062.e9; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Silver JM, 2009, BRAIN INJURY, V23, P123, DOI 10.1080/02699050802649696; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; TEASDALE G, 1974, LANCET, V2, P81; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; Tenovuo O, 2009, BRAIN INJURY, V23, P548, DOI 10.1080/02699050902926275; Trzepacz PT, 2001, J NEUROPSYCH CLIN N, V13, P229, DOI 10.1176/appi.neuropsych.13.2.229; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; Vanier M, 2000, ARCH PHYS MED REHAB, V81, P796, DOI 10.1016/S0003-9993(00)90114-X; Vespa P, 2005, J CLIN NEUROPHYSIOL, V22, P99, DOI 10.1097/01.WNP.0000154919.54202.E0; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Wheaton P, 2009, J CLIN PSYCHOPHARM, V29, P468, DOI 10.1097/JCP.0b013e3181b66f04; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Willmott C, 2009, J REHABIL MED, V41, P585, DOI 10.2340/16501977-0369; Wood S, 2000, AM J GERIAT PSYCHIAT, V8, P75, DOI 10.1097/00019442-200002000-00010; WROBLEWSKI BA, 1992, J CLIN PSYCHIAT, V53, P86; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P1103, DOI 10.1016/S0003-9993(97)90135-0; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014	68	17	17	0	5	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0048-5713			PSYCHIAT ANN	Psychiatr. Ann.	NOV	2010	40	11					540	552		10.3928/00485713-20101022-05			13	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	736IX	WOS:000288488200005	21270968	Green Accepted			2022-02-06	
J	Glang, A; Todis, B; Sublette, P; Brown, BE; Vaccaro, M				Glang, Ann; Todis, Bonnie; Sublette, Patricia; Brown, Brenda Eagan; Vaccaro, Monica			Professional Development in TBI for Educators: The Importance of Context	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injuries; education; in-service training; pediatrics; schools; staff development; students; teaching	TRAUMATIC BRAIN-INJURY; TREATMENT INTEGRITY; PEDIATRIC TBI; STUDENTS; OUTCOMES; CONSULTATION; IMPLEMENTATION; MATHEMATICS; KNOWLEDGE; BEHAVIOR	Effective instructional and behavioral support strategies implemented by trained educators can help mitigate the academic and behavioral challenges associated with childhood brain injury. However, the training provided by university teacher preparation programs is clearly inadequate, a problem that cuts across the professions that work with school-aged students. Educators need training in methods validated for students with traumatic brain injury (TBI) and in adapting strategies validated for students with other disabilities. Almost 10 years after Ylvisaker and colleagues proposed a research and professional development agenda in the area of teacher training, students with TBI continue to be underserved and underidentified for educational supports. Effective staff development practices for educators must include training in evidence-based interventions, supervised practice with new skills, and continued mentoring, feedback, and consultation in the school setting. Two models currently in use-the TBI Consulting Team and BrainSTARS models-incorporate those features. Preliminary evidence suggests that these models help teachers feel more prepared and knowledgeable in working with students with TBI. Given the urgent needs of students with TBI, validating these promising practices should be a high priority for the field of pediatric brain injury.	[Glang, Ann; Todis, Bonnie; Sublette, Patricia] Western Oregon Univ, Teaching Res Inst, Eugene, OR 97401 USA; [Brown, Brenda Eagan; Vaccaro, Monica] Brain Injury Assoc Penn, Carlisle, PA USA		Glang, A (corresponding author), Western Oregon Univ, Teaching Res Inst, 99 W 10th Ave,Ste 370, Eugene, OR 97401 USA.	glanga@wou.edu		Glang, Ann/0000-0002-3057-1977	Oregon Department of Education [8700]; Pennsylvania Department of Health	This work was supported in part by grant 8700 from the Oregon Department of Education to Teaching Research Institute, Western Oregon University, and by a grant from the Pennsylvania Department of Health to the Brain Injury Association of Pennsylvania. The authors thank Cathy Thomas and Laura Beck for their assistance in the preparation of this manuscript.	Benedict EA, 2007, TOP EARLY CHILD SPEC, V27, P174, DOI 10.1177/02711214070270030801; Blosser JL, 1991, J HEAD TRAUMA REHAB, V6, P73; Borko H., 2004, ED RES, V33, P3, DOI DOI 10.3102/0013189X033008003; Bowen JM, 2005, PREV SCH FAIL, V49, P34, DOI 10.3200/PSFL.49.4.34-41; CARPENTER TP, 1989, AM EDUC RES J, V26, P499, DOI 10.2307/1162862; Catroppa C, 2007, CHILD NEUROPSYCHOL, V13, P240, DOI 10.1080/09297040600837362; Chapman J. K., 2005, PHYS DISABILITIES ED, V21, P17; Chapman J. K., 2000, RURAL SPECIAL ED Q, V19, P3; Darling-Hammond L, 2009, EDUC LEADERSHIP, V66, P46; Davis AS, 2004, J SCHOOL PSYCHOL, V42, P87, DOI 10.1016/j.jsp.2003.11.001; Dise-Lewis JE, 2009, J HEAD TRAUMA REHAB, V24, P166, DOI 10.1097/HTR.0b013e3181a7ecb0; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Farmer JE, 1997, REHABIL PSYCHOL, V42, P273; Fixsen D.L., 2005, IMPLEMENTATION RES S; FUCHS LS, 1992, EXCEPT CHILDREN, V58, P436, DOI 10.1177/001440299205800507; Fullan M., 2007, J STAFF DEV, V28, P35; FUNK P, 1996, PHYS DISABILITIES ED, V15, P49; Garet MS, 2001, AM EDUC RES J, V38, P915, DOI 10.3102/00028312038004915; Gersten R, 2009, REV EDUC RES, V79, P1202, DOI 10.3102/0034654309334431; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Glang A, 2004, NEUROREHABILITATION, V19, P219; GLANG A, 1994, LEARNING DISABILITIE, V9, P226; Glang A, 2008, J HEAD TRAUMA REHAB, V23, P243, DOI 10.1097/01.HTR.0000327256.46504.9f; Glang A, 2006, J HEAD TRAUMA REHAB, V21, P411, DOI 10.1097/00001199-200609000-00013; Glang A, 2008, NEUROREHABILITATION, V23, P477; Grant SG, 1996, AM EDUC RES J, V33, P509; GREENSPAN AI, 1994, PEDIATRICS, V94, P425; Grossman P, 2001, TEACH COLL REC, V103, P942, DOI 10.1111/0161-4681.00140; Hux K, 1996, LANG SPEECH HEAR SER, V27, P171, DOI 10.1044/0161-1461.2702.171; Jones HA, 2008, PSYCHOL SCHOOLS, V45, P918, DOI 10.1002/pits.20342; Joyce B. R., 2002, STUDENT ACHIEVEMENT; Lerman DC, 2008, J APPL BEHAV ANAL, V41, P243, DOI 10.1901/jaba.2008.41-243; Lewis TJ, 2002, CHILD FAM BEHAV THER, V24, P165, DOI 10.1300/J019v24n01_11; Little JW, 2002, TEACH TEACH EDUC, V18, P917; McCutchen D, 2002, J LEARN DISABIL-US, V35, P69, DOI 10.1177/002221940203500106; Mohr JD, 2005, PREV SCH FAIL, V49, P53, DOI 10.3200/PSFL.49.4.53-57; Noell GH, 1997, SCHOOL PSYCHOL QUART, V12, P77, DOI 10.1037/h0088949; Odom SL, 2009, TOP EARLY CHILD SPEC, V29, P53, DOI 10.1177/0271121408329171; Penuel WR, 2007, AM EDUC RES J, V44, P921, DOI 10.3102/0002831207308221; Reynolds C. R., 2002, CLIN GUIDE BEHAV ASS; Sailors M, 2010, ELEM SCHOOL J, V110, P301, DOI 10.1086/648980; SALEND SJ, 1984, BEHAV MODIF, V8, P211, DOI 10.1177/01454455840082004; Sterling-Turner HE, 2002, SCHOOL PSYCHOL QUART, V17, P47, DOI 10.1521/scpq.17.1.47.19906; Sterling-Turner HE, 2001, SCHOOL PSYCHOL QUART, V16, P56, DOI 10.1521/scpq.16.1.56.19157; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; TODIS B, J HEAD TRAU IN PRESS; Todis B, 2008, J HEAD TRAUMA REHAB, V23, P252, DOI 10.1097/01.HTR.0000327257.84622.bc; TURNBULL H. R., 2004, EXCEPTIONAL LIVES SP; TYLER JS, 1997, CHILDREN ACQUIRED BR, P323; U.S. Department of Education, 2001, NO CHILD LEFT; Wagner M., 2006, 20063004 NCSER; WALD PJ, 2000, ED LEARNERS CREATING; Walker NW, 1999, CHILD NEUROPSYCHOL, V5, P137, DOI 10.1076/chin.5.2.137.3168; Watson T. S., 1995, J BEHAV EDUC, V5, P281, DOI [10.1007/BF02110316, DOI 10.1007/BF02110316]; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009; Ylvisaker M., 1993, STAFF DEV CLIN INTER, P57; Yoon KS., 2007, REV EVIDENCE TEACHER	58	17	17	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2010	25	6					426	432		10.1097/HTR.0b013e3181fb8f45			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	679HA	WOS:000284151300004	21076243				2022-02-06	
J	Middleton, K; Krabak, BJ; Coppel, DB				Middleton, Kim; Krabak, Brian J.; Coppel, David B.			The Influence of Pediatric Autonomic Dysfunction on Recovery After Concussion	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; post-concussive syndrome; autonomic dysfunction; pediatric; sport	INJURY		[Krabak, Brian J.] Univ Washington, Med Ctr, Seattle, WA 98105 USA; [Krabak, Brian J.] Seattle Childrens Sports Med, Seattle, WA USA; [Middleton, Kim] Univ Washington, Sch Med, Seattle, WA USA; [Krabak, Brian J.; Coppel, David B.] Univ Washington, Harborview Med Ctr, Seattle Sports Concuss Program, Dept Neurol Surg Neuropsychol Serv & Res, Seattle, WA 98104 USA		Krabak, BJ (corresponding author), Univ Washington, Med Ctr, 4245 Roosevelt Way NE,Box 356490, Seattle, WA 98105 USA.	bkrabak@u.washington.edu					Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; La Fountaine MF, 2009, AUTON NEUROSCI-BASIC, V148, P101, DOI 10.1016/j.autneu.2009.03.001; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; LOVELL M, CLIN SPORT MED, V23, P421; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db	8	17	17	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1050-642X			CLIN J SPORT MED	Clin. J. Sport Med.	NOV	2010	20	6					491	492		10.1097/JSM.0b013e3181fac088			2	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	682DC	WOS:000284379100018	21079448				2022-02-06	
J	Perheentupa, U; Kinnunen, I; Grenman, R; Aitasalo, K; Makitie, AA				Perheentupa, Ulla; Kinnunen, Ilpo; Grenman, Reidar; Aitasalo, Kalle; Makitie, Antti A.			Management and outcome of pediatric skull base fractures	INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY			English	Article						Complication; Meningitis; Frontobasal; Intensive care; Outcome; Head injury	CEREBROSPINAL-FLUID FISTULAS; TEMPORAL BONE-FRACTURES; TRAUMATIC BRAIN-INJURY; HEAD-INJURIES; CHILDREN; LEAKAGE	Objective: The management of skull base fractures in the pediatric age group continues to be a major challenge even for experienced multidisciplinary teams. This retrospective study was undertaken at a tertiary care academic hospital to evaluate the management and outcome of pediatric skull base fractures. Methods: Retrospective analysis covering a period of 13.5 years (from 1996 to 2009) and 63 patients (mean age 10.7 years; range 1-18 years) was performed. Results: A road traffic accident was the most frequent etiological factor (38%). The most common skull base fracture type was temporal bone fracture (64%). Longitudinal temporal fractures were observed in 45% and transversal in 23% of these patients; in 10 cases (25%) the fracture was comminuted or mixed type. A fracture involving the spheno-ethmoidal complex was the second most common type of basilar skull fracture (41%) followed by fracture through the orbital bone (35%). Forty-three percent of the patients had a concomitant intracranial injury. Early neurological deficits were diagnosed in 21 patients (33%) and 10 patients (16%) had permanent neurological deficits. One patient died after 1 week of intensive care treatment. Fifty-four patients (86%) were discharged home and 8 patients (13%) were discharged for further rehabilitation. Glasgow Coma Scale score of 8 or lower correlated with moderate to poor outcome. Conclusions: We conclude that skull base fracture is a rare injury in childhood. Mortality is uncommon, but this trauma is commonly associated with intracranial injury. Early neurological deficits are caused by traumatic brain injury and were observed in one-third of the patients. However, only less than one-sixth suffered from permanent neurological or neuropsychiatric disorders. (C) 2010 Elsevier Ireland Ltd. All rights reserved.	[Perheentupa, Ulla; Kinnunen, Ilpo; Grenman, Reidar; Aitasalo, Kalle] Turku Univ Hosp, Dept Otolaryngol Head & Neck Surg, FI-20521 Turku, Finland; [Perheentupa, Ulla; Kinnunen, Ilpo; Grenman, Reidar; Aitasalo, Kalle] Univ Turku, SF-20500 Turku, Finland; [Makitie, Antti A.] Helsinki Univ Hosp, Dept Otolaryngol Head & Neck Surg, Helsinki, Finland; [Makitie, Antti A.] Univ Helsinki, FIN-00014 Helsinki, Finland		Perheentupa, U (corresponding author), Turku Univ Hosp, Dept Otolaryngol Head & Neck Surg, POB 52, FI-20521 Turku, Finland.	ulla.perheentupa@utu.fi					Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; BALTAS I, 1994, NEUROSURGERY, V35, P422, DOI 10.1227/00006123-199409000-00009; BECKHARDT RN, 1991, OTOLARYNG HEAD NECK, V104, P425, DOI 10.1177/019459989110400402; Bell RB, 2004, J ORAL MAXIL SURG, V62, P676, DOI 10.1016/j.joms.2003.08.032; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Choi D, 1996, BRIT J NEUROSURG, V10, P571, DOI 10.1080/02688699646880; Fishman G, 2009, CHILD NERV SYST, V25, P915, DOI 10.1007/s00381-009-0887-6; Friedman JA, 2001, WORLD J SURG, V25, P1062, DOI 10.1007/s00268-001-0059-7; HAHN YS, 1988, CHILD NERV SYST, V4, P34; Imahara SD, 2008, J AM COLL SURGEONS, V207, P710, DOI 10.1016/j.jamcollsurg.2008.06.333; Jagannathan J, 2008, J NEUROSURG-PEDIATR, V2, P240, DOI 10.3171/PED.2008.2.10.240; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; Johnson K, 2005, CLIN RADIOL, V60, P464, DOI 10.1016/j.crad.2004.09.013; Kelly DF, 2001, WORLD J SURG, V25, P1179; Kinnunen I, 2006, J CRANIO MAXILL SURG, V34, P405, DOI 10.1016/j.jcms.2006.04.007; KITCHENS JL, 1991, J PEDIATR SURG, V26, P992, DOI 10.1016/0022-3468(91)90849-O; Kraus J, 1996, NEUROTRAUMA, P13; Kumar R, 2009, CHILD NERV SYST, V25, P813, DOI 10.1007/s00381-009-0820-z; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lanza DC, 1996, LARYNGOSCOPE, V106, P1119, DOI 10.1097/00005537-199609000-00015; LIUSHINDO M, 1989, INT J PEDIATR OTORHI, V17, P109, DOI 10.1016/0165-5876(89)90086-4; Lloyd KM, 2008, RADIOLOGY, V248, P725, DOI 10.1148/radiol.2483070362; LUNDAR T, 1985, CHILD NERV SYST, V1, P24, DOI 10.1007/BF00706726; MARENTETTE LJ, 1991, OTOLARYNG CLIN N AM, V24, P151; MCGUIRT WF, 1992, CLIN PEDIATR, V31, P12, DOI 10.1177/000992289203100103; MEALEY J, 1968, PEDIATRIC HEAD INJUR, P88; Mendizabal G R, 1992, Rev Laryngol Otol Rhinol (Bord), V113, P423; Ort S, 2004, OTOLARYNG HEAD NECK, V131, P433, DOI 10.1016/j.otohns.2004.04.006; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Rivara FP, 1999, PEDIATRICS, V103, P883; Scholsem M, 2008, NEUROSURGERY, V62, P463, DOI [10.1227/01.NEU.0000297037.51609.07, 10.1227/01.neu.0000316014.97926.82, 10.1227/01.neu.0000325884.05871.aa]; Sookplung P, 2009, CURR OPIN ANESTHESIO, V22, P572, DOI 10.1097/ACO.0b013e3283303884; Stone JA, 1999, AM J NEURORADIOL, V20, P706; THOMALE UW, 2010, CHILDS NERV SYST; van de Beek D, 2010, NEW ENGL J MED, V362, P146, DOI 10.1056/NEJMra0804573; Yilmazlar S, 2006, NEUROSURG REV, V29, P64, DOI 10.1007/s10143-005-0396-3	37	17	17	0	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-5876	1872-8464		INT J PEDIATR OTORHI	Int. J. Pediatr. Otorhinolaryngol.	NOV	2010	74	11					1245	1250		10.1016/j.ijporl.2010.07.023			6	Otorhinolaryngology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology; Pediatrics	679RK	WOS:000284178300008	20800299				2022-02-06	
J	Niemi, T; Armstrong, E				Niemi, Tomi; Armstrong, Elina			Thromboprophylactic management in the neurosurgical patient with high risk for both thrombosis and intracranial bleeding	CURRENT OPINION IN ANESTHESIOLOGY			English	Article						antithrombotic drugs; bridging therapy; neurosurgery; thromboembolism	TRAUMATIC BRAIN-INJURY; VENOUS THROMBOEMBOLISM; POSTOPERATIVE HEMATOMA; HEMORRHAGE; SURGERY; PROPHYLAXIS; STENT; ANTICOAGULANTS; ENOXAPARIN; PREVENTION	Purpose of review Pharmacologic thromboprophylaxis is indicated in neurosurgery patients having high risk for venous or arterial thrombosis. The pharmacologic thromboprophylaxis, as well as temporary interruption of antithrombotic drugs because of surgery, and possible use of substitutive medication ('bridging therapy') are reviewed. Recent findings Pharmacologic thromboprophylaxis is used for most neurosurgical patients, but clinical practices vary a lot. There are only few reports of the management of neurosurgery patients having mechanical prosthetic heart valves, atrial fibrillation with comorbidities, history of deep venous thrombosis, thrombophilia, or coronary artery stent. These patients present a high risk for both thrombosis and bleeding as temporary interruption of antithrombotic medication as well as a substitutive medication would be indicated. Generally, the bridging therapy with low-molecular-weight heparin (LMWH) is a feasible approach in patients needing interruption of vitamin K antagonists. Experiences in neurosurgery patients emphasize carefully secured hemostasis and tailored dose as well as timing of LMWH. In patients with a recent coronary artery stent scheduled for neurosurgery, an individualized plan is needed. Bridging therapy for antiplatelet agents or novel oral anticoagulants is not yet settled. Summary Pharmacologic thromboprophylaxis, or bridging therapy, should be tailored according to the individual risks and the type of neurosurgery. The bleeding risk is likely minimized by allowing coagulation capacity to normalize preoperatively and by using reduced doses of LMWH starting relatively late after neurosurgery.	[Niemi, Tomi] Univ Helsinki, Cent Hosp, Dept Anesthesiol & Intens Care Med, FI-00029 Helsinki, Finland; [Armstrong, Elina] Univ Helsinki, Cent Hosp, Dept Med Hematol, FI-00029 Helsinki, Finland		Niemi, T (corresponding author), Univ Helsinki, Cent Hosp, Dept Anesthesiol & Intens Care Med, POB 266, FI-00029 Helsinki, Finland.	tomi.niemi@hus.fi					Bratton SL, 2007, J NEUROTRAUMA S1, V24, P32; Broad L, 2007, BRIT J ANAESTH, V98, P19, DOI 10.1093/bja/ael318; Caird J, 2006, BRIT J NEUROSURG, V20, P40, DOI 10.1080/02688690600603719; Collen JF, 2008, CHEST, V134, P237, DOI 10.1378/chest.08-0023; Cutlip DE, 2001, CIRCULATION, V103, P1967; Datta Indraneel, 2010, J Trauma Manag Outcomes, V4, P1, DOI 10.1186/1752-2897-4-1; Depew AJ, 2008, AM SURGEON, V74, P906; Douketis JD, 2008, CHEST, V133, p299S, DOI 10.1378/chest.08-0675; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Gerlach R, 2004, NEUROL RES, V26, P61, DOI 10.1179/016164104773026543; Gerlach R, 2002, STROKE, V33, P1618, DOI 10.1161/01.STR.0000017219.83330.FF; Gerlach R, 2009, ACTA NEUROCHIR, V151, P873, DOI 10.1007/s00701-009-0409-z; Glotzbecker MP, 2010, SPINE, V35, pE413, DOI 10.1097/BRS.0b013e3181d9bb77; Kim KS, 2009, NEUROCRIT CARE, V11, P28, DOI 10.1007/s12028-009-9201-4; Korinth MC, 2006, ACTA NEUROCHIR, V148, P1189, DOI 10.1007/s00701-006-0868-4; Levy AS, 2010, J TRAUMA, V68, P886, DOI 10.1097/TA.0b013e3181d27dd5; Muntz JE, 2010, AM J SURG, V199, pS11, DOI 10.1016/j.amjsurg.2009.10.007; Niemi T, 2009, ACTA NEUROCHIR, V151, P1289, DOI 10.1007/s00701-009-0419-x; Norwood SH, 2008, J TRAUMA, V65, P1021, DOI 10.1097/TA.0b013e31818a0e74; Oscarsson A, 2010, BRIT J ANAESTH, V104, P305, DOI 10.1093/bja/aeq003; PALMER JD, 1994, NEUROSURGERY, V35, P1061, DOI 10.1227/00006123-199412000-00007; Pengo V, 2009, CIRCULATION, V119, P2920, DOI 10.1161/CIRCULATIONAHA.108.823211; Powner DJ, 2005, NEUROSURGERY, V57, P823, DOI 10.1227/01.NEU.0000179915.74429.b2; Raslan AM, 2010, NEUROCRIT CARE, V12, P297, DOI 10.1007/s12028-009-9316-7; Ray WZ, 2009, J NEUROSURG, V110, P1010, DOI 10.3171/2008.9.JNS08107; Savonitto S, 2010, BRIT J ANAESTH, V104, P285, DOI 10.1093/bja/aep373; Scales DC, 2009, J CRIT CARE, V24, P176, DOI 10.1016/j.jcrc.2009.03.010; Senft C, 2009, NEUROL RES, V31, P1012, DOI 10.1179/174313209X409034; Taniguchi S, 2009, HEART VESSELS, V24, P425, DOI 10.1007/s00380-008-1135-9; Tetri S, 2008, THROMB RES, V123, P206, DOI 10.1016/j.thromres.2008.01.018	30	17	17	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0952-7907	1473-6500		CURR OPIN ANESTHESIO	Curr. Opin. Anesthesiol.	OCT	2010	23	5					558	563		10.1097/ACO.0b013e32833e1589			6	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	646RR	WOS:000281560500004	20717013				2022-02-06	
J	Vanhorebeek, I; Gielen, M; Boussemaere, M; Wouters, PJ; Grandas, FG; Mesotten, D; Van den Berghe, G				Vanhorebeek, Ilse; Gielen, Marijke; Boussemaere, Magaly; Wouters, Pieter J.; Grandas, Fabian Guiza; Mesotten, Dieter; Van den Berghe, Greet			Glucose Dysregulation and Neurological Injury Biomarkers in Critically Ill Children	JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM			English	Article							INTENSIVE INSULIN THERAPY; TRAUMATIC BRAIN-INJURY; SEVERE HYPOGLYCEMIA; COGNITIVE FUNCTION; SERUM BIOMARKERS; HYPERGLYCEMIA; MARKERS; DAMAGE; S-100-BETA; ASSOCIATION	Context: Targeting normoglycemia with intensive insulin therapy (IIT) improved short-term outcome of pediatric intensive care unit (PICU) patients but increased the incidence of hypoglycemia. Both hyperglycemia and hypoglycemia may adversely affect the developing brain. Objective: We studied the impact of targeting normoglycemia with IIT on brain injury markers. Design: This is a preplanned analysis of PICU patients included in a randomized controlled study. Setting: The study was conducted at a university hospital PICU. Patients: Seven hundred PICU patients participated. Interventions: Patients were assigned to IIT targeting normal-for-age fasting blood glucose levels or insulin infusion only to prevent excessive hyperglycemia. Main Outcome Measures: Serum S100B and neuron-specific enolase (NSE), biomarkers of astrocytic and neuronal damage, respectively, were measured on fixed days (n = 700) and in a nested case-control design before and after hypoglycemia (n = 126). Results: Admission levels of S100B and NSE differed according to diagnosis and illness severity (P < 0.0001). IIT did not affect the time course of these markers. Patients experiencing hypoglycemia in PICU had higher S100B and NSE from admission onward than those without hypoglycemia. In the nested case-control study, both markers decreased after hypoglycemia (P = 0.001 and P = 0.009), unlike in the controls on matched days. Conclusions: IIT in PICU did not evoke neurological damage detectable by circulating S100B and NSE, despite increased incidence of hypoglycemia. Elevated markers in patients with hypoglycemia were not caused by hypoglycemia itself but rather reflect an increased incidence of hypoglycemia in the most severely ill. This hypoglycemia risk appears difficult to capture by classical illness severity scores. (J Clin Endocrinol Metab 95: 4669-4679, 2010)	[Vanhorebeek, Ilse] Katholieke Univ Leuven, Dept Intens Care Med, B-3000 Louvain, Belgium; Katholieke Univ Leuven, Lab Intens Care Med, B-3000 Louvain, Belgium		Vanhorebeek, I (corresponding author), Katholieke Univ Leuven, Dept Intens Care Med, B-3000 Louvain, Belgium.	ilse.vanhorebeek@med.kuleuven.be	Mesotten, Dieter/ABE-4176-2020; Van den Berghe, Greet/J-6788-2018	Mesotten, Dieter/0000-0002-3258-4720; Van den Berghe, Greet/0000-0002-5320-1362; Vanhorebeek, Ilse/0000-0002-5261-5192; Guiza, Fabian/0000-0001-7026-0957	Institute for Science and Technology, Flanders, Belgium [IWT 070695]; Research Council of the Katholieke Universiteit LeuvenKU Leuven [GOA2007/14]; Research Foundation, Flanders (Fonds voor Wetenschappelijk Onderzoek Vlaanderen, FWO)FWO; Clinical Research Fund of the University Hospitals Leuven; Flemish GovernmentEuropean Commission	This work was supported by the TBM program (Toegepast Biomedisch onderzoek met een primair Maatschappelijke finaliteit) of the Institute for Science and Technology, Flanders, Belgium (IWT 070695), the Research Council of the Katholieke Universiteit Leuven (GOA2007/14), PhD Fellowship of the Research Foundation, Flanders (Fonds voor Wetenschappelijk Onderzoek Vlaanderen, FWO) (to M.G.) and postdoctoral fellowship of the Clinical Research Fund of the University Hospitals Leuven (to D.M.). G.V.d.B., by the University of Leuven, receives structural research financing via the Methusalem program, funded by the Flemish Government.	Beardsall K, 2008, NEW ENGL J MED, V359, P1873, DOI 10.1056/NEJMoa0803725; Beers SR, 2007, J NEUROTRAUM, V24, P97, DOI 10.1089/neu.2006.0055; Berger RP, 2006, J HEAD TRAUMA REHAB, V21, P315, DOI 10.1097/00001199-200607000-00004; Bjorgaas M, 1997, ACTA PAEDIATR, V86, P148, DOI 10.1111/j.1651-2227.1997.tb08856.x; Branco Ricardo G, 2005, Pediatr Crit Care Med, V6, P470, DOI 10.1097/01.PCC.0000161284.96739.3A; BROWN TCK, 1980, AUST PAEDIATR J, V16, P28; Brunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716; Cochran A, 2003, J TRAUMA, V55, P1035, DOI 10.1097/01.TA.0000031175.96507.48; de Ferranti S, 2004, ANESTHESIOLOGY, V100, P1345, DOI 10.1097/00000542-200406000-00005; Duning T, 2010, DIABETES CARE, V33, P639, DOI 10.2337/dc09-1740; Erb MA, 2000, ANN THORAC SURG, V69, P1515, DOI 10.1016/S0003-4975(00)01141-3; Fassbender K, 1997, J NEUROL SCI, V148, P101, DOI 10.1016/S0022-510X(96)05351-8; Faustino EV, 2005, J PEDIATR-US, V146, P30, DOI 10.1016/j.jpeds.2004.08.076; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Fontella FU, 2005, BRAIN RES BULL, V65, P443, DOI 10.1016/j.brainresbull.2005.02.026; Georgiadis D, 2000, J THORAC CARDIOV SUR, V119, P138, DOI 10.1016/S0022-5223(00)70229-7; Gerlach R, 2006, NEUROSCIENCE, V141, P1697, DOI 10.1016/j.neuroscience.2006.05.008; Gursoy M, 2010, NEUROCHEM RES, V35, P429, DOI 10.1007/s11064-009-0075-9; Hall NJ, 2004, J PEDIATR SURG, V39, P898, DOI 10.1016/j.jpedsurg.2004.02.005; Hovsepyan MR, 2004, NEUROSCI LETT, V369, P224, DOI 10.1016/j.neulet.2004.07.071; Hsu AA, 2008, PEDIATR CRIT CARE ME, V9, P245, DOI 10.1097/PCC.0b013e3181727b22; JACOBSON AM, 2007, NEW ENGL J MED, V356, P1842; Jenkins KJ, 2002, J THORAC CARDIOV SUR, V123, P110, DOI 10.1067/mtc.2002.119064; Kapural M, 2002, BRAIN RES, V940, P102, DOI 10.1016/S0006-8993(02)02586-6; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Kosiborod M, 2009, JAMA-J AM MED ASSOC, V301, P1556, DOI 10.1001/jama.2009.496; Leviton A, 2002, ACTA PAEDIATR, V91, P9, DOI 10.1080/080352502753457851; Malone JI, 2008, PEDIATR DIABETES, V9, P531, DOI 10.1111/j.1399-5448.2008.00431.x; Marchi N, 2004, CLIN CHIM ACTA, V342, P1, DOI 10.1016/j.cccn.2003.12.008; Meyfroidt G, 2010, CRIT CARE MED, V38, P1021, DOI 10.1097/CCM.0b013e3181cf710e; Northam EA, 2006, NAT CLIN PRACT NEURO, V2, P78, DOI 10.1038/ncpneuro0097; Preiser JC, 2009, INTENS CARE MED, V35, P1738, DOI 10.1007/s00134-009-1585-2; RYAN CM, 1990, J PEDIATR-US, V117, P32, DOI 10.1016/S0022-3476(05)82440-0; Spinella PC, 2003, CRIT CARE MED, V31, P939, DOI 10.1097/01.CCM.0000053644.16336.52; Strachan MWJ, 1999, DIABETES-METAB RES, V15, P5, DOI 10.1002/(SICI)1520-7560(199901/02)15:1<5::AID-DMRR2>3.0.CO;2-S; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Sulter G, 1998, NEUROSCI LETT, V253, P71, DOI 10.1016/S0304-3940(98)00595-3; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Van den Berghe G, 2006, DIABETES, V55, P3151, DOI 10.2337/db06-0855; Vlasselaers D, 2010, ANN THORAC SURG, V90, P22, DOI 10.1016/j.athoracsur.2010.03.093; Vlasselaers D, 2009, LANCET, V373, P547, DOI 10.1016/S0140-6736(09)60044-1; Vriesendorp TM, 2006, CRIT CARE MED, V34, P2714, DOI 10.1097/01.CCM.0000241155.36689.91; Wysocki T, 2003, DIABETES CARE, V26, P1100, DOI 10.2337/diacare.26.4.1100; Yates AR, 2006, PEDIATR CRIT CARE ME, V7, P351, DOI 10.1097/01.PCC.0000227755.96700.98	46	17	17	0	4	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0021-972X	1945-7197		J CLIN ENDOCR METAB	J. Clin. Endocrinol. Metab.	OCT	2010	95	10					4669	4679		10.1210/jc.2010-0805			11	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	659NK	WOS:000282573300025	20668035				2022-02-06	
J	Chhabra, G; Rangarajan, K; Subramanian, A; Agrawal, D; Sharma, S; Mukhopadhayay, AK				Chhabra, Gaurav; Rangarajan, Kanchana; Subramanian, Arulselvi; Agrawal, Deepak; Sharma, Subhadra; Mukhopadhayay, A. K.			Hypofibrinogenemia in isolated traumatic brain injury in Indian patients	NEUROLOGY INDIA			English	Article						Coagulopathy; head injury; hypofibrinogenemia	COAGULOPATHY	Coagulation abnormalities are common in patients with head injuries. However, the effect of brain injury on fibrinogen levels has not been well studied prospectively to assess coagulation abnormalities in patients with moderate and severe head injuries and correlate these abnormalities with the neurologic outcome. Consecutive patients with moderate (Glasgow Comma Scale (GCS),9-12) and severe (GCS <= 8) head injuries were the subjects of this pilot study, All patients had coagulation parameters, including plasma fibrinogen levels measured. Clinical and computed tomography (CT) scan findings and immediate clinical outcome were analyzed. Of the 100 patients enrolled, only seven (7) patients had hypofibrinogenemia (fibrinogen <= 200 mg/dL). The head injury was moderate in two patients and severe in five patients. Fibrinogen levels showed a progressively increasing trend in four patients (three with severe head injuries and one with moderate head injury). CT scan revealed subdural hematoma in five patients; extradural hematoma in one; and subarachnoid hemorrhage in another patient. Of the seven patients, two patients died during hospital. Large-scale prospective studies are needed to assess the fibrinogen level in patients with head injury and its impact on outcome.	[Chhabra, Gaurav; Rangarajan, Kanchana; Subramanian, Arulselvi; Sharma, Subhadra; Mukhopadhayay, A. K.] AIIMS, Jai Prakash Narayan Apex Trauma Ctr, Dept Lab Med, Delhi, India; [Agrawal, Deepak] AIIMS, Jai Prakash Narayan Apex Trauma Ctr, Dept Neurosurg, Delhi, India		Subramanian, A (corresponding author), AIIMS, Jai Prakash Narayan Apex Trauma Ctr, Dept Lab Med, Delhi, India.	arulselvi.jpnatc@gmail.com	Subramanian, arulselvi/AAG-1670-2020; /AAG-3032-2021	Subramanian, arulselvi/0000-0001-7797-6683; /0000-0002-5499-0746			Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; GANDO S, 1992, CRIT CARE MED, V20, P594, DOI 10.1097/00003246-199205000-00009; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; Scherer RU, 1998, CRIT CARE MED, V26, P149, DOI 10.1097/00003246-199801000-00031; UEDA S, 1985, J NEUROL NEUROSUR PS, V48, P58, DOI 10.1136/jnnp.48.1.58	6	17	18	0	1	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0028-3886	1998-4022		NEUROL INDIA	Neurol. India	SEP-OCT	2010	58	5					756	757		10.4103/0028-3886.72175			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	676OU	WOS:000283922600018	21045504				2022-02-06	
J	Engel, DC; Mikocka-Walus, A; Cameron, PA; Maegele, M				Engel, D. C.; Mikocka-Walus, A.; Cameron, P. A.; Maegele, M.			Pre-hospital and in-hospital parameters and outcomes in patients with traumatic brain injury: A comparison between German and Australian trauma registries	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Traumatic brain injury; Pre-hospital management; Emergency medical service system; DOC-ALS; Paramedic; Trauma registry	SEVERE HEAD-INJURIES; GLASGOW COMA SCALE; PROGNOSTIC VALUE; MORTALITY; CARE; HYPOTENSION; SYSTEMS; AGE	Introduction: In Germany, physician-operated emergency medical services (EMS) manage most pre-hospital trauma care. Australia uses a different EMS system, deploying highly trained paramedics for road and air transport of trauma patients. The effect of these different systems on secondary insults to traumatic brain injury (TBI) patients is unclear. There is conflicting evidence regarding which system is preferable. To add to the body of evidence, we compared the profile of injury, pre-hospital management and outcomes of TBI patients from both populations. Methods: Cases aged >= 16 years, with AIS head >= 3, AIS other body parts <= 3, recorded in the Victorian State Trauma Registry (VSTR) and Trauma Registry of the German Society of Trauma Surgery (TR-DGU) from 2002 to 2007 were compared. Results: 10,183 cases (5665 German, 4518 Australian) were included. No difference in sex or median age was observed. There were major between-registry differences in type of injury, trauma circumstance, intent and severity of injury. German cases sustained more serious injury and received more pre-hospital interventions. Mortality was significantly higher amongst German patients even when adjusted for demographics, injury severity and in-and pre-hospital parameters. German patients had a longer hospital and ICU stay. Conclusion: There were clear differences in injury characteristics and outcomes in TBI patients between Germany and Australia. As differences in coding, data collection and patient selection are evident, firm conclusions regarding the contribution of variations in pre-hospital care are not possible. The differences in outcome deserve further exploration in prospective studies. (C) 2010 Elsevier Ltd. All rights reserved.	[Engel, D. C.] Univ Heidelberg Hosp, Dept Neurosurg, Heidelberg, Germany; [Mikocka-Walus, A.; Cameron, P. A.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Maegele, M.] Univ Witten Herdecke, Inst Res Operat Med IFOM, Cologne, Germany; [Maegele, M.] Univ Witten Herdecke, CMMC, Dept Traumatol & Orthoped Surg, Cologne, Germany		Engel, DC (corresponding author), Univ Heidelberg Hosp, Dept Neurosurg, Heidelberg, Germany.	doortjeengel@gmail.com	Mikocka-Walus, Antonina/B-4160-2010; Mikocka-Walus, Antonina/R-2363-2017	Mikocka-Walus, Antonina/0000-0003-4864-3956; Cameron, Peter/0000-0002-1443-557X	Department of Human Services; Victorian Trauma Foundation	Authors are unaware of any conflicts of interest. The Victorian State Trauma Registry is a Department of Human Services and Victorian Trauma Foundation funded and approved initiative. The Trauma Registry of the German Society of Trauma Surgery is an initiative of the German Society of Trauma Surgery - Polytrauma Section.	Bernard Stephen A, 2006, Emerg Med Australas, V18, P221, DOI 10.1111/j.1742-6723.2006.00850.x; *BTF, 2000, J NEUROTRAUM, V17, P457; Butcher I, 2007, J NEUROTRAUM, V24, P281, DOI 10.1089/neu.2006.0030; Cameron PA, 2004, ANZ J SURG, V74, P424, DOI 10.1111/j.1445-1433.2004.03029.x; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Nieva JLGD, 2009, J EMERG MED, V37, P189, DOI 10.1016/j.jemermed.2007.10.089; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Evans L., 1991, TRAFFIC SAFETY DRIVE; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Kannus P, 2001, JAMA-J AM MED ASSOC, V286, P673, DOI 10.1001/jama.286.6.673; KRAUS JF, 1993, ACCIDENT ANAL PREV, V25, P229, DOI 10.1016/0001-4575(93)90018-R; Luukinen H, 1999, J AM GERIATR SOC, V47, P1451, DOI 10.1111/j.1532-5415.1999.tb01566.x; Maegele M, 2007, EUR SURG RES, V39, P372, DOI 10.1159/000107097; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; RADY MY, 1994, ANN EMERG MED, V24, P685, DOI 10.1016/S0196-0644(94)70279-9; Roudsari BS, 2007, INJURY, V38, P993, DOI 10.1016/j.injury.2007.03.028; Roudsari BS, 2007, INJURY, V38, P1001, DOI 10.1016/j.injury.2007.04.008; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Sundstrom T, 2007, J NEUROTRAUM, V24, P147, DOI 10.1089/neu.2006.0099; Suzuki T, 2008, WEST J EMERG MED, V9, P166; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Westhoff J, 2003, INJURY, V34, P674, DOI 10.1016/S0020-1383(03)00147-5	24	17	17	0	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2010	41	9					901	906		10.1016/j.injury.2010.01.002			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	634SL	WOS:000280605500005	20097343				2022-02-06	
J	Phillips, J; Drummond, A; Radford, K; Tyerman, A				Phillips, Julie; Drummond, Avril; Radford, Kathryn; Tyerman, Andy			Return to work after traumatic brain injury: recording, measuring and describing occupational therapy intervention	BRITISH JOURNAL OF OCCUPATIONAL THERAPY			English	Article						Traumatic brain injury; vocational rehabilitation; occupational therapy	VOCATIONAL-REHABILITATION; TREATMENT DEFINITION; BLACK-BOX; COMMUNITY; PHYSIOTHERAPY; DELIVERY; PEOPLE; ABI	Low post-injury employment rates indicate that returning to work is difficult following traumatic brain injury (TBI). Occupational therapists assist people with TBI to return to work, but rarely is their intervention described. This has hindered research into vocational rehabilitation. As no existing tool was identified for recording intervention, a proforma was developed for this study. Using best practice guidelines and a consensus of expert opinion, 15 categories of the vocational rehabilitation process were identified. Time spent on each category was recorded in 10-minute units after each occupational therapy session. The records of 21 participants who received occupational therapy focused on vocational rehabilitation were analysed. The proforma was quick and simple to use. The analysis showed that assessment, work preparation, employer involvement, education and dealing with issues of immediate concern to participants accounted for almost 85% of face-to-face intervention. It also showed that for every 1 hour of face-to-face contact, an additional 2 hours was required for liaison and travel. This study showed that there is potential for using a proforma for quantifying and describing occupational therapy. This is the basis for further work to enable meaningful comparisons with other services and use in future studies.	[Phillips, Julie; Drummond, Avril] Univ Nottingham, Queens Med Ctr, Sch Med, Div Rehabil & Ageing,Sch Community Hlth Sci, Nottingham NG7 2UH, England; [Radford, Kathryn] Univ Cent Lancashire, Preston, Lancs, England; [Tyerman, Andy] Cambourne Ctr, Community Head Injury Serv, Aylesbury, Bucks, England		Phillips, J (corresponding author), Univ Nottingham, Queens Med Ctr, Sch Med, Div Rehabil & Ageing,Sch Community Hlth Sci, Derby Rd, Nottingham NG7 2UH, England.	julie.phillips@nottingham.ac.uk	Radford, Kate A/F-8571-2013	Radford, Kate A/0000-0001-6246-3180; Drummond, Avril/0000-0003-1220-8354	College of Occupational Therapists	This study was funded by the College of Occupational Therapists. The authors wish to acknowledge the members of the steering group for their invaluable help With this study: Dr Tracey Sach, Senior Lecturer in Health Economics, University of East Anglia; Professor Marion Walker, Professor in Stroke Rehabilitation, University of Nottingham; Dr Naseer Habuoubi, Consultant in Rehabilitation Medicine, University Hospitals Nottingham; and Mr Trevor Jones, patient representative.	[Anonymous], 2005, CLIN REHABIL, V19, P811, DOI 10.1191/0269215505cr923ed; Ballinger C, 1999, CLIN REHABIL, V13, P301, DOI 10.1191/026921599673198490; Barnes T., 2007, OCCUPATIONAL THERAPY; Barnes T, 2006, OCCUPATIONAL THERAPY; *BRIT SOC REH MED, 1998, REH TRAUM BRAIN INJ; British Society of Rehabilitation Medicine, 2003, VOC REH WAY FORW EX; British Society of Rehabilitation Medicine, 2000, VOC REH WAY FORW WOR; British Society of Rehabilitation Medicine Royal College of Physicians, 2003, REH FOLL ACQ BRAIN I; Catalano D, 2006, NEUROREHABILITATION, V21, P279; Coetzer R, 2008, NEUROPSYCHOL REHABIL, V18, P766, DOI 10.1080/09602010701860266; Creek J., 2005, BRIT J OCCUP THER, V68, P281, DOI [10.1177/030802260506800607, DOI 10.1177/030802260506800607]; De Wit L, 2007, CLIN REHABIL, V21, P450, DOI 10.1177/0269215507074385; Department for Work Pensions and the Department of Health, 2008, IMPR HLTH WORK CHANG; Department of Health, 2005, NAT SERV FRAM LONG T; Deshpande P, 2004, VOCATIONAL ASSESSMEN; Evans CC, 2008, J HEAD TRAUMA REHAB, V23, P329, DOI 10.1097/01.HTR.0000336845.06704.bc; Frank AO, 2006, INT J THER REHABIL, V13, P126, DOI 10.12968/ijtr.2006.13.3.21364; Geurtsen GJ, 2010, J REHABIL MED, V42, P97, DOI 10.2340/16501977-0508; Groswasser Z, 1999, NEUROPSYCHOL REHABIL, V9, P493, DOI 10.1080/096020199389545; Hart T, 2006, J HEAD TRAUMA REHAB, V21, P467, DOI 10.1097/00001199-200611000-00002; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P824, DOI 10.1080/09602010902995945; Huang HC, 2009, J CHIN MED ASSOC, V72, P257, DOI 10.1016/S1726-4901(09)70066-8; Johansson U, 2001, DISABIL REHABIL, V23, P474; Kendall E, 2006, J VOCAT REHABIL, V25, P149; Kuipers P, 2003, DISABIL REHABIL, V25, P154, DOI 10.1080/0963828021000024898; Murphy L, 2006, BRAIN INJURY, V20, P1119, DOI 10.1080/02699050600664335; O'Brien L, 2007, BRAIN INJURY, V21, P465, DOI 10.1080/02699050701315134; Office for National Statistics, 2000, STAND OCC CLASS 2000; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Tyerman A, 2004, VOCATIONAL ASSESSMEN; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; Vocational Rehabilitation Association, 2007, VRA STAND PRACT REP; Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Whyte J, 2003, AM J PHYS MED REHAB, V82, P639, DOI 10.1097/01.PHM.0000078200.61840.2D; Whyte J, 2009, NEUROPSYCHOL REHABIL, V19, P807, DOI 10.1080/09602010903031146	37	17	17	0	18	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0308-0226	1477-6006		BRIT J OCCUP THER	Br. J. Occup. Ther.	SEP	2010	73	9					422	430		10.4276/030802210X12839367526138			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	V26JZ	WOS:000208543200005					2022-02-06	
J	Hallen, M; Karlsson, M; Carlhed, R; Hallgren, T; Bergenheim, M				Hallen, Magnus; Karlsson, Mathias; Carlhed, Rickard; Hallgren, Thomas; Bergenheim, Mikael			S-100B in Serum and Urine After Traumatic Head Injury in Children	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						S-100B; Head trauma; Children	BRAIN-INJURY; S100B LEVELS; PROTEIN MEASUREMENTS; COMPUTED-TOMOGRAPHY; MULTICENTER; ELIMINATION; S-100-BETA; FAMILY; DAMAGE	Background: Children with head trauma are frequently seen in many emergency units. The clinical evaluation of these patients is difficult for a number of reasons and improved diagnostic tools are needed. S-100B, a protein found in glial cells, has previously been shown to be a sensible marker for brain damage after head injury in adults, but few studies have focused on its use in children. Methods: In this study, 111 children with head trauma were included and venous blood and urine samples were taken at arrival (S1 and U1) and 6 hours later (S2 and U2). S-100B levels were analyzed. Clinical and radiologic evaluations were performed according to hospital routine. Two groups were identified-group 1: no computed tomography (CT) scan performed or a CT scan without any sign of trauma-related intracranial pathology (n = 105). Group 2: A CT scan with signs of trauma-related intracranial pathology (n = 6). Results: In group 1, the median (inter quartile range) serum S-100B value in S1-samples was 0.111 mu g/L (0.086-0.153), and in group 2, it was 0.282 mu g/L (0.195-1.44) (p < 0.01). Also, S2 values significantly differed between the two groups. Urine values were, however, not significantly differing between the groups. Conclusions: Serum S-100B values within 6 hours after head trauma in children were significantly higher in patients with intracranial pathology compared with those without intracranial complications. Identification of these high-risk patients already in the emergency department is of major importance, and we suggest that S-100B could be a valuable diagnostic tool in addition to those used in clinical practice today.	[Hallen, Magnus; Hallgren, Thomas; Bergenheim, Mikael] Cent Hosp Karlstad, Dept Surg, S-65185 Karlstad, Sweden; [Karlsson, Mathias] Stockholm Soder Hosp, Karolinska Inst, Dept Clin Sci & Educ, Karlstad, Sweden; [Karlsson, Mathias] Dept Clin Res, Karlstad, Sweden; [Carlhed, Rickard] Cent Hosp Karlstad, Dept Lab Med, S-65185 Karlstad, Sweden		Bergenheim, M (corresponding author), Cent Hosp Karlstad, Dept Surg, S-65185 Karlstad, Sweden.	mikael.bergenheim@liv.se			Center of Clinical Research, County Council of Varmland, Sweden	Supported by The Center of Clinical Research, County Council of Varmland, Sweden.	Akhtar Javed I, 2003, Pediatr Crit Care Med, V4, P322; Astrand R, 2006, ACTA NEUROL SCAND, V113, P262, DOI 10.1111/j.1600-0404.2005.00573.x; BAUDIER J, 1984, BIOCHIM BIOPHYS ACTA, V790, P164, DOI 10.1016/0167-4838(84)90220-6; Berger RP, 2002, J NEUROTRAUM, V19, P1405, DOI 10.1089/089771502320914633; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; FANO G, 1995, PROG NEUROBIOL, V46, P71, DOI 10.1016/0301-0082(94)00062-M; Hallen M, 2008, CLIN CHEM LAB MED, V46, P1025, DOI 10.1515/CCLM.2008.190; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; JENSEN R, 1985, J NEUROCHEM, V45, P700, DOI 10.1111/j.1471-4159.1985.tb04048.x; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Oh EJ, 2007, J CLIN LAB ANAL, V21, P387, DOI 10.1002/jcla.20201; Berger RP, 2006, PEDIATR CRIT CARE ME, V7, P557, DOI 10.1097/01.PCC.0000244426.37793.23; Piazza O, 2007, PEDIATR NEUROSURG, V43, P258, DOI 10.1159/000103304; Poli-de-Figueiredo Luiz F, 2006, Clinics, V61, P41, DOI 10.1590/S1807-59322006000100008; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Spinella PC, 2003, CRIT CARE MED, V31, P939, DOI 10.1097/01.CCM.0000053644.16336.52; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; Ucar T, 2004, J TRAUMA, V57, P95, DOI 10.1097/01.TA.0000071352.95491.75; Unden J, 2005, BRIT J NEUROSURG, V19, P43, DOI 10.1080/02688690500089381; Unden J, 2004, SCAND J INFECT DIS, V36, P10, DOI 10.1080/00365540310017294; Ytrebo LM, 2001, SCAND J CLIN LAB INV, V61, P217; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	27	17	20	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	AUG	2010	69	2					284	289		10.1097/TA.0b013e3181ca060b			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	638JN	WOS:000280890800007	20734463				2022-02-06	
J	Wyen, H; Jakob, H; Wutzler, S; Lefering, R; Laurer, HL; Marzi, I; Lehnert, M				Wyen, Hendrik; Jakob, Heike; Wutzler, Sebastian; Lefering, Rolf; Laurer, Helmut L.; Marzi, Ingo; Lehnert, Mark		Trauma Registry DGU	Prehospital and Early Clinical Care of Infants, Children, and Teenagers Compared to an Adult Cohort Analysis of 2,961 Children in Comparison to 21,435 Adult Patients from the Trauma Registry of DGU in a 15-Year Period	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Polytrauma management including prehospital and shockroom; Pediatric; Prehospital care; Multiple trauma; Pediatric trauma	MULTIPLE INJURIES; RESUSCITATION; AIR	Background: Although the incidence of pediatric patients in emergency services is as low as 5-10%, trauma remains one of the leading causes of death during childhood. Only a few reports exist about the quality of the initial treatment of pediatric trauma patients. Therefore, we tested the hypothesis of whether pre-hospital treatment and emergency management in pediatric trauma patients is similar to the treatment that is provided for adult patients. Materials and Methods: We performed a retrospective data analysis of the German Trauma Registry of the DGU from January 1993 to December 2007. Exclusion criteria were missing information about injury severity and/or age and patients older than 50 years. All pediatric patients were subdivided into five groups (infants 0-1 year, toddlers 2-5 years, children 6-9 years, pupils 10-13 years, teenagers 14-17 years) with regard to their age and were compared with the adult cohort (18-50 years). From 24,396 patients, 2,961 were below 18 years of age, thus, about 12% of the whole population of injured patients below the age of 50 years. Results: 66.4% of infants sustained relevant head injuries (Abbreviated Injury Scale [AIS] >= 3), and this rate declined with increasing age. The mean Injury Severity Score (ISS) increased from 21.0 (+/-11.6) in the group of infants to 26.7 (+/-13.9) in the adult cohort. In all groups, the majority of patients were male. The injury pattern differed according to age, with predominant traumatic brain injury (TBI) in infants. During the preclinical treatment, infants were less often intubated and this was contrasted by a higher rate of cardiopulmonary resuscitation in this group (infants 16.2%, toddlers 6.8%, adults 3.1%). Diagnostic multislice computed tomography (CT) examination was less often performed in infants as compared to the other groups (infants 57.1%, toddlers 77.2%, adults 77.8%). Mortality and quality indicators such as timelines show no significant differences between children and adults. Conclusion: We observed typical age-dependent differences regarding the injury pattern and severity and differences referring to the preclinical and initial treatment. With respect to the high rate of serious TBI in the infants and toddlers age groups, a more focused education and training of emergency physicians and paramedics should be considered.	[Wyen, Hendrik; Jakob, Heike; Wutzler, Sebastian; Laurer, Helmut L.; Marzi, Ingo; Lehnert, Mark] Hosp Johann Wolfgang Goethe Univ, Dept Trauma Hand & Reconstruct Surg, D-60590 Frankfurt, Germany; [Lefering, Rolf] Univ Witten Herdecke, Inst Res Operat Med, IFOM, Cologne, Germany		Wyen, H (corresponding author), Hosp Johann Wolfgang Goethe Univ, Dept Trauma Hand & Reconstruct Surg, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	wyen@trauma.uni-frankfurt.de					Agran PF, 2003, PEDIATRICS, V111, pE683, DOI 10.1542/peds.111.6.e683; *ASS ADV AUT MED, 1998, ABBR INJ SCAL AIS 19; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Capizzani AR, 2010, J PEDIATR SURG, V45, P903, DOI 10.1016/j.jpedsurg.2010.02.014; Chwals WJ, 2008, J PEDIATR SURG, V43, P2268, DOI 10.1016/j.jpedsurg.2008.08.061; COWLEY RA, 1976, CLIN MED/US, V83, P16; Dykes EH, 1999, BRIT J ANAESTH, V83, P130, DOI 10.1093/bja/83.1.130; Gatzka C, 2005, UNFALLCHIRURG, V108, P470, DOI 10.1007/s00113-005-0921-4; Hammad AMM, 2009, EUR J TRAUMA EMERG S, V35, P31, DOI 10.1007/s00068-008-8025-9; Huber-Wagner S, 2009, LANCET, V373, P1455, DOI 10.1016/S0140-6736(09)60232-4; Jakob H, 2009, UNFALLCHIRURG, V112, P951, DOI 10.1007/s00113-009-1682-2; Kanz KG, 2006, UNFALLCHIRURG, V109, P278, DOI 10.1007/s00113-006-1061-1; Laurer H, 2009, UNFALLCHIRURG, V112, P771, DOI 10.1007/s00113-009-1589-y; Maegele M, 2007, INJURY, V38, P298, DOI 10.1016/j.injury.2006.10.003; Meyer PG, 2000, PAEDIATR ANAESTH, V10, P253, DOI 10.1046/j.1460-9592.2000.00496.x; Nagele P, 2004, WIEN KLIN WOCHENSCHR, V116, P398, DOI 10.1007/BF03040921; Paul TR, 1999, J TRAUMA, V47, P455, DOI 10.1097/00005373-199909000-00004; Ruchholtz S, 2007, Chirurg, VSuppl, P266; Schelhase T., 2006, WIRTSCHAFT STAT, V6, P614; Schlechtriemen T, 2006, ANAESTHESIST, V55, P255, DOI 10.1007/s00101-005-0922-2; Schmidt FL, 2002, HUM PERFORM, V15, P187, DOI 10.1207/S15327043HUP1501&02_12; Schmidt U, 2002, UNFALLCHIRURG, V105, P1000, DOI 10.1007/s00113-002-0520-6; SHARPLES PM, 1990, BRIT MED J, V300, P87, DOI 10.1136/bmj.300.6717.87; Soreide K, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-3; Suominen P, 1998, J PEDIATR SURG, V33, P1388, DOI 10.1016/S0022-3468(98)90014-8; TEASDALE G, 1974, LANCET, V2, P81; Weiss M, 2001, ANAESTHESIST, V50, P150, DOI 10.1007/s001010170030; Wilson JRF, 2009, EUR J TRAUMA EMERG S, V35, P176, DOI 10.1007/s00068-008-8095-8; Wutzler S, 2008, UNFALLCHIRURG, V111, P592, DOI 10.1007/s00113-008-1448-2; Wyen H, 2009, EUR J TRAUMA EMERG S, V35, P448, DOI 10.1007/s00068-009-9140-y	30	17	17	0	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	AUG	2010	36	4					300	307		10.1007/s00068-010-1124-4			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	639AP	WOS:000280943500003	26816034				2022-02-06	
J	Edwards, D; Das, M; Molnar, P; Hickman, JJ				Edwards, Darin; Das, Mainak; Molnar, Peter; Hickman, James J.			Addition of glutamate to serum-free culture promotes recovery of electrical activity in adult hippocampal neurons in vitro	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Adult; Neuron; Culture; Hippocampal; Electrophysiology	PYRAMIDAL NEURONS; GENE-EXPRESSION; DEFINED SYSTEM; CELL; EXCITABILITY; PROTEIN; SURFACE; PLASTICITY; MONOLAYERS; BIOSENSORS	A long-term cell culture system utilizing normal adult hippocampal neurons would represent an important tool that could be useful in research on the mature brain, neurological disorders and age-related neurological diseases. Historically, in vitro neuronal systems are derived from embryonic rather than mature brain tissue, a practice predicated upon difficulties in supporting regeneration, functional recovery and long-term survival of adult neurons in vitro. A few studies have shown that neurons derived from the hippocampal tissue of adult rats can survive and regenerate in vitro under serum-free conditions. However, while the adult neurons regenerated morphologically under these conditions, both the electrical activity characteristic of in vivo neurons as well as long-term neuronal survival was not consistently recovered in vitro. In this study, we report on the development of a defined culture system with the ability to support functional recovery and long-term survival of adult rat hippocampal neurons. In this system, the cell-adhesive substrate, N-1[3-(trimethoxysilyl) propyl]-diethylenetriamine, supported neuronal attachment, regeneration, and long-term survival of adult neurons for more than 80 days in vitro. Additionally, the excitatory neurotransmitter glutamate, applied at 25 mu M for 1-7 days after morphological neuronal regeneration in vitro, enabled full recovery of neuronal electrical activity. This low concentration of glutamate promoted the recovery of neuronal electrical activity but with minimal excitotoxicity. These improvements allowed electrically active adult neurons to survive in vitro for several months, providing a stable test-bed for the long-term study of regeneration in adult-derived neuronal systems, especially for traumatic brain injury (TBI). (C) 2010 Elsevier B.V. All rights reserved.	[Edwards, Darin; Das, Mainak; Molnar, Peter; Hickman, James J.] NanoSci Technol Ctr, Orlando, FL 32826 USA		Hickman, JJ (corresponding author), NanoSci Technol Ctr, 12424 Res Pkwy,Suite 400, Orlando, FL 32826 USA.	jhickman@mail.ucf.edu			Department of EnergyUnited States Department of Energy (DOE) [DE-FG-02-04ER 46171]; UCF internal funds; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01EB005459]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB005459] Funding Source: NIH RePORTER	Department of Energy DE-FG-02-04ER 46171 and UCF internal funds and NIH grant number 5R01EB005459.; The authors would like to acknowledge funding support from the Department of Energy, grant number DE-FG-02-04ER 46171 and National Institute of Health, grant number 5R01EB005459.	AUDITORE JV, 1966, J NEUROCHEM, V13, P1149, DOI 10.1111/j.1471-4159.1966.tb04272.x; Balazs R, 2006, CURR TOP MED CHEM, V6, P961, DOI 10.2174/156802606777323700; Barone FC, 1998, STROKE, V29, P1937, DOI 10.1161/01.STR.29.9.1937; Bousse L, 1996, SENSOR ACTUAT B-CHEM, V34, P270, DOI 10.1016/S0925-4005(96)01906-5; Brewer GJ, 1997, J NEUROSCI METH, V71, P143, DOI 10.1016/S0165-0270(96)00136-7; Brewer GJ, 2005, EXP GERONTOL, V40, P426, DOI 10.1016/j.exger.2005.03.007; Brewer GJ, 1998, NEUROBIOL AGING, V19, P561, DOI 10.1016/S0197-4580(98)00091-8; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; COCERES A, 1984, BRAIN RES, V315, P314; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Daoudal G, 2002, P NATL ACAD SCI USA, V99, P14512, DOI 10.1073/pnas.222546399; Das M, 2005, IN VITRO CELL DEV-AN, V41, P343; Das M, 2003, BIOTECHNOL PROGR, V19, P1756, DOI 10.1021/bp034076l; Das M, 2008, EXP NEUROL, V209, P171, DOI 10.1016/j.expneurol.2007.09.019; Evans MS, 1998, J NEUROSCI METH, V79, P37, DOI 10.1016/S0165-0270(97)00159-3; Ginsberg SD, 2005, AM J GERIAT PSYCHIAT, V13, P1052, DOI 10.1176/appi.ajgp.13.12.1052; Harms H, 2006, APPL MICROBIOL BIOT, V70, P273, DOI 10.1007/s00253-006-0319-4; Heiduschka P, 1998, PROG NEUROBIOL, V55, P433, DOI 10.1016/S0301-0082(98)00013-6; HICKMAN JJ, 1994, J VAC SCI TECHNOL A, V12, P607, DOI 10.1116/1.578844; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; MATTSON MP, 1988, BRAIN RES REV, V13, P179, DOI 10.1016/0165-0173(88)90020-3; MATTSON MP, 1988, J NEUROSCI, V8, P2087; Nakagawa S, 2002, J NEUROSCI, V22, P9868; Ravenscroft MS, 1998, J AM CHEM SOC, V120, P12169, DOI 10.1021/ja973669n; Schaffner AE, 1995, J NEUROSCI METH, V62, P111, DOI 10.1016/0165-0270(95)00063-1; Simpson ML, 2001, TRENDS BIOTECHNOL, V19, P317, DOI 10.1016/S0167-7799(01)01691-2; Sjostrom PJ, 2008, PHYSIOL REV, V88, P769, DOI 10.1152/physrev.00016.2007; SPARGO BJ, 1994, P NATL ACAD SCI USA, V91, P11070, DOI 10.1073/pnas.91.23.11070; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; Stenger DA, 1998, J NEUROSCI METH, V82, P167, DOI 10.1016/S0165-0270(98)00047-8; STENGER DA, 1993, BRAIN RES, V630, P136, DOI 10.1016/0006-8993(93)90651-3; Tominaga-Yoshino K, 2008, HIPPOCAMPUS, V18, P281, DOI 10.1002/hipo.20391; Verderio C, 1999, CELL MOL LIFE SCI, V55, P1448, DOI 10.1007/s000180050384; Walmsley B, 2006, J PHYSIOL-LONDON, V572, P313, DOI 10.1113/jphysiol.2006.104851; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248; Zhu DM, 2005, J NEUROSCI RES, V80, P104, DOI 10.1002/jnr.20422	38	17	21	0	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	JUL 15	2010	190	2					155	163		10.1016/j.jneumeth.2010.04.030			9	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	630EV	WOS:000280256700001	20452373	Green Accepted			2022-02-06	
J	Colgan, NC; Cronin, MM; Gobbo, OL; O'Mara, SM; O'Connor, WT; Gilchrist, MD				Colgan, Niall C.; Cronin, Michelle M.; Gobbo, Oliviero L.; O'Mara, Shane M.; O'Connor, William T.; Gilchrist, Michael D.			Quantitative MRI Analysis of Brain Volume Changes due to Controlled Cortical Impact	JOURNAL OF NEUROTRAUMA			English	Article						animal studies; MRI; rat; traumatic brain injury	HEAD-INJURY; NEUROPSYCHIATRIC SEQUELAE; EARLY INTERVENTION; MILD; RATS; PRESSURE; DEATH; INFLAMMATION; EVOLUTION; ATROPHY	More than 85% of reported brain traumas are classified clinically as "mild'' using the Glasgow Coma Scale (GCS); qualitative MRI findings are scarce and provide little correspondence to clinical symptoms. Our goal, therefore, was to establish in vivo sequelae of traumatic brain injury (TBI) following lower and higher levels of impact to the frontal lobe using quantitative MRI analysis and a mechanical model of penetrating impact injury. To investigate time-based morphological and physiological changes of living tissue requires a surrogate for the human central nervous system. The present model for TBI was a systematically varied and controlled cortical impact on deeply-anaesthetized Sprague-Dawley rats, that was designed to mimic different injury severities. Whole-brain MRI scans were performed on each rat prior to either a lower- or a higher-level of impact, and then at hourly intervals for 5 h post-impact. Both brain volume and specific anatomical structures were segmented from MR images for inter-subject comparisons post-registration. Animals subjected to lower and higher impact levels exhibited elevated intracranial pressure (ICP) in the low compensatory reserve (i.e., nearly exhausted), and terminal disturbance (i.e., exhausted) ranges, respectively. There was a statistically significant drop in cerebrospinal fluid (CSF) of 35% in the lower impacts, and 65% in the higher impacts, at 5 h compared to sham controls. There was a corresponding increase in corpus callosum volume starting at 1 h, of 60-110% and 30-40% following the lower- and higher-impact levels, respectively. A statistically significant change in the abnormal tissue from 2 h to 5 h was observed for both impact levels, with greater significance for higher impacts. Furthermore, a statistically significant difference between the lower impacts and the sham controls occurred at 3 h. These results are statistically substantiated by a fluctuation in the physical size of the corpus callosum, a decrease in the volume of CSF, and elevated levels of atrophy in the cerebral cortex.	[Colgan, Niall C.; Gilchrist, Michael D.] Natl Univ Ireland Univ Coll Dublin, Sch Elect Elect & Mech Engn, Dublin 4, Ireland; [Cronin, Michelle M.; O'Connor, William T.] Natl Univ Ireland Univ Coll Dublin, Conway Inst, Dublin 4, Ireland; [Gobbo, Oliviero L.; O'Mara, Shane M.] Trinity Coll Dublin, Inst Neurosci, Dublin, Ireland; [O'Connor, William T.] Univ Limerick, Grad Entry Med Sch, Castletroy, County Limerick, Ireland; [Gilchrist, Michael D.] Univ Ottawa, Sch Human Kinet, Ottawa, ON K1N 6N5, Canada		Gilchrist, MD (corresponding author), Natl Univ Ireland Univ Coll Dublin, Sch Elect Elect & Mech Engn, Dublin 4, Ireland.	michael.gilchrist@ucd.ie	Gobbo, Oliviero/S-2043-2019; O'Connor, William T./I-7459-2015; Colgan, Niall C/R-8537-2016; Gilchrist, Michael D/B-6100-2017; Gobbo, Oliviero L/R-1763-2016	Gobbo, Oliviero/0000-0003-4629-9485; Colgan, Niall C/0000-0002-6482-0601; Gilchrist, Michael D/0000-0003-1765-429X; Gobbo, Oliviero L/0000-0003-4629-9485; O'Mara, Shane/0000-0001-8087-8531; O'Connor, William/0000-0003-0082-1119	Higher Education Authority and Science Foundation IrelandScience Foundation Ireland [SC/2003/029]	We thank Mr. Gregory Byrne (University College Dublin) for his assistance in building the CCI apparatus, and Dr. Christian Kerskens (Trinity College Dublin) for his assistance in computer-assisted image analysis. This work was funded under an Enterprise Ireland basic research grant (SC/2003/029), using MRI facilities that were funded by the Programme for Research in Third Level Institutions by the Higher Education Authority and Science Foundation Ireland.	Andrews PJD, 2004, INTENS CARE MED, V30, P1730, DOI 10.1007/s00134-004-2376-4; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Bowen JM, 1997, DEV MED CHILD NEUROL, V39, P17; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Breen N, 2000, J ACCID EMERG MED, V17, P392; Chaudhury S, 2005, INDIAN J NEUROTRAUM, V2, P13, DOI 10.1016/S0973-0508(05)80005-X; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; COLGAN N, 2009, THESIS U COLL DUBLIN; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; Conti AC, 1998, J NEUROSCI, V18, P5663; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; Cronin C, 2008, IRISH J MED SCI, V177, P171, DOI 10.1007/s11845-008-0148-9; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; DIXON CE, 1991, J NEUROSCI METH, V39, P253; EEC, 1986, COUNC DIR 86278EEC 1; EVANS RW, 1996, MED COMPLICATIONS HE; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; Gilchrist MD, 2004, STRAIN, V40, P180, DOI 10.1111/j.1475-1305.2004.00168.x; Graham DI, 2000, ACTA NEUROPATHOL, V99, P117, DOI 10.1007/PL00007414; Gutteridge S, 2002, MAGNET RESON MED, V47, P871, DOI 10.1002/mrm.10142; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; Hurley RA, 2004, J NEUROPSYCH CLIN N, V16, P1, DOI 10.1176/appi.neuropsych.16.1.1; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; King JT, 2005, J NEUROTRAUM, V22, P947, DOI 10.1089/neu.2005.22.947; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Kuroiwa Toshihiko, 2007, Neurosurg Focus, V22, pE11, DOI 10.3171/foc.2007.22.5.12; Langlois J.A., 2004, TRAUMATIC BRAIN INJU, P1; LOFGREN J, 1973, ACTA NEUROL SCAND, V49, P557; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; MARMAROU A, 1975, J NEUROSURG, V43, P523, DOI 10.3171/jns.1975.43.5.0523; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; RYDER HW, 1953, J LAB CLIN MED, V41, P428; SALVADO O, 2004, IEEE ENG MED BIOL SO, P539; SKLAR FH, 1977, J NEUROSURG, V47, P670, DOI 10.3171/jns.1977.47.5.0670; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Sorenson SB, 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [10.1097/00001199-199106000-00003, DOI 10.1097/00001199-199106000-00003]; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; SZEWCZYKOWSKI J, 1977, J NEUROSURG, V47, P19, DOI 10.3171/jns.1977.47.1.0019; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Tofts P, 2003, QUANTITATIVE MRI OF THE BRAIN: MEASURING CHANGES CAUSED BY DISEASE, pXV; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; WHITFIELD A, 1989, BRIT J ANAESTH, V62, P694, DOI 10.1093/bja/62.6.694; Whiting M. D., 2006, ANIMAL MODELS COGNIT; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	56	17	17	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2010	27	7					1265	1274		10.1089/neu.2009.1267			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	631FD	WOS:000280331100011	20486804	Green Submitted			2022-02-06	
J	Goverover, Y; Chiaravalloti, N; DeLuca, J				Goverover, Yael; Chiaravalloti, Nancy; DeLuca, John			Pilot Study to Examine the Use of Self-Generation to Improve Learning and Memory in People With Traumatic Brain Injury	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						activities of daily living; brain injuries; executive function; learning; memory; retention (psychology)	MULTIPLE-SCLEROSIS; COGNITIVE OPERATIONS; SEMANTIC-MEMORY; ALZHEIMER-TYPE; DEMENTIA; WORDS; REHABILITATION	People with traumatic brain injury (TBI) experience memory and learning difficulties Difficulty in the initial acquisition of information is a primary reason people with TBI experience difficulties in learning and memory Treatment focusing on improving the acquisition of information will likely improve both recall and recognition performance In the "generation effect," items self-generated are remembered better than items read or otherwise provided The purpose of this study was to examine the application of the generation effect in improving memory for functional activities The study used a within-subiects design and included 10 participants with TBI and 15 healthy control participants Results demonstrated that material learned under the generated learning conditions was recalled better than when generated under provided learning conditions This finding was true in both the TBI and the control groups These results provide initial evidence supporting the use of self-generation to improve new learning of functional tasks for people with TBI	[Goverover, Yael] NYU, Dept Occupat Therapy, Steinhardt Sch Culture Educ & Human Dev, New York, NY 10012 USA; [Chiaravalloti, Nancy] Kessler Fdn Res Ctr, Neuropsychol & Neurosci Lab, W Orange, NJ USA; [Chiaravalloti, Nancy; DeLuca, John] Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA		Goverover, Y (corresponding author), NYU, Dept Occupat Therapy, Steinhardt Sch Culture Educ & Human Dev, 35 W 4th St,11th Floor, New York, NY 10012 USA.						Baldo JV, 2001, J INT NEUROPSYCH SOC, V7, P586, DOI 10.1017/S1355617701755063; Barrett AM, 2000, NEUROLOGY, V54, P1258, DOI 10.1212/WNL.54.6.1258; Basso MR, 2008, J CLIN EXP NEUROPSYC, V30, P63, DOI 10.1080/13803390601186957; Basso MR, 2006, J INT NEUROPSYCH SOC, V12, P640, DOI 10.1017/S1355617706060759; Beatty W W, 1990, J Geriatr Psychiatry Neurol, V3, P163, DOI 10.1177/089198879000300308; Chiaravalloti ND, 2002, ARCH PHYS MED REHAB, V83, P1070, DOI 10.1053/apmr.2002.33729; CRUTCHER RJ, 1989, J EXP PSYCHOL LEARN, V15, P669, DOI 10.1037/0278-7393.15.4.669; DELIS DC, 2000, DELISKAPLAN EXECUTIV; Delis DC, 1987, CALIFORNIA VERBAL LE; DELIS DC, 2001, DELISKAPLAN EXECUTIV; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; DICK MB, 1989, BRAIN COGNITION, V9, P88, DOI 10.1016/0278-2626(89)90046-8; FISHER AG, 2001, ASSESSMENT MOTOR PRO; GARDINER JM, 1984, MEM COGNITION, V12, P443, DOI 10.3758/BF03198305; Goverover Y, 2008, ARCH PHYS MED REHAB, V89, P1514, DOI 10.1016/j.apmr.2007.11.059; Hsieh S, 1999, PERCEPT MOTOR SKILL, V89, P355, DOI 10.2466/PMS.89.6.355-367; JOHNSON MK, 1981, AM J PSYCHOL, V94, P37, DOI 10.2307/1422342; Jurica PJ, 1999, MEM COGNITION, V27, P648, DOI 10.3758/BF03211558; Kinjo H, 2000, AM J PSYCHOL, V113, P95, DOI 10.2307/1423462; Lengenfelder J, 2007, REHABIL PSYCHOL, V52, P290, DOI 10.1037/0090-5550.52.3.290; MCELROY LA, 1982, J VERB LEARN VERB BE, V21, P249, DOI 10.1016/S0022-5371(82)90593-X; MITCHELL DB, 1986, J GERONTOL, V41, P79, DOI 10.1093/geronj/41.1.79; Mulligan NW, 2006, J EXP PSYCHOL LEARN, V32, P836, DOI 10.1037/0278-7393.32.4.836; Multhaup KS, 1997, NEUROPSYCHOLOGY, V11, P382, DOI 10.1037/0894-4105.11.3.382; O'Brien A, 2007, NEUROPSYCHOL REHABIL, V17, P273, DOI 10.1080/09602010600751160; Schefft BK, 2008, APPL NEUROPSYCHOL, V15, P61, DOI 10.1080/09084280801917806; SLAMECKA NJ, 1983, J VERB LEARN VERB BE, V22, P153, DOI 10.1016/S0022-5371(83)90112-3; SLAMECKA NJ, 1978, J EXP PSYCHOL-HUM L, V4, P592, DOI 10.1037/0278-7393.4.6.592; Smith A., 1982, SYMBOL DIGIT MODALIT; Smith ML, 1996, NEUROPSYCHOLOGIA, V34, P553, DOI 10.1016/0028-3932(95)00139-5; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Wechsler, 1997, WECHSLER ADULT INTEL; Wilkinson G. S, 1993, WRAT 3 WIDE RANGE AC; Wilson BA, 2002, NEUROPSYCHOL REHABIL, V12, P97, DOI 10.1080/09602010244000020	34	17	18	0	3	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490			AM J OCCUP THER	Am. J. Occup. Ther.	JUL-AUG	2010	64	4					540	546		10.5014/ajot.2010.09020			7	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	633NS	WOS:000280510400003	20825124				2022-02-06	
J	Nakajima, Y; Horiuchi, Y; Kamata, H; Yukawa, M; Kuwabara, M; Tsubokawa, T				Nakajima, Yuko; Horiuchi, Yutaka; Kamata, Hiroshi; Yukawa, Masayoshi; Kuwabara, Masato; Tsubokawa, Takashi			Distinct Time Courses of Secondary Brain Damage in the Hippocampus Following Brain Concussion and Contusion in Rats	TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE			English	Article						secondary brain damage; apoptosis; brain concussion; brain contusion; rat	CLOSED-HEAD-INJURY; APOPTOSIS; EXPRESSION; SEVERITY	Secondary brain damage (SBD) is caused by apoptosis after traumatic brain injury that is classified into concussion and contusion. Brain concussion is temporary unconsciousness or confusion caused by a blow on the head without pathological changes, and contusion is a brain injury with hemorrhage and broad extravasations. In this study, we investigated the time-dependent changes of apoptosis in hippocampus after brain concussion and contusion using rat models. We generated the concussion by dropping a plumb on the dura from a height of 3.5 cm and the contusion by cauterizing the cerebral cortex. SBD was evaluated in the hippocampus by histopathological analyses and measuring caspase-3 activity that induces apoptotic neuronal cell death. The frequency of abnormal neuronal cells with vacuolation or nuclear condensation, or those with DNA fragmentation was remarkably increased at 1 hr after concussion (about 30% for each abnormality) from the pre-injury level (0%) and reached the highest level (about 50% for each) by 48 hrs, whereas the frequency of abnormal neuronal cells was increased at 1 hr after contusion (about 10%) and reached the highest level (about 40%) by 48 hrs. In parallel, caspase-3 activity was increased sevenfold in the hippocampus at 1 hr after concussion and returned to the pre-injury level by 48 hrs, whereas after contusion, caspase-3 activity was continuously increased to the highest level at 48 hrs (fivefold). Thus, anti-apoptotic-cell-death treatment to prevent SBD must be performed by 1 hr after concussion and at latest by 48 hrs after contusion.	[Nakajima, Yuko; Horiuchi, Yutaka; Kamata, Hiroshi; Yukawa, Masayoshi; Kuwabara, Masato] Nihon Univ, Dept Vet Med, Coll Bioresonance Bioresource Sci, Kanagawa 2528510, Japan; [Tsubokawa, Takashi] Nihon Univ, Sch Med, Dept Neurosurg, Tokyo, Japan		Nakajima, Y (corresponding author), Nihon Univ, Dept Vet Med, Coll Bioresonance Bioresource Sci, 1866 Kameino, Kanagawa 2528510, Japan.	y09064823383@yahoo.co.jp					BASSETT SS, 1990, J PEDIATR PSYCHOL, V15, P225, DOI 10.1093/jpepsy/15.2.225; Cherian L, 1996, J NEUROTRAUM, V13, P371, DOI 10.1089/neu.1996.13.371; EARNSHAW WC, 1995, CURR OPIN CELL BIOL, V7, P337, DOI 10.1016/0955-0674(95)80088-3; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Hong Jun, 2002, Chin J Traumatol, V5, P36; Jiang XB, 2000, NEUROL MED-CHIR, V40, P16, DOI 10.2176/nmc.40.16; KAIJSER A, 1955, Nord Med, V54, P1308; Katoh H, 1997, BRAIN RES, V758, P153, DOI 10.1016/S0006-8993(97)00213-8; KUWABARA M, 2002, NEUROTRAUMA RES, V14, P41; Liu DY, 2004, J BIOL CHEM, V279, P48434, DOI 10.1074/jbc.M407190200; Luo Chun, 2002, Chin J Traumatol, V5, P24; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; Nag S, 2005, LAB INVEST, V85, P1189, DOI 10.1038/labinvest.3700325; NAKAJIMA Y, 2004, NEUROTRAUMA RES, V16, P60; RINK A, 1995, AM J PATHOL, V147, P1575; Schuhmann MU, 2003, J NEUROTRAUM, V20, P725, DOI 10.1089/089771503767869962; SERGIENKO TM, 1990, ZH VOPR NEIROKHIR, V4, P6; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; UCHIDA H, 2008, J JPN SOC INTENSIVE, V15, P21; Vitarbo EA, 2004, NEUROSURGERY, V55, P416, DOI 10.1227/01.NEU.0000130036.52521.2C; WILBERGER JE, 1987, NEUROSURGERY, V20, P571, DOI 10.1227/00006123-198704000-00011; Wolf BB, 1999, J BIOL CHEM, V274, P30651, DOI 10.1074/jbc.274.43.30651; YNAG SY, 2004, CHIN J TRAUMATOL, V7, P159	23	17	17	1	4	TOHOKU UNIV MEDICAL PRESS	SENDAI	2-1, SEIRYO-MACHI, AOBA-KU, SENDAI, MIYAGI 980-8575, JAPAN	0040-8727	1349-3329		TOHOKU J EXP MED	Tohoku J. Exp. Med.	JUL	2010	221	3					229	235		10.1620/tjem.221.229			7	Medicine, General & Internal; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Research & Experimental Medicine	621ZC	WOS:000279624600009	20562525				2022-02-06	
J	Christensen, HM; Dikranian, K; Li, AM; Baysac, KC; Walls, KC; Olney, JW; Roth, KA; Harris, DA				Christensen, Heather M.; Dikranian, Krikor; Li, Aimin; Baysac, Kathleen C.; Walls, Ken C.; Olney, John W.; Roth, Kevin A.; Harris, David A.			A Highly Toxic Cellular Prion Protein Induces a Novel, Nonapoptotic Form of Neuronal Death	AMERICAN JOURNAL OF PATHOLOGY			English	Article							DEFICIENT PURKINJE-CELLS; DOPPEL-INDUCED APOPTOSIS; TRAUMATIC BRAIN-INJURY; TRANSGENIC MICE; IN-VIVO; POLY(ADP-RIBOSE) POLYMERASE-1; CEREBELLAR DEGENERATION; CASPASE-3 ACTIVATION; TRUNCATED PRION; RAT-BRAIN	Several different deletions within the N-terminal tail of the prion protein (PrP) induce massive neuronal death when expressed in transgenic mice. This toxicity is dose-dependently suppressed by coexpression of full-length PrP, suggesting that it results from subversion of a normal physiological activity of cellular PrP. We performed a combined biochemical and morphological analysis of Tg(Delta CR) mice, which express PrP carrying a 21-aa deletion (residues 105-125) within a highly conserved region of the protein. Death of cerebellar granule neurons in Tg(Delta CR) mice is not accompanied by activation of either caspase-3 or caspase-8 or by increased levels of the autophagy marker, LC3-II. In electron micrographs, degenerating granule neurons displayed a unique morphology characterized by heterogeneous condensation of the nuclear matrix without formation of discrete chromatin masses typical of neuronal apoptosis. Our data demonstrate that perturbations in PrP functional activity induce a novel, nonapoptotic, nonautophagic form of neuronal death whose morphological features are reminiscent of those associated with excitotoxic stress. (Am J Pathol 2010, 176:2695-2706; DOI: 10.2353/ajpath.2010.091007)	[Christensen, Heather M.; Li, Aimin; Baysac, Kathleen C.; Harris, David A.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Dikranian, Krikor] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Olney, John W.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Walls, Ken C.; Roth, Kevin A.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA		Harris, DA (corresponding author), Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,K225, Boston, MA 02118 USA.	daharris@bu.edu	Christensen, Helen/F-5053-2012	Christensen, Helen/0000-0003-0435-2065; Harris, David/0000-0002-6985-5790; Lamb, Heather/0000-0002-8060-0633; Roth, Kevin/0000-0002-0643-995X	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD 37100, NS035107, N5057098, NS052526, NS040975, NS04691003]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R37HD037100, R01HD037100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS052526, R01NS040975, P30NS057098, R01NS035107, R01NS065244] Funding Source: NIH RePORTER	Supported by grants from the National Institutes of Health (HD 37100, to J.W.O.; NS035107 and N5057098, to K.A.R.; and NS052526 and NS040975, to D.A.H.). H.M.C. was supported by a predoctoral fellowship (NS04691003) from the National Institutes of Health.	Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Bredesen DE, 2006, NATURE, V443, P796, DOI 10.1038/nature05293; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; CAMPAGNE MV, 1995, EUR J NEUROSCI, V7, P1627; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Chiesa R, 1998, NEURON, V21, P1339, DOI 10.1016/S0896-6273(00)80653-4; Christensen HM, 2009, J NEUROCHEM, V108, P44, DOI 10.1111/j.1471-4159.2008.05719.x; Coulpier M, 2006, NEUROBIOL DIS, V23, P603, DOI 10.1016/j.nbd.2006.05.013; Curtin JF, 2003, CELL SIGNAL, V15, P983, DOI 10.1016/S0898-6568(03)00093-7; Dikranian K, 2008, EXP NEUROL, V211, P551, DOI 10.1016/j.expneurol.2008.03.012; Dikranian K, 2005, DEV BRAIN RES, V155, P1, DOI 10.1016/j.devbrainres.2004.11.005; Dikranian K, 2001, NEUROBIOL DIS, V8, P359, DOI 10.1006/nbdi.2001.0411; Dong JX, 2007, AM J PATHOL, V171, P599, DOI 10.2353/ajpath.2007.070262; Gill R, 2002, J CEREBR BLOOD F MET, V22, P420, DOI 10.1097/00004647-200204000-00006; Heitz S, 2008, DEV NEUROBIOL, V68, P332, DOI 10.1002/dneu.20555; Heitz S, 2007, DEV NEUROBIOL, V67, P670, DOI 10.1002/dneu.20366; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Ishimaru MJ, 1999, J COMP NEUROL, V408, P461; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Khosravani H, 2008, J CELL BIOL, V181, P551, DOI 10.1083/jcb.200711002; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Li AM, 2007, J NEUROSCI, V27, P852, DOI 10.1523/JNEUROSCI.4244-06.2007; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; MIALE IL, 1961, EXP NEUROL, V4, P277, DOI 10.1016/0014-4886(61)90055-3; Moore RC, 2001, P NATL ACAD SCI USA, V98, P15288, DOI 10.1073/pnas.251550798; Nicolas O, 2007, FASEB J, V21, P3107, DOI 10.1096/fj.06-7827com; Polster BM, 2004, J NEUROCHEM, V90, P1281, DOI 10.1111/j.1471-4159.2004.02572.x; Prusiner S. B., 2004, Prion biology and diseases; Radovanovic I, 2005, J NEUROSCI, V25, P4879, DOI 10.1523/JNEUROSCI.0328-05.2005; Rambold AS, 2008, EMBO J, V27, P1974, DOI 10.1038/emboj.2008.122; Ribe EM, 2008, BIOCHEM J, V415, P165, DOI 10.1042/BJ20081118; Rodriguez-Paez AC, 2005, ACTA NEUROPATHOL, V109, P603, DOI 10.1007/s00401-005-1010-z; Rossi D, 2001, EMBO J, V20, P694, DOI 10.1093/emboj/20.4.694; Roucou X, 2005, J MOL MED, V83, P3, DOI 10.1007/s00109-004-0605-5; Selimi F, 2000, J NEUROSCI, V20, P5339, DOI 10.1523/JNEUROSCI.20-14-05339.2000; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Slagsvold HH, 2003, BRAIN RES, V984, P111, DOI 10.1016/S0006-8993(03)03119-6; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; Steele AD, 2007, J NEUROSCI, V27, P13022, DOI 10.1523/JNEUROSCI.3290-07.2007; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; Trevitt CR, 2006, BRAIN, V129, P2241, DOI 10.1093/brain/awl150; Uo T, 2005, J BIOL CHEM, V280, P9065, DOI 10.1074/jbc.M413030200; Van Cruchten S, 2002, ANAT HISTOL EMBRYOL, V31, P214, DOI 10.1046/j.1439-0264.2002.00398.x; West T, 2006, NEUROBIOL DIS, V22, P523, DOI 10.1016/j.nbd.2005.12.017; Young C, 2005, NEUROBIOL DIS, V20, P608, DOI 10.1016/j.nbd.2005.04.014; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Yu SW, 2003, NEUROBIOL DIS, V14, P303, DOI 10.1016/j.nbd.2003.08.008; Zhu C, 2005, CELL DEATH DIFFER, V12, P162, DOI 10.1038/sj.cdd.4401545	52	17	17	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	JUN	2010	176	6					2695	2706		10.2353/ajpath.2010.091007			12	Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Pathology	609WU	WOS:000278689700013	20472884	Green Published, Bronze			2022-02-06	
J	Dai, SS; Li, W; An, JH; Wang, H; Yang, N; Chen, XY; Zhao, Y; Li, P; Liu, P; Chen, JF; Zhou, YG				Dai, Shuang-Shuang; Li, Wei; An, Jian-Hong; Wang, Hao; Yang, Nan; Chen, Xing-Yun; Zhao, Yan; Li, Ping; Liu, Ping; Chen, Jiang-Fan; Zhou, Yuan-Guo			Adenosine A2A receptors in both bone marrow cells and non-bone marrow cells contribute to traumatic brain injury	JOURNAL OF NEUROCHEMISTRY			English	Article						adenosine A2A receptor; bone marrow-derived cell; glutamate; knockout; neuroinflammation; traumatic brain injury	ISCHEMIA-REPERFUSION INJURY; EXCITATORY AMINO-ACIDS; A(2A) RECEPTOR; GLUTAMATE RELEASE; INDUCED EXCITOTOXICITY; CEREBRAL-ISCHEMIA; P38 MAPK; IN-VIVO; ACTIVATION; PROTECTION	P>Adenosine A2A receptors (A(2A)Rs) in bone marrow-derived cells (BMDCs) are involved in regulation of inflammation and outcome in several CNS injuries; however their relative contribution to traumatic brain injury (TBI) is unknown. In this study, we created a mouse cortical impact model, and BMDC A(2A)Rs were selectively inactivated in wild-type (WT) mice or reconstituted in global A(2A)R knockout (KO) mice (i.e. inactivation of non-BMDC A(2A)Rs) by bone marrow transplantation. When compared with WT mice, selective inactivation of BMDC A(2A)Rs significantly attenuated the neurological deficits, brain water content and cell apoptosis at 24 h post-TBI as global A(2A)R KO did. However, compared with the A(2A)R KO mice, selective reconstitution of BMDC A(2A)Rs failed to reinstate brain injury, indicating the contribution of the non-BMDC A(2A)R to TBI. Furthermore, the protective outcome by selective inactivation of BMDC A(2A)R or broad inactivation of non-BMDC A(2A)Rs was accompanied with reduced CSF glutamate level and suppression of the inflammatory cytokines interleukin-1, or interleukin-1 and tumor necrosis factor-alpha. These findings demonstrate that inactivation of A(2A)Rs in either BMDCs or non-BMDCs is sufficient to confer the protective effect as global A(2A)R KO against TBI, indicating the A(2A)R involvement in TBI by multiple cellular mechanisms of A(2A)R involvement including inhibition of glutamate release and inflammatory cytokine expressions.	[Chen, Jiang-Fan] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Dai, Shuang-Shuang; Li, Wei; An, Jian-Hong; Wang, Hao; Yang, Nan; Chen, Xing-Yun; Zhao, Yan; Li, Ping; Liu, Ping; Zhou, Yuan-Guo] Third Mil Med Univ, Inst Surg Res, State Key Lab Trauma Burn & Combined Injury, Ctr Mol Biol, Chongqing, Peoples R China; [Dai, Shuang-Shuang; Li, Wei; An, Jian-Hong; Wang, Hao; Yang, Nan; Chen, Xing-Yun; Zhao, Yan; Li, Ping; Liu, Ping; Zhou, Yuan-Guo] Third Mil Med Univ, Daping Hosp, Chongqing, Peoples R China; [Dai, Shuang-Shuang] Third Mil Med Univ, Dept Biochem & Mol Biol, Chongqing, Peoples R China; [Li, Wei] Third Mil Med Univ, Inst Surg Res, Dept Neurol, Chongqing, Peoples R China		Chen, JF (corresponding author), Boston Univ, Sch Med, Dept Neurol, 715 Albany St,C329, Boston, MA 02118 USA.	chenjf@bu.eduYuan-Guo; ygzhou@cta.cq.cn	Li, ping/J-6507-2019	Chen, Xingyun/0000-0001-7699-4425	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30328015, 30900587]	We gratefully acknowledge the technical and equipment support provided by Drs Minghui Xu and Guansong Wang. We thank Dr Xing Lei for irradiation and Mr Chun Hu for handling of the animals. This work was supported by grants from the National Natural Science Foundation of China (No 30328015 and No. 30900587).	An Jian-Hong, 2007, Zhonghua Xue Ye Xue Za Zhi, V28, P174; Blum D, 2003, J NEUROSCI, V23, P5361; BROWN J, 1996, GLUTAMATE CYTOKINE R, P3968; Carlton JT., 1999, BIOL INVASIONS, V1, P1, DOI 10.1023/A:1010026510194; Cassada DC, 2002, ANN THORAC SURG, V74, P846, DOI 10.1016/S0003-4975(02)03793-1; Cassinis G, 2002, MEMOIRE ASS GEOLOGUE, V2, P53; Chaparro-Huerta V, 2005, J NEUROIMMUNOL, V165, P53, DOI 10.1016/j.jneuroim.2005.04.025; Chen JF, 1999, J NEUROSCI, V19, P9192, DOI 10.1523/jneurosci.19-21-09192.1999; Chen JF, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-10-j0001.2001; Chen JF, 2007, PROG NEUROBIOL, V83, P310, DOI 10.1016/j.pneurobio.2007.09.002; Corsi C, 1999, NEUROREPORT, V10, P687, DOI 10.1097/00001756-199903170-00005; Corsi C, 2000, NEUROREPORT, V11, P2591, DOI 10.1097/00001756-200008030-00048; Dai Shuangshuang, 2008, Sheng Wu Gong Cheng Xue Bao, V24, P700; Day YJ, 2004, AM J PHYSIOL-GASTR L, V286, pG285, DOI 10.1152/ajpgi.00348.2003; Day YJ, 2005, J IMMUNOL, V174, P5040, DOI 10.4049/jimmunol.174.8.5040; Day YJ, 2005, AM J PHYSIOL-RENAL, V288, pF722, DOI 10.1152/ajprenal.00378.2004; Day YJ, 2003, J CLIN INVEST, V112, P883, DOI 10.1172/JCI200315483; de Mendonca A, 2000, BRAIN RES REV, V33, P258, DOI 10.1016/S0165-0173(00)00033-3; Dionisotti S, 1996, J PHARMACOL EXP THER, V278, P1209; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fenster MS, 2000, MICROCIRCULATION, V7, P129, DOI 10.1038/sj.mn.7300101; Fink JS, 2004, J NEUROCHEM, V88, P538, DOI 10.1046/j.1471-4159.2003.02145.x; Fredholm BB, 2003, CURR TOP MED CHEM, V3, P413, DOI 10.2174/1568026033392200; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Hasko G, 2006, CRIT CARE MED, V34, P1119, DOI 10.1097/01.CCM.0000206467.19509.C6; Hasko G, 2008, J LEUKOCYTE BIOL, V83, P447, DOI 10.1189/jlb.0607359; Higashi H, 2002, J NEUROSURG, V96, P117, DOI 10.3171/jns.2002.96.1.0117; Huang QY, 2006, J NEUROSCI, V26, P11371, DOI 10.1523/JNEUROSCI.1907-06.2006; Huang S, 1997, BLOOD, V90, P1600, DOI 10.1182/blood.V90.4.1600.1600_1600_1610; Jones PA, 1998, BRAIN RES, V800, P328, DOI 10.1016/S0006-8993(98)00540-X; Jones PA, 1998, NEUROSCIENCE, V85, P229, DOI 10.1016/S0306-4522(97)00613-1; Koshiba M, 1999, FASEB J, V13, pA944; Lappas CM, 2005, J IMMUNOL, V174, P1073, DOI 10.4049/jimmunol.174.2.1073; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Li W, 2008, NEUROSCIENCE, V151, P1198, DOI 10.1016/j.neuroscience.2007.11.020; Li W, 2009, EXP NEUROL, V215, P69, DOI 10.1016/j.expneurol.2008.09.012; Li Y, 2006, NEUROSCIENCE, V141, P2029, DOI 10.1016/j.neuroscience.2006.05.014; Link AA, 2000, J IMMUNOL, V164, P436, DOI 10.4049/jimmunol.164.1.436; Liu HT, 2006, GLIA, V54, P343, DOI 10.1002/glia.20400; LOHSE MJ, 1987, N-S ARCH PHARMACOL, V335, P555; Marcoli M, 2003, NEUROPHARMACOLOGY, V45, P201, DOI 10.1016/S0028-3908(03)00156-4; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; Mayne M, 2001, ANN NEUROL, V49, P727, DOI 10.1002/ana.1010; Melani A, 2006, BRAIN RES, V1073, P470, DOI 10.1016/j.brainres.2005.12.010; Monopoli A, 1998, NEUROREPORT, V9, P3955, DOI 10.1097/00001756-199812010-00034; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; OKIYAMA K, 1995, J NEUROCHEM, V64, P802; Okusa MD, 1999, AM J PHYSIOL-RENAL, V277, pF404, DOI 10.1152/ajprenal.1999.277.3.F404; OREGAN MH, 1992, NEUROSCI LETT, V138, P169, DOI 10.1016/0304-3940(92)90498-V; PALMER AM, 1994, NEUROREPORT, V6, P153, DOI 10.1097/00001756-199412300-00039; PANTER SS, 1992, NEUROSCI LETT, V136, P165, DOI 10.1016/0304-3940(92)90040-E; Pedata F, 2005, NEUROL RES, V27, P169, DOI 10.1179/016164105X21913; Pedata F, 2001, ANN NY ACAD SCI, V939, P74; Phillis JW, 1995, BRAIN RES, V705, P79, DOI 10.1016/0006-8993(95)01153-6; Popoli P, 2002, J NEUROSCI, V22, P1967, DOI 10.1523/JNEUROSCI.22-05-01967.2002; Popoli P, 1995, EUR J PHARMACOL, V287, P215, DOI 10.1016/0014-2999(95)00679-6; Reinert M, 2000, Neurosurg Focus, V8, pe10; SIMPSON RE, 1992, J NEUROCHEM, V58, P1683, DOI 10.1111/j.1471-4159.1992.tb10041.x; Sullivan GW, 1999, J INFECT DIS, V180, P1550, DOI 10.1086/315084; Takeuchi H, 2006, J BIOL CHEM, V281, P21362, DOI 10.1074/jbc.M600504200; Thiel M, 2005, PLOS BIOL, V3, P1088, DOI 10.1371/journal.pbio.0030174; Varani K, 1998, BRIT J PHARMACOL, V123, P1723, DOI 10.1038/sj.bjp.0701758; Walker BAM, 1997, J IMMUNOL, V158, P2926; Yu LQ, 2004, NAT MED, V10, P1081, DOI 10.1038/nm1103	66	17	18	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	JUN	2010	113	6					1536	1544		10.1111/j.1471-4159.2010.06716.x			9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	604WT	WOS:000278309900016	20367749	Bronze			2022-02-06	
J	Dash, PK; Redell, JB; Hergenroeder, G; Zhao, J; Clifton, GL; Moore, A				Dash, Pramod K.; Redell, John B.; Hergenroeder, Georgene; Zhao, Jing; Clifton, Guy L.; Moore, Anthony			Serum Ceruloplasmin and Copper Are Early Biomarkers for Traumatic Brain Injury-Associated Elevated Intracranial Pressure	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						brain swelling; biomarker; iron oxidase; plasma; brain trauma	DISEASE; IDENTIFICATION; MECHANISMS; EXPRESSION; DIAGNOSIS; DAMAGE; COMA	High intracranial pressure (ICP) is a prominent secondary pathology after traumatic brain injury (TBI) and is a major contributor to morbidity and mortality. Currently, there are no clinically proven methods for predicting which TBI patients will develop high ICP In the present study, we examined whether the serum levels of the copper-binding protein ceruloplasmin are differentially altered in patients with elevated ICP (>= 25 mmHg) vs. those whose ICP remained below 20 mmHg throughout the study period. Consistent with its role as an acute-phase reactant, we found that ceruloplasnnin levels were significantly increased by 3 days post-TBI compared with healthy volunteers. However, prior to this delayed increase, ceruloplasmin levels during the first 24 hr following injury were found to be significantly reduced in patients who subsequently developed high ICP This decrease was found to have prognostic accuracy in delineating TBI patients based on their ICP status (cutoff of 140 mu g/ml; sensitivity: 87%, specificity: 73%), Likewise, low total serum copper (below 1.32 mu g/ml) was also found to be predictive of high ICP (sensitivity 86%, specificity 73%). These results suggest that initial serum ceruloplasmin/copper levels may have diagnostic value in predicting patients at risk for developing high intracranial pressure. (C) 2010 Wiley-Liss, Inc.	[Dash, Pramod K.; Redell, John B.; Zhao, Jing; Moore, Anthony] Univ Texas Houston, Sch Med, Dept Neurobiol & Anat, Houston, TX 77225 USA; [Hergenroeder, Georgene; Clifton, Guy L.] Univ Texas Houston, Sch Med, Vivian L Smith Ctr Neurol Res, Houston, TX 77225 USA; [Hergenroeder, Georgene; Clifton, Guy L.] Univ Texas Houston, Sch Med, Dept Neurosurg, Houston, TX 77225 USA		Dash, PK (corresponding author), Univ Texas Houston, Sch Med, Dept Neurobiol & Anat, POB 20708, Houston, TX 77225 USA.	p.dash@uth.tmc.edu		Hergenroeder, Georgene/0000-0002-6170-2191; Dash, Pramod/0000-0001-6746-1002	Mission Connect/TIRR Foundation	Contract grant sponsor: Mission Connect/TIRR Foundation.	ABE A, 1989, CLIN CHEM, V35, P552; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Bullock R, 1995, New Horiz, V3, P448; CHAN PH, 1995, J NEUROTRAUM, V12, P815, DOI 10.1089/neu.1995.12.815; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; Choi SY, 2000, BIOCHIMIE, V82, P175, DOI 10.1016/S0300-9084(00)00380-1; Das SK, 2006, NAT CLIN PRACT NEURO, V2, P482, DOI 10.1038/ncpneuro0291; GITLIN D, 1960, NATURE, V185, P693, DOI 10.1038/185693a0; GOLDSTEIN IM, 1982, ANN NY ACAD SCI, V389, P368, DOI 10.1111/j.1749-6632.1982.tb22150.x; Hellman NE, 2002, ANNU REV NUTR, V22, P439, DOI 10.1146/annurev.nutr.22.012502.114457; Hergenroeder G, 2008, J NEUROTRAUM, V25, P79, DOI 10.1089/neu.2007.0386; Hlatky Roman, 2003, Neurosurg Focus, V14, pe2; Hoffman Richard M, 2002, BMC Fam Pract, V3, P19, DOI 10.1186/1471-2296-3-19; Incerti J, 2005, NEPHROL DIAL TRANSPL, V20, P2402, DOI 10.1093/ndt/gfi074; Kang JH, 2001, BBA-GEN SUBJECTS, V1568, P30, DOI 10.1016/S0304-4165(01)00198-2; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kuhlow CJ, 2003, GLIA, V44, P76, DOI 10.1002/glia.10273; MARMONT AM, 1992, BONE MARROW TRANSPL, V9, P1; Marrero JA, 2009, GASTROENTEROLOGY, V137, P110, DOI 10.1053/j.gastro.2009.04.005; Medeiros LR, 2009, EUR J OBSTET GYN R B, V142, P99, DOI 10.1016/j.ejogrb.2008.08.011; MENKES JH, 1988, BRAIN DEV-JPN, V10, P77, DOI 10.1016/S0387-7604(88)80074-3; Nusier MK, 2006, J HEALTH SCI, V52, P180, DOI 10.1248/jhs.52.180; OCONNOR TP, 1993, J CELL BIOL, V123, P935, DOI 10.1083/jcb.123.4.935; Oertel M, 2002, J NEUROSURG, V97, P1045, DOI 10.3171/jns.2002.97.5.1045; Petzold A, 2002, CRIT CARE MED, V30, P2705, DOI 10.1097/00003246-200212000-00015; Povlishock J T, 2000, Clin Neurosurg, V46, P113; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; REBHUN J, 1991, ANN ALLERGY, V66, P335; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; Shore PM, 2007, J NEUROTRAUM, V24, P75, DOI 10.1089/neu.2006.0062; TEASDALE G, 1974, LANCET, V2, P81; Tomas E, 1986, Virologie, V37, P279; Vassiliev V, 2005, BRAIN RES REV, V49, P633, DOI 10.1016/j.brainresrev.2005.03.003; Wang KKW, 2005, EXPERT REV PROTEOMIC, V2, P603, DOI 10.1586/14789450.2.4.603; Wang XY, 2006, SEMIN FETAL NEONAT M, V11, P343, DOI 10.1016/j.siny.2006.04.002; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; Xu XY, 2004, ANN NY ACAD SCI, V1012, P299, DOI 10.1196/annals.1306.024; YOUNG AB, 1988, J NEUROSURG, V69, P375, DOI 10.3171/jns.1988.69.3.0375; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7; Zhao J, 2007, J NEUROSCI, V27, P10240, DOI 10.1523/JNEUROSCI.1683-07.2007; ZWEIG MH, 1993, CLIN CHEM, V39, P561	43	17	17	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JUN	2010	88	8					1719	1726		10.1002/jnr.22336			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	590RQ	WOS:000277245500010	20091772				2022-02-06	
J	Harbrecht, BG; Smith, JW; Franklin, GA; Miller, FB; Richardson, JD				Harbrecht, Brian G.; Smith, Jason W.; Franklin, Glen A.; Miller, Frank B.; Richardson, J. David			Decreasing Regional Neurosurgical Workforce-A Blueprint for Disaster	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	68th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma (AAST)	OCT 01-03, 2009	Pittsburgh, PA	Amer Assoc Surg Trauma (AAST)		Head injury; Workforce; Trauma systems; Traumatic brain injury	ACUTE-CARE SURGERY; OPERATIVE MORTALITY; HOSPITAL VOLUME; TRAUMA CENTERS; BRAIN-INJURIES; CRANIOTOMY; EXPERIENCE; SYSTEM; TRENDS; IMPACT	Background: Traumatic brain injuries are a frequent cause of death and a substantial source of morbidity. Neurosurgeons ( NS) are commonly involved in the management of patients with moderate and severe traumatic brain injuries to minimize morbidity from both primary and secondary brain injuries. However, NS willing to care for injured patients have become increasingly scarce. Although many institutions have been individually affected by shortages of NS providing care to injured patients, data on regional changes in NS availability and the effect on patient care are limited. Methods: We queried a state discharge database for all traumatic intracranial hemorrhages ( ICH) and skull fractures from 2004 to 2007 by International Classification of Diseases - 9th Rev. - Clinical Modification codes. Institutions were categorized as those that admitted >30 or <30 ICH patients per year. The state medical society provided the number of NS practicing in the state per year. Results: The total number of patients with significant head injuries increased over the study period. The number of NS decreased over the same time period. A greater proportion of patients were managed in centers admitting >30 ICH per year, and the number of facilities admitting <30 ICH per year decreased. Conclusion: In this state, increasing numbers of patients with ICH are being concentrated in a small number of centers, while the number of NS available to care for them has decreased. Shortages in neurosurgical workforce for patients with traumatic ICH have the potential for catastrophic consequences on a regional basis if effective solutions to this manpower issue are not created.	[Harbrecht, Brian G.; Smith, Jason W.; Franklin, Glen A.; Miller, Frank B.; Richardson, J. David] Univ Louisville, Dept Surg, Louisville, KY 40292 USA		Harbrecht, BG (corresponding author), Univ Louisville, Dept Surg, 550 S Jackson St, Louisville, KY 40292 USA.	briang.harbrecht@louisville.edu					*AM COLL SURG COMM, 2006, RES OPT CAR INJ PAT; Barker DE, 2006, AM SURGEON, V72, P1166; Barker FG, 2004, NEUROSURGERY, V55, P506, DOI 10.1227/01.NEU.0000134284.47965.71; Begg CB, 1998, JAMA-J AM MED ASSOC, V280, P1747, DOI 10.1001/jama.280.20.1747; Branas CC, 2005, JAMA-J AM MED ASSOC, V293, P2626, DOI 10.1001/jama.293.21.2626; Ciesla DJ, 2006, AM J SURG, V192, P732, DOI 10.1016/j.amjsurg.2006.08.035; Cohn SM, 2007, J TRAUMA, V62, P951, DOI 10.1097/01.ta.0000260131.79063.50; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; DuBose JJ, 2008, ARCH SURG-CHICAGO, V143, P1213, DOI 10.1001/archsurg.143.12.1213; Earley AS, 2006, ANN SURG, V244, P498, DOI 10.1097/01.sla.0000237756.86181.50; Esposito TJ, 2000, J TRAUMA, V49, P686; Esposito TJ, 2005, ANN SURG, V242, P364, DOI 10.1097/01.sla.0000179624.50455.db; Glance LG, 2004, J TRAUMA, V56, P682, DOI 10.1097/01.TA.0000053469.92142.40; Harbrecht BG, 2009, AM SURGEON, V75, P725; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Ho V, 2003, ANN SURG, V237, P509, DOI 10.1097/00000658-200304000-00012; Ho V, 2007, HEALTH ECON POLICY L, V2, P51, DOI 10.1017/S1744133106006256; Ho V, 2006, ANN SURG ONCOL, V13, P851, DOI 10.1245/ASO.2006.07.021; Hunt JP, 2000, J TRAUMA, V49, P679, DOI 10.1097/00005373-200010000-00016; Huynh T, 2006, AM SURGEON, V72, P1162; Institute of Medicine, 2006, HOSP BAS EM CAR BREA; Lucas CE, 1997, J TRAUMA, V42, P818, DOI 10.1097/00005373-199705000-00011; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Moore EE, 2006, J AM COLL SURGEONS, V202, P698, DOI 10.1016/j.jamcollsurg.2005.12.007; Moore EE, 1998, J TRAUMA, V44, P271; Nathens AB, 2001, JAMA-J AM MED ASSOC, V285, P1164, DOI 10.1001/jama.285.9.1164; Pasquale MD, 2001, J TRAUMA, V50, P465, DOI 10.1097/00005373-200103000-00010; Pitts LH, 1998, J TRAUMA, V44, P989; Richardson JD, 1998, J TRAUMA, V44, P266, DOI 10.1097/00005373-199802000-00004; Rinker CF, 1998, J TRAUMA, V44, P984, DOI 10.1097/00005373-199806000-00009; Sander AM, 2001, J HEAD TRAUMA REHAB, V16, P356, DOI 10.1097/00001199-200108000-00006; SHACKFORD SR, 1986, J TRAUMA, V26, P812, DOI 10.1097/00005373-198609000-00006; Tepas JJ, 1998, J TRAUMA, V44, P827, DOI 10.1097/00005373-199805000-00014; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Valadka AB, 2001, NEUROSURGERY, V48, P17, DOI 10.1097/00006123-200101000-00004	36	17	17	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUN	2010	68	6					1367	1372		10.1097/TA.0b013e3181d990da			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	610ES	WOS:000278714600020	20539182				2022-02-06	
J	Macleod, AD				Macleod, A. D. (Sandy)			Post concussion syndrome: The attraction of the psychological by the organic	MEDICAL HYPOTHESES			English	Article							TRAUMATIC BRAIN-INJURY; SYMPTOMS; PHYSIOGENESIS; PSYCHOGENESIS; SEQUELAE	Post concussion symptoms following mild traumatic brain injury are a difficult clinical state to conceptualise. The constellation of symptoms include those with an organic signature (and presumed organic aetiology), and those with overt psychological features. A seemingly trivial head injury may result in enduring symptoms. The validity of post concussion syndrome (PCS) has been the focus of much medico-legal debate, as has its cause. Whether PCS is 'neurogenic' or 'psychogenic' in aetiology remains contestable. Babinski, in 1918, hypothesised that an organic factor initiated the symptoms of the disorder now known as PCS, and that this acted as a 'bait', or attractor, for pre-existing and post-injury psychological influences. This hypothesis, which has been neither proven nor disproven over the subsequent nearly one hundred years, deserves reconsideration for it is an appealing model of PCS. (C) 2010 Elsevier Ltd. All rights reserved.	Burwood Hosp, Brain Injury Rehabil Serv, Christchurch 8140, New Zealand		Macleod, AD (corresponding author), Burwood Hosp, Brain Injury Rehabil Serv, Mairehau Rd, Christchurch 8140, New Zealand.	ad.macleod@cdhb.govt.nz					Allilaire JF, 2007, B ACAD NAT MED PARIS, V191, P1329, DOI 10.1016/S0001-4079(19)32953-X; Anderson T, 2006, PRACTICAL NEUROLOGY, V6, P342, DOI DOI 10.1136/JNNP.2006.106583; Babinski J, 1918, HYSTERIA PITHIATISM; Dewhurst K., 1982, H JACKSON PSYCHIAT; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; GOETZ CG, 1995, CHARCOT CONSTRUCTING, P200; INGEBRIGSTEN T, 1998, ASPECTS MANAGEMENT M; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; JACOBSON RR, 1995, J PSYCHOSOM RES, V39, P675, DOI 10.1016/0022-3999(95)00006-5; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; LEVIN M, 1965, JAMA-J AM MED ASSOC, V191, P119; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Micale M., 2001, TRAUMATIC PASTS HIST, P115; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Nicholl J, 2009, SEMIN NEUROL, V29, P247, DOI 10.1055/s-0029-1223878; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; Simon GE, 1999, NEW ENGL J MED, V341, P1329, DOI 10.1056/NEJM199910283411801; Smith L. B., 2006, BIOL THEORY, V1, P87; Thelen E., 1994, DYNAMIC SYSTEMS APPR; Wessely S, 2003, BRIT J PSYCHIAT, V183, P314, DOI 10.1192/bjp.183.4.314; York GK, 2002, J ROY SOC MED, V95, P314, DOI 10.1258/jrsm.95.6.314	22	17	17	0	3	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877			MED HYPOTHESES	Med. Hypotheses	JUN	2010	74	6					1033	1035		10.1016/j.mehy.2010.01.002			3	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine	598UI	WOS:000277863900019	20129739				2022-02-06	
J	Wilde, EA; McCauley, SR; Kelly, TM; Levin, HS; Pedroza, C; Clifton, GL; Robertson, CS; Moretti, P				Wilde, Elisabeth A.; McCauley, Stephen R.; Kelly, Tara M.; Levin, Harvey S.; Pedroza, Claudia; Clifton, Guy L.; Robertson, Claudia S.; Moretti, Paolo			Feasibility of the Neurological Outcome Scale for Traumatic Brain Injury (NOS-TBI) in Adults	JOURNAL OF NEUROTRAUMA			English	Article						neurological functioning; Neurological Outcome Scale for Traumatic Brain Injury; outcome; traumatic brain injury	NIH STROKE SCALE; SEVERE HEAD-INJURY; ACUTE REHABILITATION; RELIABILITY; PREDICTORS; DISABILITY; SAMPLE	This article describes the design and initial implementation of the Neurological Outcome Scale for Traumatic Brain Injury (NOS-TBI) as an adaptation of the National Institutes of Health Stroke Scale (NIHSS), specifically for clinical and research use in patients with TBI, including (1) the addition of items specific to TBI, (2) adjustment to the scoring algorithm to allow quantification of deficits in patients who are comatose/vegetative or agitated, and (3) the reassignment of items (i.e., limb ataxia) that are problematic in TBI as supplemental items. The feasibility of using the NOS-TBI is discussed and limitations of the scale are highlighted. This scale offers (1) a cost-effective, brief, practicable, standardized, and quantifiable method of communicating and analyzing neurological deficits in a way that traditional neurological assessment alone cannot currently provide, and (2) a measure that non-physicians can administer. The NOS-TBI may serve a role in clinical practice in patients with TBI similar to the way the NIHSS has functioned for patients following stroke, by serving as a tool for initial stratification of injury severity, and as an outcome measure in clinical trials.	[Wilde, Elisabeth A.] Baylor Coll Med, Cognit Neurosci Lab, Houston, TX 77030 USA; [McCauley, Stephen R.; Moretti, Paolo] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [McCauley, Stephen R.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [McCauley, Stephen R.] Baylor Coll Med, Dept Phys Med & Rehabil Alliance, Houston, TX 77030 USA; [McCauley, Stephen R.] Univ Texas Houston Med Sch, Dept Neurol, Houston, TX USA; [McCauley, Stephen R.] Univ Texas Houston Med Sch, Dept Pediat, Houston, TX USA; [Pedroza, Claudia] Univ Texas Med Sch Houston, Ctr Clin Res & Evidence Based Med, Houston, TX USA; [Robertson, Claudia S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Moretti, Paolo] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA		Wilde, EA (corresponding author), Baylor Coll Med, Cognit Neurosci Lab, 1709 Dryden Rd,Suite 1200, Houston, TX 77030 USA.	ewilde@bcm.edu		Pedroza, Claudia/0000-0003-4235-1282	National Institutes of Health/National Institute of Neurological Disease and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 43353]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS043353] Funding Source: NIH RePORTER	We would like to extend our gratitude to the participants and their families, whose cooperation and patience helped make this study possible. This study was supported in part by grant NS 43353 from the National Institutes of Health/National Institute of Neurological Disease and Stroke, to Guy L. Clifton, Principal Investigator. The information in this article and the article itself has never been published either electronically or in print. None of the authors have any financial or other relationship(s) that could be construed as a conflict of interest with respect to the content of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Annoni J M, 1992, Disabil Rehabil, V14, P23; Appelros P, 2004, CEREBROVASC DIS, V17, P21, DOI 10.1159/000073894; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Callahan CD, 2002, J HEAD TRAUMA REHAB, V17, P251, DOI 10.1097/00001199-200206000-00006; Costanzo RM, 1986, CLIN MEASUREMENTS TA, P565; Dimopoulou I, 2004, AM J PHYS MED REHAB, V83, P171, DOI 10.1097/01.PHM.0000107497.77487.C1; Dromerick AW, 2000, STROKE, V31, P2984, DOI 10.1161/01.STR.31.12.2984; GOLDSTEIN LB, 1994, STROKE, V25, P1700, DOI 10.1161/01.STR.25.8.1700; GOLDSTEIN LB, 1989, ARCH NEUROL-CHICAGO, V46, P660, DOI 10.1001/archneur.1989.00520420080026; Heinemann AW, 1997, STROKE, V28, P1174, DOI 10.1161/01.STR.28.6.1174; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Josephson SA, 2006, CEREBROVASC DIS, V22, P389, DOI 10.1159/000094857; Kasner SE, 2006, LANCET NEUROL, V5, P603, DOI 10.1016/S1474-4422(06)70495-1; KEANE JR, 1992, NEUROL CLIN, V10, P849, DOI 10.1016/S0733-8619(18)30183-X; KEANE JR, 1982, NEUROLOGY, V32, P757, DOI 10.1212/WNL.32.7.757; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; McCauley SR, 2010, J NEUROTRAUM, V27, P991, DOI 10.1089/neu.2009.1195; PODOSHIN L, 1975, ARCH OTOLARYNGOL, V101, P15; PULLICINO P, 1992, STROKE, V23, P919, DOI 10.1161/str.23.6.919a; Rovit R. L., 2000, HEAD INJURY, P201; Rundek T, 2000, NEUROLOGY, V55, P1180, DOI 10.1212/WNL.55.8.1180; SABATES NR, 1991, J CLIN NEURO-OPHTHAL, V11, P273; Schlegel D, 2003, STROKE, V34, P134, DOI 10.1161/01.STR.0000048217.44714.02; SUMNER D, 1962, LANCET, V2, P895; TOKUNO T, 1995, NEUROL SURG TOKYO, V23, P497; Urbina S, 1997, PSYCHOL TESTING; Wilde EA, 2010, J NEUROTRAUM, V27, P983, DOI 10.1089/neu.2009.1194; WITYK RJ, 1994, STROKE, V25, P362, DOI 10.1161/01.STR.25.2.362	30	17	17	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2010	27	6					975	981		10.1089/neu.2009.1193			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	612VO	WOS:000278933300001	20210593	Green Published			2022-02-06	
J	Capizzani, AR; Drongowski, R; Ehrlich, PF				Capizzani, Anthony R.; Drongowski, Robert; Ehrlich, Peter F.			Assessment of termination of trauma resuscitation guidelines: are children small adults?	JOURNAL OF PEDIATRIC SURGERY			English	Article; Proceedings Paper	41st Annual Meeting of the Canadian-Association-of-Paediatric-Surgeons	OCT 01-03, 2009	Halifax, CANADA	Canadian Assoc Paediat Surg		Pediatric trauma; Prehospital traumatic cardiopulmonary arrest; Resuscitation	CARDIOPULMONARY-RESUSCITATION; CARDIAC-ARREST; SURVIVAL; CPR	Background: Guidelines for termination of resuscitation in prehospital traumatic cardiopulmonary arrest (TCPA) have recently been published for adults. Clinical criteria for termination of care include absent pulse, unorganized electrocardiogram (ECG), fixed pupils (all at the scene), and cardiopulmonary resuscitation (CPR) greater than 15 minutes. The goal of this study was to evaluate these guidelines in a pediatric trauma population. Methods: Pediatric trauma patients with documented arrest were included in the study. Data assessed were duration of CPR, ECG rhythm, pulse assessment, pupil response, transport times, and standard injury criteria (eg, mechanism of injury). Survivors were compared to nonsurvivors using descriptive statistics, chi(2), and Pearson correlation. Results: Between 2000 and 2009, 30 patients were identified as having had a TCPA. Of the 30 with a prehospital TCPA, there were 9 females and 21 males (0.2-18 years old). The average (SD) injury severity score was 35.4 (20.6). Twenty-four patients (80%) did not survive. Severe traumatic brain injury was associated with nonsurvivors in 78%. One-way analysis of variances demonstrated that CPR greater than 15 minutes (P = .011) and fixed pupils (P = .022) were significant variables to distinguish between survivors and nonsurvivors, whereas ECG rhythm (P = .34) and absent pulse (P = .056) did not, 42 +/- 28 minutes for nonsurvivors and 7 +/- 3 minutes for survivors. Conclusion: Criteria for termination of resuscitation correctly predicted 100% of those who died when all the criteria were met. More importantly, no survivors would have had resuscitation stopped. Duration of CPR seems to be a strong predictor of mortality in this study. (C) 2010 Elsevier Inc. All rights reserved.	[Ehrlich, Peter F.] Univ Michigan, Sch Med, Pediat Surg Sect, Dept Surg, Ann Arbor, MI 48109 USA; Univ Michigan, CS Mott Childrens Hosp, Ann Arbor, MI 48109 USA		Ehrlich, PF (corresponding author), Univ Michigan, Sch Med, Pediat Surg Sect, Dept Surg, Ann Arbor, MI 48109 USA.	pehrlich@med.umich.edu					Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; BECKER LB, 1991, ANN EMERG MED, V20, P355, DOI 10.1016/S0196-0644(05)81654-3; Bullock RM, 2000, J NEUROTRAUM, V17, P449; CAUKINS CM, 2002, J PEDIATR SURG, V37, P180; Committee on Trauma American College of Surgeons, 2006, RES OPT CAR INJ PAT; Cone David C, 2005, Prehosp Emerg Care, V9, P276, DOI 10.1080/10903120590961996; Fisher B, 1999, PEDIATR EMERG CARE, V15, P274; HAZINSKI MF, 1994, ANN EMERG MED, V23, P1229, DOI 10.1016/S0196-0644(94)70346-9; Hopson Laura R, 2003, Prehosp Emerg Care, V7, P141, DOI 10.1080/10903120390937274; HOPSON LR, 2003, J AM COLL SURGEONS, V1, P112; Li GH, 1999, J TRAUMA, V47, P1, DOI 10.1097/00005373-199907000-00001; LOMBARDI G, 1994, JAMA-J AM MED ASSOC, V271, P678; O'Brien E, 2008, PREHOSP EMERG CARE, V12, P57, DOI 10.1080/10903120701707989; Oyebite K, 2008, WORLD REPORT CHILD I, P1; Pickens JJ, 2005, J TRAUMA, V58, P951, DOI 10.1097/01.TA.0000162174.06448.5A; SAKLAYEN M, 1995, MEDICINE, V74, P163, DOI 10.1097/00005792-199507000-00001; SAS, 2004, SAS STAT SOFTW VERS; SHIMAZU S, 1983, J TRAUMA, V23, P213, DOI 10.1097/00005373-198303000-00006; Stockinger ZT, 2004, J AM COLL SURGEONS, V198, P227, DOI 10.1016/j.jamcollsurg.2003.10.012; Stratton SJ, 1998, J TRAUMA, V45, P96, DOI 10.1097/00005373-199807000-00021; Suominen P, 1998, RESUSCITATION, V36, P9, DOI 10.1016/S0300-9572(97)00088-9	21	17	17	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	MAY	2010	45	5					903	907		10.1016/j.jpedsurg.2010.02.014			5	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Pediatrics; Surgery	590RI	WOS:000277244600011	20438923				2022-02-06	
J	Colantonio, A; Howse, D; Patel, J				Colantonio, Angela; Howse, Dana; Patel, Jigisha			Young Adults With Traumatic Brain Injury in Long-Term Care Homes: A Population-Based Study	BRAIN IMPAIRMENT			English	Article						traumatic brain injury; young adults; long-term care		The aim of this research was to identify the number and characteristics of adults under the age of 65 with a diagnosis of traumatic brain injury (TBI) living in long-term care homes (nursing homes, homes for the aged and charitable homes) in Ontario, Canada. Methods: The study used a cross-sectional design. Secondary data analysis of a comprehensive provincial database of long-term care homes was conducted. Results: Of the 399 residents coded as having a TBI, 154 were < 65 years of age. Virtually all residents were limited in personal care and required assistance for eating (94.2%), toileting (92.2%) and dressing (99.4%). A large percentage also required care for challenging behaviours, while care needs due to substance abuse was common among 12.3% of TBI residents. Conclusion: As similar research in Australia has found, young persons in long-term care homes in Ontario, Canada, have high level personal health needs, however the appropriateness of this environment is questionable.	[Colantonio, Angela; Howse, Dana; Patel, Jigisha] Univ Toronto, Toronto, ON M5S 1A1, Canada; [Colantonio, Angela] Toronto Rehabil Inst, Toronto, ON, Canada		Colantonio, A (corresponding author), Dept Occupat Sci & Occupat Therapy, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	angela.colantonio@utoronto.ca		Colantonio, Angela/0000-0003-2094-4765	Ontario Neurotrauma Foundation; Toronto Rehabilitation Institute Foundation; Toronto Rehabilitation Institute from the Ontario Ministry of Health and Long-Term Care; Ministry of Health and Long-Term Care (MOHLTC)Ministry of Health and Long-Term Care, Ontario	Grant support for this study was provided by the Ontario Neurotrauma Foundation, the Toronto Rehabilitation Institute Foundation, and a grant to the Toronto Rehabilitation Institute from the Ontario Ministry of Health and Long-Term Care. We wish to thank Sue Guinard and her staff for their assistance in obtaining the data for this study.; Residential care and support services for persons in Ontario with TBI living in community-based accommodations are typically funded by the Ministry of Health and Long-Term Care (MOHLTC); however, residents are generally responsible for their own rental costs, personal expenses, and possibly a percentage of their food costs. These funds may come from other subsidies, such as Ontario Disability Support Program (ODSP) or other types of social support. The definition of 'developmental disability' put forth by the Ministry of Community and Social Services (MCSS), which includes limited intellectual development resulting from an illness or accident before age 18, suggests that some young persons with TBI would be eligible for developmental disability-dedicated services. The updated developmental disability act - the Services and Supports to Promote the Social Inclusion of Persons with Developmental Disabilities Act, 2008 - promotes the provision of services to persons with developmental disability via community agencies rather than institutions, and the government has recently begun actively assisting consumers to access appropriate community based support (Ontario MCSS, 2008). At the time of this writing, the revised legislation is not yet fully in effect.	Buchanan R., 2005, BRAIN INJURY, V17, P507; Colantonio A., 2005, NATURE EXTENT INAPPR; Colantonio A., HEALTHCARE IN PRESS; Community Affairs References Committee Senate, 2005, QUAL EQ AG CAR, P79; Foster M., 2007, BRAIN IMPAIR, V8, P312, DOI DOI 10.1375/BRIM.8.3.312; Kelly G, 2007, BRAIN IMPAIR, V8, P262, DOI DOI 10.1375/BRIM.8.3.262; McMillan TM, 2004, CLIN REHABIL, V18, P132, DOI 10.1191/0269215504cr712oa; *ONT MIN HLTH LONG, 2001, REP STUD REV LEV SER; Ontario Ministry of Community and Social Services, 2008, DEV SERV; Ontario Ministry of Health and Long Term Care, 2010, SEN CAR LONG TERM CA; Pickett W., 2005, CHRONIC DIS CANADA, V25, P32; Strettles B, 2005, ACCOMMODATION NSW AD; Wilson JRF, 2009, EUR J TRAUMA EMERG S, V35, P176, DOI 10.1007/s00068-008-8095-8; Winkler D., 2007, YOUNGER PEOPLE RESID; Winkler Dianne, 2006, Aust Health Rev, V30, P100	15	17	17	0	11	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	MAY	2010	11	1					31	36		10.1375/brim.11.1.31			6	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	V24IR	WOS:000208404600003					2022-02-06	
J	Fulkerson, DH; Voorhies, JM; McCanna, SP; Payner, TD; Leipzig, TJ; Scott, JA; DeNardo, AJ; Redelman, K; Horner, TG				Fulkerson, Daniel H.; Voorhies, Jason M.; McCanna, Shannon P.; Payner, Troy D.; Leipzig, Thomas J.; Scott, John A.; DeNardo, Andrew J.; Redelman, Kathleen; Horner, Terry G.			Endovascular treatment and radiographic follow-up of proximal traumatic intracranial aneurysms in adolescents: case series and review of the literature	CHILDS NERVOUS SYSTEM			English	Article						Pediatric neurosurgery; Pseudoaneurysm; Trauma; Endovascular; Skull base	ARTERY DISSECTING ANEURYSM; POSTERIOR CEREBRAL-ARTERY; INTRACAVERNOUS ANEURYSM; CHILDREN; MANAGEMENT; PSEUDOANEURYSMS; RECANALIZATION; CHILDHOOD; INJURIES; GUNSHOT	Traumatic intracranial aneurysms are rare lesions that are relatively more common in the pediatric population. Proximal traumatic aneurysms occur near the skull base. Direct surgical repair of these lesions is difficult due to the anatomically confined area, clinical status of a head injury patient, and the transmural nature of the injury. These lesions often lack a definable neck or wall suitable for clipping. While the indications and capabilities of endovascular treatment continue to expand, there are unanswered questions about the durability of treatment, especially in young patients. There are few reports examining the radiographic outcomes of endovascular treatment specifically for traumatic intracranial aneurysms. Therefore, we examined our experience treating these rare proximal lesions in an adolescent population. A retrospective review of prospectively collected data from 2000-2008 in a large, multidisciplinary neurovascular and trauma center was performed. Three pediatric patients received endovascular treatment for traumatic intracranial aneurysms near the skull base. All patients had successful obliteration of their lesion without vessel sacrifice; however, two patients required multiple procedures for coil compaction or refilling of the aneurysm. There were no complications or ischemic events related to treatment. Follow-up imaging ranged from 6 months to 3.5 years. Traumatic intracranial aneurysms at the skull base can be successfully treated with endovascular methods; however, close follow-up is necessary.	[Fulkerson, Daniel H.] Texas Childrens Hosp, Houston, TX 77030 USA; [Payner, Troy D.; Leipzig, Thomas J.; Scott, John A.; DeNardo, Andrew J.; Redelman, Kathleen; Horner, Terry G.] Indianapolis Neurosurg Grp, Indianapolis, IN USA; [Voorhies, Jason M.; McCanna, Shannon P.] Indiana Univ, Sch Med, Dept Neurosurg, Indianapolis, IN USA; [Fulkerson, Daniel H.] Texas Childrens Hosp, Baylor Coll Med, Div Pediat Neurosurg, Houston, TX 77030 USA		Fulkerson, DH (corresponding author), Texas Childrens Hosp, 6621 Fannin St,CCC 1230-01,12th Floor, Houston, TX 77030 USA.	d_fulkers@hotmail.com					AARABI B, 1988, NEUROSURGERY, V22, P1056, DOI 10.1227/00006123-198806010-00014; Baik SK, 2007, SURG NEUROL, V68, P108, DOI 10.1016/j.surneu.2006.07.023; Binning MJ, 2009, ACTA NEUROCHIR, V151, P1647, DOI 10.1007/s00701-009-0323-4; BUCKINGHAM MJ, 1988, NEUROSURGERY, V22, P398, DOI 10.1227/00006123-198802000-00022; CHOI DS, 2009, J NEUROSURG, P1; Cohen JE, 2005, J NEUROSURG, V102, P555, DOI 10.3171/jns.2005.102.3.0555; Cohen JE, 2008, NEUROSURGERY, V63, P476, DOI 10.1227/01.NEU.0000324995.57376.79; ELGINDI S, 1979, ACTA NEUROCHIR, V48, P237, DOI 10.1007/BF02056972; Feugier P, 2007, EUR J VASC ENDOVASC, V34, P663, DOI 10.1016/j.ejvs.2007.06.011; FLEISCHER A S, 1975, Surgical Neurology, V4, P233; GUTIERREZ FA, 1987, CONCEPTS PEDIATR NEU, V7, P153; Hachemi M, 2007, CHILD NERV SYST, V23, P283, DOI 10.1007/s00381-006-0269-2; HADDAD FS, 1991, NEUROSURGERY, V28, P1; HAHN YS, 1990, CHILD NERV SYST, V6, P360, DOI 10.1007/BF00298285; Hemphill JC, 1999, CRIT CARE CLIN, V15, P811, DOI 10.1016/S0749-0704(05)70089-0; Hetts SW, 2009, AM J NEURORADIOL, V30, P1315, DOI 10.3174/ajnr.A1587; HIGASHIDA RT, 1989, AM J ROENTGENOL, V153, P577, DOI 10.2214/ajr.153.3.577; Horie N, 2008, CLIN NEUROL NEUROSUR, V110, P411, DOI 10.1016/j.clineuro.2007.12.022; HUMPHREYS RP, 1985, CONCEPTS PEDIATR NEU, V6, P213; Kikuchi Y, 2007, NEUROL SURG TOKYO, V35, P813; Kneyber MCJ, 2005, NEUROLOGY, V65, P1663, DOI 10.1212/01.wnl.0000184515.35205.10; Larson P S, 2000, Neurosurg Focus, V8, pe4; Lasjaunias P, 2005, CHILD NERV SYST, V21, P437, DOI 10.1007/s00381-004-1125-x; Lempert TE, 1998, AM J NEURORADIOL, V19, P907; Liang G, 2009, NEUROL RES; LIN TK, 1995, NEUROSURGERY, V36, P407, DOI 10.1227/00006123-199502000-00025; Lv XL, 2009, NEURORADIOLOGY, V51, P749, DOI 10.1007/s00234-009-0553-4; Medel R, 2009, J NEUROSURG-PEDIATR, V4, P445, DOI 10.3171/2009.6.PEDS09104; Mitchell P, 2008, J NEUROSURG, V108, P437, DOI 10.3171/JNS/2008/108/3/0437; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Molyneux AJ, 2009, LANCET NEUROL, V8, P427, DOI 10.1016/S1474-4422(09)70080-8; Moron F, 2005, AM J NEURORADIOL, V26, P58; O'Shaughnessy BA, 2005, J NEUROSURG, V102, P231, DOI 10.3171/jns.2005.102.2.0231; Wang X, 2008, NEUROL INDIA, V56, P47, DOI 10.4103/0028-3886.39312; Yang TC, 2007, EUR NEUROL, V58, P239, DOI 10.1159/000107970; YAZBAK PA, 1995, PEDIATR NEUROSURG, V22, P15, DOI 10.1159/000121294	36	17	20	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	MAY	2010	26	5					613	620		10.1007/s00381-010-1104-3			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	582NV	WOS:000276605600007	20177686				2022-02-06	
J	Turner, JD; Mammis, A; Prestigiacomo, CJ				Turner, Jay D.; Mammis, Antonios; Prestigiacomo, Charles J.			Erythropoietin for the Treatment of Subarachnoid Hemorrhage: A Review	WORLD NEUROSURGERY			English	Article						Erythropoietin; Neuroprotection; Subarachnoid hemorrhage; Vasospasm	RECOMBINANT-HUMAN-ERYTHROPOIETIN; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; RECEPTOR MESSENGER-RNA; IN-VIVO EVIDENCE; CEREBRAL VASOSPASM; CARBAMYLATED ERYTHROPOIETIN; CEREBROSPINAL-FLUID; ENDOTHELIAL-CELLS; NEONATAL-RATS	OBJECTIVE: Subarachnoid hemorrhage (SAH) has a worldwide incidence of approximately 10.5 cases per 100,000 person-years and constitutes 3% of all strokes. Erythropoietin (EPO) has recently been proposed for the treatment of a variety of brain diseases, including SAH, because of its neuroprotective effects. Hence, the current evidence in the published literature was reviewed to determine the potential utility of EPO in the treatment of SAH. METHODS: A careful retrospective review of the literature was performed to determine the potential benefit of employing EPO in the treatment of SAH and its sequelae. RESULTS: Careful literature review revelaed that the use of EPO may not necessarily reduce the incidence of vasospasm after SAH, but it may reduce the severity and its eventual outcome. CONCLUSION: Given the recent trial results, a dose-escalation study and subsequent randomized trial should be considered.	[Turner, Jay D.; Mammis, Antonios; Prestigiacomo, Charles J.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol Surg, Newark, NJ 07103 USA; [Prestigiacomo, Charles J.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Radiol, Newark, NJ 07103 USA; [Turner, Jay D.] St Josephs Hosp, Barrow Neurol Inst, Div Neurol Surg, Phoenix, AZ USA		Prestigiacomo, CJ (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol Surg, 185 S Orange Ave, Newark, NJ 07103 USA.	presticj@umdnj.edu	Prestigiacomo, Charles J/B-3911-2018	Prestigiacomo, Charles J/0000-0002-5979-2378; /0000-0001-6867-3568; Mammis, Antonios/0000-0003-0892-9888			Adembri C, 2008, CRIT CARE MED, V36, P975, DOI 10.1097/CCM.0B013E3181644343; Alafaci C, 2000, EUR J PHARMACOL, V406, P219, DOI 10.1016/S0014-2999(00)00691-9; Ammarguellat F, 1996, NEPHROL DIAL TRANSPL, V11, P687, DOI 10.1093/oxfordjournals.ndt.a027361; ANAGNOSTOU A, 1990, P NATL ACAD SCI USA, V87, P5978, DOI 10.1073/pnas.87.15.5978; ANAGNOSTOU A, 1994, P NATL ACAD SCI USA, V91, P3974, DOI 10.1073/pnas.91.9.3974; Arcasoy MO, 2008, BRIT J HAEMATOL, V141, P14, DOI 10.1111/j.1365-2141.2008.07014.x; Ayer RE, 2008, ACTA NEUROCHIR SUPPL, V104, P33; Belayev L, 2005, STROKE, V36, P1065, DOI 10.1161/01.STR.0000160753.36093.da; Beleslin-Cokic BB, 2004, BLOOD, V104, P2073, DOI 10.1182/blood-2004-02-0744; Bernaudin M, 2000, GLIA, V30, P271, DOI 10.1002/(SICI)1098-1136(200005)30:3<271::AID-GLIA6>3.0.CO;2-H; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Bouscary D, 2003, BLOOD, V101, P3436, DOI 10.1182/blood-2002-07-2332; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; BRODERICK JP, 1994, STROKE, V25, P1342, DOI 10.1161/01.STR.25.7.1342; Buemi M, 2000, EUR J PHARMACOL, V392, P31, DOI 10.1016/S0014-2999(00)00081-9; Buemi M, 2003, J NEUROPATH EXP NEUR, V62, P228, DOI 10.1093/jnen/62.3.228; Cahill WJ, 2006, J CEREBR BLOOD F MET, V26, P1341, DOI 10.1038/sj.jcbfm.9600283; Calapai G, 2000, EUR J PHARMACOL, V401, P349, DOI 10.1016/S0014-2999(00)00466-0; Celik M, 2002, P NATL ACAD SCI USA, V99, P2258, DOI 10.1073/pnas.042693799; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chang YS, 2005, PEDIATR RES, V58, P106, DOI 10.1203/01.PDR.0000163616.89767.69; Cheetham JC, 1998, NAT STRUCT BIOL, V5, P861, DOI 10.1038/2302; Chen G, 2009, CYTOKINE, V45, P162, DOI 10.1016/j.cyto.2008.11.015; Chikuma M, 2000, AM J PHYSIOL-ENDOC M, V279, pE1242, DOI 10.1152/ajpendo.2000.279.6.E1242; Chin K, 2000, MOL BRAIN RES, V81, P29, DOI 10.1016/S0169-328X(00)00157-1; Chong ZZ, 2003, J CEREBR BLOOD F MET, V23, P320, DOI 10.1097/01.WCB.0000050061.57184.AE; Chong ZZ, 2002, J HEMATOTH STEM CELL, V11, P863, DOI 10.1089/152581602321080529; Chong ZZ, 2002, CIRCULATION, V106, P2973, DOI 10.1161/01.CIR.0000039103.58920.1F; Clark JF, 2006, J CEREBR BLOOD F MET, V26, P1223, DOI 10.1038/sj.jcbfm.9600280; Coleman TR, 2006, P NATL ACAD SCI USA, V103, P5965, DOI 10.1073/pnas.0601377103; Conrad KP, 1996, FASEB J, V10, P760, DOI 10.1096/fasebj.10.7.8635693; Corwin HL, 2007, NEW ENGL J MED, V357, P965, DOI 10.1056/NEJMoa071533; Crowley RW, 2008, DRUG DISCOV TODAY, V13, P254, DOI 10.1016/j.drudis.2007.11.010; Diaz Z, 2005, J NEUROCHEM, V93, P392, DOI 10.1111/j.1471-4159.2005.03038.x; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; DIGICAYLIOGLU M, 1995, P NATL ACAD SCI USA, V92, P3717, DOI 10.1073/pnas.92.9.3717; Dorsch Nicholas W C, 2002, Curr Opin Crit Care, V8, P128; ECKER A, 1951, J NEUROSURG, V8, P660, DOI 10.3171/jns.1951.8.6.0660; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; Ehrenreich H, 2007, BRAIN, V130, P2577, DOI 10.1093/brain/awm203; Erbayraktar S, 2003, P NATL ACAD SCI USA, V100, P6741, DOI 10.1073/pnas.1031753100; Ferro JM, 2008, J NEUROL, V255, P465, DOI 10.1007/s00415-008-0606-3; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Fisher JW, 2003, EXP BIOL MED, V228, P1; Fujii Y, 1997, J NEUROSURG, V86, P594, DOI 10.3171/jns.1997.86.4.0594; FUJII Y, 1995, NEUROSURGERY, V37, P226, DOI 10.1227/00006123-199508000-00006; Genc S, 2002, NEUROSCI LETT, V321, P73, DOI 10.1016/S0304-3940(02)00041-1; Grasso G, 2002, J NEUROSURG, V96, P565, DOI 10.3171/jns.2002.96.3.0565; Grasso G, 2002, P NATL ACAD SCI USA, V99, P5627, DOI 10.1073/pnas.082097299; Grimm C, 2002, NAT MED, V8, P718, DOI 10.1038/nm723; GROTE E, 1988, NEUROSURGERY, V22, P654, DOI 10.1227/00006123-198804000-00006; Hansen-Schwartz J, 2007, TRENDS PHARMACOL SCI, V28, P252, DOI 10.1016/j.tips.2007.04.002; Hop JW, 1997, STROKE, V28, P660, DOI 10.1161/01.STR.28.3.660; JACKOWSKI A, 1990, J CEREBR BLOOD F MET, V10, P835, DOI 10.1038/jcbfm.1990.140; Jubinsky PT, 1997, BLOOD, V90, P1867, DOI 10.1182/blood.V90.5.1867; Juul SE, 2000, PEDIATR RES, V48, P660, DOI 10.1203/00006450-200011000-00018; Juul SE, 1999, PEDIATR RES, V46, P543, DOI 10.1203/00006450-199911000-00009; Juul SE, 2004, BIOL NEONATE, V85, P138, DOI 10.1159/000074970; Juul SE, 1998, PEDIATR RES, V43, P40, DOI 10.1203/00006450-199801000-00007; Juul SE, 1997, J PEDIATR-US, V130, P428, DOI 10.1016/S0022-3476(97)70205-1; Katavetin P, 2007, KIDNEY INT, V72, pS10, DOI 10.1038/sj.ki.5002482; Kawakami M, 2000, BIOCHEM BIOPH RES CO, V279, P293, DOI 10.1006/bbrc.2000.3926; Kawakami M, 2001, J BIOL CHEM, V276, P39469, DOI 10.1074/jbc.M105832200; Kellert BA, 2007, PEDIATR RES, V61, P451, DOI 10.1203/pdr.0b013e3180332cec; Kobayashi T, 2002, BIOCHEM BIOPH RES CO, V296, P145, DOI 10.1016/S0006-291X(02)00832-X; Komotar RJ, 2008, NEUROSURGERY, V62, P396, DOI 10.1227/01.neu.0000316006.26635.b0; Komotar RJ, 2008, NEUROSURGERY, V62, P905, DOI [10.1227/01.neu.0000318175.05591.c318496195, DOI 10.1227/01.neu.0000318175.05591.c318496195]; KONISHI Y, 1993, BRAIN RES, V609, P29, DOI 10.1016/0006-8993(93)90850-M; Kornotar RJ, 2008, NEUROSURGERY, V62, P897, DOI [10.1227/01.NEU.0000310706.61025.38, 10.1227/01.neu.0000318175.05591.c3]; Koshimura K, 1999, J NEUROCHEM, V72, P2565, DOI 10.1046/j.1471-4159.1999.0722565.x; Kumral A, 2005, BIOL NEONATE, V87, P15, DOI 10.1159/000080490; Kumral A, 2003, BIOL NEONATE, V83, P224, DOI 10.1159/000068926; Lapchak PA, 2008, EXPERT OPIN INV DRUG, V17, P1175, DOI 10.1517/13543784.17.8.1175 ; Lewczuk P, 2000, NEUROREPORT, V11, P3485, DOI 10.1097/00001756-200011090-00017; Li WP, 2004, ANN NEUROL, V56, P767, DOI 10.1002/ana.20274; Linn FHH, 1996, STROKE, V27, P625, DOI 10.1161/01.STR.27.4.625; Liu C, 1997, J BIOL CHEM, V272, P32395, DOI 10.1074/jbc.272.51.32395; Magnanti M, 2001, BLOOD, V98, P2872, DOI 10.1182/blood.V98.9.2872; Mahmood A, 2007, J NEUROSURG, V107, P392, DOI 10.3171/JNS-07/08/0392; Maiese K, 2008, CYTOKINE GROWTH F R, V19, P145, DOI 10.1016/j.cytogfr.2008.01.004; Mammis A, 2009, SURG NEUROL, V71, P527, DOI 10.1016/j.surneu.2008.02.040; Marti HH, 1996, EUR J NEUROSCI, V8, P666, DOI 10.1111/j.1460-9568.1996.tb01252.x; Martinez-Estrada OM, 2003, EUR J NEUROSCI, V18, P2538, DOI 10.1046/j.1460-9568.2003.02987.x; Masuda S, 2000, AM J PHYSIOL-ENDOC M, V278, pE1038, DOI 10.1152/ajpendo.2000.278.6.E1038; MASUDA S, 1994, J BIOL CHEM, V269, P19488; McPherson RJ, 2007, NEONATOLOGY, V91, P36, DOI 10.1159/000096969; Morishita E, 1997, NEUROSCIENCE, V76, P105, DOI 10.1016/s0306-4522(96)00306-5; Murphy AM, 2008, J NEUROSURG, V109, P1155, DOI 10.3171/JNS.2008.109.12.1155; Nagai A, 2001, J NEUROPATH EXP NEUR, V60, P386, DOI 10.1093/jnen/60.4.386; Noguchi CT, 2007, CRIT REV ONCOL HEMAT, V64, P159, DOI 10.1016/j.critrevonc.2007.03.001; Ogilvie M, 2000, J BIOL CHEM, V275, P39754, DOI 10.1074/jbc.M004999200; OHMAN J, 1991, J NEUROSURG, V74, P8, DOI 10.3171/jns.1991.74.1.0008; Ostrowski RP, 2006, NEUROL RES, V28, P399, DOI 10.1179/016164106X115008; Peltonen S, 1997, J NEUROSURG, V87, P207, DOI 10.3171/jns.1997.87.2.0207; Pluta RM, 2005, PHARMACOL THERAPEUT, V105, P23, DOI 10.1016/j.pharmthera.2004.10.002; Rajajee Venkatakrishna, 2004, J Stroke Cerebrovasc Dis, V13, P47, DOI 10.1016/j.jstrokecerebrovasdis.2004.01.002; Renzi MJ, 2002, MOL BRAIN RES, V104, P86, DOI 10.1016/S0169-328X(02)00323-6; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Sabri M, 2008, BRAIN RES, V1238, P163, DOI 10.1016/j.brainres.2008.08.031; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Sakowitz OW, 2006, CURR OPIN CRIT CARE, V12, P103, DOI 10.1097/01.ccx.0000216575.03815.ee; Santhanam AVR, 2005, STROKE, V36, P2731, DOI 10.1161/01.STR.0000190021.85035.5b; Sasaki R, 2003, INTERNAL MED, V42, P142, DOI 10.2169/internalmedicine.42.142; Sehba FA, 2005, J NEUROSURG, V102, P1094, DOI 10.3171/jns.2005.102.6.1094; Silva M, 1999, J BIOL CHEM, V274, P22165, DOI 10.1074/jbc.274.32.22165; Sinor AD, 2000, NEUROSCI LETT, V290, P213, DOI 10.1016/S0304-3940(00)01361-6; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Siren AL, 2001, ACTA NEUROPATHOL, V101, P271, DOI 10.1007/s004010000297; SONOBE M, 1978, ACTA NEUROCHIR, V44, P97, DOI 10.1007/BF01401633; Springborg JB, 2007, ACTA NEUROCHIR, V149, P1089, DOI 10.1007/s00701-007-1284-z; Springborg JB, 2002, BRIT J PHARMACOL, V135, P823, DOI 10.1038/sj.bjp.0704521; Starke RM, 2008, NEUROSURGERY, V62, P1405, DOI 10.1227/01.neu.0000333471.90507.f8; Statler PA, 2007, PEDIATR RES, V61, P671, DOI 10.1203/pdr.0b013e31805341dc; Suarez JI, 2006, NEW ENGL J MED, V354, P387, DOI 10.1056/NEJMra052732; Sugawa M, 2002, NEUROSCI RES, V44, P391, DOI 10.1016/S0168-0102(02)00161-X; Tseng MY, 2009, J NEUROSURG, V111, P171, DOI 10.3171/2009.3.JNS081332; Vajkoczy P, 2005, J NEUROSURG, V103, P9, DOI 10.3171/jns.2005.103.1.0009; Villa P, 2003, J EXP MED, V198, P971, DOI 10.1084/jem.20021067; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Wojchowski DM, 2006, BLOOD CELL MOL DIS, V36, P232, DOI 10.1016/j.bcmd.2006.01.007; Wu H, 1999, DEVELOPMENT, V126, P3597; Yamaji R, 1996, EUR J BIOCHEM, V239, P494, DOI 10.1111/j.1432-1033.1996.0494u.x; Yoo JY, 2009, J NEUROSCI RES, V87, P150, DOI 10.1002/jnr.21832; Yu YP, 2005, NEUROSCI LETT, V387, P5, DOI 10.1016/j.neulet.2005.07.008; Zhou CM, 2005, J CEREBR BLOOD F MET, V25, P572, DOI 10.1038/sj.jcbfm.9600069	126	17	19	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2010	73	5					500	507		10.1016/j.wneu.2010.02.026			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	792UL	WOS:000292775800026	20920933				2022-02-06	
J	Sbordone, RJ				Sbordone, Robert J.			Neuropsychological Tests are Poor at Assessing the Frontal Lobes, Executive Functions, and Neurobehavioral Symptoms of Traumatically Brain-Injured Patients	PSYCHOLOGICAL INJURY & LAW			English	Article						Neuropsychological tests; Frontal lobes; Executive functions; Neurobehavioral symptoms; Traumatically brain-injured patients		The frontal lobes play a major role in the regulation of our emotions and behavior, planning, decision making, social conduct, actions, and executive functions. They are quite vulnerable to damage when an individual sustains a moderate or severe traumatic brain injury. Patients who sustain damage to their frontal lobes may not complain of any cognitive or neurobehavioral symptoms. They often do not show any abnormalities on standardized neuropsychological tests, particularly when the anterior and ventral areas of their frontal lobes are damaged. When these patients are observed in unstructured, novel, or complex real-world settings, they frequently exhibit cognitive difficulties, neurobehavioral symptoms, and problems with their executive functions. Since standardized neuropsychological tests are generally poor at assessing these problems and symptoms, neuropsychologists may not be aware of these problems if they have never observed these patients function in real-world settings or have never interviewed the significant others of these patients. As a consequence, neuropsychologists should not rely solely on the quantitative test data of these patients since it may provide inaccurate and misleading information.	[Sbordone, Robert J.] 24422 Ave Carlota,Suite 270, Laguna Hills, CA 92653 USA		Sbordone, RJ (corresponding author), 24422 Ave Carlota,Suite 270, Laguna Hills, CA 92653 USA.	bobneurpsy@aol.com					ALBERT ML, 1974, J NEUROL NEUROSUR PS, V37, P121, DOI 10.1136/jnnp.37.2.121; ALEXANDER MP, 1989, BRAIN LANG, V37, P656, DOI 10.1016/0093-934X(89)90118-1; Anderson S. W., 1989, CLIN NEUROPSYCHOL, V3, P327, DOI DOI 10.1080/13854048908401482; Askin-Edgar S., 2004, ESSENTIALS NEUROPSYC, P421; Barch D. M., 2003, NEUROPSYCHIATRY, P426; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P376, DOI 10.1017/S1355617705050423; Benson D.F., 1986, FRONTAL LOBES; Benson DF, 1994, NEUROLOGY THINKING; Bigler E D, 1988, Arch Clin Neuropsychol, V3, P279, DOI 10.1016/0887-6177(88)90020-0; BOYD TM, 1993, APPL COGNITIVE PSYCH, V7, P171, DOI 10.1002/acp.2350070208; Burgess P, 1996, BEHAV ASSESSMENT DYS; Butler R.W., 1993, NEUROPSYCHOLOGY, V7, P519, DOI [DOI 10.1037/0894-4105.7.4.519, 10.1037/0894-4105.7.4.519]; BUTLER RW, 1989, CLIN NEUROPSYCHOL, V3, P235; Chaytor N, 2006, ARCH CLIN NEUROPSYCH, V21, P217, DOI 10.1016/j.acn.2005.12.002; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; CICERONE KD, 1990, J CLIN EXP NEUROPSYC, V12, P92; Cripe L. I., 1996, ECOLOGICAL VALIDITY, P129; Cummings JL, 1995, ANN NY ACAD SCI, V769, P1, DOI 10.1111/j.1749-6632.1995.tb38127.x; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Damasio A. R., 1985, CLIN NEUROPSYCHOLOGY, P409; Delis DC., 2001, DELIS KAPLAN EXECUTI; FLOWERS KA, 1985, J NEUROL NEUROSUR PS, V48, P517, DOI 10.1136/jnnp.48.6.517; Gioia  G., 2000, BRIEF RATING INVENTO; Grace J, 1999, ASSESSMENT, V6, P269, DOI 10.1177/107319119900600307; Grace J, 2001, FRONTAL SYSTEM BEHAV; GRAFMAN J, 1990, ARCH NEUROL-CHICAGO, V47, P553, DOI 10.1001/archneur.1990.00530050077015; Isquith P.K., 2005, BEHAV RATING INVENTO; Jankovic J., 2003, NEUROPSYCHIATRY, P934; KAUFER DI, 1997, BEHAV NEUROLOGY NEUR, P499; LEES AJ, 1983, BRAIN, V106, P257, DOI 10.1093/brain/106.2.257; Levine B., 2002, PRINCIPLES FRONTAL L, P448; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lezak M. D., 1997, BEHAV NEUROLOGY NEUR, P43; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Long, 1996, ECOLOGICAL VALIDITY, P15; MAHER ER, 1985, J NEUROL NEUROSUR PS, V48, P1234, DOI 10.1136/jnnp.48.12.1234; MEGA MS, 1994, J NEUROPSYCH CLIN N, V6, P358; MESULAM MM, 1986, ANN NEUROL, V19, P320, DOI 10.1002/ana.410190403; Meyer GJ, 2001, AM PSYCHOL, V56, P128, DOI 10.1037//0003-066X.56.2.128; OSHANICK GJ, 1994, NEUROPSYCHIATRY TRAU, P163; Reitan RM, 1955, J GERONTOL, V10, P338, DOI 10.1093/geronj/10.3.338; Sbordone R. J., 1997, NEUROPSYCHOLOGY HDB, V1, P365; Sbordone R. J., 2007, NEUROPSYCHOLOGY PSYC; Sbordone R. J, 2000, NEUROPSYCHOLOGICAL A, P437; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; Sbordone RJ, 1999, STUD NEUROPSYCHOL DE, P227; Sbordone RJ, 2000, ARCH CLIN NEUROPSYCH, V15, P465; Silver J. M., 2004, ESSENTIALS NEUROPSYC, P241; Silver J. M., 2002, AM PSYCHIAT PRESS TX; Sohlberg M., 2001, COGNITIVE REHABILITA; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Wilson, 1993, APPL PREV PSYCHOL, V2, P209, DOI DOI 10.1016/S0962-1849(05)80091-5; Wood RL, 2006, ARCH CLIN NEUROPSYCH, V21, P429, DOI 10.1016/j.acn.2005.06.014; ZANGWILL OL, 1966, INT J NEUROL, V5, P395; [No title captured]	58	17	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1938-971X	1938-9728		PSYCHOL INJ LAW	Psychol. Inj. Law	MAR	2010	3	1			SI		25	35		10.1007/s12207-010-9068-x			11	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	VB3XZ	WOS:000415448300003					2022-02-06	
J	Semenas, E; Nozari, A; Sharma, HS; Basu, S; Rubertsson, S; Wiklund, L				Semenas, E.; Nozari, A.; Sharma, H. S.; Basu, S.; Rubertsson, S.; Wiklund, L.			Sex differences in cerebral injury after severe haemorrhage and ventricular fibrillation in pigs	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article							CATALYZED LIPID-PEROXIDATION; TRAUMATIC CARDIAC-ARREST; PERINATAL BRAIN-INJURY; NITRIC-OXIDE; BLOOD-FLOW; CARDIOPULMONARY-RESUSCITATION; GENDER-DIFFERENCES; HYPERTONIC SALINE; OXIDATIVE INJURY; METHYLENE-BLUE	Background Experimental studies of haemorrhagic shock have documented a superior haemodynamic response and a better outcome in female animals as compared with male controls. Such sexual dimorphism has, nevertheless, not been reported after circulatory arrest that follows exsanguination and shock. We aimed to study differences in cerebral injury markers after exsanguination cardiac arrest in pre-pubertal piglets. The hypothesis was that cerebral injury is less extensive in female animals, and that this difference is independent of sexual hormones or choice of resuscitative fluid. Methods Thirty-two sexually immature piglets (14 males and 18 females) were subjected to 5 min of haemorrhagic shock followed by 2 min of ventricular fibrillation and 8 min of cardiopulmonary resuscitation, using three resuscitation fluid regimens (whole blood, hypertonic saline and dextran, or acetated Ringers' solution plus whole blood and methylene blue). Haemodynamic values, cellular markers of brain injury and brain histology were studied. Results After successful resuscitation, female piglets had significantly greater cerebral cortical blood flow, tended to have lower S-100 beta values and a lower cerebral oxygen extraction ratio. Besides, in female animals, systemic and cerebral venous acidosis were mitigated. Female piglets exhibited a significantly smaller increase in neuronal nitric oxide synthase (nNOS) and inducible nitric oxide synthase (iNOS) expression in their cerebral cortex, smaller blood-brain-barrier (BBB) disruption and significantly smaller neuronal injury. Conclusion After resuscitation from haemorrhagic circulatory arrest, cerebral reperfusion is greater, and BBB permeability and neuronal injury is smaller in female piglets. An increased cerebral cortical iNOS and nNOS expression in males implies a mechanistic relationship with post-resuscitation neuronal injury and warrants further investigation.	[Semenas, E.; Sharma, H. S.; Rubertsson, S.; Wiklund, L.] Univ Uppsala Hosp, Dept Surg Sci Anesthesiol & Intens Care, Fac Med, S-75185 Uppsala, Sweden; [Nozari, A.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Anesthesia & Crit Care, Boston, MA USA; [Basu, S.] Univ Uppsala Hosp, Dept Publ Hlth & Caring Sci Clin Nutr & Metab, Fac Med, S-75185 Uppsala, Sweden		Semenas, E (corresponding author), Univ Uppsala Hosp, Dept Surg Sci Anesthesiol & Intens Care, Fac Med, S-75185 Uppsala, Sweden.	egidijus.semenas@gmail.com	Nozari, Ala/AAH-6070-2021; Sharma, Aruna/D-4430-2011	Semenas, Egidijus/0000-0002-3543-5261	Laerdal Foundation for Acute Medicine, Stavanger, Norway	The research was supported, in part, by the Laerdal Foundation for Acute Medicine, Stavanger, Norway.	Angele MK, 2000, SHOCK, V14, P81, DOI 10.1097/00024382-200014020-00001; Basu S, 1998, PROSTAG LEUKOTR ESS, V58, P319, DOI 10.1016/S0952-3278(98)90042-4; Basu S, 1998, PROSTAG LEUKOTR ESS, V58, P347, DOI 10.1016/S0952-3278(98)90070-9; Bellamy R, 1996, CRIT CARE MED, V24, pS24; Bender R, 2007, RESUSCITATION, V72, P74, DOI 10.1016/j.resuscitation.2006.05.019; BLASS N, 1976, ANESTHESIOLOGY, V45, P458, DOI 10.1097/00000542-197610000-00020; BURROWS GE, 1984, J VET PHARMACOL THER, V7, P225, DOI 10.1111/j.1365-2885.1984.tb00904.x; Buunk G, 2000, NETH J MED, V57, P106, DOI 10.1016/S0300-2977(00)00059-0; Castren M, 2009, ACTA ANAESTH SCAND, V53, P280, DOI 10.1111/j.1399-6576.2008.01881.x; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; Choudhry MA, 2005, SHOCK, V24, P101, DOI 10.1097/01.shk.0000191341.31530.5e; Diodato MD, 2001, CYTOKINE, V14, P162, DOI 10.1006/cyto.2001.0861; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; Fischer M, 2002, RESUSCITATION, V54, P269, DOI 10.1016/S0300-9572(02)00151-X; Hagberg H, 2004, J NEUROCHEM, V90, P1068, DOI 10.1111/j.1471-4159.2004.02547.x; HANNON JP, 1990, LAB ANIM SCI, V40, P293; Hurn PD, 2005, STROKE, V36, P193, DOI 10.1161/01.STR.0000153064.41332.f6; Kelner M J, 1988, Basic Life Sci, V49, P895; Kramer GC, 2003, J TRAUMA, V54, pS89, DOI 10.1097/01.TA.0000065609.82142.F1; Krep H, 2004, RESUSCITATION, V63, P73, DOI 10.1016/j.resuscitation.2004.03.023; Lang JT, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-33; Liu XL, 2003, ACTA ANAESTH SCAND, V47, P958, DOI 10.1034/j.1399-6576.2003.00189.x; Lockey D, 2006, ANN EMERG MED, V48, P240, DOI 10.1016/j.annemergmed.2006.03.015; Malorni W, 2007, ANTIOXID REDOX SIGN, V9, P1779, DOI 10.1089/ars.2007.1596; McCullough LD, 2005, J CEREBR BLOOD F MET, V25, P502, DOI 10.1038/sj.jcbfm.9600059; Midescu A, 2006, CRIT CARE MED, V34, P2806, DOI 10.1097/01.CCM.0000242517.23324.27; Moro MA, 2004, CELL CALCIUM, V36, P265, DOI 10.1016/j.ceca.2004.02.011; Nakka VP, 2008, MOL NEUROBIOL, V37, P7, DOI 10.1007/s12035-007-8013-9; Nolan JP, 2008, RESUSCITATION, V79, P350, DOI 10.1016/j.resuscitation.2008.09.017; Rhee PM, 2000, J AM COLL SURGEONS, V190, P288, DOI 10.1016/S1072-7515(99)00233-1; Rocha-e-Silva Mauricio, 2005, Clinics, V60, P159, DOI 10.1590/S1807-59322005000200013; ROSEMURGY AS, 1993, J TRAUMA, V35, P468, DOI 10.1097/00005373-199309000-00022; SCHLEIEN CL, 1991, STROKE, V22, P477, DOI 10.1161/01.STR.22.4.477; Sharma HS, 2005, CURR PHARM DESIGN, V11, P1353, DOI 10.2174/1381612053507837; Sharma HS, 1997, ANN NY ACAD SCI, V813, P581, DOI 10.1111/j.1749-6632.1997.tb51749.x; SHARMA HS, 1990, ACT NEUR S, V51, P383; Shoemaker WC, 1996, CRIT CARE MED, V24, pS12; VOORHEES WD, 1987, RESUSCITATION, V15, P113, DOI 10.1016/0300-9572(87)90022-0; Wiklund L, 2005, ANN NY ACAD SCI, V1053, P205, DOI 10.1196/annals.1344.019; Zhang F, 2004, NEUROL RES, V26, P835, DOI 10.1179/016164104X3824	40	17	17	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-5172	1399-6576		ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	MAR	2010	54	3					343	353		10.1111/j.1399-6576.2009.02125.x			11	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	552SF	WOS:000274313000012	19764903				2022-02-06	
J	Waibel, BH; Durham, CA; Newell, MA; Schlitzkus, LL; Sagraves, SG; Rotondo, MF				Waibel, Brett H.; Durham, Chris A.; Newell, Mark A.; Schlitzkus, Lisa L.; Sagraves, Scott G.; Rotondo, Michael F.			Impact of hypothermia in the rural, pediatric trauma patient	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						hypothermia; pediatric trauma; multivariate analysis; complications; length of stay; outcomes	UNCONTROLLED HEMORRHAGIC-SHOCK; MODERATE HYPOTHERMIA; BRAIN-INJURY; NEONATAL ENCEPHALOPATHY; SYSTEMIC HYPOTHERMIA; MILD HYPOTHERMIA; ADENOSINE-TRIPHOSPHATE; IMPROVES SURVIVAL; DEATH RATES; RESUSCITATION	Objective: Hypothermia is an independent predictor of mortality in adult trauma studies. However, the impact of hypothermia on the pediatric trauma population has not been described. The purpose of this study is to evaluate hypothermia as a cofactor to mortality, complications, and among survivors, hospital length of stay parameters in the pediatric trauma population. Design: Retrospective review of a prospectively collected database (National Trauma Registry of the American College of Surgeons) over a 5-yr period (July 2002 to June 2007). Setting: A rural, level I trauma center. Patients: One thousand six hundred twenty-nine pediatric patients admitted with a traumatic injury. Interventions: None. Measurements and Main Results: Multivariate regression models were used to evaluate the association of hypothermia with mortality, infectious complications, organ dysfunction, and among survivors, hospital length of stay parameters. Of 1,629 pediatric trauma patients admitted, 182 (11.1%) patients were hypothermic (temperature below 36 C) on admission. Hypothermia had an adjusted odds ratio (AOR) of 2.41 (95% confidence interval [CI], 1.12-5.22, p = .025) for mortality. After controlling for covariates, hypothermia had associations with developing pneumonia (AOR, 0.185, 95% CI, 0.040-0.853; p = .031) and a bleeding diathesis (AOR, 3.14, 95% CI, 1.04-9.44; p = .042). The median days in the hospital, intensive care unit (ICU), and ventilator were longer in the hypothermic cohort; however, after controlling for covariates, hypothermia was not associated with differences in hospital days, ICU days, or ventilator days. Conclusions: Hypothermia is a common problem at admission among pediatric trauma patients. Hypothermia is associated with an increase in the odds of death and the development of a bleeding diathesis, while having decreased odds for developing pneumonia. While the length of stay indicators were longer in the hypothermic cohort among survivors, no significant association was noted with hypothermia for hospital, ICU, or ventilator days after controlling for confounders. (Pediatr Crit Care Med 2010; 11: 199-204)	[Waibel, Brett H.; Durham, Chris A.; Newell, Mark A.; Schlitzkus, Lisa L.; Sagraves, Scott G.; Rotondo, Michael F.] E Carolina Univ, Dept Surg, Div Trauma & Surg Crit Care, Brody Sch Med, Greenville, NC 27858 USA		Waibel, BH (corresponding author), E Carolina Univ, Dept Surg, Div Trauma & Surg Crit Care, Brody Sch Med, Greenville, NC 27858 USA.	Brett.Waibel@pcmh.com					Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; [Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; Arthurs Z, 2006, AM J SURG, V191, P610, DOI 10.1016/j.amjsurg.2006.02.010; Badjatia N, 2009, CRIT CARE MED, V37, P1893, DOI 10.1097/CCM.0b013e31819fffd3; BAKER SP, 1987, NEW ENGL J MED, V316, P1384, DOI 10.1056/NEJM198705283162206; Biswas AK, 2002, CRIT CARE MED, V30, P2742, DOI 10.1097/00003246-200212000-00020; Boodhwani M, 2006, CIRCULATION, V114, pI461, DOI 10.1161/CIRCULATIONAHA.105.001354; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS21; Branas CC, 2005, JAMA-J AM MED ASSOC, V293, P2626, DOI 10.1001/jama.293.21.2626; CRIPPEN D, 1991, RESUSCITATION, V21, P271, DOI 10.1016/0300-9572(91)90052-Z; Eastridge BJ, 2006, J TRAUMA, V61, P1366, DOI 10.1097/01.ta.0000245894.78941.90; Eicher DJ, 2005, PEDIATR NEUROL, V32, P18, DOI 10.1016/j.pediatrneurol.2004.06.015; Eicher DJ, 2005, PEDIATR NEUROL, V32, P11, DOI 10.1016/j.pediatrneurol.2004.06.014; EIDELMAN Y, 1994, J TRAUMA, V37, P677, DOI 10.1097/00005373-199410000-00025; FIELD JM, 2005, HDB EMERGENCY CARDIO, P16; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; GUBLER KD, 1994, J TRAUMA, V36, P847, DOI 10.1097/00005373-199406000-00015; Hachimi-Idrissi S, 2008, RESUSCITATION, V79, P185, DOI 10.1016/j.resuscitation.2008.09.004; Hildebrand F, 2004, AM J SURG, V187, P363, DOI 10.1016/j.amjsurg.2003.12.016; Husum Hans, 2002, Prehosp Disaster Med, V17, P23; Hutchison JS, 2008, PEDIATR CLIN N AM, V55, P529, DOI 10.1016/j.pcl.2008.02.011; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Inder TE, 2004, J PEDIATR-US, V145, P835, DOI 10.1016/j.jpeds.2004.07.034; JOHANNIGMAN JA, 1992, J TRAUMA, V32, P190, DOI 10.1097/00005373-199202000-00014; JURKOVICH GJ, 1987, J TRAUMA, V27, P1019, DOI 10.1097/00005373-198709000-00011; Jurkovich GJ, 2007, SURG CLIN N AM, V87, P247, DOI 10.1016/j.suc.2006.10.003; Kettner SC, 2003, ANESTH ANALG, V96, P1772, DOI 10.1213/01.ANE.0000062520.65192.C9; Kim SH, 1998, J TRAUMA, V44, P485, DOI 10.1097/00005373-199803000-00010; Kim SH, 1997, J TRAUMA, V42, P213, DOI 10.1097/00005373-199702000-00006; Lemeshow S, 2000, APPL LOGISTIC REGRES; LUNA GK, 1987, J TRAUMA, V27, P1014, DOI 10.1097/00005373-198709000-00010; Maathuis MHJ, 2007, TRANSPLANTATION, V83, P1289, DOI 10.1097/01.tp.0000265586.66475.cc; Mack WJ, 2007, NEUROSURGERY, V60, P815, DOI 10.1227/01.NEU.0000255452.20602.C9; Mann NC, 2001, MED CARE, V39, P643, DOI 10.1097/00005650-200107000-00001; Martin RS, 2005, SHOCK, V24, P114, DOI 10.1097/01.shk.0000169726.25189.b1; MESSICK WJ, 1992, J TRAUMA, V33, P850, DOI 10.1097/00005373-199212000-00010; MEYER DM, 1988, ANN SURG, V207, P462, DOI 10.1097/00000658-198804000-00015; Mizushima Y, 2000, J TRAUMA, V48, P58, DOI 10.1097/00005373-200001000-00010; Muelleman RL, 2007, J TRAUMA, V62, P221, DOI 10.1097/01.ta.0000231696.65548.06; Nussmeier NA, 2005, TEX HEART I J, V32, P472; Prueckner S, 2001, J TRAUMA, V50, P253, DOI 10.1097/00005373-200102000-00010; REED RL, 1992, J TRAUMA, V33, P465, DOI 10.1097/00005373-199209000-00022; Rogers FB, 1999, J TRAUMA, V47, P802, DOI 10.1097/00005373-199910000-00038; RUTLEDGE R, 1994, ANN SURG, V219, P205, DOI 10.1097/00000658-199402000-00013; RUTLEDGE R, 1992, J TRAUMA, V33, P29, DOI 10.1097/00005373-199207000-00007; Sagraves SG, 2002, J TRAUMA, V53, P1209; Schneider A, 2009, ANESTH ANALG, V108, P971, DOI 10.1213/ane.0b013e318193ca99; Seekamp A, 1999, J TRAUMA, V47, P673, DOI 10.1097/00005373-199910000-00011; Shafi NI, 2006, PEDIATR CRIT CARE ME, V7, P468, DOI 10.1097/01.PCC.0000235258.79253.8C; Shafi S, 2005, J TRAUMA, V59, P1081, DOI 10.1097/01.ta.0000188647.03665.fd; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Takasu A, 2000, CRIT CARE MED, V28, P2465, DOI 10.1097/00003246-200007000-00047; Wang HE, 2005, CRIT CARE MED, V33, P1296, DOI 10.1097/01.CCM.0000165965.31895.80; Watts DD, 1998, J TRAUMA, V44, P846, DOI 10.1097/00005373-199805000-00017; Wolberg AS, 2004, J TRAUMA, V56, P1221, DOI 10.1097/01.TA.0000064328.97941.FC; Wu XR, 2003, J TRAUMA, V55, P308, DOI 10.1097/01.TA.0000079366.23533.1E; Wu XR, 2003, CRIT CARE MED, V31, P195, DOI 10.1097/00003246-200301000-00030; Wu XR, 2002, J TRAUMA, V53, P654, DOI 10.1097/00005373-200210000-00006	58	17	17	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	MAR	2010	11	2					199	204		10.1097/PCC.0b013e3181b80500			6	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	566YZ	WOS:000275410700004	19794329				2022-02-06	
J	Chang, CY; Lee, YH; Leu, SJ; Wang, CY; Wei, CP; Hung, KS; Pai, MH; Tsai, MD; Wu, CH				Chang, C. -Y.; Lee, Y. -H.; Leu, S. -J.; Wang, C. -Y.; Wei, C. -P.; Hung, K. -S.; pai, M. -H; Tsai, M. -D.; Wu, C. -H.			CC-CHEMOKINE LIGAND 18/PULMONARY ACTIVATION-REGULATED CHEMOKINE EXPRESSION IN THE CNS WITH SPECIAL REFERENCE TO TRAUMATIC BRAIN INJURIES AND NEOPLASTIC DISORDERS	NEUROSCIENCE			English	Article						CC-chemokine; glia; microglia; macrophages; glioma; source; lesion	CENTRAL-NERVOUS-SYSTEM; MONOCYTE CHEMOATTRACTANT PROTEIN-1; MESSENGER-RNA EXPRESSION; HUMAN-MALIGNANT GLIOMA; RECEPTOR EXPRESSION; CEREBROSPINAL-FLUID; HUMAN ASTROCYTOMAS; CELL INFILTRATION; DENDRITIC CELLS; MACROPHAGES	Pulmonary activation-regulated chemokine (PARC) now designated CC-chemokine ligand 18 (CCL18) has been shown to play a significant role in the pathogenesis of various tissue injuries and diseases in a proinflammatory or immune suppressive way to limit or support the inflammation or disease. While much is known about the roles of CCL18/PARC in non-neural tissues, its expression in the CNS has remained largely unexplored and controversial. Using reverse transcription polymerase chain reaction (RT-PCR) and double immunohistochemical staining, we analyzed the expression of CCL18/PARC in the human brain with special reference to traumatic brain injuries and tumors. The RT-PCR analysis revealed the expression of CCL18/PARC mRNA both in the traumatic brain and glioma tissues examined. Immunoexpression of CCL18/PARC protein was consistently detected in all cases of traumatic brain injuries examined by immunohistochemical staining. Double immunofluorescence labeling has extended the study that CCL18/PARC positive cells were macrophages/microglia, astrocytes or neurons. The CCL18/PARC expression was localized in macrophage-like cells in two of eight glioblastoma tissues whose cancer cells were CCL18/PARC negative. Unexpectedly, CCL18/PARC mRNA weakly and constitutively expressed by glioblastoma cell line was upregulated after endotoxin stimulation. The present results indicated a significant production of CCL18/PARC in different CNS traumatic and neoplasm tissues by specific cellular elements expressing the chemokine. An anti-inflammatory mechanism jointly exerted by these cells via CCL18/PARC may be involved in the CNS immunity after traumatic injury and tumorigenesis. (C) 2010 IBRO. Published by Elsevier Ltd. All rights reserved.	[Wei, C. -P.; Tsai, M. -D.] Shin Kong Wu Ho Su Mem Hosp, Dept Neurosurg, Taipei 111, Taiwan; [Chang, C. -Y.; Lee, Y. -H.; Wu, C. -H.] Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan; [Chang, C. -Y.; pai, M. -H] Taipei Med Univ, Coll Med, Dept Anat, Taipei, Taiwan; [Lee, Y. -H.; Wang, C. -Y.] Taipei Med Univ, Coll Med, Dept Physiol, Taipei, Taiwan; [Leu, S. -J.] Taipei Med Univ, Dept Microbiol & Immunol, Taipei, Taiwan; [Hung, K. -S.] Taipei Med Univ, Wan Fang Hosp, Dept Neurosurg, Taipei, Taiwan; [Tsai, M. -D.] Fu Jen Catholic Univ, Sch Med, Taipei, Taiwan; [Wu, C. -H.] Natl Def Med Ctr, Dept Biol & Anat, Taipei 114, Taiwan; [Wu, C. -H.] Natl Def Med Ctr, Inst Biol & Anat, Taipei 114, Taiwan		Tsai, MD (corresponding author), Shin Kong Wu Ho Su Mem Hosp, Dept Neurosurg, 95 Wen Chang Rd, Taipei 111, Taiwan.	M000727@ms.skh.org.tw; microgli@mail.ndmctsgh.edu.tw			Shin-Kong WHS Memorial Hospital [SKH-TMU-95-15]; National Science CouncilMinistry of Science and Technology, Taiwan [NSC96-2320-B-016-010]	This work serves as the doctoral thesis of CY Chang. The study was supported in part by grants SKH-TMU-95-15 from Shin-Kong WHS Memorial Hospital and NSC96-2320-B-016-010 from National Science Council.	Adema GJ, 1997, NATURE, V387, P713, DOI 10.1038/42716; Atamas SP, 2003, AM J RESP CELL MOL, V29, P743, DOI 10.1165/rcmb.2003-0078OC; Bajetto A, 2001, FRONT NEUROENDOCRIN, V22, P147, DOI 10.1006/frne.2001.0214; Balabanov R, 2007, J NEUROSCI, V27, P2013, DOI 10.1523/JNEUROSCI.4689-06.2007; Boven LA, 2006, BRAIN, V129, P517, DOI 10.1093/brain/awh707; Cartier L, 2005, BRAIN RES REV, V48, P16, DOI 10.1016/j.brainresrev.2004.07.021; de Haas AH, 2007, MOL NEUROBIOL, V36, P137, DOI 10.1007/s12035-007-0036-8; DESBAILLETS I, 1994, INT J CANCER, V58, P240, DOI 10.1002/ijc.2910580216; GHIMIKAR RS, 1996, J NEUROSCI RES, V46, P727; Glabinski AR, 1996, J IMMUNOL, V156, P4363; Goerdt S, 1999, PATHOBIOLOGY, V67, P222, DOI 10.1159/000028096; Guan P, 1999, GENOMICS, V56, P296, DOI 10.1006/geno.1998.5635; Guo H, 1998, SCAND J IMMUNOL, V48, P502; Hausler KG, 2002, EUR J NEUROSCI, V16, P2113, DOI 10.1046/j.1460-9568.2002.02287.x; Hesselgesser J, 1999, J NEUROVIROL, V5, P13, DOI 10.3109/13550289909029741; Hieshima K, 1997, J IMMUNOL, V159, P1140; HITCHCOCK ER, 1988, J NEUROSURG, V68, P432, DOI 10.3171/jns.1988.68.3.0432; Hsu K, 2005, J IMMUNOL, V174, P2318, DOI 10.4049/jimmunol.174.4.2318; Ishii N, 1998, J NEURO-ONCOL, V37, P17, DOI 10.1023/A:1005959719927; Ito A, 1999, J IMMUNOL, V162, P4260; Karpus WJ, 2001, J NEUROVIROL, V7, P493, DOI 10.1080/135502801753248079; Kastenbauer S, 2005, J NEUROIMMUNOL, V164, P134, DOI 10.1016/j.jneuroim.2005.03.009; Kaukola T, 2004, ANN NEUROL, V55, P186, DOI 10.1002/ana.10809; Kimura T, 2002, INT J ONCOL, V21, P707; Kodelja V, 1998, J IMMUNOL, V160, P1411; le Blanc LMP, 2006, NEUROSCI LETT, V397, P145, DOI 10.1016/j.neulet.2005.12.029; Leung SY, 2004, GASTROENTEROLOGY, V127, P457, DOI 10.1053/j.gastro.2004.05.031; Leung SY, 1997, ACTA NEUROPATHOL, V93, P518, DOI 10.1007/s004010050647; Lindhout E, 2001, J IMMUNOL, V166, P3284, DOI 10.4049/jimmunol.166.5.3284; Lumpkins K, 2008, J TRAUMA, V64, P358, DOI 10.1097/TA.0b013e318160df9b; Maru SV, 2008, J NEUROIMMUNOL, V199, P35, DOI 10.1016/j.jneuroim.2008.04.029; McManus CM, 2000, GLIA, V29, P273, DOI 10.1002/(SICI)1098-1136(20000201)29:3<273::AID-GLIA8>3.3.CO;2-0; McTigue DM, 1998, J NEUROSCI RES, V53, P368, DOI 10.1002/(SICI)1097-4547(19980801)53:3<368::AID-JNR11>3.0.CO;2-1; Mrazek F, 2002, IMMUNOL LETT, V84, P17, DOI 10.1016/S0165-2478(02)00130-X; Pardo A, 2001, J LEUKOCYTE BIOL, V70, P610; Pivarcsi A, 2004, J IMMUNOL, V173, P5810, DOI 10.4049/jimmunol.173.9.5810; Platten M, 2003, ANN NEUROL, V54, P388, DOI 10.1002/ana.10679; Quan N, 2000, J NEUROSCI, V20, P6473, DOI 10.1523/JNEUROSCI.20-17-06473.2000; Sallusto F, 1999, EUR J IMMUNOL, V29, P1617, DOI 10.1002/(SICI)1521-4141(199905)29:05<1617::AID-IMMU1617>3.0.CO;2-3; Schraufstatter I, 2004, AM J PHYSIOL-LUNG C, V286, pL494, DOI 10.1152/ajplung.00323.2002; Schutyser E, 2005, J LEUKOCYTE BIOL, V78, P14, DOI 10.1189/jlb.1204712; Schutyser E, 2002, J BIOL CHEM, V277, P24584, DOI 10.1074/jbc.M112275200; Stefini R, 2008, J NEUROSURG, V108, P958, DOI 10.3171/JNS/2008/108/5/0958; Strik HM, 2004, ANTICANCER RES, V24, P37; Struyf S, 2003, AM J PATHOL, V163, P2065, DOI 10.1016/S0002-9440(10)63564-X; TAKESHIMA H, 1994, J NEUROSURG, V80, P1056, DOI 10.3171/jns.1994.80.6.1056; Vogel TW, 2005, CLIN CANCER RES, V11, P3624, DOI 10.1158/1078-0432.CCR-04-2115; Vulcano M, 2003, J IMMUNOL, V170, P3843, DOI 10.4049/jimmunol.170.7.3843; Yamagami S, 1999, J LEUKOCYTE BIOL, V65, P744, DOI 10.1002/jlb.65.6.744; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	50	17	18	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	FEB 17	2010	165	4					1233	1243		10.1016/j.neuroscience.2009.11.050			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	549VD	WOS:000274081500021	19958819				2022-02-06	
J	Brown, CVR; Foulkrod, KH; Lopez, D; Stokes, J; Villareal, J; Foarde, K; Curry, E; Coopwood, B				Brown, Carlos V. R.; Foulkrod, Kelli H.; Lopez, Daniel; Stokes, John; Villareal, Jesus; Foarde, Katie; Curry, Eardie; Coopwood, Ben			Recombinant Factor VIIa for the Correction of Coagulopathy Before Emergent Craniotomy in Blunt Trauma Patients	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Factor VIIa; Traumatic brain injury; Craniotomy; Coagulopathy	ACTIVATED FACTOR-VII; ACUTE INTRACEREBRAL HEMORRHAGE; BRAIN-INJURY; CLINICAL-TRIAL; REVERSAL; SAFETY; RFVIIA	Background: Recombinant activated factor VII (rFVIIa) has been associated with decreased blood transfusion requirements in trauma patients. Clinical use has recently been extended to the treatment of coagulopathic patients with traumatic brain injury, and results have been encouraging. However, the cost and possible thromboembolic complications of rFVIIa have been considered barriers to its widespread use. We hypothesize that rFVIIa would provide an effective and cost efficient means of correcting coagulopathy in patients with traumatic brain injury undergoing emergent craniotomy. Methods: We performed a 2-year (2005-2006) retrospective study of adult blunt trauma patients with traumatic brain injury who presented coagulpathic (international normalized ratio [INR] >1.3) and required emergent craniotomy. We compared patients who did (rFVIIa group) and did not (no-rFVIIa group) receive rFVIIa to correct coagulopathy before craniotomy. Results: There were 14 rFVIIa patients and 14 no-rFVIIa patients. The rFVIIa patients were older (59 years vs. 41 years, p = 0.04), but there was no difference in male gender (79% vs. 79%, p = 0.68), injury severity score (29 vs. 29, p = 1.0). or Glasgow Coma Scale score (10 vs. 7, p = 0.67). Although there was no difference in admission INR (2.6 vs. 1.9, p = 0. 1 0) the rFVIIa group was more often taking preinjury coumadin (57% vs. 14%, p = 0.05). The rFVIIa group had a preoperative INR (1.2 +/- 0.4 vs. 1.4 +/- 0.2, p = 0.05), but there was no difference in the time from admission to craniotomy (135 minutes vs. 182 minutes, P = 0.51). The rFVIIa group received fewer units of packed red blood cells (PRBCs) and plasma during the perioperative period. In addition, the rVIIa group consumed fewer costs of PRBC ($756 per patient vs. S2,916 per patient, p < 0.001) and plasma ($369 per patient vs. $927 per patient, p = 0.001). The rFVIIa group still consumed fewer total costs of transfused blood products when cost of rFVIIa was included (S2,557 per patient vs. $4,110 per patient, p = 0.04). There were no thromboembolic complications in either group. Conclusions: rFVIIa provides a cost-efficient option to effectively correct coagulopathy in patients with traumatic brain injury undergoing emergent craniotomy. In addition, the use of rFVIIa is associated with decreased transfusion of PRBC and plasma and decreased transfusion-related hospital costs in this population.	[Brown, Carlos V. R.; Foulkrod, Kelli H.; Lopez, Daniel; Villareal, Jesus; Foarde, Katie; Coopwood, Ben] Univ Texas SW Med Sch Austin, Trauma Serv, Univ Med Ctr Brackenridge, Dept Surg, Austin, TX 78701 USA; [Stokes, John] Univ Med Ctr Brackenridge, Dept Neurosurg, Austin, TX USA; [Curry, Eardie] Univ Med Ctr Brackenridge, Dept Pharm, Austin, TX USA		Brown, CVR (corresponding author), Univ Texas SW Med Sch Austin, Trauma Serv, Univ Med Ctr Brackenridge, Dept Surg, 601 East,15th St, Austin, TX 78701 USA.	cvrbrown@seton.org					Bartal C, 2007, J TRAUMA, V63, P725, DOI 10.1097/TA.0b013e318031ccca; Boffard KD, 2005, J TRAUMA, V59, P8, DOI 10.1097/01.TA.0000171453.37949.B7; Dutton RP, 2003, J CLIN ANESTH, V15, P184, DOI 10.1016/S0952-8180(03)00034-5; HEDNER U, 1983, J CLIN INVEST, V71, P1836, DOI 10.1172/JCI110939; Ityas C, 2008, J CLIN ANESTH, V20, P276, DOI 10.1016/j.jclinane.2007.12.012; Ivascu FA, 2005, J TRAUMA, V59, P1131, DOI 10.1097/01.ta.0000189067.16368.83; Kenet G, 1999, LANCET, V354, P1879, DOI 10.1016/S0140-6736(99)05155-7; Kluger Y, 2007, CRIT CARE, V11, DOI 10.1186/cc6092; Martinowitz U, 2002, CAN J ANAESTH, V49, pS15; Martinowitz U, 2001, J TRAUMA, V51, P431, DOI 10.1097/00005373-200109000-00002; Mayer SA, 2005, NEW ENGL J MED, V352, P777, DOI 10.1056/NEJMoa042991; Mayer SA, 2008, NEW ENGL J MED, V358, P2127, DOI 10.1056/NEJMoa0707534; Narayan RK, 2008, NEUROSURGERY, V62, P776, DOI 10.1227/01.NEU.0000297095.04013.C4; O'Connell KA, 2006, JAMA-J AM MED ASSOC, V295, P293, DOI 10.1001/jama.295.3.293; O'Neill PA, 2002, J TRAUMA, V52, P400, DOI 10.1097/00005373-200202000-00034; Stein DM, 2008, INJURY, V39, P1054, DOI 10.1016/j.injury.2008.03.032; Stein DM, 2008, J TRAUMA, V64, P620, DOI 10.1097/TA.0b013e3181650fc7; Stein DM, 2009, J TRAUMA, V66, P63, DOI 10.1097/TA.0b013e318191bc8a; Thomas GOR, 2007, J TRAUMA, V62, P564, DOI 10.1097/TA.0b013e318031afc2	19	17	19	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	FEB	2010	68	2					348	352		10.1097/TA.0b013e3181bbfb6b			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	555FC	WOS:000274492600025	20154547				2022-02-06	
J	Hunt, T; Asplund, C				Hunt, Tamerah; Asplund, Chad			Concussion Assessment and Management	CLINICS IN SPORTS MEDICINE			English	Article						Concussion; Head injury; Athletic training; Assessment; Management	TRAUMATIC BRAIN-INJURY; COLLEGIATE FOOTBALL PLAYERS; MILD HEAD-INJURY; NEUROPSYCHOLOGICAL DEFICITS; RECOVERY; SPORT; PERFORMANCE; STATEMENT	Sport-related concussions are becoming common place in athletics and daily activity. Proper assessment and management of concussions are crucial, as repeat concussion can result in prolonged symptoms and catastrophic outcomes. New research is changing the way concussions are managed. The previously used systems have been abandoned in favor of individualized assessment and management using a multidisciplinary approach to include clinical signs, neuropsychological assessment, and postural stability. Transitioning the new evidence to clinical practice is the future of diagnosis, management, and safe return to play following sport-related concussions. This article aims to bridge this gap and provide a systematic, easy-to-use methodology in the management of sport-related concussions.	[Hunt, Tamerah] Ohio State Univ, Sch Allied Med Profess, Columbus, OH 43221 USA; [Asplund, Chad] Ohio State Univ, Dept Family Med, Div Sports Med, Columbus, OH 43221 USA		Hunt, T (corresponding author), Ohio State Univ, Sch Allied Med Profess, 2050 Kenny Rd,Suite 3100, Columbus, OH 43221 USA.	tamerah.hunt@osumc.edu	Hunt, Tamerah/E-3281-2011				ALBERSON P, 1997, BRIT MED J, V314, P1855; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Broglio SP, 2005, MED SCI SPORT EXER, V37, P689, DOI 10.1249/01.MSS.0000159019.14919.09; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; COMPTON J S, 1990, British Journal of Neurosurgery, V4, P9, DOI 10.3109/02688699009000676; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; HALLENBECK JM, 1983, J NEUROSURG, V58, P749, DOI 10.3171/jns.1983.58.5.0749; HERRING S, 2006, MED SCI SPORTS EXERC, V38, P395, DOI DOI 10.1249/01.MSS.0000202025.48774.31; Ho MR, 1997, ARCH CLIN NEUROPSYCH, V12, P1; Hoane MR, 2003, J NEUROTRAUM, V20, P1189, DOI 10.1089/089771503770802871; King NS, 1997, CLIN REHABIL, V11, P13, DOI 10.1177/026921559701100104; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; Maiese K, 2003, TRENDS PHARMACOL SCI, V24, P228, DOI 10.1016/S0165-6147(03)00078-6; Maroon J C, 1980, Clin Neurosurg, V27, P414; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2002, BRIT J SPORT MED, V36, P3, DOI 10.1136/bjsm.36.1.3; McCrory P, 2009, J SCI MED SPORT, V12, P340, DOI 10.1016/j.jsams.2009.02.004; Mendez CV, 2005, J NEUROPSYCH CLIN N, V17, P297, DOI 10.1176/appi.neuropsych.17.3.297; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; Piland SG, 2003, J ATHL TRAINING, V38, P104; Randolph C, 2005, J ATHL TRAINING, V40, P139; Rigg JL, 2005, J HEAD TRAUMA REHAB, V20, P389, DOI 10.1097/00001199-200507000-00010; ROCKSWOLD GL, 1992, J NEUROSURG, V76, P929, DOI 10.3171/jns.1992.76.6.0929; SARAN A, 1988, INT J PSYCHIAT MED, V18, P75, DOI 10.2190/15AH-JB7Q-U94T-JEAF; Solomon S, 2001, MED CLIN N AM, V85, P987, DOI 10.1016/S0025-7125(05)70355-2; TEASDALE G, 1992, J NEUROTRAUM, V9, pS545; Thompson J, 2005, NEUROSCI LETT, V377, P158, DOI 10.1016/j.neulet.2004.11.090; TYLER GS, 1980, HEADACHE, V20, P213, DOI 10.1111/j.1526-4610.1980.hed2004213.x; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; YARNELL PR, 1973, NEUROLOGY, V23, P196, DOI 10.1212/WNL.23.2.196	48	17	18	1	13	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	JAN	2010	29	1					5	+		10.1016/j.csm.2009.09.002			14	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	617CE	WOS:000279257600004	19945584				2022-02-06	
J	Milleville-Pennel, I; Pothier, J; Hoc, JM; Mathe, JF				Milleville-Pennel, Isabelle; Pothier, Johanna; Hoc, Jean-Michel; Mathe, Jean-Francois			Consequences of cognitive impairments following traumatic brain injury: Pilot study on visual exploration while driving	BRAIN INJURY			English	Article						Visual exploration; neuropsychological evaluation; driving simulator; traumatic brain injury; attention; executive functions	WORKING-MEMORY; EYE-MOVEMENTS; PERFORMANCE; ATTENTION; FIXATIONS; SYSTEM; TESTS; AGE	Research design: This study compared an analysis of eyes movements while driving with data from neuropsychological tests. Methods and procedures: Five participants suffering from TBI and six control participants took part in this study. All had good driving experience. They were invited to drive on a fixed-base driving simulator. Eye fixations were recorded using an eye tracker. Neuropsychological tests were used to assess attention, working memory, rapidity of information processing and executive functions. Main outcomes and results: Participants with TBI showed a reduction in the variety of the visual zones explored and a reduction of the distance of exploration. Moreover, neuropsychological evaluation indicates that there were difficulties in terms of divided attention, anticipation and planning. Conclusions: There is a complementarity of the information obtained. Tests give information about cognitive deficiencies but not about their translation into a dynamic situation. Conversely, visual exploration provides information about the dynamic with which information is picked up in the environment but not about the cognitive processes involved.	[Milleville-Pennel, Isabelle; Hoc, Jean-Michel] IRCCyN, F-44321 Nantes 03, France; [Pothier, Johanna; Mathe, Jean-Francois] CHU Nantes, F-44035 Nantes 01, France		Milleville-Pennel, I (corresponding author), IRCCyN, 1 Rue Noe,BP 92101, F-44321 Nantes 03, France.	isabelle.milleville-pennel@irccyn.ec-nantes.fr			foundation for 'Gueules Cassees'	This work has been undertaken within the GDR Psychoergo and in collaboration with the CHU of Nantes and ARTA (Association pour la Reinsertion des Traumatise's craniens Atlantique). It has also received the support of the foundation for 'Gueules Cassees'. We are very grateful to Robert Boisliveau for his technical assistance, to all of the participants and to Susan Watts for proofreading this paper.	Allain P, 2005, BRAIN COGNITION, V57, P4, DOI 10.1016/j.bandc.2004.08.011; Anderson SW, 2005, P 3 INT DRIV S HUM F, P286; Baddeley A, 1997, NEUROPSYCHOLOGY, V11, P187, DOI 10.1037/0894-4105.11.2.187; Baddeley A, 1996, PHILOS T ROY SOC B, V351, P1397, DOI 10.1098/rstb.1996.0123; Ball K.K., 2005, P 3 INT DRIV S HUM F, P51, DOI [10.17077/drivingassessment.1142, DOI 10.17077/DRIVINGASSESSMENT.1142]; Brickenkamp, 1998, TEST ATTENTION CONCE; BROWN J, 1958, Q J EXP PSYCHOL, V10, P12, DOI 10.1080/17470215808416249; Burgess P, 1996, BEHAV ASSESSMENT DYS; Crundall DE, 1998, ERGONOMICS, V41, P448, DOI 10.1080/001401398186937; DAMASIO HC, 1995, SPECIAL ISSUE ANN NY, V769, P241; DUNCAN J, 1986, COGNITIVE NEUROPSYCH, V3, P271, DOI 10.1080/02643298608253360; Elkin-Frankston S, 2007, ARCH CLIN NEUROPSYCH, V22, P631, DOI 10.1016/j.acn.2007.04.004; FAGLIONI P, 1998, HDB CLIN EXPT NEUROP, P525; Falkmer T, 2005, OPTOMETRY VISION SCI, V82, P732, DOI 10.1097/01.opx.0000175560.45715.5b; FATTAL C, 2006, EVALUATION TROUBLES, P123; Haut M., 1992, NEUROPSYCHOLOGY, V6, P51; Hoc JM, 2007, J COGN ENG DECIS MAK, V1, P22, DOI 10.1177/155534340700100102; HOC JM, 2009, P EUR C COGN ERG 200; LAND MF, 1994, NATURE, V369, P742, DOI 10.1038/369742a0; Land MF, 2001, MOTION VISION, P227; Land MF, 2006, PROG RETIN EYE RES, V25, P296, DOI 10.1016/j.preteyeres.2006.01.002; LECOUTRE B, REV MODULAD, V33; Lew HL, 2005, BRAIN INJURY, V19, P177, DOI 10.1080/02699050400017171; Livingstone SA, 2007, BEHAV BRAIN RES, V185, P21, DOI 10.1016/j.bbr.2007.07.015; Martens MH, 2007, TRANSPORT RES F-TRAF, V10, P33, DOI 10.1016/j.trf.2006.03.002; Martin M., 2005, MIDDLE ADULTHOOD LIF, P179, DOI DOI 10.4135/9781452225999.N6; MATTSON AJ, 1992, J NERV MENT DIS, V178, P282; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Novack TA, 2006, BRAIN INJURY, V20, P455, DOI 10.1080/02699050600664541; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; PATOMELLA AH, 2005, P 3 INT DRIV S HUM F, P104; Patomella AH, 2006, J REHABIL MED, V38, P273, DOI 10.1080/16501970600632594; PETERSON LR, 1959, J EXP PSYCHOL, V58, P193, DOI 10.1037/h0049234; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; PRADATDIEHL P, 2006, EVALUATION TROUBLES, P123; Pradhan AK, 2005, HUM FACTORS, V47, P840, DOI 10.1518/001872005775570961; Richardson JTE, 2007, CORTEX, V43, P635, DOI 10.1016/S0010-9452(08)70493-3; ROGE J, 2003, RECHERCHE TRANSPORTS, V81, P157; ROUANET H, 1983, BRIT J MATH STAT PSY, V36, P252; Rouanet H, 1996, PSYCHOL BULL, V119, P149; Serino A, 2006, BRAIN INJURY, V20, P23, DOI 10.1080/02699050500309627; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Stav WB, 2008, J SAFETY RES, V39, P1, DOI 10.1016/j.jsr.2007.10.004; STERN EB, 2004, DRIVING SIMULATION P; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Underwood G, 2003, ERGONOMICS, V46, P629, DOI 10.1080/0014013031000090116; Underwood G., 2002, TRANSPORT RES F-TRAF, V5, P87, DOI [10.1016/S1369-8478(02)00008-6, DOI 10.1016/S1369-8478(02)00008-6]; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; Vuadens P, 2001, Rev Med Suisse Romande, V121, P453; WANG CC, 2003, PHYS GUIDE ASSESSING; Wechsler D., 2000, WECHSLER ADULT INTEL; Wilson BA, 1998, NEUROPSYCHOL REHABIL, V8, P213, DOI 10.1080/713755570; YILMAZ E, 1995, OPHTHALMOLOGY VISUAL, V36, pS940; Zimmermann P, 2002, APPLIED NEUROPSYCHOLOGY OF ATTENTION: THEORY DIAGNOSIS AND REHABILITATION, P110; Zimmermann P, 2007, TEST ATTENTIONAL PER; ZIMMERMANN P, 1993, DEV ASSESSMENT REHAB; Zoccolotti P, 2000, CORTEX, V36, P93, DOI 10.1016/S0010-9452(08)70839-6; [No title captured]	60	17	18	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2010	24	4					678	691		10.3109/02699051003692159			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	570ML	WOS:000275682300012	20235770				2022-02-06	
J	Rasool, A; Wani, AH; Darzi, MA; Zaroo, MI; Iqbal, S; Bashir, SA; Rashid, S; Lone, RA				Rasool, Altaf; Wani, Adil Hafeez; Darzi, Mohammad Ashraf; Zaroo, M. Inam; Iqbal, Shabir; Bashir, Shiekh Adil; Rashid, Shafaq; Lone, Reyaz Ahmad			Incidence and pattern of bear maul injuries in Kashmir	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Incidence; Pattern; Bear maul; Encounters; Termination; Injury; Face; Fractures; Soft tissue; Viscera	BITE	Background: Injuries due to mauling by bears are rarely reported in the literature. The high incidence of such injuries in Kashmir, India, which is a valley surrounded by dense forests and is a habitat of Asiatic Black bears, urged us to undertake such a study in our department. Materials and methods: The study was conducted both retrospectively (January 1990-July 2005) and prospectively (August 2005-December 2007). Results: A total of 417 cases were recorded and all the injuries were caused by black bears alone. Majority of the patients were young to middle-aged (96.8% of cases) and predominantly males (80.33%). The incidence was highest during July to November (76.82%), and most of the attacks (97%) occurred during daytime. Soft-tissue injury occurred in all 417 cases, bones were involved in 131 (31.41%) while the visceral organs were injured in four (12.94%) patients. The face (80.57%) was most common part of the body injured, followed by the head (54.67%), and all the patients had soft-tissue injury (100%). In spite of devastating injuries caused by bear maulings, the mortality rate was only 2.39%. Conclusion: Injuries due to mauling by black bear occur mainly between July and November. The young and middle-aged men have a higher tendency to be wounded. The face and head were the most commonly affected sites, while visceral injuries were rare. Mortality was low, and reconstruction of many of the injuries was challenging, often necessitating a staged procedure. Those living in villages close to black bear habitats may benefit from education related to the risk and severity of the attacks in the hope of reducing the number of injuries seen. (C) 2009 Elsevier Ltd. All rights reserved.	[Rasool, Altaf; Wani, Adil Hafeez; Darzi, Mohammad Ashraf; Zaroo, M. Inam; Iqbal, Shabir; Bashir, Shiekh Adil; Rashid, Shafaq] Sherikashmir Inst Med Sci, Dept Plast & Reconstruct Surg, Srinagar 190015, Kashmir, India; [Lone, Reyaz Ahmad] Sherikashmir Inst Med Sci, Dept Cardiovasc & Thorac Surg, Srinagar 190015, Jammu & Kashmir, India		Rasool, A (corresponding author), Sherikashmir Inst Med Sci, Dept Plast & Reconstruct Surg, Srinagar 190015, Kashmir, India.	altafrsl@rediffmail.com					Dvivedi S, 2003, TROP DOCT, V33, P115, DOI 10.1177/004947550303300223; Floyd T, 1999, WILD ENVIRON MED, V10, P75, DOI 10.1580/1080-6032(1999)010[0075:BIHIAF]2.3.CO;2; GOVILA A, 1989, BRIT J PLAST SURG, V42, P101, DOI 10.1016/S0007-1226(89)90124-0; Hayashi Y, 2003, J TRAUMA, V55, P1178, DOI 10.1097/01.TA.0000025324.27227.D4; HERRERO S, 1970, SCIENCE, V170, P593, DOI 10.1126/science.170.3958.593; Jethani Jitendra, 2006, Indian J Ophthalmol, V54, P287; Kunimoto D, 2004, J CLIN MICROBIOL, V42, P3374, DOI 10.1128/JCM.42.7.3374-3376.2004; Middaugh J P, 1987, Alaska Med, V29, P121; Rose S C, 1982, Alaska Med, V24, P29; TOUGH SC, 1993, AM J FOREN MED PATH, V14, P22, DOI 10.1097/00000433-199303000-00005; VENKATASWAMY G, 1962, J All India Ophthalmol Soc, V10, P22; Vougiouklakis T, 2006, AM J FOREN MED PATH, V27, P266, DOI 10.1097/01.paf.0000220930.00053.43	12	17	17	0	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	JAN	2010	41	1					116	119		10.1016/j.injury.2009.07.077			4	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	547ND	WOS:000273895400022	19733351				2022-02-06	
S	Samantaray, S; Matzelle, DD; Ray, SK; Banik, NL		Andrews, RJ; Slikker, W; Trembly, B; Patterson, TA		Samantaray, Supriti; Matzelle, Denise D.; Ray, Swapan K.; Banik, Naren L.			Physiological low dose of estrogen-protected neurons in experimental spinal cord injury	NEUROPROTECTIVE AGENTS	Annals of the New York Academy of Sciences		English	Article; Proceedings Paper	9th International Conference on Neuroprotective Agents	SEP 07-11, 2008	Marine Biol Lab, Woods Hole, MA		Marine Biol Lab	estrogen; neuroprotection; spinal cord injury	GLUTAMATE-INDUCED APOPTOSIS; METHYLPREDNISOLONE; CELLS; RATS	A protective role for estrogen against neurodegeneration and neurotrauma has received enormous attention in recent years, unraveling multiple facets and thus establishing this steroid as a multiactive neuroprotectant. The present study briefly reports our findings on the neuroprotective efficacy of physiologically relevant low doses of estrogen in experimental spinal cord injury (SCI) in rats. The current finding further corroborates our earlier results on efficacy of pharmacological/supraphysiological levels of estrogen in SCI and adds to the significance of conducting preclinical studies on estrogen efficacy in SCI.	[Samantaray, Supriti; Matzelle, Denise D.; Banik, Naren L.] Med Univ S Carolina, Dept Neurosci, Div Neurol, Charleston, SC 29425 USA; [Ray, Swapan K.] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC USA		Banik, NL (corresponding author), Med Univ S Carolina, Dept Neurosci Neurol, 96 Jonathan Lucas St,MSC606,Suite 309CSB, Charleston, SC 29425 USA.	baniknl@musc.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS045967-03, R01 NS045967] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045967] Funding Source: NIH RePORTER		Miller SM, 2008, J NEUROSURG ANESTH, V20, P140, DOI 10.1097/01.ana.0000314442.40952.0d; Perot P L Jr, 1987, Cent Nerv Syst Trauma, V4, P149; Ray SK, 2000, BRAIN RES PROTOC, V5, P305, DOI 10.1016/S1385-299X(00)00027-1; Rozet I, 2008, J NEUROSURG ANESTH, V20, P137, DOI 10.1097/01.ana.0000314441.63823.b0; Samantaray S, 2008, J PINEAL RES, V44, P348, DOI 10.1111/j.1600-079X.2007.00534.x; Sribnick EA, 2007, J NEUROCHEM, V102, P203; Sribnick EA, 2006, NEUROSCIENCE, V137, P197, DOI 10.1016/j.neuroscience.2005.08.074; Sribnick EA, 2005, J NEUROSCI RES, V82, P283, DOI 10.1002/jnr.20622; Sribnick EA, 2004, J NEUROSCI RES, V76, P688, DOI 10.1002/jnr.20124; SRIBNICK EA, 2009, HDB NEUROCHEMISTRY M, P581; Sribnick EA, 2006, J NEUROSCI RES, V84, P1064, DOI 10.1002/jnr.21016; Sur P, 2003, BRAIN RES, V971, P178, DOI 10.1016/S0006-8993(03)02349-7	12	17	18	0	4	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN STREET, MALDEN 02148, MA USA	0077-8923		978-1-57331-777-1	ANN NY ACAD SCI	Ann.NY Acad.Sci.		2010	1199						86	89		10.1111/j.1749-6632.2009.05360.x			4	Multidisciplinary Sciences; Neurosciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics; Neurosciences & Neurology	BRJ59	WOS:000282838900009	20633112	Green Accepted			2022-02-06	
J	Scales, DC; Riva-Cambrin, J; Wells, D; Athaide, V; Granton, JT; Detsky, AS				Scales, Damon C.; Riva-Cambrin, Jay; Wells, Dave; Athaide, Valerie; Granton, John T.; Detsky, Allan S.			Prophylactic anticoagulation to prevent venous thromboembolism in traumatic intracranial hemorrhage: a decision analysis	CRITICAL CARE			English	Article							DEEP-VEIN THROMBOSIS; MOLECULAR-WEIGHT HEPARIN; SPONTANEOUS INTRACEREBRAL HEMORRHAGE; PNEUMATIC COMPRESSION DEVICES; QUALITY-OF-LIFE; BRAIN-INJURY; MAJOR TRAUMA; PULMONARY-EMBOLISM; HEAD TRAUMA; NEUROSURGICAL PATIENTS	Introduction: Patients with intracranial hemorrhage due to traumatic brain injury are at high risk of developing venous thromboembolism including deep vein thrombosis (DVT) and pulmonary embolism (PE). Thus, there is a trade-off between the risks of progression of intracranial hemorrhage (ICH) versus reduction of DVT/PE with the use of prophylactic anticoagulation. Using decision analysis modeling techniques, we developed a model for examining this trade-off for trauma patients with documented ICH. Methods: The decision node involved the choice to administer or to withhold low molecular weight heparin (LMWH) anticoagulation prophylaxis at 24 hours. Advantages of withholding therapy were decreased risk of ICH progression (death, disabling neurologic deficit, non-disabling neurologic deficit), and decreased risk of systemic bleeding complications (death, massive bleed). The associated disadvantage was greater risk of developing DVT/PE or death. Probabilities for each outcome were derived from natural history studies and randomized controlled trials when available. Utilities were obtained from accepted databases and previous studies. Results: The expected value associated with withholding anticoagulation prophylaxis was similar (0.90) to that associated with the LMWH strategy (0.89). Only two threshold values were encountered in one-way sensitivity analyses. If the effectiveness of LMWH at preventing DVT exceeded 80% (range from literature 33% to 82%) our model favoured this therapy. Similarly, our model favoured use of LMWH if this therapy increased the risk of ICH progression by no more than 5% above the baseline risk. Conclusions: Our model showed no clear advantage to providing or withholding anticoagulant prophylaxis for DVT/PE prevention at 24 hours after traumatic brain injury associated with ICH. Therefore randomized controlled trials are justifiable and needed to guide clinicians.	[Scales, Damon C.; Wells, Dave; Granton, John T.] Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON M4N 3M5, Canada; [Scales, Damon C.] Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; [Scales, Damon C.] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON M5B 1W8, Canada; [Scales, Damon C.] Univ Toronto, Dept Med, Toronto, ON M5B 1W8, Canada; [Riva-Cambrin, Jay] Primary Childrens Med Ctr, Dept Neurosurg, Salt Lake City, UT 84113 USA; [Riva-Cambrin, Jay] Univ Utah, Dept Neurosurg, Salt Lake City, UT 84132 USA; [Athaide, Valerie] Univ British Columbia, Fac Med, Vancouver, BC V6T 1Z3, Canada; [Granton, John T.] Univ Hlth Network, Dept Med, Toronto, ON M5G 2C4, Canada; [Granton, John T.] Univ Hlth Network, Dept Crit Care, Toronto, ON M5G 2C4, Canada; [Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Detsky, Allan S.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON M5T 3M6, Canada		Scales, DC (corresponding author), Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, 2075 Bayview Ave,Room D108, Toronto, ON M4N 3M5, Canada.	damon.scales@utoronto.ca			Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR)	DCS is supported by a New Investigator Award from the Canadian Institutes for Health Research.	Agnelli G, 1998, NEW ENGL J MED, V339, P80, DOI 10.1056/NEJM199807093390204; Brothers TE, 1997, J SURG RES, V67, P72, DOI 10.1006/jsre.1996.4962; Caroli M, 2001, SURG NEUROL, V56, P82, DOI 10.1016/S0090-3019(01)00540-7; Collen JF, 2008, CHEST, V134, P237, DOI 10.1378/chest.08-0023; COLLINS R, 1988, NEW ENGL J MED, V318, P1162, DOI 10.1056/NEJM198805053181805; Cook DJ, 2001, CRIT CARE, V5, P369; Cupitt JM, 2001, ANAESTHESIA, V56, P780; Danish SF, 2005, NEUROSURGERY, V56, P1286, DOI 10.1227/01.NEU.0000159882.11635.EA; DAVERAT P, 1991, STROKE, V22, P1, DOI 10.1161/01.STR.22.1.1; Dennis M, 2009, LANCET, V373, P1958, DOI 10.1016/S0140-6736(09)60941-7; Denson K, 2007, AM J SURG, V193, P380, DOI 10.1016/j.amjsurg.2006.12.004; Detsky AS, 1997, MED DECIS MAKING, V17, P126, DOI 10.1177/0272989X9701700202; Dickinson LD, 1998, NEUROSURGERY, V43, P1074, DOI 10.1097/00006123-199811000-00039; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; GAGE BF, 1995, JAMA-J AM MED ASSOC, V274, P1839, DOI 10.1001/jama.274.23.1839; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; Ginsberg JS, 1996, NEW ENGL J MED, V335, P1816, DOI 10.1056/NEJM199612123352407; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; GUDEMAN SK, 1979, NEUROSURGERY, V5, P309, DOI 10.1227/00006123-197909000-00002; Hirsh J, 2008, CHEST, V133, p110S, DOI 10.1378/chest.08-0652; JOFFE SN, 1975, J NEUROSURG, V42, P201, DOI 10.3171/jns.1975.42.2.0201; KAPLAN RM, 1988, HEALTH SERV RES, V23, P203; KELLETT J, 1995, MED DECIS MAKING, V15, P297, DOI 10.1177/0272989X9501500401; KERRIDGE RK, 1995, ANAESTH INTENS CARE, V23, P322, DOI 10.1177/0310057X9502300309; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Krahn MD, 1997, MED DECIS MAKING, V17, P142, DOI 10.1177/0272989X9701700204; Kurtoglu M, 2004, WORLD J SURG, V28, P807, DOI 10.1007/s00268-004-7295-6; Last J. M., 2001, DICT EPIDEMIOLOGY, VFourth; Lee TT, 1997, ANN INTERN MED, V126, P337, DOI 10.7326/0003-4819-126-5-199703010-00001; LIPPER MH, 1979, RADIOLOGY, V133, P645, DOI 10.1148/133.3.645; Macdonald RL, 2003, SURG NEUROL, V59, P363, DOI 10.1016/S0090-3019(03)00111-3; McLeod RS, 2001, ANN SURG, V233, P438, DOI 10.1097/00000658-200103000-00020; MONREAL M, 1992, CHEST, V102, P677, DOI 10.1378/chest.102.3.677; Naglie G, 1997, MED DECIS MAKING, V17, P136, DOI 10.1177/0272989X9701700203; Nathens AB, 2007, J TRAUMA, V62, P557, DOI 10.1097/TA.0b013e318031b5f5; Norwood SH, 2002, ARCH SURG-CHICAGO, V137, P696, DOI 10.1001/archsurg.137.6.696; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Patel NY, 2000, J TRAUMA, V48, P367, DOI 10.1097/00005373-200003000-00001; RADBERG JA, 1991, STROKE, V22, P571, DOI 10.1161/01.STR.22.5.571; ROGERS FB, 1993, J TRAUMA, V35, P637, DOI 10.1097/00005373-199310000-00021; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; SARASIN FP, 1993, J GEN INTERN MED, V8, P476, DOI 10.1007/BF02600108; Scales DC, 2009, J CRIT CARE, V24, P176, DOI 10.1016/j.jcrc.2009.03.010; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Shorr AF, 2001, CRIT CARE MED, V29, P1659, DOI 10.1097/00003246-200109000-00001; Siddique MS, 2002, J NEUROSURG, V96, P86, DOI 10.3171/jns.2002.96.1.0086; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; SWASH M, 1991, CLIN NEUROLOGY; Tabori U, 2000, CRIT CARE MED, V28, P840, DOI 10.1097/00003246-200003000-00038; Tengs TO, 2001, STROKE, V32, P964, DOI 10.1161/01.STR.32.4.964; TORRANCE GW, 1987, J CHRON DIS, V40, P593, DOI 10.1016/0021-9681(87)90019-1; TORRANCE GW, 1986, J HEALTH ECON, V5, P1, DOI 10.1016/0167-6296(86)90020-2; VALLADARES JB, 1980, NEUROSURGERY, V6, P138, DOI 10.1227/00006123-198002000-00004; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; ZELIKOVSKI A, 1981, J NEUROSURG, V54, P652, DOI 10.3171/jns.1981.54.5.0652	56	17	18	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care		2010	14	2							R72	10.1186/cc8980			10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	611LO	WOS:000278816800047	20406444	Green Published, gold			2022-02-06	
J	Wright, J; Zhang, G; Yu, TS; Kernie, SG				Wright, Jamie; Zhang, Gui; Yu, Tzong-Shiue; Kernie, Steven G.			Age-Related Changes in the Oligodendrocyte Progenitor Pool Influence Brain Remodeling after Injury	DEVELOPMENTAL NEUROSCIENCE			English	Article						Neural stem cell; White matter; Oligodendrocyte progenitor cells; Traumatic brain injury; Platelet-derived growth factor receptor-alpha	PERINATAL WHITE-MATTER; HIPPOCAMPAL NEUROGENESIS; ADULT NEUROGENESIS; FOREBRAIN NEUROGENESIS; SUBVENTRICULAR ZONE; CELLS; VULNERABILITY; MECHANISMS; PLASTICITY; LINEAGE	Brain remodeling occurs after all forms of brain injury, though the mechanisms underlying this phenomenon are mostly unknown. Neural stem and progenitor cells are one source of endogenous cells that may contribute to brain remodeling and subsequent recovery. In addition, certain populations of progenitors are particularly susceptible to injury, and their depletion may lead to the impairment of developmental processes that vary with age. We particularly focus on glial progenitors, which are more abundant postnatally and particularly susceptible to acquired brain injuries such as traumatic brain injury. We have recently characterized a novel transgenic mouse that expresses herpes thymidine kinase under the control of the neural-progenitor-specific nestin promoter and allows for temporally induced ablation of dividing progenitors. By genetically depleting dividing cortical progenitors at various times, we identify postnatal day 7 (P7) to P14 as a critical period for oligodendrogenesis. Targeted ablation of dividing progenitors during this window leads to cell-specific depletion of oligodendrocyte precursors expressing platelet-derived growth factor receptor-alpha and corresponding myelination and motor deficits. This modeling provides insight into how the age at which white matter injury occurs influences both injury severity and subsequent recovery. Copyright (C) 2010 S. Karger AG, Basel	[Wright, Jamie; Zhang, Gui; Yu, Tzong-Shiue; Kernie, Steven G.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Wright, Jamie; Zhang, Gui; Yu, Tzong-Shiue; Kernie, Steven G.] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA		Kernie, SG (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	steven.kernie@utsouthwestern.edu	Messier, Claude/A-2322-2008; Kernie, Steven/AAT-9912-2020	Messier, Claude/0000-0002-4791-1763; Wright, Jamie/0000-0001-5053-3583; Yu, Tzong-Shiue/0000-0003-4277-6213; Kernie, Steven/0000-0003-1371-0549	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS048192]; Seay Endowed Fund for Research on Brain and Spinal Cord Injuries in Children; Green Fellowship Program; University of Texas at Dallas and UT Southwestern; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS048192] Funding Source: NIH RePORTER	This study was supported by NIH grant R01 NS048192 (S.G.K.) and the Seay Endowed Fund for Research on Brain and Spinal Cord Injuries in Children (S.G.K.) and by the Green Fellowship Program, the University of Texas at Dallas and UT Southwestern (J.W.).	ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Back SA, 2001, J NEUROSCI, V21, P1302; Back SA, 2002, J NEUROSCI, V22, P455, DOI 10.1523/JNEUROSCI.22-02-00455.2002; Back SA, 2007, STROKE, V38, P724, DOI 10.1161/01.STR.0000254729.27386.05; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Covey MV, 2010, DEV NEUROSCI-BASEL, V32, P488, DOI 10.1159/000321607; Emsley JG, 2005, PROG NEUROBIOL, V75, P321, DOI 10.1016/j.pneurobio.2005.04.002; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gale SD, 2010, J HEAD TRAUMA REHAB, V25, P15, DOI 10.1097/HTR.0b013e3181c39960; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Giza CC, 2009, DEV NEUROREHABIL, V12, P255, DOI 10.3109/17518420903087558; Goold D, 2009, J TRAUMA, V67, P71, DOI 10.1097/TA.0b013e3181b021ae; Gourevitch R, 2004, BEHAV PHARMACOL, V15, P287, DOI 10.1097/01.fbp.0000135703.48799.71; He YT, 2009, NEUROSCI RES, V65, P272, DOI 10.1016/j.neures.2009.07.011; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Johnston MV, 2009, DEV DISABIL RES REV, V15, P94, DOI 10.1002/ddrr.64; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Koch JD, 2008, J CEREBR BLOOD F MET, V28, P1294, DOI 10.1038/jcbfm.2008.15; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Miles DK, 2008, HIPPOCAMPUS, V18, P793, DOI 10.1002/hipo.20439; Ness JK, 2004, GLIA, V46, P183, DOI 10.1002/glia.10360; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; PRINGLE NP, 1992, DEVELOPMENT, V115, P535; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Rothstein RP, 2005, DEV NEUROSCI-BASEL, V27, P149, DOI 10.1159/000085987; Sauvageot CM, 2002, CURR OPIN NEUROBIOL, V12, P244, DOI 10.1016/S0959-4388(02)00322-7; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Segovia KN, 2008, ANN NEUROL, V63, P520, DOI 10.1002/ana.21359; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Sookplung P, 2009, CURR OPIN ANESTHESIO, V22, P572, DOI 10.1097/ACO.0b013e3283303884; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Takashima S, 2009, SEMIN PEDIATR NEUROL, V16, P226, DOI 10.1016/j.spen.2009.09.004; Tasker RC, 2005, PEDIATR RES, V58, P302, DOI 10.1203/01.PDR.0000169965.08854.25; Tasker RC, 2006, DEV NEUROSCI-BASEL, V28, P302, DOI 10.1159/000094156; Volpe JJ, 2003, PEDIATRICS, V112, P176, DOI 10.1542/peds.112.1.176; Winocur G, 2006, HIPPOCAMPUS, V16, P296, DOI 10.1002/hipo.20163; Wojtowicz JM, 2006, HIPPOCAMPUS, V16, P261, DOI 10.1002/hipo.20158; Woodruff RH, 2001, INT J DEV NEUROSCI, V19, P379, DOI 10.1016/S0736-5748(00)00083-6; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008	42	17	17	0	4	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0378-5866			DEV NEUROSCI-BASEL	Dev. Neurosci.		2010	32	5-6					499	509		10.1159/000322081			11	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Neurosciences & Neurology	725RO	WOS:000287663900018	21160162	Green Published, Bronze			2022-02-06	
J	Yantz, CL; Johnson-Greene, D; Higginson, C; Emmerson, L				Yantz, Christine L.; Johnson-Greene, Doug; Higginson, Christopher; Emmerson, Lindsay			Functional cooking skills and neuropsychological functioning in patients with stroke: An ecological validity study	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Ecological validity; Predictive validity; Neuropsychological assessment; Cerebrovascular accidents; Activities of daily living; Cooking	TRAUMATIC BRAIN-INJURY; PERFORMING ACTIVITIES; COGNITIVE IMPAIRMENT; EXECUTIVE DEFICITS; COMPLEX FIGURE; TESTS; INDIVIDUALS; SATISFACTION; PREDICTION; BATTERY	Efforts to relate neuropsychological performance to real-world task functioning have predominantly yielded lackluster results, typically with neuropsychological performance accounting for modest amounts of variance in function. Nonetheless, the ecological validity of neuropsychological measures for predicting functional abilities remains a strong research interest and clinical necessity. This study relates neuropsychological performance to performance on a standardised cooking task (Rabideau Kitchen Evaluation - Revised; RKE-R) in persons with stroke. Results showed that while the composite score of mean neuropsychological performance had the largest association with meal preparation, several neuropsychological measures were significantly related to the RKE-R. Groups of left and right hemisphere stroke patients were not significantly different in terms of RKE-R performance. These results suggest that functional cooking task performance is related to intact cognitive abilities in delayed verbal memory, simple auditory attention, and visuospatial skills, as well as overall cognitive performance. Implications for neuropsychologists are discussed.	[Yantz, Christine L.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Yantz, Christine L.] Div Rehabil Psychol & Neuropsychol, Dept Phys Med & Rehabil, Baltimore, MD USA; [Johnson-Greene, Doug] Univ Miami, Leonard M Miller Sch Med, Dept Rehabil Med, Miami, FL 33136 USA; [Higginson, Christopher] Loyola Coll Maryland, Dept Psychol, Baltimore, MD USA; [Emmerson, Lindsay] VA San Diego Healthcare Syst, San Diego, CA USA		Johnson-Greene, D (corresponding author), Univ Miami, Miller Sch Med, Clin Res Bldg C-206,1120 NW 14th St, Miami, FL 33136 USA.	djgreen@med.miami.edu	Higginson, Christopher I/A-9163-2009		NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AA013898]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [K23AA013898] Funding Source: NIH RePORTER	This research was supported by NIH grant AA013898. The authors would like to thank Laura McGinnis for her assistance with collecting the Rabideau Kitchen Examination-Revised (RKE-R) data for this project.	AXELROD BN, 1994, ASSESSMENT, V0001, P00269, DOI DOI 10.1177/107319119400100307; Baum CM, 2008, AM J OCCUP THER, V62, P446, DOI 10.5014/ajot.62.4.446; Benedict, 2001, HOPKINS VERBAL LEARN; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Burgess P, 1996, BEHAV ASSESSMENT DYS; Cahn-Weiner DA, 2000, CLIN NEUROPSYCHOL, V14, P187, DOI 10.1076/1385-4046(200005)14:2;1-Z;FT187; Cahn-Weiner DA, 2007, J INT NEUROPSYCH SOC, V13, P747, DOI 10.1017/S1355617707070853; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Dodrill CB, 1997, CLIN NEUROPSYCHOL, V11, P1, DOI 10.1080/13854049708407025; Farias ST, 2003, ARCH CLIN NEUROPSYCH, V18, P655, DOI 10.1016/S0887-6177(02)00159-2; Farmer J E, 1995, Appl Neuropsychol, V2, P107, DOI 10.1207/s15324826an0203&4_2; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fortin S, 2003, CORTEX, V39, P273, DOI 10.1016/S0010-9452(08)70109-6; Godbout L, 2005, BRAIN INJURY, V19, P337, DOI 10.1080/02699050400005093; Goodglass H, 1983, ASSESSMENT APHASIA R; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Hartman-Maeir A, 2007, DISABIL REHABIL, V29, P559, DOI 10.1080/09638280600924996; Higginson CI, 2000, ARCH CLIN NEUROPSYCH, V15, P185, DOI 10.1016/S0887-6177(99)00004-9; Johnston MV, 2005, ARCH PHYS MED REHAB, V86, P735, DOI 10.1016/j.apmr.2004.10.031; Kaplan E, 1976, BOSTON NAMING TEST E; Katz N, 2000, OCCUP THER J RES, V20, P3, DOI 10.1177/153944920002000101; Kibby MY, 1998, ARCH CLIN NEUROPSYCH, V13, P523, DOI 10.1016/S0887-6177(97)00038-3; Man DWK, 2006, BRAIN INJURY, V20, P205, DOI 10.1080/02699050500454621; Mesulam M., 1985, PRINCIPLES BEHAV NEU; MEYERS J, 1995, MEYERS SCORING SYSTE; NEISTADT ME, 1994, AM J OCCUP THER, V48, P431, DOI 10.5014/ajot.48.5.431; NEISTADT ME, 1992, OCCUP THER J RES, V12, P242, DOI 10.1177/153944929201200404; Okonkwo OC, 2006, J AM GERIATR SOC, V54, P1745, DOI 10.1111/j.1532-5415.2006.00916.x; Rabin LA, 2007, CLIN NEUROPSYCHOL, V21, P727, DOI 10.1080/13854040600888776; Robertson I., 1994, TEST EVERYDAY ATTENT; Ruff RM, 2003, ARCH CLIN NEUROPSYCH, V18, P847, DOI 10.1016/j.acn.2003.07.002; Rybarczyk B, 1996, AM J GERIAT PSYCHIAT, V4, P131, DOI 10.1097/00019442-199621420-00005; Schretlen D., 1997, BRIEF TEST ATTENTION; Schretlen DJ, 2008, J INT NEUROPSYCH SOC, V14, P436, DOI 10.1017/S1355617708080387; Schwarz L, 2009, CLIN NEUROPSYCHOL, V23, P255, DOI 10.1080/13854040802220034; Silverberg ND, 2007, J INT NEUROPSYCH SOC, V13, P898, DOI 10.1017/S1355617707071135; Silverberg ND, 2009, J INT NEUROPSYCH SOC, V15, P94, DOI 10.1017/S1355617708090139; Spencer RJ, 2009, J CLIN EXP NEUROPSYC, V31, P373, DOI 10.1080/13803390802206398; *UN DAT SYST MED R, 1997, GUID UN DAT SET MED; Watanabe K, 2005, BRAIN DEV-JPN, V27, P564, DOI 10.1016/j.braindev.2005.02.007; Withaar FK, 2000, J INT NEUROPSYCH SOC, V6, P480, DOI 10.1017/S1355617700644065	41	17	18	0	17	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2010	20	5					725	738	PII 922717775	10.1080/09602011003765690			14	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	648YB	WOS:000281730300005	20521203	Green Accepted			2022-02-06	
J	Quigley, A; Tan, AA; Hoane, MR				Quigley, Andrea; Tan, Arlene A.; Hoane, Michael R.			The effects of hypertonic saline and nicotinamide on sensorimotor and cognitive function following cortical contusion injury in the rat	BRAIN RESEARCH			English	Article						Therapy; Hippocampus; Neurodegeneration; Retrograde amnesia; Traumatic brain injury; Controlled cortical impact	TRAUMATIC BRAIN-INJURY; FLUID PERCUSSION INJURY; ELEVATED INTRACRANIAL-PRESSURE; FOCAL CEREBRAL-ISCHEMIA; HEAD-INJURY; HEMORRHAGIC-SHOCK; UNITED-STATES; WISTAR RATS; RESUSCITATION; RECOVERY	Hypertonic saline (HTS) is an accepted treatment for traumatic brain injury (TBI). However, the behavioral and cognitive consequences following FITS administration have not thoroughly been examined. Recent preclinical evidence has suggested that nicotinamide (NAM) is beneficial for recovery of function following TBI. The current study compared the behavioral and cognitive consequences of HTS and NAM as competitive therapeutic agents for the treatment of TBI. Following controlled cortical impact (CCI), bolus administrations of NAM (500 mg/kg), 7.5% HTS, or 0.9% saline Vehicle (1.0 mL/kg) were given at 2, 24, and 48 h post-CCI. Behavioral results revealed that animals treated with NAM and HTS showed significant improvements in beam walk and locomotor placing compared to the Vehicle group. The Morris water maze (MWM) retrograde amnesia test was conducted on day 12 post-CCI and showed that all groups had significant retention of memory compared to injured, Vehicle-treated animals. Working memory was also assessed on days 8-20 using the MWM. The NAM and Vehicle groups quickly acquired the task; however, HTS animals showed no acquisition of this task. Histological examinations revealed that the HTS-treated animals lost significantly more cortical tissue than either the NAM or Vehicle-treated animals. HTS-treated animals showed a greater loss of hippocampal tissue compared to the other groups. In general, NAM showed a faster rate of recovery than HTS without this associated tissue loss. The results of this study reiterate the strengths of NAM following injury and show concerns with bolus administrations of HTS due to the differential effects on cognitive performance and apparent tissue loss. (C) 2009 Elsevier B.V. All rights reserved.	[Hoane, Michael R.] So Illinois Univ, Dept Psychol, Restorat Neurosci Lab, Carbondale, IL 62901 USA		Hoane, MR (corresponding author), So Illinois Univ, Dept Psychol, Restorat Neurosci Lab, Life Sci 2,MC 6502, Carbondale, IL 62901 USA.	mhoane@siu.edu		Hoane, Michael/0000-0001-7779-2657	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS045647]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R15NS045647] Funding Source: NIH RePORTER	We would like to thank Jason Beare for his help in image capturing and analysis. Funded by NIH grant NS045647 to MRH.	Anderson JT, 1997, J TRAUMA, V42, P592, DOI 10.1097/00005373-199704000-00003; Ayoub IA, 1999, NEUROSCI LETT, V259, P21, DOI 10.1016/S0304-3940(98)00881-7; Baker AJ, 2009, J NEUROTRAUM, V26, P1227, DOI 10.1089/neu.2008.0868; Barbre AB, 2006, BRAIN RES BULL, V69, P639, DOI 10.1016/j.brainresbull.2006.03.009; BARTH TM, 1990, BEHAV BRAIN RES, V39, P73, DOI 10.1016/0166-4328(90)90122-U; BATTISTELLA FD, 1991, J TRAUMA, V31, P182, DOI 10.1097/00005373-199131020-00005; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; *CDCP, TRAUM BRAIN INJ US; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; DeWitt DS, 1996, CRIT CARE MED, V24, P109, DOI 10.1097/00003246-199601000-00019; Elliott MB, 2007, J NEUROTRAUM, V24, P195, DOI 10.1089/neu.2006.0094; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Feng YZ, 2006, BRAIN RES BULL, V69, P117, DOI 10.1016/j.brainresbull.2005.11.011; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; Friedberg MH, 1999, J NEUROPHYSIOL, V81, P2243, DOI 10.1152/jn.1999.81.5.2243; Grover GJ, 2003, J CARDIOVASC PHARM, V42, P790, DOI 10.1097/00005344-200312000-00014; GUEDEL AE, 1920, INHALATION ANESTHESI; Haijima A, 2008, LEARN MEMORY, V15, P477, DOI 10.1101/lm.862308; Himmelseher S, 2001, J NEUROSURG ANESTH, V13, P120, DOI 10.1097/00008506-200104000-00009; Hoane MR, 2008, NEUROSCIENCE, V154, P861, DOI 10.1016/j.neuroscience.2008.04.044; Hoane MR, 2006, BRAIN RES, V1125, P185, DOI 10.1016/j.brainres.2006.10.019; Hoane MR, 2006, NEUROSCI LETT, V408, P35, DOI 10.1016/j.neulet.2006.07.011; Hoane MR, 2006, J NEUROTRAUM, V23, P1535, DOI 10.1089/neu.2006.23.1535; Hoane MR, 2008, OXID MED CELL LONGEV, V1, P46, DOI 10.4161/oxim.1.1.6694; Hoane MR, 2005, J NEUROTRAUM, V22, P1112, DOI 10.1089/neu.2005.22.1112; Hoane MR, 2004, J NEUROTRAUM, V21, P163, DOI 10.1089/089771504322778622; Hoane MR, 2003, J NEUROTRAUM, V20, P1189, DOI 10.1089/089771503770802871; Holland MA, 2008, J NEUROTRAUM, V25, P140, DOI 10.1089/neu.2007.0312; Hoover RC, 2004, J NEUROTRAUM, V21, P501, DOI 10.1089/089771504774129847; Horn P, 1999, NEUROL RES, V21, P758, DOI 10.1080/01616412.1999.11741010; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mokudai T, 2000, STROKE, V31, P1679, DOI 10.1161/01.STR.31.7.1679; Munar F, 2000, J NEUROTRAUM, V17, P41, DOI 10.1089/neu.2000.17.41; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V400; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; Rhee P, 2003, J TRAUMA, V54, pS52, DOI 10.1097/01.TA.0000064507.80390.10; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schatzmann C, 1998, ACT NEUR S, V71, P31; SCHELLER MS, 1991, J NEUROSURG ANESTH, V3, P291, DOI 10.1097/00008506-199112000-00009; Schmanke TD, 1996, J NEUROTRAUM, V13, P293, DOI 10.1089/neu.1996.13.293; Sell SL, 2008, ANESTHESIOLOGY, V108, P873, DOI 10.1097/ALN.0b013e31816c8a15; Smith DC, 2005, J NEUROTRAUM, V22, P1485, DOI 10.1089/neu.2005.22.1485; Smith DC, 2006, J NEUROTRAUM, V23, P1549, DOI 10.1089/neu.2006.23.1549; Soustiel JF, 2006, BRAIN RES, V1101, P136, DOI 10.1016/j.brainres.2006.05.045; Suarez JI, 1998, CRIT CARE MED, V26, P1118, DOI 10.1097/00003246-199806000-00038; Taylor G, 1996, J PEDIATR SURG, V31, P65, DOI 10.1016/S0022-3468(96)90321-8; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; Weed LH, 1919, AM J PHYSIOL, V48, P531, DOI 10.1152/ajplegacy.1919.48.4.531; WISNER DH, 1990, J TRAUMA, V30, P75, DOI 10.1097/00005373-199001000-00011; WORTHLEY LIG, 1988, J NEUROSURG, V68, P478, DOI 10.3171/jns.1988.68.3.0478; Yang J, 2002, PHARMACOL BIOCHEM BE, V73, P901, DOI 10.1016/S0091-3057(02)00939-5; Zausinger S, 2004, NEUROSURGERY, V55, P679, DOI 10.1227/01.NEU.0000134558.28977.EE; ZORNOW MH, 1990, ACT NEUR S, V51, P324	58	17	18	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	DEC 4	2009	1304						138	148		10.1016/j.brainres.2009.09.062			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	531HE	WOS:000272654400015	19781534	Green Accepted			2022-02-06	
J	Almosnino, S; Pelland, L; Pedlow, SV; Stevenson, JM				Almosnino, Sivan; Pelland, Lucie; Pedlow, Samuel V.; Stevenson, Joan M.			Between-day reliability of electromechanical delay of selected neck muscles during performance of maximal isometric efforts	BMC SPORTS SCIENCE MEDICINE AND REHABILITATION			English	Article							SURFACE EMG VARIABLES; CONCUSSION; ONSET; REPEATABILITY; VOLUNTARY; CONTRACTIONS; MUSCULATURE; ENDURANCE; FOOTBALL; OPERATOR	Background: The purpose of this study was to assess the between-day reliability of the electromechanical delay (EMD) of selected neck muscles during the performance of maximal isometric contractions in five different directions. Methods: Twenty-one physically active males participated in two testing sessions separated by seven to eight days. Using a custom-made fixed frame dynamometer, cervical force and surface electromyography (EMG) were recorded bilaterally from the splenius capitis, upper trapezius and sternocleidomastoid muscles during the performance of efforts in extension, flexion, left and right lateral bending, and protraction. The EMD was extracted using the Teager-Kaiser Energy Operator. Reliability indices calculated for each muscle in each testing direction were: the difference in scores between the two testing sessions and corresponding 95% confidence intervals, the standard error of measurement (SEM) and intra-class correlation coefficients (ICC). Results: EMD values showed no evidence of systematic difference between the two testing sessions across all muscles and testing directions. The SEM for extension, flexion and lateral bending efforts ranged between 2.5 ms to 4.8 ms, indicating a good level of measurement precision. For protraction, SEM values were higher and considered to be imprecise for research and clinical purposes. ICC values for all muscles across all testing directions ranged from 0.23 to 0.79. Conclusion: EMD of selected neck muscles can be measured with sufficient precision for the assessment of neck muscle function in an athletic population in the majority of directions tested.`	[Almosnino, Sivan; Pedlow, Samuel V.; Stevenson, Joan M.] Queens Univ, Sch Kinesiol & Hlth Studies, Biomech & Ergon Lab, Kingston, ON, Canada; [Pelland, Lucie] Queens Univ, Sch Rehabil Therapy, Kingston, ON, Canada; [Almosnino, Sivan; Pelland, Lucie; Stevenson, Joan M.] Kingston Gen Hosp, Human Mobil Res Ctr, Kingston, ON, Canada		Pelland, L (corresponding author), Queens Univ, Sch Rehabil Therapy, Kingston, ON, Canada.	sivan.almosnino@queensu.ca; lucie.pelland@queensu.ca; 5sp1@queensu.ca; joan.stevenson@queensu.ca			Ontario Neurotrauma Foundation; Queen's University Advisory Research Committee to Lucie Pelland	This study was supported by grants from the Ontario Neurotrauma Foundation and the Queen's University Advisory Research Committee to Lucie Pelland. The authors would like to acknowledge the contributions of Sue Reid, Mohammad Abdoli-Eramaki, Tara Kajaks, Joe Nashed and Alexis Twiddy.	Abbink JH, 1998, J ORAL REHABIL, V25, P365; Burnett A, 2007, J ELECTROMYOGR KINES, V17, P635, DOI 10.1016/j.jelekin.2006.06.003; CAVANAGH PR, 1979, EUR J APPL PHYSIOL, V42, P159, DOI 10.1007/BF00431022; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Eechaute C, 2007, J ATHL TRAINING, V42, P60; Falla D, 2002, EUR J APPL PHYSIOL, V87, P542, DOI 10.1007/s00421-002-0661-x; Falla D, 2002, CLIN NEUROPHYSIOL, V113, P57, DOI 10.1016/S1388-2457(01)00708-8; Grosset JF, 2009, EUR J APPL PHYSIOL, V105, P131, DOI 10.1007/s00421-008-0882-8; HAKKINEN K, 1986, EUR J APPL PHYSIOL O, V55, P147, DOI 10.1007/BF00714997; Hodges PW, 1996, ELECTROMYOGR MOTOR C, V101, P511, DOI 10.1016/S0921-884X(96)95190-5; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Howatson G, 2009, J ELECTROMYOGR KINES, V19, P975, DOI 10.1016/j.jelekin.2008.02.002; Johnston KM, 2001, J AM COLL SURGEONS, V192, P515, DOI 10.1016/S1072-7515(01)00797-9; Joines SMB, 2006, J ELECTROMYOGR KINES, V16, P485, DOI 10.1016/j.jelekin.2005.09.007; Kaiser JF, 1990, IEEE INT C AC SPEECH; Kubo K, 2001, J APPL PHYSIOL, V91, P26, DOI 10.1152/jappl.2001.91.1.26; Lauer RT, 2009, ANN BIOMED ENG, V37, P1584, DOI 10.1007/s10439-009-9727-9; Li XY, 2007, ANN BIOMED ENG, V35, P1532, DOI 10.1007/s10439-007-9320-z; Linford CW, 2006, ARCH PHYS MED REHAB, V87, P395, DOI 10.1016/j.apmr.2005.10.027; Marchie A, 2003, CAN MED ASSOC J, V169, P124; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Minshull C, 2009, J ELECTROMYOGR KINES, V19, P1013, DOI 10.1016/j.jelekin.2008.07.002; Netto Kevin J, 2006, Work, V26, P123; Paasuke M, 1999, ACTA PHYSIOL SCAND, V166, P319; QUEISSER F, 1994, EUR J APPL PHYSIOL, V68, P92, DOI 10.1007/BF00599248; Rainoldi A, 1999, J ELECTROMYOGR KINES, V9, P105, DOI 10.1016/S1050-6411(98)00042-X; Rainoldi A, 2001, J ELECTROMYOGR KINES, V11, P425, DOI 10.1016/S1050-6411(01)00022-0; Salzenstein F, 2007, J OPT SOC AM A, V24, P3717, DOI 10.1364/JOSAA.24.003717; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Solnik S, 2008, ACTA BIOENG BIOMECH, V10, P65; Sommerich CM, 2000, J ELECTROMYOGR KINES, V10, P377, DOI 10.1016/S1050-6411(00)00033-X; Stemper BD, 2006, SPINE, V31, pE733, DOI 10.1097/01.brs.0000240210.23617.e7; Stone MH, 2007, PRINCIPLES PRACTICE, P225; Strimpakos N, 2004, ARCH PHYS MED REHAB, V85, P1309, DOI 10.1016/j.apmr.2003.08.104; Strimpakos N., 2001, PHYS THER REV, V6, P39; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Zech A, 2008, J ELECTROMYOGR KINES, V18, P262, DOI 10.1016/j.jelekin.2006.08.013; Zhou S, 1996, EUR J APPL PHYSIOL, V72, P410, DOI 10.1007/BF00242269	40	17	17	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2052-1847			BMC SPORTS SCI MED R	BMC Sports Sci. Med. Rehabil.	DEC	2009	1	1							22	10.1186/1758-2555-1-22			8	Rehabilitation; Sport Sciences	Emerging Sources Citation Index (ESCI)	Rehabilitation; Sport Sciences	V30PN	WOS:000215574600022	19775461	hybrid, Green Published			2022-02-06	
J	Philip, S; Chaiwat, O; Udomphorn, Y; Moore, A; Zimmerman, JJ; Armstead, W; Vavilala, MS				Philip, Shaji; Chaiwat, Onuma; Udomphorn, Yuthana; Moore, Anne; Zimmerman, Jerry J.; Armstead, William; Vavilala, Monica S.			Variation in cerebral blood flow velocity with cerebral perfusion pressure > 40 mm Hg in 42 children with severe traumatic brain injury	CRITICAL CARE MEDICINE			English	Article						cerebral blood flow velocity; cerebral perfusion pressure; pediatric trauma; brain injury; blood pressure; middle cerebral artery flow	TRANSCRANIAL DOPPLER; AUTOREGULATION; HYPOTENSION; STRATEGIES; SURVIVAL; MODERATE	Objective: To determine the prevalence of low, normal, and high mean middle cerebral artery flow velocity when cerebral perfusion pressure is >40 mm Hg in children with severe traumatic brain injury. There is no information regarding the relationship between middle cerebral artery flow velocity and cerebral perfusion pressure in pediatric traumatic brain injury. Design: Prospective, observational study. Setting: Level I pediatric trauma center. Patients: A total of 42 children <17 yrs of age with an admission diagnosis of severe traumatic brain injury (admission Glasgow Coma Scale score of <9), traumatic brain injury on computed-tomography scan, tracheal intubation/mechanical ventilation, and intracranial pressure monitoring. Interventions: None. Measurements and Main Results: Bilateral middle cerebral arteries were insonated using transcranial Doppler ultrasonography to calculate mean middle cerebral artery flow velocity after traumatic brain injury. Low mean middle cerebral artery flow velocity was defined as middle cerebral artery flow velocity <2 standard deviation and high was defined as mean middle cerebral artery flow velocity >2 standard deviation. Patients were grouped by age (0.8-2.9, 3-5.9, 6-9.9, and 10-16.9 yrs) and gender to examine the relationship between cerebral perfusion pressure and low, high, or normal mean middle cerebral artery flow velocity. Potential confounders of the relationship between cerebral perfusion pressure and mean middle cerebral artery flow velocity (intracranial pressure, PaCO2, hematocrit, sedation, fever,and impaired autoregulation were examined). Most children (n = 33; 79%) had normal mean middle cerebral artery flow velocity but four patients (9%) had low mean middle cerebral artery flow velocity and five children (12%) had high mean middle cerebral artery flow velocity despite cerebral perfusion pressure >40 mm Hg. There was no difference in potential confounders of the relationship between cerebral perfusion pressure and mean middle cerebral artery flow velocity except for hematocrit, which was lower (25 +/- 4%; range = 21-30%) in children with high mean middle cerebral artery flow velocity. An inverse relationship between mean middle cerebral artery flow velocity and hematocrit was also found in boys aged 10 to 16.9 yrs. Conclusions: Both low and/or high mean middle cerebral artery flow velocity occur with cerebral perfusion pressure >40 mm Hg in severe pediatric traumatic brain injury. Of the potential confounders considered, only lower hematocrit was associated with high mean middle cerebral artery flow velocity. (Crit Care Med 2009; 37:2973-2978)	[Philip, Shaji; Chaiwat, Onuma; Udomphorn, Yuthana] Harborview Anesthesiol Res Ctr, Seattle, WA USA; [Zimmerman, Jerry J.; Vavilala, Monica S.] Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA; [Zimmerman, Jerry J.; Vavilala, Monica S.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Moore, Anne] Univ Washington, Cerebrovasc Lab, Seattle, WA 98195 USA; [Armstead, William] Univ Penn, Dept Anesthesiol, Philadelphia, PA 19104 USA		Philip, S (corresponding author), Harborview Anesthesiol Res Ctr, Seattle, WA USA.	vavilala@u.washington.edu			Eunice Kennedy Shriver National Instftute of Child Health and Human Development (NICHD), National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD044632] Funding Source: NIH RePORTER	This study was supported, in part, by the Eunice Kennedy Shriver National Instftute of Child Health and Human Development (NICHD), National Institutes of Health, K23.	AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; BODE H, 1988, APPL PEDIAT TRANSCRA; Carney Nancy A, 2003, Pediatr Crit Care Med, V4, pS1; CHAN KH, 1992, J NEUROSURG, V77, P55, DOI 10.3171/jns.1992.77.1.0055; CHAN KH, 2002, CHIN J TRAUMATOL, V5, P380; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Czosnyka M, 1998, J NEUROSURG, V88, P802, DOI 10.3171/jns.1998.88.5.0802; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; Fisher A. Q., 1999, TRANSCRANIAL DOPPLER, P355; Hackbarth RM, 2002, CRIT CARE MED, V30, P1630, DOI 10.1097/00003246-200207000-00038; Hebert PC, 2004, CRIT CARE CLIN, V20, P187, DOI 10.1016/j.ccc.2004.01.001; Jaffres P, 2005, INTENS CARE MED, V31, P785, DOI 10.1007/s00134-005-2630-4; Kokoska ER, 1998, J PEDIATR SURG, V33, P333, DOI 10.1016/S0022-3468(98)90457-2; Lacroix J, 2007, NEW ENGL J MED, V356, P1609, DOI 10.1056/NEJMoa066240; Langlois JA, 2001, TRAUMATIC BRAIN INJU; Mazumdar M, 2007, PEDIATRICS, V120, pe1107, DOI 10.1542/peds.2006-2002; MILLER JD, 1980, P 2 INT WORKSH AMST, P476; NEWELL DW, 1994, STROKE, V25, P793, DOI 10.1161/01.STR.25.4.793; OBRIST WD, 1979, J NEUROSURG, V51, P292, DOI 10.3171/jns.1979.51.3.0292; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Ract C, 2007, INTENS CARE MED, V33, P645, DOI 10.1007/s00134-007-0558-6; Sahuquillo J, 1998, ACT NEUR S, V71, P233; Samant UB, 2008, J NEUROTRAUM, V25, P495, DOI 10.1089/neu.2007.0491; STREBEL S, 1995, ANESTHESIOLOGY, V83, P66, DOI 10.1097/00000542-199507000-00008; Sviri GE, 2006, NEUROSURGERY, V59, P360, DOI 10.1227/01.NEU.0000223502.93013.6E; Tontisirin N, 2007, PEDIATRICS, V119, pE610, DOI 10.1542/peds.2006-2110; Trabold F, 2004, INTENS CARE MED, V30, P108, DOI 10.1007/s00134-003-2057-8; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Vavilala MS, 2005, PEDIATR RES, V58, P574, DOI 10.1203/01.PDR.0000179405.30737.0F; Vavilala MS, 2003, J TRAUMA, V55, P1039, DOI 10.1097/01.TA.0000101759.23607.57; WARD JD, 1995, MANAGEMENT PEDIAT TR, P177; White H, 2006, INTENS CARE MED, V32, P981, DOI 10.1007/s00134-006-0173-y; Wintermark M, 2004, PEDIATRICS, V113, P1642, DOI 10.1542/peds.113.6.1642	34	17	17	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	NOV	2009	37	11					2973	2978		10.1097/CCM.0b013e3181a963f6			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517IP	WOS:000271607000015	19770734	Green Accepted			2022-02-06	
J	Shields, BJ; Smith, GA				Shields, Brenda J.; Smith, Gary A.			Epidemiology of Cheerleading Fall-Related Injuries in the United States	JOURNAL OF ATHLETIC TRAINING			English	Article						injury surveillance; athletic injuries; elite athletes; collegiate athletes; high school athletes; youth athletes	RISK-FACTORS; PLAYGROUND EQUIPMENT; ARM FRACTURE; CHILDREN; SURFACE	Context. Over the past several decades, cheerleaders have been performing fewer basic maneuvers and more gymnastic tumbling runs and stunts. As the difficulty of these maneuvers has increased, cheerleading injuries have also increased. Objective: To describe the epidemiology of cheerleading fall-related injuries by type of cheerleading team and event. Design: Prospective injury surveillance study. Setting: Participant exposure and injury data were collected from US cheerleading teams via the Cheerleading RIO (Reporting Information Online) surveillance tool. Patients or Other Participants: Athletes from 412 enrolled cheerleading teams who participated in official, organized cheerleading practices, pep rallies, athletic events, or cheerleading competitions. Main Outcome Measure(s): The numbers and rates of cheerleading fall-related injuries during a 1-year period (20062007) are reported. Results: A total of 79 fall-related injuries were reported during the 1-year period. Most occurred during practice (85%, 67/79) and were sustained by high school cheerleaders (51%, 40/79). A stunt or pyramid was being attempted in 89% (70/79) of cases. Fall heights ranged from 1 to 11 ft (0.30-3.35 m) (mean = 4.7 +/- 2.0 ft [1.43 +/- 0.61 m]). Strains and sprains were the most common injuries (54%, 43/79), and 6% (5/79) of the injuries were concussions or closed head injuries. Of the 15 most serious injuries (concussions or closed head injuries, dislocations, fractures, and anterior cruciate ligament tears), 87% (13/15) were sustained while the cheerleader was performing on artificial turf, grass, a traditional foam floor, or a wood floor. The fall height ranged from 4 to 11 ft (1.22-1.52 m) for 87% of these cases (13/15). Conclusions: Cheerleading-related falls may result in severe injuries and even death, although we report no deaths in the present study. The risk for serious injury increases as fall height increases or as the impact-absorbing capacity of the surfacing material decreases (or both).	[Shields, Brenda J.] Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, Columbus, OH 43205 USA; [Smith, Gary A.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA		Shields, BJ (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA.	brenda.shields@nationwidechildrens.org			Research Institute at Nationwide Children's HospitalOhio State University	Funding for this study was provided by the Research Institute at Nationwide Children's Hospital. Debbie Bracewell, from the National Council for Spirit Safety and Education, Lisa Thompson, from Cheer Ltd, and Steve Wedge, from Cheerleaders of America, Inc, helped to categorize the cheerleading maneuvers.	ASTM, 2004, F129204 ASTM; Bertocci GE, 2004, INJURY, V35, P417, DOI 10.1016/S0020-1383(03)00062-7; Bertocci GE, 2003, ARCH PEDIAT ADOL MED, V157, P480, DOI 10.1001/archpedi.157.5.480; Boden BP, 2003, AM J SPORT MED, V31, P881, DOI 10.1177/03635465030310062501; *CBS BROADC INC, 2006, CHEERL INJ FALL COUR; Chalmers D J, 1996, Inj Prev, V2, P98, DOI 10.1136/ip.2.2.98; Chiu J, 1998, J BIOMECH, V31, P1169, DOI 10.1016/S0021-9290(98)00137-7; Cory CZ, 2006, FORENSIC SCI INT, V163, P102, DOI 10.1016/j.forsciint.2005.11.014; Giannone L., 2006, AM ASS CHEERLEADING, P1; Hutchinson MR, 1997, PHYSICIAN SPORTSMED, V25, P83, DOI 10.3810/psm.1997.09.1508; Jacobson BH, 2004, J ORTHOP SPORT PHYS, V34, P261, DOI 10.2519/jospt.2004.34.5.261; Knowles SB, 2006, J ATHL TRAINING, V41, P207; Laforest S, 2001, Inj Prev, V7, P35, DOI 10.1136/ip.7.1.35; Macarthur C, 2000, ACCIDENT ANAL PREV, V32, P377, DOI 10.1016/S0001-4575(99)00079-2; MUELLER FO, 2008, 25 NAT CTR CAT SPORT; Schulz MR, 2004, AM J SPORT MED, V32, P396, DOI 10.1177/0363546503261715; Sherker S, 2005, INJURY PREV, V11, P120, DOI 10.1136/ip.2004.007310; Sherker S, 2004, MED J AUSTRALIA, V180, P562, DOI 10.5694/j.1326-5377.2004.tb06092.x; Sherker S, 2003, INJURY PREV, V9, P279, DOI 10.1136/ip.9.3.279; Shields BJ, 2006, PEDIATRICS, V117, P122, DOI 10.1542/peds.2005-1139; Shields BJ, 2009, J ATHL TRAINING, V44, P595, DOI 10.4085/1062-6050-44.6.595; Shields BJ, 2009, J ATHL TRAINING, V44, P567, DOI 10.4085/1062-6050-44.6.567	22	17	17	3	22	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050			J ATHL TRAINING	J. Athl. Train.	NOV-DEC	2009	44	6					578	585		10.4085/1062-6050-44.6.578			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	522OU	WOS:000272008400003	19911083	Green Published			2022-02-06	
J	Singh, PK; Singh, VK; Tomar, J; Azam, A; Gupta, S; Kumar, S				Singh, Pankaj Kumar; Singh, Vinay K.; Tomar, Juhi; Azam, Amir; Gupta, Sanjeev; Kumar, Sushil			Spinal Glioblastoma Multiforme: Unusual Cause of Post-Traumatic Tetraparesis	JOURNAL OF SPINAL CORD MEDICINE			English	Article						Tetraparesis; Intramedullary tumor; Glioblastoma multiforme; Spinal cord, cervical; Spine; Whiplash injury	SURVIVAL	Background/Objective: Glioblastoma multiforme (GBM) is the most common glial cell tumor of the adult brain. However, primary GBM of the spinal cord is a rare condition. Methods: Case report. Results: A young man presented with acute onset quadriparesis after a whiplash injury. A magnetic resonance scan showed the typical appearance of a high-grade intramedullary tumor with fusiform expansion of the entire cervical cord. Subtotal decompression and biopsy was done by posterior laminectomy, followed by external beam radiotherapy. Signs and symptoms improved after the completion of radiotherapy but did not resolve completely. Death caused by respiratory failure occurred 3 months later. Conclusions: This presentation of GBM of the cervical cord is rare; an intramedullary tumor should be considered when minor cervical trauma results in disproportionate neurologic deficit. To the best of our knowledge, this is the first reported case of spinal GBM with extensive pan-cervical involvement.	[Singh, Pankaj Kumar; Singh, Vinay K.; Tomar, Juhi; Azam, Amir; Gupta, Sanjeev; Kumar, Sushil] Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England		Singh, PK (corresponding author), Royal Hallamshire Hosp, Glossop Rd, Sheffield S10 2JF, S Yorkshire, England.	we.publish@googlemail.com					ALMEFTY O, 1987, NEUROSURGERY, V20, P416, DOI 10.1227/00006123-198703000-00010; ANDREWS AA, 1978, ARCH NEUROL-CHICAGO, V35, P244, DOI 10.1001/archneur.1978.00500280062013; ASANO N, 1990, Neurologia Medico-Chirurgica, V30, P489, DOI 10.2176/nmc.30.489; Caroli E, 2005, SPINAL CORD, V43, P565, DOI 10.1038/sj.sc.3101749; Chida K, 1995, Rinsho Shinkeigaku, V35, P1235; Chigasaki H, 1978, SHINKEI SHINPO, V20, P90; KOPELSON G, 1982, CANCER, V50, P732, DOI 10.1002/1097-0142(19820815)50:4<732::AID-CNCR2820500418>3.0.CO;2-0; Marchan EM, 2007, J NEUROSURG-SPINE, V7, P656, DOI 10.3171/SPI-07/12/656; RAMAMUTHI B, 2001, TXB NEUROSURGERY, P708; RUSSEL DS, 1959, PATHOLOGY TUMORS NER; SAGERMAN RH, 1979, RADIOLOGY, V84, P401; TAKARA E, 1985, Neurological Surgery, V13, P301; YAMAZAKI M, 1992, Neurological Surgery, V20, P85; Yeung YF, 2006, ACTA ONCOL, V45, P87, DOI 10.1080/02841860500341124	14	17	18	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1079-0268	2045-7723		J SPINAL CORD MED	J. Spinal Cord. Med.	NOV	2009	32	5					583	586		10.1080/10790268.2009.11754565			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	534JX	WOS:000272893500011	20025156	Green Published			2022-02-06	
J	Bay, E; Xie, Y				Bay, Esther; Xie, Yan			Psychological and Biological Correlates of Fatigue After Mild-to-Moderate Traumatic Brain Injury	WESTERN JOURNAL OF NURSING RESEARCH			English	Article						mental health; neurology; depression; anxiety/stress; fatigue; descriptive quantitative	PITUITARY-ADRENAL AXIS; CHRONIC STRESS; PERCEIVED STRESS; HEAD-INJURY; CORTISOL; REHABILITATION; ACTIVATION; DEPRESSION; PLASTICITY; COMPLAINTS	Relationships between chronic perceived stress, cortisol response (area under the curve) and posttraumatic brain injury fatigue were examined with persons from outpatient settings. Seventy-five injured persons with traumatic brain injury and their relatives/significant others participated in this cross-sectional study. Using interviews and self-reported data from the Neurofunctional Behavioral Inventory, the Perceived Stress Scale, the Profile of Mood States-Fatigue subscale, the McGill Pain Scale, as well as self-collection of salivary cortisol over a 12-hour period (N = 50), we found that perceived chronic stress explained 40% of the variance in fatigue until depressive symptoms and pain were in the model. Hypocortisolemia was evident. Somatic symptom frequency and perceived chronic stress represented 50% of the variability in post-TBI fatigue. Fatigue and stress management interventions, as suggested in the Centers for Disease Control Acute Concussion guidelines, may be beneficial in reducing this common symptom.	[Bay, Esther; Xie, Yan] Michigan State Univ, E Lansing, MI 48824 USA		Bay, E (corresponding author), Michigan State Univ, E Lansing, MI 48824 USA.	baye@msu.edu					American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; ARNDT M, 2008, NEUROFATIGUE T UNPUB; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P33, DOI 10.1097/01.HTR.0000308719.70288.22; Bay E, 2002, J NURS SCHOLARSHIP, V34, P221, DOI 10.1111/j.1547-5069.2002.00221.x; Bay E., 2005, J NEUROSCIENCE NURSI, V36, P55; Bay Esther, 2006, Care Manag J, V7, P3, DOI 10.1891/cmaj.7.1.3; Bay E, 2008, BRAIN INJURY, V22, P233, DOI 10.1080/02699050801953073; Bay Esther, 2004, Res Theory Nurs Pract, V18, P213, DOI 10.1891/rtnp.18.2.213.61278; Bay E, 2009, BIOL RES NURS, V10, P213, DOI 10.1177/1099800408326453; Bondanelli M, 2007, J NEUROTRAUM, V24, P1687, DOI 10.1089/neu.2007.0343; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P25, DOI 10.1097/01.HTR.0000308718.88214.bb; Bushnik T, 2007, BRAIN INJURY, V21, P559, DOI 10.1080/02699050701426915; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; *CDCP, 2007, TRAUM BRAIN INJ FACT; *CDCP, 2007, HEADS TOOL KIT PHYS; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cohen S, 1995, MEASURING STRESS GUI; COHEN S, 1986, AM PSYCHOL, V41, P717; Conrad CD, 2004, NEUROSCIENCE, V125, P759, DOI 10.1016/j.neuroscience.2004.01.049; CROFFORD LJ, 1994, ARTHRITIS RHEUM-US, V37, P1583, DOI 10.1002/art.1780371105; de Groot MH, 2003, ARCH PHYS MED REHAB, V84, P1714, DOI 10.1053/S0003-9993(03)00346-0; DEMITRACK MA, 1991, J CLIN ENDOCR METAB, V73, P1224, DOI 10.1210/jcem-73-6-1224; Dijkers MPJM, 2008, J HEAD TRAUMA REHAB, V23, P3, DOI 10.1097/01.HTR.0000308716.80590.6b; Fillion L, 2008, CANCER NURS, V31, P145, DOI 10.1097/01.NCC.0000305698.97625.95; Gaab J, 2005, PSYCHONEUROENDOCRINO, V30, P599, DOI 10.1016/j.psyneuen.2005.02.001; Giza CC, 2001, J ATHL TRAINING, V36, P228; Jha A, 2008, J HEAD TRAUMA REHAB, V23, P52, DOI 10.1097/01.HTR.0000308721.77911.ea; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; KIRSCHBAUM C, 1994, PSYCHONEUROENDOCRINO, V19, P313, DOI 10.1016/0306-4530(94)90013-2; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; KREUTZER J, 1999, NEUROBEHAVIORAL FUNC; McEwen B., 2002, END STRESS WE KNOW I; McEwen BS, 2008, EUR J PHARMACOL, V583, P174, DOI 10.1016/j.ejphar.2007.11.071; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; MCNAIR DM, 1964, J ABNORM SOC PSYCH, V69, P620, DOI 10.1037/h0040902; MCNAIR DM, 2002, PROFILE MOOD STATES; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Miller MM, 2006, ANN NY ACAD SCI, V1071, P294, DOI 10.1196/annals.1364.023; NICOLSON N, 2000, J PSYCHOSOM RES, V49, P385; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Phillips Kenneth D, 2004, Biol Res Nurs, V6, P59, DOI 10.1177/1099800404264846; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Pruessner JC, 1999, PSYCHOSOM MED, V61, P197, DOI 10.1097/00006842-199903000-00012; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Sapolsky RM, 2003, NEUROCHEM RES, V28, P1735, DOI 10.1023/A:1026021307833; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; STULEMEIJER M, 2007, J NEUROLOGICAL NEURO, V10, P1; Sundstrom A, 2007, BRAIN INJURY, V21, P1049, DOI 10.1080/02699050701630367; TEASDALE G, 1974, LANCET, V2, P81; Tsigos C, 2002, J PSYCHOSOM RES, V53, P865, DOI 10.1016/S0022-3999(02)00429-4; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; van Kessel K, 2008, PSYCHOSOM MED, V70, P205, DOI 10.1097/PSY.0b013e3181643065; Vitaz TW, 2003, SURG NEUROL, V60, P285, DOI 10.1016/S0090-3019(03)00378-1; WHITEGBADEBO D, 1993, J NEUROTRAUM, V10, P297, DOI 10.1089/neu.1993.10.297; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Williams RA, 2000, J PSYCHIAT RES, V34, P227, DOI 10.1016/S0022-3956(00)00012-1; Yang CH, 2004, J NEUROSCI, V24, P11029, DOI 10.1523/JNEUROSCI.3968-04.2004	58	17	17	1	15	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0193-9459			WESTERN J NURS RES	West. J. Nurs. Res.	OCT	2009	31	6					731	747		10.1177/0193945909334856			17	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	498OZ	WOS:000270152700004	19502473				2022-02-06	
J	Deschamps, C; Faideau, M; Jaber, M; Gaillard, A; Prestoz, L				Deschamps, C.; Faideau, M.; Jaber, M.; Gaillard, A.; Prestoz, L.			Expression of ephrinA5 during development and potential involvement in the guidance of the mesostriatal pathway	EXPERIMENTAL NEUROLOGY			English	Article						Ephrin; Midbrain; Axon guidance; Dopamine; Tyrosine hydroxylase	IMMUNO-CYTOCHEMICAL LOCALIZATION; MIDBRAIN DOPAMINERGIC PATHWAYS; CENTRAL-NERVOUS-SYSTEM; PRENATAL RAT-BRAIN; AXON GUIDANCE; VISUAL-SYSTEM; TYROSINE-HYDROXYLASE; MOLECULAR-MECHANISMS; RECEPTOR EXPRESSION; NEURAL DEVELOPMENT	Identifying guidance cues that direct axon growth to their final connections during development is of crucial interest if we aim to repair circuits damaged in adulthood following neurodegenerative disorders or common traumatic injuries. In this work, we set out to determine the ephrinA5 guidance molecule involvement in the establishment of the mouse mesostriatal pathway during development. We showed, in vitro and in vivo, that a proportion of mesencephalic dopaminergic cells express the ephrinA5 receptor, EphA5. Moreover, we observed, using stripe assays, that ephrinA5 purified protein has a repulsive effect on most of the mesencephalic dopaminergic projections. In vivo, we detected rostro-caudal and ventro-dorsal ephrinA5 protein expression gradients in the vicinity of the dopaminergic axons in the ventral telencephalon and in the striatum, during the embryonic and early postnatal development. In addition, other EphA5 ligands were also detected in the mesostriatal pathway. Together, these expression patterns suggest that, ephrinAs and more specifically ephrinA5, may be actors in the guidance of dopaminergic projections. Further studies will focus on identifying the molecular specificity of these guidance cues, taking into account the mesencephalic dopaminergic heterogeneous neuronal population. This may help increase the integration of neuronal transplants in the mature lesioned brain or provide tools to re-establish mesostriatal circuits in vivo. (C) 2009 Elsevier Inc. All rights reserved.	[Deschamps, C.; Faideau, M.; Jaber, M.; Gaillard, A.; Prestoz, L.] Univ Poitiers, Inst Physiol & Biol Cellulaires, CNRS, F-86022 Poitiers, France		Prestoz, L (corresponding author), Univ Poitiers, Inst Physiol & Biol Cellulaires, CNRS, 40 Ave Recteur Pineau, F-86022 Poitiers, France.	Laetitia.Prestoz@univ-poitiers.fr		prestoz, Laetitia/0000-0002-2407-195X; Jaber, Mohamed/0000-0003-2536-1913			Banisadr G, 2003, EUR J NEUROSCI, V18, P1593, DOI 10.1046/j.1460-9568.2003.02893.x; Baschong W, 2001, J HISTOCHEM CYTOCHEM, V49, P1565, DOI 10.1177/002215540104901210; Chilton JK, 2006, DEV BIOL, V292, P13, DOI 10.1016/j.ydbio.2005.12.048; Cooper MA, 2009, J COMP NEUROL, V514, P310, DOI 10.1002/cne.22030; Cooper MA, 2009, DEV NEUROBIOL, V69, P36, DOI 10.1002/dneu.20685; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Dufour A, 2006, DEVELOPMENT, V133, P4415, DOI 10.1242/dev.02623; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Flanagan JG, 2006, CURR OPIN NEUROBIOL, V16, P59, DOI 10.1016/j.conb.2006.01.010; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Gao PP, 2000, J NEUROSCI RES, V60, P427, DOI 10.1002/(SICI)1097-4547(20000515)60:4<427::AID-JNR1>3.3.CO;2-4; Gates MA, 2004, EUR J NEUROSCI, V19, P831, DOI 10.1111/j.1460-9568.2004.03213.x; Greferath U, 2002, MECH DEVELOP, V119, pS231, DOI 10.1016/S0925-4773(03)00122-9; Hamasaki T, 2001, J NEUROSCI, V21, P4272, DOI 10.1523/JNEUROSCI.21-12-04272.2001; Haupt C, 2008, FRONT BIOSCI-LANDMRK, V13, P3136, DOI 10.2741/2915; Hernandez-Montiel HL, 2008, J COMP NEUROL, V506, P387, DOI 10.1002/cne.21503; Himanen JP, 2003, TRENDS NEUROSCI, V26, P46, DOI 10.1016/S0166-2236(02)00005-X; Hu ZL, 2004, J COMP NEUROL, V476, P301, DOI 10.1002/cne.20230; Jacobowitz D. M., 1998, CHEMOARCHITECTONIC A; Janis LS, 1999, J NEUROSCI, V19, P4962; Kaufman M.H., 1992, ATLAS MOUSE DEV; Knoll B, 2007, NAT PROTOC, V2, P1216, DOI 10.1038/nprot.2007.157; Knoll B, 2002, TRENDS NEUROSCI, V25, P145, DOI 10.1016/S0166-2236(00)02093-2; Kudo C, 2005, J COMP NEUROL, V487, P255, DOI 10.1002/cne.20551; Lin L, 2006, STEM CELLS, V24, P2504, DOI 10.1634/stemcells.2006-0119; Livesey FJ, 1997, MOL CELL NEUROSCI, V8, P417, DOI 10.1006/mcne.1997.0598; Mace K, 2002, J NEUROSCI RES, V70, P46, DOI 10.1002/jnr.10381; Mann F, 1998, J NEUROSCI, V18, P9409; Maroof AM, 2006, NEURON, V50, P185, DOI 10.1016/j.neuron.2006.04.001; Milligan ED, 2001, J NEUROSCI, V21, P2808, DOI 10.1523/JNEUROSCI.21-08-02808.2001; Mueller BK, 2006, PHILOS T R SOC B, V361, P1513, DOI 10.1098/rstb.2006.1888; Nakamura S, 2000, J NEUROSCI, V20, P4112; Nomura T, 2006, DEVELOPMENT, V133, P1335, DOI 10.1242/dev.02290; O'Leary DDM, 1999, CURR OPIN NEUROBIOL, V9, P65, DOI 10.1016/S0959-4388(99)80008-7; OSBORN M, 1982, METHOD CELL BIOL, V24, P97; Passante L, 2008, DEVELOPMENT, V135, P3281, DOI 10.1242/dev.024778; Peng J, 2005, J BIOL CHEM, V280, P29194, DOI 10.1074/jbc.M500984200; Peuckert C, 2008, MOL CELL NEUROSCI, V39, P21, DOI 10.1016/j.mcn.2008.05.011; Pfeiffenberger C, 2006, J NEUROSCI, V26, P12873, DOI 10.1523/JNEUROSCI.3595-06.2006; Plachez C, 2005, CURR TOP DEV BIOL, V69, P267, DOI 10.1016/S0070-2153(05)69010-2; Prestoz L, 2004, NEURON GLIA BIOL, V1, P73, DOI 10.1017/s1740925x04000109; Richards AB, 2007, EUR J NEUROSCI, V25, P2619, DOI 10.1111/j.1460-9568.2007.05523.x; Rogers JH, 1999, MOL BRAIN RES, V74, P225, DOI 10.1016/S0169-328X(99)00284-3; Sieber BA, 2004, MOL CELL NEUROSCI, V26, P418, DOI 10.1016/j.mcn.2004.03.009; SPECHT LA, 1981, J COMP NEUROL, V199, P255, DOI 10.1002/cne.901990208; SPECHT LA, 1981, J COMP NEUROL, V199, P233, DOI 10.1002/cne.901990207; St John JA, 2002, DEV BRAIN RES, V138, P1, DOI 10.1016/S0165-3806(02)00454-6; Uziel D, 2006, ANAT REC PART A, V288A, P135, DOI 10.1002/ar.a.20286; Van den Heuvel DMA, 2008, PROG NEUROBIOL, V85, P75, DOI 10.1016/j.pneurobio.2008.01.003; Vanderhaeghen P, 2000, NAT NEUROSCI, V3, P358, DOI 10.1038/73929; Verney C, 1999, MICROSC RES TECHNIQ, V46, P24; VOORN P, 1988, NEUROSCIENCE, V25, P857, DOI 10.1016/0306-4522(88)90041-3; Washburn Christopher P, 2007, Neurosci Bull, V23, P249, DOI 10.1007/s12264-007-0037-7; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Willson CA, 2006, J MOL HISTOL, V37, P369, DOI 10.1007/s10735-006-9067-0; Yamamoto N, 2002, PROG NEUROBIOL, V68, P393, DOI 10.1016/S0301-0082(02)00129-6; Yue Y, 1999, J NEUROSCI, V19, P2090; Zimmer G, 2007, J NEUROSCI, V27, P5643, DOI 10.1523/JNEUROSCI.0954-07.2007	60	17	19	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	OCT	2009	219	2					466	480		10.1016/j.expneurol.2009.06.020			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498QN	WOS:000270157300012	19576892				2022-02-06	
J	Lundberg, J; Le Blanc, K; Soderman, M; Andersson, T; Holmin, S				Lundberg, Johan; Le Blanc, Katarina; Soderman, Mikael; Andersson, Tommy; Holmin, Staffan			Endovascular transplantation of stem cells to the injured rat CNS	NEURORADIOLOGY			English	Article						Trauma; Mesenchymal; MAB 1281; Intra-arterial	MARROW STROMAL CELLS; TRAUMATIC BRAIN-INJURY; PROGENITOR CELLS; STROKE; MIGRATION; DIFFERENTIATION; RESPONSES; RECOVERY; MODEL	Transplantation procedures using intraparenchymal injection of stem cells result in tissue injury in addition to associated surgical risks. Intravenous injection of mesenchymal stem cells gives engraftment to lesions, but the method has low efficiency and specificity. In traumatic brain injuries (TBI), there is a transient breakdown of the blood-brain barrier and an inflammatory response, which increase migration of cells from blood to parenchyma. The aim of this investigation was to analyze the effect of intra-arterial administration on cellular engraftment. Experimental TBI was produced in a rat model. Endovascular technique was used to administer human mesenchymal stem cells in the ipsilateral internal carotid artery. Evaluation of engraftment and side effects were performed by immunohistochemical analysis of the brain and several other organs. The results were compared to intravenous administration of stem cells. Intra-arterial transplantion of mesenchymal stem cells resulted in central nervous system (CNS) engraftment without thromboembolic ischemia. We observed a significantly higher number of transplanted cells in the injured hemisphere after intra-arterial compared to intravenous administration both 1 day (p < 0.01) and 5 days (p < 0.05) after the transplantation. Some cells were also detected in the spleen but not in the other organs analyzed. Selective intra-arterial administration of mesenchymal stem cells to the injured CNS is a minimally invasive method for transplantation. The method is significantly more efficient than the intravenous route and causes no side effects in the current model. The technique can potentially be used for repeated transplantation to the CNS after TBI and in other diseases.	[Lundberg, Johan; Soderman, Mikael; Andersson, Tommy; Holmin, Staffan] Karolinska Univ Hosp, Dept Neuroradiol, Karolinska Inst, Dept Clin Neurosci, S-17176 Stockholm, Sweden; [Le Blanc, Katarina] Karolinska Univ Hosp, Dept Clin Immunol, Karolinska Inst, Dept Stem Cell Res, S-17176 Stockholm, Sweden		Holmin, S (corresponding author), Karolinska Univ Hosp, Dept Neuroradiol, Karolinska Inst, Dept Clin Neurosci, S-17176 Stockholm, Sweden.	staffan.holmin@karolinska.se	Le Blanc, Katarina/L-4631-2019	Holmin, Staffan/0000-0002-1628-1615			Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Englund U, 2002, EXP NEUROL, V173, P1, DOI 10.1006/exnr.2001.7750; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Grinnemo KH, 2006, ANN MED, V38, P144, DOI 10.1080/07853890500422982; Guzman R, 2008, STROKE, V39, P1300, DOI 10.1161/STROKEAHA.107.500470; Holmin S, 1997, J NEUROSURG, V86, P493, DOI 10.3171/jns.1997.86.3.0493; Jeong SW, 2003, STROKE, V34, P2258, DOI 10.1161/01.STR.0000083698.20199.1F; Jin KL, 2005, NEUROBIOL DIS, V18, P366, DOI 10.1016/j.nbd.2004.10.010; John D. B., 1996, THEORY PRACTICE HIST; KORDOWER JH, 1995, NEW ENGL J MED, V332, P1118, DOI 10.1056/NEJM199504273321702; Li Y, 2001, NEUROLOGY, V56, P1666, DOI 10.1212/WNL.56.12.1666; Liu WP, 2008, NEUROSCI LETT, V434, P160, DOI 10.1016/j.neulet.2007.12.067; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Politi LS, 2007, NEURORADIOLOGY, V49, P523, DOI 10.1007/s00234-007-0219-z; Schachinger V, 2006, EUR HEART J, V27, P2775, DOI 10.1093/eurheartj/ehl388; Seyfried D, 2006, J NEUROSURG, V104, P313, DOI 10.3171/jns.2006.104.2.313; Shen LH, 2006, NEUROSCIENCE, V137, P393, DOI 10.1016/j.neuroscience.2005.08.092; von Gertten C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-69; Wennersten A, 2004, J NEUROSURG, V100, P88, DOI 10.3171/jns.2004.100.1.0088	21	17	19	1	8	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0028-3940	1432-1920		NEURORADIOLOGY	Neuroradiology	OCT	2009	51	10					661	667		10.1007/s00234-009-0551-6			7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	494ZW	WOS:000269859800005	19562330				2022-02-06	
J	McEvoy, CT; Cran, GW; Cooke, SR; Young, IS				McEvoy, Claire T.; Cran, Gordon W.; Cooke, Stephen R.; Young, Ian S.			Resting energy expenditure in non-ventilated, non-sedated patients recovering from serious traumatic brain injury: Comparison of prediction equations with indirect calorimetry values	CLINICAL NUTRITION			English	Article						Brain injury; Energy expenditure; Indirect calorimetry	METABOLIC-RATE; HEAD; REQUIREMENTS; NUTRITION; THERAPY	Background & aims: Little is known about energy requirements in brain injured (TBI) patients, despite evidence suggesting adequate nutritional support can improve clinical outcomes. The study aim was to compare predicted energy requirements with measured resting energy expenditure (REE) values, in patients recovering from TBI. Methods: Indirect calorimetry (IC) was used to measure REE in 45 patients with TBI. Predicted energy requirements were determined using FAO/WHO/UNU and Harris-Benedict (HB) equations. Bland-Altman and regression analysis were used for analysis. Results: One-hundred and sixty-seven successful measurements were recorded in patients with TBI. At an individual level, both equations predicted REE poorly. The mean of the differences of standardised areas of measured REE and FAO/WHO/UNU was near zero (-9 kcal) but the variation in both directions was substantial (range -591 to +573 kcal). Similarly, the differences of areas of measured REE and HB demonstrated a mean of 1.9 kcal and range -568 to +571 kcal. Glasgow coma score, patient status, weight and body temperature were significant predictors of measured REE (p < 0.001; R(2) = 0.47). Conclusions: Clinical equations are poor predictors of measured REE in patients with TBI. The variability in REE is substantial. Clinicians should be aware of the limitations of prediction equations when estimating energy requirements in TBI patients. Crown Copyright (C) 2009 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.	[McEvoy, Claire T.] Queens Univ Belfast, Dept Med, Ctr Publ Hlth, Belfast BT12 6BJ, Antrim, North Ireland; [Cooke, Stephen R.] Royal Victoria Hosp, Reg Neurosurg Unit, Belfast Hlth & Social Care Trust, Belfast BT12 6BA, Antrim, North Ireland		McEvoy, CT (corresponding author), Queens Univ Belfast, Dept Med, Ctr Publ Hlth, Lower Ground Floor,Pathol Bldg,Grosvenor Rd, Belfast BT12 6BJ, Antrim, North Ireland.	c.mcevoy@qub.ac.uk		McEvoy, Claire/0000-0001-8512-3293; Young, Ian/0000-0003-3890-3152	Research & Development Office, Northern Ireland; Economic and Social Research CouncilUK Research & Innovation (UKRI)Economic & Social Research Council (ESRC) [ES/G007438/1] Funding Source: researchfish; ESRCUK Research & Innovation (UKRI)Economic & Social Research Council (ESRC) [ES/G007438/1] Funding Source: UKRI	All named authors made significant contributions to the study design, recruiting of patients, data collection, data analysis and preparation of the manuscript for submission. This research was supported by a grant from the Research & Development Office, Northern Ireland. This research was conducted using funding from the Research & Development Office, Northern Ireland. Reprints will be available from the authors.	Bader N, 2005, BRIT J NUTR, V94, P843, DOI 10.1079/BJN20051551; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; *BRAIN TRAUM FDN, 2007, J NEUROTRAUMA S1, V24, pS77, DOI DOI 10.1089/NEU.2006.9984; BRUDER N, 1994, CRIT CARE MED, V22, P1114, DOI 10.1097/00003246-199407000-00011; BRUDER N, 1991, CRIT CARE MED, V19, P43, DOI 10.1097/00003246-199101000-00013; CLIFTON GL, 1986, J NEUROSURG, V64, P895, DOI 10.3171/jns.1986.64.6.0895; CUNNINGHAM JJ, 1985, AM J CLIN NUTR, V41, P371, DOI 10.1093/ajcn/41.2.371; da Rocha EEM, 2005, CURR OPIN CLIN NUTR, V8, P319, DOI 10.1097/01.mco.0000165012.77567.1e; DEMPSEY DT, 1985, SURG GYNECOL OBSTET, V160, P128; DEUTSCHMAN CS, 1987, J NEUROSURG, V66, P388, DOI 10.3171/jns.1987.66.3.0388; DuBois EF, 1948, FEVER REGULATION BOD; Elia M, 2003, P NUTR SOC, V62, P529, DOI 10.1079/PNS2003255; Evans BM, 2002, J ROY SOC MED, V95, P591, DOI 10.1258/jrsm.95.12.591; Frankenfield DC, 2003, J AM DIET ASSOC, V103, P1152, DOI 10.1016/S0002-8223(03)00982-9; Frankenfield DC, 1998, J AM DIET ASSOC, V98, P439, DOI 10.1016/S0002-8223(98)00100-X; GARBY L, 1984, HUM NUTR-CLIN NUTR, V38C, P395; Hartl R, 2008, J NEUROSURG, V109, P50, DOI 10.3171/JNS/2008/109/7/0050; Harris J, 1919, PUBLICATION CARNEGIE, V279; McClave S A, 1992, Nutr Clin Pract, V7, P207, DOI 10.1177/0115426592007005207; McClave S A, 1994, New Horiz, V2, P139; McClave SA, 2001, J CLIN GASTROENTEROL, V33, P14, DOI 10.1097/00004836-200107000-00005; Miles JM, 2006, MAYO CLIN PROC, V81, P809, DOI 10.4065/81.6.809; OWEN OE, 1988, MAYO CLIN PROC, V63, P503, DOI 10.1016/S0025-6196(12)65649-3; Perel P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001530.pub2; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; Weekes Elizabeth, 1996, Journal of Parenteral and Enteral Nutrition, V20, P31, DOI 10.1177/014860719602000131; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; WEISSMAN C, 1986, ANESTHESIOLOGY, V64, P673, DOI 10.1097/00000542-198606000-00001; Wilson RF, 1998, J HEAD TRAUMA REHAB, V13, P11, DOI 10.1097/00001199-199802000-00005	30	17	22	1	6	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0261-5614			CLIN NUTR	Clin. Nutr.	OCT	2009	28	5					526	532		10.1016/j.clnu.2009.04.009			7	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	518IQ	WOS:000271685100007	19423202	Green Published			2022-02-06	
J	Broglio, SP; Guskiewicz, KM				Broglio, Steven P.; Guskiewicz, Kevin M.			Concussion in Sports: The Sideline Assessment	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						mild traumatic brain injury; symptoms; postural control; neurocognitive status	COLLEGIATE FOOTBALL PLAYERS; INJURY SURVEILLANCE SYSTEM; HIGH-SCHOOL; NEUROPSYCHOLOGICAL PERFORMANCE; POSTURAL STABILITY; SYMPTOMS; EPIDEMIOLOGY; RECOVERY; IMPACT	Context: The vast differences between individual athletes makes identifying and evaluating sports-related concussion one of the most complex and perplexing injuries faced by medical personnel. Evidence Acquisition: This review summarizes the existing literature supporting the use of a multifaceted approach to concussion evaluation on the sideline of the athletic field. Information was drawn from a PubMed search (MEDLINE) for the terms sport concussion for the most recent and relevant literature. Conclusions: By using a standardized clinical examination that is supported by objective measures of concussion-related symptoms, mental status, and postural control, the medical professional becomes well equipped to make an informed diagnosis.	[Broglio, Steven P.] Univ Illinois, 906 South Goodwin Ave, Urbana, IL 61801 USA; [Guskiewicz, Kevin M.] Univ North Carolina Chapel Hill, Chapel Hill, NC 27514 USA		Broglio, SP (corresponding author), Univ Illinois, 906 South Goodwin Ave, Urbana, IL 61801 USA.	broglio@illinois.edu		Guskiewicz, Kevin/0000-0002-8682-2130			Agel J, 2007, J ATHL TRAINING, V42, P249; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Broglio SP, 2009, J SCI MED SPORT, V12, P388, DOI 10.1016/j.jsams.2007.12.010; Cantu RC, 2007, NEUROSURGERY, V60, P963, DOI 10.1227/01.NEU.0000255430.62291.7B; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P224; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Dart AM, 2001, J AM COLL CARDIOL, V37, P975, DOI 10.1016/S0735-1097(01)01108-1; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Dick R, 2007, J ATHL TRAINING, V42, P173; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; Giza CC, 2001, J ATHL TRAINING, V36, P228; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McCrory PR, 2000, CLIN J SPORT MED, V10, P235, DOI 10.1097/00042752-200010000-00002; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; Moore KL, 1999, CLIN ORIENTED ANATOM, P1082; Patel AV, 2007, J ATHL TRAINING, V42, P66; Piland SG, 2003, J ATHL TRAINING, V38, P104; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Sanders MJ, 2001, MOSBYS PARAMEDIC TXB, P624; Susco TM, 2004, J ATHL TRAINING, V39, P241; Wilkins JC, 2004, J ATHL TRAINING, V39, P156	41	17	17	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	SEP-OCT	2009	1	5					361	369		10.1177/1941738109343158			9	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	V13JZ	WOS:000214411000002	23015894	Green Published			2022-02-06	
J	Neal, MD; Cushieri, J; Rosengart, MR; Alarcon, LH; Moore, EE; Maier, RV; Minei, JP; Billiar, TR; Peitzman, AB; Sperry, JL				Neal, Matthew D.; Cushieri, Joseph; Rosengart, Matthew R.; Alarcon, Louis H.; Moore, Ernest E.; Maier, Ronald V.; Minei, Joseph P.; Billiar, Timothy R.; Peitzman, Andrew B.; Sperry, Jason L.		Inflammation & Host Response Injur	Preinjury Statin Use Is Associated With a Higher Risk of Multiple Organ Failure After Injury: A Propensity Score Adjusted Analysis	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	22nd Annual Meeting of the Eastern-Association-for-the-Surgery-of-Trauma	JAN 13-17, 2009	Lake Buena Vista, FL	Eastern Assoc Surg Trauma		Preinjury statin use; Multiple organ failure; Cox proportional hazard regression	SCALE COLLABORATIVE PROJECT; ORIENTED RESEARCH CORE; STANDARD OPERATING PROCEDURES; IMPROVES ENDOTHELIAL FUNCTION; PERIOPERATIVE BETA-BLOCKER; ACUTE CORONARY SYNDROMES; CLINICAL CARE; HOST RESPONSE; PREEXISTING CONDITIONS; TRAUMA PATIENTS	Background: Recent studies suggest that statin use may improve outcome in critically ill patients. This has been attributed to the pleiomorphic effect and modulation of inflammatory mediators that occurs with statin use. We sought to determine whether preinjury statin (PIS) use was associated with improved outcome in severely injured blunt trauma patients. Methods: Data were obtained from a multicenter prospective cohort study evaluating outcomes in blunt injured adults with hemorrhagic shock. Patients aged 55 years and older were analyzed. Those with isolated traumatic brain injury, cervical cord injury, and those who survived <24 hours were excluded. A propensity score predicting statin use was created using logistic regression. Cox proportional hazard regression was then used to evaluate the effects of PIS use oil mortality and the development of multiple organ failure (MOF, multiple organ dysfunction syndrome >5) and nosocomial infection (NI) after adjusting for important injury characteristics and the propensity of taking PISs. Results: Overall mortality and MOF rates for the study cohort (n = 295) were 21% and 50%, respectively. Over 24% of patients (n = 71) reported PIS use. Kaplan-Meier analysis revealed no difference in NI or mortality over time but did show a significant higher incidence of MOF in those with PIS use (p = 0.04). Regression analysis verified PIS was independently associated with an 80% higher risk of MOF (hazard ratio: 1.8; 95% confidence interval, 1.1-2.9) and was found to be one of the strongest independent risk factors for the development of MOF. Conclusion: PIS use was independently associated with a higher risk of MOF postinjury. These results are contrary to previous analyses. The protective effect of statins may be lost in the severely injured, and modulation of the inflammatory response may result in higher morbidity. Further studies are required to better understand the impact and potential therapeutic utility of this commonly prescribed medication both before and after injury.	[Neal, Matthew D.; Rosengart, Matthew R.; Alarcon, Louis H.; Billiar, Timothy R.; Peitzman, Andrew B.; Sperry, Jason L.] Univ Pittsburgh, Med Ctr, Dept Surg, Div Gen Surg & Trauma, Pittsburgh, PA 15213 USA; [Cushieri, Joseph; Maier, Ronald V.] Univ Washington, Harborview Med Ctr, Div Gen Surg & Trauma, Seattle, WA 98104 USA; [Cushieri, Joseph; Maier, Ronald V.] Univ Washington, Dept Surg, Washington, DC USA; [Moore, Ernest E.] Denver Hlth Med Ctr, Dept Surg, Denver, CO USA; Univ Colorado, Hlth Sci Ctr, Denver, CO USA; [Minei, Joseph P.] Univ Texas SW Med Ctr Dallas, Dept Surg, Div Burn, Dallas, TX 75390 USA		Sperry, JL (corresponding author), Univ Pittsburgh, Med Ctr, Dept Surg, Div Gen Surg & Trauma, 200 Lothrop St, Pittsburgh, PA 15213 USA.	sperryjl@upmc.edu		Alarcon, Louis/0000-0001-6994-8412	NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2 RR024154-03, KL2 RR024154] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54 GM062119-1, U54 GM062119] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2RR024154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54GM062119] Funding Source: NIH RePORTER		Almog Y, 2004, CIRCULATION, V110, P880, DOI 10.1161/01.CIR.0000138932.17956.F1; Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; Brandt C A, 2003, AMIA Annu Symp Proc, P794; CARRICO CJ, 1986, ARCH SURG-CHICAGO, V121, P196; Chiu W, 2007, J TRAUMA, V63, P510; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; Cuschieri J, 2008, J TRAUMA, V65, P944, DOI 10.1097/TA.0b013e3181826df7; Daumerie G, 2008, CURR OPIN ANESTHESIO, V21, P60, DOI 10.1097/ACO.0b013e3282f35ea5; Davis K, 2008, J TRAUMA, V64, P73; Dupuis J, 1999, CIRCULATION, V99, P3227, DOI 10.1161/01.CIR.99.25.3227; Efron DT, 2008, J TRAUMA, V64, P66, DOI 10.1097/TA.0b013e31815b842a; Enderson BL, 2007, J TRAUMA, V62, P33; Hackam DG, 2006, LANCET, V367, P413, DOI 10.1016/S0140-6736(06)68041-0; Harbrecht BG, 2007, J TRAUMA, V63, P703, DOI 10.1097/TA.0b013e31811eadea; Heeschen C, 2002, CIRCULATION, V105, P1446, DOI 10.1161/01.CIR.0000012530.68333.C8; Hollis S, 2006, J TRAUMA, V61, P1255, DOI 10.1097/01.ta.0000243889.07090.da; Huggins GS, 1998, CIRCULATION, V98, P1291, DOI 10.1161/01.CIR.98.13.1291; Kennedy DM, 2000, J TRAUMA, V48, P451, DOI 10.1097/00005373-200003000-00012; Kruger P, 2006, INTENS CARE MED, V32, P75, DOI 10.1007/s00134-005-2859-y; Kruger Peter S, 2006, Crit Care Resusc, V8, P223; Le Manach Y, 2007, ANESTH ANALG, V104, P1326, DOI 10.1213/01.ane.0000263029.72643.10; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; Lee TH, 1999, NEW ENGL J MED, V341, P1838, DOI 10.1056/NEJM199912093412410; Li JJ, 2006, MED HYPOTHESES, V66, P1199, DOI 10.1016/j.mehy.2005.06.035; Li JJ, 2006, CLIN CHIM ACTA, V366, P269, DOI 10.1016/j.cca.2005.10.021; Liappis AP, 2001, CLIN INFECT DIS, V33, P1352, DOI 10.1086/323334; Lindenauer PK, 2005, NEW ENGL J MED, V353, P349, DOI 10.1056/NEJMoa041895; Lindenauer PK, 2004, JAMA-J AM MED ASSOC, V291, P2092, DOI 10.1001/jama.291.17.2092; Maier RV, 2005, J TRAUMA, V59, P762, DOI 10.1097/01.ta.0000177656.85206.cd; Majumdar SR, 2006, BMJ-BRIT MED J, V333, P999, DOI 10.1136/BMJ.38992.565972.7C; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Marshall JC, 1999, EUR J SURG, V163, P62; McGwin G, 2004, J TRAUMA, V56, P1291, DOI 10.1097/01.TA.0000089354.02065.D0; MILZMAN DP, 1992, J TRAUMA, V32, P236, DOI 10.1097/00005373-199202000-00021; Mina AA, 2003, J TRAUMA, V54, P842, DOI 10.1097/01.TA.0000063271.05829.15; Minei JP, 2006, J TRAUMA, V60, P1106, DOI 10.1097/01.ta.0000220424.34835.f1; Moore FA, 2006, J TRAUMA, V61, P82, DOI 10.1097/01.ta.0000225933.08478.65; MORRIS JA, 1990, JAMA-J AM MED ASSOC, V263, P1942, DOI 10.1001/jama.263.14.1942; MORRIS JA, 1990, J TRAUMA, V30, P1476, DOI 10.1097/00005373-199012000-00006; Mortensen EM, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-82; Nathens AB, 2005, J TRAUMA, V59, P764, DOI 10.1097/01.ta.0000177759.17704.35; Neideen T, 2008, J TRAUMA, V65, P1016, DOI 10.1097/TA.0b013e3181897eac; ODriscoll G, 1997, CIRCULATION, V95, P1126, DOI 10.1161/01.cir.95.5.1126; Osamah H, 1997, BRIT J CLIN PHARMACO, V44, P77, DOI 10.1046/j.1365-2125.1997.00625.x; Pryor JP, 2007, J TRAUMA, V62, P61; Ridker PM, 1998, CIRCULATION, V97, P1671, DOI 10.1161/01.CIR.97.17.1671; Ridker PM, 1998, CIRCULATION, V98, P839, DOI 10.1161/01.CIR.98.9.839; Riordan WP, 2007, J TRAUMA, V63, P503, DOI 10.1097/TA.0b013e3181271c34; Schouten O, 2007, AM J CARDIOL, V100, P316, DOI 10.1016/j.amjcard.2007.02.093; Shepherd J, 2006, J INTERN MED, V260, P305, DOI 10.1111/j.1365-2796.2006.01700.x; Spencer FA, 2004, ANN INTERN MED, V140, P857, DOI 10.7326/0003-4819-140-11-200406010-00006; Stevenson Judy, 2004, J Perianesth Nurs, V19, P392; Terblanche M, 2006, LANCET INFECT DIS, V6, P242, DOI 10.1016/S1473-3099(06)70439-X; Thomsen RW, 2006, CRIT CARE MED, V34, P1080, DOI 10.1097/01.CCM.0000207345.92928.E4; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; West MA, 2006, J TRAUMA, V61, P436, DOI 10.1097/01.ta.0000232517.83039.c4; Westphal S, 2008, ANGIOLOGY, V59, P613, DOI 10.1177/0003319708316005; Williams TM, 2008, ANN SURG, V247, P30, DOI 10.1097/SLA.0b013e3181492c0d	58	17	17	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	SEP	2009	67	3					476	484		10.1097/TA.0b013e3181ad66bb			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	493IL	WOS:000269729900008	19741387	Green Accepted			2022-02-06	
J	Park, SJ; Hur, JW; Kwon, KY; Rhee, JJ; Lee, JW; Lee, HK				Park, Sung Jun; Hur, Jin Woo; Kwon, Ki Young; Rhee, Jong Joo; Lee, Jong Won; Lee, Hyun Koo			Time to Recover Consciousness in Patients with Diffuse Axonal Injury: Assessment with Reference to Magnetic Resonance Grading	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Brain stem; Consciousness; Diffuse axonal injury; MRI	SEVERE HEAD-INJURY; CEREBRAL WHITE MATTER; TRAUMATIC COMA; CT	Objective : This study was conducted to investigate the correlation between the degrees of injury on brain magnetic resonance imaging (MRI) and the time interval to recovery of consciousness in patients with diffuse axonal injury. Methods : From January 2004 to December 2008, 25 patients with diffuse axonal injury were treated at our hospital. We retrospectively investigated the patients' medical records and radiological findings. We divided the patients into three groups according to the grade of MRI finding : grade I, small scattered lesions on the white matter of the cerebral hemisphere; grade II, focal lesions on the corpus callosum; and grade III, additional focal lesions on the brain stem. Result : Seven patients belonged to the grade I group; 10 to the grade II group; and 8 to the grade III group. The mean Glasgow Coma Scale (GCS) score of all patients at the time of admission was 7.28. Recovery of consciousness was observed in 23 of the 25 patients; the remaining two patients never regained consciousness. The time interval to recovery of consciousness (awake status) ranged from 1 day to 125 days (mean 22.1 days) : grade I group patients, within approximately 1 week (mean 3.7 days); grade II group patients, within approximately 2 weeks (mean 12.5 days); and grade III group patients, within approximately 2 months (mean 59.5 days). Conclusion : Our study results suggest a correlation between the mean time interval to recovery of consciousness in patients with diffuse axonal injuries and the degrees of brain injuries seen on MRI. Patients with grade I and II diffuse axonal injuries recovered consciousness within 2 weeks, while patients with grade III injuries required approximately 2 months.	[Park, Sung Jun; Hur, Jin Woo; Kwon, Ki Young; Rhee, Jong Joo; Lee, Jong Won; Lee, Hyun Koo] Cheongju St Marys Hosp, Dept Neurosurg, Cheongju 360568, South Korea		Hur, JW (corresponding author), Cheongju St Marys Hosp, Dept Neurosurg, 589-5 Jujung Dong, Cheongju 360568, South Korea.	somalh@naver.com					ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Eum SW, 1998, J KOREAN NEUROSURG S, V27, P1668; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; KALFF R, 1989, CHILD NERV SYST, V5, P156, DOI 10.1007/BF00272118; Kim CH, 1997, J KOREAN NEUROSURG S, V26, P241; Kim HJ, 2001, J KOREAN NEUROSURG S, V30, P168; Lee HS, 1990, J KOREAN NEUROSURG S, V19, P1101; LEVATI A, 1982, J NEUROSURG, V57, P779, DOI 10.3171/jns.1982.57.6.0779; LEVI L, 1990, NEUROSURGERY, V27, P429, DOI 10.1227/00006123-199009000-00015; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; Oh KS, 2001, J KOREAN NEUROSUR S1, V30, pS20; Park SW, 1991, J KOREAN NEUROSURG S, V20, P983; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; WILLIAMS JM, 1984, J NEUROSURG, V61, P581, DOI 10.3171/jns.1984.61.3.0581; ZIMMERMAN RA, 1978, RADIOLOGY, V127, P393, DOI 10.1148/127.2.393; ZIMMERMAN RA, 1986, AM J ROENTGENOL, V147, P1215, DOI 10.2214/ajr.147.6.1215	20	17	21	0	1	KOREAN NEUROSURGICAL SOC	SEOUL	#402 POSCO # OFFICE BUILDING 151 SUNHWA-DONG, JUNG-GU, SEOUL, 100-130, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	SEP	2009	46	3					205	209		10.3340/jkns.2009.46.3.205			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	507GC	WOS:000270839100005	19844619	gold, Green Published			2022-02-06	
J	Wen, L; Liu, WG; Ma, L; Zhan, RY; Li, G; Yang, XF				Wen, L.; Liu, W. G.; Ma, L.; Zhan, R. Y.; Li, G.; Yang, X. F.			Spontaneous rapid resolution of acute subdural hematoma after head trauma: Is it truly rare?	IRISH JOURNAL OF MEDICAL SCIENCE			English	Article						Acute subdural hematoma; Spontaneous resolution; Traumatic brain injury	REDISTRIBUTION; PATIENT	Spontaneous rapid resolution of acute subdural hematoma (ASDH) is a rare phenomenon for this severe insult after head trauma. We present a 22-year-old patient who developed ASDH with a moderate midline shift and compression of lateral ventricle after a truncal collision but without a direct beat on the head. Conservative management was performed under close monitoring because of unexpected improvement of clinical signs and symptoms. Unexpectedly, the ASDH resolved spontaneously within 13 h after the trauma, and he was discharged 1 week later without any neurological deficit. In addition, similar cases reported in literature were reviewed. Because most of the patients developing ASDH underwent emergent surgical intervention, the incidence of this phenomenon may be underestimated. Although emergent surgical removal remains the first choice for the treatment of ASDH, conservative management with careful monitoring may also work out in selected patients who show neurologic and radiologic improvements.	[Wen, L.; Zhan, R. Y.; Li, G.; Yang, X. F.] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Neurosurg, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, W. G.; Ma, L.] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Dept Neurosurg, Hangzhou 310003, Zhejiang, Peoples R China; [Wen, L.; Liu, W. G.; Ma, L.; Zhan, R. Y.; Li, G.; Yang, X. F.] Zhejiang Univ, Inst Brain Med, Hangzhou 310003, Zhejiang, Peoples R China		Yang, XF (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Neurosurg, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China.	jediwen@163.com					Berker M, 2003, ACTA NEUROCHIR, V145, P715, DOI 10.1007/s00701-003-0090-6; Cohen JE, 1998, SURG NEUROL, V50, P241, DOI 10.1016/S0090-3019(97)00026-8; Erol FS, 2004, PEDIATR NEUROSURG, V40, P238, DOI 10.1159/000082299; Huang Shu-Hung, 2005, Kaohsiung Journal of Medical Sciences, V21, P291; Imai K, 2003, NEUROL MED-CHIR, V43, P125, DOI 10.2176/nmc.43.125; Inamasu J, 2002, AM J EMERG MED, V20, P376, DOI 10.1053/ajem.2002.33955; JURAN V, 1997, CLIN NEUROL NEURO S1, V99, pS73; Kato N, 2001, NEUROL MED-CHIR, V41, P140, DOI 10.2176/nmc.41.140; Kundra SN, 2005, NEUROL INDIA, V53, P124, DOI 10.4103/0028-3886.15083; KUROIWA T, 1993, J NEUROSURG, V78, P126, DOI 10.3171/jns.1993.78.1.0126; Matsuyama T, 1997, SURG NEUROL, V48, P193, DOI 10.1016/S0090-3019(96)00484-3; Niikawa S, 1989, Neurol Med Chir (Tokyo), V29, P820, DOI 10.2176/nmc.29.820; Tsui EYK, 2000, EUR J RADIOL, V36, P53, DOI 10.1016/S0720-048X(99)00167-9	13	17	20	0	3	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0021-1265	1863-4362		IRISH J MED SCI	Irish J. Med. Sci.	SEP	2009	178	3					367	371		10.1007/s11845-008-0168-5			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	480YB	WOS:000268772100026	18807104				2022-02-06	
J	Wang, JP; Jiang, C; Li, X; Liu, CL; Cheng, NN; Hao, YJ				Wang, Jianping; Jiang, Chao; Li, Xin; Liu, Chunling; Cheng, Ningning; Hao, Yujin			RETRACTED: The protective mechanism of progesterone on blood-brain barrier in cerebral ischemia in rats (Retracted article. See vol. 81, pg. 524, 2010)	BRAIN RESEARCH BULLETIN			English	Article; Retracted Publication						Cerebral ischemia; Progesterone; Tumor necrosis factor alpha; Matrix metalloproteinase-9; Claudin5; Blood-brain barrier	TUMOR-NECROSIS-FACTOR; MATRIX METALLOPROTEINASES; INFLAMMATORY RESPONSE; ARTERY OCCLUSION; FACTOR-ALPHA; CELL-DEATH; INJURY; EXPRESSION; ALLOPREGNANOLONE; EDEMA	Recent studies demonstrate that progesterone (PROG) significantly reduces cerebral edema and enhances functional recovery from traumatic brain injury (TBI) and stroke in several animal models, but its concrete mechanism is still unknown. This study was designed to investigate the inhibitory effects of PROG on inflammatory response after stroke and its influence on the structure of blood-brain barrier (BBB). In the treatment group, PROG was dissolved in 22.5% 2-hydroxypropyl-bcyclodextrin and given in a dose of 8 mg/kg by intraperitoneal injection 1 h and 6 h after permanent occlusion of middle cerebral artery (pMCAO). Additional injections of 15 mg/kg were administered subcutaneously once a day after pMCAO. The expression of tumor necrosis factor-alpha (TNF-alpha), matrix metalloproteinase-9 (MMP-9) and claudin5 was measured by western blot technique. Evan's blue extravasation and brain water content in the ipsilateral hemisphere was also detected to evaluate the permeability of BBB. Western blot analysis revealed that the expression of TNF-alpha and MMP-9 were reduced while claudin5 was up-regulated in brain tissues of PROG-treated rats. In addition, examination of BBB permeability also showed that administration of PROG significantly reduced Evan's blue extravasation and brain water content in the ipsilateral hemisphere compared to vehicle-treated rats. Our findings reveal that PROG inhibited the inflammatory response after experimental stroke and mitigated the severity of brain damage, suggesting a role for PROG in the integrity of the BBB and subsequent edema formation following cerebral ischemia. (C) 2009 Elsevier Inc. All rights reserved.	[Wang, Jianping; Jiang, Chao; Li, Xin; Liu, Chunling; Cheng, Ningning; Hao, Yujin] Zhengzhou Univ, Affiliated Hosp 2, Dept Neurol, Zhengzhou 450014, Henan, Peoples R China		Wang, JP (corresponding author), Zhengzhou Univ, Affiliated Hosp 2, Dept Neurol, Zhengzhou 450014, Henan, Peoples R China.	jcmd666@126.com					Abdallah Y, 2007, CARDIOVASC RES, V73, P568, DOI 10.1016/j.cardiores.2006.11.027; Begley DJ, 2003, PROG DRUG RES, V61, P39; Botchkina GI, 1997, MOL MED, V3, P765, DOI 10.1007/BF03401714; Cai WY, 2008, NEUROPHARMACOLOGY, V55, P127, DOI 10.1016/j.neuropharm.2008.04.023; Cunningham LA, 2005, GLIA, V50, P329, DOI 10.1002/glia.20169; deVries HE, 1996, J NEUROIMMUNOL, V64, P37, DOI 10.1016/0165-5728(95)00148-4; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Dziewulska D, 2003, CLIN NEUROPATHOL, V22, P35; Fryclenlund DS, 2006, P NATL ACAD SCI USA, V103, P13532, DOI 10.1073/pnas.0605796103; Galani R, 2001, RESTOR NEUROL NEUROS, V18, P161; GEARING AJH, 1994, NATURE, V370, P555, DOI 10.1038/370555a0; Gibson CL, 2005, EXP NEUROL, V193, P522, DOI 10.1016/j.expneurol.2005.01.009; Gibson CL, 2004, J CEREBR BLOOD F MET, V24, P805, DOI 10.1097/01.WCB.0000125365.83980.00; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; GOTTSCHALL PE, 1995, J NEUROCHEM, V64, P1513; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Hu ZY, 2009, CURR MED CHEM, V16, P1418, DOI 10.2174/092986709787846523; Kumon Y, 2000, J NEUROSURG, V92, P848, DOI 10.3171/jns.2000.92.5.0848; Mani SK, 2006, MOL ENDOCRINOL, V20, P1322, DOI 10.1210/me.2005-0466; Manicone AM, 2008, SEMIN CELL DEV BIOL, V19, P34, DOI 10.1016/j.semcdb.2007.07.003; Meistrell ME, 1997, SHOCK, V8, P341; Nawashiro H, 1997, BRAIN RES, V778, P265, DOI 10.1016/S0006-8993(97)00981-5; Overall CM, 2002, BIOL CHEM, V383, P1059, DOI 10.1515/BC.2002.114; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Sayeed I, 2006, ANN EMERG MED, V47, P381, DOI 10.1016/j.annemergmed.2005.12.011; Sayeed L, 2007, RESTOR NEUROL NEUROS, V25, P151; Schaeffer V, 2008, NEUROCHEM INT, V52, P948, DOI 10.1016/j.neuint.2008.01.010; Schonbeck U, 1998, J IMMUNOL, V161, P3340; Shen J, 2007, EUR J PHARMACOL, V558, P88, DOI 10.1016/j.ejphar.2006.11.059; SMITH SS, 2004, CLIN J MED S, V2, pS4; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Svedin P, 2007, J NEUROSCI, V27, P1511, DOI 10.1523/JNEUROSCI.4391-06.2007; Tsukita S, 1998, GENES CELLS, V3, P569, DOI 10.1046/j.1365-2443.1998.00212.x; Vagnerova K, 2008, ANESTH ANALG, V107, P201, DOI 10.1213/ane.0b013e31817326a5; Vincent T, 2008, J IMMUNOL, V181, P5730, DOI 10.4049/jimmunol.181.8.5730; Vizuete ML, 1999, NEUROBIOL DIS, V6, P245, DOI 10.1006/nbdi.1999.0246; Williams AJ, 2006, NEUROCHEM INT, V49, P106, DOI 10.1016/j.neuint.2006.03.018; Xi G, 2002, ACT NEUR S, V81, P253	40	17	22	0	13	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	AUG 14	2009	79	6					426	430		10.1016/j.brainresbull.2009.05.018			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	478UR	WOS:000268614400015	19477244				2022-02-06	
J	Vulliemoz, S; Perrig, S; Pellise, D; Vargas, MI; Gasche, Y; Ives, JR; Seeck, M				Vulliemoz, Serge; Perrig, Stephen; Pellise, Daniel; Vargas, Maria I.; Gasche, Yvan; Ives, John R.; Seeck, Margitta			Imaging Compatible Electrodes for Continuous Electroencephalogram Monitoring in the Intensive Care Unit	JOURNAL OF CLINICAL NEUROPHYSIOLOGY			English	Article	62nd Annual Meeting of the American-Epilepsy-Society	DEC 05-09, 2008	Seattle, WA	Amer Epilepsy Soc		Coma; Critical care; Continuous EEG; Long-term monitoring; Imaging; Electrodes	TRAUMATIC BRAIN-INJURY; CONTINUOUS EEG; SUBARACHNOID HEMORRHAGE; NONCONVULSIVE SEIZURES; INTRACEREBRAL HEMORRHAGE; ELECTROGRAPHIC SEIZURES; ICU; QUALITY; MRI	Continuous electroencephalogram in the intensive care unit is increasingly recognized as An important diagnostic and prognostic tool in critically ill patients. Metal disc electrodes or subdermal needle electrodes are neither computed tomography nor magnetic resonance imaging compatible. Their frequent replacement required for imaging purposes is time consuming and contributes to scalp breakdown. We have developed and report Oil two new types of imaging compatible electrodes. The subdermal wire electrode and the silver-epoxy-coated conductive plastic electrode are magnetic resonance imaging, Computed tomography, and angiogram compatible. Moreover, the subdermal wire electrode does not require my daily maintenance. The electrodes were used on a total of 24 intensive care unit patients (subdermal wire electrode = 20, conductive plastic electrodes = 4) who required continuous electroencephalogram. During all average of 62.2 +/- 44 hours of electroencephalogram recording, 54% of the patients underwent imaging procedures (nine magnetic resonance imagings, five computed tomographic scans, and two angiograms) of good quality without the need to remove/replace the electrodes. The continuous electronencephalogram revealed epileptogenic activity that was not detected oil standard 20-minute recordings in 28% of patients screened, with electrographic seizures in 11%. These two types of imaging compatible electrodes offer definite advantages in clinical practice. The combined diagnostic information of continuous electroencephalogram and easy-to-plan imaging yields important results and improves the clinical management and treatment of intensive care unit patients.	[Vulliemoz, Serge; Perrig, Stephen; Pellise, Daniel; Seeck, Margitta] Univ Hosp Geneva, Dept Clin Neurosci, CH-1211 Geneva 14, Switzerland; [Vargas, Maria I.] Univ Hosp Geneva, Dept Radiol, CH-1211 Geneva, Switzerland; [Gasche, Yvan] Univ Hosp Geneva, Dept Anaesthesiol Pharmacol & Intens Care, CH-1211 Geneva 14, Switzerland; Univ Geneva, Fac Med, Geneva, Switzerland; [Ives, John R.] Univ Western Ontario, Dept Clin Neurol Sci, London, ON, Canada		Vulliemoz, S (corresponding author), Univ Hosp Geneva, EEG & Epilepsy Unit, Dept Neurol, 24 Micheli Du Crest, CH-1211 Geneva 14, Switzerland.	serge.vulliemoz@hcuge.ch		Vargas, Maria Isabel/0000-0002-6571-5336			Claassen J, 2007, NEUROLOGY, V69, P1356, DOI 10.1212/01.wnl.0000281664.02615.6c; Claassen J, 2005, J CLIN NEUROPHYSIOL, V22, P92, DOI 10.1097/01.WNP.0000145006.02048.3A; Claassen J, 2004, CLIN NEUROPHYSIOL, V115, P2699, DOI 10.1016/j.clinph.2004.06.017; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Das RR, 2009, NEUROCRIT CARE, V10, P368, DOI 10.1007/s12028-008-9142-3; Hirsch LJ, 2004, J CLIN NEUROPHYSIOL, V21, P332; Ives JR, 2006, CLIN NEUROPHYSIOL, V117, P1870, DOI 10.1016/j.clinph.2006.04.010; Ives JR, 2005, J CLIN NEUROPHYSIOL, V22, P119, DOI 10.1097/01.WNP.0000152659.30753.47; IVES JR, 1993, ELECTROEN CLIN NEURO, V87, P417, DOI 10.1016/0013-4694(93)90156-P; Jette N, 2006, ARCH NEUROL-CHICAGO, V63, P1750, DOI 10.1001/archneur.63.12.1750; Jirsch J, 2007, CLIN NEUROPHYSIOL, V118, P1660, DOI 10.1016/j.clinph.2006.11.312; Krakow K, 2000, HUM BRAIN MAPP, V10, P10, DOI 10.1002/(SICI)1097-0193(200005)10:1<10::AID-HBM20>3.0.CO;2-T; Kull LL, 2005, J CLIN NEUROPHYSIOL, V22, P107, DOI 10.1097/01.WNP.0000158361.24544.2D; LABAR DR, 1991, ELECTROEN CLIN NEURO, V78, P325, DOI 10.1016/0013-4694(91)90094-K; LUFKIN R, 1988, AM J NEURORADIOL, V9, P953; Mirsattari SM, 2004, CLIN NEUROPHYSIOL, V115, P2175, DOI 10.1016/j.clinph.2004.04.011; Scheuer ML, 2002, EPILEPSIA, V43, P114, DOI 10.1046/j.1528-1157.43.s.3.7.x; Stevens TK, 2007, J MAGN RESON IMAGING, V25, P872, DOI 10.1002/jmri.20872; Tallgren P, 2005, CLIN NEUROPHYSIOL, V116, P799, DOI 10.1016/j.clinph.2004.10.001; Vespa P, 2005, J CLIN NEUROPHYSIOL, V22, P99, DOI 10.1097/01.WNP.0000154919.54202.E0; Vespa PM, 1997, ELECTROEN CLIN NEURO, V103, P607, DOI 10.1016/S0013-4694(97)00071-0; Vespa PM, 2002, J NEUROSURG, V97, P84, DOI 10.3171/jns.2002.97.1.0084; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; Young GB, 2006, CLIN NEUROPHYSIOL, V117, P1376, DOI 10.1016/j.clinph.2006.02.006; Young GB, 2005, NEUROCRIT CARE, V2, P5, DOI 10.1385/NCC:2:1:005; Young GB, 1996, NEUROLOGY, V47, P83	26	17	17	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0736-0258			J CLIN NEUROPHYSIOL	J. Clin. Neurophysiol.	AUG	2009	26	4					236	243		10.1097/WNP.0b013e3181af1c95			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	480OQ	WOS:000268746000004	19584749				2022-02-06	
J	Roozenbeek, B; Maas, AIR; Marmarou, A; Butcher, I; Lingsma, HF; Lu, J; McHugh, GS; Murray, GD; Steyerberg, EW				Roozenbeek, Bob; Maas, Andrew I. R.; Marmarou, Anthony; Butcher, Isabella; Lingsma, Hester F.; Lu, Juan; McHugh, Gillian S.; Murray, Gordon D.; Steyerberg, Ewout W.		IMPACT Study Grp	The Influence of Enrollment Criteria on Recruitment and Outcome Distribution in Traumatic Brain Injury Studies: Results from the Impact Study	JOURNAL OF NEUROTRAUMA			English	Article						enrollment criteria; heterogeneity; outcome distribution; randomized controlled trial; recruitment; traumatic brain injury	HEAD-INJURY; CLINICAL-TRIALS; NEUROPROTECTIVE AGENTS; DESIGN; EFFICACY	Substantial heterogeneity exists among patients who suffer from traumatic brain injury (TBI). Strict enrollment criteria may diminish heterogeneity in randomized controlled trials (RCTs), but will also decrease recruitment and may affect the outcome distribution. The aim of this study was to investigate the influences of commonly used enrollment criteria for RCTs in TBI on potential recruitment and on outcome distribution. We used individual patient data from the International Mission on Prognosis and Analysis of Clinical Trials in TBI (IMPACT) database, including six therapeutic phase III RCTs (n-5816) and three surveys (n-2217) in TBI. The primary outcome was the Glasgow Outcome Scale (GOS) at 6 months after injury, which we dichotomized as favorable/unfavorable. We investigated the influences of commonly used enrollment criteria on recruitment and outcome distribution: time window between injury and admission to study hospital <= 8 h; age at injury <= 65 years; >= 1 reactive pupil; motor score > 1; Glasgow Coma Scale <= 8. Application of all enrollment criteria resulted in a large reduction of recruitment in both the surveys (up to 65%) and the RCTs (up to 41%). Among the remaining patients, fewer had an unfavorable outcome in both the surveys (original, 60%; remaining, 44%) and the RCTs (original, 43%; remaining, 38%). Applying these enrollment criteria to patients from the surveys resulted in an outcome distribution that approximated the outcome observed in the RCTs. The use of strict enrollment criteria leads to substantial reductions in the recruitment of RCTs in TBI. The outcome in TBI studies depends strongly on the enrollment criteria.	[Maas, Andrew I. R.] Univ Antwerp Hosp, Dept Neurosurg, Antwerp, Belgium; [Roozenbeek, Bob; Lingsma, Hester F.; Steyerberg, Ewout W.] Erasmus MC, Ctr Med Decis Making, Dept Publ Hlth, Rotterdam, Netherlands; [Roozenbeek, Bob; Maas, Andrew I. R.] Erasmus MC, Dept Neurosurg, Rotterdam, Netherlands; [Marmarou, Anthony; Lu, Juan] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA USA; [Butcher, Isabella; McHugh, Gillian S.; Murray, Gordon D.] Univ Edinburgh, Div Community Hlth Sci, Edinburgh, Midlothian, Scotland		Maas, AIR (corresponding author), Univ Antwerp Hosp, Dept Neurosurg, Wilrijkstr 10, B-2650 Edegem, Belgium.	andrew.maas@uza.be	Maas, Andrew IR/C-5584-2013; Steyerberg, Ewout/C-1509-2018	Maas, Andrew IR/0000-0003-1612-1264; Steyerberg, Ewout/0000-0002-7787-0122; Murray, Gordon/0000-0001-9866-4734; Lu, Juan/0000-0002-5389-7603	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS-42691]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS042691] Funding Source: NIH RePORTER; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0800803] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0800803] Funding Source: researchfish	Grant support was provided by NIH NS-42691.	BULLOCK MR, 2002, NEUROSURG FOCUS; Choi SC, 2001, NEUROL RES, V23, P190, DOI 10.1179/016164101101198325; Edwards P, 2005, LANCET, V365, P1957; Hernandez AV, 2006, J NEUROTRAUM, V23, P1295, DOI 10.1089/neu.2006.23.1295; Hukkelhoven CWPM, 2006, J CLIN EPIDEMIOL, V59, P132, DOI 10.1016/j.jclinepi.2005.06.009; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Kompanje EJO, 2005, ACTA NEUROCHIR, V147, P633, DOI 10.1007/s00701-005-0525-3; Maas AIR, 1999, NEUROSURGERY, V44, P1286, DOI 10.1097/00006123-199906000-00076; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Machado SG, 1999, J NEUROTRAUM, V16, P1131, DOI 10.1089/neu.1999.16.1131; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Slieker FJA, 2008, NEUROSURGERY, V62, P1321, DOI 10.1227/01.neu.0000333304.79931.4d	14	17	17	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2009	26	7					1069	1075		10.1089/neu.2008.0569			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	470HJ	WOS:000267965500012	19594383	Green Published, Green Submitted			2022-02-06	
J	Wu, KLH; Hsu, C; Chan, JYH				Wu, Kay L. H.; Hsu, Chin; Chan, Julie Y. H.			Nitric Oxide and Superoxide Anion Differentially Activate Poly(ADP-ribose) Polymerase-1 and Bax to Induce Nuclear Translocation of Apoptosis-Inducing Factor and Mitochondrial Release of Cytochrome c after Spinal Cord Injury	JOURNAL OF NEUROTRAUMA			English	Article						apoptosis; mitochondrial respiratory enzyme complex; nitric oxide; spinal cord injury; superoxide anion	ROSTRAL VENTROLATERAL MEDULLA; TRAUMATIC BRAIN-INJURY; 2 DISTINCT PATHWAYS; CELL-DEATH; OXIDATIVE STRESS; GLUTATHIONE-PEROXIDASE; PROTEIN NITRATION; RESPIRATORY-CHAIN; IN-VITRO; SYNTHASE	We reported previously that complete spinal cord transection (SCT) results in depression of mitochondrial respiratory chain enzyme activity that triggers apoptosis via sequential activations of apoptosis-inducing factor (AIF)- and caspase- dependent cascades in the injured spinal cord. This study tested the hypothesis that nitric oxide (NO) and superoxide anion (O-2(center dot-)) serve as the interposing signals between SCT and impaired mitochondrial respiratory functions. Adult Sprague-Dawley rats manifested a significant increase in NO or O-2(center dot-) level in the injured spinal cord during the first 3 days after SCT. The augmented O-2(center dot-) production, along with concomitant reduction in mitochondrial respiratory chain enzyme activity or ATP level, nuclear translocation of AIF, cytosolic release of cytochrome c, and DNA fragmentation were reversed by osmotic minipump infusion of a NO trapping agent, carboxy-PTIO, or a superoxide dismutase mimetic, tempol, into the epicenter of the transected spinal cord. Intriguingly, carboxy-PTIO significantly suppressed upregulation of poly(ADP-ribose) polymerase-1 (PARP-1) in the nucleus, attenuated nuclear translocation of AIF, inhibited mitochondrial translocation of Bax and antagonized mitochondrial release of cytochrome c; whereas tempol only inhibited the later two cellular events after SCT. We conclude that overproduction of NO and O-2(center dot-) in the injured spinal cord promulgates mitochondrial dysfunction and triggers AIF- and caspase- dependent apoptotic signaling cascades via differential upregulation of nuclear PARP-1 and mitochondrial translocation of Bax.	[Wu, Kay L. H.; Chan, Julie Y. H.] Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung 81346, Taiwan; [Wu, Kay L. H.; Hsu, Chin] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan		Chan, JYH (corresponding author), Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung 81346, Taiwan.	yhwa@isca.vghks.gov.tw	Chan, Julie/X-5253-2019		National Science CouncilMinistry of Science and Technology, Taiwan [NSC96-2320-B075-B-001]; Kaohsiung Veterans General Hospital [VGHKS 96G-21]	This study was supported by the National Science Council ( research grant NSC96-2320-B075-B-001 to J.Y.H.C.) and the Kaohsiung Veterans General Hospital ( research grant VGHKS 96G-21 to J.Y.H.C.), Taiwan, Republic of China.	Abdelkarim GE, 2001, INT J MOL MED, V7, P255; Aulak KS, 2004, AM J PHYSIOL-HEART C, V286, pH30, DOI 10.1152/ajpheart.00743.2003; Austin JW, 2008, J NEUROTRAUM, V25, P411, DOI 10.1089/neu.2007.0436; Bao F, 2004, J NEUROCHEM, V88, P1335, DOI 10.1046/j.1471-4159.2003.02240.x; Beattie MS, 2002, PROG BRAIN RES, V137, P37; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Besson VC, 2005, BRAIN RES, V1041, P149, DOI 10.1016/j.brainres.2005.01.096; BONFOCO E, 1995, EXP CELL RES, V218, P189, DOI 10.1006/excr.1995.1147; Brown GC, 1999, BBA-BIOENERGETICS, V1411, P351, DOI 10.1016/S0005-2728(99)00025-0; Brown GC, 1997, MOL CELL BIOCHEM, V174, P189, DOI 10.1023/A:1006800322719; Brown GC, 2007, CARDIOVASC RES, V75, P283, DOI 10.1016/j.cardiores.2007.03.022; Carlson Gregory D, 2002, Spine J, V2, P116, DOI 10.1016/S1529-9430(01)00029-8; Chan JYH, 2007, MOL PHARMACOL, V71, P1129, DOI 10.1124/mol.106.031161; Chan SHH, 2005, FREE RADICAL BIO MED, V39, P603, DOI 10.1016/j.freeradbiomed.2005.04.012; Chuang YC, 2002, J BIOMED SCI, V9, P542, DOI 10.1159/000064727; Clementi E, 1998, P NATL ACAD SCI USA, V95, P7631, DOI 10.1073/pnas.95.13.7631; Conti A, 2007, BRAIN RES REV, V54, P205, DOI 10.1016/j.brainresrev.2007.01.013; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Dawson VL, 2004, J BIOENERG BIOMEMBR, V36, P287, DOI 10.1023/B:JOBB.0000041755.22613.8d; Galkin A, 2007, J BIOL CHEM, V282, P37448, DOI 10.1074/jbc.M707543200; Genovese T, 2005, J PHARMACOL EXP THER, V313, P529, DOI 10.1124/jpet.104.080705; Hoch FL, 1998, J BIOENERG BIOMEMBR, V30, P511, DOI 10.1023/A:1020576315771; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; Joseph Troy W, 2003, Methods Mol Biol, V234, P211; Kantrow SP, 1997, ARCH BIOCHEM BIOPHYS, V345, P278, DOI 10.1006/abbi.1997.0264; Keane RW, 2006, J NEUROTRAUM, V23, P335, DOI 10.1089/neu.2006.23.335; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Kwak EK, 2005, J KOREAN MED SCI, V20, P663, DOI 10.3346/jkms.2005.20.4.663; Latini A, 2003, J NEUROSCI RES, V74, P103, DOI 10.1002/jnr.10735; Maier C, 2007, INTENS CARE MED, V33, P845, DOI 10.1007/s00134-007-0585-3; Meany DL, 2006, FREE RADICAL BIO MED, V41, P950, DOI 10.1016/j.freeradbiomed.2006.06.003; Naithani S, 2003, MOL BIOL CELL, V14, P324, DOI 10.1091/mbc.E02-08-0490; Nakahara S, 2002, J NEUROTRAUM, V19, P1467, DOI 10.1089/089771502320914697; Nomura K, 2001, BIOL SIGNAL RECEPT, V10, P81; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Paradies G, 2001, MITOCHONDRION, V1, P151, DOI 10.1016/S1567-7249(01)00011-3; Sastre J, 2000, IUBMB LIFE, V49, P427; Satake K, 2000, MOL BRAIN RES, V85, P114, DOI 10.1016/S0169-328X(00)00253-9; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Sheeran FL, 2006, BBA-BIOENERGETICS, V1757, P543, DOI 10.1016/j.bbabio.2006.03.008; Sheh YL, 2007, FREE RADICAL BIO MED, V42, P1610, DOI 10.1016/j.freeradbiomed.2007.02.019; Stefanis L, 2005, NEUROSCIENTIST, V11, P50, DOI 10.1177/1073858404271087; Sugawara T, 2002, FASEB J, V16, P1997, DOI 10.1096/fj.02-0251fje; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; Vaziri ND, 2004, BRAIN RES, V995, P76, DOI 10.1016/j.brainres.2003.09.056; Wingrave JM, 2003, J NEUROSCI RES, V73, P95, DOI 10.1002/jnr.10607; Wu KLH, 2007, J NEUROCHEM, V101, P1552, DOI 10.1111/j.1471-4159.2006.04445.x; Xu W, 2005, SPINAL CORD, V43, P204, DOI 10.1038/sj.sc.3101674; Xu Z, 2006, LIFE SCI, V79, P1895, DOI 10.1016/j.lfs.2006.06.023; Yakovlev AG, 2001, MOL NEUROBIOL, V24, P131; Yeo JE, 2008, CELL PHYSIOL BIOCHEM, V21, P225, DOI 10.1159/000113764; Yu FS, 2006, J NEUROTRAUM, V23, P595, DOI 10.1089/neu.2006.23.595; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zhang XP, 2002, J NEUROCHEM, V82, P181, DOI 10.1046/j.1471-4159.2002.00975.x	55	17	17	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2009	26	7					965	977		10.1089/neu.2008.0692			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	470HJ	WOS:000267965500003	19473058				2022-02-06	
J	Chapon, C; Franconi, F; Lacoeuille, F; Hindre, F; Saulnier, P; Benoit, JP; Le Jeune, JJ; Lemaire, L				Chapon, Catherine; Franconi, Florence; Lacoeuille, Franck; Hindre, Francois; Saulnier, Patrick; Benoit, Jean-Pierre; Le Jeune, Jean-Jacques; Lemaire, Laurent			Imaging E-selectin expression following traumatic brain injury in the rat using a targeted USPIO contrast agent	MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE			English	Article						Brain; Trauma; Selectin; MRI; SPIO	EARLY ENDOTHELIAL ACTIVATION; IN-VIVO; CARBOHYDRATE INTERACTIONS; ADHESION MOLECULES; PUBLIC-HEALTH; HEAD-INJURY; MRI; INFLAMMATION; ACCUMULATION; ARTHRITIS	The aim of this work was to map E-selectin expression in a traumatic brain injury model using a newly-designed MR contrast agent. Iron cores, responsible for susceptibility effects and therefore used as T2* contrast agents, need to be coated in order to be stabilized and need to be targeted to be useful. We have designed a molecule coating composed, at one end, of bisphosphonate to ensure anchorage of the coating on the iron core and, at the other end, of Fukuda's defined heptapeptide known to target selectin binding sites. The synthesized nanoparticles were able to non-invasively target the traumatic brain lesion, inducing a specific T2* decrease of about 25% up to at least 70 min post-injection of the targeted contrast agent.	[Chapon, Catherine; Lacoeuille, Franck; Hindre, Francois; Saulnier, Patrick; Benoit, Jean-Pierre; Le Jeune, Jean-Jacques; Lemaire, Laurent] Univ Angers, UMR S646, F-49100 Angers, France; [Chapon, Catherine; Lacoeuille, Franck; Hindre, Francois; Saulnier, Patrick; Benoit, Jean-Pierre; Le Jeune, Jean-Jacques; Lemaire, Laurent] INSERM, U646, F-49100 Angers, France; [Franconi, Florence] Univ Angers, Serv Commun Anal Spect, Angers, France		Lemaire, L (corresponding author), Univ Angers, UMR S646, F-49100 Angers, France.	laurent.lemaire@univ-angers.fr	SAULNIER, Patrick/K-4271-2015; LACOEUILLE, Franck/K-4430-2015; Benoit, Jean-Pierre/K-4387-2015; hindre, francois/K-5613-2015; FRANCONI, Florence/K-4258-2015; LEMAIRE, Laurent/A-3100-2011	LACOEUILLE, Franck/0000-0002-7070-7664; FRANCONI, Florence/0000-0001-6725-0803; LEMAIRE, Laurent/0000-0002-1308-9345; Hindre, Francois/0000-0002-2727-7996; Saulnier, Patrick/0000-0002-6408-3533; BENOIT, Jean-Pierre/0000-0002-6178-7199	Fondation des Gueules Cassees, Paris, France	We would like to thank the technicians from I'animalerie Hospitalo-Universitaire d'Angers for the housing and care of the animals used in this study, Ms. Joelle Dorat for the synthesis of the nanoparticles and Dr. David Rees for editing the manuscript. This work was partly funded by a grant from la Fondation des Gueules Cassees, Paris, France.	Babes L, 1999, J COLLOID INTERF SCI, V212, P474, DOI 10.1006/jcis.1998.6053; Barber PA, 2004, ANN NEUROL, V56, P116, DOI 10.1002/ana.20162; Beaumont A, 2006, ACTA NEUROCHIR SUPPL, V96, P171; Beduneau A, 2008, J CONTROL RELEASE, V126, P44, DOI 10.1016/j.jconrel.2007.11.001; Boutry S, 2005, MAGN RESON MED, V53, P800, DOI 10.1002/mrm.20403; Canet-Soulas E, 2007, MAGN RESON MATER PHY, V20, P129, DOI 10.1007/s10334-007-0078-y; CHAPMAN PT, 1994, ARTHRITIS RHEUM, V37, P1752, DOI 10.1002/art.1780371207; Danton GH, 2003, J NEUROPATH EXP NEUR, V62, P127, DOI 10.1093/jnen/62.2.127; Dardzinski BJ, 2001, MAGN RESON IMAGING, V19, P1209, DOI 10.1016/S0730-725X(01)00448-9; Franconi F, 2006, NMR BIOMED, V19, P527, DOI 10.1002/nbm.1014; Frijns CJM, 2002, STROKE, V33, P2115, DOI 10.1161/01.STR.0000021902.33129.69; Fukuda MN, 2000, CANCER RES, V60, P450; Funovics M, 2005, NEOPLASIA, V7, P904, DOI 10.1593/neo.05352; Gellissen J, 1999, MAGN RESON IMAGING, V17, P557, DOI 10.1016/S0730-725X(98)00206-9; Ham ASW, 2007, BIOTECHNOL BIOENG, V96, P596, DOI 10.1002/bit.21153; Kang HW, 2002, BIOCONJUGATE CHEM, V13, P122, DOI 10.1021/bc0155521; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Kay A, 2001, WORLD J SURG, V25, P1210, DOI 10.1007/s00268-001-0084-6; KLATZO I, 1987, ACTA NEUROPATHOL, V72, P236, DOI 10.1007/BF00691095; Kneuer C, 2006, DRUG DISCOV TODAY, V11, P1034, DOI 10.1016/j.drudis.2006.09.004; LASKY LA, 1995, ANNU REV BIOCHEM, V64, P113, DOI 10.1146/annurev.bi.64.070195.000553; Laurent S, 2004, BIOCONJUGATE CHEM, V15, P99, DOI 10.1021/bc034114m; Ley K, 2003, J EXP MED, V198, P1285, DOI 10.1084/jem.20031664; Lindner JR, 2001, CIRCULATION, V104, P2107, DOI 10.1161/hc4201.097061; Lythgoe MF, 1997, MAGN RESON MED, V38, P662, DOI 10.1002/mrm.1910380421; MARTENS CL, 1995, J BIOL CHEM, V270, P21129, DOI 10.1074/jbc.270.36.21129; Mathe JF, 2005, ANN FR ANESTH, V24, P688, DOI 10.1016/j.annfar.2005.03.029; MCAFEE JG, 1983, INVEST RADIOL, V18, P479, DOI 10.1097/00004424-198309000-00014; McEver RP, 1997, GLYCOCONJUGATE J, V14, P585, DOI 10.1023/A:1018584425879; Mowat P, 2007, NMR BIOMED, V20, P21, DOI 10.1002/nbm.1084; Ohshima H, 2000, J COLLOID INTERF SCI, V228, P190, DOI 10.1006/jcis.2000.6942; Ohyama C, 1999, EMBO J, V18, P1516, DOI 10.1093/emboj/18.6.1516; Pasco A, 2007, J NEUROTRAUM, V24, P1321, DOI 10.1089/neu.2006.0136; PHILLIPS ML, 1990, SCIENCE, V250, P1130, DOI 10.1126/science.1701274; Portet D, 2001, J COLLOID INTERF SCI, V238, P37, DOI 10.1006/jcis.2001.7500; Rao VLR, 2003, J NEUROSCI RES, V71, P208, DOI 10.1002/jnr.10486; Reinert M, 2000, J NEUROSURG, V93, P800, DOI 10.3171/jns.2000.93.5.0800; Renkonen R, 2002, TRANSPLANTATION, V74, P2, DOI 10.1097/00007890-200207150-00002; Reynolds PR, 2006, RADIOLOGY, V241, P469, DOI 10.1148/radiol.2412050490; Runnels JM, 2006, MOL IMAGING, V5, P31, DOI 10.2310/7290.2006.00004; Sibson NR, 2004, MAGN RESON MED, V51, P248, DOI 10.1002/mrm.10723; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Stanimirovic D, 2000, BRAIN PATHOL, V10, P113; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; STOOLMAN LM, 1989, CELL, V56, P907, DOI 10.1016/0092-8674(89)90620-X; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Van Putten HP, 2005, J NEUROTRAUM, V22, P857; Vonarbourg A, 2005, ELECTROPHORESIS, V26, P2066, DOI 10.1002/elps.200410145; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; WELLER G, 2003, BIOTECHNOL BIOENG, V92, P780; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Zinn KR, 1999, ARTHRITIS RHEUM, V42, P641, DOI 10.1002/1529-0131(199904)42:4<641::AID-ANR6>3.0.CO;2-T	52	17	20	0	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0968-5243	1352-8661		MAGN RESON MATER PHY	Magn. Reson. Mat. Phys. Biol. Med.	JUN	2009	22	3					167	174		10.1007/s10334-008-0161-z			8	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	458OG	WOS:000267032800004	19107536	Green Submitted, Green Accepted			2022-02-06	
J	Coles, JP; Cunningham, AS; Salvador, R; Chatfield, DA; Carpenter, A; Pickard, JD; Menon, DK				Coles, Jonathan P.; Cunningham, Alison S.; Salvador, Raymond; Chatfield, Doris A.; Carpenter, Adrian; Pickard, John D.; Menon, David K.			Early metabolic characteristics of lesion and nonlesion tissue after head injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						cerebral blood flow; cerebral contusions; cerebral metabolism; magnetic resonance imaging; positron emission tomography; traumatic brain injury	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; MAGNETIC-RESONANCE-SPECTROSCOPY; COMBINED MICRODIALYSIS; REGIONAL OXYGENATION; N-ACETYLASPARTATE; ISCHEMIA; VOLUME; DYSFUNCTION; DAMAGE	We defined lesion and structurally normal regions using magnetic resonance imaging at follow-up in patients recovering from head injury. Early metabolic characteristics in these regions of interest (ROIs) were compared with physiology in healthy volunteers. Fourteen patients with severe head injury had positron emission tomography within 72 h, and magnetic resonance imaging at 3 to 18 months after injury. Cerebral blood flow (CBF), oxygen utilization (CMRO2), and oxygen extraction fraction (OEF) were all lower in lesion ROIs, compared with nonlesion and control ROIs (P < 0.001); however, there was substantial overlap in physiology. Control ROIs showed close coupling among CBF, blood volume (CBV), and CMRO2, whereas relationships within lesion and nonlesion ROIs were abnormal. The relationship between CBF and CMRO2 generally remained coupled but the slope was reduced; that for CBF and OEF was variable; whereas that between CBF and CBV was highly variable. There was considerable heterogeneity between and within patients. Although irreversibly damaged tissue is characterized by marked derangements in physiology, a more detailed analysis shows acute changes in physiology and physiologic relationships within regions of the brain that appear structurally normal at follow-up. Such pathophysiological derangements may result in selective neuronal loss and impact on functional outcome. Journal of Cerebral Blood Flow & Metabolism (2009) 29, 965-975; doi:10.1038/jcbfm.2009.22; published online 18 March 2009	[Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Dept Anaesthesia, Div Anaesthesia, Cambridge CB2 2QQ, England; [Coles, Jonathan P.; Cunningham, Alison S.; Salvador, Raymond; Chatfield, Doris A.; Carpenter, Adrian; Pickard, John D.; Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Wolfson Brain Imaging Ctr, Cambridge CB2 2QQ, England; [Salvador, Raymond] CASM, Barcelona, Spain; [Salvador, Raymond] CIBERSAM, Barcelona, Spain; [Pickard, John D.] Univ Cambridge, Addenbrookes Hosp, Dept Neurosurg, Cambridge CB2 2QQ, England		Menon, DK (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Anaesthesia, Div Anaesthesia, Box 63,Hills Rd, Cambridge CB2 2QQ, England.	dkm13@wbic.cam.ac.uk		Coles, Jonathan/0000-0003-4013-679X; Salvador, Raymond/0000-0001-5557-1562	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission; Royal College of Anaesthetists/British Journal of Anaesthesia; Academy of Medical Sciences/Health Foundation; Cambridge NIHR Biomedical Research CentreNational Institute for Health Research (NIHR); Spanish health ministryInstituto de Salud Carlos IIISpanish Government [CP07/00048]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0001237, G0600986, G9439390] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986, G0001237, G9439390] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327] Funding Source: researchfish	These studies were supported by the Medical Research Council, a Technology Foresight from the UK Government and by a Royal College of Anaesthetists/British Journal of Anaesthesia project grant. Dr Coles is funded by an Academy of Medical Sciences/Health Foundation Clinician Scientist award and the Cambridge NIHR Biomedical Research Centre. The contribution by Raymond Salvador was partially funded by the project CP07/00048 from the Spanish health ministry.	Alian Aymen A, 2008, J Clin Monit Comput, V22, P169, DOI 10.1007/s10877-008-9118-z; Barker PB, 2004, CLINICAL MR NEUROIMAGING: DIFFUSION, PERFUSION AND SPECTROSCOPY, P7, DOI 10.1017/CBO9780511544958.003; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Bouma GJ, 1998, ACT NEUR S, V71, P272; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Cunningham AS, 2005, BRAIN, V128, P1931, DOI 10.1093/brain/awh536; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; GRAHAM DI, 1971, LANCET, V1, P265; Hutchinson PJ, 2002, J CEREBR BLOOD F MET, V22, P735, DOI 10.1097/00004647-200206000-00012; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; LEBRUNGRANDIE P, 1983, ARCH NEUROL-CHICAGO, V40, P230, DOI 10.1001/archneur.1983.04050040060010; LEENDERS KL, 1990, BRAIN, V113, P27, DOI 10.1093/brain/113.1.27; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Marchal G, 1999, BRAIN, V122, P2387, DOI 10.1093/brain/122.12.2387; MARCHAL G, 1992, ARCH NEUROL-CHICAGO, V49, P1013, DOI 10.1001/archneur.1992.00530340029014; MARCOUX FW, 1982, STROKE, V13, P339, DOI 10.1161/01.STR.13.3.339; Marmarou A, 2005, ACT NEUR S, V95, P149; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; McLaughlin MR, 1996, J NEUROSURG, V85, P871, DOI 10.3171/jns.1996.85.5.0871; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Nortje J, 2008, CRIT CARE MED, V36, P273, DOI 10.1097/01.CCM.0000292014.60835.15; Robertson CL, 2004, J BIOENERG BIOMEMBR, V36, P363, DOI 10.1023/B:JOBB.0000041769.06954.e4; Sakoh M, 2000, J NEUROSURG, V93, P647, DOI 10.3171/jns.2000.93.4.0647; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; Smielewski Peter, 1800, J Clin Monit Comput, V17, P427, DOI 10.1023/A:1026293611455; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Steiner LA, 2003, J CEREBR BLOOD F MET, V23, P1371, DOI 10.1097/01.WCB.0000090861.67713.10; Stengel A, 2004, MAGN RESON MED, V52, P228, DOI 10.1002/mrm.20171; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa P, 2004, BRAIN PATHOL, V14, P210, DOI 10.1111/j.1750-3639.2004.tb00055.x; von Oettingen G, 2002, NEUROSURGERY, V50, P781, DOI 10.1097/00006123-200204000-00019; Wu HM, 2004, J NEUROTRAUM, V21, P149, DOI 10.1089/089771504322778613	44	17	17	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAY	2009	29	5					965	975		10.1038/jcbfm.2009.22			11	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	439PU	WOS:000265640300010	19293825	Bronze			2022-02-06	
J	Bartal, C; Yitzhak, A				Bartal, Carmi; Yitzhak, Avraham			The role of thromboelastometry and recombinant factor VIIa in trauma	CURRENT OPINION IN ANESTHESIOLOGY			English	Article						coagulopathy; damage control strategy; recombinant factor VIIa; thromboelastometry; trauma	ACTIVATED FACTOR-VII; COAGULATION-FACTOR-VII; COAGULOPATHIC PATIENTS; MASSIVE TRANSFUSION; CELL TRANSFUSION; DOUBLE-BLIND; BLOOD; RFVIIA; MORTALITY; EFFICACY	Purpose of review Recombinant factor VIIa (rFVIIa) and thromboelastography have acquired increasing importance in patients with severe bleeding and coagulopathy. This article reviews the current opinions regarding their use, with the purpose of clarifying the ambiguities that exist in dealing with trauma patients. Recent findings Recent evidence encourages the early use of rFVIIa and thromboelastography in the severe trauma patient with hemorrhagic shock, as a component of the damage control strategy. rFVIIa may decrease short-term mortality and the rate of required blood components during resuscitation, with no apparent increase in thromboembolic complications. Thromboelastometry enables better and earlier recognition of the coagulopathy accompanying such trauma patients. In patients with traumatic brain injury and coagulopathy, rFVIIa may delay or even halt the need for surgery, with no proven decrease in mortality. In those who needed urgent neurosurgical intervention, rFVIIa may rapidly correct the coagulopathy, enabling earlier and safer surgical intervention. Summary Thromboelastometry may guide the medical staff when and to whom rFVIIa could be administered. Evidence also encourages the use of rFVIIa in traumatic brain injury. More research is required to prove decreases in mortality using both thromboelastography and rFVIIa in trauma, with a focus on clear end points and goal-directed therapy.	[Bartal, Carmi] Soroka Univ, Med Surg Intens Care Unit, Crit Care Dept, Med Ctr, Beer Sheva, Israel; [Yitzhak, Avraham] Soroka Univ, Surg Dept A, Div Surg, Med Ctr, Beer Sheva, Israel; [Yitzhak, Avraham] Ben Gurion Univ Negev, Fac Hlth Sci, IL-84105 Beer Sheva, Israel		Bartal, C (corresponding author), Soroka Univ, Med Surg Intens Care Unit, Crit Care Dept, Med Ctr, Beer Sheva, Israel.	carmibt@zahav.net.il		bartal, carmi/0000-0003-0894-5466			Bartal C, 2007, J TRAUMA, V63, P725, DOI 10.1097/TA.0b013e318031ccca; BEELKLEY AC, 2008, CRIT CARE MED, V36, pS267; Boffard KD, 2005, J TRAUMA, V59, P8, DOI 10.1097/01.TA.0000171453.37949.B7; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; BUGLER E, 2002, CRIT CARE MED, V30, P1870; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Coats TJ, 2004, RESUSCITATION, V60, P101, DOI 10.1016/j.resuscitation.2003.08.001; DeLoughery TG, 2004, CRIT CARE CLIN, V20, P13, DOI 10.1016/S0749-0704(03)00089-7; Dutton RP, 2004, J TRAUMA, V57, P709, DOI 10.1097/01.TA.0000140646.66852.AB; GANTER MT, 2007, YB INTENSIVE CARE EM, P835; Goodnough LT, 2002, INTENS CARE MED, V28, pS221, DOI 10.1007/s00134-002-1468-2; Hansen Mads Koch, 2006, Ugeskr Laeger, V168, P3535; Hawryluk GWJ, 2006, J NEUROSURG, V105, P859, DOI 10.3171/jns.2006.105.6.859; Ho CH, 1998, TRANSFUSION, V38, P1011, DOI 10.1046/j.1537-2995.1998.38111299056308.x; Horton JD, 2008, AM SURGEON, V74, P413; HOYT DB, 1994, J TRAUMA, V37, P426, DOI 10.1097/00005373-199409000-00016; James KMH, 2008, ANESTH ANALG, V107, P402, DOI 10.1213/ane.0b013e3181770b87; Karadimov D, 2003, J NEUROSURG ANESTH, V15, P330, DOI 10.1097/00008506-200310000-00008; Kaufmann CR, 1997, J TRAUMA, V42, P716, DOI 10.1097/00005373-199704000-00023; Kenet G, 1999, LANCET, V354, P1879, DOI 10.1016/S0140-6736(99)05155-7; Kheirabadi BS, 2007, J TRAUMA, V63, P1079, DOI 10.1097/TA.0b013e31815885f1; Kozek-Langenecker S, 2007, MINERVA ANESTESIOL, V73, P401; KOZEKLANGENECKE.S, 2007, YB INTENSIVE CARE EM, P848; Levrat A, 2008, BRIT J ANAESTH, V100, P792, DOI 10.1093/bja/aen083; Lu J, 2005, ACT NEUR S, V95, P281; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Malone DL, 2006, J TRAUMA, V60, pS91, DOI 10.1097/01.ta.0000199549.80731.e6; Marik PE, 2008, CRIT CARE MED, V36, P2667, DOI 10.1097/CCM.0b013e3181844677; Martinowitz U, 2005, J THROMB HAEMOST, V3, P640, DOI 10.1111/j.1538-7836.2005.01203.x; Martinowitz U, 2001, J TRAUMA, V50, P721, DOI 10.1097/00005373-200104000-00021; MATHIESEN T, 1995, ACTA NEUROL SCAND, V91, P208; Mayer SA, 2005, NEW ENGL J MED, V352, P777, DOI 10.1056/NEJMoa042991; Mayer SA, 2005, STROKE, V36, P74, DOI 10.1161/01.STR.0000149628.80251.b8; Mayer SA, 2003, STROKE, V34, P224, DOI 10.1161/01.STR.0000046458.67968.E4; Mayer SA, 2008, NEW ENGL J MED, V358, P2127, DOI 10.1056/NEJMoa0707534; Meng ZH, 2003, J TRAUMA, V55, P886, DOI 10.1097/01.TA.0000066184.20808.A5; Narayan RK, 2008, NEUROSURGERY, V62, P776, DOI 10.1227/01.NEU.0000297095.04013.C4; Nekludov M, 2007, J NEUROTRAUM, V24, P1699, DOI 10.1089/neu.2007.0322; Park P, 2003, NEUROSURGERY, V53, P34, DOI 10.1227/01.NEU.0000068830.54968.A8; Perkins JG, 2007, J TRAUMA, V62, P1095, DOI 10.1097/TA.0b013e31804798a4; Raobaikady R, 2005, BRIT J ANAESTH, V94, P586, DOI 10.1093/bja/aei102; Rizoli SB, 2006, J TRAUMA, V61, P1419, DOI 10.1097/01.ta.0000243045.56579.74; Rizoli SB, 2006, EXPERT OPIN BIOL TH, V6, P73, DOI 10.1517/14712598.6.1.73; Rugeri L, 2007, J THROMB HAEMOST, V5, P289, DOI 10.1111/j.1538-7836.2007.02319.x; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Schreiber MA, 2004, CRIT CARE CLIN, V20, P101, DOI 10.1016/S0749-0704(03)00095-2; Schreiber MA, 2007, J AM COLL SURGEONS, V205, P541, DOI 10.1016/j.jamcollsurg.2007.05.007; Schurr MJ, 2004, J TRAUMA, V57, P718; Siddique MS, 2002, J NEUROSURG, V96, P86, DOI 10.3171/jns.2002.96.1.0086; Spinella PC, 2008, J TRAUMA, V64, P286, DOI 10.1097/TA.0b013e318162759f; Stein DM, 2008, J TRAUMA, V64, P620, DOI 10.1097/TA.0b013e3181650fc7; Stein DM, 2005, J TRAUMA, V59, P609, DOI 10.1097/01.ta.0000177655.67763.df; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Valeri CR, 2001, TRANSFUSION, V41, P977, DOI 10.1046/j.1537-2995.2001.41080977.x; Veldman A, 2003, CURR MED CHEM, V10, P797, DOI 10.2174/0929867033457728; VESHCHEV I, 2002, MED SCI MONITOR, V8, P98; Viuff D, 2008, BRIT J ANAESTH, V101, P324, DOI 10.1093/bja/aen175; Watts DD, 1998, J TRAUMA, V44, P846, DOI 10.1097/00005373-199805000-00017; Yasuda CL, 2003, ARQ NEURO-PSIQUIAT, V61, P1011, DOI 10.1590/S0004-282X2003000600023; Young G, 2007, BLOOD COAGUL FIBRIN, V18, P547, DOI 10.1097/MBC.0b013e328201c9a9; Yusim Y, 2006, J CLIN ANESTH, V18, P545, DOI 10.1016/j.jclinane.2006.02.012; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	64	17	18	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0952-7907	1473-6500		CURR OPIN ANESTHESIO	Curr. Opin. Anesthesiol.	APR	2009	22	2					281	288		10.1097/ACO.0b013e328325a6be			8	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	435MY	WOS:000265349200022	19390255				2022-02-06	
J	Itoh, T; Satou, T; Nishida, S; Tsubaki, M; Hashimoto, S; Ito, H				Itoh, Tatsuki; Satou, Takao; Nishida, Shozo; Tsubaki, Masahiro; Hashimoto, Shigeo; Ito, Hiroyuki			Improvement of cerebral function by anti-amyloid precursor protein antibody infusion after traumatic brain injury in rats	MOLECULAR AND CELLULAR BIOCHEMISTRY			English	Article						Amyloid precursor protein; Anti-APP antibody; Brain function; Traumatic brain injury; Water maze	CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; HEAD-INJURY; AXONAL INJURY; GLIAL-CELLS; NEUROFIBRILLARY TANGLES; NEURITE OUTGROWTH; BETA-SECRETASE; DAMAGED AXONS; EXPRESSION	We previously demonstrated the increased amyloid precursor protein (APP) immunoreactivity around the site of damage after traumatic brain injury (TBI). However, the function of APP after TBI has not been evaluated. In this study, we investigated the effects of direct infusion of an anti-APP antibody into the damaged brain region on cerebral function and morphological changes following TBI in rats. Three days after TBI, there were many TUNEL-positive neurons and astrocytes around the damaged region and a significantly greater number of TUNEL-positive cells in the PBS group compared with the anti-APP group found. Seven days after TBI, there were significantly a greater number of large glial fibrillary acidic protein-positive cells, long elongated projections, and microtubule-associated protein-2-positive cells around the damaged region in the anti-APP group compared with the PBS group found. Seven days after TBI, the region of brain damage was significantly smaller and the time to arrival at a platform was significantly shorter in the anti-APP group compared with the PBS group. Furthermore, after TBI in the anti-APP group, the time to arrival at the platform recovered to that observed in uninjured sham operation group rats. These data suggest that the overproduction of APP after TBI inhibits astrocyte activity and reduces neural cell survival around the damaged brain region, which speculatively may be related to the induction of Alzheimer disease-type dementia after TBI.	[Itoh, Tatsuki; Satou, Takao; Ito, Hiroyuki] Kinki Univ, Sch Med, Dept Pathol, Osaka 5898511, Japan; [Satou, Takao] Kinki Univ Hosp, Div Hosp Pathol, Osaka, Japan; [Satou, Takao] Kinki Univ, Div Sports Med, Inst Life Sci, Osaka 5898511, Japan; [Nishida, Shozo; Tsubaki, Masahiro] Kinki Univ, Sch Pharmaceut Sci, Osaka 5898511, Japan; [Hashimoto, Shigeo] PL Hosp, Dept Pathol, Osaka, Japan		Itoh, T (corresponding author), Kinki Univ, Sch Med, Dept Pathol, 377-2 Ohno Higashi, Osaka 5898511, Japan.	tatsuki@med.kindai.ac.jp					Bechmann I, 2000, ANN NY ACAD SCI, V911, P192; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Bouron A, 2004, EUR J NEUROSCI, V20, P2071, DOI 10.1111/j.1460-9568.2004.03680.x; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999; Deller T, 2000, ANN NY ACAD SCI, V911, P207; Elvander E, 2004, NEUROSCIENCE, V126, P541, DOI 10.1016/j.neuroscience.2004.03.058; Feng Z, 2004, J PINEAL RES, V37, P129, DOI 10.1111/j.1600-079X.2004.00144.x; Gallo V, 2001, SCIENCE, V292, P872, DOI 10.1126/science.1060854; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; Green-Sadan T, 2003, EUR J NEUROSCI, V18, P2093, DOI 10.1046/j.1460-9568.2003.02943.x; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Itoh T, 2005, NEUROREPORT, V16, P1687, DOI 10.1097/01.wnr.0000183330.44112.ab; ITOH T, 2009, NEUROL RES IN PRESS; Itoh T, 2007, NEUROL RES, V29, P734, DOI 10.1179/016164107X208086; Jurynec MJ, 2003, MOL CELL NEUROSCI, V23, P69, DOI 10.1016/S1044-7431(03)00019-8; MASTERS CL, 1985, EMBO J, V4, P2757, DOI 10.1002/j.1460-2075.1985.tb04000.x; Matrone C, 2008, J ALZHEIMERS DIS, V13, P81; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Mills J, 1999, J NEUROCHEM, V72, P443, DOI 10.1046/j.1471-4159.1999.0720443.x; Murakami N, 1998, J NEUROTRAUM, V15, P993, DOI 10.1089/neu.1998.15.993; Nakagawa K, 2006, J NEUROCHEM, V96, P924, DOI 10.1111/j.1471-4159.2005.03595.x; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; OTSUKA N, 1991, BRAIN RES, V568, P335, DOI 10.1016/0006-8993(91)91422-W; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pierce JES, 1996, J NEUROSCI, V16, P1083; ROBAKIS NK, 1987, P NATL ACAD SCI USA, V84, P4190, DOI 10.1073/pnas.84.12.4190; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; ROBERTS GW, 1988, LANCET, V2, P1456; RUDGE JS, 1990, J NEUROSCI, V10, P3594; RUMBLE B, 1989, NEW ENGL J MED, V320, P1446, DOI 10.1056/NEJM198906013202203; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; SELKOE DJ, 1986, J NEUROCHEM, V46, P1820; Silver IA, 1997, NEUROSCIENCE, V78, P589, DOI 10.1016/S0306-4522(96)00600-8; Smith DH, 2003, NEUROMOL MED, V4, P59, DOI 10.1385/NMM:4:1-2:59; Vigo FS, 2009, NEUROBIOL AGING, V30, P1379, DOI 10.1016/j.neurobiolaging.2007.11.017; STEPHENSON DT, 1992, BRAIN RES, V593, P128, DOI 10.1016/0006-8993(92)91274-I; Stone JR, 2002, J NEUROTRAUM, V19, P601, DOI 10.1089/089771502753754073; Suh YH, 2002, PHARMACOL REV, V54, P469, DOI 10.1124/pr.54.3.469; Sun KH, 2004, APOPTOSIS, V9, P833, DOI 10.1023/B:APPT.0000045793.44842.e7; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; Van den Heuvel C, 1999, EXP NEUROL, V159, P441, DOI 10.1006/exnr.1999.7150; Van den Heuvel C, 2004, J NEUROTRAUM, V21, P1562, DOI 10.1089/0897715042441783; Xiong Y, 2008, BRAIN RES, V1230, P247, DOI 10.1016/j.brainres.2008.06.127	49	17	17	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0300-8177			MOL CELL BIOCHEM	Mol. Cell. Biochem.	APR	2009	324	1-2					191	199		10.1007/s11010-008-0013-1			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	413HB	WOS:000263782400020	19130181				2022-02-06	
J	Manolakaki, D; Velmahos, GC; Spaniolas, K; de Moya, M; Alam, HB				Manolakaki, Dimitra; Velmahos, George C.; Spaniolas, Konstantinos; de Moya, Marc; Alam, Hasan B.			Early Magnetic Resonance Imaging Is Unnecessary In Patients With Traumatic Brain Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Magnetic resonance imaging; Traumatic brain injury; head CT scan	MINOR HEAD-INJURY; COMPUTED-TOMOGRAPHY	Introduction: Computed tomography (CT) is routinely performed in traumatic brain injury (TBI). Magnetic resonance imaging (MRI) is considered more sensitive than CT for subtle abnormalities. Because CT does not always explain the posttraumatic neurologic examination, MRI is being performed with increasing frequency. Although MRI at a later stage may be of significant prognostic value, the role of early MRI is questionable. Our objective was to evaluate the role of early MRI in the initial management of patients with TBI. Methods: This is a 3-year prospective study (January 2005-December 2007) of adult patients with TBI who, in addition to CT, had MRI of the head within 48 hours of admission to the hospital. The findings from the two imaging studies were compared. The outcome was any change in management based on MRI findings. Results: We identified 123 trauma patients who had MRI within 18 hours +/- 14.5 hours of CT (median: 12 hours). In 82 (67%) patients, the findings of CT and MRI were identical. In the remaining 41 patients there were discrepancies between CT and MRI 35 patients had slight differences in the location or size of the lesions found and six had minor brain lesion detected by MRI and not CT. Compared with patients who had identical CT and MRI, those who showed differences in the two tests had higher severity of head in-jury, lower initial blood pressure, and a higher rate of intubation. Based on CT findings, 78 (63%) patients received TBI-related interventions: 8 craniotomies, 12 intracranial pressure monitoring catheters, 14 mannitol infusions, and 72 antiepileptic medications. There was no change in treatment because of MRI. Conclusion: Early MRI may be superior to CT in describing subtle TBI findings, but this information does not affect management. Head CT is the only imaging test necessary in the first 48 hours after TBI.	Massachusetts Gen Hosp, Div Trauma Emergency Surg & Surg Crit Care, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA		Velmahos, GC (corresponding author), 165 Cambridge St,Suite 810, Boston, MA 02114 USA.	gvelmahos@partners.org					Coles JP, 2007, BRIT J ANAESTH, V99, P49, DOI 10.1093/bja/aem141; DOEZEMA D, 1991, ANN EMERG MED, V20, P1281, DOI 10.1016/S0196-0644(05)81065-0; Firsching R, 1998, J NEUROSURG, V89, P707, DOI 10.3171/jns.1998.89.5.0707; Furlow Bryant, 2006, Radiol Technol, V78, P145; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hollingworth W, 2000, CLIN RADIOL, V55, P825, DOI 10.1053/crad.2000.0546; Nagy KK, 1999, J TRAUMA, V46, P268, DOI 10.1097/00005373-199902000-00012; ORRISON WW, 1994, AM J NEURORADIOL, V15, P351; PITTS LH, 1991, ANN EMERG MED, V20, P1387, DOI 10.1016/S0196-0644(05)81089-3; Schuster R, 2005, AM SURGEON, V71, P701; SKLAR EML, 1992, RADIOL CLIN N AM, V30, P353; YOKOTA H, 1991, J TRAUMA, V31, P351, DOI 10.1097/00005373-199103000-00007	12	17	17	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	APR	2009	66	4					1008	1012		10.1097/TA.0b013e31819adba2			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	431KI	WOS:000265059800011	19359907				2022-02-06	
J	Persaud-Sawin, DA; Banach, L; Harry, GJ				Persaud-Sawin, Dixie-Ann; Banach, Lynna; Harry, Gaylla Jean			Raft Aggregation with Specific Receptor Recruitment Is Required for Microglial Phagocytosis of A beta(42)	GLIA			English	Article						microglia; phagocytosis; rafts; CD36	TRAUMATIC BRAIN-INJURY; GPI-ANCHORED PROTEINS; AMYLOID BETA-PEPTIDE; ALZHEIMERS-DISEASE; LIPID RAFTS; MACROPHAGE PHAGOCYTOSIS; ANTIINFLAMMATORY DRUGS; SCAVENGER RECEPTOR; APOPTOTIC CELL; CD36	Microglial phagocytosis contributes to the maintenance of brain homeostasis. Mechanisms involved, however, remain unclear. Using A beta 42 solely as a stimulant, we provide novel insight into regulation of microglial phagocytosis by rafts. We demonstrate the existence of an A beta 42 threshold level of 250 pg/mL, above which microglial phagocytic function is impaired. Low levels of A beta 42 facilitate fluorescent bead uptake, whereas phagocytosis is inhibited when A beta 42 accumulates. We also show that region-specific raft clustering occurs before microglial phagocytosis. Low A beta 42 levels stimulated this type of raft aggregation, but high A beta 42 levels inhibited it. Additionally, treatment with high A beta 42 concentrations caused a redistribution of the raft structural. protein flotillin1 from low to higher density fractions along a sucrose gradient. This suggests a loss of raft structural integrity. Certain non-steroidal anti-inflammatory drugs, e.g., the cyclooxygenase 2-specific nonsteroidal anti-inflammatory drugs, celecoxib, raise A beta 42 levels. We demonstrated that prolonged celecoxib exposure can disrupt rafts in a manner similar to that seen in an elevated A beta 42 environment: abnormal raft aggregation and Flot1 distribution. This resulted in aberrant receptor recruitment to rafts and impaired receptor-mediated phagocytosis by microglial cells. Specifically, recruitment of the scavenger receptor CD36 to rafts during active phagocytosis was affected. Thus, we propose that maintaining raft integrity is crucial for determining microglial phagocytic outcomes and disease progression. (C) 2008 Wiley-Liss, Inc.	[Persaud-Sawin, Dixie-Ann] NIEHS, Neurobiol Lab, Neurotoxicol Grp, NIH, Res Triangle Pk, NC 27709 USA		Persaud-Sawin, DA (corresponding author), NIEHS, Neurobiol Lab, Neurotoxicol Grp, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	sawind@niehs.nih.gov	Harry, Gaylia Jean/AAC-1171-2022	Harry, Gaylia Jean/0000-0002-0829-7318	Division of Intramural Research of NIEHS (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1Z01ES101623-05]; NTEHS Chemistry Contract [10015-42-05]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [Z01ES101623] Funding Source: NIH RePORTER	Grant sponsor: Division of Intramural Research of NIEHS (NIH); Grant number: #1Z01ES101623-05; Grant sponsor: NTEHS Chemistry Contract; Grant number: #10015-42-05.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Aronoff DM, 2004, J IMMUNOL, V173, P559, DOI 10.4049/jimmunol.173.1.559; Arvanitis DN, 2005, J NEUROCHEM, V94, P1696, DOI 10.1111/j.1471-4159.2005.03331.x; Babuke T, 2007, EUR J CELL BIOL, V86, P525, DOI 10.1016/j.ejcb.2007.03.003; Bamberger ME, 2003, J NEUROSCI, V23, P2665; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Bottcher A, 2006, ARTHRITIS RHEUM-US, V54, P927, DOI 10.1002/art.21660; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Butovsky O, 2005, MOL CELL NEUROSCI, V29, P381, DOI 10.1016/j.mcn.2005.03.005; Chan WY, 2007, BRAIN RES REV, V53, P344, DOI 10.1016/j.brainresrev.2006.11.002; Cheng JL, 2006, BIOCHEM BIOPH RES CO, V351, P246, DOI 10.1016/j.bbrc.2006.10.042; Chung HY, 1999, J BIOL CHEM, V274, P32301, DOI 10.1074/jbc.274.45.32301; Ciesielski-Treska J, 2004, GLIA, V46, P101, DOI 10.1002/glia.10363; Coraci IS, 2002, AM J PATHOL, V160, P101, DOI 10.1016/S0002-9440(10)64354-4; Coras R, 2007, MOL CANCER THER, V6, P1745, DOI 10.1158/1535-7163.MCT-06-0763; Cuzzocrea S, 2002, BIOCHEM PHARMACOL, V63, P785, DOI 10.1016/S0006-2952(01)00908-X; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; El Khoury JB, 2003, J EXP MED, V197, P1657, DOI 10.1084/jem.20021546; Eto M, 2003, EUR J NEUROSCI, V17, P2659, DOI 10.1046/j.1460-9568.2003.02711.x; Fantini Jacques, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402005392; Fiala M, 2005, J ALZHEIMERS DIS, V7, P221, DOI 10.3233/jad-2005-7304; Fullekrug J, 2004, ANN NY ACAD SCI, V1014, P164, DOI 10.1196/annals.1294.017; Gamerdinger M, 2007, MOL PHARMACOL, V72, P141, DOI 10.1124/mol.107.034009; Gasparini L, 2004, J NEUROCHEM, V91, P521, DOI 10.1111/j.1471-4159.2004.02743.x; Gregory CD, 2004, IMMUNOLOGY, V113, P1, DOI 10.1111/j.1365-2567.2004.01959.x; Griffin WST, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-5; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Hashimoto M, 2003, J NEUROCHEM, V85, P1468, DOI 10.1046/j.1471-4159.2003.01791.x; Hull M, 2006, NEUROCHEM INT, V48, P663, DOI 10.1016/j.neuint.2005.08.013; Janich P, 2007, FEBS LETT, V581, P1783, DOI 10.1016/j.febslet.2007.03.065; Johnson AJ, 2002, BIOCHEM J, V366, P831, DOI 10.1042/BJ20020279; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Kay JG, 2006, J BIOL CHEM, V281, P11949, DOI 10.1074/jbc.M600857200; KEYSTONE EC, 1977, ARTHRITIS RHEUM, V20, P1396, DOI 10.1002/art.1780200714; Kim HY, 2006, J BIOL CHEM, V281, P11872, DOI 10.1074/jbc.M511706200; Koenigsknecht J, 2004, J NEUROSCI, V24, P9838, DOI 10.1523/JNEUROSCI.2557-04.2004; Koenigsknecht-Talboo J, 2005, J NEUROSCI, V25, P8240, DOI 10.1523/JNEUROSCI.1808-05.2005; Koizumi S, 2007, NATURE, V446, P1091, DOI 10.1038/nature05704; KOROTZER AR, 1993, BRAIN RES, V624, P121, DOI 10.1016/0006-8993(93)90068-X; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; Krysko DV, 2006, APOPTOSIS, V11, P1709, DOI 10.1007/s10495-006-9527-8; Kukar T, 2005, NAT MED, V11, P545, DOI 10.1038/nm1235; Kunjathoor VV, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-23; Kusumi A, 2004, TRAFFIC, V5, P213, DOI 10.1111/j.1600-0854.2004.0178.x; Langhorst MF, 2005, CELL MOL LIFE SCI, V62, P2228, DOI 10.1007/s00018-005-5166-4; Leuchtenberger S, 2006, CURR PHARM DESIGN, V12, P4337, DOI 10.2174/138161206778793029; Lingwood D, 2007, NAT PROTOC, V2, P2159, DOI 10.1038/nprot.2007.294; Liu H, 2007, CELL BIOL INT, V31, P508, DOI 10.1016/j.cellbi.2006.11.018; Liu Y, 2005, BRAIN, V128, P1778, DOI 10.1093/brain/awh531; Lucas M, 2006, J IMMUNOL, V177, P4047, DOI 10.4049/jimmunol.177.6.4047; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; Makranz C, 2006, GLIA, V53, P441, DOI 10.1002/glia.20303; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Mitrasinovic OM, 2002, J BIOL CHEM, V277, P29889, DOI 10.1074/jbc.M200868200; Monaco S, 2006, CURR MED CHEM, V13, P1903, DOI 10.2174/092986706777585022; Moore KJ, 2002, J BIOL CHEM, V277, P47373, DOI 10.1074/jbc.M208788200; Nair P, 2006, NUTR HOSP, V21, P638; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; O'Banion MK, 1997, ADV EXP MED BIOL, V433, P177; O'Brien BA, 2002, DIABETES, V51, P2481, DOI 10.2337/diabetes.51.8.2481; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Paresce DM, 1996, NEURON, V17, P553, DOI 10.1016/S0896-6273(00)80187-7; PARK JY, 2008, IMPLICATIONS PARKINS, V56, P1215; Persaud-Sawin DA, 2004, PEDIATR RES, V56, P449, DOI 10.1203/01.PDR.0000136152.54638.95; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Puglielli L, 2008, NEUROBIOL AGING, V29, P795, DOI 10.1016/j.neurobiolaging.2007.01.010; Quintana A, 2008, DEV NEUROBIOL, V68, P195, DOI 10.1002/dneu.20584; Reddy SM, 2002, J IMMUNOL, V169, P702, DOI 10.4049/jimmunol.169.2.702; REN Y, 1995, J EXP MED, V181, P1857, DOI 10.1084/jem.181.5.1857; Ricciarelli R, 2004, FREE RADICAL BIO MED, V36, P1018, DOI 10.1016/j.freeradbiomed.2004.01.007; Rogers J, 2002, GLIA, V40, P260, DOI 10.1002/glia.10153; Sadowski MJ, 2006, P NATL ACAD SCI USA, V103, P18787, DOI 10.1073/pnas.0604011103; Salman H, 1999, CANCER LETT, V147, P175, DOI 10.1016/S0304-3835(99)00290-6; Seitz HM, 2007, J IMMUNOL, V178, P5635, DOI 10.4049/jimmunol.178.9.5635; Selkoe DJ, 2001, J ALZHEIMERS DIS, V3, P75, DOI 10.3233/JAD-2001-3111; Seveau S, 2001, MOL BIOL CELL, V12, P3550, DOI 10.1091/mbc.12.11.3550; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Sierra A, 2007, GLIA, V55, P412, DOI 10.1002/glia.20468; Simons K, 2000, TRENDS CELL BIOL, V10, P459, DOI 10.1016/S0962-8924(00)01847-X; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; Stipursky J, 2007, GLIA, V55, P1023, DOI 10.1002/glia.20522; Streit WJ, 2005, NEUROL RES, V27, P685, DOI 10.1179/016164105X49463; Streit WJ, 2006, TRENDS NEUROSCI, V29, P506, DOI 10.1016/j.tins.2006.07.001; Stuart LM, 2007, J BIOL CHEM, V282, P27392, DOI 10.1074/jbc.M702887200; Sue W, 2006, AM J CLIN NUTR, V83, p470S; Swanson JA, 1999, J CELL SCI, V112, P307; Tahara K, 2006, BRAIN, V129, P3006, DOI 10.1093/brain/awl249; Thorne RF, 2000, J BIOL CHEM, V275, P35264, DOI 10.1074/jbc.M003969200; Thorne RF, 2006, BIOCHEM BIOPH RES CO, V351, P51, DOI 10.1016/j.bbrc.2006.09.156; Tian TH, 2007, NAT CELL BIOL, V9, P905, DOI 10.1038/ncb1615; Tohyama Y, 2006, IUBMB LIFE, V58, P304, DOI 10.1080/15216540600746377; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Urano Y, 2005, J LIPID RES, V46, P904, DOI 10.1194/jlr.M400333-JLR200; Wang RB, 2006, J SURG RES, V136, P58, DOI 10.1016/j.jss.2006.06.003; Wang YJ, 2006, DRUG DISCOV TODAY, V11, P931, DOI 10.1016/j.drudis.2006.08.004; Wyss-Coray T, 2001, NAT MED, V7, P612, DOI 10.1038/87945; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com	100	17	18	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	FEB	2009	57	3					320	335		10.1002/glia.20759			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	392BF	WOS:000262277200008	18756527	Green Accepted			2022-02-06	
J	Casanueva, FF; Castro, AI; Micic, D; Kelestimur, F; Dieguez, C				Casanueva, Felipe F.; Castro, Ana I.; Micic, Dragan; Kelestimur, Fahrettin; Dieguez, Carlos			New Guidelines for the Diagnosis of Growth Hormone Deficiency in Adults	HORMONE RESEARCH			English	Article; Proceedings Paper	40th International Symposium on Endocrinology and Metabolism	APR 23-MAY 24, 2008	Paris, FRANCE			Insulin tolerance test; Growth hormone-releasing hormone (GHRH)-arginine; Growth hormone releasing hexapeptide; Glucagon; Insulin like growth factor I	GH-RELEASING HORMONE; (GH)-RELEASING HORMONE; STIMULATION TEST; SECRETION; ARGININE; TESTS	Background: The task of diagnosing growth hormone deficiency (GHD) in adults is cumbersome because of the paucity of biological endpoints. Consequently, over the past decade different organizations have attempted to develop homogeneous criteria and methodology for worldwide use. GHD should be biochemically confirmed within an appropriate clinical context-but only if there is the intention to treat. Clinically, patients investigated for GHD should include those with signs and symptoms or a past history of hypo-thalamo-pituitary dysfunction and those with a history of cranial irradiation, tumour treatment, traumatic brain injury or subarachnoid haemorrhage. Conclusions: Subjects with >= 3 pituitary hormone deficiencies plus a low insulin-like growth factor I level do not need provocative testing. For those who must be tested, arguably the most commonly used provocative tests are the insulin tolerance test and the glucagon, GH-releasing hormone (GHRH) + arginine and GHRH + GH-releasing hexapeptide tests. Cutoffs differ across tests and results may be influenced by gender, age, body mass index and the assay reference preparation. Copyright (C) 2009 S. Karger AG, Basel	[Casanueva, Felipe F.; Castro, Ana I.] Univ Santiago, Complejo Hosp, Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr,Dept Med, Santiago De Compostela, Spain; [Dieguez, Carlos] Univ Santiago de Compostela, Sch Med, Dept Physiol, ES-15780 Santiago De Compostela, Spain; [Micic, Dragan] Univ Childrens Hosp, Dept Endocrinol, Belgrade, Serbia; [Kelestimur, Fahrettin] Erciyes Univ, Sch Med, Dept Endocrinol, Kayseri, Turkey		Casanueva, FF (corresponding author), Univ Santiago de Compostela, Univ Hosp, Dept Med, Div Endocrine, Calle San Francisco SN,POB 563, ES-15780 Santiago De Compostela, Spain.	meffcasa@usc.es	kelestimur, f/ABE-9873-2021				Abs R, 2005, GROWTH HORM IGF RES, V15, P349, DOI 10.1016/j.ghir.2005.06.018; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 1998, J CLIN ENDOCR METAB, V83, P1615, DOI 10.1210/jc.83.5.1615; Attanasio A, 1998, J CLIN ENDOCR METAB, V83, P379; Biller BMK, 2002, J CLIN ENDOCR METAB, V87, P2067, DOI 10.1210/jcem.87.5.8509; CASANUEVA FF, 2004, GROWTH HORMONE DEFIC, P91; Clemmons DR, 2001, HORM RES, V55, P73, DOI 10.1159/000063480; Darzy KH, 2003, J CLIN ENDOCR METAB, V88, P95, DOI 10.1210/jc.2002-021094; Gharib Hossein, 2003, Endocr Pract, V9, P64; Ghigo E, 2008, GROWTH HORM IGF RES, V18, P1, DOI 10.1016/j.ghir.2007.07.004; Giustina A, 1998, ENDOCR REV, V19, P717, DOI 10.1210/er.19.6.717; Gomez JM, 2002, CLIN ENDOCRINOL, V56, P329, DOI 10.1046/j.1365-2265.2002.01472.x; Hartman ML, 2002, J CLIN ENDOCR METAB, V87, P477, DOI 10.1210/jc.87.2.477; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; HOFFMAN DM, 1994, LANCET, V344, P482, DOI 10.1016/S0140-6736(94)91821-X; Jansson C, 1997, CLIN CHEM, V43, P950; JORGENSEN JOL, 1989, LANCET, V1, P1221; Kelestimur F, 2006, CLIN ENDOCRINOL, V64, P667, DOI 10.1111/j.1365-2265.2006.02525.x; POPOVIC V, 1995, J CLIN ENDOCR METAB, V80, P942, DOI 10.1210/jc.80.3.942; Popovic V, 2000, LANCET, V356, P1137, DOI 10.1016/S0140-6736(00)02755-0; Tanriverdi F, 2008, ANN INTERN MED, V148, P827, DOI 10.7326/0003-4819-148-11-200806030-00005	21	17	17	0	5	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0301-0163	1663-2826		HORM RES	Horm. Res.		2009	71			1			112	115		10.1159/000178051			4	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Endocrinology & Metabolism	395UI	WOS:000262548600025	19153519				2022-02-06	
J	Chalton, LD; McMillan, TM				Chalton, L. D.; McMillan, T. M.			Can 'partial' PTSD explain differences in diagnosis of PTSD by questionnaire self-report and interview after head injury?	BRAIN INJURY			English	Article						Post-traumatic stress disorder; head injury; trauma; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; VIETNAM VETERANS; SCALE; VALIDATION; FLASHBACKS; SURVIVORS; ERRORS	Objective: Can the concept of 'partial' PTSD explain the disparity between the relatively high incidence of PTSD found using self-report questionnaires and the relatively low incidence using structured interview? It was hypothesized that self-report of greater PTSD symptom severity is associated with increased heart rate and movement when responding to questions about the traumatic event, if 'partial' PTSD is an explanation. Research design: A within participants single group design. Methods: Twenty-one adults with head injury underwent self-report (Post-traumatic Stress Disorder Scale) and interview (Clinical Assessment of PTSD) assessments of PTSD, the Traumatic Memory Interview, self-report of mood (Hospital Anxiety and Depression Scale) and cognitive assessment (Wechsler Test of Adult Reading, Auditory Verbal Learning Test, Hayling Test, Digit Symbol Test), during which heart rate and motor activity were recorded. Results: Self-report of greater PTSD symptom severity was not associated with increases in heart rate or movement during questions about the traumatic event. In fact, heart rate decreased from baseline in those with higher self-report scores for PTSD, consistent with curiosity about the traumatic event and not 'partial' PTSD. Conclusion: These preliminary findings agree with an emerging theme suggesting that, although PTSD can occur after head injury, it is easily over-diagnosed.	[Chalton, L. D.] Bridgeton Hlth Ctr, Clin Psychol, Glasgow, Lanark, Scotland; [McMillan, T. M.] Univ Glasgow, Psychol Med, Fac Med, Glasgow, Lanark, Scotland; [Chalton, L. D.] Bridgeton Hlth Ctr, Glasgow, Lanark, Scotland; [McMillan, T. M.] Univ Glasgow, Fac Med, Glasgow, Lanark, Scotland		McMillan, TM (corresponding author), Univ Glasgow, Gartnavel Royal Hosp, Fac Med, 1055 Great Western Rd, Glasgow G12 OXH, Lanark, Scotland.	t.m.mcmillan@clinmed.gla.ac.uk			NHS Education Scotland	This study was completed in part fulfilment of the Doctorate in Clinical Psychology at the University of Glasgow, funded by NHS Education Scotland.	American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Blanchard E B, 1982, Psychiatr Q, V54, P220, DOI 10.1007/BF01064817; BLANCHARD EB, 1986, BEHAV THER, V17, P592, DOI 10.1016/S0005-7894(86)80097-1; Blanchard EB, 1999, POSTTRAUMATIC STRESS DISORDER, P248; Bryant RA, 2004, PSYCHOSOM MED, V66, P760, DOI 10.1097/01.psy.0000138121.13198.84; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Bryant RA, 1996, J TRAUMA STRESS, V9, P621; Buckley TC, 2001, PSYCHOSOM MED, V63, P585, DOI 10.1097/00006842-200107000-00011; Burgess P.W., 1997, HAYLING BRIXTON TEST; Ehlers A, 1998, J ABNORM PSYCHOL, V107, P508, DOI 10.1037/0021-843X.107.3.508; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Halligan SL, 2006, J TRAUMA STRESS, V19, P721, DOI 10.1002/jts.20167; Harvey AG, 2003, J INT NEUROPSYCH SOC, V9, P663, DOI 10.1017/S1355617703940069; Hellawell SJ, 2002, BEHAV RES THER, V40, P1143, DOI 10.1016/S0005-7967(01)00080-8; Hollows S. E., 1985, ADULT MEMORY INFORM; Hopper JW, 2006, J PSYCHOSOM RES, V60, P83, DOI 10.1016/j.jpsychores.2005.06.002; King NS, 2008, BRAIN INJURY, V22, P1, DOI 10.1080/02699050701829696; MALLOY PF, 1983, J CONSULT CLIN PSYCH, V51, P488, DOI 10.1037/0022-006X.51.4.488; McMillan TM, 1996, BRAIN INJURY, V10, P749, DOI 10.1080/026990596124016; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; McMillan TM, 2001, BRAIN INJURY, V15, P39, DOI 10.1080/02699050118030; Pitman RK, 1996, COMPR PSYCHIAT, V37, P409, DOI 10.1016/S0010-440X(96)90024-3; Sanchez-Navarro JP, 2006, INT J PSYCHOPHYSIOL, V61, P34, DOI 10.1016/j.ijpsycho.2005.10.023; Sbordone RJ, 1999, NEUROREHABILITATION, V13, P69; Stekelenburg JJ, 2002, PSYCHOPHYSIOLOGY, V39, P707, DOI 10.1111/1469-8986.3960707; Sumpter RE, 2006, BRAIN INJURY, V20, P93, DOI 10.1080/02699050500394090; Sumpter RE, 2005, BRIT J PSYCHIAT, V186, P423, DOI 10.1192/bjp.186.5.423; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; van der Hart Onno, 2005, J Trauma Dissociation, V6, P55, DOI 10.1300/J229v06n01_04; VANDERKOLK BA, 1990, TRAUMATIC MEMO UNPUB; Veazey CH, 2004, APPL PSYCHOPHYS BIOF, V29, P51, DOI 10.1023/B:APBI.0000017863.35714.a1; Weschler D., 2001, WESCHLER TEST ADULT; WESCHLER D, 1997, WESCHLER ADULT INTEL, V3; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	37	17	17	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2009	23	2					77	82	PII 908438598	10.1080/02699050802635273			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	403LD	WOS:000263083200001	19191086				2022-02-06	
S	Fins, JJ		Schiff, ND; Laureys, S		Fins, Joseph J.			Being Conscious of Their Burden Severe Brain Injury and the Two Cultures Challenge	DISORDERS OF CONSCIOUSNESS	Annals of the New York Academy of Sciences		English	Article; Proceedings Paper	87th Annual Conference of the Association-for-Reseach-in-Nervous-and-Mental-Disease	DEC 07-08, 2007	New York Acad Med, New York, NY	Assoc Res Nervous & Mental Dis	New York Acad Med	medical ethics; neuroethics; disorders of consciousness; persistent vegetative state; minimally conscious state; traumatic brain injury	VEGETATIVE STATE; LATE RECOVERY; LIFE; DISORDERS; DIAGNOSIS; END; STIMULATION; NEUROETHICS; CARE	Writing 50 years after the publication of C. R Snow's Two Cultures and The Scientific Revolution, this paper considers the many cultures that have to intersect to sustain and deepen the advances in the diagnosis and treatment of patients with disorders of consciousness. To bridge this "two-culture divide," the paper contextualizes scientific developments in this field within work in medical ethics and the humanities. The author asserts that this line of inquiry cannot go forward responsibly absent input from the humanities and an appreciation of the lived experiences of patients and families who confront the quotidian and existential challenges of severe brain injury.	Cornell Univ, Div Med Eth, New York Presbyterian Weill Cornell Med Ctr, Weill Med Coll, New York, NY 10021 USA		Fins, JJ (corresponding author), Cornell Univ, Div Med Eth, New York Presbyterian Weill Cornell Med Ctr, Weill Med Coll, 435 E 70th St,Suite 4-J, New York, NY 10021 USA.	jjfins@med.cornell.edu		Fins, Joseph/0000-0002-7221-0053			Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Annas GJ, 2005, NEW ENGL J MED, V352, P1710, DOI 10.1056/NEJMlim050643; ARROYO J, 2002, GUARDIAN        0731; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; BAUBY JD, 1997, DIVING BELL BUTTERFL; BERENSON A, 2007, ARMYS AGGRESSIVE SUR; BILMES L, 2006, 12054 NAT BUR EC RES; BLAKE R, 2007, DAY D HERBERT WOKE; BRODY H, 1992, HEALERS POWER; Carey Benedict, 2005, N Y Times Web; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; CHRISTAKIS NA, 1999, DEATH FORETOLD PROPH; Drazen JM, 2005, NEW ENGL J MED, V352, P2121, DOI 10.1056/NEJMe048332; Fins JJ, 1999, J PAIN SYMPTOM MANAG, V17, P6, DOI 10.1016/S0885-3924(98)00109-2; Fins JJ, 2005, PROG BRAIN RES, V150, P565, DOI 10.1016/S0079-6123(05)50040-2; Fins JJ, 2005, NEW YORK REV BOOKS, V52, P63; Fins JJ, 2004, ARCH NEUROL-CHICAGO, V61, P1354, DOI 10.1001/archneur.61.9.1354; Fins JJ, 2003, NAT REV NEUROSCI, V4, P323, DOI 10.1038/nrn1079; Fins JJ, 2005, HASTINGS CENT REP, V35, P22, DOI 10.2307/3527759; Fins JJ, 2000, NEUROL RES, V22, P273; FINS JJ, 2008, JAMA-J AM MED ASSOC, V299, P959; Fins JJ, 2006, PALLIATIVE ETHIC CAR; Fins JJ., 2007, PLUM POSNERS DIAGNOS; Fins JJ, 2008, AM J BIOETHICS, V8, P46, DOI 10.1080/15265160802334490; Fins JJ, 2008, AM J BIOETHICS, V8, P3, DOI 10.1080/15265160802318113; Fins JJ, 2006, HASTINGS CENT REP, V36, P8, DOI 10.1353/hcr.2006.0094; Fins JJ, 2007, ARCH NEUROL-CHICAGO, V64, P1400, DOI 10.1001/archneur.64.10.1400; Fins JJ, 2007, AM J BIOETHICS, V7, P51, DOI 10.1080/15265160601064231; Fins Joseph J, 2006, Palliat Support Care, V4, P169; Fins JJ, 2007, NEUROLOGY, V68, P304, DOI 10.1212/01.wnl.0000252376.43779.96; Fins JJ, 2007, NEUROLOGY, V68, P79, DOI 10.1212/01.wnl.0000253019.00880.72; Freud Sigmund, 1965, INTERPRETATION DREAM; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GLASSER R, 2007, SHOCK WAVE BRAIN INJ; GROOPMAN J, 2007, NEW YORKER      1015; HOLLAND NH, 1998, J PSYCHOL STUDY ARTS; Ivins BJ, 2006, NEUROEPIDEMIOLOGY, V27, P154, DOI 10.1159/000096127; Jones E, 1957, LIFE WORK SIGMUND FR; JONSEN A, 2002, NEUROETHICS MAPPING, P273; Kobylarz EJ, 2005, NEUROPSYCHOL REHABIL, V15, P323, DOI 10.1080/09602010443000605; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Laureys S, 2000, BRAIN, V123, P1589, DOI 10.1093/brain/123.8.1589; Laureys S, 2008, NEUROLOGY, V70, pE14, DOI 10.1212/01.wnl.0000303264.66049.c1; Leon-Carrion J, 2002, BRAIN INJURY, V16, P571, DOI 10.1080/02699050110119781; *MULT TASK FORC PV, 1994, NEW ENGL J MED, P1572; Naccache L, 2006, SCIENCE, V313, P1395, DOI 10.1126/science.1132881; *NERVECENTER, 2006, ANN NEUROL, pA13; OCONNOR A, 2005, NY TIMES        0504; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; ORSZAG PR, 2007, SENATE REPORT, P110; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; PASCRELL W, 2006, 2 FED INT C TRAUM BR; Posner JB, 2007, PLUM POSNERS DIAGNOS; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Rees PM, 2007, LANCET, V369, P512, DOI 10.1016/S0140-6736(07)60238-4; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schiff ND, 2005, NEUROLOGY, V64, P514, DOI 10.1212/01.WNL.0000150883.10285.44; SCHIFF ND, 2003, CEREBRUM, V5, P7; Schwaber P, 1976, Psychoanal Study Child, V31, P515; Snow C. P., 1959, 2 CULTURES SCI REVOL; SNOW CP, 1964, 2 CULTURES 2 LOOK; SOLOMON MZ, 1993, AM J PUBLIC HEALTH, V83, P14, DOI 10.2105/AJPH.83.1.14; Tavalaro J, 1997, LOOK YES; Taylor Matthew, 2007, GUARDIAN        1027; THOMAS L, 1983, YOUNGEST SCI; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; WALLIS A, 2007, COMMUNICATION   0904; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wijdicks EFM, 2007, NEUROLOGY, V68, P1092, DOI 10.1212/01.wnl.0000259401.36220.1a; Wilson FC, 2002, NEUROREHABILITATION, V17, P231; Wolfson J, 2005, HASTINGS CENT REP, V35, P16, DOI 10.1353/hcr.2005.0071; 2007, BBC NEWS        1027; 2007, J TRAUMD, V62, P103	73	17	18	0	7	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN STREET, MALDEN 02148, MA USA	0077-8923		978-1-57331-743-6	ANN NY ACAD SCI	Ann.NY Acad.Sci.		2009	1157						131	147		10.1111/j.1749-6632.2009.04473.x			17	Multidisciplinary Sciences; Neurosciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics; Neurosciences & Neurology	BJH38	WOS:000265826300012	19351362				2022-02-06	
J	Janowski, M; Date, I				Janowski, Miroslaw; Date, Isao			Systemic Neurotransplantation - A Problem-Oriented Systematic Review	REVIEWS IN THE NEUROSCIENCES			English	Article						systemic; neurotransplantation; intravenous; stem cells; cell therapy; neurological disorders	MARROW STROMAL CELLS; CORD BLOOD-CELLS; TRAUMATIC BRAIN-INJURY; MESENCHYMAL STEM-CELLS; CEREBRAL-ISCHEMIA MODEL; ADULT-RAT BRAIN; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; AMYOTROPHIC-LATERAL-SCLEROSIS; COLONY-STIMULATING FACTOR; TRANSPLANTED BONE-MARROW	Systemic neurotransplantation (SNT) was introduced in the laboratory in 2000 and currently it is being widely examined in animal models of neurological disorders. The aim of this systematic review was to evaluate the current state of knowledge in the field of experimental SNT and the premise for the introduction of clinical trials. PubMed was searched and 60 articles utilizing an SNT approach were found and subjected to analysis. The time window for cell transplantation was addressed in only two studies, with contradictory results. Immunosuppression was applied in 25% of studies. No study addressed the justification for immunosuppression. Bone marrow was the most frequent source of grafted cells, followed by cord blood and then by cells of embryonic origin. Studies investigating dose-dependency revealed no satisfactory results with transplantation of less than 106 cells/animal; the efficient dose most frequently ranged from 10(6) - 10(7) cells/animal (mice and rats). The behavioral effects of cell transplantation were assessed in 75% of all studies; significant improvement was achieved in 95% of them. Morphological effect was evaluated in half of the studies; significant positive effect was achieved in 73% of them. Experimental attempts to elucidate the mechanisms mediating cell-dependent effect were not undertaken in half of the studies. In the other half, the most frequent mechanisms were growth factors, neurogenesis and immunomodulation. SNT still seems to be at the very initial stage of development. Many critical factors have not been sufficiently addressed in laboratory studies and they must be clarified before the introduction of clinical trials.	[Janowski, Miroslaw] Polish Acad Sci, Med Res Ctr, Dept NeuroRepair, PL-02106 Warsaw, Poland; [Janowski, Miroslaw] Med Univ Warsaw, Dept Neurosurg, Warsaw, Poland; [Date, Isao] Okayama Univ, Dept Neurol Surg, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan		Janowski, M (corresponding author), Polish Acad Sci, Med Res Ctr, Dept NeuroRepair, Pawinskiego 5, PL-02106 Warsaw, Poland.	mjanowsk@amwaw.edu.pl		Janowski, Miroslaw/0000-0001-5261-7975	Polish Ministry of Scientific Research and Higher EducationMinistry of Science and Higher Education, Poland [2P05/A05430]	The authors express their appreciation to Prof Krystyna Domanska-Janik, Head of the Department of NeuroRepair. Medical Research Center, Warsaw, Poland, for critical review of the manuscript. This study was supported by the Polish Ministry of Scientific Research and Higher Education, grant no. 2P05/A05430.	Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; BJORKLUND A, 1979, BRAIN RES, V177, P555, DOI 10.1016/0006-8993(79)90472-4; Borlongan CV, 2004, STROKE, V35, P2385, DOI 10.1161/01.STR.0000141680.49960.d7; Buzanska L, 2002, J CELL SCI, V115, P2131; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen Ruifeng, 2000, Journal of Medicine (Westbury), V31, P21; Chen SH, 2006, EXP NEUROL, V199, P67, DOI 10.1016/j.expneurol.2005.11.015; Chen SH, 2005, CRIT CARE MED, V33, P1377, DOI 10.1097/01.CCM.0000165966.28936.89; Chu K, 2005, NEUROSCI RES, V53, P384, DOI 10.1016/j.neures.2005.08.010; Chu K, 2004, NEUROSCI RES, V50, P459, DOI 10.1016/j.neures.2004.08.015; Chu K, 2004, BRAIN RES, V1023, P213, DOI 10.1016/j.brainres.2004.07.045; Chu K, 2003, NEUROSCI LETT, V343, P129, DOI 10.1016/S0304-3940(03)00174-5; Chu K, 2004, BRAIN RES, V1016, P145, DOI 10.1016/j.brainres.2004.04.038; Conti L, 2006, BRAIN PATHOL, V16, P143, DOI 10.1111/j.1750-3639.2006.00009.x; Corti S, 2005, FASEB J, V19, P1860, DOI 10.1096/fj.05-4170fje; Corti S, 2004, BRAIN, V127, P2518, DOI 10.1093/brain/awh273; Coyne TM, 2006, STEM CELLS, V24, P2483, DOI 10.1634/stemcells.2006-0174; Eclancher F, 1996, BRAIN RES, V737, P201, DOI 10.1016/0006-8993(96)00732-9; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Eliopoulos N, 2005, BLOOD, V106, P4057, DOI 10.1182/blood-2005-03-1004; Ende N, 2000, LIFE SCI, V67, P53, DOI 10.1016/S0024-3205(00)00602-0; Ende Norman, 2002, Journal of Medicine (Westbury), V33, P173; Ende Norman, 2001, Journal of Medicine (Westbury), V32, P231; Ende Norman, 2001, Journal of Medicine (Westbury), V32, P241; Fujiwara Y, 2004, NEUROSCI LETT, V366, P287, DOI 10.1016/j.neulet.2004.05.080; Garbuzova-Davis S, 2003, J HEMATOTH STEM CELL, V12, P255, DOI 10.1089/152581603322022990; Honma T, 2006, EXP NEUROL, V199, P56, DOI 10.1016/j.expneurol.2005.05.004; Horita Y, 2006, J NEUROSCI RES, V84, P1495, DOI 10.1002/jnr.21056; Iihoshi S, 2004, BRAIN RES, V1007, P1, DOI 10.1016/j.brainres.2003.09.084; Jendelova P, 2003, MAGNET RESON MED, V50, P767, DOI 10.1002/mrm.10585; Jendelova P, 2004, J NEUROSCI RES, V76, P232, DOI 10.1002/jnr.20041; Jeong SW, 2003, STROKE, V34, P2258, DOI 10.1161/01.STR.0000083698.20199.1F; Jin HK, 2003, MOL THER, V8, P876, DOI 10.1016/j.ymthe.2003.07.008; Jin KL, 2005, NEUROBIOL DIS, V18, P366, DOI 10.1016/j.nbd.2004.10.010; Kang SK, 2006, STEM CELLS DEV, V15, P583, DOI 10.1089/scd.2006.15.583; Lee RH, 2006, BLOOD, V107, P2153, DOI 10.1182/blood-2005-07-2701; Lee ST, 2006, J NEUROSCI METH, V152, P250, DOI 10.1016/j.jneumeth.2005.09.013; Lee ST, 2005, NEUROSCI RES, V52, P243, DOI 10.1016/j.neures.2005.03.016; Li Y, 2006, EXP NEUROL, V198, P313, DOI 10.1016/j.expneurol.2005.11.029; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Lichtenwalner RJ, 2006, J CEREBR BLOOD F MET, V26, P1, DOI 10.1038/sj.jcbfm.9600170; Lindvall O, 2005, KIDNEY INT, V68, P1937, DOI 10.1111/j.1523-1755.2005.00623.x; Lindvall O, 2006, NATURE, V441, P1094, DOI 10.1038/nature04960; Liu H, 2006, BRAIN, V129, P2734, DOI 10.1093/brain/awl207; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Mahmood A., 2003, NEUROSURGERY, V53, P702; Makinen S, 2006, BRAIN RES, V1123, P207, DOI 10.1016/j.brainres.2006.09.056; Moon LDF, 2001, EUR J NEUROSCI, V14, P1667, DOI 10.1046/j.0953-816x.2001.01795.x; Nakano K, 2001, TRANSPLANTATION, V71, P1735, DOI 10.1097/00007890-200106270-00006; Newcomb JD, 2006, CELL TRANSPLANT, V15, P213, DOI 10.3727/000000006783982043; Newman MB, 2005, STEM CELLS DEV, V14, P576, DOI 10.1089/scd.2005.14.576; Nomura T, 2005, NEUROSCIENCE, V136, P161, DOI 10.1016/j.neuroscience.2005.06.062; Offner H, 2006, J CEREBR BLOOD F MET, V26, P654, DOI 10.1038/sj.jcbfm.9600217; Offner H, 2006, J IMMUNOL, V176, P6523, DOI 10.4049/jimmunol.176.11.6523; Pan Y, 2005, EXP NEUROL, V192, P365, DOI 10.1016/j.expneurol.2004.11.011; Park KW, 2001, NEUROSCI RES, V40, P315, DOI 10.1016/S0168-0102(01)00242-5; PERLOW MJ, 1979, SCIENCE, V204, P643, DOI 10.1126/science.571147; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Ruffini F, 2001, GENE THER, V8, P1207, DOI 10.1038/sj.gt.3301523; SALTHOUSE TN, 1964, STAIN TECHNOL, V39, P123; Saporta S, 2003, J HEMATOTH STEM CELL, V12, P271, DOI 10.1089/152581603322023007; Seyfried D, 2006, J NEUROSURG, V104, P313, DOI 10.3171/jns.2006.104.2.313; Shen LH, 2006, NEUROSCIENCE, V137, P393, DOI 10.1016/j.neuroscience.2005.08.092; Shen LH, 2007, J CEREBR BLOOD F MET, V27, P6, DOI 10.1038/sj.jcbfm.9600311; Sykova E, 2006, CELL MOL NEUROBIOL, V26, P1113, DOI 10.1007/s10571-006-9007-2; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Taguchi A, 2007, EUR J NEUROSCI, V26, P126, DOI 10.1111/j.1460-9568.2007.05640.x; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Urdzikova L, 2006, J NEUROTRAUM, V23, P1379, DOI 10.1089/neu.2006.23.1379; Vendrame M, 2004, STROKE, V35, P2390, DOI 10.1161/01.STR.0000141681.06735.9b; Vendrame M, 2005, STEM CELLS DEV, V14, P595, DOI 10.1089/scd.2005.14.595; Vendrame M, 2006, EXP NEUROL, V199, P191, DOI 10.1016/j.expneurol.2006.03.017; Willing AE, 2003, J NEUROSCI RES, V73, P296, DOI 10.1002/jnr.10659; Willing AE, 2003, CELL TRANSPLANT, V12, P449, DOI 10.3727/000000003108746885; Xiao J, 2005, STEM CELLS DEV, V14, P722, DOI 10.1089/scd.2005.14.722; Yang G, 2006, TRANSPL IMMUNOL, V16, P166, DOI 10.1016/j.trim.2006.08.001; Young PP, 2004, EXP NEUROL, V188, P104, DOI 10.1016/j.expneurol.2004.03.007; Zhang J, 2006, J NEUROSCI RES, V84, P587, DOI 10.1002/jnr.20962; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369	90	17	17	0	11	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0334-1763	1607-8470		REV NEUROSCIENCE	Rev. Neurosci.		2009	20	1					39	60					22	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	443IM	WOS:000265903400004	19526733				2022-02-06	
J	Katz-Leurer, M; Rotem, H; Keren, O; Meyer, S				Katz-Leurer, Michal; Rotem, Hemda; Keren, Ofer; Meyer, Shirley			The relationship between step variability, muscle strength and functional walking performance in children with post-traumatic brain injury	GAIT & POSTURE			English	Article						Children; Traumatic brain injury; Gait; Variability; Muscle strength	CEREBRAL-PALSY; GAIT VARIABILITY; SCALE; YOUNG; COST	The objective of this study was to investigate the association between step variability, muscle strength and functional walking performance in children post-traumatic brain injury (TBI) and typically developed (TD) children. A convenience sample of 16 children post-TBI and 16 TD age and sex matched controls participated in this cross sectional study. The main outcome measures included step length and step time variability, measured with an electronic walkway, strength of four lower-extremity muscle groups, tested bilaterally with a hand held dynamometer, walking performance as assessed by the 2-min walk test, energy expenditure index (EEI) and rating of perceived exertion (OMNI scale). Significant differences were found in walking parameters between the groups (e.g., 2-min walk test: TBI 109 +/- 31 compared to TD 168 +/- 19 m). Children post-TBI had significantly greater variability in step time and step length in comparison to TD controls (e.g., step length variability: TBI 16.3 +/- 13.6 compared to TD 4.9 +/- 2.0). TD children had significantly higher mean strength values than children post-TBI in the knee extensor and hip abductor muscle groups (p < 0.05). The 2-min walk test correlated inversely with the step time and length variability only among children post-TBI while muscle strength values correlated positively with the 2-min walk test only in TD children. This study found that step time and length variability and lower-extremity muscle strength correlated differently to distance covered during the 2-min walk test among children post-TBI and among TD children. (C) 2008 Elsevier B.V. All rights reserved.	[Katz-Leurer, Michal] Tel Aviv Univ, Sch Hlth Profess, Sackler Fac Med, Phys Therapy Dept, IL-69978 Tel Aviv, Israel; [Katz-Leurer, Michal; Rotem, Hemda; Keren, Ofer; Meyer, Shirley] Alyn Childrens Orthoped Hosp & Rehabil Ctr, Jerusalem, Israel		Katz-Leurer, M (corresponding author), Tel Aviv Univ, Sch Hlth Profess, Sackler Fac Med, Phys Therapy Dept, IL-69978 Tel Aviv, Israel.	michalkz@post.tau.ac.il					Crompton J, 2007, DEV MED CHILD NEUROL, V49, P106, DOI 10.1111/j.1469-8749.2007.00106.x; Damiano DL, 1998, ARCH PHYS MED REHAB, V79, P119, DOI 10.1016/S0003-9993(98)90287-8; Hausdorff JM, 1999, J APPL PHYSIOL, V86, P1040, DOI 10.1152/jappl.1999.86.3.1040; Hausdorff JM, 1998, MOVEMENT DISORD, V13, P428, DOI 10.1002/mds.870130310; Katz-Leurer M, 2008, BRAIN INJURY, V22, P153, DOI 10.1080/02699050801895399; Kosak M, 2005, J REHABIL RES DEV, V42, P103, DOI 10.1682/JRRD.2003.11.0171; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Leitner Y, 2007, J NEUROL, V254, P1330, DOI 10.1007/s00415-006-0522-3; Littlewood RA, 2004, CLIN NUTR, V23, P99, DOI 10.1016/S0261-5614(03)00100-6; Livingstone MBE, 2000, MED SCI SPORT EXER, V32, P1513, DOI 10.1097/00005768-200008000-00022; Provost Beth, 2007, Pediatr Phys Ther, V19, P2, DOI 10.1097/01.pep.0000249418.25913.a3; Robertson RJ, 2006, MED SCI SPORT EXER, V38, P158, DOI 10.1249/01.mss.0000190595.03402.66; Rosano C, 2007, NEUROEPIDEMIOLOGY, V29, P193, DOI 10.1159/000111582; Taylor NF, 2004, ARCH PHYS MED REHAB, V85, P77, DOI 10.1016/S0003-9993(03)00379-4; TEASDALE G, 1974, LANCET, V2, P81; Thies SB, 2005, GAIT POSTURE, V22, P26, DOI 10.1016/j.gaitpost.2004.06.004; Thorpe DE, 2005, ARCH PHYS MED REHAB, V86, P2342, DOI 10.1016/j.apmr.2005.07.301; ZARRUGH MY, 1978, EUR J APPL PHYSIOL O, V38, P215, DOI 10.1007/BF00430080	18	17	17	0	5	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362			GAIT POSTURE	Gait Posture	JAN	2009	29	1					154	157		10.1016/j.gaitpost.2008.06.013			4	Neurosciences; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics; Sport Sciences	396LC	WOS:000262592200029	18701292				2022-02-06	
J	Orgado, JM; Fernandez-Ruiz, J; Romero, J				Martinez Orgado, Jose; Fernandez-Ruiz, Javier; Romero, Julian			The endocannabinoid system in neuropathological states	INTERNATIONAL REVIEW OF PSYCHIATRY			English	Article							CANNABINOID AGONIST WIN-55212; CLOSED-HEAD INJURY; PARKINSONS-DISEASE; IN-VIVO; ALZHEIMER-DISEASE; BASAL GANGLIA; CB2 RECEPTORS; BRAIN-DAMAGE; RAT MODEL; CANNABIDIOL	The endocannabinoid system (ECS) exerts important modulatory functions in the central nervous system (CNS), particularly the retrograde control of excitatory or inhibitory synapses, which enables this system to participate in the control of important neurobiological processes in healthy conditions. However, this physiological relevance acquires a maximal interest in neuropathological conditions affecting either the function or the structures of specific areas of the brain, conditions that have been associated with important changes in the activity of this modulatory system (e.g. losses of CB1 receptors (CB1R), up-regulation of CB2 receptors (CB2R), generation of endocannabinoids) that are susceptible to pharmacological adaptation. Among the group of brain disorders that have been associated with the endocannabinoid system, a special interest has been concentrated in various neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease and ischemia. These three disorders will be reviewed here from the perspective of the types of changes experienced by the cannabinoid signalling in humans and cellular or animal models, and from a possible usefulness of certain cannabinoid compounds to alleviate symptoms and/or to delay their progression.	[Martinez Orgado, Jose; Romero, Julian] Fdn Hosp Alcorcon CIBERNED, Laboratorio Apoyo Investigac, Madrid, Spain; [Fernandez-Ruiz, Javier] Univ Complutense, Facultad Medicina, Dept Bioquim Biol Mol CIBERNED, Madrid, Spain; [Martinez Orgado, Jose; Romero, Julian] CIBERNED, Fdn Hosp Alcorcon, Lab Apoyo Invest, Madrid, Spain; [Fernandez-Ruiz, Javier] Univ Complutense, Fac Med, Dept Bioquim & Biol Mol, CIBERNED, E-28040 Madrid, Spain		Orgado, JM (corresponding author), Hosp Univ Fdn Alcorcon, Lab Apoyo Invest, C Budapest 1, Madrid 28922, Spain.	jromero@fhalcorcon.es	PAREDES, JULIAN ROMERO/F-4772-2016; Martinez-Orgado, Jose/ABF-6898-2021; FERNANDEZ RUIZ, JOSE JAVIER/S-3875-2018	PAREDES, JULIAN ROMERO/0000-0002-2897-606X; Martinez-Orgado, Jose/0000-0003-4405-3545; FERNANDEZ RUIZ, JOSE JAVIER/0000-0002-4490-0604			Aisen PS, 2002, LANCET NEUROL, V1, P279, DOI 10.1016/S1474-4422(02)00133-3; Allam MF, 2005, NEUROL RES, V27, P206, DOI 10.1179/016164105X22057; Alvarez FJ, 2008, PEDIATR RES, V64, P653, DOI 10.1203/PDR.0b013e318186e5dd; Benito C, 2008, BRIT J PHARMACOL, V153, P277, DOI 10.1038/sj.bjp.0707505; Benito C, 2007, J NEUROSCI, V27, P2396, DOI 10.1523/JNEUROSCI.4814-06.2007; Carlsson A, 2002, J NEURAL TRANSM, V109, P777, DOI 10.1007/s007020200064; Carroll CB, 2004, NEUROLOGY, V63, P1245, DOI 10.1212/01.WNL.0000140288.48796.8E; Citron M, 2004, NAT REV NEUROSCI, V5, P677, DOI 10.1038/nrn1495; Di Monte DA, 2003, LANCET NEUROL, V2, P531; Dickson DW, 1997, J NEUROPATH EXP NEUR, V56, P321, DOI 10.1097/00005072-199704000-00001; Ehrhart J, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-29; Esposito Ennio, 2007, Expert Rev Neurother, V7, P677, DOI 10.1586/14737175.7.6.677; Esposito G, 2007, BRIT J PHARMACOL, V151, P1272, DOI 10.1038/sj.bjp.0707337; Eubanks LM, 2006, MOL PHARMACEUT, V3, P773, DOI 10.1021/mp060066m; Farrer MJ, 2006, NAT REV GENET, V7, P306, DOI 10.1038/nrg1831; Fernandez-Lopez D, 2007, PEDIATR RES, V62, P255, DOI 10.1203/PDR.0b013e318123fbb8; Fernandez-Lopez D, 2006, PEDIATR RES, V60, P169, DOI 10.1203/01.pdr.0000228839.00122.6c; Fernandez-Ruiz J, 2005, MIL DRUG TH, P79; Franklin A, 2003, EUR J PHARMACOL, V474, P195, DOI 10.1016/S0014-2999(03)02074-0; Galve-Roperh I, 2007, NEUROSCIENTIST, V13, P109, DOI 10.1177/1073858406296407; Garcia-Arencibia M, 2007, BRAIN RES, V1134, P162, DOI 10.1016/j.brainres.2006.11.063; GARCIAARENCIBIA M, 2009, CURRENT DRU IN PRESS; GARCIAARENCIBIA M, 2009, J NEURAL TR IN PRESS; GLASS M, 1993, NEUROSCIENCE, V56, P523, DOI 10.1016/0306-4522(93)90352-G; Hajos N, 2001, NEUROSCIENCE, V106, P1, DOI 10.1016/S0306-4522(01)00287-1; Hampson AJ, 1998, P NATL ACAD SCI USA, V95, P8268, DOI 10.1073/pnas.95.14.8268; Hansen HH, 2001, J NEUROCHEM, V78, P1415, DOI 10.1046/j.1471-4159.2001.00542.x; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Howlett AC, 2004, NEUROPHARMACOLOGY, V47, P345, DOI 10.1016/j.neuropharm.2004.07.030; Jimenez-Del-Rio M, 2008, NEUROSCI RES, V61, P404, DOI 10.1016/j.neures.2008.04.011; Jin KL, 2000, ANN NEUROL, V48, P257, DOI 10.1002/1531-8249(200008)48:2<257::AID-ANA18>3.3.CO;2-G; Knoller N, 2002, CRIT CARE MED, V30, P548, DOI 10.1097/00003246-200203000-00009; Lastres-Becker I, 2005, NEUROBIOL DIS, V19, P96, DOI 10.1016/j.nbd.2004.11.009; Lastres-Becker I, 2001, EUR J NEUROSCI, V14, P1827, DOI 10.1046/j.0953-816x.2001.01812.x; Lipton Stuart A, 2004, NeuroRx, V1, P101, DOI 10.1602/neurorx.1.1.101; Lleo A, 2006, ANNU REV MED, V57, P513, DOI 10.1146/annurev.med.57.121304.131442; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Maresz K, 2005, J NEUROCHEM, V95, P437, DOI 10.1111/j.1471-4159.2005.03380.x; Martinez-Orgado J, 2003, MOL BRAIN RES, V114, P132, DOI 10.1016/S0169-328X(03)00163-3; Martinez-Orgado Jose, 2007, Recent Pat CNS Drug Discov, V2, P131; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Molina-Holgado F, 2003, J NEUROSCI, V23, P6470; NADLER V, 1995, BRAIN RES, V685, P1, DOI 10.1016/0006-8993(95)00367-Y; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Olanow CW, 2007, MOVEMENT DISORD, V22, pS335, DOI 10.1002/mds.21675; Passmore MJ, 2008, INT J GERIATR PSYCH, V23, P116, DOI 10.1002/gps.1828; Pisani A, 2005, ANN NEUROL, V57, P777, DOI 10.1002/ana.20462; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128; Sagredo O, 2007, MOL NEUROBIOL, V36, P82, DOI 10.1007/s12035-007-0004-3; Sagredo O, 2007, EUR J NEUROSCI, V26, P843, DOI 10.1111/j.1460-9568.2007.05717.x; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Sethi KD, 2002, CURR OPIN NEUROL, V15, P457, DOI 10.1097/00019052-200208000-00009; Sieradzan KA, 2001, NEUROLOGY, V57, P2108, DOI 10.1212/WNL.57.11.2108; Streit WJ, 2005, BRAIN RES REV, V48, P234, DOI 10.1016/j.brainresrev.2004.12.013; Sue W, 2006, AM J CLIN NUTR, V83, p470S; Venderova K, 2004, MOVEMENT DISORD, V19, P1102, DOI 10.1002/mds.20111; Volicer L, 1997, INT J GERIATR PSYCH, V12, P913, DOI 10.1002/(SICI)1099-1166(199709)12:9<913::AID-GPS663>3.3.CO;2-4; Volpe JJ, 2001, NEUROLOGY NEWBORN, P331; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Walther S, 2006, PSYCHOPHARMACOLOGY, V185, P524, DOI 10.1007/s00213-006-0343-1; Wimo A, 2003, ALZ DIS ASSOC DIS, V17, P63, DOI 10.1097/00002093-200304000-00002; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Zdanys K, 2008, PROG NEURO-PSYCHOPH, V32, P1362, DOI 10.1016/j.pnpbp.2008.01.008; Zhang M, 2008, NEUROSCIENCE, V152, P753, DOI 10.1016/j.neuroscience.2008.01.022; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	66	17	18	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0954-0261	1369-1627		INT REV PSYCHIATR	Int. Rev. Psych.		2009	21	2					172	180	PII 910429548	10.1080/09540260902782828			9	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	435HA	WOS:000265333500010	19367511				2022-02-06	
J	Munoz-Sanchez, MA; Murillo-Cabezas, F; Cayuela-Dominguez, A; Rincon-Ferrari, MD; Amaya-Villar, R; Leon-Carrion, J				Munoz-Sanchez, M. A.; Murillo-Cabezas, F.; Cayuela-Dominguez, A.; Rincon-Ferrari, M. D.; Amaya-Villar, R.; Leon-Carrion, J.			Skull fracture, with or without clinical signs, in mTBI is an independent risk marker for neurosurgically relevant intracranial lesion: A cohort study	BRAIN INJURY			English	Article						Mild traumatic head injury; skull fracture; intracranial haemorrhagic injury; Injury Severity Score; Glasgow Coma Scale	MILD HEAD-INJURY; COMPUTED-TOMOGRAPHY; MANAGEMENT; RADIOGRAPHY; GUIDELINES; ADMISSION; TRAUMA; ADULTS; SCALE; SCORE	Primary objective: To explore the possibility of identifying skull fracture, with or without clinical signs, as a predictor of positive CT scans in mild traumatic brain injury (mTBI). Research design: Prospective cohort study, matched 1:1 for five potential confounding variables (age, sex, symptoms, mechanism of injury and extracranial trauma severity). Methods and procedures: The study was performed on patients with mTBI (Glasgow Coma Scale 15-14), with or without radiologically demonstrated skull fracture. The cohort with skull fracture included 155 patients selected from a sample of 5097 mTBI patients treated during 1998 at the Critical Care and Emergency Department of the Trauma Centre. The cohort without skull fracture was prospectively recruited from patients with mTBI treated in the same department from 2002-2005. Main outcomes and results: The percentage of patients with intracranial lesion (IL) was significantly higher in mTBI patients with skull fracture than in those without. The risk of requiring neurosurgery was 5-fold higher when skull fracture was present. Of mTBI patients with skull fracture and IL, 63.2% showed no clinical signs of bone injury. Conclusions: Skull fracture, with or without clinical signs, in mTBI patients is associated with an increased risk of neurosurgically-relevant intracranial lesion.	[Cayuela-Dominguez, A.] Virgen Rocio Univ Hosp, Res Unit, Seville, Spain; [Leon-Carrion, J.] Univ Seville, Human Neuropsychol Lab, Seville, Spain; [Munoz-Sanchez, M. A.; Murillo-Cabezas, F.; Rincon-Ferrari, M. D.; Amaya-Villar, R.] Virgen Rocio Univ Hosp, Crit Care & Emergency Dept, Seville, Spain		Munoz-Sanchez, MA (corresponding author), C Pablo Ruiz Picasso 4, Seville 41909, Spain.	angeles.munoz.sspa@juntadeandalucia.es	Murillo-Cabezas, Francisco/AAO-3348-2021; IBIS, NEUROCRITICOS/C-1805-2016		The Andalusian Health Service	Supported by Grant of The Andalusian Health Service.	*AM ASS AUT MED, 1990, ABBR INJ SCAL AIS 19; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Boran BO, 2006, PEDIATR NEUROSURG, V42, P203, DOI 10.1159/000092355; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; BORZUCK P, 1995, ANN EMERG MED, V25, P731; COOPER PR, 1983, NEUROSURGERY, V13, P136, DOI 10.1227/00006123-198308000-00005; DELACEY G, 1990, BRIT J RADIOL, V63, P14, DOI 10.1259/0007-1285-63-745-14; FEUERMAN T, 1988, NEUROSURGERY, V22, P449, DOI 10.1227/00006123-198803000-00001; Gomez PA, 1996, BRIT J NEUROSURG, V10, P453, DOI 10.1080/02688699647078; Graham DI, 1996, NEUROPATH APPL NEURO, V22, P505, DOI 10.1111/j.1365-2990.1996.tb01125.x; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hofman PAM, 2000, J NEUROL NEUROSUR PS, V68, P416, DOI 10.1136/jnnp.68.4.416; Hutchinson PJA, 1998, J ACCID EMERG MED, V15, P84; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; JENNETT B, 1980, CLIN RADIOL, V31, P463, DOI 10.1016/S0009-9260(80)80195-4; Lee JS, 2003, ACAD EMERG MED, V10, P1128, DOI 10.1197/S1069-6563(03)00372-5; MACLAREN RE, 1993, ARCH EMERG MED, V10, P138; MENDELOW AD, 1983, BRIT MED J, V287, P1173, DOI 10.1136/bmj.287.6400.1173; Munoz-Sanchez M, 2005, CHILD NERV SYST, V21, P128, DOI 10.1007/s00381-004-1036-x; Munoz-Sanchez MA, 2006, STUD NEUROPSYCH DEV, P17; MUNOZSANCHEZ MA, 1997, MED INTENSIVA, V21, P378; Ono K, 2007, NEUROL MED-CHIR, V47, P291, DOI 10.2176/nmc.47.291; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Study Group on Head Injury of the Italian Society for Neurosurgery, 1996, J NEUROSURG SCI, V40, P11; TEASDALE G, 1974, LANCET, V2, P81; Viola L, 2000, ACTA NEUROCHIR, V142, P1281, DOI 10.1007/s007010070026; Yavuz MS, 2003, AM J FOREN MED PATH, V24, P339, DOI 10.1097/01.paf.0000103011.14578.c3	30	17	17	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2009	23	1					39	44	PII 906993469	10.1080/02699050802590346			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	399FY	WOS:000262787000008	19096969				2022-02-06	
J	Strandberg, T				Strandberg, Thomas			Adults with Acquired Traumatic Brain Injury: Experiences of a Changeover Process and Consequences in Everyday Life	SOCIAL WORK IN HEALTH CARE			English	Article; Proceedings Paper	5th international Conference of Social Work in Health and Mental Health	DEC 10-14, 2006	Hong Kong, PEOPLES R CHINA			traumatic brain injury; changeover process; everyday life; content analysis	REHABILITATION; DISABILITY; SELF; EPIDEMIOLOGY; NARRATIVES; PEOPLE	The purpose of this study is to illuminate the changeover process, support, and consequences experienced by adults who acquired traumatic brain injury (TBI). Fifteen persons were in-depth interviewed using a semi-structured interview guide. Data were analyzed by latent-content analysis and structured into six themes. Consequences were negative as well as positive. Significant others were important as a driving force for training and life-situation. The informants were initially satisfied with social supports but in the longer term became more critical regarding accessibility to such supports. The majority had difficulties in returning to working life after injury. The outcomes seemed to be a prolonged process, probably never-ending, which gradually became integrated as a part of life.	[Strandberg, Thomas] Univ Orebro, SIDR, SE-70215 Orebro, Sweden; [Strandberg, Thomas] Malardalen Univ, Dept Social Sci, Vasteras, Sweden		Strandberg, T (corresponding author), Univ Orebro, SIDR, SE-70215 Orebro, Sweden.	thomas.strandberg@hi.oru.se					Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; BERNER B, 2005, SAMHALLSVETENSKAPENS, P117; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Campbell M., 2000, REHABILITATION TRAUM; Chamberlain DJ, 2006, J ADV NURS, V54, P407, DOI 10.1111/j.1365-2648.2006.03840.x; Clarke E, 1996, ILLUSTRATED HIST BRA; Clarke E, 1996, HUMAN BRAIN SPINAL C; Corbin JM, 1988, UNENDING WORK CARE M; Danermark B., 2002, EXPLAINING SOC CRITI; DANNEFJORD P, 2005, SAMHALLSVETENSKAPENS, P13; Dean S, 2000, PSYCHOL REP, V86, P653, DOI 10.2466/pr0.2000.86.2.653; ERIKSSON PS, 2003, J REHABIL MED, V41, P17; Eysenck M.W., 2000, COGNITIVE PSYCHOL ST; Fine M, 2005, AGEING SOC, V25, P601, DOI 10.1017/S0144686X05003600; Finset A, 2002, HODESKADE VIRKNINGER; Fischer S, 2004, BRAIN INJURY, V18, P547, DOI 10.1080/02699050310001645793; Freeman EA, 1997, BRAIN INJURY, V11, P143, DOI 10.1080/026990597123746; Gerstenbrand F, 2001, BRAIN INJURY, V15, P95; Goldstein K., 1942, AFTEREFFECTS BRAIN I; Graham H., 1983, LABOUR LOVE WOMEN WO, P13; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; GUSTAVSSON A, 2004, SCAND J DISABIL RES, V6, P55, DOI DOI 10.1080/15017410409512639; HARRY GJ, 1992, MOL NEUROBIOL, V6, P203; Hodgkinson A, 2000, J HEAD TRAUMA REHAB, V15, P1208, DOI 10.1097/00001199-200012000-00003; Honneth A., 1995, STRUGGLE RECOGNITION; INKMANN CM, 2001, 3008493 UMI PAC GRAD; JOHANSSON U, 2004, THESIS UMEA U; Johnson B P, 1995, J Neurosci Nurs, V27, P113; Johnson Susan, 2003, Case Manager, V14, P58, DOI 10.1067/mcm.2003.27; JUMISKO E, 2005, THESIS LULEA U TECHN; KROGSTAD JM, 2001, VAD AR FORVARVAD HJA; Kvale S., 1996, INTERVIEWS INTRO QUA, V1st ed.; LEWINGTON P, 1996, THESIS U BRIT COLUMB; Lippert-Gruner M, 2002, J REHABIL MED, V34, P211, DOI 10.1080/165019702760279198; Luria A.R., 1973, WORKING BRAIN INTRO; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; MEAD GH, 1976, MEDVETANDET JAGET SA; MELLERGARD P, 1998, GRUNDLAGGANDE NEUROK; Morse J.M., 2002, READ ME 1 USERS GUID; Nochi M, 1997, DISABIL SOC, V12, P533, DOI 10.1080/09687599727119; Nochi M, 1998, QUAL HEALTH RES, V8, P665, DOI 10.1177/104973239800800507; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Nordenfelt L, 2003, DISABIL REHABIL, V25, P1075, DOI 10.1080/0963828031000137748; Nordgren C, 2003, J REHABIL MED, V35, P121, DOI 10.1080/16501970310010466; O'Leary CA, 2000, BEHAV INTERVENT, V15, P205, DOI 10.1002/1099-078X(200007/09)15:3<205::AID-BIN56>3.3.CO;2-B; OATLEY K, 1992, ANNU REV PSYCHOL, V43, P55, DOI 10.1146/annurev.ps.43.020192.000415; Oddy M, 2001, BRAIN DAM B, P287; Odman P.-J., 2004, KUNSKAPANDE METODER, P71; Peloso PM, 2004, J REHABIL MED, V36, P22, DOI 10.1080/16501960410023714; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; SJODEN S, 1998, SOM BRO ATT MOTA FOR; Soderback I, 1992, Disabil Rehabil, V14, P30; Stalnacke B.-M., 2005, SKALLSKADADE UMEA 20; STRANDBERG T, 2006, VUXNA FORVARVAD TRAU; *SWED RES COUNC, 2002, FORSK PRINC IN HUM S; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tham K, 2000, AM J OCCUP THER, V54, P398, DOI 10.5014/ajot.54.4.398; THOMSEN IV, 1992, SCAND J REHABIL MED, P142; Toglia JP, 2005, COGNITION OCCUPATION, P29; vanBalen HGG, 1996, DISABIL REHABIL, V18, P181, DOI 10.3109/09638289609166298	61	17	17	0	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0098-1389	1541-034X		SOC WORK HEALTH CARE	Soc. Work Health Care		2009	48	3					276	297	PII 910359364	10.1080/00981380802599240			22	Social Work	Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Social Work	434WD	WOS:000265303900006	19360531				2022-02-06	
J	Wallenquist, U; Brannval, K; Clausen, F; Lewen, A; Hillered, L; Forsberg-Nilsson, K				Wallenquist, U.; Brannval, K.; Clausen, F.; Lewen, A.; Hillered, L.; Forsberg-Nilsson, K.			Grafted neural progenitors migrate and form neurons after experimental traumatic brain injury	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						TBI; EGFP transgenic mice; transplantation; migration; regeneration; neural stem cells; CNS	STEM-CELLS; STEM/PROGENITOR CELLS; CONTUSION TRAUMA; SPINAL-CORD; ADULT; DIFFERENTIATION; TRANSPLANTATION; NEUROGENESIS; ENGRAFTMENT; CNS	Purpose: Neural stem and progenitor cells (NSPC) generate neurons and glia, a feature that makes them attractive for cell replacement therapies. However, efforts to transplant neural progenitors in animal models of brain injury typically result in high cell mortality and poor neuronal differentiation. Methods: In an attempt to improve the outcome for grafted NSPC after controlled cortical impact we transplanted Enhanced Green Fluorescent Protein (EGFP)-positive NSPC into the contra lateral ventricle of mice one week after injury. Results: Grafted EGFP-NSPC readily migrated to the injured hemisphere where we analyzed the proportion of progenitors and differentiated progeny at different time points. Transplantation directly into the injured parenchyma, resulted in few brains with detectable EGFP-NSPC. On the contrary, in more than 90% of the mice that received a transplant into the lateral ventricle detectable EGFP-positive cells were found. The cells were integrated into the lateral ventricle wall of the un-injured hemisphere, throughout the corpus callosum, and in the cortical perilesional area. At one-week post transplantation, grafted cells that had migrated to the perilesion area mainly expressed markers of neural progenitors and neurons, while in the corpus callosum and the ventricular lining, grafted cells with a glial fate were more abundant. After 3 months, grafted cells in the perilesion area were less abundant whereas cells that had migrated to the walls of the third-and lateral-ventricle of the injured hemisphere were still detectable, suggesting that the injury site remained a hostile environment. Conclusion: Transplantation to the lateral ventricle, presumably for being a neurogenic region, provides a favorable environment improving the outcome for grafted NSPC both in term of their appearance at the cortical site of injury, and their acquisition of neural markers.	[Wallenquist, U.; Brannval, K.; Forsberg-Nilsson, K.] Uppsala Univ, Dept Med Biochem & Microbiol, Biomed Ctr, S-75123 Uppsala, Sweden; [Clausen, F.; Lewen, A.; Hillered, L.] Univ Uppsala Hosp, Dept Neurosci, Uppsala, Sweden		Forsberg-Nilsson, K (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Biomed Ctr, Box 582, S-75123 Uppsala, Sweden.	karin.nilsson@imbim.uu.se	Forsberg-Nilsson, Karin/D-9604-2019; Lewen, Anders/A-5156-2013	Forsberg-Nilsson, Karin/0000-0003-0692-6245; Lewen, Anders/0000-0003-4925-1348; Clausen, Fredrik/0000-0003-3592-4417; Hillered, Lars/0000-0002-2808-9292	Swedish Research Council MedicineSwedish Research Council; Uppsala University Hospital	This study was supported by grants from the Swedish Research Council Medicine (LH and KFN) and Uppsala University Hospital. The authors would like to thank the animal facility personnel for excellent assistance with animal care. Dr. J. Grawe, Cell Analysis Core Facility, Rudbeck laboratory, Uppsala University, is acknowledged for expert advice with confocal microscopy, and Drs T. Olofsson and H. Kalimu for advice on brain morphology.	Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Bakshi A, 2005, BRAIN RES, V1065, P8, DOI 10.1016/j.brainres.2005.09.059; Brannvall K, 2006, NEUROREPORT, V17, P623; Brustle O, 1995, NEURON, V15, P1275, DOI 10.1016/0896-6273(95)90007-1; Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536; Chow SY, 2000, BRAIN RES, V874, P87, DOI 10.1016/S0006-8993(00)02443-4; Clausen F, 2007, J NEUROTRAUM, V24, P1295, DOI 10.1089/neu.2006.0258; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fricker RA, 1999, J NEUROSCI, V19, P5990, DOI 10.1523/JNEUROSCI.19-14-05990.1999; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Herrera DG, 1999, ANN NEUROL, V46, P867, DOI 10.1002/1531-8249(199912)46:6<867::AID-ANA9>3.0.CO;2-Z; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hoane MR, 2004, J NEUROTRAUM, V21, P163, DOI 10.1089/089771504322778622; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Israelsson C, 2006, J NEUROSCI RES, V84, P47, DOI 10.1002/jnr.20856; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KIRSCHENBAUM B, 1994, CEREB CORTEX, V4, P576, DOI 10.1093/cercor/4.6.576; Kukekov VG, 1999, EXP NEUROL, V156, P333, DOI 10.1006/exnr.1999.7028; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lewen A, 1999, ACTA NEUROCHIR, V141, P193, DOI 10.1007/s007010050286; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Longhi L, 2004, J NEUROTRAUM, V21, P1723, DOI 10.1089/neu.2004.21.1723; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Mehler Mark F, 2002, Results Probl Cell Differ, V39, P27; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Schouten JW, 2004, J NEUROTRAUM, V21, P1501, DOI 10.1089/neu.2004.21.1501; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Suslov ON, 2002, P NATL ACAD SCI USA, V99, P14506, DOI 10.1073/pnas.212525299; Sykova E, 2005, ANN NY ACAD SCI, V1049, P146, DOI 10.1196/annals.1334.014; Tamaki S, 2002, J NEUROSCI RES, V69, P976, DOI 10.1002/jnr.10412; Wang KKW, 2006, CURR OPIN NEUROL, V19, P514, DOI 10.1097/WCO.0b013e3280102b10; Wennersten A, 2004, J NEUROSURG, V100, P88, DOI 10.3171/jns.2004.100.1.0088	49	17	18	0	5	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2009	27	4					323	334		10.3233/RNN-2009-0481			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	492BS	WOS:000269629700007	19738325				2022-02-06	
J	Wen, J; Shi, YK; Li, YP; Wang, L; Cheng, L; Gao, Z; Li, L				Wen, Jin; Shi, Ying Kang; Li, You Ping; Wang, Li; Cheng, Lan; Gao, Zhan; Li, Ling			Risk factors of earthquake inpatient death: a case control study	CRITICAL CARE			English	Article							HANSHIN-AWAJI EARTHQUAKE; 1999 MARMARA EARTHQUAKE; INJURY; MORTALITY; POPULATION; MODERATE; FAILURE; TURKEY	Introduction At 2: 28 p. m. on 12 May, 2008, a devastating earthquake measuring 8.0 on the Richter scale hit Wenchuan County, Sichuan Province in southwest China, and resulted in the deaths of thousands of people. To date, few epidemiological studies have been conducted on the determinants of the mortality of patients hospitalised after an earthquake. This paper is aimed at identifying the contributing factors of mortality and providing a clinical reference for the management of those injured in earthquakes. Methods A hospital-based case-control study was conducted. Cases included all deaths (n = 36) due to earthquake injuries in the West China Hospital. Controls were the quake survivors from the same hospital by at a ratio of four survivors to one death matched for sex and age. Data sources included death certificates and medical records. A conditional logistic regression was performed to assess the odds ratio (OR) of variables used in the study. A chi-squared test for trend was performed to reveal the possible relations between risk factor (variable) number and case fatality. Results People with a severe traumatic brain injury (TBI) had the greatest risk of death (adjusted OR = 253.3, 95% confidence interval (CI) = 8.9 to 7208.6), followed by patients with multiple system organ failure (MSOF; adjusted OR = 87.8, 95% CI = 3.9 to 1928.3). Prior major disease and infection significantly increased the risk of earthquake-related death (adjusted OR = 14.9, 95% CI = 1.9 to 119.0; adjusted OR = 13.7, 95% CI = 1.8 to 103.7; respectively). The number of fatal cases increased as the risk factor numbers also increased. Conclusions Severe TBI, infection, MSOF and prior major disease are the significant determinants of earthquake- related inpatient death in the 2008 Wenchuan earthquake. Future research with a large sample size including macro- and micro-level factors is needed.	[Shi, Ying Kang] Sichuan Univ, W China Hosp, Dept Thorac & Cardiovasc Surg, Chengdu 610041, Peoples R China; [Wen, Jin; Li, You Ping; Wang, Li; Cheng, Lan; Gao, Zhan; Li, Ling] Sichuan Univ, W China Hosp, Chinese Evidence Based Med Ctr, Chengdu 610041, Peoples R China; [Wen, Jin; Li, You Ping; Wang, Li; Cheng, Lan; Gao, Zhan; Li, Ling] Sichuan Univ, W China Hosp, Dept Clin Epidemiol, Chengdu 610041, Peoples R China		Shi, YK (corresponding author), Sichuan Univ, W China Hosp, Dept Thorac & Cardiovasc Surg, Chengdu 610041, Peoples R China.	huaxiwenjin@163.com	Wang, Li/T-1407-2017	Wang, Li/0000-0003-1585-8846			Armenian HK, 1997, INT J EPIDEMIOL, V26, P806, DOI 10.1093/ije/26.4.806; Bellomo R, 2001, INTENS CARE MED, V27, P1685, DOI 10.1007/s00134-001-1120-6; Bouras T, 2007, J NEUROTRAUM, V24, P1355, DOI 10.1089/neu.2005.370; Bulut M, 2005, EMERG MED J, V22, P494, DOI 10.1136/emj.2004.016295; Bywaters EGL, 1998, J AM SOC NEPHROL, V9, P322; Chan CC, 2003, ANN EPIDEMIOL, V13, P502, DOI 10.1016/S1047-2797(03)00040-1; Chou YJ, 2004, AM J EPIDEMIOL, V160, P688, DOI 10.1093/aje/kwh270; Duman H, 2003, EMERG MED J, V20, P251, DOI 10.1136/emj.20.3.251; FRY DE, 1980, ARCH SURG-CHICAGO, V115, P136; JUAN X, 2008, J EVID BASED MED, V1, P20; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mahue-Giangreco M, 2001, ANN EPIDEMIOL, V11, P347, DOI 10.1016/S1047-2797(01)00220-4; Oncul O, 2002, J HOSP INFECT, V51, P47, DOI 10.1053/jhin.2002.1205; Osaki Y, 2001, AM J EPIDEMIOL, V153, P153, DOI 10.1093/aje/153.2.153; Peek-Asa C, 2003, INJ PREV, V9, P62, DOI 10.1136/ip.9.1.62; Tanaka H, 1999, AM J EMERG MED, V17, P186, DOI 10.1016/S0735-6757(99)90059-1; Valadka A. B., 2004, TRAUMA, P385	17	17	17	0	9	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care		2009	13	1							R24	10.1186/cc7729			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	421IC	WOS:000264351600024	19243616	Green Published, gold			2022-02-06	
J	Wong, GK; Tang, BYH; Yeung, JHH; Collins, G; Rainer, T; Ng, SC; Poon, WS				Wong, G. K.; Tang, B. Y. H.; Yeung, J. H. H.; Collins, G.; Rainer, T.; Ng, S. C.; Poon, W. S.			Traumatic intracerebral haemorrhage: Is the CT pattern related to outcome?	BRITISH JOURNAL OF NEUROSURGERY			English	Article						Cerebral contusion; intracerebral haemorrhage; outcome; trauma	BRAIN-INJURY; PROGNOSTIC VALUE; HEAD-INJURY; COMA	It is believed by many neurosurgeons that in addition to age and neurological status, the CT patterns of traumatic intracerebral haemorrhages are related to outcome. The aim of this study was to find out whether this is the case. The study was conducted in a regional level I trauma centre in Hong Kong. We prospectively collected data of patients with traumatic intracerebral haematomas over a 4-year period. Of 464 patients with head injuries, traumatic intracerebral haematoma was significantly associated with inpatient mortality and one year unfavorable outcome after adjustment for age, sex, post-resuscitation GCS, and presence of acute subdural haematoma. One hundred-and-fourteen patients had traumatic intracerebral haematomas and were included for further analysis. The mean age was 49, the male to female ratio was 2 to 1, and the median Glasgow Coma Scale (GCS) score on admission was 12. Logistic regression analysis showed that age and GCS score/GCS motor component score were significant factors for inpatient mortality, one-year mortality and one-year outcome. There was an association between temporal haematomas and inpatient mortality, subdural haematomas and inpatient mortality, and bilateral haematomas and unfavourable one-year outcome. In patients with severe head injury, a traumatic haematoma of more than 50 ml was associated higher inpatient mortality. In addition to age and GCS score, the CT patterns of bilateral haematomas, temporal haematomas and associated subdural haematomas were suggestive of poor outcome or mortality.	[Wong, G. K.] Chinese Univ Hong Kong, Dept Surg, Div Neurosurg, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; [Yeung, J. H. H.; Collins, G.; Rainer, T.] Chinese Univ Hong Kong, Prince Wales Hosp, Accid & Emergency Med Acad Unit, Hong Kong, Hong Kong, Peoples R China		Wong, GK (corresponding author), Chinese Univ Hong Kong, Dept Surg, Div Neurosurg, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China.	georgewong@surgery.cuhk.edu.hk	Rainer, Timothy H/I-2591-2013; Poon, Wai Sang/F-1558-2011; Wong, George KC/A-6378-2011; Wong, George Kwok Chu/L-4344-2016; Tang, Yan Ho Bruce/X-4573-2019; Graham, Colin A/B-4535-2013	Rainer, Timothy H/0000-0003-3355-3237; Wong, George KC/0000-0002-6078-2548; Tang, Yan Ho Bruce/0000-0002-5374-8472; Graham, Colin A/0000-0002-4381-7470			ANDREWS BT, 1988, J NEUROSURG, V69, P518, DOI 10.3171/jns.1988.69.4.0518; [Anonymous], 2008, BMJ-BRIT MED J, V336, P425, DOI DOI 10.1136/bmj.39461.643438.25; Caroli M, 2001, SURG NEUROL, V56, P82, DOI 10.1016/S0090-3019(01)00540-7; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; JENNETT B, 1975, LANCET, V1, P480; KUMCHEV Y, 1998, FOLIO MED PLOVDIV, V4091, P52; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; TEASDALE G, 1974, LANCET, V2, P81	12	17	19	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.		2009	23	6					601	605		10.3109/02688690902948184			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	585TK	WOS:000276851900008	19922273				2022-02-06	
J	Zoghi-Moghadam, M; Sadegh, AM				Zoghi-Moghadam, Mohamad; Sadegh, Ali M.			Global/local head models to analyse cerebral blood vessel rupture leading to ASDH and SAH	COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING			English	Article						head impact; ASDH; bridging veins; global; local; finite element model	DIFFUSE AXONAL INJURY; FINITE-ELEMENT-ANALYSIS; ACUTE SUBDURAL-HEMATOMA; BRAIN-INJURY; IMPACT; BIOMECHANICS; SIMULATIONS; CONCUSSION; PRIMATE	Blunt and rotational head impacts due to vehicular collisions, falls and contact sports cause relative motion between the brain and skull. This increases the normal and shear stresses in the (skull/brain) interface region consisting of cerebrospinal fluid (CSF) and subarachnoid space (SAS) trabeculae. The relative motion between the brain and skull can explain many types of traumatic brain injuries (TBI) including acute subdural hematomas (ASDH) and subarachnoid hemorrhage (SAH) which is caused by the rupture of bridging veins that transverse from the deep brain tissue to the superficial meningeal coverings. The complicated geometry of the SAS trabeculae makes it impossible to model all the details of the region. Investigators have compromised this layer with solid elements, which may lead to inaccurate results. In this paper, the failure of the cerebral blood vessels due to the head impacts have been investigated. This is accomplished through a global/local modelling approach. Two global models, namely a global solid model (GSM) of the skull/brain and a global fluid model (GFM) of the SAS/CSF, were constructed and were validated. The global models were subjected to two sets of impact loads (head injury criterion, HIC=740 and 1044). The relative displacements between the brain and skull were determined from GSM. The CSF equivalent fluid pressure due to the impact loads were determined by the GFM. To locally study the mechanism of the injury, the relative displacement between the brain and skull along with the equivalent fluid pressure were implemented into a new local solid model (LSM). The strains of the cerebral blood vessels were determined from LSM. These values were compared with their relevant experimental ultimate strain values. The results showed an agreement with the experimental values indicating that the second impact (HIC=1044) was strong enough to lead to severe injury. The global/local approach provides a reliable tool to study the cerebral blood vessel ruptures leading to ASDH and/or SAH.	[Zoghi-Moghadam, Mohamad; Sadegh, Ali M.] CUNY City Coll, Dept Mech Engn, New York, NY 10031 USA		Sadegh, AM (corresponding author), CUNY City Coll, Dept Mech Engn, New York, NY 10031 USA.	sadegh@ccny.cuny.edu					Abel JM, 1978, P 22 STAPP CAR CRASH; Al-Bsharat AS, 1999, P 43 STAPP CAR CRASH; *ANSYS INC, 2001, US MAN VERS 6 1; Anzelius A, 1943, ACTA PATH MICROBIO S, V48, P153; Bandak F.A., 1994, STAPP CAR CRASH C SO, V38, P145; Blumenfeld H., 2002, NEUROANATOMY CLIN CA; Bradshaw DRS, 2001, J BIOMECH, V34, P85, DOI 10.1016/S0021-9290(00)00135-4; ENGIN AE, 1969, J BIOMECH, V2, P325, DOI 10.1016/0021-9290(69)90089-X; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli TA, 1972, P 16 STAPP CAR CRASH; Gurdjian ES, 1944, J NEUROSURG, V1, P393, DOI 10.3171/jns.1944.1.6.0393; GURDJIAN ES, 1961, J NEUROSURG, V18, P58, DOI 10.3171/jns.1961.18.1.0058; GURDJIAN ES, 1955, SURG GYNECOL OBSTET, V101, P680; Hall JE., 2006, TXB MED PHYSL; Hardy WN, 2001, P 45 STAPP CAR CRASH; Hodgson V.R., 1979, P 23 STAPP CAR CRASH; HODGSON VR, 1983, P 27 STAPP CAR CRASH; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147, DOI 10.1093/oxfordjournals.bmb.a071895; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Huang HM, 1999, J TRAUMA, V47, P538, DOI 10.1097/00005373-199909000-00019; Ivarsson J, 2000, J BIOMECH, V33, P181, DOI 10.1016/S0021-9290(99)00144-X; Kleinberger M, 1998, DEV IMPROVED INJURY; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; KLEIVEN S, 2002, P 46 STAPP CAR CRASH; Kleiven S, 2002, TRAFFIC INJ PREV, V3, P303, DOI DOI 10.1080/15389580214633; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; LEE MC, 1989, J BIOMECH, V22, P537, DOI 10.1016/0021-9290(89)90005-5; LEE MC, 1987, P 31 STAPP CAR CRASH; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Monson KL, 2003, J BIOMECH ENG-T ASME, V125, P288, DOI 10.1115/1.1554412; MONSON KL, 2000, CRASHWORTHINESS OCCU, V49, P255; Nahum AM, 1977, P 21 STAPP CAR CRASH; Newman J, 2000, P 44 STAPP CAR CRASH; NEWMAN JA, 1980, P 24 STAPP CAR CRASH; Nishimoto T, 1998, J BIOMECH ENG-T ASME, V120, P140, DOI 10.1115/1.2834294; Nishimoto T, 2000, JSAE REV, V21, P117, DOI 10.1016/S0389-4304(99)00079-X; OMMAYA AK, 1971, J NEUROSURG, V35, P503, DOI 10.3171/jns.1971.35.5.0503; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; Ono K., 1980, P 24 STAPP CAR CRASH; RUAN JS, 1994, J BIOMECH ENG-T ASME, V116, P44, DOI 10.1115/1.2895703; RUAN JS, 1993, P 37 STAPP CAR CRASH; Sarkar S, 2004, TRENDS BIOMATER ARTI, V17, P130; Trosseille X., 1992, P 36 STAPP CAR CRASH; TURQUIER F, 1996, P 40 STAPP CAR CRASH; UENO K, 1995, J NEUROTRAUM, V12, P695, DOI 10.1089/neu.1995.12.695; Viano D., 1997, INT J CRASHWORTHINES, V2, P191; Ward C, 1980, P 24 STAPP CAR CRASH; WILLINGER R, 1995, J NEUROTRAUM, V12, P743, DOI 10.1089/neu.1995.12.743; Willinger R, 1999, ANN BIOMED ENG, V27, P403, DOI 10.1114/1.165; Young PG, 2003, J SOUND VIB, V267, P1107, DOI 10.1016/S0022-460X(03)00200-1; ZHANG L, 2001, P 45 STAPP CAR CRASH; ZHANG L, 2002, P 46 STAPP CAR CRASH; Zhou C, 1995, P 39 STAPP CAR CRASH; ZOGHIMOGHADAM M, 2006, THESIS CITY U NEW YO; 1995, GRAYS ANATOMY	57	17	21	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1025-5842	1476-8259		COMPUT METHOD BIOMEC	Comput. Methods Biomech. Biomed. Eng.		2009	12	1					1	12	PII 903082957	10.1080/10255840802020420			12	Computer Science, Interdisciplinary Applications; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering	390SB	WOS:000262182900001	18821190				2022-02-06	
J	Maher, AD; Patki, P; Lindon, JC; Want, EJ; Holmes, E; Craggs, M; Nicholson, JK				Maher, Anthony D.; Patki, Prasad; Lindon, John C.; Want, Elizabeth J.; Holmes, Elaine; Craggs, Michael; Nicholson, Jeremy K.			Seminal Oligouridinosis: Low Uridine Secretion as a Biomarker for Infertility in Spinal Neurotrauma	CLINICAL CHEMISTRY			English	Article								BACKGROUND: Compromised sexual health is a major rehabilitative barrier for men with lower-spinal cord injury (SCI). Although studies have revealed decreased sperm motility, the quantitative biochemical changes that underlie the infertility mechanism remain poorly understood. METHODS: We employed a nontargeted approach combining 800 MHz hydrogen nuclear magnetic resonance (H-1 NMR) spectroscopy and ultra-performance liquid chromatography-mass spectrometry (UPLC-MS) with pattern recognition methods to analyze seminal fluid metabolite profiles in 10 men with and 8 without SCI above thoracic vertebra 10 (T10). RESULTS: The metabolic phenotype for SCI could be predicted from the H-1 NMR data. The median concentration of uridine in fertile controls was 1.55 mmol/L (range 1.0-5.0 mmol/L), but was undetectable by both NMR and MS in all but 2 individuals from the SCI group, one who later fathered a child without assisted fertility techniques. CONCLUSIONS: We hypothesize that uridine is likely to be an essential precursor to metabolites required for capacitation and is a potential marker for the prognosis of post-SCI functional fertility recovery. We derived the term "seminal oligouridinosis" to describe this newly identified condition.	[Patki, Prasad; Craggs, Michael] Royal Natl Orthopaed Hosp, Dept Neurol, Stanmore HA7 4LP, Middx, England; [Maher, Anthony D.; Lindon, John C.; Want, Elizabeth J.; Holmes, Elaine; Nicholson, Jeremy K.] Univ London Imperial Coll Sci Technol & Med, Dept Biomol Med, SORA Div, Fac Med, London, England; [Craggs, Michael] Univ Coll London, Div Surg & Intervent Sci, Stanmore, Middx, England; [Craggs, Michael] Royal Natl Orthopaed Hosp, Spinal Res Ctr, Stanmore HA7 4LP, Middx, England		Craggs, M (corresponding author), Royal Natl Orthopaed Hosp, Dept Neurol, Stanmore HA7 4LP, Middx, England.	michael.craggs@ucl.ac.uk; j.nicholson@imperial.ac.uk	Nicholson, Jeremy K/B-3395-2012; Holmes, Elaine/ABE-6606-2020	Nicholson, Jeremy K/0000-0002-8123-8349; Holmes, Elaine/0000-0002-0556-8389; Lindon, John/0000-0002-0916-6360	EUEuropean Commission [LSHG-512066]	Research Funding: A.D. Maher received funding from the EU FP6 MolPAGE project (LSHG-512066).	Brackett NL, 1999, HUM REPROD UPDATE, V5, P216, DOI 10.1093/humupd/5.3.216; Lindon JC, 2007, FEBS J, V274, P1140, DOI 10.1111/j.1742-4658.2007.05673.x; LYNCH MJ, 1994, J PHARMACEUT BIOMED, V12, P5, DOI 10.1016/0731-7085(94)80004-9; Nicholson JK, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100095; Niemeyer T, 2006, NUCLEOS NUCLEOT NUCL, V25, P1215, DOI 10.1080/15257770600894584; Patki P, 2008, J SPINAL CORD MED, V31, P27, DOI 10.1080/10790268.2008.11753977; Trygg J, 2002, J CHEMOMETR, V16, P283, DOI 10.1002/cem.724; World Health Organization, 1999, WHO LAB MAN EX HUM S	8	17	17	0	10	AMER ASSOC CLINICAL CHEMISTRY	WASHINGTON	2101 L STREET NW, SUITE 202, WASHINGTON, DC 20037-1526 USA	0009-9147	1530-8561		CLIN CHEM	Clin. Chem.	DEC	2008	54	12					2063	2066		10.1373/clinchem.2008.112219			4	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	377JZ	WOS:000261248800020	18832471				2022-02-06	
J	Noble, AJ; Schenk, T				Noble, Adam J.; Schenk, Thomas			Posttraumatic stress disorder in the family and friends of patients who have suffered spontaneous subarachnoid hemorrhage Clinical article	JOURNAL OF NEUROSURGERY			English	Article						caregiver; family; outcome; posttraumatic stress disorder; subarachnoid hemorrhage	TRAUMATIC BRAIN-INJURY; LIAISON NURSE SERVICE; QUALITY-OF-LIFE; PSYCHOSOCIAL OUTCOMES; COPING STYLE; PROGNOSTIC-FACTORS; DEPRESSION SCALE; HOSPITAL ANXIETY; ASAH PATIENTS; CARERS	Object. Significant others (SOS). Such as Spouses and life partners, of patients who have survived subarachnoid hemorrhage (SAH) can experience psychiatric symptoms and psychosocial disability. The cause of Such symptoms has not been established. Authors of the present Study analyzed whether posttraumatic stress disorder (PTSD) subsequent 10 it loved one's SAH is a plausible explanation for these symptoms. Methods. The authors examined a large representative sample of 86 patient/SO pairs 3.5 months postictus. All SOS were evaluated using a diagnostic PTSD Measure. and coping skills were assessed. The cognitive, physical. and emotional Status of patients was comprehensively examined. Results. Twenty-six percent of SOS met the diagnostic criteria for PTSD, which represents a 3-fold increase ill the rate expected within the general Population. To establish the cause of PTSD, a logistic regression was performed, and results of this test showed that the use of maladaptive coping strategies was the best predictor of the disorder. A patient's level of disability held no significant association with the development of PTSD in his or her SO. Conclusions. The elevated incidence of PTSD in SOS helps to explain why these persons report concerning levels of psychiatric symptomatology and psychosocial disability. Greater attention must be given to an SO's adjustment to the experience of having, it loved one stiffer an SAH. This need is all the inore pertinent ggiven that SOS often act,is informal caregivers and that PTSD Could interfere with their ability to effectively minister. Because bad coping skills seem to be the main cause of PTSD. teaching SOS better strategies might prevent the disorder and any resulting psychosocial disability. (DOI: 10.3171/JNS.2008.109.12.1027)	[Noble, Adam J.] Univ Durham, Wolfson Res Inst, Dept Psychol, Stockton On Tees TS17 6BH, England		Noble, AJ (corresponding author), Univ Durham, Wolfson Res Inst, Dept Psychol, Queens Campus, Stockton On Tees TS17 6BH, England.	a_j_noble@hotmail.com	Noble, Adam/A-2786-2013; Noble, Adam/F-2604-2013	Noble, Adam/0000-0002-8070-4352	Clarke Lister Brain Haemorrhage Foundation	We are most grateful to the patients and families who willingly participated in this research and to the Clarke Lister Brain Haemorrhage Foundation for their generous Support of this research.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Berry E, 1997, BRIT J NEUROSURG, V11, P378; Berry E, 1998, BRIT J CLIN PSYCHOL, V37, P365, DOI 10.1111/j.2044-8260.1998.tb01392.x; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bryant RA, 2000, BRAIN INJURY, V14, P175, DOI 10.1080/026990500120826; BRYANT RA, 1995, BEHAV RES THER, V33, P631, DOI 10.1016/0005-7967(94)00093-Y; Buchanan KM, 2000, NEUROSURGERY, V46, P831, DOI 10.1097/00006123-200004000-00012; Burgess P, 1996, BEHAV ASSESSMENT DYS; Cadell S, 2003, AIDS CARE, V15, P639, DOI 10.1080/09540120310001595122; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P429, DOI 10.1348/014466501163904; de Vries APJ, 1999, PEDIATRICS, V104, P1293, DOI 10.1542/peds.104.6.1293; DRAKE CG, 1988, J NEUROSURG, V68, P985; Eid J, 2003, PERS INDIV DIFFER, V35, P771, DOI 10.1016/S0191-8869(02)00282-9; Foa E. B., 1995, POSTTRAUMATIC STRESS; FOA EB, 1989, BEHAV THER, V20, P155, DOI 10.1016/S0005-7894(89)80067-X; Fuemmeler BF, 2005, CHILD HEALTH CARE, V34, P289, DOI 10.1207/s15326888chc3404_4; Fuemmeler BF, 2001, CHILD HEALTH CARE, V30, P169, DOI 10.1207/S15326888CHC3003_1; Gil S, 2005, ANXIETY STRESS COPIN, V18, P351, DOI 10.1080/10615800500392732; Hellawell DJ, 2001, DISABIL REHABIL, V23, P300, DOI 10.1080/769979114; Hellawell DJ, 1999, CLIN REHABIL, V13, P333, DOI 10.1191/026921599669500092; Hop JW, 1998, STROKE, V29, P798, DOI 10.1161/01.STR.29.4.798; Hop JW, 2001, J NEUROSURG, V95, P957, DOI 10.3171/jns.2001.95.6.0957; Hutter B, 2000, NEUROPSYCHOLOGICAL S; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; Low JTS, 1999, SOC SCI MED, V49, P711, DOI 10.1016/S0277-9536(99)00194-X; MCKENNA P, 1989, BRIT MED J, V299, P485, DOI 10.1136/bmj.299.6697.485; Mezue W, 2004, BRIT J NEUROSURG, V18, P135, DOI 10.1080/02688690410001680984; ODER W, 1990, SCAND J REHABIL MED, V22, P85; ODER W, 1991, J NEUROSURG, V74, P601, DOI 10.3171/jns.1991.74.4.0601; Ogden JA, 1997, NEUROSURGERY, V41, P25, DOI 10.1097/00006123-199707000-00008; OYEBODE F, 1986, BRIT J HOSP MED, V36, P104; OYEBODE F, 1986, BR J HOSP MED, V36, P106; Oyebode J, 2003, ADV PSYCHIAT TREATME, V9, P45, DOI [10.1192/apt.9.1.45, DOI 10.1192/APT.9.1.45]; Parker G., 1990, DUE CARE ATTENTION R; PONSTORD J, 1995, TRAUMATIC BRAIN INJU; Pritchard C, 2004, BRIT J NEUROSURG, V18, P347, DOI 10.1080/02688690400004993; Pritchard C, 2004, SURG NEUROL, V62, P7, DOI 10.1016/j.surneu.2004.01.018; Pritchard C, 2004, SURG NEUROL, V62, P17, DOI 10.1016/j.surneu.2004.01.019; Pritchard C, 2001, BRIT J NEUROSURG, V15, P456, DOI 10.1080/02688690120097679; ROBERTS AR, 1994, CRISIS INTERV TIME-L, V1, P1; *STAT U NEW YORK B, 1993, GUID US UN DAT SET M; Toomela A, 2004, J REHABIL MED, V36, P63, DOI 10.1080/16501970310017414; Turton P, 2006, BRIT J PSYCHIAT, V188, P165, DOI 10.1192/bjp.188.2.165; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; Wermer MJH, 2007, NEUROSURGERY, V60, P91, DOI 10.1227/01.NEU.0000249215.19591.86; Wilson BA, 1999, RIVERMEAD BEHAV MEMO; Younger P, 2003, MATER WORLD, V11, P25; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	51	17	19	0	13	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085			J NEUROSURG	J. Neurosurg.	DEC	2008	109	6					1027	1033		10.3171/JNS.2008.109.12.1027			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	376SY	WOS:000261204500011	19035715				2022-02-06	
J	Kapoor, T; Altenhof, W; Howard, A; Rasico, J; Zhu, FC				Kapoor, Tanya; Altenhof, William; Howard, Andrew; Rasico, Jim; Zhu, Fuchun			Methods to mitigate injury to toddlers in near-side impact crashes	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Child safety; Rigid ISOFIX; Flexible LATCH; Numerical modeling; Head and neck injuries; Sled testing	MOTOR-VEHICLE CRASHES; CHILDREN	This research focuses on the injury potential of children seated in forward-facing child safety seats during side impact crashes in a near-side seated position. Side impact dynamic sled tests were conducted by NHTSA at Transportation Research Center Inc. (TRC) using a Hybrid III 3-year-old child dummy seated in a convertible forward/rearward child safety seat. The seat was equipped with a LATCH and a top tether and the dummy was positioned in forward-facing/near-side configuration. The test was completed using an acceleration pulse with a closing speed of 24.1 km/h, in the presence of a rigid wall and absence of a vehicle body. A fully deformable finite element model of a child restraint seat, for side impact crash investigations, has been developed which has also been previously validated for frontal and far side impacts. A numerical model utilizing a Hybrid III 3-year-old dummy, employing a similar set-up as the experimental sled test was generated and simulated using LS DYNA. The numerical model was validated by comparing the head and the chest accelerations, resultant upper and lower neck forces and moments from the experimental and numerical tests. The simulation results were observed to be in good agreement to the experimental observations. A numerical model of the near-side laboratory tests, utilizing a Q3s; child dummy, was also created for parametric studies regarding different ISOFIX configurations. Further, numerical simulations were completed for both the dummy models with rectangular and cross-shaped sections of rigid ISOFIX systems. In addition, studies were conducted to confine lateral movement of the dummy's head by adding energy absorbing foam on the side wings in the vicinity of the contact region of the CRS. It was observed that the use of rigid ISOFIX system reduced the lateral displacement of the CRS and different injury parameters. Addition of energy absorbing foam blocks was effective in further reducing the lateral displacement of the dummy's head. The lateral displacement of the head was reduced by 68 mm by using cross-shaped section ISOFIX with energy absorbing foam near the vicinity of the head of the Hybrid III 3-year-old dummy compared to the flexible LATCH configuration without foam. For the Q3s dummy, the lateral displacement of the head was reduced by 48 mm by utilizing a cross-shaped section rigid ISOFIX system with the addition of energy absorbing foam compared to the flexible LATCH configuration. (C) 2008 Elsevier Ltd. All rights reserved.	[Kapoor, Tanya; Altenhof, William] Univ Windsor, Dept Mech Automot & Mat Engn, Windsor, ON N9B 3P4, Canada; [Howard, Andrew] Hosp Sick Children, Div Orthoped Surg, Toronto, ON M5G 1X8, Canada		Altenhof, W (corresponding author), Univ Windsor, Dept Mech Automot & Mat Engn, 410 Sunset Ave, Windsor, ON N9B 3P4, Canada.	altenh1@uwindsor.ca	Howard, Andrew/C-7163-2009	Howard, Andrew/0000-0001-7226-6471			American society for testing and materials [ASTM], 2004, STAND TEST METH TENS; Arbogast KB, 2004, ACCIDENT ANAL PREV, V36, P585, DOI 10.1016/S0001-4575(03)00065-4; Bandak, 1999, DEV IMPROVED INJURY; BENDJELLAL F, 2006, P 4 INT C PROT CHILD; CARLSON M, 2007, Q3S 3 YEARS OLD SIDE; CHARLTON J, 2003, PRELIMINARY EVALUATI, P1; *CLEPA, 2004, GRSP3519 CLEPA, P1; Hallquist JO., 1998, LS DYNA THEORETICAL; Howard A, 2004, J TRAUMA, V56, P1276, DOI 10.1097/01.TA.0000078883.74947.EB; KLINICH K, 2003, P 19 ESV C; *LS DYNA, 2007, LS DYNA MOD Q3S DUMM; *LS DYNA, 2000, LS DYNA MOD HYBR 3 3; *NAT HIGHW TRAFF S, 2006, 4585 NAT HIGHW TRAFF; National Board of Health and Welfare, 2005, DESCR REG NURS COMP; Newgard CD, 2005, ACCIDENT ANAL PREV, V37, P668, DOI 10.1016/j.aap.2005.03.008; Society of Automotive Engineers (SAE), 2003, SAE J211 1 INSTR I 1; *STAT CAN, 2003, MAJ CAUS DEATH; Turchi R, 2004, INT J CRASHWORTHINES, V9, P419, DOI 10.1533/ijcr.2004.0300; WANG Q, 2006, P 9 INT LS DYNA US C; WANG Q, 2006, SAE 2006 C DETR US A; Webber, 2000, UMTRI RES REV, V31, P1; 2003, FED REG, V68, P1; 2003, READ REV BRITAX WIZA; 2002, FED REG, V67, P1	24	17	21	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	NOV	2008	40	6					1880	1892		10.1016/j.aap.2008.07.008			13	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	378UN	WOS:000261349800012	19068290				2022-02-06	
J	Lange, RT; Iverson, GL; Franzen, MD				Lange, Rael T.; Iverson, Grant L.; Franzen, Michael D.			Effects of day-of-injury alcohol intoxication on neuropsychological outcome in the acute recovery period following traumatic brain injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Ethanol; Head injury; Cognition; Neurocognitive; Acute outcome; Risk factors	ACUTE ETHANOL INTOXICATION; GLASGOW COMA SCALE; HEAD-INJURY; SUBSTANCE-ABUSE; INDUCED NEUROTOXICITY; WHITE-MATTER; ASSOCIATION; DISRUPTION; DEFICITS; LEVEL	Some researchers have found that day-of-injury alcohol intoxication is associated with worse outcome following traumatic brain injury (TBI). The purpose of this study is to examine the effects of day-of-injury intoxication on the acute neuropsychological outcome froth TBI. Participants were 36 patients with TBI (18 sober, 18 intoxicated) matched on injury severity characteristics and demographic variables. A larger group of 146 patients (112 sober, 36 intoxicated) with TBI was also selected for analyses; not matched on injury severity or demographic variables. Patients had no history of pre-injury alcoholism and were assessed within 10 days post-injury on 13 cognitive measures. Unexpectedly, patients who were sober at the time of injury performed lower on many of the cognitive measures compared to those who were intoxicated. In contrast to the research literature, these results suggest that individuals who were intoxicated at the time of injury performed similarly, and in some cases, better than those who were sober at the time of injury. Crown Copyright (C) 2008 Published by Elsevier Ltd on behalf of National Academy of Neuropsychology. All rights reserved.	[Lange, Rael T.; Iverson, Grant L.] BC Mental Hlth & Addict Serv, Vancouver, BC V5Z 4CZ, Canada; [Lange, Rael T.; Iverson, Grant L.] Univ British Columbia, Vancouver, BC V5Z 4CZ, Canada		Lange, RT (corresponding author), BC Mental Hlth & Addict Serv, Suite 201,601 W Broadway, Vancouver, BC V5Z 4CZ, Canada.	rlange@bcmhs.bc.ca		Iverson, Grant/0000-0001-7348-9570			Albrecht-Anoschenko J, 2005, ZBL NEUROCHIR, V66, P59, DOI 10.1055/s-2005-836487; Alexander S, 2004, J NEUROTRAUM, V21, P575, DOI 10.1089/089771504774129900; Altura BM, 1999, ALCOHOL, V19, P119, DOI 10.1016/S0741-8329(99)00025-7; ALTURA BM, 1995, ALCOHOL, V12, P433, DOI 10.1016/0741-8329(95)00026-N; Barker LH, 1999, J INT NEUROPSYCH SOC, V5, P593, DOI 10.1017/S1355617799577023; Benton AL, 1994, MULTILINGUAL APHASIA; Bigler ED, 1996, BRAIN INJURY, V10, P197, DOI 10.1080/026990596124511; Biros MH, 1999, ACAD EMERG MED, V6, P1088, DOI 10.1111/j.1553-2712.1999.tb00109.x; Blondell RD, 2002, J STUD ALCOHOL, V63, P380, DOI 10.15288/jsa.2002.63.380; Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; BOMBARDIER CH, 1995, WESTERN J MED, V162, P150; BRISMAR B, 1983, ACTA CHIR SCAND, V149, P11; Brooks N, 1989, Brain Inj, V3, P235, DOI 10.3109/02699058909029638; Cebere A, 2003, NEUROCHEM RES, V28, P1193, DOI 10.1023/A:1024228412198; CHANDLER LJ, 1993, ALCOHOL CLIN EXP RES, V17, P54, DOI 10.1111/j.1530-0277.1993.tb00726.x; ChathamShowalter PE, 1996, PSYCHOSOMATICS, V37, P285, DOI 10.1016/S0033-3182(96)71567-0; Christensen M A, 2001, J Neurosci Nurs, V33, P184; Cohen J., 2013, STAT POWER ANAL BEHA; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Cunningham RM, 2002, ALCOHOL ALCOHOLISM, V37, P236, DOI 10.1093/alcalc/37.3.236; DANYSZ W, 1992, ALCOHOL CLIN EXP RES, V16, P499, DOI 10.1111/j.1530-0277.1992.tb01407.x; DIKMEN SS, 1995, ANN EMERG MED, V26, P167, DOI 10.1016/S0196-0644(95)70147-8; EDNA TH, 1982, ACTA CHIR SCAND, V148, P209; GALBRAITH S, 1976, BRIT J SURG, V63, P128, DOI 10.1002/bjs.1800630210; GURNEY JG, 1992, J TRAUMA, V33, P709, DOI 10.1097/00005373-199211000-00020; Gururaj G, 2004, J Indian Med Assoc, V102, P157; Hall D, 2005, SCOT MED J, V50, P24, DOI 10.1177/003693300505000110; Heaton R., 2000, WISCONSIN CARD SORTI; Heaton R. K., 2004, REVISED COMPREHENSIV; Is M, 2005, NEUROSURG QUART, V15, P60, DOI 10.1097/01.wnq.0000152407.39871.c7; JAGGER J, 1984, NEUROSURGERY, V15, P303, DOI 10.1227/00006123-198409000-00002; Janis LS, 1998, J NEUROTRAUM, V15, P105, DOI 10.1089/neu.1998.15.105; KAPLAN C P, 1992, Brain Injury, V6, P337, DOI 10.3109/02699059209034948; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; Kolakowsky-Hayner SA, 1999, BRAIN INJURY, V13, P571; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; Kreutzer JS, 1996, J HEAD TRAUMA REHAB, V11, P58, DOI 10.1097/00001199-199610000-00006; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; Lange RT, 2007, ARCH CLIN NEUROPSYCH, V22, P900; Lange RT, 2007, NEUROPSYCHOLOGY, V21, P590, DOI 10.1037/0894-4105.21.5.590; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Mautes AEM, 2001, ACTA NEUROCHIR, V143, P51, DOI 10.1007/s007010170138; NATH FP, 1986, INJURY, V17, P150, DOI 10.1016/0020-1383(86)90320-7; Parsons OA, 1998, ALCOHOL CLIN EXP RES, V22, P954, DOI 10.1097/00000374-199806000-00029; Pfefferbaum A, 2000, ALCOHOL CLIN EXP RES, V24, P1214, DOI 10.1111/j.1530-0277.2000.tb02086.x; Pfefferbaum A, 2002, NEUROIMAGE, V15, P708, DOI 10.1006/nimg.2001.1018; PORIES SE, 1992, J TRAUMA, V32, P60, DOI 10.1097/00005373-199201000-00013; Reitan RM, 1992, TRAIL MAKING TEST MA; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1983, REHABILITATION HEAD, P9; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; Shih HC, 2003, AM J EMERG MED, V21, P91, DOI 10.1053/ajem.2003.50025; Smith-Seemiller L, 1996, Appl Neuropsychol, V3, P41, DOI 10.1207/s15324826an0301_6; SOLOMON DA, 1992, NEUROPSYCHOL REV, V3, P249, DOI 10.1007/BF01109050; Sperry JL, 2006, J TRAUMA, V61, P1305, DOI 10.1097/01.ta.0000240113.13552.96; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Stuke L, 2007, ANN SURG, V245, P651, DOI 10.1097/01.sla.0000250413.41265.d3; TAKADERA T, 1990, BRAIN RES, V537, P109, DOI 10.1016/0006-8993(90)90346-D; Tate PS, 1999, BRAIN INJURY, V13, P767; Tien HCN, 2006, ARCH SURG-CHICAGO, V141, P1185, DOI 10.1001/archsurg.141.12.1185; TOBIS JS, 1982, SCAND J REHABIL MED, V14, P83; Tureci E, 2004, NEUROL RES, V26, P108, DOI 10.1179/016164104225013699; Vickery CD, 2008, ARCH PHYS MED REHAB, V89, P48, DOI 10.1016/j.apmr.2007.07.047; WARD RE, 1982, AM J SURG, V144, P153, DOI 10.1016/0002-9610(82)90617-1; Wechsler D, 1987, MEMORY SCALE REVISED; Wilde EA, 2004, J NEUROTRAUM, V21, P137, DOI 10.1089/089771504322778604; WOOLF PD, 1990, ALCOHOL CLIN EXP RES, V14, P205, DOI 10.1111/j.1530-0277.1990.tb00473.x; ZINK BJ, 1995, J NEUROSURG, V82, P822, DOI 10.3171/jns.1995.82.5.0822	69	17	17	0	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	NOV-DEC	2008	23	7-8					809	822		10.1016/j.acn.2008.07.004			14	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	384QI	WOS:000261758900007	18768292	Bronze			2022-02-06	
J	Citron, BA; Arnold, PM; Haynes, NG; Ameenuddin, S; Farooque, M; SantaCruz, K; Festoff, BW				Citron, Bruce A.; Arnold, Paul M.; Haynes, Neal G.; Ameenuddin, Syed; Farooque, Mohammed; SantaCruz, Karen; Festoff, Barry W.			Neuroprotective effects of caspase-3 inhibition on functional recovery and tissue sparing after acute spinal cord injury	SPINE			English	Article						apoptosis; executioner enzyme; trophic; behavior; neuropathology; RNA; RT-PCR; gene microarrays	INTERLEUKIN-1-BETA CONVERTING-ENZYME; RANDOMIZED CONTROLLED-TRIAL; ISCHEMIC BRAIN-INJURY; NEURONAL CELL-DEATH; CEREBRAL-ISCHEMIA; RAT MODEL; IN-VIVO; NEUROLOGICAL DYSFUNCTION; INFLAMMATORY CYTOKINE; TIRILAZAD MESYLATE	Study Design. We used gene microarrays and found that caspase-related death genes were upregulated. We tested caspase inhibition and evaluated its effect on the spinal cord after traumatic injury. Objective. The logical extension of previous studies was to determine whether downstream CASP genes might also be involved and whether inhibition might prevent injury-induced cell death. Summary of Background Data. Apoptotic cell death occurs in all endogenous cellular compartments of the spinal cord, peaking at 3 days after injury in neurons, astrocytes, and microglia. The downstream effector caspase-3 cleaves several important cellular sites after being activated by upstream initiator caspases. Along with others, we have previously identified caspase signature cleavage of PARP, a-fodrin, and DFF45/ICAD in the injured rat spinal cord. We also showed rapid upregulation of caspase-3 gene expression along with localization of active caspase-3 in neurons and activated microglia after SCI. Others have reported that a more general active-site mimetic peptide ketone, benzylocarbonyl-Val-Ala-Asp-fluromethylketone (zVAD-fmk) was neuroprotective after rat spinal cord injury (SCI). Methods. In this study, we administered the caspase-3 subfamily tetrapeptide cell permeable inhibitor Z-Asp(O-Me)-Glu(O-Me)-Val-Asp(O-Me) fluoromethyl ketone (DEVDfmk) intraperitoneally 1 hour after laminectomy and moderate (25 g cm force) SCI in rats. Results. We used the open field locomotor rating (LRS) over a 14-day course and found statistically significant improvement in DEVD-fmk-treated rats, LRS, 9.8 +/- 0.93 SEM, compared with vehicle, 6.6 +/- 0.4 (P < 0.05). Histologic analysis of percent spinal cord tissue volume spared was 50% greater for DEVD-fmk versus control (P < 0.5). Conclusion. These results indicate neuroprotection at both the cellular level and with substantial functional recovery, suggesting caspase-3 inhibition may be a viable therapy in the early hours after experimental SCI.	[Citron, Bruce A.; Arnold, Paul M.; Haynes, Neal G.; Ameenuddin, Syed; Farooque, Mohammed; Festoff, Barry W.] Vet Affairs Med Ctr, Neurobiol Res Lab, Kansas City, MO USA; [Citron, Bruce A.; Farooque, Mohammed; Festoff, Barry W.] Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS 66103 USA; [Arnold, Paul M.; Haynes, Neal G.] Univ Kansas, Med Ctr, Dept Neurosurg, Kansas City, KS 66103 USA; [SantaCruz, Karen] Univ Kansas, Med Ctr, Dept Pathol, Kansas City, KS 66103 USA; [Festoff, Barry W.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA		Festoff, BW (corresponding author), VA Med Ctr, Neurobiol Res Lab 151, 4801 Linwood Blvd, Kansas City, MO 64128 USA.	bfestoff@kumc.edu					ARENDS MJ, 1991, INT REV EXP PATHOL, V32, P223; Arnold PM, 2000, J NEUROCHEM, V74, pS73; Barut S, 2005, SURG NEUROL, V64, P213, DOI 10.1016/j.surneu.2005.03.042; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Beattie MS, 1997, EXP NEUROL, V148, P453, DOI 10.1006/exnr.1997.6695; Beattie MS, 2000, J NEUROTRAUM, V17, P915, DOI 10.1089/neu.2000.17.915; Bethea JR, 1998, J NEUROSCI, V18, P3251; Bossenmeyer-Pourie C, 1999, MOL BRAIN RES, V71, P225, DOI 10.1016/S0169-328X(99)00190-4; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; Bracken MB, 1998, J NEUROSURG, V89, P699, DOI 10.3171/jns.1998.89.5.0699; BRACKEN MB, 1992, J NEUROSURG, V76, P23, DOI 10.3171/jns.1992.76.1.0023; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; Bredesen DE, 2000, J NEUROTRAUM, V17, P801, DOI 10.1089/neu.2000.17.801; Chan YM, 2001, NEUROREPORT, V12, P541, DOI 10.1097/00001756-200103050-00022; Chen J, 1998, J NEUROSCI, V18, P4914; Cheng Y, 1998, J CLIN INVEST, V101, P1992, DOI 10.1172/JCI2169; Citron BA, 2000, EXP NEUROL, V166, P213, DOI 10.1006/exnr.2000.7523; Citron BA, 2000, J NEUROTRAUM, V17, P1191, DOI 10.1089/neu.2000.17.1191; Colak A, 2005, J NEUROSURG-SPINE, V2, P327, DOI 10.3171/spi.2005.2.3.0327; Coleman WP, 2000, J SPINAL DISORD, V13, P185, DOI 10.1097/00002517-200006000-00001; CONSTANTINI S, 1994, J NEUROSURG, V80, P97, DOI 10.3171/jns.1994.80.1.0097; Conti AC, 1998, J NEUROSCI, V18, P5663; De Biase A, 2005, PHYSIOL GENOMICS, V22, P368, DOI 10.1152/physiolgenomics.00081.2005; DEOLMOS JS, 1994, NEUROTOXICOL TERATOL, V16, P545, DOI 10.1016/0892-0362(94)90033-7; DUCKER TB, 1994, SPINE, V19, P2281, DOI 10.1097/00007632-199410150-00006; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; Emery E, 1998, J NEUROSURG, V89, P911, DOI 10.3171/jns.1998.89.6.0911; Festoff BW, 2004, J NEUROTRAUM, V21, P907, DOI 10.1089/0897715041526168; Friedlander RM, 1997, J EXP MED, V185, P933, DOI 10.1084/jem.185.5.933; GEHRMANN J, 1995, J NEUROPATH EXP NEUR, V54, P680, DOI 10.1097/00005072-199509000-00010; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; HALL ED, 1996, NEUROTRAUMA, P1405; HAMBURGER V, 1975, J COMP NEUROL, V160, P535, DOI 10.1002/cne.901600408; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; HAMERS FPT, 1999, J NEUROTRAUM, V16, P1010; HAMERS FPT, 1998, J NEUROTRAUM, V15, P873; Hara H, 1999, Nihon Yakurigaku Zasshi, V113, P97; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Hurlbert RJ, 2000, J NEUROSURG, V93, P1, DOI 10.3171/spi.2000.93.1.0001; Keane RW, 2001, J NEUROPATH EXP NEUR, V60, P422, DOI 10.1093/jnen/60.5.422; Klusman I, 1997, BRAIN RES, V762, P173, DOI 10.1016/S0006-8993(97)00381-8; Knoblach SM, 2005, J NEUROSCI RES, V80, P369, DOI 10.1002/jnr.20465; Krupinski J, 2000, NEUROBIOL DIS, V7, P332, DOI 10.1006/nbdi.2000.0310; Lankhorst AJ, 1999, J NEUROTRAUM, V16, P323, DOI 10.1089/neu.1999.16.323; Lee YL, 2000, NEUROCHEM INT, V36, P417, DOI 10.1016/S0197-0186(99)00133-3; Lemke M, 1990, J NEUROTRAUM, V7, P41, DOI 10.1089/neu.1990.7.41; Li GL, 1996, J NEUROPATH EXP NEUR, V55, P280, DOI 10.1097/00005072-199603000-00003; Li H, 2000, STROKE, V31, P176, DOI 10.1161/01.STR.31.1.176; Liu XZ, 1997, J NEUROSCI, V17, P5395; Namura S, 1998, J NEUROSCI, V18, P3659; Nath R, 2001, CELL MOL BIOL LETT, V6, P173; Nemecek S, 1978, Adv Neurol, V20, P395; NOBLE LJ, 1985, EXP NEUROL, V88, P135, DOI 10.1016/0014-4886(85)90119-0; O'Neill R R, 1989, Appl Theor Electrophor, V1, P163; Ozawa H, 2002, EXP NEUROL, V177, P306, DOI 10.1006/exnr.2002.7998; Pointillart V, 2000, SPINAL CORD, V38, P71, DOI 10.1038/sj.sc.3100962; Pong K, 2001, EXP NEUROL, V171, P84, DOI 10.1006/exnr.2001.7747; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Puka-Sundvall M, 2000, DEV BRAIN RES, V125, P43, DOI 10.1016/S0165-3806(00)00111-5; Rabchevsky AG, 1999, J NEUROTRAUM, V16, P817, DOI 10.1089/neu.1999.16.817; Rabchevsky AG, 2000, EXP NEUROL, V164, P280, DOI 10.1006/exnr.2000.7399; Riss TL, 2001, UROLOGY, V57, P141, DOI 10.1016/S0090-4295(00)00960-2; Rodriguez I, 1996, J EXP MED, V184, P2067, DOI 10.1084/jem.184.5.2067; Saez-Valero J, 2000, NEUROSCI LETT, V293, P207, DOI 10.1016/S0304-3940(00)01532-9; Short DJ, 2000, SPINAL CORD, V38, P273, DOI 10.1038/sj.sc.3100986; Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.0.CO;2-Y; Simakajornboon N, 2001, BRAIN RES, V895, P111, DOI 10.1016/S0006-8993(01)02054-6; Siman R, 1999, NEUROSCIENCE, V92, P1425, DOI 10.1016/S0306-4522(99)00034-2; Smirnova IV, 1998, J NEUROBIOL, V36, P64, DOI 10.1002/(SICI)1097-4695(199807)36:1<64::AID-NEU6>3.3.CO;2-4; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Underwood DC, 2000, J PHARMACOL EXP THER, V293, P281; Verdaguer E, 2002, BRIT J PHARMACOL, V135, P1297, DOI 10.1038/sj.bjp.0704581; Viviani B, 2000, GLIA, V32, P84, DOI 10.1002/1098-1136(200010)32:1<84::AID-GLIA80>3.0.CO;2-Q; Wiessner C, 2000, CELL MOL BIOL, V46, P53; Wu KLH, 2003, NEUROBIOL DIS, V14, P19, DOI 10.1016/S0969-9961(03)00078-0; Wu M, 2001, Zhonghua Fu Chan Ke Za Zhi, V36, P79; Yaginuma H, 2001, MOL CELL NEUROSCI, V18, P168, DOI 10.1006/mcne.2001.1009; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yong C, 1998, J NEUROTRAUM, V15, P459, DOI 10.1089/neu.1998.15.459; Yoshizawa K, 2002, GRAEF ARCH CLIN EXP, V240, P214, DOI 10.1007/s00417-002-0427-5	83	17	19	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-2436	1528-1159		SPINE	SPINE	OCT 1	2008	33	21					2269	2277		10.1097/BRS.0b013e3181831f7e			9	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	354KF	WOS:000259637800003	18827691				2022-02-06	
J	Hsiao, KY; Hsiao, CT; Weng, HH; Chen, KH; Lin, LJ; Huang, YM				Hsiao, K-Y; Hsiao, C-T; Weng, H-H; Chen, K-H; Lin, L-J; Huang, Y-M			Factors predicting mortality in victims of blunt trauma brain injury in emergency department settings	EMERGENCY MEDICINE JOURNAL			English	Article							GLASGOW COMA SCALE; HEAD-INJURY; HYPOTENSION; TOMOGRAPHY; MODERATE; HYPOXIA; SCORE; RISK	Objective: The aim of the s-tudy was to identify risk factors for mortality in patients brought to the emergency department (ED) after blunt traumatic brain injury (TBI). Methods: The medical records of such patients who visited the ED from June 2004 to May 2005 were retrospectively reviewed. Data (age, gender, initial Glasgow coma scale (GCS) scores, initial vital signs, brain computed tomography scan findings and cause of trauma) were collected from the records of 204 TBI patients, who were treated at the ED and needed intensive care. Among these patients, 48 died in the intensive care unit (ICU) of the hospital. Logistic regression was used to assess factors affecting mortality after trauma. Results: Age (odds ratio (OR) 1.04; 95% CI 1.01 to similar to 1.07), GCS score less than 9 (OR 19.29; 95% CI 5.04 to similar to 73.82) and skull bone fracture (OR 10.44; 95% CI 3.59 to similar to 30.38) were identified as possible risk factors of mortality in TBI patients. Conclusion: These predictors appear to be clinically relevant and may help improve ED triage of TBI patients in need of ICU care.	[Hsiao, K-Y; Hsiao, C-T; Lin, L-J] Chang Gung Mem Hosp, Dept Emergency Med, Chiayi, Taiwan; [Weng, H-H] Chang Gung Mem Hosp, Dept Diagnost Radiol, Chiayi, Taiwan; [Chen, K-H] Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Chiayi, Taiwan; [Hsiao, K-Y; Hsiao, C-T; Weng, H-H; Chen, K-H; Lin, L-J; Huang, Y-M] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Huang, Y-M] Chang Gung Mem Hosp, Dept Nursing, Chiayi, Taiwan; [Weng, H-H] Kaohsiung Med Univ, Grad Inst Occupat Safety & Hlth, Coll Hlth Sci, Kaohsiung, Taiwan		Huang, YM (corresponding author), Chiayi Chang Gung Mem Hosp, Dept Emergency Med, 6 W Sect,Chia Pu Rd, Puzih City 613, Chiayi County, Taiwan.	richard.smith@msa.hinet.net	Weng, Hsu-Huei/N-8329-2014	Weng, Hsu-Huei/0000-0002-2020-8912			Celli P, 1997, Minerva Chir, V52, P1467; Cho DY, 1997, INTENS CARE MED, V23, P77, DOI 10.1007/s001340050294; Davis DP, 2006, J TRAUMA, V60, P985, DOI 10.1097/01.ta.0000205860.96209.1c; Davis DP, 2005, ANN EMERG MED, V46, P115, DOI 10.1016/j.annemergmed.2005.01.024; Harris C, 2003, J AM COLL SURGEONS, V197, P711, DOI 10.1016/S1072-7515(03)00729-4; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Miller KJ, 2005, J NEUROSURG, V103, P239, DOI 10.3171/jns.2005.103.2.0239; Newgard CD, 2005, EMERG MED J, V22, P855, DOI 10.1136/emj.2004.020206; Ong LC, 1996, PEDIATR NEUROSURG, V24, P285, DOI 10.1159/000121057; Perel P, 2007, J EVAL CLIN PRACT, V13, P464, DOI 10.1111/j.1365-2753.2006.00713.x; SERVADEI F, 1988, SURG NEUROL, V30, P364, DOI 10.1016/0090-3019(88)90199-1; Shafi S, 2005, J TRAUMA, V59, P830, DOI 10.1097/01.ta.0000188147.36232.c0; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; TINTINALLI JE, 2003, EMERGENCY MED COMPRE, P1557	14	17	17	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	OCT	2008	25	10					670	673		10.1136/emj.2007.053405			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	358EF	WOS:000259899000013	18843067				2022-02-06	
J	Ellis, J; Del Castillot, E; Bayon, MM; Grimm, R; Clark, JF; Pyne-Geithman, G; Wilbur, S; Caruso, JA				Ellis, Jenny; Del Castillot, Estela; Montes Bayon, Maria; Grimm, Rudolf; Clark, Joseph F.; Pyne-Geithman, Gail; Wilbur, Steve; Caruso, Joseph A.			A preliminary study of metalloproteins in CSF by CapLC-ICPMS and nanoLC-CHIP/ITMS	JOURNAL OF PROTEOME RESEARCH			English	Article						metals; metalloproteins; ICPMS; nanoLC-CHIP/ITMS; stroke; vasospasm; cerebrospinal fluid; CSF	INTEGRATED MICROFLUIDIC DEVICE; PLASMA-MASS SPECTROMETRY; CEREBROSPINAL-FLUID; HUMAN SERUM; VASCULAR REACTIVITY; MAGNESIUM; LEAD; IRON; CHROMATOGRAPHY; MANGANESE	Cerebrospinal fluid (CSF) has frequently been studied to explore the total metal concentrations in patients with neurodegenerative diseases. Some examples of neurologic diseases include but are not limited to intracerebral hemorrhage, intraventricular hemorrhage, traumatic brain injury, subarachnoid hemorrhage and hydrocephalus. In this study, however, a comprehensive approach was begun using metallomics methods, First, two molecular weight cutoff filters were used to separate CSF constituents by molecular weight. The remaining CSF was then separated with capillary liquid chromatography/normal bore liquid chromatography and analyzed with inductively coupled mass spectrometry (ICPMS). With this ICPMS screening, a possible iron associated protein was suggested by nanoliquid chromatography-CHIP/ion trap mass spectrometry (nanoLC-CHIP/ITMS) identification in conjunction with a Spectrum Mill database search. In this preliminary study, three different types of pooled CSF were partially characterized by their metal (Pb, Mg, Zn, Fe and Cu) containing species with suggestions for fuller studies. Chemical 'differences' in the CSF and metal constituents suggests some utility in this analysis for understanding some of the complications observed following subarachnoid hemorrhage.	[Ellis, Jenny; Del Castillot, Estela; Caruso, Joseph A.] Univ Cincinnati, Dept Chem, Cincinnati, OH 45221 USA; [Ellis, Jenny; Grimm, Rudolf; Clark, Joseph F.; Pyne-Geithman, Gail; Wilbur, Steve; Caruso, Joseph A.] Univ Cincinnati, Agilent Technol Met Ctr Amer, Cincinnati, OH 45221 USA; [Grimm, Rudolf; Wilbur, Steve] Agilent Technol, Life Sci Sol Unit, Santa Clara, CA 95052 USA; [Clark, Joseph F.; Pyne-Geithman, Gail] Univ Cincinnati, Dept Neurol, Cincinnati, OH 45221 USA; [Del Castillot, Estela; Montes Bayon, Maria] Univ Oviedo, Fac Chem, Dept Phys & Analyt Chem, E-33006 Oviedo, Spain		Caruso, JA (corresponding author), Univ Cincinnati, Dept Chem, Cincinnati, OH 45221 USA.	joseph.caruso@uc.edu	Del Castillo Busto, M Estela/A-5868-2012; Del Castillo Busto, Maria Estela/AAF-8892-2020	Del Castillo Busto, Maria Estela/0000-0001-6595-5236	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS050569] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS050569-04] Funding Source: Medline		ALCOCK NW, 1969, CLIN SCI, V22, P185; BENEDICT CR, 1978, STROKE, V9, P237, DOI 10.1161/01.STR.9.3.237; Bergdahl IA, 1996, J ANAL ATOM SPECTROM, V11, P735, DOI 10.1039/ja9961100735; Bocca B, 2004, SPECTROCHIM ACTA B, V59, P559, DOI 10.1016/j.sab.2004.02.007; Busto MEDC, 2008, ANALYST, V133, P379, DOI 10.1039/b715311b; CARRIER O, 1976, BLOOD VESSELS, V13, P321; Durken M, 2000, FREE RADICAL BIO MED, V28, P887, DOI 10.1016/S0891-5849(00)00174-X; ELYAZIGI A, 1988, CLIN CHEM, V34, P1084; Fernandes KG, 2005, J ANAL ATOM SPECTROM, V20, P210, DOI 10.1039/b414185g; Fortier MH, 2005, ANAL CHEM, V77, P1631, DOI 10.1021/ac048506d; Fujioka M, 2000, STROKE, V31, P797; Fujiwara Y, 1999, TOXICOLOGY, V133, P147, DOI 10.1016/S0300-483X(99)00025-6; Godlewska-Zylkiewicz B, 1998, ANAL CHIM ACTA, V358, P185, DOI 10.1016/S0003-2670(97)00612-0; Gomez-Ariza JL, 2004, ANAL CHIM ACTA, V524, P15, DOI 10.1016/j.aca.2004.01.061; Hall GS, 1999, ANAL COMMUN, V36, P93, DOI 10.1039/a900478e; Hardouin J, 2007, J SEP SCI, V30, P1482, DOI 10.1002/jssc.200600444; Hardouin J, 2006, RAPID COMMUN MASS SP, V20, P3236, DOI 10.1002/rcm.2725; HORN E, 1906, MED REV, V32, P264; Idama TO, 1998, BRIT J OBSTET GYNAEC, V105, P260, DOI 10.1111/j.1471-0528.1998.tb10084.x; Inagaki K, 2000, ANALYST, V125, P197, DOI 10.1039/a907088e; IOSE I, 2006, NEW ENGL J MED, V354, P387; Jakubowski N, 2004, J ANAL ATOM SPECTROM, V19, P1, DOI 10.1039/b313299b; Kaltashov IA, 2006, ANAL BIOANAL CHEM, V386, P472, DOI 10.1007/s00216-006-0636-6; KASSELL NF, 1985, STROKE, V16, P562, DOI 10.1161/01.STR.16.4.562; Kessler H, 2006, J NEURAL TRANSM, V113, P1763, DOI 10.1007/s00702-006-0485-7; Kikumoto K, 1998, ANESTH ANALG, V87, P859, DOI 10.1097/00000539-199810000-00021; KIS B, 2007, PEPTIDE MEDIATORS BR; Lampl Y, 1998, J NEUROL, V245, P584, DOI 10.1007/s004150050249; Lazard EM, 1933, AM J OBSTET GYNECOL, V26, P647, DOI 10.1016/S0002-9378(33)90285-9; Lobinski R., 2003, RSC CHROM M; Loftspring MC, 2007, J NEUROCHEM, V102, P1990, DOI 10.1111/j.1471-4159.2007.04667.x; Mason MG, 2001, APPL ENVIRON MICROB, V67, P4512, DOI 10.1128/AEM.67.10.4512-4519.2001; McCord JM, 1998, SEMIN HEMATOL, V35, P5; Melo TM, 2003, BIOL TRACE ELEM RES, V93, P1, DOI 10.1385/BTER:93:1-3:1; Michalke B, 2007, ELECTROPHORESIS, V28, P1380, DOI 10.1002/elps.200600686; Michalke B, 2007, J ANAL ATOM SPECTROM, V22, P267, DOI 10.1039/b610639k; Molina JA, 1998, J NEURAL TRANSM, V105, P479, DOI 10.1007/s007020050071; MORELAND RS, 1981, ARCH BIOCHEM BIOPHYS, V208, P325, DOI 10.1016/0003-9861(81)90516-6; Muniz CS, 2001, J ANAL ATOM SPECTROM, V16, P587, DOI 10.1039/b100947h; Ni ZM, 2004, KIDNEY INT, V66, P2329, DOI 10.1111/j.1523-1755.2004.66032.x; Ninonuevo M, 2005, ELECTROPHORESIS, V26, P3641, DOI 10.1002/elps.200500246; Ninonuevo MR, 2006, J AGR FOOD CHEM, V54, P7471, DOI 10.1021/jf0615810; PALATY V, 1971, J PHYSIOL-LONDON, V218, P353, DOI 10.1113/jphysiol.1971.sp009622; Prange A, 2005, ANAL BIOANAL CHEM, V383, P372, DOI 10.1007/s00216-005-3420-0; PRASAD DMV, 1978, EUR J PHARMACOL, V52, P421, DOI 10.1016/0014-2999(78)90303-5; Purdy RE, 1997, AM J HYPERTENS, V10, P997, DOI 10.1016/S0895-7061(97)00108-8; PYNEGAITHMAN G, 2007, COMMUNICATION; RUSSELL WE, 1973, EUR J BIOCHEM, V33, P459, DOI 10.1111/j.1432-1033.1973.tb02703.x; SHULL S, 1991, J BIOL CHEM, V266, P24398; SPEICH M, 1989, CLIN CHEM, V35, P833; Srbek J, 2007, J SEP SCI, V30, P2046, DOI 10.1002/jssc.200700053; Stuerenburg HJ, 2000, J NEURAL TRANSM, V107, P321, DOI 10.1007/s007020050026; Suarez JI, 2006, NEW ENGL J MED, V354, P387, DOI 10.1056/NEJMra052732; Van Bergen P, 1999, FREE RADICAL RES, V31, P631, DOI 10.1080/10715769900301201; Venne K, 2005, ANAL CHEM, V77, P2176, DOI 10.1021/ac048410j; Vindlacheruvu Raghu R, 2002, Practitioner, V246, P608; Vollmer M, 2006, J SEP SCI, V29, P499, DOI 10.1002/jssc.200500334; Wagner KR, 2003, J CEREBR BLOOD F MET, V23, P629, DOI 10.1097/01.WCB.0000073905.87928.6D; WEBB RC, 1981, AM J PHYSIOL, V241, pH211, DOI 10.1152/ajpheart.1981.241.2.H211; WEBER A, 1969, BIOCHEMISTRY-US, V8, P2266, DOI 10.1021/bi00834a005; Wijdicks EFM, 2001, J NEUROSURG, V94, P252, DOI 10.3171/jns.2001.94.2.0252; Yuan XL, 2005, J MASS SPECTROM, V40, P176, DOI 10.1002/jms.737; ZHENGYU L, 1995, NEUROSURGERY, V37, P1154	63	17	19	0	12	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1535-3893	1535-3907		J PROTEOME RES	J. Proteome Res.	SEP	2008	7	9					3747	3754		10.1021/pr800024k			8	Biochemical Research Methods	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	345RZ	WOS:000259015500013	18662025	Green Accepted			2022-02-06	
J	Hartman, M; Watson, RS; Linde-Zwirble, W; Clermont, G; Lave, J; Weissfeld, L; Kochanek, P; Angus, D				Hartman, Mary; Watson, Robert Scott; Linde-Zwirble, Walter; Clermont, Gilles; Lave, Judith; Weissfeld, Lisa; Kochanek, Patrick; Angus, Derek			Pediatric traumatic brain injury is inconsistently regionalized in the United States	PEDIATRICS			English	Article						trauma; triage; brain injury; regionalization; pediatric	TRIAGE CRITERIA; BLUNT TRAUMA; SYSTEM; CARE; CHILDREN; CENTERS; MORTALITY; VOLUME; HOSPITALIZATION; MECHANISM	OBJECTIVES. Traumatic brain injury is a leading cause of death in children. On the basis of evidence of better outcomes, the American College of Surgery Committee on Trauma recommends that children with severe traumatic brain injury receive care at high-level trauma centers. We assessed rates of adherence to these recommendations and factors associated with adherence. METHODS. We studied population and hospital discharge data from 2001 from all of the health care referral regions (n = 68) in 6 US states (Florida, Massachusetts, New Jersey, New York, Texas, and Virginia). We identified children with severe traumatic brain injury by using International Classification of Diseases, Ninth Revision, Clinical Modification, codes and American College of Surgery Committee on Trauma criteria. We defined "high- level centers" as either level I or pediatric trauma centers. We considered an area to be well regionalized if >= 90% of severe traumatic brain injury hospitalizations were in high-level centers. We also explored how use of level II trauma centers affected rates of care at high-level centers. RESULTS. Of 2117 admissions for severe pediatric traumatic brain injury, 67.3% were in high-level centers, and 87.3% were in either high-level or level II centers. Among states, 56.4% to 93.6% of severe traumatic brain injury admissions were in high-level centers. Only 2 states, Massachusetts and Virginia, were well regionalized. Across health care referral regions, 0% to 100% of severe traumatic brain injury admissions were in high-level centers, and only 19.1% of health care referral regions were well regionalized. Only a weak relationship existed between the distance to the nearest high-level center and regionalization. The age of statewide trauma systems had no relationship to the extent of regionalization. CONCLUSIONS. Despite evidence for improved outcomes of severely injured children admitted to high-level trauma centers, we found that almost one third of the children with severe traumatic brain injury failed to receive care in such centers. Only 2 of 6 states and less than one fifth of 68 health care referral regions were well regionalized. This study highlights problems with current pediatric trauma care that can serve as a basis for additional research and health care policy.	[Hartman, Mary; Watson, Robert Scott; Linde-Zwirble, Walter; Clermont, Gilles; Lave, Judith; Weissfeld, Lisa; Angus, Derek] Univ Pittsburgh, Clin Res Investigat & Syst Modeling Acute Illness, Pittsburgh, PA 15261 USA; [Hartman, Mary] Duke Childrens Hosp, Div Pediat Crit Care Med, Durham, NC USA; [Kochanek, Patrick] Univ Pittsburgh, Dept Crit Care Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15261 USA; [Lave, Judith] Univ Pittsburgh, Dept Hlth Policy & Management, Pittsburgh, PA 15261 USA; [Weissfeld, Lisa] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Linde-Zwirble, Walter] ZD Associates LLC, Perkasie, PA USA		Watson, RS (corresponding author), Univ Pittsburgh, Clin Res Investigat & Syst Modeling Acute Illness, 3550 Terrace St,Room 606C Scaife Hall, Pittsburgh, PA 15261 USA.	watsonrs@upmc.edu	Kochanek, Patrick M/D-2371-2015; Angus, Derek C/E-9671-2012	Kochanek, Patrick M/0000-0002-2627-913X; Watson, R. Scott/0000-0002-2581-7186	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD046489] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32 HD040686, K23 HD046489, K23 HD046489-04, T32 HD040686-08, T32 HD40686] Funding Source: Medline		*AG HEALTHC ADM, 2000, HOSP INP DAT FIL STA; *AM COLL SURG COMM, 1990, RES OPT CAR INJ PAT; American Hospital Association, 2000, AHA GUID HLTH CAR FI; Baez AA, 2003, J TRAUMA, V54, P344, DOI 10.1097/01.TA.0000046258.81127.E1; CALES RH, 1985, JAMA-J AM MED ASSOC, V254, P1059, DOI 10.1001/jama.254.8.1059; Champion HR, 1986, TRAUMA CARE SYSTEMS, P79; Demetriades D, 2005, ANN SURG, V242, P512, DOI 10.1097/01.sla.0000184169.73614.09; *DEP HLTH SEN SERV, 2000, DISCH DAT UB 92 YTD; *DEP PUBL HLTH, 2000, MASS HOSP INP DAT 19; Dudley RA, 2000, JAMA-J AM MED ASSOC, V283, P1159, DOI 10.1001/jama.283.9.1159; Hall JR, 1996, J PEDIATR SURG, V31, P72, DOI 10.1016/S0022-3468(96)90322-X; *HEALTHC INF COUNC, 2002, TEX HOSP INP DISCH P; Henry MC, 1996, AM J EMERG MED, V14, P124, DOI 10.1016/S0735-6757(96)90117-5; Hulka F, 1997, J TRAUMA, V42, P514, DOI 10.1097/00005373-199703000-00020; Iezzoni L I, 1990, Int J Technol Assess Health Care, V6, P272; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Johnson DL, 1996, PEDIATR NEUROSURG, V25, P309, DOI 10.1159/000121145; KANE G, 1992, J TRAUMA, V32, P576, DOI 10.1097/00005373-199205000-00007; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Ma MHM, 1999, J TRAUMA, V46, P168; MacKenzie EJ, 2003, JAMA-J AM MED ASSOC, V289, P1515, DOI 10.1001/jama.289.12.1515; *MASS TRAUM CTR, 2002, MASS OFF EM MED SERV; Mullins RJ, 1998, J TRAUMA, V44, P609, DOI 10.1097/00005373-199804000-00009; Murray JA, 2000, AM SURGEON, V66, P863; NAKAYAMA DK, 1992, J PEDIATR SURG, V27, P427, DOI 10.1016/0022-3468(92)90328-5; Nathens AB, 2000, J TRAUMA, V48, P25, DOI 10.1097/00005373-200001000-00005; Nathens AB, 2000, JAMA-J AM MED ASSOC, V283, P1990, DOI 10.1001/jama.283.15.1990; Nathens AB, 2001, JAMA-J AM MED ASSOC, V285, P1164, DOI 10.1001/jama.285.9.1164; *NEW JERS DEP HLTH, 2002, NEW JERS TRAUM CTR; *NEW YORK STAT DEP, 2006, NEW YORK STAT TRAUM; *NEW YORK STAT DEP, 2000, NEW YORK STAT DEP HL; Ni H, 2002, INJURY PREV, V8, P60, DOI 10.1136/ip.8.1.60; Potoka DA, 2001, J TRAUMA, V51, P824, DOI 10.1097/00005373-200111000-00002; Potoka DA, 2000, J TRAUMA, V49, P237, DOI 10.1097/00005373-200008000-00009; Reid SR, 2001, ARCH PEDIAT ADOL MED, V155, P784, DOI 10.1001/archpedi.155.7.784; Rubenfeld GD, 1999, AM J RESP CRIT CARE, V160, P358, DOI 10.1164/ajrccm.160.1.9807118; Santaniello JM, 2003, SURGERY, V134, P698, DOI 10.1016/S0039-6060(03)00331-3; SHACKFORD SR, 1986, J TRAUMA, V26, P812, DOI 10.1097/00005373-198609000-00006; SHATNEY CH, 1994, J TRAUMA, V37, P275, DOI 10.1097/00005373-199408000-00021; *STAT DEP HLTH, 2002, STAT APPR TRAUM CTR; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Trunkey DD, 2000, CLIN ORTHOP RELAT R, P36; Ventura S J, 2001, Natl Vital Stat Rep, V49, P1; *VIRG DEP HLTH OFF, 2006, TRAUM CTR; *VIRG HLTH INF, 2000, PUBL US FIL PUF1 PAT; *WASH STAT OFF EM, 2003, WASH STAT DES TRAUM	46	17	18	0	2	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005			PEDIATRICS	Pediatrics	JUL	2008	122	1					E172	E180		10.1542/peds.2007-3399			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	320YN	WOS:000257271200082	18595962	Green Accepted			2022-02-06	
J	Srivastava, N; Seth, K; Srivastava, N; Khanna, VK; Agrawal, AK				Srivastava, Nishi; Seth, Kavita; Srivastava, Nalini; Khanna, Vinay K.; Agrawal, Ashok Kumar			Functional restoration using basic fibroblast growth factor (bFGF) infusion in kainic acid induced cognitive dysfunction in rat: Neurobehavioural and neurochemical studies	NEUROCHEMICAL RESEARCH			English	Article						cognitive dysfunction; Kainic acid; bFGF; neurogenesis; dentate gyrus; BrdU; ChAT	HIPPOCAMPAL NEUROTROPHIN LEVELS; TRAUMATIC BRAIN-INJURY; TEMPORAL-LOBE EPILEPSY; LONG-TERM POTENTIATION; DENTATE GYRUS; ENHANCED NEUROGENESIS; ADULT HIPPOCAMPUS; KNOCKOUT MICE; KAINATE MODEL; PROLIFERATION	Neurogenesis occurs in dentate gyrus of adult hippocampus under the influence of various mitogenic factors. Growth factors besides instigating the proliferation of neuronal progenitor cells (NPCs) in dentate gyrus, also supports their differentiation to cholinergic neurons. In the present study, an attempt has been made to investigate the neurotrophic effect of bFGF in Kainic acid (KA) induced cognitive dysfunction in rats. Stereotaxic lesioning using (KA) was performed in hippocampal CA3 region of rat's brain. Four-weeks post lesioning rats were assessed for impairment in learning and memory using Y maze followed by bFGF infusion in dentate gyrus region. The recovery was evaluated after bFGF infusion using neurochemical, neurobehavioural and immunohistochemical approaches and compared with lesioned group. Significant impairment in learning and memory (P < 0.01) observed in lesioned animals, four weeks post lesioning exhibited significant restoration (P < 0.001) following bFGF infusion twice at one and four week post lesion. The bFGF infused animals exhibited recovery in hippocampus cholinergic (76%)/ dopaminergic (46%) receptor binding and enhanced Choline acetyltransferase (ChAT) immunoreactivity in CA3 region. The results suggest restorative potential of bFGF in cognitive dysfunctions, possibly due to mitogenic effect on dentate gyrus neurogenic area leading to generation and migration of newer cholinergic neurons.	[Srivastava, Nishi; Seth, Kavita; Khanna, Vinay K.; Agrawal, Ashok Kumar] Ind Toxicol Res Ctr, Div Dev Toxicol, Lucknow 226001, Uttar Pradesh, India; [Srivastava, Nalini] Jiwaji Univ, Sch Studies, Gwalior 474001, India		Agrawal, AK (corresponding author), Ind Toxicol Res Ctr, Div Dev Toxicol, Post Box 80,MG Marg, Lucknow 226001, Uttar Pradesh, India.	aka33@rediffmail.com	Singh, Nishi/A-1086-2009				Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Adhami VM, 1996, NEUROCHEM RES, V21, P915, DOI 10.1007/BF02532341; Agrawal AK, 2004, NEUROBIOL DIS, V16, P516, DOI 10.1016/j.nbd.2004.04.014; AGRAWAL AK, 1981, TOXICOL APPL PHARM, V58, P89, DOI 10.1016/0041-008X(81)90119-8; AULS DS, 2002, PROG NEUROBIOL, V68, P209; BARONE S, 1991, EXP NEUROL, V114, P351, DOI 10.1016/0014-4886(91)90161-5; Bauer S, 2006, J NEUROSCI, V26, P12089, DOI 10.1523/JNEUROSCI.3047-06.2006; Bellucci A, 2006, NEUROBIOL DIS, V23, P260, DOI 10.1016/j.nbd.2006.03.012; Broughton SK, 2007, J NEUROCHEM, V100, P628, DOI 10.1111/j.1471-4159.2006.04171.x; Chaturvedi RK, 2006, NEUROSCI LETT, V398, P44, DOI 10.1016/j.neulet.2005.12.042; Choi YS, 2003, MOL CELLS, V16, P232; Chun SK, 2006, NEUROBIOL LEARN MEM, V86, P322, DOI 10.1016/j.nlm.2006.05.005; Dinocourt C, 2006, EUR J NEUROSCI, V24, P1857, DOI 10.1111/j.1460-9568.2006.05067.x; Doetsch F, 2005, CURR OPIN NEUROBIOL, V15, P121, DOI 10.1016/j.conb.2005.01.018; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fagan AM, 1997, J NEUROSCI, V17, P2499; Felling RJ, 2003, J NEUROSCI RES, V73, P277, DOI 10.1002/jnr.10670; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; Ford-Perriss M, 2001, CLIN EXP PHARMACOL P, V28, P493, DOI 10.1046/j.1440-1681.2001.03477.x; Gould E, 2002, J NEUROSCI, V22, P619, DOI 10.1523/JNEUROSCI.22-03-00619.2002; Gray WP, 1998, BRAIN RES, V790, P52, DOI 10.1016/S0006-8993(98)00030-4; Gross CG, 2000, NAT REV NEUROSCI, V1, P67, DOI 10.1038/35036235; Hagood SK, 2006, J NEUROTRAUM, V23, P205, DOI 10.1089/neu.2006.23.205; Ikeda T, 2002, INT J DEV NEUROSCI, V20, P555, DOI 10.1016/S0736-5748(02)00082-5; JIN K, 2005, P NATL ACAD SCI USA, V102, P17889; Kar S, 2004, J PSYCHIATR NEUROSCI, V29, P427; Kempermann G, 2004, CURR OPIN NEUROBIOL, V14, P186, DOI 10.1016/j.conb.2004.03.001; Laplante F, 2004, NEUROPSYCHOPHARMACOL, V29, P1620, DOI 10.1038/sj.npp.1300467; Leker RR, 2007, STROKE, V38, P153, DOI 10.1161/01.STR.0000252156.65953.a9; Lisman JE, 2001, HIPPOCAMPUS, V11, P551; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Machon O, 2005, MOL CELL NEUROSCI, V30, P388, DOI 10.1016/j.mcn.2005.08.003; MANFRED KRUG, 2001, HIPPOCAMPUS, V11, P157; Maric D, 2007, J NEUROSCI, V27, P1836, DOI 10.1523/JNEUROSCI.5141-06.2007; Monje ML, 2003, CURR OPIN NEUROL, V16, P129, DOI 10.1097/00019052-200304000-00002; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Nakagawa E, 2000, EPILEPSIA, V41, P10, DOI 10.1111/j.1528-1157.2000.tb01498.x; Otmakhova NA, 1998, J NEUROSCI, V18, P1270; Otmakhova NA, 1996, J NEUROSCI, V16, P7478; Parent JM, 1997, J NEUROSCI, V17, P3727; Paxinos G, 1997, RAT BRAIN STEREOTAXI; Ramirez JJ, 1999, NEUROREPORT, V10, P1201, DOI 10.1097/00001756-199904260-00008; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rosato-Siri M, 2006, J PHYSIOL-LONDON, V576, P361, DOI 10.1113/jphysiol.2006.114587; Row BW, 2007, BEHAV BRAIN RES, V177, P308, DOI 10.1016/j.bbr.2006.11.028; Roy TS, 2002, J PHARMACOL EXP THER, V300, P124, DOI 10.1124/jpet.300.1.124; Shetty AK, 2004, J NEUROSCI RES, V78, P520, DOI 10.1002/jnr.20302; Shetty AK, 2003, J NEUROCHEM, V87, P147, DOI 10.1046/j.1471-4159.2003.01979.x; Shimazu K, 2006, LEARN MEMORY, V13, P307, DOI 10.1101/lm.76006; Smith C, 2001, EUR J NEUROSCI, V13, P443, DOI 10.1046/j.1460-9568.2001.01400.x; Spencer B, 2001, MOL THER, V3, P746, DOI 10.1006/mthe.2001.0307; Sun YJ, 2006, DEV BIOL, V289, P329, DOI 10.1016/j.ydbio.2005.10.016; Tureyen K, 2005, NEUROSURGERY, V57, P1254, DOI 10.1227/01.NEU.0000186040.96929.8A; Vorobyov V, 2005, BRAIN RES, V1051, P123, DOI 10.1016/j.brainres.2005.06.001; Yoshimura S, 2003, J CLIN INVEST, V112, P1202, DOI 10.1172/JCI200316618; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Youssoufian M, 2007, EUR J NEUROSCI, V25, P1647, DOI 10.1111/j.1460-9568.2007.05428.x; Zaman V, 2001, NEUROBIOL DIS, V8, P942, DOI 10.1006/nbdi.2001.0440	59	17	21	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	JUL	2008	33	7					1169	1177		10.1007/s11064-007-9478-7			9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	307MF	WOS:000256322300001	17955369				2022-02-06	
J	Cotena, S; Piazza, O; Tufano, R				Cotena, S.; Piazza, O.; Tufano, R.			The use of erythtropoietin in cerebral diseases	PANMINERVA MEDICA			English	Article						erythropoietin; cerebral arterial diseases; neuroprotective agents	RECOMBINANT-HUMAN-ERYTHROPOIETIN; EXPERIMENTAL INTRACEREBRAL HEMORRHAGE; RECEPTOR MESSENGER-RNA; NECROSIS-FACTOR-ALPHA; BRAIN-INJURY; NEURONAL APOPTOSIS; FOCAL ISCHEMIA; NITRIC-OXIDE; WHOLE-BLOOD; CELL-DEATH	Global and focal cerebral ischemia is followed by a secondary damage characterized by oxidative stress, excitotoxicity, inflammation and apoptosis. Erythropoietin (EPO) exerts antiapoptotic, anti-inflammatory, antioxidative, angiogenetic and neurotrophic properties. Its potential therapeutic role has been demonstrated in several animal models of cerebral ischemia and also in a clinical trial of ischemic stroke, so it could be considered an ideal compound for neuroprotection in ischemic stroke and in cardiac arrest. Intracerebral hemorrhage (ICH) is the least treatable form of stroke; the mechanisms involved in the secondary brain injury include hematoma mass effect, neuronal apoptosis and necrosis, inflammation. It has been demonstrated in an experimental ICH that EPO intervenes in the inflammatory process, reduces brain water content, hemorrhage volume and hemispheric atrophy, promotes cell survival, preserves cerebral blood flow, has antiapoptotic protective function against oxidative stress and excitotoxic damage. EPO can attenuate acute vasoconstriction and prevent brain ischemic damage in subarachnoid hemorrhage. The neuroprotective function of EPO has been studied also in traumatic brain injury: it reduces the inflammation and improves cognitive and motor deficits. The authors review some of the physiological actions of EPO in the physiopathology of ischemic and hemorrhagic stroke, subarachnoid hemorrhage and brain trauma, and its potential usefulness in the brain injured patient management.	[Cotena, S.; Piazza, O.; Tufano, R.] Univ Naples Federico II, Dept Anesthesiol & Resuscitat, I-80131 Naples, Italy		Cotena, S (corresponding author), Univ Naples Federico II, Dept Anesthesiol & Resuscitat, Via Pansini 5 Ed 8, I-80131 Naples, Italy.	si_mi@inwind.it	Piazza, Ornella/G-5339-2012; Piazza, Ornella/Q-2716-2019	Piazza, Ornella/0000-0002-0316-5930; Piazza, Ornella/0000-0002-0316-5930			Adembri C, 2004, J NEUROTRAUM, V21, P1103, DOI 10.1089/0897715041651079; Agnello D, 2002, BRAIN RES, V952, P128, DOI 10.1016/S0006-8993(02)03239-0; Alafaci C, 2000, EUR J PHARMACOL, V406, P219, DOI 10.1016/S0014-2999(00)00691-9; Baron JC, 2005, CEREBROVASC DIS, V20, P154, DOI 10.1159/000087199; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Bryl E, 1998, ARTIF ORGANS, V22, P177, DOI 10.1046/j.1525-1594.1998.06002.x; Calvillo L, 2003, P NATL ACAD SCI USA, V100, P4802, DOI 10.1073/pnas.0630444100; Castillo J, 2002, NEUROLOGY, V58, P624, DOI 10.1212/WNL.58.4.624; Chavez JC, 2006, J NEUROSCI, V26, P9471, DOI 10.1523/JNEUROSCI.2838-06.2006; Choi K, 1998, DEVELOPMENT, V125, P725; Citerio G, 2006, MINERVA ANESTESIOL, V72, P407; CLARK DA, 1986, J LAB CLIN MED, V108, P423; Coleman TR, 2006, P NATL ACAD SCI USA, V103, P5965, DOI 10.1073/pnas.0601377103; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Coughlin SR, 1999, P NATL ACAD SCI USA, V96, P11023, DOI 10.1073/pnas.96.20.11023; Dery O, 1998, AM J PHYSIOL-CELL PH, V274, pC1429, DOI 10.1152/ajpcell.1998.274.6.C1429; Donovan FM, 1997, J NEUROSCI, V17, P5316; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; Ehrenreich H, 2004, MOL PSYCHIATR, V9, P42, DOI 10.1038/sj.mp.4001442; Ehrenreich H, 2001, EUR ARCH PSY CLIN N, V251, P149, DOI 10.1007/s004060170034; Ferriero DM, 2005, EPILEPSIA, V46, P45, DOI 10.1111/j.1528-1167.2005.00302.x; Gawel M, 2003, ANN NEUROL, V54, pS32; Gong C, 2000, BRAIN RES, V871, P57, DOI 10.1016/S0006-8993(00)02427-6; Grasso G, 2001, J Neurosurg Sci, V45, P7; Grasso G, 2002, P NATL ACAD SCI USA, V99, P5627, DOI 10.1073/pnas.082097299; Hamada R, 2000, STROKE, V31, P794, DOI 10.1161/01.STR.31.3.791-c; Hebert P C, 1999, Minerva Anestesiol, V65, P293; Henrich-Noack P, 2006, BRAIN RES, V1070, P232, DOI 10.1016/j.brainres.2005.10.100; Hua Y, 2003, J CEREBR BLOOD F MET, V23, P1448, DOI 10.1097/01.WCB.0000090621.86921.D5; Huang FP, 2002, J NEUROSURG, V96, P287, DOI 10.3171/jns.2002.96.2.0287; Iadecola C, 1997, TRENDS NEUROSCI, V20, P132, DOI 10.1016/S0166-2236(96)10074-6; JENKINS A, 1989, NEUROPATH APPL NEURO, V15, P477, DOI 10.1111/j.1365-2990.1989.tb01247.x; Juul SE, 1998, EARLY HUM DEV, V52, P235, DOI 10.1016/S0378-3782(98)00030-9; Keller M, 2006, NEUROBIOL DIS, V24, P357, DOI 10.1016/j.nbd.2006.07.007; Lee ST, 2006, J NEUROCHEM, V96, P1728, DOI 10.1111/j.1471-4159.2006.03697.x; Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313; Li Y, 2007, J CEREBR BLOOD F MET, V27, P1043, DOI 10.1038/sj.jcbfm.9600417; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Mayne M, 2001, ANN NEUROL, V49, P727, DOI 10.1002/ana.1010; Mayne M, 2001, STROKE, V32, P240, DOI 10.1161/01.STR.32.1.240; Morishita E, 1997, NEUROSCIENCE, V76, P105, DOI 10.1016/s0306-4522(96)00306-5; Nakamura T, 2004, J NEUROSURG, V100, P672, DOI 10.3171/jns.2004.100.4.0672; NICLOU S, 1994, CELL MOL BIOL, V40, P421; Noorbakhsh F, 2003, NAT REV NEUROSCI, V4, P981, DOI 10.1038/nrn1255; Peeling J, 2001, EXP NEUROL, V167, P341, DOI 10.1006/exnr.2000.7564; Power C, 2003, ANN NEUROL, V53, P731, DOI 10.1002/ana.10553; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Santhanam AVR, 2006, AM J PHYSIOL-HEART C, V291, pH781, DOI 10.1152/ajpheart.00045.2006; Santhanam AVR, 2005, STROKE, V36, P2731, DOI 10.1161/01.STR.0000190021.85035.5b; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Siren AL, 2001, EUR ARCH PSY CLIN N, V251, P179, DOI 10.1007/s004060170038; Siren AL, 2001, ACTA NEUROPATHOL, V101, P271, DOI 10.1007/s004010000297; Squadrito F, 1999, BRIT J PHARMACOL, V127, P482, DOI 10.1038/sj.bjp.0702521; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; Villa P, 2003, J EXP MED, V198, P971, DOI 10.1084/jem.20021067; Villa P, 2007, J CEREBR BLOOD F MET, V27, P552, DOI 10.1038/sj.jcbfm.9600370; Wang HC, 2005, J MANUF SCI E-T ASME, V127, P33, DOI 10.1115/1.1830492; WEINSTEIN JR, 1995, J NEUROSCI, V15, P2906; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xi GH, 2003, J NEUROCHEM, V84, P3, DOI 10.1046/j.1471-4159.2003.01268.x; Xue MZ, 2000, NEUROSCI LETT, V283, P230, DOI 10.1016/S0304-3940(00)00971-X; Yamaji R, 1996, EUR J BIOCHEM, V239, P494, DOI 10.1111/j.1432-1033.1996.0494u.x; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje	66	17	21	0	3	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0031-0808	1827-1898		PANMINERVA MED	Panminerva Medica	JUN	2008	50	2					185	192					8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353LR	WOS:000259569800011	18607342				2022-02-06	
J	McGwin, G; Zoghby, JT; Griffin, R; Rue, LW				McGwin, Gerald, Jr.; Zoghby, Jonathan T.; Griffin, Russell; Rue, Loring W., III			Incidence of golf cart-related injury in the United States	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						golf; injury; incidence; epidemiology	POPULATION; SPORTS	Background: Golf carts have become a popular mode of transportation off of the links because of their small size, low maintenance, and ease of use. Case reports suggest severe, debilitating injuries as a consequence of golf cart incidents. To date, there has been no national population-based study of golf cart-related injuries. Methods: The National Electronic Injury Surveillance System identified individuals who visited participating emergency departments from January 1, 2002 to December 31, 2005 for injuries sustained as a result of golf carts. Results: An estimated 48,255 (95% confidence interval, 35,342-61,108) golf cart-related injuries occurred in the U.S. between 2002 and 2005; the injury rate was 4.14 of 100,000 population. The highest injury rates were observed in 10 to 19 year olds and those aged 80 and older. Male patients had a higher injury rate than female patients, and whites had a higher rate than blacks or Asians. Contusions/abrasions were the most common diagnosis for the hip and lower extremity region; fractures were the most common diagnosis for shoulder and upper extremity region; and intracranial injuries, including concussions, subdural hematomas, and hemorrhage, were the most common diagnosis for head and neck region. The two most common geographic settings of injuries were sports fields such as golf courses (45.0%) and places of residence (16.0%). Conclusion: The popularity of golf carts as a means of transportation calls for mandatory safety standards to be met along with implementation of available safety courses for children who will potentially be operating these vehicles.	[McGwin, Gerald, Jr.] Univ Alabama Birmingham, Dept Surg, Ctr Injury Sci, Sch Med, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Surg, Sect Trauma Burns & Surg Crit Care, Sch Med,Div Gen Surg, Birmingham, AL 35294 USA		McGwin, G (corresponding author), Univ Alabama Birmingham, Dept Surg, Ctr Injury Sci, Sch Med, 120 Kracke Bldg,1922 7th Ave S, Birmingham, AL 35294 USA.	mcgwin@uab.edu					*BUY COM ED STAFF, GOLD CARS UT VEH BUY; Conn JM, 2003, INJURY PREV, V9, P117, DOI 10.1136/ip.9.2.117; Dellinger AM, 2002, AM J EPIDEMIOL, V155, P234, DOI 10.1093/aje/155.3.234; ELIAS J, INSPECTION TESTING L; Gilchrist J., 2004, Morbidity and Mortality Weekly Report, V53, P447; *INS I HIGHW SAF, 2002, STATUS REPORT, V37, P4; Levy AS, 2002, J TRAUMA, V53, P695, DOI 10.1097/00005373-200210000-00013; *NAT GOLD FDN, MIN GOLF PART US; Passaro K T, 1996, Inj Prev, V2, P124, DOI 10.1136/ip.2.2.124; *PGA CONS MARK DEP, PROF EX FORM INT GOL; Rahimi SY, 2005, J NEUROSURG, V102, P163, DOI 10.3171/jns.2005.102.2.0163; Schroeder T., 2001, NEISS SAMPLE DESIGN; Seluga KJ, 2006, ACCIDENT ANAL PREV, V38, P1151, DOI 10.1016/j.aap.2006.04.023; Thomas KE, 2006, BRIT J SPORT MED, V40, P619, DOI 10.1136/bjsm.2006.025858; TUNG MY, 2000, SINGAP MED J, V10, P504; US Consumer Product Safety Commission, 2000, NEISS NAT EL INJ SUR; WANG CC, 2003, PHYS GUIDE ASSESSING	17	17	17	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUN	2008	64	6					1562	1566		10.1097/TA.0b013e3181238d39			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	313MG	WOS:000256744100026	18545124				2022-02-06	
J	Slieker, FJA; Kompanje, EJO; Murray, GD; Ohman, J; Stocchetti, N; Teasdale, G; Maas, AIR				Slieker, Francois J. A.; Kompanje, Erwin J. O.; Murray, Gordon D.; Ohman, Juha; Stocchetti, Nino; Teasdale, Graham; Maas, Andrew I. R.		SAPHIR & Pharmos TBI Invest	Importance of screening logs in clinical trials for severe traumatic brain injury	NEUROSURGERY			English	Article						clinical trials; Consolidated Standards of Reporting Trials guidelines; dexanabinol; neuroprotection; N-methyl-D-aspartate glutamate antagonists; screening logs; traumatic brain injury	GLASGOW COMA SCALE; SEVERE HEAD-INJURIES; ADULTS; IMPACT	OBJECTIVE: The primary intent for obtaining screening logs in a randomized clinical trial is to assess selection bias in patient recruitment. This is particularly relevant to focused trials in heterogeneous populations such as traumatic brain injury (TBI) patients. We aimed to investigate the benefits of collecting screening logs in two randomized clinical trials conducted in TBI. METHODS: Screening logs were collected as part of the conduct of two multicenter trials of neuroprotective agents in TBI: the Salzburg Atherosclerosis Prevention Program in Subjects at High Individual Risk study (n = 924) and the clexanabinol study (n = 861). Centers were requested to submit monthly information on all patients with TBI admitted to the intensive care unit, including demographics, time of injury and admission, injury severity, and, if not recruited, the reason(s) for exclusion. RESULTS: In the Salzburg Atherosclerosis Prevention Program in Subjects at High Individual Risk study, 52 centers submitted admission data on 4166 patients. in the clexanabinol trial, 96 centers submitted data on 7052 patients. On average, only 20% of patients screened for the Salzburg Atherosclerosis Prevention Program in Subjects at High Individual Risk study and 10% for the clexanabinol trial were enrolled. The main reasons for exclusion were neurological status (29 and 26%, respectively), age (24 and 30%, respectively), and admission outside of the time window (17 and 21%, respectively). Differences in patient characteristics between screened and enrolled patients, with substantial country-specific variation, were observed. CONCLUSION: The collection of screening logs is necessary to report trial results according to the Consolidated Standards of Reporting Trials guidelines and to assess the generalizability of findings. Our experience shows the feasibility of collecting screening logs and illustrates how the potential for selection bias may creep into well-designed randomized clinical trials as a result of factors outside the control of investigators. Consistency and accuracy in screening log completion may further serve as an early indicator of center performance in a trial.	[Slieker, Francois J. A.; Kompanje, Erwin J. O.; Maas, Andrew I. R.] Erasmus MC, Dept Neurosurg, Rotterdam, Netherlands; [Kompanje, Erwin J. O.] Erasmus MC, Dept Intens Care, Rotterdam, Netherlands; [Murray, Gordon D.] Univ Edinburgh, Sch Med, Edinburgh, Midlothian, Scotland; [Ohman, Juha] Pirkanmaa Hosp Dist, Tampere, Finland; [Stocchetti, Nino] Univ Milan, Osped Policlin Ist Ricovero & Cura Carattere Sci, Milan, Italy; [Teasdale, Graham] Univ Glasgow, Glasgow, Lanark, Scotland; [Teasdale, Graham] Royal Coll Physicians & Surg, Glasgow, Lanark, Scotland		Maas, AIR (corresponding author), Univ Antwerp Hosp, Dept Neurosurg, Wilrijkstr 10, B-2650 Edegem, Belgium.	Andrew.Maas@uza.be	Maas, Andrew IR/C-5584-2013; Stocchetti, Nino/O-7444-2017	Maas, Andrew IR/0000-0003-1612-1264; Stocchetti, Nino/0000-0003-3250-6834; Ohman, Juha/0000-0002-6592-1367; Murray, Gordon/0000-0001-9866-4734			Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Buechler CM, 1998, J TRAUMA, V45, P429, DOI 10.1097/00005373-199809000-00001; Dimond K, 2002, J BIOLAW BUS, V5, P50; Edwards P, 2005, LANCET, V365, P1957; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hernandez AV, 2006, J NEUROTRAUM, V23, P1295, DOI 10.1089/neu.2006.23.1295; Kannus P, 1999, AM J EPIDEMIOL, V149, P143; Kannus P, 1997, LANCET, V350, P1174, DOI 10.1016/S0140-6736(97)26042-3; KANNUS P, JAMA, V286, P673; Luukinen H, 1999, J AM GERIATR SOC, V47, P1451, DOI 10.1111/j.1532-5415.1999.tb01566.x; MAAS AI, 2004, ANN SURG, V239, P772; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Moskopp D, 1995, NEUROSURG REV, V18, P253, DOI 10.1007/BF00383876; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131	18	17	17	0	4	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	JUN	2008	62	6					1321	1328		10.1227/01.neu.0000333304.79931.4d			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	334MS	WOS:000258226500033	18824999				2022-02-06	
J	Wirtz, SJ; Trent, RB				Wirtz, Stephen J.; Trent, Roger B.			Passive surveillance of shaken baby syndrome using hospital inpatient data	AMERICAN JOURNAL OF PREVENTIVE MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; CHILDREN; STATE	Background: The conference from which these articles came addressed the question of public health surveillance for shaken baby syndrome (SBS) and explores one component of a comprehensive SBS surveillance system that would be relatively easy to implement and maintain: passive surveillance based on hospital inpatient data. Provisional exclusion and inclusion criteria are proposed for a two-level case definition of diagnosed SBS (strict definition) and cases presumed to be SBS (broad definition). The strict SBS definition is based on the single SBS code in the ICD-9-CM (995.55). The broader presumptive SBS definition is based on research studies that have identified a pattern of diagnostic codes often considered part of the clinical diagnosis of SBS. Results: Based on 2006 analyses, California inpatient data are presented for 1998-2004. The strict SBS definition identified 366 cases over the 7 years, whereas the broader definition captured nearly 1000 cases. Annual rates show little fluctuation from the overall rate of 5.1 for strict SBS and 14.0 for broad SBS (per 100,000 children aged <2 years). Selected demographic and outcome characteristics are presented for each definition. The broad definition produces rates that are roughly comparable to those produced in careful clinical and population-based studies that also included children who died without being hospitalized. Conclusions: Despite the limitations of inpatient data, a passive surveillance system like the one proposed here can provide a critical component for a comprehensive SBS surveillance system and may be adequate for some purposes, including identifying high-risk areas or groups for intervention and monitoring trends over time.	[Wirtz, Stephen J.; Trent, Roger B.] Calif Dept Publ Hlth, Epidemiol & Prevent Injury Control Branch, Sacramento, CA 95899 USA		Wirtz, SJ (corresponding author), Calif Dept Publ Hlth, Epidemiol & Prevent Injury Control Branch, MS 7214,POB 997377, Sacramento, CA 95899 USA.	steve.wirtz@cdph.ca.gov			PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [U81/CCU720885, 200-2005-F-14668, U81/CCU720887] Funding Source: Medline		ALEXANDER R, 1990, AM J DIS CHILD, V144, P58, DOI 10.1001/archpedi.1990.02150250068033; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; [Anonymous], 2001, MMWR Recomm Rep, V50, P1; *COUNC STAT TERR E, 2005, STAT COLL US CAUS IN; Dias MS, 2005, PEDIATRICS, V115, DOI 10.1542/peds.2004-1896; Ellis A A, 2001, Inj Prev, V7, P316, DOI 10.1136/ip.7.4.316; Ettaro L, 2004, CHILD ABUSE NEGLECT, V28, P1099, DOI 10.1016/j.chiabu.2004.06.006; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Injury Surveillance Workgroup, 2003, CONS REC US HOSP DIS; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Kairys SW, 2001, PEDIATRICS, V108, P206; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; King WJ, 2003, CAN MED ASSOC J, V168, P155; Leeb R. T., 2007, CHILD MALTREATMENT S; *MIN PUBL WORKS GO, 2001, JOINT STAT SHAK BAB; MINUS R, 2006, S MEAS INC INFL CHIL; *NAT CTR SHAK BAB, 2006, PREV SHAK BAB SYNDR; *NCIPC CDC, 2001, REC FRAM ECODE GROUP; *NCIPC CDC, CHILD MALTR CDC ACT; Runyan D., 2002, WORLD REPORT VIOLENC, P57; Saltzman, 2002, SEXUAL VIOLENCE SURV; Saltzman L. E., 1999, INTIMATE PARTNER VIO; Schnitzer PG, 2008, AM J PUBLIC HEALTH, V98, P296, DOI 10.2105/AJPH.2006.087783; *STAT TERR INJ PRE, INJ SURV WORKGR; Steenkamp M, 2006, INJURY PREV, V12, P3, DOI 10.1136/ip.2006.012518; Theodore AD, 2005, PEDIATRICS, V115, pE331, DOI 10.1542/peds.2004-1033; Webster RA, 2003, AM J PREV MED, V25, P58, DOI 10.1016/S0749-3797(03)00091-6; WIRTZ S, 2005, 4 ANN INJ PREV SUMM; Zolotor Adam J, 2005, N C Med J, V66, P360	30	17	18	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0749-3797	1873-2607		AM J PREV MED	Am. J. Prev. Med.	APR	2008	34	4		S			S134	S139		10.1016/j.amepre.2007.11.004			6	Public, Environmental & Occupational Health; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; General & Internal Medicine	279TT	WOS:000254378300007	18374263				2022-02-06	
J	Zhang, J; Groff, RF; Chen, XH; Browne, KD; Huang, J; Schwartz, ED; Meaney, DF; Johnson, VE; Stein, SC; Rojkjaer, R; Smith, DH				Zhang, Jun; Groff, Robert F.; Chen, Xiao-Han; Browne, Kevin D.; Huang, Jason; Schwartz, Eric D.; Meaney, David F.; Johnson, Victoria E.; Stein, Sherman C.; Rojkjaer, Rasmus; Smith, Douglas H.			Hemostatic and neuroprotective effects of human recombinant activated factor VII therapy after traumatic brain injury in pigs	EXPERIMENTAL NEUROLOGY			English	Article						traumatic brain injury; TBI; rFVIIa; cerebral contusion; recombinant activated factor VII; hemostasis; diffuse axonal injury; neuroprotection	V LIVER-INJURIES; SPONTANEOUS INTRACEREBRAL HEMORRHAGE; DIFFUSE AXONAL INJURY; HEAD TRAUMA; COMPUTERIZED-TOMOGRAPHY; VENOUS THROMBOEMBOLISM; COAGULOPATHIC PIGS; RISK-FACTORS; THROMBIN; DAMAGE	Human recombinant activated factor-VII (rFVIIa) has been used successfully in the treatment of spontaneous intracerebral hemorrhage. In addition, there is increasing interest in its use to treat uncontrolled bleeding of other origins, including trauma. The aim of this study was to evaluate the safety and potential effectiveness of rFVIIa to mitigate bleeding using a clinically relevant model of traumatic brain injury (TBI) in the pig. A double injury model was chosen consisting of (1) an expanding cerebral contusion induced by the application of negative pressure to the exposed cortical surface and (2) a rapid rotational acceleration of the head to induce diffuse axonal injury (DA1). Injuries were performed on 10 anesthetized pigs. Five minutes after injury, 720 mu g/kg rFVIIa (n = 5) or vehicle control (n = 5) was administered intravenously. Magnetic resonance imaging (MRI) studies were performed within 30 min and at 3 days post-TB1 to determine the temporal expansion of the cerebral contusion. Euthanasia and histopathologic analysis were performed at day 3. This included observations for hippocampal neuronal degeneration, axonal pathology and microclot formation. The expansion of contusion volume over the 3 days post-injury period was reduced significantly in animals treated with rFVIIa compared to vehicle controls. Surprisingly, immunohistochemical analysis demonstrated that the number of dead/dying hippocampal neurons and axonal pathology was reduced substantially by rFVIIa treatment compared to vehicle. In addition, there was no difference in the extent of microthrombi between groups. rFVIIa treatment after TBI in the pig reduced expansion of hemorrhagic cerebral contusion volume without exacerbating the severity of microclot formation. Finally, rFVIIa treatment provided a Surprising neuroprotective effect by reducing hippocampal neuron degeneration as well as the extent of DAI. (C) 2008 Published by Elsevier Inc.	[Zhang, Jun; Groff, Robert F.; Chen, Xiao-Han; Browne, Kevin D.; Johnson, Victoria E.; Stein, Sherman C.; Smith, Douglas H.] Univ Penn, Dept Neurosurg, Sch Med, Philadelphia, PA 19104 USA; [Zhang, Jun; Groff, Robert F.; Chen, Xiao-Han; Browne, Kevin D.; Johnson, Victoria E.; Stein, Sherman C.; Smith, Douglas H.] Univ Penn, Penn Ctr Brain Injury & Repair, Sch Med, Philadelphia, PA 19104 USA; [Huang, Jason] Univ Rochester, Sch Med & Dent, Dept Neurol Surg, Rochester, NY 14642 USA; [Schwartz, Eric D.] Univ Pittsburgh, Med Ctr, Dept Radiol, Pittsburgh, PA 15213 USA; [Meaney, David F.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Rojkjaer, Rasmus] Novo Nordisk Res US, N Brunswick, NJ USA; [Zhang, Jun] Peoples Liberat Army Gen Hosp, Dept Neurosurg, Beijing, Peoples R China		Smith, DH (corresponding author), Univ Penn, Dept Neurosurg, Sch Med, 105 Hayden Hall,3320 Smith Walk, Philadelphia, PA 19104 USA.	smithdou@mail.med.upenn.edu	Huang, Jason H/J-4739-2019; smith, douglas/A-1321-2007	Huang, Jason H/0000-0002-4426-0168; Meaney, David/0000-0002-0954-4122	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01 NS056202, R01 NS038104, R01 NS035712, R01 NS035712-12, P01 NS056202-020003, NS38104] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038104, R01NS035712, P01NS056202] Funding Source: NIH RePORTER		ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; Aiyagari V, 2005, J CRIT CARE, V20, P176, DOI 10.1016/j.jcrc.2005.02.004; Aldouri M, 2002, PATHOPHYSIOL HAEMO T, V32, P41, DOI 10.1159/000057301; BANNINGER H, 1994, BIOCHEM J, V298, P157; BLOMBACK B, 1994, THROMB RES, V75, P521, DOI 10.1016/0049-3848(94)90227-5; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Chuang CS, 2000, STAT SINICA, V10, P1; CLOYD JC, 1986, J PHARMACOL EXP THER, V236, P301; Dutton RP, 2004, J TRAUMA, V57, P709, DOI 10.1097/01.TA.0000140646.66852.AB; Felix B, 1999, STEREOTAXIC ATLAS PI; Figueroa BE, 1998, STROKE, V29, P1202, DOI 10.1161/01.STR.29.6.1202; Filsoufi F, 2006, ANN THORAC SURG, V82, P1779, DOI 10.1016/j.athoracsur.2006.05.076; Friederich PW, 2003, LANCET, V361, P201, DOI 10.1016/S0140-6736(03)12268-4; FUJII Y, 1994, J NEUROSURG, V80, P51, DOI 10.3171/jns.1994.80.1.0051; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Gerotziafas GT, 2004, THROMB HAEMOSTASIS, V91, P977, DOI 10.1160/THo3-10-0638; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gingrich MB, 2000, TRENDS NEUROSCI, V23, P399, DOI 10.1016/S0166-2236(00)01617-9; Gorbacheva LR, 2006, BIOCHEMISTRY-MOSCOW+, V71, P1082, DOI 10.1134/S000629790610004X; Gustafsson O, 1999, ACTA RADIOL, V40, P360, DOI 10.3109/02841859909177748; He S, 2003, J THROMB HAEMOST, V1, P1215, DOI 10.1046/j.1538-7836.2003.00242.x; Hoffman M, 2003, BLOOD REV, V17, pS1, DOI 10.1016/S0268-960X(03)90000-2; Kamphusien PW, 2002, AM J MED, V112, P332, DOI 10.1016/S0002-9343(01)01116-0; KEIMOWITZ RM, 1973, J NEUROSURG, V39, P178, DOI 10.3171/jns.1973.39.2.0178; Kenet G, 1999, LANCET, V354, P1879, DOI 10.1016/S0140-6736(99)05155-7; Khan AZ, 2005, AM J SURG, V189, P331, DOI 10.1016/j.amjsurg.2004.11.021; Kjalke M, 2007, J THROMB HAEMOST, V5, P774, DOI 10.1111/j.1538-7836.2007.02389.x; Kurtoglu M, 2004, WORLD J SURG, V28, P807, DOI 10.1007/s00268-004-7295-6; Lisman T, 2002, BLOOD, V99, P175, DOI 10.1182/blood.V99.1.175; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; Lobato RD, 1997, ACTA NEUROCHIR, V139, P385, DOI 10.1007/BF01808871; Martinowitz U, 2005, J THROMB HAEMOST, V3, P640, DOI 10.1111/j.1538-7836.2005.01203.x; Martinowitz U, 2002, CAN J ANAESTH, V49, pS15; Martinowitz U, 2001, J TRAUMA, V51, P431, DOI 10.1097/00005373-200109000-00002; Mayer SA, 2005, NEW ENGL J MED, V352, P777, DOI 10.1056/NEJMoa042991; Mayer SA, 2005, STROKE, V36, P74, DOI 10.1161/01.STR.0000149628.80251.b8; Mayo A, 2004, VOX SANG, V87, P34, DOI 10.1111/j.1423-0410.2004.00533.x; McArthur DL, 2004, BRAIN PATHOL, V14, P185, DOI 10.1111/j.1750-3639.2004.tb00052.x; Monroe DM, 1997, BRIT J HAEMATOL, V99, P542, DOI 10.1046/j.1365-2141.1997.4463256.x; O'Neill PA, 2002, J TRAUMA, V52, P400, DOI 10.1097/00005373-200202000-00034; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Pusateri AE, 2005, THROMB HAEMOSTASIS, V93, P275, DOI 10.1160/TH04-03-0200; Ripoll MA, 2004, NEURORADIOLOGY, V46, P435, DOI 10.1007/s00234-004-1191-5; Ripoll MA, 2002, ACTA RADIOL, V43, P2, DOI 10.1080/028418502127347538; Schreiber MA, 2005, CRIT CARE, V9, pS25, DOI 10.1186/cc3782; Schreiber MA, 2003, J AM COLL SURGEONS, V196, P691, DOI 10.1016/S1072-7515(02)01835-5; Schreiber MA, 2002, J TRAUMA, V53, P252, DOI 10.1097/00005373-200208000-00011; Schurr MJ, 2004, J TRAUMA, V57, P718; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; Shreiber DI, 1999, J NEUROPATH EXP NEUR, V58, P153, DOI 10.1097/00005072-199902000-00005; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Sondeen JL, 2004, SHOCK, V22, P163, DOI 10.1097/01.shk.0000129202.76706.bd; Sorensen BB, 2003, BLOOD, V102, P1708, DOI 10.1182/blood-2003-01-0157; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Steiner T, 2006, NEUROSURGERY, V59, P767, DOI 10.1227/01.NEU.0000232837.34992.32; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21; TANNO H, 1992, J NEUROTRAUM, V9, P335, DOI 10.1089/neu.1992.9.335; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Vaslef SN, 2002, J TRAUMA, V53, P257; White Christopher E, 2006, Curr Surg, V63, P310, DOI 10.1016/j.cursur.2006.04.013; Zaaroor M, 2004, SEMIN HEMATOL, V41, P175, DOI 10.1053/j.seminhematol.2003.11.033; [No title captured]	71	17	18	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	APR	2008	210	2					645	655		10.1016/j.expneurol.2007.12.019			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	287CL	WOS:000254894200037	18291370	Green Accepted			2022-02-06	
J	Carlotti, APCP; Bohn, D; Matsuno, AK; Pasti, DM; Gowrishankar, M; Halperin, ML				Carlotti, A. P. C. P.; Bohn, D.; Matsuno, A. K.; Pasti, D. M.; Gowrishankar, M.; Halperin, M. L.			Indicators of lean body mass catabolism: emphasis on the creatinine excretion rate	QJM-AN INTERNATIONAL JOURNAL OF MEDICINE			English	Article							TOTAL PARENTERAL-NUTRITION; CRITICALLY ILL CHILDREN; NITROGEN-BALANCE; ARGININE METABOLISM; INJURY; SEPSIS; ADULTS; MUSCLE; CARE; AGE	Background: The major stress response to critical illness leads to a catabolic state and loss of lean body mass. Aims: To test whether an increased rate of creatinine excretion might provide unique and timely information to monitor cell catabolism; to relate this information to balances of cell constituents (nitrogen, potassium, phosphate and magnesium); to evaluate the effectiveness of nutritional therapy to reverse this catabolic process. Design: Prospective observational study. Methods: Children with severe traumatic brain injury admitted to the paediatric critical care units of The Hospital for Sick Children, Toronto, Canada and Hospital das Clnicas, Faculty of Medicine of Ribeiro Preto, University of So Paulo, Brazil were studied. Complete 24 h urine collections were obtained for measurement of creatinine excretion rate and daily balances of nitrogen, potassium, phosphate and magnesium. Results: Seventeen patients were studied for 310 days. On Day 1, all had negative balances for protein and phosphate. Balances for these intracellular constituents became positive when protein intake was >= 1 g/kg/day and energy intake was >= 50% of estimated energy expenditure (P < 0.0001). Creatinine excretion rate was positively correlated with the urea appearance rate (r = 0.60; P < 0.0001), and negatively with protein balance (r = -0.45; P < 0.0001). Sepsis developed in four patients; before its clinical detection, there were negative balances for all intracellular markers and an abrupt rise in the excretion of creatinine. Conclusions: Negative balances of intracellular components and an increase in rate of creatinine excretion heralded the onset of catabolism.	[Carlotti, A. P. C. P.; Matsuno, A. K.; Pasti, D. M.] Univ Sao Paulo, Fac Med Ribeirao, Hosp Clin, Dept Paediat, BR-14049900 Ribeirao Preto, SP, Brazil; [Bohn, D.] Hosp Sick Children, Dept Crit Care Med, Toronto, ON M5G 1X8, Canada; [Bohn, D.] Univ Toronto, Dept Anaesthesia & Med, Toronto, ON, Canada; [Gowrishankar, M.] Univ Alberta, Stollery Childrens Hosp, Div Paediat Nephrol, Edmonton, AB, Canada; [Halperin, M. L.] Univ Toronto, St Michaels Hosp, Dept Nephrol, Toronto, ON M5B 1W8, Canada		Carlotti, APCP (corresponding author), Univ Sao Paulo, Fac Med Ribeirao, Hosp Clin, Dept Paediat, Av Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.	carlotti@fmrp.usp.br	Carlotti, Ana PCP/G-4893-2012; Matsuno, Alessandra Kimie/H-9507-2012	Carlotti, Ana PCP/0000-0003-2760-8801; Matsuno, Alessandra Kimie/0000-0002-3491-1641			AGUILANIU B, 1992, JPEN-PARENTER ENTER, V16, P248, DOI 10.1177/0148607192016003248; ALTMAN PL, 1992, BIOL DATA BOOK, P1990; BISTRIAN BR, 1975, AM J CLIN NUTR, V28, P1148, DOI 10.1093/ajcn/28.10.1148; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Briassoulis G, 2002, J NUTR BIOCHEM, V13, P560, DOI 10.1016/S0955-2863(02)00200-0; Brosnan JT, 2007, ANNU REV NUTR, V27, P241, DOI 10.1146/annurev.nutr.27.061406.093621; Brosnan ME, 2004, J NUTR, V134, p2791S, DOI 10.1093/jn/134.10.2791S; CHEEMADHADLI S, 1993, CAN J PHYSIOL PHARM, V71, P120, DOI 10.1139/y93-017; CLAUSEN T, 1986, PHYSIOL REV, V66, P542, DOI 10.1152/physrev.1986.66.3.542; Coss-Bu JA, 2001, AM J CLIN NUTR, V74, P664; DRUML W, 1993, NUTR KIDNEY, P314; GHAZALI S, 1974, ARCH DIS CHILD, V49, P97, DOI 10.1136/adc.49.2.97; Halperin ML, 1998, FLUID ELECTROLYTE AC; HOLLIDAY MA, 1957, PEDIATRICS, V19, P823; IAPICHINO G, 1985, JPEN-PARENTER ENTER, V9, P42, DOI 10.1177/014860718500900142; JUNGAS RL, 1992, PHYSIOL REV, V72, P419, DOI 10.1152/physrev.1992.72.2.419; Langley Joanne M, 2005, Pediatr Crit Care Med, V6, pS9, DOI 10.1097/01.PCC.0000161932.73262.D7; Luiking YC, 2005, JPEN-PARENTER ENTER, V29, pS70, DOI 10.1177/01486071050290S1S70; Mazzola CA, 2002, CRIT CARE MED, V30, pS393, DOI 10.1097/00003246-200211001-00003; McCall M, 2003, JPEN-PARENTER ENTER, V27, P27, DOI 10.1177/014860710302700127; Morris SM, 2002, ANNU REV NUTR, V22, P87, DOI 10.1146/annurev.nutr.22.110801.140547; POLLACK MM, 1985, JPEN-PARENTER ENTER, V9, P309, DOI 10.1177/0148607185009003309; SCHWARTZ GJ, 1976, J PEDIATR-US, V88, P828, DOI 10.1016/S0022-3476(76)81125-0; Shew S B, 1999, Semin Pediatr Surg, V8, P131; SKOGERBOE KJ, 1990, CLIN CHEM, V36, P752; THRELFALL CJ, 1984, J TRAUMA, V24, P516, DOI 10.1097/00005373-198406000-00009; WALSER M, 1987, JPEN-PARENTER ENTER, V11, pS73, DOI 10.1177/014860718701100510	27	17	19	0	9	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1460-2725			QJM-INT J MED	QJM-An Int. J. Med.	MAR	2008	101	3					197	205		10.1093/qjmed/hcm127			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	267EG	WOS:000253491700004	18222987	Green Published, Bronze			2022-02-06	
J	Vickery, CD; Sherer, M; Evans, CC; Gontkovsky, ST; Lee, JE				Vickery, Chad D.; Sherer, Mark; Evans, Clea C.; Gontkovsky, Samuel T.; Lee, Jae Eun			The relationship between self-esteem and functional outcome in the acute stroke-rehabilitation setting	REHABILITATION PSYCHOLOGY			English	Article						stroke; depression; self-esteem; rehabilitation outcome	TRAUMATIC BRAIN-INJURY; DEPRESSIVE SYMPTOMS; ANTIDEPRESSANT TREATMENT; POSTSTROKE DEPRESSION; GERIATRIC DEPRESSION; SOCIAL SUPPORT; SCALE; VALIDATION; PERSISTENCE; RECOVERY	Objective: To explore the relationship between self-esteem and functional recovery in patients with acute stroke. Design: A nonconsecutive sample of stroke survivors received ratings of functional status and completed self-report measures of self-esteem and depressive symptoms. Bivariate correlational analyses and multivariate regression analyses explored the relationships of functional status and self-report of self-esteem and depressive symptoms. Setting: Acute inpatient rehabilitation hospital. Participants: A group of 176 right- or left-hemisphere stroke participants. Main Outcome Measures: Self-care and mobility domain scores (based on Functional Independence Measure ratings) at admission and discharge. Efficiency scores for each domain. Visual Analogue Self-Esteem Scale (S. M. Brumfitt & P. Sheeran, 1999) and Geriatric Depression Scale (J. A. Yesavage et al., 1983). Results: Regression analyses indicated that lower self-esteem ratings were related to poorer discharge self-care and mobility scores and poorer efficiency in these domains, whereas ratings of depressive symptoms were not. However, interactions between self-esteem ratings and ratings of depressive symptoms were noted. Exploratory analyses suggested that self-esteem ratings mediated the relationship between ratings of depressive symptoms and functional outcome indices. Conclusions: Self-esteem ratings may have a mediating/moderating role in the relationship between emotional functioning and functional outcome. This may have implications for research in this area and the type of mental health treatment available to stroke rehabilitation patients.	[Vickery, Chad D.; Evans, Clea C.] Methodist Rehabil Ctr, Neuropsychol Dept, Jackson, MS 39216 USA; [Sherer, Mark] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Gontkovsky, Samuel T.; Lee, Jae Eun] Methodist Rehabil Ctr, Dept Res, Jackson, MS 39216 USA		Vickery, CD (corresponding author), Methodist Rehabil Ctr, Neuropsychol Dept, 1350 E Woodrow Wilson, Jackson, MS 39216 USA.	chadvickery@hotmail.com					Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Baumeister RF, 2003, HANDBOOK OF SELF AND IDENTITY, P197; BROWN JD, 1995, J PERS SOC PSYCHOL, V68, P712, DOI 10.1037/0022-3514.68.4.712; BROWN JD, 1998, SELF; Brumfitt SM, 1999, BRIT J CLIN PSYCHOL, V38, P387, DOI 10.1348/014466599162980; Chang AM, 1999, J CLIN NURS, V8, P477, DOI 10.1046/j.1365-2702.1999.0196a.x; Conn VS., 1992, HLTH VALUES J HLTH B, V16, P25; Coopersmith, 1967, ANTECEDENTS SELF EST; Cully JA, 2005, ARCH PHYS MED REHAB, V86, P2256, DOI 10.1016/j.apmr.2005.07.292; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Ellis-Hill CS, 2000, CLIN REHABIL, V14, P279, DOI 10.1191/026921500671231410; ESSEX MJ, 1989, J AGING HEALTH, V1, P327; Fitts WH., 1996, TENNESSEE SELF CONCE; Fung LCL, 2006, J CLIN NURS, V15, P505, DOI 10.1111/j.1365-2702.2006.01328.x; Gammon J, 1996, J ADV NURS, V24, P303, DOI 10.1046/j.1365-2648.1996.17911.x; Gillen R, 2001, ARCH PHYS MED REHAB, V82, P1645, DOI 10.1053/apmr.2001.26249; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; HEATHERTON TF, 1991, J PERS SOC PSYCHOL, V60, P895, DOI 10.1037/0022-3514.60.6.895; HOBFOLL SE, 1984, AM J COMMUN PSYCHOL, V12, P87, DOI 10.1007/BF00896930; Holmbeck GN, 1997, J CONSULT CLIN PSYCH, V65, P599, DOI 10.1037/0022-006X.65.4.599; Keppel CC, 2000, NEUROPSYCHOL REHABIL, V10, P15, DOI 10.1080/096020100389273; Koehler M L, 1989, Rehabil Nurs, V14, P9; Leary MR, 2003, HANDBOOK OF SELF AND IDENTITY, P401; Li L, 1998, J SOC PSYCHOL, V138, P13, DOI 10.1080/00224549809600349; May LA, 2002, SPINAL CORD, V40, P341, DOI 10.1038/sj.sc.3101311; MCFARLIN DB, 1984, J PERS, V52, P138, DOI 10.1111/j.1467-6494.1984.tb00349.x; Myers R. H., 1990, CLASSICAL MODERN REG; Narushima K, 2003, J NERV MENT DIS, V191, P645, DOI 10.1097/01.nmd.0000092197.97693.d2; Ng JYY, 2000, PERCEPT MOTOR SKILL, V91, P107; Paolucci S, 2001, CEREBROVASC DIS, V12, P264, DOI 10.1159/000047714; Ravaud JF, 1999, SCAND J REHABIL MED, V31, P31; Rosenberg M., 1979, CONCEIVING SELF; SANDELANDS LE, 1988, J APPL PSYCHOL, V73, P208, DOI 10.1037/0021-9010.73.2.208; Schroevers MJ, 2003, SOC SCI MED, V57, P375, DOI 10.1016/S0277-9536(02)00366-0; Tarlow EM, 1996, J RES PERS, V30, P120, DOI 10.1006/jrpe.1996.0008; Vickery CD, 2006, REHABIL PSYCHOL, V51, P30, DOI 10.1037/0090-5550.51.1.30; VICKERY CD, IN PRESS CLIN REHABI; VICKERY CD, 2006, PSYCHOMETRIC CHARACT; Vickery CD, 2006, CLIN REHABIL, V20, P1075, DOI 10.1177/0269215506071269; Waschull SB, 1996, PERS SOC PSYCHOL B, V22, P4, DOI 10.1177/0146167296221001; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; 1996, UNIFORM DATA SET MED	42	17	18	0	14	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	FEB	2008	53	1					101	109		10.1037/0090-5550.53.1.101			9	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	266JR	WOS:000253431900013					2022-02-06	
J	Bilotta, F; Branca, G; Lam, A; Cuzzone, V; Doronzio, A; Rosa, G				Bilotta, Federico; Branca, Giovanna; Lam, Arthur; Cuzzone, Vincenzo; Doronzio, Andrea; Rosa, Giovanni			Endotracheal lidocaine in preventing endotracheal suctioning-induced changes in cerebral hemodynamics in patients with severe head trauma	NEUROCRITICAL CARE			English	Article						endotracheal suctioning; lidocaine instillation; intracranial pressure; severe head trauma	INTRACRANIAL-PRESSURE; BRAIN-INJURY; REMIFENTANIL; INCREASES; ISCHEMIA	Introduction In patients with severe head trauma, endotracheal suctioning can result in adverse reactions including cough, systemic hypertension, increased intracranial pressure, and reduced cerebral perfusion pressure. The aim of this prospective, blinded clinical trial in mechanically ventilated patients with severe head trauma whose cough reflexes were still intact was to assess the effectiveness of endotracheally instilled lidocaine in preventing endotracheal suctioning-induced changes in cerebral hemodynamics (increase in intracranial pressure and reduced cerebral perfusion pressure) after a single endotracheal suctioning. Methods and Results Ten minutes after lidocaine instillation into the endotracheal tube, secretions were suctioned for <30 s through a standard closed endotracheal suctioning circuit. Heart rate, arterial pressure, intracranial pressure, and cerebral perfusion pressure were continuously monitored. The first patient studied received an endotracheal lidocaine dose of 2.0 mg/kg. The dose for the next study patient was titrated upwards or downwards in 0.5 mg/kg steps according to, whether the intracranial pressure reached the predefined threshold of 20 mmHg. A total of 41 patients were studied. Lidocaine instillation into the endotracheal tube had no effect on hemodynamic and ventilatory variables. In 21 patients lidocaine dose instilled into the endotracheal tube effectively prevented the endotracheal suctioning-induced intracranial pressure increase behind the predefined threshold of :20 mmHg and cerebral perfusion pressure remained unchanged. In the remaining 20, although intracranial pressure rose significantly cerebral perfusion pressure remained constant. Conclusions In mechanically ventilated patients with severe head trauma endotracheal lidocaine instillation effectively and dose-dependently prevents the endotracheal suctioning-induced intracranial pressure increase and cerebral perfusion pressure reduction.	[Bilotta, Federico; Branca, Giovanna; Cuzzone, Vincenzo; Doronzio, Andrea; Rosa, Giovanni] Univ Roma La Sapienza, Dept Anesthesiol Intens Care & Pain Med, I-00199 Rome, Italy; [Lam, Arthur] Univ Washington, Dept Anesthesiol & Neurol Surg, Seattle, WA 98195 USA		Bilotta, F (corresponding author), Univ Roma La Sapienza, Dept Anesthesiol Intens Care & Pain Med, Viale Somalia 81, I-00199 Rome, Italy.	bilotta@tiscali.it					Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Carhuapoma JR, 1999, CRIT CARE MED, V27, P2843, DOI 10.1097/00003246-199912000-00049; Cremer OL, 2004, ANESTH ANALG, V99, P1211, DOI 10.1213/01.ANE.0000133917.67728.2A; DIXON WJ, 1991, NEUROSCI BIOBEHAV R, V15, P47, DOI 10.1016/S0149-7634(05)80090-9; FLETCHER S, 2000, ANAESTHESIOL, V13, P155; Gemma M, 2002, J NEUROSURG ANESTH, V14, P50, DOI 10.1097/00008506-200201000-00010; HSIANG JK, 1994, CRIT CARE MED, V22, P1471, DOI 10.1097/00003246-199409000-00019; Jee D, 2003, ANESTH ANALG, V96, P293, DOI 10.1097/00000539-200301000-00058; Kerr ME, 1997, NURS RES, V46, P195, DOI 10.1097/00006199-199707000-00003; Kerr ME, 1999, CRIT CARE MED, V27, P2776, DOI 10.1097/00003246-199912000-00028; Leone M, 2004, ANESTH ANALG, V99, P1193, DOI 10.1213/01.ANE.0000132546.79769.91; Menon DK, 2006, CURR OPIN CRIT CARE, V12, P85, DOI 10.1097/01.ccx.0000216572.19062.8f; MILLER JD, 1974, INJURY, V5, P265, DOI 10.1016/S0020-1383(74)80021-5; Orsi GB, 2006, J HOSP INFECT, V64, P23, DOI 10.1016/j.jhin.2006.02.022; RUDY EB, 1991, HEART LUNG, V20, P667; Stapelfeldt C, 2005, ANESTH ANALG, V100, P226, DOI 10.1213/01.ANE.0000142122.57201.6B; Tipps LB, 2000, NEUROSURGERY, V46, P596, DOI 10.1097/00006123-200003000-00015; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; Wang DX, 2002, ANESTH ANALG, V95, P1134, DOI 10.1097/00000539-200211000-00002; WHITE PF, 1982, ANESTHESIOLOGY, V57, P242, DOI 10.1097/00000542-198209000-00019; YANO M, 1986, ANESTHESIOLOGY, V64, P651, DOI 10.1097/00000542-198605000-00019; Young PJ, 1999, ANAESTHESIA, V54, P1183, DOI 10.1046/j.1365-2044.1999.01035.x; 1996, J NEUROOTRAUMA, V13, P641	23	17	25	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care		2008	8	2					241	246		10.1007/s12028-007-9012-4			6	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	270KE	WOS:000253718900003	17928962				2022-02-06	
J	Chan, RCK; Bode, RK				Chan, R. C. K.; Bode, R. K.			Analysis of patient and proxy ratings on the Dysexecutive Questionnaire: an application of Rasch analysis	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							ATTENTIONAL DEFICITS; COMPLAINTS; AWARENESS; SYMPTOMS	Background: We provide an alternate method of analysing self-report and proxy-report data on subjective complaints of dysexecutive symptoms among a group of patients with traumatic brain injury. Objective: The purpose of this study was to examine differences in the ratings of patients and proxies on a measure of the dysexecutive syndrome and further explore the insight impairment problem in patients with traumatic brain injury. Methods: Rasch analysis was conducted on the ratings of the Dysexecutive Questionnaire (DEX) by a sample of patients and their proxies. Results: While the average scores based on patient and proxy ratings were approximately the same (mean patient raw score = 30.12 and mean proxy raw score = 31.32), differential item functioning was found in five DEX items. As a result, the relationship between measures obtained from patient and proxy ratings was only in the moderate range (intraclass correlation = 0.46). Conclusions: Identification of differential item functioning in five of the 20 DEX items reflected the different perspectives of patients and their proxies in reporting the frequency of dysexecutive behaviour and suggests that these ratings are not interchangeable.	[Chan, R. C. K.] Chinese Acad Sci, Inst Psychol, Neuropsychol & Appl Cognit Neurosci Lab, Beijing 100101, Peoples R China; [Chan, R. C. K.] Chinese Acad Sci, Key Lab Mental Hlth, Inst Psychol, Beijing, Peoples R China; [Bode, R. K.] Rehabil Inst Chicago, Ctr Rehabil Outcomes Res, Chicago, IL 60611 USA		Chan, RCK (corresponding author), Chinese Acad Sci, Inst Psychol, Neuropsychol & Appl Cognit Neurosci Lab, Beijing 100101, Peoples R China.	rckchan@psych.ac.cn	Chan, Raymond CK/B-6717-2009	Chan, Raymond CK/0000-0002-3414-450X			Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P606, DOI 10.1017/S1355617705050721; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; BOND TG, 2001, APPLYING RASCH MODEL; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess P. W., 2002, PRINCIPLES FRONTAL L, P557, DOI 10.1093/acprof:oso/9780195134971.003.0033; Chan RCK, 2002, J CLIN EXP NEUROPSYC, V24, P1081, DOI 10.1076/jcen.24.8.1081.8371; Chan RCK, 2002, J INT NEUROPSYCH SOC, V8, P771, DOI 10.1017/S1355617702860052; Chan RCK, 2001, BRAIN INJURY, V15, P71, DOI 10.1080/02699050150209156; Chan RCK, 2001, BRIT J PSYCHOL, V92, P551, DOI 10.1348/000712601162338; Goldstein, 1996, ECOLOGICAL VALIDITY, P75; Linacre J.M., 2000, USERS GUIDE WINSTEPS; Rasch G., 1980, PROBABLISTIC MODELS; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Wright B, 1994, MEASUREMENT T, V8, P370	15	17	17	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	JAN	2008	79	1					86	88		10.1136/jnnp.2007.117184			3	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	240ZD	WOS:000251625800024	17635974				2022-02-06	
J	Dijkers, MPJM; Bushnik, T				Dijkers, Marcel P. J. M.; Bushnik, Tamara			Assessing fatigue after traumatic brain injury: An evaluation of the Barroso Fatigue Scale	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injuries; fatigue; mental fatigue; psychometrics	MINOR HEAD-INJURY; WORK; DEPRESSION; PREVALENCE; RECOVERY; OUTCOMES; ADULTS; SLEEP	Objective: To assess the suitability of the Barroso Fatigue Scale (BFS) for assessment of posttraumatic brain injury (Post-TBI) fatigue. Design: Analysis of self-report data. Setting: Community. Participants: 183 individuals with TBI in California, and 233 individuals with TBI and a comparison group of 85 persons without brain injury in New York. Interventions: None. Results: Both individuals with TBI and comparison participants reported high levels of fatigue on the Fatigue Severity Scale and the Fatigue Assessment Instrument, which can be scored from the BFS. Factor analysis of 40 BFS items resulted in 5 factors; because factors appeared to be based on both substantive issues and the format and location of the items, a BFS scoring algorithm was not pursued. The other 16 BFS items provided useful information in understanding post-TBI fatigue. Conclusions: The BFS in its current format is not recommended for assessing fatigue as a multidimensional entity after TBI. It may have utility for the 3 widely known fatigue measures that can be derived from it, and it generates information on the circumstances of fatigue.	[Dijkers, Marcel P. J. M.] Mt Sinai Sch Med, Dept Rehabil Med, New York, NY 10029 USA; [Bushnik, Tamara] Santa Clara Valley Med Ctr, San Jose, CA 95128 USA		Dijkers, MPJM (corresponding author), Mt Sinai Sch Med, Dept Rehabil Med, Box 1240,1 Gustave Levy Pl, New York, NY 10029 USA.	marcel.dijkers@mssm.edu		Bushnik, Tamara/0000-0003-3328-257X; Dijkers, Marcel/0000-0002-8362-5596			Aaronson L S, 1999, Image J Nurs Sch, V31, P45; Barroso Julie, 2002, J Assoc Nurses AIDS Care, V13, P66, DOI 10.1016/S1055-3290(06)60242-2; Barroso Julie, 2003, Clin Nurs Res, V12, P49, DOI 10.1177/1054773802238740; Bateman A, 2001, ARCH PHYS MED REHAB, V82, P174, DOI 10.1053/apmr.2001.19744; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; BELZA BL, 1995, J RHEUMATOL, V22, P639; BELZA BL, 1993, NURS RES, V42, P93; Borgaro SR, 2004, BRAIN INJURY, V18, P685, DOI 10.1080/02699050310001646080; Borgaro SR, 2005, J HEAD TRAUMA REHAB, V20, P416, DOI 10.1097/00001199-200509000-00003; Bushnik T, 2007, BRAIN INJURY, V21, P559, DOI 10.1080/02699050701426915; Clinchot DM, 1998, AM J PHYS MED REHAB, V77, P291, DOI 10.1097/00002060-199807000-00006; Darko DF, 1998, NEUROENDOCRINOLOGY, V67, P317, DOI 10.1159/000054329; DAVID A, 1990, BMJ-BRIT MED J, V301, P1199, DOI 10.1136/bmj.301.6762.1199; DeLuca J, 2005, ISS CLIN COGN NEUROP, P319; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dittner AJ, 2004, J PSYCHOSOM RES, V56, P157, DOI 10.1016/S0022-3999(03)00371-4; ENGLANDER J, 1992, Brain Injury, V6, P161, DOI 10.3109/02699059209029654; Fellus J, 2007, BRAIN INJURY MED, P545; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; Hillier SL, 1997, BRAIN INJURY, V11, P661; KESHAVAN MS, 1981, BRIT J PSYCHIAT, V138, P157, DOI 10.1192/bjp.138.2.157; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; KRUPP LB, 1990, J RHEUMATOL, V17, P1450; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; Michielsen HJ, 2003, J PSYCHOSOM RES, V54, P345, DOI 10.1016/S0022-3999(02)00392-6; MIDDELBOE T, 1992, ACTA NEUROL SCAND, V85, P5; Mota Dalete D C F, 2006, Res Theory Nurs Pract, V20, P49, DOI 10.1891/rtnp.20.1.49; Neuberger G. B., 2003, ARTHRIT CARE RES, V49, pS175; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Piper B.F., 1989, KEY ASPECTS COMFORT, P199; Reyes-Gibby CC, 2006, J PAIN SYMPTOM MANAG, V32, P118, DOI 10.1016/j.jpainsymman.2006.01.008; Ricci JA, 2007, J OCCUP ENVIRON MED, V49, P1, DOI 10.1097/01.jom.0000249782.60321.2a; Rimes KA, 2007, PEDIATRICS, V119, pE603, DOI 10.1542/peds.2006-2231; SCHWARTZ JE, 1993, J PSYCHOSOM RES, V37, P753, DOI 10.1016/0022-3999(93)90104-N; *STAT SOC CAN, OBST SLEEP APN CAS S; Stein KD, 2004, J PAIN SYMPTOM MANAG, V27, P14, DOI 10.1016/j.jpainsymman.2003.06.003; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Wijeratne C, 2007, J PSYCHOSOM RES, V62, P153, DOI 10.1016/j.jpsychores.2006.09.011; WRIGHTSON P, 1981, INJURY, V12, P445, DOI 10.1016/0020-1383(81)90161-3; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383; [No title captured]	47	17	17	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2008	23	1					3	16		10.1097/01.HTR.0000308716.80590.6b			14	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	256HS	WOS:000252719800004	18219230				2022-02-06	
J	Donders, J				Donders, Jacobus			Subtypes of learning and memory on the California Verbal Learning Test-Second Edition (CVLT-II) in the standardization sample	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						cluster analysis; California Verbal Learning Test-Second Edition; learning; memory; subtypes	TRAUMATIC BRAIN-INJURY; TEST-2ND EDITION; CLUSTER-ANALYSIS; PERFORMANCE; PATTERNS	The purpose of this study was to determine representative, core profile subtypes of learning and memory, based on four variables representing different latent constructs, in the standardization sample of the California Verbal Learning Test-Second Edition (CVLT-II; Delis, Kramer, Kaplan, Ober, 2000). Two-stage cluster analysis identified six reliable subtypes. Variability in both level and pattern of performance contributed to the differentiation of these subtypes. Level of education was meaningfully related to variability in overall performance of the subtypes. Implications for the interpretation of CVLT-II findings obtained in clinical practice are discussed.	Mary Free Bed Rehabil Hosp, Psychol Serv, Grand Rapids, MI 49503 USA		Donders, J (corresponding author), Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy SE, Grand Rapids, MI 49503 USA.	jacobus.donders@maryfreebed.com					Baldo JV, 2002, J INT NEUROPSYCH SOC, V8, P539, DOI 10.1017/S135561770281428X; BLASHFIELD RK, 1976, PSYCHOL BULL, V83, P377, DOI 10.1037/0033-2909.83.3.377; CARTER RL, 1989, PSYCHOMETRIKA, V54, P9, DOI 10.1007/BF02294446; Curtiss G, 2001, J INT NEUROPSYCH SOC, V7, P574, DOI 10.1017/S1355617701755051; DELIS D, 1994, CALIFORNIA VERBAL LE; DELIS D, 1987, CALIFORNIA VERBAL LE; Delis DC, 2005, J INT NEUROPSYCH SOC, V11, P708, DOI 10.1017/S1355617705050812; DELIS DC, 2000, CALIFORNIA VERBAL LE; DESPHANDE SA, 1996, J CLIN EXPT NEUROPSY, V18, P836; Donders J, 2001, ASSESSMENT, V8, P193, DOI 10.1177/107319110100800207; Donders J, 1999, DEV NEUROPSYCHOL, V16, P163, DOI 10.1207/S15326942DN1602_2; DONDERS J, ASSESSMENT IN PRESS; Donders J, 2006, PSYCHOL ASSESSMENT, V18, P458, DOI 10.1037/1040-3590.18.4.458; Fuerst DR, 1995, CHILD NEUROPSYCHOL, V1, P38, DOI 10.1080/09297049508401341; Hair J.F., 2002, READING UNDERSTANDIN, P147; Jacobs ML, 2007, ARCH CLIN NEUROPSYCH, V22, P143, DOI 10.1016/j.acn.2006.12.002; MILLIGAN GW, 1980, PSYCHOMETRIKA, V45, P325, DOI 10.1007/BF02293907; MILLIGAN GW, 1985, PSYCHOMETRIKA, V50, P159, DOI 10.1007/BF02294245; MILLIGAN GW, 2003, HDB PSYCHOL RES METH, V2, P165; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; SAS Institute Inc., 1990, SAS STAT US GUID VER, V1; Schinka JA, 1998, PSYCHOL ASSESSMENT, V10, P171, DOI 10.1037/1040-3590.10.2.171; Stricker JL, 2002, J INT NEUROPSYCH SOC, V8, P425, DOI 10.1017/S1355617702813224; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925	24	17	17	0	10	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2008	30	7					741	748		10.1080/13803390701689595			8	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	345EH	WOS:000258978400001	18608653				2022-02-06	
J	Forsyth, RJ; Parslow, RC; Tasker, RC; Hawley, CA; Morris, KP				Forsyth, Rob J.; Parslow, Roger C.; Tasker, Robert C.; Hawley, Carol A.; Morris, Kevin P.		UK Paediatric Traumatic Brain Inju	Prediction of raised intracranial pressure complicating severe traumatic brain injury in children: Implications for trial design	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						traumatic brain injury; children; intracranial pressure; randomized clinical trial; treatment; monitoring	CEREBRAL PERFUSION-PRESSURE; RANDOMIZED CONTROLLED-TRIALS; HEAD-INJURY; CARE MANAGEMENT; INTENSIVE-CARE; QUALITY	Objectives. To describe current patterns of management of raised intracranial pressure (ICP) in traumatic brain injury relevant to clinician buy-in to possible randomized controlled trials of treatments of raised ICP. To examine the feasibility of early identification of children at sufficient risk of developing raised ICP to permit a uniform approach between centers to the initiation of ICP monitoring. This would permit quantification of ICP elevation and enrollment as appropriate to randomized controlled trials of raised ICP interventions. Design: Logistic regression modeling of death before pediatric intensive care unit discharge and decision tree and logistic regression of development of raised ICP through analysis of a prospectively collected, standardized, national data set. Setting: Pediatric intensive care units in the United Kingdom and Eire. Patients: Patients were 501 children < 16 yrs of age primarily admitted to intensive care unit for management of traumatic brain injury in the United Kingdom and Eire between February 2001 and August 2003. Measurements and Main Results. The data analyzed included demographic, acute physiologic, and cranial imaging variables. Death was associated with both raised ICP and the nonmeasurement of ICP. In a subset of 199 patients, an empirically derived decision rule predicted the development of raised ICP at any point during ICU admission with sensitivity of 73% and specificity of 74% (positive predictive value 82% and negative predictive value 63%). Logistic regression modeling performed comparably. The decision rule also predicted raised ICP in 20% of children not undergoing ICP monitoring. Conclusions. Simple models based on early clinical data may predict the development of raised ICP sufficiently well to encourage a consistent approach between centers to initiation of ICP monitoring. We estimate studies designed to detect reductions in ICU mortality will require > 320 children per arm, although this figure may be higher if more conservative assumptions are made.	[Forsyth, Rob J.] Royal Victoria Infirm, Sir James Spence Inst Child Hlth, Sch Clin Med Sci Child Hlth, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Parslow, Roger C.] Univ Leeds, LIGHT, Ctr Biostat & Epidemiol, Paediat Epidemiol Grp, Leeds, W Yorkshire, England; [Tasker, Robert C.] Univ Cambridge, Sch Clin, Addenbrookes Hosp, Cambridge, England; [Hawley, Carol A.] Univ Warwick, Warwick Med Sch, Div Hlth & Community, Coventry CV4 7AL, W Midlands, England; [Morris, Kevin P.] Prince Wales Childrens Hosp, Birmingham, W Midlands, England		Forsyth, RJ (corresponding author), Royal Victoria Infirm, Sir James Spence Inst Child Hlth, Sch Clin Med Sci Child Hlth, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.	r.j.forsyth@newcastle.ac.uk	Parslow, Roger/AAV-1477-2020; Hawley, Carol/AAG-3830-2019; Forsyth, Rob/H-9193-2019; Tasker, Robert C/R-5837-2019; Forsyth, Rob J/I-9226-2012; Chater, Tim/Q-4355-2016	Forsyth, Rob/0000-0002-5657-4180; Forsyth, Rob J/0000-0002-5657-4180; Parslow, Roger/0000-0002-3945-5294; Chater, Tim/0000-0002-1138-0147; Tasker, Robert/0000-0003-3647-8113			ADELSON PD, 2003, PEDIAT CRIT CARE M S, V4, P19; Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Breiman L., 1984, CLASSIFICATION REGRE; Chambers IR, 2005, CHILD NERV SYST, V21, P195, DOI 10.1007/s00381-004-1060-x; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Dickinson K, 2000, BMJ-BRIT MED J, V320, P1308, DOI 10.1136/bmj.320.7245.1308; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; Dunham CM, 2004, J TRAUMA, V56, P482, DOI 10.1097/01.TA.0000114537.52540.95; ESPARZA J, 1985, CHILD NERV SYST, V1, P109, DOI 10.1007/BF00706691; FORSYTH RJ, 2006, ROUTINE INTRACRANIAL; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Lannoo E, 1998, INTENS CARE MED, V24, P236, DOI 10.1007/s001340050556; Mazzola CA, 2002, CRIT CARE MED, V30, pS393, DOI 10.1097/00003246-200211001-00003; Miller MT, 2004, J TRAUMA, V56, P967, DOI 10.1097/01.TA.0000123699.16465.8B; Morris KP, 2006, INTENS CARE MED, V32, P1606, DOI 10.1007/s00134-006-0285-4; *MRC, 1998, NEUR AC BRAIN INJ TR; Murray GD, 2000, BRIT MED J, V321, P1223, DOI 10.1136/bmj.321.7270.1223; Murray GD, 2005, J NEUROTRAUM, V22, P511, DOI 10.1089/neu.2005.22.511; *OFF NAT STAT, 2004, SERIES DH3; Office for National Statistics, 2002, SERIES DH3, V35; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; PFENNINGER J, 1983, INTENS CARE MED, V9, P13, DOI 10.1007/BF01693699; Reinert MM, 1999, NEUROL RES, V21, P330, DOI 10.1080/01616412.1999.11740940; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; Sackett DL, 2000, CAN MED ASSOC J, V162, P1311; Segal S, 2001, INTENS CARE MED, V27, P236, DOI 10.1007/s001340000717; Segui-Gomez M, 2003, EPIDEMIOL REV, V25, P3, DOI 10.1093/epirev/mxg007; Steinberg D, 1995, TREE STRUCTURED NONP	29	17	17	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JAN	2008	9	1					8	14		10.1097/01.PCC.0000298759.78616.3A			7	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	252QR	WOS:000252462200003	18477907				2022-02-06	
J	Izaute, M; Durozard, C; Eldigier, E; Teissedre, F; Perreve, A; Gerbaud, L				Izaute, Marie; Durozard, Carole; Eldigier, Emilie; Teissedre, Frederique; Perreve, Anne; Gerbaud, Laurent			Perceived social support and locus of control after a traumatic brain injury (TBI)	BRAIN INJURY			English	Article						locus of control; perceived social support; social rehabilitation; traumatic brain injury	CLOSED-HEAD-INJURY; PSYCHOSOCIAL ADJUSTMENT; COPING STRATEGIES; DEPRESSION; INDIVIDUALS; STRESS	Research design: The aim of the study was to investigate the social rehabilitation related to the perceived social support and the locus of control (LC) of patients with traumatic brain injury (TBI). Methods and procedures: A group of 46 patients 3-5 years after injury was evaluated. For the social rehabilitation, patients were categorized as 'high rehabilitation' or 'low rehabilitation' as regards vocational rehabilitation. Low rehabilitation patients should confirm the idea of an external locus of control more than high rehabilitation patients. Main outcomes and results: As far as perceived social support is concerned, both groups reported a poor level of social support, although the patients considered as high rehabilitation exhibited greater satisfaction in terms of social support. When one considers LC, patients with TBI were associated with a weaker internal LC than non-patients with TBI. In patients exhibiting a high level of rehabilitation, the LC was less frequently attributed to 'chance' or 'powerful others'. Patients with a low level of rehabilitation explained their difficulties in terms of external factors. Conclusions: It is therefore necessary to take rehabilitation, perceived high-quality social support and low external LC into account if one is to improve the rehabilitation of TBI patients.	[Izaute, Marie; Durozard, Carole; Eldigier, Emilie; Teissedre, Frederique] Univ Blaise Pascal, CNRS, UMR 6024, LAPSCO, F-63037 Clermont Ferrand, France; [Perreve, Anne; Gerbaud, Laurent] Univ Auvergne, SSIU, Clermont Ferrand, France		Izaute, M (corresponding author), Univ Blaise Pascal, CNRS, UMR 6024, LAPSCO, 34 Ave Carnot, F-63037 Clermont Ferrand, France.	marie.izaute@univ-bpclermont.fr					Bamdad MJ, 2003, BRAIN INJURY, V17, P1011, DOI 10.1080/0269905031000110553; Bechtold KT, 2000, ARCH CLIN NEUROPSYCH, V15, P810, DOI 10.1016/S0887-6177(00)80291-7; Bruchon-Schweitzer M., 2003, PSYCHOL FR, V48, P41; BRUCHONSCHWEITZ.M, 2002, PSYCHOL SANTE MODELE, P43; Charles N, 2007, NEUROREHABILITATION, V22, P61; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; DICKMEN S, 1993, ARCH PHYS MED REHAB, V84, P1449; Eisenberg, 1987, NEUROBEHAVIORAL RECO, P215; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Gollaher K, 1998, BRAIN INJURY, V12, P255, DOI 10.1080/026990598122557; Junque C, 1997, BRAIN INJURY, V11, P251, DOI 10.1080/026990597123557; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; Kendall E, 2003, J VOCAT REHABIL, V19, P31; KESSLER RC, 1992, SER CLIN C, P259; Kinsella GJ, 1998, NEUROPSYCHOL REHABIL, V8, P351, DOI 10.1080/713755576; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Lazarus RS, 2000, AM PSYCHOL, V55, P665, DOI 10.1037//0003-066X.55.6.665; LEACH LR, 1994, BRAIN INJURY, V8, P599, DOI 10.3109/02699059409151012; LEVENSON H, 1972, 80TH P ANN CONV AM P, V7, P259; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; Millet P, 2003, J VOCATIONAL REHABIL, V19, P59; MOORE A D, 1992, Brain Injury, V6, P89, DOI 10.3109/02699059209008129; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Pelletier PM, 2000, BRAIN COGNITION, V44, P45; Rutterford NA, 2006, J INT NEUROPSYCH SOC, V12, P359, DOI 10.1017/S1355617706060450; SARASON IG, 1987, J SOC PERS RELAT, V4, P497, DOI 10.1177/0265407587044007; Seligman M., 1975, HELPLESSNESS; Shaw L, 2002, DISABIL REHABIL, V24, P185, DOI 10.1080/09638280110066299; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; SykesHorn W, 1997, ARCH PHYS MED REHAB, V78, P1327, DOI 10.1016/S0003-9993(97)90305-1; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Tomberg T, 2007, BRAIN INJURY, V21, P479, DOI 10.1080/02699050701311737; Tomberg T, 2005, BRAIN INJURY, V19, P1181, DOI 10.1080/02699050500150153; Vogenthaler D R, 1989, Brain Inj, V3, P369, DOI 10.3109/02699058909004561; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104; [No title captured]; [No title captured]	42	17	17	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2008	22	10					758	764		10.1080/02699050802366002			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	347MJ	WOS:000259145400005	18787985				2022-02-06	
J	Riganello, F; Quintieri, M; Candelieri, A; Conforti, D; Dolce, G				Riganello, F.; Quintieri, M.; Candelieri, A.; Conforti, D.; Dolce, G.			Heart Rate Response to Music An Artificial Intelligence Study on Healthy and Traumatic Brain-Injured Subjects	JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						heart rate variability; emotional response to music; data mining procedures; traumatic brain injured patients; healthy controls	POSTTRAUMATIC-STRESS-DISORDER; POWER SPECTRUM ANALYSIS; RATE-VARIABILITY; VEGETATIVE STATE; CONSCIOUSNESS; PREDICTION; TREE; HRV; CLASSIFICATION; SCHIZOPHRENIA	Background and rationale: Investigation of the brain's emotional response to music is limited by methodological problems mainly related to the characterization of the emotions and concomitant brain conditions. In this study, artificial intelligence procedures were applied to identify significant music-induced changes in heart rate variability and to classify autonomic reactions to stimuli requiring complex brain operations. Both healthy subjects and traumatic brain-injury (TBI) patients were studied in order to test the method's validity. Methods: 16 TBI patents and 26 healthy subjects were requested to listen to selected music samples while the heart beat was continuously recorded. The parametric and nonparametric frequency spectra were computed on the heart rate and the spectra descriptors were entered into a 1-R rules (very simple classification rules) data-mining procedure. Data-mining procedures independently classified the heart-rate spectral patterns and the emotions reported by subjects as positive, indifferent, or negative. Results and conclusions: The data-mining procedures sorted the nu_LF descriptor as the spectral parameter that allowed clustering the emotions reported by the subjects as positive and negative. Classification by nu_LF was comparable to that by self-reported emotions, with an overall correct classification by author in 76.0% of controls and 70% of patients. The identification of negative and positive emotions was correct in 81.3% and 68.9% of controls and in 65% and 74% of TBI patients, without significant differences between healthy subjects and TBI patients. This observation suggests that autonomic concomitants of emotions are detectable in response to complex emotional stimuli.	[Riganello, F.; Quintieri, M.; Dolce, G.] S Anna Inst, Intens Care Unit, I-88900 Crotone, Italy; [Riganello, F.; Quintieri, M.; Dolce, G.] RAN, Crotone, Italy; [Candelieri, A.; Conforti, D.] Univ Calabria, Lab Decis Making Clin Serv, Dept Elect Informat & Systemist, I-87036 Cosenza, Italy		Riganello, F (corresponding author), S Anna Inst, Intens Care Unit, Via Siris 11, I-88900 Crotone, Italy.	francescoriganello@alice.it; giulianodolce@libero.it	Riganello, Francesco/AAC-3976-2020; Riganello, Francesco/N-2615-2014; /AAI-7627-2021; Campailla, Jasmin/AAK-2420-2021; Conforti, Domenico/D-2734-2011	Riganello, Francesco/0000-0003-0678-9252; Riganello, Francesco/0000-0003-0678-9252; /0000-0003-1431-576X; Conforti, Domenico/0000-0002-4816-4333	University of Calabria; Italian Ministry of University and Research (2004-2007)Ministry of Education, Universities and Research (MIUR)	This research has been supported by the S. Anna Institute, Crotone, and the University of Calabria under the special project "MIMERICA," funded by the Italian Ministry of University and Research (2004-2007). Thanks are due to Professors Leon Sazbon, MD, (the University of Tel Aviv, Israel) and Walter G. Sannita, MD (University of Genova, Genova, Italy, and State University of New York, Stony Brook, NY, USA) for their continuing support and valuable advice.	Allerdings MD, 2006, BRAIN COGNITION, V60, P193, DOI 10.1016/j.bandc.2004.09.018; Aoki K, 2001, AM J PHYSIOL-REG I, V281, pR591, DOI 10.1152/ajpregu.2001.281.2.R591; APPELHANS BM, 2007, BIOL PSYCHOL, V12; Appelhans BM, 2006, REV GEN PSYCHOL, V10, P229, DOI 10.1037/1089-2680.10.3.229; AYSIN B, 2007, IEEE ENG MED BIOL SO, V22, P5047; Aysin B, 2006, 2006 28TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-15, P1726; Barbieri R, 2002, AM J PHYSIOL-REG I, V283, pR1210, DOI 10.1152/ajpregu.00127.2002; Beda A, 2007, PSYCHOPHYSIOLOGY, V44, P767, DOI 10.1111/j.1469-8986.2007.00542.x; Braga ANG, 2002, AM J PHYSIOL-REG I, V282, pR1663, DOI 10.1152/ajpregu.00583.2001; Briswas A. K., 2000, CRITICAL CARE MED, V28, P3907; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Brown S, 2004, NEUROREPORT, V15, P2033, DOI 10.1097/00001756-200409150-00008; Camm AJ, 1996, CIRCULATION, V93, P1043; Chambers AS, 2002, PSYCHOPHYSIOLOGY, V39, P861, DOI 10.1111/1469-8986.3960861; Cohen H, 1998, BIOL PSYCHIAT, V44, P1054, DOI 10.1016/S0006-3223(97)00475-7; Cohen H, 2000, PSYCHIAT RES, V96, P1, DOI 10.1016/S0165-1781(00)00195-5; Cohen H, 2006, AUTON NEUROSCI-BASIC, V128, P1, DOI 10.1016/j.autneu.2005.06.007; Coleman MR, 2007, BRAIN, V130, P2494, DOI 10.1093/brain/awm170; Critchley HD, 2005, NEUROIMAGE, V24, P751, DOI 10.1016/j.neuroimage.2004.10.013; CRITCHLEY R, 1977, MUSIC BRAIN; Dolce G, 2008, BRAIN INJURY, V22, P617, DOI 10.1080/02699050802132503; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Eibe F., 2004, MACHINE LEARNING WEK; Fitch WT, 2005, ANN NY ACAD SCI, V1060, P29, DOI 10.1196/annals.1360.004; Frazier TW, 2004, PSYCHOPHYSIOLOGY, V41, P75, DOI 10.1046/j.1469-8986.2003.00131.x; Gehi A, 2005, ARCH GEN PSYCHIAT, V62, P661, DOI 10.1001/archpsyc.62.6.661; Hagen C., 1972, LEVELS COGNITIVE FUN; Hansson-Sandsten M, 2007, IEEE T BIO-MED ENG, V54, P1770, DOI 10.1109/TBME.2007.904527; Hildebrandt H, 2007, J NEUROL SCI, V260, P150, DOI 10.1016/j.jns.2007.04.035; HOLTE RC, 1993, MACH LEARN, V11, P63, DOI 10.1023/A:1022631118932; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Imberty M., 1997, PERCEPTION COGNITION, P429; IMBERTY M, 1979, ENTENDRE MUSIQUE SEM, V1; Imberty M., 1976, SIGNIFICATION MEANIN; Imberty Michel, 1981, ECRITURES TEMPS SEMA, V2; Janata P, 2002, SCIENCE, V298, P2167, DOI 10.1126/science.1076262; Jentschke S, 2005, ANN NY ACAD SCI, V1060, P231, DOI 10.1196/annals.1360.016; JOHN ER, LANCET IN PRESS; Kamber, 2006, DATA MINING CONCEPTS; Keren O, 2005, BRAIN INJURY, V19, P605, DOI 10.1080/02699050400024946; King ML, 1997, BRAIN INJURY, V11, P445; Koelsch S, 2006, HUM BRAIN MAPP, V27, P239, DOI 10.1002/hbm.20180; Kohavi R., P 14 INT JOINT C ART, P1137; Kotani K, 2007, METHOD INFORM MED, V46, P376, DOI 10.1160/ME0352; LAFRANCHI PA, 2003, AM J PHYSIOL-REG I, V283, pR815; Laureys S, 2004, NEUROLOGY, V63, P916, DOI 10.1212/01.WNL.0000137421.30792.9B; Laureys S, 2007, CONSCIOUS COGN, V16, P722, DOI 10.1016/j.concog.2007.04.004; LeDoux J.E., 1996, EMOTIONAL BRAIN; Lehrer PM, 2003, PSYCHOSOM MED, V65, P796, DOI 10.1097/01.PSY.0000089200.81962.19; Lippert-Gruner M, 2006, BRAIN INJURY, V20, P569, DOI 10.1080/02699050600664467; Luecken LJ, 2005, PSYCHOSOM MED, V67, P514, DOI 10.1097/01.psy.0000160466.10397.18; Malpas SC, 2002, AM J PHYSIOL-HEART C, V282, pH6, DOI 10.1152/ajpheart.2002.282.1.H6; Mandal MK, 1998, SCHIZOPHRENIA BULL, V24, P399, DOI 10.1093/oxfordjournals.schbul.a033335; Mashin V., 2000, HUMAN PHYSL, V26, P420, DOI DOI 10.1007/BF02760270; Morita I, 2007, ACTA NEUROCHIR SUPPL, V97, P455; Neuhaus C, 2008, NEUROSCI LETT, V441, P11, DOI 10.1016/j.neulet.2008.05.101; Nikki S.R., 2004, PSYCHOL MUSIC, V32, P371; Niskanen JP, 2004, COMPUT METH PROG BIO, V76, P73, DOI 10.1016/j.cmpb.2004.03.004; Owen AM, 2007, ARCH NEUROL-CHICAGO, V64, P1098, DOI 10.1001/archneur.64.8.1098; Pang BC, 2007, J NEUROTRAUM, V24, P136, DOI 10.1089/neu.2006.0113; Parker RS, 1996, BRAIN INJURY, V10, P287, DOI 10.1080/026990596124467; Parncutt Richard, 2006, CHILD MUSICIAN HDB M, P1, DOI [10.1093/acprof:oso/9780198530329.003.0001, DOI 10.1093/ACPROF:OSO/9780198530329.003.0001]; Peretz I, 1998, COGNITION, V68, P111, DOI 10.1016/S0010-0277(98)00043-2; Perrin F, 2006, ARCH NEUROL-CHICAGO, V63, P562, DOI 10.1001/archneur.63.4.562; Plutchik Robert, 1994, PSYCHOL BIOL EMOTION; Qiu J, 2007, LANCET NEUROL, V6, P946, DOI 10.1016/S1474-4422(07)70255-7; REITERO N, 2002, AM J PHYSIOL-REG I, V283, pR1327; Rovlias A, 2004, J NEUROTRAUM, V21, P886, DOI 10.1089/0897715041526249; RUIZ MH, 2008, HUMAN BRAIN MAPPING, V20; Sannita WG, 2006, CLIN NEUROPHYSIOL, V117, P2569, DOI 10.1016/j.clinph.2006.04.026; Scholten MRM, 2006, J PSYCHIAT RES, V40, P638, DOI 10.1016/j.jpsychires.2006.03.005; SUDA M, 2008, NEUROLOGICAL RES, V15; Tarasti E., 1994, THEORY MUSICAL SEMIO; Thaut MH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002312; Trainor L, 2008, NATURE, V453, P598, DOI 10.1038/453598a; Urakawa K, 2005, TOHOKU J EXP MED, V206, P213, DOI 10.1620/tjem.206.213; Valkonen-Korhonen M, 2003, PSYCHOPHYSIOLOGY, V40, P716, DOI 10.1111/1469-8986.00072; VANBEMMEL JH, 1997, HDB MED INFORM; Wijnen VJM, 2006, CLIN NEUROPHYSIOL, V117, P1794, DOI 10.1016/j.clinph.2006.03.006; Witten I., 2005, DATA MINING PRACTICA, Vsecond; Yap L, 2008, CLIN MED, V8, P229, DOI 10.7861/clinmedicine.8-2-229b; Yien HW, 1997, CRIT CARE MED, V25, P258, DOI 10.1097/00003246-199702000-00011	82	17	17	1	13	HOGREFE PUBLISHING CORP	BOSTON	361 NEWBURY ST, 5 FL, BOSTON, MA, UNITED STATES	0269-8803	2151-2124		J PSYCHOPHYSIOL	J. Psychophysiol.		2008	22	4					166	174		10.1027/0269-8803.22.4.166			9	Psychology, Biological; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	468TC	WOS:000267843500002					2022-02-06	
J	Ventsel, G; Kolk, A; Talvik, I; Vali, M; Vaikmaa, M; Talvik, T				Ventsel, Gerli; Kolk, Anneli; Talvik, Inga; Vaeli, Marika; Vaikmaa, Maarja; Talvik, Tiina			The incidence of childhood traumatic brain injury in Tartu and Tartu County in Estonia	NEUROEPIDEMIOLOGY			English	Article						traumatic brain injury, structure; traumatic brain injury, children; traumatic brain injury, incidence, etiology	MILD HEAD-INJURY; YOUNG-CHILDREN; RECOVERY; OUTCOMES	Background: Traumatic brain injury (TBI) is a major health problem in childhood. Estonia and other Baltic states have the highest trauma-related mortality in the European Union. There are no data on the incidence and causes of TBI for children in Estonia. The aim of this study was to estimate the incidence, structure and main causes of TBI in Tartu and Tartu County. Methods: The study was carried out at Tartu University Hospital, between January 1, 2001, and December 31, 2005. For inclusion in the study the following criteria had to be fulfilled: age 0-14 years, documented brain trauma and neurological symptoms and residency in Tartu or Tartu County. Over the study period the inclusion criteria were fulfilled in 478 cases [272 boys (57%) and 206 girls (43%)]. Results: The incidence of TBI in childhood in Tartu and Tartu County was 369: 100,000 (405: 100,000 for boys, 330: 100,000 for girls). The incidence was highest among children from 0 to 4 years of age - 566: 100,000. The main cause of TBI in all age groups was falling - 63.6%. According to severity, 82% of the cases were mild and 18% were moderate and severe. Conclusions: There is an urgent need for governmental prevention programs for TBI in children in Estonia. Copyright (c) 2008 S. Karger AG, Basel.	[Kolk, Anneli; Talvik, Inga; Talvik, Tiina] Univ Tartu Hosp, Childrens Clin, Dept Paediat Neurol, EE-51014 Tartu, Estonia; [Ventsel, Gerli; Kolk, Anneli; Talvik, Inga; Talvik, Tiina] Childrens Clin, Tartu, Estonia; [Vaeli, Marika] Dept Pathol Anat & Forens Med, Tartu, Estonia; [Vaikmaa, Maarja] Univ Tartu, EE-50090 Tartu, Estonia		Talvik, T (corresponding author), Univ Tartu Hosp, Childrens Clin, Dept Paediat Neurol, Lunini 6, EE-51014 Tartu, Estonia.	Tiina.Talvik@kliinikum.ee					Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; BARKER RA, 2004, A Z NEUROLOGICAL PRA, P860; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Catroppa C, 2005, J INT NEUROPSYCH SOC, V11, P84, DOI 10.1017/S1355617705050101; Catroppa C, 2004, BRAIN LANG, V88, P68, DOI 10.1016/S0093-934X(03)00159-7; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Ganesalingam K, 2006, J INT NEUROPSYCH SOC, V12, P609, DOI 10.1017/S1355617706060796; Hanten G, 2004, ANN NEUROL, V56, P847, DOI 10.1002/ana.20298; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Korinthenberg R, 2004, BRAIN DEV-JPN, V26, P113, DOI 10.1016/S0387-7604(03)00110-4; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Makaroff KL, 2003, DEV MED CHILD NEUROL, V45, P497, DOI 10.1017/S0012162203000926; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; *MIN SOC AFF, 1995, INT CLASS DIS REL HL; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Talvik I, 2006, ACTA PAEDIATR, V95, P799, DOI 10.1080/08035250500464923; VINCENTEN J, 2004, EUR CHILD SAFETY ALI	18	17	17	1	5	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0251-5350	1423-0208		NEUROEPIDEMIOLOGY	Neuroepidemiology		2008	30	1					20	24		10.1159/000113302			5	Public, Environmental & Occupational Health; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Neurosciences & Neurology	263WL	WOS:000253247100005	18204293				2022-02-06	
J	Yasseen, B; Colantonio, A; Ratcliff, G				Yasseen, Baseer; Colantonio, Angela; Ratcliff, Graham			Prescription medication use in persons many years following traumatic brain injury	BRAIN INJURY			English	Article						traumatic brain injury; medication; medical management; therapy	NEUROPATHIC PAIN; UNITED-STATES; EPIDEMIOLOGY; PERSPECTIVE; ADULTS	Background: This research study examined the prevalence of prescription medication use in persons many years following moderate-to-severe traumatic brain injury (TBI). Design: Retrospective cohort study. Setting and subjects: Consecutive records were examined of persons with moderate-to-severe TBI who were discharged from a large rehabilitation hospital in Pennsylvania from 1973-1989. Consenting participants (n = 306) were interviewed, who were traced up to 24 years post-injury. Data on current use of prescription medications, in addition to demographic characteristics and health conditions were collected from the participants. Results: The prevalence of prescription medication was 58.9% in the sample, greater in females (65.6%) than in males (56.1%). The most prescribed medication types were anti-convulsants (25.8%) followed by anti-depressants (8.2%), painkillers (8.2%) and anti-anxiety medications (5.9%). On average, persons with TBI were prescribed 2.64 (SD = 2.14) medications with a range of 1-12. Conclusion: The research findings indicate a high prevalence of prescription medications in persons with past history of TBI. There is also a high prevalence of anti-convulsants medication use.	[Colantonio, Angela] Univ Toronto, Dept Occupat Therapy, Fac Med, Toronto, ON M5G 1V7, Canada; [Yasseen, Baseer] Univ Toronto, Fac Pharm, Toronto, ON M5G 1V7, Canada; [Colantonio, Angela] Toronto Rehabil Inst, Toronto, ON, Canada; [Ratcliff, Graham] Clin Neuropsychol Serv, Pittsburgh, PA USA		Colantonio, A (corresponding author), Univ Toronto, Dept Occupat Therapy, Fac Med, 500 Univ Ave,Room 950, Toronto, ON M5G 1V7, Canada.	angela.colantonio@utoronto.ca		Colantonio, Angela/0000-0003-2094-4765	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS34740-2]; NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [F33 AGO5856-01A1]; Toronto Rehabilitation InstituteUniversity of Toronto; Toronto Rehabilitation Institute Foundation; Ontario Ministry of Health and Long term CareMinistry of Health and Long-Term Care, Ontario; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS034740] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [F33AG005856] Funding Source: NIH RePORTER	This project was supported by NINDS (NS34740-2) and NIA (F33 AGO5856-01A1), Toronto Rehabilitation Institute, Toronto Rehabilitation Institute Foundation and the Ontario Work Study Program. The Toronto Rehabilitation Institute receives funding from the Ontario Ministry of Health and Long term Care. We are truly grateful to our study participants and staff who made this research possible.	AMAN MG, 1994, J DEV PHYS DISABIL, V6, P87; Colantonio A, 2004, INT J REHABIL RES, V27, P209, DOI 10.1097/00004356-200409000-00006; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; DASTUR DK, 1987, EPILEPSIA, V28, P147, DOI 10.1111/j.1528-1157.1987.tb03641.x; Devitt R, 2006, DISABIL REHABIL, V28, P547, DOI 10.1080/00222930500219258; Francisco GE, 2007, BRAIN INJURY, V21, P1007, DOI 10.1080/02699050701559558; Hall GC, 2006, PAIN, V122, P156, DOI 10.1016/j.pain.2006.01.030; Jensen TS, 2002, EUR J PAIN, V6, P61, DOI 10.1053/eujp.2001.0324; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; LADER MH, 1984, PSYCHOL MED, V14, P203, DOI 10.1017/S0033291700003214; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Savica R, 2007, EUR J NEUROL, V14, P1317, DOI 10.1111/j.1468-1331.2007.01970.x; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; TRIMBLE MR, 1985, CLIN NEUROPHARMACOL, V8, P211, DOI 10.1097/00002826-198509000-00002; *US DEP HHS, 2005, CHARTB TRENDS HLTH A; Vespa PM, 2000, CNS DRUGS, V13, P129, DOI 10.2165/00023210-200013020-00006; Vogenthaler D R, 1989, Brain Inj, V3, P369, DOI 10.3109/02699058909004561; 1999, INT CLASSIFICATION D	20	17	18	0	3	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2008	22	10					752	757		10.1080/02699050802320132			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	347MJ	WOS:000259145400004	18787984				2022-02-06	
J	Shein, NA; Doron, H; Horowitz, M; Trembovler, V; Alexandrovich, AG; Shohami, E				Shein, Na'ama A.; Doron, Hanny; Horowitz, Michal; Trembovler, Victoria; Alexandrovich, Alexander G.; Shohami, Esther			Altered cytokine expression and sustained hypothermia following traumatic brain injury in heat acclimated mice	BRAIN RESEARCH			English	Article						closed head injury; inflammation; neuroprotection	CENTRAL-NERVOUS-SYSTEM; NECROSIS-FACTOR-ALPHA; SPINAL-CORD-INJURY; POSTTRAUMATIC HYPOTHERMIA; THERAPEUTIC HYPOTHERMIA; INFLAMMATORY RESPONSE; TNF-ALPHA; ACTIVATED MICROGLIA; GENE-EXPRESSION; CROSS-TOLERANCE	Long-term exposure to moderate ambient heat (heat acclimation, HA, 30 days at 34 +/- 1 degrees C) provides protection toward a variety of stressors including traumatic brain injury. As previous studies suggested an anti-inflammatory effect of HA and given the ability of augmented pre-injury anti-inflammatory cytokine expression to harbor neuroprotection and to attenuate early post-injury expression of pro-inflammatory mediators, we hypothesized that HA-induced neuroprotection may involve enhanced pre-injury expression of anti-inflammatory mediators or a reduction in post-injury TNF alpha (TNF alpha) expression. Since the attenuation of inflammatory-associated entities has also been linked to mild hypothermia, an established neuroprotective paradigm, the effect of HA on post-injury body temperature was also studied. HA mice and normothermic (NT) counterparts were examined using a closed head injury model. Cytokines were measured within the ipsilateral cortex. Pre-injury protein levels of anti-inflammatory interleukins 10 and 4 (IL-10, IL-4) were quantified by enzyme-linked immunosorbent assays (ELISA). mRNA and protein levels of TNF alpha were quantified during the initial 2 h post-injury using semi-quantitative and real-time polymerase chain reaction (sqRT-PCR and qRT-PCR) or ELISA, respectively. Rectal temperatures were measured. HA induced augmented pre-injury IL-10 expression and a post-injury reduction in TNF alpha mRNA levels, as well as altered expression dynamics of TNF alpha protein. TNF alpha protein levels decreased relative to the sham state in HA mice only; HA mice displayed sustained post-injury hypothermia, namely significantly lower body temperature at 4 h post-injury. Given the evidence on the neuroprotective nature of hypothermia and anti-inflammatory cytokines, we suggest that these changes may contribute to PIA-induced neuroprotection. (C) 2007 Elsevier B.V. All rights reserved.	[Shein, Na'ama A.; Doron, Hanny; Horowitz, Michal] Hebrew Univ Jerusalem, Fac Med Dent, Environm Physiol Lab, Dept Physiol, IL-91120 Jerusalem, Israel; [Shein, Na'ama A.; Doron, Hanny; Trembovler, Victoria; Alexandrovich, Alexander G.; Shohami, Esther] Hebrew Univ Jerusalem, Dept Pharmacol, IL-91120 Jerusalem, Israel		Shohami, E (corresponding author), Hebrew Univ Jerusalem, Fac Med Dent, Environm Physiol Lab, Dept Physiol, IL-91120 Jerusalem, Israel.	horowitz@cc.huji.ac.il; esty@cc.huji.ac.il					Arieli Y, 2003, BRAIN RES, V962, P15, DOI 10.1016/S0006-8993(02)03681-8; Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; BeitYannai E, 1997, J CEREBR BLOOD F MET, V17, P273, DOI 10.1097/00004647-199703000-00004; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Bethea JR, 1999, J NEUROTRAUM, V16, P851, DOI 10.1089/neu.1999.16.851; Bethea JR, 2002, CURR OPIN NEUROL, V15, P355, DOI 10.1097/00019052-200206000-00021; Bettelli E, 1998, J IMMUNOL, V161, P3299; CHAO CC, 1993, J IMMUNOL, V151, P1473; Chatzipanteli K, 2000, J NEUROTRAUM, V17, P321, DOI 10.1089/neu.2000.17.321; Chatzipanteli K, 2000, J CEREBR BLOOD F MET, V20, P531, DOI 10.1097/00004647-200003000-00012; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Dietrich WD, 2007, PROG BRAIN RES, V162, P201, DOI 10.1016/S0079-6123(06)62011-6; Dietrich WD, 1999, EXP NEUROL, V158, P444, DOI 10.1006/exnr.1999.7115; DIETRICH WD, 1992, J NEUROTRAUM, V9, pS475; Feuerstein GZ, 1997, ANN NY ACAD SCI, V825, P179, DOI 10.1111/j.1749-6632.1997.tb48428.x; Frenkel D, 2003, J IMMUNOL, V171, P6549, DOI 10.4049/jimmunol.171.12.6549; GIULIAN D, 1993, J NEUROSCI RES, V36, P681, DOI 10.1002/jnr.490360609; Giulian D, 1996, NEUROCHEM INT, V29, P65, DOI 10.1016/0197-0186(95)00140-9; GIULIAN D, 1993, STROKE, V24, pI84; Hensler T, 2000, INFLAMM RES, V49, P524, DOI 10.1007/s000110050626; Horowitz M, 2003, NEWS PHYSIOL SCI, V18, P215, DOI 10.1152/nips.01453.2003; Horowitz M, 2004, J APPL PHYSIOL, V97, P1496, DOI 10.1152/japplphysiol.00306.2004; Horowitz M, 2002, COMP BIOCHEM PHYS A, V131, P475, DOI 10.1016/S1095-6433(01)00500-1; Horowitz M, 1998, NEWS PHYSIOL SCI, V13, P218; Ishikawa M, 1999, STROKE, V30, P1679, DOI 10.1161/01.STR.30.8.1679; Ishikawa T, 1999, CELL MOL NEUROBIOL, V19, P199, DOI 10.1023/A:1005401926320; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; Lotocki G, 2006, EUR J NEUROSCI, V24, P2283, DOI 10.1111/j.1460-9568.2006.05123.x; Maloyan A, 2005, PHYSIOL GENOMICS, V23, P79, DOI 10.1152/physiolgenomics.00279.2004; Maloyan A, 1999, AM J PHYSIOL-REG I, V276, pR1506, DOI 10.1152/ajpregu.1999.276.5.R1506; Matsushita Y, 2001, CRIT CARE MED, V29, P2060, DOI 10.1097/00003246-200111000-00004; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; SAIA RS, IN PRESS SHOCK  0705; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Schwab M, 1998, ACTA NEUROBIOL EXP, V58, P29; Schwimmer H, 2004, MOL BRAIN RES, V130, P95, DOI 10.1016/j.molbrainres.2004.07.011; Schwimmer H, 2006, J APPL PHYSIOL, V100, P1992, DOI 10.1152/japplphysiol.00850.2005; Shein NA, 2005, J CEREBR BLOOD F MET, V25, P1456, DOI 10.1038/sj.jcbfm.9600142; SHEIN NA, IN PRESS J NEUR 0822; Shein NA, 2007, PROG BRAIN RES, V161, P353, DOI 10.1016/S0079-6123(06)61025-X; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Shohami E, 1997, J NEUROIMMUNOL, V72, P169, DOI 10.1016/S0165-5728(96)00181-6; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; SHOHAMI E, 1994, ACTA NEUROCHIR, P443; Sredni-Kenigsbuch D, 2002, INT J NEUROSCI, V112, P665, DOI 10.1080/00207450290025725; Trembovler V, 1999, J INTERF CYTOK RES, V19, P791, DOI 10.1089/107999099313640; Truettner JS, 2005, J CEREBR BLOOD F MET, V25, P1505, DOI 10.1038/sj.jcbfm.9600150; Truettner JS, 2005, MOL BRAIN RES, V138, P124, DOI 10.1016/j.molbrainres.2005.04.006; Vila N, 2003, STROKE, V34, P671, DOI 10.1161/01.STR.0000057976.53301.69; YOUSEF MK, 1975, AM J PHYSIOL, V229, P427, DOI 10.1152/ajplegacy.1975.229.2.427	54	17	18	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	DEC 14	2007	1185						313	320		10.1016/j.brainres.2007.09.024			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247FY	WOS:000252064400033	17963735				2022-02-06	
